0001090872-19-000022.txt : 20191219 0001090872-19-000022.hdr.sgml : 20191219 20191219171101 ACCESSION NUMBER: 0001090872-19-000022 CONFORMED SUBMISSION TYPE: 10-K PUBLIC DOCUMENT COUNT: 138 CONFORMED PERIOD OF REPORT: 20191031 FILED AS OF DATE: 20191219 DATE AS OF CHANGE: 20191219 FILER: COMPANY DATA: COMPANY CONFORMED NAME: AGILENT TECHNOLOGIES, INC. CENTRAL INDEX KEY: 0001090872 STANDARD INDUSTRIAL CLASSIFICATION: LABORATORY ANALYTICAL INSTRUMENTS [3826] IRS NUMBER: 770518772 STATE OF INCORPORATION: DE FISCAL YEAR END: 1031 FILING VALUES: FORM TYPE: 10-K SEC ACT: 1934 Act SEC FILE NUMBER: 001-15405 FILM NUMBER: 191296602 BUSINESS ADDRESS: STREET 1: 5301 STEVENS CREEK BLVD CITY: SANTA CLARA STATE: CA ZIP: 95051 BUSINESS PHONE: (408) 345-8886 MAIL ADDRESS: STREET 1: 5301 STEVENS CREEK BLVD, MS 1A-LC STREET 2: P.O. BOX 58059 CITY: SANTA CLARA STATE: CA ZIP: 95052-8059 FORMER COMPANY: FORMER CONFORMED NAME: AGILENT TECHNOLOGIES INC DATE OF NAME CHANGE: 19990816 FORMER COMPANY: FORMER CONFORMED NAME: HP MEASUREMENT INC DATE OF NAME CHANGE: 19990716 10-K 1 a-10312019x10k.htm 10-K Document
0.030.030.03150000005000000less than 10 percentless than 10 percent03000000132000000153000000false--10-31FY20190001090872falseLarge Accelerated FilerfalsefalseP8YP13YP3YP5Y0.5280.5960.6560.010.0120000000002000000000318000000309000000Less than 10 percentLess than 10 percentLess than 10 percent0.02680.00830.01810.00220.03250.02250.03000.02250.02660.00220.02520.00670.02680.00830.06250.04000.06000.04000.05750.04000.04250.02000.03250.02000.03250.0225000.250.600.610.250.000.310.380.000.600.400.800.800.200.200.250.000.800.200004000000000000520000003000000250000003000000300000000100000020000000.010.0112500000012500000000000.630.660.660.150.140.1525.0130.0140.013040P4Y0MP2Y6MP4Y1MP5Y0MP4Y0MP2Y6MP4Y1MP5Y0M0000 0001090872 2018-11-01 2019-10-31 0001090872 2019-04-30 0001090872 2019-12-10 0001090872 2017-11-01 2018-10-31 0001090872 2016-11-01 2017-10-31 0001090872 us-gaap:ServiceOtherMember 2017-11-01 2018-10-31 0001090872 us-gaap:ProductMember 2016-11-01 2017-10-31 0001090872 us-gaap:ServiceOtherMember 2016-11-01 2017-10-31 0001090872 us-gaap:ServiceOtherMember 2018-11-01 2019-10-31 0001090872 us-gaap:ProductMember 2017-11-01 2018-10-31 0001090872 us-gaap:ProductMember 2018-11-01 2019-10-31 0001090872 2019-10-31 0001090872 2018-10-31 0001090872 2016-10-31 0001090872 2017-10-31 0001090872 us-gaap:CommonStockMember 2016-10-31 0001090872 us-gaap:CommonStockMember 2019-10-31 0001090872 us-gaap:TreasuryStockMember 2016-11-01 2017-10-31 0001090872 us-gaap:AdditionalPaidInCapitalMember 2017-10-31 0001090872 us-gaap:CommonStockMember 2017-11-01 2018-10-31 0001090872 us-gaap:AdditionalPaidInCapitalMember 2016-11-01 2017-10-31 0001090872 us-gaap:TreasuryStockMember 2019-10-31 0001090872 us-gaap:ParentMember 2018-11-01 2019-10-31 0001090872 us-gaap:RetainedEarningsMember 2019-10-31 0001090872 us-gaap:RetainedEarningsMember 2018-11-01 2019-10-31 0001090872 us-gaap:TreasuryStockMember 2016-10-31 0001090872 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2017-10-31 0001090872 us-gaap:NoncontrollingInterestMember 2019-10-31 0001090872 us-gaap:ParentMember 2018-10-31 0001090872 us-gaap:RetainedEarningsMember 2018-10-31 0001090872 us-gaap:AdditionalPaidInCapitalMember 2017-11-01 2018-10-31 0001090872 us-gaap:TreasuryStockMember 2017-11-01 2018-10-31 0001090872 us-gaap:NoncontrollingInterestMember 2018-10-31 0001090872 us-gaap:TreasuryStockMember 2017-10-31 0001090872 us-gaap:NoncontrollingInterestMember 2016-10-31 0001090872 us-gaap:AdditionalPaidInCapitalMember 2016-10-31 0001090872 us-gaap:ParentMember 2016-11-01 2017-10-31 0001090872 us-gaap:CommonStockMember 2018-11-01 2019-10-31 0001090872 us-gaap:ParentMember 2017-11-01 2018-10-31 0001090872 us-gaap:RetainedEarningsMember 2017-11-01 2018-10-31 0001090872 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2018-11-01 2019-10-31 0001090872 us-gaap:TreasuryStockMember 2018-11-01 2019-10-31 0001090872 us-gaap:CommonStockMember 2016-11-01 2017-10-31 0001090872 us-gaap:RetainedEarningsMember 2016-11-01 2017-10-31 0001090872 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2016-10-31 0001090872 us-gaap:RetainedEarningsMember 2017-10-31 0001090872 us-gaap:AdditionalPaidInCapitalMember 2018-11-01 2019-10-31 0001090872 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2018-10-31 0001090872 us-gaap:AdditionalPaidInCapitalMember 2018-10-31 0001090872 us-gaap:CommonStockMember 2017-10-31 0001090872 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2019-10-31 0001090872 us-gaap:CommonStockMember 2018-10-31 0001090872 us-gaap:ParentMember 2019-10-31 0001090872 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2016-11-01 2017-10-31 0001090872 us-gaap:ParentMember 2016-10-31 0001090872 us-gaap:NoncontrollingInterestMember 2018-11-01 2019-10-31 0001090872 us-gaap:TreasuryStockMember 2018-10-31 0001090872 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2017-11-01 2018-10-31 0001090872 us-gaap:NoncontrollingInterestMember 2017-10-31 0001090872 us-gaap:ParentMember 2017-10-31 0001090872 us-gaap:NoncontrollingInterestMember 2016-11-01 2017-10-31 0001090872 us-gaap:AdditionalPaidInCapitalMember 2019-10-31 0001090872 us-gaap:RetainedEarningsMember 2016-10-31 0001090872 srt:MaximumMember 2018-11-01 2019-10-31 0001090872 srt:MaximumMember 2019-10-31 0001090872 srt:MinimumMember us-gaap:SoftwareDevelopmentMember 2018-11-01 2019-10-31 0001090872 a:LasergenMember 2016-03-01 2016-03-02 0001090872 srt:MaximumMember us-gaap:MachineryAndEquipmentMember 2018-11-01 2019-10-31 0001090872 srt:MinimumMember us-gaap:MachineryAndEquipmentMember 2018-11-01 2019-10-31 0001090872 a:LasergenMember 2017-11-01 2018-10-31 0001090872 srt:MinimumMember 2018-11-01 2019-10-31 0001090872 a:LasergenMember 2016-03-02 0001090872 srt:MinimumMember 2019-10-31 0001090872 srt:MaximumMember us-gaap:SoftwareDevelopmentMember 2018-11-01 2019-10-31 0001090872 a:ImpactofAdoptingNewRevenueRecognitionGuidanceMember 2018-11-01 0001090872 a:ImpactofAdoptingNewInvestmentsValuationGuidanceMember 2018-11-01 0001090872 a:ImpactofAdoptingNewIntraEntityTaxGuidanceMember 2018-11-01 0001090872 2018-11-01 0001090872 a:ImpactofAdoptingNewTaxEffectsinAOCIGuidanceMember 2018-11-01 0001090872 a:ImpactofAdoptingNewRetirementBenefitsGuidanceMember 2016-11-01 2017-10-31 0001090872 a:ImpactofAdoptingNewRetirementBenefitsGuidanceMember 2017-11-01 2018-10-31 0001090872 a:ImpactofAdoptingNewRetirementBenefitsGuidanceMember 2018-11-01 2019-10-31 0001090872 a:BioTekMember 2019-10-31 0001090872 a:BioTekMember 2018-11-01 2019-10-31 0001090872 a:BioTekMember us-gaap:DevelopedTechnologyRightsMember 2019-10-31 0001090872 a:BioTekMember us-gaap:TrademarksAndTradeNamesMember 2019-10-31 0001090872 a:BioTekMember us-gaap:CustomerRelationshipsMember 2019-10-31 0001090872 a:BioTekMember us-gaap:OrderOrProductionBacklogMember 2019-10-31 0001090872 a:BioTekMember us-gaap:OrderOrProductionBacklogMember 2018-11-01 2019-10-31 0001090872 a:BioTekMember us-gaap:TrademarksAndTradeNamesMember 2018-11-01 2019-10-31 0001090872 a:ACEABiosciencesInc.Member 2018-11-01 2019-10-31 0001090872 srt:MinimumMember a:BioTekMember us-gaap:DevelopedTechnologyRightsMember 2018-11-01 2019-10-31 0001090872 srt:MaximumMember a:BioTekMember us-gaap:DevelopedTechnologyRightsMember 2018-11-01 2019-10-31 0001090872 srt:MinimumMember a:BioTekMember us-gaap:CustomerRelationshipsMember 2018-11-01 2019-10-31 0001090872 srt:MaximumMember a:BioTekMember us-gaap:CustomerRelationshipsMember 2018-11-01 2019-10-31 0001090872 a:DiagnosticsandClinicalMarketMember 2018-11-01 2019-10-31 0001090872 a:EnvironmentalandForensicsMarketMember 2018-11-01 2019-10-31 0001090872 a:AcademiaandGovernmentMarketMember 2018-11-01 2019-10-31 0001090872 a:NonInstrumentationandOtherMember 2018-11-01 2019-10-31 0001090872 a:PharmaceuticalandBiopharmaceuticalMarketMember 2018-11-01 2019-10-31 0001090872 a:InstrumentationMember 2018-11-01 2019-10-31 0001090872 a:ChemicalandEnergyMarketMember 2018-11-01 2019-10-31 0001090872 a:FoodMarketMember 2018-11-01 2019-10-31 0001090872 srt:AmericasMember 2018-11-01 2019-10-31 0001090872 srt:AsiaPacificMember 2018-11-01 2019-10-31 0001090872 srt:EuropeMember a:LifeSciencesandAppliedMarketsMember 2018-11-01 2019-10-31 0001090872 a:LifeSciencesandAppliedMarketsMember 2018-11-01 2019-10-31 0001090872 srt:AmericasMember a:DiagnosticsAndGenomicsMember 2018-11-01 2019-10-31 0001090872 srt:AmericasMember a:AgilentCrossLabMember 2018-11-01 2019-10-31 0001090872 srt:EuropeMember a:AgilentCrossLabMember 2018-11-01 2019-10-31 0001090872 srt:AsiaPacificMember a:AgilentCrossLabMember 2018-11-01 2019-10-31 0001090872 srt:AmericasMember a:LifeSciencesandAppliedMarketsMember 2018-11-01 2019-10-31 0001090872 srt:AsiaPacificMember a:DiagnosticsAndGenomicsMember 2018-11-01 2019-10-31 0001090872 srt:AsiaPacificMember a:LifeSciencesandAppliedMarketsMember 2018-11-01 2019-10-31 0001090872 a:DiagnosticsAndGenomicsMember 2018-11-01 2019-10-31 0001090872 srt:EuropeMember 2018-11-01 2019-10-31 0001090872 a:AgilentCrossLabMember 2018-11-01 2019-10-31 0001090872 srt:EuropeMember a:DiagnosticsAndGenomicsMember 2018-11-01 2019-10-31 0001090872 us-gaap:DifferenceBetweenRevenueGuidanceInEffectBeforeAndAfterTopic606Member 2018-11-01 2018-11-01 0001090872 us-gaap:DifferenceBetweenRevenueGuidanceInEffectBeforeAndAfterTopic606Member 2019-10-31 0001090872 us-gaap:CostOfSalesMember 2018-11-01 2019-10-31 0001090872 us-gaap:SellingGeneralAndAdministrativeExpensesMember 2017-11-01 2018-10-31 0001090872 us-gaap:CostOfSalesMember 2016-11-01 2017-10-31 0001090872 us-gaap:SellingGeneralAndAdministrativeExpensesMember 2018-11-01 2019-10-31 0001090872 us-gaap:CostOfSalesMember 2017-11-01 2018-10-31 0001090872 us-gaap:ResearchAndDevelopmentExpenseMember 2016-11-01 2017-10-31 0001090872 us-gaap:ResearchAndDevelopmentExpenseMember 2017-11-01 2018-10-31 0001090872 us-gaap:SellingGeneralAndAdministrativeExpensesMember 2016-11-01 2017-10-31 0001090872 us-gaap:ResearchAndDevelopmentExpenseMember 2018-11-01 2019-10-31 0001090872 us-gaap:EmployeeStockOptionMember 2019-10-31 0001090872 us-gaap:InventoriesMember 2018-11-01 2019-10-31 0001090872 us-gaap:EmployeeStockOptionMember 2018-11-01 2019-10-31 0001090872 us-gaap:EmployeeStockMember 2019-10-31 0001090872 us-gaap:RestrictedStockUnitsRSUMember 2018-11-01 2019-10-31 0001090872 a:LTPPRSUMember 2018-11-01 2019-10-31 0001090872 a:LTPPRSUMember 2017-11-01 2018-10-31 0001090872 a:LtppMember 2016-11-01 2017-10-31 0001090872 a:LtppMember 2017-11-01 2018-10-31 0001090872 a:LtppMember 2018-11-01 2019-10-31 0001090872 a:LTPPRSUMember 2016-11-01 2017-10-31 0001090872 a:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRange03Member 2019-10-31 0001090872 a:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRange02Member 2019-10-31 0001090872 a:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRange01Member 2019-10-31 0001090872 a:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRange02Member 2018-11-01 2019-10-31 0001090872 a:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRange01Member 2018-11-01 2019-10-31 0001090872 a:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRange03Member 2018-11-01 2019-10-31 0001090872 us-gaap:InventoriesMember 2017-11-01 2018-10-31 0001090872 us-gaap:ForeignCountryMember 2019-10-31 0001090872 a:TaxInterestandPenaltiesMember 2018-11-01 2019-10-31 0001090872 a:U.S.TaxCutsandJobsActof2017Member 2017-11-01 2018-10-31 0001090872 a:TaxInterestandPenaltiesMember 2017-11-01 2018-10-31 0001090872 us-gaap:DomesticCountryMember 2019-10-31 0001090872 us-gaap:ForeignCountryMember 2018-11-01 2019-10-31 0001090872 a:TaxInterestandPenaltiesMember 2016-11-01 2017-10-31 0001090872 us-gaap:CaliforniaFranchiseTaxBoardMember 2019-10-31 0001090872 a:BioTekandACEAMember 2018-11-01 2019-10-31 0001090872 a:AdvancedAnalyticalTechnologiesIncAATIMember a:DiagnosticsAndGenomicsMember 2018-11-01 2019-10-31 0001090872 a:BioTekandACEAMember a:LifeSciencesandAppliedMarketsMember 2018-11-01 2019-10-31 0001090872 a:DiagnosticsAndGenomicsMember 2017-11-01 2018-10-31 0001090872 a:AgilentCrossLabMember 2017-11-01 2018-10-31 0001090872 a:AgilentCrossLabMember 2019-10-31 0001090872 a:LifeSciencesandAppliedMarketsMember 2017-11-01 2018-10-31 0001090872 a:LifeSciencesandAppliedMarketsMember 2017-10-31 0001090872 a:AgilentCrossLabMember 2018-10-31 0001090872 a:DiagnosticsAndGenomicsMember 2019-10-31 0001090872 a:DiagnosticsAndGenomicsMember 2018-10-31 0001090872 a:LifeSciencesandAppliedMarketsMember 2019-10-31 0001090872 a:AgilentCrossLabMember 2017-10-31 0001090872 a:LifeSciencesandAppliedMarketsMember 2018-10-31 0001090872 a:DiagnosticsAndGenomicsMember 2017-10-31 0001090872 us-gaap:OrderOrProductionBacklogMember 2019-10-31 0001090872 us-gaap:TrademarksMember 2019-10-31 0001090872 a:ThirdPartyTechnologyandLicensesMember 2018-10-31 0001090872 us-gaap:TrademarksMember 2018-10-31 0001090872 a:ThirdPartyTechnologyandLicensesMember 2019-10-31 0001090872 us-gaap:DevelopedTechnologyRightsMember 2018-10-31 0001090872 us-gaap:CustomerRelationshipsMember 2019-10-31 0001090872 us-gaap:DevelopedTechnologyRightsMember 2019-10-31 0001090872 us-gaap:CustomerRelationshipsMember 2018-10-31 0001090872 us-gaap:FairValueInputsLevel3Member us-gaap:FairValueMeasurementsRecurringMember 2019-10-31 0001090872 us-gaap:FairValueMeasurementsRecurringMember 2019-10-31 0001090872 us-gaap:FairValueInputsLevel2Member us-gaap:FairValueMeasurementsRecurringMember 2019-10-31 0001090872 us-gaap:FairValueInputsLevel1Member us-gaap:FairValueMeasurementsRecurringMember 2019-10-31 0001090872 us-gaap:FairValueInputsLevel3Member us-gaap:FairValueMeasurementsRecurringMember 2018-10-31 0001090872 us-gaap:FairValueInputsLevel1Member us-gaap:FairValueMeasurementsRecurringMember 2018-10-31 0001090872 us-gaap:FairValueMeasurementsRecurringMember 2018-10-31 0001090872 us-gaap:FairValueInputsLevel2Member us-gaap:FairValueMeasurementsRecurringMember 2018-10-31 0001090872 a:SeniorNotes2022Member us-gaap:TreasuryLockMember 2019-10-31 0001090872 a:SeniorNotes2026Member us-gaap:TreasuryLockMember us-gaap:CashFlowHedgingMember 2019-10-31 0001090872 2016-09-14 2016-09-15 0001090872 a:SeniorNotes2022Member us-gaap:TreasuryLockMember 2012-07-01 0001090872 a:SeniorNotes2020Member 2011-08-09 0001090872 2017-11-01 2018-01-31 0001090872 a:SeniorNotes2029Member us-gaap:TreasuryLockMember 2019-08-01 0001090872 a:SeniorNotes2026Member us-gaap:TreasuryLockMember us-gaap:CashFlowHedgingMember 2016-02-01 0001090872 a:SeniorNotes2029Member us-gaap:TreasuryLockMember 2019-10-31 0001090872 us-gaap:OtherCurrentAssetsMember us-gaap:ForeignExchangeContractMember us-gaap:NondesignatedMember 2019-10-31 0001090872 us-gaap:OtherCurrentAssetsMember us-gaap:ForeignExchangeContractMember us-gaap:NondesignatedMember 2018-10-31 0001090872 us-gaap:AccruedLiabilitiesMember us-gaap:ForeignExchangeContractMember us-gaap:CashFlowHedgingMember us-gaap:DesignatedAsHedgingInstrumentMember 2019-10-31 0001090872 us-gaap:OtherCurrentAssetsMember us-gaap:ForeignExchangeContractMember us-gaap:CashFlowHedgingMember us-gaap:DesignatedAsHedgingInstrumentMember 2018-10-31 0001090872 us-gaap:AccruedLiabilitiesMember us-gaap:ForeignExchangeContractMember us-gaap:NondesignatedMember 2019-10-31 0001090872 us-gaap:AccruedLiabilitiesMember us-gaap:ForeignExchangeContractMember us-gaap:CashFlowHedgingMember us-gaap:DesignatedAsHedgingInstrumentMember 2018-10-31 0001090872 us-gaap:OtherCurrentAssetsMember us-gaap:ForeignExchangeContractMember us-gaap:CashFlowHedgingMember us-gaap:DesignatedAsHedgingInstrumentMember 2019-10-31 0001090872 us-gaap:AccruedLiabilitiesMember us-gaap:ForeignExchangeContractMember us-gaap:NondesignatedMember 2018-10-31 0001090872 currency:JPY us-gaap:ForwardContractsMember us-gaap:NondesignatedMember us-gaap:ShortMember 2019-10-31 0001090872 currency:DKK us-gaap:ForwardContractsMember us-gaap:NondesignatedMember us-gaap:LongMember 2019-10-31 0001090872 currency:AUD us-gaap:ForwardContractsMember us-gaap:CashFlowHedgingMember us-gaap:DesignatedAsHedgingInstrumentMember us-gaap:LongMember 2019-10-31 0001090872 currency:KRW us-gaap:ForwardContractsMember us-gaap:CashFlowHedgingMember us-gaap:DesignatedAsHedgingInstrumentMember us-gaap:ShortMember 2019-10-31 0001090872 currency:CNY us-gaap:ForwardContractsMember us-gaap:NondesignatedMember us-gaap:ShortMember 2019-10-31 0001090872 currency:JPY us-gaap:ForwardContractsMember us-gaap:CashFlowHedgingMember us-gaap:DesignatedAsHedgingInstrumentMember us-gaap:ShortMember 2019-10-31 0001090872 us-gaap:ForwardContractsMember us-gaap:CashFlowHedgingMember us-gaap:DesignatedAsHedgingInstrumentMember us-gaap:ShortMember 2019-10-31 0001090872 currency:SEK us-gaap:ForwardContractsMember us-gaap:NondesignatedMember us-gaap:ShortMember 2019-10-31 0001090872 currency:EUR us-gaap:ForwardContractsMember us-gaap:CashFlowHedgingMember us-gaap:DesignatedAsHedgingInstrumentMember us-gaap:ShortMember 2019-10-31 0001090872 currency:KRW us-gaap:ForwardContractsMember us-gaap:NondesignatedMember us-gaap:ShortMember 2019-10-31 0001090872 currency:GBP us-gaap:ForwardContractsMember us-gaap:NondesignatedMember us-gaap:LongMember 2019-10-31 0001090872 currency:MYR us-gaap:ForwardContractsMember us-gaap:NondesignatedMember us-gaap:LongMember 2019-10-31 0001090872 us-gaap:ForwardContractsMember us-gaap:NondesignatedMember us-gaap:LongMember 2019-10-31 0001090872 currency:GBP us-gaap:ForwardContractsMember us-gaap:CashFlowHedgingMember us-gaap:DesignatedAsHedgingInstrumentMember us-gaap:ShortMember 2019-10-31 0001090872 currency:SGD us-gaap:ForwardContractsMember us-gaap:NondesignatedMember us-gaap:LongMember 2019-10-31 0001090872 currency:CHF us-gaap:ForwardContractsMember us-gaap:NondesignatedMember us-gaap:ShortMember 2019-10-31 0001090872 currency:SGD us-gaap:ForwardContractsMember us-gaap:CashFlowHedgingMember us-gaap:DesignatedAsHedgingInstrumentMember us-gaap:LongMember 2019-10-31 0001090872 currency:CAD us-gaap:ForwardContractsMember us-gaap:NondesignatedMember us-gaap:LongMember 2019-10-31 0001090872 currency:CAD us-gaap:ForwardContractsMember us-gaap:CashFlowHedgingMember us-gaap:DesignatedAsHedgingInstrumentMember us-gaap:ShortMember 2019-10-31 0001090872 currency:CNY us-gaap:ForwardContractsMember us-gaap:CashFlowHedgingMember us-gaap:DesignatedAsHedgingInstrumentMember us-gaap:ShortMember 2019-10-31 0001090872 currency:XXX us-gaap:ForwardContractsMember us-gaap:NondesignatedMember us-gaap:ShortMember 2019-10-31 0001090872 currency:EUR us-gaap:ForwardContractsMember us-gaap:NondesignatedMember us-gaap:LongMember 2019-10-31 0001090872 us-gaap:ForeignExchangeContractMember us-gaap:CashFlowHedgingMember us-gaap:DesignatedAsHedgingInstrumentMember us-gaap:CostOfSalesMember 2016-11-01 2017-10-31 0001090872 us-gaap:ForeignExchangeContractMember us-gaap:CashFlowHedgingMember us-gaap:DesignatedAsHedgingInstrumentMember us-gaap:CostOfSalesMember 2017-11-01 2018-10-31 0001090872 us-gaap:InterestRateSwapMember us-gaap:CashFlowHedgingMember us-gaap:DesignatedAsHedgingInstrumentMember us-gaap:OtherComprehensiveIncomeMember 2016-11-01 2017-10-31 0001090872 us-gaap:ForwardContractsMember us-gaap:CashFlowHedgingMember us-gaap:DesignatedAsHedgingInstrumentMember us-gaap:CostOfSalesMember 2017-11-01 2018-10-31 0001090872 us-gaap:ForeignExchangeContractMember us-gaap:CashFlowHedgingMember us-gaap:DesignatedAsHedgingInstrumentMember us-gaap:AccumulatedOtherComprehensiveIncomeMember 2017-11-01 2018-10-31 0001090872 us-gaap:NondesignatedMember us-gaap:OtherIncomeMember 2018-11-01 2019-10-31 0001090872 us-gaap:InterestRateSwapMember us-gaap:CashFlowHedgingMember us-gaap:DesignatedAsHedgingInstrumentMember us-gaap:OtherComprehensiveIncomeMember 2018-11-01 2019-10-31 0001090872 us-gaap:NondesignatedMember us-gaap:OtherIncomeMember 2016-11-01 2017-10-31 0001090872 us-gaap:InterestRateSwapMember us-gaap:CashFlowHedgingMember us-gaap:DesignatedAsHedgingInstrumentMember us-gaap:OtherComprehensiveIncomeMember 2017-11-01 2018-10-31 0001090872 us-gaap:ForeignExchangeContractMember us-gaap:CashFlowHedgingMember us-gaap:DesignatedAsHedgingInstrumentMember us-gaap:AccumulatedOtherComprehensiveIncomeMember 2018-11-01 2019-10-31 0001090872 us-gaap:ForeignExchangeContractMember us-gaap:CashFlowHedgingMember us-gaap:DesignatedAsHedgingInstrumentMember us-gaap:CostOfSalesMember 2018-11-01 2019-10-31 0001090872 us-gaap:ForwardContractsMember us-gaap:CashFlowHedgingMember us-gaap:DesignatedAsHedgingInstrumentMember us-gaap:CostOfSalesMember 2016-11-01 2017-10-31 0001090872 us-gaap:NondesignatedMember us-gaap:OtherIncomeMember 2017-11-01 2018-10-31 0001090872 us-gaap:ForwardContractsMember us-gaap:CashFlowHedgingMember us-gaap:DesignatedAsHedgingInstrumentMember us-gaap:CostOfSalesMember 2018-11-01 2019-10-31 0001090872 us-gaap:ForeignExchangeContractMember us-gaap:CashFlowHedgingMember us-gaap:DesignatedAsHedgingInstrumentMember us-gaap:AccumulatedOtherComprehensiveIncomeMember 2016-11-01 2017-10-31 0001090872 us-gaap:ForeignPlanMember us-gaap:PensionPlansDefinedBenefitMember 2018-10-31 0001090872 a:OtherPlanAssetsMember us-gaap:FairValueInputsLevel1Member us-gaap:ForeignPlanMember us-gaap:PensionPlansDefinedBenefitMember 2018-10-31 0001090872 us-gaap:CashAndCashEquivalentsMember us-gaap:FairValueInputsLevel3Member us-gaap:ForeignPlanMember us-gaap:PensionPlansDefinedBenefitMember 2018-10-31 0001090872 us-gaap:FixedIncomeSecuritiesMember us-gaap:FairValueInputsLevel2Member us-gaap:ForeignPlanMember us-gaap:PensionPlansDefinedBenefitMember 2018-10-31 0001090872 a:OtherPlanAssetsMember us-gaap:FairValueInputsLevel2Member us-gaap:ForeignPlanMember us-gaap:PensionPlansDefinedBenefitMember 2018-10-31 0001090872 us-gaap:CashAndCashEquivalentsMember us-gaap:ForeignPlanMember us-gaap:PensionPlansDefinedBenefitMember 2018-10-31 0001090872 us-gaap:EquitySecuritiesMember us-gaap:FairValueInputsLevel2Member us-gaap:ForeignPlanMember us-gaap:PensionPlansDefinedBenefitMember 2018-10-31 0001090872 us-gaap:CashAndCashEquivalentsMember us-gaap:FairValueInputsLevel1Member us-gaap:ForeignPlanMember us-gaap:PensionPlansDefinedBenefitMember 2018-10-31 0001090872 us-gaap:FixedIncomeSecuritiesMember us-gaap:FairValueInputsLevel1Member us-gaap:ForeignPlanMember us-gaap:PensionPlansDefinedBenefitMember 2018-10-31 0001090872 a:OtherPlanAssetsMember us-gaap:ForeignPlanMember us-gaap:PensionPlansDefinedBenefitMember 2018-10-31 0001090872 us-gaap:FairValueInputsLevel3Member us-gaap:ForeignPlanMember us-gaap:PensionPlansDefinedBenefitMember 2018-10-31 0001090872 us-gaap:EquitySecuritiesMember us-gaap:ForeignPlanMember us-gaap:PensionPlansDefinedBenefitMember 2018-10-31 0001090872 us-gaap:FixedIncomeSecuritiesMember us-gaap:FairValueInputsLevel3Member us-gaap:ForeignPlanMember us-gaap:PensionPlansDefinedBenefitMember 2018-10-31 0001090872 us-gaap:FixedIncomeSecuritiesMember us-gaap:ForeignPlanMember us-gaap:PensionPlansDefinedBenefitMember 2018-10-31 0001090872 us-gaap:EquitySecuritiesMember us-gaap:FairValueInputsLevel3Member us-gaap:ForeignPlanMember us-gaap:PensionPlansDefinedBenefitMember 2018-10-31 0001090872 us-gaap:FairValueInputsLevel1Member us-gaap:ForeignPlanMember us-gaap:PensionPlansDefinedBenefitMember 2018-10-31 0001090872 us-gaap:FairValueInputsLevel2Member us-gaap:ForeignPlanMember us-gaap:PensionPlansDefinedBenefitMember 2018-10-31 0001090872 us-gaap:EquitySecuritiesMember us-gaap:FairValueInputsLevel1Member us-gaap:ForeignPlanMember us-gaap:PensionPlansDefinedBenefitMember 2018-10-31 0001090872 a:OtherPlanAssetsMember us-gaap:FairValueInputsLevel3Member us-gaap:ForeignPlanMember us-gaap:PensionPlansDefinedBenefitMember 2018-10-31 0001090872 us-gaap:CashAndCashEquivalentsMember us-gaap:FairValueInputsLevel2Member us-gaap:ForeignPlanMember us-gaap:PensionPlansDefinedBenefitMember 2018-10-31 0001090872 us-gaap:CashAndCashEquivalentsMember us-gaap:FairValueInputsLevel2Member country:US us-gaap:DefinedBenefitPostretirementHealthCoverageMember 2019-10-31 0001090872 a:OtherPlanAssetsMember us-gaap:FairValueInputsLevel1Member country:US us-gaap:DefinedBenefitPostretirementHealthCoverageMember 2019-10-31 0001090872 us-gaap:FixedIncomeSecuritiesMember us-gaap:FairValueInputsLevel1Member country:US us-gaap:DefinedBenefitPostretirementHealthCoverageMember 2019-10-31 0001090872 us-gaap:CashAndCashEquivalentsMember country:US us-gaap:DefinedBenefitPostretirementHealthCoverageMember 2019-10-31 0001090872 country:US us-gaap:DefinedBenefitPostretirementHealthCoverageMember 2019-10-31 0001090872 us-gaap:EquitySecuritiesMember us-gaap:FairValueInputsLevel2Member country:US us-gaap:DefinedBenefitPostretirementHealthCoverageMember 2019-10-31 0001090872 us-gaap:FixedIncomeSecuritiesMember us-gaap:FairValueInputsLevel2Member country:US us-gaap:DefinedBenefitPostretirementHealthCoverageMember 2019-10-31 0001090872 us-gaap:CashAndCashEquivalentsMember us-gaap:FairValueInputsLevel3Member country:US us-gaap:DefinedBenefitPostretirementHealthCoverageMember 2019-10-31 0001090872 a:OtherPlanAssetsMember country:US us-gaap:DefinedBenefitPostretirementHealthCoverageMember 2019-10-31 0001090872 a:OtherPlanAssetsMember us-gaap:FairValueInputsLevel3Member country:US us-gaap:DefinedBenefitPostretirementHealthCoverageMember 2019-10-31 0001090872 us-gaap:FixedIncomeSecuritiesMember country:US us-gaap:DefinedBenefitPostretirementHealthCoverageMember 2019-10-31 0001090872 us-gaap:FairValueInputsLevel2Member country:US us-gaap:DefinedBenefitPostretirementHealthCoverageMember 2019-10-31 0001090872 us-gaap:FairValueInputsLevel3Member country:US us-gaap:DefinedBenefitPostretirementHealthCoverageMember 2019-10-31 0001090872 a:OtherPlanAssetsMember us-gaap:FairValueInputsLevel2Member country:US us-gaap:DefinedBenefitPostretirementHealthCoverageMember 2019-10-31 0001090872 us-gaap:FairValueInputsLevel1Member country:US us-gaap:DefinedBenefitPostretirementHealthCoverageMember 2019-10-31 0001090872 us-gaap:EquitySecuritiesMember us-gaap:FairValueInputsLevel3Member country:US us-gaap:DefinedBenefitPostretirementHealthCoverageMember 2019-10-31 0001090872 us-gaap:EquitySecuritiesMember us-gaap:FairValueInputsLevel1Member country:US us-gaap:DefinedBenefitPostretirementHealthCoverageMember 2019-10-31 0001090872 us-gaap:EquitySecuritiesMember country:US us-gaap:DefinedBenefitPostretirementHealthCoverageMember 2019-10-31 0001090872 us-gaap:CashAndCashEquivalentsMember us-gaap:FairValueInputsLevel1Member country:US us-gaap:DefinedBenefitPostretirementHealthCoverageMember 2019-10-31 0001090872 us-gaap:FixedIncomeSecuritiesMember us-gaap:FairValueInputsLevel3Member country:US us-gaap:DefinedBenefitPostretirementHealthCoverageMember 2019-10-31 0001090872 country:US us-gaap:DefinedBenefitPostretirementHealthCoverageMember 2016-11-01 2017-10-31 0001090872 us-gaap:ForeignPlanMember us-gaap:PensionPlansDefinedBenefitMember 2017-11-01 2018-10-31 0001090872 country:US us-gaap:PensionPlansDefinedBenefitMember 2018-11-01 2019-10-31 0001090872 country:US us-gaap:PensionPlansDefinedBenefitMember 2016-11-01 2017-10-31 0001090872 country:US us-gaap:PensionPlansDefinedBenefitMember 2017-11-01 2018-10-31 0001090872 us-gaap:ForeignPlanMember us-gaap:PensionPlansDefinedBenefitMember 2016-11-01 2017-10-31 0001090872 us-gaap:ForeignPlanMember us-gaap:PensionPlansDefinedBenefitMember 2018-11-01 2019-10-31 0001090872 country:US us-gaap:DefinedBenefitPostretirementHealthCoverageMember 2017-11-01 2018-10-31 0001090872 country:US us-gaap:DefinedBenefitPostretirementHealthCoverageMember 2018-11-01 2019-10-31 0001090872 a:OtherPlanAssetsMember country:US us-gaap:PensionPlansDefinedBenefitMember 2018-10-31 0001090872 us-gaap:EquitySecuritiesMember us-gaap:FairValueInputsLevel1Member country:US us-gaap:PensionPlansDefinedBenefitMember 2018-10-31 0001090872 us-gaap:FairValueInputsLevel3Member country:US us-gaap:PensionPlansDefinedBenefitMember 2018-10-31 0001090872 us-gaap:FixedIncomeSecuritiesMember country:US us-gaap:PensionPlansDefinedBenefitMember 2018-10-31 0001090872 us-gaap:FairValueInputsLevel2Member country:US us-gaap:PensionPlansDefinedBenefitMember 2018-10-31 0001090872 us-gaap:FixedIncomeSecuritiesMember us-gaap:FairValueInputsLevel1Member country:US us-gaap:PensionPlansDefinedBenefitMember 2018-10-31 0001090872 a:OtherPlanAssetsMember us-gaap:FairValueInputsLevel2Member country:US us-gaap:PensionPlansDefinedBenefitMember 2018-10-31 0001090872 us-gaap:FairValueInputsLevel1Member country:US us-gaap:PensionPlansDefinedBenefitMember 2018-10-31 0001090872 us-gaap:EquitySecuritiesMember us-gaap:FairValueInputsLevel3Member country:US us-gaap:PensionPlansDefinedBenefitMember 2018-10-31 0001090872 country:US us-gaap:PensionPlansDefinedBenefitMember 2018-10-31 0001090872 us-gaap:CashAndCashEquivalentsMember us-gaap:FairValueInputsLevel2Member country:US us-gaap:PensionPlansDefinedBenefitMember 2018-10-31 0001090872 us-gaap:CashAndCashEquivalentsMember us-gaap:FairValueInputsLevel3Member country:US us-gaap:PensionPlansDefinedBenefitMember 2018-10-31 0001090872 us-gaap:EquitySecuritiesMember country:US us-gaap:PensionPlansDefinedBenefitMember 2018-10-31 0001090872 us-gaap:CashAndCashEquivalentsMember us-gaap:FairValueInputsLevel1Member country:US us-gaap:PensionPlansDefinedBenefitMember 2018-10-31 0001090872 us-gaap:CashAndCashEquivalentsMember country:US us-gaap:PensionPlansDefinedBenefitMember 2018-10-31 0001090872 a:OtherPlanAssetsMember us-gaap:FairValueInputsLevel1Member country:US us-gaap:PensionPlansDefinedBenefitMember 2018-10-31 0001090872 us-gaap:EquitySecuritiesMember us-gaap:FairValueInputsLevel2Member country:US us-gaap:PensionPlansDefinedBenefitMember 2018-10-31 0001090872 a:OtherPlanAssetsMember us-gaap:FairValueInputsLevel3Member country:US us-gaap:PensionPlansDefinedBenefitMember 2018-10-31 0001090872 us-gaap:FixedIncomeSecuritiesMember us-gaap:FairValueInputsLevel2Member country:US us-gaap:PensionPlansDefinedBenefitMember 2018-10-31 0001090872 us-gaap:FixedIncomeSecuritiesMember us-gaap:FairValueInputsLevel3Member country:US us-gaap:PensionPlansDefinedBenefitMember 2018-10-31 0001090872 us-gaap:ForeignPlanMember us-gaap:PensionPlansDefinedBenefitMember 2019-10-31 0001090872 country:US us-gaap:PensionPlansDefinedBenefitMember 2019-10-31 0001090872 us-gaap:AccumulatedOtherComprehensiveIncomeMember country:JP us-gaap:PensionPlansDefinedBenefitMember 2017-10-31 0001090872 a:OtherPlanAssetsMember country:US us-gaap:PensionPlansDefinedBenefitMember 2019-10-31 0001090872 srt:MinimumMember us-gaap:EquitySecuritiesMember us-gaap:ForeignPlanMember us-gaap:PensionPlansDefinedBenefitMember 2019-10-31 0001090872 us-gaap:EquitySecuritiesMember country:US us-gaap:PensionPlansDefinedBenefitMember 2019-10-31 0001090872 us-gaap:DeferredProfitSharingMember us-gaap:FixedIncomeSecuritiesMember country:US 2019-10-31 0001090872 srt:MaximumMember us-gaap:PensionPlansDefinedBenefitMember 2018-11-01 2019-10-31 0001090872 srt:MaximumMember us-gaap:FixedIncomeSecuritiesMember us-gaap:ForeignPlanMember us-gaap:PensionPlansDefinedBenefitMember 2019-10-31 0001090872 country:JP us-gaap:PensionPlansDefinedBenefitMember 2017-11-01 2018-01-31 0001090872 us-gaap:DeferredProfitSharingMember 2018-10-31 0001090872 us-gaap:AccumulatedOtherComprehensiveIncomeMember country:JP us-gaap:PensionPlansDefinedBenefitMember 2016-11-01 2017-10-31 0001090872 srt:MaximumMember us-gaap:EquitySecuritiesMember us-gaap:ForeignPlanMember us-gaap:PensionPlansDefinedBenefitMember 2019-10-31 0001090872 us-gaap:FixedIncomeSecuritiesMember country:US us-gaap:PensionPlansDefinedBenefitMember 2019-10-31 0001090872 srt:MinimumMember us-gaap:PensionPlansDefinedBenefitMember 2018-11-01 2019-10-31 0001090872 us-gaap:DeferredProfitSharingMember 2019-10-31 0001090872 srt:MinimumMember us-gaap:FixedIncomeSecuritiesMember us-gaap:ForeignPlanMember us-gaap:PensionPlansDefinedBenefitMember 2019-10-31 0001090872 us-gaap:PensionPlansDefinedBenefitMember 2018-11-01 2019-10-31 0001090872 srt:MinimumMember us-gaap:RealEstateMember us-gaap:ForeignPlanMember us-gaap:PensionPlansDefinedBenefitMember 2019-10-31 0001090872 a:DifferenceBetweenFairValuesoftheObligationSettledandAssetsTransferredMember country:JP us-gaap:PensionPlansDefinedBenefitMember 2016-11-01 2017-10-31 0001090872 country:JP us-gaap:PensionPlansDefinedBenefitMember 2017-10-31 0001090872 us-gaap:DeferredProfitSharingMember us-gaap:EquitySecuritiesMember country:US 2019-10-31 0001090872 country:JP us-gaap:PensionPlansDefinedBenefitMember 2016-11-01 2017-10-31 0001090872 srt:MaximumMember us-gaap:RealEstateMember us-gaap:ForeignPlanMember us-gaap:PensionPlansDefinedBenefitMember 2019-10-31 0001090872 us-gaap:FairValueInputsLevel2Member country:US us-gaap:DefinedBenefitPostretirementHealthCoverageMember 2018-10-31 0001090872 us-gaap:EquitySecuritiesMember us-gaap:FairValueInputsLevel1Member country:US us-gaap:DefinedBenefitPostretirementHealthCoverageMember 2018-10-31 0001090872 a:OtherPlanAssetsMember us-gaap:FairValueInputsLevel3Member country:US us-gaap:DefinedBenefitPostretirementHealthCoverageMember 2018-10-31 0001090872 country:US us-gaap:DefinedBenefitPostretirementHealthCoverageMember 2018-10-31 0001090872 us-gaap:CashAndCashEquivalentsMember us-gaap:FairValueInputsLevel1Member country:US us-gaap:DefinedBenefitPostretirementHealthCoverageMember 2018-10-31 0001090872 us-gaap:FixedIncomeSecuritiesMember us-gaap:FairValueInputsLevel1Member country:US us-gaap:DefinedBenefitPostretirementHealthCoverageMember 2018-10-31 0001090872 us-gaap:EquitySecuritiesMember country:US us-gaap:DefinedBenefitPostretirementHealthCoverageMember 2018-10-31 0001090872 us-gaap:CashAndCashEquivalentsMember country:US us-gaap:DefinedBenefitPostretirementHealthCoverageMember 2018-10-31 0001090872 us-gaap:FairValueInputsLevel1Member country:US us-gaap:DefinedBenefitPostretirementHealthCoverageMember 2018-10-31 0001090872 us-gaap:FairValueInputsLevel3Member country:US us-gaap:DefinedBenefitPostretirementHealthCoverageMember 2018-10-31 0001090872 us-gaap:EquitySecuritiesMember us-gaap:FairValueInputsLevel3Member country:US us-gaap:DefinedBenefitPostretirementHealthCoverageMember 2018-10-31 0001090872 us-gaap:FixedIncomeSecuritiesMember country:US us-gaap:DefinedBenefitPostretirementHealthCoverageMember 2018-10-31 0001090872 a:OtherPlanAssetsMember us-gaap:FairValueInputsLevel1Member country:US us-gaap:DefinedBenefitPostretirementHealthCoverageMember 2018-10-31 0001090872 us-gaap:EquitySecuritiesMember us-gaap:FairValueInputsLevel2Member country:US us-gaap:DefinedBenefitPostretirementHealthCoverageMember 2018-10-31 0001090872 us-gaap:CashAndCashEquivalentsMember us-gaap:FairValueInputsLevel3Member country:US us-gaap:DefinedBenefitPostretirementHealthCoverageMember 2018-10-31 0001090872 a:OtherPlanAssetsMember us-gaap:FairValueInputsLevel2Member country:US us-gaap:DefinedBenefitPostretirementHealthCoverageMember 2018-10-31 0001090872 us-gaap:CashAndCashEquivalentsMember us-gaap:FairValueInputsLevel2Member country:US us-gaap:DefinedBenefitPostretirementHealthCoverageMember 2018-10-31 0001090872 us-gaap:FixedIncomeSecuritiesMember us-gaap:FairValueInputsLevel3Member country:US us-gaap:DefinedBenefitPostretirementHealthCoverageMember 2018-10-31 0001090872 a:OtherPlanAssetsMember country:US us-gaap:DefinedBenefitPostretirementHealthCoverageMember 2018-10-31 0001090872 us-gaap:FixedIncomeSecuritiesMember us-gaap:FairValueInputsLevel2Member country:US us-gaap:DefinedBenefitPostretirementHealthCoverageMember 2018-10-31 0001090872 a:OtherPlanAssetsMember us-gaap:FairValueInputsLevel1Member country:US us-gaap:PensionPlansDefinedBenefitMember 2019-10-31 0001090872 us-gaap:CashAndCashEquivalentsMember us-gaap:FairValueInputsLevel2Member country:US us-gaap:PensionPlansDefinedBenefitMember 2019-10-31 0001090872 us-gaap:FairValueInputsLevel3Member country:US us-gaap:PensionPlansDefinedBenefitMember 2019-10-31 0001090872 us-gaap:FixedIncomeSecuritiesMember us-gaap:FairValueInputsLevel2Member country:US us-gaap:PensionPlansDefinedBenefitMember 2019-10-31 0001090872 us-gaap:EquitySecuritiesMember us-gaap:FairValueInputsLevel2Member country:US us-gaap:PensionPlansDefinedBenefitMember 2019-10-31 0001090872 a:OtherPlanAssetsMember us-gaap:FairValueInputsLevel3Member country:US us-gaap:PensionPlansDefinedBenefitMember 2019-10-31 0001090872 us-gaap:FixedIncomeSecuritiesMember us-gaap:FairValueInputsLevel3Member country:US us-gaap:PensionPlansDefinedBenefitMember 2019-10-31 0001090872 us-gaap:FairValueInputsLevel2Member country:US us-gaap:PensionPlansDefinedBenefitMember 2019-10-31 0001090872 us-gaap:CashAndCashEquivalentsMember us-gaap:FairValueInputsLevel3Member country:US us-gaap:PensionPlansDefinedBenefitMember 2019-10-31 0001090872 us-gaap:EquitySecuritiesMember us-gaap:FairValueInputsLevel3Member country:US us-gaap:PensionPlansDefinedBenefitMember 2019-10-31 0001090872 us-gaap:EquitySecuritiesMember us-gaap:FairValueInputsLevel1Member country:US us-gaap:PensionPlansDefinedBenefitMember 2019-10-31 0001090872 us-gaap:FixedIncomeSecuritiesMember us-gaap:FairValueInputsLevel1Member country:US us-gaap:PensionPlansDefinedBenefitMember 2019-10-31 0001090872 us-gaap:FairValueInputsLevel1Member country:US us-gaap:PensionPlansDefinedBenefitMember 2019-10-31 0001090872 us-gaap:CashAndCashEquivalentsMember country:US us-gaap:PensionPlansDefinedBenefitMember 2019-10-31 0001090872 a:OtherPlanAssetsMember us-gaap:FairValueInputsLevel2Member country:US us-gaap:PensionPlansDefinedBenefitMember 2019-10-31 0001090872 us-gaap:CashAndCashEquivalentsMember us-gaap:FairValueInputsLevel1Member country:US us-gaap:PensionPlansDefinedBenefitMember 2019-10-31 0001090872 a:RetirementandpostretirementbenefitsMember country:US us-gaap:PensionPlansDefinedBenefitMember 2018-10-31 0001090872 a:EmployeecompensationandbenefitsMember country:US us-gaap:DefinedBenefitPostretirementHealthCoverageMember 2019-10-31 0001090872 us-gaap:OtherAssetsMember country:US us-gaap:DefinedBenefitPostretirementHealthCoverageMember 2018-10-31 0001090872 a:RetirementandpostretirementbenefitsMember country:US us-gaap:DefinedBenefitPostretirementHealthCoverageMember 2019-10-31 0001090872 a:EmployeecompensationandbenefitsMember us-gaap:ForeignPlanMember us-gaap:PensionPlansDefinedBenefitMember 2019-10-31 0001090872 us-gaap:OtherAssetsMember country:US us-gaap:DefinedBenefitPostretirementHealthCoverageMember 2019-10-31 0001090872 country:US us-gaap:PensionPlansDefinedBenefitMember 2017-10-31 0001090872 a:RetirementandpostretirementbenefitsMember country:US us-gaap:PensionPlansDefinedBenefitMember 2019-10-31 0001090872 a:EmployeecompensationandbenefitsMember country:US us-gaap:DefinedBenefitPostretirementHealthCoverageMember 2018-10-31 0001090872 country:US us-gaap:DefinedBenefitPostretirementHealthCoverageMember 2017-10-31 0001090872 us-gaap:ForeignPlanMember us-gaap:PensionPlansDefinedBenefitMember 2017-10-31 0001090872 a:EmployeecompensationandbenefitsMember us-gaap:ForeignPlanMember us-gaap:PensionPlansDefinedBenefitMember 2018-10-31 0001090872 a:RetirementandpostretirementbenefitsMember country:US us-gaap:DefinedBenefitPostretirementHealthCoverageMember 2018-10-31 0001090872 a:RetirementandpostretirementbenefitsMember us-gaap:ForeignPlanMember us-gaap:PensionPlansDefinedBenefitMember 2019-10-31 0001090872 a:RetirementandpostretirementbenefitsMember us-gaap:ForeignPlanMember us-gaap:PensionPlansDefinedBenefitMember 2018-10-31 0001090872 us-gaap:OtherAssetsMember us-gaap:ForeignPlanMember us-gaap:PensionPlansDefinedBenefitMember 2018-10-31 0001090872 a:EmployeecompensationandbenefitsMember country:US us-gaap:PensionPlansDefinedBenefitMember 2018-10-31 0001090872 a:EmployeecompensationandbenefitsMember country:US us-gaap:PensionPlansDefinedBenefitMember 2019-10-31 0001090872 us-gaap:OtherAssetsMember country:US us-gaap:PensionPlansDefinedBenefitMember 2018-10-31 0001090872 us-gaap:OtherAssetsMember country:US us-gaap:PensionPlansDefinedBenefitMember 2019-10-31 0001090872 us-gaap:OtherAssetsMember us-gaap:ForeignPlanMember us-gaap:PensionPlansDefinedBenefitMember 2019-10-31 0001090872 us-gaap:FixedIncomeSecuritiesMember us-gaap:FairValueInputsLevel3Member us-gaap:ForeignPlanMember us-gaap:PensionPlansDefinedBenefitMember 2019-10-31 0001090872 us-gaap:CashAndCashEquivalentsMember us-gaap:FairValueInputsLevel2Member us-gaap:ForeignPlanMember us-gaap:PensionPlansDefinedBenefitMember 2019-10-31 0001090872 a:OtherPlanAssetsMember us-gaap:ForeignPlanMember us-gaap:PensionPlansDefinedBenefitMember 2019-10-31 0001090872 us-gaap:FixedIncomeSecuritiesMember us-gaap:ForeignPlanMember us-gaap:PensionPlansDefinedBenefitMember 2019-10-31 0001090872 a:OtherPlanAssetsMember us-gaap:FairValueInputsLevel3Member us-gaap:ForeignPlanMember us-gaap:PensionPlansDefinedBenefitMember 2019-10-31 0001090872 us-gaap:CashAndCashEquivalentsMember us-gaap:ForeignPlanMember us-gaap:PensionPlansDefinedBenefitMember 2019-10-31 0001090872 us-gaap:CashAndCashEquivalentsMember us-gaap:FairValueInputsLevel1Member us-gaap:ForeignPlanMember us-gaap:PensionPlansDefinedBenefitMember 2019-10-31 0001090872 us-gaap:CashAndCashEquivalentsMember us-gaap:FairValueInputsLevel3Member us-gaap:ForeignPlanMember us-gaap:PensionPlansDefinedBenefitMember 2019-10-31 0001090872 us-gaap:EquitySecuritiesMember us-gaap:FairValueInputsLevel3Member us-gaap:ForeignPlanMember us-gaap:PensionPlansDefinedBenefitMember 2019-10-31 0001090872 us-gaap:FairValueInputsLevel2Member us-gaap:ForeignPlanMember us-gaap:PensionPlansDefinedBenefitMember 2019-10-31 0001090872 us-gaap:FairValueInputsLevel1Member us-gaap:ForeignPlanMember us-gaap:PensionPlansDefinedBenefitMember 2019-10-31 0001090872 us-gaap:EquitySecuritiesMember us-gaap:ForeignPlanMember us-gaap:PensionPlansDefinedBenefitMember 2019-10-31 0001090872 a:OtherPlanAssetsMember us-gaap:FairValueInputsLevel1Member us-gaap:ForeignPlanMember us-gaap:PensionPlansDefinedBenefitMember 2019-10-31 0001090872 a:OtherPlanAssetsMember us-gaap:FairValueInputsLevel2Member us-gaap:ForeignPlanMember us-gaap:PensionPlansDefinedBenefitMember 2019-10-31 0001090872 us-gaap:FixedIncomeSecuritiesMember us-gaap:FairValueInputsLevel1Member us-gaap:ForeignPlanMember us-gaap:PensionPlansDefinedBenefitMember 2019-10-31 0001090872 us-gaap:FixedIncomeSecuritiesMember us-gaap:FairValueInputsLevel2Member us-gaap:ForeignPlanMember us-gaap:PensionPlansDefinedBenefitMember 2019-10-31 0001090872 us-gaap:EquitySecuritiesMember us-gaap:FairValueInputsLevel2Member us-gaap:ForeignPlanMember us-gaap:PensionPlansDefinedBenefitMember 2019-10-31 0001090872 us-gaap:EquitySecuritiesMember us-gaap:FairValueInputsLevel1Member us-gaap:ForeignPlanMember us-gaap:PensionPlansDefinedBenefitMember 2019-10-31 0001090872 us-gaap:FairValueInputsLevel3Member us-gaap:ForeignPlanMember us-gaap:PensionPlansDefinedBenefitMember 2019-10-31 0001090872 us-gaap:FairValueInputsLevel3Member country:US us-gaap:DefinedBenefitPostretirementHealthCoverageMember 2017-11-01 2018-10-31 0001090872 us-gaap:FairValueInputsLevel3Member country:US us-gaap:DefinedBenefitPostretirementHealthCoverageMember 2018-11-01 2019-10-31 0001090872 us-gaap:FairValueInputsLevel3Member country:US us-gaap:DefinedBenefitPostretirementHealthCoverageMember 2017-10-31 0001090872 us-gaap:FairValueInputsLevel3Member country:US us-gaap:PensionPlansDefinedBenefitMember 2017-10-31 0001090872 us-gaap:FairValueInputsLevel3Member country:US us-gaap:PensionPlansDefinedBenefitMember 2017-11-01 2018-10-31 0001090872 us-gaap:FairValueInputsLevel3Member country:US us-gaap:PensionPlansDefinedBenefitMember 2018-11-01 2019-10-31 0001090872 srt:MinimumMember us-gaap:EquitySecuritiesMember us-gaap:ForeignPlanMember us-gaap:PensionPlansDefinedBenefitMember 2018-10-31 0001090872 srt:MinimumMember us-gaap:CashAndCashEquivalentsMember us-gaap:ForeignPlanMember us-gaap:PensionPlansDefinedBenefitMember 2019-10-31 0001090872 srt:MinimumMember us-gaap:FixedIncomeSecuritiesMember us-gaap:ForeignPlanMember us-gaap:PensionPlansDefinedBenefitMember 2018-10-31 0001090872 us-gaap:DeferredProfitSharingMember us-gaap:EquitySecuritiesMember country:US 2018-10-31 0001090872 srt:MaximumMember us-gaap:CashAndCashEquivalentsMember us-gaap:ForeignPlanMember us-gaap:PensionPlansDefinedBenefitMember 2019-10-31 0001090872 srt:MaximumMember us-gaap:RealEstateMember us-gaap:ForeignPlanMember us-gaap:PensionPlansDefinedBenefitMember 2018-10-31 0001090872 us-gaap:DeferredProfitSharingMember us-gaap:FixedIncomeSecuritiesMember country:US 2018-10-31 0001090872 srt:MaximumMember us-gaap:CashAndCashEquivalentsMember us-gaap:ForeignPlanMember us-gaap:PensionPlansDefinedBenefitMember 2018-10-31 0001090872 srt:MaximumMember us-gaap:EquitySecuritiesMember us-gaap:ForeignPlanMember us-gaap:PensionPlansDefinedBenefitMember 2018-10-31 0001090872 srt:MaximumMember us-gaap:FixedIncomeSecuritiesMember us-gaap:ForeignPlanMember us-gaap:PensionPlansDefinedBenefitMember 2018-10-31 0001090872 srt:MinimumMember us-gaap:CashAndCashEquivalentsMember us-gaap:ForeignPlanMember us-gaap:PensionPlansDefinedBenefitMember 2018-10-31 0001090872 srt:MinimumMember us-gaap:RealEstateMember us-gaap:ForeignPlanMember us-gaap:PensionPlansDefinedBenefitMember 2018-10-31 0001090872 srt:MinimumMember us-gaap:ForeignPlanMember us-gaap:PensionPlansDefinedBenefitMember 2017-11-01 2018-10-31 0001090872 srt:MaximumMember us-gaap:ForeignPlanMember us-gaap:PensionPlansDefinedBenefitMember 2017-11-01 2018-10-31 0001090872 srt:MinimumMember us-gaap:ForeignPlanMember us-gaap:PensionPlansDefinedBenefitMember 2016-11-01 2017-10-31 0001090872 srt:MaximumMember us-gaap:ForeignPlanMember us-gaap:PensionPlansDefinedBenefitMember 2018-11-01 2019-10-31 0001090872 srt:MaximumMember us-gaap:ForeignPlanMember us-gaap:PensionPlansDefinedBenefitMember 2016-11-01 2017-10-31 0001090872 srt:MinimumMember us-gaap:ForeignPlanMember us-gaap:PensionPlansDefinedBenefitMember 2018-11-01 2019-10-31 0001090872 srt:MinimumMember us-gaap:ForeignPlanMember us-gaap:PensionPlansDefinedBenefitMember 2019-10-31 0001090872 srt:MaximumMember us-gaap:ForeignPlanMember us-gaap:PensionPlansDefinedBenefitMember 2018-10-31 0001090872 srt:MinimumMember us-gaap:ForeignPlanMember us-gaap:PensionPlansDefinedBenefitMember 2018-10-31 0001090872 srt:MaximumMember us-gaap:ForeignPlanMember us-gaap:PensionPlansDefinedBenefitMember 2019-10-31 0001090872 a:PenaltyreduceoverperiodoftimeMember 2019-10-31 0001090872 a:SeniorNotes2020Member 2010-07-13 0001090872 a:SeniorNotes2017Member 2007-10-23 2007-10-24 0001090872 a:SeniorNotes2020Member 2019-09-17 2019-09-17 0001090872 a:SeniorNotes2020Member 2011-08-08 2011-08-09 0001090872 a:SeniorNotes2020Member 2011-08-09 0001090872 a:SeniorNotes2017Member 2017-11-01 2017-11-01 0001090872 a:SeniorNotes2017Member 2007-10-24 0001090872 a:SeniorNotes2020Member 2010-07-12 2010-07-13 0001090872 2019-08-07 0001090872 a:SeniorNotes2017Member 2014-10-20 2014-10-20 0001090872 2019-03-13 2019-03-13 0001090872 2019-10-21 0001090872 2016-09-15 0001090872 a:SeniorNotes2023Member 2013-06-17 2013-06-18 0001090872 a:SeniorNotes2022Member 2012-09-10 0001090872 a:SeniorNotes2022Member 2012-09-09 2012-09-10 0001090872 2016-02-01 0001090872 a:SeniorNotes2023Member 2013-06-18 0001090872 a:SeniorNotes2026Member 2016-09-15 0001090872 a:SeniorNotes2029Member 2019-09-04 2019-09-05 0001090872 a:SeniorNotes2029Member 2019-09-05 0001090872 a:SeniorNotes2026Member 2016-09-14 2016-09-15 0001090872 a:SeniorNotes2029Member 2018-10-31 0001090872 a:SeniorNotes2029Member 2019-10-31 0001090872 a:SeniorNotes2022Member 2019-10-31 0001090872 a:SeniorNotes2026Member 2019-10-31 0001090872 a:SeniorNotes2023Member 2019-10-31 0001090872 a:SeniorNotes2023Member 2018-10-31 0001090872 a:SeniorNotes2020Member 2018-10-31 0001090872 a:SeniorNotes2022Member 2018-10-31 0001090872 a:SeniorNotes2026Member 2018-10-31 0001090872 a:A2015RepurchaseProgramMember 2016-11-01 2017-10-31 0001090872 us-gaap:SubsequentEventMember 2019-11-20 2019-11-20 0001090872 a:A2019RepurchaseProgramMember 2018-11-01 2019-10-31 0001090872 a:A2015RepurchaseProgramMember 2018-10-31 0001090872 a:A2019RepurchaseProgramMember 2019-10-31 0001090872 a:A2015RepurchaseProgramMember 2017-11-01 2018-10-31 0001090872 a:A2015RepurchaseProgramMember 2015-05-28 0001090872 a:A2019RepurchaseProgramMember 2018-11-19 0001090872 2018-11-01 2018-11-01 0001090872 us-gaap:AccumulatedDefinedBenefitPlansAdjustmentNetPriorServiceCostCreditMember 2018-11-01 2018-11-01 0001090872 us-gaap:AociDerivativeQualifyingAsHedgeExcludedComponentParentMember 2018-11-01 2018-11-01 0001090872 us-gaap:AccumulatedDefinedBenefitPlansAdjustmentNetUnamortizedGainLossMember 2018-11-01 2018-11-01 0001090872 us-gaap:AccumulatedTranslationAdjustmentMember 2018-11-01 2018-11-01 0001090872 a:SegmentTotalMember 2018-10-31 0001090872 a:SegmentTotalMember 2018-11-01 2019-10-31 0001090872 a:SegmentTotalMember 2017-11-01 2018-10-31 0001090872 a:SegmentTotalMember 2019-10-31 0001090872 country:US 2017-11-01 2018-10-31 0001090872 a:RestOfWorldMember 2016-11-01 2017-10-31 0001090872 a:RestOfWorldMember 2017-11-01 2018-10-31 0001090872 a:RestOfWorldMember 2018-11-01 2019-10-31 0001090872 country:CN 2016-11-01 2017-10-31 0001090872 country:US 2016-11-01 2017-10-31 0001090872 country:CN 2017-11-01 2018-10-31 0001090872 country:US 2018-11-01 2019-10-31 0001090872 country:CN 2018-11-01 2019-10-31 0001090872 a:LifeSciencesandAppliedMarketsMember 2016-11-01 2017-10-31 0001090872 a:AgilentCrossLabMember 2016-11-01 2017-10-31 0001090872 a:SegmentTotalMember 2016-11-01 2017-10-31 0001090872 a:DiagnosticsAndGenomicsMember 2016-11-01 2017-10-31 0001090872 a:RestOfWorldMember 2019-10-31 0001090872 country:US 2018-10-31 0001090872 country:DE 2018-10-31 0001090872 country:US 2019-10-31 0001090872 country:DE 2019-10-31 0001090872 a:RestOfWorldMember 2018-10-31 0001090872 us-gaap:ValuationAllowanceOfDeferredTaxAssetsMember 2017-11-01 2018-10-31 0001090872 us-gaap:ValuationAllowanceOfDeferredTaxAssetsMember 2016-10-31 0001090872 us-gaap:ValuationAllowanceOfDeferredTaxAssetsMember 2019-10-31 0001090872 us-gaap:ValuationAllowanceOfDeferredTaxAssetsMember 2018-11-01 2019-10-31 0001090872 us-gaap:ValuationAllowanceOfDeferredTaxAssetsMember 2018-10-31 0001090872 us-gaap:ValuationAllowanceOfDeferredTaxAssetsMember 2017-10-31 0001090872 us-gaap:ValuationAllowanceOfDeferredTaxAssetsMember 2016-11-01 2017-10-31 xbrli:pure iso4217:USD xbrli:shares iso4217:USD xbrli:shares utreg:Y a:contracts a:segment
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
_____________________________________________________________
Form 10-K
_____________________________________________________________

(MARK ONE) 
☒ ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934. 
For the fiscal year ended October 31, 2019 
or 
☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934. 
For transition period from to

Commission File Number: 001-15405
_____________________________________________________________
Agilent Technologies, Inc.
(Exact name of registrant as specified in its charter)

 
Delaware
 
 
 
77-0518772
 
(State or other jurisdiction of incorporation or organization)
 
(IRS Employer Identification No.)
 
Address of principal executive offices: 5301 Stevens Creek Blvd., Santa Clara, California 95051
Registrant's telephone number, including area code: (800) 227-9770
Securities registered pursuant to Section 12(b) of the Act:
Title of each Class
 
Trading Symbol
 
Name of each Exchange on which registered
Common Stock, $0.01 par value
 
 
A
 
 
 
New York Stock Exchange
 

Securities registered pursuant to Section 12(g) of the Act: None
_____________________________________________________________
Indicate by check mark if the registrant is a well-known seasoned issuer, as defined in Rule 405 of the Securities Act. Yes ☒ No ☐
Indicate by check mark if the registrant is not required to file reports pursuant to Section 13 or Section 15(d) of the Act. Yes ☐ No ☒
Indicate by check mark whether the registrant (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the registrant was required to file such reports), and (2) has been subject to such filing requirements for the past 90 days. Yes ☒ No ☐
Indicate by check mark whether the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T (§232.405 of this chapter) during the preceding 12 months (or for such shorter period that the registrant was required to submit such files). Yes ☒ No ☐
Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, a smaller reporting company or an emerging growth company. See the definitions of "large accelerated filer," "accelerated filer", "smaller reporting company" and "emerging growth company" in Rule 12b-2 of the Exchange Act.
Large accelerated filer
☒
 
Accelerated filer
☐
 
Non-accelerated filer
☐
 
Smaller reporting company
☐
 
 
 
 
Emerging growth company
☐
 

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐
Indicate by check mark whether the registrant is a shell company (as defined in Rule 12b-2 of the Exchange Act). Yes ☐ No ☒
The aggregate market value of the registrant's common equity held by non-affiliates as of April 30, 2019, was approximately $18.9 billion. Shares of stock held by officers, directors and 5 percent or more stockholders have been excluded in that such persons may be deemed to be affiliates. This determination of affiliate status is not necessarily a conclusive determination for other purposes.
As of December 10, 2019, there were 310,183,415 outstanding shares of common stock, par value $0.01 per share.
_____________________________________________________________
DOCUMENTS INCORPORATED BY REFERENCE
Document Description
 
10-K Part 
Portions of the Proxy Statement for the Annual Meeting of Stockholders (the "Proxy Statement") to be held on March 18, 2020, and to be filed pursuant to Regulation 14A within 120 days after registrant's fiscal year ended October 31, 2019 are incorporated by reference into Part III of this Report
 
III

Table of Contents            

TABLE OF CONTENTS
 
 
Page
 
 
 
 



2
Table of Contents            

Forward-Looking Statements

This report contains forward-looking statements including, without limitation, statements regarding growth opportunities, including for revenue and our end markets, strength and drivers of the markets we sell into, sales funnels, our strategic direction, new product and service introductions and the position of our current products and services, market demand for and adoption of our products, the ability of our products and solutions to address customer needs and meet industry requirements, our focus on differentiating our product solutions, improving our customers’ experience and growing our earnings, future financial results, our operating margin, mix, our investments, including in manufacturing infrastructure, research and development and expanding and improving our applications and solutions portfolios, expanding our position in developing countries and emerging markets, our focus on balanced capital allocation, our contributions to our pension and other defined benefit plans, impairment of goodwill and other intangible assets, the effect of the U.S. Tax Cuts and Jobs Act of 2017 (the "Tax Act") and U.S. and other tariffs, the impact of foreign currency movements, our hedging programs and other actions to offset the effects of tariffs and foreign currency movements, our future effective tax rate, tax valuation allowance and unrecognized tax benefits, the impact of local government regulations on our ability to pay vendors or conduct operations, our ability to satisfy our liquidity requirements, including through cash generated from operations, the potential impact of adopting new accounting pronouncements, indemnification, source and supply of materials used in our products, our sales, our purchase commitments, our capital expenditures, the integration and effects of our acquisitions and other transactions, and our stock repurchase program and dividends that involve risks and uncertainties. Our actual results could differ materially from the results contemplated by these forward-looking statements due to various factors, including those discussed in Part I Item 1A and elsewhere in this Form 10-K.

PART I


Item 1.    Business

Overview

Agilent Technologies Inc. ("we", "Agilent" or the "company"), incorporated in Delaware in May 1999, is a global leader in life sciences, diagnostics and applied chemical markets, providing application focused solutions that include instruments, software, services and consumables for the entire laboratory workflow.

For fiscal year ended October 31, 2019, we have three business segments comprised of the life sciences and applied markets business, diagnostics and genomics business and the Agilent CrossLab business.

Our life sciences and applied markets business provides application-focused solutions that include instruments and software that enable customers to identify, quantify and analyze the physical and biological properties of substances and products, as well as enable customers in the clinical and life sciences research areas to interrogate samples at the molecular and cellular level. Our diagnostics and genomics business is comprised of six areas of activity providing active pharmaceutical ingredients ("APIs") for oligo-based therapeutics as well as solutions that include reagents, instruments, software and consumables which enable customers in the clinical and life sciences research areas to interrogate samples at the cellular and molecular level. The Agilent CrossLab business spans the entire lab with its extensive consumables and services portfolio, which is designed to improve customer outcomes. In addition, we conduct centralized order fulfillment and supply chain operations for our businesses through the order fulfillment and supply chain organization ("OFS"). OFS provides resources for manufacturing, engineering and strategic sourcing to our respective businesses. Each of our businesses, together with OFS and Agilent Technologies Research Laboratories, is supported by our global infrastructure organization, which provides shared services in the areas of finance, information technology, legal, certain procurement services, workplace services and human resources.

We sell our products primarily through direct sales, but we also utilize distributors, resellers, manufacturer's representatives and electronic commerce. As of October 31, 2019, we employed approximately 16,300 people worldwide. Our primary research and development and manufacturing sites are in California, Colorado, Delaware, Massachusetts, Texas and Vermont in the U.S. and in Australia, China, Denmark, Germany, Italy, Japan, Malaysia, Singapore and the United Kingdom.


3
Table of Contents            

Life Sciences and Applied Markets Business
Our life sciences and applied markets business provides application-focused solutions that include instruments and software that enable customers to identify, quantify and analyze the physical and biological properties of substances and products, as well as enable customers in the clinical and life sciences research areas to interrogate samples at the molecular and cellular level. Key product categories include: liquid chromatography ("LC") systems and components; liquid chromatography mass spectrometry ("LCMS") systems; gas chromatography ("GC") systems and components; gas chromatography mass spectrometry ("GCMS") systems; inductively coupled plasma mass spectrometry ("ICP-MS") instruments; atomic absorption ("AA") instruments; microwave plasma-atomic emission spectrometry ("MP-AES") instruments; inductively coupled plasma optical emission spectrometry ("ICP-OES") instruments; raman spectroscopy; cell analysis plate based assays; flow cytometer; real-time cell analyzer; cell imaging systems; microplate reader; laboratory software for sample tracking; information management and analytics; laboratory automation and robotic systems; dissolution testing; vacuum pumps and measurement technologies.

We employed approximately 5,400 people as of October 31, 2019 in our life sciences and applied markets business.

Life Sciences and Applied Markets
Our life sciences and applied markets business focuses primarily on the following five markets:
The Pharmaceutical, Biopharmaceutical, CRO & CMO Market. This market consists of “for-profit” companies who participate across the pharmaceutical value chain in the areas of therapeutic research, discovery & development, clinical trials, manufacturing and quality assurance and quality control. One sub-segment of this market is core and emerging pharmaceutical companies ("pharma"). A second sub-segment includes biopharmaceutical companies ("biopharma"), contract research organizations ("CROs") and contract manufacturing organizations ("CMOs"). Biopharma companies and, to a somewhat lesser extent, CROs and CMOs typically participate in specific points in the pharmaceutical industry value chain. Additionally, due to the relatively low drug efficacy within oncology, pharma companies are partnering with diagnostic companies to bring validated tests to the market with their new drugs.
The Academic and Government Market. This market consists primarily of “not-for-profit” organizations and includes academic institutions, large government institutes and privately funded organizations. The academic and government market plays an influential role in technology adoption and therapeutic developments for pharmaceutical and molecular diagnostics companies. After decades of investment in basic biomedical research by government funding bodies, the focus has widened to include translational research - multidisciplinary scientific efforts directed at accelerating therapy development.
The Chemical & Energy Market.    The natural gas and petroleum refining markets use our products to measure and control the quality of their finished products and to verify the environmental safety of their operations. Petroleum refiners use our measurement solutions to analyze crude oil composition, perform raw material analysis, verify and improve refining processes and ensure the overall quality of gasoline, fuels, lubricants and other products. Our solutions are also used in the development, manufacturing and quality control of fine chemicals and other industrial applications such as materials analysis.

The Environmental & Forensics Market.    Our instruments, software and workflow solutions are used by the environmental market for applications such as laboratory and field analysis of chemical pollutants in air, water, soil and solid waste. Environmental industry customers include all levels of government, the industrial and manufacturing sectors, engineering and consulting companies, commercial testing laboratories and colleges and universities. Drug testing and forensics laboratories use our instruments, software and workflow solutions for applications such as analyzing evidence associated with crime, screening athletes for performance enhancing drugs, analyzing samples for recreational drugs, or detecting and identifying biological and chemical warfare agents. Some of our instruments are used in mobile laboratories as well. Customers include local, state, federal, and international law enforcement agencies and health laboratories.

The Food Market.    Our instruments, software, and workflow solutions are used throughout the food production chain, including incoming inspection, new product development, quality control and assurance, and packaging. For example, our mass spectrometer portfolio is used to analyze contaminants and residual pesticides in food. There is also a significant food safety market involved in analyzing food for pathogen contamination, accurate verification of species type and evidence of genetically modified content.

Life Sciences and Applied Markets Products and Applications
Our products fall into eight main areas of work: liquid chromatography, gas chromatography, mass spectrometry, spectroscopy, software and informatics, lab automation and robotics, vacuum technology and cell analysis.

4
Table of Contents            

Our key products and applications include the following technologies:
Liquid Chromatography
A liquid chromatograph ("LC") or a high-performance liquid chromatograph ("HPLC") is used to separate molecules of a liquid mixture to determine the quantity and identity of the molecules present. The Agilent LC portfolio is modular in construction and can be configured as analytical and preparative systems. These systems can be stepwise upgraded to highly sophisticated, automated workflow solutions such as method development, multi‑method/walk-up, high-capacity/high-throughput or multi‑dimensional LC and can be extended to application‑based analyzers e.g. for bio-molecular separations, chiral analysis or size exclusion chromatography. As a leader in liquid chromatography, we continue to expand our application space with new HPLC columns, new services and diagnostics offerings and ongoing instrument and software product enhancements.
Gas Chromatography

Agilent is the world's leading provider of gas chromatographs, both laboratory and portable models. GC's are used to separate any gas, liquid or solid that can be vaporized and then detect the molecules present to determine their identity and quantity. Agilent provides custom or standard analyzers configured for specific chemical analysis applications, such as detailed speciation of a complex hydrocarbon stream, calculation of gas calorific values in the field, or analysis of a new bio-fuel formulation. We also offer related software, accessories and consumable products for these and other similar instruments.

Mass Spectrometry

A mass spectrometer (“MS”) identifies and quantifies chemicals based on a chemical's molecular mass and characteristic patterns of fragment ion masses that result when a molecule is broken apart. Liquid chromatography is commonly used to separate compounds and introduce them to the MS system. The combined use of LC and MS is frequently used both to identify and quantify chemical compounds. Mass spectrometry is an important tool in analyzing small molecules and can also be used to characterize and quantify proteins and other biological entities. Agilent's LCMS portfolio includes instruments built around four main analyzer types - single quadrupole, triple quadrupole, time-of-flight ("TOF") and quadrupole time-of-flight ("QTOF"). We significantly expanded our mass spectrometry portfolio in recent years with a focus on improving performance, sensitivity, and ease of use.

Spectroscopy

Spectroscopy is a technique for analyzing the individual chemical components of substances based on the absorption or emission of electromagnetic radiation of specific wavelengths of light. Our spectroscopy instruments include AA spectrometers, microwave plasma-atomic emission spectrometers ("MP-AES"), ICP-OES, ICP-MS, fluorescence spectrophotometers, ultraviolet- visible ("UV-Vis") spectrophotometers, Fourier Transform infrared ("FT-IR" spectrophotometers, near-infrared ("NIR") spectrophotometers, raman spectrometers and sample automation products. We also offer related software, accessories and consumable products for these and other similar instruments.

Software and Informatics

We provide software for instrument control, data acquisition, data analysis, laboratory content and business process management, and informatics. Our software facilitates the compliant use of instruments in pharmaceutical quality assurance/quality control environments. With our OpenLab Laboratory Software Suite, Agilent has a scalable, open software platform that enables customers to capture, analyze, and share scientific data throughout the lab and across the enterprise.

Lab Automation and Robotics

We offer a comprehensive suite of workflow solutions to our life science customers with the addition of automated liquid handling and robotics that range from standalone instrumentation to bench-top automation solutions. These solutions strengthen our offering of automated sample preparation solutions across a broad range of applications.


5
Table of Contents            

Vacuum Technology

Our vacuum technologies products are used to create, control, measure and test vacuum environments in life science, industrial and scientific applications where ultra-clean, high-vacuum environments are needed. Vacuum technologies' customers are typically OEMs that manufacture equipment for these applications, or government and research organizations that require vacuum solutions in their facilities. Products include a wide range of high and ultra-high vacuum pumps (diffusion, turbomolecular and ion getter), intermediate vacuum pumps (rotary vane, sorption and dry scroll), vacuum instrumentation (vacuum control instruments, sensor gauges and meters) and vacuum components (valves, flanges and other mechanical hardware). These products also include helium mass spectrometry and helium-sensing leak detection instruments used to identify and measure leaks in hermetic or vacuum environments. In addition to product sales, we also offer a wide range of services including an exchange and rebuild program, assistance with the design and integration of vacuum systems, applications support and training in basic and advanced vacuum technologies.

Cell Analysis

Our cell analysis tools are used to study cell signaling pathways, general cell function and behavior through metabolic profile analysis, real-time cellular impedance measurements, and traditional cytometry techniques. Characterizing cellular behavior and function is an increasingly critical step in understanding normal behavior versus diseased states, advancements of those diseases, and response to therapies, providing researchers with a more targeted approach for drug discovery and ultimately more effective therapeutics.  Our cell analysis portfolio includes cell analysis plate-based assays, flow cytometer, real-time cell analyzer, microplate reader, cell imaging system and related consumables. Cell analysis customers are typically academic institutions and pharma and biopharma companies.

Life Sciences and Applied Markets Customers
We had approximately 23,700 customers for our life sciences and applied markets business in fiscal 2019. No single customer represented a material amount of the net revenue of the life sciences and applied markets business. A significant number of our life sciences and applied markets customers are also customers of our Agilent CrossLab business.
The life sciences and applied markets business is susceptible to seasonality in its orders and revenues primarily related to U.S. and foreign government budgets, chemical and energy and environmental customers and large pharmaceutical company budgets. Historically, the result is that our first and fourth fiscal quarters tend to deliver the strongest profits for this group. However, general economic trends, new product introductions and competition might overshadow this trend in any given year.
Life Sciences and Applied Markets Sales, Marketing and Support
The life sciences and applied markets channels focus on the therapeutics and human disease research customer base (pharma, biopharma, CRO, CMO and generics), clinical customer base (high complexity clinical testing labs), emerging life sciences opportunities in life science research institutes and applied markets (chemical and energy, food, environmental and forensics). We deploy a multi-channel approach, marketing products to our customers through direct sales, electronic commerce, resellers, manufacturers' representatives and distributors. We primarily use direct sales to market our solutions to our pharmaceutical, biopharmaceutical, clinical, life science research and applied market accounts. Sales agents supplement direct sales by providing broader geographic coverage and coverage of smaller accounts. Our active reseller program augments our ability to provide more complete solutions to our customers. We sell our consumable products through distributors, electronic commerce and direct sales.
Our products typically come with standard warranties, and extended warranties are available for additional cost.
Life Sciences and Applied Markets Manufacturing
Our manufacturing supports our diverse product range and customer‑centric focus. We assemble highly configurable products to individual customer orders and make standard products to stock. We employ advanced manufacturing techniques and supply chain management systems to reduce costs and manufacturing cycle times. Our manufacturing process then converts these designs into standard as well as custom products for shipment to customers. We selectively use third parties to provide some supply chain processes for manufacturing, warehousing and logistics. Inside the U.S., we have manufacturing facilities in California, Delaware, Massachusetts and Vermont. Outside of the U.S., we have manufacturing facilities in Germany, Malaysia and Singapore. We have FDA registered sites in California, Vermont, Germany and Singapore.

6
Table of Contents            

Life Sciences and Applied Markets Competition
The markets for analytical instruments in which we compete are characterized by evolving industry standards and intense competition. Our principal competitors in the life sciences and applied markets arena include: Danaher Corporation, PerkinElmer Inc., Shimadzu Corporation, Thermo Fisher Scientific Inc. and Waters Corporation. Agilent competes on the basis of product performance, reliability, support quality, applications expertise, global channel coverage and price.

Diagnostics and Genomics Business

Our diagnostics and genomics business includes the genomics, nucleic acid contract manufacturing and research and development, pathology, companion diagnostics, reagent partnership and biomolecular analysis businesses.

Our diagnostics and genomics business is comprised of six areas of activity providing active pharmaceutical ingredients ("APIs") for oligo-based therapeutics as well as solutions that include reagents, instruments, software and consumables, which enable customers in the clinical and life sciences research areas to interrogate samples at the cellular and molecular level. First, our genomics business includes arrays for DNA mutation detection, genotyping, gene copy number determination, identification of gene rearrangements, DNA methylation profiling, gene expression profiling, as well as next generation sequencing ("NGS") target enrichment and genetic data management and interpretation support software. This business also includes solutions that enable clinical labs to identify DNA variants associated with genetic disease and help direct cancer therapy. Second, our nucleic acid solutions business provides equipment and expertise focused on production of synthesized oligonucleotides under pharmaceutical good manufacturing practices ("GMP") conditions for use as API in an emerging class of drugs that utilize nucleic acid molecules for disease therapy. Third, our pathology solutions business is focused on product offerings for cancer diagnostics and anatomic pathology workflows. The broad portfolio of offerings includes immunohistochemistry ("IHC"), in situ hybridization ("ISH"), hematoxylin and eosin ("H&E") staining and special staining. Fourth, we also collaborate with a number of major pharmaceutical companies to develop new potential pharmacodiagnostics, also known as companion diagnostics, which may be used to identify patients most likely to benefit from a specific targeted therapy. Fifth, the reagent partnership business is a provider of reagents used for turbidimetry and flow cytometry. Finally, our biomolecular analysis business provides complete workflow solutions, including instruments, consumables and software, for quality control analysis of nucleic acid samples.  Samples are analyzed using quantitative and qualitative techniques to ensure accuracy in further genomics analysis techniques utilized in clinical and life science research applications.

We employed approximately 2,800 people as of October 31, 2019 in our diagnostics and genomics business.

Diagnostics and Genomics Market

Within the diagnostics and genomics business, we focus primarily on the diagnostics and clinical market. A significant part of our clinical diagnostic customers are in pathology labs throughout the world. Our high-quality, automated pathology tissue staining platforms and solutions are used most heavily by the large labs located in hospitals, medical centers, and reference labs. The market is skewed towards mature economies, with most of the market in North America, Western Europe and Japan. The mix is changing, however, as emerging markets increase spending on human health.

The clinical market for genomics consists of high complexity clinical labs performing patient testing, including “for-profit” reference laboratories, hospital labs, and molecular diagnostic companies. While these labs primarily purchase in vitro diagnostics ("IVD") labeled testing kits, they often develop and validate their own molecular based tests. Analyte Specific Reagents ("ASRs") are often used by these labs.

Diagnostics and Genomics Products

Our products fall into eight main areas of work: pathology products, specific proteins and flow reagents, companion diagnostics, target enrichment, cytogenetic research solutions and microarrays, PCR and qPCR instrumentation and molecular biology reagents, nucleic acid solutions and automated electrophoresis and microfluidics.


7
Table of Contents            

Pathology

This area consists of routine clinical solutions for tissue-based cancer diagnostics with solutions that comprise antibodies, reagents, instruments and software targeting both primary and advanced cancer diagnostics. Our CoverStainer and Artisan based product families target primary cancer diagnostics through hematoxylin and eosin staining as well as special stains for additional insights and detection of potentially carcinogenic tissue. Dako Omnis and Autostainer based IHC solution and Instant Quality Fluorescence In Situ Hybridization ("IQFISH") technologies provide advanced tumor typing through investigation of protein and gene expression. These products also include companion diagnostic tests that are used to help identify patients most likely to benefit from a specific targeted therapy.
Specific Proteins and Flow Reagents

Our reagent OEM business is a provider of clinical diagnostic products within the areas of specific proteins for turbidimetry and reagents for flow cytometry. These are sold to OEM customers as customized reagent solutions supplied to top IVD companies or through retail partners.

Companion Diagnostics

In our companion diagnostics business, we partner with a number of major pharmaceutical companies to develop new potential pharmacodiagnostics, which may be used to identify patients most likely to benefit from a specific targeted therapy. We support pharmaceutical companies during each phase of their drug development process, from early pre-clinical through commercial launch activities. Companion diagnostics has a history of developing clinically relevant and validated tests, with accurate and effective scoring and interpretation guidelines, that enable successful regulatory approvals in our worldwide markets.

Target Enrichment

We provide a target enrichment portfolio composed of two main platforms, SureSelect and HaloPlex, both enabling customers to select specific target regions of the genome for sequencing. Customers can customize our products for their regions of interest using the SureDesign software, or they can choose from a wide range of catalog products, including gene panels for specific applications and Exome designs, which allow analysis of the entire coding sequences of the genome. The technologies provide an easy sample prep workflow that can be automated with the Agilent Bravo platform for scalability. HaloPlex provides less-than-24-hours fast workflow, which makes it suitable for labs that require fast turnaround time from sample to results. These products are used for mutation detection and genotyping. Results can be easily analyzed using Agilent software solutions GeneSpring or SureCall. Our solutions also enable clinical labs to identify DNA variants associated with genetic diseases and help direct cancer therapy.

Cytogenetic Research Solutions and Microarrays

We provide microarrays for comparative genomic hybridization (“CGH”), mostly used by customers in cytogenetic laboratories. The arrays allow customers to detect genome-wide copy number alterations, with high levels of resolution (from entire chromosomal copy number changes to specific microdeletions or duplications). The arrays are offered in many formats allowing the customers to choose from different levels of resolution and number of samples per arrays. Arrays can also be customized using the SureDesign software. In addition to the microarrays, Agilent's solution includes reagents for sample processing, hardware for reading the microarrays, and software to help users view the data in a meaningful way. In addition to the CGH portfolio, the cytogenetics solution comprises a line of oligonucleotide probes for fluorescent in situ hybridization ("FISH") called SureFISH. Additionally, Agilent provides a wide range of microarrays to the research market for different types of applications: gene expression, microRNA, methylation, splice variants, and chromatin immunoprecipitation applications. Arrays are offered as catalog designs or customizable designs, with no minimum order size and short delivery time, which differentiates us from other vendors and enables researchers the maximum flexibility in their studies.


8
Table of Contents            

PCR and qPCR Instrumentation and Molecular Biology Reagents

Polymerase chain ceaction ("PCR") is a standard laboratory method used to amplify the amount of genetic material of a given sample to enable further interrogation.  Quantitative PCR ("qPCR") or real time PCR is also a standard method used in genomic research facilities to measure the amount of a specific nucleic acid sequence within a sample.  There are several applications for qPCR, among the most common are identifying the expression level of a specific gene, or calculating the amount of a specific pathogen present in a sample. Agilent offers a complete portfolio of PCR & qPCR instruments, as well as specialty enzymes for amplifying difficult sample types. In addition to PCR and qPCR enzymes, Agilent offers a wide range of molecular biology reagents including tools for cloning and mutagenesis applications.

Nucleic Acid Solutions

Our nucleic acid solutions business is a contract manufacturing and development services business with equipment and expertise focused on mid to large scale production of synthesized oligonucleotide APIs under pharmaceutical GMP conditions for an emerging class of drugs that utilize oligonucleotide molecules for disease therapy.  These drugs have advanced from single strand DNA molecules to complex, highly modified molecules including antisense, aptamers, double-stranded RNA, and RNA mixtures. These advancements in the technology have greatly improved the efficacy of delivery and stability of the oligos in-vivo. Our nucleic acid solutions business offers industry leading experience to efficiently advance our customer’s oligo drug candidates from clinical trials to commercial launch with a common goal of patient health and safety.  

Automated Electrophoresis and Microfluidics
Automated electrophoresis is a separation technique for bio molecules such as proteins, peptides and nucleic acids (RNA and DNA) and is used to determine the identity of a molecule by either size or charge. It is widely used as a QC tool to check sample integrity prior to subsequent analysis. Prominent examples are nucleic acid preparation products in front of polymerase chain reaction, NGS and microarrays.

Diagnostics and Genomics Customers

We had approximately 11,500 customers for our diagnostics and genomics business in fiscal 2019. No single customer represented a material amount of the net revenue of the diagnostics and genomics business.

Diagnostics and Genomics Sales, Marketing and Support

The diagnostics and genomics channels focus on the therapeutics and human disease research customer base (pharma, biopharma, CRO, CMO and generics), clinical customer base (pathology labs and high complexity clinical testing labs) and on emerging life sciences opportunities in life science research institutes. We deploy a multi-channel approach, marketing products to our customers through direct sales, electronic commerce, resellers, manufacturers' representatives and distributors. We primarily use direct sales to market our solutions to our pharmaceutical, biopharmaceutical and clinical accounts. Sales agents supplement direct sales by providing broader geographic coverage and coverage of smaller accounts. Our active reseller program augments our ability to provide more complete solutions to our customers. We sell our consumable products through distributors, telesales, electronic commerce and direct sales. We utilize telesales for more mature product lines, as well as for reorders of reagent products.
Diagnostics and Genomics Manufacturing

Our manufacturing supports our diverse product range and customer-centric focus. We assemble highly configurable products to individual customer orders and make standard products to stock. We employ advanced manufacturing techniques and supply chain management systems to reduce costs and manufacturing cycle times. We selectively use third parties to provide some supply chain processes for manufacturing, warehousing and logistics. In the U.S., we have manufacturing facilities in California, Colorado and Texas. Outside of the U.S., we have manufacturing facilities in Denmark and Malaysia. Our FDA registered sites include California, Colorado, Texas and Denmark. We utilize just-in-time manufacturing and so typically do not maintain a high level of inventory.

Diagnostics and Genomics Competition

The markets for diagnostics and genomics analytical products in which we compete are characterized by evolving industry standards and intense competition. Our principal competitors in the diagnostics and genomics arena include: Roche Ventana

9
Table of Contents            

Medical Systems, Inc., a member of the Roche Group, Leica Biosystems, Inc., a division of Danaher Corporation, Abbott Laboratories, Ilumina, Inc. and Affymetrix, Inc., a division of Thermo Fisher Scientific Inc. Agilent competes on the basis of product performance, reliability, support quality, applications expertise, whole solution offering, global channel coverage and price.

Diagnostics and Genomics Government Regulation
Some of the products the diagnostics and genomics business sells are subject to regulatory approval by the FDA and other regulatory bodies throughout the world.  These regulations govern a wide variety of product related activities, from quality management, design and development to labeling, manufacturing, promotion, sales and distribution.  We continually invest in our manufacturing infrastructure to gain and maintain certifications necessary for the level of clearance.

Agilent CrossLab Business

The Agilent CrossLab business spans the entire lab with its extensive consumables and services portfolio, which is designed to improve customer outcomes. The majority of the portfolio is vendor neutral, meaning Agilent can serve and supply customers regardless of their instrument purchase choices. Solutions range from chemistries and supplies to services and software helping to connect the entire lab. Key product categories in consumables include GC and LC columns, sample preparation products, custom chemistries, and a large selection of laboratory instrument supplies. Services include startup, operational, training and compliance support, software as a service, as well as asset management and consultative services that help increase customer productivity. Custom service and consumable bundles are tailored to meet the specific application needs of various industries and to keep instruments fully operational and compliant with the respective industry requirements.

Our Agilent CrossLab business employed approximately 5,500 people as of October 31, 2019.

Agilent CrossLab Markets

The Pharmaceutical, Biopharmaceutical, CRO & CMO Market. Our services and consumable products support customers in this market that consists of “for-profit” companies who participate across the pharmaceutical value chain in the areas of therapeutic research, discovery and development, clinical trials, manufacturing and quality assurance and quality control. One sub-segment of this market is core and emerging pharmaceutical companies ("pharma"). A second sub-segment includes biopharmaceutical companies ("biopharma"), contract research organizations ("CROs") and contract manufacturing organizations ("CMOs"). Biopharma companies and, to a somewhat lesser extent, CROs and CMOs typically participate in specific points in the pharmaceutical industry value chain. Additionally, due to the relatively low drug efficacy within oncology, pharma companies are partnering with diagnostic companies to bring validated tests to the market with their new drugs.
The Academic and Government Market. Our services and consumable products support customers in this market that consists primarily of “not-for-profit” organizations and includes academic institutions, large government institutes and privately funded organizations. The academic and government market plays an influential role in technology adoption and therapeutic developments for pharmaceutical and molecular diagnostics companies. After decades of investment in basic biomedical research by government funding bodies, the focus has widened to include translational research - multidisciplinary scientific efforts directed at accelerating therapy development.
The Chemical & Energy Market.    The natural gas and petroleum refining markets use our services and consumable products to support their quality control and environmental safety reviews. Petroleum refiners use our services and consumable products to support their analysis of crude oil composition and raw materials, as well as help improve their refining processes and improve the quality of their products.  Our services and consumable products are also used in the development, manufacturing and quality control of fine chemicals and other industrial applications, such as material analysis.

The Environmental & Forensics Market.    Our services and consumable products support the environmental industry customers that perform laboratory and field analysis of chemical pollutants in air, water, soil and solid waste. Environmental industry customers include all levels of government, the industrial and manufacturing sectors, engineering and consulting companies, commercial testing laboratories and colleges and universities. Our services and consumable products also support drug testing and forensics laboratories that are involved with analyzing evidence associated with crime, screening athletes for performance enhancing drugs, analyzing samples for recreational drugs, or detecting and identifying biological and chemical warfare agents. Customers include local, state, federal, and international law enforcement agencies and commercial testing laboratories.


10
Table of Contents            

The Food Market.    Our services and consumable products support the food production chain, including incoming inspection, new product development, quality control and assurance, and packaging. Our services and consumable products also support the food safety market in their work to analyze food for concerns ranging from pathogen contamination, genetic modification, species verification and others.

The Diagnostics and Clinical Market. Our services and consumable products support clinical diagnostic customers in pathology labs throughout the world. The market is skewed towards the mature economies, with most of the market in North America, Western Europe and Japan. The mix is changing, however, as emerging markets increase spending on human health.
Agilent CrossLab Products and Applications

Chemistries and Supplies

We offer a broad range of market specific consumables and supplies to complete customers' analytical workflows from sample preparation through separation and analysis to storage, with the support of our technology platforms. This includes sample preparation consumables such as solid phase extraction ("SPE") and filtration products, self-manufactured GC and LC columns, chemical standards, and instrument replacement parts. Consumable products also include scientific instrument parts and supplies such as filters and fittings for GC systems; xenon lamps and cuvettes for UV-Vis-NIR, fluorescence, FT-IR and raman spectroscopy instruments; and graphite furnace tubes, hollow cathode lamps and specialized sample introduction glassware for our AA, ICP-OES and ICP-MS products.

Services and Support

We offer a wide range of startup, operational, educational and compliance support services for our measurement and data handling systems. Our support services include maintenance, troubleshooting, repair and training for all of our chemical and bioanalytical instrumentation hardware and software products. Special service bundles have also been designed to meet the specific application needs of various industries. As customers continue to outsource laboratory operations and consolidate suppliers, our enterprise services consist of a broad portfolio of integrated laboratory management services including instrument services, lab supply management, asset management, procurement, informatics and scientific services. Advancements in our offering software and service solutions will help our customers operate a more digitally connected smart lab that can derive more value out of data analytics, artificial intelligence and robotics.

Remarketed Instruments

We refurbish and resell certified pre-owned instruments to value-oriented customers who demand Agilent quality and performance at a budget conscious price.

Agilent CrossLab Customers

We had approximately 52,500 Agilent CrossLab customers in fiscal 2019 and no single customer represented a material amount of the net revenue of the Agilent CrossLab business. A significant number of our Agilent CrossLab customers are also customers of our life sciences and applied markets business.

The service and consumables business is mostly recurring in nature, and is not as susceptible to market seasonality and industry cycles in comparison to our instrument businesses. The vendor neutral portion of the portfolio allows the business to perform relatively independent from our instrument business.

Agilent CrossLab Sales, Marketing and Support

We deploy a multi-channel approach, marketing products and services to our customers through direct sales, electronic commerce, resellers, manufacturers' representatives and distributors. We primarily use direct sales to market our solutions to our large accounts. Sales agents supplement direct sales by providing broader geographic coverage and coverage of smaller accounts. Our active reseller program augments our ability to provide more complete solutions to our customers. We utilize telesales to enhance the transactional sales model of our products. All channels are supported by technical product and application specialists to meet our customer’s specific requirements.
We deliver our support services to customers in a variety of ways, including on-site assistance with repair or exchange of returned products, telephone support and self-diagnostic services provided over the Internet. We also offer special industry-focused service bundles that are designed to meet the specific needs of hydrocarbon processing, environmental, pharmaceutical and

11
Table of Contents            

biopharmaceutical customers to keep instruments fully operational and compliant with the respective industry requirements. Our products typically come with standard warranties, and extended warranties are available for additional cost.
Agilent CrossLab Manufacturing

Our primary manufacturing sites for the consumables business are in California and Delaware in the U.S., and in the Netherlands and the United Kingdom outside of the U.S. Our direct service delivery organization is regionally based operating in 30 countries.

Agilent CrossLab Competition

Our principal competitors in the services and consumable products arena include many of our competitors from the instrument business, such as: Danaher Corporation, PerkinElmer, Inc., Shimadzu Corporation, Thermo Fisher Scientific Inc. and Waters Corporation, as well as numerous niche consumables and service providers. Agilent competes on the basis of product performance, reliability, support quality, applications expertise, global channel coverage and price.

Agilent Technologies Research Laboratories

Agilent Technologies Research Laboratories ("Agilent Labs") is our central research organization based in Santa Clara, California. The Research Labs create competitive advantage through high-impact technology, driving market leadership and growth in Agilent's core businesses and expanding Agilent's footprint into adjacent markets. At the cross-roads of the organization, the Research Labs are able to identify and enable synergies across Agilent's businesses to create competitive differentiation and compelling customer value.

The technical staff have advanced degrees that cover a wide range of scientific and engineering fields, including molecular and cell biology, chemistry, physics, pathology, mathematics, software and informatics, artificial intelligence, deep and machine learning, image processing, nano/microfabrication, fluidics, and business.

Global Infrastructure Organization

We provide support to our businesses through our global infrastructure organization. This support includes services in the areas of finance, tax, treasury, legal, real estate, insurance services, workplace services, human resources, information technology services, order administration and other corporate infrastructure expenses. Generally, these organizations are managed from Santa Clara, California, with operations and services provided worldwide. As of the end of October 2019, our global infrastructure organization employed approximately 2,600 people worldwide.

Agilent Order Fulfillment Organizations

Our order fulfillment and supply chain organization (“OFS”) focuses on order fulfillment and supply chain operations in our businesses. OFS provides resources for manufacturing, engineering and strategic sourcing to our respective businesses. In general, OFS employees are dedicated to specific businesses and the associated costs are directly allocated to those businesses.

        The following discussions of Research and Development, Backlog, Intellectual Property, Materials, Environmental and Acquisition and Disposal of Material Assets include information common to each of our businesses.

Research and Development

We anticipate that we will continue to have significant research and development expenditures in order to maintain our competitive position with a continuing flow of innovative, high-quality products and services. Our research and development efforts focus on potential new products and product improvements covering a wide variety of technologies, none of which is individually significant to our operations. Our research seeks to improve on various technical competencies in software, systems and solutions, life sciences and diagnostics. In each of these research fields, we conduct research that is focused on specific product development for release in the short-term as well as other research that is intended to be the foundation for future products over a longer time-horizon. Most of our product development research is designed to improve products already in production, focus on major new product releases, and develop new product segments for the future. We remain committed to invest significantly in research and development and have focused our development efforts on key strategic opportunities to align our business with available markets and position ourselves to capture market share.


12
Table of Contents            

Backlog

We believe that backlog is not a meaningful indicator of future business prospects for our business segments since a significant portion of our revenue for a given quarter is derived from the current quarter's orders.  Therefore, we believe that backlog information is not material to an understanding of our business.

Intellectual Property

We generate patent and other intellectual property rights covering significant inventions and other innovations in order to create a competitive advantage. While we believe that our licenses, patents and other intellectual property rights have value, in general no single license, patent or other intellectual property right is in itself material. In addition, our intellectual property rights may be challenged, invalidated or circumvented or may otherwise not provide significant competitive advantage.

Materials

Our life sciences and applied markets, diagnostics and genomics and Agilent CrossLab businesses all purchase materials from thousands of suppliers on a global basis. Some of the parts that require custom design work are not readily available from alternate suppliers due to their unique design or the length of time necessary for design work. Our long-term relationships with suppliers allow us to proactively manage technology road maps and product discontinuance plans and monitor their financial health. To address any potential disruption in our supply chain, we use a number of techniques, including qualifying multiple sources of supply and redesign of products for alternative components. In addition, while we generally attempt to keep our inventory at minimal levels, we do purchase incremental inventory as circumstances warrant to protect the supply chain.

Environmental

Our R&D, manufacturing and distribution operations involve the use of hazardous substances and are regulated under international, federal, state and local laws governing health and safety and the environment. We apply strict standards for protection of the environment and occupational health and safety to sites inside and outside the U.S., even if not subject to regulation imposed by foreign governments. We believe that our properties and operations at our facilities comply in all material respects with applicable environmental laws and occupational health and safety laws. We are also regulated under a number of international, federal, state, and local laws regarding recycling, product packaging and product content requirements. We believe we are substantially in compliance with such environmental, product content/disposal and recycling laws.

We maintain a comprehensive Environmental Site Liability insurance policy which may cover certain clean-up costs or legal claims related to environmental contamination. This policy covers specified active, inactive and divested locations.



13
Table of Contents            

Information about our Executive Officers
The names of our current executive officers and their ages, titles and biographies appear below:

Henrik Ancher-Jensen, 54, has served as our Senior Vice President, Agilent and President, Order Fulfillment since September 2013.  From September 2012 to September 2013, Mr. Ancher-Jensen served as our Vice President, Global Product Supply, Diagnostics and Genomics Group.  From September 2010 to September 2012 he served as Corporate Vice President, Global Operations of Dako A/S, a Danish diagnostics company, and as Dako’s Vice President, Supply Chain and Chief Information Officer from 2006 to September 2010.  Prior to joining Dako, he spent more than 15 years in senior management roles and management consulting with Chr. Hansen, Deloitte Consulting and NVE.

Mark Doak, 64, has served as our Senior Vice President, Agilent and President, Agilent CrossLab Group since September 2014. From August 2008 to September 2014, Mr. Doak served as our Vice President and General Manager of the Services and Support Division.  Prior to that, he held several senior management positions across functions in marketing, quality and services.

Rodney Gonsalves, 54, has served as our Vice President, Corporate Controllership and Chief Accounting Officer since May 2015.  From September 2009 to May 2015, Mr. Gonsalves served as Vice President and operational CFO for various business groups within the company, most recently for the Life Sciences and Applied Markets Group. Prior to that, Mr. Gonsalves served in various capacities for Agilent, including as vice president of Investor Relations, controller, corporate governance and customer financing in Agilent’s Global Infrastructure Organization, and controller for the Photonics Systems Business Unit.  Before joining Agilent, Mr. Gonsalves held a variety of positions in finance with Hewlett- Packard Co.  

Dominique P. Grau, 60, has served as our Senior Vice President, Human Resources since August 2014. From May 2012 to August 2014 Mr. Grau served as Vice President, Worldwide Human Resources. Prior to that, he served as Vice President, Compensation, Benefits and HR Services from May 2006 to May 2012. Mr. Grau had previously served in various capacities for Agilent and Hewlett-Packard Company.

Robert W. McMahon, 51, has served as our Senior Vice President since August 2018 and Chief Financial Officer since September 2018. He previously served as the Chief Financial Officer of Hologic, Inc., a medical technology company from May 2014 to August 2018.  Prior to Hologic, Mr. McMahon spent 20 years with Johnson & Johnson most recently as Worldwide Vice President of Finance and Business Development for Ortho Clinical Diagnostics a division of Johnson & Johnson's Medical Device and Diagnostics Group.

Michael R. McMullen, 58, has served as Chief Executive Officer since March 2015 and as President since September 2014. From September 2014 to March 2015 he also served as Chief Operating Officer. From September 2009 to September 2014 he served as Senior Vice President, Agilent and President, Chemical Analysis Group. Prior to that, he served in various capacities for Agilent, including as our Vice President and General Manager of the Chemical Analysis Solutions Unit of the Life Sciences and Chemical Analysis Group and Country Manager for Agilent's China, Japan and Korea Life Sciences and Chemical Analysis Group. Prior to that, Mr. McMullen served as Controller for the Hewlett‑Packard Company and Yokogawa Electric Joint Venture from July 1996 to March 1999. Since September 2018, Mr. McMullen has served as a member of the Board of Directors of Coherent, Inc.

Samraat S. Raha, 47, has served as our Senior Vice President, Agilent and President, Diagnostics and Genomics Group since April 2018.  From May 2017 to April 2018, Mr. Raha served as our Senior Vice President, Strategy and Corporate Development.  From June 2013 to January 2017 he served as Vice President, Global Marketing for Illumina, Inc. and from 2008 to 2012 he served as Vice President and General Manager, Genomic Assays / NextGen qPCR for Life Technologies, Inc. 

Michael Tang, 45, has served as our Senior Vice President, General Counsel and Secretary since January 2016. From May 2015 to January 2016 he served as Vice President, Assistant General Counsel and Secretary and from November 2013 to April 2015 he served as Vice President, Assistant General Counsel and Assistant Secretary. From March 2012 to October 2013 he served as Business Development Manager in Agilent’s Corporate Development group. Prior to that, Mr. Tang served in various capacities in Agilent's legal department. Before joining Agilent, Mr. Tang worked at Wilson Sonsini Goodrich & Rosati, a California law firm and Fenwick & West LLP, a California law firm.

Jacob Thaysen, 44, has served as our Senior Vice President, Agilent and President, Life Sciences and Applied Markets Group, since April 2018. From November 2014 to April 2018 he served as Senior Vice President, Agilent and President, Diagnostics and Genomics Group.  From October 2013 to November 2014 he served as Vice President and General Manager of the Diagnostics and Genomics business. Prior to that he served as Vice President and General Manager of the Genomics Solutions unit from January 2013 to October 2013. Before joining Agilent, he served in various capacities at Dako A/S, a Danish diagnostics company,

14
Table of Contents            

including as Corporate Vice President of R&D, Vice President, System Development, R&D, Vice President, Strategic Marketing and Vice President, Global Sales Operations. Prior to Dako, Mr. Thaysen worked as a management consultant and Chief Technical Officer and founder of a high-tech start-up company.

Investor Information
We are subject to the informational requirements of the Securities Exchange Act of 1934 (“Exchange Act”). Therefore, we file periodic reports, proxy statements and other information with the Securities and Exchange Commission (“SEC”). The SEC maintains an Internet site (http://www.sec.gov) that contains reports, proxy and information statements and other information regarding issuers that file electronically.
Our financial and other information can be accessed at our Investor Relations website. The address is www.investor.agilent.com. We make available, free of charge, copies of our annual report on Form 10-K, quarterly reports on Form 10-Q, current reports on Form 8-K and amendments to those reports filed or furnished pursuant to Section 13(a) or 15(d) of the Exchange Act as soon as reasonably practicable after filing such material electronically or otherwise furnishing it to the SEC.
Our Amended and Restated Bylaws, Corporate Governance Standards, the charters of our Audit and Finance Committee, our Compensation Committee, our Executive Committee and our Nominating/Corporate Governance Committee, as well as our Standards of Business Conduct (including code of ethics provisions that apply to our principal executive officer, principal financial officer, principal accounting officer and senior financial officers) are available on our website at www.investor.agilent.com under “Corporate Governance”. These items are also available in print to any stockholder in the United States and Canada who requests them by calling (877) 942-4200. This information is also available by writing to the company at the address on the cover of this Annual Report on Form 10-K.

Item 1A.  Risk Factors

Risks, Uncertainties and Other Factors That May Affect Future Results
Our operating results and financial condition could be harmed if the markets into which we sell our products decline or do not grow as anticipated.

Visibility into our markets is limited. Our quarterly sales and operating results are highly dependent on the volume and timing of orders received during the fiscal quarter, which are difficult to forecast and may be cancelled by our customers. In addition, our revenue and earnings forecasts for future fiscal quarters are often based on the expected seasonality of our markets. However, the markets we serve do not always experience the seasonality that we expect as customer spending policies and budget allocations, particularly for capital items, may change. Any decline in our customers' markets or in general economic conditions would likely result in a reduction in demand for our products and services. Also, if our customers' markets decline, we may not be able to collect on outstanding amounts due to us. Such declines could harm our consolidated financial position, results of operations, cash flows and stock price, and could limit our profitability. Also, in such an environment, pricing pressures could intensify. Since a significant portion of our operating expenses is relatively fixed in nature due to sales, research and development and manufacturing costs, if we were unable to respond quickly enough these pricing pressures could further reduce our operating margins.


15
Table of Contents            

If we do not introduce successful new products and services in a timely manner to address increased competition through frequent new product and service introductions, rapid technological changes and changing industry standards, our products and services may become obsolete, and our operating results may suffer.

We generally sell our products in industries that are characterized by increased competition through frequent new product and service introductions, rapid technological changes and changing industry standards. Without the timely introduction of new products, services and enhancements, our products and services may become technologically obsolete over time, in which case our revenue and operating results could suffer. The success of our new products and services will depend on several factors, including our ability to:

•
properly identify customer needs and predict future needs;
•
innovate and develop new technologies, services and applications;
•
appropriately allocate our research and development spending to products and services with higher growth prospects;
•
successfully commercialize new technologies in a timely manner;
•
manufacture and deliver new products in sufficient volumes and on time;
•
differentiate our offerings from our competitors' offerings;
•
price our products competitively;
•
anticipate our competitors' development of new products, services or technological innovations; and
•
control product quality in our manufacturing process.

In addition, if we fail to accurately predict future customer needs and preferences or fail to produce viable technologies, we may invest in research and development of products and services that do not lead to significant revenue, which would adversely affect our profitability. Even if we successfully innovate and develop new and enhanced products and services, we may incur substantial costs in doing so, and our operating results may suffer. In addition, promising new products may fail to reach the market or realize only limited commercial success because of real or perceived concerns of our customers. Furthermore, as we collaborate with pharmaceutical customers to develop drugs such as companion diagnostics assays or provide drug components like active pharmaceutical ingredients, we face risks that those drug programs may be cancelled upon clinical trial failures.

General economic conditions may adversely affect our operating results and financial condition.

Our business is sensitive to negative changes in general economic conditions, both inside and outside the United States. Slower global economic growth and uncertainty in the markets in which we operate may adversely impact our business resulting in:

•
reduced demand for our products, delays in the shipment of orders, or increases in order cancellations;
•
increased risk of excess and obsolete inventories;
•
increased price pressure for our products and services; and
•
greater risk of impairment to the value, and a detriment to the liquidity, of our investment portfolio.

Failure to adjust our purchases due to changing market conditions or failure to accurately estimate our customers' demand could adversely affect our income.

Our income could be harmed if we are unable to adjust our purchases to reflect market fluctuations, including those caused by the seasonal nature of the markets in which we operate. The sale of our products and services are dependent, to a large degree, on customers whose industries are subject to seasonal trends in the demand for their products. During a market upturn, we may not be able to purchase sufficient supplies or components to meet increasing product demand, which could materially affect our results. In the past, we have experienced a shortage of parts for some of our products. In addition, some of the parts that require custom design are not readily available from alternate suppliers due to their unique design or the length of time necessary for design work. Should a supplier cease manufacturing such a component, we would be forced to reengineer our product. In addition to discontinuing parts, suppliers may also extend lead times, limit supplies or increase prices due to capacity constraints or other factors. In order to secure components for the production of products, we may continue to enter into non-cancelable purchase commitments with vendors, or at times make advance payments to suppliers, which could impact our ability to adjust our inventory to declining market demands. If demand for our products is less than we expect, we may experience additional excess and obsolete inventories and be forced to incur additional expenses.


16
Table of Contents            

Demand for some of our products and services depends on the capital spending policies of our customers, research and development budgets and on government funding policies.

Our customers include pharmaceutical companies, laboratories, universities, healthcare providers, government agencies and public and private research institutions. Many factors, including public policy spending priorities, available resources, mergers and consolidations, institutional and governmental budgetary policies and spending priorities, and product and economic cycles, have a significant effect on the capital spending policies of these entities. Fluctuations in the research and development budgets at these organizations could have a significant effect on the demand for our products and services. Research and development budgets fluctuate due to changes in available resources, consolidation, spending priorities, general economic conditions and institutional and governmental budgetary policies. The timing and amount of revenue from customers that rely on government funding or research may vary significantly due to factors that can be difficult to forecast, including changes in spending authorizations and budgetary priorities for our products and services. If demand for our products and services is adversely affected, our revenue and operating results would suffer.

Economic, political, foreign currency and other risks associated with international sales and operations could adversely affect our results of operations.

Because we sell our products worldwide, our business is subject to risks associated with doing business internationally. We anticipate that revenue from international operations will continue to represent a majority of our total revenue. International revenue and costs are subject to the risk that fluctuations in foreign currency exchange rates could adversely affect our financial results when translated into U.S. dollars for financial reporting purposes. The unfavorable effects of changes in foreign currency exchange rates have decreased revenues by approximately 2 percentage points in the year ended October 31, 2019. When movements in foreign currency exchange rates have a negative impact on revenue, they will also have a positive impact by reducing our costs and expenses. In addition, many of our employees, contract manufacturers, suppliers, job functions, outsourcing activities and manufacturing facilities are located outside the United States. Accordingly, our future results could be harmed by a variety of factors, including:

•
interruption to transportation flows for delivery of parts to us and finished goods to our customers;
•
changes in a specific country's or region's political, economic or other conditions;
•
changes in diplomatic and trade relationships, such as the United Kingdom's exit from the European Union, including new tariffs, trade protection measures, import or export licensing requirements, new or different customs duties trade embargoes and sanctions and other trade barriers;
•
tariffs imposed by the U.S. on goods from other countries and tariffs imposed by other countries on U.S. goods, including the tariffs enacted and proposed by the U.S. government on various imports from China and by the Chinese government on certain U.S. goods;
•
negative consequences from changes in or differing interpretations of laws and regulations, including those related to tax and import/export;
•
difficulty in staffing and managing widespread operations;
•
differing labor regulations;
•
differing protection of intellectual property;
•
unexpected changes in regulatory requirements; and
•
geopolitical uncertainty or turmoil, including terrorism and war.

We sell our products into many countries and we also source many components and materials for our products from and manufacture our products in various countries. Tariffs recently announced and implemented could have negative impact on our business, results of operations and financial condition. It may be time-consuming and expensive for us to alter our business operations in order to adapt to any such change. Further, additional tariffs, the scope and duration of which, if implemented, remains uncertain, which have been proposed or threatened and the potential escalation of a trade war and retaliatory measures could have a material adverse effect on our business, results of operations and financial condition.

Most of our accounting and tax processes including general accounting, cost accounting, accounts payable, accounts receivables and tax functions are centralized at locations in India and Malaysia. If conditions change in those countries, it may adversely affect operations, including impairing our ability to pay our suppliers and collect our receivables. Our results of operations, as well as our liquidity, may be adversely affected and possible delays may occur in reporting financial results.

In addition, although the majority of our products are priced and paid for in U.S. dollars, a significant amount of certain types of expenses, such as payroll, utilities, tax, and marketing expenses, are paid in local currencies. Our hedging programs reduce, but do not always entirely eliminate, within any given twelve-month period, the impact of currency exchange rate movements, and therefore fluctuations in exchange rates, including those caused by currency controls, could impact our business,

17
Table of Contents            

operating results and financial condition by resulting in lower revenue or increased expenses. For expenses beyond that twelve-month period, our hedging strategy does not mitigate our exposure. In addition, our currency hedging programs involve third party financial institutions as counterparties. The weakening or failure of financial institution counterparties may adversely affect our hedging programs and our financial condition through, among other things, a reduction in available counterparties, increasingly unfavorable terms, and the failure of the counterparties to perform under hedging contracts.

Our strategic initiatives to adjust our cost structure could have long-term adverse effects on our business and we may not realize the operational or financial benefits from such actions.

We have implemented multiple strategic initiatives across our businesses to adjust our cost structure, and we may engage in similar activities in the future. These strategic initiatives and our regular ongoing cost reduction activities may distract management, could slow improvements in our products and services and limit our ability to increase production quickly if demand for our products increases. In addition, delays in implementing our strategic initiatives, unexpected costs or failure to meet targeted improvements may diminish the operational and financial benefits we realize from such actions. Any of the above circumstances could have an adverse effect on our business and operating results and financial condition.

Our business will suffer if we are not able to retain and hire key personnel.

Our future success depends partly on the continued service of our key research, engineering, sales, marketing, manufacturing, executive and administrative personnel. If we fail to retain and hire a sufficient number of these personnel, we will not be able to maintain or expand our business. The markets in which we operate are very dynamic, and our businesses continue to respond with reorganizations, workforce reductions and site closures. We believe our pay levels are very competitive within the regions that we operate. However, there is intense competition for certain highly technical specialties in geographic areas where we continue to recruit, and it may become more difficult to hire and retain our key employees.

Our acquisitions, strategic investments and alliances, joint ventures, exiting of businesses and divestitures may result in financial results that are different than expected.

In the normal course of business, we frequently engage in discussions with third parties relating to possible acquisitions, strategic investments and alliances, joint ventures and divestitures, and generally expect to complete several transactions per year. In addition, we may decide to exit a particular business within our product portfolio. As a result of such transactions, our financial results may differ from our own or the investment community's expectations in a given fiscal quarter, or over the long term. We may have difficulty developing, manufacturing and marketing the products of a newly acquired company in a way that enhances the performance of our combined businesses or product lines. Acquired businesses may also expose us to new risks and new markets and we may have difficulty addressing these risks in a cost effective and timely manner. Transactions such as acquisitions have resulted, and may in the future result in, unexpected significant costs and expenses. In the future, we may be required to record charges to earnings during the period if we determine there is an impairment of goodwill or intangible assets, up to the full amount of the value of the assets, or, in the case of strategic investments and alliances, consolidate results, including losses, of third parties or write down investment values or loans and convertible notes related to the strategic investment.

Integrating the operations of acquired businesses within Agilent could be a difficult, costly and time-consuming process that involves a number of risks. Acquisitions and strategic investments and alliances may require us to integrate and collaborate with a different company culture, management team, business model, business infrastructure and sales and distribution methodology and assimilate and retain geographically dispersed, decentralized operations and personnel. Depending on the size and complexity of an acquisition, our successful integration of the entity depends on a variety of factors, including introducing new products and meeting revenue targets as expected, the retention of key employees and key customers, increased exposure to certain governmental regulations and compliance requirements and increased costs and use of resources. Further, the integration of acquired businesses is likely to result in our systems and internal controls becoming increasingly complex and more difficult to manage. Any difficulties in the assimilation of acquired businesses into our control system could harm our operating results or cause us to fail to meet our financial reporting obligations.

Even if we are able to successfully integrate acquired businesses within Agilent, we may not be able to realize the revenue and other synergies and growth that we anticipated from the acquisition in the time frame that we expected, and the costs of achieving these benefits may be higher than what we expected. As a result, the acquisition and integration of acquired businesses may not contribute to our earnings as expected, we may not achieve our operating margin targets when expected, or at all, and we may not achieve the other anticipated strategic and financial benefits of such transactions.

A successful divestiture depends on various factors, including our ability to effectively transfer liabilities, contracts, facilities and employees to the purchaser, identify and separate the intellectual property to be divested from the intellectual property that

18
Table of Contents            

we wish to keep and reduce fixed costs previously associated with the divested assets or business. In addition, if customers of the divested business do not receive the same level of service from the new owners, this may adversely affect our other businesses to the extent that these customers also purchase other Agilent products. In exiting a business, we may still retain liabilities associated with the support and warranty of those businesses and other indemnification obligations. All of these efforts require varying levels of management resources, which may divert our attention from other business operations. If we do not realize the expected benefits or synergies of such transactions, our consolidated financial position, results of operations, cash flows and stock price could be negatively impacted.

If we fail to maintain an effective system of internal controls, we may not be able to accurately report our financial results, which could lead to a loss of investor confidence in our financial statements and have an adverse effect on our stock price.

Effective internal controls are necessary for us to provide reliable and accurate financial statements and to effectively prevent fraud. We devote significant resources and time to comply with the internal control over financial reporting requirements of the Sarbanes Oxley Act of 2002 and continue to enhance our controls. However, we cannot be certain that we will be able to prevent future significant deficiencies or material weaknesses. Inadequate internal controls could cause investors to lose confidence in our reported financial information, which could have a negative effect on investor confidence in our financial statements, the trading price of our stock and our access to capital.

Our customers and we are subject to various governmental regulations. Compliance with or changes in such regulations may cause us to incur significant expenses, and if we fail to maintain satisfactory compliance with certain regulations, we may be forced to recall products and cease their manufacture and distribution, and we could be subject to civil or criminal penalties.

Our customers and we are subject to various significant international, federal, state and local regulations, including but not limited to regulations in the areas of health and safety, packaging, product content, employment, labor and immigration, import/export controls, trade restrictions and anti-competition. In addition, as a global organization, we are subject to data privacy and security laws, regulations, and customer-imposed controls in numerous jurisdictions as a result of having access to and processing confidential, personal, sensitive and/or patient health data in the course of our business. The EU's General Data Protection Regulation ("GDPR"), which became effective in May 2018, applies to all of our activities related to products and services that we offer to EU customers and workers. The GDPR established new requirements regarding the handling of personal data and includes significant penalties for non-compliance (including possible fines of up to 4 percent of total company revenue). Other governmental authorities around the world have passed or are considering similar types of legislative and regulatory proposals concerning data protection. Each of these privacy, security and data protection laws and regulations could impose significant limitations and increase our cost of providing our products and services where we process end user personal data and could harm our results of operations and expose us to significant fines, penalties and other damages.

We must also comply with complex foreign and U.S. laws and regulations, such as the U.S. Foreign Corrupt Practices Act, the U.K. Bribery Act, and other local laws prohibiting corrupt payments to governmental officials, anti-competition regulations and sanctions imposed by the U.S. Office of Foreign Assets Control and other similar laws and regulations. Violations of these laws and regulations could result in fines and penalties, criminal sanctions, restrictions on our business conduct and on our ability to offer our products in one or more countries, and could also materially affect our brand, our ability to attract and retain employees, our international operations, our business and our operating results. Although we have implemented policies and procedures designed to ensure compliance with these laws and regulations, there can be no assurance that our employees, contractors, or agents will not violate our policies.

These regulations are complex, change frequently and have tended to become more stringent over time. We may be required to incur significant expenses to comply with these regulations or to remedy any violations of these regulations. Any failure by us to comply with applicable government regulations could also result in the cessation of our operations or portions of our operations, product recalls or impositions of fines and restrictions on our ability to carry on or expand our operations. In addition, because many of our products are regulated or sold into regulated industries, we must comply with additional regulations in marketing our products. We develop, configure and market our products to meet customer needs created by these regulations. Any significant change in these regulations could reduce demand for our products, force us to modify our products to comply with new regulations or increase our costs of producing these products. If demand for our products is adversely affected or our costs increase, our operating results and business would suffer.

Our products and operations are also often subject to the rules of industrial standards bodies, like the International Standards Organization, as well as regulation by other agencies such as the FDA. We also must comply with work safety rules. If we fail to adequately address any of these regulations, our businesses could be harmed.


19
Table of Contents            

We are subject to extensive regulation by the FDA and certain similar foreign regulatory agencies, and failure to comply with such regulations could harm our reputation, business, financial condition and results of operations.

A number of our products are subject to regulation by the FDA and certain similar foreign regulatory agencies. In addition, a number of our products may in the future be subject to regulation by the FDA and certain similar foreign regulatory agencies. These regulations govern a wide variety of product-related activities, from quality management, design and development to labeling, manufacturing, promotion, sales and distribution. If we or any of our suppliers or distributors fail to comply with FDA and other applicable regulatory requirements or are perceived to potentially have failed to comply, we may face, among other things, warning letters; adverse publicity affecting both us and our customers; investigations or notices of non-compliance, fines, injunctions, and civil penalties; import or export restrictions; partial suspensions or total shutdown of production facilities or the imposition of operating restrictions; increased difficulty in obtaining required FDA clearances or approvals or foreign equivalents; seizures or recalls of our products or those of our customers; or the inability to sell our products. Any such FDA or other regulatory agency actions could disrupt our business and operations, lead to significant remedial costs and have a material adverse impact on our financial position and results of operations. In addition, the global regulatory environment has become increasingly stringent. For example, the EU has adopted the EU In Vitro Diagnostic Regulation (the “EU IVDR”), which imposes stricter requirements for the marketing and sale of medical devices, including in the area of clinical evaluation requirements, quality systems and post-market surveillance. Manufacturers will have until May 2022 to meet the EU IVDR requirements for in vitro diagnostic medical devices currently on the market. Failure to meet these requirements could adversely impact our business in the EU and other regions that tie their product registrations to the EU requirements.

Some of our products are subject to particularly complex regulations such as regulations of toxic substances and failure to comply with such regulations could harm our business.

Some of our products and related consumables are used in conjunction with chemicals whose manufacture, processing, distribution and notification requirements are regulated by the U.S. Environmental Protection Agency (“EPA”) under the Toxic Substances Control Act, and by regulatory bodies in other countries under similar laws. The Toxic Substances Control Act regulations govern, among other things, the testing, manufacture, processing and distribution of chemicals, the testing of regulated chemicals for their effects on human health and safety and the import and export of chemicals. The Toxic Substances Control Act prohibits persons from manufacturing any chemical in the United States that has not been reviewed by the EPA for its effect on health and safety, and placed on an EPA inventory of chemical substances. We must ensure conformance of the manufacturing, processing, distribution of and notification about these chemicals to these laws and adapt to regulatory requirements in all applicable countries as these requirements change. If we fail to comply with the notification, record-keeping and other requirements in the manufacture or distribution of our products, then we could be subject to civil penalties, criminal prosecution and, in some cases, prohibition from distributing or marketing our products until the products or component substances are brought into compliance.

Our business may suffer if we fail to comply with government contracting laws and regulations.

We derive a portion of our revenue from direct and indirect sales to U.S., state, local, and foreign governments and their respective agencies. Such contracts are subject to various procurement laws and regulations, and contract provisions relating to their formation, administration and performance. Failure to comply with these laws, regulations or provisions in our government contracts could result in the imposition of various civil and criminal penalties, termination of contracts, forfeiture of profits, suspension of payments, increased pricing pressure or suspension from future government contracting. If our government contracts are terminated, if we are suspended from government work, or if our ability to compete for new contracts is adversely affected, our business could suffer.

Our reputation, ability to do business and financial statements may be harmed by improper conduct by any of our employees, agents or business partners.

We cannot provide assurance that our internal controls and compliance systems will always protect us from acts committed by employees, agents or business partners of ours (or of businesses we acquire or partner with) that would violate U.S. and/or non-U.S. laws, including the laws governing payments to government officials, bribery, fraud, kickbacks and false claims, pricing, sales and marketing practices, conflicts of interest, competition, employment practices and workplace behavior, export and import compliance, money laundering and data privacy. In particular, the U.S. Foreign Corrupt Practices Act, the U.K. Bribery Act and similar anti-bribery laws in other jurisdictions generally prohibit companies and their intermediaries from making improper payments to government officials for the purpose of obtaining or retaining business, and we operate in many parts of the world that have experienced governmental corruption to some degree. Any such improper actions or allegations of such acts could damage our reputation and subject us to civil or criminal investigations in the United States and in other jurisdictions and related shareholder lawsuits, could lead to substantial civil and criminal, monetary and non-monetary penalties and could cause us to incur significant legal and investigatory fees. In addition, the government may seek to hold us liable as a successor for violations committed by

20
Table of Contents            

companies in which we invest or that we acquire. We also rely on our suppliers to adhere to our supplier standards of conduct, and material violations of such standards of conduct could occur that could have a material effect on our business, reputation and financial statements.

Our retirement and post retirement pension plans are subject to financial market risks that could adversely affect our future results of operations and cash flows.

We have significant retirement and post retirement pension plan assets and obligations. The performance of the financial markets and interest rates impact our plan expenses and funding obligations. Significant decreases in market interest rates, decreases in the fair value of plan assets and investment losses on plan assets will increase our funding obligations, and adversely impact our results of operations and cash flows.

The impact of consolidation and acquisitions of competitors is difficult to predict and may harm our business.

The life sciences industry is intensely competitive and has been subject to increasing consolidation. Consolidation in our industries could result in existing competitors increasing their market share through business combinations and result in stronger competitors, which could have a material adverse effect on our business, financial condition and results of operations. We may not be able to compete successfully in increasingly consolidated industries and cannot predict with certainty how industry consolidation will affect our competitors or us.

If we are unable to successfully manage the consolidation and streamlining of our manufacturing operations, we may not achieve desired efficiencies and our ability to deliver products to our customers could be disrupted.

Although we utilize manufacturing facilities throughout the world, we have consolidated, and may further consolidate, our manufacturing operations to certain of our plants to achieve efficiencies and gross margin improvements. Additionally, we typically consolidate the production of products from our acquisitions into our supply chain and manufacturing processes, which are technically complex and require expertise to operate. If we are unable to establish processes to efficiently and effectively produce high quality products in the consolidated locations, we may not achieve the anticipated synergies and production may be disrupted, which could adversely affect our business and operating results.

Our operating results may suffer if our manufacturing capacity does not match the demand for our products.

Because we cannot immediately adapt our production capacity and related cost structures to rapidly changing market conditions, when demand does not meet our expectations, our manufacturing capacity may exceed our production requirements. If during an economic downturn we had excess manufacturing capacity, then our fixed costs associated with excess manufacturing capacity would adversely affect our gross margins, and operating results. If, during a general market upturn or an upturn in one of our segments, we cannot increase our manufacturing capacity to meet product demand, we may not be able to fulfill orders in a timely manner which could lead to order cancellations, contract breaches or indemnification obligations. This inability could materially and adversely limit our ability to improve our results.

Dependence on contract manufacturing and outsourcing other portions of our supply chain, including logistics and third-party package delivery services, may adversely affect our ability to bring products to market and damage our reputation. Dependence on outsourced information technology and other administrative functions may impair our ability to operate effectively.

As part of our efforts to streamline operations and to manage costs, we outsource aspects of our manufacturing processes and other functions and continue to evaluate additional outsourcing. If our contract manufacturers or other outsourcers fail to perform their obligations in a timely manner or at satisfactory quality levels, our ability to bring products to market and our reputation could suffer. For example, during a market upturn, our contract manufacturers may be unable to meet our demand requirements, which may preclude us from fulfilling our customers' orders on a timely basis. The ability of these manufacturers to perform is largely outside of our control. If one or more of the third-party package delivery providers experiences a significant disruption in services or institutes a significant price increase, we may have to seek alternative providers, our costs could increase, and the delivery of our products could be prevented or delayed. Additionally, changing or replacing our contract manufacturers, logistics providers or other outsourcers could cause disruptions or delays. In addition, we outsource significant portions of our information technology ("IT") and other administrative functions. Since IT is critical to our operations, any failure to perform on the part of our IT providers could impair our ability to operate effectively. In addition to the risks outlined above, problems with manufacturing or IT outsourcing could result in lower revenue and unexecuted efficiencies, and impact our results of operations and our stock price.


21
Table of Contents            

Environmental contamination from past and ongoing operations could subject us to substantial liabilities.

Certain properties we have previously owned or leased are undergoing remediation for subsurface contamination.  Although we are indemnified for liability relating to the required remediation at some of those properties, we may be subject to liability if these indemnification obligations are not fulfilled.  In other cases, we have agreed to indemnify the current owners of certain properties for liabilities related to contamination, including companies with which we have previously been affiliated such as HP, Inc., Hewlett-Packard Enterprise (formerly Hewlett-Packard Company) and Varian Medical Systems, Inc.  Further, other properties we have previously owned or leased at which we have operated in the past, or for which we have otherwise contractually assumed, or provided indemnities for, certain actual or contingent environmental liabilities may or do require remediation. While we are not aware of any material liabilities associated with any potential environmental contamination at any of those properties or facilities, we may be exposed to material liability if environmental contamination at material levels is found to exist. In addition, in connection with the acquisition of certain companies, we have assumed other costs and potential or contingent liabilities for environmental matters.  Any significant costs or liabilities could have an adverse effect on results of operations.

Our current and historical manufacturing processes and operations involve, or have involved, the use of certain substances regulated under various foreign, federal, state and local environment protection and health and safety laws and regulations. As a result, we may become subject to liabilities for environmental contamination and these liabilities may be substantial. Although our policy is to apply strict standards for environmental protection and health and safety at our sites inside and outside the United States, we may not be aware of all conditions that could subject us to liability. Further, in the event that any future climate change legislation would require that stricter standards be imposed by domestic or international environmental regulatory authorities, we may be required to make certain changes and adaptations to our manufacturing processes. Failure to comply with these environmental protection and health and safety laws and regulations could result in civil, criminal, regulatory, administrative or contractual sanction, including fines, penalties or suspensions. If we have any violations of, or incur liabilities pursuant to these laws or regulations, our financial condition and operating results could be adversely affected.


Third parties may claim that we are infringing their intellectual property and we could suffer significant litigation or licensing expenses or be prevented from selling products or services.

From time to time, third parties may claim that one or more of our products or services infringe their intellectual property rights. We analyze and take action in response to such claims on a case by case basis. Any dispute or litigation regarding patents or other intellectual property could be costly and time-consuming due to the complexity of our technology and the uncertainty of intellectual property litigation and could divert our management and key personnel from our business operations. A claim of intellectual property infringement could force us to enter into a costly or restrictive license agreement, which might not be available under acceptable terms or at all, could require us to redesign our products, which would be costly and time-consuming, and/or could subject us to significant damages or to an injunction against the development and sale of certain of our products or services. Our intellectual property portfolio may not be useful in asserting a counterclaim, or negotiating a license, in response to a claim of intellectual property infringement. In certain of our businesses, we rely on third party intellectual property licenses and we cannot ensure that these licenses will continue to be available to us in the future or can be expanded to cover new products on favorable terms or at all.

Third parties may infringe our intellectual property and we may suffer competitive injury or expend significant resources enforcing our rights.

Our success depends in large part on our proprietary technology, including technology we obtained through acquisitions. We rely on various intellectual property rights, including patents, copyrights, trademarks and trade secrets, as well as confidentiality provisions and licensing arrangements, to establish our proprietary rights. If we do not enforce our intellectual property rights successfully, our competitive position may suffer which could harm our operating results.

Our pending patent, copyright and trademark registration applications may not be allowed or competitors may challenge the validity or scope of our patents, copyrights or trademarks. In addition, our patents, copyrights, trademarks and other intellectual property rights may not provide us with a significant competitive advantage.

We may need to spend significant resources monitoring and enforcing our intellectual property rights and we may not be aware of or able to detect or prove infringement by third parties. Our competitive position may be harmed if we cannot detect infringement and enforce our intellectual property rights quickly or at all. In some circumstances, we may choose to not pursue enforcement because an infringer has a dominant intellectual property position or for other business reasons. In addition, competitors might avoid infringement by designing around our intellectual property rights or by developing non-infringing competing technologies. Intellectual property rights and our ability to enforce them may be unavailable or limited in some countries which

22
Table of Contents            

could make it easier for competitors to capture market share and could result in lost revenues. Furthermore, some of our intellectual property is licensed to others which may allow them to compete with us using that intellectual property.

Changes in tax laws, unfavorable resolution of tax examinations, or exposure to additional tax liabilities could have a material adverse effect on our results of operations, financial condition and liquidity.

We are subject to taxes in the U.S., Singapore and various foreign jurisdictions. Governments in the jurisdictions in which we operate implement changes to tax laws and regulations periodically. Any implementation of tax laws that fundamentally change the taxation of corporations in the U.S. or Singapore could materially impact our effective tax rate and could have a significant adverse impact on our financial results.

The U.S. Tax Cuts and Job Act ("the Tax Act") significantly changed the taxation of U.S. based multinational corporations. Our compliance with the Tax Act requires the use of estimates in our financial statements and exercise of significant judgment in accounting for its provisions. The implementation of the Tax Act requires interpretations and implementing regulations by the Internal Revenue Service ("IRS"), as well as state tax authorities. The legislation could be subject to potential amendments and technical corrections, any of which could materially lessen or increase certain adverse impacts of the legislation. As regulations and guidance evolve with respect to the Tax Act, and as we gather information and perform more analysis, our results may differ from previous estimates and may materially affect our financial position.

We are also subject to examinations of our tax returns by tax authorities in various jurisdictions around the world. We regularly assess the likelihood of adverse outcomes resulting from ongoing tax examinations to determine the adequacy of our provision for taxes. These assessments can require a high degree of judgment and estimation. Intercompany transactions associated with the sale of inventory, services, intellectual property and cost share arrangements are complex and affect our tax liabilities. The calculation of our tax liabilities involves dealing with uncertainties in the application of complex tax laws and regulations in multiple jurisdictions. There can be no assurance that the outcomes from ongoing tax examinations will not have an adverse effect on our operating results and financial condition. A difference in the ultimate resolution of tax uncertainties from what is currently estimated could have an adverse effect on our financial results and condition.

If tax incentives change or cease to be in effect, our income taxes could increase significantly.

We benefit from tax incentives extended to our foreign subsidiaries to encourage investment or employment. Several jurisdictions have granted us tax incentives which require renewal at various times in the future. The incentives are conditioned on achieving various thresholds of investments and employment, or specific types of income. Our taxes could increase if the incentives are not renewed upon expiration. If we cannot or do not wish to satisfy all or parts of the tax incentive conditions, we may lose the related tax incentive and could be required to refund tax incentives previously realized. As a result, our effective tax rate could be higher than it would have been had we maintained the benefits of the tax incentives.

We have outstanding debt and may incur other debt in the future, which could adversely affect our financial condition, liquidity and results of operations.

We are party to a $1 billion five-year unsecured credit facility that will expire on March 13, 2024. As of October 31, 2019, the company had $115 million outstanding under the credit facility. On August 7, 2019, we entered into an amendment to the credit agreement, which provides for a $500 million short-term loan facility that was used in full to complete the acquisition of BioTek. On October 21, 2019, we entered into a second amendment to the credit agreement, which refreshed the amount available for additional incremental term loan facilities under the credit agreement to permit additional incremental facilities of up to $500 million. We had no borrowings under the additional incremental facilities as of October 31, 2019. We also currently have outstanding an aggregate principal amount of $1.8 billion in senior unsecured notes. We may borrow additional amounts in the future and use the proceeds from any future borrowing for general corporate purposes, future acquisitions, expansion of our business or repurchases of our outstanding shares of common stock

Our incurrence of this debt and increases in our aggregate levels of debt, may adversely affect our operating results and financial condition by, among other things:

•
increasing our vulnerability to downturns in our business, to competitive pressures and to adverse economic and industry conditions; 
•
requiring the dedication of an increased portion of our expected cash flows from operations to service our indebtedness, thereby reducing the amount of expected cash flows available for other purposes, including capital expenditures, acquisitions, stock repurchases and dividends; and 
•
limiting our flexibility in planning for, or reacting to, changes in our business and our industry.

23
Table of Contents            


Our credit facility imposes restrictions on us, including restrictions on our ability to create liens on our assets and engage in certain types of sale and leaseback transactions and the ability of our subsidiaries to incur indebtedness, and requires us to maintain compliance with specified financial ratios. Our ability to comply with these ratios may be affected by events beyond our control. In addition, the indentures governing our senior notes contain covenants that may adversely affect our ability to incur certain liens or engage in certain types of sale and leaseback transactions. If we breach any of the covenants and do not obtain a waiver from the lenders or noteholders, then, subject to applicable cure periods, our outstanding indebtedness could be declared immediately due and payable.

If we suffer a loss to our factories, facilities or distribution system due to catastrophe, our operations could be seriously harmed.

Our factories, facilities and distribution system are subject to catastrophic loss due to fire, flood, terrorism, increasing severity or frequency of extreme weather events, or other natural or man-made disasters. In particular, several of our facilities could be subject to a catastrophic loss caused by earthquake due to their locations. Our production facilities, headquarters and laboratories in California, and our production facilities in Japan, are all located in areas with above-average seismic activity. If any of our facilities were to experience a catastrophic loss, it could disrupt our operations, delay production, shipments and revenue and result in large expenses to repair or replace the facility. If such a disruption were to occur, we could breach agreements, our reputation could be harmed, and our business and operating results could be adversely affected. In addition, because we have consolidated our manufacturing facilities and we may not have redundant manufacturing capability readily available, we are more likely to experience an interruption to our operations in the event of a catastrophe in any one location. Although we carry insurance for property damage and business interruption, we do not carry insurance or financial reserves for interruptions or potential losses arising from earthquakes or terrorism. Also, our third-party insurance coverage will vary from time to time in both type and amount depending on availability, cost and our decisions with respect to risk retention. Economic conditions and uncertainties in global markets may adversely affect the cost and other terms upon which we are able to obtain third-party insurance. If our third-party insurance coverage is adversely affected or to the extent we have elected to self-insure, we may be at a greater risk that our financial condition will be harmed by a catastrophic loss.

If we experience a significant disruption in, or breach in security of, our information technology systems, or if we fail to implement new systems and software successfully, our business could be adversely affected.

We rely on several centralized information technology systems throughout our company to provide products and services, keep financial records, process orders, manage inventory, process shipments to customers and operate other critical functions. Our information technology systems may be susceptible to damage, disruptions or shutdowns due to power outages, hardware failures, computer viruses, attacks by computer hackers, telecommunication failures, user errors, catastrophes or other unforeseen events. Our information technology systems also may experience interruptions, delays or cessations of service or produce errors in connection with system integration, software upgrades or system migration work that takes place from time to time. If we were to experience a prolonged system disruption in the information technology systems that involve our interactions with customers or suppliers, it could result in the loss of sales and customers and significant incremental costs, which could adversely affect our business. In addition, security breaches of our information technology systems could result in the misappropriation or unauthorized disclosure of confidential information belonging to us or to our employees, partners, customers or suppliers, which could result in our suffering significant financial or reputational damage.

Adverse conditions in the global banking industry and credit markets may adversely impact the value of our cash investments or impair our liquidity.

As of October 31, 2019, we had cash and cash equivalents of approximately $1,382 million invested or held in a mix of money market funds, time deposit accounts and bank demand deposit accounts. Disruptions in the financial markets may, in some cases, result in an inability to access assets such as money market funds that traditionally have been viewed as highly liquid. Any failure of our counterparty financial institutions or funds in which we have invested may adversely impact our cash and cash equivalent positions and, in turn, our operating results and financial condition.


24
Table of Contents            

Regulations related to “conflict minerals” may cause us to incur additional expenses and could limit the supply and increase the cost of certain metals used in manufacturing our products.

We are subject to the rules of the SEC which require disclosures by public companies of specified minerals, known as conflict minerals, that are necessary to the functionality or production of products manufactured or contracted to be manufactured. The rule, which requires an annual disclosure report to be filed with the SEC by May 31st of each year, requires companies to perform due diligence, disclose and report whether or not such minerals originate from the Democratic Republic of Congo or an adjoining country. Our ongoing implementation of these rules could affect sourcing at competitive prices and availability in sufficient quantities of certain minerals used in the manufacture of our products, including tin, tantalum, gold and tungsten. The number of suppliers who provide conflict-free minerals may be limited. In addition, there may be material costs associated with complying with the disclosure requirements, such as costs related to the due diligence process of determining the source of certain minerals used in our products, as well as costs of possible changes to products, processes, or sources of supply as a consequence of such verification activities. As our supply chain is complex and we use contract manufacturers for some of our products, we may not be able to sufficiently verify the origins of the relevant minerals used in our products through the due diligence procedures that we implement, which may harm our reputation. We may also encounter challenges to satisfy those customers who require that all of the components of our products be certified as conflict-free, which could place us at a competitive disadvantage if we are unable to do so.

We cannot assure that we will continue to pay dividends on our common stock.

Since the first quarter of fiscal year 2012, we have paid a quarterly dividend on our common stock. The timing, declaration, amount and payment of any future dividends fall within the discretion of our Board of Directors and will depend on many factors, including our available cash, estimated cash needs, earnings, financial condition, operating results, capital requirements, as well as limitations in our contractual agreements, applicable law, regulatory constraints, industry practice and other business considerations that our Board of Directors considers relevant. A change in our dividend program could have an adverse effect on the market price of our common stock.

Item 1B.    Unresolved Staff Comments

None.

Item 2. Properties
As of October 31, 2019, we owned or leased a total of approximately 6.6 million square feet of space worldwide. Of that, we owned approximately 4.5 million square feet and leased the remaining 2.1 million square feet. Our sales and support facilities occupied a total of approximately 0.8 million square feet. Our manufacturing plants, R&D facilities and warehouse and administrative facilities occupied approximately 5.8 million square feet. All of our businesses share sales offices throughout the world.

Information about each of our businesses appears below:

Life Sciences & Applied Markets Business. Our life sciences and applied markets business has manufacturing and R&D facilities in Australia, China, Germany, Italy, Malaysia, Singapore, United Kingdom and the United States.

Diagnostics and Genomics Business. Our diagnostics and genomics business has manufacturing and R&D facilities in Belgium, Denmark, Malaysia and the United States.

Agilent CrossLab Business. Our Agilent CrossLab business has manufacturing and R&D facilities in Australia, China, Germany, Japan, Netherlands, Singapore, United Kingdom and the United States.

Item 3. Legal Proceedings
We are involved in lawsuits, claims, investigations and proceedings, including, but not limited to, intellectual property, commercial, real estate, environmental and employment matters, which arise in the ordinary course of business. There are no matters pending that we currently believe are probable and reasonably possible of having a material impact to our business, consolidated financial condition, results of operations or cash flows.


25
Table of Contents            

Item 4. Mine Safety Disclosures
Not applicable.

PART II

Item 5. Market for the Registrant's Common Equity, Related Stockholder Matters and Issuer Purchases of Equity Securities
Our common stock is listed on the New York Stock Exchange with the ticker symbol “A”. As of December 2, 2019, there were 20,989 common stockholders of record.


The information required by this item with respect to equity compensation plans is included under the caption "Equity Compensation Plans" in our Proxy Statement for the Annual Meeting of Stockholders to be held March 18, 2020, to be filed with the Securities and Exchange Commission pursuant to Regulation 14A, and is incorporated herein by reference.


26
Table of Contents            


STOCK PRICE PERFORMANCE GRAPH

The graph below shows the cumulative total stockholder return on our common stock with the cumulative total return of the S&P 500 Index and our peer group, consisting of all companies in the Health Care and Materials Indexes of the S&P 500, assuming an initial investment of $100 on October 31, 2014 and the reinvestment of all dividends. The cumulative returns on our common stock have also been adjusted to reflect the spin-off of our electronic measurement business into an independent publicly traded company called Keysight Technologies, Inc. on November 1, 2014.

Agilent’s stock price performance shown in the following graph is not indicative of future stock price performance. The data for this performance graph was compiled for us by Standard and Poor’s.

chart-4a62e386e6ad510aa63.jpg

 
 
 
        INDEXED RETURNS
 
 
Base
 
            Years Ending
 
 
 
Period
 
 
 
 
 
Company Name / Index
10/31/2014
10/31/2015

10/31/2016

10/31/2017

10/31/2018

10/31/2019

Agilent Technologies
100
96.51

112.56

177.46

170.53

201.15

S&P 500
100
105.20

109.94

135.93

145.91

166.81

Peer Group
100
106.66

104.08

128.12

138.06

151.39



27
Table of Contents            

ISSUER PURCHASES OF EQUITY SECURITIES

The table below summarizes information about the company’s purchases, based on trade date, of its equity securities registered pursuant to Section 12 of the Exchange Act during the quarterly period ended October 31, 2019. The total number of shares of common stock purchased by the company during the fiscal year ended October 31, 2019 is 10,436,060 shares.
Period
 
Total Number of
Shares of Common
Stock Purchased(1)
 
Weighted Average
Price Paid per Share of
Common Stock(2)
 
Total
Number of
Shares of Common
Stock Purchased as
Part of Publicly
Announced Plans or
Programs(1)
 
Maximum
Approximate Dollar
Value of Shares of
Common Stock that
May Yet Be
Purchased Under the
Plans or Programs
(in millions)(1)
 
 
 
 
 
 
 
 
 
August 1, 2019 through
August 31, 2019
 
234,947

 
69.42

 
234,947

 
$
1,060

September 1, 2019 through
September 30, 2019
 
208,701

 
75.77

 
208,701

 
$
1,044

October 1, 2019 through
October 31, 2019
 
222,205

 
$
74.93

 
222,205

 
$
1,027

Total
 
665,853

 
$
73.25

 
665,853

 
 


    
(1)
On November 19, 2018 we announced that our board of directors had approved a new share repurchase program (the "2019 repurchase program") designed, among other things, to reduce or eliminate dilution resulting from issuance of stock under the company's employee equity incentive programs. The 2019 share repurchase program authorizes the purchase of up to $1.75 billion of our common stock at the company's discretion and has no fixed termination date. As of October 31, 2019, we had remaining authorization to repurchase up to $1.03 billion of our common stock under this program. The 2019 repurchase program does not require the company to acquire a specific number of shares and may be suspended, amended or discontinued at any time. As of October 31, 2019, all repurchased shares have been retired.

(2)
The weighted average price paid per share of common stock does not include the cost of commissions.


28
Table of Contents            

Item 6.    Selected Financial Data
SELECTED FINANCIAL DATA
(Unaudited)

 
Years Ended October 31,
 
2019
 
2018
 
2017
 
2016
 
2015
 
(in millions, except per share data)
Consolidated Statement of Operations Data:
 
 
 
 
 
 
 
 
 
Net revenue
$
5,163

 
$
4,914

 
$
4,472

 
$
4,202

 
$
4,038

Income from continuing operations before taxes
$
919

 
$
946

 
$
803

 
$
544

 
$
480

Income from continuing operations
$
1,071

 
$
316

 
$
684

 
$
462

 
$
438

Loss from discontinued operations, net of taxes
$
—

 
$
—

 
$
—

 
$
—

 
$
(37
)
Net income
$
1,071

 
$
316

 
$
684

 
$
462

 
$
401

Net income per share — basic:
 
 
 
 
 
 
 
 
 
Income from continuing operations
$
3.41

 
$
0.98

 
$
2.12

 
$
1.42

 
$
1.32

Loss from discontinued operations, net of taxes
—

 
—

 
—

 
—

 
(0.12
)
Net income per share - basic
$
3.41

 
$
0.98

 
$
2.12

 
$
1.42

 
$
1.20

Net income per share — diluted:
 
 
 
 
 
 
 
 
 
Income from continuing operations
$
3.37

 
$
0.97

 
$
2.10

 
$
1.40

 
$
1.31

Loss from discontinued operations, net of taxes
—

 
—

 
—

 
—

 
(0.11
)
Net income per share - diluted
$
3.37

 
$
0.97

 
$
2.10

 
$
1.40

 
$
1.20

Weighted average shares used in computing basic net income per share
314

 
321

 
322

 
326

 
333

Weighted average shares used in computing diluted net income per share
318

 
325

 
326

 
329

 
335

Cash dividends declared per common share
$
0.656

 
$
0.596

 
0.528

 
$
0.460

 
$
0.400


 
 
October 31,
 
2019
 
2018
 
2017
 
2016
 
2015
 
(in millions)
Consolidated Balance Sheet Data:
 
 
 
 
 
 

 
 
Cash and cash equivalents
$
1,382

 
$
2,247

 
$
2,678

 
$
2,289

 
$
2,003

Working capital
$
1,109

 
$
2,677

 
$
2,906

 
$
2,690

 
$
2,710

Total assets
$
9,452

 
$
8,541

 
$
8,426

 
$
7,794

 
$
7,479

Long-term debt
$
1,791

 
$
1,799

 
$
1,801

 
$
1,904

 
$
1,655

Stockholders' equity
$
4,748

 
$
4,567

 
$
4,831

 
$
4,243

 
$
4,167

 
 
 
 
 
 
 
 
 
 

29
Table of Contents            


Item 7.    Management's Discussion and Analysis of Financial Condition and Results of Operations

The following discussion should be read in conjunction with the consolidated financial statements and notes thereto included elsewhere in this Annual Report on Form 10-K. This report contains forward-looking statements including, without limitation, statements regarding growth opportunities, including for revenue and our end markets, strength and drivers of the markets we sell into, sales funnels, our strategic direction, new product and service introductions and the position of our current products and services, market demand for and adoption of our products, the ability of our products and solutions to address customer needs and meet industry requirements, our focus on differentiating our product solutions, improving our customers’ experience and growing our earnings, future financial results, our operating margin, mix, our investments, including in manufacturing infrastructure, research and development and expanding and improving our applications and solutions portfolios, expanding our position in developing countries and emerging markets, our focus on balanced capital allocation, our contributions to our pension and other defined benefit plans, impairment of goodwill and other intangible assets, the effect of the U.S. Tax Cuts and Jobs Act of 2017 (the "Tax Act") and U.S. and other tariffs, the impact of foreign currency movements, our hedging programs and other actions to offset the effects of tariffs and foreign currency movements, our future effective tax rate, tax valuation allowance and unrecognized tax benefits, the impact of local government regulations on our ability to pay vendors or conduct operations, our ability to satisfy our liquidity requirements, including through cash generated from operations, the potential impact of adopting new accounting pronouncements, indemnification, source and supply of materials used in our products, our sales, our purchase commitments, our capital expenditures, the integration and effects of our acquisitions and other transactions and our stock repurchase program and dividends, that involve risks and uncertainties. Our actual results could differ materially from the results contemplated by these forward-looking statements due to various factors, including those discussed in Part I Item 1A and elsewhere in this Form 10-K.

Overview and Executive Summary

Agilent Technologies Inc. ("we", "Agilent" or the "company"), incorporated in Delaware in May 1999, is a global leader in life sciences, diagnostics and applied chemical markets, providing application focused solutions that include instruments, software, services and consumables for the entire laboratory workflow.

In 2019, we acquired 100 percent of the stock of ACEA Biosciences Inc. ("ACEA"), a developer of cell analysis tools, for $250 million. In addition, we completed the acquisition of privately-owned Lionheart Technologies LLC ("BioTek"), a leader in the design, manufacture and distribution of innovative life science instrumentation for $1.17 billion. The financial results of these businesses have been included in our financial results from the date of the close.

In 2018, we acquired seven businesses for a combined purchase price of approximately $536 million. The largest of which was Advanced Analytical Technologies, Inc. ("AATI") for approximately $268 million in cash. In 2017, we acquired two businesses for a combined purchase price of approximately $125 million in cash.

Agilent's net revenue of $5,163 million in 2019 increased 5 percent when compared to 2018. Foreign currency movements for 2019 had an overall unfavorable impact on revenue of approximately 2 percentage points compared to 2018. Acquisitions in 2019 had an overall favorable impact of 2 percentage points when compared to 2018. Revenue in the life sciences and applied markets business increased 1 percent in 2019 when compared to 2018. Foreign currency movements had an unfavorable impact on revenue of 2 percentage points in 2019 when compared to 2018. Revenue in the diagnostics and genomics business increased 8 percent in 2019 when compared to 2018. Foreign currency movements had an unfavorable impact on revenue of 3 percentage points in 2019 when compared to 2018. Revenue in the Agilent CrossLab business increased 8 percent in 2019 when compared to 2018. Foreign currency movements had an unfavorable impact on revenue of 3 percentage points in 2019 when compared to 2018.

Agilent's net revenue of $4,914 million increased 10 percent in 2018 when compared to 2017. Foreign currency movements for 2018 had an overall favorable impact on revenue of approximately 2 percentage points compared to 2017. Acquisitions in 2018 had an overall favorable impact of 1 percentage point when compared to 2017. Revenue in the life sciences and applied markets business increased 9 percent in 2018 when compared to 2017. Foreign currency movements had an overall favorable impact on revenue of 2 percentage point in 2018 when compared to 2017. Revenue in the diagnostics and genomics business increased 10 percent in 2018 when compared to 2017. Foreign currency movements had an overall favorable impact of 3 percentage points on revenue in 2018 when compared to 2017. Revenue in the Agilent CrossLab business increased 11 percent in 2018 when compared to 2017. Foreign currency movements had an overall favorable impact on revenue of 2 percentage points in 2018 when compared to 2017.

Net income was $1,071 million in 2019 compared to net income of $316 million and $684 million in 2018 and 2017, respectively. Net income for the year ended October 31, 2019 was impacted by a discrete tax benefit of $299 million related to

30
Table of Contents            

restructuring and the extension of the company's tax incentive in Singapore. Net income for the year ended October 31, 2018 was impacted by a discrete tax charge of $552 million related to the enactment of the Tax Act that was passed on December 22, 2017. As of October 31, 2019 and 2018, we had cash and cash equivalents balances of $1,382 million and $2,247 million, respectively.

On May 28, 2015 we announced that our board of directors had approved a share repurchase program (the "2015 repurchase program"). The 2015 share repurchase program authorizes the purchase of up to $1.14 billion of our common stock at the company's discretion through and including November 1, 2018. The 2015 repurchase program did not require the company to acquire a specific number of shares and could have been suspended or discontinued at any time. During the year ended October 31, 2017, we repurchased and retired approximately 4.1 million shares for $194 million under this authorization. During the year ended October 31, 2018, we repurchased and retired approximately 6.4 million shares for $422 million under this authorization. As of October 31, 2018, we had remaining authorization to repurchase up to $188 million of our common stock under this program which expired on November 1, 2018.

On November 19, 2018 we announced that our board of directors had approved a new share repurchase program (the "2019 repurchase program") designed, among other things, to reduce or eliminate dilution resulting from issuance of stock under the company's employee equity incentive programs. The 2019 share repurchase program authorizes the purchase of up to $1.75 billion of our common stock at the company's discretion and has no fixed termination date. The 2019 repurchase program does not require the company to acquire a specific number of shares and may be suspended, amended or discontinued at any time. During the year ended October 31, 2019, we repurchased and retired approximately 10.4 million shares for $723 million under this authorization. As of October 31, 2019, we had remaining authorization to repurchase up to $1.03 billion of our common stock under this program.

During the year ended October 31, 2019, cash dividends of 0.656 per share, or $206 million were declared and paid on the company's outstanding common stock. During the year ended October 31, 2018, cash dividends of 0.596 per share, or $191 million were declared and paid on the company's outstanding common stock. During the year ended October 31, 2017, cash dividends of 0.528 per share, or $170 million were declared and paid on the company's outstanding common stock.

On November 20, 2019 we declared a quarterly dividend of $0.18 per share of common stock, or approximately $56 million which will be paid on January 22, 2020 to shareholders of record as of the close of business on December 31, 2019. The timing and amounts of any future dividends are subject to determination and approval by our board of directors.

Looking forward, we continue to focus on differentiating product solutions, improving our customers' experience, continued growth and earnings expansion. We remain optimistic that we have the ability and resilience to manage any changing market conditions to deliver positive results in fiscal year 2020. In addition, we remain focused on a balanced capital allocation through our dividend and share repurchase programs. We expect foreign currency to negatively impact revenue for 2020 but we also anticipate the contribution from our recent acquisitions to partially offset the currency impact.

Critical Accounting Policies and Estimates

The preparation of financial statements in accordance with accounting principles generally accepted in the U.S. requires management to make estimates and assumptions that affect the amounts reported in our consolidated financial statements and accompanying notes. Management bases its estimates on historical experience and various other assumptions believed to be reasonable. Although these estimates are based on management's best knowledge of current events and actions that may impact the company in the future, actual results may be different from the estimates. An accounting policy is deemed to be critical if it requires an accounting estimate to be made based on assumptions about matters that are highly uncertain at the time the estimate is made and if different estimates that reasonably could have been used or changes in the accounting estimate that are reasonably likely to occur could materially change the financial statements. Our critical accounting policies are those that affect our financial statements materially and involve difficult, subjective or complex judgments by management. Those policies are revenue recognition, inventory valuation, retirement and post-retirement plan assumptions, valuation of goodwill and purchased intangible assets and accounting for income taxes.

Revenue Recognition.    On November 1, 2018, we adopted Accounting Standard Codification Topic 606, Revenue from Contracts with Customers ("ASC 606").

We enter into contracts to sell products, services or combinations of products and services. Products may include hardware or software and services may include one-time service events or services performed over time.

We derive revenue primarily from the sale of analytical and diagnostics products and services. A performance obligation is a promise in a contract to transfer a distinct product or service to a customer and is the unit of account under ASC 606. Revenue is recognized when control of the promised products or services is transferred to our customers and the performance obligation

31
Table of Contents            

is fulfilled in an amount that reflects the consideration that we expect to be entitled in exchange for those products or services, the transaction price. For equipment, consumables, and most software licenses, control transfers to the customer at a point in time. We use present right to payment, legal title, physical possession of the asset, and risks and rewards of ownership as indicators to determine the transfer of control to the customer. Where acceptance is not a formality, the customer must have documented their acceptance of the product or service. For products that include installation, if the installation meets the criteria to be considered a separate performance obligation, product revenue is recognized when control has passed to the customer, and recognition of installation revenue occurs once completed. Product revenue, including sales to resellers and distributors is reduced for provisions for warranties, returns, and other adjustments in the period the related sales are recorded.

Service revenue includes extended warranty, customer and software support including: Software as a Service, post contract support, consulting including companion diagnostics, and training and education. Instrument service contracts and software maintenance contracts are typically annual contracts, which are billed at the beginning of the contract or maintenance period. Revenue for these contracts is recognized on a straight-line basis to revenue over the service period, as a time-based measure of progress best reflects our performance in satisfying this obligation. There are no deferred costs associated with the service contract, as the cost of the service is recorded when the service is performed. Service calls not included in a support contract are recognized to revenue at the time a service is performed.

We have sales from standalone software. These arrangements typically include software licenses and maintenance contracts, both of which we have determined are distinct performance obligations. We determine the amount of the transaction price to allocate to the license and maintenance contract based on the relative standalone selling price of each performance obligation. Software license revenue is recognized at the point in time when control has been transferred to the customer. The revenue allocated to the software maintenance contract is recognized on a straight-line basis over the maintenance period, which is the contractual term of the contract, as a time-based measure of progress best reflects our performance in satisfying this obligation. Unspecified rights to software upgrades are typically sold as part of the maintenance contract on a when-and-if-available basis.

Our multiple-element arrangements are generally comprised of a combination of instruments, installation or other start-up services, and/or software, and/or support or services. Hardware and software elements are typically delivered at the same time and revenue is recognized when control passes to the customer. Service revenue is deferred and recognized over the contractual period or as services are rendered and accepted by the customer. Our arrangements generally do not include any provisions for cancellation, termination, or refunds that would significantly impact recognized revenue.

For contracts with multiple performance obligations, we allocate the consideration to which we expect to be entitled to each performance obligation based on relative standalone selling prices and recognize the related revenue when or as control of each individual performance obligation is transferred to customers. We estimate the standalone selling price by calculating the average historical selling price of our products and services per country for each performance obligation. Stand-alone selling prices are determined for each distinct good or service in the contract and then we allocate the transaction price in proportion to those standalone selling prices by performance obligations.

A portion of our revenue relate to lease arrangements. Standalone lease arrangements are outside the scope of ASC 606 and are therefore accounted for in accordance with ASC 840, Leases. Each of these contracts is evaluated as a lease arrangement, either as an operating lease or a sales-type capital lease using the current lease classification guidance.

Inventory Valuation.    We assess the valuation of our inventory on a periodic basis and make adjustments to the value for estimated excess and obsolete inventory based upon estimates about future demand and actual usage. Such estimates are difficult to make under most economic conditions. The excess balance determined by this analysis becomes the basis for our excess inventory charge. Our excess inventory review process includes analysis of sales forecasts, managing product rollovers and working with manufacturing to maximize recovery of excess inventory. If actual market conditions are less favorable than those projected by management, additional write-downs may be required. If actual market conditions are more favorable than anticipated, inventory previously written down may be sold to customers, resulting in lower cost of sales and higher income from operations than expected in that period.

Retirement and Post-Retirement Benefit Plan Assumptions.    Retirement and post-retirement benefit plan costs are a significant cost of doing business. They represent obligations that will ultimately be settled sometime in the future and therefore are subject to estimation. Pension accounting is intended to reflect the recognition of future benefit costs over the employees' average expected future service to Agilent based on the terms of the plans and investment and funding decisions. To estimate the impact of these future payments and our decisions concerning funding of these obligations, we are required to make assumptions using actuarial concepts within the framework of accounting principles generally accepted in the U.S. Two critical assumptions are the discount rate and the expected long-term return on plan assets. Other important assumptions include, expected future salary

32
Table of Contents            

increases, expected future increases to benefit payments, expected retirement dates, employee turnover, retiree mortality rates, and portfolio composition. We evaluate these assumptions at least annually.

The discount rate is used to determine the present value of future benefit payments at the measurement date - October 31 for both U.S. and non-U.S. plans. For 2019 and 2018, the U.S. discount rates were based on the results of matching expected plan benefit payments with cash flows from a hypothetically constructed bond portfolio. In 2019, discount rates for the U.S. plans decreased compared to the previous year. For 2019 and 2018, the discount rate for non-U.S. plans was generally based on published rates for high quality corporate bonds and in 2019, decreased compared to the previous year. If we changed our discount rate by 1 percent, the impact would be less than $1 million in U.S. pension expense and $13 million on non-U.S. pension expense. Lower discount rates increase present values of the pension benefit obligation and subsequent year pension expense; higher discount rates decrease present values of the pension benefit obligation and subsequent year pension expense.

The company uses alternate methods of amortization as allowed by the authoritative guidance which amortizes the actuarial gains and losses on a consistent basis for the years presented. For U.S. Plans, gains and losses are amortized over the average future lifetime of participants using the corridor method. For most Non-U.S. Plans and U.S. Post-Retirement Benefit Plans, gains and losses are amortized using a separate layer for each year's gains and losses.

In the U.S., target asset allocations for our retirement and post-retirement benefit plans are approximately 80 percent to equities and approximately 20 percent to fixed income investments. Our Deferred Profit-Sharing Plan target asset allocation is approximately 60 percent to equities and approximately 40 percent to fixed income investments. Approximately 3 percent of our U.S. equity portfolio consists of limited partnerships. Outside the U.S., our target asset allocation ranges from 31 to 60 percent to equities, from 38 to 61 percent to fixed income investments, and from zero to 25 percent to real estate, depending on the plan. All plans' assets are broadly diversified. Due to fluctuations in equity markets, our actual allocations of plan assets at October 31, 2019 and 2018 differ from the target allocation. Our policy is to bring the actual allocation in line with the target allocation.

Equity securities include exchange-traded common stock and preferred stock of companies from broadly diversified industries. Fixed income securities include a global portfolio of corporate bonds of companies from diversified industries, government securities, mortgage-backed securities, asset-backed securities, derivative instruments and other. Other investments include a group trust consisting primarily of private equity partnerships.

The expected long-term return on plan assets is estimated using current and expected asset allocations as well as historical and expected returns. Plan assets are valued at fair value. If we changed our estimated return on assets by 1 percent, the impact would be $4 million on U.S. pension expense and $9 million on non-U.S. pension expense. For 2019, actual return on assets was above expectations which, along with contributions during the year, decreased next year’s pension cost as well as resulting in an increase of the funded status at year end. The net periodic pension and post-retirement benefit costs recorded were a $10 million expense in 2019, $3 million benefit in 2018 and $15 million expense in 2017. The years ended October 31, 2018 and 2017 included a gain on curtailment and settlements of $5 million and $32 million, respectively.

Goodwill and Purchased Intangible Assets. Under the authoritative guidance, we have the option to perform a qualitative assessment to determine whether further impairment testing is necessary. The accounting standard gives an entity the option to first assess qualitative factors to determine whether performing the two-step test is necessary. If an entity believes, as a result of its qualitative assessment, that it is more-likely-than-not (i.e. greater than 50% chance) that the fair value of a reporting unit is less than its carrying amount, the quantitative impairment test will be required. Otherwise, no further testing will be required.

The guidance includes examples of events and circumstances that might indicate that a reporting unit's fair value is less than its carrying amount. These include macro-economic conditions such as deterioration in the entity's operating environment or industry or market considerations; entity-specific events such as increasing costs, declining financial performance, or loss of key personnel; or other events such as an expectation that a reporting unit will be sold or a sustained decrease in the stock price on either an absolute basis or relative to peers.

If it is determined, as a result of the qualitative assessment, that it is more-likely-than-not that the fair value of a reporting unit is less than its carrying amount, the provisions of authoritative guidance require that we perform a two-step impairment test on goodwill. In the first step, we compare the fair value of each reporting unit to its carrying value. The second step (if necessary) measures the amount of impairment by applying fair-value-based tests to the individual assets and liabilities within each reporting unit. As defined in the authoritative guidance, a reporting unit is an operating segment, or one level below an operating segment. We aggregate components of an operating segment that have similar economic characteristics into our reporting units.

In fiscal year 2019, we assessed goodwill impairment for our three reporting units which consisted of three segments: life sciences and applied markets, diagnostics and genomics and Agilent CrossLab. We performed a qualitative test for goodwill

33
Table of Contents            

impairment of the three reporting units, as of September 30, 2019. Based on the results of our qualitative testing, we believe that it is more-likely-than-not that the fair value of each reporting unit is greater than its respective carrying value. Each quarter we review the events and circumstances to determine if goodwill impairment is indicated. There was no impairment of goodwill during the years ended October 31, 2019, 2018 and 2017.

Purchased intangible assets consist primarily of acquired developed technologies, proprietary know-how, trademarks, and customer relationships and are amortized using the best estimate of the asset's useful life that reflect the pattern in which the economic benefits are consumed or used up or a straight-line method ranging from 6 months to 15 years. Our determination of the fair value of the intangible assets acquired involves the use of significant estimates and assumptions. Specifically, our determination of the fair value of the developed product technology and in-process research and development ("IPR&D") acquired involve significant estimates and assumptions related to revenue growth rates and discount rates. Our determination of the fair value of customer relationships acquired involved significant estimates and assumptions related to revenue growth rates, discount rates, and customer attrition rates. Our determination of the fair value of the tradename acquired involved the use of significant estimates and assumptions related to revenue growth rates, royalty rates and discount rates. The company believes that the fair value assigned to the assets acquired and liabilities assumed are based on reasonable assumptions and estimates that marketplace participants would use. Actual results could differ materially from these estimates. IPR&D is initially capitalized at fair value as an intangible asset with an indefinite life and assessed for impairment thereafter. When the IPR&D project is complete, it is reclassified as an amortizable purchased intangible asset and is amortized over its estimated useful life. If an IPR&D project is abandoned, we will record a charge for the value of the related intangible asset to our consolidated statement of operations in the period it is abandoned.

We continually monitor events and changes in circumstances that could indicate carrying amounts of finite-lived intangible assets may not be recoverable. When such events or changes in circumstances occur, we assess the recoverability of finite-lived intangible assets by determining whether the carrying value of such assets will be recovered through undiscounted expected future cash flows. If the total of the undiscounted future cash flows is less than the carrying amount of those assets, we recognize an impairment loss based on the excess of the carrying amount over the fair value of the assets. During 2018, we recorded an impairment charge of $21 million related to purchased intangible assets within the diagnostics and genomics segment that were deemed unrecoverable.

Our indefinite-lived intangible assets are IPR&D intangible assets. The accounting guidance allows a qualitative approach for testing indefinite-lived intangible assets for impairment, similar to the issued impairment testing guidance for goodwill and allows the option to first assess qualitative factors (events and circumstances) that could have affected the significant inputs used in determining the fair value of the indefinite-lived intangible asset to determine whether it is more-likely-than-not (i.e. greater than 50% chance) that the indefinite-lived intangible asset is impaired. An organization may choose to bypass the qualitative assessment for any indefinite-lived intangible asset in any period and proceed directly to calculating its fair value. We performed a qualitative test for impairment of indefinite-lived intangible assets as of September 30, 2019. Based on the results of our qualitative testing, we believe that it is more-likely-than-not that the fair value of these indefinite-lived intangible assets is greater than their respective carrying values. Each quarter we review the events and circumstances to determine if impairment of indefinite-lived intangible asset is indicated. During the year ended October 31, 2019, 2018 and 2017 there were no impairments of indefinite-lived intangible assets.

Accounting for Income Taxes. We must make certain estimates and judgments in determining income tax expense for financial statement purposes. These estimates and judgments occur in the calculation of tax credits, benefits and deductions, and in the calculation of certain tax assets and liabilities which arise from differences in the timing of recognition of revenue and expense for tax and financial statement purposes, as well as interest and penalties related to uncertain tax positions. Significant changes to these estimates may result in an increase or decrease to our tax provision in a subsequent period. On a quarterly basis, we provide for income taxes based upon an estimated annual effective tax rate. The effective tax rate is highly dependent upon the geographic composition of worldwide earnings, tax regulations governing each region, availability of tax credits and the effectiveness of our tax planning strategies. We monitor the changes in many factors and adjust our effective income tax rate on a timely basis. If actual results differ from these estimates, this could have a material effect on our financial condition and results of operations.

Significant management judgment is also required in determining whether deferred tax assets will be realized in full or in part. When it is more-likely-than-not that all or some portion of deferred tax assets may not be realized, a valuation allowance must be established against such deferred tax assets. We consider all available positive and negative evidence on a jurisdiction-by-jurisdiction basis when assessing whether it is more likely than not that deferred tax assets are recoverable. We consider evidence such as our past operating results, the existence of losses in recent years and our forecast of future taxable income.


34
Table of Contents            

The calculation of our tax liabilities involves dealing with uncertainties in the application of complex tax law and regulations in a multitude of jurisdictions. Although the guidance on the accounting for uncertainty in income taxes prescribes the use of a recognition and measurement model, the determination of whether an uncertain tax position has met those thresholds will continue to require significant judgment by management. In accordance with the guidance on the accounting for uncertainty in income taxes, for all U.S. and other tax jurisdictions, we recognize potential liabilities for anticipated tax audit issues based on our estimate of whether, and the extent to which, additional taxes and interest will be due. The ultimate resolution of tax uncertainties may differ from what is currently estimated, which could result in a material impact on income tax expense. If our estimate of income tax liabilities proves to be less than the ultimate assessment, a further charge to expense would be required. If events occur and the payment of these amounts ultimately proves to be unnecessary, the reversal of the liabilities would result in tax benefits being recognized in the period when we determine the liabilities are no longer necessary. We include interest and penalties related to unrecognized tax benefits within the provision for income taxes on the consolidated statements of operations.

On December 22, 2017, the Tax Act was enacted into law. The Tax Act significantly changed the existing U.S. tax law and included numerous provisions that affect our business. There were no substantial changes from our 2018 Annual Report on Form 10-K to the transition tax expenses amount. The company will continue to assess the impact of the further guidance from federal and state tax authorities on its business and consolidated financial statements. Any future adjustments will be recognized as discrete income tax expense or benefit in the period the adjustments are determined. We have completed our analysis and elected to treat global intangible low-tax income ("GILTI") as “current period cost”. See Note 6, "Income Taxes" for more details.

Adoption of New Pronouncements

See Note 2, "New Accounting Pronouncements," to the consolidated financial statements for a description of new accounting pronouncements.

Foreign Currency

Our revenues, costs and expenses, and monetary assets and liabilities are exposed to changes in foreign currency exchange rates as a result of our global operating and financing activities. The unfavorable effects of changes in foreign currency exchange rates has decreased revenue by approximately 2 percentage point for the year ended October 31, 2019. When movements in foreign currency exchange rates have a negative impact on revenue it will also have a positive impact on our costs and expenses. The favorable effects of changes in foreign currency exchange rates has increased revenue by approximately 2 percentage points for the year ended October 31, 2018. When movements in foreign currency exchange rates have a positive impact on revenue it will also have a negative impact on our costs and expenses. We calculate the impact of foreign currency exchange rates movements by applying the actual foreign currency exchange rates in effect during the last month of each quarter of the current year to both the applicable current and prior year periods. We hedge revenues, expenses and balance sheet exposures that are not denominated in the functional currencies of our subsidiaries on a short term and anticipated basis. We do experience some fluctuations within individual lines of the consolidated statement of operations and balance sheet because our hedging program is not designed to offset the currency movements in each category of revenues, expenses, monetary assets and liabilities. Our hedging program is designed to hedge currency movements on a relatively short-term basis (up to a rolling twelve-month period). Therefore, we are exposed to currency fluctuations over the longer term. To the extent that we are required to pay for all, or portions, of an acquisition price in foreign currencies, we may enter into foreign exchange contracts to reduce the risk that currency movements will impact the U.S. dollar cost of the transaction.
 

35
Table of Contents            

Results from Operations

Net Revenue

 
Years Ended October 31,
 
2019 over 2018
Change
 
2018 over 2017 Change
 
2019
 
2018
 
2017
 
 
(in millions)
 
 
 
 
Net revenue:
 
 
 
 
 
 
 
 
 
Products
$
3,877

 
$
3,746

 
$
3,397

 
3%
 
10%
Services and other
$
1,286

 
$
1,168

 
$
1,075

 
10%
 
9%
Total net revenue
$
5,163

 
$
4,914

 
$
4,472

 
5%
 
10%
 
 
Years Ended October 31,
 
2019 over 2018
Change
 
2018 over 2017 Change
 
2019
 
2018
 
2017
 
% of total net revenue:
 
 
 
 
 
 
 
 
 
Products
75
%
 
76
%
 
76
%
 
(1) ppt
 
—
Services and other
25
%
 
24
%
 
24
%
 
1 ppt
 
—
Total
100
%
 
100
%
 
100
%
 
 
 
 

Agilent's net revenue of $5,163 million for the year ended October 31, 2019 increased 5 percent when compared to 2018. Foreign currency movements for 2019 had an unfavorable impact of approximately 2 percentage points when compared to 2018. Agilent's net revenue of $4,914 million increased 10 percent in 2018 when compared to 2017. Foreign currency movements for 2018 had a favorable impact of approximately 2 percentage points when compared to 2017.

Product revenue includes revenue generated from the sales of our analytical instrumentation, software and consumables. Revenue from products increased 3 percent for the year ended October 31, 2019, when compared to 2018. The growth in product revenue was impacted by increased sales within our cell analysis business, mainly due to contributions from our recent acquisitions. In addition, product revenue growth was impacted by strong sales in our consumables and nucleic acid solutions businesses partially offset by revenue weakness in our liquid chromatography, gas chromatography, liquid chromatography mass spectrometry and spectroscopy products. Revenue from products increased 10 percent for the year ended October 31, 2018, when compared to 2017. The growth in product revenue was led by strong revenue growth from products within our spectroscopy, mass spectrometry and our consumables businesses.

Services and other revenue primarily consists of revenue generated from Agilent CrossLab services and services in the diagnostics and genomics business. Some of the prominent services in the Agilent CrossLab business include repair and maintenance on multi-vendor instruments, compliance services and installation services. Some of the prominent services in the diagnostics and genomics business include consulting services related to the companion diagnostics and nucleic acid businesses.

Services and other revenue increased 10 percent in 2019 as compared to 2018. Services and other revenue in the Agilent CrossLab business increased 9 percent in 2019 as compared to 2018, with a 3 percentage point unfavorable currency impact. Nearly all major service offerings from the Agilent CrossLab business contributed to the revenue growth across all geographic regions. Services in the diagnostics and genomics business is increasing due to growth in service revenue throughout all our businesses.

Services and other revenue increased 9 percent in 2018 as compared to 2017. Services and other revenue increased in all major service categories within our Agilent CrossLab business. Services in the diagnostics and genomics business is increasing due to growth in service revenue in our genomics and pathology businesses. 


36
Table of Contents            

Net Revenue By Segment

 
Years Ended October 31,
 
2019 over 2018
Change
 
2018 over 2017 Change
 
2019
 
2018
 
2017
 
 
(in millions)
 
 
 
 
Net revenue by segment:
 
 
 
 
 
 
 
 
 
Life sciences and applied markets
$
2,302

 
$
2,270

 
$
2,081

 
1%
 
9%
Diagnostics and genomics
$
1,021

 
$
943

 
$
860

 
8%
 
10%
Agilent CrossLab
$
1,840

 
$
1,701

 
$
1,531

 
8%
 
11%
Total net revenue
$
5,163

 
$
4,914

 
$
4,472

 
5%
 
10%

Revenue in the life sciences and applied markets business increased 1 percent in 2019 when compared to 2018. Foreign currency movements had an overall unfavorable impact on revenue of 2 percentage points in 2019 when compared to 2018. Acquisitions had an overall favorable impact on revenue growth of 4 percentage points and primarily impacted the pharmaceutical and academia and government markets when compared to the same period last year. As a result, revenue growth was favorable within academia and government, moderate within the pharmaceutical and moderate within the environmental and forensics markets which was mostly offset by declines in revenue from the food market and to a lesser extent from the chemical and energy market when compared to the same period last year. Revenue in the life sciences and applied markets business increased 9 percent in 2018 when compared to 2017. Foreign currency movements had an overall favorable impact of 2 percentage points in 2018 when compared to 2017. For the year ended October 31, 2018, our performance within the life science and applied markets business was led by strong growth throughout the year in the pharmaceutical market. Chemical and energy markets and the environmental and forensics markets continued to show strong growth when compared to 2017.

Revenue in the diagnostics and genomics business increased 8 percent in 2019 when compared to 2018. Foreign currency movements had an overall unfavorable impact on revenue of 3 percentage points in 2019 when compared to 2018. Revenue growth within the diagnostics and clinical market and the pharmaceutical market continued to be strong led by performance from our nucleic acid solutions and biomolecular analysis businesses. Revenue in the diagnostics and genomics business increased 10 percent in 2018 when compared to 2017. Foreign currency movements had an overall favorable impact on revenue of 3 percentage points in 2018 when compared to 2017. For the year ended October 31, 2018, our performance within the diagnostics and genomics business was led by strong growth in our genomics, companion diagnostics and biomolecular analysis businesses.

Revenue in the Agilent CrossLab business increased 8 percent in 2019 when compared to 2018. Foreign currency movements had an overall unfavorable impact on revenue of 3 percentage points in 2019 when compared to 2018. Our performance in the Agilent CrossLab business saw continued growth in all key end markets with strong growth in the pharmaceutical, academia and government and food markets. Revenue generated by Agilent CrossLab increased 11 percent in 2018 when compared to 2017. Foreign currency movements had an overall favorable impact of 2 percent percentage points in 2018 when compared to 2017. Our performance in the Agilent CrossLab business saw continued growth in all key end markets with strong growth in the pharmaceutical and food markets.
 
Costs and Expenses

 
Years Ended October 31,
 
2019 over 2018
Change
 
2018 over 2017 Change
 
2019
 
2018
 
2017
 
(in millions, except margin data)
 
 
 
 
 
 
 
 
 
Gross margin on products
56.7
%
 
57.4
%
 
56.6
%
 
(1) ppt
 
1 ppt
Gross margin on services and other
47.3
%
 
45.3
%
 
44.2
%
 
2 ppts
 
1 ppt
Total gross margin
54.3
%
 
54.5
%
 
53.6
%
 
—
 
1 ppt
Research and development
$
404

 
$
387

 
$
341

 
5%
 
14%
Selling, general and administrative
$
1,460

 
$
1,389

 
$
1,251

 
5%
 
11%
Operating margin
18.2
%
 
18.4
%
 
18.1
%
 
—
 
—

Total gross margin growth for the year ended October 31, 2019 was flat when compared to last year. Total gross margins for the year ended October 31, 2019 reflects the impact of efficiency gains, lower inventory charges and favorable currency impact on costs offset by higher wages and variable pay, product mix, higher expenses related to tariffs and higher amortization expense of intangible assets.

Total gross margin growth for the year ended October 31, 2018 increased 1 percentage point when compared to the prior year. Increases in total gross margins for the year ended October 31, 2018 reflects higher sales volume, favorable business mix, lower manufacturing material costs and lower amortization expense of intangible assets partially offset by higher wages and variable pay, an impairment of certain intangible assets and unfavorable currency movements.

Gross inventory charges were $19 million in 2019, $26 million in 2018 and $24 million in 2017. Sales of previously written down inventory were $6 million in 2019, $8 million in 2018 and $9 million in 2017.

 Research and development expenses increased 5 percent for the year ended October 31, 2019 when compared with last year. Research and development expenses increased due to increased program spending on new products related to all of our businesses in addition to higher wages and variable pay and additional expenses related to acquired businesses partially offset by favorable currency movements when compared to spending in the same periods last year. Research and development expenses increased 14 percent for the year ended October 31, 2018 when compared with 2017. Research and development expenses increased due to increased program spending on new products related to all of our businesses in addition to higher wages and variable pay, unfavorable currency movements and additional expenses related to acquired businesses when compared to spending in 2017.

Selling, general and administrative expenses increased 5 percent in 2019 compared to 2018. Selling, general and administrative expenses increase was due to increased wages and variable pay, higher commissions, higher legal expenses, higher acquisition and integration costs and higher transformation initiatives expenses partially offset by operational efficiencies and savings and favorable currency impact. Selling, general and administrative expenses increased 11 percent in 2018 compared to 2017. Selling, general and administrative expenses increase was due to higher wages and variable pay, higher commissions, increased corporate costs, higher share-based compensation expense, higher transformational initiative costs, an impairment of certain intangible assets and unfavorable currency movements.

Total operating margin was flat for the year ended October 31, 2019, when compared to last year. Operating margins was impacted by higher wages and variable pay, higher acquisition and integration costs, higher expenses related to tariffs and higher transformation initiatives expenses offset by operational efficiencies and savings and favorable currency impact. Total operating margin was flat for the year ended October 31, 2018, when compared to 2017. Operating margins was impacted by higher gross margins, lower acquisition and integration costs and lower amortization expense offset by increased wages and variable pay, an impairment of certain intangible assets, higher transformational initiative costs and the additional research and development and selling, general and administrative expenses related to our recent acquisitions.

37
Table of Contents            


Interest expense for the years ended October 31, 2019, 2018 and 2017 was $74 million, $75 million and $79 million, respectively, and relates to the interest charged on our senior notes and the amortization of the deferred loss recorded upon termination of the forward starting interest rate swap contracts partially offset by the amortization of deferred gains recorded upon termination of interest rate swap contracts.

At October 31, 2019, our headcount was approximately 16,300 compared to 14,800 in 2018.

Other income (expense), net

For the year ended October 31, 2019, other income (expense), net includes income of $12 million related to the provision of site service costs to, and lease income from, Keysight Technologies, Inc. ("Keysight") and $9 million loss on the extinguishment of debt.

For the year ended October 31, 2018, other income (expense), net includes the net gain of $20 million related to the step-up of our initial investment in Lasergen, $15 million of income related to a special one-time settlement with a third-party, a $5 million pension settlement gain related to the substitutional portion of the defined benefit pension plans established under the Japanese Welfare Pension Insurance Law and income of $12 million related to the provision of site service costs to, and lease income from, Keysight.

For the year ended October 31, 2017, other income (expense), net includes $32 million pension settlement gain related to the substitutional portion of the defined benefit pension plans established under the Japanese Welfare Pension Insurance Law and$12 million of income related to the provision of site service costs to and lease income from Keysight.

Income Taxes

 
Years Ended October 31,
 
2019
 
2018
 
2017
 
(in millions)
Provision (benefit) for income taxes
$
(152
)
 
$
630

 
$
119


For 2019, the company's income tax benefit was $152 million with an effective tax rate of (16.5) percent. For the year ended October 31, 2019, our effective tax rate and the resulting provision for income taxes were significantly impacted by the discrete benefit of $299 million related to the extension of the company’s tax incentive in Singapore.

For 2018, the company's income tax expense was $630 million with an effective tax rate of 66.6 percent. For the year ended October 31, 2018, our effective tax rate and the resulting provision for income taxes were significantly impacted by the discrete charge of $552 million related to the enactment of the Tax Act as discussed below.

For 2017, the company’s income tax expense was $119 million with an effective tax rate of 14.8 percent. Our effective tax rate is impacted by earnings realized in foreign jurisdictions with statutory tax rates lower than the federal statutory tax rate. During the year, the company determined a portion of current year foreign earnings from its low tax jurisdictions would not be considered as indefinitely reinvested. As such, a deferred tax liability for that portion of unremitted foreign earnings was accrued causing an increase in the annual tax expense. Our annual effective tax rate also included tax benefits due to the settlement of an audit in Germany for the years 2005 through 2008 and the lapse of U.S. statute of limitation for the fiscal years 2012 and 2013. This benefit was offset by a deferred tax liability required for the tax expected upon repatriation of related unremitted foreign earnings that were not asserted as indefinitely invested outside the U.S.

The company has negotiated tax holidays in several different jurisdictions, most significantly in Singapore. The tax holidays provide lower rates of taxation on certain classes of income and require various thresholds of investments and employment or specific types of income in those jurisdictions. In December 2018, the tax holiday in Singapore was renegotiated and extended through 2027. Other tax holidays are due for renewal in 2020. As a result of the incentives, the impact of the tax holidays decreased income taxes by $368 million, $87 million, and $93 million in 2019, 2018, and 2017, respectively. The benefit of the tax holidays on net income per share (diluted) was approximately $1.16, $0.27, and $0.29 in 2019, 2018 and 2017, respectively. The increase in the benefit from 2018 to 2019 is primarily due to the Singapore restructuring and tax incentive modifications completed in 2019 in response to Singapore tax law changes. Of the $1.16 benefit of the tax incentives on net income per share (diluted) in 2019, $0.94 of the benefit relates to one-time items from the Singapore restructuring.

38
Table of Contents            


2017 U.S. Tax Reform - Tax Cuts and Jobs Act

On December 22, 2017, the Tax Act was enacted into law. The Tax Act enacted significant changes affecting our fiscal year 2018, including, but not limited to, (1) reducing the U.S. federal corporate tax rate and (2) imposing a one-time transition tax on certain unrepatriated earnings of foreign subsidiaries that had not been previously taxed in the U.S.

The Tax Act also established new tax provisions affecting our fiscal year 2019, including, but not limited to, (1) creating a new provision designed to tax global intangible low-tax income (“GILTI”); (2) generally eliminating U.S. federal taxes on dividends from foreign subsidiaries; (3) eliminating the corporate alternative minimum tax (“AMT”); (4) creating the base erosion anti-abuse tax (“BEAT”); (5) establishing a deduction for foreign derived intangible income ("FDII"); (6) repealing domestic production activity deduction; and (7) establishing new limitations on deductible interest expense and certain executive compensation.

ASC 740, Income Taxes, requires companies to recognize the effect of the tax law changes in the period of enactment. However, the SEC staff issued Staff Accounting Bulletin 118 ("SAB 118") which allowed companies to record provisional amounts during a measurement period not extending beyond one year from the Tax Act enactment date. For the year ended October 31, 2018, the company recognized income tax expense related to the Tax Act of $552 million which includes (1) an expense of $499 million of U.S. transition tax and correlative items on deemed repatriated earnings of non-U.S. subsidiaries and (2) an expense of $53 million associated with the impact on deferred taxes resulting from the decreased U.S. corporate tax rate as described below.

Deemed Repatriation Transition Tax ("Transition Tax"): The Transition Tax is based on the company’s total unrepatriated post-1986 earnings and profits ("E&P") of its foreign subsidiaries and the amount of non-U.S. taxes paid (Tax Pools) on such earnings. Historically, the company permanently reinvested a significant portion of these post-1986 E&P outside the U.S. For the remaining portion, the company previously accrued deferred taxes. Since the Tax Act required all foreign earnings to be taxed currently, the company recorded an income tax expense of $651 million for its one-time transition U.S. federal tax and a benefit of $152 million for the reversal of related deferred tax liabilities. The resulting $499 million net transition tax, reduced by existing tax credits, will be paid over 8 years in accordance with the election available under the Tax Act. We have completed our accounting for charges related to the Transition Tax.

Reduction of U.S. Federal Corporate Tax Rate: The reduction of the corporate income tax rate requires companies to remeasure their deferred tax assets and liabilities as of the date of enactment. The amount recorded for the year ended October31, 2018 for the remeasurement due to tax rate change is $53 million. We have completed our accounting for the measurement of deferred taxes.

GILTI: The Tax Act subjects a U.S. corporation to tax on its GILTI. U.S. GAAP allows companies to make an accounting policy election to either (1) treat taxes due on future GILTI inclusions in the U.S. taxable income as a current-period expense when incurred (“period cost method”) or (2) factoring such amounts into a company’s measurement of its deferred taxes (“deferred method”). We have completed our analysis and elected to treat GILTI as a “current period cost”.

Indefinite Reinvestment Assertion: Prior to the enactment of the Tax Act, the company had indefinite investment assertion on a significant portion of its undistributed earnings from foreign subsidiaries. As a result of the enactment of the Tax Act, we have reevaluated our historic assertion and no longer consider these earnings to be indefinitely reinvested in our foreign subsidiaries. The company has recorded a deferred tax liability of $10 million for foreign withholding taxes on repatriation of remaining undistributed earnings.

In the U.S., tax years remain open back to the year 2016 for federal income tax purposes and the year 2015 for significant states. In other major jurisdictions where the company conducts business, the tax years generally remain open back to the year 2009.

With these jurisdictions and the U.S., it is reasonably possible that there could be significant changes to our unrecognized tax benefits in the next twelve months due to either the expiration of a statute of limitation or a tax audit settlement which will be partially offset by an anticipated tax liability related to unremitted foreign earnings, where applicable. Given the number of years and numerous matters that remain subject to examination in various tax jurisdictions, management is unable to estimate the range of possible changes to the balance of our unrecognized tax benefits.

The calculation of our tax liabilities involves dealing with uncertainties in the application of complex tax law and regulations in a multitude of jurisdictions. Although the guidance on the accounting for uncertainty in income taxes prescribes the use of a recognition and measurement model, the determination of whether an uncertain tax position has met those thresholds will continue to require significant judgment by management. In accordance with the guidance on the accounting for uncertainty in income

39
Table of Contents            

taxes, for all U.S. and other tax jurisdictions, we recognize potential liabilities for anticipated tax audit issues based on our estimate of whether, and the extent to which, additional taxes and interest will be due. The ultimate resolution of tax uncertainties may differ from what is currently estimated, which could result in a material impact on income tax expense. If our estimate of income tax liabilities proves to be less than the ultimate assessment, a further charge to expense would be required. If events occur and the payment of these amounts ultimately proves to be unnecessary, the reversal of the liabilities would result in tax benefits being recognized in the period when we determine the liabilities are no longer necessary.

Segment Overview

Through October 31, 2019, we have three business segments comprised of the life sciences and applied markets business, diagnostics and genomics business and the Agilent CrossLab business.

In 2019, we adopted new guidance related to the presentation of the net periodic pension and postretirement benefit cost. See Note 2, "New Accounting Pronouncements" for more information. As a result, we have recast our historical segment results to conform to this new presentation required under this guidance.

Life Sciences and Applied Markets

Our life sciences and applied markets business provides application-focused solutions that include instruments and software that enable customers to identify, quantify and analyze the physical and biological properties of substances and products, as well as enable customers in the clinical and life sciences research areas to interrogate samples at the molecular and cellular level. Key product categories include: liquid chromatography ("LC") systems and components; liquid chromatography mass spectrometry ("LCMS") systems; gas chromatography ("GC") systems and components; gas chromatography mass spectrometry ("GCMS") systems; inductively coupled plasma mass spectrometry ("ICP-MS") instruments; atomic absorption ("AA") instruments; microwave plasma-atomic emission spectrometry (“MP-AES”) instruments; inductively coupled plasma optical emission spectrometry ("ICP-OES") instruments; raman spectroscopy; cell analysis plate based assays; flow cytometer; real-time cell analyzer; cell imaging systems; microplate reader; laboratory software for sample tracking; information management and analytics; laboratory automation and robotic systems; dissolution testing; vacuum pumps and measurement technologies.

Net Revenue

 
Years Ended October 31,
 
2019 over 2018
Change
 
2018 over 2017 Change
 
2019
 
2018
 
2017
 
 
(in millions)
 
 
 
 
Net revenue
$
2,302

 
$
2,270

 
$
2,081

 
1%
 
9%

Life science and applied markets business revenue in 2019 increased 1 percent compared to 2018. Foreign currency movements for 2019 had an overall unfavorable currency impact of 2 percentage points on revenue growth when compared to the same period last year. Acquisitions had an overall favorable impact on revenue growth of 3 percentage points when compared to the same period last year. Geographically, revenue increased 12 percent in the Americas with a 1 percentage point unfavorable currency impact, decreased 4 percent in Europe with a 3 percentage point unfavorable currency impact and decreased 2 percent in Asia Pacific with a 1 percentage point unfavorable currency impact. From a product standpoint revenue was driven by strength in sales in our gas chromatography mass spectrometry, cell analysis primarily due to contributions from our recent acquisitions and informatics businesses which was offset by weakness in our liquid chromatography, gas chromatography, liquid chromatography mass spectrometry and spectroscopy products when compared to the same period last year.

End market revenue performance in 2019 were also mixed with the pharmaceutical, academia and government, diagnostics and clinical and forensics markets delivering strong revenue growth, environmental delivering moderate growth while chemical and energy markets decreased modestly, and food delivered weak results compared to the same period last year.

Life science and applied markets business revenue in 2018 increased 9 percent compared to 2017. Foreign currency movements for 2018 had an overall favorable currency impact of 2 percentage points on revenue growth when compared to 2017. Geographically, revenue increased 8 percent in the Americas with no currency impact, increased 12 percent in Europe with a 5 percentage point favorable currency impact and increased 8 percent in Asia Pacific with a 1 percentage point favorable currency impact. From a product standpoint liquid chromatography mass spectrometry, spectroscopy and cell analysis systems led with double digit growth. Gas chromatography mass spectrometry and gas chromatography also posted strong results helped by growth in the chemical and energy markets.

40
Table of Contents            


End market performance in 2018 was led by pharmaceutical markets which were strong throughout the year. Chemical and energy markets kept the momentum from 2017 and delivered strong growth. Academic and government and environmental markets also delivered strong growth. Food market contracted mainly driven by consolidations of governmental agencies in China.

Looking forward, despite short term uncertainties, we are optimistic about our long-term growth opportunities in the life sciences and applied markets as our broad portfolio of products and solutions are well suited to address customer needs. We anticipate strong growth from our new product introductions and recent acquisitions as we continue to invest in expanding and improving our applications and solutions portfolio. While we anticipate volatility in our markets, we expect continued growth across most end markets in the long term.

Gross Margin and Operating Margin

The following table shows the life sciences and applied markets business' margins, expenses and income from operations for 2019 versus 2018, and 2018 versus 2017.
 
Years Ended October 31,
 
2019 over 2018
Change
 
2018 over 2017 Change
 
2019
 
2018
 
2017
 
(in millions, except margin data)
 
 
 
 
 
 
 
 
 
Total gross margin
61.0
%
 
61.3
%
 
60.3
%
 
—
 
1 ppt
Research and development
$
216

 
$
220

 
$
199

 
(1)%
 
10%
Selling, general and administrative
$
646

 
$
630

 
$
587

 
3%
 
7%
Operating margin
23.5
%
 
23.9
%
 
22.6
%
 
—
 
1 ppt
Income from operations
$
542

 
$
543

 
$
470

 
—
 
16%

Gross margin was flat in 2019 compared to 2018. Gross margin was impacted by unfavorable mix and higher expenses related to tariffs which was offset by favorable currency impact. Gross margin increased 1 percentage point in 2018 compared to 2017. The increase was due to increased volume and lower manufacturing material costs.

Research and development expenses decreased 1 percent in 2019 when compared to 2018. Research and development was impacted by lower discretionary spending and a favorable currency offset by additional expenses related to our recent acquisitions as well as higher wages and variable pay. Research and development expenses increased 10 percent in 2018 when compared to 2017. The increase in research and development was due to higher program funding in product development as well as wage and variable pay increases and unfavorable currency related effects.

Selling, general and administrative expenses increased 3 percent in 2019 compared to 2018. Selling, general and administrative expenses was impacted by higher wages and variable pay and additional expenses related to our recent acquisitions partially offset by operational savings and a favorable currency impact. Selling, general and administrative expenses increased 7 percent in 2018 compared to 2017. Selling, general and administrative expenses increased due to increased marketing and sales force investments as well as wages and variable pay increases, higher share-based compensation expense and unfavorable currency related effects.

Operating margin was relatively flat in 2019 compared to 2018. Operating margin reflects relatively flat revenue growth partially offset by an increase in selling, general and administrative expenses. Operating margin increased 1 percentage points in 2018 compared to 2017. The increase in operating margin was a product of revenue growth and improved gross margin offset slightly by unfavorable currency impact.

Income from Operations        

Income from operations in 2019 decreased by $1 million or was relatively flat when compared to 2018 on a revenue increase of $32 million. The decrease was due to the impact of our recent acquisitions. Income from operations in 2018 increased by $73 million or 16 percent when compared to 2017 on a revenue increase of $189 million. The increase was due to higher revenues and lower cost of sales on incremental revenues.


41
Table of Contents            

Diagnostics and Genomics

Our diagnostics and genomics business includes the genomics, nucleic acid contract manufacturing and research and development, pathology, companion diagnostics, reagent partnership and biomolecular analysis businesses.

Our diagnostics and genomics business is comprised of six areas of activity providing active pharmaceutical ingredients ("APIs") for oligo-based therapeutics as well as solutions that include reagents, instruments, software and consumables, which enable customers in the clinical and life sciences research areas to interrogate samples at the cellular and molecular level. First, our genomics business includes arrays for DNA mutation detection, genotyping, gene copy number determination, identification of gene rearrangements, DNA methylation profiling, gene expression profiling, as well as next generation sequencing ("NGS") target enrichment and genetic data management and interpretation support software. This business also includes solutions that enable clinical labs to identify DNA variants associated with genetic disease and help direct cancer therapy. Second, our nucleic acid solutions business provides equipment and expertise focused on production of synthesized oligonucleotides under pharmaceutical good manufacturing practices ("GMP") conditions for use as API in an emerging class of drugs that utilize nucleic acid molecules for disease therapy. Third, our pathology solutions business is focused on product offerings for cancer diagnostics and anatomic pathology workflows. The broad portfolio of offerings includes immunohistochemistry ("IHC"), in situ hybridization ("ISH"), hematoxylin and eosin ("H&E") staining and special staining. Fourth, we also collaborate with a number of major pharmaceutical companies to develop new potential pharmacodiagnostics, also known as companion diagnostics, which may be used to identify patients most likely to benefit from a specific targeted therapy. Fifth, the reagent partnership business is a provider of reagents used for turbidimetry and flow cytometry. Finally, our biomolecular analysis business provides complete workflow solutions, including instruments, consumables and software, for quality control analysis of nucleic acid samples.  Samples are analyzed using quantitative and qualitative techniques to ensure accuracy in further genomics analysis techniques utilized in clinical and life science research applications.

Net Revenue

 
Years Ended October 31,
 
2019 over 2018
Change
 
2018 over 2017 Change
 
2019
 
2018
 
2017
 
 
(in millions)
 
 
 
 
Net revenue
$
1,021

 
$
943

 
$
860

 
8%
 
10%

Diagnostics and genomics business revenue in 2019 increased 8 percent compared to 2018. Foreign currency movements for 2019 had an overall unfavorable impact on revenue growth of 3 percentage points when compared to the same period last year. Geographically, revenue increased 17 percent in the Americas with a 1 percentage point unfavorable currency impact, was flat in Europe with a 4 percentage point unfavorable currency impact and increased 2 percent in Asia Pacific with a 2 percentage point unfavorable currency impact. The growth in Americas was driven by strong growth in our nucleic acid solutions, companion diagnostics and biomolecular analysis business. In Europe we saw strong growth in the biomolecular analysis business offset by softness in the genomics business. In Asia Pacific the growth was driven by our biomolecular analysis businesses and negatively impacted by softness in the genomics business.

Revenue growth in 2019 was led by strong revenue performance in our nucleic acid solutions, companion diagnostics and biomolecular analysis business. The diagnostics and clinical research market remains strong and growing driven by an aging population and unhealthy lifestyle developments such as poor diet and physical inactivity.

Diagnostics and genomics business revenue in 2018 increased 10 percent compared to 2017. Foreign currency movements for 2018 had an overall favorable impact on revenue growth of 3 percentage points when compared to the same period last year and acquisitions had an overall favorable impact on revenue growth of 2 percentage points when compared to the same period last year. Geographically, revenue increased 11 percent in the Americas with a 1 percentage point unfavorable currency impact, increased 11 percent in Europe with a 6 percentage point favorable currency impact and increased 2 percent in Asia Pacific with a 1 percentage point favorable currency impact. The growth in the Americas was supported by continued strength in our genomics business, strong growth in the companion diagnostic business and our biomolecular analysis business. Europe results represented growth in our genomics and the biomolecular analysis business. The performance in Americas and Europe were led by growth in sales in genomics (particularly target enrichment and arrays). In Asia Pacific, our relatively smaller region, growth increased due to higher shipment volumes in China.

The revenue growth in 2018 was due to positive growth from all businesses and strength in Americas, Europe and China regions. This was led by revenue growth in our arrays and next generation sequencing solution portfolio offering within the

42
Table of Contents            

genomics business mainly driven by SureSelect NGS target enrichment products, continued ramp in revenue growth in our reagent partnership business due to demand for our reagents and strength in our biomolecular analysis business consumables portfolio. The end markets in diagnostics and clinical research remain strong and growing driven by an aging population and lifestyle.

Looking forward, we are optimistic about our growth opportunities in our end markets and continue to invest in expanding and improving our applications and solutions portfolio. We remain positive about our growth in our end markets, as our OMNIS products, PD-L1 assays and SureFISH continue to gain strength with our customers in clinical oncology applications and our next generation sequencing target enrichment solutions continue to be adopted. Market demand in the nucleic acid solutions business related to therapeutic oligo programs continues to be strong and, with our newly opened nucleic acid solutions production facility in Frederick, we are well positioned to serve more of the market demand. We will continue to invest in research and development and seek to expand our position in developing countries and emerging markets.


Gross Margin and Operating Margin

The following table shows the diagnostics and genomics business's margins, expenses and income from operations for 2019 versus 2018, and 2018 versus 2017.

 
Years Ended October 31,
 
2019 over 2018
Change
 
2018 over 2017 Change
 
2019
 
2018
 
2017
 
(in millions, except margin data)
 
 
 
 
 
 
 
 
 
Total gross margin
54.7
%
 
56.3
%
 
55.2
%
 
(2) ppts
 
1 ppt
Research and development
$
125

 
$
109

 
$
89

 
15%
 
22%
Selling, general and administrative
$
248

 
$
249

 
$
218

 
—
 
14%
Operating margin
18.2
%
 
18.4
%
 
19.4
%
 
—
 
(1) ppt
Income from operations
$
185

 
$
173

 
$
167

 
7%
 
4%

Gross margin decreased 2 percentage points in 2019 when compared to 2018. The decrease in gross margin was driven by an unfavorable product mix and a higher fixed cost structure due to the addition of a second nucleic acid manufacturing facility that offset gains from higher sales volumes. Gross margin increased 1 percentage point in 2018 when compared to 2017, mainly driven from higher volumes were partially offset by higher wages and variable pay.

Research and development expenses increased 15 percent in 2019 when compared to 2018. The increase was due to additional expenses related to prior year's acquisitions, higher wages and variable pay and increased spending around the development of clinical applications and solutions. Research and development expenses increased 22 percent in 2018 when compared to 2017. The increase was mainly due to additional expenses related to the acquisition of Lasergen, increase in wages and variable pay and unfavorable currency movements.

Selling, general and administrative expenses was flat in 2019 when compared to 2018. Selling, general and administrative expenses were impacted by efficiency gains offsetting higher wages and variable pay. Selling, general and administrative expenses increased 14 percent in 2018 when compared to 2017. Selling, general and administrative expenses increase was due to the additional expenses related to the acquisitions of Lasergen and AATI, increases in wages and variable pay and unfavorable currency movements.

Operating margin was flat in 2019 when compared to 2018. Operating margin was impacted by higher sales volume, offsetting the gross margin deterioration and the increase in research and development spending. Operating margin decreased 1 percentage point in 2018 when compared to 2017. The decline in operating margin was due additional expenses related to the acquisitions of Lasergen and AATI.

Income from Operations

Income from operations in 2019 increased by $12 million or 7 percent when compared to 2018 on a revenue increase of $78 million. The increase was due to higher volume partially offset by the gross margin percentage decline and higher research and development expenses. Income from operations in 2018 increased by $6 million or 4 percent when compared to 2017 on a revenue increase of $83 million. The increase was due to higher volumes partially offset by higher expenses related to the acquisitions.

43
Table of Contents            


Agilent CrossLab

The Agilent CrossLab business spans the entire lab with its extensive consumables and services portfolio, which is designed to improve customer outcomes. Most of the portfolio is vendor neutral, meaning Agilent can serve and supply customers regardless of their instrument purchase choices. Solutions range from chemistries and supplies to services and software helping to connect the entire lab. Key product categories in consumables include GC and LC columns, sample preparation products, custom chemistries, and a large selection of laboratory instrument supplies. Services include startup, operational, training and compliance support, software as a service, as well as asset management and consultative services that help increase customer productivity. Custom service and consumable bundles are tailored to meet the specific application needs of various industries and to keep instruments fully operational and compliant with the respective industry requirements.

Net Revenue
 
Years Ended October 31,
 
2019 over 2018
Change
 
2018 over 2017 Change
 
2019
 
2018
 
2017
 
 
(in millions)
 
 
 
 
Total net revenue
$
1,840

 
$
1,701

 
$
1,531

 
8%
 
11%

Agilent CrossLab business revenue in 2019 increased 8 percent when compared to 2018. Foreign currency movements for 2019 had an overall unfavorable impact of 3 percentage points when compared to 2018. Acquisitions in 2018 added 1 percentage point to the revenue growth reported for 2019. Revenue growth in 2019 was driven broadly by our entire services and consumables portfolio. Geographically, revenue increased 9 percent in the Americas with an 1 percentage point unfavorable currency impact, increased 5 percent in Europe with a 5 percentage points unfavorable currency impact and increased 10 percent in Asia Pacific with a 3 percentage points unfavorable currency impact. In 2019, Agilent CrossLab business saw strong revenue growth in all key end markets, except in the diagnostics and clinical market, when compared to the same periods last year.

Agilent CrossLab business revenue in 2018 increased 11 percent when compared to 2017. Foreign currency movements for 2018 had an overall favorable impact of 2 percentage points when compared to 2017. Acquisitions in 2018 did not have a material impact on the revenue growth for 2018. Revenue growth in 2018 was driven by the entire portfolio, including all consumables, all major service categories and remarketed instruments. Geographically, revenue increased 7 percent in the Americas with no currency impact, increased 12 percent in Europe with a 6 percentage point favorable currency impact and increased 15 percent in Asia Pacific with a 2 percentage point favorable currency impact. Agilent CrossLab business saw a broad based and sustained revenue growth in most key end markets throughout 2018, especially from the pharmaceutical and food markets.

Looking forward, we anticipate strength in key end markets will continue to drive our revenue growth in the near term. The Agilent CrossLab portfolio of products and service capabilities are well positioned to succeed in changing market conditions in our key end markets. Geographically, the business is well diversified across all regions to swiftly take advantage of local market opportunities and to help hedge against market volatility in any one region. Other factors for near term revenue growth include continued expansion of digital capabilities and leveraging of our deep understanding of customer work flows.




44
Table of Contents            

Gross Margin and Operating Margin

The following table shows the Agilent CrossLab business's margins, expenses and income from operations for 2019 versus 2018 and 2018 versus 2017.

 
Years Ended October 31,
 
2019 over 2018
Change
 
2018 over 2017 Change
 
2019
 
2018
 
2017
 
(in millions, except margin data)
 
 
 
 
 
 
 
 
 
Total gross margin
51.8
%
 
50.4
%
 
49.4
%
 
1 ppt
 
1 ppt
Research and development
$
58

 
$
56

 
$
50

 
3%
 
12%
Selling, general and administrative
$
421

 
$
413

 
$
371

 
2%
 
11%
Operating margin
25.8
%
 
22.8
%
 
21.9
%
 
3 ppts
 
1 ppt
Income from operations
$
475

 
$
388

 
$
336

 
23%
 
16%

Gross margin for products and services increased 1 percentage point in 2019 when compared to 2018. Gross margin was impacted by higher sales volume, combined with efficiency gains in the service delivery operation and efficiency gains in the logistics and manufacturing processes for the consumables business partially offset by higher wages and variable pay partly due to increased headcount. Gross margin for products and services increased 1 percentage point in 2018 when compared to 2017. Gross margin increase came primarily from higher sales volume.

Research and development expenses increased 3 percent in 2019 when compared to 2018. Research and development increased due to higher wages and variable pay and additional research and development expenditures from our prior year's acquisitions. Research and development expenses increased 12 percent in 2018 when compared to 2017. Research and development increase was primarily due to higher wages across the various research organizations, and due to increased headcount in the areas of software development, iLab development and customer training curriculum development.

Selling, general and administrative expenses increased 2 percent in 2019 when compared to 2018. Selling, general and administrative expenses were impacted by additional operating expenses from our prior year's acquisitions and overall higher wages and variable pay partially offset by a favorable impact from foreign currency movements. Selling, general and administrative expenses increased 11 percent in 2018 when compared to 2017. Selling, general and administrative expenses increased due to higher wages, higher variable pay, increased corporate infrastructure costs, and increased sales force investments.

Operating margin increased 3 percentage points in 2019 when compared to 2018. The increase in operating margin was driven by the higher sales volume, combined with efficiency gains across the service delivery operations, order fulfillment processes and other operations. Operating margin increased 1 percentage point in 2018 when compared to 2017. The increase in operating margin was primarily due to higher sales volume.

Income from Operations

Income from operations in 2019 increased by $87 million or 23 percent when compared to 2018 on a revenue increase of $139 million. Income from operations in 2018 increased by $52 million or 16 percent when compared to 2017 on a revenue increase of $170 million.

Financial Condition

Liquidity and Capital Resources

Our financial position as of October 31, 2019 consisted of cash and cash equivalents of $1,382 million as compared to $2,247 million as of October 31, 2018.

As of October 31, 2019, approximately $1,310 million of our cash and cash equivalents is held outside of the U.S. by our foreign subsidiaries and can be repatriated to the U.S. as local working capital and other regulatory conditions permit. We utilize a variety of funding strategies to ensure that our worldwide cash is available in the locations in which it is needed.

As a result of the Tax Act, we are required to pay a one-time transition tax on deferred foreign income not previously subject to U.S. federal income tax. This is offset by tax attributes that results in a net tax payable of $200 million. The first installment of $36 million was paid in the second quarter of 2019 and the remaining will be paid over the next seven years. As part of the

45
Table of Contents            

business integration of some of our prior acquisitions, we undertook corporate restructurings in the fourth quarter of fiscal year 2019 that involved on-shoring certain intangible properties held by our foreign subsidiaries to the United States.  These restructurings resulted in a cash tax liability of $231 million which is payable in the first quarter of fiscal year 2020.

We believe our cash and cash equivalents, cash generated from operations, and ability to access capital markets and credit lines will satisfy, for at least the next twelve months, our liquidity requirements, both globally and domestically, including the following: working capital needs, capital expenditures, business acquisitions, stock repurchases, cash dividends, contractual obligations, commitments, principal and interest payments on debt, and other liquidity requirements associated with our operations.

Net Cash Provided by Operating Activities

Net cash provided by operating activities was $1,021 million in 2019 as compared to $1,087 million provided in 2018 and $889 million provided in 2017. We paid approximately $118 million under our variable and incentive pay programs in 2019, as compared to a total of $103 million paid in 2018 and $91 million in 2017. Net cash paid for income taxes was approximately $159 million in 2019, as compared to $102 million in 2018 and $63 million in 2017. For the year ended October 31, 2019, the net change of zero in tax-related assets and liabilities related to the enactment of the U.S. Tax Act compared to $552 million in the same period of 2018, which primarily consisted of an estimated provision of $499 million of U.S. transition tax on deemed repatriated earnings of non-U.S. subsidiaries as well as an estimated $53 million associated with the impact on deferred taxes resulting from the decreased U.S. corporate income tax rate. For the years ended October 31, 2019, 2018 and 2017, other assets and liabilities used cash of $43 million, $4 million and $98 million, respectively. The increase in cash usage for the year ended October 31, 2019 and October 31, 2017 in other assets and liabilities is primarily due to taxes.

In 2019, the change in accounts receivable used cash of $106 million, $65 million in 2018, and $81 million in 2017. Days' sales outstanding as of October 31, were 61 days in 2019, 54 days in 2018 and 55 days in 2017. The change in accounts payable provided cash of $29 million in 2019, $40 million in 2018 and $2 million in 2017. Cash used in inventory was $36 million in 2019, $83 million in 2018 and $61 million in 2017. Inventory days on-hand decreased to 97 days in 2019 compared to 98 days in 2018 and increased compared to 95 days in 2017.

We made no contributions to our U.S defined benefit plans in 2019 and 2018. We contributed $25 million to our U.S. defined benefit plans in 2017. We contributed $21 million each year to our non-U.S. defined benefit plans in 2019, 2018 and 2017, respectively. We did not contribute to our U.S. post-retirement benefit plans in 2019, 2018 and 2017. Our non-U.S. defined benefit plans are generally funded ratably throughout the year. Total contributions in 2019 were $21 million or equal to total contribution in 2018. Our annual contributions are highly dependent on the relative performance of our assets versus our projected liabilities, among other factors. We do not expect to contribute to our U.S. plans and U.S. post-retirement benefit plans during 2020. We expect to contribute $24 million to our non-U.S. defined benefit plans during 2020.
        
Net Cash Used in Investing Activities

Net cash used in investing activities in 2019 was $1,590 million and in 2018 was $705 million as compared to net cash used of $304 million in 2017.

Investments in property, plant and equipment were $155 million in 2019, $177 million in 2018 and $176 million in 2017. In 2019 we invested $1,408 million in acquisitions of businesses and intangible assets, net of cash acquired for the acquisition of two businesses compared to the acquisition of seven businesses for $516 million in 2018 and the acquisition of two businesses for $128 million in 2017. In 2019 there were approximately $23 million in purchases of fair value investments compared to $11 million outlay in 2018 and $1 million in 2017.

Net Cash Used in Financing Activities

Net cash used in financing activities in 2019 was $299 million compared to $797 million in 2018 and $202 million in 2017.

Treasury Stock Repurchases

On May 28, 2015 we announced that our board of directors had approved a share repurchase program (the "2015 repurchase program"). The 2015 share repurchase program authorizes the purchase of up to $1.14 billion of our common stock at the company's discretion through and including November 1, 2018. The 2015 repurchase program did not require the company to acquire a specific number of shares and could have been suspended or discontinued at any time. During the year ended October 31, 2017, we repurchased and retired approximately 4.1 million shares for $194 million under this authorization. During the year ended October 31, 2018, we repurchased and retired approximately 6.4 million shares for $422 million under this authorization. As of

46
Table of Contents            

October 31, 2018, we had remaining authorization to repurchase up to $188 million of our common stock under this program which expired on November 1, 2018.

On November 19, 2018 we announced that our board of directors had approved a new share repurchase program (the "2019 repurchase program") designed, among other things, to reduce or eliminate dilution resulting from issuance of stock under the company's employee equity incentive programs. The 2019 share repurchase program authorizes the purchase of up to $1.75 billion of our common stock at the company's discretion and has no fixed termination date. The 2019 repurchase program does not require the company to acquire a specific number of shares and may be suspended, amended or discontinued at any time. During the year ended October 31, 2019, we repurchased and retired approximately 10.4 million shares for $723 million under this authorization. As of October 31, 2019, we had remaining authorization to repurchase up to $1.03 billion of our common stock under this program.

Dividends

For the years ended October 31, 2019, 2018 and 2017 cash dividends of $206 million, $191 million and $170 million were paid on the company's outstanding common stock, respectively. On November 20, 2019 we declared a quarterly dividend of $0.18 per share of common stock, or approximately $56 million which will be paid on January 22, 2020 to shareholders of record as of the close of business on December 31, 2019. The timing and amounts of any future dividends are subject to determination and approval by our board of directors.

Credit Facility

On March 13, 2019, Agilent entered into a credit agreement with a group of financial institutions which provides for a $1 billion five-year unsecured credit facility that will expire on March 13, 2024. The credit facility replaces the existing credit facility which terminated on the closing date of the new facility. For the year ended October 31, 2019, we borrowed $305 million and repaid $190 million. As of October 31, 2019, the company had borrowings of $115 million outstanding under the credit facility. We were in compliance with the covenants for the credit facility during the year ended October 31, 2019. On August 7, 2019, we entered into an amendment to the credit agreement, which provides for a $500 million short-term loan facility that was used in full to complete the BioTek acquisition and which is outstanding at October 31, 2019. On October 21, 2019, we entered into a second amendment to the credit agreement, which refreshed the amount available for additional incremental term loan facilities under the credit agreement to permit additional incremental facilities of up to $500 million. We had no borrowings under the additional incremental facilities as of October 31, 2019.

Short-term and Long-term Debt

On October 24, 2007, the company issued an aggregate principal amount of $600 million in senior notes ("2017 senior notes"). On October 20, 2014, we settled the redemption of $500 million of the $600 million outstanding aggregate principal amount of our 2017 senior notes. The 2017 senior notes were repayable within one year as of October 31, 2017 and were reclassified to short-term debt. The remaining $100 million in 2017 senior notes matured and were paid in full on November 1, 2017.

On July 13, 2010, the company issued an aggregate principal amount of $500 million in senior notes ("2020 senior notes"). The 2020 senior notes were issued at 99.54% of their principal amount. The notes were scheduled to mature on July 15, 2020, and bear interest at a fixed rate of 5.00% per annum. The interest was payable semi-annually on January 15th and July 15th of each year and payments commenced on January 15, 2011.

On August 9, 2011, we terminated our interest rate swap contracts related to our 2020 senior notes that represented the notional amount of $500 million. The asset value, including interest receivable, upon termination for these contracts was approximately $34 million. The gain was deferred and amortized to interest expense over the remaining life of the 2020 senior notes.

On September 17, 2019, we repaid the $500 million outstanding aggregate principal amount of our 2020 senior notes due July 15, 2020 that were called for redemption on August 16, 2019. The redemption price of approximately $512 million included a $12 million prepayment penalty. The redemption price was computed in accordance with the terms of the 2020 senior notes as the present value of the remaining scheduled payments of principal and unpaid interest related to the redemption.  The prepayment penalty plus amortization of the previously deferred interest swap gain of $4 million and amortization of previously deferred debt issuance costs and discount of $1 million was recorded in other income (expense) net in the consolidated statement of operations. We also paid accrued and unpaid interest of $4 million on the 2020 senior notes up to but not including the redemption date.

On September 10, 2012, the company issued an aggregate principal amount of $400 million in senior notes ("2022 senior notes"). The 2022 senior notes were issued at 99.80% of their principal amount. The notes will mature on October 1, 2022, and

47
Table of Contents            

bear interest at a fixed rate of 3.20% per annum. The interest is payable semi-annually on April 1st and October 1st of each year and payments commenced on April 1, 2013.

In July 2012, Agilent executed treasury lock agreements for $400 million in connection with future interest payments to be made on our 2022 senior notes issued on September 10, 2012. The treasury lock contracts were terminated on September 10, 2012 and we recognized a deferred gain in accumulated other comprehensive income which is being amortized to interest expense over the life of the 2022 senior notes. The remaining gain to be amortized related to the treasury lock agreements at October 31, 2019 was $1 million.

On June 18, 2013, the company issued aggregate principal amount of $600 million in senior notes ("2023 senior notes"). The 2023 senior notes were issued at 99.544% of their principal amount. The notes will mature on July 15, 2023 and bear interest at a fixed rate of 3.875% per annum. The interest is payable semi-annually on January 15th and July 15th of each year and payments commenced January 15, 2014.

On September 15, 2016, the company issued aggregate principal amount of $300 million in senior notes ("2026 senior notes"). The 2026 senior notes were issued at 99.624%% of their principal amount. The notes will mature on September 22, 2026 and bear interest at a fixed rate of 3.050% per annum. The interest is payable semi-annually on March 22nd and September 22nd of each year and payments commenced March 22, 2017.

In February 2016, Agilent executed three forward-starting pay fixed/receive variable interest rate swaps for the notional amount of $300 million in connection with future interest payments to be made on our 2026 senior notes issued on September 15, 2016. The swap arrangements were terminated on September 15, 2016 with a payment of $10 million and we recognized this as a deferred loss in accumulated other comprehensive income which is being amortized to interest expense over the life of the 2026 senior notes.The remaining loss to be amortized related to the interest rate swap agreements at October 31, 2019 was $7 million.

On September 5, 2019, the company issued an aggregate principal amount of $500 million in senior notes ("2029 senior notes"). The 2029 senior notes were issued at 99.316% of their principal amount. The notes will mature on September 15, 2029, and bear interest at a fixed rate of 2.75% per annum. The interest is payable semi-annually on March 15th and September 15th of each year and payments commence on March 15, 2020.

In August 2019, Agilent executed treasury lock agreements for $250 million in connection with future interest payments to be made on our 2029 senior notes issued on September 5, 2019. The treasury lock contracts were terminated on September 6, 2019 and we recognized a deferred loss of $6 million in accumulated other comprehensive income which is being amortized to interest expense over the life of the 2029 senior notes. The remaining loss to be amortized related to the treasury lock agreements at October 31, 2019 was $6 million.

Capital Leases

The company leases certain property and equipment under capital leases. As of October 31, 2019, the current and non-current portion of the company’s capital lease obligations had an aggregate carrying value of approximately $6 million.

Off Balance Sheet Arrangements and Other

We have contractual commitments for non-cancelable operating leases. See Note 16, "Commitments and Contingencies", to our consolidated financial statements for further information on our non-cancelable operating leases.

Our liquidity is affected by many factors, some of which are based on normal ongoing operations of our business and some of which arise from fluctuations related to global economics and markets. Our cash balances are generated and held in many locations throughout the world. Local government regulations may restrict our ability to move cash balances to meet cash needs under certain circumstances. We do not currently expect such regulations and restrictions to impact our ability to pay vendors and conduct operations throughout our global organization.


48
Table of Contents            

Contractual Commitments

Our cash flows from operations are dependent on a number of factors, including fluctuations in our operating results, accounts receivable collections, inventory management, and the timing of tax and other payments. As a result, the impact of contractual obligations on our liquidity and capital resources in future periods should be analyzed in conjunction with such factors.

The following table summarizes our total contractual obligations at October 31, 2019 for Agilent operations and excludes amounts recorded in our consolidated balance sheet (in millions):

 
Less than one
year
 
One to three years
 
Three to five years
 
More than five years
Operating leases
$
52

 
$
70

 
$
35

 
$
56

Commitments to contract manufacturers and suppliers
481

 
12

 
—

 
—

Other purchase commitments
77

 
—

 
—

 
—

Retirement plans
24

 
—

 
—

 
—

Transitional pension contributions to our U.S. 401(k) plan
$
6

 
$
3

 
$
—

 
$
—

Total
$
640

 
$
85

 
$
35

 
$
56


Operating Leases.    Commitments under operating leases relate primarily to leasehold property, see Note 16, "Commitments and Contingencies".

Commitments to Contract Manufacturers and Suppliers.    We purchase components from a variety of suppliers and use several contract manufacturers to provide manufacturing services for our products. During the normal course of business, we issue purchase orders with estimates of our requirements several months ahead of the delivery dates. The above amounts represent the commitments under the open purchase orders with our suppliers that have not yet been received. However, our agreements with these suppliers usually provide us the option to cancel, reschedule, and adjust our requirements based on our business needs prior to firm orders being placed. We expect to fulfill most of our purchase commitments for inventory within one year.

In addition to the above-mentioned commitments to contract manufacturers and suppliers, in the past we recorded a liability for firm, non-cancelable and unconditional purchase commitments for quantities in excess of our future demand forecasts consistent with our policy relating to excess inventory. As of October 31, 2019 and 2018, the liability for our firm, non-cancelable and unconditional purchase commitments was less than $1 million. These amounts are included in other accrued liabilities in our consolidated balance sheet.

Other Purchase Commitments.    We have categorized "other purchase commitments" related to contracts with professional services suppliers. Typically, we can cancel contracts without penalties. For those contracts that are not cancelable without penalties, we are disclosing the termination fees and costs or commitments for continued spending that we are obligated to pay to a supplier under each contact's termination period before such contract can be cancelled. Our contractual obligations with these suppliers under "other purchase commitments" were approximately $77 million within the next year. Approximately $25 million of the contracts relate to penalties that will reduce over the next 14 years.

Retirement Plans.    Commitments under the retirement plans relate to expected contributions to be made to our U.S. and non-U.S. defined benefit plans and to our post-retirement medical plans for the next year only. Contributions after next year are impractical to estimate. Effective May 1, 2016 until April 30, 2022, we will provide an additional transitional company contribution for certain eligible employees equal to 3 percent, 4 percent or 5 percent of an employee's annual eligible compensation due to the U.S. Retirement Plan benefits being frozen.

We had no material off-balance sheet arrangements as of October 31, 2019 or October 31, 2018.


49
Table of Contents            

On Balance Sheet Arrangements

The following table summarizes our total contractual obligations on our October 31, 2019 balance sheet (in millions):

 
Less than one
year
 
One to three years
 
Three to five years
 
More than five years
Senior notes
$
—

 
$
400

 
$
600

 
$
800

Credit facility
115

 
—

 
—

 
—

Short term loan
500

 
—

 
—

 
—

Interest expense
59

 
118

 
69

 
87

Transition tax
35

 
—

 
39

 
90

Capital leases
1

 
1

 
1

 
3

Total
$
710

 
$
519

 
$
709

 
$
980



Other long-term liabilities as of October 31, 2019 and October 31, 2018 include $328 million and $607 million, respectively, related to long-term income tax liabilities. Of these amounts, $199 million and $215 million related to uncertain tax positions as of October 31, 2019 and October 31, 2018, respectively. We are unable to accurately predict when these amounts will be realized or released. However, it is reasonably possible that there could be significant changes to our unrecognized tax benefits in the next twelve months due to either the expiration of a statute of limitations or a tax audit settlement. The remaining $129 million in other long-term liabilities relates to the one-time transition tax payable.


50
Table of Contents            

Item 7A.    Quantitative and Qualitative Disclosures About Market Risk

We are exposed to foreign currency exchange rate risks inherent in our sales commitments, anticipated sales, and assets and liabilities denominated in currencies other than the functional currency of our subsidiaries. We hedge future cash flows denominated in currencies other than the functional currency using sales forecasts up to twelve months in advance. Our exposure to exchange rate risks is managed on an enterprise-wide basis. This strategy utilizes derivative financial instruments, including option and forward contracts, to hedge certain foreign currency exposures with the intent of offsetting gains and losses that occur on the underlying exposures with gains and losses on the derivative contracts hedging them. We do not currently and do not intend to utilize derivative financial instruments for speculative trading purposes. To the extent that we are required to pay for all, or portions, of an acquisition price in foreign currencies, we may enter into foreign exchange contracts to reduce the risk that currency movements will impact the cost of the transaction.

Our operations generate non-functional currency cash flows such as revenues, third party vendor payments and inter-company payments. In anticipation of these foreign currency cash flows and in view of volatility of the currency market, we enter into such foreign exchange contracts as are described above to manage our currency risk. Approximately 51 percent of our revenue in 2019, 53 percent of our revenue in 2018 and 51 percent of our revenues in 2017 were generated in U.S. dollars. The unfavorable effects of changes in foreign currency exchange rates, principally as a result of the strength of the U.S. dollar, has decreased revenue by approximately 2 percentage points in the year ended October 31, 2019. We calculate the impact of foreign currency exchange rates movements by applying the actual foreign currency exchange rates in effect during the last month of each quarter to the current year to both the applicable current and prior year periods.

We performed a sensitivity analysis assuming a hypothetical 10 percent adverse movement in foreign exchange rates to the hedging contracts and the underlying exposures described above. As of October 31, 2019 and 2018, the analysis indicated that these hypothetical market movements would not have a material effect on our consolidated financial position, results of operations, statement of comprehensive income or cash flows.

We are also exposed to interest rate risk due to the mismatch between the interest expense we pay on our loans at fixed rates and the variable rates of interest we receive from cash, cash equivalents and other short-term investments. We have issued long-term debt in U.S. dollars or foreign currencies at fixed interest rates based on the market conditions at the time of financing. We believe that the fair value of our fixed rate debt changes when the underlying market rates of interest change, and we may use interest rate swaps to modify such market risk.

We performed a sensitivity analysis assuming a hypothetical 10 percent adverse movement in interest rates relating to the underlying fair value of our fixed rate debt. As of October 31, 2019 and 2018, the sensitivity analyses indicated that a hypothetical 10 percent adverse movement in interest rates would result in an immaterial impact to the fair value of our fixed interest rate debt.


51
Table of Contents            

Item 8.    Financial Statements and Supplementary Data



52
Table of Contents            


REPORT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM


To the Board of Directors and Stockholders of Agilent Technologies, Inc.

Opinions on the Financial Statements and Internal Control over Financial Reporting
We have audited the accompanying consolidated balance sheets of Agilent Technologies, Inc. and its subsidiaries (the “Company”) as of October 31, 2019 and 2018, and the related consolidated statements of operations, comprehensive income, equity and cash flows for each of the three years in the period ended October 31, 2019, including the related notes and schedule of valuation and qualifying accounts for each of the three years in the period ended October 31, 2019 appearing under Item 15(a)(2) (collectively referred to as the “consolidated financial statements”). We also have audited the Company's internal control over financial reporting as of October 31, 2019, based on criteria established in Internal Control - Integrated Framework (2013) issued by the Committee of Sponsoring Organizations of the Treadway Commission (COSO).
In our opinion, the consolidated financial statements referred to above present fairly, in all material respects, the financial position of the Company as of October 31, 2019 and 2018, and the results of its operations and its cash flows for each of the three years in the period ended October 31, 2019 in conformity with accounting principles generally accepted in the United States of America. Also in our opinion, the Company maintained, in all material respects, effective internal control over financial reporting as of October 31, 2019, based on criteria established in Internal Control - Integrated Framework (2013) issued by the COSO.
Change in Accounting Principle
As discussed in Note 2 to the consolidated financial statements, the Company changed the manner in which it accounts for revenues from contracts with customers in 2019.
Basis for Opinions
The Company's management is responsible for these consolidated financial statements, for maintaining effective internal control over financial reporting, and for its assessment of the effectiveness of internal control over financial reporting, included in Management’s Report on Internal Control over Financial Reporting appearing under Item 9A. Our responsibility is to express opinions on the Company’s consolidated financial statements and on the Company's internal control over financial reporting based on our audits. We are a public accounting firm registered with the Public Company Accounting Oversight Board (United States) (PCAOB) and are required to be independent with respect to the Company in accordance with the U.S. federal securities laws and the applicable rules and regulations of the Securities and Exchange Commission and the PCAOB.
We conducted our audits in accordance with the standards of the PCAOB. Those standards require that we plan and perform the audits to obtain reasonable assurance about whether the consolidated financial statements are free of material misstatement, whether due to error or fraud, and whether effective internal control over financial reporting was maintained in all material respects.
Our audits of the consolidated financial statements included performing procedures to assess the risks of material misstatement of the consolidated financial statements, whether due to error or fraud, and performing procedures that respond to those risks. Such procedures included examining, on a test basis, evidence regarding the amounts and disclosures in the consolidated financial statements. Our audits also included evaluating the accounting principles used and significant estimates made by management, as well as evaluating the overall presentation of the consolidated financial statements. Our audit of internal control over financial reporting included obtaining an understanding of internal control over financial reporting, assessing the risk that a material weakness exists, and testing and evaluating the design and operating effectiveness of internal control based on the assessed risk. Our audits also included performing such other procedures as we considered necessary in the circumstances. We believe that our audits provide a reasonable basis for our opinions.

As described in Management’s Report on Internal Control over Financial Reporting, management has excluded ACEA Biosciences (“ACEA”) and Lionheart Technologies LLC (“BioTek”) from its assessment of internal control over financial reporting as of October 31, 2019 because they were acquired by the Company in purchase business combinations during 2019. We have also excluded ACEA and BioTek from our audit of internal control over financial reporting. ACEA and BioTek are wholly-owned subsidiaries whose total assets and total revenues excluded from management’s assessment and our audit of internal control over financial reporting collectively represent approximately 2% and less than 2%, respectively, of the related consolidated financial statement amounts as of and for the year ended October 31, 2019.

53
Table of Contents            

Definition and Limitations of Internal Control over Financial Reporting
A company’s internal control over financial reporting is a process designed to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles. A company’s internal control over financial reporting includes those policies and procedures that (i) pertain to the maintenance of records that, in reasonable detail, accurately and fairly reflect the transactions and dispositions of the assets of the company; (ii) provide reasonable assurance that transactions are recorded as necessary to permit preparation of financial statements in accordance with generally accepted accounting principles, and that receipts and expenditures of the company are being made only in accordance with authorizations of management and directors of the company; and (iii) provide reasonable assurance regarding prevention or timely detection of unauthorized acquisition, use, or disposition of the company’s assets that could have a material effect on the financial statements.
Because of its inherent limitations, internal control over financial reporting may not prevent or detect misstatements. Also, projections of any evaluation of effectiveness to future periods are subject to the risk that controls may become inadequate because of changes in conditions, or that the degree of compliance with the policies or procedures may deteriorate.
Critical Audit Matters
The critical audit matters communicated below are matters arising from the current period audit of the consolidated financial statements that were communicated or required to be communicated to the audit committee and that (i) relate to accounts or disclosures that are material to the consolidated financial statements and (ii) involved our especially challenging, subjective, or complex judgments. The communication of critical audit matters does not alter in any way our opinion on the consolidated financial statements, taken as a whole, and we are not, by communicating the critical audit matters below, providing separate opinions on the critical audit matters or on the accounts or disclosures to which they relate.
Uncertain Tax Positions
As described in Note 6 to the consolidated financial statements, the Company has recorded liabilities for uncertain tax positions of $227 million as of October 31, 2019. As disclosed by management, the estimate of the Company’s tax liabilities relating to uncertain tax positions requires management to assess uncertainties and to make judgments about the application of complex tax law and regulations in a multitude of jurisdictions. The Company is subject to taxes in the U.S., Singapore and various other foreign jurisdictions and is subject to examinations of its tax returns by tax authorities in various jurisdictions around the world. The Company has a number of years and matters which remain subject to examination by tax authorities in various jurisdictions that could result in significant changes to unrecognized tax benefits due to either the expiration of a statute of limitation or a tax audit settlement which will be partially offset by an anticipated tax liability related to unremitted foreign earnings, where applicable.
The principal considerations for our determination that performing procedures relating to uncertain tax positions is a critical audit matter are there was significant judgment by management when determining uncertain tax positions, including a high degree of estimation uncertainty relative to the numerous and complex tax laws, tax audits, and potential for significant adjustments as a result of such audits. This in turn led to a high degree of auditor judgment, effort, and subjectivity in performing procedures to evaluate the timely identification and accurate measurement of uncertain tax positions. Also, the evaluation of audit evidence available to support the tax liabilities for uncertain tax positions is complex and required significant auditor judgment as the nature of the evidence is often highly subjective, and the audit effort involved the use of professionals with specialized skill and knowledge to assist in evaluating the audit evidence obtained.
Addressing the matter involved performing procedures and evaluating audit evidence in connection with forming our overall opinion on the consolidated financial statements. These procedures included testing the effectiveness of controls relating to the identification and recognition of the liability for uncertain tax positions, and controls addressing completeness of the uncertain tax positions, as well as controls over measurement of the liability. These procedures also included, among others, testing the completeness, accuracy, and relevance of information used in the calculation of the liability for uncertain tax positions, including intercompany agreements, international, federal, and state filing positions, and the related final tax returns, testing the calculation of the liability for uncertain tax positions by jurisdiction, including management’s assessment of the technical merits of tax positions and estimates of the amount of tax benefit expected to be sustained, testing the completeness of management’s assessment of both the identification of uncertain tax positions and possible outcomes of each uncertain tax position, and evaluating the status and results of income tax audits with the relevant tax authorities. Professionals with specialized skill and knowledge were used to assist in the evaluation of the Company’s uncertain tax positions related to the application of relevant tax laws.

54
Table of Contents            

Valuation of acquired developed product technology intangible assets - BioTek acquisition
As described in Notes 1 and 3 to the consolidated financial statements, in 2019 the Company completed the acquisition of BioTek for consideration of $1.17 billion, of which $387 million of developed product technology intangible assets were recorded. Management estimated the fair value of the developed product technology using the multi-period excess earnings method under the income approach by discounting forecasted future cash flows directly related to products expecting to result from the projects, net of returns on contributory assets. Management’s determination of the fair value of the developed product technology intangible assets acquired involved the use of significant estimates and assumptions related to revenue growth rates and the discount rates.
The principal considerations for our determination that performing procedures relating to the valuation of acquired developed product technology intangible assets in connection with the BioTek acquisition is a critical audit matter are (i) there was a high degree of auditor judgment and subjectivity in applying procedures relating to the fair value measurement of acquired developed product technology intangible assets due to the significant amount of judgment by management when developing the estimate, (ii) significant audit effort was required in evaluating the significant assumptions relating to the estimate, such as the revenue growth rates and the discount rates, and (iii) the audit effort involved the use of professionals with specialized skill and knowledge to assist in evaluating the audit evidence obtained from these procedures.
Addressing the matter involved performing procedures and evaluating audit evidence in connection with forming our overall opinion on the consolidated financial statements. These procedures included testing the effectiveness of controls relating to the acquisition accounting, including controls over management’s valuation of the acquired developed product technology intangible assets and controls over the development of the assumptions related to the valuation of the acquired developed product technology intangible assets, including the revenue growth rates and the discount rates. These procedures also included, among others, reading the purchase agreement, testing management’s process for estimating the fair value of the acquired developed technology intangible assets, testing the completeness, accuracy, and relevance of underlying data used in estimating the fair value of the acquired developed technology intangible assets, and evaluating the appropriateness of the valuation methods and the reasonableness of the significant assumptions, including the revenue growth rates and the discount rates. Evaluating the reasonableness of the revenue growth rates involved considering the past performance of the acquired business, as well as economic and industry forecasts. Professionals with specialized skill and knowledge were used to assist in the evaluation of the Company’s fair value estimate and certain significant assumptions, including the discount rates.




/s/ PricewaterhouseCoopers LLP
 
 
 
San Jose, California
 
December 19, 2019
 
 
 
We have served as the Company’s auditor since 1999.
 





55
Table of Contents            


AGILENT TECHNOLOGIES, INC.
CONSOLIDATED STATEMENT OF OPERATIONS
 
Years Ended October 31,
 
2019
 
2018
 
2017
 
(in millions, except per
share data)
Net revenue:
 
 
 
 
 
Products
$
3,877

 
$
3,746

 
$
3,397

Services and other
1,286

 
1,168

 
1,075

Total net revenue
5,163

 
4,914

 
4,472

Costs and expenses:
 
 
 
 
 
Cost of products
1,680

 
1,595

 
1,473

Cost of services and other
678

 
639

 
600

Total costs
2,358

 
2,234

 
2,073

Research and development
404

 
387

 
341

Selling, general and administrative
1,460

 
1,389

 
1,251

Total costs and expenses
4,222

 
4,010

 
3,665

Income from operations
941

 
904

 
807

Interest income
36

 
38

 
22

Interest expense
(74
)
 
(75
)
 
(79
)
Other income (expense), net
16

 
79

 
53

Income before taxes
919

 
946

 
803

Provision (benefit) for income taxes
(152
)
 
630

 
119

Net income
$
1,071

 
$
316

 
$
684

 
 
 
 
 
 
Net income per share:
 
 
 
 
 
Basic
$
3.41

 
$
0.98

 
$
2.12

Diluted
$
3.37

 
$
0.97

 
$
2.10

 
 
 
 
 
 
Weighted average shares used in computing net income per share:
 
 
 
 
 
Basic
314

 
321

 
322

Diluted
318

 
325

 
326

 
 
 
 
 
 
   
The accompanying notes are an integral part of these consolidated financial statements.

56
Table of Contents            

AGILENT TECHNOLOGIES, INC.
CONSOLIDATED STATEMENT OF COMPREHENSIVE INCOME
(in millions)


 
Years Ended October 31,
 
2019
 
2018
 
2017
 
 
 
 
 
 
Net income
$
1,071

 
$
316

 
$
684

Other comprehensive income (loss):

 

 

Gain (loss) on derivative instruments, net of tax expense (benefit) of $(2), $1 and $0
(4
)
 
6

 
—

Amounts reclassified into earnings related to derivative instruments, net of tax expense (benefit) of $(2), $1 and $0
(6
)
 
3

 
(1
)
Foreign currency translation, net of tax expense (benefit) of $(10), $7 and $3
10

 
(58
)
 
41

Net defined benefit pension cost and post retirement plan costs:

 

 

Change in actuarial net loss, net of tax expense (benefit) of $(25), $(3) and $52
(93
)
 
(7
)
 
123

Change in net prior service benefit, net of tax benefit of $(2), $(2) and $(3)
(6
)
 
(6
)
 
(6
)
Other comprehensive income (loss)
(99
)
 
(62
)
 
157

Total comprehensive income
$
972

 
$
254

 
$
841


The accompanying notes are an integral part of these consolidated financial statements.


57
Table of Contents            

AGILENT TECHNOLOGIES, INC.
CONSOLIDATED BALANCE SHEET
 
October 31,
 
2019
 
2018
 
(in millions, except
par value and
share data)
ASSETS
 
 
 
Current assets:
 
 
 
Cash and cash equivalents
$
1,382

 
$
2,247

Accounts receivable, net
930

 
776

Inventory
679

 
638

Other current assets
198

 
187

Total current assets
3,189

 
3,848

Property, plant and equipment, net
850

 
822

Goodwill
3,593

 
2,973

Other intangible assets, net
1,107

 
491

Long-term investments
102

 
68

Other assets
611

 
339

Total assets
$
9,452

 
$
8,541

LIABILITIES AND EQUITY
 
 
 
Current liabilities:
 
 
 
Accounts payable
$
354

 
$
340

Employee compensation and benefits
334

 
304

Deferred revenue
336

 
324

Short-term debt
616

 
—

Other accrued liabilities
440

 
203

Total current liabilities
2,080

 
1,171

Long-term debt
1,791

 
1,799

Retirement and post-retirement benefits
360

 
239

Other long-term liabilities
473

 
761

Total liabilities
4,704

 
3,970

Commitments and contingencies (Note 16)


 


Total equity:
 
 
 
Stockholders' equity:
 
 
 
Preferred stock; $0.01 par value; 125 million shares authorized; none issued and outstanding
—

 
—

Common stock; $0.01 par value; 2 billion shares authorized; 309 million shares at October 31, 2019 and 318 million shares at October 31, 2018 issued
3

 
3

Additional paid-in-capital
5,277

 
5,308

Accumulated deficit
(18
)
 
(336
)
Accumulated other comprehensive loss
(514
)
 
(408
)
Total stockholders' equity
4,748

 
4,567

Non-controlling interest
—

 
4

Total equity
4,748

 
4,571

Total liabilities and equity
$
9,452

 
$
8,541

   The accompanying notes are an integral part of these consolidated financial statements.

58
Table of Contents            

AGILENT TECHNOLOGIES, INC.
CONSOLIDATED STATEMENT OF CASH FLOWS
 
Years Ended October 31,
 
2019
 
2018
 
2017
 
(in millions)
Cash flows from operating activities:
 
 
 
 
 
Net income
$
1,071

 
$
316

 
$
684

Adjustments to reconcile net income to net cash provided by operating activities:
 
 
 
 
 
Depreciation and amortization
238

 
210

 
212

Share-based compensation
72

 
70

 
60

Deferred taxes
(255
)
 
(16
)
 
102

Excess and obsolete inventory related charges
19

 
26

 
24

Gain on step acquisition
—

 
(20
)
 
—

Asset impairment charges
—

 
21

 
—

Loss on extinguishment of debt
9

 
—

 
—

Other
6

 
9

 
7

Changes in assets and liabilities:
 
 
 
 
 
Accounts receivable, net
(106
)
 
(65
)
 
(81
)
Inventory
(36
)
 
(83
)
 
(61
)
Accounts payable
29

 
40

 
2

Employee compensation and benefits
23

 
31

 
38

Changes in assets and liabilities due to Tax Act
—

 
552

 
—

Treasury lock agreement payment
(6
)
 
—

 
—

Other assets and liabilities
(43
)
 
(4
)
 
(98
)
Net cash provided by operating activities
1,021

 
1,087

 
889

Cash flows from investing activities:
 
 
 
 
 
Investments in property, plant and equipment
(155
)
 
(177
)
 
(176
)
Proceeds from the sale of property, plant and equipment
—

 
1

 
—

Proceeds from divestitures
—

 
—

 
2

Payment to acquire fair value investment
(23
)
 
(11
)
 
(1
)
Payment in exchange for convertible note
(3
)
 
(2
)
 
(1
)
Payment to acquire intangible assets
(1
)
 
—

 
—

Acquisitions of businesses and intangible assets, net of cash acquired
(1,408
)
 
(516
)
 
(128
)
Net cash used in investing activities
(1,590
)
 
(705
)
 
(304
)
Cash flows from financing activities:
 
 
 
 
 
Issuance of common stock under employee stock plans
54

 
56

 
66

Payment of taxes related to net share settlement of equity awards
(16
)
 
(30
)
 
(14
)
Treasury stock repurchases
(723
)
 
(422
)
 
(194
)
Payment of dividends
(206
)
 
(191
)
 
(170
)
Issuance of senior notes
497

 
—

 
—

Debt issuance costs
(4
)
 
—

 
—

Purchase of non-controlling interest
(4
)
 
—

 
—

Proceeds from credit facility and short-term loan
805

 
483

 
400

Repayment of debt and credit facility
(702
)
 
(693
)
 
(290
)
Net cash used in financing activities
(299
)
 
(797
)
 
(202
)
Effect of exchange rate movements
2

 
(17
)
 
8

Net increase (decrease) in cash, cash equivalents and restricted cash
(866
)
 
(432
)
 
391

Cash, cash equivalents and restricted cash at beginning of year
2,254

 
2,686

 
2,295

Cash, cash equivalents and restricted cash at end of year
$
1,388

 
$
2,254

 
$
2,686

 
 
 
 
 
 
Supplemental cash flow information:
 
 
 
 
 
Income tax payments, net
$
159

 
$
102

 
$
63

Interest payments
$
80

 
$
80

 
$
82

Non-cash change in investments in property, plant and equipment -increase (decrease)
$
(21
)
 
$
(5
)
 
$
29

   
The accompanying notes are an integral part of these consolidated financial statements.

59
Table of Contents            

AGILENT TECHNOLOGIES, INC.
CONSOLIDATED STATEMENT OF EQUITY
 
Common Stock
 
Treasury Stock
 
 
 
Accumulated
Other
Comprehensive
Income/(Loss)
 
 
 
 
 
 
 
Number
of
Shares
 
Par
Value
 
Additional
Paid-in
Capital
 
Number
of
Shares
 
Treasury
Stock at
Cost
 
Retained
Earnings
(Accumulated Deficit)
 
Total Stockholders' Equity
 
Non-
Controlling
Interest
 
Total
Equity
 
(in millions, except number of shares in thousands)
Balance as of October 31, 2016
613,536

 
$
6

 
$
9,159

 
(290,075
)
 
$
(10,508
)
 
$
6,089

 
$
(503
)
 
$
4,243

 
$
3

 
$
4,246

Components of comprehensive income, net of tax:
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Net income
—

 
—

 
—

 
—

 
—

 
684

 
—

 
684

 
—

 
684

Other comprehensive income
—

 
—

 
—

 
—

 
—

 
—

 
157

 
157

 
—

 
157

Total comprehensive income
 

 
 

 
 

 
 

 
 

 
 

 
 

 
841

 
 

841

Cash dividends declared ($0.528 per common share)
—

 
—

 
—

 
—

 
—

 
(170
)
 
—

 
(170
)
 
—

 
(170
)
Change in non-controlling interest
—

 
—

 
—

 
—

 
—

 
—

 
—

 
—

 
1

 
1

Share-based awards issued
2,621

 
—

 
51

 
—

 
—

 
—

 
—

 
51

 
—

 
51

Repurchase of common stock
—

 
—

 
—

 
(4,107
)
 
(194
)
 
—

 
—

 
(194
)
 
—

 
(194
)
Retirement of treasury stock
(294,182
)
 
(3
)
 
(3,970
)
 
294,182

 
10,702

 
(6,729
)
 
 
 
—

 
—

 
—

Share-based compensation
—

 
—

 
60

 
—

 
—

 
—

 
—

 
60

 
—

 
60

Balance as of October 31, 2017
321,975

 
$
3

 
$
5,300

 
—

 
$
—

 
$
(126
)
 
$
(346
)
 
$
4,831

 
$
4

 
$
4,835

Components of comprehensive income, net of tax:
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Net income
—

 
—

 
—

 
—

 
—

 
316

 
—

 
316

 
—

 
316

Other comprehensive loss
—

 
—

 
—

 
—

 
—

 
—

 
(62
)
 
(62
)
 
—

 
(62
)
Total comprehensive income
 

 
 

 
 

 
 

 
 

 
 

 
 

 
254

 
 
 
254

Cash dividends declared ($0.596 per common share)
—

 
—

 
—

 
—

 
—

 
(191
)
 
—

 
(191
)
 
—

 
(191
)
Share-based awards issued
2,176

 
—

 
25

 
—

 
—

 
—

 
—

 
25

 
—

 
25

Repurchase of common stock
—

 
—

 
—

 
(6,436
)
 
(422
)
 
—

 
—

 
(422
)
 
—

 
(422
)
Retirement of treasury stock
(6,436
)
 
—

 
(87
)
 
6,436

 
422

 
(335
)
 
—

 
—

 
—

 
—

Share-based compensation
—

 
—

 
70

 
—

 
—

 
—

 
—

 
70

 
—

 
70

Balance as of October 31, 2018
317,715

 
$
3

 
$
5,308

 
—

 
$
—

 
$
(336
)
 
$
(408
)
 
$
4,567

 
$
4

 
$
4,571

Effects of adoption of new accounting standards
—

 
$
—

 
$
—

 
—

 
$
—

 
$
33

 
$
(7
)
 
$
26

 
$
—

 
$
26

Components of comprehensive income, net of tax:
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Net income
—

 
—

 
—

 
—

 
—

 
1,071

 
—

 
1,071

 
—

 
1,071

Other comprehensive loss
—

 
—

 
—

 
—

 
—

 
—

 
(99
)
 
(99
)
 
—

 
(99
)
Total comprehensive income
 

 
 

 
 

 
 

 
 

 
 

 
 

 
972

 
 
 
972

Purchase of non-controlling interest
—

 
—

 
—

 
—

 
—

 
—

 
—

 
—

 
(4
)
 
(4
)
Cash dividends declared ($0.656 per common share)             
—

 
—

 
—

 
—

 
—

 
(206
)
 
—

 
(206
)
 
—

 
(206
)
Share-based awards issued
1,792

 
—

 
40

 
—

 
—

 
—

 
—

 
40

 
—

 
40

Repurchase of common stock
—

 
—

 
—

 
(10,436
)
 
(723
)
 
—

 
—

 
(723
)
 
—

 
(723
)
Retirement of treasury stock
(10,436
)
 
—

 
(143
)
 
10,436

 
723

 
(580
)
 
—

 
—

 
—

 
—

Share-based compensation
—

 
—

 
72

 
—

 
—

 
—

 
—

 
72

 
—

 
72

Balance as of October 31, 2019
309,071

 
$
3

 
$
5,277

 
—

 
$
—

 
$
(18
)
 
$
(514
)
 
$
4,748

 
$
—

 
$
4,748

The accompanying notes are an integral part of these consolidated financial statements.

60
Table of Contents            

AGILENT TECHNOLOGIES, INC.
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS
1.     OVERVIEW AND SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES

Overview.    Agilent Technologies, Inc. ("we", "Agilent" or the "company"), incorporated in Delaware in May 1999, is a global leader in life sciences, diagnostics and applied chemical markets, providing application focused solutions that include instruments, software, services and consumables for the entire laboratory workflow.

Basis of Presentation.    The accompanying consolidated financial statements have been prepared by us pursuant to the rules and regulations of the U.S. Securities and Exchange Commission ("SEC") and is in conformity with U.S. generally accepted accounting principles ("GAAP"). Our fiscal year end is October 31. Unless otherwise stated, all years and dates refer to our fiscal year.

Principles of Consolidation.    The consolidated financial statements include the accounts of the company and our wholly- and majority-owned subsidiaries. All significant intercompany accounts and transactions have been eliminated.

Use of Estimates.    The preparation of financial statements in accordance with U.S. GAAP requires management to make estimates and assumptions that affect the amounts reported in our consolidated financial statements and accompanying notes. Management bases its estimates on historical experience and various other assumptions believed to be reasonable. Although these estimates are based on management's best knowledge of current events and actions that may impact the company in the future, actual results may be different from the estimates. Our critical accounting policies are those that affect our financial statements materially and involve difficult, subjective or complex judgments by management. Those policies are revenue recognition, valuation of goodwill and purchased intangible assets, inventory valuation, retirement and post-retirement plan assumptions and accounting for income taxes.

Retirement of Treasury Shares. Upon the formal retirement of treasury shares, we deduct the par value of the retired treasury shares from common stock and allocate the excess of cost over par as a deduction to additional paid-in capital, based on the pro-rata portion of additional paid-in-capital, and the remaining excess as a deduction to retained earnings. All retired treasury shares revert to the status of authorized but unissued shares.

Revenue Recognition.    We enter into contracts to sell products, services or combinations of products and services. Products may include hardware or software and services may include one-time service events or services performed over time.

We derive revenue primarily from the sale of analytical and diagnostics products and services. A performance obligation is a promise in a contract to transfer a distinct product or service to a customer and is the unit of account under Accounting Standard Codification Topic 606, Revenue from Contracts with Customers (“ASC 606’’). See also Note 2, "New Accounting Pronouncements" and Note 4, "Revenue" for additional information on revenue recognition.

Revenue is recognized when control of the promised products or services is transferred to our customers and the performance obligation is fulfilled in an amount that reflects the consideration that we expect to be entitled in exchange for those products or services, the transaction price. For equipment, consumables, and most software licenses, control transfers to the customer at a point in time. We use present right to payment, legal title, physical possession of the asset, and risks and rewards of ownership as indicators to determine the transfer of control to the customer. Where acceptance is not a formality, the customer must have documented their acceptance of the product or service. For products that include installation, if the installation meets the criteria to be considered a separate performance obligation, product revenue is recognized when control has passed to the customer, and recognition of installation revenue occurs once completed. Product revenue, including sales to resellers and distributors is reduced for provisions for warranties, returns, and other adjustments in the period the related sales are recorded.

Service revenue includes extended warranty, customer and software support including: Software as a Service, post contract support, consulting including companion diagnostics, and training and education. Instrument service contracts and software maintenance contracts are typically annual contracts, which are billed at the beginning of the contract or maintenance period. Revenue for these contracts is recognized on a straight-line basis to revenue over the service period, as a time-based measure of progress best reflects our performance in satisfying this obligation. There are no deferred costs associated with the service contract, as the cost of the service is recorded when the service is performed. Service calls not included in a support contract are recognized to revenue at the time a service is performed.


61
Table of Contents            

We have sales from standalone software. These arrangements typically include software licenses and maintenance contracts, both of which we have determined are distinct performance obligations. We determine the amount of the transaction price to allocate to the license and maintenance contract based on the relative standalone selling price of each performance obligation. Software license revenue is recognized at the point in time when control has been transferred to the customer. The revenue allocated to the software maintenance contract is recognized on a straight-line basis over the maintenance period, which is the contractual term of the contract, as a time-based measure of progress best reflects our performance in satisfying this obligation. Unspecified rights to software upgrades are typically sold as part of the maintenance contract on a when-and-if-available basis.

Our multiple-element arrangements are generally comprised of a combination of instruments, installation or other start-up services, and/or software, and/or support or services. Hardware and software elements are typically delivered at the same time and revenue is recognized when control passes to the customer. Service revenue is deferred and recognized over the contractual period or as services are rendered and accepted by the customer. Our arrangements generally do not include any provisions for cancellation, termination, or refunds that would significantly impact recognized revenue.

For contracts with multiple performance obligations, we allocate the consideration to which we expect to be entitled to each performance obligation based on relative standalone selling prices and recognize the related revenue when or as control of each individual performance obligation is transferred to customers. We estimate the standalone selling price by calculating the average historical selling price of our products and services per country for each performance obligation. Standalone selling prices are determined for each distinct good or service in the contract and then we allocate the transaction price in proportion to those standalone selling prices by performance obligations.

A portion of our revenue relates to lease arrangements. Standalone lease arrangements are outside the scope of ASC 606 and are therefore accounted for in accordance with ASC 840, Leases. Each of these contracts is evaluated as a lease arrangement, either as an operating lease or a sales-type capital lease using the current lease classification guidance.

Deferred Revenue.    Contract liabilities (deferred revenue) primarily relate to multiple element arrangements for which billing has occurred but transfer of control of all elements (performance obligations) to the customer has either partially or not occurred at the balance sheet date. This includes cash received from customers for products and related installation and services in advance of the transfer of control. Contract liabilities are classified as either in current liabilities in deferred revenue or long-term in other long-term liabilities in the consolidated balance sheet based on the timing of when we expect to complete our performance obligation.

Accounts Receivable, net.    Trade accounts receivable are recorded at the invoiced amount and do not bear interest. Such accounts receivable have been reduced by an allowance for doubtful accounts, which is our best estimate of the amount of probable credit losses in our existing accounts receivable. We determine the allowance based on customer specific experience and the aging of such receivables, among other factors. The allowance for doubtful accounts as of October 31, 2019 and 2018 was not material. We do not have any off-balance-sheet credit exposure related to our customers. Accounts receivable are also recorded net of estimated product returns which are not material.

Shipping and Handling Costs.  Our shipping and handling costs charged to customers are included in net revenue, and the associated expense is recorded in cost of products for all periods presented.

Inventory.    Inventory is valued at standard cost, which approximates actual cost computed on a first-in, first-out basis, not in excess of market value. We assess the valuation of our inventory on a periodic basis and make adjustments to the value for estimated excess and obsolete inventory based on estimates about future demand. The excess balance determined by this analysis becomes the basis for our excess inventory charge. Our excess inventory review process includes analysis of sales forecasts, managing product rollovers and working with manufacturing to maximize recovery of excess inventory.

Acquisitions. Agilent accounts for the acquisition of a business using the acquisition method of accounting and we allocate the fair value of the purchase price to the tangible assets acquired, liabilities assumed, and intangible assets acquired, including in-process research and development (“IPR&D”), based on their estimated fair values. The excess value of the cost of an acquired business over the fair value of the assets acquired and liabilities assumed is recognized as goodwill. The fair value of IPR&D is initially capitalized as an intangible asset with an indefinite life. When an IPR&D project is completed, the IPR&D is reclassified as an amortizable purchased intangible asset and amortized to costs of revenues over the asset’s estimated useful life.

Our determination of the fair value of the intangible assets acquired involves the use of significant estimates and assumptions. Specifically, our determination of the fair value of the developed product technology and IPR&D acquired involve significant estimates and assumptions related to revenue growth rates and discount rates. Our determination of the fair value of customer

62
Table of Contents            

relationships acquired involved significant estimates and assumptions related to revenue growth rates, discount rates, and customer attrition rates. Our determination of the fair value of the tradename acquired involved the use of significant estimates and assumptions related to revenue growth rates, royalty rates and discount rates. The company believes that the fair value assigned to the assets acquired and liabilities assumed are based on reasonable assumptions and estimates that marketplace participants would use. Actual results could differ materially from these estimates.

Goodwill and Purchased Intangible Assets. Under the authoritative guidance we have the option to perform a qualitative assessment to determine whether further impairment testing is necessary. The accounting standard gives an entity the option to first assess qualitative factors to determine whether performing the two-step test is necessary. If an entity believes, as a result of its qualitative assessment, that it is more-likely-than-not (i.e. greater than 50% chance) that the fair value of a reporting unit is less than its carrying amount, the quantitative impairment test will be required. Otherwise, no further testing will be required.

The guidance includes examples of events and circumstances that might indicate that a reporting unit's fair value is less than its carrying amount. These include macro-economic conditions such as deterioration in the entity's operating environment or industry or market considerations; entity-specific events such as increasing costs, declining financial performance, or loss of key personnel; or other events such as an expectation that a reporting unit will be sold or a sustained decrease in the stock price on either an absolute basis or relative to peers.

If it is determined, as a result of the qualitative assessment, that it is more-likely-than-not that the fair value of a reporting unit is less than its carrying amount, the provisions of authoritative guidance require that we perform a two-step impairment test on goodwill. In the first step, we compare the fair value of each reporting unit to its carrying value. The second step (if necessary) measures the amount of impairment by applying fair-value-based tests to the individual assets and liabilities within each reporting unit. As defined in the authoritative guidance, a reporting unit is an operating segment, or one level below an operating segment. We aggregate components of an operating segment that have similar economic characteristics into our reporting units.

In fiscal year 2019, we assessed goodwill impairment for our three reporting units which consisted of three segments: life sciences and applied markets, diagnostics and genomics and Agilent CrossLab. We performed a qualitative test for goodwill impairment of the three reporting units, as of September 30, 2019, our annual impairment test date. Based on the results of our qualitative testing, we believe that it is more-likely-than-not that the fair value of each reporting unit is greater than its respective carrying value. Each quarter we review the events and circumstances to determine if goodwill impairment is indicated. There was no impairment of goodwill during the years ended October 31, 2019, 2018 and 2017.

Purchased intangible assets consist primarily of acquired developed technologies, proprietary know-how, trademarks, and customer relationships and are amortized using the best estimate of the asset's useful life that reflect the pattern in which the economic benefits are consumed or used up or a straight-line method ranging from 6 months to 15 years. IPR&D is initially capitalized at fair value as an intangible asset with an indefinite life and assessed for impairment thereafter. When the IPR&D project is complete, it is reclassified as an amortizable purchased intangible asset and is amortized over its estimated useful life. If an IPR&D project is abandoned, Agilent will record a charge for the value of the related intangible asset to Agilent's consolidated statement of operations in the period it is abandoned.

Agilent's indefinite-lived intangible assets are IPR&D intangible assets. The accounting guidance allows a qualitative approach for testing indefinite-lived intangible assets for impairment, similar to the issued impairment testing guidance for goodwill and allows the option to first assess qualitative factors (events and circumstances) that could have affected the significant inputs used in determining the fair value of the indefinite-lived intangible asset to determine whether it is more-likely-than-not (i.e. greater than 50% chance) that the indefinite-lived intangible asset is impaired. An organization may choose to bypass the qualitative assessment for any indefinite-lived intangible asset in any period and proceed directly to calculating its fair value. We performed a qualitative test for impairment of indefinite-lived intangible assets as of September 30, 2019. Based on the results of our qualitative testing, we believe that it is more-likely-than-not that the fair value of these indefinite-lived intangible assets is greater than their respective carrying values. Each quarter we review the events and circumstances to determine if impairment of indefinite-lived intangible asset is indicated. During the year ended October 31, 2019, 2018 and 2017 there were no impairments of indefinite-lived intangible assets.

Share-Based Compensation.    For the years ended 2019, 2018 and 2017, we accounted for share-based awards made to our employees and directors including employee stock option awards, restricted stock units, employee stock purchases made under our Employee Stock Purchase Plan ("ESPP") and performance share awards under Agilent Technologies, Inc. Long-Term Performance Program ("LTPP") using the estimated grant date fair value method of accounting. Under the fair value method, we recorded compensation expense for all share-based awards of $72 million in 2019, $71 million in 2018 and $61 million in 2017. See Note 5, "Share-based Compensation" for additional information.

63
Table of Contents            


Retirement and Post-Retirement Plans. Substantially all of our employees are covered under various defined benefit and/or defined contribution retirement plans. Additionally, we sponsor post-retirement health care benefits for our eligible U.S. employees. Assumptions used to determine the benefit obligations and the expense for these plans are derived annually. See Note 14, “Retirement plans and post-retirement pension plans” for additional information.

Taxes on Income.    Income tax expense or benefit is based on income or loss before taxes. Deferred tax assets and liabilities are recognized principally for the expected tax consequences of temporary differences between the tax bases of assets and liabilities and their reported amounts. See Note 6, "Income Taxes" for more information.

Warranty.    Our standard warranty terms typically extend for one year from the date of delivery. We accrue for standard warranty costs based on historical trends in warranty charges as a percentage of net product revenue. The accrual is reviewed regularly and periodically adjusted to reflect changes in warranty cost estimates. Estimated warranty charges are recorded within cost of products at the time products are sold. See Note 15, "Guarantees".

Advertising.    Advertising costs are generally expensed as incurred and amounted to $36 million in 2019, $41 million in 2018 and $38 million in 2017.

Research and Development.    Costs related to research, design and development of our products are charged to research and development expense as they are incurred.

Sales Taxes.    Sales taxes collected from customers and remitted to governmental authorities are not included in our revenue.

Net Income Per Share.    Basic net income per share is computed by dividing net income - the numerator - by the weighted average number of common shares outstanding - the denominator - during the period excluding the dilutive effect of stock options and other employee stock plans. Diluted net income per share gives effect to all potential common shares outstanding during the period unless the effect is anti-dilutive. The dilutive effect of share-based awards is reflected in diluted net income per share by application of the treasury stock method, which includes consideration of unamortized share-based compensation expense and the dilutive effect of in-the-money options and non-vested restricted stock units. Under the treasury stock method, the amount the employee must pay for exercising stock options and unamortized share-based compensation expense are assumed proceeds to be used to repurchase hypothetical shares. See Note 7, "Net Income Per Share".

Cash, Cash Equivalents and Short-Term Investments.  We classify investments as cash equivalents if their original or remaining maturity is three months or less at the date of purchase. Cash equivalents are stated at cost, which approximates fair value.

As of October 31, 2019, approximately $1,310 million of our cash and cash equivalents is held outside of the U.S. by our foreign subsidiaries. Our cash and cash equivalents mainly consist of short-term deposits held at major global financial institutions, institutional money market funds, and similar short duration instruments with original maturities of 90 days or less. We continuously monitor the creditworthiness of the financial institutions and institutional money market funds in which we invest our funds.

We classify investments as short-term investments if their original maturities are greater than three months and their remaining maturities are one year or less. Currently, we have no short-term investments.

Variable Interest Entities. We make a determination upon entering into an arrangement whether an entity in which we have made an investment is considered a Variable Interest Entity (“VIE”).  The company evaluates its investments in privately held companies on an ongoing basis. We account for these investments under either the equity method or as equity investments without determinable fair value, depending on the circumstances. We periodically reassess whether we are the primary beneficiary of a VIE. The reassessment process considers whether we have acquired the power to direct the most significant activities of the VIE through changes in governing documents or other circumstances. We also reconsider whether entities previously determined not to be VIEs have become VIEs, based on changes in facts and circumstances including changes in contractual arrangements and capital structure.

During the year ended October 31, 2016, Agilent made a preferred stock investment in Lasergen, Inc. ("Lasergen") for $80 million. This investment in Lasergen was accounted for under the cost method. Agilent’s initial ownership stake was 48 percent and included an option to acquire the remaining shares until March 2018. During the year ended October 31, 2018, we exercised our option and acquired all of the remaining shares of Lasergen that we did not already own for an additional cash consideration of approximately $107 million. The fair value remeasurement of our previous investment immediately before the acquisition

64
Table of Contents            

resulted in a net gain of $20 million and was recorded in other income. Lasergen was previously considered a VIE. As of October 31, 2019 and 2018, we have no material VIE's.
Investments. Equity investments without readily determinable fair value consist of non-marketable equity securities (typically investments in privately-held companies). These investments are accounted for using the measurement alternative at cost and we adjust for impairments and observable price changes (orderly transactions for the identical or a similar security from the same issuer) included in net income as and when it occurs. Equity investments with readily determinable fair value consist of shares we own in a special fund and are reported at fair value, with gains or losses resulting from changes in fair value included in net income. Prior to fiscal year 2019, both equity investments without determinable fair value and with determinable fair value were accounted for using cost method of accounting, measured at historical cost less other-than-temporary investment. Trading securities, which is comprised of mutual funds, bonds and other similar instruments, other investments and deferred compensation liability are reported at fair value, with gains or losses resulting from changes in fair value recognized currently in net income. Equity method investments are reported at the amount of the company’s initial investment and adjusted each period for the company’s share of the investee’s income or loss and dividend paid. There are no equity method investments as of October 31, 2019 and 2018. The company assesses investments for impairment whenever events or changes in circumstances indicate that the carrying value of an investment may not be recoverable.

Fair Value of Financial Instruments. The carrying values of certain of our financial instruments including cash and cash equivalents, accounts receivable, accounts payable, accrued compensation and other accrued liabilities approximate fair value because of their short maturities. The fair value of long-term equity investments which are readily determinable, and which are not accounted under the equity method are reported at fair value using quoted market prices for those securities when available with gains and losses included in net income. The fair value of long-term equity investments which are not readily determinable, and which are not accounted under the equity method are reported at cost with adjustments for observable changes in prices or impairments included in net income. The fair value of our senior notes, calculated from quoted prices which are primarily Level 1 inputs under the accounting guidance fair value hierarchy exceeds the carrying value by approximately $62 million as of October 31, 2019 and is lower than the carrying value by approximately $15 million as of October 31, 2018. The change in the fair value over carrying value in the year ended October 31, 2019 is primarily due to fluctuations in market interest rates. The fair value of foreign currency contracts used for hedging purposes is estimated internally by using inputs tied to active markets. These inputs, for example, interest rate yield curves, foreign exchange rates, and forward and spot prices for currencies are observable in the market or can be corroborated by observable market data for substantially the full term of the assets or liabilities. See also Note 12, "Fair Value Measurements" for additional information on the fair value of financial instruments.

Concentration of Credit Risk.    Financial instruments that potentially subject Agilent to significant concentration of credit risk include money market fund investments, time deposits and demand deposit balances. These investments are categorized as cash and cash equivalents. In addition, Agilent has credit risk from derivative financial instruments used in hedging activities and accounts receivable. We invest in a variety of financial instruments and limit the amount of credit exposure with any one financial institution. We have a comprehensive credit policy in place and credit exposure is monitored on an ongoing basis.

Credit risk with respect to our accounts receivable is diversified due to the large number of entities comprising our customer base and their dispersion across many different industries and geographies. Credit evaluations are performed on customers requiring credit over a certain amount and we sell the majority of our products through our direct sales force. Credit risk is mitigated through collateral such as letter of credit, bank guarantees or payment terms like cash in advance. No single customer accounted for more than 10 percent of accounts receivable as of October 31, 2019, or 2018.

Derivative Instruments.    Agilent is exposed to global foreign currency exchange rate and interest rate risks in the normal course of business. We enter into foreign exchange hedging contracts, primarily forward contracts and purchased options, interest rate swaps and interest rate locks to manage financial exposures resulting from changes in foreign currency exchange rates and interest rates. In the vast majority of cases, these contracts are designated at inception as hedges of the related foreign currency or interest exposures. Foreign currency exposures include committed and anticipated revenue and expense transactions and assets and liabilities that are denominated in currencies other than the functional currency of the subsidiary. Interest rate exposures are associated with the company's fixed-rate debt. For option contracts, we exclude time value from the measurement of effectiveness. To qualify for hedge accounting, contracts must reduce the foreign currency exchange rate and interest rate risk otherwise inherent in the amount and duration of the hedged exposures and comply with established risk management policies. Foreign exchange hedging contracts generally mature within twelve months, interest rate swaps mature at the same time as the maturity of the debt and interest rate locks mature at the same time as the issuance of debt. In order to manage foreign currency exposures in a few limited jurisdictions we may enter into foreign exchange contracts that do not qualify for hedge accounting. In such circumstances, the local foreign currency exposure is offset by contracts owned by the parent company. We do not use derivative financial instruments for trading or speculative purposes.

65
Table of Contents            


All derivatives are recognized on the balance sheet at their fair values. For derivative instruments that are designated and qualify as a fair value hedge, changes in value of the derivative are recognized in the consolidated statement of operations in the current period, along with the offsetting gain or loss on the hedged item attributable to the hedged risk. For derivative instruments that are designated and qualify as a cash flow hedges, changes in the value of the effective portion of the derivative instrument is recognized in comprehensive income (loss), a component of stockholders' equity. Amounts associated with cash flow hedges are reclassified and recognized in income when either the forecasted transaction occurs or it becomes probable the forecasted transaction will not occur. Derivatives not designated as hedging instruments are recorded on the balance sheet at their fair value and changes in the fair values are recorded in the income statement in the current period. Derivative instruments are subject to master netting arrangements and are disclosed gross in the balance sheet. Changes in the fair value of the ineffective portion of derivative instruments are recognized in earnings in the current period. Ineffectiveness in 2019, 2018 and 2017 was not material. Cash flows from derivative instruments are classified in the statement of cash flows in the same category as the cash flows from the hedged or economically hedged item, primarily in operating activities.

Property, Plant and Equipment.    Property, plant and equipment are stated at cost less accumulated depreciation. Additions, improvements and major renewals are capitalized; maintenance, repairs and minor renewals are expensed as incurred. When assets are retired or disposed of, the assets and related accumulated depreciation and amortization are removed from our general ledger, and the resulting gain or loss is reflected in the consolidated statement of operations. Buildings and improvements are depreciated over the lesser of their useful lives or the remaining term of the lease and machinery and equipment over 3 years to 10 years. We use the straight-line method to depreciate assets.

Leases.    We lease buildings, machinery and equipment under operating and capital leases for original terms ranging generally from less than 1 year to 30 years. Certain leases contain renewal options for periods up to 6 years. In addition, we lease equipment to customers in connection with our diagnostics business using both capital and operating leases. As of October 31, 2019 and 2018 our diagnostics and genomics segment has approximately $37 million and $32 million, respectively, of lease receivables related to capital leases and approximately $17 million and $20 million, respectively, of net assets for operating leases.  We depreciate the assets related to the operating leases over their estimated useful lives, typically five years.

Capitalized Software.    We capitalize certain internal and external costs incurred to acquire or create internal use software. Capitalized software is included in property, plant and equipment and is depreciated over 3 years to 5 years once development is complete.

Impairment of Long-Lived Assets.    We continually monitor events and changes in circumstances that could indicate carrying amounts of long-lived assets, including intangible assets, may not be recoverable. When such events or changes in circumstances occur, we assess the recoverability of long-lived assets by determining whether the carrying value of such assets will be recovered through undiscounted expected future cash flows. If the total of the undiscounted future cash flows is less than the carrying amount of those assets, we recognize an impairment loss based on the excess of the carrying amount over the fair value of the assets. During 2019, there were no impairments of other assets or intangible assets. During 2018, we recorded an impairment charge of $21 million related to purchased intangible assets within the diagnostics and genomics segment that were deemed unrecoverable. During 2017, there were no impairments of other assets or intangible assets.

Employee Compensation and Benefits.    Amounts owed to employees, such as accrued salary, bonuses and vacation benefits are accounted for within employee compensation and benefits. The total amount of accrued vacation benefit was $115 million and $107 million as of October 31, 2019, and 2018, respectively.

Foreign Currency Translation.    We translate and remeasure balance sheet and income statement items into U.S. dollars. For those subsidiaries that operate in a local currency functional environment, all assets and liabilities are translated into U.S. dollars using current exchange rates at the balance sheet date; revenue and expenses are translated using monthly exchange rates which approximate to average exchange rates in effect during each period. Resulting translation adjustments are reported as a separate component of accumulated other comprehensive income (loss) in stockholders' equity.

For those subsidiaries that operate in a U.S. dollar functional environment, foreign currency assets and liabilities are remeasured into U.S. dollars at current exchange rates except for non-monetary assets and capital accounts which are remeasured at historical exchange rates. Revenue and expenses are generally remeasured at monthly exchange rates which approximate average exchange rates in effect during each period. Gains or losses from foreign currency remeasurement are included in consolidated net income. Net gains or losses resulting from foreign currency transactions, including hedging gains and losses, are reported in other income (expense), net and were $7 million loss for 2019, $3 million loss for 2018 and $2 million loss for 2017.


66
Table of Contents            

2.     NEW ACCOUNTING PRONOUNCEMENTS

Recently Adopted Accounting Pronouncements
In May 2014, the FASB issued new revenue recognition guidance, ASC Topic 606, which provides a single comprehensive model for entities to use in accounting for revenue arising from contracts with customers and will supersede most current revenue recognition guidance. The objective of the new revenue standard is to significantly enhance comparability and clarify principles of revenue recognition practices across entities, industries, jurisdictions and capital markets. Under the new guidance, there are specific criteria to determine if a performance obligation should be recognized over time or at a point in time.

On November 1, 2018, we adopted ASC 606 using the modified retrospective approach only to contracts not completed as of this date. Results for reporting periods after November 1, 2018 are presented under ASC 606, while prior period amounts were not adjusted and continue to be reported in accordance with ASC Topic 605, Revenue Recognition.

We recorded a net increase to beginning retained earnings of $23 million as of November 1, 2018 due to the cumulative impact of adopting ASC 606. The impact to beginning retained earnings is primarily due to an increase in contract assets (unbilled accounts receivable), a reduction in inventory and a reduction in contract liabilities (deferred revenue). The net increase in retained earnings and resulting changes in assets and liabilities was mainly driven by the change in timing of the recognition of revenue from the fulfillment of separate performance obligations as control transfers to the customer.

Had we continued to use the revenue recognition guidance in effect prior to fiscal year 2019, no material changes would have resulted to the consolidated statements of income, comprehensive income, or cash flows for the year ended October 31, 2019. As a result, comparisons of revenue and operating profit performance between periods are not materially affected by the adoption of this standard. Refer to Note 1, "Overview and Summary of Significant Accounting Policies"for a description of the company’s revenue recognition policies and Note 4, "Revenue" for the disclosures required by the standard.

As of November 1, 2018, we elected to early adopt new accounting guidance which amends reporting comprehensive income to allow a reclassification from accumulated other comprehensive income ("AOCI") to retained earnings for the deferred taxes previously recorded in AOCI that exceed the current federal tax rate of 21 percent resulting from the enacted corporate tax rate in the U.S. Tax Cuts and Jobs Act ("the Tax Act"). The adoption of this guidance resulted in a reclassification of $7 million from AOCI to beginning retained earnings on our consolidated balance sheet.

As of November 1, 2018, we adopted new accounting guidance which eliminates the exception in ASC 740, Income Taxes against immediate recognition of income tax consequences of intra-entity transfers of assets other than inventory. The amendment in this update should be applied on a modified retrospective basis through a cumulative-effect adjustment directly to retained earnings as of the beginning of period of adoption. We recorded a net decrease in beginning retained earnings of $2 million as of November 1, 2018 due to removing unamortized tax expense previously deferred.

As of November 1, 2018, we adopted new accounting guidance which addresses certain aspects of recognition, measurement, presentation and disclosure of financial instruments and also the related guidance which addresses technical corrections and improvements to this guidance. The guidance requires entities to measure equity investments that do not result in consolidation and are not accounted for under the equity method at fair value and recognize any changes in fair value in net income. The total impact of adoption to our consolidated balance sheet was an increase of $7 million to long-term investments and a net increase of $5 million to beginning retained earnings.



67
Table of Contents            

The following table summarizes the impacts of recently adopted accounting pronouncements on our consolidated balance sheet as of November 1, 2018:

 
October 31,
2018
 
Impact of Adopting New
 
November 1,
2018
 
As Reported
 
Revenue Recognition Guidance
 
Tax Effects on Items in AOCI Guidance
 
Intra-Entity Tax Guidance
 
Investments Valuation Guidance
 
As Adopted
 
(in millions)
ASSETS
 

 
 
 
 
 
 
 
 
 
 

Current assets:
 

 
 
 
 
 
 
 
 
 
 

Cash and cash equivalents
$
2,247

 
$
—

 
$
—

 
$
—

 
$
—

 
$
2,247

Accounts receivable, net
776

 
24

 
—

 
—

 
—

 
800

Inventory
638

 
(10
)
 
—

 
—

 
—

 
628

Other current assets
187

 
3

 
—

 
—

 
—

 
190

Total current assets
3,848

 
17

 
—

 
—

 
—

 
3,865

Property, plant and equipment, net
822

 
—

 
—

 
—

 
—

 
822

Goodwill
2,973

 
—

 
—

 
—

 
—

 
2,973

Other intangible assets, net
491

 
—

 
—

 
—

 
—

 
491

Long-term investments
68

 
—

 
—

 
—

 
7

 
75

Other assets
339

 
(3
)
 
—

 
(2
)
 
(2
)
 
332

Total assets
$
8,541

 
$
14

 
$
—

 
$
(2
)
 
$
5

 
$
8,558

LIABILITIES AND EQUITY
 

 
 
 
 
 
 
 
 
 
 

Current liabilities:
 

 
 
 
 
 
 
 
 
 
 

Accounts payable
$
340

 
$
—

 
$
—

 
$
—

 
$
—

 
$
340

Employee compensation and benefits
304

 
—

 
—

 
—

 
—

 
304

Deferred revenue
324

 
(11
)
 
—

 
—

 
—

 
313

Other accrued liabilities
203

 
—

 
—

 
—

 
—

 
203

Total current liabilities
1,171

 
(11
)
 
—

 
—

 
—

 
1,160

Long-term debt
1,799

 
—

 
—

 
—

 
—

 
1,799

Retirement and post-retirement benefits
239

 
—

 
—

 
—

 
—

 
239

Other long-term liabilities
761

 
2

 
—

 
—

 
—

 
763

Total liabilities
3,970

 
(9
)
 
—

 
—

 
—

 
3,961

 
 
 
 
 
 
 
 
 
 
 
 
Total equity:
 

 
 
 
 
 
 
 
 
 
 

Stockholders’ equity:
 

 
 
 
 
 
 
 
 
 
 

Preferred stock; $0.01 par value; 125 million shares authorized; none issued and outstanding
—

 
—

 
—

 
—

 
—

 
—

Common stock; $0.01 par value; 2 billion shares authorized; 318 million shares at October 31, 2018 issued
3

 
—

 
—

 
—

 
—

 
3

Additional paid-in-capital
5,308

 
—

 
—

 
—

 
—

 
5,308

Accumulated deficit
(336
)
 
23

 
7

 
(2
)
 
5

 
(303
)
Accumulated other comprehensive loss
(408
)
 
—

 
(7
)
 
—

 
—

 
(415
)
Total stockholders' equity
4,567

 
23

 
—

 
(2
)
 
5

 
4,593

Non-controlling interest
4

 
—

 
—

 
—

 
—

 
4

Total equity
4,571

 
23

 
—

 
(2
)
 
5

 
4,597

Total liabilities and equity
$
8,541

 
$
14

 
$
—

 
$
(2
)
 
$
5

 
$
8,558









68
Table of Contents            

As of November 1, 2018, we adopted new accounting guidance which requires amounts generally described as restricted cash and restricted cash equivalents to be included with cash and cash equivalents when reconciling the beginning-of-period and end-of-period total amounts shown on the statement of cash flows. A reconciliation of cash, cash equivalents and restricted cash to the consolidated balance sheet follows:
 
October 31
 
2019
 
2018
 
2017
 
(in millions)
 
 
Cash and cash equivalents
$
1,382

 
$
2,247

 
$
2,678

Restricted cash included in other assets
6

 
7

 
8

Total cash, cash equivalents and restricted cash
$
1,388

 
$
2,254

 
$
2,686



As of November 1, 2018, we adopted new accounting guidance which requires employers that present a measure of operating income in their statements of operations to include only the service cost component of net periodic postretirement benefit cost in operating expenses. The service cost component of net periodic pension and postretirement benefit cost should be presented in the same operating expense line items as other employee compensation costs arising from services rendered during the period. The other components of net periodic pension and postretirement benefit costs, including interest costs, expected return on assets, amortization of prior service cost/credit and actuarial gains/losses, and settlement and curtailment effects, are to be included separately and outside of any subtotal of operating income. The adoption of this guidance resulted in a reclassification of income from our income from operations to other income (expense), net on our consolidated statement of operations of approximately $10 million, $24 million and $34 million in the year ended October 31, 2019, 2018 and 2017, respectively. As adoption is required to be on a retrospective basis, we have recast our historical consolidated statements of operations and segment information to conform to current year presentation.

New Accounting Pronouncements Not Yet Adopted

In February 2016, the FASB issued guidance which amends the existing accounting standards for leases. Consistent with existing guidance, the recognition, measurement, and presentation of expenses and cash flows arising from a lease by a lessee primarily will depend on its classification. Under the new guidance, a lessee will be required to recognize right-of-use assets ("ROU") and lease liabilities on the balance sheet. On November 1, 2019, we adopted the lease accounting guidance using the modified retrospective method for all lease arrangements at the beginning of the period of adoption. Results for reporting periods beginning November 1, 2019 will be presented under the new accounting guidance, while prior period amounts will not be adjusted. As of November 1, 2019, the new accounting guidance had a material impact on our consolidated balance sheet but is expected to have an insignificant impact on the consolidated net income and cash flows. The most significant impact was the recognition of ROU assets and lease liabilities for operating leases, while the accounting for capital leases remained substantially unchanged. For leases that commenced before the effective date of adoption of the new accounting guidance, we elected the permitted practical expedients to not reassess the following: (i) whether any expired or existing contracts contain leases; (ii) the lease classification for any expired or existing leases; and (iii) capitalization of initial direct costs for any existing leases.
As a result of the cumulative impact of adopting the new accounting guidance we will record operating lease ROU assets around $195 million and operating lease liabilities of the same amounts, primarily related to real estate and automobile leases.
The accounting applied to lease arrangements in which we are the lessor is largely unchanged from that applied under the prior standard and will not have a significant impact to our consolidated balance sheet, net income or cash flows
In January 2017, the FASB issued an amendment to modify the concept of impairment from the condition that exists when the carrying amount of goodwill exceeds its implied fair value to the condition that exists when the carrying amount of a reporting unit exceeds its fair value. The amendment also simplifies the subsequent measurement of goodwill by eliminating Step 2 from the goodwill impairment test. The amendments are effective for us beginning November 1, 2020. Early adoption is permitted for interim or annual goodwill impairment tests performed on testing dates after January 1, 2017. We do not expect to early adopt nor do we expect this guidance to have a material impact on our consolidated financial statements and disclosures.


69
Table of Contents            

In August 2018, the FASB issued updates to improve the disclosure requirements on fair value measurements in Topic 820, Fair Value Measurement which eliminates certain disclosure requirements and modifies others. These amendments are effective for us beginning November 1, 2020, and for interim periods within that year with early adoption permitted. We currently do not expect this guidance to have a material impact on our consolidated financial statements and disclosures.

In August 2018, the FASB issued updates to improve the effectiveness of disclosures for defined benefit plans under Accounting Standard Codification Topic 715-20. The amendments in this guidance remove disclosures that no longer are considered cost beneficial, clarify the specific requirements of disclosures, and add disclosure requirements identified as relevant. These amendments are effective for us beginning November 1, 2021, with early adoption permitted. We currently do not expect this guidance to have a material impact on our consolidated financial statements and disclosures.

Other amendments to GAAP in the U.S. that have been issued by the FASB or other standards-setting bodies that do not require adoption until a future date are not expected to have a material impact on our consolidated financial statements upon adoption.

3.     ACQUISITIONS

Acquisition of BioTek and ACEA

On August 23, 2019 we completed the acquisition of privately-owned Lionheart Technologies LLC ("BioTek"), a leader in the design, manufacture and distribution of innovative life science instrumentation for $1.17 billion, under the merger agreement. As a result of the acquisition, BioTek has become a wholly-owned subsidiary of Agilent. Accordingly, the results of BioTek are included in Agilent's consolidated financial statements from the acquisition date. For the period from August 24, 2019 to October 31, 2019, BioTek’s net revenue was $35 million and net loss was $12 million. The acquisition of BioTek and its portfolio is another step to expand our position in the cell analysis market.

The consideration paid was $1.17 billion. Agilent funded the acquisition using existing cash of $470 million and debt of $700 million.

The BioTek acquisition was accounted for in accordance with the authoritative accounting guidance. The acquired assets and assumed liabilities were recorded by Agilent at their estimated fair values. Agilent determined the estimated fair values with the assistance of appraisals or valuations performed by third party specialists, discounted cash flow analyses, and estimates made by management. We expect to realize revenue synergies, leverage and expand the existing sales channels and product development resources, and utilize the assembled workforce. These factors, among others, contributed to a purchase price in excess of the estimated fair value of BioTek’s net identifiable assets acquired (see summary of net assets below), and, as a result, we have recorded goodwill in connection with this transaction.
 
Goodwill acquired was allocated to our operating segments and reporting units as a part of the purchase price allocation. All goodwill was allocated to the life sciences and applied markets reporting unit.

Agilent’s acquisition of BioTek is treated as an asset purchase for tax purposes. The tax basis of the acquired assets equals the fair market value on acquisition date.


70
Table of Contents            

The following table summarizes the allocation of the purchase price to the estimated fair values of the assets acquired and liabilities assumed on the closing date of August 23, 2019 (in millions):
Cash and cash equivalents
 
 
$
10

 
Accounts receivable
 
 
28

 
Inventories
 
 
21

 
Other current assets
 
 
2

 
Property, plant and equipment
 
 
8

 
Intangible assets
 
 
641

 
Goodwill
 
 
483

 
Total assets acquired
 
1,193
 
 
Accounts payable
 
 
(4
)
 
Deferred revenue
 
 
(5
)
 
Employee compensation and benefits
 
 
(7
)
 
Other accrued liabilities
 
 
(2
)
 
Long-term debt
 
 
(4
)
 
Net assets acquired
 
 
$
1,171

 



The fair value of cash and cash equivalents, accounts receivable, other current assets, accounts payable and other accrued liabilities were generally determined using historical carrying values given the short-term nature of these assets and liabilities.
 
The fair values for acquired intangible assets and deferred revenue were determined with the input from third party valuation specialists.
 
The fair values of certain other assets, inventory, property, plant and equipment, investments, long-term debt, and certain other long-term liabilities were determined internally using historical carrying values and estimates made by management.
 
Valuations of intangible assets acquired
 
The components of intangible assets acquired in connection with the BioTek acquisition were as follows (in millions):

 
Fair Value
 
Estimated
Useful Life
Developed product technology
 
$
387

 
 
5-13 years
Customer relationships
 
202

 
 
3-8 years
Backlog
 
5

 
 
2 months
Tradenames and trademarks
 
43

 
 
10 years
Total intangible assets subject to amortization
 
637

 
 
 
In-process research and development
 
4

 
 
 
Total intangible assets
 
$
641

 
 
 


As noted above, the intangible assets, including in-process research and development, were valued with input from valuation specialists. Agilent used variations of the income approach in determining the fair value of intangible assets acquired in the BioTek acquisition. Specifically, the developed product technology and in-process research and development were valued using the multi-period excess earnings method under the income approach by discounting forecasted cash flows directly related to the products expecting to result from the projects, net of returns on contributory assets. The Company utilized the incremental cash flow method for determining the fair value of the customer relationships acquired, and the relief from royalty method to determine the fair value of the tradename. Order backlog was valued on a direct cash flow basis.

The primary in-process research and development project acquired relates to a next version of a product which will be released in 2020. Total costs to complete for all BioTek in-process research and development were estimated at approximately $2 million as of the close date.


71
Table of Contents            

Acquisition and integration costs directly related to the BioTek acquisition totaled $4 million for the year ended October 31, 2019 and were recorded in selling, general and administrative expenses. Such costs are expensed in accordance with the authoritative accounting guidance.


On November 14, 2018, we acquired 100 percent of the stock of ACEA Biosciences (“ACEA”), a developer of cell analysis tools, for $250 million. The financial results of ACEA have been included in our financial results from the acquisition date.
 
The following represents the unaudited proforma operating results as if BioTek and ACEA had been included in the company's consolidated statements of operations as of the beginning of fiscal 2018 (in millions, except per share amounts):

 
2019
 
2018
Net revenue
$
5,308

 
$
5,112

Net income
$
1,012

 
$
210

Net income per share — basic
$
3.22

 
$
0.65

Net income per share — diluted
$
3.18

 
$
0.65



The unaudited proforma financial information assumes that the companies were combined as of November 1, 2017 and include business combination accounting effects from the acquisition including amortization charges from acquired intangible assets, the impact on cost of sales due to the respective estimated fair value adjustments to inventory, changes to interest income for cash used in the acquisition, interest expense and currency losses associated with debt paid in connection with the acquisition and acquisition related transaction costs and tax related effects. The proforma information as presented above is for informational purposes only and is not indicative of the results of operations that would have been achieved if the acquisition had taken place at the beginning of fiscal 2018.
 
The unaudited proforma financial information for the year ended October 31, 2019 combines the historical results of Agilent for the year ended October 31, 2019 (which includes BioTek and ACEA after the acquisition date) and for BioTek for the ten months ended August 23, 2019.
 
The unaudited proforma financial information for the year ended October 31, 2018 combines the historical results of Agilent and ACEA for the year ended October 31, 2018 and BioTek for the year ended December 31, 2018 (due to differences in reporting periods).

4.     REVENUE

The following table presents the company’s total revenue and segment revenue disaggregated by geographical region:
 
Year Ended October 31, 2019
 
Life Sciences and Applied Markets
 
Diagnostics and Genomics
 
Agilent CrossLab
 
Total
 
(in millions)
Revenue by Region
 
 
 
 
 
 
 
Americas
$
692

 
$
505

 
$
664

 
$
1,861

Europe
551

 
368

 
522

 
1,441

Asia Pacific
1,059

 
148

 
654

 
1,861

Total
$
2,302

 
$
1,021

 
$
1,840

 
$
5,163

 
 
 
 
 
 
 
 

72
Table of Contents            


The following table presents the company’s total revenue disaggregated by end markets and by revenue type:
 
 
 
Year Ended October 31, 2019
 
(in millions)
Revenue by End Markets
 
 
Pharmaceutical and Biopharmaceutical
 
$
1,604

Chemical and Energy
 
1,199

Diagnostics and Clinical
 
785

Food
 
486

Academia and Government
 
474

Environmental and Forensics
 
615

Total
 
$
5,163

 
 
 
Revenue by Type
 
 
Instrumentation
 
$
2,150

Non-instrumentation and other
 
3,013

Total
 
$
5,163



Revenue by region is based on the ship to location of the customer. Revenue by end market is determined by the market indicator of the customer and by customer type. Instrumentation revenue includes sales from instruments, remarketed instruments and third-party products. Non-instrumentation and other revenue includes sales from contract and per incident services, our companion diagnostics and our nucleic acid solutions businesses as well as sales from spare parts, consumables, reagents, vacuum pumps, subscriptions, software licenses and associated services.


Contract Balances

Contract Assets

Contract assets (unbilled accounts receivable) primarily relate to the company's right to consideration for work completed but not billed at the reporting date. The unbilled receivables are reclassified to trade receivables when billed to customers. Contract assets are generally classified as current assets and are included in "Accounts receivable, net" in the consolidated balance sheet.

The balance of contract assets as of October 31, 2019 and as of November 1, 2018, the date of adoption of ASC 606, were $110 million and $57 million, respectively. The increase in unbilled receivables during the year ended October 31, 2019 is a result of recognition of revenue upon the transfer of the control to the customer. In some instances, transfer of control is prior to invoicing the customers and excluding amounts transferred to trade receivables during the period amounted to $53 million.


73
Table of Contents            

Contract Liabilities

The following table provides information about contract liabilities (deferred revenue) and the significant changes in the balances during the year ended October 31, 2019:

 
 
Contract
Liabilities
 
 
(in millions)
 
 
 
Ending balance as of October 31, 2018
 
$
367

Impact of adoption of new revenue recognition guidance
 
(11
)
Net revenue deferred in the period
 
303

Revenue recognized that was included in the contract liability balance at the beginning of the period
 
(287
)
Change in deferrals from customer cash advances, net of revenue recognized
 
5

Contract liabilities acquired in business combinations
 
9

Currency translation and other adjustments
 
—

Ending balance as of October 31, 2019
 
$
386



Contract liabilities primarily relate to multiple element arrangements for which billing has occurred but transfer of control of all elements to the customer has either partially or not occurred at the balance sheet date. This includes cash received from customers for products and related installation and services in advance of the transfer of control. Contract liabilities are classified as either current in deferred revenue or long-term in other long-term liabilities in the consolidated balance sheet based on the timing of when we expect to complete our performance obligation.

Contract Costs

Incremental costs of obtaining a contract with a customer are recognized as an asset if it expects the benefit of those costs to be longer than one year. We have determined that certain sales incentive programs meet the requirements to be capitalized. The change in total capitalized costs to obtain a contract was immaterial during the year ended October 31, 2019 and are included in other current and long-term assets on the consolidated balance sheet. We have applied the practical expedient to expense costs as incurred for costs to obtain a contract with a customer when the amortization period would have been one year or less. These costs include the company's internal sales force compensation program, as we have determined that annual compensation is commensurate with annual sales activities.

Transaction Price Allocated to the Remaining Performance Obligations

We have applied the practical expedient in ASC 606-10-50-14 and have not disclosed information about transaction price allocated to remaining performance obligations that have original expected durations of one year or less.
 
The estimated revenue expected to be recognized for remaining performance obligations that have an original term of more than one year, as of October 31, 2019, was $207 million, the majority of which is expected to be recognized over the next 12 months. Remaining performance obligations primarily include extended warranty, customer manufacturing contracts, and software maintenance contracts and revenue associated with lease arrangements.

5.     SHARE-BASED COMPENSATION

Agilent accounts for share-based awards in accordance with the provisions of the accounting guidance which requires the measurement and recognition of compensation expense for all share-based payment awards made to our employees and directors including employee stock option awards, restricted stock units, employee stock purchases made under our ESPP and performance share awards granted to selected members of our senior management under the LTPP based on estimated fair values.


74
Table of Contents            

Description of Share-Based Plans

Employee Stock Purchase Plan.    Effective November 1, 2000, we adopted the ESPP. The ESPP allows eligible employees to contribute up to ten percent of their base compensation to purchase shares of our common stock at 85 percent of the closing market price at purchase date. Currently, there are 75 million shares authorized for issuance in connection with the ESPP.

Under our ESPP, employees purchased 603,488 shares for $37 million in 2019, 558,116 shares for $32 million in 2018 and 618,270 shares for $26 million in 2017. As of October 31, 2019, the number of shares of common stock authorized and available for issuance under our ESPP was 26,055,571. This excludes the number of shares of common stock to be issued to participants in consideration of the aggregate participant contributions totaling $20 million as of October 31, 2019.

Incentive Compensation Plans.    On November 15, 2017 and March 21, 2018, the Board of Directors and the stockholders, respectively, approved the Agilent Technologies, Inc. 2018 Stock Plan (the "2018 Plan") which amends, including renaming and extending the term of, the Agilent Technologies, Inc. 2009 Stock Plan (the "2009 Plan"). The 2009 plan replaced the Agilent Technologies, Inc. Amended and Restated 1999 Stock Plan and 1999 Non-Employee Director Stock Plan. The 2018 Plan provides for the grant of awards in the form of stock options, stock appreciation rights ("SARs"), restricted stock, restricted stock units ("RSUs"), performance shares and performance units with performance-based conditions on vesting or exercisability, and cash awards. The 2018 Plan has a term of ten years. As of October 31, 2019, 28,676,526 shares were available for future awards under the 2018 Stock Plan.

Stock options under the 2018 Stock Plan may be either "incentive stock options", as defined in Section 422 of the Internal Revenue Code, or non-statutory. Options were granted prior to November 1, 2015 and generally vest at a rate of 25 percent per year over a period of four years from the date of grant with a maximum contractual term of ten years. The exercise price for stock options is generally not less than 100 percent of the fair market value of our common stock on the date the stock award is granted. Agilent issues new shares of common stock when employee stock options are exercised.

Effective November 1, 2003, the Compensation Committee of the Board of Directors approved the LTPP, which is a performance stock award program administered under the 2018 Stock Plan, for the company's executive officers and other key employees. Participants in this program are entitled to receive unrestricted shares of the company's stock after the end of a three-year period, if specified performance targets are met. Certain LTPP awards are generally designed to meet the criteria of a performance award with the performance metrics and peer group comparison based on the Total Stockholders’ Return (“TSR”) set at the beginning of the performance period. Effective November 1, 2015, the Compensation Committee of the Board of Directors approved another type of performance stock award, for the company's executive officers and other key employees. Participants in this program are also entitled to receive unrestricted shares of the company's stock after the end of a three-year period, if specified performance targets over the three-year period are met. The performance target for grants made in 2016 were based on Operating Margin (“OM”) and the performance grants made in 2017, 2018 and 2019 were based on Earnings Per Share ("EPS"). In the case of LTPP-OM, the performance targets for all the three years of performance period were set at the time of grant. The performance targets for LTPP-EPS grants for year 2 and year 3 of the performance period are set in the first quarter of year 2 and year 3, respectively. All LTPP awards granted after November 1, 2015, are subject to a one-year post-vest holding period.

Based on the performance metrics the final LTPP award may vary from zero to 200 percent of the target award. The maximum contractual term for awards under the LTPP program is three years and the maximum award value for awards granted in 2017 and 2016 cannot exceed 300 percent of the grant date target value. We consider the dilutive impact of these programs in our diluted net income per share calculation only to the extent that the performance conditions are expected to be met.

We also issue restricted stock units under our share-based plans. The estimated fair value of the restricted stock unit awards granted under the Stock Plans is determined based on the market price of Agilent's common stock on the date of grant adjusted for expected dividend yield. Restricted stock units generally vest, with some exceptions, at a rate of 25 percent per year over a period of four years from the date of grant. All restricted stock units granted to our executives after November 1, 2015, are subject to a one-year post-vest holding period.

Impact of Share-based Compensation Awards

We have recognized compensation expense based on the estimated grant date fair value method under the authoritative guidance. For all share-based awards we have recognized compensation expense using a straight-line amortization method. As the guidance requires that share-based compensation expense be based on awards that are ultimately expected to vest, estimated share-based compensation has been reduced for estimated forfeitures.


75
Table of Contents            

The impact on our results for share-based compensation was as follows:

 
Years Ended October 31,
 
2019
 
2018
 
2017
 
(in millions)
Cost of products and services
$
18

 
$
16

 
$
15

Research and development
7

 
7

 
6

Selling, general and administrative
47

 
48

 
40

Total share-based compensation expense
$
72

 
$
71

 
$
61



At October 31, 2019 and 2018 there was no share-based compensation capitalized within inventory.

Valuation Assumptions

For all periods presented, shares granted under the LTPP (TSR) were valued using a Monte Carlo simulation. The ESPP allows eligible employees to purchase shares of our common stock at 85 percent of the fair market value at the purchase date.

The estimated fair value of restricted stock unit awards, LTPP (OM) and LTPP (EPS) was determined based on the market price of Agilent's common stock on the date of grant adjusted for expected dividend yield and as appropriate, a discount related to the one-year post vesting. The compensation cost for LTPP (OM) and LTPP (EPS) awards reflect the cost of awards that are probable to vest at the end of the performance period.

The following assumptions were used to estimate the fair value of awards granted.

 
Years Ended October 31,
 
2019
 
2018
 
2017
LTPP:
 
 
 
 
 
Volatility of Agilent shares
22%
 
21%
 
23%
Volatility of selected peer-company shares
15%-66%
 
14%-66%
 
15%-63%
Pair-wise correlation with selected peers
30%
 
32%
 
36%
 
 
 
 
 
 
Post-vest restriction discount for all executive awards
5.0%
 
4.8%
 
5.3%


Shares granted under the LTPP (TSR) were valued using a Monte Carlo simulation model. The Monte Carlo simulation fair value model requires the use of highly subjective and complex assumptions, including the price volatility of the underlying stock. For LTPP (TSR) grants in 2017 and thereafter, we used our own historical stock price volatility.

All LTPP awards granted to our executives have a one-year post-vest holding restriction. The estimated discount associated with post-vest holding restrictions is calculated using the Finnerty model. The model calculates the potential lost value if the employee were able to sell the shares during the lack of marketability period, instead of being required to hold the shares.



76
Table of Contents            

Share-Based Payment Award Activity

Employee Stock Options

The following table summarizes employee stock option award activity of our employees and directors for 2019.

 
Options
Outstanding
 
Weighted
Average
Exercise Price
 
(in thousands)
 
 
Outstanding at October 31, 2018
1,997

 
$
35

Exercised
(552
)
 
$
33

Forfeited
—

 
$
—

Outstanding at October 31, 2019
1,445

 
$
36


The options outstanding and exercisable for equity share-based payment awards at October 31, 2019 were as follows:

 
Options Outstanding
 
Options Exercisable
Range of
Exercise Prices
Number
Outstanding
 
Weighted
Average
Remaining
Contractual
Life
 
Weighted
Average
Exercise
Price
 
Aggregate
Intrinsic
Value
 
Number
Exercisable
 
Weighted
Average
Remaining
Contractual
Life
 
Weighted
Average
Exercise
Price
 
Aggregate
Intrinsic
Value
 
(in thousands)
 
(in years)
 
 
 
(in thousands)
 
(in thousands)
 
(in years)
 
 
 
(in thousands)
$25.01 - 30
483

 
2.5
 
$
26

 
23,769

 
483

 
2.5
 
$
26

 
23,769

$30.01 - 40
296

 
4.1
 
$
39

 
10,845

 
296

 
4.1
 
$
39

 
10,845

$40.01 - over
666

 
5.0
 
$
41

 
23,211

 
666

 
5.0
 
$
41

 
23,211

 
1,445

 
4.0
 
$
36

 
$
57,825

 
1,445

 
4.0
 
$
36

 
$
57,825



The aggregate intrinsic value in the table above represents the total pre-tax intrinsic value, based on the company's closing stock price of $75.75 at October 31, 2019, which would have been received by award holders had all award holders exercised their awards that were in-the-money as of that date. The total number of in-the-money awards exercisable at October 31, 2019 was approximately 1.4 million.

The following table summarizes the aggregate intrinsic value of options exercised in 2019, 2018 and 2017:

 
Aggregate
Intrinsic Value
 
Weighted
Average
Exercise
Price
 
(in thousands)
 
 
Options exercised in fiscal 2017
$
36,175

 
$
30

Options exercised in fiscal 2018
$
28,417

 
$
32

Options exercised in fiscal 2019
$
24,409

 
$
33



As of October 31, 2019, the unrecognized share-based compensation costs for outstanding stock option awards, net of expected forfeitures, was zero. The amount of cash received from the exercise of share-based awards granted was $54 million in 2019, $56 million in 2018 and $66 million in 2017.


77
Table of Contents            

Non-Vested Awards

The following table summarizes non-vested award activity in 2019 primarily for our LTPP and restricted stock unit awards.
 
Shares
 
Weighted
Average
Grant Price
 
(in thousands)
 
 
Non-vested at October 31, 2018
3,181

 
$
57

Granted
1,309

 
$
68

Vested
(1,530
)
 
$
45

Forfeited
(78
)
 
$
60

Change in LTPP shares in the year due to exceeding performance targets
291

 
$
—

Non-vested at October 31, 2019
3,173

 
$
60



As of October 31, 2019, the unrecognized share-based compensation costs for non-vested restricted stock awards, net of expected forfeitures, was approximately $94 million which is expected to be amortized over a weighted average period of 2.2 years. The total fair value of restricted stock awards vested was $69 million for 2019, $58 million for 2018 and $42 million for 2017.

6.     INCOME TAXES

The domestic and foreign components of income before taxes are:

 
Years Ended October 31,
 
2019
 
2018
 
2017
 
(in millions)
U.S. operations
$
189

 
$
169

 
$
116

Non-U.S. operations
730

 
777

 
687

Total income before taxes
$
919

 
$
946

 
$
803



The provision for income taxes is comprised of:

 
Years Ended October 31,
 
2019
 
2018
 
2017
 
(in millions)
U.S. federal taxes:
 
 
 
 
 
Current
$
(191
)
 
$
520

 
$
15

Deferred
—

 
51

 
110

Non-U.S. taxes:
 
 
 
 
 
Current
290

 
95

 
1

Deferred
(267
)
 
(22
)
 
(7
)
State taxes, net of federal benefit:
 
 
 
 
 
Current
4

 
1

 
1

Deferred
12

 
(15
)
 
(1
)
Total provision (benefit)
$
(152
)
 
$
630

 
$
119



78
Table of Contents            



The differences between the U.S. federal statutory income tax rate and our effective tax rate are:

 
Years Ended October 31,
 
2019
 
2018
 
2017
 
(in millions)
Profit before tax times statutory rate
$
193

 
$
221

 
$
281

Non-U.S. income taxed at different rates
(8
)
 
(93
)
 
(43
)
Change in unrecognized tax benefits
(13
)
 
(17
)
 
(110
)
Impact of the Tax Act
—

 
552

 
—

Extension of the tax incentive in Singapore
(299
)
 
—

 
—

Other, net
(25
)
 
(33
)
 
(9
)
Provision (benefit) for income taxes
$
(152
)
 
$
630

 
$
119

Effective tax rate
(16.5
)%
 
66.6
%
 
14.8
%



For 2019, the company's income tax benefit was $152 million with an effective tax rate of (16.5) percent. For the year ended October 31, 2019, our effective tax rate and the resulting provision for income taxes were significantly impacted by the discrete benefit of $299 million related to the extension of the company’s tax incentive in Singapore.

As part of the business integration of some of our prior acquisitions, we undertook corporate restructurings in the fourth quarter of fiscal year 2019 that involved on-shoring certain intangible properties held by our foreign subsidiaries to the United States.  These restructurings resulted in a cash tax liability of $231 million.  These taxes generate tax attributes that will offset our transition tax liability which is included in other long-term liabilities in our consolidated balance sheet. 

For 2018, the company's income tax expense was $630 million with an effective tax rate of 66.6 percent. For the year ended October 31, 2018, our effective tax rate and the resulting provision for income taxes were significantly impacted by the discrete charge of $552 million related to the enactment of the U.S. Tax Cuts and Jobs Act (the “Tax Act”) as discussed below.

For 2017, the company’s income tax expense was $119 million with an effective tax rate of 14.8 percent. Our effective tax rate is impacted by earnings realized in foreign jurisdictions with statutory tax rates lower than the federal statutory tax rate. During the year, the company determined a portion of current year foreign earnings from its low tax jurisdictions would not be considered as indefinitely reinvested. As such, a deferred tax liability for that portion of unremitted foreign earnings was accrued causing an increase in the annual tax expense. Our annual effective tax rate also included tax benefits due to the settlement of an audit in Germany for the years 2005 through 2008 and the lapse of U.S. statute of limitation for the fiscal years 2012 and 2013. This benefit was offset by a deferred tax liability required for the tax expected upon repatriation of related unremitted foreign earnings that were not asserted as indefinitely invested outside the U.S.

The company has negotiated tax holidays in several different jurisdictions, most significantly in Singapore. The tax holidays provide lower rates of taxation on certain classes of income and require various thresholds of investments and employment or specific types of income in those jurisdictions. In December 2018, the tax holiday in Singapore was renegotiated and extended through 2027. Other tax holidays are due for renewal in 2020. As a result of the incentives, the impact of the tax holidays decreased income taxes by $368 million, $87 million, and $93 million in 2019, 2018, and 2017, respectively. The benefit of the tax holidays on net income per share (diluted) was approximately $1.16, $0.27, and $0.29 in 2019, 2018 and 2017, respectively. The increase in the benefit from 2018 to 2019 is primarily due to the Singapore restructuring and tax incentive modifications completed in 2019 in response to Singapore tax law changes. Of the $1.16 benefit of the tax incentives on net income per share (diluted) in 2019, $0.94 of the benefit relates to one-time items from the Singapore restructuring.

2017 U.S. Tax Reform - Tax Cuts and Jobs Act

On December 22, 2017, the Tax Act was enacted into law. The Tax Act enacted significant changes affecting our fiscal year 2018, including, but not limited to, (1) reducing the U.S. federal corporate tax rate and (2) imposing a one-time transition tax on certain unrepatriated earnings of foreign subsidiaries that had not been previously taxed in the U.S.

The Tax Act also established new tax provisions affecting our fiscal year 2019, including, but not limited to, (1) creating a new provision designed to tax global intangible low-tax income (“GILTI”); (2) generally eliminating U.S. federal taxes on

79
Table of Contents            

dividends from foreign subsidiaries; (3) eliminating the corporate alternative minimum tax (“AMT”); (4) creating the base erosion anti-abuse tax (“BEAT”); (5) establishing a deduction for foreign derived intangible income ("FDII"); (6) repealing domestic production activity deduction; and (7) establishing new limitations on deductible interest expense and certain executive compensation.

ASC 740, Income Taxes, requires companies to recognize the effect of the tax law changes in the period of enactment. However, the SEC staff issued Staff Accounting Bulletin 118 ("SAB 118") which allowed companies to record provisional amounts during a measurement period not extending beyond one year from the Tax Act enactment date. For the year ended October 31, 2018, the company recognized income tax expense related to the Tax Act of $552 million which includes (1) an expense of $499 million of U.S. transition tax and correlative items on deemed repatriated earnings of non-U.S. subsidiaries and (2) an expense of $53 million associated with the impact on deferred taxes resulting from the decreased U.S. corporate tax rate as described below.

Deemed Repatriation Transition Tax ("Transition Tax"): The Transition Tax is based on the company’s total unrepatriated post-1986 earnings and profits ("E&P") of its foreign subsidiaries and the amount of non-U.S. taxes paid (Tax Pools) on such earnings. Historically, the company permanently reinvested a significant portion of these post-1986 E&P outside the U.S. For the remaining portion, the company previously accrued deferred taxes. Since the Tax Act required all foreign earnings to be taxed currently, the company recorded an income tax expense of $651 million for its one-time transition U.S. federal tax and a benefit of $152 million for the reversal of related deferred tax liabilities. The resulting $499 million net transition tax, reduced by existing tax credits, will be paid over 8 years in accordance with the election available under the Tax Act. We have completed our accounting for charges related to the Transition Tax.

Reduction of U.S. Federal Corporate Tax Rate: The reduction of the corporate income tax rate requires companies to remeasure their deferred tax assets and liabilities as of the date of enactment. The amount recorded for the year ended October31, 2018 for the remeasurement due to tax rate change is $53 million. We have completed our accounting for the measurement of deferred taxes.

GILTI: The Tax Act subjects a U.S. corporation to tax on its GILTI. U.S. GAAP allows companies to make an accounting policy election to either (1) treat taxes due on future GILTI inclusions in the U.S. taxable income as a current-period expense when incurred (“period cost method”) or (2) factoring such amounts into a company’s measurement of its deferred taxes (“deferred method”). We have completed our analysis and elected to treat GILTI as a “current period cost”.

Indefinite Reinvestment Assertion: Prior to the enactment of the Tax Act, the company had indefinite investment assertion on a significant portion of its undistributed earnings from foreign subsidiaries. As a result of the enactment of the Tax Act, we have reevaluated our historic assertion and no longer consider these earnings to be indefinitely reinvested in our foreign subsidiaries. The company has recorded a deferred tax liability of $10 million for foreign withholding taxes on repatriation of remaining undistributed earnings.

80
Table of Contents            



The significant components of deferred tax assets and deferred tax liabilities included on the consolidated balance sheet are:

 
Years Ended October 31,
 
2019
 
2018
 
(in millions)
Deferred Tax Assets
 
 
 
Intangibles
$
131

 
$
—

Property, plant and equipment
—

 
8

Pension benefits and retiree medical benefits
71

 
49

Employee benefits, other than retirement
34

 
34

Net operating loss, capital loss, and credit carryforwards
195

 
185

Share-based compensation
32

 
31

Deferred revenue
38

 
38

Other
35

 
19

Deferred tax assets
$
536

 
$
364

Tax valuation allowance
(134
)
 
(135
)
Deferred tax assets, net of valuation allowance
$
402

 
$
229

 
 
 
 
Deferred Tax Liabilities
 
 
 
Intangibles
$
—

 
$
(112
)
Property, plant and equipment
(16
)
 
—

Other
(7
)
 
(21
)
Deferred tax liabilities
$
(23
)
 
$
(133
)
Net deferred tax assets (liabilities)
$
379

 
$
96



The increase in 2019 as compared to 2018 for the deferred tax asset and liabilities was primarily due to the benefit of $299 million related to the extension of the company’s tax incentive in Singapore.

Valuation allowances require an assessment of both positive and negative evidence when determining whether it is more likely than not that deferred tax assets are recoverable. Such assessment is required on a jurisdiction by jurisdiction basis. As of October 31, 2019, we continued to maintain a valuation allowance of $134 million until sufficient positive evidence exists to support reversal. The valuation allowance is primarily related to deferred tax assets for the states of California and Colorado, along with the net operating losses in the Netherlands and capital losses in the U.S. and Australia.

At October 31, 2019, we had federal, state and foreign net operating loss carryforwards of approximately $48 million, $571 million and $577 million, respectively. The federal and state net operating loss carryforwards are subject to various limitations under Section 382 of the Internal Revenue Code and applicable state tax laws. If not utilized, the federal and state net operating loss carryforwards will begin to expire in 2020. If not utilized, $155 million of the foreign net operating loss carryforwards will begin to expire in 2020. The remaining $422 million of the foreign net operating losses carry forward indefinitely. At October 31, 2019, we had federal and foreign capital loss carryforwards of $48 million and $116 million, respectively. If not utilized, the federal capital loss carryforwards will expire in 2022. The foreign capital losses carry forward indefinitely. At October 31, 2019, we had state tax credit carryforwards of approximately $78 million. The state tax credits carry forward indefinitely.

The breakdown between long-term deferred tax assets and deferred tax liabilities was as follows:

 
October 31,
 
2019
 
2018
 
(in millions)
Long-term deferred tax assets (included within other assets)
$
410

 
$
165

Long-term deferred tax liabilities (included within other long-term liabilities)
(31
)
 
(69
)
Total
$
379

 
$
96




81
Table of Contents            


The breakdown between current and long-term income tax assets and liabilities, excluding deferred tax assets and liabilities, was as follows:
 
October 31,
 
2019
 
2018
 
(in millions)
Current income tax assets (included within other current assets)
$
68

 
$
59

Long-term income tax assets (included within other assets)
4

 
19

Current income tax liabilities (included within other accrued liabilities)
(292
)
 
(71
)
Long-term income tax liabilities (included within other long-term liabilities)
(328
)
 
(607
)
Total
$
(548
)
 
$
(600
)


Uncertain Tax Positions

The aggregate changes in the balances of our gross unrecognized tax benefits including all federal, state and foreign tax jurisdictions are as follows:

 
2019
 
2018
 
2017
 
(in millions)
Balance, beginning of year
$
214

 
$
224

 
$
293

Additions for tax positions related to the current year
7

 
27

 
32

Additions for tax positions from prior years
12

 
2

 
1

Reductions for tax positions from prior years
(2
)
 
(13
)
 
(3
)
Settlements with taxing authorities
—

 
—

 
(52
)
Statute of limitations expirations
(25
)
 
(26
)
 
(47
)
Balance, end of year
$
206

 
$
214

 
$
224



As of October 31, 2019, we had $227 million of unrecognized tax benefits, including interest and penalties of which $204 million, if recognized, would affect our effective tax rate. However, approximately $23 million of the unrecognized tax benefits were related to state income tax positions that, if recognized, would be in the form of a deferred tax asset that would likely not affect our effective tax rate due to a valuation allowance.

We recognized a tax expense of $9 million, a tax expense of $11 million and a tax benefit of $9 million of interest and penalties related to unrecognized tax benefits in 2019, 2018 and 2017, respectively. Interest and penalties accrued as of October 31, 2019 and 2018 were $36 million and $27 million, respectively.

In the U.S., tax years remain open back to the year 2016 for federal income tax purposes and the year 2015 for significant states. In other major jurisdictions where the company conducts business, the tax years generally remain open back to the year 2009.

With these jurisdictions and the U.S., it is reasonably possible that there could be significant changes to our unrecognized tax benefits in the next twelve months due to either the expiration of a statute of limitation or a tax audit settlement which will be partially offset by an anticipated tax liability related to unremitted foreign earnings, where applicable. Given the number of years and numerous matters that remain subject to examination in various tax jurisdictions, management is unable to estimate the range of possible changes to the balance of our unrecognized tax benefits.


82
Table of Contents            

7.     NET INCOME PER SHARE

The following is a reconciliation of the numerators and denominators of the basic and diluted net income per share computations for the periods presented below.
 
Years Ended October 31,
 
2019
 
2018
 
2017
 
(in millions)
Numerator:
 
 
 
 
 
Net income
$
1,071

 
$
316

 
$
684

Denominators:
 
 
 
 
 
Basic weighted average shares
314

 
321

 
$
322

Potential common shares — stock options and other employee stock plans
4

 
4

 
4

Diluted weighted average shares
318

 
325

 
326


The dilutive effect of share-based awards is reflected in diluted net income per share by application of the treasury stock method, which includes consideration of unamortized share-based compensation expense and the dilutive effect of in-the-money options and non-vested restricted stock units. Under the treasury stock method, the amount the employee must pay for exercising stock options and unamortized share-based compensation expense collectively are assumed proceeds to be used to repurchase hypothetical shares. An increase in the fair market value of the company's common stock can result in a greater dilutive effect from potentially dilutive awards.

We exclude stock options with exercise prices greater than the average market price of our common stock from the calculation of diluted earnings per share because their effect would be anti-dilutive. In addition, we exclude from the calculation of diluted earnings per share, stock options, ESPP, LTPP and restricted stock awards whose combined exercise price and unamortized fair value collectively were greater than the average market price of our common stock because their effect would also be anti-dilutive.

In 2019, 2018 and 2017, we issued approximately 2 million, 2 million and 3 million, of share-based awards, respectively.  For the years ended 2019, 2018 and 2017, the impact of the anti-dilutive potential common shares that were excluded from the calculation of diluted earnings per share was not material.

8.     INVENTORY

 
October 31,
 
2019
 
2018
 
(in millions)
Finished goods
$
416

 
$
386

Purchased parts and fabricated assemblies
263

 
252

Inventory
$
679

 
$
638



Inventory-related excess and obsolescence charges of $19 million were recorded in cost of products in 2019, $26 million in 2018 and $24 million in 2017. We record excess and obsolete inventory charges for both inventory on our site as well as inventory at our contract manufacturers and suppliers where we have non-cancelable purchase commitments.


83
Table of Contents            

9.     PROPERTY, PLANT AND EQUIPMENT, NET

 
October 31,
 
2019
 
2018
 
(in millions)
Land
$
57

 
$
55

Buildings and leasehold improvements
1,012

 
952

Machinery and equipment
546

 
512

Software
160

 
141

Total property, plant and equipment
1,775

 
1,660

Accumulated depreciation and amortization
(925
)
 
(838
)
Property, plant and equipment, net
$
850

 
$
822



There were no asset impairments in 2019 and 2017 and less than $1 million asset impairments in 2018. Depreciation expenses were $111 million in 2019, $102 million in 2018 and $94 million in 2017. In 2019 we retired approximately $23 million of fully depreciated assets that were no longer in use.

10.   GOODWILL AND OTHER INTANGIBLE ASSETS

The following table presents goodwill balances and the movements for each of our reportable segments during the years ended October 31, 2018 and 2019:
 
Life Sciences and Applied Markets
 
Diagnostics and Genomics
 
Agilent CrossLab
 
Total
 
(in millions)
Goodwill as of October 31, 2017
$
773

 
$
1,330

 
$
504

 
$
2,607

Foreign currency translation impact
(7
)
 
(4
)
 
(4
)
 
(15
)
Goodwill arising from acquisitions
37

 
281

 
63

 
381

Goodwill as of October 31, 2018
$
803

 
$
1,607

 
$
563

 
$
2,973

Foreign currency translation impact
(1
)
 
(2
)
 
(2
)
 
(5
)
Goodwill arising from acquisitions and adjustments
636

 
(11
)
 
—

 
625

Goodwill as of October 31, 2019
$
1,438

 
$
1,594

 
$
561

 
$
3,593

 
 
 
 
 
 
 
 


As of September 30, 2019, our annual impairment test date, we assessed goodwill impairment for our reporting units and no impairment was indicated.


84
Table of Contents            

The component parts of other intangible assets at October 31, 2018 and 2019 are shown in the table below:
 
Other Intangible Assets
 
Gross
Carrying
Amount
 
Accumulated
Amortization
and Impairments
 
Net Book
Value
 
(in millions)
As of October 31, 2018:
 
 
 
 
 
Purchased technology
$
947

 
$
683

 
$
264

Trademark/Tradename
151

 
88

 
63

Customer relationships
107

 
63

 
44

Third-party technology and licenses
$
28

 
$
19

 
$
9

Total amortizable intangible assets
$
1,233

 
$
853

 
$
380

In-Process R&D
111

 
—

 
111

Total
$
1,344

 
$
853

 
$
491

As of October 31, 2019:
 
 
 
 
 
Purchased technology
$
1,413

 
$
763

 
$
650

Backlog
5

 
5

 
—

Trademark/Tradename
196

 
102

 
94

Customer relationships
329

 
87

 
242

Third-party technology and licenses
$
28

 
$
22

 
$
6

Total amortizable intangible assets
$
1,971

 
$
979

 
$
992

In-Process R&D
115

 
—

 
115

Total
$
2,086

 
$
979

 
$
1,107

 
 
 
 
 
 


In 2019, we acquired two businesses, BioTek and ACEA, for a combined purchase price of approximately $1.4 billion. See Note 3, "Acquisitions", for additional information.

During fiscal year 2019, we recorded additions to goodwill of $636 million and to other intangible assets of $744 million related to the acquisition of ACEA and BioTek. In the second quarter of fiscal year 2019, we recorded a measurement period adjustment to goodwill of $11 million for deferred tax assets related to pre-acquisition net operating losses of Advanced Analytical Technologies, Inc. The increase to other intangible assets due to foreign currency translation was not material in 2019.

During fiscal year 2018, we recorded additions to goodwill of $381 million and to intangible assets of $262 million related to the acquisition of seven businesses. During the year other intangible assets decreased $1 million, due to the impact of foreign exchange translation.

In general, for United States federal tax purposes, goodwill from asset purchases is amortizable however any goodwill created as part of a stock acquisition is not deductible.

In 2019, there were no impairments of other intangible assets recorded. During 2018, we recorded an impairment charge of $21 million related to purchased intangible assets within the diagnostics and genomics segment that were deemed unrecoverable. In 2017, there were no impairments of other intangible assets recorded.

Amortization expense of intangible assets was $128 million in 2019, $110 million in 2018, and $120 million in 2017.

Future amortization expense related to existing finite-lived purchased intangible assets associated with business combinations for the next five fiscal years and thereafter is estimated below:
Estimated future amortization expense:
 
 
(in millions)
2020
$
186

2021
$
172

2022
$
150

2023
$
107

2024
$
86

Thereafter
$
291




85
Table of Contents            


11.   INVESTMENTS

The following table summarizes the company's equity investments as of October 31, 2019 and 2018 (net book value):

 
October 31,
 
2019
 
2018
 
(in millions)
Long-Term
 
 
 
Equity investments - without readily determinable fair value
$
47

 
$
23

Equity investments - with readily determinable fair value
25

 
15

Trading securities
30

 
30

Total
$
102

 
$
68



Equity investments without readily determinable fair value (RDFV) consist of non-marketable equity securities issued by private companies. These investments are accounted for using the measurement alternative at cost adjusting for impairments and observable price changes (orderly transactions for the identical or a similar security from the same issuer). The adjustments are included in net income in the period in which they occur. Equity investments with RDFV consist of shares we own in a special fund and are reported at fair value, with gains or losses resulting from changes in fair value included in net income. Prior to fiscal year 2019, both equity investments without RDFV and with RDFV were accounted for using cost method of accounting, measured at historical cost less other-than-temporary impairment. Trading securities are reported at fair value, with gains or losses resulting from changes in fair value recognized currently in earnings.

During 2018, we acquired all of the remaining shares of Lasergen, Inc. (Lasergen), for an additional cash consideration of approximately $107 million, an investment that was accounted for under the cost method in 2017 for approximately $80 million. The fair value remeasurement of our previous investment immediately before the acquisition resulted in a net gain of $20 million and was recorded in other income.

Our investments without RDFV, are subject to periodic impairment review. The impairment analysis requires significant judgment to identify events or circumstances that would likely have significant adverse effect on the future value of the investment.

Net unrealized gains on our equity securities with RDFV were $3 million in 2019. Net unrealized gains on our equity securities without RDFV were not material in 2019. Upon adoption of new accounting guidance relating to financial instruments beginning fiscal year 2019, the gains and losses on such securities are recognized in other income (expense) and therefore not applicable in prior periods. As of November 1, 2019, total impact of adoption of said accounting guidance to our consolidated balance sheet was an increase of $7 million to equity securities with RDFV (included within long-term investments) and a net increase of$5 million to beginning retained earnings.

Net unrealized gains on our trading securities portfolio were $3 million in 2019, $1 million in 2018 and $4 million in 2017.

12.   FAIR VALUE MEASUREMENTS

The authoritative guidance defines fair value as the price that would be received from selling an asset or paid to transfer a liability in an orderly transaction between market participants at the measurement date. When determining the fair value measurements for assets and liabilities required or permitted to be recorded at fair value, we consider the principal or most advantageous market and assumptions that market participants would use when pricing the asset or liability.

Fair Value Hierarchy

The guidance establishes a fair value hierarchy that prioritizes the use of inputs used in valuation techniques into three levels. A financial instrument's categorization within the fair value hierarchy is based upon the lowest level of input that is significant to the fair value measurement. There are three levels of inputs that may be used to measure fair value:

Level 1 — applies to assets or liabilities for which there are quoted prices in active markets for identical assets or liabilities.

Level 2 — applies to assets or liabilities for which there are inputs other than quoted prices included within level 1 that are

86
Table of Contents            

observable, either directly or indirectly, for the asset or liability such as: quoted prices for similar assets or liabilities in active markets; quoted prices for identical or similar assets or liabilities in less active markets; or other inputs that can be derived principally from, or corroborated by, observable market data.

Level 3 — applies to assets or liabilities for which there are unobservable inputs to the valuation methodology that are significant to the measurement of the fair value of the assets or liabilities.

Financial Assets and Liabilities Measured at Fair Value on a Recurring Basis

Financial assets and liabilities measured at fair value on a recurring basis as of October 31, 2019 were as follows:

 
 
 
Fair Value Measurement at October 31, 2019 Using
 
October 31,
2019
 
Quoted Prices
in Active
Markets for
Identical Assets
(Level 1)
 
Significant
Other
Observable
Inputs
(Level 2)
 
Significant
Unobservable
Inputs
(Level 3)
 
(in millions)
Assets:
 
 
 
 
 
 
 
Short-term
 
 
 
 
 
 
 
Cash equivalents (money market funds)
$
784

 
$
784

 
$
—

 
$
—

Derivative instruments (foreign exchange contracts)
12

 
—

 
12

 
—

Long-term
 
 
 
 
 
 
 
Trading securities
30

 
30

 
—

 
—

Other investments
25

 
—

 
25

 
—

Total assets measured at fair value
$
851

 
$
814

 
$
37

 
$
—

Liabilities:
 
 
 
 
 
 
 
Short-term
 
 
 
 
 
 
 
Derivative instruments (foreign exchange contracts)
$
6

 
$
—

 
$
6

 
$
—

Long-term
 
 
 
 
 
 
 
Deferred compensation liability
30

 
—

 
30

 
—

Total liabilities measured at fair value
$
36

 
$
—

 
$
36

 
$
—



87
Table of Contents            


Financial assets and liabilities measured at fair value on a recurring basis as of October 31, 2018 were as follows:

 
 
 
Fair Value Measurement at October 31, 2018 Using
 
October 31,
2018
 
Quoted Prices
in Active
Markets for
Identical Assets
(Level 1)
 
Significant
Other
Observable
Inputs
(Level 2)
 
Significant
Unobservable
Inputs
(Level 3)
 
(in millions)
Assets:
 
 
 
 
 
 
 
Short-term
 
 
 
 
 
 
 
Cash equivalents (money market funds)
$
1,355

 
$
1,355

 
$
—

 
$
—

Derivative instruments (foreign exchange contracts)
16

 
—

 
16

 
—

Long-term
 
 
 
 
 
 
 
Trading securities
30

 
30

 
—

 
—

Total assets measured at fair value
$
1,401

 
$
1,385

 
$
16

 
$
—

Liabilities:
 
 
 
 
 
 

Short-term
 
 
 
 
 
 
 
Derivative instruments (foreign exchange contracts)
$
5

 
$
—

 
$
5

 
$
—

Long-term
 
 
 
 
 
 
 
Deferred compensation liability
30

 
—

 
30

 
—

Total liabilities measured at fair value
$
35

 
$
—

 
$
35

 
$
—


Our money market funds and trading securities are generally valued using quoted market prices and therefore are classified within level 1 of the fair value hierarchy. Our derivative financial instruments are classified within level 2, as there is not an active market for each hedge contract, but the inputs used to calculate the value of the instruments are tied to active markets. Our deferred compensation liability is classified as level 2 because, although the values are not directly based on quoted market prices, the inputs used in the calculations are observable. Other investments represent shares we own in a special fund that targets underlying investments of approximately 40 percent in debt securities and 60 percent in equity securities. It has been classified as level 2 because, although the shares of the fund are not traded on any active stock exchange, each of the individual underlying securities are and hence we have a readily determinable value for the underlying securities, from which we are able to determine the fair market value for the special fund itself.

Trading securities, which is comprised of mutual funds, bonds and other similar instruments, other investments and deferred compensation liability are reported at fair value, with gains or losses resulting from changes in fair value recognized currently in net income. Certain derivative instruments are reported at fair value, with unrealized gains and losses, net of tax, included in accumulated other comprehensive loss within stockholders' equity. Realized gains and losses from the sale of these instruments are recorded in net income.

Assets and Liabilities Measured at Fair Value on a Non-Recurring Basis

Long-Lived Assets

For assets measured at fair value on a non-recurring basis, the following table summarizes the impairments included in net income for the years ended October 31, 2019, 2018 and 2017:

 
Years Ended
October 31,
 
2019
 
2018
 
2017
 
(in millions)
Long-lived assets held and used
$
—

 
$
21

 
$
—

Long-lived assets held for sale
$
—

 
$
—

 
$
—




88
Table of Contents            

There were no impairments of long-lived assets held and used in 2019 and 2017. For 2018, long lived assets held and used with a carrying amount of $21 million were written down to their fair value of zero, resulting in an impairment charge of $21 million, which relates to purchased intangible assets within the diagnostics and genomics segment that were deemed unrecoverable and was included in net income.

There were no impairments of long-lived assets held for sale in 2019, 2018 and 2017.

Fair values for the impaired long-lived assets during 2018 were measured using level 3 inputs. To determine the fair value of long-lived assets in 2018, we used the income approach based on projected discounted cash flows expected to be generated by the long-lived assets over the remaining useful life.

For 2019, there were no impairments or material changes in non-marketable securities without readily determinable fair value. As of October 31, 2019 and October 31, 2018, the carrying amount of non-marketable equity securities without readily determinable fair values was $47 million and $23 million, respectively.

Fair values for the non-marketable securities included in long-term investments on the consolidated balance sheet were measured using Level 3 inputs because they are primarily equity stock issued by private companies without quoted market prices. To estimate the fair value of our non-marketable securities, we use the measurement alternative to record these investments at cost and to adjust for impairments and observable price changes (orderly transactions for the identical or a similar security from the same issuer) as and when it occurs.

13.   DERIVATIVES

We are exposed to foreign currency exchange rate fluctuations and interest rate changes in the normal course of our business. As part of our risk management strategy, we use derivative instruments, primarily forward contracts purchased options to hedge economic and/or accounting exposures resulting from changes in foreign currency exchange rates.

Fair Value Hedges

We are exposed to interest rate risk due to the mismatch between the interest expense we pay on our loans at fixed rates and the variable rates of interest we receive from cash, cash equivalents and other short-term investments. We have issued long-term debt in U.S. dollars at fixed interest rates based on the market conditions at the time of financing. The fair value of our fixed rate debt changes when the underlying market rates of interest change, and, in the past, we have used interest rate swaps to change our fixed interest rate payments to U.S. dollar LIBOR-based variable interest expense to match the floating interest income from our cash, cash equivalents and other short-term investments. As of October 31, 2019, all interest rate swap contracts had either been terminated or had expired.

On August 9, 2011, we terminated five interest rate swap contracts related to our 2020 senior notes that represented the notional amount of $500 million. On September 17, 2019, the 2020 senior notes were redeemed, and the remaining gain associated with the terminated interest rate swap contracts was realized.

Cash Flow Hedges

We enter into foreign exchange contracts to hedge our forecasted operational cash flow exposures resulting from changes in foreign currency exchange rates. These foreign exchange contracts, carried at fair value, have maturities between one and twelve months. These derivative instruments are designated and qualify as cash flow hedges under the criteria prescribed in the authoritative guidance and are assessed for effectiveness against the underlying exposure every reporting period. For open contracts as of October 31, 2019 and entered into on or after November 1, 2018, changes in the time value of the foreign exchange contract are excluded from the assessment of hedge effectiveness and are recognized in cost of sales over the life of the foreign exchange contract. The changes in fair value of the effective portion of the derivative instrument are recognized in accumulated other comprehensive income (loss).  Amounts associated with cash flow hedges are reclassified to cost of sales in the consolidated statement of operations when the forecasted transaction occurs. If it becomes probable that the forecasted transaction will not occur, the hedge relationship will be de-designated and amounts accumulated in other comprehensive income (loss) will be reclassified to other income (expense), net in the current period. Changes in the fair value of the ineffective portion of derivative instruments are recognized in other income (expense), net in the consolidated statement of operations in the current period. We record the premium paid (time value) of an option on the date of purchase as an asset. For options designated as cash flow hedges, changes in the time value are excluded from the assessment of hedge effectiveness and are recognized in cost of sales over the

89
Table of Contents            

life of the option contract. For the years ended October 31, 2019, 2018 and 2017, ineffectiveness and gains and losses recognized in other income (expense),net due to de-designation of cash flow hedge contracts were not significant.

In July 2012, Agilent executed treasury lock agreements for $400 million in connection with future interest payments to be made on our 2022 senior notes issued on September 10, 2012. We designated the treasury lock as a cash flow hedge. The treasury lock contracts were terminated on September 10, 2012 and we recognized a deferred gain in accumulated other comprehensive income which is being amortized to interest expense over the life of the 2022 senior notes. The remaining gain to be amortized related to the treasury lock agreements at October 31, 2019 was $1 million.

In February 2016, Agilent executed three forward-starting pay fixed/receive variable interest rate swaps for the notional amount of $300 million in connection with future interest payments to be made on our 2026 senior notes issued on September 15, 2016. These derivative instruments were designated and qualified as cash flow hedges under the criteria prescribed in the authoritative guidance. The swap arrangements were terminated on September 15, 2016 with a payment of $10 million and we recognized this as a deferred loss in accumulated other comprehensive income which is being amortized to interest expense over the life of the 2026 senior notes. The remaining loss to be amortized related to the interest rate swap agreements at October 31, 2019 was $7 million.

In August 2019, Agilent executed treasury lock agreements for $250 million in connection with future interest payments to be made on our 2029 senior notes issued on September 5, 2019. We designated the treasury lock as a cash flow hedge. The treasury lock contracts were terminated on September 6, 2019 and we recognized a deferred loss of $6 million in accumulated other comprehensive income which is being amortized to interest expense over the life of the 2029 senior notes. The remaining loss to be amortized related to the treasury lock agreements at October 31, 2019 was $6 million.

Other Hedges

Additionally, we enter into foreign exchange contracts to hedge monetary assets and liabilities that are denominated in currencies other than the functional currency of our subsidiaries. These foreign exchange contracts are carried at fair value and do not qualify for hedge accounting treatment and are not designated as hedging instruments. Changes in value of the derivative instruments are recognized in other income (expense),net in the consolidated statement of operations, in the current period, along with the offsetting foreign currency gain or loss on the underlying assets or liabilities.

Our use of derivative instruments exposes us to credit risk to the extent that the counterparties may be unable to meet the terms of the agreement. We do, however, seek to mitigate such risks by limiting our counterparties to major financial institutions which are selected based on their credit ratings and other factors. We have established policies and procedures for mitigating credit risk that include establishing counterparty credit limits, monitoring credit exposures, and continually assessing the creditworthiness of counterparties.

A number of our derivative agreements contain threshold limits to the net liability position with counterparties and are dependent on our corporate credit rating determined by the major credit rating agencies. The counterparties to the derivative instruments may request collateralization, in accordance with derivative agreements, on derivative instruments in net liability positions.

The aggregate fair value of all derivative instruments with credit-risk-related contingent features that were in a net liability position as of October 31, 2019, was $2 million. The credit-risk-related contingent features underlying these agreements had not been triggered as of October 31, 2019.

90
Table of Contents            


There were 261 foreign exchange forward contracts open as of October 31, 2019 and designated as cash flow hedges. There were 205 foreign exchange forward contracts open as of October 31, 2019 not designated as hedging instruments. The aggregated notional amounts by currency and designation as of October 31, 2019 were as follows:
 
 
Derivatives Designated as
Cash Flow Hedges
 
Derivatives
Not
Designated
as Hedging
Instruments
 
 
Forward
Contracts USD
 
Forward
Contracts USD
Currency
 
Buy/(Sell)
 
Buy/(Sell)
 
 
(in millions)
Euro
 
$
(40
)
 
$
141

British Pound
 
(45
)
 
1

Canadian Dollar
 
(38
)
 
25

Australian Dollar
 
4

 
—

Malaysian Ringgit
 
—

 
11

Japanese Yen
 
(82
)
 
(7
)
Danish Krone
 
—

 
237

Korean Won
 
(59
)
 
(32
)
Singapore Dollar
 
14

 
28

Swiss Franc
 
—

 
(2
)
Chinese Yuan Renminbi
 
(59
)
 
(70
)
Swedish Krona
 
—

 
(8
)
Other
 
—

 
(23
)
 
 
$
(305
)
 
$
301



Derivative instruments are subject to master netting arrangements and are disclosed gross in the balance sheet in accordance with the authoritative guidance. The gross fair values and balance sheet location of derivative instruments held in the consolidated balance sheet as of October 31, 2019 and 2018 were as follows:

Fair Values of Derivative Instruments
Asset Derivatives
 
Liability Derivatives
 
 
Fair Value
 
 
 
Fair Value
Balance Sheet Location
 
October 31,
2019
 
October 31,
2018
 
Balance Sheet Location
 
October 31,
2019
 
October 31,
2018
(in millions)
Derivatives designated as hedging instruments:
 
 
 
 
 
 
 
 
 
 
Cash flow hedges
 
 
 
 
 
 
 
 
 
 
Foreign exchange contracts
 
 
 
 
 
 
 
 
 
 
Other current assets
 
$
3

 
$
11

 
Other accrued liabilities
 
$
2

 
$
1

 
 
 
 
 
 
 
 
 
 
 
Derivatives not designated as hedging instruments:
 
 
 
 
 
 
 
 
 
 
Foreign exchange contracts
 
 
 
 
 
 
 
 
 
 
Other current assets
 
$
9

 
$
5

 
Other accrued liabilities
 
$
4

 
$
4

Total derivatives
 
$
12

 
$
16

 
 
 
$
6

 
$
5




91
Table of Contents            

The effect of derivative instruments for foreign exchange contracts designated as hedging instruments and not designated as hedging instruments in our consolidated statement of operations were as follows:

 
Years Ended October 31,
 
2019
 
2018
 
2017
 
(in millions)
Derivatives designated as hedging instruments:
 
 
 
 
 
Cash flow hedges
 
 
 
 
 
Loss on interest rate swaps recognized in other comprehensive income (loss)
$
(6
)
 
$
—

 
$
—

Loss reclassified from accumulated other comprehensive income into interest expense
$
(1
)
 
$
(1
)
 
$
—

Gain (loss) recognized in accumulated other comprehensive income (loss)
$
—

 
$
7

 
$
—

Gain (loss) reclassified from accumulated other comprehensive income (loss) into cost of sales
$
9

 
$
(3
)
 
$
1

Gain (loss) on time value of forward contracts recorded in cost of sales
$
2

 
$
—

 
$
—

Derivatives not designated as hedging instruments:
 
 
 
 
 
Gain (loss) recognized in other income (expense), net
$
2

 
$
(2
)
 
$
5



At October 31, 2019 the estimated amount of existing net gain that is expected to be reclassified from accumulated other comprehensive income to cost of sales within the next twelve months is $4 million.

14.   RETIREMENT PLANS AND POST RETIREMENT PENSION PLANS

General.    Substantially all of our employees are covered under various defined benefit and/or defined contribution retirement plans. Additionally, we sponsor post-retirement health care benefits for our eligible U.S. employees.

Agilent provides defined benefits to U.S. employees, who meet eligibility criteria under the Agilent Technologies, Inc. Retirement Plan (the "RP").

For eligible service through October 31, 1993, the benefit payable under the Agilent Retirement Plan is reduced by any amounts due to the eligible employee under the Agilent defined contribution Deferred Profit-Sharing Plan (the "DPSP"), which was closed to new participants as of November 1993.

As of October 31, 2019 and 2018, the fair value of plan assets of the DPSP was $132 million and $141 million, respectively. Note that the projected benefit obligation for the DPSP equals the fair value of plan assets.

Effective November 1, 2014, Agilent’s U.S. defined benefit retirement plan was closed to new entrants including new employees, new transfers to the U.S. payroll and rehires. As of April 30, 2016, benefits under the RP were frozen. Any pension benefit earned in the U.S. Plans through April 30, 2016 remained fully vested, and there are no additional benefit accruals after April 30, 2016.

Agilent also maintains a Supplemental Benefits Retirement Plan ("SBRP") in the U.S., which is a supplemental unfunded non-qualified defined benefit plan to provide benefits that would be provided under the RP but for limitations imposed by the Internal Revenue Code. The RP and the SBRP comprise the "U.S. Plans" in the tables below.

Eligible employees outside the U.S. generally receive retirement benefits under various retirement plans based upon factors such as years of service and/or employee compensation levels. Eligibility is generally determined in accordance with local statutory requirements.


92
Table of Contents            

Post-Retirement Medical Benefit Plans.    In addition to receiving retirement benefits, Agilent U.S. employees who meet eligibility requirements as of their termination date may participate in the Agilent Technologies, Inc. Health Plan for Retirees.
–
Eligible retirees who were less than age 50 as of January 1, 2005 and who retire after age 55 with 15 or more years of service are eligible for a fixed amount which can be utilized to pay for either sponsored plans and/or individual Medicare plans.
–
Effective January 1, 2012, employees who were at least age 50 as of January 1, 2005 and who retire after age 55 with 15 or more years of service are eligible for fixed dollar subsidies and stipends. Grandfathered retirees receive a fixed monthly subsidy toward pre-65 premium costs (subsidy capped at 2011 levels) and a fixed monthly stipend post-65. The subsidy amounts will not increase.
–
Any new employee hired on or after November 1, 2014, will not be eligible to participate in the retiree medical plans upon retiring.
–
As of April 30, 2016, benefits under this plan were changed for Active employees who have not met the eligibility requirement - 55 years old with at least 15 years of Agilent service, as of April 30, 2016 - for the Retiree Medical Account (RMA) under the U.S. Post Retirement Benefit Plan These employees will only be eligible for 50 percent of the current RMA reimbursement amount upon retirement.

401(k) Defined Contribution Plan.    Eligible Agilent U.S. employees may participate in the Agilent Technologies, Inc. 401(k) Plan. Effective April 30, 2016, we began matching contributions to employees up to a maximum of 6 percent of an employee's annual eligible compensation. Effective May 1, 2016 until April 30, 2022, we will provide an additional transitional company contribution for certain eligible employees equal to 3 percent, 4 percent or 5 percent of an employee's annual eligible compensation due to the RP benefits being frozen. The maximum contribution to the 401(k) Plan is 50 percent of an employee's annual eligible compensation, subject to regulatory limitations. The 401(k) Plan employer expense included in income from operations was $39 million in 2019, $37 million in 2018 and $33 million in 2017.

Japanese Welfare Pension Insurance Law. In Japan, Agilent has employees' pension fund plans, which are defined benefit pension plans established under the Japanese Welfare Pension Insurance Law (JWPIL). The plans are composed of (a) a substitutional portion based on the pay-related part of the old-age pension benefits prescribed by JWPIL (similar to social security benefits in the United States) and (b) a corporate portion based on a contributory defined benefit pension arrangement established at the discretion of the company. During the year ended October 31, 2017, Agilent received government approval and returned the substitutional portion of Japan's pension plan to the Japanese government, as allowed by the JWPIL. The initial transfer resulted in a net gain of $32 million recorded in other income (expense), net in the consolidated statement of operations. The net gain consisted of two parts - a gain of $41 million, representing the difference between the fair values of the Accumulated Benefit Obligation (ABO) settled of $65 million and the assets transferred from the pension trust to the government of Japan of $24 million, offset by a settlement loss of $9 million related to the recognition of previously unrecognized actuarial losses included in accumulated other comprehensive income. In the first quarter of fiscal year 2018, after the Japanese government’s final review of our initial payment, we received a refund of $5 million which was recorded as a settlement gain.





93
Table of Contents            


Components of Net periodic cost.   The service cost component is recorded in cost of sales and operating expenses in the consolidated statement of operations. All other cost components are recorded in other income (expense), net in the consolidated statement of operations. The company uses alternate methods of amortization as allowed by the authoritative guidance which amortizes the actuarial gains and losses on a consistent basis for the years presented. For U.S. Plans, gains and losses are amortized over the average future lifetime of participants using the corridor method. For most Non-U.S. Plans and U.S. Post-Retirement Benefit Plans, gains and losses are amortized using a separate layer for each year's gains and losses.

For the years ended October 31, 2019, 2018 and 2017, components of net periodic benefit cost and other amounts recognized in other comprehensive income were comprised of:
 
Pensions
 
U.S. Post-Retirement Benefit Plans
 
U.S. Plans
 
Non-U.S. Plans
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
2019
 
2018
 
2017
 
2019
 
2018
 
2017
 
2019
 
2018
 
2017
 
(in millions)
Net periodic benefit cost (benefit)
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Service cost — benefits earned during the period
$
—

 
$
—

 
$
—

 
$
20

 
$
20

 
$
19

 
$
—

 
$
1

 
$
1

Interest cost on benefit obligation
18

 
16

 
15

 
14

 
13

 
12

 
4

 
3

 
3

Expected return on plan assets
(27
)
 
(28
)
 
(25
)
 
(43
)
 
(46
)
 
(41
)
 
(7
)
 
(7
)
 
(7
)
Amortization of net actuarial loss
1

 
1

 
3

 
34

 
29

 
36

 
4

 
8

 
11

Amortization of prior service benefit
—

 
—

 
—

 
—

 
—

 
—

 
(8
)
 
(8
)
 
(9
)
Total periodic benefit cost (benefit)
$
(8
)
 
$
(11
)
 
$
(7
)
 
$
25

 
$
16

 
$
26

 
$
(7
)
 
$
(3
)
 
$
(1
)
Curtailments and settlements
$
—

 
$
—

 
$
—

 
$
—

 
$
(5
)
 
$
(32
)
 
$
—

 
$
—

 
$
—

Other changes in plan assets and benefit obligations recognized in other comprehensive (income) loss
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Net actuarial (gain) loss
$
51

 
$
2

 
$
(19
)
 
$
104

 
$
49

 
$
(128
)
 
$
5

 
$
(2
)
 
$
(9
)
Amortization of net actuarial loss
(1
)
 
(1
)
 
(3
)
 
(34
)
 
(29
)
 
(36
)
 
(4
)
 
(8
)
 
(11
)
Prior service cost (benefit)
—

 
—

 
—

 
—

 
—

 
—

 
—

 
—

 
—

Amortization of prior service benefit
—

 
—

 
—

 
—

 
—

 
—

 
8

 
8

 
9

Gain due to settlement
—

 
—

 
—

 
—

 
—

 
32

 
—

 
—

 
—

Foreign currency
—

 
—

 
—

 
(3
)
 
1

 
2

 
—

 
—

 
—

Total recognized in other comprehensive (income) loss
$
50

 
$
1

 
$
(22
)
 
$
67

 
$
21

 
$
(130
)
 
$
9

 
$
(2
)
 
$
(11
)
Total recognized in net periodic benefit cost (benefit) and other comprehensive (income) loss
$
42

 
$
(10
)
 
$
(29
)
 
$
92

 
$
32

 
$
(136
)
 
$
2

 
$
(5
)
 
$
(12
)















94
Table of Contents            




Funded Status.    As of October 31, 2019 and 2018, the funded status of the defined benefit and post-retirement benefit plans was:

 
U.S. Defined
Benefit Plans
 
Non-U.S. Defined
Benefit Plans
 
U.S.
Post-Retirement
Benefit Plans
 
2019
 
2018
 
2019
 
2018
 
2019
 
2018
 
(in millions)
Change in fair value of plan assets:
 
 
 
 
 
 
 
 
 
 
 
Fair value — beginning of year
$
401

 
$
414

 
$
825

 
$
855

 
$
90

 
$
95

Actual return on plan assets
50

 
8

 
85

 
(9
)
 
11

 
1

Employer contributions
—

 
—

 
21

 
21

 
—

 
—

Participants' contributions
—

 
—

 
1

 
—

 
—

 
—

Benefits paid
(19
)
 
(21
)
 
(29
)
 
(26
)
 
(6
)
 
(6
)
Settlements
—

 
—

 
—

 
5

 
—

 
—

Currency impact
—

 
—

 
8

 
(21
)
 
—

 
—

Fair value — end of year
$
432

 
$
401

 
$
911

 
$
825

 
$
95

 
$
90

Change in benefit obligation:
 
 
 
 
 
 
 
 
 
 
 
Benefit obligation — beginning of year
$
420

 
$
445

 
$
913

 
$
935

 
$
87

 
$
97

Service cost
—

 
—

 
20

 
20

 
—

 
1

Interest cost
18

 
16

 
14

 
13

 
4

 
3

Participants' contributions
—

 
—

 
1

 
—

 
—

 
—

Plan amendment
—

 
—

 
—

 
1

 
—

 
—

Actuarial (gain) loss
74

 
(19
)
 
143

 
(6
)
 
9

 
(7
)
Benefits paid
(21
)
 
(22
)
 
(29
)
 
(27
)
 
(6
)
 
(7
)
Currency impact
—

 
—

 
5

 
(23
)
 
—

 
—

Benefit obligation — end of year
$
491

 
$
420

 
$
1,067

 
$
913

 
$
94

 
$
87

Overfunded (underfunded) status of PBO
$
(59
)
 
$
(19
)
 
$
(156
)
 
$
(88
)
 
$
1

 
$
3

Amounts recognized in the consolidated balance sheet consist of:
 
 
 
 
 
 
 
 
 
 
 
Other assets
$
—

 
$
—

 
$
106

 
$
95

 
$
1

 
$
3

Employee compensation and benefits
(1
)
 
(1
)
 
—

 
—

 
—

 
—

Retirement and post-retirement benefits
(58
)
 
(18
)
 
(262
)
 
(183
)
 
—

 
—

Total net asset (liability)
$
(59
)
 
$
(19
)
 
$
(156
)
 
$
(88
)
 
$
1

 
$
3

Amounts Recognized in Accumulated Other Comprehensive Income (loss):
 
 
 
 
 
 
 
 
 
 
 
Actuarial (gains) losses
$
115

 
$
65

 
$
330

 
$
263

 
$
10

 
$
10

Prior service costs (benefits)
—

 
—

 
—

 
—

 
(12
)
 
(20
)
Total
$
115

 
$
65

 
$
330

 
$
263

 
$
(2
)
 
$
(10
)


The amounts in accumulated other comprehensive income expected to be recognized by Agilent as components of net expense during 2020 are as follows:
 
U.S. Defined
Benefit Plans
 
Non-U.S. Defined
Benefit Plans
 
U.S. Post-Retirement
Benefit Plans
 
(in millions)
Amortization of net prior service cost (benefit)
$
—

 
$
—

 
$
(7
)
Amortization of actuarial net loss (gain)
$
3

 
$
48

 
$
4




95
Table of Contents            

Investment Policies and Strategies as of October 31, 2019 and 2018. In the U.S., target asset allocations for our retirement and post-retirement benefit plans are approximately 80 percent to equities and approximately 20 percent to fixed income investments. Our DPSP target asset allocation is approximately 60 percent to equities and approximately 40 percent to fixed income investments. Approximately 3 percent of our U.S. equity portfolio consists of limited partnerships. The general investment objective for all our plan assets is to obtain the optimum rate of investment return on the total investment portfolio consistent with the assumption of a reasonable level of risk. Specific investment objectives for the plans' portfolios are to: maintain and enhance the purchasing power of the plans' assets; achieve investment returns consistent with the level of risk being taken; and earn performance rates of return in accordance with the benchmarks adopted for each asset class. Outside the U.S., our target asset allocation ranges from 31 to 60 percent to equities, from 38 to 61 percent to fixed income investments, and from zero to 25 percent to real estate, depending on the plan. All plans' assets are broadly diversified. Due to fluctuations in equity markets, our actual allocations of plan assets at October 31, 2019 and 2018 differ from the target allocation. Our policy is to bring the actual allocation in line with the target allocation.

Equity securities include exchange-traded common stock and preferred stock of companies from broadly diversified industries. Fixed income securities include a global portfolio of corporate bonds of companies from diversified industries, government securities, mortgage-backed securities, asset-backed securities, derivative instruments and other. Other investments include a group trust consisting primarily of private equity partnerships. Portions of the cash and cash equivalent, equity, and fixed income investments are held in commingled funds that are valued using Net Asset Value (“NAV”) as the practical expedient. In addition, some of the investments valued using NAV as the practical expedient may have limits on their redemption to weekly or monthly and/or may require prior written notice specified by each fund.

Fair Value.    The measurement of the fair value of pension and post-retirement plan assets uses the valuation methodologies and the inputs as described in Note 12, "Fair Value Measurements".

Cash and Cash Equivalents - Cash and cash equivalents consist of short-term investment funds. The funds also invest in short-term domestic fixed income securities and other securities with debt-like characteristics emphasizing short-term maturities and quality. Some of our cash and cash equivalents are held in commingled funds. Other cash and cash equivalents are classified as Level 1 investments.

Equity - Some equity securities consisting of common and preferred stock that are not traded on an active market are valued at quoted prices reported by investment dealers based on the underlying terms of the security and comparison to similar securities traded on an active market; these are classified as Level 2 investments. Securities which have quoted prices in active markets are classified as Level 1 investments.

Fixed Income - Some of the fixed income securities are not actively traded and are valued at quoted prices based on the terms of the security and comparison to similar securities traded on an active market; these are classified as Level 2 investments. Securities which have quoted prices in active markets are classified as Level 1 investments.

Other Investments - Other investments also includes partnership investments where, due to their private nature, pricing inputs are not readily observable. Asset valuations are developed by the general partners that manage the partnerships. These valuations are based on proprietary appraisals, application of public market multiples to private company cash flows, utilization of market transactions that provide valuation information for comparable companies and other methods. Holdings of limited partnerships are classified as Level 3.

Agilent has adopted the accounting guidance related to the presentation of certain investments using the NAV practical expedient. The accounting guidance exempts investments using this practical expedient from categorization within the fair value hierarchy.


96
Table of Contents            

The following tables present the fair value of U.S. Defined Benefit Plans assets classified under the appropriate level of the fair value hierarchy as of October 31, 2019 and 2018.
 
 
 
Fair Value Measurement at October 31, 2019 Using
 
 
 
October 31,
2019
 
Quoted Prices
in Active
Markets for
Identical Assets
(Level 1)
 
Significant
Other
Observable
Inputs
(Level 2)
 
Significant
Unobservable
Inputs
(Level 3)
 
Not Subject to Leveling (1)
 
(in millions)
Cash and Cash Equivalents
$
1

 
$
—

 
$
—

 
$
—

 
$
1

Equity
336

 
78

 
—

 
—

 
258

Fixed Income
91

 
46

 
—

 
—

 
45

Other Investments
4

 
—

 
—

 
4

 
—

Total assets measured at fair value
$
432

 
$
124

 
$
—

 
$
4

 
$
304

(1) Investments measured at the net asset value per share (or its equivalent) practical expedient have not been classified in the fair value hierarchy.
 
 
 
Fair Value Measurement at October 31, 2018 Using
 
 
 
October 31,
2018
 
Quoted Prices
in Active
Markets for
Identical Assets
(Level 1)
 
Significant
Other
Observable
Inputs
(Level 2)
 
Significant
Unobservable
Inputs
(Level 3)
 
Not Subject to Leveling (1)
 
(in millions)
Cash and Cash Equivalents
$
4

 
$
—

 
$
—

 
$
—

 
$
4

Equity
308

 
69

 
—

 
—

 
239

Fixed Income
83

 
36

 
5

 
—

 
42

Other Investments
6

 
—

 
—

 
6

 
—

Total assets measured at fair value
$
401

 
$
105

 
$
5

 
$
6

 
$
285

(1) Investments measured at the net asset value per share (or its equivalent) practical expedient have not been classified in the fair value hierarchy.

For U.S. Defined Benefit Plans assets measured at fair value using significant unobservable inputs (level 3), the following table summarizes the change in balances during 2019 and 2018:
 
Years Ended
October 31.
 
2019
 
2018
Balance, beginning of year
$
6

 
$
7

Realized gains/(losses)
(1
)
 
—

Unrealized gains/(losses)
1

 
1

Purchases, sales, issuances, and settlements
(2
)
 
(2
)
Transfers in (out)
—

 
—

Balance, end of year
$
4

 
$
6

















97
Table of Contents            


The following tables present the fair value of U.S. Post-Retirement Benefit Plans assets classified under the appropriate level of the fair value hierarchy as of October 31, 2019 and 2018.
 
 
 
Fair Value Measurement at October 31, 2019 Using
 
 
 
October 31,
2019
 
Quoted Prices
in Active
Markets for
Identical Assets
(Level 1)
 
Significant
Other
Observable
Inputs
(Level 2)
 
Significant
Unobservable
Inputs
(Level 3)
 
Not Subject to Leveling (1)
 
(in millions)
Cash and Cash Equivalents
$
3

 
$
—

 
$
—

 
$
—

 
$
3

Equity
69

 
18

 
—

 
—

 
51

Fixed Income
21

 
11

 
—

 
—

 
10

Other Investments
2

 
—

 
—

 
2

 
—

Total assets measured at fair value
$
95

 
$
29

 
$
—

 
$
2

 
$
64

(1) Investments measured at the net asset value per share (or its equivalent) practical expedient have not been classified in the fair value hierarchy.

 
 
 
Fair Value Measurement at October 31, 2018 Using
 
 
 
October 31,
2018
 
Quoted Prices
in Active
Markets for
Identical Assets
(Level 1)
 
Significant
Other
Observable
Inputs
(Level 2)
 
Significant
Unobservable
Inputs
(Level 3)
 
Not Subject to Leveling (1)
 
(in millions)
Cash and Cash Equivalents
$
3

 
$
—

 
$
—

 
$
—

 
$
3

Equity
65

 
15

 
—

 
—

 
50

Fixed Income
18

 
9

 
—

 
—

 
9

Other Investments
4

 
—

 
—

 
4

 
—

Total assets measured at fair value
$
90

 
$
24

 
$
—

 
$
4

 
$
62

(1) Investments measured at the net asset value per share (or its equivalent) practical expedient have not been classified in the fair value hierarchy.


For U.S. Post-Retirement Benefit Plans assets measured at fair value using significant unobservable inputs (level 3), the following table summarizes the change in balances during 2019 and 2018:
 
Years Ended
October 31,
 
2019
 
2018
Balance, beginning of year
$
4

 
$
4

Realized gains/(losses)
(1
)
 
—

Unrealized gains/(losses)
—

 
1

Purchases, sales, issuances, and settlements
(1
)
 
(1
)
Transfers in (out)
—

 
—

Balance, end of year
$
2

 
$
4



98
Table of Contents            



The following tables present the fair value of non-U.S. Defined Benefit Plans assets classified under the appropriate level of the fair value hierarchy as of October 31, 2019 and 2018:

 
 
 
Fair Value Measurement at October 31, 2019 Using
 
 
 
October 31,
2019
 
Quoted Prices
in Active
Markets for
Identical Assets
(Level 1)
 
Significant
Other
Observable
Inputs
(Level 2)
 
Significant
Unobservable
Inputs
(Level 3)
 
Not Subject to Leveling (1)
 
(in millions)
Cash and Cash Equivalents
$
1

 
$
—

 
$
1

 
$
—

 
$
—

Equity
512

 
318

 
61

 
—

 
133

Fixed Income
398

 
98

 
213

 
—

 
87

Other Investments
—

 
—

 
—

 
—

 
—

Total assets measured at fair value
$
911

 
$
416

 
$
275

 
$
—

 
$
220

(1) Investments measured at the net asset value per share (or its equivalent) practical expedient have not been classified in the fair value hierarchy.

 
 
 
Fair Value Measurement at October 31, 2018 Using
 
 
 
October 31,
2018
 
Quoted Prices
in Active
Markets for
Identical Assets
(Level 1)
 
Significant
Other
Observable
Inputs
(Level 2)
 
Significant
Unobservable
Inputs
(Level 3)
 
Not Subject to Leveling (1)
 
(in millions)
 
 
Cash and Cash Equivalents
$
2

 
$
—

 
$
2

 
$
—

 
$
—

Equity
489

 
298

 
60

 
—

 
131

Fixed Income
334

 
76

 
228

 
—

 
30

Other Investments
—

 
—

 
—

 
—

 
—

Total assets measured at fair value
$
825

 
$
374

 
$
290

 
$
—

 
$
161

(1) Investments measured at the net asset value per share (or its equivalent) practical expedient have not been classified in the fair value hierarchy.





99
Table of Contents            

The table below presents the combined projected benefit obligation ("PBO"), accumulated benefit obligation ("ABO") and fair value of plan assets, grouping plans using comparisons of the PBO and ABO relative to the plan assets as of October 31, 2019 or 2018.
 
2019
 
2018
 
Benefit
Obligation
 
 
 
Benefit
Obligation
 
 
 
Fair Value of
Plan Assets
 
Fair Value of
Plan Assets
 
PBO
 
PBO
 
 
(in millions)
U.S. defined benefit plans where PBO exceeds the fair value of plan assets
$
491

 
$
432

 
$
420

 
$
401

U.S. defined benefit plans where fair value of plan assets exceeds PBO
—

 
—

 
—

 
—

Total
$
491

 
$
432

 
$
420

 
$
401

 
 
 
 
 
 
 
 
Non-U.S. defined benefit plans where PBO exceeds or is equal to the fair value of plan assets
$
752

 
$
490

 
$
563

 
$
380

Non-U.S. defined benefit plans where fair value of plan assets exceeds PBO
315

 
421

 
350

 
445

Total
$
1,067

 
$
911

 
$
913

 
$
825

 
 
 
 
 
 
 
 
 
ABO
 
 
 
ABO
 
 
U.S. defined benefit plans where ABO exceeds the fair value of plan assets
$
491

 
$
432

 
$
420

 
$
401

U.S. defined benefit plans where the fair value of plan assets exceeds ABO
—

 
—

 
—

 
—

Total
$
491

 
$
432

 
$
420

 
$
401

 
 
 
 
 
 
 
 
Non-U.S. defined benefit plans where ABO exceeds or is equal to the fair value of plan assets
$
651

 
$
418

 
$
543

 
$
380

Non-U.S. defined benefit plans where fair value of plan assets exceeds ABO
381

 
493

 
343

 
445

Total
$
1,032

 
$
911

 
$
886

 
$
825



Contributions and Estimated Future Benefit Payments.    During fiscal year 2020, we do not expect to contribute to the U.S. defined benefit plans and the Post-Retirement Medical Plans. We expect to contribute $24 million to plans outside the U.S. The following table presents expected future benefit payments for the next 10 years:

 
U.S. Defined
Benefit Plans
 
Non-U.S. Defined
Benefit Plans
 
U.S. Post-Retirement
Benefit Plans
 
(in millions)
2020
$
35

 
$
25

 
$
8

2021
$
36

 
$
27

 
$
8

2022
$
33

 
$
29

 
$
7

2023
$
35

 
$
32

 
$
7

2024
$
37

 
$
32

 
$
7

2025 - 2029
$
146

 
$
170

 
$
35



Assumptions.    The assumptions used to determine the benefit obligations and expense for our defined benefit and post-retirement benefit plans are presented in the tables below. The expected long-term return on assets below represents an estimate of long-term returns on investment portfolios consisting of a mixture of equities, fixed income and alternative investments in proportion to the asset allocations of each of our plans. We consider long-term rates of return, which are weighted based on the asset classes (both historical and forecasted) in which we expect our pension and post-retirement funds to be invested. Discount rates reflect the current rate at which pension and post-retirement obligations could be settled based on the measurement dates of the plans - October 31. The U.S. discount rates at October 31, 2019 and 2018, were determined based on the results of matching expected plan benefit payments with cash flows from a hypothetically constructed bond portfolio. The non-U.S. rates were generally

100
Table of Contents            

based on published rates for high-quality corporate bonds. The range of assumptions that were used for the non-U.S. defined benefit plans reflects the different economic environments within various countries.

Assumptions used to calculate the net periodic cost in each year were as follows:

 
For years ended October 31,
 
2019
 
2018
 
2017
U.S. defined benefit plans:
 
 
 
 
 
Discount rate
4.50%
 
3.75%
 
3.75%
Expected long-term return on assets
7.00%
 
7.00%
 
7.25%
Non-U.S. defined benefit plans:
 
 
 
 
 
Discount rate
0.83-2.68%
 
0.67-2.52%
 
0.22-2.66%
Average increase in compensation levels
2.25-3.25%
 
2.00-3.25%
 
2.00-4.25%
Expected long-term return on assets
4.00-5.75%
 
4.00-6.00%
 
4.00-6.25%
U.S. post-retirement benefits plans:
 
 
 
 
 
Discount rate
4.25%
 
3.50%
 
3.50%
Expected long-term return on assets
7.00%
 
7.00%
 
7.25%
Current medical cost trend rate
6.00%
 
6.00%
 
6.00%
Ultimate medical cost trend rate
3.50%
 
3.50%
 
3.50%
Medical cost trend rate decreases to ultimate rate in year
2029
 
2029
 
2029

Assumptions used to calculate the benefit obligation were as follows:

 
As of the Years Ending October 31,
 
2019
 
2018
U.S. defined benefit plans:
 
 
 
Discount rate
3.25%
 
4.50%
Non-U.S. defined benefit plans:
 
 
 
Discount rate
0.22-1.81%
 
0.83-2.68%
Average increase in compensation levels
2.25-3.00%
 
2.25-3.25%
U.S. post-retirement benefits plans:
 
 
 
Discount rate
3.00%
 
4.25%
Current medical cost trend rate
6.25%
 
6.00%
Ultimate medical cost trend rate
4.50%
 
3.50%
Medical cost trend rate decreases to ultimate rate in year
2029
 
2029


Health care trend rates do not have a significant effect on the total service and interest cost components or on the post-retirement benefit obligation amounts reported for the U.S. Post-Retirement Benefit Plan for the year ended October 31, 2019.

15.   GUARANTEES

Standard Warranty

We accrue for standard warranty costs based on historical trends in warranty charges as a percentage of net product shipments. The accrual is reviewed regularly and periodically adjusted to reflect changes in warranty cost estimates. Estimated warranty charges are recorded within cost of products at the time products are sold. The standard warranty accrual balances are held in other accrued and other long-term liabilities on our consolidated balance sheet. Our standard warranty terms typically extend to one years from the date of delivery, depending on the product.

101
Table of Contents            


A summary of the standard warranty accrual activity is shown in the table below. The standard warranty accrual balances are recorded in other accrued liabilities.

 
October 31,
 
2019
 
2018
 
(in millions)
Balance as of October 31, 2018 and 2017
$
35

 
$
34

Accruals for warranties including change in estimates
54

 
53

Settlements made during the period
(57
)
 
(52
)
Balance as of October 31, 2019 and 2018
$
32

 
$
35


Accruals for warranties due within one year
32

 
35



Bank Guarantees

Guarantees consist primarily of outstanding standby letters of credit and bank guarantees and were approximately $40 million as of October 31, 2019. A standby letter of credit is a guarantee of payment issued by a bank on behalf of us that is used as payment of last resort should we fail to fulfill a contractual commitment with a third party. A bank guarantee is a promise from a bank or other lending institution that if we default on a loan, the bank will cover the loss.

Indemnifications in Connection with Transactions

In connection with various divestitures, acquisitions, spin-offs and other transactions, we have agreed to indemnify certain parties, their affiliates and/or other related parties against certain damages and expenses that might occur in the future. These indemnifications may cover a variety of liabilities, including, but not limited to, employee, tax, environmental, intellectual property, litigation and other liabilities related to the business conducted prior to the date of the transaction. In our opinion, the fair value of these indemnification obligations was not material as of October 31, 2019.

Indemnifications to Officers and Directors

Our corporate bylaws require that we indemnify our officers and directors, as well as those who act as directors and officers of other entities at our request, against expenses, judgments, fines, settlements and other amounts actually and reasonably incurred in connection with any proceedings arising out of their services to Agilent and such other entities, including service with respect to employee benefit plans. In addition, we have entered into separate indemnification agreements with each director and each board-appointed officer of Agilent which provide for indemnification of these directors and officers under similar circumstances and under additional circumstances. The indemnification obligations are more fully described in the bylaws and the indemnification agreements. We purchase standard insurance to cover claims or a portion of the claims made against our directors and officers. Since a maximum obligation is not explicitly stated in our bylaws or in our indemnification agreements and will depend on the facts and circumstances that arise out of any future claims, the overall maximum amount of the obligations cannot be reasonably estimated. Historically, we have not made payments related to these obligations, and the fair value for these indemnification obligations was not material as of October 31, 2019.

Other Indemnifications

As is customary in our industry and as provided for in local law in the U.S. and other jurisdictions, many of our standard contracts provide remedies to our customers and others with whom we enter into contracts, such as defense, settlement, or payment of judgment for intellectual property claims related to the use of our products. From time to time, we indemnify customers, as well as our suppliers, contractors, lessors, lessees, companies that purchase our businesses or assets and others with whom we enter into contracts, against combinations of loss, expense, or liability arising from various triggering events related to the sale and the use of our products and services, the use of their goods and services, the use of facilities and state of our owned facilities, the state of the assets and businesses that we sell and other matters covered by such contracts, usually up to a specified maximum amount. In addition, from time to time we also provide protection to these parties against claims related to undiscovered liabilities, additional product liability or environmental obligations. In our experience, claims made under such indemnifications are rare and the associated estimated fair value of the liability was not material as of October 31, 2019.


102
Table of Contents            

In connection with the sale of several of our businesses, we have agreed to indemnify the buyers of such business, their respective affiliates and other related parties against certain damages that they might incur in the future. The continuing indemnifications primarily cover damages relating to liabilities of the businesses that Agilent retained and did not transfer to the buyers, as well as other specified items. In our opinion, the fair value of these indemnification obligations was not material as of October 31, 2019.

16.   COMMITMENTS AND CONTINGENCIES

Operating Lease Commitments:    We lease certain real and personal property from unrelated third parties under non-cancelable operating leases. Certain leases require us to pay property taxes, insurance and routine maintenance, and include escalation clauses. Total rent expense was $75 million in 2019, $64 million in 2018 and $57 million in 2017.

Future non-cancelable minimum lease payments and future minimum lease income under operating leases at October 31, 2019:
 
 
Future Minimum
Lease Payments
 
Future Minimum
Lease Income
 
 
(in millions)
2020
 
$
52

 
$
8

2021
 
$
41

 
$
6

2022
 
$
29

 
$
5

2023
 
$
21

 
$
—

2024
 
$
14

 
$
—

Thereafter
 
$
56

 
$
—



Other Purchase Commitments.   Typically, we can cancel contracts with professional services suppliers without penalties. For those contracts that are not cancelable without penalties, the termination fees and costs or commitments for continued spending that we are obligated to pay to a supplier under each contact's termination period before such contract can be cancelled were approximately $77 million. Approximately $25 million of the penalties for the new contracts will reduce over the next 14 years.

Contingencies: We are involved in lawsuits, claims, investigations and proceedings, including, but not limited to, intellectual property, commercial, real estate, environmental and employment matters, which arise in the ordinary course of business. There are no matters pending that we currently believe are reasonably possible of having a material impact to our business, consolidated financial condition, results of operations or cash flows.


103
Table of Contents            

17.   SHORT-TERM DEBT

Credit Facilities

On March 13, 2019, Agilent entered into a credit agreement with a group of financial institutions which provides for a $1 billion five-year unsecured credit facility that will expire on March 13, 2024. The credit facility replaces the existing credit facility which terminated on the closing date of the new facility. For the year ended October 31, 2019, we borrowed $305 million and repaid $190 million under the credit facility. As of October 31, 2019, the company had borrowings of $115 million outstanding under the credit facility. We were in compliance with the covenants for the credit facility during the year ended October 31, 2019. On August 7, 2019, we entered into an amendment to the credit agreement, which provides for a $500 million short-term loan facility that was used in full to complete the BioTek acquisition and which is outstanding at October 31, 2019. On October 21, 2019, we entered into a second amendment to the credit agreement, which refreshed the amount available for additional incremental term loan facilities under the credit agreement to permit additional incremental facilities of up to $500 million. We had no borrowings under the additional incremental facilities as of October 31, 2019.

Capital Leases

The company leases certain property and equipment under capital leases. As of October 31, 2019, the current portion of the company’s capital lease obligations had an aggregate carrying value of $1 million.

2020 Senior Notes

On July 13, 2010, the company issued an aggregate principal amount of $500 million in senior notes ("2020 senior notes"). The 2020 senior notes were issued at 99.54% of their principal amount. The notes were scheduled to mature on July 15, 2020, and bear interest at a fixed rate of 5.00% per annum.

On August 9, 2011, we terminated our interest rate swap contracts related to our 2020 senior notes that represented the notional amount of $500 million. The asset value, including interest receivable, upon termination for these contracts was approximately $34 million. The gain was deferred and amortized to interest expense over the remaining life of the 2020 senior notes.

On September 17, 2019, we repaid the $500 million outstanding aggregate principal amount of our 2020 senior notes due July 15, 2020 that were called for redemption on August 16, 2019. The redemption price of approximately $512 million included a $12 million prepayment penalty. The redemption price was computed in accordance with the terms of the 2020 senior notes as the present value of the remaining scheduled payments of principal and unpaid interest related to the redemption.  The prepayment penalty plus amortization of the previously deferred interest swap gain of $4 million and amortization of previously deferred debt issuance costs and discount of $1 million was recorded in other income (expense), net in the consolidated statement of operations. We also paid accrued and unpaid interest of $4 million on the 2020 senior notes up to but not including the redemption date.

2017 Senior Notes

On October 24, 2007, the company issued an aggregate principal amount of $600 million in senior notes ("2017 senior notes"). On October 20, 2014, we settled the redemption of $500 million of the $600 million outstanding aggregate principal amount of our 2017 senior notes. The 2017 senior notes were repayable within one year as of October 31, 2017 and were reclassified to short-term debt. The remaining $100 million in 2017 senior notes matured and were paid in full on November 1, 2017.
 

104
Table of Contents            

18.   LONG-TERM DEBT

Senior Notes

The following table summarizes the company's long-term senior notes and the related interest rate swaps:

 
October 31, 2019
 
October 31, 2018
 
Amortized
Principal
 
Swap
 
Total
 
Amortized
Principal
 
Swap
 
Total
 
(in millions)
2020 Senior Notes
$
—

 
$
—

 
$
—

 
$
499

 
$
7

 
$
506

2022 Senior Notes
399

 
—

 
399

 
399

 
—

 
399

2023 Senior Notes
597

 
—

 
597

 
597

 
—

 
597

2026 Senior Notes
298

 
—

 
298

 
297

 
—

 
297

2029 Senior Notes
492

 
—

 
492

 
—

 
—

 
—

Total
$
1,786

 
$
—

 
$
1,786

 
$
1,792

 
$
7

 
$
1,799




2020 Senior Notes

The 2020 senior notes were repaid in 2019, see Note 17, "Short-Term Debt".

2022 Senior Notes

On September 10, 2012, the company issued an aggregate principal amount of $400 million in senior notes ("2022 senior notes"). The 2022 senior notes were issued at 99.80% of their principal amount. The notes will mature on October 1, 2022, and bear interest at a fixed rate of 3.20% per annum. The interest is payable semi-annually on April 1st and October 1st of each year and payments commenced on April 1, 2013.

In July 2012, Agilent executed treasury lock agreements for $400 million in connection with future interest payments to be made on our 2022 senior notes issued on September 10, 2012. The treasury lock contracts were terminated on September 10, 2012 and we recognized a deferred gain in accumulated other comprehensive income which is being amortized to interest expense over the life of the 2022 senior notes. The remaining gain to be amortized related to the treasury lock agreements at October 31, 2019 was $1 million.

2023 Senior Notes

On June 18, 2013, the company issued aggregate principal amount of $600 million in senior notes ("2023 senior notes"). The 2023 senior notes were issued at 99.544% of their principal amount. The notes will mature on July 15, 2023 and bear interest at a fixed rate of 3.875% per annum. The interest is payable semi-annually on January 15th and July 15th of each year and payments commenced January 15, 2014.

2026 Senior Notes

On September 15, 2016, the company issued aggregate principal amount of $300 million in senior notes ("2026 senior notes"). The 2026 senior notes were issued at 99.624% of their principal amount. The notes will mature on September 22, 2026 and bear interest at a fixed rate of 3.05% per annum. The interest is payable semi-annually on March 22nd and September 22nd of each year and payments commenced March 22, 2017.

In February 2016, Agilent executed three forward-starting pay fixed/receive variable interest rate swaps for the notional amount of $300 million in connection with future interest payments to be made on our 2026 senior notes issued on September 15, 2016. The swap arrangements were terminated on September 15, 2016 with a payment of $10 million and we recognized this as a deferred loss in accumulated other comprehensive income which is being amortized to interest expense over the life of the 2026 senior notes.The remaining loss to be amortized related to the interest rate swap agreements at October 31, 2019 was $7 million.


105
Table of Contents            

2029 Senior Notes

On September 5, 2019, the company issued an aggregate principal amount of $500 million in senior notes ("2029 senior notes"). The 2029 senior notes were issued at 99.316% of their principal amount. The notes will mature on September 15, 2029, and bear interest at a fixed rate of 2.75% per annum. The interest is payable semi-annually on March 15th and September 15th of each year and payments commence on March 15, 2020.

In August 2019, Agilent executed treasury lock agreements for $250 million in connection with future interest payments to be made on our 2029 senior notes issued on September 5, 2019. We designated the treasury lock as a cash flow hedge. The treasury lock contracts were terminated on September 6, 2019 and we recognized a deferred loss of $6 million in accumulated other comprehensive income which is being amortized to interest expense over the life of the 2029 senior notes. The remaining loss to be amortized related to the treasury lock agreements at October 31, 2019 was $6 million.

Capital Leases

The company leases certain property and equipment under capital leases. As of October 31, 2019, the non-current portion of the company’s capital lease obligations had an aggregate carrying value of $5 million to be paid over 12 years.

19.   STOCKHOLDERS' EQUITY

Stock Repurchase Program

On May 28, 2015 we announced that our board of directors had approved a share repurchase program (the "2015 repurchase program"). The 2015 share repurchase program authorizes the purchase of up to $1.14 billion of our common stock at the company's discretion through and including November 1, 2018. The 2015 repurchase program did not require the company to acquire a specific number of shares and could have been suspended or discontinued at any time. During the year ended October 31, 2017, we repurchased and retired approximately 4.1 million shares for $194 million under this authorization. During the year ended October 31, 2018, we repurchased and retired approximately 6.4 million shares for $422 million under this authorization. As of October 31, 2018, we had remaining authorization to repurchase up to $188 million of our common stock under this program which expired on November 1, 2018.

On November 19, 2018 we announced that our board of directors had approved a new share repurchase program (the "2019 repurchase program") designed, among other things, to reduce or eliminate dilution resulting from issuance of stock under the company's employee equity incentive programs. The 2019 share repurchase program authorizes the purchase of up to $1.75 billion of our common stock at the company's discretion and has no fixed termination date. The 2019 repurchase program does not require the company to acquire a specific number of shares and may be suspended, amended or discontinued at any time. During the year ended October 31, 2019, we repurchased and retired approximately 10.4 million shares for $723 million under this authorization. As of October 31, 2019, we had remaining authorization to repurchase up to $1.03 billion of our common stock under this program.


Cash Dividends on Shares of Common Stock

During the year ended October 31, 2019, cash dividends of 0.656 per share, or $206 million were declared and paid on the company's outstanding common stock. During the year ended October 31, 2018, cash dividends of 0.596 per share, or $191 million were declared and paid on the company's outstanding common stock. During the year ended October 31, 2017, cash dividends of 0.528 per share, or $170 million were declared and paid on the company's outstanding common stock.

On November 20, 2019 we declared a quarterly dividend of $0.18 per share of common stock, or approximately $56 million which will be paid on January 22, 2020 to shareholders of record as of the close of business on December 31, 2019. The timing and amounts of any future dividends are subject to determination and approval by our board of directors.


106
Table of Contents            

Accumulated Other Comprehensive Income (Loss)

The following table summarizes the components of our accumulated other comprehensive income (loss) as of October 31, 2019 and 2018, net of tax effect:

 
October 31,
 
2019
 
2018
 
(in millions)
Foreign currency translation, net of tax expense of $(5) and $(15) for 2019 and 2018, respectively
$
(204
)
 
(214
)
Unrealized losses (including prior service benefit) on defined benefit plans, net of tax benefit of $153 and $132 for 2019 and 2018, respectively
(306
)
 
(201
)
Unrealized gains (losses) on derivative instruments, net of tax benefit of $3 and $0 for 2019 and 2018, respectively
(4
)
 
7

Total accumulated other comprehensive loss
$
(514
)
 
$
(408
)

Changes in accumulated other comprehensive income (loss) by component and related tax effects for the years ended October 31, 2019 and 2018 were as follows (in millions):

 
 
 
 
Net defined benefit pension cost and post retirement plan costs
 
 
 
 
 
 
Foreign currency translation
 
Prior service credits
 
Actuarial Losses
 
Unrealized gains (losses) on derivatives
 
Total
 
 
(in millions)
As of October 31, 2017
 
$
(156
)
 
$
140

 
$
(328
)
 
$
(2
)
 
$
(346
)
 
 
 
 
 
 
 
 
 
 
 
Other comprehensive income (loss) before reclassifications
 
(51
)
 
—

 
(49
)
 
7

 
(93
)
 
 
 
 
 
 
 
 
 
 
 
Amounts reclassified out of accumulated other comprehensive income (loss)
 
—

 
(8
)
 
39

 
4

 
35

 
 
 
 
 
 
 
 
 
 
 
Tax (expense) benefit
 
(7
)
 
2

 
3

 
(2
)
 
(4
)
 
 
 
 
 
 
 
 
 
 
 
Other comprehensive income (loss)
 
(58
)
 
(6
)
 
(7
)
 
9

 
(62
)
 
 
 
 
 
 
 
 
 
 
 
As of October 31, 2018
 
$
(214
)
 
$
134

 
$
(335
)
 
$
7

 
$
(408
)
 
 
 
 
 
 
 
 
 
 
 
Impact of adoption of new guidance on tax effects in accumulated other comprehensive income (loss)
 
—

 
3

 
(9
)
 
(1
)
 
(7
)
 
 
 
 
 
 
 
 
 
 
 
As of November 1, 2018
 
(214
)
 
137

 
(344
)
 
6

 
(415
)
 
 
 
 
 
 
 
 
 
 
 
Other comprehensive loss before reclassifications
 
—

 
—

 
(157
)
 
(6
)
 
(163
)
 
 
 
 
 
 
 
 
 
 
 
Amounts reclassified out of accumulated other comprehensive income
 
—

 
(8
)
 
39

 
(8
)
 
23

 
 
 
 
 
 
 
 
 
 
 
Tax benefit
 
10

 
2

 
25

 
4

 
41

 
 
 
 
 
 
 
 
 
 
 
Other comprehensive income (loss)
 
10

 
(6
)
 
(93
)
 
(10
)
 
(99
)
 
 
 
 
 
 
 
 
 
 
 
As of October 31, 2019
 
$
(204
)
 
$
131

 
$
(437
)
 
$
(4
)
 
$
(514
)
 
 
 
 
 
 
 
 
 
 
 

107
Table of Contents            


Reclassifications out of accumulated other comprehensive income (loss) for the years ended October 31, 2019 and 2018 were as follows (in millions):
Details about Accumulated Other
Comprehensive Income components

Amounts Reclassified
from Other Comprehensive Income

Affected line item in
statement of operations


2019

2018









Unrealized gains and (losses) on derivatives

$
8


$
(4
)

Cost of products and interest expense


8


(4
)

Total before income tax


(2
)

1


(Provision)/benefit for income tax


6


(3
)

Total net of income tax
Net defined benefit pension cost and post retirement plan costs:













Actuarial net loss

(39
)

(39
)

Other (income) expense
Prior service benefit

8


8


Other (income) expense


(31
)

(31
)

Total before income tax


12


10


Benefit for income tax


(19
)

(21
)

Total net of income tax







Total reclassifications for the period

$
(13
)

$
(24
)



Amounts in parentheses indicate reductions to income and increases to other comprehensive income.

Reclassifications of prior service benefit and actuarial net loss in respect of retirement plans and post retirement pension plans are included in the computation of net periodic cost (see Note 14, "Retirement Plans and Post Retirement Pension Plans").

20.   SEGMENT INFORMATION

Description of Segments. We are a global leader in life sciences, diagnostics and applied chemical markets, providing application focused solutions that include instruments, software, services and consumables for the entire laboratory workflow.
Agilent has three business segments comprised of the life sciences and applied markets business, diagnostics and genomics business and the Agilent CrossLab business each of which comprises a reportable segment. The three operating segments were determined based primarily on how the chief operating decision maker views and evaluates our operations. Operating results are regularly reviewed by the chief operating decision maker to make decisions about resources to be allocated to the segment and to assess its performance. Other factors, including market separation and customer specific applications, go-to-market channels, products and services and manufacturing are considered in determining the formation of these operating segments.
In 2019, we adopted new guidance related to the presentation of the net periodic pension and postretirement benefit cost. See Note 2, "New Accounting Pronouncements" for more information. As a result, we have recast our historical segment results to conform to this new presentation required under this guidance.

A description of our three reportable segments is as follows:

Our life sciences and applied markets business provides application-focused solutions that include instruments and software that enable customers to identify, quantify and analyze the physical and biological properties of substances and products, as well as enable customers in the clinical and life sciences research areas to interrogate samples at the molecular and cellular level. Key product categories include: liquid chromatography ("LC") systems and components; liquid chromatography mass spectrometry ("LCMS") systems; gas chromatography ("GC") systems and components; gas chromatography mass spectrometry ("GCMS") systems; inductively coupled plasma mass spectrometry ("ICP-MS") instruments; atomic absorption ("AA") instruments;

108
Table of Contents            

microwave plasma-atomic emission spectrometry ("MP-AES") instruments; inductively coupled plasma optical emission spectrometry ("ICP-OES") instruments; raman spectroscopy; cell analysis plate based assays; flow cytometer; real-time cell analyzer; cell imaging systems; microplate reader; laboratory software for sample tracking; information management and analytics; laboratory automation and robotic systems; dissolution testing; vacuum pumps and measurement technologies.

Our diagnostics and genomics business is comprised of six areas of activity providing active pharmaceutical ingredients ("APIs") for oligo-based therapeutics as well as solutions that include reagents, instruments, software and consumables, which enable customers in the clinical and life sciences research areas to interrogate samples at the cellular and molecular level. First, our genomics business includes arrays for DNA mutation detection, genotyping, gene copy number determination, identification of gene rearrangements, DNA methylation profiling, gene expression profiling, as well as next generation sequencing ("NGS") target enrichment and genetic data management and interpretation support software. This business also includes solutions that enable clinical labs to identify DNA variants associated with genetic disease and help direct cancer therapy. Second, our nucleic acid solutions business provides equipment and expertise focused on production of synthesized oligonucleotides under pharmaceutical good manufacturing practices ("GMP") conditions for use as API in an emerging class of drugs that utilize nucleic acid molecules for disease therapy. Third, our pathology solutions business is focused on product offerings for cancer diagnostics and anatomic pathology workflows. The broad portfolio of offerings includes immunohistochemistry ("IHC"), in situ hybridization ("ISH"), hematoxylin and eosin ("H&E") staining and special staining. Fourth, we also collaborate with a number of major pharmaceutical companies to develop new potential pharmacodiagnostics, also known as companion diagnostics, which may be used to identify patients most likely to benefit from a specific targeted therapy. Fifth, the reagent partnership business is a provider of reagents used for turbidimetry and flow cytometry. Finally, our biomolecular analysis business provides complete workflow solutions, including instruments, consumables and software, for quality control analysis of nucleic acid samples.  Samples are analyzed using quantitative and qualitative techniques to ensure accuracy in further genomics analysis techniques utilized in clinical and life science research applications.

The Agilent CrossLab business spans the entire lab with its extensive consumables and services portfolio, which is designed to improve customer outcomes. Most of the portfolio is vendor neutral, meaning Agilent can serve and supply customers regardless of their instrument purchase choices. Solutions range from chemistries and supplies to services and software helping to connect the entire lab. Key product categories in consumables include GC and LC columns, sample preparation products, custom chemistries, and a large selection of laboratory instrument supplies. Services include startup, operational, training and compliance support, software as a service, as well as asset management and consultative services that help increase customer productivity. Custom service and consumable bundles are tailored to meet the specific application needs of various industries and to keep instruments fully operational and compliant with the respective industry requirements.

A significant portion of the segments' expenses arise from shared services and infrastructure that we have historically provided to the segments in order to realize economies of scale and to efficiently use resources. These expenses, collectively called corporate charges, include legal, accounting, tax, real estate, insurance services, information technology services, treasury, order administration, other corporate infrastructure expenses and costs of centralized research and development. Charges are allocated to the segments, and the allocations have been determined on a basis that we consider to be a reasonable reflection of the utilization of services provided to or benefits received by the segments. In addition, we do not allocate amortization and impairment of acquisition-related intangible assets, pension curtailment or settlement gains, restructuring and transformational initiatives expenses, acquisition and integration costs, business exit and divestiture costs, special compliance costs, some nucleic acid solutions division ("NASD") site costs and certain other charges to the operating margin for each segment because management does not include this information in its measurement of the performance of the operating segments.Transformational initiatives include expenses associated with targeted cost reduction activities such as manufacturing transfers, site consolidations, legal entity and other business reorganizations, in-sourcing or outsourcing of activities.

The following tables reflect the results of our reportable segments under our management reporting system. The performance of each segment is measured based on several metrics, including segment income from operations. These results are used, in part, by the chief operating decision maker in evaluating the performance of, and in allocating resources to, each of the segments.


109
Table of Contents            

The profitability of each of the segments is measured after excluding restructuring and asset impairment charges, transformational initiatives, investment gains and losses, interest income, interest expense, acquisition and integration costs, non-cash amortization and other items as noted in the reconciliations below.
 
Life Sciences and Applied Markets
 
Diagnostics and Genomics
 
Agilent CrossLab
 
Total
Segments
 
(in millions)
Year Ended October 31, 2019:
 
 
 
 
 
 
 
Total net revenue
$
2,302

 
$
1,021

 
$
1,840

 
$
5,163

Income from operations
$
542

 
$
185

 
$
475

 
$
1,202

Depreciation expense
$
41

 
$
35

 
$
35

 
$
111

Share-based compensation expense
$
33

 
$
14

 
$
25

 
$
72

Year Ended October 31, 2018:
 
 
 
 
 
 
 
Total net revenue
$
2,270

 
$
943

 
$
1,701

 
$
4,914

Income from operations
$
543

 
$
173

 
$
388

 
$
1,104

Depreciation expense
$
38

 
$
33

 
$
31

 
$
102

Share-based compensation expense
$
33

 
$
14

 
$
24

 
$
71

Year Ended October 31, 2017:
 
 
 
 
 
 
 
Total net revenue
$
2,081

 
$
860

 
$
1,531

 
$
4,472

Income from operations
$
470

 
$
167

 
$
336

 
$
973

Depreciation expense
$
35

 
$
30

 
$
29

 
$
94

Share-based compensation expense
$
30

 
$
10

 
$
21

 
$
61




The following table reconciles reportable segments' income from operations to Agilent's total enterprise income before taxes:

 
Years Ended October 31,
 
2019
 
2018
 
2017
 
(in millions)
Total reportable segments' income from operations
$
1,202

 
$
1,104

 
$
973

Amortization of intangible assets related to business combinations
(125
)
 
(105
)
 
(117
)
Acquisition and integration costs
(48
)
 
(23
)
 
(30
)
Transformational initiatives
(44
)
 
(25
)
 
(12
)
Asset impairments
—

 
(21
)
 
—

Business exit and divestiture costs (primarily our NMR business)
—

 
(9
)
 
—

NASD site costs
(12
)
 
(8
)
 
—

Special compliance costs
(2
)
 
(4
)
 
—

Other (1) 
(30
)
 
(5
)
 
(7
)
Interest Income
36

 
38

 
22

Interest Expense
(74
)
 
(75
)
 
(79
)
Other income (expense), net
16

 
79

 
53

Income before taxes, as reported
$
919

 
$
946

 
$
803



(1) The other category primarily includes legal costs related to our pursuing our claim against a third party in addition to other miscellaneous adjustments and settlements.
 
Major Customers.    No customer represented 10 percent or more of our total net revenue in 2019, 2018 or 2017.


110
Table of Contents            

The following table reflects segment assets and capital expenditures under our management reporting system. Segment assets include allocations of corporate assets, goodwill, net other intangibles and other assets. Unallocated assets primarily consist of cash, cash equivalents, the valuation allowance relating to deferred tax assets and other assets.
 
Life Sciences and Applied Markets
 
Diagnostics and Genomics
 
Agilent CrossLab
 
Total
Segments
 
(in millions)
As of and for the Year Ended October 31, 2019:
 
 
 
 
 
 
 
Assets
$
3,202

 
$
2,620

 
$
1,331

 
$
7,153

Capital expenditures
$
59

 
$
48

 
$
48

 
$
155

As of and for the Year Ended October 31, 2018:
 
 
 
 
 
 
 
Assets
$
1,744

 
$
2,679

 
$
1,267

 
$
5,690

Capital expenditures
$
47

 
$
92

 
$
38

 
$
177


The following table reconciles segment assets to Agilent's total assets:

 
October 31,
 
2019
 
2018
 
(in millions)
Total reportable segments' assets
$
7,153

 
$
5,690

Cash, cash equivalents
1,382

 
2,247

Prepaid expenses
94

 
80

Investments
102

 
68

Long-term and other receivables
100

 
102

Other
621

 
354

Total assets
$
9,452

 
$
8,541



The other category primarily includes deferred tax assets and overfunded pension assets which are not allocated to the segments.

The following table presents summarized information for net revenue by geographic region. Revenues from external customers are generally attributed to countries based upon the customer's location.

 
United
States
 
China(1)
 
Rest of the
World
 
Total
 
(in millions)
Net revenue:
 
 
 
 
 
 
 
Year Ended October 31, 2019
$
1,619

 
$
1,019

 
$
2,525

 
$
5,163

Year Ended October 31, 2018
$
1,414

 
$
1,015

 
$
2,485

 
$
4,914

Year Ended October 31, 2017
$
1,314

 
$
900

 
$
2,258

 
$
4,472

1.
China also includes Hong Kong net revenue.



The following table presents summarized information for long-lived assets by geographic region. Long lived assets consist of property, plant, and equipment, long-term receivables and other long-term assets excluding intangible assets. The rest of the world primarily consists of Asia and the rest of Europe.

 
United
States
 
Germany
 
Rest of the
World
 
Total
 
(in millions)
Long-lived assets:
 
 
 
 
 
 
 
October 31, 2019
$
621

 
$
122

 
$
404

 
$
1,147

October 31, 2018
$
565

 
$
117

 
$
362

 
$
1,044



111
Table of Contents            



112
Table of Contents            

QUARTERLY SUMMARY
(Unaudited)

 
Three Months Ended
 
January 31,
 
April 30,
 
July 31,
 
October 31,
 
(in millions, except per share data)
2019
 
 
 
 
 
 

Net revenue
$
1,284

 
$
1,238

 
$
1,274

 
$
1,367

Gross profit
707

 
669

 
692

 
737

Income from operations
250

 
216

 
225

 
250

Net income
504

 
182

 
191

 
194

 
 
 
 
 
 
 
 
Net income per share — Basic
$
1.58

 
$
0.57

 
$
0.61

 
$
0.63

Net income per share — Diluted
$
1.57

 
$
0.57

 
$
0.60

 
$
0.62

 
 
 
 
 
 
 
 
Weighted average shares used in computing net income per share:
 
 
 
 
 
 
 
Basic
318

 
317

 
312

 
309

Diluted
322

 
321

 
316

 
313

 
 
 
 
 
 
 
 
Cash dividends per common share
$
0.164

 
$
0.164

 
$
0.164

 
$
0.164

 
 
 
 
 
 
 
 
2018
 
 
 
 
 
 
 
Net revenue
$
1,211

 
$
1,206

 
$
1,203

 
$
1,294

Gross profit (1)
670

 
643

 
659

 
708

Income from operations (1)
229

 
210

 
221

 
244

Net income (loss)

(320
)
 
205

 
236

 
195

 
 
 
 
 
 
 
 
Net income (loss) per share — Basic
$
(0.99
)
 
$
0.64

 
$
0.74

 
$
0.61

Net income (loss) per share — Diluted
$
(0.99
)
 
$
0.63

 
$
0.73

 
$
0.61

 
 
 
 
 
 
 
 
Weighted average shares used in computing net income per share:
 
 
 
 
 
 
 
Basic
323

 
322

 
320

 
319

Diluted
323

 
326

 
324

 
322

 
 
 
 
 
 
 
 
Cash dividends per common share
$
0.149

 
$
0.149

 
$
0.149

 
$
0.149


 
(1) In 2019, we adopted new guidance related to the presentation of the net periodic pension and postretirement benefit cost. See Note 2, "New Accounting Pronouncements" for more information. As a result, we have recast our 2018 quarterly gross profit and income from operations to reflect this new guidance.

113
Table of Contents            

Item 9.    Changes in and Disagreements with Accountants on Accounting and Financial Disclosure

None.

Item 9A.    Controls and Procedures

Evaluation of Disclosure Controls and Procedures

Our management has evaluated, under the supervision and with the participation of our Chief Executive Officer and Chief Financial Officer, the effectiveness of our disclosure controls and procedures as of October 31, 2019, pursuant to and as required by Rule 13a-15(b) under the Securities Exchange Act of 1934 (“Exchange Act”). Based on that evaluation, our Chief Executive Officer and Chief Financial Officer have concluded that, as of October 31, 2019, the company's disclosure controls and procedures, as defined by Rule 13a-15(e) under the Exchange Act, were effective and designed to ensure that (i) information required to be disclosed in the company's reports filed under the Exchange Act is recorded, processed, summarized and reported within the time periods specified in the SEC's rules and forms, and (ii) information is accumulated and communicated to management, including the Chief Executive Officer and Chief Financial Officer, as appropriate to allow timely decisions regarding required disclosures.

Management's Report on Internal Control Over Financial Reporting
Our management is responsible for establishing and maintaining adequate internal control over financial reporting, as such term is defined in Exchange Act Rule 13a-15(f). Under the supervision and with the participation of our management, including our Chief Executive Officer and Chief Financial Officer, we assessed the effectiveness of our internal control over financial reporting based on the framework in Internal Control - Integrated Framework (2013) issued by the Committee of Sponsoring Organizations of the Treadway Commission ("COSO"). As a result of that assessment, management concluded that our internal control over financial reporting was effective as of October 31, 2019 based on criteria in Internal Control - Integrated Framework (2013) issued by the COSO.

SEC staff guidance discusses the exclusion of an acquired business’s internal controls from management’s annual assessment of the internal controls over financial reporting when it is not possible to conduct assessments for the acquired business in the period between the acquisition date and the date of management’s assessment. The company completed the acquisitions of Lionheart Technologies LLC ("BioTek") on August 23, 2019 and ACEA Biosciences ("ACEA") on November 14, 2018. Management excluded both BioTek and ACEA from its assessment of the effectiveness of the company’s internal control over financial reporting as of October 31, 2019.  BioTek and ACEA combined constituted approximately 2 percent of total assets and less than 2 percent of total revenue as of and for the year ended October 31, 2019.

The effectiveness of our internal control over financial reporting as of October 31, 2019 has been audited by PricewaterhouseCoopers LLP, an independent registered public accounting firm, as stated in their report which appears in Item 8 of this Annual Report on Form 10-K.

Changes in Internal Control Over Financial Reporting

There were no changes in our internal control over financial reporting that occurred during Agilent's last fiscal quarter that have materially affected, or are reasonably likely to materially affect, our internal control over financial reporting.

Item 9B.    Other Information

None.

PART III


Item 10. Directors, Executive Officers and Corporate Governance
Information regarding our directors appears under “Proposal No. 1 - Election of Directors” in our Proxy Statement for the Annual Meeting of Stockholders (“Proxy Statement”), to be held March 18, 2020. That portion of the Proxy Statement is incorporated by reference into this report. Information regarding our executive officers appears in Item 1 of this report under “Executive Officers of the Registrant.” Information regarding our Audit and Finance Committee and our Audit and Finance

114
Table of Contents            

Committee's financial expert appears under “Audit and Finance Committee Report” and “Corporate Governance” in our Proxy Statement. That portion of the Proxy Statement is incorporated by reference into this report.
Other than an amendment and restatement of our bylaws to implement “proxy access” starting in our 2021 annual meeting, which was previously disclosed in our Current Report on Form 8-K filed on September 18, 2019, there were no material changes to the procedures by which security holders may recommend nominees to our Board of Directors. Information regarding our code of ethics (the company's Standards of Business Conduct) applicable to our principal executive officer, our principal financial officer, our controller and other senior financial officers appears in Item 1 of this report under “Investor Information.” We will post amendments to or waivers from a provision of the Standards of Business Conduct with respect to those persons on our website at www.investor.agilent.com.

Compliance with Section 16(a) of the Exchange Act
Information about compliance with Section 16(a) of the Exchange Act appears under “Section 16(a) Beneficial Ownership Reporting Compliance” in the Proxy Statement. That portion of the Proxy Statement is incorporated by reference into this report.

Item 11.    Executive Compensation

Information about compensation of our named executive officers appears under “Executive Compensation” in the Proxy Statement. Information about compensation of our directors appears under “Compensation of Non-Employee Directors” and “Compensation Committee Report” in the Proxy Statement. Those portions of the Proxy Statement are incorporated by reference into this report.

Item 12.    Security Ownership of Certain Beneficial Owners and Management and Related Stockholder Matters

Information about security ownership of certain beneficial owners and management appears under "Beneficial Ownership" in the Proxy Statement. That portion of the Proxy Statement is incorporated by reference into this report.

EQUITY COMPENSATION PLAN INFORMATION

The following table summarizes information about our equity compensation plans as of October 31, 2019. All outstanding awards relate to our common stock.

Plan Category
Number of Securities
to be Issued upon
Exercise of
Outstanding Options,
Warrants and Rights
 
Weighted-average
Exercise Price of
Outstanding
Options,
Warrants and
Rights
 
Number of Securities
Remaining Available for
Future Issuance under
Equity Compensation Plans
(Excluding Securities
Reflected in Column
(a))
 
(a)
 
(b)
 
(c)
Equity compensation plans approved by security holders (1)(2)(3)
4,617,581

 
$
36

 
54,732,097

Equity compensation plans not approved by security holders
—

 
—

 
—

Total
4,617,581

 
$
36

 
54,732,097


(1)
The number of securities remaining available for future issuance in column (c) includes 26,055,571 shares of common stock authorized and available for issuance under our current Employee Stock Purchase Plan ("ESPP"). The number of shares authorized for issuance under the ESPP is subject to an automatic annual increase of the lesser of one percent of the outstanding common stock of Agilent or an amount determined by the Compensation Committee of our Board of Directors. Under the terms of the ESPP, in no event shall the aggregate number of shares issued under the ESPP exceed 75 million shares.

(2)
We issue securities under our equity compensation plans in forms other than options, warrants or rights. On November 15, 2017 and March 21, 2018, the Board and the stockholders, respectively, approved the Agilent Technologies, Inc. 2018 Stock Plan (the “2018 Plan”), which was an amendment and restatement of the company’s 2009 Stock Plan, approved by the Board and the stockholders, respectively, on November 19, 2008 and March 11, 2009. The 2018 Plan provides for awards of stock-based incentive compensation to our employees (including officers), directors and consultants. The 2018 Plan provides for the grant of awards in the form of stock options, stock appreciation rights, restricted stock, restricted stock

115

units, performance shares and performance units with performance-based conditions to vesting or exercisability, and cash awards. The 2018 Plan has a term of ten years.

(3)
We issue securities under our equity compensation plans in forms which do not require a payment by the recipient to us at the time of exercise or vesting, including restricted stock, restricted stock units and performance units. Accordingly, the weighted-average exercise price in column (b) does not take these awards into account.

Item 13.    Certain Relationships and Related Transactions, and Director Independence

Information about certain relationships and related transactions appears under "Related Person Transactions Policy and Procedures" in the Proxy Statement. Information about director independence appears under the heading "Corporate Governance — Director Independence" in the Proxy Statement. Each of those portions of the Proxy Statement is incorporated by reference into this report.

Item 14.    Principal Accounting Fees and Services

Information about principal accountant fees and services as well as related pre-approval policies appears under "Fees Paid to PricewaterhouseCoopers LLP" and "Policy on Preapproval of Audit and Permissible Non-Audit Services of Independent Registered Public Accounting Firm" in the Proxy Statement. Those portions of the Proxy Statement are incorporated by reference into this report.

PART IV


116
Table of Contents            

Item 15.    Exhibits, Financial Statement Schedules

(a)
The following documents are filed as part of this report:
1.
Financial Statements.
See Index to Consolidated Financial Statements under Item 8 on Page 52 of this report.
2.
Financial Statement Schedule.
The following additional financial statement schedule should be considered in conjunction with our consolidated financial statements. All other schedules have been omitted because the required information is either not applicable or not sufficiently material to require submission of the schedule:

SCHEDULE II

SCHEDULE II
VALUATION AND QUALIFYING ACCOUNTS

Column A
 
Column B
 
Column C
 
Column D
 
Column E
Description
 
Balance at
Beginning
of Period
 
Additions Charged to
Expenses or
Other Accounts*
 
Deductions Credited to Expenses or Other Accounts**
 
Balance at
End of
Period
 
 
(in millions)
2019
 
 
 
 
 
 
 
 
Tax valuation allowance
 
$
135

 
$
9

 
$
(10
)
 
$
134

2018
 
 
 
 
 
 
 
 
Tax valuation allowance
 
$
138

 
$
4

 
$
(7
)
 
$
135

2017
 
 
 
 
 
 
 
 
Tax valuation allowance
 
$
129

 
$
14

 
$
(5
)
 
$
138


* Additions include current year additions charged to expenses and current year build due to increases in net deferred tax assets, return to provision true-ups, other adjustments and other comprehensive income impact to deferred taxes.

** Deductions include current year releases credited to expenses and current year reductions due to decreases in net deferred tax assets, return to provision true-ups, other adjustments and other comprehensive income impact to deferred taxes.


117
Table of Contents            

3.
Exhibits.
Exhibits are incorporated herein by reference or are filed with this report as indicated below (numbered in accordance with Item 601 of Regulation S-K):
 
 
 
 
Incorporation by Reference
Exhibit
Number
 
Description
 
Form
 
Date
 
Exhibit
Number
 
Filed
Herewith
 
 
 
 
 
 
 
 
 
 
 
 
2.1

 
 
 
8-K
 
8/5/2014
 
2.1
 
 
 
 
 
 
 
 
 
 
 
 
 
 
3.1

 
 
 
S-1
 
8/16/1999
 
3.1
 
 
 
 
 
 
 
 
 
 
 
 
 
 
3.2

 
 
 
 
 
 
 
 
 
X
 
 
 
 
 
 
 
 
 
 
 
 
4.1

 
 
 
8-K
 
11/27/2001
 
99.3
 
 
 
 
 
 
 
 
 
 
 
 
 
 
4.2

 
 
 
S-3ASR
 
10/24/2007
 
4.01
 
 
 
 
 
 
 
 
 
 
 
 
 
 
4.3

 
 
 
8-K
 
9/13/2012
 
4.01
 
 
 
 
 
 
 
 
 
 
 
 
 
 
4.4

 
 
 
8-K
 
6/21/2013
 
4.01
 
 
 
 
 
 
 
 
 
 
 
 
 
 
4.5

 
 
 
8-K
 
9/22/2016
 
4.01
 
 
 
 
 
 
 
 
 
 
 
 
 
 
4.6

 
 
 
8-K
 
9/16/2019
 
4.1
 
 
 
 
 
 
 
 
 
 
 
 
 
 
4.7

 
 
 
8-K
 
9/16/2019
 
4.2
 
 
 
 
 
 
 
 
 
 
 
 
 
 
4.8

 
 
 
 
 
 
 
 
 
X
 
 
 
 
 
 
 
 
 
 
 
 
10.1

 
 
 
10-K
 
12/22/2006
 
10.8
 
 
 
 
 
 
 
 
 
 
 
 
 
 
10.2

 
 
 
8-K
 
11/12/2004
 
10.1
 
 
 
 
 
 
 
 
 
 
 
 
 
 
10.3

 
 
 
8-K
 
11/12/2004
 
10.2
 
 
 
 
 
 
 
 
 
 
 
 
 
 
10.4

 
 
 
10-Q
 
9/5/2008
 
10.1
 
 
 
 
 
 
 
 
 
 
 
 
 
 
10.5

 
 
 
DEF14A
 
1/27/2009
 
Appendix A
 
 
 
 
 
 
 
 
 
 
 
 
 
 
10.6

 
 
 
10‑K
 
12/20/2010
 
10.17
 
 
 
 
 
 
 
 
 
 
 
 
 
 

118
Table of Contents            


 
 
 
 
Incorporation by Reference
Exhibit
Number
 
Description
 
Form
 
Date
 
Exhibit
Number
 
Filed
Herewith
 
 
 
 
 
 
 
 
 
 
 
 
10.7

 
 
 
10-K
 
12/21/2009
 
10.31
 
 
 
 
 
 
 
 
 
 
 
 
 
 
10.8

 
 
 
10‑K
 
12/20/2010
 
10.19
 
 
 
 
 
 
 
 
 
 
 
 
 
 
10.9

 
 
 
10-K
 
12/21/2009
 
10.32
 
 
 
 
 
 
 
 
 
 
 
 
 
 
10.10

 
 
 
10‑K
 
12/20/2010
 
10.21
 
 
 
 
 
 
 
 
 
 
 
 
 
 
10.11

 
 
 
10-K
 
12/21/2015
 
10.26
 
 
 
 
 
 
 
 
 
 
 
 
 
 
10.12

 
 
 
10-K
 
12/21/2015
 
10.28
 
 
 
 
 
 
 
 
 
 
 
 
 
 
10.13

 
 
 
10-K
 
12/21/2015
 
10.29
 
 
 
 
 
 
 
 
 
 
 
 
 
 
10.14

 
 
 
DEF14A
 
2/7/2019
 
Appendix B
 
 
 
 
 
 
 
 
 
 
 
 
 
 
10.15

 
 
 
10-Q
 
5/31/2018
 
10.1
 
 
 
 
 
 
 
 
 
 
 
 
 
 
10.16

 
 
 
10-Q
 
5/31/2018
 
10.2
 
 
 
 
 
 
 
 
 
 
 
 
 
 
10.17

 
 

 
10-K
 
12/20/2018
 
10.17
 
 
 
 
 
 
 
 
 
 
 
 
 
 
10.18

 
 

 
10-K
 
12/20/2018
 
10.18
 
 
 
 
 
 
 
 
 
 
 
 
 
 
10.19

 
 
 
10-K
 
12/21/2017
 
10.17
 
 
 
 
 
 
 
 
 
 
 
 
 
 
10.20

 
 
 
10-Q
 
3/9/2006
 
10.63
 
 
 
 
 
 
 
 
 
 
 
 
 
 
10.21

 
 
 
10-K
 
12/21/2009
 
10.39
 
 
 
 
 
 
 
 
 
 
 
 
 
 
10.22

 
 
 
10-K
 
12/21/2017
 
10.20
 
 
 
 
 
 
 
 
 
 
 
 
 
 
10.23

 
 
 
DEF14A
 
2/6/2015
 
Annex A
 
 
 
 
 
 
 
 
 
 
 
 
 
 
10.24

 
 
 
8-K
 
4/10/2008
 
10.1
 
 
 
 
 
 
 
 
 
 
 
 
 
 

119
Table of Contents            


 
 
 
 
Incorporation by Reference
Exhibit
Number
 
Description
 
Form
 
Date
 
Exhibit
Number
 
Filed
Herewith
 
 
 
 
 
 
 
 
 
 
 
 
10.25

 
 
 
10-K
 
12/22/2014
 
10.35
 
 
 
 
 
 
 
 
 
 
 
 
 
 
10.26

 
 
 
8-K
 
4/10/2008
 
10.3
 
 
 
 
 
 
 
 
 
 
 
 
 
 
10.27

 
 
 
10-K
 
12/22/2014
 
10.37
 
 
 
 
 
 
 
 
 
 
 
 
 
 
10.28

 
 
 
10-K
 
12/21/2009
 
10.50
 
 
 
 
 
 
 
 
 
 
 
 
 
 
10.29

 
 
 
10-K
 
12/22/2014
 
10.39
 
 
 
 
 
 
 
 
 
 
 
 
 
 
10.30

 
 
 
8-K
 
8/5/2014
 
10.1
 
 
 
 
 
 
 
 
 
 
 
 
 
 
10.31

 
 
 
8-K
 
8/5/2014
 
10.2
 
 
 
 
 
 
 
 
 
 
 
 
 
 
10.32

 
 
 
8-K
 
8/5/2014
 
10.3
 
 
 
 
 
 
 
 
 
 
 
 
 
 
10.33

 
 
 
8-K
 
8/5/2014
 
10.4
 
 
 
 
 
 
 
 
 
 
 
 
 
 
10.34

 
 
 
8-K
 
8/5/2014
 
10.5
 
 
 
 
 
 
 
 
 
 
 
 
 
 
10.35

 
 
 
8-K
 
3/13/2019
 
10.1
 
 
 
 
 
 
 
 
 
 
 
 
 
 
10.36

 
 
 
8-K
 
8/8/2019
 
10.1
 
 
 
 
 
 
 
 
 
 
 
 
 
 
10.37

 
 

 
8-K
 
10/22/2019
 
10.1
 
 
 
 
 
 
 
 
 
 
 
 
 
 
10.38

 
 
 
10-K
 
12/22/2014
 
10.62
 
 
 
 
 
 
 
 
 
 
 
 
 
 
10.39

 
 
 
10-K
 
12/21/2015
 
10.70
 
 
 
 
 
 
 
 
 
 
 
 
 
 
10.40

 
 
 
10-Q
 
3/8/2016
 
10.1
 
 
 
 
 
 
 
 
 
 
 
 
 
 

120
Table of Contents            

 
 
 
 
Incorporation by Reference
Exhibit
Number
 
Description
 
Form
 
Date
 
Exhibit
Number
 
Filed
Herewith
 
 
 
 
 
 
 
 
 
 
 
 
10.41

 
 
 
10-K
 
12/20/2018
 
10.41
 
 
 
 
 
 
 
 
 
 
 
 
 
 
10.42

 
 
 
10-K
 
12/21/2017
 
10.40
 
 
 
 
 
 
 
 
 
 
 
 
 
 
21.1

 
 
 
 
 
 
 
 
 
X
 
 
 
 
 
 
 
 
 
 
 
 
23.1

 
 
 
 
 
 
 
 
 
X
 
 
 
 
 
 
 
 
 
 
 
 
24.1

 
 
 
 
 
 
 
 
 
X
 
 
 
 
 
 
 
 
 
 
 
 
31.1

 
 
 
 
 
 
 
 
 
X
 
 
 
 
 
 
 
 
 
 
 
 
31.2

 
 
 
 
 
 
 
 
 
X
 
 
 
 
 
 
 
 
 
 
 
 
32.1

 
 
 
 
 
 
 
 
 
X
32.2

 
 
 
 
 
 
 
 
 
X
 
 
 
 
 
 
 
 
 
 
 
 
101.INS
 
XBRL Instance Document.- the instance document does not appear in the Interactive Data File because its XBRL tags are embedded within the Inline XBRL document.
 
 
 
 
 
 
 
X
 
 
 
 
 
 
 
 
 
 
 
101.SCH
 
XBRL Taxonomy Extension Schema Document.
 
 
 
 
 
 
 
X
 
 
 
 
 
 
 
 
 
 
 
101.CAL
 
XBRL Taxonomy Extension Calculation Linkbase Document.
 
 
 
 
 
 
 
X
 
 
 
 
 
 
 
 
 
 
 
101.LAB
 
XBRL Taxonomy Extension Label Linkbase Document.
 
 
 
 
 
 
 
X
 
 
 
 
 
 
 
 
 
 
 
101.PRE
 
XBRL Taxonomy Extension Presentation Linkbase Document.
 
 
 
 
 
 
 
X
 
 
 
 
 
 
 
 
 
 
 
101.DEF
 
XBRL Taxonomy Extension Definition Linkbase Document.
 
 
 
 
 
 
 
X
 
 
 
 
 
 
 
 
 
 
 
 

*
Indicates management contract or compensatory plan, contract or arrangement.



121
Table of Contents            

SIGNATURES

Pursuant to the requirements of Section 13 or 15(d) of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized.

 
 
AGILENT TECHNOLOGIES, INC.
 
 
 
 
 
 
 
BY
 
/s/ MICHAEL TANG
 
 
 
 
Michael Tang
 
 
 
 
Senior Vice President,
 
 
 
 
General Counsel and Secretary

Date: December 19, 2019


122
Table of Contents            

POWER OF ATTORNEY

KNOW ALL PERSONS BY THESE PRESENTS, that each person whose signature appears below constitutes and appoints Michael Tang and P. Diana Chiu, or either of them, his or her attorneys-in-fact, for such person in any and all capacities, to sign any amendments to this report and to file the same, with exhibits thereto, and other documents in connection therewith, with the Securities and Exchange Commission, hereby ratifying and confirming all that any of said attorneys-in-fact, or substitute or substitutes, may do or cause to be done by virtue hereof. Pursuant to the requirements of the Securities Exchange Act of 1934, this report has been signed below by the following persons on behalf of the registrant and in the capacities and on the dates indicated.

Signature
 
Title
 
Date
 
 
 
 
 
/s/ MICHAEL R. MCMULLEN
 
Director, President and Chief Executive Officer
 
December 19, 2019
Michael R. McMullen
 
(Principal Executive Officer)
 
 
 
 
 
 
 
/s/ ROBERT W. MCMAHON
 
Senior Vice President and Chief Financial Officer
 
December 19, 2019
Robert W. McMahon
 
(Principal Financial Officer)
 
 
 
 
 
 
 
/s/ RODNEY GONSALVES
 
Vice President, Corporate Controllership
 
December 19, 2019
Rodney Gonsalves
 
(Principal Accounting Officer)
 
 
 
 
 
 
 
/s/ KOH BOON HWEE

Chairman of the Board of Directors

December 19, 2019
Koh Boon Hwee




 
 
 
 
 
/s/ MALA ANAD
 
Director
 
December 19, 2019
Mala Anad
 
 
 
 
 
 
 
 
 
/s/ HANS E. BISHOP
 
Director
 
December 19, 2019
Hans E. Bishop
 
 
 
 
 
 
 
 
 
/s/ PAUL N. CLARK
 
Director
 
December 19, 2019
Paul N. Clark
 
 
 
 
 
 
 
 
 
/s/ HEIDI KUNZ
 
Director
 
December 19, 2019
Heidi Kunz
 
 
 
 
 
 
 
 
 
/s/ DANIEL K. PODOLSKY, M.D.
 
Director
 
December 19, 2019
Daniel K. Podolsky, M.D.
 
 
 
 
 
 
 
 
 
/s/ SUE H. RATAJ
 
Director
 
December 19, 2019
Sue H. Rataj
 
 
 
 
 
 
 
 
 
/s/ GEORGE A. SCANGOS, Ph D
 
Director
 
December 19, 2019
George A. Scangos, Ph D.
 
 
 
 
 
 
 
 
 
/s/ DOW R. WILSON
 
Director
 
December 19, 2019
Dow R. Wilson
 
 
 
 
 
 
 
 
 
/s/ TADATAKA YAMADA, M.D.
 
Director
 
December 19, 2019
Tadataka Yamada, M.D.
 
 
 
 



123
 EX-3.2 2 a-10312019xexx32.htm EXHIBIT 3.2 Exhibit


Exhibit 3.2
AMENDED AND RESTATED BYLAWS
OF
AGILENT TECHNOLOGIES, INC.
Article I
CORPORATE OFFICES
1.1    Registered Office. The registered office of the corporation shall be fixed in the Certificate of Incorporation of the corporation.
1.2    Other Offices. The board of directors may at any time establish branch or subordinate offices at any place or places where the corporation is qualified to do business.
ARTICLE II    
MEETINGS OF STOCKHOLDERS
2.1    Place of Meetings. Meetings of stockholders shall be held at any place within or outside the State of Delaware designated by the board of directors. In the absence of any such designation, stockholders’ meetings shall be held at the registered office of the corporation.
2.2    Annual Meeting.
(a)    The annual meeting of stockholders shall be held each year on a date and at a time designated by the board of directors. At the meeting, directors shall be elected, and any other proper business may be transacted.
(b)    At an annual meeting of the stockholders, only such business shall be conducted as shall have been properly brought before the meeting. To be properly brought before an annual meeting, business must be: (A) specified in the notice of meeting (or any supplement thereto) given by or at the direction of the board of directors, (B) otherwise properly brought before the meeting by or at the direction of the board of directors, or (C) otherwise properly brought before the meeting by a stockholder. For nominations or other business to be properly brought before a stockholders’ meeting by a stockholder pursuant to clause (C) of the preceding sentence, the stockholder must have given timely notice thereof in writing to the secretary of the corporation and such other business must otherwise be a proper matter for stockholder action. To be timely for purposes of advance notice requirements, a compliant notice of a stockholder proposal and/or director nomination must be delivered to the secretary at the principal executive offices of the corporation not less than one hundred twenty (120) calendar days in advance of the first anniversary of the date the corporation’s proxy statement was released to stockholders for the preceding year’s annual meeting. In no event shall the public announcement of an adjournment or postponement of a stockholders’ meeting (or such adjournment or postponement) commence a new time period for the giving of a stockholder’s notice as described above. A stockholder’s notice to the secretary shall set forth the information required by paragraph (g) of this Section 2.2. Notwithstanding anything in these Amended and Restated Bylaws (the “Bylaws”) to the contrary, no business shall be conducted at any annual meeting except in accordance with the procedures set forth in this paragraph (b). The chairman of the annual meeting shall, if the facts warrant, determine and declare at the meeting that business was not properly brought before the meeting and in accordance with the provisions of this paragraph (b), and, if he should so determine, he shall so declare at the meeting that any such business not properly brought before the meeting shall not be transacted.
(c)    Only persons who are nominated in accordance with the procedures set forth in this paragraph (c) (and, as applicable with respect to a Proxy Access Notice, paragraph (f) of this Section 2.2) shall be eligible for election as directors.
(i)    Nominations of persons for election to the board of directors of the corporation may be made at a meeting of stockholders by or at the direction of the board of directors or by any stockholder of the corporation entitled to vote in the election of directors at the meeting who complies with the notice procedures set forth in this paragraph (c) (and, as applicable with respect to a Proxy Access Notice, paragraph (f) of this Section 2.2). Such nominations, other than those made by or at the direction of the board of directors, shall be made pursuant to timely notice in writing to the secretary of the corporation in accordance with the provisions of paragraph (b) of this Section 2.2. Such stockholder’s notice shall set forth as to each person, if any, whom the stockholder proposes to nominate for election or re-election as a director and as to such stockholder giving notice, the information required to be provided pursuant to paragraph (g) of this Section 2.2. At the request of the board of directors, any person nominated by a stockholder for election as a director shall furnish to the secretary of the corporation that information required to be set forth in the stockholder’s notice of nomination which pertains to the nominee. No person shall be eligible for election as a director of the corporation unless nominated in accordance with the procedures set forth in this paragraph (c). The chairman of the meeting shall, if the facts warrant, determine and declare at the meeting that a nomination was not made in accordance with the procedures prescribed by these Bylaws, and if he should so determine, he shall so declare at the meeting, and the defective nomination shall be disregarded.
(ii)    To be eligible to be a nominee of any stockholder for election or reelection as a director of the corporation, a person must deliver (in accordance with the time periods prescribed for delivery of notice under Section 2.2 of these Bylaws) to the secretary at the principal executive offices of the corporation a written questionnaire with respect to the background and qualifications of such individual and the background of any other person or entity on whose behalf, directly or indirectly, the nomination is being made (which questionnaire shall be provided to the requesting stockholder by the secretary following written request), and a written representation and agreement (in the form provided by the secretary to the requesting stockholder following written request) that such individual:
(A)    (1) is not and will not become a party to: (i) any agreement, arrangement or understanding with, and has not given any commitment or assurance to, any person or entity as to how such person, if elected as a director of the corporation, will act or vote on any issue or question (a “Voting Commitment”) that has not been disclosed to the corporation, and (ii) any Voting Commitment that could limit or interfere with such individual’s ability to comply, if elected as a director of the corporation, with such individual’s fiduciary duties under applicable law; (2) is not and will not become a party to any agreement, arrangement or understanding with any person or entity other than the corporation with respect to any direct or indirect compensation, reimbursement or indemnification in connection with service or action as a director that has not been disclosed therein;
(B)    agrees to promptly provide to the corporation such other information as the corporation may reasonably request;
(C)    in such individual’s personal capacity and on behalf of any person or entity on whose behalf, directly or indirectly, the nomination is being made, would be in compliance, if elected as a director of the corporation, and will comply, with all applicable corporate governance, conflict of interest, confidentiality and stock ownership and trading policies and guidelines of the corporation publicly disclosed from time to time.

(d)    Subject to Rule 14a-8 under the Securities Exchange Act of 1934, as amended (the “Exchange Act”) and paragraph (f) of this Section 2.2, nothing in these Bylaws shall be construed to permit any stockholder, or give any stockholder the right, to include or have disseminated or described in the corporation’s proxy statement any nomination of a director or directors or any other business proposal, statement or communication.
(e)    Notwithstanding any other provisions of this Section 2.2, unless otherwise required by law, if the stockholder (or a qualified representative of the stockholder) does not appear at the annual or special meeting of stockholders of the corporation to present a nomination or proposed business, such nomination shall be disregarded and such proposed business shall not be transacted, notwithstanding that proxies in respect of such vote may have been received by the corporation. For purposes of this Section 2.2, to be considered a qualified representative of the stockholder, a person must be a duly authorized officer, manager or partner of such stockholder or must be authorized by a writing executed by such stockholder or an electronic transmission delivered by such stockholder to act for such stockholder as proxy at the meeting of stockholders and such person must produce such writing or electronic transmission, or a reliable reproduction of the writing or electronic transmission, at the meeting of stockholders.
(f)    Inclusion of Stockholder Director Nominations in the Corporation’s Proxy Materials.
(i)    Subject to the terms and conditions set forth in these Bylaws, the corporation shall include in its proxy statement for an annual meeting of stockholders held after the 2020 annual meeting of the stockholders the name, together with the Required Information (as defined below), of qualifying person(s) nominated for election (the “Stockholder Nominee”) to the board of directors by an eligible stockholder or eligible group of stockholders that satisfy the requirements of this paragraph (f) of Section 2.2, including qualifying as an Eligible Stockholder (as defined in subsection (v) below) and that expressly elects at the time of providing the written notice required by this paragraph (f) of Section 2.2 (a “Proxy Access Notice”) to have its nominee included in the corporation’s proxy materials pursuant to this paragraph (f) of Section 2.2. For the purposes of this Section 2.2(f):
(A)    “Constituent Holder” shall mean any stockholder, fund included within a Qualifying Fund (as defined in subsection (v) below) or beneficial holder whose stock ownership is counted for the purpose of qualifying as holding the Proxy Access Request Required Shares (as defined in subsection (v) below) or qualifying as an Eligible Stockholder (as defined in subsection (v) below); and
(B)    a stockholder (including any Constituent Holder) shall be deemed to “own” only those outstanding shares of voting stock as to which the stockholder (or such Constituent Holder) itself possesses both (a) the full voting and investment rights pertaining to the shares and (b) the full economic interest in (including the opportunity for profit and risk of loss on) such shares. The number of shares calculated in accordance with the foregoing clauses (a) and (b) shall be deemed not to include (and to the extent any of the following arrangements have been entered into by affiliates of the stockholder (or of any Constituent Holder), shall be reduced by) any shares (x) sold by such stockholder or Constituent Holder (or any of either’s affiliates) in any transaction that has not been settled or closed, including any short sale, (y) borrowed by such stockholder or Constituent Holder (or any of either’s affiliates) for any purposes or purchased by such stockholder or Constituent Holder (or any of either’s affiliates) pursuant to an agreement to resell, or (z) subject to any option, warrant, forward contract, swap, contract of sale, other derivative or similar agreement entered into by such stockholder or Constituent Holder (or any of either’s affiliates), whether any such instrument or agreement is to be settled with shares, cash or other consideration, in any such case which instrument or agreement has, or is intended to have, or if exercised by either party thereto would have, the purpose or effect of (i) reducing in any manner, to any extent or at any time in the future, such stockholder’s or Constituent Holder’s (or either’s affiliates’) full right to vote or direct the voting of any such shares, and/or (ii) hedging, offsetting or altering to any degree gain or loss arising from the full economic ownership of such shares by such stockholder or Constituent Holder (or either’s affiliates). For purposes of this Section 2.2(f), a stockholder (including any Constituent Holder) shall “own” shares held in the name of a nominee or other intermediary so long as the stockholder itself (or such Constituent Holder itself) retains the right to instruct how the shares are voted with respect to the election of directors and the right to direct the disposition thereof and possesses the full economic interest in the shares. For purposes of this Section 2.2(f), a stockholder’s (including any Constituent Holder’s) ownership of shares shall be deemed to continue during any period in which the stockholder has loaned such shares so long as such stockholder retains the power to recall such shares on no greater than five (5) business days’ notice or has delegated any voting power over such shares by means of a proxy, power of attorney or other instrument or arrangement so long as such delegation is revocable at any time by the stockholder; provided, that in the case of loaned shares, such shares are recalled either (i) no later than the final date when a Proxy Access Notice pursuant to this Section 2.2(f) may be timely delivered to the secretary or (ii) upon the request of the corporation following the corporation’s indication to the Eligible Stockholder that its nominee(s) will be included in the corporation’s proxy statement subject to the terms herein; provided that, in either such case where the shares are recalled in accordance with the foregoing, such shares remain recalled (and otherwise “owned” as defined herein) through the annual meeting. The terms “owned,” “owning” and other variations of the word “own” shall have correlative meanings.
(ii)    For purposes of this Section 2.2, the “Required Information” that the corporation will include in its proxy statement is: (i) the information concerning the Stockholder Nominee and the Eligible Stockholder that the corporation determines is required to be disclosed in the corporation’s proxy statement by the regulations promulgated under Regulation 14A under the Exchange Act; and (ii) if the Eligible Stockholder so elects, a Statement (as defined in paragraph (f)(vii) below). The corporation shall also include the name of the Stockholder Nominee in its proxy card. For the avoidance of doubt, and any other provision of these Bylaws notwithstanding, the corporation may in its sole discretion solicit against, and include in the proxy statement (and other proxy materials) its own statements or other information relating to, any Eligible Stockholder and/or Stockholder Nominee, including any information provided to the corporation with respect to the foregoing.
(iii)    To be timely, a stockholder’s Proxy Access Notice must be delivered to the secretary at the principal executive offices of the corporation not less than one hundred twenty (120) calendar days in advance of the first anniversary of the date the corporation’s proxy statement was released to stockholders for the preceding year’s annual meeting. In no event shall the public announcement of an adjournment or postponement of a stockholders’ meeting (or such adjournment or postponement) commence a new time period for the giving of a Proxy Access Notice.
(iv)    The number of Stockholder Nominees (including Stockholder Nominees that were submitted by an Eligible Stockholder for inclusion in the corporation’s proxy materials pursuant to this paragraph (f) of Section 2.2 but either are subsequently withdrawn or that the board of directors decides to nominate as board of directors’ nominees) appearing in the corporation’s proxy materials with respect to an annual meeting of stockholders shall not exceed the greater of (x) two (2) and (y) the largest whole number that does not exceed twenty percent (20%) of the number of directors in office as of the last day on which a Proxy Access Notice may be delivered in accordance with the procedures set forth in this paragraph (f) of Section 2.2 (such greater number, the “Permitted Number”); provided, however, that the Permitted Number available for proxy access candidates shall be reduced by:
(A)    the number of such director candidates for which the corporation shall have received one or more valid stockholder notices nominating director candidates pursuant to paragraph (c) of this Section 2.2 (but not this paragraph (f)) of these By-laws;
(B)    the number of directors in office or director candidates that in either case will be included in the corporation’s proxy materials with respect to such annual meeting as an unopposed (by the corporation) nominee pursuant to an agreement, arrangement or other understanding with a stockholder or group of stockholders (other than any such agreement, arrangement or understanding entered into in connection with an acquisition of voting stock, by such stockholder or group of stockholders, from the corporation), other than any such director referred to in this clause (B) who at the time of such annual meeting will have served as a director continuously, as a nominee of the board of directors, for at least two (2) terms; and
(C)    the number of directors in office that will be included in the corporation’s proxy materials with respect to such annual meeting for whom access to the corporation’s proxy materials was previously provided pursuant to this paragraph (f) of this Section 2.2, other than any such director referred to in this clause (C) who at the time of such annual meeting will have served as a director continuously, as a nominee of the board of directors, for at least two (2) terms;
provided, further, that in no circumstance shall the Permitted Number exceed the number of directors to be elected at the applicable annual meeting as noticed by the corporation and in the event the board of directors resolves to reduce the size of the board of directors effective on or prior to the date of the annual meeting, the Permitted Number shall be calculated based on the number of directors in office as so reduced. An Eligible Stockholder submitting more than one Stockholder Nominee for inclusion in the corporation’s proxy statement pursuant to this paragraph (f) of Section 2.2 shall rank such Stockholder Nominees based on the order that the Eligible Stockholder desires such Stockholder Nominees to be selected for inclusion in the corporation’s proxy statement and include such specified rank in its Proxy Access Notice. If the number of Stockholder Nominees pursuant to this paragraph (f) of Section 2.2 for an annual meeting of stockholders exceeds the Permitted Number, then the highest ranking qualifying Stockholder Nominee from each Eligible Stockholder will be selected by the corporation for inclusion in the proxy statement until the Permitted Number is reached, going in order of the amount (largest to smallest) of the ownership position as disclosed in each Eligible Stockholder’s Proxy Access Notice. If the Permitted Number is not reached after the highest ranking Stockholder Nominee from each Eligible Stockholder has been selected, this selection process will continue as many times as necessary, following the same order each time, until the Permitted Number is reached.

(v)    An “Eligible Stockholder” is one or more stockholders of record who own and have owned, or are acting on behalf of one or more beneficial owners who own and have owned (in each case as defined above), in each case continuously for at least three (3) years as of both the date that the Proxy Access Notice is received by the corporation pursuant to this paragraph (f) of Section 2.2, and as of the record date for determining stockholders eligible to vote at the annual meeting, at least three percent (3%) of the aggregate voting power of the voting stock (the “Proxy Access Request Required Shares”), and who continue to own the Proxy Access Request Required Shares at all times between the date such Proxy Access Notice is received by the corporation and the date of the applicable annual meeting; provided that the aggregate number of stockholders, and, if and to the extent that a stockholder is acting on behalf of one or more beneficial owners, of such beneficial owners, whose stock ownership is counted for the purpose of satisfying the foregoing ownership requirement shall not exceed twenty (20). Two or more collective investment funds that are part of the same family of funds by virtue of being under common management and investment control, under common management and sponsored primarily by the same employer or a “group of investment companies” (as such term is defined in Section 12(d)(1)(G)(ii) of the Investment Company Act of 1940, as amended) (a “Qualifying Fund”) shall be treated as one stockholder for the purpose of determining the aggregate number of stockholders in this paragraph (f)(v); provided that each fund included within a Qualifying Fund otherwise meets the requirements set forth in this paragraph (f) of Section 2.2. No shares may be attributed to more than one group constituting an Eligible Stockholder under this paragraph (f) of Section 2.2 (and, for the avoidance of doubt, no stockholder may be a member of more than one group constituting an Eligible Stockholder). A record holder acting on behalf of one or more beneficial owners will not be counted separately as a stockholder with respect to the shares owned by beneficial owners on whose behalf such record holder has been directed in writing to act, but each such beneficial owner will be counted separately, subject to the other provisions of this paragraph (f)(v), for purposes of determining the number of stockholders whose holdings may be considered as part of an Eligible Stockholder’s holdings. For the avoidance of doubt, Proxy Access Request Required Shares will qualify as such if, and only if, the beneficial owner of such shares as of the date of the Proxy Access Notice has itself individually beneficially owned such shares continuously for the three-year (3-year) period ending on that date and through the other applicable dates referred to above (in addition to the other applicable requirements being met).
(vi)    No later than the final date when a Proxy Access Notice pursuant to this paragraph (f) of Section 2.2 may be timely delivered to the secretary, an Eligible Stockholder (including each Constituent Holder) must provide the following information in writing to the secretary:
(A)    with respect to each Constituent Holder, the name and address of, and number of shares of voting stock owned by, such person;
(B)    one or more written statements from the record holder of the shares (and from each intermediary through which the shares are or have been held during the requisite three-year (3-year) holding period) verifying that, as of a date within seven (7) days prior to the date the Proxy Access Notice is delivered to the corporation, such person owns, and has owned continuously for the preceding three (3) years, the Proxy Access Request Required Shares, and such person’s agreement to provide:
(1)    within ten (10) days after the record date for the annual meeting, written statements from the record holder and intermediaries verifying such person’s continuous ownership of the Proxy Access Request Required Shares through the record date, together with any additional information reasonably requested to verify such person’s ownership of the Proxy Access Request Required Shares; and
(2)    immediate notice if the Eligible Stockholder ceases to own any of the Proxy Access Request Required Shares prior to the date of the applicable annual meeting of stockholders;
(C)    the information contemplated by paragraphs (g)(i), (iii) and (iv) of this Section 2.2 of these Bylaws (with references to a “stockholder” therein to include such Eligible Stockholder (including each Constituent Holder));
(D)    a representation that such person:
(1)    acquired the Proxy Access Request Required Shares in the ordinary course of business and not with the intent to change or influence control of the corporation, and does not have any such intent;
(2)    has not nominated and will not nominate for election to the board of directors at the annual meeting any person other than the Stockholder Nominee(s) being nominated pursuant to this paragraph (f) Section 2.2;
(3)    has not engaged and will not engage in, and has not been and will not be a “participant” in another person’s, “solicitation” within the meaning of Rule 14a-1(l) under the Exchange Act in support of the election of any individual as a director at the annual meeting other than its Stockholder Nominee(s) or a nominee of the board of directors;
(4)    will not distribute to any stockholder any form of proxy for the annual meeting other than the form distributed by the corporation; and
(5)    will provide facts, statements and other information in all communications with the corporation and its stockholders that are and will be true and correct in all material respects and do not and will not omit to state a material fact necessary in order to make the statements made, in light of the circumstances under which they were made, not misleading, and will otherwise comply with all applicable laws, rules and regulations in connection with any actions taken pursuant to this paragraph (f) of Section 2.2;
(E)    in the case of a nomination by a group of stockholders that together is such an Eligible Stockholder, the designation by all group members of one group member that is authorized to act on behalf of all members of the nominating stockholder group with respect to the nomination and matters related thereto, including withdrawal of the nomination; and
(F)    an undertaking that such person agrees to:
(1)    assume all liability stemming from, and indemnify and hold harmless the corporation and each of its directors, officers and employees individually against any liability, loss or damages in connection with any threatened or pending action, suit or proceeding, whether legal, administrative or investigative, against the corporation or any of its directors, officers or employees arising out of any legal or regulatory violation arising out of the Eligible Stockholder’s communications with the stockholders of the corporation or out of the information that the Eligible Stockholder (including such person) provided to the corporation;
(2)    promptly provide to the corporation such other information as the corporation may reasonably request; and
(3)    file with the Securities and Exchange Commission any solicitation by the Eligible Stockholder of stockholders of the corporation relating to the annual meeting at which the Stockholder Nominee will be nominated.

In addition, no later than the final date when a nomination pursuant to this paragraph (f) of Section 2.2 may be delivered to the corporation, a Qualifying Fund whose share ownership is counted for purposes of qualifying as an Eligible Stockholder must provide to the secretary documentation reasonably satisfactory to the board of directors that demonstrates that the funds included within the Qualifying Fund satisfy the definition thereof. In order to be considered timely, any information required by this paragraph (f) of Section 2.2 to be provided to the corporation must be supplemented (by delivery to the secretary): (1) no later than ten (10) days following the record date for the applicable annual meeting, to disclose the foregoing information as of such record date; and (2) no later than eight (8) days before the annual meeting, to disclose the foregoing information as of the date that is no earlier than ten (10) days prior to such annual meeting. For the avoidance of doubt, the requirement to update and supplement such information shall not permit any Eligible Stockholder or other person to change or add any proposed Stockholder Nominee or be deemed to cure any defects or limit the remedies (including, without limitation, under these Bylaws) available to the corporation relating to any defect.

(vii)    The Eligible Stockholder may provide to the secretary, at the time the information required by this paragraph (f) of Section 2.2 is originally provided, a written statement for inclusion in the corporation’s proxy statement for the annual meeting, not to exceed five hundred (500) words, in support of the candidacy of such Eligible Stockholder’s Stockholder Nominee (the “Statement”). Notwithstanding anything to the contrary contained in this paragraph (f) of Section 2.2, the corporation may omit from its proxy materials any information or Statement that it, in good faith, believes is materially false or misleading, omits to state any material fact, directly or indirectly without factual foundation impugns the character, integrity or personal reputation of or makes charges concerning improper, illegal or immoral conduct or associations with respect to any person or would violate any applicable law or regulation.
(viii)    No later than the final date when a nomination pursuant to this paragraph (f) of Section 2.2 may be delivered to the corporation, each Stockholder Nominee must:
(A)    provide the completed and signed questionnaire, representation and agreement required by Section 2.2(c) of these Bylaws;
(B)    provide an executed agreement, in a form deemed satisfactory by the board of directors or its designee (which form shall be provided by the corporation reasonably promptly upon written request of a stockholder), that such Stockholder Nominee consents to being named in the corporation’s proxy statement and form of proxy card (and will not agree to be named in any other person’s proxy statement or form of proxy card with respect to the corporation) as a nominee and intends to serve as a director of the corporation for the entire term if elected;
(C)    complete, sign and submit all questionnaires, representations and agreements required by these Bylaws or of the corporation’s directors generally; and
(D)    provide such additional information as necessary to permit the board of directors to determine: (a) if any of the matters referred to in paragraph (f)(x) below apply; (b) if such Stockholder Nominee has any direct or indirect relationship with the corporation other than those relationships that have been deemed categorically immaterial pursuant to the corporation’s Corporate Governance Guidelines; or (c) is or has been subject to any event specified in Rule 506(d)(1) of Regulation D (or any successor rule) under the Securities Act of 1933, as amended (the “Securities Act”) or Item 401(f) of Regulation S-K (or any successor rule) under the Exchange Act, without reference to whether the event is material to an evaluation of the ability or integrity of such Stockholder Nominee.
In the event that any information or communications provided by the Eligible Stockholder (or any Constituent Holder) or the Stockholder Nominee to the corporation or its stockholders ceases to be true and correct in all material respects or omits a material fact necessary to make the statements made, in light of the circumstances under which they were made, not misleading, each Eligible Stockholder or Stockholder Nominee, as the case may be, shall promptly notify the secretary of any defect in such previously provided information and of the information that is required to correct any such defect; it being understood for the avoidance of doubt that providing any such notification shall not be deemed to cure any such defect or limit the remedies (including, without limitation, under these Bylaws) available to the corporation relating to any such defect.

(ix)    Any Stockholder Nominee who is included in the corporation’s proxy materials for a particular annual meeting of stockholders but either (1) withdraws from or becomes ineligible or unavailable for election at that annual meeting or (2) does not receive votes cast in favor of the Stockholder Nominee’s election of at least twenty (20) percent of the shares represented in person or by proxy at the annual meeting will be ineligible to be a Stockholder Nominee pursuant to this paragraph (f) of Section 2.2 for the next two (2) annual meetings. Any Stockholder Nominee who is included in the corporation’s proxy statement for a particular annual meeting of stockholders, but subsequently is determined not to satisfy the eligibility requirements of this paragraph (f) of Section 2.2 or any other provision of these Bylaws, the Articles of Incorporation or any applicable regulation any time before the annual meeting of stockholders, will not be eligible for election at the relevant annual meeting of stockholders.
(x)    The corporation shall not be required to include, pursuant to this paragraph (f) of Section 2.2, a Stockholder Nominee in its proxy materials for any annual meeting of stockholders, or, if the proxy statement already has been filed, to allow the nomination of (or vote with respect to) a Stockholder Nominee (and may declare such nomination ineligible), notwithstanding that proxies in respect of such vote may have been received by the corporation:
(A)    who is not independent under the listing standards of the principal U.S. exchange upon which the common stock of the corporation is listed, any applicable rules of the Securities and Exchange Commission and any publicly disclosed standards used by the board of directors in determining and disclosing independence of the corporation’s directors;
(B)    whose service as a member of the board of directors would violate or cause the corporation to be in violation of these Bylaws, the Articles of Incorporation, the rules and listing standards of the principal U.S. exchange upon which the common stock of the corporation is traded, or any applicable law, rule or regulation;
(C)    who is or has been, within the past three (3) years, an officer or director of a competitor, as defined in Section 8 of the Clayton Antitrust Act of 1914, as amended, or who is a subject of a pending criminal proceeding, has been convicted in a criminal proceeding within the past ten (10) years or is subject to an order of the type specified in Rule 506(d) of Regulation D promulgated under the Securities Act;
(D)    if the Eligible Stockholder (or any Constituent Holder) or applicable Stockholder Nominee otherwise breaches or fails to comply in any material respect with its obligations pursuant to this paragraph (f) of Section 2.2 or any agreement, representation or undertaking required by this paragraph; or
(E)    if the Eligible Stockholder ceases to be an Eligible Stockholder for any reason, including, but not limited to, not owning the Proxy Access Request Required Shares through the date of the applicable annual meeting.
Clauses (A), (B), and (C) and, to the extent related to a breach or failure by the Stockholder Nominee, clause (D), will result in the exclusion from the proxy materials pursuant to this paragraph (f) of Section 2.2 of the specific Stockholder Nominee to whom the ineligibility applies, or, if the proxy statement already has been filed, the ineligibility of such Stockholder Nominee to be nominated; provided, however, that clause (E) and, to the extent related to a breach or failure by an Eligible Stockholder (or any Constituent Holder), clause (D) will result in the voting stock owned by such Eligible Stockholder (or Constituent Holder) being excluded from the Proxy Access Request Required Shares (and, if as a result the Proxy Access Notice shall no longer have been filed by an Eligible Stockholder, the exclusion from the proxy materials pursuant to this paragraph (f) of Section 2.2 of all of the applicable stockholder’s Stockholder Nominees from the applicable annual meeting of stockholders or, if the proxy statement has already been filed, the ineligibility of all of such stockholder’s Stockholder Nominees to be nominated).

(g)    Disclosure Requirements. To be in proper form, a stockholder’s notice pursuant to this Section 2.2 must include the following, as applicable:
(i)    As to the stockholder giving the notice and the beneficial owner, if any, on whose behalf the nomination or proposal, as applicable, is made, a stockholder’s notice must set forth: (A) the name and address of such stockholder, as they appear on the corporation’s books, of such beneficial owner, if any, and of their respective affiliates or associates or others acting in concert therewith; (B) (1) the class or series and number of shares of the corporation which are, directly or indirectly, owned beneficially and of record by such stockholder, such beneficial owner and their respective affiliates or associates or others acting in concert therewith, (2) any option, warrant, convertible security, stock appreciation right, or similar right with an exercise or conversion privilege or a settlement payment or mechanism at a price related to any class or series of shares of the corporation or with a value derived, in whole or in part, from the value of any class or series of shares of the corporation, or any derivative or synthetic arrangement having the characteristics of a long position in any class or series of shares of the corporation, or any contract, derivative, swap or other transaction or series of transactions designed to produce economic benefits and risks that correspond substantially to the ownership of any class or series of shares of the corporation, including due to the fact that the value of such contract, derivative, swap or other transaction or series of transactions is determined by reference to the price, value or volatility of any class or series of shares of the corporation, whether or not such instrument, contract or right shall be subject to settlement in the underlying class or series of shares of the corporation, through the delivery of cash or other property, or otherwise, and without regard to whether the stockholder of record, the beneficial owner, if any, or any affiliates or associates or others acting in concert therewith, may have entered into transactions that hedge or mitigate the economic effect of such instrument, contract or right, or any other direct or indirect opportunity to profit or share in any profit derived from any increase or decrease in the value of shares of the corporation (any of the foregoing, a “Derivative Instrument”) directly or indirectly owned beneficially by such stockholder, the beneficial owner, if any, or any affiliates or associates or others acting in concert therewith, (3) any proxy, contract, arrangement, understanding or relationship pursuant to which such stockholder, such beneficial owner or any of their respective affiliates or associates or others acting in concert therewith has any right to vote any class or series of shares of the corporation, (4) any agreement, arrangement, understanding, relationship or otherwise, including any repurchase or similar so-called “stock borrowing” agreement or arrangement, involving such stockholder, such beneficial owner or any of their respective affiliates or associates or others acting in concert therewith, directly or indirectly, the purpose or effect of which is to mitigate loss to, reduce the economic risk (of ownership or otherwise) of any class or series of the shares of the corporation by, manage the risk of share price changes for, or increase or decrease the voting power of, such stockholder, such beneficial owner or any of their respective affiliates or associates or others acting in concert therewith with respect to any class or series of the shares of the corporation, or which provides, directly or indirectly, the opportunity to profit or share in any profit derived from any decrease in the price or value of any class or series of the shares of the corporation (any of the foregoing, a “Short Interest”), (5) any rights to dividends on the shares of the corporation owned beneficially by such stockholder, such beneficial owner or any of their respective affiliates or associates or others acting in concert therewith that are separated or separable from the underlying shares of the corporation, (6) any proportionate interest in shares of the corporation or Derivative Instruments held, directly or indirectly, by a general or limited partnership in which such stockholder, such beneficial owner or any of their respective affiliates or associates or others acting in concert therewith is a general partner or, directly or indirectly, beneficially owns an interest in a general partner of such general or limited partnership, (7) any performance-related fees (other than an asset-based fee) that such stockholder, such beneficial owner or any of their respective affiliates or associates or others acting in concert therewith is entitled to based on any increase or decrease in the value of shares of the corporation or Derivative Instruments, if any, including, without limitation, any such interests held by members of the immediate family sharing the same household of such stockholder, such beneficial owner and their respective affiliates or associates or others acting in concert therewith, (8) any equity interests or any Derivative Instruments or Short Interests in any principal competitor of the corporation held by such stockholder, such beneficial owner or any of their respective affiliates or associates or others acting in concert therewith and (9) any direct or indirect interest of such stockholder, such beneficial owner and their respective affiliates or associates or others acting in concert therewith in any contract with the corporation, any affiliate of the corporation or any principal competitor of the corporation (including, in any such case, any employment agreement, collective bargaining agreement or consulting agreement); (C) all information that would be required to be set forth in a Schedule 13D filed pursuant to Rule 13d-1(a) or an amendment pursuant to Rule 13d-2(a) if such a statement were required to be filed under the Exchange Act and the rules and regulations promulgated thereunder by such stockholder, such beneficial owner and their respective affiliates or associates or others acting in concert therewith, if any; and (D) any other information relating to such stockholder, such beneficial owner or any of their respective affiliates or associates or others acting in concert therewith, if any, that would be required to be disclosed in a proxy statement and form or proxy or other filings required to be made in connection with solicitations of proxies for, as applicable, the proposal and/or for the election of directors in a contested election pursuant to Section 14 of the Exchange Act and the rules and regulations promulgated thereunder;
(ii)    If the notice includes any business other than a nomination of a director or directors that the stockholder proposes to bring before the meeting, a stockholder’s notice must, in addition to the matters set forth in subsection (i) above, also set forth: (A) a brief description of the business desired to be brought before the meeting, the reasons for conducting such business at the meeting and any material interest of such stockholder, such beneficial owner and each of their respective affiliates or associates or others acting in concert therewith, if any, in such business; (B) the text of the proposal or business (including the text of any resolutions proposed for consideration and, in the event that such proposal or business includes a proposal to amend these Bylaws, the text of the proposed amendment); and (C) a description of all agreements, arrangements and understandings between such stockholder, such beneficial owner and each of their respective affiliates or associates or others acting in concert therewith, if any, and any other person or persons (including their names) in connection with the proposal of such business by such stockholder;
(iii)    As to each individual, if any, whom the stockholder proposes to nominate for election or reelection to the board of directors, a stockholder’s notice must, in addition to the matters set forth in subsection (i) above, also set forth: (A) all information relating to such individual that would be required to be disclosed in a proxy statement or other filings required to be made in connection with solicitations of proxies for election of directors in a contested election pursuant to Section 14 of the Exchange Act and the rules and regulations promulgated thereunder (including such individual’s written consent to being named in the proxy statement as a nominee and written statement of intent to serve as a director for the full term if elected); (B) if directors are to be elected at such meeting for terms ending at different annual meetings, the annual meeting at which the term for which such person is being nominated ends; and (C) a description of all direct and indirect compensation and other material monetary agreements, arrangements and understandings during the past three (3) years, and any other material relationships, between or among such stockholder and beneficial owner, if any, and their respective affiliates and associates, or others acting in concert therewith, on the one hand, and each proposed nominee, and his or her respective affiliates and associates, or others acting in concert therewith, on the other hand, including, without limitation, all information that would be required to be disclosed pursuant to Rule 404 promulgated under Regulation S-K if the stockholder making the nomination and any beneficial owner on whose behalf the nomination is made, if any, or any affiliate or associate thereof or person acting in concert therewith, were the “registrant” for purposes of such rule, and the nominee were a director or executive officer of such registrant; and
(iv)    With respect to each individual, if any, whom the stockholder proposes to nominate for election or reelection to the board of directors, a stockholder’s notice must, in addition to the matters set forth in subsections (i) and (iii) above, also include the completed and signed questionnaire, representation, agreement required by Section 2.2(c) of these Bylaws. The corporation may require any proposed nominee to furnish such other information as may reasonably be required by the corporation to determine the eligibility of such proposed nominee to serve as an independent director of the corporation or that could be material to a reasonable stockholder’s understanding of the independence, or lack thereof, of such nominee. Notwithstanding anything to the contrary, only persons who are nominated in accordance with the procedures set forth in these Bylaws, including, without limitation, this Section 2.2, shall be eligible for election as directors.
(h)    In addition, to be considered timely, a stockholder’s notice shall further be updated and supplemented, if necessary, so that the information provided or required to be provided in such notice shall be true and correct as of the record date for the meeting and as of the date that is ten (10) days prior to the meeting or any adjournment or postponement thereof, and such update and supplement shall be delivered to the secretary at the principal executive offices of the corporation not later than ten (10) days after the record date for the meeting in the case of the update and supplement required to be made as of the record date, and not later than eight (8) days prior to the date for the meeting or any adjournment or postponement thereof in the case of the update and supplement required to be made as of ten (10) days prior to the meeting or any adjournment or postponement thereof. The obligation to update and supplement as set forth in this paragraph or any other Section of these Bylaws shall not limit the corporation’s rights with respect to any deficiencies in any notice provided by a stockholder, extend any applicable deadlines hereunder or under any other provision of these Bylaws or enable or be deemed to permit a stockholder who has previously submitted notice hereunder or under any other provision of these Bylaws to amend or update any proposal or to submit any new proposal, including by changing or adding nominees, matters, business and or resolutions proposed to be brought before a meeting of the stockholders.
2.3    Special Meeting. A special meeting of the stockholders may be called at any time by the board of directors or the chairman of the board. In addition, prior to the Trigger Date (as defined in the Certificate of Incorporation), the corporation will call a special meeting of stockholders promptly upon request by Hewlett-Packard Company, a Delaware corporation, so long as such entity is a stockholder of the corporation. Special meetings of the stockholders may not be called by any other person or persons. Only such business shall be considered at a special meeting of stockholders as shall have been stated in the notice for such meeting. Subject to Section 2.2 of these Bylaws, in the event the corporation calls a special meeting of stockholders for the purpose of electing one or more directors to the board of directors and at which stockholders may nominate candidates for election at such meeting, a stockholder may nominate an individual or individuals (as the case may be) for election to such position(s) as specified in the corporation’s notice of meeting, provided that the stockholder gives timely notice thereof (including the completed and signed questionnaire, representation and agreement required by Section 2.2(c)(ii) of these Bylaws), and timely updates and supplements thereof in accordance with 2.2(h) of these Bylaws, in each case in proper form (including the disclosures required by Section 2.2(c) and 2.2(g) of these Bylaws), in writing, to the secretary. To be so timely, a stockholder’s notice shall be delivered to the secretary at the principal executive offices of the corporation not earlier than the close of business on the one hundred and twentieth (120th) day prior to the date of such special meeting and not later than the close of business on the later of the ninetieth (90th) day prior to the date of such special meeting or, if the first public announcement of the date of such special meeting is less than one hundred (100) days prior to the date of such special meeting, the tenth (10th) day following the day on which public announcement is first made of the date of the special meeting. In no event shall any adjournment or postponement of a special meeting of stockholders, or the public announcement thereof, commence a new time period for the giving of a stockholder’s notice as described above.
2.4    Organization. Meetings of stockholders shall be presided over by the chairman of the board, if any, or in his or her absence by the vice chairman of the board, if any, or in his or her absence, or in the absence of the foregoing persons by a chairman of the meeting, which chairman must be an officer or director of the corporation, designated by the board of directors. The secretary or in his or her absence an assistant secretary or in the absence of the secretary and all assistant secretaries a person whom the chairman of the meeting shall appoint shall act as secretary of the meeting and keep a record of the proceedings thereof.
The board of directors of the corporation shall be entitled to make such rules or regulations for the conduct of meetings of stockholders as it shall deem necessary, appropriate or convenient. Subject to such rules and regulations of the board of directors, if any, the chairman of the meeting shall have the right and authority to prescribe such rules, regulations and procedures and to do all such acts as, in the judgment of such chairman, are necessary, appropriate or convenient for the proper conduct of the meeting, including, without limitation, establishing an agenda or order of business for the meeting, rules and procedures for maintaining order at the meeting and the safety of those present, limitations on participation in such meeting to stockholders of record of the corporation and their duly authorized and constituted proxies, and such other persons as the chairman shall permit, restrictions on entry to the meeting after the time fixed for the commencement thereof, limitations on the time allotted to questions or comments by participants and regulation of the opening and closing of the polls for balloting and matters which are to be voted on by ballot. Unless and to the extent determined by the board of directors or the chairman of the meeting, meetings of stockholders shall not be required to be held in accordance with rules of parliamentary procedure.
2.5    Notice of Stockholders’ Meetings. All notices of meetings of stockholders shall be sent or otherwise given in accordance with Section 2.6 of these Bylaws not less than ten (10) nor more than sixty (60) days before the date of the meeting. The notice shall specify the place, date, and hour of the meeting and (i) in the case of a special meeting, the purpose or purposes for which the meeting is called (no business other than that specified in the notice may be transacted) or (ii) in the case of the annual meeting, those matters which the board of directors, at the time of giving the notice, intends to present for action by the stockholders (but any proper matter may be presented at the meeting for such action). The notice of any meeting at which directors are to be elected shall include the name of any nominee or nominees who, at the time of the notice, the board intends to present for election.
2.6    Manner of Giving Notice; Affidavit of Notice.
(a)    Notice of any meeting of stockholders shall be given personally or by mail or, to the extent and in the manner permitted by applicable law, by electronic transmission. If mailed, such notice shall be deemed to be given when deposited in the United States mail, postage prepaid, directed to the stockholder at such stockholder’s address as it appears on the records of the corporation, or, if a stockholder shall have filed with the secretary of the corporation a written request that notices to such stockholder be mailed to some other address, then directed to such stockholder at such other address.
(b)    For notice given by electronic transmission to a stockholder to be effective, such stockholder must consent to the corporation’s giving notice by that particular form of electronic transmission. A stockholder may revoke consent to receive notice by electronic transmission by written notice to the corporation. A stockholder’s consent to notice by electronic transmission shall be deemed revoked if the corporation is unable to deliver by electronic transmission two consecutive notices and such inability becomes known to the secretary or an assistant secretary of the corporation, or to the transfer agent or other person responsible for the giving of notice.
(c)    Notices are deemed given (i) if by facsimile, when directed to a number at which the stockholder has consented to receive notice; (ii) if by electronic mail, when directed to an electronic mail address at which the stockholder has consented to receive such notice; (iii) if by posting on an electronic network together with a separate notice to the stockholder of such specific posting, upon the later to occur of (A) such posting and (B) the giving of such separate notice of such posting; and (iv) if by any other form of electronic communication, when directed to the stockholder in the manner consented to by the stockholder. An affidavit of the secretary or an assistant secretary, or of the transfer agent of the corporation that the notice has been given by a form of electronic transmission shall, in the absence of fraud, be prima facie evidence of the facts stated therein.
(d)    If a stockholder meeting is to be held via electronic communications and stockholders will take action at such meeting, the notice of such meeting must: (i) specify the means of remote communications, if any, by which stockholders and proxy holders may be deemed to be present and vote at such meeting; and (ii) provide the information required to access the stockholder list. A waiver of notice may be given by electronic transmission.
(e)    Without limiting the manner by which notice otherwise may be given effectively to stockholders, and except as prohibited by applicable law, any notice to stockholders given by the corporation under any provision of applicable law, the certificate of incorporation, or these Bylaws shall be effective if given by a single written notice to stockholders who share an address if consented to by the stockholders at that address to whom such notice is given. Any such consent shall be revocable by the stockholder by written notice to the corporation. Any stockholder who fails to object in writing to the corporation, within 60 days of having been given written notice by the corporation of its intention to send the single notice permitted under this Section 2.6, shall be deemed to have consented to receiving such single written notice.
2.7    Quorum. The holders of a majority in voting power of the stock issued and outstanding and entitled to vote thereat, present in person or represented by proxy, shall constitute a quorum at all meetings of the stockholders for the transaction of business except as otherwise provided by statute or by the Certificate of Incorporation. If, however, such quorum is not present or represented at any meeting of the stockholders, then either (i) the chairman of the meeting or (ii) the stockholders by the vote of the holders of a majority of the stock, present in person or represented by proxy shall have power to adjourn the meeting in accordance with Section 2.8 of these Bylaws.
When a quorum is present at any meeting, the vote of the holders of a majority of the stock having voting power present in person or represented by proxy shall decide any question brought before such meeting, unless the question is one upon which, by express provision of the laws of the State of Delaware or of the Certificate of Incorporation or these Bylaws, a vote of a greater number or voting by classes is required, in which case such express provision shall govern and control the decision of the question.
If a quorum be initially present, the stockholders may continue to transact business until adjournment, notwithstanding the withdrawal of enough stockholders to leave less than a quorum, if any action taken is approved by a majority of the stockholders initially constituting the quorum.
2.8    Adjourned Meeting; Notice. In addition to, for the avoidance of doubt, the power of the chairman (as referred to in Section 2.4 of these Bylaws) of the applicable stockholders’ meeting, annual or special, to adjourn such a meeting from time to time, whether or not a quorum is present, any stockholders’ meeting, annual or special, whether or not a quorum is present, may be adjourned from time to time by the vote of the majority of the voting power of the shares represented at that meeting, either in person or by proxy. In the absence of a quorum, no other business may be transacted at that meeting except as provided in Section 2.7 of these Bylaws.
When any meeting of stockholders, either annual or special, is adjourned to another time or place, notice need not be given of the adjourned meeting if the time and place are announced at the meeting at which the adjournment is taken. However, if a new record date for the adjourned meeting is fixed or if the adjournment is for more than thirty (30) days from the date set for the original meeting, then notice of the adjourned meeting shall be given. Notice of any such adjourned meeting shall be given to each stockholder of record entitled to vote at the adjourned meeting in accordance with the provisions of Sections 2.5 and 2.6 of these Bylaws. At any adjourned meeting the corporation may transact any business which might have been transacted at the original meeting.
2.9    Voting. The stockholders entitled to vote at any meeting of stockholders shall be determined in accordance with the provisions of Section 2.12 of these Bylaws, subject to the provisions of Sections 217 and 218 of the General Corporation Law of Delaware (relating to voting rights of fiduciaries, pledgers and joint owners, and to voting trusts and other voting agreements).
Except as may be otherwise provided in the Certificate of Incorporation, by these Bylaws or required by law, each stockholder shall be entitled to one vote for each share of capital stock held by such stockholder.
Any stockholder entitled to vote on any matter may vote part of the shares in favor of the proposal and refrain from voting the remaining shares or, except when the matter is the election of directors, may vote them against the proposal; but if the stockholder fails to specify the number of shares which the stockholder is voting affirmatively, it will be conclusively presumed that the stockholder’s approving vote is with respect to all shares which the stockholder is entitled to vote.
2.10    Validation of Meetings; Waiver of Notice; Consent. The transactions of any meeting of stockholders, either annual or special, however called and noticed, and wherever held, shall be as valid as though they had been taken at a meeting duly held after regular call and notice, if a quorum be present either in person or by proxy.
Whenever notice is required to be given under any provision of the General Corporation Law of Delaware or of the Certificate of Incorporation or these Bylaws, a written waiver thereto, signed by the person entitled to notice, whether before or after the time stated therein, will be deemed equivalent to notice. Attendance by a person at a meeting shall also constitute a waiver of notice of and presence at that meeting, except when the person objects at the beginning of the meeting to the transaction of any business because the meeting is not lawfully called or convened. Attendance at a meeting is not a waiver of any right to object to the consideration of matters required by law to be included in the notice of the meeting but not so included, if that objection is expressly made at the meeting. Neither the business to be transacted at, nor the purpose of, any regular or special meeting of the stockholders need be specified in any written waiver of notice unless so required by the Certificate of Incorporation or these Bylaws.
2.11    No Stockholder Action by Written Consent. Effective as of the Trigger Date, any action required or permitted to be taken by the stockholders of the corporation must be effected at a duly called annual or special meeting of such holders and may not be effected by any consent in writing by such holders.
2.12    Record Date for Stockholder Notice; Voting; Giving Consents. For purposes of determining the stockholders entitled to notice of any meeting or to vote thereat, the board of directors may fix, in advance, a record date, which shall not be more than sixty (60) days nor less than ten (10) days before the date of any such meeting, and in such event only stockholders of record on the date so fixed are entitled to notice and to vote, notwithstanding any transfer of any shares on the books of the corporation after the record date, except as otherwise provided in the Certificate of Incorporation, by these Bylaws, by agreement or by applicable law.
If the board of directors does not so fix a record date, the record date for determining stockholders entitled to notice of or to vote at a meeting of stockholders shall be at the close of business on the business day next preceding the day on which notice is given, or, if notice is waived, at the close of business on the business day next preceding the day on which the meeting is held.
A determination of stockholders of record entitled to notice of or to vote at a meeting of stockholders shall apply to any adjournment of the meeting unless the board of directors fixes a new record date for the adjourned meeting, but the board of directors shall fix a new record date if the meeting is adjourned for more than thirty (30) days from the date set for the original meeting.
The record date for any other purpose shall be as provided in Section 8.1 of these Bylaws.
2.13    Proxies. Every person entitled to vote for directors, or on any other matter, shall have the right to do so either in person or by one or more agents authorized by a written proxy filed with the secretary of the corporation. A written proxy may be in the form of a telegram, cablegram, or other means of electronic transmission which sets forth or is submitted with information from which it can be determined that the telegram, cablegram, or other means of electronic transmission was authorized by the person. No such proxy shall be voted or acted upon after three (3) years from its date, unless the proxy provides for a longer period. A duly executed proxy shall be irrevocable if it states that it is irrevocable and if, and only as long as, it is coupled with an interest sufficient in law to support an irrevocable power. The revocability of a proxy that states on its face that it is irrevocable shall be governed by the provisions of Section 212(e) of the General Corporation Law of Delaware. A stockholder may revoke any proxy which is not irrevocable by attending the meeting and voting in person or by filing an instrument in writing revoking the proxy or by filing another duly executed proxy bearing a later date with the secretary of the corporation.
A proxy is not revoked by the death or incapacity of the maker unless, before the vote is counted, written notice of such death or incapacity is received by the corporation.
2.14    Inspectors of Election. Before any meeting of stockholders, the board of directors shall appoint an inspector or inspectors of election to act at the meeting or its adjournment. The number of inspectors shall be either one (1) or three (3). If any person appointed as inspector fails to appear or fails or refuses to act, then the chairman of the meeting may, and upon the request of any stockholder or a stockholder’s proxy shall, appoint a person to fill that vacancy.
Such inspectors shall have such duties as prescribed by applicable law or as assigned.
The inspectors of election shall perform their duties impartially, in good faith, to the best of their ability and as expeditiously as is practical. If there are three (3) inspectors of election, the decision, act or certificate of a majority is effective in all respects as the decision, act or certificate of all. Any report or certificate made by the inspectors of election is prima facie evidence of the facts stated therein.
ARTICLE III    
DIRECTORS
3.1    Powers. Subject to the provisions of the General Corporation Law of Delaware and to any limitations in the Certificate of Incorporation or these Bylaws relating to action required to be approved by the stockholders or by the outstanding shares, the business and affairs of the corporation shall be managed and all corporate powers shall be exercised by or under the direction of the board of directors.
3.2    Number. The authorized number of directors shall be fixed and may be changed from time to time by resolution of the board of directors.
No reduction of the authorized number of directors shall have the effect of removing any director before that director’s term of office expires. If for any cause, the directors shall not have been elected at an annual meeting, they may be elected as soon thereafter as convenient at a special meeting of the stockholders called for that purpose in the manner provided in these Bylaws.
3.3    Election and Term of Office of Directors. Except as provided in the Certificate of Incorporation or Section 3.4 of these Bylaws, directors shall be classified, with respect to the time for which they severally hold office, into three classes, as nearly equal in number as possible, one class to be originally elected for a term expiring at the annual meeting of stockholders to be held in 2000, another class to be originally elected for a term expiring at the annual meeting of stockholders to be held in 2001, and another class to be originally elected for a term expiring at the annual meeting of stockholders to be held in 2002, with each class to hold office until its successor is duly elected and qualified. At each succeeding annual meeting of stockholders, directors elected to succeed those directors whose terms then expire shall be elected for a term of office to expire at the third succeeding annual meeting of stockholders after their election, with each director to hold office until such person’s successor shall have been elected and qualified or until such person’s earlier resignation or removal. Each director, including a director elected or appointed to fill a vacancy, shall hold office until his successor is elected and qualified or until his earlier resignation or removal.
Except as provided in Section 3.4 of these Bylaws, each director shall be elected by the vote of a majority of the votes cast with respect to the director at any meeting for the election of directors at which a quorum is present, provided that if the number of nominees exceeds the number of directors to be elected, the directors shall be elected by the vote of a plurality of the shares represented in person or by proxy at any such meeting and entitled to vote on the election of directors. For purposes of this paragraph, a majority of the votes cast means that the number of shares voted “for” a director must exceed 50% of the votes cast with respect to that director. The votes cast shall include votes to withhold authority in each case and exclude abstentions with respect to that director’s election. If an incumbent director is not elected due to a failure to receive a majority of the votes cast as described above and his or her successor is not otherwise elected and qualified, the director shall offer to tender his or her resignation to the board of directors promptly following the certification of the stockholder vote. The Nominating/
Corporate Governance Committee will consider the offer to resign and make a recommendation to the board of directors on whether to accept or reject the resignation, or whether other action should be taken. The board of directors will act on the Committee’s recommendation and publicly disclose its decision and the rationale behind it within 90 days from the date of the certification of the election results. Any director who tenders his or her offer to resign shall not participate in either the Nominating/Corporate Governance Committee’s or board of directors’ consideration or other actions regarding whether to accept the resignation offer. However, if each member of the Nominating/Corporate Governance Committee failed to receive a majority of the votes cast at the same election, then the independent directors who did receive a majority of the votes cast shall appoint a committee amongst themselves to consider the resignation offers and recommend to the board of directors whether to accept them. However, if the only directors who received a majority of the votes cast in the same election constitute three or fewer directors, all directors may participate in the action regarding whether to accept the resignation offers.
If an incumbent director offers to resign pursuant to the foregoing paragraph and the resignation offer is not accepted by the board of directors, such director shall continue to serve until the next annual meeting and until his or her successor is duly elected, or his or her earlier resignation or removal. If a director’s resignation is accepted by the board of directors, or if a nominee for director is not elected and the nominee is not an incumbent director, then the board of directors, in its sole discretion, may fill any resulting vacancy pursuant to the provisions of Section 3.4 hereof or may decrease the size of the board of directors pursuant to the provisions of Section 3.2 hereof.
Except as otherwise provided in the foregoing two paragraphs, each director, including a director elected or appointed to fill a vacancy, shall hold office until his successor is elected and qualified or until his earlier resignation or removal.
Directors need not be stockholders unless so required by the Certificate of Incorporation or by these Bylaws; wherein other qualifications for directors may be prescribed. Election of directors need not be by written ballot unless so required by the Certificate of Incorporation or by these Bylaws; wherein other qualifications for directors may be prescribed.
3.4    Resignation and Vacancies. Any director may resign effective on giving written notice to the chairman of the board, the chief executive officer, the secretary or the board of directors, unless the notice specifies a later time for that resignation to become effective. If the resignation of a director is effective at a future time, the board of directors may elect a successor to take office when the resignation becomes effective.
Unless otherwise provided in the Certificate of Incorporation or these Bylaws:
(a)    Vacancies and newly created directorships resulting from any increase in the authorized number of directors elected by all of the stockholders having the right to vote as a single class may be filled by a majority of the directors then in office, even if less than a quorum, or by a sole remaining director. Each director so elected shall hold office for the remainder of the full term of the class of directors in which the new directorship was created or the vacancy occurred and until a successor has been elected and qualified.
(b)    Whenever the holders of any class or classes of stock or series thereof are entitled to elect one or more directors by the provisions of the Certificate of Incorporation, vacancies and newly created directorships of such class or classes or series may be filled by a majority of the directors elected by such class or classes or series thereof then in office, or by a sole remaining director so elected.
If at any time, by reason of death or resignation or other cause, the corporation should have no directors in office, then any officer or any stockholder or an executor, administrator, trustee or guardian of a stockholder, or other fiduciary entrusted with like responsibility for the person or estate of a stockholder, may call a special meeting of stockholders solely for he purpose of electing directors in accordance with the provisions of the Certificate of Incorporation or these Bylaws, or may apply to the Court of Chancery for a decree summarily ordering an election as provided in Section 211 of the General Corporation Law of Delaware.
If, at the time of filling any vacancy or any newly created directorship, the directors then in office constitute less than a majority of the whole board (as constituted immediately prior to any such increase), then the Court of Chancery may, upon application of any stockholder or stockholders holding at least ten percent (10%) of the total number of the then outstanding shares having the right to vote for such directors, summarily order an election to be held to fill any such vacancies or newly created directorships, or to replace the directors chosen by the directors then in office as aforesaid, which election shall be governed by the provisions of Section 211 of the General Corporation Law of Delaware as far as applicable.
3.5    Removal. Unless otherwise restricted by statute, by the Certificate of Incorporation or by these Bylaws, any director or the entire board of directors may be removed from office only for cause by the holders of a majority of the shares then entitled to vote at an election of directors.
3.6    Place of Meetings; Meetings by Telephone. Regular meetings of the board of directors may be held at any place within or outside the State of Delaware that has been designated from time to time by resolution of the board of directors. In the absence of such a designation, regular meetings shall be held at the principal executive office of the corporation. Special meetings of the board of directors may be held at any place within or outside the State of Delaware that has been designated in the notice of the meeting or, if not stated in the notice or if there is no notice, at the principal executive office of the corporation.
Any meeting, regular or special, may be held by conference telephone or similar communication equipment, so long as all directors participating in the meeting can hear one another; and all such directors shall be deemed to be present in person at the meeting.
3.7    Regular Meetings. Regular meetings of the board of directors may be held without notice if the times of such meetings are fixed by the board of directors.
3.8    Special Meetings; Notice. Special meetings of the board of directors for any purpose or purposes may be called at any time by the chairman of the board, the vice chairman of the board, the chief executive officer, the president, the chairman of the executive committee, any vice president or the secretary or by any two (2) or more of the directors.
Notice of the time and place of special meetings shall be delivered personally or by telephone to each director or sent by mail, facsimile, electronic mail, posting on an electronic network or other electronic or wireless means to the extent and in the manner permitted by applicable law, charges prepaid, addressed to each director at that director’s address, facsimile number, electronic mail address or other electronic address, as the case may be, as it is shown on the records of the corporation or if the address is not readily ascertainable, notice shall be addressed to the director at the city or place in which the meetings of directors are regularly held. If the notice is mailed, it shall be deposited in the United States mail at least four (4) days before the time of the holding of the meeting. If the notice is delivered personally or by telephone, facsimile, electronic mail, posting on an electronic network or other electronic or wireless means, it shall be delivered at least twenty-four (24) hours before the time of the holding of the meeting. Any oral notice given personally or by telephone may be communicated either to the director or to a person at the office of the director who the person giving the notice has reason to believe will promptly communicate it to the director. If the meeting is to be held at the principal executive office of the corporation, the notice need not specify the place of the meeting. Moreover, a notice of special meeting need not state the purpose of such meeting, and, unless indicated in the notice thereof, any and all business may be transacted at a special meeting.
3.9    Quorum. A majority of the authorized number of directors shall constitute a quorum for the transaction of business, except to fill vacancies in the board of directors as provided in Section 3.4 and to adjourn as provided in Section 3.11 of these Bylaws. Every act or decision done or made by a majority of the directors present at a duly held meeting at which a quorum is present shall be regarded as the act of the board of directors, subject to the provisions of the Certificate of Incorporation and applicable law.
3.10    Waiver of Notice. Notice of a meeting need not be given to any director (i) who waives notice of the meeting in writing or by electronic transmission, whether before or after the meeting, or (ii) who attends the meeting without protesting, prior thereto or at its commencement, the lack of notice to such directors. The transactions of any meeting of the board, however called and noticed or wherever held, are as valid as though had at a meeting duly held after regular call and notice if a quorum is present and if, either before or after the meeting, each of the directors not present signs a written waiver of notice. All such waivers shall be filed with the corporate records or made part of the minutes of the meeting. A waiver of notice need not specify the purpose of any regular or special meeting of the board of directors.
3.11    Adjournment. A majority of the directors present, whether or not constituting a quorum, may adjourn any meeting to another time and place.
3.12    Notice of Adjournment. Notice of the time and place of holding an adjourned meeting need not be given if announced unless the meeting is adjourned for more than twenty-four (24) hours. If the meeting is adjourned for more than twenty-four (24) hours, then notice of the time and place of the adjourned meeting shall be given before the adjourned meeting takes place, in the manner specified in Section 3.8 of these Bylaws, to the directors who were not present at the time of the adjournment.
3.13    Board Action by Written Consent Without a Meeting. Any action required or permitted to be taken by the board of directors may be taken without a meeting, provided that all members of the board of directors individually or collectively consent thereto in writing, or by electronic transmission to that action. Such action by written consent shall have the same force and effect as a unanimous vote of the board of directors. Such consent, whether in writing or by electronic transmission, and any counterparts thereof shall be filed with the minutes of the proceedings of the board.
3.14    Organization. Meetings of the board of directors shall be presided over by the chairman of the board, if any, or in his or her absence by the vice chairman of the board, if any, or in his or her absence by the chairman of the executive committee, if any, or in his or her absence by the chief executive officer, if any, or in his or her absence by the president, if any, or in his or her absence by the executive vice president. In the absence of all such directors, a president pro tem chosen by a majority of the directors present shall preside at the meeting. The secretary shall act as secretary of the meeting, but in his or her absence the chairman of the meeting may appoint any person to act as secretary of the meeting.
3.15    Fees and Compensation of Directors. Directors and members of committees may receive such compensation, if any, for their services and such reimbursement of expenses as may be fixed or determined by resolution of the board of directors. This Section 3.15 shall not be construed to preclude any director from serving the corporation in any other capacity as an officer, agent, employee or otherwise and receiving compensation for those services.
ARTICLE IV    
COMMITTEES
4.1    Committees of Directors. The board of directors may designate one (1) or more committees, each consisting of one or more directors, to serve at the pleasure of the board of directors. The board of directors may designate one (1) or more directors as alternate members of any committee, who may replace any absent member at any meeting of the committee. Any committee, to the extent provided in the resolution of the board, shall have all the authority of the board, but no such committee shall have the power or authority to (i) approve or adopt or recommend to the stockholders any action or matter that requires the approval of the stockholders under the General Corporation Law of Delaware or (ii) adopt, amend or repeal any Bylaw of the corporation.
4.2    Meetings and Action of Committees. Meetings and actions of committees shall be governed by, and held and taken in accordance with, the provisions of Article III of these Bylaws, Section 3.6 (place of meetings), Section 3.7 (regular meetings), Section 3.8 (special meetings and notice), Section 3.9 (quorum), Section 3.10 (waiver of notice), Section 3.11 (adjournment), Section 3.12 (notice of adjournment), and Section 3.13 (action without meeting), with such changes in the context of those Bylaws as are necessary to substitute the committee and its members for the board of directors and its members; provided, however, that the time of regular meetings of committees may be determined either by resolution of the board of directors or by resolution of the committee, that special meetings of committees may also be called by resolution of the board of directors, and that notice of special meetings of committees shall also be given to all alternate members, who shall have the right to attend all meetings of the committee. The board of directors may adopt rules for the government of any committee not inconsistent with the provisions of these Bylaws.
4.3    Committee Minutes. Each committee shall keep regular minutes of its meetings and report the same to the board of directors when required.
4.4    Executive Committee. In the event that the board of directors appoints an executive committee, such executive committee, in all cases in which specific directions to the contrary shall not have been given by the board of directors, shall have and may exercise, during the intervals between the meetings of the board of directors, all the powers and authority of the board of directors in the management of the business and affairs of the corporation (except as provided in Section 4.1 hereof) in such manner as the executive committee may deem in the best interests of the corporation.
ARTICLE V    
OFFICERS
5.1    Officers. The officers of this corporation shall consist of a chief executive officer, a president, one or more vice presidents, a secretary and a chief financial officer who shall be chosen by the board of directors and such other officers, including but not limited to a chairman of the board, a vice chairman of the board, a chairman of the executive committee and a treasurer as the board of directors shall deem expedient, who shall be chosen in such manner and hold their offices for such terms as the board of directors may prescribe. Any two or more of such offices may be held by the same person. The board of directors may designate one or more vice presidents as executive vice presidents or senior vice presidents. The board of directors may from time to time designate the president or any executive vice president as the chief operating officer of the corporation. Any vice president, treasurer or assistant treasurer, or assistant secretary respectively may exercise any of the powers of the chief executive officer, the president, the chief financial officer, or the secretary, respectively, as directed by the board of directors and shall perform such other duties as are imposed upon such officer by the Bylaws or the board of directors.
5.2    Election of Officers. In addition to officers elected by the board of directors in accordance with Sections 5.1 and 5.3, the corporation may have one or more appointed vice presidents. Such vice presidents may be appointed by the chairman of the board, the chief executive officer or the president and shall have such duties as may be established by the chairman, the chief executive officer or president. Vice presidents appointed pursuant to this Section 5.2 may be removed in accordance with Section 5.4.
5.3    Terms of Office and Compensation. The term of office and salary of each of said officers and the manner and time of the payment of such salaries shall be fixed and determined by the board of directors and may be altered by said board from time to time at its pleasure, subject to the rights, if any, of said officers under any contract of employment.
5.4    Removal; Resignation of Officers and Vacancies. Any officer of the corporation may be removed at the pleasure of the board of directors at any meeting or, except in the case of an officer chosen by the board of directors, at the pleasure of any officer who may be granted such power by a resolution of the board of directors. Any officer may resign at any time upon written notice to the corporation without prejudice to the rights, if any, of the corporation under any contract to which the officer is a party. If any vacancy occurs in any office of the corporation, the board of directors may elect a successor to fill such vacancy for the remainder of the unexpired term and until a successor is duly chosen and qualified.
5.5    Chairman of the Board. The chairman of the board, if such an officer be elected, shall have general supervision, direction and control of the corporation’s business and its officers, and, if present, preside at meetings of the stockholders and the board of directors and exercise and perform such other powers and duties as may from time to time be assigned to him by the board of directors or as may be prescribed by these Bylaws. The chairman of the board shall report to the board of directors.
5.6    Vice Chairman of the Board. The vice chairman of the board of directors, if there shall be one, shall, in the case of the absence, disability or death of the chairman, exercise all the powers and perform all the duties of the chairman of the board. The vice chairman shall have such other powers and perform such other duties as may be granted or prescribed by the board of directors.
5.7    Chairman of Executive Committee. The chairman of the executive committee, if there be one, shall have the power to call meetings of the board of directors to be held subject to the limitations prescribed by law or by these Bylaws, at such times and at such places as the chairman of the executive committee shall deem proper. The chairman of the executive committee shall have such other powers and be subject to such other duties as the board of directors may from time to time prescribe.
5.8    Chief Executive Officer; President.
(a)    The powers and duties of the chief executive officer are:
(i)    To call meetings of the board of directors to be held, subject to the limitations prescribed by law or by these Bylaws, at such times and at such places as the chief executive officer shall deem proper.
(ii)    To affix the signature of the corporation to all deeds, conveyances, mortgages, leases, obligations, bonds, certificates and other papers and instruments in writing which have been authorized by the board of directors or which, in the judgment of the chief executive officer, should be executed on behalf of the corporation.
(iii)    To have such other powers and be subject to such other duties as the board of directors may from time to time prescribe.
(b)    The powers and duties of the president are:
(i)    To affix the signature of the corporation to all deeds, conveyances, mortgages, leases, obligations, bonds, certificates and other papers and instruments in writing which have been authorized by the board of directors or which, in the judgment of the president, should be executed on behalf of the corporation.
(ii)    To have such other powers and be subject to such other duties as the board of directors may from time to time prescribe.
5.9    Vice Presidents. In case of the absence, disability or death of the president, the elected vice president, or one of the elected vice presidents, shall exercise all the powers and perform all the duties of the president. If there is more than one elected vice president, the order in which the elected vice presidents shall succeed to the powers and duties of the president shall be as fixed by the board of directors. The elected vice president or elected vice presidents shall have such other powers and perform such other duties as may be granted or prescribed by the board of directors.
Vice presidents appointed pursuant to Section 5.2 shall have such powers and duties as may be fixed by the chairman, chief executive officer or president, except that such appointed vice presidents may not exercise the powers and duties of the chief executive officer or president.
5.10    Secretary. The powers and duties of the secretary are:
(a)    To keep a book of minutes at the principal office of the corporation, or such other place as the board of directors may order, of all meetings of its directors and stockholders with the time and place of holding, whether regular or special, and, if special, how authorized, the notice thereof given, the names of those present at directors’ meetings, the number of shares present or represented at stockholders’ meetings and the proceedings thereof.
(b)    To keep the seal of the corporation and affix the same to all instruments which may require it.
(c)    To keep or cause to be kept at the principal office of the corporation, or at the office of the transfer agent or agents, a share register, or duplicate share registers, showing the names of the stockholders and their addresses, the number of and classes of shares, and the number and date of cancellation of every certificate surrendered for cancellation.
(d)    To keep a supply of certificates for shares of the corporation, to fill in all certificates issued, and to make a proper record of each such issuance; provided, that so long as the corporation shall have one or more duly appointed and acting transfer agents of the shares, or any class or series of shares, of the corporation, such duties with respect to such shares shall be performed by such transfer agent or transfer agents.
(e)    To transfer upon the share books of the corporation any and all shares of the corporation upon the surrender of a properly endorsed certificate or certificates for a like number of shares (or, with respect to uncertificated shares, by delivery of duly executed instructions or in any other manner permitted by applicable law); provided, that so long as the corporation shall have one or more duly appointed and acting transfer agents of the shares, or any class or series of shares, of the corporation, such duties with respect to such shares shall be performed by such transfer agent or transfer agents, and the method of transfer of each certificate shall be subject to the reasonable regulations of the transfer agent, and also, if the corporation then has one or more duly appointed and acting registrars, to the reasonable regulations of the registrar; and provided, further that no certificate for shares of stock shall be issued or delivered or, if issued or delivered, shall have any validity whatsoever until and unless it has been signed or authenticated in the manner provided in Section 8.5 hereof.
(f)    To make service and publication of all notices that may be necessary or proper, and without command or direction from anyone. In case of the absence, disability, refusal, or neglect of the secretary to make service or publication of any notices, then such notices may be served and/or published by the president or a vice president, or by any person thereunto authorized by either of them or by the board of directors or by the holders of a majority of the outstanding shares of the corporation.
(g)    Generally to do and perform all such duties as pertain to the office of secretary and as may be required by the board of directors.
5.11    Chief Financial Officer. The powers and duties of the chief financial officer are:
(a)    To supervise the corporate-wide treasury functions and financial reporting to external bodies.
(b)    To have the custody of all funds, securities, evidence of indebtedness and other valuable documents of the corporation and, at the chief financial officer’s discretion, to cause any or all thereof to be deposited for account of the corporation at such depositary as may be designated from time to time by the board of directors.
(c)    To receive or cause to be received, and to give or cause to be given, receipts and acquaintances for monies paid in for the account of the corporation.
(d)    To disburse, or cause to be disbursed, all funds of the corporation as may be directed by the board of directors, taking proper vouchers for such disbursements.
(e)    To render to the chief executive officer and to the board of directors, whenever they may require, accounts of all transactions and of the financial condition of the corporation.
(f)    Generally to do and perform all such duties as pertain to the office of chief financial officer and as may be required by the board of directors.
ARTICLE VI    
INDEMNIFICATION OF DIRECTORS, OFFICERS, EMPLOYEES
AND OTHER AGENTS
6.1    Indemnification of Directors and Officers. The corporation shall, to the maximum extent and in the manner permitted by the General Corporation Law of Delaware, indemnify each of its directors and officers against expenses (including attorneys’ fees), judgments, fines, settlements and other amounts actually and reasonably incurred in connection with any action, suit or proceeding, whether civil, criminal, administrative or investigative (a “proceeding”), arising by reason of the fact that such person is or was a director or officer of the corporation; provided, however, that the corporation may modify the extent of such indemnification by individual contracts with its directors and executive officers and, provided, further, that, subject to Section 6.5 hereof the corporation shall not be required to indemnify any director or officer in connection with any proceeding (or part thereof) initiated by such person unless (i) such indemnification is expressly required to be made by law, (ii) the proceeding was authorized in advance by the board of directors of the corporation, (iii) such indemnification is provided by the corporation, in its sole discretion, pursuant to the powers vested in the corporation under the General Corporation Law of Delaware or (iv) such indemnification is required to be made pursuant to an individual contract. For purposes of this Section 6.1, a “director” or “officer” of the corporation includes any person (i) who is or was a director or officer of the corporation, (ii) who is or was serving at the request of the corporation as a director or officer of another corporation, partnership, joint venture, trust or other enterprise, including service with respect to employee benefit plans, or (iii) who was a director or officer of a corporation which was a predecessor corporation of the corporation or of another enterprise at the request of such predecessor corporation.
6.2    Indemnification of Others. The corporation shall have the power, to the maximum extent and in the manner permitted by the General Corporation Law of Delaware, to indemnify each of its employees and agents (other than directors and officers) against expenses (including attorneys’ fees), judgments, fines, settlements and other amounts actually and reasonably incurred in connection with any proceeding, arising by reason of the fact that such person is or was an employee or agent of the corporation. For purposes of this Section 6.2, an “employee” or “agent” of the corporation (other than a director or officer) includes any person (i) who is or was an employee or agent of the corporation, (ii) who is or was serving at the request of the corporation as an employee or agent of another corporation, partnership, joint venture, trust or other enterprise, including service with respect to employee benefit plans, or (iii) who was an employee or agent of a corporation which was a predecessor corporation of the corporation or of another enterprise at the request of such predecessor corporation.
6.3    Insurance. The corporation may purchase and maintain insurance on behalf of any person who is or was a director, officer, employee or agent of the corporation, or is or was serving at the request of the corporation as a director, officer, employee or agent of another corporation, limited liability company, partnership, joint venture, trust or other enterprise, including service with respect to employee benefit plans, against any liability asserted against him or her and incurred by him or her in any such capacity, or arising out of his or her status as such, whether or not the corporation would have the power to indemnify him or her against such liability under the provisions of the General Corporation Law of Delaware.
6.4    Expenses. The corporation shall advance to any person who was or is a party or is threatened to be made a party to any threatened, pending or completed action, suit or proceeding, whether civil, criminal, administrative or investigative, by reason of the fact that he or she is or was a director or officer of the corporation, or is or was serving at the request of the corporation as a director or officer of another corporation, limited liability company, partnership, joint venture, trust or other enterprise, including service with respect to employee benefit plans, prior to the final disposition of the proceeding, promptly following request therefor, all expenses incurred by any director or officer in connection with such proceeding, provided, however, that to the extent required by law, such payment of expenses in advance of the final disposition of the proceeding shall be made only upon receipt of an undertaking by or on behalf of such person to repay said amounts advanced if it should be determined ultimately that such person is not entitled to be indemnified under this Bylaw or otherwise; provided, however, that the corporation shall not be required to advance expenses to any director or officer in connection with any proceeding (or part thereof) initiated by such person unless (i) the proceeding was authorized in advance by the board of directors of the corporation or (ii) such advancement of expenses is required to be made pursuant to an individual contract.
Notwithstanding the foregoing, unless otherwise determined pursuant to Section 6.6 or required to be made pursuant to an individual contract, no advance shall be made by the corporation to an officer of the corporation (except by reason of the fact that such officer is or was a director of the corporation in which event this paragraph shall not apply) in any action, suit or proceeding, whether civil, criminal, administrative or investigative, if a determination is reasonably and promptly made (i) by a majority vote of the directors who are not parties to the proceeding, or (ii) if there are no such directors, or if such directors so direct, by independent legal counsel in a written opinion, that the facts known to the decision-making party at the time such determination is made demonstrate clearly and convincingly that such person acted in bad faith or in a manner that such person did not reasonably believe to be in or not opposed to the best interests of the corporation.
6.5    Claims. If a claim for indemnification (following the final disposition of such action, suit or proceeding) or advancement of expenses under this Article VI is not paid in full within forty-five (45) days after a written claim therefor has been received by the corporation, the director or officer may file suit to recover the unpaid amount of such claim and, if successful, in whole or in part, shall be entitled to be paid the expense of prosecuting such claim to the fullest extent permitted by law.
6.6    Non-Exclusivity of Rights. The rights conferred on any person by this Bylaw shall not be exclusive of any other right which such person may have or hereafter acquire under any statute, provision of the Certificate of Incorporation, Bylaws, agreement, vote of stockholders or disinterested directors or otherwise, both as to action in his official capacity and as to action in another capacity while holding office. The corporation is specifically authorized to enter into individual contracts with any or all of its directors, officers, employees or agents respecting indemnification and advances, to the fullest extent not prohibited by the General Corporation Law of Delaware.
6.7    Other Sources. The corporation’s obligation, if any, to indemnify or to advance expenses to any person so entitled pursuant to this Article VI who was or is serving at the request of the corporation as a director, officer, employee or agent of another corporation, limited liability company, partnership, joint venture, trust or other enterprise, including service with respect to employee benefit plans, shall be reduced by any amount such person may collect as indemnification or advancement of expenses from such other corporation, limited liability company, partnership, joint venture, trust or other enterprise.
6.8    Survival of Rights. The rights conferred on any person by this Bylaw shall continue as to a person who has ceased to be a director, officer, employee or other agent and shall inure to the benefit of the heirs, executors and administrators of such a person.
6.9    Amendments. Any repeal or modification of this Bylaw shall only be prospective and shall not adversely affect the rights under this Bylaw in effect at the time of the alleged occurrence of any action or omission to act that is the cause of any proceeding against any agent of the corporation.
ARTICLE VII    
RECORDS AND REPORTS
7.1    Maintenance and Inspection of Records. The corporation shall, either at its principal executive office or at such place or places as designated by the board of directors, keep a record of its stockholders listing their names and addresses and the number and class of shares held by each stockholder, a copy of these Bylaws as amended to date, accounting books and other records.
Any stockholder of record, in person or by attorney or other agent, shall, upon written demand under oath stating the purpose thereof, have the right during the usual hours for business to inspect for any proper purpose the corporation’s stock ledger, a list of its stockholders, and its other books and records and to make copies or extracts therefrom. A proper purpose shall mean a purpose reasonably related to such person’s interest as a stockholder. In every instance where an attorney or other agent is the person who seeks the right to inspection, the demand under oath shall be accompanied by a power of attorney or such other writing that authorizes the attorney or other agent to so act on behalf of the stockholder. The demand under oath shall be directed to the corporation at its registered office in Delaware or at its principal place of business.
7.2    Inspection by Director. Any director shall have the right to examine the corporation’s stock ledger, a list of its stockholders and its other books and records for a purpose reasonably related to his or her position as a director. The Court of Chancery is hereby vested with the exclusive jurisdiction to determine whether a director is entitled to the inspection sought. The Court may summarily order the corporation to permit the director to inspect any and all books and records, the stock ledger, and the stock list and to make copies or extracts therefrom. The Court may, in its discretion, prescribe any limitations or conditions with reference to the inspection, or award such other and further relief as the Court may deem just and proper.
7.3    Representation of Shares of Other Corporations. The chief executive officer, president or any other officer of this corporation authorized by the board of directors is authorized to vote, represent, and exercise on behalf of this corporation all rights incident to any and all shares or other equity securities of any other entity or entities standing in the name of this corporation. The authority herein granted may be exercised either by such person directly or by any other person authorized to do so by proxy or power of attorney duly executed by such person having the authority.
ARTICLE VIII    
GENERAL MATTERS
8.1    Record Date for Purposes Other than Notice and Voting. For purposes of determining the stockholders entitled to receive payment of any dividend or other distribution or allotment of any rights or the stockholders entitled to exercise any rights in respect of any other lawful action, the board of directors may fix, in advance, a record date, which shall not be more than sixty (60) days before any such action. In that case, only stockholders of record at the close of business on the date so fixed are entitled to receive the dividend, distribution or allotment of rights, or to exercise such rights, as the case may be, notwithstanding any transfer of any shares on the books of the corporation after the record date so fixed, except as otherwise provided in the Certificate of Incorporation, by these Bylaws, by agreement or by law.
If the board of directors does not so fix a record date, then the record date for determining stockholders for any such purpose shall be at the close of business on the day on which the board adopts the applicable resolution or the sixtieth (60th) day before the date of that action, whichever is later.
8.2    Checks; Drafts; Evidences of Indebtedness. From time to time, the board of directors shall determine by resolution which person or persons may sign or endorse all checks, drafts, other orders for payment of money, notes or other evidences of indebtedness that are issued in the name of or payable to the corporation, and only the persons so authorized shall sign or endorse those instruments.
8.3    Corporate Contracts and Instruments; How Executed. The board of directors, except as otherwise provided in these Bylaws, may authorize any officer or officers, or agent or agents, to enter into any contract or execute any instrument in the name of and on behalf of the corporation; such authority may be general or confined to specific instances. Unless so authorized or ratified by the board of directors or within the agency power of an officer, no officer, agent or employee shall have any power or authority to bind the corporation by any contract or engagement or to pledge its credit or to render it liable for any purpose or for any amount.
8.4    Fiscal Year. The fiscal year of this corporation shall begin on the first day of November of each year and end on the last day of October of the following year.
8.5    Stock Certificates. There shall be issued to each holder of fully paid shares of the capital stock of the corporation a certificate or certificates for such shares; provided that the board of directors may provide by resolution or resolutions that some or all of any or all classes or series of its stock shall be uncertificated shares. Any such resolution shall not apply to shares represented by a certificate until such certificate is surrendered to the corporation. Every holder of shares of the corporation represented by certificates shall be entitled to have a certificate signed by, or in the name of the corporation by, the chairman or vice chairman of the board of directors, or the chief executive officer or the president or a vice president, and by the treasurer or an assistant treasurer, or the secretary or an assistant secretary of such corporation representing the number of shares registered in certificate form. Any or all of the signatures on the certificate may be a facsimile. In case any officer, transfer agent or registrar who has signed or whose facsimile signature has been placed upon a certificate has ceased to be such officer, transfer agent or registrar before such certificate is issued, it may be issued by the corporation with the same effect as if he or she were such officer, transfer agent or registrar at the date of issue.
8.6    Special Designation on Certificates. If the corporation is authorized to issue more than one class of stock or more than one series of any class, then the powers, the designations, the preferences, and the relative, participating, optional or other special rights of each class of stock or series thereof and the qualifications, limitations or restrictions of such preferences and/or rights shall be set forth in full or summarized on the face or back of the certificate that the corporation shall issue to represent such class or series of stock; provided, however, that, except as otherwise provided in Section 202 of the General Corporation Law of Delaware, in lieu of the foregoing requirements there may be set forth on the face or back of the certificate that the corporation shall issue to represent such class or series of stock a statement that the corporation will furnish without charge to each stockholder who so requests the powers, the designations, the preferences, and the relative, participating, optional or other special rights of each class of stock or series thereof and the qualifications, limitations or restrictions of such preferences and/or rights. Within a reasonable time after the issuance or transfer of uncertificated stock, the corporation shall send to the registered owner thereof a written notice containing the information required to be set forth or stated on certificates pursuant to this Section 8.6 or Section 156, 202(a) or 218(a) of the General Corporation Law of Delaware or, with respect to this Section 8.6, a statement that the corporation will furnish without charge to each stockholder who so requests the powers, designations, preferences and relative participating, optional or other special rights of each class of stock or series thereof and the qualifications, limitations or restrictions of such preferences and/or rights. Except as otherwise expressly provided by law, the rights and obligations of the holders of uncertificated stock and the rights and obligations of the holders of certificates representing stock of the same class and series shall be identical.
8.7    Lost Certificates. The corporation may issue a new share certificate or new certificate for any other security in the place of any certificate theretofore issued by it, alleged to have been lost, stolen or destroyed, and the corporation may require the owner of the lost, stolen or destroyed certificate or the owner’s legal representative to give the corporation a bond (or other adequate security) sufficient to indemnify it against any claim that may be made against it (including any expense or liability) on account of the alleged loss, theft or destruction of any such certificate or the issuance of such new certificate. The board of directors may adopt such other provisions and restrictions with reference to lost certificates, not inconsistent with applicable law, as it shall in its discretion deem appropriate.
8.8    Construction; Definitions. Unless the context requires otherwise, the general provisions, rules of construction, and definitions in the General Corporation Law of Delaware shall govern the construction of these Bylaws. Without limiting the generality of this provision, the singular number includes the plural, the plural number includes the singular, and the term “person” includes both a corporation and a natural person.
8.9    Provisions Additional to Provisions of Law. All restrictions, limitations, requirements and other provisions of these Bylaws shall be construed, insofar as possible, as supplemental and additional to all provisions of law applicable to the subject matter thereof and shall be fully complied with in addition to the said provisions of law unless such compliance shall be illegal.
8.10    Provisions Contrary to Provisions of Law. Any article, section, subsection, subdivision, sentence, clause or phrase of these Bylaws which upon being construed in the manner provided in Section 8.9 hereof, shall be contrary to or inconsistent with any applicable provisions of law, shall not apply so long as said provisions of law shall remain in effect, but such result shall not affect the validity or applicability of any other portions of these Bylaws, it being hereby declared that these Bylaws would have been adopted and each article, section, subsection, subdivision, sentence, clause or phrase thereof, irrespective of the fact that any one or more articles, sections, subsections, subdivisions, sentences, clauses or phrases is or are illegal.
8.11    Notices. Any reference in these Bylaws to the time a notice is given or sent means, unless otherwise expressly provided, the time a written notice by mail is deposited in the United States mails, postage prepaid; or the time any other written notice is personally delivered to the recipient or is delivered to a common carrier for transmission, or actually transmitted by the person giving the notice by electronic means, to the recipient; or the time any oral notice is communicated, in person or by telephone or wireless, to the recipient or to a person at the office of the recipient who the person giving the notice has reason to believe will promptly communicate it to the recipient.
ARTICLE IX    
AMENDMENTS
Subject to Section 6.9 hereof, the original or other bylaws of the corporation may be adopted, amended or repealed (1) at any annual or special meeting of stockholders, by the affirmative vote of the holders of a majority of the voting power of the stock issued and outstanding and entitled to vote thereat, provided, however, that any proposed alteration or repeal of, or the adoption of any Bylaw inconsistent with, Section 2.2, 2.3, 2.5 or 2.11 of Article II of the Bylaws or with Section 3.2, 3.3, 3.4 or 3.5 of Article III of the Bylaws or this sentence, by the stockholders shall require the affirmative vote of the holders of at least 80% of the voting power of all Voting Stock then outstanding, voting together as a single class; and, provided, further, however, that in the case of any such stockholder action at a special meeting of stockholders, notice of the proposed alteration, repeal or adoption of the new Bylaw or Bylaws must be contained in the notice of such special meeting, or (2) by the affirmative vote of a majority of the board of directors. The fact that the power to amend these Bylaws has been so conferred upon the directors shall not divest the stockholders of the power, nor limit their power to adopt, amend or repeal bylaws.
Whenever an amendment or new bylaw is adopted, it shall be copied in the book of bylaws with the original bylaws, in the appropriate place. If any bylaw is repealed, the fact of repeal with the date of the meeting at which the repeal was enacted or the filing of the operative written consent(s) shall be stated in said book.


 EX-4.8 3 a-10312019xexx48.htm EXHIBIT 4.8 Exhibit

Exhibit 4.8
Description of the Registrant’s Securities Registered Pursuant to Section 12 of the Securities Exchange Act of 1934
As of October 31, 2019, Agilent Technologies, Inc. has Common Stock (as defined below) registered under Section 12 of the Securities Exchange Act of 1934, as amended (the “Exchange Act”).
The following description of our Common Stock is a summary and does not purport to be complete. It is subject to and qualified in its entirety by reference to our Amended and Restated Certificate of Incorporation (the “Certificate of Incorporation”) and our Amended and Restated Bylaws (the “Bylaws”), each of which are incorporated by reference as an exhibit to the Annual Report on Form 10-K of which this Exhibit 4.8 is a part. We encourage you to read our Certificate of Incorporation, our Bylaws and the applicable provisions of Delaware General Corporation Law, for additional information.
Authorized Capital Shares
Our authorized capital shares consist of 2,000,000,000 shares of common stock, $0.01 par value per share (“Common Stock”), and 125,000,000 shares of undesignated preferred stock, $0.01 par value per share (“Preferred Stock”). The outstanding shares of our Common Stock are fully paid and nonassessable.
Voting Rights
The holders of Common Stock are entitled to one vote per share on all matters to be voted upon by the stockholders. Our Common Stock does not have cumulative voting rights.
Dividend Rights

Subject to preferences that may be applicable to any outstanding Preferred Stock, the holders of Common Stock are entitled to receive ratably such dividends, if any, as may be declared from time to time by the board of directors out of funds legally available for that purpose.
Liquidation Rights

In the event of our liquidation, dissolution or winding up, the holders of Common Stock are entitled to share ratably in all assets remaining after payment of liabilities, subject to prior distribution rights of Preferred Stock, if any, then outstanding.
Other Rights and Preferences

The holders of Common Stock have no preemptive or conversion rights or other subscription rights. There is no redemption or sinking fund provisions applicable to the Common Stock.
Listing
The Common Stock is traded on the New York Stock Exchange under the trading symbol “A.”



Anti-Takeover Effects of Our Certificate of Incorporation and Bylaws and Delaware Law

Some provisions of Delaware law and our Certificate of Incorporation and Bylaws could make the following more difficult:

•
acquisition of us by means of a tender offer;
•
acquisition of us by means of a proxy contest or otherwise; or
•
removal of our incumbent officers and directors.

These provisions, summarized below, are expected to discourage coercive takeover practices and inadequate takeover bids. These provisions are also designed to encourage persons seeking to acquire control of us to first negotiate with our board. We believe that the benefits of increased protection give us the potential ability to negotiate with the proponent of an unfriendly or unsolicited proposal to acquire or restructure us and outweigh the disadvantages of discouraging such proposals because negotiation of such proposals could result in an improvement of their terms.

Election and Removal of Directors. Our board of directors is divided into three classes. The directors in each class will serve for a three-year term, one class being elected each year by our stockholders. This system of electing and removing directors may discourage a third party from making a tender offer or otherwise attempting to obtain control of us because it generally makes it more difficult for stockholders to replace a majority of the directors.

Special Meetings. Under our Bylaws, only the board of directors and the chairman of the board may call special meetings of stockholders.

Advance Notice and Proxy Access. Our Bylaws establish advance notice procedures with respect to stockholder proposals and the nomination of candidates for election as directors, other than nominations made by or at the direction of the board of directors or a committee of the board of directors. Further, our Bylaws contain “proxy access” provisions, which permit an eligible stockholder or a group of up to 20 stockholders owning 3% or more of the Company’s outstanding shares of Common Stock continuously for at least three years to nominate and include in the Company’s proxy materials director nominees constituting up to the greater of (i) two individuals or (ii) 20% of the board; provided that the nominating stockholder(s) and nominee(s) satisfy the requirements described in the Bylaws. These provisions might preclude our stockholders from bringing matters before our annual meeting of stockholders or from making nominations for directors at our annual meeting of stockholders if the proper procedures are not followed.
Delaware Anti-Takeover Law. We are subject to Section 203 of the Delaware General Corporation Law, an anti-takeover law. In general, Section 203 prohibits a publicly held Delaware corporation from engaging in a "business combination" with an "interested stockholder" for a period of three years following the date the person became an interested stockholder, unless the "business combination" or the transaction in which the person became an interested stockholder is approved in a prescribed manner. Generally, a "business combination" includes a merger, asset or stock sale, or other transaction resulting in a financial benefit to the interested stockholder. Generally, an "interested stockholder" is a person who, together with affiliates and associates, owns or within three years prior to the determination of interested stockholder status, did own, 15% or more of a corporation's voting stock. The existence of this provision may have an anti-takeover effect with respect to transactions not approved


in advance by the board of directors, including discouraging attempts that might result in a premium over the market price for the shares of Common Stock held by stockholders.

No Stockholder Action by Written Consent. Our Certificate of Incorporation does not provide the right of stockholders to act by written consent without a meeting.

No Cumulative Voting. Our Certificate of Incorporation and Bylaws do not provide for cumulative voting in the election of directors.

Undesignated Preferred Stock. The authorization of undesignated preferred stock makes it possible for the board of directors to issue preferred stock with voting or other rights or preferences that could impede the success of any attempt to change control of us. These and other provisions may have the effect of deferring hostile takeovers or delaying changes in control or management of us.

Amendment of Charter Provisions. The amendment of the above provisions pertaining to the election and removal of directors and special meetings would require approval by holders of at least 80% of the outstanding Common Stock.



 EX-21.1 4 a-10312019xexx211.htm EXHIBIT 21.1 Exhibit
Exhibit 21.1
SIGNIFICANT SUBSIDIARIES


 
Organized Under the Laws of
Agilent Technologies World Trade, Inc.
Delaware
Dako ApS
Denmark
Agilent Technologies Luxembourg Holding S.à.r.l.
Luxembourg
Agilent Technologies Luxco S.à.r.l.
Luxembourg
Agilent Technologies Singapore (Holding) Pte. Ltd.
Singapore
Agilent Technologies Singapore (International) Pte. Ltd.
Singapore
AT Singapore (Global) Pte Ltd.
Singapore
Agilent Technologies Rhone AG
Switzerland
Lionheart Technologies LLC
Vermont
BioTek Instruments LLC
Vermont



 EX-23.1 5 a-10312019xexx231.htm EXHIBIT 23.1 Exhibit
Exhibit 23.1 

CONSENT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM 
       
 We hereby consent to the incorporation by reference in the Registration Statements on Forms S-3 (No. 333-233593) and S-8 (No’s. 333-230454, 333-189051, 333-158096, 333-157002, 333-150873, 333-116400, 333-88864, 333-47024, 333-38194, 333-38080, 333-35016, and 333-91121) of Agilent Technologies, Inc. of our report dated December 19, 2019 relating to the consolidated financial statements, financial statement schedule and the effectiveness of internal control over financial reporting, which appears in this Form 10-K.

/s/ PRICEWATERHOUSECOOPERS LLP

San Jose, California
December 19, 2019





EX-31.1 6 a-10312019xexx311.htm EXHIBIT 31.1 Exhibit
Exhibit 31.1 
CERTIFICATION PURSUANT TO
RULES 13a-14(a) AND 15d-14(a) UNDER THE SECURITIES EXCHANGE ACT OF 1934, AS ADOPTED
SECTION 302 OF THE SARBANES-OXLEY ACT OF 2002
 

I, Michael R. McMullen, certify that:

1.
I have reviewed this Form 10-K of Agilent Technologies, Inc. 

2.
Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report; 

3.
Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this report; 

4.
The registrant's other certifying officer(s) and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules13a-15(e) and 15d-15(e)) and internal control over financial reporting (as defined in Exchange Act Rules 13a-15(f) and 15d-15(f)) for the registrant and have: 

(a)
Designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared; 
(b)
Designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles; 
(c)
Evaluated the effectiveness of the registrant's disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation; and 
(d)
Disclosed in this report any change in the registrant's internal control over financial reporting that occurred during the registrant's most recent fiscal quarter (the registrant's fourth fiscal quarter in the case of an annual report) that has materially affected, or is reasonably likely to materially affect, the registrant's internal control over financial reporting; and 

5.
The registrant's other certifying officer(s) and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the registrant's auditors and the audit committee of the registrant's board of directors (or persons performing the equivalent functions): 

(a)
All significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the registrant's ability to record, process, summarize and report financial information; and 
(b)
Any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant's internal control over financial reporting.

Date:
December 19, 2019
 
/s/ Michael R. McMullen
 
 
 
Michael R. McMullen
 
 
 
Director, President and Chief Executive Officer


 EX-31.2 7 a-10312019xexx312.htm EXHIBIT 31.2 Exhibit
Exhibit 31.2

CERTIFICATION PURSUANT TO
RULES 13a-14(a) AND 15d-14(a) UNDER THE SECURITIES EXCHANGE ACT OF 1934, AS ADOPTED
SECTION 302 OF THE SARBANES-OXLEY ACT OF 2002
 

I, Robert W. McMahon, certify that:

1.
I have reviewed this Form 10-K of Agilent Technologies, Inc. 

2.
Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report; 

3.
Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this report; 

4.
The registrant's other certifying officer(s) and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules13a-15(e) and 15d-15(e)) and internal control over financial reporting (as defined in Exchange Act Rules 13a-15(f) and 15d-15(f)) for the registrant and have: 

(a)
Designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared; 
(b)
Designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles; 
(c)
Evaluated the effectiveness of the registrant's disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation; and 
(d)
Disclosed in this report any change in the registrant's internal control over financial reporting that occurred during the registrant's most recent fiscal quarter (the registrant's fourth fiscal quarter in the case of an annual report) that has materially affected, or is reasonably likely to materially affect, the registrant's internal control over financial reporting; and 

5.
The registrant's other certifying officer(s) and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the registrant's auditors and the audit committee of the registrant's board of directors (or persons performing the equivalent functions): 

(a)
All significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the registrant's ability to record, process, summarize and report financial information; and 
(b)
Any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant's internal control over financial reporting.

Date:
December 19, 2019
 
/s/ Robert W. McMahon
 
 
 
Robert W. McMahon



 
 
 
Senior Vice President and Chief Financial Officer


 EX-32.1 8 a-10312019xexx321.htm EXHIBIT 32.1 Exhibit


Exhibit 32.1 

CERTIFICATION PURSUANT TO
18 U.S.C. SECTION 1350,
AS ADOPTED PURSUANT TO SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002

       
 In connection with the Annual Report of Agilent Technologies, Inc. (the "Company"), on Form 10-K for the period ended October 31, 2019, as filed with the Securities and Exchange Commission on the date hereof (the "Report"), I, Michael R. McMullen, Chief Executive Officer of the Company, certify, pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002, that:

(1)
The Report fully complies with the requirements of Section 13(a) or 15(d) of the Securities Exchange Act of 1934; and 
(2)
The information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company.

        A signed original of this written statement required by Section 906 has been provided to the Company and will be retained by the Company and furnished to the Securities and Exchange Commission or its staff upon request.

Date:
December 19, 2019
 
/s/ Michael R. McMullen
 
 
 
Michael R. McMullen
 
 
 
Director, President and Chief Executive Officer


 
 
 
 EX-32.2 9 a-10312019xexx322.htm EXHIBIT 32.2 Exhibit


Exhibit 32.2 

CERTIFICATION PURSUANT TO
18 U.S.C. SECTION 1350,
AS ADOPTED PURSUANT TO SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002

       
 In connection with the Annual Report of Agilent Technologies, Inc. (the "Company"), on Form 10-K for the period ended October 31, 2019, as filed with the Securities and Exchange Commission on the date hereof (the "Report"), I, Robert W. McMahon, Chief Financial Officer of the Company, certify, pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002, that:

(1)
The Report fully complies with the requirements of Section 13(a) or 15(d) of the Securities Exchange Act of 1934; and 
(2)
The information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company.

        A signed original of this written statement required by Section 906 has been provided to the Company and will be retained by the Company and furnished to the Securities and Exchange Commission or its staff upon request.

Date:
December 19, 2019
 
/s/ Robert W. McMahon
 
 
 
Robert W. McMahon



 
 
 
Senior Vice President and Chief Financial Officer



 EX-101.SCH 10 a-20191031.xsd XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT 2407404 - Disclosure - ACQUISITIONS ACQUISITIONS - Intangible Assets (Details) link:presentationLink link:calculationLink link:definitionLink 2407405 - Disclosure - ACQUISITIONS ACQUISITIONS - Proforma Operating Results (Details) link:presentationLink link:calculationLink link:definitionLink 2407403 - Disclosure - ACQUISITIONS - Assets and Liabilities Assumed (Details) link:presentationLink link:calculationLink link:definitionLink 2107100 - Disclosure - ACQUISITIONS (Notes) link:presentationLink link:calculationLink link:definitionLink 2307301 - Disclosure - ACQUISITIONS (Tables) link:presentationLink link:calculationLink link:definitionLink 2407402 - Disclosure - ACQUISITIONS - Text (Details) link:presentationLink link:calculationLink link:definitionLink 2122100 - Disclosure - COMMITMENTS AND CONTINGENCIES link:presentationLink link:calculationLink link:definitionLink 2422402 - Disclosure - COMMITMENTS AND CONTINGENCIES (Details) link:presentationLink link:calculationLink link:definitionLink 2322301 - Disclosure - COMMITMENTS AND CONTINGENCIES (Tables) link:presentationLink link:calculationLink link:definitionLink 1004000 - Statement - CONSOLIDATED BALANCE SHEET link:presentationLink link:calculationLink link:definitionLink 1004501 - Statement - CONSOLIDATED BALANCE SHEET (Parenthetical) link:presentationLink link:calculationLink link:definitionLink 1005000 - Statement - CONSOLIDATED STATEMENT OF CASH FLOWS link:presentationLink link:calculationLink link:definitionLink 1003000 - Statement - CONSOLIDATED STATEMENT OF COMPREHENSIVE INCOME link:presentationLink link:calculationLink link:definitionLink 1003001 - Statement - CONSOLIDATED STATEMENT OF COMPREHENSIVE INCOME (Parenthetical) link:presentationLink link:calculationLink link:definitionLink 1006000 - Statement - CONSOLIDATED STATEMENT OF EQUITY link:presentationLink link:calculationLink link:definitionLink 1006501 - Statement - CONSOLIDATED STATEMENT OF EQUITY (Parenthetical) link:presentationLink link:calculationLink link:definitionLink 1001000 - Statement - CONSOLIDATED STATEMENT OF OPERATIONS link:presentationLink link:calculationLink link:definitionLink 2119100 - Disclosure - DERIVATIVES link:presentationLink link:calculationLink link:definitionLink 2419402 - Disclosure - DERIVATIVES (Details) link:presentationLink link:calculationLink link:definitionLink 2419403 - Disclosure - DERIVATIVES, Disclosures and derivative instrument aggregated notional amounts by currency and designations (Details) link:presentationLink link:calculationLink link:definitionLink 2419405 - Disclosure - DERIVATIVES, Effect of derivative instruments on Consolidated Statement of Operations (Details) link:presentationLink link:calculationLink link:definitionLink 2419404 - Disclosure - DERIVATIVES, Fair value of derivative instruments and Consolidated Balance Sheet location (Details) link:presentationLink link:calculationLink link:definitionLink 2319301 - Disclosure - DERIVATIVES (Tables) link:presentationLink link:calculationLink link:definitionLink 0001000 - Document - Document And Entity Information link:presentationLink link:calculationLink link:definitionLink 2118100 - Disclosure - FAIR VALUE MEASUREMENTS link:presentationLink link:calculationLink link:definitionLink 2418403 - Disclosure - FAIR VALUE MEASUREMENTS FAIR VALUE MEASURMENTS - Fair value of assets and liabilities measured on non recurring (Details) link:presentationLink link:calculationLink link:definitionLink 2418402 - Disclosure - FAIR VALUE MEASUREMENTS, Fair value of assets and liabilities measured on a recurring basis (Details) link:presentationLink link:calculationLink link:definitionLink 2318301 - Disclosure - FAIR VALUE MEASUREMENTS (Tables) link:presentationLink link:calculationLink link:definitionLink 2115100 - Disclosure - GOODWILL AND OTHER INTANGIBLE ASSETS link:presentationLink link:calculationLink link:definitionLink 2415405 - Disclosure - GOODWILL AND OTHER INTANGIBLE ASSETS Amortization Expense and Future Amortization Expense (Details) link:presentationLink link:calculationLink link:definitionLink 2415404 - Disclosure - GOODWILL AND OTHER INTANGIBLE ASSETS Disclosures and Components of Other Intangibles (Details) link:presentationLink link:calculationLink link:definitionLink 2415403 - Disclosure - GOODWILL AND OTHER INTANGIBLE ASSETS Roll forward (Details) link:presentationLink link:calculationLink link:definitionLink 2315301 - Disclosure - GOODWILL AND OTHER INTANGIBLE ASSETS (Tables) link:presentationLink link:calculationLink link:definitionLink 2415402 - Disclosure - GOODWILL AND OTHER INTANGIBLE ASSETS Text (Details) link:presentationLink link:calculationLink link:definitionLink 2121100 - Disclosure - GUARANTEES link:presentationLink link:calculationLink link:definitionLink 2421402 - Disclosure - GUARANTEES (Details) link:presentationLink link:calculationLink link:definitionLink 2321301 - Disclosure - GUARANTEES (Tables) link:presentationLink link:calculationLink link:definitionLink 2111100 - Disclosure - INCOME TAXES link:presentationLink link:calculationLink link:definitionLink 2411404 - Disclosure - INCOME TAXES - 2017 U.S. Tax Reform - Tax Cuts and Jobs Act (Details) link:presentationLink link:calculationLink link:definitionLink 2411406 - Disclosure - INCOME TAXES - Carryforwards (Details) link:presentationLink link:calculationLink link:definitionLink 2411407 - Disclosure - INCOME TAXES - Current and long-term income tax assets and liabilities (Details) link:presentationLink link:calculationLink link:definitionLink 2411405 - Disclosure - INCOME TAXES INCOME TAXES - Deferred Taxes and other (Details) link:presentationLink link:calculationLink link:definitionLink 2411403 - Disclosure - INCOME TAXES INCOME TAXES Effective tax rate and tax holidays (Details) link:presentationLink link:calculationLink link:definitionLink 2411402 - Disclosure - INCOME TAXES INCOME TAXES- Provision (Details) link:presentationLink link:calculationLink link:definitionLink 2411408 - Disclosure - INCOME TAXES INCOME TAXES - Uncertain Tax Positions (Details) link:presentationLink link:calculationLink link:definitionLink 2311301 - Disclosure - INCOME TAXES (Tables) link:presentationLink link:calculationLink link:definitionLink 2113100 - Disclosure - INVENTORY link:presentationLink link:calculationLink link:definitionLink 2413402 - Disclosure - INVENTORY (Details) link:presentationLink link:calculationLink link:definitionLink 2313301 - Disclosure - INVENTORY (Tables) link:presentationLink link:calculationLink link:definitionLink 2116100 - Disclosure - INVESTMENTS link:presentationLink link:calculationLink link:definitionLink 2416402 - Disclosure - INVESTMENTS (Details) link:presentationLink link:calculationLink link:definitionLink 2316301 - Disclosure - INVESTMENTS (Tables) link:presentationLink link:calculationLink link:definitionLink 2124100 - Disclosure - LONG-TERM DEBT link:presentationLink link:calculationLink link:definitionLink 2424402 - Disclosure - LONG-TERM DEBT - Carrying Value (Details) link:presentationLink link:calculationLink link:definitionLink 2424404 - Disclosure - LONG-TERM DEBT LONG-TERM DEBT - Other (Details) link:presentationLink link:calculationLink link:definitionLink 2424403 - Disclosure - LONG-TERM DEBT - Senior Notes (Details) link:presentationLink link:calculationLink link:definitionLink 2324301 - Disclosure - LONG-TERM DEBT (Tables) link:presentationLink link:calculationLink link:definitionLink 2112100 - Disclosure - NET INCOME (LOSS) PER SHARE link:presentationLink link:calculationLink link:definitionLink 2412402 - Disclosure - NET INCOME (LOSS) PER SHARE (Details) link:presentationLink link:calculationLink link:definitionLink 2312301 - Disclosure - NET INCOME (LOSS) PER SHARE (Tables) link:presentationLink link:calculationLink link:definitionLink 2105100 - Disclosure - NEW ACCOUNTING PRONOUNCEMENTS link:presentationLink link:calculationLink link:definitionLink 2405402 - Disclosure - NEW ACCOUNTING PRONOUNCEMENTS - Impact of adopting new guidance (Details) link:presentationLink link:calculationLink link:definitionLink 2405404 - Disclosure - NEW ACCOUNTING PRONOUNCEMENTS NEW ACCOUNTING PRONOUNCEMENTS - Restricted cash (Details) link:presentationLink link:calculationLink link:definitionLink 2305301 - Disclosure - NEW ACCOUNTING PRONOUNCEMENTS (Tables) link:presentationLink link:calculationLink link:definitionLink 2405403 - Disclosure - NEW ACCOUNTING PRONOUNCEMENTS - Textuals (Details) link:presentationLink link:calculationLink link:definitionLink 2101100 - Disclosure - OVERVIEW AND SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES link:presentationLink link:calculationLink link:definitionLink 2401402 - Disclosure - OVERVIEW AND SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Details) link:presentationLink link:calculationLink link:definitionLink 2201201 - Disclosure - OVERVIEW AND SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Policies) link:presentationLink link:calculationLink link:definitionLink 2114100 - Disclosure - PROPERTY, PLANT AND EQUIPMENT, NET link:presentationLink link:calculationLink link:definitionLink 2414402 - Disclosure - PROPERTY, PLANT AND EQUIPMENT, NET (Details) link:presentationLink link:calculationLink link:definitionLink 2314301 - Disclosure - PROPERTY, PLANT AND EQUIPMENT, NET (Tables) link:presentationLink link:calculationLink link:definitionLink 2420402 - Disclosure - RETIREMENT PLANS AND POST RETIEMENT PENSION PLANS - Deferred Profit Sharing Plan (Details) link:presentationLink link:calculationLink link:definitionLink 2120100 - Disclosure - RETIREMENT PLANS AND POST RETIREMENT PENSION PLANS link:presentationLink link:calculationLink link:definitionLink 2420411 - Disclosure - RETIREMENT PLANS AND POST RETIREMENT PENSION PLANS, Assumptions (Details) link:presentationLink link:calculationLink link:definitionLink 2420405 - Disclosure - RETIREMENT PLANS AND POST RETIREMENT PENSION PLANS, Components of Net Periodic Costs (Details) link:presentationLink link:calculationLink link:definitionLink 2420403 - Disclosure - RETIREMENT PLANS AND POST RETIREMENT PENSION PLANS Defined Contribution (Details) link:presentationLink link:calculationLink link:definitionLink 2420410 - Disclosure - RETIREMENT PLANS AND POST RETIREMENT PENSION PLANS, Expected Benefit Payments (Details) link:presentationLink link:calculationLink link:definitionLink 2420409 - Disclosure - RETIREMENT PLANS AND POST RETIREMENT PENSION PLANS, Fair Value of Plan Assets (Details) link:presentationLink link:calculationLink link:definitionLink 2420407 - Disclosure - RETIREMENT PLANS AND POST RETIREMENT PENSION PLANS, Financial Statement Location (Details) link:presentationLink link:calculationLink link:definitionLink 2420406 - Disclosure - RETIREMENT PLANS AND POST RETIREMENT PENSION PLANS, Funded Status (Details) link:presentationLink link:calculationLink link:definitionLink 2420404 - Disclosure - RETIREMENT PLANS AND POST RETIREMENT PENSION PLANS, JWPIL (Details) link:presentationLink link:calculationLink link:definitionLink 2420408 - Disclosure - RETIREMENT PLANS AND POST RETIREMENT PENSION PLANS RETIREMENT PLANS AND POST RETIREMENT PENSION PLANS, Target Allocations (Details) link:presentationLink link:calculationLink link:definitionLink 2320301 - Disclosure - RETIREMENT PLANS AND POST RETIREMENT PENSION PLANS (Tables) link:presentationLink link:calculationLink link:definitionLink 2408403 - Disclosure - REVENUE - Revenue by End Markets (Details) link:presentationLink link:calculationLink link:definitionLink 2408402 - Disclosure - REVENUE - Revenue by Region (Details) link:presentationLink link:calculationLink link:definitionLink 2408405 - Disclosure - REVENUE REVENUE - Contract Balances (Details) link:presentationLink link:calculationLink link:definitionLink 2108100 - Disclosure - REVENUE REVENUE (Notes) link:presentationLink link:calculationLink link:definitionLink 2408404 - Disclosure - REVENUE REVENUE - Revenue by Type (Details) link:presentationLink link:calculationLink link:definitionLink 2308301 - Disclosure - REVENUE REVENUE (Tables) link:presentationLink link:calculationLink link:definitionLink 2130100 - Schedule - Schedule II Valuation and Qualifying Accounts link:presentationLink link:calculationLink link:definitionLink 2430401 - Schedule - Schedule II Valuation and Qualifying Accounts (Details) link:presentationLink link:calculationLink link:definitionLink 2128100 - Disclosure - SEGMENT INFORMATION link:presentationLink link:calculationLink link:definitionLink 2428406 - Disclosure - SEGMENT INFORMATION - Entity-Wide Disclosure Long-Lived Assets (Details) link:presentationLink link:calculationLink link:definitionLink 2428405 - Disclosure - SEGMENT INFORMATION - Entity-Wide Disclosures Revenue (Details) link:presentationLink link:calculationLink link:definitionLink 2428402 - Disclosure - SEGMENT INFORMATION Profitability (Details) link:presentationLink link:calculationLink link:definitionLink 2428403 - Disclosure - SEGMENT INFORMATION Reconciliation of Reportable Results (Details) link:presentationLink link:calculationLink link:definitionLink 2428403 - Disclosure - SEGMENT INFORMATION Reconciliation of Reportable Results (Details) link:presentationLink link:calculationLink link:definitionLink 2428404 - Disclosure - SEGMENT INFORMATION Segment Assets (Details) link:presentationLink link:calculationLink link:definitionLink 2328301 - Disclosure - SEGMENT INFORMATION (Tables) link:presentationLink link:calculationLink link:definitionLink 2109100 - Disclosure - SHARE-BASED COMPENSATION link:presentationLink link:calculationLink link:definitionLink 2409403 - Disclosure - SHARE-BASED COMPENSATION Allocated Share-based compensation expense (Details) link:presentationLink link:calculationLink link:definitionLink 2409404 - Disclosure - SHARE-BASED COMPENSATION-Fair Value Assumptions (Details) link:presentationLink link:calculationLink link:definitionLink 2409402 - Disclosure - SHARE-BASED COMPENSATION General Disclosures (Details) link:presentationLink link:calculationLink link:definitionLink 2409407 - Disclosure - SHARE-BASED COMPENSATION Non-vested award activity disclosure (Details) link:presentationLink link:calculationLink link:definitionLink 2409406 - Disclosure - SHARE-BASED COMPENSATION Shares Authorized by Exercise Price Range (Details) link:presentationLink link:calculationLink link:definitionLink 2409405 - Disclosure - SHARE-BASED COMPENSATION Stock Option Activity (Details) link:presentationLink link:calculationLink link:definitionLink 2309301 - Disclosure - SHARE-BASED COMPENSATION (Tables) link:presentationLink link:calculationLink link:definitionLink 2123100 - Disclosure - SHORT-TERM DEBT link:presentationLink link:calculationLink link:definitionLink 2423401 - Disclosure - SHORT-TERM DEBT - Credit Facility and Capital Lease (Details) link:presentationLink link:calculationLink link:definitionLink 2423402 - Disclosure - SHORT-TERM DEBT - Senior Notes (Details) link:presentationLink link:calculationLink link:definitionLink 2127100 - Disclosure - STOCKHOLDERS' EQUITY link:presentationLink link:calculationLink link:definitionLink 2427404 - Disclosure - STOCKHOLDERS' EQUITY -Accumulated other comprehensive income (Details) link:presentationLink link:calculationLink link:definitionLink 2427405 - Disclosure - STOCKHOLDERS' EQUITY - Changes in accumulated other comprehensive income (Details) link:presentationLink link:calculationLink link:definitionLink 2427402 - Disclosure - STOCKHOLDERS' EQUITY Stock Repurchases (Details) link:presentationLink link:calculationLink link:definitionLink 2427403 - Disclosure - STOCKHOLDERS' EQUITY STOCKHOLDERS EQUITY DIvidends (Details) link:presentationLink link:calculationLink link:definitionLink 2427406 - Disclosure - STOCKHOLDERS' EQUITY STOCKHOLDERS' EQUITY - Reclassifications out of accumulated other comprehensive income (Details) link:presentationLink link:calculationLink link:definitionLink 2327301 - Disclosure - STOCKHOLDERS' EQUITY (Tables) link:presentationLink link:calculationLink link:definitionLink EX-101.CAL 11 a-20191031_cal.xml XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT EX-101.DEF 12 a-20191031_def.xml XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT EX-101.LAB 13 a-20191031_lab.xml XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT Guarantees [Abstract] Product Warranties Disclosures [Abstract] Summary of standard warranty accrual activity Movement in Standard Product Warranty Accrual [Roll Forward] Beginning balance Standard Product Warranty Accrual Accruals for warranties including change in estimates Standard Product Warranty Accrual, Increase for Warranties Issued Settlements made during the period Standard Product Warranty Accrual, Decrease for Payments Ending balance Standard Product Warranty Accrual, Balance Sheet Classification [Abstract] Standard Product Warranty Accrual, Balance Sheet Classification [Abstract] Accruals for warranties due within one year Standard Product Warranty Accrual, Current Accruals for warranties due after one year Standard Product Warranty Accrual, Noncurrent Bank Guarantees Letters of Credit Outstanding, Amount Earnings Per Share [Abstract] NET INCOME (LOSS) PER SHARE Earnings Per Share [Text Block] Inventory Disclosure [Abstract] INVENTORY Inventory Disclosure [Text Block] Segment Reporting [Abstract] Schedule of Segment Reporting Information, by Segment [Table] Retirement Plan Type [Axis] Retirement Plan Type [Axis] Retirement Plan Type [Domain] Retirement Plan Type [Domain] Pension Plan Pension Plan [Member] Retirement Plan Sponsor Location [Axis] Retirement Plan Sponsor Location [Axis] Retirement Plan Sponsor Location [Domain] Retirement Plan Sponsor Location [Domain] U.S. Plan Domestic Plan [Member] Property, Plant and Equipment, Type [Axis] Property, Plant and Equipment, Type [Axis] Property, Plant and Equipment, Type [Domain] Property, Plant and Equipment, Type [Domain] Business Segments [Axis] Segments [Axis] Segments [Domain] Segments [Domain] Diagnostics and Genomics Diagnostics and Genomics [Member] Diagnostics and Genomics segment includes; DNA mutation detection; genotyping; gene copy number determination; identification of gene rearrangements; DNA methylation profiling; gene expression profiling; and automated gel electrophoresis-based sample analysis systems. Segment Total [Member] Segment Total [Member] Reportable amounts associated with all reporting segments included in a reconciliation from segment reporting to consolidated income from operations, before taxes. Life Sciences and Applied Markets Life Sciences and Applied Markets [Member] Life Sciences and Applied Markets [Member] Segment Reporting Information [Line Items] Reconcilitation between statement results and enterprise results [Abstract] Segment Reporting Information, Operating Income (Loss) [Abstract] Total reportable segment income from operations Segment income (loss) from operations The net result for the period of deducting segment operating expenses from segment operating revenues. Amortization Amortization Acquisition and integration costs Business Combination, Acquisition Related Costs Transformational initiatives Transformational Programs The charge against earnings in the period, comprised of costs associated with restructuring activities not otherwise specified in the taxonomy that are not part of a specific plan as required by GAAP. Asset impairment charges Impairment of Intangible Assets (Excluding Goodwill) Business exit and divestiture costs (primarily our NMR business) Business Exit Costs NASD Site costs Property, Plant and Equipment, Additions Pension curtailment gain Defined Benefit Plan, Net Periodic Benefit Cost (Credit), Gain (Loss) Due to Curtailment Pension settlement gain Defined Benefit Plan, Net Periodic Benefit Cost (Credit), Gain (Loss) Due to Settlement Special compliance costs Special compliance costs Special compliance costs Other Segment Reporting Other reconciling items for operating profit loss segment to consolidated Amount of an item in the reconciliation of total profit or loss from reportable segments to the entity's consolidated income before income taxes, extraordinary items, discontinued operations. Interest income Investment Income, Interest Interest Expense Interest Expense Other income (expense), net Other Nonoperating Income (Expense) Income before taxes Income (Loss) from Continuing Operations before Equity Method Investments, Income Taxes, Noncontrolling Interest Defined Benefit Plan [Abstract] Schedule of Defined Benefit Plans Disclosures [Table] Post-Retirement Benefit Plan Postretirement Health Coverage [Member] U.S. Plan UNITED STATES Non-U.S. Plans Foreign Plan [Member] Scenario [Axis] Scenario [Axis] Scenario [Domain] Scenario [Domain] Defined Benefit Plan Disclosure [Line Items] Defined Benefit Plan, Expected Future Employer Contributions, Next Fiscal Year Future benefit payments [Abstract] Defined Benefit Plan, Expected Future Benefit Payment [Abstract] 2020 Defined Benefit Plan, Expected Future Benefit Payment, Next Twelve Months 2021 Defined Benefit Plan, Expected Future Benefit Payment, Year Two 2022 Defined Benefit Plan, Expected Future Benefit Payment, Year Three 2023 Defined Benefit Plan, Expected Future Benefit Payment, Year Four 2024 Defined Benefit Plan, Expected Future Benefit Payment, Year Five 2025 - 2029 Defined Benefit Plan, Expected Future Benefit Payment, Five Fiscal Years Thereafter Share-based Payment Arrangement, Noncash Expense [Abstract] Schedule of Share-based Compensation Arrangements by Share-based Payment Award [Table] Exercise Price Range [Axis] Exercise Price Range [Axis] Exercise Price Range [Domain] Exercise Price Range [Domain] Share Based Compensation Shares Authorized Under Stock Option Plans Exercise Price Range 01 [Member] Share Based Compensation Shares Authorized Under Stock Option Plans Exercise Price Range 01 [Member] Supplementary information on outstanding and exercisable share awards as of the balance sheet date which stratifies outstanding options by ranges of exercise prices. Share Based Compensation Shares Authorized Under Stock Option Plans Exercise Price Range 02 [Member] Share Based Compensation Shares Authorized Under Stock Option Plans Exercise Price Range 02 [Member] Supplementary information on outstanding and exercisable share awards as of the balance sheet date which stratifies outstanding options by ranges of exercise prices. Share Based Compensation Shares Authorized Under Stock Option Plans Exercise Price Range 03 [Member] Share Based Compensation Shares Authorized Under Stock Option Plans Exercise Price Range 03 [Member] Supplementary information on outstanding and exercisable share awards as of the balance sheet date which stratifies outstanding options by ranges of exercise prices. Award Type [Axis] Award Type [Domain] Stock Options Share-based Payment Arrangement, Option [Member] LTPP [Member] Long Term Performance Plan. LTPP & RSU [Member] LTPP & RSU [Member] LTPP & RSU [Member] Income Statement Location [Axis] Income Statement Location [Axis] Income Statement Location [Domain] Income Statement Location [Domain] Share-based Compensation Arrangement by Share-based Payment Award [Line Items] Volatility of Agilent shares (in hundreths) Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Expected Volatility Rate Volatility of selected peer-company shares, Minimum (in hundreths) Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Expected Volatility Rate, Minimum Volatility of selected peer-company shares, Maximum (in hundreths) Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Expected Volatility Rate, Maximum Pair-wise correlation with selected peers (in hundredths) Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Peer Company Shares Price Wise Correlationy Rate The measure of the percentage amount of share price correlation during the period with a selected group of peer companies. Pair-wise correlations with selected peers is calculated as the correlation between each pair and the sum of correlations divided by the number of pairs to produce the average correlation between each pair. Post-vest restriction discount for all executive awards Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Discount for Postvesting Restrictions Inventory Schedule of Inventory, Current [Table Text Block] Entity Wide Disclosure On Geographic Areas Attributed To Individual Foreign Countries [Table] Entity Wide Disclosure On Geographic Areas Attributed To Individual Foreign Countries [Table] Entity Wide Disclosure On Geographic Areas Attributed To Individual Foreign Countries [Table] Geographical [Axis] Geographical [Axis] Geographical [Domain] Geographical [Domain] UNITED STATES CHINA CHINA Rest Of World Rest Of World [Member] A specified country or group of countries about which segment information is provided by the entity. This element is used for a group of countries not specifically disclosed. JAPAN JAPAN GERMANY GERMANY Entity Wide Disclosure Entity Wide Disclosure On Geographic Areas Attributed To Individual Foreign Countries [Line Items] Entity Wide Disclosure On Geographic Areas Attributed To Individual Foreign Countries [Line Items] Revenue by geography Geographic Areas, Revenues from External Customers [Abstract] Net revenue Revenue from Contract with Customer, Excluding Assessed Tax Revenue from Contract with Customer [Abstract] Disaggregation of Revenue [Table] Disaggregation of Revenue [Table] Segments [Axis] Agilent CrossLab Agilent CrossLab [Member] Agilent CrossLab [Member] Americas Americas [Member] Europe Europe [Member] Asia Pacific Asia Pacific [Member] Disaggregation of Revenue [Line Items] Disaggregation of Revenue [Line Items] Derivative Instruments and Hedging Activities Disclosure [Abstract] Aggregated notional amounts by currency and designation Schedule of Derivative Instruments [Table Text Block] Gross fair values and balance sheet location of derivative instruments held in the consolidated balance sheet Schedule of Derivative Instruments in Statement of Financial Position, Fair Value [Table Text Block] Effect of derivative instruments for foreign exchange contracts in the consolidated statement of operations Derivative Instruments, Gain (Loss) [Table Text Block] Operating Activities [Axis] Operating Activities [Axis] Operating Activities [Domain] Operating Activities [Domain] Fair Value Hierarchy and NAV [Axis] Fair Value Hierarchy and NAV [Domain] Fair Value Hierarchy and NAV [Domain] Quoted Prices in Active Markets for Identical Assets (Level 1) [Member] Fair Value, Inputs, Level 1 [Member] Significant Unobservable Inputs (Level 3) Fair Value, Inputs, Level 3 [Member] Significant Other Observable Inputs (Level 2) Fair Value, Inputs, Level 2 [Member] Defined Benefit Plan, Plan Assets, Category [Axis] Defined Benefit Plan, Plan Assets, Category [Domain] Cash and Cash Equivalents Cash and Cash Equivalents [Member] Equity Securities Equity Securities [Member] Fixed Income Securities Fixed Income Securities [Member] Other Investments Other Plan Assets [Member] Assets held in a defined plan not otherwise previously defined. Fair value of plan assets [Abstract] Fair value of plan assets [Abstract] Fair value of plan assets [Abstract] Fair Value of Plan Assets Defined Benefit Plan, Plan Assets, Amount Net asset value excluded from fair value by input Net asset value excluded from fair value by input Represents investments for which fair value is measured using net asset value (NAV) per share practical expedient, and excluded from the fair value schedule by input. Other assets Assets for Plan Benefits, Defined Benefit Plan Defined Benefit Plan, Pension Plan with Projected Benefit Obligation in Excess of Plan Assets, Plan Assets Defined Benefit Plan, Pension Plan with Projected Benefit Obligation in Excess of Plan Assets, Plan Assets Fair value of plan assets for defined benefit plan with benefit obligation in excess of plan assets. Fair value of plan assets for defined benefit plan with benefit obligation in excess of plan assets. Fair value of plan assets for defined benefit plan with benefit obligation in excess of plan assets. Defined Benefit plan, change in fair value of plan assets, significant unobservable inputs (Level 3) (Roll Forward] Defined Benefit Plan, Change in Fair Value of Plan Assets [Roll Forward] Balance, beginning of year Balance, beginning of year Assets, usually stocks, bonds, and other investments, that have been segregated and restricted (usually in a trust) to provide benefits, at their fair value as of the measurement date. Plan assets include amounts contributed by the employer (and by employees for a contributory plan) and amounts earned from investing the contributions, less benefits paid. If a plan has liabilities other than for benefits, those non-benefit obligations may be considered as reductions of plan assets. Realized gains/(losses) Defined Benefit Plan, Plan Assets Level 3 Reconciliation, Increase (Decrease) for Actual Return (Loss) on Plan Assets Sold Unrealized gains/(losses) Defined Benefit Plan, Plan Assets Level 3 Reconciliation, Increase (Decrease) for Actual Return (Loss) on Plan Assets Still Held Purchases, sales, issuances, and settlements Defined Benefit Plan, Plan Assets Level 3 Reconciliation, Increase (Decrease) for Purchase, Sale, and Settlement Transfers in (out) Defined Benefit Plan, Plan Assets Level 3 Reconciliation, Increase (Decrease) for Assets Transferred into (out of) Level 3 Balance, end of year Balance, end of year Assets, usually stocks, bonds, and other investments, that have been segregated and restricted (usually in a trust) to provide benefits, at their fair value as of the measurement date. Plan assets include amounts contributed by the employer (and by employees for a contributory plan) and amounts earned from investing the contributions, less benefits paid. If a plan has liabilities other than for benefits, those non-benefit obligations may be considered as reductions of plan assets. Projected benefit obligation and fair value of plan assets [Abstract] Defined Benefit Plan Analysis Of Benefit Obligations In Relation To Fair Value Of Plan Assets [Abstract] Defined Benefit Plan Analysis Of Benefit Obligations In Relation To Fair Value Of Plan Assets [Abstract] Total projected benefit obligation - aggregate benefit obligation Defined Benefit Plan Projected Benefit Obligation Total Aggregate Benefit Obligation If aggregate disclosures are presented for the projected benefit obligation, the aggregate benefit obligation value. Defined Benefit obligation where Fair Value exceeds Pension benefit obligation Defined Benefit obligation where Fair Value exceeds Pension benefit obligation Amount of benefit obligation for defined benefit plan where fair value of plan assets exceeds pension benefit obligation Fair Value of plan assets where fair value exceeds pension benefit obligation Fair Value of plan assets where fair value exceeds pension benefit obligation Fair value of plan assets for defined benefit plan where fair value of plan assets exceeds pension benefit obligation. Benefit Obligation Defined Benefit Plan, Benefit Obligation Accumulated benefit obligation and fair value of plan assets Retirement Benefits [Abstract] Accumulated benefit obligation in excess of fair value of plan assets - aggregate benefit obligation Defined Benefit Plan, Plan with Accumulated Benefit Obligation in Excess of Plan Assets, Accumulated Benefit Obligation Total accumulated benefit obligation - aggregate benefit obligation Defined Benefit Plan Accumulated Benefit Obligation Total Aggregate Benefit Obligation If aggregate disclosures are presented for the accumulated benefit obligation, the aggregate fair value of assets. Accumulated benefit obligation in excess of accumulated benefit obligation - aggregate fair value of plan assets Defined Benefit Plan, Plan with Accumulated Benefit Obligation in Excess of Plan Assets, Plan Assets Accumulated Benefit Obligation where Fair Value of plan Assets exceeds ABO Accumulated Benefit Obligation where Fair Value of plan Assets exceeds ABO Amount of accumulated benefit obligation for defined benefit pension plan where the fair value of plan assets exceeds accumulated benefit obligation. Fair value of plan assets for defined benefit pension plan where the fair value of plan assets exceeds ABO. Fair value of plan assets for defined benefit pension plan where the fair value of plan assets exceeds ABO. Fair value of plan assets for defined benefit pension plan where the fair value of plan assets exceeds accumulated benefit obligation. Accounting Policies [Abstract] Schedule of Business Acquisitions, by Acquisition [Table] Schedule of Business Acquisitions, by Acquisition [Table] Product and Service [Axis] Product and Service [Axis] Product and Service [Domain] Product and Service [Domain] Finite-Lived Intangible Assets by Major Class [Axis] Finite-Lived Intangible Assets by Major Class [Axis] Finite-Lived Intangible Assets, Major Class Name [Domain] Finite-Lived Intangible Assets, Major Class Name [Domain] Purchased technology Developed Technology Rights [Member] Restructuring Plan [Axis] Restructuring Plan [Axis] Restructuring Plan [Domain] Restructuring Plan [Domain] Statistical Measurement [Axis] Statistical Measurement [Axis] Statistical Measurement [Domain] Statistical Measurement [Domain] Minimum Minimum [Member] Maximum Maximum [Member] Machinery and Equipment [Member] Machinery and Equipment [Member] Software Development [Member] Software Development [Member] Business Acquisition [Axis] Business Acquisition [Axis] Business Acquisition, Acquiree [Domain] Business Acquisition, Acquiree [Domain] Lasergen [Member] Lasergen [Member] Lasergen [Member] Business Acquisition [Line Items] Business Acquisition [Line Items] Revisions [Abstract] Revisions [Abstract] Revisions [Abstract] Goodwill and Intangible Assets Goodwill and Intangible Assets Disclosure [Abstract] Goodwill impairment Goodwill, Impairment Loss Finite Lived Intangible Assets Useful Life Finite-Lived Intangible Asset, Useful Life Impairment of indefinite-lived intangible assets Impairment of Intangible Assets, Indefinite-lived (Excluding Goodwill) Share-based Payment Arrangement, Noncash Expense [Abstract] Share-based compensation expense Share-based Payment Arrangement, Expense Advertising Expense Marketing and Advertising Expense [Abstract] Advertising costs expensed as incurred Advertising Expense Cash and Cash Equivalents Cash and Cash Equivalents [Abstract] Cash and cash equivalents held outside the U.S. Non-United States Held Cash And Cash Equivalents Dollar amount of cash and cash equivalents held in financial institutions outside of the United States at period end. Variable Interest Entity Variable Interest Entity, Not Primary Beneficiary, Disclosures [Abstract] Cost method investments, original cost Cost Method Investments, Original Cost Ownership percentage Variable Interest Entity, Qualitative or Quantitative Information, Ownership Percentage Purchase price for acquisition Business Combination, Consideration Transferred Remeasurement Gain on step acquisition Business Combination, Step Acquisition, Equity Interest in Acquiree, Remeasurement Gain Variable interest entity Variable Interest Entity, Consolidated, Carrying Amount, Assets Fair Value Disclosures Fair Value Disclosures [Abstract] Equity Method Investments Equity Method Investments Fair value of long term debt in excess of carrying value Fair value of long term debt in excess of carrying value Amount of fair value of long term debt in excess of carrying value. Fair value lower than carrying value Fair value lower than carrying value Amount of fair value of long term debt is lower than of carrying value. Accounts Receivable Accounts Receivable Additional Disclosures [Abstract] Maximum percentage of accounts receivable a single customer accounts for Single Customer Accounts Recivable Concentration Risk Percentage Description Description of amount of total accounts receivable balance that is associated with any single customer. Derivative Instruments Derivative Instrument Detail [Abstract] Hedging contracts general maturity Description Of Types And Terms Of Fair Value Hedging Instruments Used Description of the types and terms of derivatives designated as fair value hedging instruments. For example, interest rate swaps, forward contracts, and so forth. Long -Lived Assets Long -Lived Assets [Abstract] Long -Lived Assets [Abstract] Property, Plant and Equipment, Useful Life Property, Plant and Equipment, Useful Life Operating Lease Term - Minimum Lessee, Operating Lease, Term of Contract Lease renewal options Lessee, Operating Lease, Renewal Term Lease receivable Financing Receivable, after Allowance for Credit Loss operating lease net assets operating lease net assets operating lease net assets where Agilent is the lessor Impairment of finite-lived intangible assets Impairment of Intangible Assets, Finite-lived Employee Compensation and Benefits Employee-related Liabilities [Abstract] Employee compensation and benefits accrued Accrued Employee Benefits Foreign Currency Translation Foreign Currency Translation [Abstract] Foreign currency translation net gain (Ioss) Foreign Currency Transaction Gain (Loss), Realized Statement of Comprehensive Income [Abstract] Statement [Table] Statement [Table] Statement [Line Items] Statement [Line Items] Unrealized gains (losses) on derivatives reclassification out of AOCI to cost of sales Derivative Instruments, Gain (Loss) Reclassified from Accumulated OCI into Income, Effective Portion, Net Other Comprehensive Income (Loss), Reclassification Adjustment from AOCI on Derivatives, Tax Other Comprehensive Income (Loss), Reclassification Adjustment from AOCI on Derivatives, Tax Other Comprehensive Income (Loss), Reclassification Adjustment from AOCI on Derivatives, Net of Tax Other Comprehensive Income (Loss), Reclassification Adjustment from AOCI on Derivatives, Net of Tax Other Comprehensive Income Defined Benefit Plan Amortization Of Net Actuarial Loss Other Comprehensive Income Defined Benefit Plan Amortization Of Net Actuarial Loss The change in other comprehensive income due to the amortization of the net actuarial gains (losses) into net periodic pension costs. Amortization of prior service benefit Other Comprehensive (Income) Loss, Defined Benefit Plan, Prior Service Cost (Credit), Reclassification Adjustment from AOCI, before Tax Other Comprehensive (Income) Loss, Defined Benefit Plan, Reclassification Adjustment from AOCI, before Tax Other Comprehensive (Income) Loss, Defined Benefit Plan, Reclassification Adjustment from AOCI, before Tax Other Comprehensive (Income) Loss, Defined Benefit Plan, Reclassification Adjustment from AOCI, Tax Other Comprehensive (Income) Loss, Defined Benefit Plan, Reclassification Adjustment from AOCI, Tax Other Comprehensive (Income) Loss, Defined Benefit Plan, Reclassification Adjustment from AOCI, after Tax Other Comprehensive (Income) Loss, Defined Benefit Plan, Reclassification Adjustment from AOCI, after Tax Reclassification from Accumulated Other Comprehensive Income, Current Period, Net of Tax Reclassification from Accumulated Other Comprehensive Income, Current Period, Net of Tax Accumulated Other Comprehensive Income (Loss) [Table] Accumulated Other Comprehensive Income (Loss) [Table] Equity Components [Axis] Equity Components [Axis] Equity Component [Domain] Equity Component [Domain] Accumulated Foreign Currency Adjustment Attributable to Parent [Member] Accumulated Foreign Currency Adjustment Attributable to Parent [Member] Accumulated Defined Benefit Plans Adjustment, Net Prior Service Attributable to Parent [Member] Accumulated Defined Benefit Plans Adjustment, Net Prior Service Attributable to Parent [Member] Accumulated Defined Benefit Plans Adjustment, Net Gain (Loss) Attributable to Parent [Member] Accumulated Defined Benefit Plans Adjustment, Net Gain (Loss) Attributable to Parent [Member] AOCI, Derivative Qualifying as Hedge, Excluded Component, Parent [Member] AOCI, Derivative Qualifying as Hedge, Excluded Component, Parent [Member] Beginning Balance Accumulated Other Comprehensive Income (Loss), Net of Tax New Accounting Pronouncement or Change in Accounting Principle, Effect of Adoption, Quantification New Accounting Pronouncement or Change in Accounting Principle, Effect of Adoption, Quantification Other Comprehensive Income (Loss), before Reclassifications Other Comprehensive Income (Loss), before Tax Amounts Reclassified out of Accumulated Other Comprehensive Income Reclassification from Accumulated Other Comprehensive Income, Current Period, before Tax Tax (expense) benefit Other Comprehensive Income (Loss), Tax Other Comprehensive Income (Loss) Other Comprehensive Income (Loss), Net of Tax Ending Balance Beginning Balance Accumulated Other Comprehensive Income (Loss), Foreign Currency Translation Adjustment, Net of Tax Other Comprehensive Income (Loss), before Reclassifications Other Comprehensive Income (Loss), Foreign Currency Transaction and Translation Adjustment, before Tax Amounts Reclassified Amounts Reclassified out of Accumulated Other Comprehensive Income Other Comprehensive Income (Loss), Foreign Currency Transaction and Translation Reclassification Adjustment from AOCI, Realized upon Sale or Liquidation, before Tax Tax (expense) benefit Other Comprehensive Income (Loss), Foreign Currency Translation Adjustment, Tax Other Comprehensive Income (Loss) Other Comprehensive Income (Loss), Foreign Currency Transaction and Translation Adjustment, Net of Tax, Portion Attributable to Parent Ending Balance Other Comprehensive (Income) Loss, Defined Benefit Plan, Prior Service Cost (Credit), after Reclassification Adjustment, before Tax [Abstract] Other Comprehensive (Income) Loss, Defined Benefit Plan, Prior Service Cost (Credit), after Reclassification Adjustment, before Tax [Abstract] Beginning Balance Accumulated Other Comprehensive (Income) Loss, Defined Benefit Plan, Prior Service Cost (Credit), after Tax Other Comprehensive (Income) Loss, before Reclassifications Other Comprehensive (Income) Loss, Defined Benefit Plan, Prior Service Cost (Credit), before Tax Amounts Reclassified out of Accumulated Other Comprehensive Income Tax (expense) benefit Other Comprehensive (Income) Loss, Defined Benefit Plan, Prior Service Cost (Credit), Tax Other Comprehensive (Income) Loss Other Comprehensive (Income) Loss, Defined Benefit Plan, Prior Service Cost (Credit), after Tax Ending Balance Other Comprehensive Income (Loss), Defined Benefit Plan, Gain (Loss), after Reclassification Adjustment, before Tax [Abstract] Other Comprehensive Income (Loss), Defined Benefit Plan, Gain (Loss), after Reclassification Adjustment, before Tax [Abstract] Beginning Balance Accumulated Other Comprehensive Income (Loss), Defined Benefit Plan, Gain (Loss), after Tax Other Comprehensive Income (Loss), before Reclassifications Other Comprehensive Income (Loss), Defined Benefit Plan, Gain (Loss) Arising During Period, before Tax Amounts reclassified out of accumulated other comprehensive income Other Comprehensive Income (Loss), Defined Benefit Plan, Gain (Loss), Reclassification Adjustment from AOCI, before Tax Tax (expense) benefit Other Comprehensive Income (loss) pension and other post retirement benefit plans, amortization of net loss, tax Other Comprehensive Income (loss) pension and other post retirement benefit plans, amortization of net loss, tax Other comprehensive income (loss) Other Comprehensive Income (Loss), Defined Benefit Plan, Gain (Loss) Arising During Period, after Tax Ending Balance Unrealized Gain (Loss) on Foreign Currency Derivatives, Net, before Tax [Abstract] Unrealized Gain (Loss) on Foreign Currency Derivatives, Net, before Tax [Abstract] Beginning Balance Accumulated Other Comprehensive Income (Loss), Cumulative Changes in Net Gain (Loss) from Cash Flow Hedges, Effect Net of Tax Other Comprehensive Income (Loss), before Reclassifications Other Comprehensive Income (Loss), Unrealized Gain (Loss) on Derivatives Arising During Period, before Tax Amounts Reclassified out of Accumulated Other Comprehensive Income Other Comprehensive Income (Loss), Reclassification Adjustment from AOCI on Derivatives, before Tax Tax (expense) benefit Other Comprehensive Income (Loss), Derivatives Qualifying as Hedges, Tax Other Comprehensive Income (Loss) Other Comprehensive Income (Loss), Derivatives Qualifying as Hedges, Net of Tax, Portion Attributable to Parent Ending Balance Instrumentation Instrumentation [Member] Instrumentation [Member] Non-Instrumentation and Other Non-Instrumentation and Other [Member] Non-Instrumentation and Other[Member] Income Tax Disclosure [Abstract] Effective Income Tax Rate Reconciliation, Other Reconciling Items, Amount Effective Income Tax Rate Reconciliation, Other Reconciling Items, Amount Deferred Income Tax Expense (Benefit) Deferred Income Tax Expense (Benefit) Taxes Payable, Current Taxes Payable, Current Income before income tax Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest [Abstract] U.S. operations Income (Loss) from Continuing Operations before Income Taxes, Domestic Non-U.S. operations Income (Loss) from Continuing Operations before Income Taxes, Foreign Provision (benefit) for income taxes Components of Income Tax Expense (Benefit), Continuing Operations [Abstract] U.S. federal taxes - current Current Federal Tax Expense (Benefit) U.S. federal taxes - deferred Deferred Federal Income Tax Expense (Benefit) Non-U.S. taxes - current Current Foreign Tax Expense (Benefit) Non-U.S. taxes - deferred Deferred Foreign Income Tax Expense (Benefit) State taxes, net of federal benefit - current Current State and Local Tax Expense (Benefit) State taxes, net of federal benefit - deferred Deferred State and Local Income Tax Expense (Benefit) Income tax expense (benefit) Income Tax Expense (Benefit) GOODWILL AND OTHER INTANGIBLE ASSETS Goodwill and Intangible Assets Disclosure [Text Block] Schedule of Defined Benefit Plans Disclosures [Table] Deferred Bonus and Profit Sharing Arrangements, Individual Contracts, Type of Deferred Compensation [Axis] Deferred Bonus and Profit Sharing Arrangements, Individual Contracts, Type of Deferred Compensation [Axis] Deferred Bonus and Profit Sharing Arrangement, Individual Contract, Type of Deferred Compensation [Domain] Deferred Bonus and Profit Sharing Arrangement, Individual Contract, Type of Deferred Compensation [Domain] Deferred Profit Sharing [Member] Deferred Profit Sharing [Member] Defined Benefit Plan Disclosure [Line Items] Business Combinations [Abstract] BioTek [Member] BioTek [Member] BioTek [Member] Cash and cash equivalents Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Cash and Equivalents Accounts receivables Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Current Assets, Receivables Inventories Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Inventory Other current assets Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Current Assets, Other Property, plant, and equipment Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Property, Plant, and Equipment Intangible assets Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Intangible Assets, Other than Goodwill Goodwill Additions Goodwill, Acquired During Period Total assets acquired Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Assets Accounts payable Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Current Liabilities, Accounts Payable Deferred revenue Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Current Liabilities, Deferred Revenue Employee compensation and benefits Employee compensation and benefits assumed Total obligations related to services received from employees, such as accrued salaries and bonuses, payroll taxes and fringe benefits. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer) assumed at the acquisition date. Other accrued liabilities Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Current Liabilities, Other Long-term debt Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Noncurrent Liabilities, Long-term Debt Net assets acquired Business Combination, Recognized Identifiable Assets Acquired, Goodwill, and Liabilities Assumed, Net FAIR VALUE MEASUREMENTS Fair Value Disclosures [Text Block] Proforma net revenue Business Acquisition, Pro Forma Revenue Proforma net income Business Acquisition, Pro Forma Net Income (Loss) Proforma net income per share - basic Business Acquisition, Pro Forma Earnings Per Share, Basic Proforma net income per share - diluted Business Acquisition, Pro Forma Earnings Per Share, Diluted Commitments and Contingencies Disclosure [Abstract] Schedule of Future Minimum Rental Payments for Operating Leases [Table Text Block] Schedule of Future Minimum Rental Payments for Operating Leases [Table Text Block] New Accounting Pronouncements and Changes in Accounting Principles [Abstract] Schedule of New Accounting Pronouncements and Changes in Accounting Principles [Table Text Block] Schedule of New Accounting Pronouncements and Changes in Accounting Principles [Table Text Block] Number of operating segments Number of Operating Segments Percentage of revenue from a single customer Concentration Risk, Customer Select income statement components Segment Reporting Information, Profit (Loss) [Abstract] Income from operations Operating Income (Loss) Depreciation expense Depreciation Share-based compensation Share-based Payment Arrangement, Noncash Expense SHARE-BASED COMPENSATION Share-based Payment Arrangement [Text Block] Fair Value, Recurring and Nonrecurring [Table] Impaired Long-Lived Assets Held and Used by Type [Axis] Impaired Long-Lived Assets Held and Used by Type [Axis] Impaired Long-Lived Assets Held and Used, Asset Name [Domain] Impaired Long-Lived Assets Held and Used, Asset Name [Domain] Measurement Frequency [Axis] Measurement Frequency [Domain] Fair Value, Recurring [Member] Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items] Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items] Assets, Short-term [Abstract] Assets, Current [Abstract] Cash equivalents (money market funds) Cash and Cash Equivalents, Fair Value Disclosure Derivative instruments (foreign exchange contracts) Fair Value Assets Measured On Recurring Basis Derivative Instruments Foreign Exhange Contracts This element represents a certain statement of financial position asset which includes foreign exchange contracts derivative instruments, measured at fair value on a recurring basis. Assets, Long-term [Abstract] Assets, Noncurrent [Abstract] Trading securities Debt Securities, Trading, and Equity Securities, FV-NI Other investments Alternative Investment Total assets measured at fair value Fair Value Assets Measured On Recurring Basis Total Assets This element represents total assets, measured at fair value on a recurring basis. Liabilities, Short-term [Abstract] Liabilities, Current [Abstract] Derivative instruments (foreign exchange contracts) Derivative Liability Liabilities, Long-term [Abstract] Liabilities, Noncurrent [Abstract] Deferred compensation liability Fair Value Liabilities Measured On Recurring Basis Deferred Compensation Liability This element represents a certain statement of financial position liability which deferred compensation liability, measured at fair value on a recurring basis. Total liabilities measured at fair value Fair Value Liabilities Measured On Recurring Basis Total Liabilities This element represents total liabilities, measured at fair value on a recurring basis. Current income tax assets (included within other current assets) Income Taxes Receivable, Current Long-term income tax assets (included within other assets) Income Taxes Receivable, Noncurrent Current income tax liabilities (included within other accrued liabilities) Accrued Income Taxes, Current Long-term income tax liabilities (included within other long-term liabilities) Accrued Income Taxes, Noncurrent Total Total income tax payable, net of income tax receivable Total amounts payable to taxing authorities for taxes that are based on the reporting entity's earnings, net of amounts receivable from taxing authorities for refunds of overpayments or recoveries of income taxes. Reconciliation of the numerators and denominators of the basic and diluted net income per share Schedule of Earnings Per Share, Basic and Diluted [Table Text Block] Debt Disclosure [Abstract] Schedule of Interest Rate Swaps pertaining to Senior Notes offered Schedule of Long-term Debt Instruments [Table Text Block] SEC Schedule, 12-09, Valuation and Qualifying Accounts [Abstract] Schedule II - Valuation and Qualifying Accounts SEC Schedule, 12-09, Schedule of Valuation and Qualifying Accounts Disclosure [Text Block] Defined Benefit Plan, Plan Assets, Category [Axis] Defined Benefit Plan, Plan Assets, Category [Domain] Real Estate Real Estate [Member] Target Allocation Percentage of Plan Assets Defined Benefit Plan, Plan Assets, Target Allocation, Percentage Defined Benefit Plan Us Portfolio Equity Securities Percentage Of Alternative Investments Defined Benefit Plan Us Portfolio Equity Securities Percentage Of Alternative Investments Actual percentage of alternative investments that the US equity portfolio consist. Schedule of Finite-Lived Intangible Assets [Table] Schedule of Finite-Lived Intangible Assets [Table] Advanced Analytical Technologies, Inc (AATI) [Member] Advanced Analytical Technologies, Inc (AATI) [Member] Advanced Analytical Technologies, Inc (AATI) BioTek and ACEA [Member] BioTek and ACEA [Member] BioTek and ACEA Biosciences [Member] Finite-Lived Intangible Assets [Line Items] Finite-Lived Intangible Assets [Line Items] Intangible Assets, Including Goodwill) Intangible Assets, Net (Including Goodwill) [Abstract] Additions and adjustments to other intangibles Finite-Lived Intangible Assets, Period Increase (Decrease) Indefinite-lived Intangible Assets, Purchase Accounting Adjustments Indefinite-lived Intangible Assets, Purchase Accounting Adjustments Foreign exchange translation impact to other intangible assets Finite Lived Intangible Assets, Foreign Currency Translation Gain (Loss) Goodwill and Intangible Asset Impairment [Abstract] Goodwill and Intangible Asset Impairment [Abstract] Business Acquisition Business Acquisition, Date of Acquisition [Abstract] Number of Businesses Acquired Number of Businesses Acquired Statement of Stockholders' Equity [Abstract] Cash Dividends Declared (per common share) Common Stock, Dividends, Per Share, Declared Statement of Financial Position [Abstract] Balance Sheet Location [Axis] Balance Sheet Location [Axis] Balance Sheet Location [Domain] Balance Sheet Location [Domain] Other Assets [Member] Other Assets [Member] Adjustments for New Accounting Pronouncements [Axis] Adjustments for New Accounting Pronouncements [Axis] Type of Adoption [Domain] Type of Adoption [Domain] Impact of Adopting New Revenue Recognition Guidance [Member] Impact of Adopting New Revenue Recognition Guidance [Member] Impact of Adopting Accounting Standard Update No. 2014-09, Revenue from Contracts with Customers (Topic 606) (“ASC 606’’) [Member] Impact of Adopting New Tax Effects in AOCI Guidance [Member] Impact of Adopting New Tax Effects in AOCI Guidance [Member] Impact of Adopting Accounting Standards Update No. 2018-02 Income Statement - Reporting Comprehensive Income, Reclassification of Certain Tax Effects from Accumulated Other Comprehensive Income [Member] Impact of Adopting New Intra-Entity Tax Guidance [Member] Impact of Adopting New Intra-Entity Tax Guidance [Member] Impact of Adopting Accounting Standard 2016-16 Income Taxes (Topic 740), Intra-Entity Transfers of Assets Other Than Inventory[Member] Impact of Adopting New Investments Valuation Guidance [Member] Impact of Adopting New Investments Valuation Guidance [Member] Impact of Adopting Accounting Standards Update No. 2016-01, Financial Instruments - Overall (Subtopic 825-10), Recognition and Measurement of Financial Assets and Financial Liabilities. Impact of Adopting New Retirement Benefits Guidance [Member] Impact of Adopting New Retirement Benefits Guidance [Member] Impact of Adopting Accounting Standard Update No. 2017-07, Compensation - Retirement Benefits (Topic 715), Improving the Presentation of Net Periodic Pension Cost and Net Periodic Postretirement Benefit Costs Statement, Scenario [Axis] Class of Stock [Axis] Class of Stock [Axis] Class of Stock [Domain] Class of Stock [Domain] Cash and cash equivalents Cash and Cash Equivalents, at Carrying Value Accounts receivable, net Accounts Receivable, after Allowance for Credit Loss, Current Inventory Inventory, Net Other current assets Other Assets, Current Total current assets Assets, Current Property, plant and equipment, net Property, Plant and Equipment, Net Goodwill Goodwill Other intangible assets, net Intangible Assets, Net (Excluding Goodwill) Long-term Investments Long-term Investments Other assets Other Assets, Noncurrent Total assets Assets Accounts payable Accounts Payable, Current Employee compensation and benefits Employee-related Liabilities, Current Deferred revenue Deferred Revenue, Current Other accrued liabilities Other Liabilities, Current Total current liabilities Liabilities, Current Long-term debt Long-term Debt, Excluding Current Maturities Retirement and post-retirement benefits Liability, Defined Benefit Plan, Noncurrent Other long-term liabilities Other Liabilities, Noncurrent Total liabilities Liabilities Preferred stock; $0.01 par value; 125 million shares authorized; none issued and outstanding Preferred Stock, Value, Issued Common stock; $0.01 par value; 2 billion shares authorized; 318 million shares at October 31, 2018 issued Common Stock, Value, Issued Additional paid-in-capital Additional Paid in Capital Accumulated deficit Retained Earnings (Accumulated Deficit) Effective Income Tax Rate Reconciliation, at Federal Statutory Income Tax Rate, Percent Effective Income Tax Rate Reconciliation, at Federal Statutory Income Tax Rate, Percent Accumulated other comprehensive loss Total stockholders' equity Stockholders' Equity Attributable to Parent Non-controlling interest Stockholders' Equity Attributable to Noncontrolling Interest Total equity Stockholders' Equity, Including Portion Attributable to Noncontrolling Interest Total liabilities and equity Liabilities and Equity INCOME TAXES Income Tax Disclosure [Text Block] Initial Application Period Cumulative Effect Transition [Axis] Initial Application Period Cumulative Effect Transition [Axis] Initial Application Period Cumulative Effect Transition [Domain] Initial Application Period Cumulative Effect Transition [Domain] Difference between Revenue Guidance in Effect before and after Topic 606 [Member] Difference between Revenue Guidance in Effect before and after Topic 606 [Member] Revenue, Remaining Performance Obligation, Amount Revenue, Remaining Performance Obligation, Amount Contract with Customer, Asset, after Allowance for Credit Loss Contract with Customer, Asset, after Allowance for Credit Loss Contract Liability ending balance as of October 31, 2018 Contract with Customer, Liability Deferred Revenue, Period Increase (Decrease) Deferred Revenue, Period Increase (Decrease) Increase (Decrease) in Contract with Customer, Liability Increase (Decrease) in Contract with Customer, Liability Contract with Customer, Liability, Revenue Recognized Contract with Customer, Liability, Revenue Recognized Increase (Decrease) in Deferred Revenue and Customer Advances and Deposits Increase (Decrease) in Deferred Revenue and Customer Advances and Deposits Contract with Customer, Liability, Increase (Decrease) for Contract Acquired in Business Combination Contract with Customer, Liability, Increase (Decrease) for Contract Acquired in Business Combination Translation Adjustment Functional to Reporting Currency, Net of Tax, Period Increase (Decrease) Translation Adjustment Functional to Reporting Currency, Net of Tax, Period Increase (Decrease) Contract Liability ending balance as of October 31, 2019 Derivative [Table] Interest Rate Swap On Senior Notes [Axis] Interest Rate Swap On Senior Notes [Axis] Pertinent information about each long-term debt arrangement including the carrying amount as of the balance sheet date, by type of long-term debt. These are debt arrangements that originally required repayment more than twelve months after issuance or greater than the normal operating cycle of the company, if longer. Interest Rate Swap On Senior Notes [Domain] Interest Rate Swap On Senior Notes [Domain] Type of long-term debt arrangement, such as notes, line of credit, commercial paper, asset-based financing, project financing, letter of credit financing. These are debt arrangements that originally required repayment more than twelve months after issuance or greater than the normal operating cycle of the company, if longer. Hedging Relationship [Axis] Hedging Relationship [Domain] Cash Flow Hedges Cash Flow Hedging [Member] Hedging Designation [Axis] Hedging Designation [Domain] Derivatives Designated as Hedging Instrument Designated as Hedging Instrument [Member] Derivatives Not Designated as Hedging Instruments Not Designated as Hedging Instrument [Member] Derivative Instrument [Axis] Derivative Instrument [Axis] Derivative Contract [Domain] Derivative Contract [Domain] Forward Contracts Buy/(Sell) [Member] Forward Contracts [Member] Treasury Lock [Member] Treasury Lock [Member] Foreign Exchange Contracts [Member] Foreign Exchange Contract [Member] Other Current Assets [Member] Accrued Liabilities [Member] Accrued Liabilities [Member] Derivative [Line Items] Derivative, Fair Value, Net [Abstract] Derivative Asset, Fair Value Derivative Asset, Fair Value, Gross Asset Derivative Liability, Fair Value Derivative Liability, Fair Value, Gross Liability GUARANTEES Product Warranty Disclosure [Text Block] Document and Entity Information [Abstract] Document and Entity Information [Abstract] Entities [Table] Entities [Table] Legal Entity [Axis] Legal Entity [Axis] Entity [Domain] Entity [Domain] Entity Information [Line Items] Entity Information [Line Items] Document Type Document Annual Report Document Annual Report Document Period End Date Document Period End Date Document Transition Report Document Transition Report Entity File Number Entity File Number Entity Registrant Name Entity Incorporation, State or Country Code Entity Incorporation, State or Country Code Entity Tax Identification Number Entity Tax Identification Number Entity Address, Address Line One Entity Address, Address Line One Entity Address, City or Town Entity Address, City or Town Entity Address, State or Province Entity Address, State or Province Entity Address, Postal Zip Code Entity Address, Postal Zip Code City Area Code City Area Code Local Phone Number Local Phone Number Title of 12(b) Security Title of 12(b) Security Trading Symbol Trading Symbol Security Exchange Name Security Exchange Name Entity Well-known Seasoned Issuer Entity Voluntary Filers Entity Current Reporting Status Entity Interactive Data Current Entity Interactive Data Current Entity Filer Category Entity Small Business Entity Small Business Entity Emerging Growth Company Entity Emerging Growth Company Entity Shell Company Entity Shell Company Entity Public Float Entity Common Stock, Shares Outstanding Documents Incorporated by Reference [Text Block] Documents Incorporated by Reference [Text Block] Amendment Flag Document Fiscal Year Focus Document Fiscal Period Focus Current Fiscal Year End Date Entity Central Index Key Operating Loss Carryforwards [Table] Operating Loss Carryforwards [Table] Nature of Uncertainty [Axis] Nature of Uncertainty [Axis] Significant Change in Unrecognized Tax Benefits is Reasonably Possible, Nature of Uncertainty [Domain] Significant Change in Unrecognized Tax Benefits is Reasonably Possible, Nature of Uncertainty [Domain] Tax Interest and Penalties [Member] Tax Interest and Penalties [Member] Tax Interest and Penalties [Member] Income Tax Authority [Axis] Income Tax Authority [Axis] Income Tax Authority [Domain] Income Tax Authority [Domain] Income Tax Authority, Name [Axis] Income Tax Authority, Name [Axis] Income Tax Authority, Name [Domain] Income Tax Authority, Name [Domain] Tax Period [Axis] Tax Period [Axis] Tax Period [Domain] Tax Period [Domain] Tax year 2014 Tax Year 2014 [Member] Operating Loss Carryforwards [Line Items] Operating Loss Carryforwards [Line Items] Unrecognized tax benefit including interest and penalties Unrecognized tax benefit including interest and penalties Unrecognized tax benefit including interest and penalties. Unrecognized Tax Benefits, Income Tax Penalties and Interest Expense Unrecognized Tax Benefits, Income Tax Penalties and Interest Expense Unrecognized Tax Benefits Rollforward Unrecognized Tax Benefits, Income Tax Penalties and Interest Accrued [Abstract] Balance, beginning of year Unrecognized Tax Benefits Additions for tax positions related to the current year Unrecognized Tax Benefits, Increase Resulting from Current Period Tax Positions Additions for tax positions from prior years Unrecognized Tax Benefits, Increase Resulting from Prior Period Tax Positions Reductions for tax positions from prior years Unrecognized Tax Benefits, Decrease Resulting from Prior Period Tax Positions Settlements with taxing authorities Unrecognized Tax Benefits, Decrease Resulting from Settlements with Taxing Authorities Statute of limitations expirations Unrecognized Tax Benefits, Reduction Resulting from Lapse of Applicable Statute of Limitations Balance, end of year Unrecognized Tax Benefits, Income Tax Penalties and Interest Expense [Abstract] Unrecognized Tax Benefits, Income Tax Penalties and Interest Expense [Abstract] Interest and penalties accrued related to unrecognized tax benefits accrued and reported Unrecognized Tax Benefits, Income Tax Penalties and Interest Accrued Unrecognized Tax Benefits that Would Impact Effective Tax Rate Unrecognized Tax Benefits that Would Impact Effective Tax Rate Income tax expense (benefit) Unrecognized tax benefits that would not impact the effective tax rate Unrecognized tax benefits that would not impact the effective tax rate The total amount of unrecognized tax benefits that, if recognized, would not affect the effective tax rate. Schedule of Investments [Abstract] Long-Term [Abstract] Marketable Securities [Abstract] Equity investments - without readily determinable fair value Equity Securities without Readily Determinable Fair Value, Amount Equity investments - with readily determinable fair value Equity Securities, FV-NI Total Lasergen Investments, Debt and Equity Securities [Abstract] Additional consideration paid Payments to Acquire Businesses, Gross Gain on step acquisition Cost method investment, VIE Variable Interest Entity, Nonconsolidated, Carrying Amount, Assets Amounts included in other income (expense), net [Abstract] Gain (Loss) on Investments, Marketable Securities [Abstract] Gain (Loss) on Investments, Marketable Securities [Abstract] Other-than-temporary impairment of equity method investment Equity Method Investment, Other than Temporary Impairment Net unrealized gains on our equity securities with RDFV Equity Securities, FV-NI, Unrealized Gain (Loss) Net unrealized gains on trading securities Trading Securities, Change in Unrealized Holding Gain (Loss) Senior Notes 2020 [Member] Senior Notes 2020 [Member] Notes Payable with the highest claim on the assets of the issuer in case of bankruptcy or liquidation (with maturities initially due after one year or beyond the operating cycle if longer), including current and non-current portion. Senior note holders are paid off in full before any payments are made to junior note holders. Interest Rate Swap [Member] Interest Rate Swap [Member] Other Comprehensive Income (Loss) [Member] Other Comprehensive Income (Loss) [Member] Accumulated Other Comprehensive Income (Loss) AOCI Attributable to Parent [Member] Cost of Sales [Member] Cost of Sales [Member] Other income (expense) [Member] Other Income [Member] Loss on interest rate swaps recognized in other comprehensive income Interest Rate Cash Flow Hedge Gain (Loss) Reclassified to Earnings, Net Interest Rate Cash Flow Hedge Gain (Loss) Reclassified to Earnings, Net Gain (loss) recognized in accumulated other comprehensive income(loss) Gain(loss reclassified from accumulated other comprehensive income (loss) into cost of sales Foreign Currency Cash Flow Hedge Gain (Loss) to be Reclassified During Next 12 Months Foreign Currency Cash Flow Hedge Gain (Loss) to be Reclassified During Next 12 Months Gain (loss) recognized in other income (expense), net within continuing operations Derivative, Gain (Loss) on Derivative, Net Cash Flow Hedge Gain (Loss) to be Reclassified within Twelve Months Cash Flow Hedge Gain (Loss) to be Reclassified within Twelve Months OVERVIEW AND SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES Basis of Presentation and Significant Accounting Policies [Text Block] Share-based Payment Arrangement, Expensed and Capitalized, Amount [Table] Inventories Inventories [Member] Cost of Product and Services Research and Development Research and Development Expense [Member] Selling, General and Administrative Selling, General and Administrative Expenses [Member] Share-based Payment Arrangement, Expensed and Capitalized, Amount [Line Items] Share-based compensation disclosures Share-based Payment Arrangement [Abstract] Share-based Payment Arrangement, Expensed and Capitalized, Amount Share-based Payment Arrangement, Expensed and Capitalized, Amount [Abstract] Share-based compensation expense Share-based Payment Arrangement, Amount Capitalized Supplemental Employee Retirement Plan [Member] Supplemental Employee Retirement Plan [Member] Net periodic benefit cost (benefit) [Abstract] Defined Benefit Plan, Net Periodic Benefit Cost (Credit) [Abstract] Service cost - benefits earned during the period Defined Benefit Plan, Service Cost Interest cost on benefit obligation Defined Benefit Plan, Interest Cost Expected return on plan assets Defined Benefit Plan, Expected Return (Loss) on Plan Assets Amortization of net actuarial loss Defined Benefit Plan, Amortization of Gain (Loss) Amortization of prior service benefit Defined Benefit Plan, Amortization of Prior Service Cost (Credit) Total periodic benefit cost (benefit) Defined Benefit Plan, Net Periodic Benefit Cost (Credit) Curtaliment and settlement Defined Benefit Plan, Net Periodic Benefit Cost (Credit), Gain (Loss) Due to Settlement and Curtailment Other changes in plan assets and benefit obligations recognized in other comprehensive (income) loss [Abstract] Net actuarial (gain) loss Amortization of net actuarial loss Prior service cost (benefit) Amortization of prior service benefit Gain due to settlement Foreign currency Other Comprehensive Income (Loss), Foreign Currency Transaction and Translation Gain (Loss), before Reclassification and Tax Total recognized in other comprehensive (income) loss Other Comprehensive Income Defined Benefit Plans Period Increase Decrease Amounts recognized in other comprehensive income (but not yet recognized in net periodic benefit cost), including the net gain (loss) and net prior service cost (credit) arising during the period. Total recognized in net periodic benefit cost (benefit) and other comprehensive (income) loss Other Comprehensive Income (Loss), Defined Benefit Plan, Transition Asset (Obligation), Reclassification Adjustment from AOCI, before Tax Stockholders' Equity Note [Abstract] Share Repurchase Program [Table] Share Repurchase Program [Table] Retained Earnings Retained Earnings [Member] Additional Paid-in Capital Additional Paid-in Capital [Member] Subsequent Event Type [Axis] Subsequent Event Type [Axis] Subsequent Event Type [Domain] Subsequent Event Type [Domain] Subsequent Event [Member] Subsequent Event [Member] Share Repurchase Program [Axis] Share Repurchase Program [Axis] Share Repurchase Program [Domain] Share Repurchase Program [Domain] 2015 Repurchase Program [Member] 2015 Repurchase Program [Member] 2015 Repurchase Program - On May 28, 2015 we announced that our board of directors had approved a new share repurchase program. The new share repurchase program authorizes the purchase of up to $1.14 billion of our common stock through and including November 1, 2018. The new program will commence, at the option of the company, on either November 1, 2015, or the date on which we complete the purchase of $365 million of common stock under the existing stock repurchase program in fiscal 2015. Upon commencement, the new program replaces our existing stock repurchase program, which authorized the repurchase of shares to reduce or eliminate share dilution from equity programs. 2019 Repurchase Program [Member] 2019 Repurchase Program [Member] 2019 Repurchase Program [Member] Share Repurchases Program Authorization Date [Axis] Share repurchases programs by authorization date. Share Repurchases Authorization Program Date [Domain] Date upon which the share repurchase authorization agreement was approved. Share Repurchase Program [Line Items] Share Repurchase Program [Line Items] Stock Repurchase Program, Authorized Amount Stock Repurchase Program, Authorized Amount Stock Repurchased and Retired During Period, Shares Stock Repurchased and Retired During Period, Shares Stock Repurchased and Retired During Period, Value Stock Repurchased and Retired During Period, Value Remaining authorized repurchase amount Stock Repurchase Program, Remaining Authorized Repurchase Amount Long-term Debt, Unclassified [Abstract] Schedule of Long-term Debt Instruments [Table] Schedule of Long-term Debt Instruments [Table] Senior Notes 2029 [Member] Senior Notes 2029 [Member] Senior Notes 2029 [Member] Senior Notes 2022 [Member] Senior Notes 2022 [Member] Bond that takes priority over other debt securities by the issuer. In the event the issuer goes bankrupt, senior debt holders receive priority for (must receive) repayment prior to (relative to) junior and unsecured ( general) creditors. Long-term Debt, Type [Axis] Long-term Debt, Type [Axis] Long-term Debt, Type [Domain] Long-term Debt, Type [Domain] Debt Instrument [Axis] Debt Instrument [Axis] Debt Instrument, Name [Domain] Debt Instrument, Name [Domain] Senior Notes 2023 [Member] Senior Notes 2023 [Member] Senior Notes 2023 [Member] Senior Notes 2026 [Member] Senior Notes 2026 [Member] Senior Notes 2026 Debt Instrument [Line Items] Debt Instrument [Line Items] Debt Instrument Net Discount Premium Amount Debt Instrument Net Discount Premium Amount The carry amount of debt instrument, stated principal amount of the debt instrument at time of issuance net of any unamortized premium or discount. Issuance date of debt Debt Instrument, Issuance Date Aggregate face amount of debt Debt Instrument, Face Amount Issue rate percentage of principal amount Percentage Of Face Amount Of Senior Note Instrument Issued Proceeds obtained expressed as a percentage of debt instrument face value. Maturity date Debt Instrument, Maturity Date Fixed interest rate per annum (in hundredths) Debt Instrument, Interest Rate, Stated Percentage Interest payment frequency Debt Instrument, Frequency of Periodic Payment Date payments commenced Debt Instrument, Date of First Required Payment Derivative, Notional Amount Derivative, Notional Amount Remaining gain loss to be amortized on derivative Remaining gain loss to be amortized on derivative Remaining gain loss to be amortized on derivative Schedule of Short-term Debt [Table] Schedule of Short-term Debt [Table] Short-term Debt, Type [Axis] Short-term Debt, Type [Axis] Short-term Debt, Type [Domain] Short-term Debt, Type [Domain] Senior Notes 2017 [Member] Senior Notes 2017 [Member] Notes Payable with the highest claim on the assets of the issuer in case of bankruptcy or liquidation (with maturities initially due after one year or beyond the operating cycle if longer), including current and non-current portion. Senior note holders are paid off in full before any payments are made to junior note holders. Short-term Debt [Line Items] Short-term Debt [Line Items] Debt Instrument, Face Amount Debt Instrument, Redemption Period, Start Date Debt Instrument, Redemption Period, Start Date Extinguishment of Debt, Amount Extinguishment of Debt, Amount Percentage Of Face Amount Of Senior Note Instrument Issued Interest Rate Derivatives Terminated Date Interest Rate Derivatives Terminated Date Interest Rate Swap Terminated Date Notional Amount Of Terminated Interest Rate Fair Value Hedge Derivatives Notional Amount Of Terminated Interest Rate Fair Value Hedge Derivatives Aggregate notional amount of all interest rate derivatives designated as hedging instruments in fair value hedges that were terminated. Notional amount refers to the monetary amount specified in the interest rate derivative contract. Terminated Interest Rate Fair Value Hedge Derivative Assets At Fair Value Terminated Interest Rate Fair Value Hedge Derivative Assets At Fair Value The asset value of interest rate swap contracts upon termination. Debt Instrument, Redemption Period, End Date Debt Instrument, Redemption Period, End Date Early Repayment of Senior Debt Early Repayment of Senior Debt Early repayment of senior notes including prepayment penalty Early repayment of senior notes including prepayment penalty The cash outflow for the extinguishment of long-term borrowing (including prepayment penalty), with the highest claim on the assets of the entity in case of bankruptcy or liquidation, before its maturity. Early repayment of senior notes prepayment penalty Early repayment of senior notes prepayment penalty Early repayment of senior notes prepayment penalty accelerated amortization of interest rate swap gain accelerated amortization of interest rate swap gain accelerated amortization of interest rate swap gain Amortization of Debt Issuance Costs and Discounts Amortization of Debt Issuance Costs and Discounts Debt Instrument, Increase, Accrued Interest Debt Instrument, Increase, Accrued Interest Repayments of senior debt Repayments of Senior Debt Property, Plant and Equipment [Abstract] Property, Plant and Equipment Property, Plant and Equipment [Table Text Block] Schedule of Segment Reporting Information, by Segment [Table] Segment Reporting Information [Line Items] Long-Lived Assets Long-Lived Assets Defined Contribution Plan [Table] Defined Contribution Plan [Table] 401(k) Additional company contribution 3 Percent 5 Percent Retirement Plan Name [Axis] Retirement Plan Name [Axis] Retirement Plan Name [Domain] Retirement Plan Name [Domain] Collective Bargaining Arrangement [Axis] Collective Bargaining Arrangement [Axis] Collective Bargaining Arrangement [Domain] Collective Bargaining Arrangement [Domain] Defined Contribution Plan Disclosure [Line Items] Defined Contribution Plan Disclosure [Line Items] Maximum employer matching contribution in the 401(k) plan (in hundredths) Defined Contribution Plan, Employer Matching Contribution, Percent of Match Transitional company contribution to employee 401(k) Transitional company contribution to employee 401(k) Additional transitional company contribution to employee 401(k) plans for certain employees. Maximum employee contribution to 401(k) Defined Contribution Plan, Maximum Annual Contributions Per Employee, Percent 401(k) Plan employer expense Defined Contribution Plan, Cost ACEA Biosciences, Inc. [Member] ACEA Biosciences, Inc. [Member] ACEA Biosciences, Inc. [Member] Net income Net Income (Loss), Including Portion Attributable to Noncontrolling Interest Cash payment to acquire business Liability incurred to pay for acquisition Business Combination, Consideration Transferred, Liabilities Incurred Acquisition transaction costs Business Acquisition, Transaction Costs Estimated costs to complete in-process research and development projects estimated costs to complete in-process research and development projects estimated costs to complete in-process research and development projects Standard Warranty Schedule of Product Warranty Liability [Table Text Block] Schedule of Product Warranty Liability classification Schedule of Product Warranty Liability classification [Table Text Block] Schedule of Product Warranty Liability classification [Table Text Block] Loss Contingencies [Table] Loss Contingencies [Table] Other Commitments [Axis] Other Commitments [Axis] Other Commitments [Domain] Other Commitments [Domain] Penalty reduce over period of time [Member] Penalty reduce over period of time [Member] Penalty reduce over period of time [Member] Loss Contingencies by Nature of Contingency [Axis] Loss Contingency Nature [Axis] Loss Contingency, Nature [Domain] Loss Contingency, Nature [Domain] Loss Contingencies [Line Items] Loss Contingencies [Line Items] Other Commitment Other Commitment Operating Leases, Future Minimum Payments Due, Fiscal Year Maturity [Abstract] Future minimum lease payments 2020 Operating Leases, Future Minimum Payments Due, Next Twelve Months Future minimum lease payments 2021 Operating Leases, Future Minimum Payments, Due in Two Years Future minimum lease payments 2022 Operating Leases, Future Minimum Payments, Due in Three Years Future minimum lease payments 2023 Operating Leases, Future Minimum Payments, Due in Four Years Future minimum lease payments 2024 Operating Leases, Future Minimum Payments, Due in Five Years Future minimum lease payments thereafter Operating Leases, Future Minimum Payments, Due Thereafter Operating Leases, Future Minimum Payments Receivable [Abstract] Future minimum lease income 2020 Operating Leases, Future Minimum Payments Receivable, Current Future minimum lease income 2021 Operating Leases, Future Minimum Payments Receivable, in Two Years Future minimum lease income 2022 Operating Leases, Future Minimum Payments Receivable, in Three Years Total rent expense Operating Leases, Rent Expense Equity [Abstract] Schedule of Stock by Class [Table] Schedule of Stock by Class [Table] Class of Stock [Line Items] Class of Stock [Line Items] Dividends [Abstract] Dividends [Abstract] Cash dividends declared Dividends, Common Stock, Cash Dividends Payable, Date Declared Dividends Payable, Date Declared Aggregate cash dividends paid (per common share) Common Stock, Dividends, Per Share, Cash Paid Aggregate cash dividends paid Payments of Ordinary Dividends, Common Stock Dividends payment date Dividends Payable, Date to be Paid Dividends date of record Dividends Payable, Date of Record Hedging Relationship [Axis] Hedging Relationship [Domain] Variable Rate [Axis] Variable Rate [Axis] Variable Rate [Domain] Variable Rate [Domain] Debt Instrument, Redemption, Period [Axis] Debt Instrument, Redemption, Period [Axis] Debt Instrument, Redemption, Period [Domain] Debt Instrument, Redemption, Period [Domain] interest rate swap payments interest rate swap payments interest rate swap payments Interest Rate Swap Interest Rate Swap Forward based contracts in which two parties agree to swap periodic payments that are fixed at the outset of the swap contract with variable payments based on a market interest rate (index rate) over a specified period recorded in debt. Terminated Interest Rate Fair Value Hedge Asset Unamortized Amount Terminated Interest Rate Fair Value Hedge Asset Unamortized Amount The unamortized amount of interest rate swap contracts upon termination. Capital Lease Obligations, Noncurrent Capital Lease Obligations, Noncurrent Income Tax Holiday [Table] Income Tax Holiday [Table] Foreign Foreign Tax Authority [Member] Income Tax Holiday [Line Items] Income Tax Holiday [Line Items] Effective Income Tax Rate Reconciliation Effective Income Tax Rate Reconciliation, Amount [Abstract] Profit before tax times statutory rate Effective Income Tax Rate Reconciliation at Federal Statutory Income Tax Rate, Amount State income taxes, net of federal benefit Effective Income Tax Rate Reconciliation, State and Local Income Taxes, Amount Non-U.S. income taxed at different rates Effective Income Tax Rate Reconciliation, Foreign Income Tax Rate Differential, Amount Change in unrecognized tax benefits Income tax reconciliation change in US deferred tax reserves Income tax reconciliation change in US deferred tax reserves U.S. Tax Reform Effective Income Tax Rate Reconciliation, Change in Enacted Tax Rate, Amount Tax Cuts and Jobs Act, Income Tax Expense (Benefit) Tax Cuts and Jobs Act, Income Tax Expense (Benefit) Valuation allowances Effective Income Tax Rate Reconciliation, Change in Deferred Tax Assets Valuation Allowance, Amount Adjustments to earnings of foreign subsidiaries Effective Income Tax Rate Reconciliation, Other Adjustments, Amount Effective tax rate (in hundredths) Effective Income Tax Rate Reconciliation, Percent Net discrete tax expense Other Tax Expense (Benefit) Tax Holidays [Abstract] Tax Holidays [Abstract] Tax Holidays [Abstract] Impact of the income tax holidays Income Tax Holiday, Aggregate Dollar Amount Benefit of income tax holidays on net income per share Income Tax Holiday, Income Tax Benefits Per Share Numerator: Numerator [Abstract] Numerator [Abstract] Denominator: Denominators [Abstract] Denominators [Abstract] Basic weighted average shares Weighted Average Number of Shares Outstanding, Basic Potential common shares - stock options and other employeee stock plans Incremental Common Shares Attributable to Dilutive Effect of Share-based Payment Arrangements Diluted weighted average shares Weighted Average Number of Shares Outstanding, Diluted Share-based awards issued Shares Granted or Issued, Share-based Payment Arrangement [Abstract] Total number of share-based awards issued (in shares) Share-based Compensation Arrangement by Share-based Payment Award, Shares Issued in Period Antidilutive shares excluded from EPS computation (in shares) Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount STOCKHOLDERS EQUITY Stockholders' Equity Note Disclosure [Text Block] Designated as Hedging Instrument Position [Axis] Position [Axis] Position [Domain] Position [Domain] Buy Long [Member] Sell Short [Member] Currency [Axis] Currency [Axis] All Currencies [Domain] All Currencies [Domain] Euro Euro Member Countries, Euro British Pounds United Kingdom, Pounds Canadian Dollars Canada, Dollars Australian Dollars Australia, Dollars Malaysian Ringgit Malaysia, Ringgits Japanese Yen Japan, Yen Danish Krone Denmark, Kroner Korean Won Korea (South), Won Singapore, Dollars Singapore, Dollars Swiss Franc Switzerland, Francs China, Yuan Renminbi China, Yuan Renminbi Sweden, Kronor Sweden, Kronor Other Currency No currency Revenue from External Customers by Products and Services [Table] Revenue from External Customers by Products and Services [Table] Revenue from External Customer [Line Items] Revenue from External Customer [Line Items] Segment profitability Schedule of Segment Reporting Information, by Segment [Table Text Block] Reconciliation of segment results to total enterprise results Reconciliation of Operating Profit (Loss) from Segments to Consolidated [Table Text Block] Assets and capital expenditures directly managed by each segment Assets And Capital Expenditures Directly Managed By Each Segment [Table Text Block] Tabular disclosure of the total assets and capital expenditures for each reportable segment. An entity discloses certain information on each reportable segment if the amounts (a) are included in the measure of segment profit or loss reviewed by the chief operating decision maker or (b) are otherwise regularly provided to the chief operating decision maker, even if not included in that measure of segment profit or loss. Revenue and assets by geographic areas Schedule of Revenue from External Customers and Long-Lived Assets, by Geographical Areas [Table Text Block] DERIVATIVES Derivative Instruments and Hedging Activities Disclosure [Text Block] Inventory, Current [Table] Inventory, Current [Table] Inventory [Axis] Inventory [Axis] Inventory [Domain] Inventory [Domain] Inventory [Line Items] Inventory [Line Items] Finished goods Inventory, Finished Goods, Gross Purchased parts and fabricated assemblies Inventory, Work in Process and Raw Materials Inventory Inventory-related excess and obsolescence charges Inventory Write-down SEGMENT INFORMATION Segment Reporting Disclosure [Text Block] Allocated Share-based compensation expense disclosure Share-based Payment Arrangement, Expensed and Capitalized, Amount [Table Text Block] Share-based compensation arrangement by share-based payment award fair value assumptions and methodology schedule Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions And Methodology [Text Block] Tabular disclosure of the significant assumptions used during the year to estimate the fair value of stock options, and long-term performance plan grants. Summary of stock option award activity Disclosure of Share-based Compensation Arrangements by Share-based Payment Award [Table Text Block] Schedule of share-based compensation, shares authorized under stock option plans, by exercise price range Share-based Payment Arrangement, Option, Exercise Price Range [Table Text Block] Schedule of intrinsic value of options exercised and the fair value of options granted Share Based Compensation Arrangement By Share Based Payment Award Fair Value Intrinsic Value Options Exercised [Text Block] Disclosure of grant date fair value of stock options granted and the intrinsic value of a stock option exercised during the period under share-based compensation plan. Non-vested award activity disclosure Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Nonvested Roll Forward [Text Block] Disclosure of components of non-vested stock option or other award plan under which share-based compensation is awarded to employees, typically comprised of the amount of unearned compensation, compensation expense, and changes in the quantity and fair value of the shares granted, exercised, forfeited, and issued and outstanding pertaining to that plan. Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding [Roll Forward] Outstanding, beginning balance (in shares) Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Number Exercised (in shares) Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercises in Period Options Forfeited (in shares) Share-based Compensation Arrangement by Share-based Payment Award, Options, Forfeitures and Expirations in Period Outstanding, ending balance (in shares) Share-based Compensation Arrangement by Share-based Payment Award, Options, Additional Disclosures [Abstract] Share-based Compensation Arrangement by Share-based Payment Award, Options, Additional Disclosures [Abstract] Weighted-average exercise price per share, beginning of period (in dollars per share) Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Weighted Average Exercise Price Weighted-average exercise price per share, exercised (in dollars per share) Share-based Compensation Arrangements by Share-based Payment Award, Options, Exercises in Period, Weighted Average Exercise Price Weighted-average exercise price per share, cancelled, expired and forfeited (in dollars per shares) Share Based Compensation Arrangement By Share Based Payment Award Options Cancelled Forfeitures And Expirations In Period Weighted Average Exercise Price For presentations that combine terminations, the weighted average price of expired options and the price at which grantees could have acquired the underlying shares with respect to stock options that were terminated during the reporting period due to noncompliance with plan terms during the reporting period. Weighted-average exercise price per share, end of period (in dollars per share) Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Period End Number Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Period End Number Consolidation Items [Axis] Consolidation Items [Axis] Consolidation Items [Domain] Consolidation Items [Domain] Subsegments [Axis] Subsegments [Axis] Subsegments [Domain] Subsegments [Domain] Subsegments Consolidation Items [Axis] Subsegments Consolidation Items [Axis] Subsegments Consolidation Items [Domain] Subsegments Consolidation Items [Domain] Segment Reporting Reconciliation Item Assets Segment Reporting Reconciliation Item Assets Amounts of assets held by an entity, and used in a reconciliation of assets by segment to the entity consolidated balance sheet. Cash and cash equivalents Segment Reporting Reconciliation Item Cash And Cash Equivalents Amounts of cash, cash equivalents and short term investments held by an entity, and used in a reconciliation of assets by segment to the entity consolidated balance sheet. Prepaid expenses Segment Reporting Reconciliation Item Prepaids Amount of prepaid expense balance held by an entity, and used in a reconciliation of assets by segment to the entity consolidated balance sheet. Investments Segment Reporting Reconciliation Item Investments Amount of investments held by an entity, and used in a reconciliation of assets by segment to the entity consolidated balance sheet. Long term and other receivables Segment Reporting Reconciliation Item Long Term And Other Receivables Amount of long-term and other receivables held by an entity, and used in a reconciliation of assets by segment to the entity consolidated balance sheet. Other Segment Reporting Reconciliation Item Other Assets Amount of other assets and assets not otherwise identified in other reconciliation balances, and used in a reconciliation of assets by segment to the entity consolidated balance sheet. Capital expenditures Payments to Acquire Property, Plant, and Equipment Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Nonvested, Number of Shares [Roll Forward] Non-vested beginning (in shares) Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Nonvested, Number Granted (in shares) Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Grants in Period Vested (in shares) Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Vested in Period Forfeited (in shares) Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Forfeited in Period Change in LTPP shares vested in the year due to performance conditions Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Incremental Issuance In Period The issuance in the number of non-vested shares under a share-based award plan made during the period on other than stock option plans (for example, phantom stock plan, stock appreciation rights plan, performance target plan). Non-vested ending (in shares) Share-based Compensation Arrangement by Share-based Payment Award, Options, Additional Disclosures [Abstract] Sharebased Compensation Arrangement By Sharebased Payment Award Equity Instruments Other Than Options Nonvested Additional Disclosures [Abstract] Sharebased Compensation Arrangement By Sharebased Payment Award Equity Instruments Other Than Options Nonvested Additional Disclosures [Abstract] Non-vested at October 31, 2018 -Weighted Average Grant Price (in dollars per share) Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Nonvested, Weighted Average Grant Date Fair Value Granted - Weighted Average Grant Price (in dollars per share) Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Grants in Period, Weighted Average Grant Date Fair Value Vested- Weighted Average Grant Price (in dollars per share) Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Vested in Period, Weighted Average Grant Date Fair Value Foreited- Weighted Average Grant Price (in dollars per share) Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Forfeitures, Weighted Average Grant Date Fair Value Change in LTPP shares vested in the year due to performance conditions Fair Value Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Fy 2006 Ltpp Incremental Issuance Nonvested Weighted Average Grant Date Fair Value The weighted average fair value of incremental issuance associated with FY2007 LTPP nonvested awards on share-based plans excluding option plans (for example, phantom stock plan, stock appreciation rights plan, revenue or profit achievement stock award plan) for which the employer is contingently obligated to issue equity instruments or transfer assets to an employee. Non-vested at October 31, 2019 -Weighted Average Grant Price (in dollars per share) Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price Period End Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price Period End Unrecognized share-based compensation costs for non-vested restricted stock awards, net of expected forfeitures Share-based Payment Arrangement, Nonvested Award, Excluding Option, Cost Not yet Recognized, Amount Weighted-average period non-vested restricted stock awards are expected to be amortized over (in years) Employee Service Share Based Compensation Unrecognized Compensation Costs On Nonvested Equity Other Than Stock Option Awards Weighted Average Period Of Recognition The weighted average period over which unrecognized share-based compensation costs on equity other than stock options are expected to be reported Total fair value of restricted stock awards vested Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Vested in Period, Fair Value U.S. Tax Cuts and Jobs Act of 2017 [Member] U.S. Tax Cuts and Jobs Act of 2017 [Member] Tax Cuts and Jobs Act enacted December 22, 2017 [Member] Net transition tax Net transition tax U.S. net transition tax composed of the provisional one-time transition tax on foreign earnings reduced by related deferred tax liabilities adjustment. U.S. Tax Reform tax expense Tax Cuts and Jobs Act, Decrease in Deferred Tax Liability due to Transition Tax Tax Cuts and Jobs Act, Decrease in Deferred Tax Liability due to Transition Tax Tax Cuts and Jobs Act, Change in Tax Rate, Income Tax Expense (Benefit) Tax Cuts and Jobs Act, Change in Tax Rate, Income Tax Expense (Benefit) Net transition tax Tax Cuts and Jobs Act, Transition Tax for Accumulated Foreign Earnings, Income Tax Expense Foreign Earnings Repatriated Foreign Earnings Repatriated Defered Tax Liability for Unremmitted earnings of foreign subsidiaries Deferred Tax Liabilities, Undistributed Foreign Earnings Acquisitions Disclosure Mergers, Acquisitions and Dispositions Disclosures [Text Block] Domestic Domestic Tax Authority [Member] State California Franchise Tax Board [Member] Net Operating loss carryforwards Deferred Tax Assets, Operating Loss Carryforwards, Components [Abstract] Federal net operating loss carryforwards Deferred Tax Assets, Operating Loss Carryforwards, Domestic State net operating loss carryforwards Deferred Tax Assets, Operating Loss Carryforwards, State and Local Foreign net operating loss carryforwards Deferred Tax Assets, Operating Loss Carryforwards, Foreign Net operating loss carryforwards, subject to expiration Deferred Tax Assets, Operating Loss Carryforwards, Subject to Expiration Net operating loss carryforwards, not subject to expiration Deferred Tax Assets, Operating Loss Carryforwards, Not Subject to Expiration Capital Loss Carryforward Deferred Tax Assets, Operating Loss Carryforwards, Alternative [Abstract] Capital loss carryforwards Deferred Tax Assets, Capital Loss Carryforwards Tax Credit Carryforwards Deferred Tax Assets, Tax Credit Carryforwards [Abstract] Tax credit carryforwards Tax Credit Carryforward, Amount Statement of Cash Flows [Abstract] Cash and cash equivalents Restricted cash included in other assets Restricted Cash, Noncurrent Cash, cash equivalents and restricted cash Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents Disaggregation of Revenue Disaggregation of Revenue [Table Text Block] Contract with Customer, Asset and Liability Contract with Customer, Asset and Liability [Table Text Block] Business description and basis of presentation Business Description and Basis of Presentation [Text Block] Principles of consolidation Consolidation, Policy [Policy Text Block] Use of estimates Use of Estimates, Policy [Policy Text Block] Retirement of treasury shares Retirement of Treasury Shares accounting policy [Policy Text Block] Disclosure of the accounting policy for the retirement of the company's treasury shares. [Policy Text Block] Revenue recognition Revenue [Policy Text Block] Accounts receivable, net Receivable [Policy Text Block] Shipping and handling costs Shipping and Handling Cost, Policy [Policy Text Block] Inventory Inventory, Policy [Policy Text Block] Acquisitions Business Combinations Policy [Policy Text Block] Goodwill and purchased intangible assets Goodwill and Intangible Assets, Policy [Policy Text Block] Share-based compensation Share-based Payment Arrangement [Policy Text Block] Retirement and post-retirement plans Pension and Other Postretirement Plans, Policy [Policy Text Block] Taxes on income Income Tax, Policy [Policy Text Block] Warranty Standard Product Warranty, Policy [Policy Text Block] Advertising Advertising Cost [Policy Text Block] Research and development Research, Development, and Computer Software, Policy [Policy Text Block] Sales taxes Revenue Recognition Excise And Sales Taxes [Policy Text Block] Describes whether the entity presents excise and sales taxes on either a gross basis (included in revenues and costs) or a net basis (excluded from revenue). Net income (loss) per share Earnings Per Share, Policy [Policy Text Block] Cash, cash equivalents and short term investments Cash and Cash Equivalents, Policy [Policy Text Block] Variable interest entity Consolidation, Variable Interest Entity, Policy [Policy Text Block] Investments Investment, Policy [Policy Text Block] Fair value of financial instruments Fair Value of Financial Instruments, Policy [Policy Text Block] Concentration of credit risk Concentration Risk, Credit Risk, Policy [Policy Text Block] Derivative instruments Derivatives, Policy [Policy Text Block] Property, plant and equipment Property, Plant and Equipment, Policy [Policy Text Block] Leases Lessee, Leases [Policy Text Block] Capitalized software Internal Use Software, Policy [Policy Text Block] Impairment of long-lived assets Impairment or Disposal of Long-Lived Assets, Including Intangible Assets, Policy [Policy Text Block] Employee compensation and benefits Compensation Related Costs, Policy [Policy Text Block] Foreign currency translation Foreign Currency Transactions and Translations Policy [Policy Text Block] Restatement [Axis] Restatement [Axis] Restatement [Domain] Restatement [Domain] Retained Earnings (Accumulated Deficit) Operating Lease, Right-of-Use Asset Operating Lease, Right-of-Use Asset Developed product technology Customer relationships Customer Relationships [Member] Backlog Order or Production Backlog [Member] Tradenames and trademarks Trademarks and Trade Names [Member] Finite-lived intangible assets acquired Finite-Lived Intangible Assets, Gross In-Process R&D Indefinite-lived Intangible Assets (Excluding Goodwill) Total intangible assets acquired - excluding goodwill Intangible Assets, Gross (Excluding Goodwill) Acquired Finite-lived Intangible Assets, Weighted Average Useful Life Acquired Finite-lived Intangible Assets, Weighted Average Useful Life Assumptions used to calculate the net periodic cost Defined Benefit Plan, Weighted Average Assumptions Used in Calculating Net Periodic Benefit Cost [Abstract] Discount rate (in hundredths) Defined Benefit Plan, Assumptions Used Calculating Net Periodic Benefit Cost, Discount Rate Average increase in compensation levels (in hundredths) Defined Benefit Plan, Assumptions Used Calculating Net Periodic Benefit Cost, Rate of Compensation Increase Expected long-term return on assets (in hundredths) Defined Benefit Plan, Assumptions Used Calculating Net Periodic Benefit Cost, Expected Long-term Rate of Return on Plan Assets Current medical cost trend rate Current medical cost trend rate Weighted average rate of current medical cost trend rate used to determine net periodic benefit cost of defined benefit plan. Ultimate medical cost trend rate Ultimate medical cost trend rate Weighted average rate of ultimate medical cost trend rate used to determine net periodic benefit cost of defined benefit plan. Medical cost trend rate decreases to ultimate rate in year Defined Benefit Plan, Year Health Care Cost Trend Rate Reaches Ultimate Trend Rate Assumptions used to calculate the benefit obligation Defined Benefit Plan, Weighted Average Assumptions Used in Calculating Benefit Obligation [Abstract] Discount rate (in hundredths) Defined Benefit Plan, Assumptions Used Calculating Benefit Obligation, Discount Rate Defined Benefit Plan, Assumptions Used Calculating Benefit Obligation, Rate of Compensation Increase Defined Benefit Plan, Assumptions Used Calculating Benefit Obligation, Rate of Compensation Increase Defined Benefit Plan, Health Care Cost Trend Rate Assumed, Next Fiscal Year Defined Benefit Plan, Health Care Cost Trend Rate Assumed, Next Fiscal Year Defined Benefit Plan, Ultimate Health Care Cost Trend Rate Defined Benefit Plan, Ultimate Health Care Cost Trend Rate Derivative Instrument Risk [Axis] Derivative Contract Type [Domain] Terminated Interest Rate Swaps Interest Rate Derivatives [Abstract] Number of Interest Rate Swap Contracts Designated as Fair Value Hedges Terminated Number of interest rate derivative instruments held by the entity at the reporting date. Notional Amount of Terminated Interest Rate Swaps Asset value of terminated interest rate swaps Derivative Instruments and Hedging Activities Disclosure [Abstract] Derivative, Net Liability Position, Aggregate Fair Value Derivative, Net Liability Position, Aggregate Fair Value Derivative Contracts [Abstract] Derivative Contracts [Abstract] Number Of Foreign Exchange Forward Contracts Designated As Cash Flow Hedge Number Of Foreign Exchange Forward Contracts Designated As Cash Flow Hedge Number of foreign currency exchange forward contract derivatives held by the entity at the reporting date and designated as cash flow hedges. Number Of Foreign Exchange Forward Contracts Not Designated As Hedges Number Of Foreign Exchange Forward Contracts Not Designated As Hedges Number of foreign currency exchange forward contract derivatives held by the entity at the reporting date and not designated as hedges. Revenue from Contract with Customer Revenue from Contract with Customer [Text Block] Schedule of net pension and post-retirement benefit costs Schedule of Defined Benefit Plans Disclosures [Table Text Block] Schedule of Funded status of Defined Benefit and Post-Retirement Benefit plans Changes in Projected Benefit Obligations, Fair Value of Plan Assets, and Funded Status of Plan [Table Text Block] Amounts in accumulated other comprehensive income expected to be recognized as components of net expense during the next fiscal year Schedule of Amounts in Accumulated Other Comprehensive Income (Loss) to be Recognized over Next Fiscal Year [Table Text Block] Defined benefit plan assets by fair value hierarchy Defined benefit plan assets by fair value hierarchy [Table Text Block] Tabular disclosure of fair value of plan assets by the level within the fair value hierarchy in which the fair value measurements in their entirety fall, segregating fair value measurements using quoted prices in active markets for identical assets or liabilities (Level 1), Significant other observable inputs (Level 2), and significant unobservable inputs (Level 3). Defined benefit plans assets measured at fair value using significant unobservable inputs (level 3) Schedule of Effect of Significant Unobservable Inputs, Changes in Plan Assets [Table Text Block] Combined projected benefit obligation, accumulated benefit obligations and fair value of plan assets Defined Benefit Plan, Plan with Projected Benefit Obligation in Excess of Plan Assets [Table Text Block] Schedule of expected benefit payments Schedule of Expected Benefit Payments [Table Text Block] Assumptions used to calculate the net periodic cost and benefit obligation Defined Benefit Plan, Assumptions [Table Text Block] Amounts recognized in the consolidated balance sheet Schedule of Amounts Recognized in Balance Sheet [Table Text Block] Amounts recognized in accumulated other comprehensive income (loss) Schedule of Amounts Recognized in Other Comprehensive Income (Loss) [Table Text Block] Accumulated Other Comprehensive Income (Loss) [Line Items] Accumulated Other Comprehensive Income (Loss) [Line Items] Accumulated other comprehensive income Schedule of Accumulated Other Comprehensive Income (Loss) [Table Text Block] Reclassification out of Accumulated Other Comprehensive Income [Table Text Block] Reclassification out of Accumulated Other Comprehensive Income [Table Text Block] Share-based Payment Arrangement, Option, Exercise Price Range [Table] Award Type [Axis] Award Type [Domain] Share-based Payment Arrangement, Option [Member] Range of Exercise Prices - $25.01 - $30 [Member] Share-based Payment Arrangement, Option, Exercise Price Range [Line Items] Sharebased Compensation Arrangement By Exercise Price Range [Abstract] Sharebased Compensation Arrangement By Sharebased Payment Award Stock Option Plan By Exercise Price Range [Abstract] Sharebased Compensation Arrangement By Sharebased Payment Award Stock Option Plan By Exercise Price Range [Abstract] Minimum price of options outstanding, end of the period (in dollars per share) Share-based Payment Arrangement, Option, Exercise Price Range, Lower Range Limit Maximum price of options outstanding, end of the period (in dollars per share) Share-based Payment Arrangement, Option, Exercise Price Range, Upper Range Limit Number Outstanding (in shares) Share-based Payment Arrangement, Option, Exercise Price Range, Shares Outstanding Weighted Average Remaining Contractual Life (in years) Share-based Payment Arrangement, Option, Exercise Price Range, Outstanding, Weighted Average Remaining Contractual Term Weighted Average Exercise Price (in dollars per share) Share-based Payment Arrangement, Option, Exercise Price Range, Outstanding, Weighted Average Exercise Price Aggregate Intrinsic Value - Options outstanding Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested and Expected to Vest, Outstanding, Aggregate Intrinsic Value Number Exercisable (in shares) Share-based Payment Arrangement, Option, Exercise Price Range, Shares Exercisable Weighted Average Remaining Contractual Life (in years) Share-based Payment Arrangement, Option, Exercise Price Range, Exercisable, Weighted Average Remaining Contractual Term Weighted Average Exercise Price (in dollars per share) Share-based Payment Arrangement, Option, Exercise Price Range, Exercisable, Weighted Average Exercise Price Aggregate Intrinsic Value - Options Exercisable Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercisable, Intrinsic Value Closing stock price basis for aggregate intrinsic value (in dollars per share) Entity Closing Stock Price Fair market closing stock price for entity share at end of fiscal year as reflected on national stock exchange. In-the-money awards exercisable (in shares) Share Based Compensation Arrangement By Share Based Payment Award Options In The Money Exercisable Number The number of Stocks options eligible for exercise and at an exercise price below the closing market price of the underlying stock on the last trading day of the fiscal year as reflected on the national stock exchange. Aggregate instrinsic value of options [Abstract] Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Additional Disclosures [Abstract] Options exercised in period aggregate intrinsic value Share Based Compensation Arrangement By Share Based Payment Award Options Exercises In Period Aggregate Intrinsic Value As of the balance sheet date, the total dollar difference between fair values of the underlying shares reserved for issuance and exercise prices of the options exercised in period. Options exercised in period aggregate weighted average exercise price (in dollars per share) Amount of cash received from the exercise of share-based awards granted Proceeds, Issuance of Shares, Share-based Payment Arrangement, Including Option Exercised Share-based Payment Arrangement, Nonvested Award, Cost Not yet Recognized, Amount Share-based Payment Arrangement, Nonvested Award, Cost Not yet Recognized, Amount Other Comprehensive Income (Loss), Net of Tax, Portion Attributable to Parent [Abstract] Gain (loss) on derivative instruments, tax expense (benefit) Other Comprehensive Income (Loss), Unrealized Gain (Loss) on Derivatives Arising During Period, Tax Amounts reclassified into earnings related to derivative instruments, tax expense (benefit) Foreign currency translation, tax expense (benefit) Change in actuarial net loss, tax expense (benefit) Other Comprehensive Income (Loss), Defined Benefit Plan, Gain (Loss) Arising During Period, Tax Change in net prior service benefit, tax (benefit) Short-term Debt [Abstract] Line of Credit Facility [Table] Lender Name [Axis] Lender Name [Axis] Line of Credit Facility, Lender [Domain] Line of Credit Facility, Lender [Domain] Credit Facility [Axis] Credit Facility [Axis] Credit Faciity [Domain] Credit Facility [Domain] Line of Credit Facility [Line Items] Line of Credit Facility [Abstract] Credit facility initiation date Line of Credit Facility, Initiation Date Short-term debt terms (years) Short-term Debt, Terms Short-term Debt Proceeds from Lines of Credit Repayments of Lines of Credit Repayments of Lines of Credit Line of credit facility expiration date Line of Credit Facility, Expiration Date Maximum borrowing capacity after increase Line of Credit Facility, Maximum Borrowing Capacity Line of credit outstanding balance Line of Credit Facility, Fair Value of Amount Outstanding Short-term Bank Loans and Notes Payable Short-term Bank Loans and Notes Payable Capital Lease Obligations [Abstract] Capital Lease Obligations [Abstract] Capital Lease Obligations, Current Capital Lease Obligations, Current Fair Value, Recurring and Nonrecurring [Table] In Process Research and Development [Member] In Process Research and Development [Member] Measurement Frequency [Axis] Measurement Frequency [Domain] Fair Value Hierarchy and NAV [Axis] Carrying value of long-lived asset Impaired Assets to be Disposed of by Method Other than Sale, Carrying Value of Asset Long lived assets held for use impairment Impairment of Long-Lived Assets Held-for-use impairments or material changes in non-marketable securities without readily determinable fair value Equity Securities without Readily Determinable Fair Value, Impairment Loss, Annual Amount Fair value of assets, nonrecurring Assets, Fair Value Disclosure Long lived assets held for sale Impairment Impairment of Long-Lived Assets to be Disposed of carrying amount of non-marketable equity securities without readily determinable fair values Other comprehensive income (loss): Other Comprehensive Income (Loss), Net of Tax [Abstract] Gain (loss) on derivative instruments, net of tax expense (benefit) of $(2), $1 and $0 Other Comprehensive Income (Loss), Unrealized Gain (Loss) on Derivatives Arising During Period, Net of Tax Amounts reclassified into earnings related to derivative instruments, net of tax expense (benefit) of $(2), $1 and $0 Foreign currency translation, net of tax expense (benefit) of $(10), $7 and $3 Other Comprehensive Income (Loss), Foreign Currency Transaction and Translation Gain (Loss) Arising During Period, Net of Tax Net defined benefit pension cost and post retirement plan costs: Other Comprehensive (Income) Loss, Defined Benefit Plan, after Reclassification Adjustment, after Tax [Abstract] Change in actuarial net loss, net of tax expense (benefit) of $(25), $(3) and $52 Change in net prior service benefit, net of tax benefit of $(2), $(2) and $(3) Other comprehensive income (loss) Total comprehensive income Comprehensive Income (Loss), Net of Tax, Including Portion Attributable to Noncontrolling Interest Income before income taxes domestic and foreign Schedule of Income before Income Tax, Domestic and Foreign [Table Text Block] Provision for income taxes from operations Schedule of Components of Income Tax Expense (Benefit) [Table Text Block] Tax rate reconciliation, U.S. federal statutory rate to effective tax rate from operations Schedule of Effective Income Tax Rate Reconciliation [Table Text Block] Significant components of deferred tax assets and deferred tax liabilities Schedule of Deferred Tax Assets and Liabilities [Table Text Block] Current and long-term deferred tax assets and deferred tax liabilities Current And Long Term Tax Assets And Current And Long Term Tax Liabilities Disclosure [Text Block] Description containing the entire income tax comparison of temporary differences on current and long term deferred tax assets and liabilities disclosure. This element may be used as a single block of text to encapsulate the entire disclosure including data and tables. Current and Long Term Tax Assets and Liabilities [Table Text Block] Current and Long Term Tax Assets and Liabilities [Table Text Block] Tabular disclosure of the breakdown between current and long term income tax payable and receivable and their location in the consolidated balance sheet. Income tax contingencies rollforward Summary of Income Tax Contingencies [Table Text Block] Fair Value Assets And Liabilities Measured On Recurring Basis Schedule of Fair Value, Assets and Liabilities Measured on Recurring Basis [Table Text Block] Impairment of Long-lived assets included in net income Impairment of Long-lived assets included in net income [Text Block] For long-lived assets of an entity, disclosures may include a description of the impaired long-lived asset and facts and circumstances leading to the impairment, amount of the impairment loss and where the loss is located in the income statement, method(s) for determining fair value, and the segment in which the impaired long-lived asset is reported. Goodwill balances and movements for each reportable segments during the period Schedule of Goodwill [Table Text Block] Components of other intangibles during the period Schedule Of Other Intangible Assets By Major Class [Text Block] Disclosure of other intangibles assets, in total and by major class, including the gross carrying amount and accumulated amortization. A major class is composed of intangible assets that can be grouped together because they are similar, either by their nature or by their use in the operations of a company. Future Amortization expense for the next five years and thereafter Schedule of Finite-Lived Intangible Assets, Future Amortization Expense [Table Text Block] Common Stock Common Stock [Member] Treasury Stock Treasury Stock [Member] Retained Earnings (Accumulated Deficit) Total Stockholders Equity Parent [Member] Non-controlling Interest Noncontrolling Interest [Member] Treasury Stock, Number of shares Treasury Stock, Shares Treasury Stock, Value Treasury Stock, Value Balance (in shares) Shares, Issued Balance Components of comprehensive income, net of tax: Comprehensive Income (Loss), Net of Tax, Attributable to Parent [Abstract] Other comprehensive income (loss) Total comprehensive income Comprehensive Income (Loss), Net of Tax, Attributable to Parent Adjustment due to adoption of ASU 2019-09 Cumulative Effect of New Accounting Principle in Period of Adoption Non-controlling interest Noncontrolling Interest, Period Increase (Decrease) Cash dividends declared Share-based awards issued (in shares) Shares Issued, Shares, Share-based Payment Arrangement, after Forfeiture Share-based awards issued Shares Issued, Value, Share-based Payment Arrangement, after Forfeiture Repurchase of common stock (in shares) Stock Repurchased During Period, Shares Repurchase of common stock Stock Repurchased During Period, Value Retirement of treasury stock (shares) Treasury Stock, Shares, Retired Retirement of treasury stock, cost method Treasury Stock, Retired, Cost Method, Amount Share-based compensation APIC, Share-based Payment Arrangement, Increase for Cost Recognition Balance Balance (in shares) Property, Plant and Equipment [Table] Property, Plant and Equipment [Table] Property, Plant and Equipment [Line Items] Property, Plant and Equipment [Line Items] Land Land Buildings and leasehold improvements Buildings and Improvements, Gross Machinery and equipment Machinery and Equipment, Gross Software Capitalized Computer Software, Gross Total property, plant and equipment Property, Plant and Equipment, Gross Accumulated depreciation and amortization Accumulated Depreciation, Depletion and Amortization, Property, Plant, and Equipment Property, plant and equipment, net Tangible Asset Impairment Charges Tangible Asset Impairment Charges Fully depreciated assets no longer in use Fully depreciated assets no longer in use Fully depreciated assets no longer in use retired in the period RETIREMENT PLANS AND POST RETIREMENT PENSION PLANS Pension and Other Postretirement Benefits Disclosure [Text Block] Foreign currency translation, net of tax expense of $(5) and $(15) for 2019 and 2018, respectively Unrealized losses (including prior service benefit) on defined benefit plans, net of tax benefit of $153 and $132 for 2019 and 2018, respectively Accumulated Other Comprehensive (Income) Loss, Defined Benefit Plan, after Tax Unrealized gains (losses) on derivative instruments, net of tax benefit of $3 and $0 for 2019 and 2018, respectively Foreign currency translation, tax Foreign currency translation, tax Tax effect on the change in the balance sheet adjustment that results from the adjustment that results from the process of translating subsidiary financial statements and foreign equity investments into reporting currency as of the balance sheet date. Unrealized losses on defined benefit plans, tax Unrealized losses on defined benefit plans, tax The tax effect of the total net gains (losses) and changes in benefit cost which haven't yet been recognized as components of periodic benefit costs, as of the balance sheet date. Unrealized gains (losses) on derivative instruments, tax Unrealized gains (losses) on derivative instruments, tax Tax effect on the change in the balance sheet adjustment that results from the unrealized gains (losses) on derivative instruments as of the balance sheet date. Amortization Expense, Maturity Schedule [Abstract] Finite-Lived Intangible Assets, Amortization Expense, Maturity Schedule [Abstract] Amortization of intangible assets during the period Amortization of Intangible Assets Future amortization expense for 2020 Finite-Lived Intangible Assets, Amortization Expense, Next Twelve Months Future amortization expense for 2021 Finite-Lived Intangible Assets, Amortization Expense, Year Two Future amortization expense for 2022 Finite-Lived Intangible Assets, Amortization Expense, Year Three Future amortization expense for 2023 Finite-Lived Intangible Assets, Amortization Expense, Year Four Future amortization expense for 2024 Finite-Lived Intangible Assets, Amortization Expense, Year Five Future amortization thereafter Finite-Lived Intangible Assets, Amortization Expense, after Year Five SHORT-TERM DEBT Short-term Debt [Text Block] Difference Between Fair Values of the Obligation Settled and Assets Transferred [Member] Difference Between Fair Values of the Obligation Settled and Assets Transferred [Member] Difference Between Fair Values of the Obligation Settled and Assets Transferred [Member] Industry Sector [Axis] Industry Sector [Axis] Industry Sector [Domain] Industry Sector [Domain] Investment Objective [Axis] Investment Objective [Axis] Investment Objective [Domain] Investment Objective [Domain] Settlement gain (loss) Schedule of Share-based Compensation Arrangements by Share-based Payment Award [Table] Employee Stock Purchase Plan Employee Stock [Member] Restricted Stock Units (RSUs) [Member] Restricted Stock Units (RSUs) [Member] Share-based Compensation Arrangement by Share-based Payment Award [Line Items] Employee stock purchase plan [Abstract] Employee stock purchase plan [Abstract] Employee stock purchase plan [Abstract] Compensation percentage maximum eligible contribution to purchase shares of common stock Share-based Compensation Arrangement by Share-based Payment Award, Maximum Employee Subscription Rate ESPP eligible employee common stock purchase price ratio Share-based Compensation Arrangement by Share-based Payment Award, Purchase Price of Common Stock, Percent Maximum number of shares authorized for issuance under the ESPP (in shares) Share-based Compensation Arrangement by Share-based Payment Award, Number of Shares Authorized Number of shares purchased under ESPP (in shares) Stock Issued During Period, Shares, Employee Stock Purchase Plans Aggregate Value stock issued under Employee Stock Purchase Plan Stock Issued During Period, Value, Employee Stock Purchase Plan Aggregate participants contributions to ESPP Aggregate participants contributions to ESPP Aggregate participant contributions to employee stock purchase plan for the purchase of shares of the company's common stock not yet issued to participants at the end of the period. Shares are excluded from the available for issuance balance at the end of the period. Incentive compensation plans [Abstract] Share-based Compensation Arrangement by Share-based Payment Award, Additional General Disclosures [Abstract] Term of the 2018 Stock Plan (in years) Share Based Compensation Arrangement By Share Based Payment Stock Plan Award Terms Of Award Description of pertinent provisions of share based compensation awards that have actual or potential impact upon the company's financial statements. Common stock available for future awards under the 2018 Stock Plan (in shares) Share-based Compensation Arrangement by Share-based Payment Award, Number of Shares Available for Grant Percentage which rate options generally vest per year (in hundredths) Share-based Compensation Arrangement by Share-based Payment Award, Award Vesting Rights, Percentage Number of years from the date of grant generally vest (in years) Share-based Compensation Arrangement by Share-based Payment Award, Award Vesting Period Maximum contractual term (in years) Share Based Compensation Arrangement By Share Based Payment Award Award Maximum Contractual Term Reflects the duration as to when the share-based award expires as specified in the award agreement, which may be presented in a variety of ways (for example, in years, months, quarter of a year). Percentage market value of the common stock option exercise price is generally not less than (in hundredths) Share Based Compensation Arrangement By Share Based Payment Award Incentive Compensation Plan Percent Of Market Price An entity may opt to disclose the percent of market value on offering date that participants pay for options granted. Minimum final share award percentage of the target award based on performance metrics (in hundredths) Share Based Compensation Arrangement Minimum Payout Range The minimum payout range for participants of the original target grant based upon the company's attainments of pre-established operating ratio targets. Maximum final share award percentage of the target award based on performance metrics (in hundredths) Share Based Compensation Arrangement Maximum Payout Range The maximum payout range for participants of the original target grant based upon the company's attainments of pre-established operating ratio targets. Time period after which participants of the performance stock award plan are entitled to receive unrestricted share of the company's stock, if specified performance targets are met Share Based Compensation Arrangement Performance Stock Award Vesting Period Description of the period of time over which an employee's right to exercise an award is no longer contingent on satisfaction of either a service condition, market condition or a performance condition, which may be expressed in a variety of ways (for example, in years, month and year). COMMITMENTS AND CONTINGENCIES Commitments and Contingencies Disclosure [Text Block] INVESTMENTS Investments in Debt and Marketable Equity Securities (and Certain Trading Assets) Disclosure [Text Block] Employee compensation and benefits [Member] Employee compensation and benefits [Member] Employee compensation and benefits [Member] Retirement and post-retirement benefits Retirement and post-retirement benefits [Member] Retirement and post-retirement benefits [Member] Change in fair value of plan assets: [Roll Forward] Fair Value Balance, beginning of year Actual return on plan assets Defined Benefit Plan, Plan Assets, Increase (Decrease) for Actual Return (Loss) Employer contributions Defined Benefit Plan, Plan Assets, Contributions by Employer Defined Benefit Plan, Plan Assets, Contributions by Plan Participant Defined Benefit Plan, Plan Assets, Contributions by Plan Participant Benefits paid Defined Benefit Plan, Plan Assets, Benefits Paid Settlements Defined Benefit Plan, Plan Assets, Payment for Settlement Defined Benefit Plan, Benefit Obligation, (Increase) Decrease for Remeasurement due to Settlement Defined Benefit Plan, Plan Assets, Period Increase (Decrease) Currency impact Defined Benefit Plan, Plan Assets, Foreign Currency Translation Gain (Loss) Fair Value Balance, end of year Change in benefit obligation: [Roll Forward] Defined Benefit Plan, Change in Benefit Obligation [Roll Forward] Benefit Obligation Balance, Beginning of year Service cost Interest cost Participant's contributions Defined Benefit Plan, Benefit Obligation, Contributions by Plan Participant Plan amendment Defined Benefit Plan, Net Periodic Benefit Cost (Credit), Increase (Decrease) for Plan Amendment Actuarial (gain) loss Defined Benefit Plan, Benefit Obligation, Actuarial Gain (Loss) Benefits paid Defined Benefit Plan, Benefit Obligation, Benefits Paid Currency impact Defined Benefit Plan, Benefit Obligation, Foreign Currency Translation Gain (Loss) Benefit Obligation Balance, end of year Funded status of plan [Abstract] Defined Benefit Plan, Funded (Unfunded) Status of Plan [Abstract] Funded status of plan Defined Benefit Plan, Funded (Unfunded) Status of Plan Actuarial (gains) losses Defined Benefit Plan Amounts Recognized In Other Comprehensive Income Net Actuarial Gain Loss Before Tax The net increase or decrease of changes in the value of either the benefit obligation or the plan assets resulting from experience different from that assumed or from a change in an actuarial assumption, or the consequence of a decision to temporarily deviate from the substantive plan, recognized in other comprehensive income. Prior service costs (benefits) Other Comprehensive (Income) Loss, Defined Benefit Plan, Prior Service Cost (Credit), after Reclassification Adjustment, before Tax Total Other Comprehensive (Income) Loss, Defined Benefit Plan, after Reclassification Adjustment, before Tax End Markets [Axis] End Markets [Axis] End Markets [Axis] End Markets [Domain] End Markets [Domain] [Domain] for End Markets [Axis] Pharmaceutical and Biopharmaceutical Market Pharmaceutical and Biopharmaceutical Market [Member] Pharmaceutical and Biopharmaceutical Market [Member] Chemical and Energy Market Chemical and Energy Market [Member] Chemical and Energy Market [Member] Diagnostics and Clinical Market Diagnostics and Clinical Market [Member] Diagnostics and Clinical Market [Member] Food Market Food Market [Member] Food Market [Member] Academia and Government Market Academia and Government Market [Member] Academia and Government Market [Member] Environmental and Forensics Market Environmental and Forensics Market [Member] Environmental and Forensics Market [Member] Long-term Debt, Gross Long-term Debt, Gross LONG-TERM DEBT Long-term Debt [Text Block] Trademark/Tradename Trademarks [Member] Customer Relationships Third-Party Technology and Licenses [Member] Third-Party Technology and Licenses [Member] Third-Party Technology and Licenses [Member] Schedule of Other Intangible Assets By Major Class [Abstract] Finite-Lived Intangible Assets, Net [Abstract] Gross Carrying Amount Accumulated Amortization Finite-Lived Intangible Assets, Accumulated Amortization Total amortizable intangible assets Finite-Lived Intangible Assets, Net Gross Book Value Income Statement [Abstract] Products Product [Member] Services and Other Service, Other [Member] Net revenue: Revenues [Abstract] Costs and expenses: Operating Expenses [Abstract] Cost of revenue Cost of Goods and Services Sold Research and development Research and Development Expense Selling, general and administrative Selling, General and Administrative Expense Total costs and expenses Costs and Expenses Income from operations Interest income Interest expense Provision (benefit) for income taxes Net income Net income per share: Net income per share - basic Earnings Per Share, Basic Net income per share - diluted Earnings Per Share, Diluted Weighted Averge Shares Used In Computing Net Income Per Share Weighted Averge Shares Used In Computing Net Income Loss Per Share [Abstract] Weighted Averge Shares Used In Computing Net Income Loss Per Share [Abstract] Basic (in shares) Diluted (in shares) Schedule of Goodwill [Table] Goodwill [Line Items] Goodwill - Rollforward Goodwill [Roll Forward] Beginning Balance Foreign currency translation impact Goodwill, Foreign Currency Translation Gain (Loss) Goodwill arising from acquisitions Ending Balance Amounts recognized in the consolidated balance sheet Defined Benefit Plan, Amounts for Asset (Liability) Recognized in Statement of Financial Position [Abstract] Amounts Recognized in Accumulated Other Comprehensive Income (loss): [Abstract] Defined Benefit Plan, Amounts Recognized in Other Comprehensive Income (Loss) [Abstract] Accumulated other comprehensive income expected to be recognized as components of net expense during the next fiscal year [Abstract] Defined Benefit Plan, Expected Amortization, Next Fiscal Year [Abstract] Amortization of net prior service cost (benefit) Defined Benefit Plan, Expected Amortization of Prior Service Cost (Credit), Next Fiscal Year Defined Benefit Plan, Expected Amortization of Gain (Loss), Next Fiscal Year Defined Benefit Plan, Expected Amortization of Gain (Loss), Next Fiscal Year Components of Deferred Tax Assets Components of Deferred Tax Assets [Abstract] Intangibles Deferred Tax Assets, Goodwill and Intangible Assets Property, plant and equipment Deferred Tax Assets, Property, Plant and Equipment Warranty reserves Deferred Tax Assets, Tax Deferred Expense, Reserves and Accruals, Warranty Reserves Pension benefits and retiree medical benefits Deferred Tax Assets, Tax Deferred Expense, Compensation and Benefits, Postretirement Benefits Employee benefits, other than retirement Deferred Tax Assets, Tax Deferred Expense, Compensation and Benefits, Employee Benefits Net operating loss, capital loss and credit carryforwards Deferred Tax Assets, Operating Loss Carryforwards Share-based compensation Deferred Tax Assets, Tax Deferred Expense, Compensation and Benefits, Share-based Compensation Cost Deferred revenue Deferred Tax Assets, Deferred Income Other Deferred Tax Assets, Other Subtotal Deferred Tax Assets, Gross Tax valuation allowance Deferred Tax Assets, Valuation Allowance Total deferred tax assets Deferred Tax Assets, Net of Valuation Allowance Components of Deferred Tax Liabilities Components of Deferred Tax Liabilities [Abstract] Intangibles Deferred Tax Liabilities, Intangible Assets Property, plant and equipment Deferred Tax Liabilities, Property, Plant and Equipment Deferred Tax Liabilities, Unrealized Gains on Trading Securities Deferred Tax Liabilities, Unrealized Gains on Trading Securities Employee benefits, other than retirement Deferred Tax Assets, Tax Deferred Expense, Compensation and Benefits Unremmitted earnings of foreign subsidiaries Deferred revenue Deferred Tax Liabilities, Tax Deferred Income Other Deferred Tax Liabilities, Other Subtotal Deferred Tax Liabilities, Gross Total deferred tax liabilities Deferred Tax Liabilities, Net Long Term Deferred Tax Assets And Liabilities [Abstract] Current And Long Term Deferred Tax Assets And Liabilities [Abstract] Current And Long Term Deferred Tax Assets And Liabilities [Abstract] Long-term deferred tax assets (included within other assets) Deferred Tax Assets, Net of Valuation Allowance, Noncurrent Long-term deferred tax liabilities (included within other long-term liabilities) Deferred Tax Liabilities, Net, Noncurrent Total Deferred Tax Assets, Net Cash flows from operating activities: Net Cash Provided by (Used in) Operating Activities [Abstract] Adjustments to reconcile net income to net cash provided by operating activities: Adjustments to Reconcile Net Income (Loss) to Cash Provided by (Used in) Operating Activities [Abstract] Depreciation and amortization Depreciation, Depletion and Amortization Deferred taxes Excess and obsolete inventory related charges Gain on step acquisition Loss on extinguishment of debt Gain (Loss) on Extinguishment of Debt Other Other Noncash Income (Expense) Changes in assets and liabilities: Increase (Decrease) in Operating Capital [Abstract] Accounts receivable, net Increase (Decrease) in Accounts Receivable Inventory Increase (Decrease) in Inventories Accounts payable Increase (Decrease) in Accounts Payable Employee compensation and benefits Increase (Decrease) in Employee Related Liabilities Change in assets and liabilities due to Tax Act Change in assets and liabilities due to Tax Act Change in assets and liabilities due to Tax Act Treasury lock agreement payment Other assets and liabilities Increase (Decrease) in Other Operating Assets and Liabilities, Net Net cash provided by operating activities Net Cash Provided by (Used in) Operating Activities Cash flows from investing activities: Net Cash Provided by (Used in) Investing Activities [Abstract] Investments in property, plant and equipment Proceeds from the sale of property, plant and equipment Proceeds from Sale of Property, Plant, and Equipment Proceeds from divestitures Proceeds from Divestiture of Businesses, Net of Cash Divested Payment to acquire fair value investment Payments to Acquire Investments Payment in exchange for convertible note Payments to Acquire Notes Receivable Payment to acquire intangible assets Payments to Acquire Intangible Assets Acquisitions of businesses and intangible assets, net of cash acquired Payments to Acquire Businesses, Net of Cash Acquired Net cash used in investing activities Net Cash Provided by (Used in) Investing Activities Cash flows from financing activities: Net Cash Provided by (Used in) Financing Activities [Abstract] Issuance of common stock under employee stock plans Payment of taxes related to net share settlement of equity awards Payment, Tax Withholding, Share-based Payment Arrangement Treasury stock repurchases Payments for Repurchase of Common Stock Payment of dividends Issuance of senior notes Proceeds from Issuance of Senior Long-term Debt Debt issuance costs Payments of Debt Issuance Costs Purchase of non-controlling interest Payments to Acquire Additional Interest in Subsidiaries Proceeds from credit facility and short-term loan Proceeds from Short-term Debt Repayments of debt and credit facility Repayments of Short-term Debt Net cash used in financing activities Net Cash Provided by (Used in) Financing Activities Effect of exchange rate movements Effect of Exchange Rate on Cash and Cash Equivalents Net increase (decrease) in cash, cash equivalents and restricted cash Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect Cash, cash equivalents and restricted cash at beginning of year Cash, cash equivalents and restricted cash at end of year Supplemental Cash Flow Information [Abstract] Supplemental Cash Flow Information [Abstract] Income tax payments, net Income Taxes Paid Interest payments Interest Paid, Excluding Capitalized Interest, Operating Activities Non-cash changes in investments in property, plant and equipment increase (decrease) Non-cash changes in investments in property, plant and equipment increase (decrease) Changes to the cost of fixed assets that are not the result of cash capital expenditures. Schedule of the fair value of assets and liabilities assumed Schedule of Recognized Identified Assets Acquired and Liabilities Assumed [Table Text Block] Components of intangible assets acquired Finite-Lived and Indefinite-Lived Intangible Assets Acquired as Part of Business Combination [Table Text Block] Proforma operating results Business Acquisition, Pro Forma Information [Table Text Block] LIABILITIES AND EQUITY Liabilities and Equity [Abstract] Total equity: Stockholders' Equity, Including Portion Attributable to Noncontrolling Interest [Abstract] Stockholders' equity: Stockholders' Equity Attributable to Parent [Abstract] Preferred stock par value (in dollars per share) Preferred Stock, Par or Stated Value Per Share Preferred stock shares authorized (in shares) Preferred Stock, Shares Authorized Preferred Stock, Shares Issued (in shares) Preferred Stock, Shares Issued Preferred Stock, Shares Outstanding (in shares) Preferred Stock, Shares Outstanding Common stock par value (in dollars per share) Common Stock, Par or Stated Value Per Share Common stock shares authorized (in shares) Common Stock, Shares Authorized Common stock issued (in shares) Common Stock, Shares, Issued NEW ACCOUNTING PRONOUNCEMENTS New Accounting Pronouncements and Changes in Accounting Principles [Text Block] SEC Schedule, 12-09, Valuation and Qualifying Accounts Disclosure [Table] SEC Schedule, 12-09, Valuation Allowances and Reserves Type [Axis] SEC Schedule, 12-09, Valuation Allowances and Reserves [Domain] SEC Schedule, 12-09, Valuation Allowance, Deferred Tax Asset [Member] SEC Schedule, 12-09, Valuation and Qualifying Accounts Disclosure [Line Items] Movement in valuation and qualifying accounts [Roll Forward] SEC Schedule, 12-09, Movement in Valuation Allowances and Reserves [Roll Forward] Balance at Beginning of Period SEC Schedule, 12-09, Valuation Allowances and Reserves, Amount Additions Charged to Expenses or Other Accounts SEC Schedule, 12-09, Valuation Allowances and Reserves, Additions, Charge to Cost and Expense Deductions Credited to Expenses or Other Accounts SEC Schedule, 12-09, Valuation Allowances and Reserves, Deduction Balance at End of Period PROPERTY, PLANT AND EQUIPMENT, NET Property, Plant and Equipment Disclosure [Text Block] Equity Investments Marketable Securities [Table Text Block] Realized gains and losses on sale of available-for-sale securities and other than temporary impairments Included in Other income (expense) Schedule of Other Nonoperating Income (Expense) [Table Text Block] ASSETS Assets [Abstract] Current assets: Accounts receivable, net Other current assets Total current assets Goodwill Other intangible assets, net Long-term investments Total assets Current liabilities: Accounts payable Employee compensation and benefits Deferred revenue Short-term debt Short-term Debt Other accrued liabilities Total current liabilities Long-term debt Other long-term liabilities Total liabilities Commitments and contingencies (Note 16) Commitments and Contingencies Common stock; $0.01 par value; 2 billion shares authorized; 309 million shares at October 31, 2019 and 318 million shares at October 31, 2018 issued Total stockholders' equity Total equity Total liabilities and equity EX-101.PRE 14 a-20191031_pre.xml XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT GRAPHIC 15 chart-4a62e386e6ad510aa63.jpg GRAPHIC begin 644 chart-4a62e386e6ad510aa63.jpg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end XML 16 R26.htm IDEA: XBRL DOCUMENT v3.19.3.a.u2
SHORT-TERM DEBT
 12 Months Ended
Oct. 31, 2019
Short-term Debt [Abstract]  
SHORT-TERM DEBT SHORT-TERM DEBT

Credit Facilities

On March 13, 2019, Agilent entered into a credit agreement with a group of financial institutions which provides for a $1 billion five-year unsecured credit facility that will expire on March 13, 2024. The credit facility replaces the existing credit facility which terminated on the closing date of the new facility. For the year ended October 31, 2019, we borrowed $305 million and repaid $190 million under the credit facility. As of October 31, 2019, the company had borrowings of $115 million outstanding under the credit facility. We were in compliance with the covenants for the credit facility during the year ended October 31, 2019. On August 7, 2019, we entered into an amendment to the credit agreement, which provides for a $500 million short-term loan facility that was used in full to complete the BioTek acquisition and which is outstanding at October 31, 2019. On October 21, 2019, we entered into a second amendment to the credit agreement, which refreshed the amount available for additional incremental term loan facilities under the credit agreement to permit additional incremental facilities of up to $500 million. We had no borrowings under the additional incremental facilities as of October 31, 2019.

Capital Leases

The company leases certain property and equipment under capital leases. As of October 31, 2019, the current portion of the company’s capital lease obligations had an aggregate carrying value of $1 million.

2020 Senior Notes

On July 13, 2010, the company issued an aggregate principal amount of $500 million in senior notes ("2020 senior notes"). The 2020 senior notes were issued at 99.54% of their principal amount. The notes were scheduled to mature on July 15, 2020, and bear interest at a fixed rate of 5.00% per annum.

On August 9, 2011, we terminated our interest rate swap contracts related to our 2020 senior notes that represented the notional amount of $500 million. The asset value, including interest receivable, upon termination for these contracts was approximately $34 million. The gain was deferred and amortized to interest expense over the remaining life of the 2020 senior notes.

On September 17, 2019, we repaid the $500 million outstanding aggregate principal amount of our 2020 senior notes due July 15, 2020 that were called for redemption on August 16, 2019. The redemption price of approximately $512 million included a $12 million prepayment penalty. The redemption price was computed in accordance with the terms of the 2020 senior notes as the present value of the remaining scheduled payments of principal and unpaid interest related to the redemption.  The prepayment penalty plus amortization of the previously deferred interest swap gain of $4 million and amortization of previously deferred debt issuance costs and discount of $1 million was recorded in other income (expense), net in the consolidated statement of operations. We also paid accrued and unpaid interest of $4 million on the 2020 senior notes up to but not including the redemption date.

2017 Senior Notes

On October 24, 2007, the company issued an aggregate principal amount of $600 million in senior notes ("2017 senior notes"). On October 20, 2014, we settled the redemption of $500 million of the $600 million outstanding aggregate principal amount of our 2017 senior notes. The 2017 senior notes were repayable within one year as of October 31, 2017 and were reclassified to short-term debt. The remaining $100 million in 2017 senior notes matured and were paid in full on November 1, 2017.

XML 17 R22.htm IDEA: XBRL DOCUMENT v3.19.3.a.u2
DERIVATIVES
 12 Months Ended
Oct. 31, 2019
Derivative Instruments and Hedging Activities Disclosure [Abstract]  
DERIVATIVES
13.   DERIVATIVES

We are exposed to foreign currency exchange rate fluctuations and interest rate changes in the normal course of our business. As part of our risk management strategy, we use derivative instruments, primarily forward contracts purchased options to hedge economic and/or accounting exposures resulting from changes in foreign currency exchange rates.

Fair Value Hedges

We are exposed to interest rate risk due to the mismatch between the interest expense we pay on our loans at fixed rates and the variable rates of interest we receive from cash, cash equivalents and other short-term investments. We have issued long-term debt in U.S. dollars at fixed interest rates based on the market conditions at the time of financing. The fair value of our fixed rate debt changes when the underlying market rates of interest change, and, in the past, we have used interest rate swaps to change our fixed interest rate payments to U.S. dollar LIBOR-based variable interest expense to match the floating interest income from our cash, cash equivalents and other short-term investments. As of October 31, 2019, all interest rate swap contracts had either been terminated or had expired.

On August 9, 2011, we terminated five interest rate swap contracts related to our 2020 senior notes that represented the notional amount of $500 million. On September 17, 2019, the 2020 senior notes were redeemed, and the remaining gain associated with the terminated interest rate swap contracts was realized.

Cash Flow Hedges

We enter into foreign exchange contracts to hedge our forecasted operational cash flow exposures resulting from changes in foreign currency exchange rates. These foreign exchange contracts, carried at fair value, have maturities between one and twelve months. These derivative instruments are designated and qualify as cash flow hedges under the criteria prescribed in the authoritative guidance and are assessed for effectiveness against the underlying exposure every reporting period. For open contracts as of October 31, 2019 and entered into on or after November 1, 2018, changes in the time value of the foreign exchange contract are excluded from the assessment of hedge effectiveness and are recognized in cost of sales over the life of the foreign exchange contract. The changes in fair value of the effective portion of the derivative instrument are recognized in accumulated other comprehensive income (loss).  Amounts associated with cash flow hedges are reclassified to cost of sales in the consolidated statement of operations when the forecasted transaction occurs. If it becomes probable that the forecasted transaction will not occur, the hedge relationship will be de-designated and amounts accumulated in other comprehensive income (loss) will be reclassified to other income (expense), net in the current period. Changes in the fair value of the ineffective portion of derivative instruments are recognized in other income (expense), net in the consolidated statement of operations in the current period. We record the premium paid (time value) of an option on the date of purchase as an asset. For options designated as cash flow hedges, changes in the time value are excluded from the assessment of hedge effectiveness and are recognized in cost of sales over the
life of the option contract. For the years ended October 31, 2019, 2018 and 2017, ineffectiveness and gains and losses recognized in other income (expense),net due to de-designation of cash flow hedge contracts were not significant.

In July 2012, Agilent executed treasury lock agreements for $400 million in connection with future interest payments to be made on our 2022 senior notes issued on September 10, 2012. We designated the treasury lock as a cash flow hedge. The treasury lock contracts were terminated on September 10, 2012 and we recognized a deferred gain in accumulated other comprehensive income which is being amortized to interest expense over the life of the 2022 senior notes. The remaining gain to be amortized related to the treasury lock agreements at October 31, 2019 was $1 million.

In February 2016, Agilent executed three forward-starting pay fixed/receive variable interest rate swaps for the notional amount of $300 million in connection with future interest payments to be made on our 2026 senior notes issued on September 15, 2016. These derivative instruments were designated and qualified as cash flow hedges under the criteria prescribed in the authoritative guidance. The swap arrangements were terminated on September 15, 2016 with a payment of $10 million and we recognized this as a deferred loss in accumulated other comprehensive income which is being amortized to interest expense over the life of the 2026 senior notes. The remaining loss to be amortized related to the interest rate swap agreements at October 31, 2019 was $7 million.

In August 2019, Agilent executed treasury lock agreements for $250 million in connection with future interest payments to be made on our 2029 senior notes issued on September 5, 2019. We designated the treasury lock as a cash flow hedge. The treasury lock contracts were terminated on September 6, 2019 and we recognized a deferred loss of $6 million in accumulated other comprehensive income which is being amortized to interest expense over the life of the 2029 senior notes. The remaining loss to be amortized related to the treasury lock agreements at October 31, 2019 was $6 million.

Other Hedges

Additionally, we enter into foreign exchange contracts to hedge monetary assets and liabilities that are denominated in currencies other than the functional currency of our subsidiaries. These foreign exchange contracts are carried at fair value and do not qualify for hedge accounting treatment and are not designated as hedging instruments. Changes in value of the derivative instruments are recognized in other income (expense),net in the consolidated statement of operations, in the current period, along with the offsetting foreign currency gain or loss on the underlying assets or liabilities.

Our use of derivative instruments exposes us to credit risk to the extent that the counterparties may be unable to meet the terms of the agreement. We do, however, seek to mitigate such risks by limiting our counterparties to major financial institutions which are selected based on their credit ratings and other factors. We have established policies and procedures for mitigating credit risk that include establishing counterparty credit limits, monitoring credit exposures, and continually assessing the creditworthiness of counterparties.

A number of our derivative agreements contain threshold limits to the net liability position with counterparties and are dependent on our corporate credit rating determined by the major credit rating agencies. The counterparties to the derivative instruments may request collateralization, in accordance with derivative agreements, on derivative instruments in net liability positions.

The aggregate fair value of all derivative instruments with credit-risk-related contingent features that were in a net liability position as of October 31, 2019, was $2 million. The credit-risk-related contingent features underlying these agreements had not been triggered as of October 31, 2019.

There were 261 foreign exchange forward contracts open as of October 31, 2019 and designated as cash flow hedges. There were 205 foreign exchange forward contracts open as of October 31, 2019 not designated as hedging instruments. The aggregated notional amounts by currency and designation as of October 31, 2019 were as follows:
 
 
Derivatives Designated as
Cash Flow Hedges
 
Derivatives
Not
Designated
as Hedging
Instruments
 
 
Forward
Contracts USD
 
Forward
Contracts USD
Currency
 
Buy/(Sell)
 
Buy/(Sell)
 
 
(in millions)
Euro
 
$
(40
)
 
$
141

British Pound
 
(45
)
 
1

Canadian Dollar
 
(38
)
 
25

Australian Dollar
 
4

 
—

Malaysian Ringgit
 
—

 
11

Japanese Yen
 
(82
)
 
(7
)
Danish Krone
 
—

 
237

Korean Won
 
(59
)
 
(32
)
Singapore Dollar
 
14

 
28

Swiss Franc
 
—

 
(2
)
Chinese Yuan Renminbi
 
(59
)
 
(70
)
Swedish Krona
 
—

 
(8
)
Other
 
—

 
(23
)
 
 
$
(305
)
 
$
301



Derivative instruments are subject to master netting arrangements and are disclosed gross in the balance sheet in accordance with the authoritative guidance. The gross fair values and balance sheet location of derivative instruments held in the consolidated balance sheet as of October 31, 2019 and 2018 were as follows:

Fair Values of Derivative Instruments
Asset Derivatives
 
Liability Derivatives
 
 
Fair Value
 
 
 
Fair Value
Balance Sheet Location
 
October 31,
2019
 
October 31,
2018
 
Balance Sheet Location
 
October 31,
2019
 
October 31,
2018
(in millions)
Derivatives designated as hedging instruments:
 
 
 
 
 
 
 
 
 
 
Cash flow hedges
 
 
 
 
 
 
 
 
 
 
Foreign exchange contracts
 
 
 
 
 
 
 
 
 
 
Other current assets
 
$
3

 
$
11

 
Other accrued liabilities
 
$
2

 
$
1

 
 
 
 
 
 
 
 
 
 
 
Derivatives not designated as hedging instruments:
 
 
 
 
 
 
 
 
 
 
Foreign exchange contracts
 
 
 
 
 
 
 
 
 
 
Other current assets
 
$
9

 
$
5

 
Other accrued liabilities
 
$
4

 
$
4

Total derivatives
 
$
12

 
$
16

 
 
 
$
6

 
$
5



The effect of derivative instruments for foreign exchange contracts designated as hedging instruments and not designated as hedging instruments in our consolidated statement of operations were as follows:

 
Years Ended October 31,
 
2019
 
2018
 
2017
 
(in millions)
Derivatives designated as hedging instruments:
 
 
 
 
 
Cash flow hedges
 
 
 
 
 
Loss on interest rate swaps recognized in other comprehensive income (loss)
$
(6
)
 
$
—

 
$
—

Loss reclassified from accumulated other comprehensive income into interest expense
$
(1
)
 
$
(1
)
 
$
—

Gain (loss) recognized in accumulated other comprehensive income (loss)
$
—

 
$
7

 
$
—

Gain (loss) reclassified from accumulated other comprehensive income (loss) into cost of sales
$
9

 
$
(3
)
 
$
1

Gain (loss) on time value of forward contracts recorded in cost of sales
$
2

 
$
—

 
$
—

Derivatives not designated as hedging instruments:
 
 
 
 
 
Gain (loss) recognized in other income (expense), net
$
2

 
$
(2
)
 
$
5



At October 31, 2019 the estimated amount of existing net gain that is expected to be reclassified from accumulated other comprehensive income to cost of sales within the next twelve months is $4 million.
XML 18 R43.htm IDEA: XBRL DOCUMENT v3.19.3.a.u2
DERIVATIVES (Tables)
 12 Months Ended
Oct. 31, 2019
Derivative Instruments and Hedging Activities Disclosure [Abstract]  
Aggregated notional amounts by currency and designation The aggregated notional amounts by currency and designation as of October 31, 2019 were as follows:
 
 
Derivatives Designated as
Cash Flow Hedges
 
Derivatives
Not
Designated
as Hedging
Instruments
 
 
Forward
Contracts USD
 
Forward
Contracts USD
Currency
 
Buy/(Sell)
 
Buy/(Sell)
 
 
(in millions)
Euro
 
$
(40
)
 
$
141

British Pound
 
(45
)
 
1

Canadian Dollar
 
(38
)
 
25

Australian Dollar
 
4

 
—

Malaysian Ringgit
 
—

 
11

Japanese Yen
 
(82
)
 
(7
)
Danish Krone
 
—

 
237

Korean Won
 
(59
)
 
(32
)
Singapore Dollar
 
14

 
28

Swiss Franc
 
—

 
(2
)
Chinese Yuan Renminbi
 
(59
)
 
(70
)
Swedish Krona
 
—

 
(8
)
Other
 
—

 
(23
)
 
 
$
(305
)
 
$
301
Gross fair values and balance sheet location of derivative instruments held in the consolidated balance sheet The gross fair values and balance sheet location of derivative instruments held in the consolidated balance sheet as of October 31, 2019 and 2018 were as follows:

Fair Values of Derivative Instruments
Asset Derivatives
 
Liability Derivatives
 
 
Fair Value
 
 
 
Fair Value
Balance Sheet Location
 
October 31,
2019
 
October 31,
2018
 
Balance Sheet Location
 
October 31,
2019
 
October 31,
2018
(in millions)
Derivatives designated as hedging instruments:
 
 
 
 
 
 
 
 
 
 
Cash flow hedges
 
 
 
 
 
 
 
 
 
 
Foreign exchange contracts
 
 
 
 
 
 
 
 
 
 
Other current assets
 
$
3

 
$
11

 
Other accrued liabilities
 
$
2

 
$
1

 
 
 
 
 
 
 
 
 
 
 
Derivatives not designated as hedging instruments:
 
 
 
 
 
 
 
 
 
 
Foreign exchange contracts
 
 
 
 
 
 
 
 
 
 
Other current assets
 
$
9

 
$
5

 
Other accrued liabilities
 
$
4

 
$
4

Total derivatives
 
$
12

 
$
16

 
 
 
$
6

 
$
5
Effect of derivative instruments for foreign exchange contracts in the consolidated statement of operations
The effect of derivative instruments for foreign exchange contracts designated as hedging instruments and not designated as hedging instruments in our consolidated statement of operations were as follows:

 
Years Ended October 31,
 
2019
 
2018
 
2017
 
(in millions)
Derivatives designated as hedging instruments:
 
 
 
 
 
Cash flow hedges
 
 
 
 
 
Loss on interest rate swaps recognized in other comprehensive income (loss)
$
(6
)
 
$
—

 
$
—

Loss reclassified from accumulated other comprehensive income into interest expense
$
(1
)
 
$
(1
)
 
$
—

Gain (loss) recognized in accumulated other comprehensive income (loss)
$
—

 
$
7

 
$
—

Gain (loss) reclassified from accumulated other comprehensive income (loss) into cost of sales
$
9

 
$
(3
)
 
$
1

Gain (loss) on time value of forward contracts recorded in cost of sales
$
2

 
$
—

 
$
—

Derivatives not designated as hedging instruments:
 
 
 
 
 
Gain (loss) recognized in other income (expense), net
$
2

 
$
(2
)
 
$
5
XML 19 R47.htm IDEA: XBRL DOCUMENT v3.19.3.a.u2
LONG-TERM DEBT (Tables)
 12 Months Ended
Oct. 31, 2019
Debt Disclosure [Abstract]  
Schedule of Interest Rate Swaps pertaining to Senior Notes offered
The following table summarizes the company's long-term senior notes and the related interest rate swaps:

 
October 31, 2019
 
October 31, 2018
 
Amortized
Principal
 
Swap
 
Total
 
Amortized
Principal
 
Swap
 
Total
 
(in millions)
2020 Senior Notes
$
—

 
$
—

 
$
—

 
$
499

 
$
7

 
$
506

2022 Senior Notes
399

 
—

 
399

 
399

 
—

 
399

2023 Senior Notes
597

 
—

 
597

 
597

 
—

 
597

2026 Senior Notes
298

 
—

 
298

 
297

 
—

 
297

2029 Senior Notes
492

 
—

 
492

 
—

 
—

 
—

Total
$
1,786

 
$
—

 
$
1,786

 
$
1,792

 
$
7

 
$
1,799
XML 20 R94.htm IDEA: XBRL DOCUMENT v3.19.3.a.u2
RETIREMENT PLANS AND POST RETIREMENT PENSION PLANS, Financial Statement Location (Details)
$ in Millions
Oct. 31, 2019
USD ($)
Pension Plan | Non-U.S. Plans  
Accumulated other comprehensive income expected to be recognized as components of net expense during the next fiscal year [Abstract]  
Amortization of net prior service cost (benefit) $ 0
Defined Benefit Plan, Expected Amortization of Gain (Loss), Next Fiscal Year 48
Pension Plan | U.S. Plan  
Accumulated other comprehensive income expected to be recognized as components of net expense during the next fiscal year [Abstract]  
Amortization of net prior service cost (benefit) 0
Defined Benefit Plan, Expected Amortization of Gain (Loss), Next Fiscal Year 3
Post-Retirement Benefit Plan | U.S. Plan  
Accumulated other comprehensive income expected to be recognized as components of net expense during the next fiscal year [Abstract]  
Amortization of net prior service cost (benefit) (7)
Defined Benefit Plan, Expected Amortization of Gain (Loss), Next Fiscal Year $ 4
XML 21 R64.htm IDEA: XBRL DOCUMENT v3.19.3.a.u2
SHARE-BASED COMPENSATION-Fair Value Assumptions (Details)
 12 Months Ended
Oct. 31, 2019
Oct. 31, 2018
Oct. 31, 2017
LTPP [Member]      
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]      
Volatility of Agilent shares (in hundreths) 22.00% 21.00% 23.00%
Volatility of selected peer-company shares, Minimum (in hundreths) 15.00% 14.00% 15.00%
Volatility of selected peer-company shares, Maximum (in hundreths) 66.00% 66.00% 63.00%
Pair-wise correlation with selected peers (in hundredths) 30.00% 32.00% 36.00%
LTPP & RSU [Member]      
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]      
Post-vest restriction discount for all executive awards 5.00% 4.80% 5.30%
XML 22 R60.htm IDEA: XBRL DOCUMENT v3.19.3.a.u2
REVENUE REVENUE - Revenue by Type (Details) - USD ($)
$ in Millions
 12 Months Ended
Oct. 31, 2019
Oct. 31, 2018
Oct. 31, 2017
Disaggregation of Revenue [Line Items]      
Net revenue $ 5,163 $ 4,914 $ 4,472
Instrumentation      
Disaggregation of Revenue [Line Items]      
Net revenue 2,150    
Non-Instrumentation and Other      
Disaggregation of Revenue [Line Items]      
Net revenue $ 3,013    
XML 23 R90.htm IDEA: XBRL DOCUMENT v3.19.3.a.u2
RETIREMENT PLANS AND POST RETIREMENT PENSION PLANS Defined Contribution (Details) - USD ($)
$ in Millions
 12 Months Ended
Oct. 31, 2019
Oct. 31, 2018
Oct. 31, 2017
Defined Contribution Plan Disclosure [Line Items]      
Maximum employer matching contribution in the 401(k) plan (in hundredths) 6.00%    
Maximum employee contribution to 401(k) 50.00%    
401(k) Plan employer expense $ 39 $ 37 $ 33
401(k) Additional company contribution      
Defined Contribution Plan Disclosure [Line Items]      
Transitional company contribution to employee 401(k) 4.00%    
401(k) Additional company contribution | 3 Percent      
Defined Contribution Plan Disclosure [Line Items]      
Transitional company contribution to employee 401(k) 3.00%    
401(k) Additional company contribution | 5 Percent      
Defined Contribution Plan Disclosure [Line Items]      
Transitional company contribution to employee 401(k) 5.00%    
XML 24 R106.htm IDEA: XBRL DOCUMENT v3.19.3.a.u2
STOCKHOLDERS' EQUITY Stock Repurchases (Details) - USD ($)
shares in Millions, $ in Millions
 12 Months Ended
Oct. 31, 2019
Oct. 31, 2018
Oct. 31, 2017
Nov. 19, 2018
May 28, 2015
2015 Repurchase Program [Member]          
Share Repurchase Program [Line Items]          
Stock Repurchase Program, Authorized Amount         $ 1,140
Stock Repurchased and Retired During Period, Shares   6.4 4.1    
Stock Repurchased and Retired During Period, Value   $ 422 $ 194    
Remaining authorized repurchase amount   $ 188      
2019 Repurchase Program [Member]          
Share Repurchase Program [Line Items]          
Stock Repurchase Program, Authorized Amount       $ 1,750  
Stock Repurchased and Retired During Period, Shares 10.4        
Stock Repurchased and Retired During Period, Value $ 723        
Remaining authorized repurchase amount $ 1,030        
XML 25 R68.htm IDEA: XBRL DOCUMENT v3.19.3.a.u2
INCOME TAXES INCOME TAXES- Provision (Details) - USD ($)
$ in Millions
 12 Months Ended
Oct. 31, 2019
Oct. 31, 2018
Oct. 31, 2017
Income Tax Disclosure [Abstract]      
Effective Income Tax Rate Reconciliation, Other Reconciling Items, Amount $ (299) $ 0 $ 0
Deferred Income Tax Expense (Benefit) (255) (16) 102
Taxes Payable, Current 231    
Income before income tax      
U.S. operations 189 169 116
Non-U.S. operations 730 777 687
Income before taxes 919 946 803
Provision (benefit) for income taxes      
U.S. federal taxes - current (191) 520 15
U.S. federal taxes - deferred 0 51 110
Non-U.S. taxes - current 290 95 1
Non-U.S. taxes - deferred (267) (22) (7)
State taxes, net of federal benefit - current 4 1 1
State taxes, net of federal benefit - deferred 12 (15) (1)
Income tax expense (benefit) $ (152) $ 630 $ 119
XML 26 R98.htm IDEA: XBRL DOCUMENT v3.19.3.a.u2
RETIREMENT PLANS AND POST RETIREMENT PENSION PLANS, Assumptions (Details)
 12 Months Ended
Oct. 31, 2019
Oct. 31, 2018
Oct. 31, 2017
U.S. Plan | Pension Plan      
Assumptions used to calculate the net periodic cost      
Discount rate (in hundredths) 4.50% 3.75% 3.75%
Expected long-term return on assets (in hundredths) 7.00% 7.00% 7.25%
Assumptions used to calculate the benefit obligation      
Discount rate (in hundredths) 3.25% 4.50%  
U.S. Plan | Post-Retirement Benefit Plan      
Assumptions used to calculate the net periodic cost      
Discount rate (in hundredths) 4.25% 3.50% 3.50%
Expected long-term return on assets (in hundredths) 7.00% 7.00% 7.25%
Current medical cost trend rate 6.00% 6.00% 6.00%
Ultimate medical cost trend rate 3.50% 3.50% 3.50%
Medical cost trend rate decreases to ultimate rate in year 2029 2029 2029
Assumptions used to calculate the benefit obligation      
Discount rate (in hundredths) 3.00% 4.25%  
Defined Benefit Plan, Health Care Cost Trend Rate Assumed, Next Fiscal Year 6.25% 6.00%  
Defined Benefit Plan, Ultimate Health Care Cost Trend Rate 4.50% 3.50%  
Non-U.S. Plans | Pension Plan | Minimum      
Assumptions used to calculate the net periodic cost      
Discount rate (in hundredths) 0.83% 0.67% 0.22%
Average increase in compensation levels (in hundredths) 2.25% 2.00% 2.00%
Expected long-term return on assets (in hundredths) 4.00% 4.00% 4.00%
Assumptions used to calculate the benefit obligation      
Discount rate (in hundredths) 0.22% 0.83%  
Defined Benefit Plan, Assumptions Used Calculating Benefit Obligation, Rate of Compensation Increase 2.25% 2.25%  
Non-U.S. Plans | Pension Plan | Maximum      
Assumptions used to calculate the net periodic cost      
Discount rate (in hundredths) 2.68% 2.52% 2.66%
Average increase in compensation levels (in hundredths) 3.25% 3.25% 4.25%
Expected long-term return on assets (in hundredths) 5.75% 6.00% 6.25%
Assumptions used to calculate the benefit obligation      
Discount rate (in hundredths) 1.81% 2.68%  
Defined Benefit Plan, Assumptions Used Calculating Benefit Obligation, Rate of Compensation Increase 3.00% 3.25%  
XML 27 R102.htm IDEA: XBRL DOCUMENT v3.19.3.a.u2
SHORT-TERM DEBT - Senior Notes (Details) - USD ($)
$ in Millions
Sep. 17, 2019
Nov. 01, 2017
Oct. 20, 2014
Aug. 09, 2011
Jul. 13, 2010
Oct. 24, 2007
Sep. 15, 2016
Short-term Debt [Line Items]              
Notional Amount Of Terminated Interest Rate Fair Value Hedge Derivatives             $ 10
Senior Notes 2017 [Member]              
Short-term Debt [Line Items]              
Issuance date of debt           Oct. 24, 2007  
Debt Instrument, Face Amount           $ 600  
Debt Instrument, Redemption Period, Start Date     Oct. 20, 2014        
Extinguishment of Debt, Amount     $ 500        
Repayments of senior debt   $ 100          
Senior Notes 2020 [Member]              
Short-term Debt [Line Items]              
Issuance date of debt         Jul. 13, 2010    
Debt Instrument, Face Amount       $ 500 $ 500    
Percentage Of Face Amount Of Senior Note Instrument Issued         99.54%    
Maturity date         Jul. 15, 2020    
Fixed interest rate per annum (in hundredths)         5.00%    
Debt Instrument, Redemption Period, End Date Sep. 17, 2019            
Early Repayment of Senior Debt $ 500            
Early repayment of senior notes including prepayment penalty 512            
Early repayment of senior notes prepayment penalty 12            
accelerated amortization of interest rate swap gain 4            
Amortization of Debt Issuance Costs and Discounts 1            
Debt Instrument, Increase, Accrued Interest $ 4            
Senior Notes 2020 [Member]              
Short-term Debt [Line Items]              
Interest Rate Derivatives Terminated Date       Aug. 09, 2011      
Notional Amount Of Terminated Interest Rate Fair Value Hedge Derivatives       $ 500      
Terminated Interest Rate Fair Value Hedge Derivative Assets At Fair Value       $ 34      
XML 28 R56.htm IDEA: XBRL DOCUMENT v3.19.3.a.u2
ACQUISITIONS ACQUISITIONS - Intangible Assets (Details) - USD ($)
$ in Millions
 12 Months Ended
Oct. 31, 2019
Oct. 31, 2018
Business Acquisition [Line Items]    
Finite-lived intangible assets acquired $ 1,971 $ 1,233
In-Process R&D 115 111
Total intangible assets acquired - excluding goodwill 2,086 1,344
BioTek [Member]    
Business Acquisition [Line Items]    
Finite-lived intangible assets acquired 637  
In-Process R&D 4  
Total intangible assets acquired - excluding goodwill 641  
Developed product technology    
Business Acquisition [Line Items]    
Finite-lived intangible assets acquired 1,413 947
Developed product technology | BioTek [Member]    
Business Acquisition [Line Items]    
Finite-lived intangible assets acquired 387  
Customer relationships    
Business Acquisition [Line Items]    
Finite-lived intangible assets acquired 329 $ 107
Customer relationships | BioTek [Member]    
Business Acquisition [Line Items]    
Finite-lived intangible assets acquired 202  
Backlog    
Business Acquisition [Line Items]    
Finite-lived intangible assets acquired 5  
Backlog | BioTek [Member]    
Business Acquisition [Line Items]    
Finite-lived intangible assets acquired $ 5  
Acquired Finite-lived Intangible Assets, Weighted Average Useful Life 2 months  
Tradenames and trademarks | BioTek [Member]    
Business Acquisition [Line Items]    
Finite-lived intangible assets acquired $ 43  
Acquired Finite-lived Intangible Assets, Weighted Average Useful Life 10 years  
Minimum | Developed product technology | BioTek [Member]    
Business Acquisition [Line Items]    
Acquired Finite-lived Intangible Assets, Weighted Average Useful Life 5 years  
Minimum | Customer relationships | BioTek [Member]    
Business Acquisition [Line Items]    
Acquired Finite-lived Intangible Assets, Weighted Average Useful Life 3 years  
Maximum | Developed product technology | BioTek [Member]    
Business Acquisition [Line Items]    
Acquired Finite-lived Intangible Assets, Weighted Average Useful Life 13 years  
Maximum | Customer relationships | BioTek [Member]    
Business Acquisition [Line Items]    
Acquired Finite-lived Intangible Assets, Weighted Average Useful Life 8 years  
XML 29 R52.htm IDEA: XBRL DOCUMENT v3.19.3.a.u2
NEW ACCOUNTING PRONOUNCEMENTS - Textuals (Details) - USD ($)
$ in Millions
 12 Months Ended
Nov. 01, 2018
Oct. 31, 2019
Oct. 31, 2018
Oct. 31, 2017
New Accounting Pronouncement or Change in Accounting Principle, Effect of Adoption, Quantification $ (7)      
Retained Earnings (Accumulated Deficit) (303) $ (18) $ (336)  
Long-term Investments 75 $ 102 68  
Effective Income Tax Rate Reconciliation, at Federal Statutory Income Tax Rate, Percent   21.00%    
Operating Lease, Right-of-Use Asset   $ 195    
Impact of Adopting New Revenue Recognition Guidance [Member]        
Retained Earnings (Accumulated Deficit) 23      
Long-term Investments 0      
Impact of Adopting New Tax Effects in AOCI Guidance [Member]        
Retained Earnings (Accumulated Deficit) 7      
Long-term Investments 0      
Impact of Adopting New Intra-Entity Tax Guidance [Member]        
Retained Earnings (Accumulated Deficit) (2)      
Long-term Investments 0      
Impact of Adopting New Investments Valuation Guidance [Member]        
Retained Earnings (Accumulated Deficit) 5      
Long-term Investments $ 7      
Impact of Adopting New Retirement Benefits Guidance [Member]        
New Accounting Pronouncement or Change in Accounting Principle, Effect of Adoption, Quantification   $ 10 $ 24 $ 34
XML 30 R113.htm IDEA: XBRL DOCUMENT v3.19.3.a.u2
SEGMENT INFORMATION Segment Assets (Details) - USD ($)
$ in Millions
 12 Months Ended
Oct. 31, 2019
Oct. 31, 2018
Oct. 31, 2017
Nov. 01, 2018
Segment Reporting Information [Line Items]        
Segment Reporting Reconciliation Item Assets $ 7,153 $ 5,690    
Cash and cash equivalents 1,382 2,247    
Prepaid expenses 94 80    
Investments 102 68    
Long term and other receivables 100 102    
Other 621 354    
Total assets 9,452 8,541   $ 8,558
Capital expenditures 155 177 $ 176  
Life Sciences and Applied Markets        
Segment Reporting Information [Line Items]        
Total assets 3,202 1,744    
Capital expenditures 59 47    
Diagnostics and Genomics        
Segment Reporting Information [Line Items]        
Total assets 2,620 2,679    
Capital expenditures 48 92    
Agilent CrossLab        
Segment Reporting Information [Line Items]        
Total assets 1,331 1,267    
Capital expenditures 48 38    
Segment Total [Member]        
Segment Reporting Information [Line Items]        
Total assets 7,153 5,690    
Capital expenditures $ 155 $ 177    
XML 31 R89.htm IDEA: XBRL DOCUMENT v3.19.3.a.u2
RETIREMENT PLANS AND POST RETIEMENT PENSION PLANS - Deferred Profit Sharing Plan (Details) - USD ($)
$ in Millions
Oct. 31, 2019
Oct. 31, 2018
Deferred Profit Sharing [Member]    
Defined Benefit Plan Disclosure [Line Items]    
Fair Value of Plan Assets $ 132 $ 141
XML 32 R79.htm IDEA: XBRL DOCUMENT v3.19.3.a.u2
GOODWILL AND OTHER INTANGIBLE ASSETS Roll forward (Details) - USD ($)
$ in Millions
 12 Months Ended
Oct. 31, 2019
Oct. 31, 2018
Goodwill - Rollforward    
Beginning Balance $ 2,973 $ 2,607
Foreign currency translation impact (5) (15)
Goodwill arising from acquisitions 625 381
Ending Balance 3,593 2,973
Life Sciences and Applied Markets    
Goodwill - Rollforward    
Beginning Balance 803 773
Foreign currency translation impact (1) (7)
Goodwill arising from acquisitions 636 37
Ending Balance 1,438 803
Diagnostics and Genomics    
Goodwill - Rollforward    
Beginning Balance 1,607 1,330
Foreign currency translation impact (2) (4)
Goodwill arising from acquisitions   281
Indefinite-lived Intangible Assets, Purchase Accounting Adjustments (11)  
Ending Balance 1,594 1,607
Agilent CrossLab    
Goodwill - Rollforward    
Beginning Balance 563 504
Foreign currency translation impact (2) (4)
Goodwill arising from acquisitions 0 63
Ending Balance $ 561 $ 563
ZIP 33 0001090872-19-000022-xbrl.zip IDEA: XBRL DOCUMENT begin 644 0001090872-19-000022-xbrl.zip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

1SBK$FH2!)]^=E2C6_>SL^RH0O_9%'2VI^6$+M_"I(R\5 MP6G'(^&&*X1P:A%7EC()02"X%5!0E[*&X-D//^=%R//)OH:&@TM"?[QH:;4J MS?EPSTS@:5M^T/(!6;+!>_0H'TAY3M>/YOYA1[F4HV)-BBNR=T@]JYLWEEG0 M?IB+:M?F;=$<=GL."VT4,((IS+'SYAH!5K!4"\8H5?!Q(/@I3&@TOPUH_I9@ M3LO=K_V!>;#WOX3PY*@,D,SF07:SY&+TNR=L4>^+[5>6.T5WE#3, ,X!=()I M;9D RLLR9Q!P)%/SA :NI_"+'_:O(7%SV$K\JTORCQ_<%;V3;9;);/JRA3YP!!AY>612S?)8OKD$+2/516[0*N MG%$+.RVO=7*KY)A.AA#$0D.L_$<9E'*+"(LW4?/E] M?SD&K]O'NV68KR%R&H@\S"_RHBC]X+"G%$*?_U4.!AG^S7_/HSY.4^V5Z<$/_\>7EI OF>,V-O\B:K M*@C"GI&RDUFE*2#4H-1!;#&S*482N%"@BUH)&5U+'4BS8GR[3*]JH@=AT?=# MHEYKSM5D@$=#@/?;6L-%GJQXNLW!MR+L_)0GH(-J+99"$6(,M5T)6;U)6J)Q MYQ+_^D$)J:^J?6D;2>;$F^C,(N,-=>JX18AC!U-LB=#24=UJWY*;BH:;IA?5 MXI1KLS1!KI??5T=<;_O*:'"],^4.8Y-A-8*.W3<=.QET5"L1THBHM[RU51XA MI/9T5(9("K"BSZ+CH9!OG]1KUZ ^IGW[@- &.U--KL>+66,79MUM<7_MM]%T,?/@M+0AEV\KW=;2QMR_K\G:>+K$ MF'L^EU8Y@Z6Q4%CFK1>FL.70.MGRO!H,\G$X&9P/NY.;7C13"%^%681)])3I M]^/DY]VCE4QZ Y8J M82@15ELLE">_4$QH3N7:_IGJS/#CA:N.*4V^FC -Y4W7>A*SGM)_?ZD3)905 M>8"O"LJF91T>CR_3JSSYKG8(OW^73/)Y4RY@Y51^67N@Q)&5(_AE:K*?9"@] MX\') V2QJ%W/NWBU?]S@;;,WZXRUC@ &I4@1UX);XAG'PP;&!*NU7)F[L?M! MJ&F0JVHZ3=R@IURS1]2HCR:MJ[4JT[.I9M'&IU8U47F6:7=!@Y-+VH%\)6DG M>=G_8HY/+V,SHLU?)B(UD&B5 H(X(D @)JV'*D2,%!*Q;7)\ &\RE\GG\-<+ ML GRYT9DFK1+1(+S"_@II?ET,C,A@9P;)I#%D#AG.'5U?)MIY\W9C=-\=D+$ M[1N/OG::C\>]NVD^;RZVLE.'#G/*F:#>X+#.2HN8"<:% 2:U *5/B.W=D.JO M\ZR8WQ]4)0WU03 OR'Y%&)3Q*[+/D.HLG\_']19F-XBV;UF% '3JV@DHJ<*8 M6:F%)1PZH)9E B1:2\5)?P_'N!>CV6458@V+?Y^X[HI@/0^Q7KQ"1-S3BT1P M?8. ^!W@/4_J],H[GU<1\3*TM*QS&GS*27VZ]-[C0[PZN%?=.1AGL]GH8E3% MKSIG!$/\H8G&-=&QO3-;NULF&9"..H=D"K$)IY21J9G-4N36_,;NR?;']E[$ MW^!GZ/\+L/!&C ;WK,77N:3*PQRV=*\# M5)3T^(#]-O]7Y>Q2'WE/#K5J]Z M"R?FODIIO:OB=[=AU>95_#"7$#DB#1"&&HN"%R(8QL"EB@M"8Q6_2:SBM]%T MH=A9%;^_3B=?GU7$CQB%;"JI4-[BTQ0:QU!3VXYR)#M%_ R7WO\FCF%FC *" M&P+J%"7HE8%XM(C?D^]9*^+WUX\?_G-W-?R>\_YMAH]B"<"7G/;M^4&[S2IG MUCN4E?_3&BVS1P50&B>5 IA*_W_@>4G44N4Y2V#+.P*(#<;6&6(MTU (ZZU[ M7 L@!Q2;NQ+4AUAB,%,OIN-Q><(^*=M,)+/%U556^(MFW:#5_YLEXVEHX!%L MW-4-XDGC#U?;N>O9PK,?GL]$KR]VZ_=WKEYIP +\HG>I$/[N/FX2;-?Q2J\3 M"*K.)M72AB8$];=_/O.F>/@[A'":O^^9Y:?1E5_C#_E-\LOT*EOK1G,S&LXO M_:]^'E_"UE@1NI2-_9+G/S2_K!DQ9\OV8?Z2L$I_/D/D["\/=A>KWD'('_[4 M7'3W._CP5W*CNS;[BK[BN]@KODN<]!H>5[^[!^WH.U9PO2A+"87P[/'9U^)? MSPU>_YZ4>]_)OX'R?[MM)56[ANWY:FIWBP MJV5X%DO@-^"(%RS-WGA$-:=!'C3O7F,4/S?AYQ,'IE/EPG#T*I+^)$G_:3J/ M8G^BM(_*)W+AVW-A5#XG2_J'E$_TB/Y\AIYBBL-P@K\;39J4AMGWVY#Z2S;X M+;2[F0Q#1'A:_/!O@T&>7UP<1I3LR8*/>\.\!]=M[S/>I*WZDU0^T'[K;T>% MAQJQ]TK>7EGQ1B&+0A:%+ I9%+(H9%'(HI#M2.%LO.>(YQ*BM)Z(H90CY M+S#A%&MJ(!95QA6E4E#;UE983?GZD,^;@_0_%_G5:'%UWP&+LJ. ^-M+SL#L M\DRTE&O)[G=/,D44BB@44>A-4*A3&])HYRASR,)4Z30D@1+;H! S6MQ?6C:$ M^:5Q9.WY=X4($3CE#DH <*,8T1Y)9[$ M,J?A#EP2^3(11;NK +U3EZ2WML 1J/R3D#K95EC 4%"$%;"&8V6$44K36BD: M1,,%?3[[^+R^FPVQVV8DO1O&*XM4+\2*PTT>(8RR]RRN ($)2F)JT M+F!"-7%8;VES1H46)2Y*'"2XE3BDE +((9="!VB*A,.JB2EQA_'K1[:CU$6I M.TJIH]TJB-Y\Y!*FDDO-4FNQ;/0<83(E^XSD1C,RBM)W0951H)YQ:C'<9NMSI>O1%;CO%@85.E5$$,*=2)Y0T MVM0Q32I3:LCKQS3Q[K8=9-SX/-:-SY,68 H[>5*.6\48D10#2YD3#+):@#%R M!.\S/+J%J.[3KHV2&B6U+Y**V]U]+ECJ,':2,N8,X-82TT1:E8;\=2.M4J$8[.4KJ*4AJI^\81$BE0OHO <024.IP MX]%R)\5:\>?]AI*CFCWA+%@6LV!+\62=)C0:P)0)1JB6WGU%P%K5)*FG+$7T M]2/&;&N+]Z'%*'6J682LLMP$9*093&3AK0*$5%*;?[#/-N(5\Q M?2&*5V_%B_ VR9P*I[V!)J6Q7')+O535X@4T4*\JN&XY[CJ0( :14[\,J<""A(JJA-#>(65 !@N5&6N'V& M7[<0];UF#T1)CY)^))+.VG(C#$BOX9&6EH?YPA2S4M(%A% ZB%\W$AS5?!3^ M*/S[%7[1"G_*4TRQ(XQ#FGIAI4BDI?!3@5.7[B*WX84^?%3^4?ZC_.]3_@5H M2[-H(Y$7?FZU \@9([2PI?Q+(9GC>PV/1TF/DAXE?:^2CMIS[\!BP"4 UMOU M2"'M_7E72KHQRCFV;<)'E/V>1_@/))"_:4OB5@A5 MJ,VZQ-W;6]Y^+V7QT<5M]-)IXU)S_@(/0]6Y4 MB.QB5.6?-]5;OTS'PS^51YG (T>9GAQRLVJLCZNVJU%]NLR3W3BO2M&_3A)FC%MJNF[]]U__)(/> ?E-XIZ$Q!6IP7[,$ M.MF^G!*J@%(644B,A,"FNK($C+^!F\36NRMPU1"P7M30W\CG M7_/K^6<(/H<_-VI?T[40AOX]5_XEE\/L]C;/BGQR]I?P@O+2!()W0<#1FFZ[ M8S)LN/;ODKF'F,'TRM]XFXS\U/-AXI^1??U:Y%_]R)+K8C09C*ZS<9*5IE$R MO=B6U/_^E%77*1K)I/"$<]Z& Y@#+ A4#2T9M.R)UNG^$?E]%MV/+2&WHN/V MIS< 6+,&$[^&8__+MK0-NF%%;WQW5L);][.S[\^36LF@>Y1,PQ#SK:7["8IW M.M=(:UR*&)8T12JU6H5S>"7%K1=G:MK PL]Y,? DRK[F'R]:2G^\:(FU*M7Y M<,]2[66>$/6_. EU8OX:-B38XKNM>T]@R7^)$M M/,FG;X[DLHV'"T]UQU,J-%+8&2P@J(L)64PL?\*G^RG,:#2_#4C^1D#^<3"? MEC#^KA2QO:%X-ADF7_P[O/-M. M_5,]BX;9Y,\4<^3O[VQU4$]+H85)L4FA$5K5[KHE1LDG@'TEICCW/X8M&+RZ MD/_XP3U7S/$YVH>47WL6RR;^7954+YE@-$NNL]O@9N\(P.^764_8-@Z#1:BF M@#R**\!39@S0=45+ Z@FY F-7>3_6N23P>W'"T_1T70X&ORVR\?CV"?G< 'XGB?+(.ZX"FG VKWX)XEI#PYUOO)CFV> R"0!22O5U M-?M9,-+\+P,OSV\-T9[M-:"FZD,U9:*[RY1K3"'#YA; =H]LI[ M5'A1]H0?%5Z0JPF_E>E=DJO":XCWA-?;>>.G$_[X<9+\]V)\6SI [Q+U=33V M3T_RW_/!PB-^,B_R;+8H;I/Q=/";=UF*/*]$Q=-XSSY*" BWA>VE]E:+0P8S M!YGEFK9;853K9;KC:/+-@[*7@&+TS2O/;[EG3O_H;/RPBX(_AP4HF3W[?'.DP^./<7U'4)I7M^+RRVCV6WES<]&G>EG_ZE?U8!P=OW23O*+4S6A^F5PL M2FMVJ0F7,#J?>D/)&[O#TM2=+HI[?)_:[?'?KSOBE89=9;U MS"IVFORK[P: M38)1UA^32_RPL-?\C7ST_'_98/!XFHQKA[C;?BB M=-.+_#*?S#P!_27^[SSQZ.W5A5?T7_+1Y&LP[HMY^4@_T>7L\]^O_5U^QM_\ M8X+'/QY=Y+5OL#[_:HI%?N5'$IY9CJA:M_;Q15X-S7\^7UN0CBQNXSNNJ$A< M8;+8:%37$IBSK#CUD$8:GG3E/'ZP(93'.-.)=1?FJ4.*SV>SF9A MVLNEGGI0;<3V@1<XS'/!8S\RC6\BW#P?L"C5$Z^M+)SAQ MPB)!$%0B-+H'M38P##YU"/H)7Y_]C?QJ-^IB\8)DN H?V,&[^<_VX3M9C1IP M2;W91J1D0"*I<5J?#37<8O8$]1[SX5F3'D$#Q+.W:46"7]V'9P_Y\.SM,N$\ MQ5L''4/-(&44<"@4!PAPVJ3(X) M5L'?:=PC(AA>G=. M]<92N7]7^J>L\-XR0I-A*7==*?=_]M^;AIV,16YIR%(4RFF,@ )86=Z$-96A M:(?>]/YPMB%(:2'SZ$&_\:A^G"0N_U*488U ]_O2URZ+/ ]TOPFNZYRW>:5\5+FDKV>YRS MG>)&JWF1'R\^+>?5Y1Z7C8K_R<:+_+_RX=>\35^:/6D?[2)G:8_\M)X>.+_T MADXVZZ8)AC2QUTX37.73\]4LP7) 3V0)K@/8Z:8*PDZJH!(0,"VM!HRP%$JM M;)6?88'R)B5\XU1!MIM4P4?OG_VGG]!?_83T;9!G/\-? N_XA9M=CJY7GFRR MV:4;3V_JZW86@EJO']3#/,3=A/@?+)\1>&;DW8:J+DGY<77AW7%WAAG^_X_1?/>+^]SR[\F'[(QC?9[TNNV-B_JJ 2$CB%$6R =*V^M-O)@X" M$JD;I$ R:W;=X@4@\[WW>V>^AR#3!D,;8_ZL;A&%D>C@6GO!=R*UVJRDBQQ0 MB:TO_W<3"6\SVBU.++#SJR/&EW12FEEOB5;(6$F%DE1%%#K;LXR&&:(H1_(M M>H ?7S&5=M\,Y]!BHJ^I--@JF\4"6FF81"I20 D!K)0VBD%L,"#\P=.K]Z?2 MGCM+\O&A6%K;1T?35,)1K_%6,2($6!I+ F0$A( QUXYZV/HW;?Q :/:^5)JL M'(W"SY"O,Q&4[CR3)N_*I,E7S*3!5JDKMQ(@88R V"D(2TQ,K2,X<]**8],. M3W212>N2"5Z:2,-PO:/X,2;2X(TRUE@ K&.L&(?*#_MF(D9,&L",H?2!4<#W M)]*VC]U5_>KVP+L'>338JDZ-*?!5*Q!HQK%3ML;(R,FNH$ JA"'H,H_6&\E% M[PZR-A6V:E-C*V,.'$41DII9P&(5.2DTP)OTB#V0=7E*&NV9,KFK)-JJ&K4M MXX\J2>T!K+:*4A&P-E;._,7.+"8R4HH+)ZB2:J-\#7*':;1MH6Q-D )A0>C^ M\*INZ(?I0"TOW VJ#I>]ZO\ >)U@V2/;G_ M@V=SMP6_PU(=/2=T*WMSRAO1/J?@Y,,IN,II?C?X[]2M/W?L7Z8VUKL?^$3- M,,G=,TQFWP>7/CWU@K81K+SO_5TCBNS+#KQHWG3^@5"[UT8(28U0U!?\<\-) MI(2(B$)P/>?KC4>?]*E)<2M%42'[_WPU79P)W2JS[3+K)N]MSO&8M-M]S3DV M)LYVDO\2S7QVHHU6&'&&*9_^@.BV^/J%Z:H>F>% M;"U^KY/Y>)%,!K\X\CXS>+_%]OH]L-N^MH*_DV*3!L,T6_@F0O-LYES0Q76A MR[R5/R_J4)9>;)W&+#>V_,V[@2H46MU!LX:FTZK::?IVN'2:S_UZ[H7?:_+S M=MRYF/K)?\YO7G8P.W/K+]/*@\OD5EAZ6 V!&'SS926[4*>2M\I*(V"A58:X MSTT<(^<=0VV)E<;B6*PUTJOXL&##3\VJ/LZFU<9L;4[A>F2B,]5:*K*BLWVA M#B$JW-_\EL^T,5/]VGR_61I]@MA3/2?4&!E+!BG1E".FJ 2*1!(K)"44/EWI M\[2K_&?+Z;[32KK)$5\63M5<.I1*L]PZX5I<>P7F!\,Y1>EL89] C;P)<+(A MG\J1N(RTDB7C M.=JD([5X\GVG7XS][#A M]0"5?8^H]PN3Z72V+"KK%Y?.KO=^[=DLR8IB_-'8>8V+65;IO+G3P]\*_S&_ M3,I9(C4=YB4=!F^\*CTIKKW^:9/A8EDN;B<9>ZI\T(OKSYWS[.<>Z3? MDG(5@#!)4H$;_R**$9'88&YCI8T4EM(:L02+FH'D-Y"TX%5ZOVZ%"\ M&S1LM8&A1LXJ<#[P("OCPS>J#!P[)S MY63D!,&YZ6=IZIY^Z;[OY--)2E8\V$):G[@0&,"'Y"ZD9J.?BM74&Y]F>@IA&I3Z(@71E&GPI=7]VK)'WULP]MW MVVMK67/S%N/<*W(V86X"(1<$">Q--<$]4:OCR,PR_EQR%A7\NZ'FLVO]Y08D M[8J4I>];%OA7^J5P:=[M F_$_N,-;95U.3_*>5+"(@$<[%",3=EPUT 81V+M M@/0+\4;T"F_8NRTRZ>[PAC9%6X1$#-LH-@HCJ$W,(VQJ]<%CL%8@\#*\V0(U MG]TK':V/5M\!WJB7)9"V@"_>66DR'3<>UQM\+1-Q)PX%:_7VEH9"YSQH0PDW M4$E$6$PU5RJBV*R7D&UV*%;)C,:S:+ZST<>H1]'V@D_=SFR/3S=Y&"W>K7V" M,L.6_I@7BL=]<\VGZ)WSWMOR^F;K9+EWSPXK3-/OCP@MR(VAA2JWGHY.?4+3 MR7V97W54GU[DIZ7'W2H'TUE5.%M7=_@/ M?>E9BZ$VA3IF:=Y%K.,JN?8)E56(P\M43V(=SS^=VQO?HUW! "RA-M+$&.<5 M8TXLE'[X#R0&"*77.JV^T/>03[16'R%W+_ ](#@,YT,TV5A, 3(&,Z.,CB). M"6+8T5-3:S!B;"T;^S+G8POD?/8AZ*8S]IX['R\$F)XY'ZW.8D3ZVGDJ@398 M:LH9C+ES/IA4%G '-EMU/N13G(^MJGNP@5&WJ>[7O8^#]RT.^*DV5G;EEP,S M_C9VMQGE11%NJ7J*(_4%)Q2BU+.5]'-_G1#UW(@L*K1'#;FW=:BM0G )&^LB MQBPRDL>1BD2LHY@K7J52'()#MF8MEMQ7,-^*/YU%4;"G28<3]S^C1Q93US]K M@RY>82ZX%W/!.T;7*U [.956&'FG@ZW;>!*U&CDJ0J2Q%@H(HA@)A7'5H=,B MQN%Z1^5ZZUOD\)BQS3)V!+98R%X<.QA5_%,=,1L74;2;?NULN<@7[F,OS6V5 MV/LGF+E0)[(>(O*7O9M8B3IH\ MH#"&*)(&1@KXPU"J;FAH(2%TK1'P,T6<=R_B:#UQLU\B3AIO&!/--:;2&B:Q M=984D+JVI: #X!>(^*:=?YZ(\RV>?7RYB/?.=>BG0_-J':AJKJ>M,\>6DQ@0 M(Z"().!:2VVK8JP8LNANQ?:Y[//@C]O7F&.2ZU_=\UZJZ>A_',*O';='X!_P M]X^S;[\C<+,OQI?E65ZT85C8;^Z?K]?S],81N%N?/_84_BH/B()H!5)&XN1(1!9#)E1TC(4<8"-KIJ &@1I!Q;C%FCY MD%)"CU9*<)LZR5.RC7F%CNHT5?00H5F3*XH5))8IS4&$GLL2C^[=?4-G^MQ?=5 EVWU2?%)E4)XJR-M7H9]\X-LY#LL MU*<])[.RPN)LF3NS(,]?GPEX$V$2QO (2F$X1X!A)+C3VI66CB58']FS04M_ M.O^M6'3?N,"IF%)+-Z'8+ M_6\Z7'@6&J7MTHOB D6A4N)PX_J.>J:]2.S-6MFMYXW-&MNGY(_IF;- MCSGT^Y(SPR_L];RUC*)JM8GY5)0QZAMM8CZ4;6+>^+[W/]W= !]>IJ/E MQ.F,UIV+&]^X;WE;?].""^\]%^ZL4PVMB FCOH[)CQM6U=Y'R'#=.A<>PUA* MH:AFU$0TTACSVN2!VOFK]]+XP?N\^%SX\00JO,(\GTTFL^]%Y+9 FGQY=94T MQ:D^+#2;II4>]5KPD2V-WOBF.S]5%EA/O]ZP$5_'5X[-/Z;?![_-KI+I[:?]/AXM+MV?;JEG MSK!.L[=#)RS)/$_?UW^L&1?^<9Q1LO#'A_WMI_]Y(KRELACY?[+5I[774-R" MXS__7'_I]F?PGH_N^ZSSCQ[WLPUK_)9FB_$PF53;=#9;+&97/]\@ON^LTJ9L M^W7Y_1MO905'H)+ZF\W7;EHGW6DPW3)WJDU9D9R?=+_X.Y=:6>K-HXNGKE5L M7FJKI=*&]?:4TETM_E%TQ@_0N8*-:F%P_F.0SR;CT>!/H/BOHZVI[E) XMHM M=L\V;15]<]]VP"9/V O?.,HWWGQ_.1XYE=.% @U,\P*F$0%D#EB9O!E/ZY#^ M;1?V:90^2X9_7&2SY73DS;%9]OY/PV'J+.K]L"A._A;/,K /=7_Z(RZK5KY><4W^<<>X]Y&^I;T&_ M$_"]DQ!;W\+_>,8*'V2;YTA+P3:=>%[%>M[BCMUQ9Q?&]Y4(^_D^3Z<'U,_:S7Y\;+&D?[PKGOO@:K6 M]?-BM],%';) @P(O88JNN'P32O8*'%_+@$(/&5!=;D)O9)^#5E$/ !P"R&0< MF=BW6X*H#J!"8EY)]D7'LK^A+]U1RWY/;>%GK_&?TRQU5_QW-97 #XEK6O[- M,]_)/D^S;^.A[[\W3<_'BY]\TG[D_IJFH_J]P7SBV/2&X51_X@TG2'%I.$&, MGF@,$;CLP\'V#V!T=> S[Z:BKLL\PBV,BL MI48PJKB5T-(8*F)U52JH"8WP6@'1[F7V"=;!O0[!^AF88Y#9HXF.M(P"/[DE M+_/(:5ZI_GJ>RF"\&JARM^ZO-#_8LMY_*%Y[D.X(PLWY)JNHB9$D2AN!141( M)&#=1 I1N=: \9'@H\LON??T93*]2/,/4XS*%S?'3JO\EY^< ME=LBJ[Z[X$2G[LE+>:C_$-8KY.JK/7*06/(0E+1&+F,B8V%]VV]@022QU$C5 MK7F10&O'E5X+2KJQ9G@?$&3K8+"I)/D0XQE?9WY\U$/E<=Z<>3%YL2/O:+;T M94\OR0H_+P?\JEFM7W%>:MGH-&44 FQQ3%'$%E2S4=0,13K$[ ? M"8J[LY1HMZ'1UGKPAX\)AR@+S-)N%?BWKNM:-$=Y:A]Z[PO:M6ZY6O\H0Y MTM6AB[/KYMQ&U?2XFO.\.GQ0]LFMF_7D_>JY]XKG-,HN*4E>G8LIGM"X2K*+\;1\O&2YF-5OE#!8O-/1(0X$'SS%@5G79R[D MLWZ%PKUZ?:]7C7OTR< _@/4]NJC_ -9ZZ.M[=,']-@YH[+X@W_E"Z[5498;? M;45>&HYS_T>3Y"^*K8I/GQ/#/"0>"?*^]^L[&EH&@^-PUM>S4X2[5UOW'9\* M+'&4+/'Y1JWX,$M'XV"?'"DOJ.%BF63C9#+XI:@;#&QPE&SPR#+2P!['R1Y% MJ4ZPE ]Z?2LF]P-Z.E_L[GDV-%"H?E&.@&PU)[HQ&B14'(=N#X?1[8')IB[: M,$.10)@C2)6,94QYW0I>(JQ?Z<0W[[9F!CX\-.ZX3GP' L UF, >P"_.&SP M"W%D1!1KZOZ+321CC$EUKH/&1*\U*+YU\'223!^!: ZIBE#0ES(2I&?Y0A?! M(.7;AN\&PLCZ *(])!)Q5NG5A$5L50BMA8)*;E6A*%J MC!)T<+4^U?69D.1/F>5E,')W.(0?GMP73*D 7 &X]@6X6F=D&90":@0$H)3$ M.H)&5MV_8D446!LG^EIG9#N&-!0 +0!: +1# 33> !IDD4!*"R$YTHK& (-J M,F\< 6K6)O.^_+!7U]86"8&K_N;1JN,I=-[)@9M>I]1VM]1>%4\&"@<*!PH' M"@<*!PH'"A_\LH^FTN73PR?]4^>6I'[<]23)\_&YVP/O?3RKP]0!!PR.>W2 M!*W9J\A$3'(977V3CW&V,66;NW\]N';-1=T#0EO]_I]ELE.27GA4$@NCG4(L1Q'D/Q?E! MA8[E2IXYP]@8PRV(E8Y,+"FNIG50#;2 3U'H]S;X;TFZ#ZW_TUUVYG;\W^FH MSA%N5-[H>/="26DE=\8[,<(:(:L$.3,D MBME3=/QN-;+$02.'Q/@Q+?48 _*!PD>P["-::J#PH2\U4/C0EWJ,%#Z:Q+BZ M&VQ#$S3!M032(8VJ-B2T1L<085A%S0Z5%3ZJ14662[ Z!?G3"S6'( MG>GUG839PW'B !1' 10/X01M<((CKF1L(VZAU3"2S%A0&0D1@7IM2-E]./&P M\G\B5M1)NIV@ ]Y)XCV8!4':=RSMO)%V&"MI* (*86@LHQ!S51?:$,V>Y!(\ M+.TW%.1[0&$0XBW!,1EJW:5Z.8\ 4PD=4 $,L)YE7+GS@V@-P6X=MB M6@CGPX?/2T]_L<,B&$P/6GA#UOS0EWJ,T?I X2-8]A$M-5#XT)<:*'SH2SU& M"A]-UMPY(8,WZ0\_Y#/]J9[Y&7SE(_*5'\J"8=2DP"6U)C:4$6$)L" 21%CT5.OO#^Y*CO:5])<-97=R+&4GO61#K#O(]HYEF[62TTP#3HR."82* M,T1)=>S30(*IHK5L)W=*M2^0K ;")]-144HYOR'5E07I9\+G2:O.978^31?^ MUXL=G3+;R2&S(,Y!G'=MCHM&GC$W,0%,.]E%G$<&6Q95$\ P (]15>W4LO_ M6+J5G5^[#5!YV==]5T=#0S_W(.5!RIV4$] J/96^C"RR@"L6(18++NKN3)IR M]:0BDYUU70F"')+5Q[347H_/#AP0."!P0." P &! P('! X(R?3MF/X/]F8/ M/G[P\5<^/L6TB-V<-ITH + 1<\+M &%R+"-61"< -C@A6&P%1= M'K4%5CTZPO^HSNSYG:W9[QB;V&DQ3AB7&.0_R+^7?][(O[*"VUA00I0A')-8 MXLHNT))H8IXO_X_OU]Z9\#_&# @E>0$%C@(%'@(!R58@8*24,*81P)@;CC&D MC%0)0!M)*Q\/ O>D^'?A!]S7%#J4ZP0QWD,Q?DB9,]@H\QC&D0(HTLIP$AO" M6(PK9UU!#&#QP0."!P0." P &! P('! XX MPG2^RGWO^$_#Q>PLS088G@Z\=Q7<^R' M%2P ' +(9!R9&$(N8-4A@$-(S-IDR4>TSGMLLX [0B(?RI!(I\>48*?G&U[* M(OT/F 2 # !YP #Y$#YRW"KHD-QX>)162869%2JN"[VT(FOM1M<3MX] S#O' M JCS19KM!"(A[@5$AHQ/0+R >*]@$LH6Y,72"(U!C+1EE@@JF*U-0LKD6M.H MYT*>+V')O;&8YKO#.=QMF^5@"@9@#,"XQ\#X "X*V. B)C(6E@,'C19$$DN- M5-6-!R*!UFK^'^DJZ_)+[CU]F4POTOS#M#7ZQ;>KUTE^&3NN+PM_RA9;W3C/ MNRKL"^9@0+V >OU!O8?,08&;!H,,J4B)2&$#8H,Q!L!6,W.D!C9#I,!^ZM1?)CD!;1G7PPG@Z2QI$: MS$*GDN>)TX.'F%[JSO7QD-,#WKUDH'7&"472<@%C;#D$( 9801T+B!13C-#; MWOW']+MS\-U^+-S:/F>SJ?MS6'02_Y25\_W=WT=.!'ZO'N#W+POWRM_/_FLY7ES[Z,)LZE[F MZL&!T(;N,4]#H,\R" ;,"9@7,Z@"S<(-9-N9"8JB%>]-"JRT0<8%9 MBA"ET=K!B=?"K-XVPSM\(.EEG0DYHKS6#M;:R[Q6H'&@<:!QH'&@<:!QH/'A MK_MHZDS*#C@?W3[[&,D@=,!YF0]_B#XZY,W1#FFEE)1S09@2Q@@+8N!\=*:U ME$B*YYYH>W[SEP^5AP[=__L=BA[W@-E_[SM P*%"P$,((!L$0% #AP&"FMA( M0W2, 2\0P#*E%;*OT=YDBR \4[F5812B"#3.U;K"#8#Z*4 +)+8*?0X@M1: MJH0LA#H61"K;6<^B!QMX;%&2,0GJ/(C^48C^0Y)_XZPVD\ 0 +"$BG()@+!> M\@V((+)F;?S4*[2H>"8FO/8@NJ#2@USO6J731J532[C3YLY,5\ "PPT#R'"& M).)64_%HP4 M/IK$]Z<-_1%\7X3!6>J\D720I<-)DN>KPN \>-I'Y&D_X&AC05:.-H&&Q5(@ MKA060HH8DVKF:RRATFLI\:?FP^]\+/6;)9(&J*4Y9 Q;70L *#5F#X20[O6(>,^^V#'VIQUVKUK_P6ZCQEQ M&+H='WPL/M XT#C0.- XT#C0.-#X"-9]-,EQ=>6[9N6M)+B?*+ LYQ$\:LA M\+N/R.]^P.VFDC5A>0UH)"CE%!)LH*%6\3I;'AN^-BJZBVSY;[=*.9KLN3^( MHC[I#[]5\;M_SF?3+\X7_Y3],OZ7G[/AOQYRIY-&]S^6%X#B M4('B(9S #4Z8."8Q/;"3K@3KOC M![,@2'M?S +:B#O#7'&*A2"$QY$?'@ZK/#Q#SE90W8K[C=S\;C-W0=<'Z3\* MZ7](^'DC_) 9& $3*1X!$M,8(R0KX_K: %V+]\-GU,DBPV&:5[>WV M<3O)TK^:Z@Y)]\-?ZU$&^0.-CV+=Q[360./#7VN@\>&O]2AI?#1)=^>/#,[* M<&-PEH.S7#O+ C0C:0602 ,9189:@+F&L"Y:QQ(3N-9\^:4]UW=6T@X.VE<. MLGNLLHMX<^ $F=RS/K)%G#J2U-)*4 MQD!A203%I))GS>AZ5_3[='4KV[PVL#S?<@YJ)Q,/@J@&4=VQJ(HF?TP%M!%% M0"$D!78*F I0BFHD(<-KHTON$]5M2R,\:'$,&>'#7^NC(] /#:,_L'T)/!!X M(/! X(' X$' @\<.0\<3<9Z4P_U\OCWX(T/28:B[^"TUTX[ ;#)A4$4(<*Y M\]3=9E').,)ULV6IF'ATY\6G]TNOYY=]]A%T]\%BD8W/EHOD;))^G7U.?(WX M-D, (=$=A'LOA?N!\UP$X"9Z;@@'%FM.H$8157%,,"NE6QN$XT=/1'A4*_7\ MSE[JFT<5=BO/H;5JD/\@_U[^:2/_BF(D$*>4"\R5H"3FU9$N'1$BQ?/E__$- MUCL3_L>DQ&5HR!I@(," AP'>&/D\ULI #1P"Q,H0R")2%\5(*#%\/ S_UJ,\719H?!3K/J:U!AH?_EH#C0]_K4=)XZ/)G:O<-U/_-%S,SM)L M@.'IP#LRP9-^PL)OE)3@^8_!:+8\FZ0OJBFYKN_F?KE>O;)U;_F,;^_,@ MY]RW3\_:CAV'(E"KIRS5D%.E$#8 159)(W7=9)(@$:_UE'U$3[G'GJ*_(W+Q MH8Q<='HV#W1ZXN?%#/2DP,;K2E@(8@;H#=#;5;$7:K7WC26-&10(61OI&#+E M@;?, QDJH[5BK_6T[R.P^,XF_NI\D68[ 5^(.SW?]6P6>EUQ":5A 4L#EG9K MQK;:)3,C&(V4D9(0(66DM*JZR#!+&8NZ E-?6I-[ S?-=X>@!/->(&@P7P/D M!L@]:LB5#>1:14V,)%':""PB0B(!2\CE'%&)GADYT.67W'OZ,IE>I/F':6NZ MC&]KKY/\,G8B4U8ZE1V[=A=+")&$ ,4!B@,4OS84XQL#!(VFA$J(+8XY@LB2 MJ(1B%4/!G@O%NP-5"@.L'GA9FCB>+/@.EMK')'B@<*!PH'"@<*!PH/"Q+/48 M*5Q8EW\MSI*MWB__+2WXC\LK=\5A^=I[#N/I,BE-^N)K92:L^'.S:3Q,G;>1 MW5KL9#Q-W];E=@C\N8LE0L!OK:_X]S*KKS)/+M*W9UF:_/$V\>'^]\GD>W*= MNWO]]3*KEG/?,]ZV]XO7XZDCEOL"(1L)E3QE"8/+S#M@?\H)M9PR Z2A,8VP M4C1BSA-DVF!H8\R?LSU?/8E].9[V[M]TD:\V*WGRU8J7W\NM.9M-1BL&>_F_ MFTAXF]%N<6+A3']UQ/B23M+"W7S+C"7.?T9N$S51%AE%R^X,QKW"VKQ%)W5V MOV+PNP]Y8:845>[N80K5/QBFDTGUZ7^> M@)/BM;OEL'Z]X6F_CJ_2?/ Q_3[X;7:5K$78OX]'BTOWI]ND*J;FS*M),L_3 M]_4?:QKU9!7H6IEBT /'77&P\AZ$__GGDS6#M;K_LS[J_(*=WPO=_1%N_>SQ M)PU>H77ANI'8L)!XJJ2(S6:)21?)>)(/DC./GRT]/2@4=:$.;FCK0:FN"U2= M36_82:_K%MT=;7[67MU;Q+:2/OX*'2]WSR3J:K9TA!XT2C<=%;MSGLVN2D89 M;&*2WG/&[@L<#Q1&5%&7X%##*]7!>)%>.4.KV*1\X=#$'X#PQMELGF:EN=:W M/,XNT>.@%]>S9L#/2U=N34Z>>;PO,,6!,X4X0J8XW,7U5)/MW-K9_^6]:L8C M4#)0,E#RJ)9W:)KCG],L=5?\M_,,+_QAHB*H7<3>T_RGP6PZ]/?M'[>Z* M7'L4+MB#"N>[%]J#UI.CO!6'-V(HH@0%)+R[@2D>4Z@M5,:X=.$*VUX]XA(HG. M$6E[IRSNYH?^=_$]=@C;$\O9-R_Q*9-Y-ALMAXO2+9#(X2YTDK*JR%\F/(PB*'[CGTHE&VV6<:=>*C9"FDQL4.N*((J*D59%B M$%2]++!BVCYZ/-I-O3:\U7NXT').MWV:ML:H[6J*$@I1F"#KARKK#XDZ:WQ2 M@0B4"!G"#:2"Z9CQJFDCMACH1X\[[TS4GV:YWM?S-F1^#D%@#V%Y;SYGLV_C MW/'@3W\]*]N=%F?\NK$O]]WD/E978Q=:JM,]ZD5/MH=T6ZL[IF$H D)R+F,0 M(3_7%U;GK;514M,MZK;.)H+>H^#8#A5<3]L6!N@(T-&="RQ@8Q=K'5E!C37. M.M;:6AMK6F$'%U"1U\&.[L.ZN \@\BP'N7\M'X\8=0YZW65,>)H6E0]'%1-V M4.30I1C3,*@=%U_BX<%SZ$M!?/G'W/^1I8MQ5IZHG4^2\M/\_>&Z=.%,1Z#D M(2TU+&]OEQ<"1<>[[L%BF63CRK?TQT_[ M9[SLXF#$HT.6?3S+G!HLF/Q+R>/^?+'.TM'8?<\?P=AR"64:$MID!9K6/CD #9JHT'B[6(^P4,W;7X $8 MCA,8#GK=4>^>Q;'ZE&%4[2!]H'V@?;'ONY# M"QB5*CZ[97KG1>3,V=B#N?O9;-0_$^?53X3=--2Q,ZM'L^79)#WTD9GWK+0' M"9^'?%=$96M&@XDH1V?WIXQ=(=KJY=9YMS3 MSX4@[3; M;W6E/=P02A\"M 5H&L+T,7%"KJX,1(P +FAQBBN&,6K9'5DD-TQ M=&TAIK:]&;\!NO88NO;$JK[7>_CK(G',MWJ_^+?U.)/Q-'U[F18/"Q'X\\^M MY_,!\?'Y=?G6>#IRPOD>,[>B+3US*8(?EU?N)\-^/*5[)(\_X^DR6:'D5W>C M+^DD+8#B+>=*&*P1M$9HJ32,:'G@TI!(<"W>PI-R:>WK_$U=.6=UD0_&T\$\ M\:AWF>:I?SGRF)DZ%\F/:RY\H\6L#H:6LYN'69KX[[KW9\41L&$;2JOOOKNY MM7W8RG6"]^"I;JNJO!R6O:&+0['[R5H',$_!+,WGCAO\3V^U5K)6_C!GJ3+1#DM^;B MGU>W]0FK0?N3ZK;%-TY^>K/F]O,G9;#)RET#@W?_Y$V3@Y_:___<&I-WM MA=VTG[ZD%YY@OZ5S?_YZ>F'&^=#QVC)+/?1$D]GPCY,-2,08PA8JR@F+ :#( M"HAK)').9_RV*3^,;(0A1)3!2$06F-@(6B=2)9*ZM+H<*Z0CM7CR?>#)('4& MV-QKNVR9GOSMB_W[K_;CU\&'C_&GWWY57S]\^KB&]C<8X6'8?W^_'+L_ZL=Q MOW0ZUR.HITG]N.\&7]VUGLV2]]=Y(XF$2 5NIM(H(S$QC'$2(2F 8H: "F<) M0F+-)9FG\X_.6V?>.BOI>@Q$;QJB6U7&*P\87## 7Z;IT/O!#MV'.7I M].1O!7$?AT-NWQ/G42,TD6:795C*A+/.HYDCCGNX==56#!7R1\.!KZ-T^\E?Z3?DHG3%([FLV56_\#)X[O!:B.]D;:< M+$IS*TLOEI,D7.9DMOW.7NSL/2*C]SB#5Q M2MK'.OQK?]UJ^24WSP;.Y/2<.W;/XVY5$,8)BWOSJ?M[F%82[[7(57D.<[7/[P8#52*; MY^9B 9?)-__ P\19^Y[]+\>.*;)"Z]5<5_.^6XZCI[]8N;)Q7BS[QO*R]%_+ ML2?WE^>HK6.VJU43E)N6$.>,-O5.H0&K5-IG76U[Z#628TWS!PP M?[\]YZ@'#--/-O[DN/;QUEQE6_MO-5KH[>--ZU(=5=9U^:UT6E"QUG-E,,PO MT:WX=/"O95+\53[5-)E<_SLM\?KR.B\ T']P-IY-9A?%2_> 'F%GDP33)GB28^4%>&[YS6S&87 M/K"7)U=S[R*XQ?GK7,V<1^IMD5*?N[L6+R;IMW3R;O#_TNOZL0;>G+APN%Y$ M"8N]>^]N[+#:>SG9S,G8[")+W,H';TY^T2<_#?+K?)%>U<[)U7PV]9O\\QT_ MNDJ\3>_#6.[M=)&5E_GU2W.AGP<7;CEK]_K[???:\(M--_K[K1LY-O;13[<' MU^YR2[=A(Q\LRZ^2C3__H#^_+2[08J:?W0Y[3\(9:/DL*W'XS8E2M[_UB"!8 M+9RWI;(EA,/4D_CG!V(&'4@D!.+6$Q?_7F;U5>;)1?KVS''>'V^3<_=,[Y/) M]^0Z]]&RRZQ:SB.1I4A/M&$%$K(15Y*G+&'@,-^IC3_EA%I.F0'2T)A&6"D: M,8X@TP9#&V/^K/JB0EJ=;&NOMQR!5YN5=!'C6P_P/>_?322\S6@=A,#0RT)@ M^%5"8$YFL]EW;].6$O^VDN/T:IP7-O8MX?_U\UMEUX3_'@1QYGZ!W'==T*/) MI_4K9LE5LOIN/IS-KW\N\+I4/+FS+^;>9ZC\68=23NI^'OA8SV!X[96'!PBG M')+)V\7X*FW]]M_^@^*ELY\N"L^I!L)B,\KK9D7LZ^=V,&FE*[VG4"J6P<)9 M47^X:_S<]AJ\7^=P8>6!%K?U,9<;ETN6B]E5XUQFL[.9^T[S,".W7Y42'SA? M>U'\,W/+ MG+TM.=='())Y\9.\;0G=8;^YA[@HXZ(;@Z2W0Z.G591NVW;5RI(J6')E9)5V M50G"\3C+G0?M/;,-&UXNSX>+,B?(Q2Z9CVIP56?E?"2DP-'3XM>+Z[G;W>)O M'S.97P^FA5.UBI@DY7E-]SE#T? M3YH[I#^\SY[?^JA%K:ECU>*K5;0H=UZ]VT;/&V]./O[=H]LBR2Y2;V)GCB K M:/"_\5(_2A;);=@H]MO=N-J"?#GW?M:*UCZV.FY';B?YK-G(6_Q3,T!-;X=# M-ZS[8@N^^5QKX1DXY!F.BY#,]_'BLGE*)Q".:XNGNTPG<_=&EA;&LF.9K.+E M:Q]V<3PX*HD]70XGJ3<,A^.V5[+NQ?A R'RU>-]?U;D.>;I*%I2;7^7I"ZF\ M+O+X3KI'I4@5MW(@ZJ]6AE-N2>3%;'8[Z#8OW&#/\,XN_O6S(Y1_]'%3)[WT MZ\T'3GR]T#BX<03*"K51I++]@XRRY46US^Y&$_= -U=="425J:@W<;5;CHQ9 MM5GS9''I ?QZTTZ-\PU[X>Y_GOJ5E!>O*+&6H)E6:KVY09T:R-Z,BXU7CIS"W,?_]?_<6#RL_4>R2(I@YV%:^J#K#ZJ M5KWY;A"[+5I1F3FWG[U=^N^L6LM86GY>W^F,Z^3STO5%?QL-3^4@FU5\FU#TD79&H+F-OY M4A5<^3J!R?@/;RL5X>NJFX4SB=P"5J'E$B]6&L+Q23P^]ZOW>%NI 5_,LG"@ MDU^.YS?X)*G%*BNK)$JE43Y4D2U;9F>.0J4-YC>[;3AEQ;V)VYY\"TI<)63]3Z:04"10C_3@W;4K"M)$+_@O?]M.,*S+H[ M1^FOE]_*"9<0X7- [GFJZJTU[JNS,RL@K,7:4=BQN%M6)=97GNL;B\K)R<(7 M@CDT'?SJ!;Q*6S2 ZB[P+9V.'%-/'1IER>34V^X%VM7K&/I-<$]0\J77]]Z= M6MEL67J19*-)6BH==_5QUI(EYQ,X9O**97@Y\VMP3_)EI40*:Z?$F!JXQ_6: MET6 L>#X&]FIE5'I57V1@BKR&5.O\6]NK;O5G;&S&WMPY=7 M'A\JA\K9.ZN<6Q,B+#>A_>BGI5YS=W%[?MNF)#)A7B MK':\,!\*HZJN.6R8J[9[O-OAGE^7NU%7S-VT^9T03$I6E) MMTW92\>4Z:C@*V\$SI9%;>2RQ27N G^DZ?Q& /E\.?$9Y&;/;NS4HA2X4ET5 MCGQ9+UE<]KI.?'60LCQ8D%-%-7WAOGCY]M5I34*T3K7\I1Y%X"E>V,M>R'-G MQ:2WLLWCZ7F6>.IYV[>*^-<)S2:+.:D=V[5L>B'-1;6]_\"'5KREZTU]IPJK M&+_/0]7\DIZ[)_]<<%H\TR!UTKQ("P?9J>U"8*M=.+T1I%E%2ZY; M7UAD13S%&S[%0I.13[^[3:L"A&=I.FU7>OBXD@^/C?,5J>OJ@KIL MPF]8/BM=PRP];V&HOT-IQJP\YT8WMMC#J;/*@/7Z:9@Z"JZ*.U8%"8,/[E%& MI5-56.^CV<#Y\*M5#I+6Y)N259V!/<<.Y4V]D]> M@*ROLZBJ IRUYG&O_+4O+%XL)B7Z7CA SSV;U!2KT=V19YJO6*.(W;C;%0B= MM]BT]2 K#_VB4E8%M4];95(_JB+FD;^(LSB717E'\:7:M6DIE?H37WA^A\OL M+E06Q[PY^:B^&.\OC1?5+ZM\EE_XM&;2BI\J#FH*1:X2[[\6]G51RU67+9RE MP\3+:4M=C6;N IY4M>05]0EM*7(7\K1OAR%KTZ>IM*G?VE"L\O6^G:_OVHC5 MK<#$RDD:EC7?=72@BM%Y5,J77MCR6VY_2?#45_U4FS@M&N?4I3P%PA06SJ)T MD,H]75$W2V?9A;/>_IVLW)NW!;KYB\\*<[!Y>=YZGF#@/S*U5)0[^?*!@ERE M^5AA5&U3%$4V5;7'IB*$,@;D/VVQ=%:7>5>1]C+\<8M9;\C%>,7>=?E<$>'[ MYGAYXL.&6>']-_[MZG?E,9)"'[>+Y$KEURZ0\W[Y:74XQ=F5CRN..$^XXNM3SO+$,>>.0-WYLXO=%>6-R M\K=GGGMQ[O1H.4D_G=\^ ?.A4?#1=?7AO6=A,)66&XN D9 8@2,4H?HA#:*X M=19&"1L!JR-EB92,<@P,J:KEA$$POGV8I0\05&@(G_AQ"F9U2ZX5UL[,,#[2,W96G#BZM!)^RK#XM"B?]:_>8P_KU!O[X M.KYRFM.7$?\V2O5O7JS:2FKE;^>S+^\OQR,E& M%P"X41\^N4O<%GKJ/N'X?V7\-6L33]T,L=G<^,5G=;ZT2W955;+[:UFRVY-6 M"($O=LL7YE82_N]5SC"PPU&RP^UL96"#HV2#HB=CX4'6QW[VIQ%E5WOP* :! M=)=C6K=&[S?.-7*_F'A_:%/3IR-IKKUA9_XG3;*!G?I,TJ?A8N;KMC \+8Z* MOG\I>.SU7MTO(/U9>&]51Z!^H'Z@?J#^(5'_>28A[.]*F_DC6?HMG2[3'3E$ MO>QEVZ-6M?J?:@M"^0:W/ M_/D[_/=X<:FK.D=;ITI4T:\E'=W72_OWZJ*_?_'E7L6,J*HXH_:KU(]Q_GOR MNP_/U=&Y9#JJ8G-5:.[7U)\7Z*CK%H,LYS*_6Q?0(8A !4GH&*;)IIL*P M$M8X*%%&.PHJ);#PD,*AU5C*?D!**[*KIJ,ZKML9EL!3T.G8N8 E 4N.!4L0 M),T<7(SB& FK1"R5MH ;Q LLX80*:7$OL*1*"]19@0Y!1) NY[\'$ D@0=3EDZ-40 MI.,42X]C*A\VEISO"'3NW+U>HM&#M-X#F*(-3&DJ8X:<46.!LMHZ^R:2L:96 MN6]2"M9@:M5\LAG1O2^A%DJZ#+2\'M?NQ?3-?;>$ BCM&I1XTX\] B26*+8$ M2\5C" C0L (E@"*P=B)A*Z"T[6"-H &- AH%-.HG&DFT0B-$)*.$<\4AI+$5 M[@NL0B,3017M!(VV%>YQOFB H0!# 89Z"4,8-C!$G6_&K!20:FUBB[F5Y01# MC6(I =@)#&TE8 1/4:) 735N=#0XQZ+R %-Y 2.W]* M4F?5<(B081'15E0Q:H$171MVWZ;ZOD1]2,B('ZFU$H#B94!!X0HH(!4<4BF8 MX998# T2NK(]F+;Q6G5-MT"QY4@,[M(#"@@1$.)H$((W[5F L9P8)B2)$:81 MI;'BM2EA(&?;18AM14<"- 1H"-#P'&B0#30P9S H(HEP'H6VD"F+HPH:E,)( M;A<:MA.Q@ ?A51Q/@X&IWCNZ>FT_PU8AX\ST2>972+8_8E[H&[+,'K7T0UY'4"+.TQ+"&Y@B4L M,")*"RYD' $A=0Q9'5N1)%HSC[8%2]NN=R$!CP(>!3SJ)QX1T13?602DE(1P M;12G $*KRIZ\R$J*UF*]V\*C;<5T4"AX"4 4@*BG0,0:(*)6Q)I9R'AL%8N$ M8!)4AI$D*(IW!41;B2#Q4/"RM=CSZS:A$R]M0K<76[)C(.Z9H@FT#+0,M RT M?+6U'D_FYK7:O073?\>F/VU5DW D8X"5B)'4FAFD58PKTU]K3-9,_VZ:)X@^ MYG'0*>)=]F/IGZ\0(A8!MO88MD23RA&8X4@H:Z"*J)&2,FM*V&)$DFA+3>B> M"%M;SO-($A+/ :T"6O43K1@0K<0S-19R:H"5!A@>*5F=_F%66[%V^N=5T&I[ M;>XXZ+*&+P!5 *H 5!T"%1*M!@PZ D;%B!H5<6,8DJ;*2,=4JK4*F5 92B&;\D;0 6(09QT0!1I2DPM8'(A$1:V'BK2#%UHY,"Q$@ M(D!$@(@G0P0'#40H@[B.J%#.UW ?,V$AJ1+@0L5X-]['EIJ]0=!E2*/_D8N] M+\%YQ69O(>ZZ:Q!"+3M%8XY49!344601BABHTME460F?VO6IE[$/W*6UTK_P M:D@"!3#:8S BM-6] 2B. 2"&6TVB&&M5.TU,,4:V"T;;;D$7:F8""@44ZBD* ML69<4JPCHB@E$&C,+,$"US4SW+A_GMHQMR\QFU )$^ GP$]/X4KV$F_U!%0$:U\I$-@9: M:L6LH5!HA&C=NU=9&*\9-8]NM-#/B$](81^IZ1(@XV60@1I#).+<882*N8HI MCN-(4F'J8I?(K!_0W!9D[%/3NH 5 2N.!BM(,\U52I^UCH7 /-("1R:BU6%N MY\X(^OR&]OOO7H!WAYRT#U0/U _4+\G"P_4W_$F'%S& MX[5:T 7WXD7NA62T->G84&8UBJG2A$!@-:!5"P%L+-E2"P'>Q_P'.@7B(/R1 M$+$(D+)K2&G58J"84&P8Y":.8P$@,EQ5[9,TU6;MO.^K0,J6\R."==F:,B!) M0)(C01($0!/[5-(JC0VAA$@-B=4,U$6E+([B?A@GVVO$1CLM/PT@$D#D:$ $ M-2#B?!MH8J.YYH +C"53K"X--M57C$46Q>5YC@UX&6DCHVW^8 >X 2H< 2@PU MDP:=\:2 @%92HJ"-D!3UN!$1 ;T;4-IV*2OC 8T"&@4TZB<:"=B@D9":&@DL MMP0;Z2PD7I?".61:SU5M!8VV=M08LP!# 88"#/42AB!H8$B0*!84X&9HJ,.98, C8Q106@%;]Y'4$49H5WBTM9!.Z*P?@"@ 44^! MB#9 Q&/"!38<*B1Q%$%%L*FK76)CUL)&VP*BK020V&&C4!%9^NLB.9ND]?N= M7+O3X8W%31SIWEZ6/>(@ G_>TNKNNV-K?_]WZ0SI\^ORK?'48=_B M/69.SK;S5#>V99WA9<'PZ\<-W1>'XTD9:/UTOJH6^YS-SL<+7RWFCR+6TO!U MIF?3?#89CYRXC+ZZ&T23V?"/DT*$_34.HO#1LJY/D2PRMHP'##DA"AU\C3WW)LMTY->$.#K9>I$ M>^+TFMNL0<'D@ZS:S#1W?\YG6?EN7NW=7P;CC\QA_7K#*K^.KQQU/J;?![_-KI(U8^3[>+2X M='^Z=9S-LE&:>2R=)/,\?5__\?-M!#U9A<]7/<8@.KD[NE[>@\H__WRR!NW5 M_>_YZ+[/.O^HAS=[7A%E7Y,2QZV)7<6ZT-SG\,"M0>_ D4 M_W6;#1T6<-5:FWCJ9HC->^$;O.8W.[R6VX/A:6<%MEOGC:YVHYOVAEM@C"=L MS=98Q5LXQUGU$$@/H BD/U;2\Z (GFU+!*XS^Q/"+IN [H_ '4WP7@W_M1SGXX)9D^G(&ZSI1>G8.+;* M%R^U1SO=G]Z(,>*MYIL1PTPS&3.H,)8H%E5GB1@HRM;$N"[CU8W-WZ+!;Z5W MH/W.;]-R)6(7;N7^R'NOQ+ROFO:*@F85+)V.D6L^5K# MN1?)),N= MV=N[Z8NP/[)\:/'AKUDRS4OZ.]HF$V=O._YR+[ZEQQSY9:+)RT01MPQI[OY_ M[ QH3F5L:X/:T)@T>9G;F_DYFSG7Y6J[AG.7Z=W]D<,0@#H,0>.@)6A*4L&1 MT5AR3*T@W))*0VHKA'V6H'5GU89(;Q"T/18TU @: $)(8#2G6B!K 8Y%E5JQ M!HMG:K3N0KQ=5D#NCZ =3X37UQT,QE?S9)P59=G'Z#D^)*VT-4TI@D 2053, M">74"(@K^Q-C&5,&'&&!&?0]H("PUMFN3%5EP)A0 M@>.NI;,[>W8G+57V1_\&<3Y4<7Y(FF4CS=8PAK6TP,8RCJ1$%E4U$$8PQCJ7 MYN<;S<>E:P\M[%H']P?IC_&BJ',8^8CK8KQ89FE9YS!X,\\<%V3N.H/9,AM\ M_/6W58'N'?AU$([L ](J6F?Z-'+_Q[!$!$@G S&.@:A3*LY&)G>E5*S;]")S M O?&_.VME7M,VJ_/8O.0S2I:1]> A AS)R444A1)HI1:9308M&M:[E%RTYEA MVN4,F<,Q/X.<]4/.'A(SVHA9#!3&B@"C*-,1 )$&MC[0A3FYLQ+O7C'KI\78 M?\-PWZ.F']47,\C'BS14P=XI>[PQ#1%'! )!-(@X(!%F6%6F80RQ6J^V^9SY M\Y.+Z\^39+I0TY']UW(\]WZ=Q#AHQ#A!R18M@,T "!.,0):,TL4C@2K MPJDH]K4&G4AP/RWB$$/=^I#"N9]Z.2D&%$[&R738C6G<9]%[2'M*C)K^1(QJ M RD$S+NG^\9Z<+GBY._ MO8$>H9;SOSW[ 8[7S7Q0"\MF*&P4L01Q'2F*8J/(6NN\WXKF MT&YE!7^L1CM-+SXLTJL\GF4;ICNM!INU!SN]V$K.W=:Y]\(AS!!;"D+_D-!C MT)H$+9R4 V&EB;"UU IF2"7TR(B8\IT*_=.,]L<(?9?'S8+,!YG?7YG'CL/?O)+FB\&'XK. MS4?KW&/ 6B7W%F(I4$0@!MP/4B>HJI)2B%A-UTKNI[Y0V@MHN8OUIFXS7HW9 M(3CY(3)V&,+#FY/[((=F?^=JI-@P@&$7Q-$6S%B 3G0!(82VUBK( &4%>'R"2/ M3;36K>3)(MB904L['7S25Q$\HF!N8;F>I8[DZ6"1_$CSTT'B)^;ZFI)T]&*B M8D?4T6SIA_&^1&;OW.?J;OZGK\ _SQKI_=#^O&3F]_.V8\? 1YJ!C%Q";3F" M6#G$8[&DJNYAH=P_9D-EA.=77\$49[,K/?,3PI>^]&DU&3PJ6+G\WE?/S[^. MIS/WL->UUZ^FHYM7\2=P%]>_IHO+V:C)?VWU<*"$V[-DGL)1KRL]H>MP@-8 MK9U"*R/-@1%&G!$)A5)$@A@#B%=U,UP3MJ%NYC6AM;O6>F1[<9H K0%: [0> M*;0*W)3H0RT@LQ!;29SQ2A'GK*[GI3:&_8+6SGQ_ ;;G_.\_M!8Q@[\N$K>$ M^OTNKMU:S#U'<;M#"?) M^&J07"3C:;X8)(/%Y3@;#>9)MO 7&_A%%3+O?UO<]&J<#]/)))FFLV7N/O_? M925?12/S/%TL)FGQ^MTM3BC%X^/RRBUM^(2])**;O=ND .][B): ^#6.SZ]O M4!1W0M+RI?_Z^_'"W6SHKO%K\K^S;*#=/1VH9!9U(TJ;@-Z)][!4WTFI_HJWRR_>?N[68WIN M2[-;NFD;< XAN/7$Q;^767V5>7*1OCW+TN2/M\FY>Z;WR>1[_WU,JN6 M\\B]+Q1J>^,A(1MW/GG*$@:7F;=1_I03:CEE!DA#8QIAI6C$G+'%M,'0QI@_ M9WN^>NWLQ=W;8#?FLB7/ [7OY=:Z#HJ?]N(N%M1KO%B86Y^M41XTLZ M20O3["UC"%NH*"/%TUFPS].-CRM,2PR MUMG:%L(HUI&D>O6T<235VU;"V@!GD@-%2"Q0Q%4DZB&J1IC(HI-!ZNS9N1?! M;)D^('2WW!%9FS3WX ON!E^\B7,^FS@'V)LIA>'H%,^YWY#VY,^J=*5QHKZMBVXL?9?6)X$%^G2_2JW>#+S#?XY[2ZJ%.UU=T: MP\WQ5SYV%IB_5Y)?GA;_#E+GRGQS_L?4W]%=;.!>5%SMK_6]Z'M8F'?%1LV< M[W*>9IFW]9(?[1VZ\20O,:-;W[YAI8%;!J]_W;[9H_'MI_T^'BTNW9]N'95?Y)RE M23+/T_?U'VN@?;)*;JX2\9"=W)W[+.]!V9]_/EES[JK[W_V1>-:OGO?1+N\E M>[>N5RVN?*T*$OP*%21/2-17EE^S-O'4S1";;8U?QN?IX,MPG#IP+-%/S>>3 ML0/%7Y/LC_2N'K&!+PZ<+\PXN9C.G-4R++GB[^ET=N5>!'8X2G90%V-O6 UT M-LOS7Y*SP 9'R09??6BK_ H!H%TEXT!MD;O-^/IP/UB MXCV[%YW#V>\"QTV 6'BZ7C.>S[+"V_R?-,D&UCETH\&GX6)VYEQ(#$\'/OKQ M_J5PLM>[]Y)T^@'7$03J!^H'ZO=DX8'Z.Z;^\XQ$V-^5EBF-'?E%O:SMVI\S M4PPU$Q,H$T10@J14#$$,(VJC,@O$L39"W"["*NE\JS[J0YGC^KWZTN]?%LFB MR*'4@VIK=TG]&.>_)[_[J%L==',V9!5RJR)NOZ97SGCLHIW<*0('T13K"$(+ M 2)Z!A&DU5P ^OE$@BAKK394&4%5"1$T9CA>:PS2"42T K!J.JK#KYUA SIE MJ,M9"0$; C8<#3:T>C(;A(B4AEL$M6: 12BJNGQQWW]]K/K8'QG MH !/,88!% (H!%!X.BB(!A0D=EY$;$#$)+5826%893 8P"A?.S/7"2BL9C$L MDDEGB,!/8:>M&E[W6$5WF8H>!R+TAOJ^'4'(ZTUR?M99M!<<->L)Z/!6_R6! M+& $QS360 $5,0Q%#3H1L&O-7SXGUP5\?)VIX;^6XRR]A;OH#OI MDMA;H^:0 ^8!JO8>JEI]JA36,="1DA(8S/QYC+I/%1%\#ICFKVI.;2O^$\ I@%, I[Z" M$VW R9]55$QP'<<(6D#\<=82G+1R'N"K&E!;B4-!NI.1%?T/3^U%W<\+ZV7% M2^ME]V*3=HS7/=-'@9:!EH&6@9;]+T#=^X303BM3@UNP8[= M >$ X20Q+$U M2"-"))"F+D81VN"UF,6=>6?1NUI6>,K)3L9,ANA$B$X$&'HZ#+5&K:,(@UC) MB$I$):'"P8^NHA,11Y)L!8:V7R^[FR%\ 7\"_@3\>3K^M*;5 "> #P!>'H)/!(VP!-1'AD.M+-Q-":2"F)A!3R" M$RVW CQ;R;?04R:[/![4/]0YN /(KUCWVTMLV2,(:96=1%QJ9F)F!-' &A+' MNAIDS+0&\=K1@1=E=D4?JWA)E]9.;XV:8+L$&.D:1BA?P0C1JJC[-\!2@+7[ M7U3UMN;0,+1FB>P21K8N^)X=#CV(TUN35Y9S :5WOI+7DT(*S]Y M__B%[7XKUW_?^O8-I#W##@LSM#+;\[]4YGDHVSC(L@T"6V7S&!I)"2(86D@B8*&4]5%_ MHYABS=S2*H+P6ST8\[?*WQL78R8_+-*K^UJY]; ?6__J,GJ%./L>V RPLFM8 M:97!&PNU)9)(#J!&@D=,R1I6&!=Q)[ B.H&54.ZU7X$-7^VU:>[Q \8KVJ7Q MNF/!DZ0Y!BVV>>MZ7=XBD6H M7]@/;7T,8H4@;FH"#*+6 LJQ^TM&*HY%U=68:R. WHI8=:/?T"DZC++"HW', M/SN?/!F/RFKF_*Y*YD>+8*?;T1?9Q+AU\D!+B1!&"!&E*#/.GZV;_TH11T^1 MS6KKMZ?D9#C(?:@>['$+)&W&BF')&"1:(F()0D!@&?%*64:< -610':C'D7P M_?;)]_LP_9;FB[O&;Q^+9I&<[&#J-D^&J_N MEYE_I#2[*CJ!SA;N:[YF,AU_\\G7X.2M"R>&C7!RH+FT0#,B8TV,9!&IVGLY MD04 /T4X/26^.D*HZ>B3)\-O#16VJ/8.V\[LE?3V55$>I)#BUD!(Z8Q1&TE( M%..1M=J;HE4DAI)F6&SW0MJ-1NW6-NV?D!Z:,U@PQO$:KY@VHL>$!( ;H35R M?S()2'UHD6OC_GN*Z!7;NN5B'H;"L-4#TV[[+$FLU<$1Q50;#8$E4#*KH#%U M^P"KH@AV)TG=*"U,NTPI]%\W[;L?^+5U .XY5L6-NGL\_S$8S9:^>OM(PYBZ2GZ>$=FIA/YO6K\O7P8D.H!= KTO0(ZU:+< BY_-0I"'DC%*&51W' MCR*F)7A*)\HN$LRGE'3IZQP:Z&WHOM#%M?O>3.#I=N-E6F4-ALDBO9AEUX-Y MYE@L<[\:C*?#R7*4YHY!S],L2T>#1?*C[K]0Y!L\FB^+B6.^J,R+4/7I]\OQ M\'*09.E@.EL,DLEDYJ\_\ET;_*BR^E#8NUND*_GYX_+*/>VPKZTR;CSD7=/] M;N/!E^%E.EI.TD_GOZ7?TNDRS>-L=F5_+-)LFDRT6\',7<_W;_,QRE_&W])1 M"2'1]=_3V466S"^]U*HL3?*OGJV_NIM&;EO_."E@R[_\DD[2 @C>4@DA #&* M+7: %2'%J[ZYAD18.K^TB?%08*7ABLO(:& !I=Q6=36&46#LR2!UB#3WXILM MTY->$&53IY!YEN:>I0;Y\LKS[[\=MXVG)81ZQO13\J;I8I"5VS\XNQY/IZD"P6V?AL67'VT,&C>^U^ M?9;D[JWEW-W7LWO]\[_D@T(0BEL-]@M:CJ]/"?S_[;UK<^,VM@7Z^=Y?@7(J MYW1/V3+?C^Y)JJA7XDFWW6,[DY/[)05+D,5IBM205-N>7W\!D'K9DMNB)8ND M5E?*$=]8V!L;V L;&];1>AHA^X95+'>(_89Y2@[[6WN=G$"6A;==A/\['U6S MOK1T,G/96ZTUAQZ42P]:0S^DT[IY]=O^GDS&:^J1U\/'9[I._?Q.%?D@ M)N-#G^@Y5&6\9$DJ=FKFXT!IF?Z(XJ /7=B*+I0J!8R<@JE.?,2;)OE1363Y MJ=-TX_G!]"%]2+\DP"']-Y9^[79"^Y/1F'3D/$^> MXY;HZC%YPX2FI9P@KTXHHFW,-Q1H64ZWK7=:UVJ_-X MYBJ?$A'352W^6Z1J=5 GO1.M^*O5!@+V O8"^*V MG'A[LJ9[!6U*G;=MJ M4W.LIM5MYO:BV=&:3\*#W]!>T+\$&W\QD!S\UC8LTHY-S83A@.& X=C8<#C* MW'!P*^+9;MOK&&Y+U17=:4X'&J[I>-J3D+IM&HZMI/Q5K6UF$J_+HJE*\AJK M=NM /O$:Y!-WM,6TQHK75!3#-AS/:JKZC FQS2=[LF['X#A[8$(,%1DB MZ\JWPR95WB89\W5&;EOM-&W;5$W;-;INI]G6I^RL:YC&CKRGC6S2UMB6;3I- ML$FP2;!)6[1)UCP;:-=LVHJKJVU5;>N=CN)U]3P7=DMK>F9SCS9I5XR.X< X MP3C!.)74.#ESX]3IN*KE6DK;-72[RP<5:K.3LT8M,93:I7':@JDQCMV:^V8O MIY,V60%025;)!BE=!?/B*G/STK*M=LMPO99G&*;3<0VK-1W[N%['VU&TC+T' MCDC?JATJ[<@& QC8BVW;"VTAI;2K=-I=WEVU34773AK6 M3@8:V',DZ]XCJ,ZNFEUG;9KJUV[V5&G;&^SU71WQ*R\ MR%KLBEG1S%KL, '# AAV+79L6I%G+ON[M=Q&Y&E95F4B,IQ,4?/J>C'WPM5^N?*>R6?A\L\O MMWLC^^C+J].5"-3'>=^>E;'(LO&=,J[(._;XFQL74F81(5ROHWDBO%^C\);\ M)OXLI!)KD.\I1N&B;U-?48B"A2A3!KM [/<4B.R TTR+J_/8B22"9.D^;LP3 M/TM%,HZC,6]B#\=D'- P/9:Y',6F]V,Q$CS./B(WE5K82FIA@ZGY]?S=;-I] M\/*F-+SU!9SL6H,(J/$\"0JY$P/*A2R3><$2<=U+?"H_E"X\U)F(\C8JIDA/ MGU^X>\F*(H/>DQZ@@IGFZOHM9- [H&15R* '/1!Z\ OOW&GX\.I$XF]3(] . MI+2KBRZ4*M\94MHAI=VAI+3[]-BS1F([)+>JB/3+-#%49^#EE#[:/J2/Q':% MD.;QN1E@I+2KT&RXJ5G./(S&:+4]M6/8W8[>=#6K[1IYY@A=XT\\":,YC\+> M)([YF/JYO2G?,OP6.U=7I1> '2B9'7#L>:HZTU L1^_J2K?CM(R.82KZU ZT MS?:3X-NMV@&Q5=KKP_"U6H3%P [ #KRQ'="5>8I;Q6Z9;LMM^VV MD]D!R^N8FKH3.[";@%E#P:H<& 08A (&09L;!*/K*%Y;4?66:QA-P[5-+U^5 MH[M-RWF2Z>EE!F$KR^Y4PZY# S^V5;;4UMC=IPG:>"V:FNVPV2HVQS7P-; UL#6;-'6+"3L;QFNWNPH MCJW93DLL03:]/,5)5^]H=A'6]/NV9C=LB6YMDSZ%T8'1@='9GM$Q%I+].Y;5 M-#W%Z;2Z3:]E.4W%M/(!CN?P?\6,SG82TQH'D)!M> MT $OTP<:W-&'1*R,&L8YG!>N0Y0R75SDIQIB[?13%'03"&08"U7_(>$^@6U: M;<5MFUVSJ7N>V;1L3;5:;5WM='6[2/5JLLNC&;Y.'JX*L M7_]WE0B?4;1=*-+JE:'E4G7M]:I.I3U/U+9M:*YGM%S7-2U5<35;_.?PGY[= MZG:.,@U9J >TD8JWD4=#"KGZ>''8H?_B17 MOW_^[%W^^?(5V25"\>[WD$[Z8JWE^_*7?YV!V\!@+=R]-%(_Z*7OAEEL1??6 M%X+C8R5=_KYUIV!M'_/:Q6Z[6.JZMBYVM]Z1CQ48^._2!7 @5*<)A*\(]) $-PX#KP.!8,PX5#R95P M+)+>L7%*QBPFR9#&C/1I2@\XA<**"EN_FA)K:4NE#*7M-R!]2!_2A_3W)_U" M@XK_KI59'_=_8;AUI\6//KYESA*$K'IR,!/O^,3:F_I$^Y>)VVEB$:6 M+V*\5!JZ+[ZB9KII6442'4(WH9MOH)ONXW!UZ"9TLQRZ:>OUZ-/K1D2?A;UH MQ,@@CD9$;&\GUYRMV;_HQ;I93A743*5*CLX!^/E55RC5@D)!H;:H4)H)A8)" M'6R7=S#?7JH=VZ=Y(:SQJDPN^XDLKAGN0\(*&=,#9(7F MRV.G^<@<3=4^DB9-_![RO%8NSZO:,(N$V)=OD%RJ)ECUJ&2TL.VU,*5AUB/ M!"T,+:RD+QK!RZ65+=5.J1S+08U5/B\>6SX605STFD:Y6:ISPD![6J"E4D M+AT*!85:.V1#7D-7"'H_E7_C-DW%D[>:BX/:76WF!/T6%.1N;K2E@9-K/1- M3"D2,XTFAB:&)O;B)E:/[/!H8FAB96UBV,OV]4UJ"[A^B:,D(>,X&O@IF>+; MO':2R7@-? [O8^"'[&3*.6O*CPLOL,?IT<_OU/?\TY/Q&AM6\35)EHUDV>7J M&ZJN4$:E%KE!H4JO4&:1[!10*"C4&FBV4B2%6?D'<6_J,&T!\%F6FW801R,2 MC5E,4S\*D\J/\RJ6_$?3ZI'\IU2MHZP&N6JZJ19Q3J";T,VWL)N83(1NEE0W M#?"791CA+FP8^RZ(DN3],L;M?NR9!EYQA^V=KA49!SP5\&O0;$O7WX,SJ* * M:HI9),#U5 MM;)30?NA_=O4?AO:#^T_6.VW*K5U4SFYRWWZ',]N5+?UEH3%;OOW4[Z+JOH. M3)TCG] F2]PF>7^()=YH86AAN_2WT,+0PM#"RN;3E:^%[74>J0JSB37#?4A8 M(>/Z8X6,ZX_U(&5\,"SL'[)"69]0CH_>LHR 3<@DX>?\4.PQ.9ZDO% DG/.U M,Z+V0Y6"A9$^$_)9\55-NH9L#7*K:RJA8@.P\DWCP>.K MHVYBLQGH9EEULQXIV*";==3-(CYP^703H3D'--T+&1\$[D/""AG7'^M!ROA@ M0G-:-!D2_@F?UVX_D4$WO6@TBL(L]@9QZQ6,6U<-;(A1=<\-30Q-#$T,30Q- M#$T,30Q-#$WL>S3J:4IO C8[WW^T/\F3S?,6RO?O29+Z@X<=%?'M"[&J26Y8 M"GG*#[F-2#_H6_*VWZGOR5E(-$5UC\D=([0?C<6JD)#=D=N)WZ=ACY&8!52< M3".2#AD9QRSA99 [*Y)H(,^)12+<4?6COM_C/\)$7*-AGXRC)(U9ZL=LQ)\A M-RQD8M_M'C_=(%>,D?,H940[)D?G_)->K\>56"X[^1)'(?_=D\\E1V00Q604 MQ8SX(?\YDE]O$.(EA/(")I,@E0"&])LH<(\F*8DFL4#FD/],:)RR.'@@MXN; M?XOR^:OWB^108S8(6"_E\/QDJ3[X5_&O^+\G;6#:0!^WB84FT.,ZP.)'UNR9 MO3<+MP=5?1R9(O\.X^E;QO26G=S$C'X]H0->I@\TN*,/"?_6Z3#.X5#B]W\Z M2ES7]CS/U:R.U375KN,V6]UNIZ4HG697<]2N>(8NU<,+#8*TW8O60#6,E>: M;H*=#+G&_W3T0V*8'=NTVHK;-KMF4_<\LVG9FFJUVKK:Z>IVD7J]%AV!,!8M M?D4TZ%DMTXW?)@_OLJJYB8+^S+J^_N\JV3^CH6_2=ZR >Y:R459@M_$]*$6^ M)F__X*<<26_5]UM#&MZR1*P3%#:T[2?T-F:9I29W?CJ<&G(J3O">8,&NBP>Z M?L@-J4\#\6@OB)+)8UJSBJ.$7?3/YU'(&B\OU<[J86;4NJ[:[2B>Y;HMV_2: MFF-;':UI=U7-XD-7W7QLU$K45+S]M!5^*HZ"1"H^']3T6)]K>U(O==>VHNY/ MZ_/HY\XW&DQF0\VYN2"[J-?M0RJK7;G@0^,1#?E@1@[+AS0A+*MIUC\FW(]D ML1S7)Q,^)O[FSX;STKA+)X */]0?ST0C!MNMH<\&I'//>I/4Y^/PB\' [_$W MB2>S:W/+GU\[EF_CKBH?:O-'0L:'Y_G;^G-A]Q:%/9X)FU!Y<\'FRVNAET8W M+,Z,@*X>2S^H\-N.R7@2)Q/>YPGW0924%R]F_YEPYZ=/;A[(Y23(4YRJ.CU1 MS7J^HK7&G^OSV%U[GNRA^7]9BH JJYND'1*8"&C[\;_("A9$ M^MP##==(A"U*9+&FA7,9+RBJ?'&?);RA9IXQ]WG%AV7UO_/?9V]=\%7GFL!O MOF'3PF;9%I9QQ&P8@O[NM%<5\T6(DP2<3/9#(:T9C74E\6 M,7L7RUIN_J74SW(Y<&\]($ M]GJ3T21C"<2-8KYZ$OJ]*6TP-S7'PN/F&B6&@N)KA4P&%R(=<\SCV.=?D*TM M"*(["8P[^7V.*)%N?,QN:2R_-:O]N9(D&PRL2M$)/Z(D9<3%]WJQU8[A%CKF MSS.1YA@EM]*B(W47Q5U$C6QNDRS699+V- MM'?<,OIIRB09K_,?69/\*XGDT4FW05M7N['-Y3)G1@=SCN^,@T!YOK2X]?Y/73'JD+>1DNX MB%_7.^W"0I;3E>'C%7X_'0SF$Q:BCY^(AI!9I'NN^DEN ?G+:6\Z).=GA962 M&P[8'Y,G32+)Y@7F[6AV)PW#";]OWMJF3?;I*]8WJR'C@R?9TX11*F9*LJZ& M#V?XP_U);[$U)[('$E]X4OSIP"T;T?&Q97K'6#B_-_&E^>^+SDF8L,P"J);X(3?E/1\QN67\$?$J>R!WG+2"=RX"R&M/<^'U6+0:PFY-F;%CA*I"!?ES(RP& MY4/!-.N$OL1\='?'-3$>1I.$M2(Q-YID7_STZ8MP!XFHUS&3E2L<+3_A=_.G MQQ,^1NX)EW!*^0_\>)0-=E/9:V;VRH_S&N&&T.>#8*[^7#NE-9N3MD[6,KF) M]#*+._+=^D/G:@0AM&/ 1#G\H#VS('I&$G>@]^"@XX#T(E49*<$+< M^M-8A$70) JY"_M O^KZ&0D-?/H@>/-BEO2AC>;L%(\M>TZJMU6N[;IFEW/ M,+O=CNUJ;551FEV[Q!-6S;U,6%UPVQQSVS C^,HIX'TW]@UG9O=J&&>-P51L MK=WV',MH66;;4EW=MKNNVW3;6K=EZ4Z1QI#'YNRB+7SQ+J_)V=E9"2; ]SCE MWE2-IJ)TNHKIJ:9I65Q0XFU[/WY+/*T['+OSQ^P=R)4;O MTH6>NI/YF/PS8W+@(AC--.I]'7)!B+I^-__ZXN/32>J\C=\E" \JF)AX,;;U,7H_D5&CN0Y)=REF S[J$]03'S=%F<.2 MC9 :9+W0V$P]HYEZKG*"U)D3E#M,2[)=H>1YP2^E4Q;3,&U,!;J^,)YP_A:B MLQ:I:G%V]3TE#^9\G"ZG0# G8C(K'I/Y5KV>"/7*&\S_)@N>$KL?,]YF5]KE MYQI=YGU/&ZZX)W]H5??UO,'>A5TKW= W\ULD)RK^XY#Z$E86!9',8.9LW&UY*:_@L:P8VNOE>US#O9]3I+, HZ_^.- M8_;-CR:)B$98#/20TZS"L>=?6Z:RB'/R6Q[QP<]E%?6A'&M:/'._WE6!:N7F&?WRT[I>9TQJ*5S6^\%ZV"#^-H/NTA7C>. MN1+Z8]EP'G6/QX]NF+>QI1MRQB+(9ZXCJ1<)"_TH?OI(H2[W+/S&%2I:\I)G M7>P?7$9^$,B5+W,US"HWYLK! <7YQ!(5TLHG[O-&^6Q]93/[(BQ!+DP1 N>* M)28 $CD-D^G7';M)?#'7P^^_NVOX>6$;-*.0&EPXY6N]E0J%>1SARPV(+ZVW ME,]5-J#.%DE-5]T)RSITFH68L3,!T;F@8IG4V'4^%O*OK/^?2KG%:%^O_>PW]927Y M#A?2>O3(>12>=+BIB1[XH/L) [(T[EYX<-TX?;V-DCUU9J22=5:*RO6M.S!3 MNS=!GMH;65,QVLU5B$Z3MQ01=30?E\\Y/^.+< M5Z17'Z6)_9:YK(V'Q'Z-(C$4@L9IR#=]MEZDV0Q,T/>NB3+_9^):%]+ M/?4XH.$K5V_E>4X4^2]#VQ?K8>0'/H11R+8>*=4@'O?K.:Y$..DRD.M.NNI9 M@HPI@S%-UBB,I>YPHECA=?%PJY!TLY=%0ERYB3:4F/ M!4%^]:\V+VILV?LG<]AN% M%KS@L;WF1%^?M,C9M)DX:\(,N#4B+=Z";Z/XX;59^S-=G/)2XWN21('?)U-# MM>,:>M(#;:N.SB>2C193O+-UJFLMS5L4*)L[/LN634S&SSCO;U$:[L_&/3\1 M;N]>RW&QT#E=C*6O>;S7 OU!XUAF 9'^BKB2K&YA;VY72KM#;DTMR'3'^9-\ MQ_ERM%<9Z%ZB5KO?L^=N]Y$\G>'+ID:]MF>Z^RTGO=F6GI M&W)'\$5&^T3=THQ79_UTAUC?_RV;PWL2D?E.??].>_].+])R*K93J'%LJ?:Q MZ:BU2'1?*IW'7A)%8=9O+PD=^YC7NGU5S.J;QK&M:\>*:]="+4OEF>Y]:"/R M5STWO'FC[F/W6BPS0VE%FFMI#6@-[.1._2XHU6$J%12I5/UHU7=UOA:I^?8] MS,MGZV1\WI.INHIZ_L4P[=M 'JS;LE5:8+^R?VO.8,^M=[N$ IIMI9IMG;JA MW5 1Y53H0ONP[J8\6UL)0)Y^;574J_%*FQ=^I& M!DRSCA73/#9MM? K2#*D(FV*6/^WL(2'T$DZC.8[ZBR#\Y=B MG[+U/WE^E]FB8KD\DWR9Q+TA%2&G8KG!NZ/.U9L2/O*INL+1>+P[$M1R)92A_.+ MBTN;EJJ 7\\3T,I3<$!$M6PWI9)NH90USNCM$LI#% M\7B:;\C_QH*'XSG-+Q- YD9A<<^'8W(6]AK9QMNYY9,&3]R?9U*0U\39>2K( M>>JL[R7O6K5/@Z8H[L+'CIP!45I3CSNIMF+I'GWT)DQ=?3,R^QJ>7*%6F^/E?DAAD)I<'3UZ2N*@)B$OI".KQ7EPNQQ8!A M.IX0VR NG)9W9EF=%D[GZBEVG\EW=N$J*;*'20V4"4O%JAEZXP?<2F5[ O9H M,LSUZ;'^B8TE:+:YF6BW+)3[C[QRV[VERC.<[\B*1+WT0?9(>7]BS"18Y]E6[].$I%[;[;3ILB-.%L>&D_;T^+F>R\P MIUF#7=F,&W)[=9F0471@XKMWC];:S0LPENO=%ERPF]P%ZTQC2GC M-\^Z">%<9/NY-"HQ5NXO)"9J=3N>J2A-MV.US+:A-YM=K6N;9M?3FVVKW15M MKJ2)B?3][%B>)[^1V85$+S#TQ\E2OJ%K/HY(:"\?)X@K4W^.C_VFFP)MDE/] ML',03;,-Q4\J/,XK/%VH\,: M"YL]K2KKR]2AW/S*8?]+$JCM*EW2&Y@I MMVGKEF4I[8YEJHK15%REV]0ZMN,I;;OS\JTY=FR3C+W8I"^SI+_>?%^Q+LM' MME=B^]O>,TOJ2I!L9V_699XO.>_"A0\XF%9=DE>=2,9TQP>WV9[UF47ACM]) MYDA3DEIN\6].(L M$_H7P2CF6V&*W(S9E:F(Q;USPY'F>QS(C>>^9!O/+2J('X^>2[^VUY2,>T@3 M:]M.L^EXGF4XW,:8IF,YG:[B6EJW:76Z+:_(4&CGV__\JP2MNEQ,Q>-Y^ ), M1:X0FNK9NF/QH;#2,MV.V>RZNJO9>MM2VY;351\K!+;#**S,9=D.XX0[PB=< M,#$?(W[(DO?MW(\QUXX9.O=#_T:25O-M)^>V]ZHWY$/68/\=^T9DT*. !U6? M*O[K""+3V =!9!7EAS9;W;W7V>QY2LM^U)MDNS6(;C_;C4/LYB'VM5[>$.+# M]WB0,JB,NQ=.49*RA7JV5>12V51FA:5;8;H>D]R;\62/U6'-%,'36E_L<;?% MC5\Q)D?<]V* S_M&&=@D1\*K<.=N@3#^Q)'C?$$_FMJCYM/8HGVU#K*Q:/5I M++-^?MOD\NYS( M1"O=Q:3>B^71UD@,C"?>'@[[(6"GF:_V^=%@E"Q_^>Q)F M&S#*V;A\ Z-Y(UOQVB1/1)QM;#0=(V7[/\N-W",9=2,^UZ/<#<]G*.3417\I M2S-OC\R7K\E7\$TW8XJR,\E$3#N+>8W@8;[C%+<#TXF09'(CG?5Y O-I>3Y4 ME_W=4J#I"N6_:OW::?_^J4,>[VGKWXN4U>=\\!'[/;F#%2_.I7!VNFV1L_J? MQI_7[2.YR09WV_CP8]ID+@;_HL%$2M,+^_^<< 2#!ZZ9.0N2M+/=QR8QN^9O M; 91[^N1]/W$X17+-_\\T13+5@VS:W0MK^WH3M-4[&Y7-9IMHV5V3.=$.;G[ M>M+E/L.)JAEMJ^NTK#:_L^ERQ\M3Y:TMQ^.NHWHDB^^'$];WTHV_PQ]G28^. MA7,=3]CNW>E29JA?JR?[+]J_O$^_9RGSO?,V^>?OWJ>S[I]GY[\0K]6Z^/W\ M^FK?OMIF7URX>ZE?+FW&<]=M.(JI6(ZF61R38[XR_[E]M'ZDDT6;Y#8EWF.N8#S[Q="[^)L1_R.)O0?R' M+/XVQ'_(XN^\*O5$3>NFS3WMV!\_W?D4K>- -*!) QE'3%/I2#?9K1^*%9SR M*!J(6!P_ZD,Y#E(YO/YT%4AK2.-;$88:2<7HW(MH>1&+%7(]\-IEH&DNMGR=S%UM+CY+G(N;=@75%H9RI)X"M*' M]"%]2!_2+X'T2SJF+QX92._)MVDP%J$B1) ^605]**/ZMQO([S.;ZVO*O;5T MEG_/BIV%$';C;.VWC/'KJXYC6+IE,U4S[5D$G^>V[+;6-4RWU78UTW,[NIY% M\'4-SS25:9SA)#FYI73\81YA.-7IQ O[ETRL'65)[LT?+4N?UBT!:K+F/6Y^W,2Q*6)I]EEJ8CF05#?G62](](G_7\ M$0V2GXY.+&Y:N4:UFUW&;NM)L=YNN.C4KCJ&V-S,K^9S#==2* MDI2?SWGDHW7!T=6P-"[L#.P,[,Q3._/N>X;&G1L:U?.:3;O;59JMEM/RC*[B M.;FA,=NMMK:9H9G/6U7K1U;DQTA7%;7L= M4^TJ1ELDS^B8G6NS8LQG_UU5U]J6;IN:I1J*81MM3LOJ>%NH=U^YTS>DL7=MTMQ;_:57&L]2PR 5F M!69E<[-BJ?/)?[6C:RW=:'9MIVO:>E?QW'9F5MINN]/>V2R=72$F7<4T'0P- M#$V!:3I+GUN:KFLUS5:SW=:TEJ.TNU:SV9Q.TS6-KK'%:;HJ&9=MTN.8IH,Q M.EQC]#U;9"+DL>XACTN;.#[:N7KZ@1)L#_9&6TC^C7C]:6IM/^P%DSXCO0E7 MH# E#XS&LUTE$]*;9=XF;)I(F8;]Y=MO)G[0)_T)$[?Q%\:,BOO\D(0LY5J7 M*2=)Z3V1_ZC4T6,2LW02A^*A<1Q]\^4NCF+3O9/)F%_-MI>D?5$3^9[((E&O M/-N+1N.8#7EY_&],?#(:\?^-QEQ#Q>L6/\F2!BF=!$JJ%W\C"TFT5VI&S(), MN+V%%-OK-2.>ORY7#VY9GE$/:,8J"[:T.:'221M,3&1,@S^QF M4UO]:+UARKYHO>$^K89=Z#&W6#F4M]RXUEF]S>R+XS%>S[=4G3VJ.SL&?/N) MA+)WT/*>8LVMM.Q,GNQ/M)9NVMG>*V>S[E^,]7C'?SGM^+\3,O6&!NOQX&G% M.]ZBJO)AT]JQR0H<;U&LTSZ,GS)F]Q.DC03FWI,-$4UCL64J'CRAJ5WC(F'_$ $"U^S MWC#D-7+KL^0X>^0L[#7DO;^QAT1(8NU-[\:3.)G04 ;XBH@H8BGJNYOW[[3W MRR%1Y.KDMV.2](:L/PE8(FY/AXR\"!49TF^,EYL7.AKY*0?X43S\0.[\(.#G M23(9CP-Y*PV"ARQNN9_%1\N/=%ID,N9OC-E_)BQ)YXN?*%KK&[76M2%M&\-S M3GZ#I:VJ[$[-4V&,(,"*"K#8^+*VLJL)/DP% "J@ BJ@ BJ@ BJ@ BJ@5GPJ M0,=40)E\K(/%=\!3 8JJ.;;BNHJB.<;BJ1/7/JZ+B1840D6&TK5 M5G8UP0?6&U !%5 !%5 !%5 !%5 !M?*LMP;6NSP^UL'BJPOK34]415M->+%6O.V*!M%()%P9B5VJFC0.V<,QD9>SY##G7 U%8N/L.@07NWP@8<'5$ %5$ %5$ % M5$ %5$"M/ ^/"/$2^5@'B^^0>7C#-BQ7L17%=FSCE&JJ[=JN^E]V?V+\I11. MD7[&BQ^FDYA-TZ!?]-)H3G0;DNBVCS?BYD7^\#2>)"EC9!#%\KC/;E*2S AX M,.=5INZN3G3OZA*&J:+B4Y53S1#DN0T15E2$1@,S'S7$!_(<4 $54 $54 $5 M4 $54 &U\N1YD3@GD.U$=6U'_4*HTT3D%;]BXU1&D!-5EYN+:G-.7?#CK6C$/Y[M-OI[ MXZI!FC3\2LYE-?&W>DD2]7QY!.:\PKP=8LZK*SOW5-7%3IQ%IL(AP3)($*QY M+?&!-0=40 540 540 540 540*T\:VZ -2^/CW6P^,":ZXJIV*YR2E7]1#7< M+;#F[!L+7\B;_V,2,J*IDC+7BU+F\I9N%(_$&W\)HAM^^3Q*Y]'I^:O^YP=' M4^V/"=$;CFW^2*Y8Z/,[Q*T)Z4]X011-1^AZE2E $/#5E9UUJJF"@$?:D*I* M$ 1\+?&!@ =40 540 540 540 540*T\ 6^"@"^/CW6P^$# 6ZIAJ;H(6[=. M5,=VS;_4UQ'P'5$EF\:M:YHDX:TW).$54UDBX:<#@J]QJZDKP5%: M"M[55'5 !%5 !%5 !%5 !%5 !M?*\N@->O3P^UL'BJPNO3D]415<% M>W7/[N\-IR@SWF9)+_;'DK"6]'=OPN_S60):&OB #_B #_BV@6_$OQVPZLPM M_!^8Z5(J+Z "*J "*J "*J "*J"6 &J5F6E5*;0Z%]1TC9L-J.FW#?E6#-NP M7,525%,SK5.JJ;:IV?I_V?V)JOQ5F-SV;OV A2FY9KUAR '<^BPYS@1S%O8: M1'5=EURE4>\K^1+P=[_S1BSLBP!Q&;Q]R9*4IC)@G'0& ]9+.09RSI5%!(AG M[U$-$26N6.\;?P-C7N%04E5!)'=UA:=E"<05)!"OK B50@$"M15>3?"!,0=4 M0 540 540 540 540*T^8UYDW2T8\QHWF[HR'&5ES+,D*8K!_^_:UFF?W:O% M=^Z<9BGQ[FC<)]YMS#+2^YW(;J5Y&],P38B$)Q.A;,BM@QZO-#V'/"?5 ME9VJGJJ2'3<@PJJ*L%B,0FV%5Q-\8,/'DX>O8\?,H/ %#7FD%!D,.V8$AKX,(B\4DU%9X-<$'AAQ0 M 150 150 150 150 ;7Z#'D11QL,>8V;35T9CM(RY(IAF?Q0,6W-54^IXIQH MJJ.9?ZF"*^\7#B7_'NG=&8V#Z(&Q*?$]X>6D"5O,OR+VXIQG7^D?$[8N]XI, MO>(@]4K5J;N3?\(J551X[JDIB'/D[JBJ !%:7DM\(,X!%5 !%5 !%5 !%5 ! M%5"K3YR;(,[+XV0=++X#)L[S5.4N_VVHFDA5SG^:UG_[;* :=%>TN:8HB!6O M#>?6[G15PX-!J:CXU%/-%J2W"PE65(+>>,S"OG^?P41+K!\^\-^ "JB "JB M"JB "JB "JC5Y[^+[/ %_KO&S::N9$>Y^6]5_G+=4ZIIBFIHTZTZ5?NU658R MDOMB+$ ]2;DR3Z[RB!"7&5A$+I99@'E"WHES5+PA(2/:9X0.4O[T12^-9B'D MNHPA5Q7$D%>;T%.5__G!T13W(Y*P5%:$(@/+J6B,$&%51:@T5!O2JQT^D.F M"JB "JB "JB "JB "JC3@?%I2F\"-CLO_\H_&2L\/5[O>2U#$1S>25Y^55-^ MW(ICICY>H"W_#N/I6\;TEIW]'@% M[FM_Q!)RSN[(932B3YSL$8UO_3 K'IVDT?1$9J7DF3N_GPX_N&[#44S%9Y?4 M;5\R[$*/N<7*H11[3"_TF#._M)($T7= @H#' C[@6X-OUO+L-Z$?&L'DFH/VZ 9UQ3O>HBH[V53XVK'+"AQO4:SSB)LEO=B7X0Z0^IZD7C(K+T)A]J8+&]0%%&7/BM*FZ:J.'XI2)47!>*C$XR$H M>:V4O.L'K%\V%?^5>W!W?CI$X$TIA[^ "JB "JB "JB "JB 6@*H%5_%6F21 MQ*8K!;&*M4+-9B_X#GX5*S^A*HZERBR.IF.;^2I6O?#V1UM?Q8IUJ15?$7>" M%:F5%9YVJJE(]%AI$2H-'=L;U0\?B'% !51 !51 !51 !51 !=3J$^-%]A$& M,5[C9E-7BJ/(H-Z&^-M)<*Q6A#HJ\ MXN0A$I#UR"]VN$#.0ZH@ JH@ JH@ JH@ JH@%I]%FVM;RL/RF!87Y/=52L.^/)V%C]_&-$Q9GZ01XLLKI-B( M+X<($5]>(Q$J#0T)6^J'#Q0ZH (JH (JH (JH (JH )J#2CT(LX:*/0:MYNZ M5AZ:H)$595A$I#LR"]VN$#IPZH@ JH@ JH@ JH@ JH M@%H#3KW(&F)PZC5N-W7E.*K*J3O[X-0_1;Q2KQE_P1>N'?Q%-.PQ\B6.;F,Z MFA+M+^?4"4CU:I-Z(-6K*SR0ZI47H=+0BNQ64UOIU00?2'5 !51 !51 !51 M!51 !=0:D.HZ2/7R>%D'BP^D^EI2?4M[BVY&JI^S.]*Y9[U)*HH.^KSAH%JT+\T<4[7E*+LN7?K!X(GOV:]8<@1W/HL.8$ZK*D!O/&9AW[_/8#8A MQ]KA P,.J( *J( *J( *J( *J(!: P:\2+ 9&/ :MYNZLAUE9<#S ')'O%YQ M3^F)8NB*H*>S /(=;1:Z&#^^Q(2_.-$Y8L6KS=FIRLD_88(J*CSS5)>AXLC5 M454)BK$7A%<[?.#) 150 150 150 150 150:\"3%]EJ"CQYC=M-72F.BO+D MVCYX\I+^M@\8$GESRYZLX3DD_CR>TW(4X2L[BVY+%=^8LOOW:*/SO;6QZ M-1F/ TGITX T6<@&?DHN6>K'&<\O*?UW'O_=9WU"PSZ_F*14A.1W!@/62SDJ M\ID^9*_4%$G9&^^Q06K%"3P0Z-45GG:JR2PV"*2NK @1!E]+?"#0 150 150 M 150 150 150JT^@:PH(]/)X60>+[X )=%4Q+--5+$4U==T]I8IU8AFJ^I?* M[E6E;^F[XL^?CW1?39RGPSB:W YGD>[9ZU1!G2LFJ/.J4W?(_UY9X>FG[BEO MA$4V;X$ RR! /A:S=$BO=OA G ,JH (JH (JH (JH (JH-: .%=!G)?'RSI8 M? =,G"N&;5@N/Z$JCJ6>4DUU3<W9'$N@MBO>K4'F+2JRN\/"9= M*;+2#"(LA0B5A@[IU0\?J'5 !51 !51 !51 !51 !=0:4.L:J/7R>%D'B^^0 MJ?7GD[IHRKZX=>1SJ81>@SN'\#XBGTL=1%APB6!MI5<3?.#. 150 150 150 M 150 150:\"=%UE##.Z\QNVFKAQ'6;ES3;%LVU!-_MM0U5.:,=Y_]=E -:C@ MS7](H]YNN'-56DLHBR#0\U#UI$'>T830?C06O#J_ M=;ZGJ2N_8"RRZ1M#>(\V4E$>L-WIJH8'\554?-JI)7AX$P*LJ "],&3W! VP M?OC Q ,JH (JH (JH (JH (JH-: B3? Q)?'RSI8? ?,Q.>9U1U%TRW7/*6* M<\)/*6Z>6ETM&L3>C>(1B09D92SZ&3\U"OT!%X'DVKW;F&4;DMZP](XQ<>9Y M'E^\;IXRAG\G'3+)W]/PX9ALI.;F-&O)W3 R_2!!G?T(>'?.AW&.9SGROB8]93'?LA%P6\P MC)5BH)M R-G.'Q+#[-BFU5;WBU3/M1"@X %; M_ HO)=5S4T4]&?J\_J_JT3XC*(])Z3MN?PK)DY>6X:%YY=LA<+5 M:%&QQ/'B!T(1X!TLF1-5R4R%;**DQX(@O_K3D7(DCWG!>]/C%;BO_1%+R#F[ M(Y?1B#YQLTO'CT=/+')V2=WV)<,N])A; MK!Q*L>REO^SV#E0/.*^4IYM<; MM$\195V.75;@>(MBG4_$NK+#;-MOKIBOF27;EL#;+.G%_E@T M:$A]3U(OF947D31[TX4-Z@**LF=%:=-T5<]0/6 M+YN*_\H]N#L_'2+TII3#7T %5$ %5$ %5$ %5$ M =2JKX(MDG)JTY6&6 5; MH7:S%WP'O HVW\O)$*\WS/E>3D:VEY-NOG89[+7/8G)&6D,:WLZBR^(H(%>, M2T%DHGSI(E@R6_\J%ZH.?38@G7O6F\B]G?*%K%BW6NV5:=KJ4 M!18BK)@(E8:.+*#UPP?^'% !%5 !%5 !%5 !%5 !M0;\N07^O#Q>UL'B.V#^ M_#M9)/6=9)'< IG^**/DVKR1[Z*4EY"D_(N+^2'_-UE'P+]'ZLA*4X!('5E= MV2%U9-4E* AX"*]V^,"_ RJ@ BJ@ BJ@ BJ@ BJ@UH!_M\&_E\?+.EA\!\R_ M?R]^W=Y._/J6 ]ASNIV\@&D7^S6I]L?5?#N+WX-MKS;?![J]NL)#P'OE1:@T M]")CN-I*KR;X0+@#*J "*J "*J "*J "*J#6@' O$MH&PKW&[::N'$=I"7?# M-BR7GU 5QU)/J::ZIF.;_V7W)ZKREZF\EF\7FTP]"2K?0<1[,F8]?^"S/F'3 MKR7B_0O4.WDWB.+%RT,_9OUCP@+6$V'X_.(XCD:1^"WWBR/_F 0/>0R]<4PT M17$1#E]U@A $?76%IYUJJ@B(?[SO(T18&1$J#5.!]&J'#P0]H (JH (JH (J MH (JH )J#0CZ(JXV"/H:MYNZB_$Q'O;BDB?LLA\2_@X\&D5YO) Y-> M7>$AU+WR(E0:.N9!ZH_)CT96YW M;W([2=(\B%S$D(M(\IL'R9%O$M_^&WM(1-6ONPE<>H6Y/"1IK[#L3DT0Z546 M(!^;J1!>[?"!1P=40 540 540 540 540*T!CU[$60./7N-V4U>*HZ(\NE:4 M1^^,QD'TP!C(] -4=I#ID!W(],H+4"P9A/!JAP]D.J "*J "*J "*J "*J " M:@W(]"+.&LCT&K>;NE(<%273]:)D^EF8LD D-I_0@'R)HS&O\0H^6#6 M(3LPZY47H!BM07BUPP=F'5 !%5 !%5 !%5 !%5 !M0;,>A%G#*H*)MN%F73+QD-2"=):8J\+X>H M[^#3(3OPZ947(!^CF1!>[?"!3P=40 540 540 540 540*T!GU[$60.?7N-V M4U>*H[1\NJL[BJFZ_+=FNZ?,4AW-M?\29/I)X9U(6S'K^^E3_OPSY:4AJBZI M/Y-D.A5YO% HE=7=OJIJ@L6W84$*RI!;$5:2WQ@ MT0$54 $54 $54 $54 $54&O HEM@T8=F=.F#4 MJRQ ,.JUQ =&'5 !%5 !%5 !%5 !%5 !M0:,N@U&O3Q>UL'B Z/N*KJM.]:V M&77M.4;]HI=&-RPFFKH?3AU&I&Z-#"0^9"?&%:>:!AJ_VB($C5]#?*#Q 150 M 150 150 150 150:T#C.Z#QR^-E'2R^ Z;QLY^J(5YOF*?T1%5T5618OF?W M]ZIB:47Y_$],Y&@GT8! M71G;O\3J_X/VHAMR/:0/"0OE^06>_V\(?*\T:0?2O+K"TW+2'#G9*RM"I6%I MD%[M\($U!U1 !51 !51 !51 !51 K0%K7B0^#:QYC=M-73F.DK/FIGB]J/)J\W3@R:LK/.U44P5/CNTO M*RM"I6$KD%[M\($G!U1 !51 !51 !51 !51 K3Y/;A1QUL"3U[C=U)7C*#E/ M;DF>7"2)453)DUOW,EO,CEAR?O[WQE6#G'&4 S_T4T8N61#U,MIAF4?ZL$^S]AN2HJ/#U+ MP5YDJQ4(L P"1.Z66N(#NPZH@ JH@ JH@ JH@ JH@#H=&)^F]"9@L_/]/+_P ME"6>'J]WO):A"$[O)"^_JBD_;B=R[3&/+O\.X^E;QO26G=S$C'X]H0->I@\T MN*,/"?_6Z3#.X3Q7QL=$ICSV0RX*?H-AK!0#W01"3F#^D!AFQS:MMN*VS:[9 MU#W/;%J"GVRU=;73U>TBU7,M!"@XQQ:_PHN<+%* &[Y-'MYE57,3!?V9^KS^ M[RH1/J-HSPEIK%*HX7/Q!&\8@&2TU95;)F*IL'Z;$@R*_^ M=*022HM^SR;E/4^.6QW? MDR0*_#Z1\[>*L@6;]4S53M_Q3+3&MFJRDTT]+U=;Z4IY/AG=L/@P&_.;JVGQ M:(AMB;O-DE[LCT7CALSW)//\*])#>/*)M[?X7>ZX[$T7-J@+*,K+%&57EH.F MJX8 4),JJD0,3"E M'!P#*J "*J "*J "*J ":@F@5GV%:9$%"YNNXL,*TPJUF[W@PPI31[Q>=>>9 M&)TL$Z-1M36FE]$-EZU87TJ'$9:7ED#SD;^QPL+;7FC7!!W(=4 $54 $54 $54 $54 &U!N1ZD3UI0:[7N-W4E>,H.;EN M2W+=F9/K=DZN%][FR+OU Q:FY)KUAB&'<.NSY)BCR M:O-UH,NK3)?+W8YL2+"RS:]8 NW:2J\F^$"7 RJ@ BJ@ BJ@ BJ@ BJ@OH@N M?P7FW;OVO.?,9XNX+QUM3"T>17O,C^@%=2F))DV9X-8+$]RM*$P$ MB1T-9$J4,9,[/9%+=NLGW-=G??)E+U>M$D3'DED*X?C\!@ Q_P 1_P M 5_9\8'!AD\&J( *J( *J( *J( *J&"P7\Y@&V"P#]V)K#N^#1CLEX#+>>H? M$J/C*$ZWZ=H=6S.59M?K=EMNIZDT=47O>BVM2,5]B>Y8G,5@H)DD1.(* M\-K !WS !WS 5W9\X+7AJ0$JH (JH (JH (JH (J>.T7X]*1>N3@G//5(2U212#TB-Y^,!J0U]-F =.Y9;R)39E\,^%46D_$D3B8B04D:D2N1 M3CL*\VPCBI;1WHQV]">V-+2H/W(FL.[Y]T][:EFGOKA_2 ML.?3 +1W1342^( /^( /^$![E]J[*8/R BJ@ BJ@ BJ@ BJ@ FH)H%:=]M80 M[7WH3F3=\>V9]M;V&.WM*A9H[_)I)/ !'_ !'_!5B/9>C9*C*._0'A$M!]Y0 M2H&O:!,I^[A^C^$L&->CN0$?\ $?\-6P.T?B)G89+2L,=(.^I-1MP= M;)Q(MM.?GN_GY_D/EI P2@D=CQF-ISN]G D/DO9DF$2;II1T_8"1&]:CDX2_ M)DV(_$Y*;Q-"8T;8Z(9Q\?3)G9\.9^\0%'%VX_1[#6@5\ $?\ $?\%6@5]X# ME;IVQ+BU2&BX H *J( *J( *J( *J"6$6B_9:MLXC6]C\)H M]$ Z]RD+$Q%U>=4;LA&=TXL0+_ !'_ !'_!5H'L$K5BWO4TF%65>_9=>T7HL&O4F0+:S^Y(=?;VC"0/(!'_ !'_ !7Z4Z MRT,B^=S#&:$#*J "*J "*J "*J"6$&J=2+Y/7K.DPJRKW[)KDN\3O6$!Z#W@ M S[@ S[@JV8W>4CT'B;@ 150 150 150 150]PFU3O3>E\M.28595[]EU_3> MEY@EW#5"$!_P 1_P 1_P5;BW!,M7+ST%5$ %5$ %5$ %5$ M+]0ZL7SM3K>D MPJRKW[)KEJ_-!G[H@^,#/N #/N #ONKVE=BON.Z:"ZB "JB "JB "JB "J@E M@"H'QJ55-^_+B38?O?;^+3GY=+*(M%>BP(\MK[ MZ4@YDL?\KM[T./_(HSI7K6G-Y1^^]D?LCEQ&(QI^)$]+D#L(^0OO_'XZ M_*!;F:ARQ5CA3ZQUF8Z>K\5'WU]2*C57D(UK\6^;NG7?*>2"J/\]25)_\+ - M69^%?5Z,E,N#2X+>,KD+<8_?);8;)E',?X_&+$QH&L4/9!S0\'CI,HUC&F:/ MK>(YEY3ZN^C\D+>W-!/T;O3XN2*L4ML5E;ZD'?KLIKSL)YJQR\)/3S\&\]0. M;*;RA68R-/61Q.7?83RW [?LY"9F].L)'? R?:#!'7U(1!,>QCD<2OS^3T>) M8;A-J]OJ:K9MF;K2=1RK[3:[W;;:=#M6IRV>H4OU\,*F(HG_10&IQFH!T4VP MDV',!C\=_9 89LKZ6MC0:DQ:_P M(B>S6J8;OTT>WF55U NW5V2_GWO7OEYVKEQN" MM^I4-[3VNS"17R9Q,J'1W"0^9O^9^+$TYXE0P2O6$Y-:F<1575A\U7S7 M?R^NB?OY]0E_L<_[C\Y];RBZ N*)GF% 5%UOV) & W+S(%\TX>#C[ ;YYIA-0OZ4 M?"&=I,,HYM#ZC9?7\MO+]>GS"WU3:;!RF*AS'311S69STHB"@XX1]F/YX8GN/GK*]YM'ZL5OV"=UJ_G%Y\N M?CGK7!UGZ,_.6VL'W<\JW*:G&:5\/FL]:O7^42NO?-?RCY8JEN3!3[@*S.^ MM^$@/_N](64!N:;A+2P0\ $?\.W: LG;/_@I?W5/3(.PT(]B\B^_QV1&&E]0 MRLD1Y)!)U-I^W]1B>-DW9!S(MZH:/]Z(@BC],W7M9P#[K1;%,6/8AC$(FOL!Z M;'3#XGP>V#TFFJ*Z!;]X]#.I1+56(0)'VUX$3L=1G&[3M3NV9BK-KM?MMMQ. M4VGJBM[U6AHB[<<@>$EX%'%8O/28#?BF9S,OEA_RU#]E' M@X#TJ(@Q$2%!QR*D1Y0WNSYB83\++)+!1O/ '_$D/S7P>:,383X)O_68W/%" M$78_]&]$()",]DFC8WES)(O;S]?7)Z($''Z8Q2IEMXJG\W<\BE,2+YC%*K6B MT,EE9*T(@H'5_6]H+(,_%D9_LRK-C/ M XPW":R0L%<(QK?R)P#>2:+CW+MAF.J MIJ69NP[[TNWU45KJ,P%<5J''5'.3N*\]N5WNIKKMKNJ%'P_K92"ET#]!#4T[ ME)(XH8?L9.]>VM=^&D#2AR!IP0J4G>!%;!6@ BJ@%K%/98M4*F3199P2F88H M73;(Y];GWS]]ZIR75 GJIN0[$&B;.^B]-(J/YQ.MTBMN#7TVX"XZ=]=3_QLC M%X.!WV-Q22H"@MY@\P$G8K][G21"PL"1BAUIOK-;OOL1^ MV//'-'AJK-Z7!';=Q?J6^. 0 BJ@ FI9H1ZB0WAYT>Q<7I,_I#_H_7H!=["R MPZF5D;<+#F'7#RD?;O'1%AS"BHL:#N'4(;R,>#6DTG[U/M-A!'>PHK)=<@>? MF"JX@_7#!W<04 $54,L*]3#=P?9YYT_RR\7YE??I7X]3&99& ^JFX3N0YJ,% MF*05Q6,1O,/D4H,X"@(6)T-_7)(:@(3A!+["">R'[('\$H4)#;ZQI"0RATZ_ MQ@?T>KUH$J:\ ' "ZXNOC$[@EI9>E5JF@ JH@ HG<)43^-O%KZ1Y<7%.?OVC MTRF)^-=G+BP(=,62O#* VY8<6T/JQR/^3+ZML.OVF0:4>"'MET38=5=FX .^*L_(8?0+J( *J(?J MOOWJG5^13H,TSZY^O?A24OG73;_APT&"\.'6^G"_TC"1-LE/AA'"B($/^,J% M#XX%!C[@@QM7;ID"*J "*MRXE?-QG;/V&?GM]_/_KZ2RKYMNPX># M!.'#K9^+8W[?)[]-PO^61-IUUV;@ SXX<.66*: "*J#"@5OEP+6]\[/.)_); M@WRY:%]\NOKMSV/RN=%NE%03ZJ;I<.<@0;AS:]VY-@U]%DCK%/6C(/GZ .L$ M?,!70GQE=.ZJA/W2^?B\I<.\1KDJN6= M_W)Q=4R^# GR5U9T4 Q_K@82A#^7^W._L"B^9=(X]6AX&R69<<($'? !7[GP MP;<#5$ %U+)"/43?KGWQ![ELD#_./EU=G)=4_'53;WATD" \NO4AE]&=-$E^ MD$1A201>=X4&/N"#&U=NF0(JH (JW+A5;MRUU_:NO=\\\J?WF?_$&I4JCXGA MSM5 @G#G'@R,3$N:'1M[5EM;^(X$/[<_@IOJJ[NI$M"H.R2D")1H-U(7+ZM&5/!VUO15DD(!Y[/(_GF1E;L?MA^'7@_WTU K%, M*+BZ.1M[ Z#IIGG;&ICFT!^"+_Z?8W!B-"S@"\@R(@EGD)KFZ%(#6BQEZIAF MGN=&WC*XB$S_VBRF.C$IYQDVD$1:[] M1+W# S?&$*G_ _>#KH,A#^<)9A*$ M D.)$9AGA$7@%N%L!BR@ZP\C!SR]%R2*)6@V+!O<1.Y#)>XI/M2EG4I_"A-![QR<)SL ESL$U3R#KEGT9 M^88=JY'*;H%>:?9<"!A,E&XVZ@]LVSIO?QH.&FU[U.^TFZ/S=LONC/J?[59C MJ/5<$ZIOJ;5BE!*&]1@7RW"L9N.X*_%"ZI"2B#GEXE9,VZ5EMQ"LPTQ8C 5Y MJE"V\LI P"E2,]1.^7AD?6ITFY9AN68Q:D-TH2()B^>>V0!?J;$&X,2[N/3. MO4'_T@>3F[.)-_3ZU]YHLA5.BJ?/;&Z.4FD$HK>; '[(U(I^"A%2>:878)U& MNJCT"4-*MVRO&F!<))!VESJ2I\64BV)*"0.*08@IK7M/M896MK,4ALOVYAF7 M0!$15L&#<\F7@C)'*DE.D(P=NVUT[,Y)ZW/[N!MP@;#00TXI3#/L+!^>L5, M5\Z5"*@A"B@[U9I%QDI4_(B'WAIW9:EC'7>7@Y[V6?;WOC43W&$A20AIC2'@ M4O*D^XB#IO+GJH-7V]7X1Z+*#\V*A!5>N3(UI3QW8H(4EZ\1AU7=>!R)3YRP M?GTU'35Z*UV C%."P%&C_+S)^O\M#3J;.J"SOEQ]%1%DJA^!&Y4O L@8@S', M,\"G:[STG\,A@.$L$GS.4!'!7#A'88CQ=/K6?GJM>M6/""TV$%.80X%?$AX[$@5#.., ]-/)%D3O M$)],[4>S7]G^)-O'\P5. CX7$?BB:F5QD)\8'X^:S9.N(0RZG\G_W2E[D/X_ M"HN0OS@2]HSP=UD@)@H$3+G X+>Z0/P.KB0VP%BB_:P.#Q[9U^*P$A)>X50& MJY=++PN,_>)_YVN%OQH&%Y0'-?^_ZL)V<:%6LS/$^G@&/ M95*4USY;T?U>6#7+M^'@R,S$N M:'1MY5;?C]HX$'[>_2NFK&YUE0B)\P,"Y)#8)+3<;0%!5N@>0V*(K\%&MEF6 M_O5G)Z&JU'UH;_=Z4N^!,)X9SWSY)OZ2X$TT#Y,_%S$413DY!&$/)?XM]:646ELTSTISX.$[+& &3[!DNU3.JQB@GS" V0=Y%"C5SM' M00HTW:N]PKMS(F?<[443U/6BL3>VW3N_Y_:]233IN6.W-0K,5/VJ75\T+0G% M1H'U;0R0;?TRE/A)&FE)=G10W=S7K0/M>0XTH07FY*L=U?)4M]BP,E&C_Y3",\P%P,IPX-<9ZX#C.(;M.%[?>0LIS57 UX';&]]& MO:&X)%BNY[8K&_E]RT.-[?E6OWNQ>Y9E7VS+[SF-C;JN9=6V[_O=IHS;L^S& M='S4_VQ:?I/K>!92I34FO>PC9*.WP+8PWI%2DY'@K*"L9#N"11NF-.OH*#MR M1822A2[B Y M*X$]8OY%K9HCA:0-IX)D!:2' TZYJ)\@(JKG!)!E_-'Y]N/QPW7P%1J:PH3% M+>+FJYWY_O_BY"5BE%'Y77R9M")6R;1FG)/VA /Z- M<_9SC^Q_VK#Q:NNJ\9K5E^QU4'UBC_X&4$L#!!0 ( %R)DT^\LOU'@S,3$N:'1M[5M14QLW$'Y.?H7J3%N8 ML3D?AK08AQG'=AJF"62,F;2/\IWLTZ [726=C?OKNRN=\1D;L ,I)N/,$$[2 MKG97VD^[JSL:/[7/6[V_OW1(9&)!OER^_W3:(J6*YWVMM3ROW6N3C[W/G\C! M7M4G/443S0V7"16>USDKD5)D3%KWO/%XO#>N[4DU]'I=#Z0Z2OBDTKEAK(E MTXGBP\B0_:I_1+Y*=<5'=$IAN!'LI',=\3XW#<\U09B72VOT93@Y:81\1+29 M"/:N-)")J0QHS,6DWN,QT^2,C4E7QC0YMF.:_\OJ?C4UQZ@]<)XT*$EH#+SZ M-[_:JKVM55O5SN'AVW;KR&\VH7%8K55KOQ^T_-))PZ/P8[D*0@5/6"5B:$;= MWZ_^?&S8M:E0P8=)W1I7$'UD)3>P8YG./(F8XK<9;&OL!/2E"&&&?%%^>>._ MK1[7_#W?/34\I%U3QP"VBJGOH&2KT^V=?CAM-7NGYV?@@]V+R^99C_3.GT;- M?!L?KV?W\E/G@O@U6O$/=N@N:9ZUB7\8YJW+LW:G2WH?.^2BT[KLGO9.@;CS M5^MC\^R/#FFV>N3\ _&/:@=ETKP@S?;YEUZG/;5P==VL-4N4^^5-;7_#]A76 M 7/? X^9T*PI$P"I@P?3(B)J*D_HWZ+RV-H7S#03XB4 MAB&$DW>E:LFV=4J#:7N%,$ 6#Q #PDPX91[ST$3U_8/T&L<\$^)@_N!9TCGR M$2Y90$5NOY%IZ?[%FK>ABJ52&1)* MV)9$0OX*O)0GA"83DB5&90PD049KDUOP7TIB:"E.!1G0 +H4D3$WQ$A'MT"0 ML(!I3=4$26)ZQ4!N84X-?2$H R*%S8I!!A($7$%<)L(,F(5-D',$!3G2& M_\WXQTRQ?!(T(.9:0*Z,V?>8FP@,U"D+K((X;PJJR1#,A'V 1>E/BLMPO(7? MBX=?[>7 CY$!3\#!$2LSARX#]H ,RAH&^)!LB'MA0N(T4F@ ! * $I5IRV^@141V0@Y%A/ M$:K8D&L#=;0A%#N=WJ!EN0 T/55F0=LMUEX^U@XV#FN].-6@P<3IG';N8Z0 \EBB(D8%[$='PKK+M4-W-PVA;:9!%/BKS>,>QE(94\R 9GIU%LSU^@R D4MRV:/,%$P M86G$M0UV0,42.P_6_K,P60RUB@EJD9:GCS.@E/,PC(,<0B;HHJ7@H;W]U5E? M\Y!3A=4=X2[)M<$_P9DRC8FG/9JTS5)M:)2:@4(&0C$RI12W)A,4(SJ89968 M);# X=+A8A8/3WV&A!!T@9^%*P;9+8;NPU!_PS&T!5*%5P%:$0Y9 :BL 5C#"4L0KDD"UZZ #N.8IQ,XM>)X M/,'&@:9 MN5OV*A&1WE S+!4'#]]LD/ZT"+7 9VX-0)]CG'SKZ(]W]'#C'+WM/&G1(_%N M+R\4[,@MAU\C*F#>)(,@4^AQA21E;KY8:@,]^!X)9M&P".2?#+(;F'1G@7@ M<($S^A9=KF8 3FPO(?%^,LEN=-EUFD14WV1Q>+I;>+'0ACUK?1Z2)D3P*R;R M&\E;].5'+,@:8%JY;K(H^ 'JII=TKW'X(]QKV-=1X?0,*,\B :D(B9GP0"Q MM48VN5 3@5X4*B(CE;Y)W6P'3!;'W!C&EH;8OH2T$$="#CI9]AW +$0TC1$3 M?F-%-CU5_P(073SKBN: HH,$,8!77@]AK=M 6> MA3SON[DV&#-ZA8F<*SIL*F?+)?N*;'J9OA;"\@K?75 NB5TT!$;-;D+7$C3F MY140 ["@"BJ[/%)#$JFS.*8*++5FY*G!TA<.VQSQA[U):$(J.%!P1I?!V9B- M*>"N]CUJ[M=EEUOQ9"3%B&&"E=!A_CI8Y6&(Q:F0$P:CXTBZP$/G4 ->_LA< M./5H9N2TPW[ZZ7HI2B"%H*EF]>G#PK;, M, XDH&'RKG10NAO23L3ASP7\WSH<[AGS[V$[FHT]?)+TI3$ROG5 P/(7]Z/8 M=O1S76[9]MV>%=S@R;\Q:P.FZ^L<02_*.,AFXSY3^2NOH[+]P'I#K,5C#=^> MUR,> HJ?X@2Z,R _9%^.QUQ[/[TF]L4%>5.U_U[&;GO:6_8]YUU1XKD@O$G[ MOK5O:]]WQ^46D\^^IUO[7K9]3Y\9Y;=J9?)%,C55QOY9W.N&_7N]D_\ 4$L#!!0 ( %R) MDT]-*/T[JP@ ,@Y 5 82TQ,#,Q,C Q.7AE>'@S,3(N:'1M[5OA<]JX M$O_<_A4Z.G6W229U^AWSJ?_E,ZGM5G_05334W7*94>%[WM$1*L3%9P_/&X_'>>']/JJ'7/_=P MJKHGI-1L+S1AZ?AM$[N.W[YIQHR&\/M-\Y=*A71DD"2;9E-%!_&AM2J_B'Y)M45']&IA.%&L./N=F2?:?X_UO"KF3E" MZV'D<9.2E"8P5G=K?OV@7>_^[K^O'=3?_W'HOZ_6#GYOM0[W3_QZ]:1TW/0H M_-A1*W!]C6 MV"D82!'"#,6B_/8.;#S:]_=J30^E?H9U,&"@CK]+?P!!PM0S+$^[>][OG?3: MK7[O[!2B__SBLG7:)_VSIS&S"* ?M_/\\G/W@OC[M.+7=^@N:9UVB'\0%JW+ MTT[WG/0_=%5T0'^&2!504_AN9E>Y?K$5?"V\JN&Z-JM/YV-7R]Q;7JK#Y M;@N/'F7B]T07B>F($<5&G(V!=IB8:W(B5>)@YUN3DU](5@#*@4EHN##A0(N (>#V(I M# =+0J;(..9!3'2._\W&CYEBQ23H0,*U (:.G'_,30P.ZHP%UD"<-P/39 AN MPC[ H@PF\\MPM(7?BX??_LN!'R,13R' $2NS@"X#]D <'JNYYSR-()=0K)/A M-60P03IG';N8YQ!(HED!,Q M+V([Y#H04N@\%TS; MJOM@ASDC;-6-+=?D6 "F#IDX/<%D-0=8!R TY4$]!?ETVJ(%;1%H0U]O8QDD MD,DVMOAY2Y@@D@+8VXMLD.I%AJY\':?Y8FYU.M8H):I!7T<0:4O"X>R7&6 )VTY+HC*G)[2F-DL2B"DHB/(";TBM(&&.0:^<8U5]OMD@@VD1:H'/W!J /4KBPOW,.)MOC)$\#>T>YN[VN> U)=/.N*UH"B@Q0 MQ@%=>#V&MVT!9X"%@O?=7!N,&;U"(N>*#DOE;+ED7Y%-+],?A;"BPG<7E"MR M%PUAH&8WJ6L%&HOR"H0!6% %E1V/U$ B=9XD5(&GUHV"&JQ\X;#EB*_V)J$% M5#!2<$:7(=B8S2D0KO8]:A'79<>M>#J28L208*5T6+P.5D4:8DDFY(3!TW$L M7>*A"ZB!*/]!KKDJ(Z]]LM_]99W'?YEN.N+)OG8XG7!N_!*'L>-Y&L)8VYY7 MD"),Q4V$0M3@E#9 GPR-MZR%S8V<=MBO=+H>!T^_"LX/X-QAJA)( M(6BF66/Z86E;9A@'$; P_5"JE^Z&M%-Q\.L<_F\=#O<\\^\9=CA[]O!),I#& MR.36 0'+/[\?\VTGO]#EEJWF]FPN#)[\.V8=P'3C,4?0BW(.V&PR8*IXY758 MME_KWA!O\5C#M^>-F(> XJY,R _Y5^"QL-[/KHE]<4'>5>V_E[';GO:6 MO\UY5X[X60#>I%W?^K?U[]E1^0 BGU/UO83LU6G;GFU;_[;^_:-GVP5+.52\ M_^4!(U\5TQRK,7MWTHXYB\C)3=%ZYJYB'ZI8B_X'B\?GJE:+7OST9FJ,_:/& MMTW[UY;'_P=02P,$% @ 7(F33YW$[*Q">@ J-0" !0 !A+3$P,S$R M,#$Y>&5X>#,R+FAT;>V]:Y/;1I(N_'GW5^!X8S>Z(V!;+C^77$9I6>T9Q M;,DK:6;>_0B28#=&), !P&YQ?_W):U56HS[*)?+K)?__JGGU^?9E]\^?77?W]V^O77KSZ\RO[RX9>?L^=? M/3G)/K1%W55]U=3%XNNOS]Y\D7UQT?>K[[_^^NKJZJNK9U\U[?G7']Y]C4,] M_WK1-%WYU:R???'CO_^ '_WX[__VPT59S."___;#__GRR^Q5,UTOR[K/IFU9 M].4L6W=5?9[]?59V'[.3[,LOW9.GS6K35N<7??;TR?;JH)E7_P]?\)[SL:WG;#Y-FMOGQAUEUF77]9E'^?U_,F[K_G3_YT]MW3T[,GSY__]/*/STY.OGM^=O:'DR]^_.'K OX__4K_1]^\ MJ.KRRXL2U_+]R=,G__FB+S_U7Q:+ZKS^?E'.>_OZI_3Z'_"3U,2K^J)LJ]0O M)BV\'C_669BYT'?7SFI5S&9P%E].FKYOEM\_>[KZ9&=*9W'WJ=*?5_S:2;.8 MP1!RBMFSKYZ&2[C#;*= 8V7[(--]^?WCY ?[XT__\ M_/+O[S/_OGUSV=O/F0?SD[_\N;MSV___/KL?9Z]?G/ZUHAR9 MR,NVKZ:+,GNMFW";\Z#'OZ]ZF.\T=4+_]1_/GK[ ,SA]^^[7M^_@@+*W/_WT M^O3L_:WI*]XDNK=VGY]_!P_K&IZXK0$XH.?@-S!'[VN[4^&H]SBGNX=L3P]*&)Y"R?0 M"IUT=R6425.T2"/9K&K+:=^T7;8L-EG19T6]R7K0 +*RZXO)HNHNL@FH.=.+ MK&FS;CUI6CA,)A*:B?YFM2B0W%K^1Y==P=O+ >U57?;/-:QP7@'E]4TV:[() M*CEEU]T?1=V7>+N6A%Z^^_#Z].>S[/5M&/9O1TE. OQR=O;A]9L_OPF""X%>^///LE[+L83_O=+]U#!ROZYOIQPMX20DW MW#'^BW(Q"^_M5=5?@"" Z]NL^ZZ:\%4NBJL"[C-8(G"N9)M,-O3, MD)/ W%^S3"DF75GSPO!5W1JXB(X W" /IO=?__'=TY,_O,B6.OW!=/L=)=SA MRZ:G!R:;7M8U<'6EW@?<_S]^>__[_\6/1\7QOFPWB^>"]U.NPC47N2S@6FW* M NYNG179#.]L4?,%9U&^XZU]R5=,WIH;W<"]L%S )^4LYQ? G6Y(*UFUS0K^ MHZ*<= EXND?_2($_.#R2F.P12;Q$5IT@"CPM2Q@Y4,!"^*P["W=VTZ:>K?$P MLD(_O2@N@1;*LI83A!]/VF:-?J5).6]$@9,W H5\:'"@L6<'<\P-1:P[?.[[ M[.CE<=:MRBFK@&)\U$TOK%Q7=P2BB&7&:K4HR2F&E%;VS7%V7EW"C(&2\1FF M62958ZH,"3S/COYTS/1Z577CJS KOL4[X/&CTUN\IK '"3O]$PQ4-\N*)65' MDIFNFMO1?OM9;).M@Q=FJW7;K0ORR0(5%9MV6_US# MT2+UP=$6,+7E:E'A-GF"C?81)M%T< -@YE_#X$H9YBSU*@!77L!.M6P(A5LA M%+=JJWI:K6"X\E,Y7??PN#.[$KL%D\H61!H7-)?H!GJY[1<#>N$]ZW]U?T+=5 M#?]>,F4((9/X7Q5M<=X6JXOLZ%QN.%CE[X6U@>8);W_3]&@1P&G6=#K B=$^ M.!=^#5?N)2Q^AO.%&_JNI&.?97_:@)G094?X>ISSTRO8VFE6>5W [@)!U0=PNZ30\Z4@GWA%VGS\/CTP>N#4[W2!M\BSH>;'V'1W]UT61X;B)?RFWDLM.MF!YG M1T0X0*4%Z%[5M)@L9!SX,6ANI"04V:_$\%].IT@0;X@QY7:@>9*Y'%M;HCJO M<&SDEV18D,CO IODX2CEY/GS!R&5:H](Y8W5(.>.:((-%Y:<\ @G5 PQ[);% MK&3[]'-@IK*&7]"MEFN&%@'^WY9>6 M(15>CR>_!_VXBR:JZEXMYSRJ@SG#[;)"#P2ZZV4MUA/YS77;]MJ,F]R[M MB1$/ ],OYKYFL;S7<]"!,0RT"QF0OK!EU=&]*K>=- QOK*:KBXJ/N"^JNM/) MT -E22JKKO5Z 6.6F%C#NEZPCG-O$G5$S[QG!;,(MDN43+KEUR\ ##&U0-A# M" R&57=V]=U)B^0AB$.53^_LD^-G+X2X M7[Y"KXL+R(RQ 6*!.]\8=(W(W2/?AC@VLJ,1NC.V^J5+9(/ M0',@%69K]@C%/Y1C$!\Z[R > VHXFXR87D/N+;@A<_7'+TCDX\#\5^X9H8NQ M3TKD"G3WCYAQA@MR5\Y)(5F52!7B2H8X)&K@]W?>+!;-%6E4LF/RRV,)#9C/ M\81A2=ZC!XRQ9%_,D4@!E!=^+H.W;9_<^%R8+T8'\?W]LI8@"^V/[HD'C!<" MKWFY1ZSFZ.0820Z%#1[N5>4L?E"TR3%;M#V>X?<9G/L7,9QT '7-7K[XJN6[?$9OHFT'S\?6*U[:*Y8HHPVJ)$ MM79@=+0Z$- X+!D?#4^F@M=3]HO>,[ 0U 7VMX9(]M3-UWO#D#QU912& 1$X M732=OY AFX6-0#E#KQP,R\--240O*OB0^00(ZGFI3"RZ"][C.JD6%9T2FT>; M&^_+EL'G\.>TPHL\ Q8,K)[DA(-R:A-#T$%E4H" :F'/R> MUV]Y+VU567>R!VU9+2>@S+N)( ]8UDXJH!HV!0XL@HRWK&PO*\Z;*E+"=BN% M8$REJE_QA-#%@DL2:)R4S M @XEHJ?@1IS6L4;ET\S@4"QY?JJ_*+/S!K3IFM\#S&<.3Y#/@.0"D!]_6B%Q M5,5"MX34JZRYJF$G+JH5ZZYM00QUU< 8R,7QP_-UA1I[G=:G.4"WV!BF-6_1 M)X,&@'B<;F#IW9EN4Y4@!Q!\F.W1[7J_GOQ#A.*[-5#:R?/BR^]$H%/*()A9 MZ#8$@CC[-+U N9R]9)([^>.SY^PSE=BAC1/:AYU^A!1VK;L48XA1<%+BD#:> MV/7MFK6J%3HN^MC^ID8"FY(=@+)!X(NCB.Q7 MM6:K@5HQ&BO'5QJV00%CSP3:T$ON+487CM.L@]R,"4^BAKRN1?LXO)A;N4=D MGPB(^]2W. P;$*=X$WVRBHW% YDZOY^E. MK3 74#P@$LM&9RXF76U)*DQYE&.\0W89X)[)SS+=AL84ZVLFE PU-D!QKR M$9!W>'@W.IW804:^N-D:!&.Q[B^:%@A-TYGAV651%^&H.@PW"#4WK M!_.CD'M? S?L].)/4[\'RX<4C[8!+L%;O@1^AJOVR4FIWZ))-.TYR2K^KE#^ M%OFH8WKSE&!V!GX)MF+)7^@RU#,YG"9Q[0+SC"K2>_ D< ;!-MEE.U3/3S6 M.=\;ULE_VO3Q+WY\C3*TDR-Z;TCGEA)?$LQ':OBPXCC=R9,-#",B9VKO@2/5_U0\YDS%[HFWYT+0.:] M:&-/GSQ]LD,V-%MCH&PB^SXO25J[&,0[E<*OC=%^1*EX%JS<)1;:^S,WV[79K=-3*^)YUNQN6Q[*-$ M/V!RY2<4EAW(/MHSEZ%!-B'F")"KA<5\Z3SZ84*NB/%K5F)6I\3*AV!R5^JGH#LWTG"B.-\[R\*#/WO.MG[8P8OD!L\ K+> M*Z=U:#]Z'HXT/"1VDX8YPS *>4;D:@#=Z5W@>B+.-\/"4+7 .B8=(+[+QL=C M)<+& >>424M:?6HRP'O+Q1PS[($1(B^$LP:V61QS='@-,Y47<4+T)1 RZ0_D MF.DT+<@FJ_$,*6(V,<.4H,P DY\Z!RA2J=DN?+!9 ;/OUS5Z0^=LZ\XK#DJU M5?<1E[UHT*:OC\7\H9=)ED^]7D[$9.,Y3(O%=+W8EDF$>=/G#;Z>:V\Z6KK. M/3XIM)"-)^J(1"NO&FA>_4E:S.&"XR9*UAG+F&KE:6IHXX+N 68H6%.]]^C& MIRA>\L0YFNQ"&!+L.!34'*V4O3CZ!.MI%J,6Z7!05PD&KRTK5.)\T-)-]9AV M%I$+Q&W@4+G,?;_-JB8HUES^!?R-G@O,/L/"M?]%>G9& (V[DOBNIJ/! MQ*]09>4*CBE\TET5J]S]371/^\?N,9AD=2E^$6 %7 Q=$ZY&<3D=Y_KQ@Q0 M5OM=!4-%CF"7-."F46D]G9((1V>):&%Q17?A*_#4"R0!&:$\&AX>+(7_C;T) M3I@VN^J(!=62?(,7DC^?H]NFG59""+P\C7US":1$DO@W@38 !L)\+KXP3+:@ M:RB^<9SE$LPF5&3D>(5?< JQ0_[0I)QUOV[+?' D;JN31^.^Q2,:/1OYZ)B9 M,B.9:3ZWHYBP4*XI=X M$-EYP6 'Q,8+8.KX"(>F!H+"JV'."\>\[&;4.DZF.S@@P0[(LUN*^*%4E_F3 M5:T%N,52JAE=BF#KHMKH"2AGE,#1-;!GK '&HD%D^!8Y+X\@54H2KX966)[A MA8%3QPP=*\);(@*]DU$:WDC6O^3:N<$-0BN0CBV+D2GE )LQ*.T\.RM"=4>/8C%&RRZ8X+([-+07+GS80'A/DC)X>M7/B- M)!*M,)6!BG)!SM7I>I.A6R*D3@?5P,4?6VJ2E=.N5WQQX@H$Z_OS6N>8]P2S M)J8NRH1/)D2LNZ9CG M!A5$/I7H!M=^HL[PM(G<'TXN2$NN8AC\L/P#\H5>3D8_'QN($EH*91!!@(4U?!. M7FHHL.?:I. $/7.,'>_D/4(5R3_=64EO:]'P>,D8X!3QY-&)59'8S-A;8,>. M"RFV91,',N$@F>,^<4<+Z#*F:Z<4H]]A6/X%85@2A'"(%_!RG^Y?X/-.L,W MU$U^3UK %6K6H)\O,>([DS!XDD//*>M:*D0+-FJO!D#!4^O0XJDQ[QM9 M^JPMKLB+Y)281#1_5DY!+(35YD67>-(;P;PIQY+(YQ-;=UKBL')E-S!!9%H( MJ\-U)J5(] 1TV2>?':$#(V"AP,:/[;Z_9>HX+]X!$2T3_'YZWF= M10LT9ZSN0Y%$[(6ZL0=L7$"PBA6*",[O6-<8"$>]\6B8-7WL @5CP<5!728; M9*GJS#B$DLYM.S(%FRX6M&L9:!!G3!1BXIC3?ZXK"0Q$F0WY6+ G.=/=E*V:("B*%XOS3,0-]A:ERJ:,CTB!6@Z6E@XHR"1$TZXZ, MI2[$A$CK,#E'J]&H02&LN@#Y%3][*L]#J=3[5,%X/:]@A?F!N0 +-"!DT3J& MGHWQX:D(H+RLB-#26$=I36OHV[SUI3G=VTNS^X79:EW^\>E]7(4O?O1JZ7S= MXF[[H!68^].JG:Z7R$@=^E927S760XIX^\;@A[OJ)%^R.A1!K 2E2G84%I," MP)>"#9VROH#"F\4EFU^L(+.'!Q:_!8J.4RC(RR.U3E73*OG/I"7",-Z2I_?% M5R'Z/+ )N6,DCG:M"=3IY-%Y^W+$*!;+F:J-&893G$\IK_ -+6CO3KJ9!S);AL=4E-YA-ANO5KKEV;I[X#+:5'BWTXY ME;+L=6S@)J=ZLPW=K5R";V*7)$=+4AJ/ 8HLEI@GG1VI_C(7AW]\FY"])&"_1';@/&E:LN\&?$9<4@U#!O )4Q#-,QG-,E7\09EW B M9N"4F9E%X["CFF()OL$C Q*H&-$IVG$&4F9Z28,H^Z[A"^2KL%HW?'-6'^NR*/"Q&1/9XI>JC'S"!RM"S *;TR M+ SW$(WALIVS]IGWU1;GYRVE9$796/QM4 E@R^!VJ4)1'ZG@FUR89+:>#WFP MR6/U+)B9A3HJL;5)V5^5(N]HKTB,W^*P'(*E5?_&M-,\@V[*[^87)G?V3^.HVE4=2:*ARPIC@IMH#RZ_$(X8< W.B79$"RBCF9O@1/PGG>%FU_9HFRT@\G-6!44/* M4Z/JN3=1.GNSR+<^WZV:NFN0],!"6!8MOEMS 7$ZY7*U:#92:J^WP7F, M@K2)T4'BI\1!,TH@RA9.G1[/CHY/CHS\?4SJ*;,1K/^PI#;OQ M^"O/GUC\E6-3(!E5L+GB2&>\]-*1NF!6'R.'1H1AN=$NQ)^.O( DC&\2\>T= MJ_!\*AU>2\DVMN6P-PO\,,:PY.Y)F*GH^[::$,0"W-C0[N*#GDI:KQ0OI54X M336ZOJ 5683N=RI]IPXB_&Z:L .Z[;>=Y#$U)1&Q8YKJW%!D>U _QUBZ$A?= M8_HI^5:ZP*H8ILYH>C$)^\DF\98(KXNO4CAUIS6SS4VD+18"1XI), MTYD\PX7D<:+I*%9,3/#YH"=1?)=&;A O6*H_'8%:Q)+.,T3/Z[[$FF)0<6M!2,]=XSZ;D\L$;38&C.M9O26HI M@R7/9I5-B1[\.&!? BU7]L<'F,)RN4\I9&_N*[=^*_?>-=,^'R^N]GDTQ)92 M13\*HW.I35R]+6_S%;>T=_@]?^!^J2N682-')^B1J#B2J3>;M00<)JQR4%8< M%U^K/,PMJM+O8?S[/4NKW2@VB4D[=G'?4-E0&T4!%^J9<>H%]74J.DRQEJ\S M4D\*O9QFVU5]6F(I*@1+KN,,.$^EAAO6NA12.L4+W&'"W ,/4PGX!V78>XIN)."F(?9)JY)C)=_8-Y#'HF$]UM271 MPCT?D@^R6/T,E^=DCRZ/T!7>F:.3)T)6WA<>N[127JK=[QP;].YJ(52@)_H4 M"7BB"^LM=W8\6;7/K"5&GR+PT3=U9(HK7?MQ+;5!TTQ(;]3WZ;!Z]B)TL8#TJ/Q],AY\+IA7*;G(E&+ M%D,\Y+;&Q?%C()M7>T0V1=P>QS>L83[_NPYRWSL^U6K279EMY3)3JAI5]&F# M/3XHHJ @!F2?-;VO+B!D%VZFSI6CE/@P7ZRI5$F""XG:,5907?T$:?L&NP8' M?<@K^"\IMQ4AR@-Z!MUGTCTBQ^$[D^'5H*V$SV?$!Q,9'PARP,X]/Z=K7$U& M:CP* GFVAP12UN?%>4P>_"'T3#C@QG527-L1C M)D:_\4.G,B@>CY%ECI'R M,4T96\K?*#]@70I8>$M06_(6K0E0!W@G&LZPS5N#75FH0IWB:/Z7N"Z?G.A3 M/C'B7GR4C&Z_:.ZU!$\M"/Q+E2R3Q:X-Z)R3= ,HE MG7Z]R>-(57:I\>3<[0> :O?56V7G;$U>&2>92-G%! M^3EC91,VG7>W-BIA%E^,2S=KI@1>/,@:X(*,8DI2<-Q'S>FJY9+:HGJ4$=I1 M*IR(D^OQFWCEMLL4E2<$D-J,%N<,]3 5V8'U12"*-VOOQ,-N UY4B#]T="[( M/2!@)G+*F\'6'B/.ZJ;YN:*/R/641": Q;#$1KM29IBUM2OR:*M MK]M2>@K,R;&%_00JC ;),"^XU;=J";28\)2G'O>A?F/#?17@JBMT/&O M/R3)L3\YZ/N4A/YA3!%!R30F"O( WB2V/6[&3[&*MX7WUV11>E"08IAU=WM( MA;'$/FEJ)(6!U"= 45./OGD"3 :AQ[L\$;82K*SIQK',K19>ZFJ'31MEJEH# M1W5?@^[/W''<74]L?D.Y 37V1E LGFMK>E/& _G!*:G1 S=[9)U89!)2L6ZN MH.73+ITW"(%:P+1S!)6NRDN&T]:A,+,6!N1T9N/NQM=WQ@]?;T)/?"YZQ&+# M9K[[2YD;/H1'.P<%:"81A^5J?2X=(X#K8I\@](-B0L-YB\Z31ODR!0I6Z]XU M0L?9%1^Q..>"(!TLXC@,"PR;1EHX-T"U7,)N$LX!-@(F]MYUS;2R)GT D.DC M\ZTTUF'_ 2\^].T;1T/UH#W5'Y#G[1/3VZ7RYF%5>G*ZI9@"*H_?9X_ :;U/ MM3"V,(FB:*4FW& X!/Y)WA(XF+JHL/=4E!Y'A3$N5=^*-]O59!K 6?Z.9OEP MQXC&A_:8-TB,5([-.0&L+@=VJ3A=$G9IT[(;F&)C*)?9?4(CN4IT9_ E4!J, M*>R\>M2O1C48T[,F*#0^SDT )<4-T'JE\#)9G92;52QOUH2"RGZ"Y KLQ\#E M0"X*3KLHIJU[@VG($&;_QZ]HVM0;4O&] ,HS@+33P@F"6F@8$2]* $JXPE2O M@UE4;2FX!7/%>WL,]V^?TLV5=>;$-L5,GI !3-76AH=V,1/M0B[:15:"23=/ MGK2C/7]MS\NZ;%&C?"QAWGU*$5=6*ZT0DG5#%KR+"MC8&3+F_6M\AQUT=Q7' MC#KC:E!\L#\ UPRA"CY)KQI2D.'DL5-M-1]GH!<%&R_2B<_8#N+1 ,I$UVDR M#RE(-T/GE?V)>"]]::0(G2EPQ7.P:*=D[(!=H&9,J$6FJ?M4/BNS/V.WN9I< M5G]>5ZA,UEA!A>W00-$@H]E@L(7M4Z55AD,-A%VDY,QOGGS+X"V4KNG[#KUR MC4UA'_% T=R ']@L3A/G<, NSYY98)?0G@T>=\ N,/!K$!K9\RM-:$W&]@%.S0%9P?J;1S="WSF/S9+0,@8:C56D#1N]% M3SNXS01^*R>WF<+OGNZ;*S35ISW2:%[">2:CX1<-=\6^.9PYX39F7%:QI@;C MVQ%R36L?%,*:NBC%Y!3I ?Y,"5,./Y%:"H1-65S%1.'X?/C:EJ)UKIY+ 8) MAQ&[N'!#X3G<6Z=I)S;&K3HHT/#(X@Y#SX$VAG@33OV7IH/.V3G9:%N99$&' MQY>W&))4QY(ZOILC&5..*%"_:2]D)] 1VO4]T4H8@;@!K3 *6-#\B? M1(&> M:>3"AL-YOUB)"2";DJA?\=9H3EP?0(;%+BT.'KS$52PXL^!UG/Q8J'VV KF1Q!#&\!Z>:@T]7#VQ".>(#.\WWBHA_B##4KQ*TJ(7 M[/7]1",&C.1V#1$U;:ZX" /WV*(%16[C;2E,[YI1SD*!"1=Q6GK#O>8)TS;R M4'@YOH(BYA'C72]\I]"=TA0E'84::R)6G,.F]Y-?=YZL M$DZ>J@Z (ZGHBD?A;!_=(=]O=*N/[\5C"(3M4P1%\@;+]E*:?%B,UI$S#8/3 MU"9LW0U:P8J2!@3@T^!OICM(1I:K8?L,-Z=OBYEBP0^"[EQ/%X;>?X\H/ C[ M-+[,W"9_KA* ^(13*74:0?%T46QZ^.!E#<^W MF+/I')LGSZUCD^A#9EHX7RN]3HM6IFVUI P"6ZWB5(II4\-]$T.H2#T\7+1F M.7(3@$;J^XR;-^Q TF]6Y:C'=^#N'7:A'[IX'P.I[U-$91LNUS4>5L.7DBFB MO58(3[C_"='+O*@6'3OUJ&Q8 KJQ)Y656.IE#V+_7/W"-[*JE7WZ4'R40*%] M$:5H<#Q!$ ,"<\N$DY6A2@1A9G.9C:6_914-]Y=+J2W;* MX8;?&,-P)V"Y?8N]G%+SORX#VR3'OIE6/1] MBW:=C!QHD\%7Q^(9@=U;+WK7E>Z3YL8Z>,J[-2-7EQX+ENE8G(?Z-7* P3JA MZ/C*6]K?@]&VA.(T;!JU*" M@@,T1 +HFW04L-,-/')M8%#'D0D.?BU(N^KTR18-Z-T6'I@.;\L^Y0]&ICBC M(=>(T G'4K$-G.O.6);;B)JR#H2PKR5JF7G\8K=)LAVWAE?_JW5 .QTI!8ZYZ]3SEX>)B0ZHJM' M6@T$BJ8\EA M:;.PN*.)M/?:Y(,.-;%ONY5:- )7L">8+X_Y+<,& M P..IXD1I#@@CGPS'EZ;-,W'+9W%_))]]D/5JLV#P=!B#CRYHBI44ZO!?Y%! MY3J=,7K%%*P7'*4MT6!Z0W MY*H/V XRLB*IT$QTB,]'&@<)?=SG/N020(5YK]B'=U6T;8$F(#H]X%G2 #KV M+&"3"-)RX'QA^I4D7>#M)Q]+!V8$AD;I$\4)P53O=EIQR1 /2JK#JH4+L"BE ME!*)KI=ZS56QT;3D98F^P:I;4G\^_,VT#+0\F'E\>EN/K%$X]0SSQS!OI<5( M"^43P=5:" H)!7ISKU7PPY*_4IX1]\"@!&1W$/=\-[6!DX>EOODB/CC); MNSPA2BYS!>ON0.FJW=]VA$'^R29,;!3O]Q0&EPE@)!+=>DZ9O/%B-5D2GD?3 M78J=N[Y=LRM'UT:.<+J8KB;"^"/-]1.SAAP^"RK 5LS#@].BNS % MU:3#($O1C] #IKAYFA1ZCM&,*"/4"E''1].]P(SD%!?7';FEB]-B7DQ+CEH\ M5DL!G%5"6\4[\MMZ7&[NO&^)1.B&"EO7-9(0W\(Y0R\Q MOH3P"?E8&!ZS-DXPG:)GB&8[*^7?:MJZ6S+*4(],!KC#!<@]:.TKS_=>NV6Z M?.*1HM"$U$S*R<]RYABYD W\M,D-KS"L.]?$2@GZ4]#)I*=;/9RUAEV%OH>Z MNF?1[U+KF2FX/K\W9D!'SX]C]_'XSN3AOH1WW_-M]E?"KH$<9-)4W:)KOL3, M?" /V\ ],FV)=-%,8Y]O1_NC9U/50/+O7386;_E&8SKC20IM#-J:Q@&4T]% M)H5C+@38ALY;8$DH@ -F@W(W.\*B:"]5S;8?;Q$[)ATP 2L8U^NOV@[Z.Q[^_0&"%UR02.\?<@3-\<^PY#%<0(?8@U0B*;;A%4]]1 M!GQNLG XQMJW=<9;B7]0;J/:#$:!VL8]OW72!4\>J[1Z[@2!>TE% MN,F:1X M[:C-VSBA,28ME]^YU'SL%@!&C\.BJO=&4%'87JCZHH:M!)AEMS0Q MG*ABVWITFMFU]1]!+U+\,R8H)%N(X!BWSU+FKCCM-2&IF[J M,'A7$HAJTF/U.3TMWS'IH#>XWYBUR2F/7&4L0@KX:^>E@.91^:R9U('HWOWV M5$=!U3\>CU5TNBOZVQZ5\ZRH*98J+LU#VV+D(MSDF&PUE,R G1,%V\4;0;3E ML*M7MJ?-8B'KGA0M(N:2!FWU7X0A6"_ZX//C%QS?7H1%P<2?.&4PR@A'AX%Z MAIF)OI^"G4M=0YZ]DM"A-72XHSE2SWY5,J*N6S91.2H M?B^:#;]QI%&).M/3F/HV@8K.G4?YK9VQS!\%L._5L3'[0WPN7^7VF]]IS]2W M4H[/12;*&0>Y:.4[YRC"R6%K^FA #&:D@*DM4&NGB!:5FB!14$1BOQ0QP3E\ MW;0>DL*4304)T@6WZ:,NF^XA2\T:8SMYKM?\SI1YS\E\GR4"MT\AN-<:*^,6 MFQSS9/>':\=F%;>H8L2"F+0Q(FKLDQ0X2([QDS)BRJ4<*[W37VQ^Z2@67RWA;P:_0]P_&T[1&6U?"<4-<"UXA MG] N+ 1&=VLV&.WV>?9L 9=:N_O.X*&R@01VZPJ_:"OXF&&XC M$&X#338&11NBX,(B?*?7%%":JJ#S-1QXA(EVS"*H"IJ'MII!*P]E*B94XM*( M,!!Z?6;29&!6S2DT'5=ZRJ@;WH S+[/HL1<[I$.\_8ZT589=;NFI8@ULN($D-[]QKQ$^?&YSY);@2T MQJ C6-]_S9QJ+XK."FTO6)#+-4!#,(A M-]Z%9V^UP^$C%AKH'@:BSV/BN3FD(!!]7YQ4TY_ )Y;NH#/2,@#$J7![FBO"DP\Y%N.;J0 0"^!S*4+?.1K5AE2 :&J=)TK#U2 M,>\EC+-MEZ).NY1FD5Q%RF)-'@3O1S2UJ#52L.7)>>V^__>RA/LD")&+OGI\ MO)%2,6"Q06%?D*?ZWEO[EA,;P"D/")DJ$)&7KQ5WI^F\!33'ZBB7:\JLLK4R_D'2*P=^1>43HB MD:42O4IP^!%T!?7O&D)K "&/#I5\_V M1< .:Q,3\WV/]>% (K^XQFNW=\QRL7E8=QN?L/98D4Q>@3IF:,%M;1YZKHRI M,/'*Q:WP2>X;Z/6(@"=^ %Z"9(X]0]FK$JXSJKY!MDG' MU=K$@U%X4_;61B!MPHJ(:,*P-^_#:7:C9R) @'(N5 <^&B"!<=_6BTT4['#J M@U'BJ';KNJTJ]+>^&IUKV,9@A\$1D 02PN/%=?<[3!/ M%?TN.UMA^_2$(.6GQUUU D@"P:D^5R\] O?]**LW1.MK=_'HHBR%L M'HH/+.3:^@+/07I"\GE'F7=!#=_(1AL/7]_)PL MHX:OY.5_O,6[#3C%O&JQJR^A.F)4IED#,6D@Z=J!$%\2YTC3MSL$!D32@M@V MFN8-U+2G;EEA:UO\Q!5'IZ8-4^(UD4D3+8+()GSK5RC;L8WLI;=/KS-N*&GG M&E:>9XZ5#R?IS&6$(:3ZS8(49E)2X&96!D%?2OF;^?9[0IH'AKXF2*#H#GT, MFN[S@])TW[;G15W]KRI&MU9S?S&:5""X3<.QLF,?TB5GEHXJKT&8"!BSB

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�REG/HM0B+V0$J)5>-YBLX[C_N$N:8/U M70T6[-%V[YLUA\0TR]+;=(#N>;Q!N3<_E]>3=L<'\BZ1J'0PSYHGIC$/;N"G8ME!Q7LL8)#L%>RE #X10+^V^5%9I?, M7YK?C$6ZGE#^/'RKSCG&XMUP/J'!O_%,08.2H[, %Y2.G>$[L:ETV0E5XPM> MEC?%G_EZ@0A#;1M!D,:^GX4)([X?TH3"*.MBF,=CHA9'3+[L.%XTD.ICAQ*4 MMD09D75)^EWSI"?QHU"DJM:NJ3)3Y=>4B?^NYLM"C.A*>V?[C1H?,?FHZO:A M9FQU[86]M-$Y]-8QSDP"WB_7Q?6V>*AF 881I@GVQ?\CE$4$TJYIPL,XU5G! ML-*@8VV]-'&60$&-5'/1P@[;:LL5@Q.M)\XV.':R0J'"VYFU":NT3V-5PJY) MI<-NJENO^V5['XKM=5T+<;G^^FM9+KXO5ZO=;2G,(AK@P",L1F% 240"VD% M,==:Q;7:L&,M?#,TZXE9@Q5T8+6K=MLD7DT.1^-<3Q:/T"V0@E^.<#Y:Y0@= M*L\HI1./3$,QW9CVIA*X,_XL9(^?BLVRE*4Q-T5>%;1H_G?F^8$71P&%01! MGB"89$&'(XNPTGS<7>O.UW@7]8.'3>&M?/&?3[L-\[(MN[O<&:)YJM&!*WKG MF0-XP6;269]:%(!!AQC\TF%67H)TGH,>Y]0L(>WIGVEHK4/[U%-5*TRJYZT+ M>4;B)!;1^>]%Z^W%47F%=*\TLS#"8<2#@, 4>83$,8[C#E*4,EUU23X(DX3#;DIEE_7S1L:\^>;3;ZN5O5R_Z_Y9ATF&B7J1W(=$M$M,LG0PW MSK"JYN\6;]:O,5T+I5IN9+S9+>PD?L)BF)*048)#ZD',20=!P(IT)-YJPXX5 MO<-:+Z6\%@JPQZNR2CJ %]14>S0'Z(FT3>Z=Z+$.CV?DUXD[IJ&V;DPK!^C. M>EJ*GZKENJ@J-/_7T[*J5U]IOI6W1?8_V$,(HQ1E7A"CA)'0#Y"7==N,+(VY M5KILM6'79\E:K. FYY8VJ5932Q'8UA/+(^1>P4D4GE'X^"'HZFE#I%GU-*) M/Z:AEFY,*P?HSWIJ^>%)'C7[>-=!*1HPFV(Q\RAF'A59KLAX$R_B7D*[5)>% M/F$ZVMBC&<=*V""3 W./#73@]"2Q#Y=J C@0C7IR9\:@$UT[S<\9%;- ZC0T MRX8AI?4.IWG+5I9GDEGBQ[LOVW+^YWVY$JQ5S2W@_6L;7HP3/^0I96$"D4?$ M)+QY>RS"&8T3U?N=5AIS-[)V^.3@.D3X;UV9A;$2""7FSHPYN\Q/8_A9MNGU M+4X'C*D.2E(^/)3KNEFZ_+9<%.O%[OTH6LQ7N=0#$L8H"P,_]9,,^U% @G37 M=.(1I5HX5AMTG#B0O+H'.W2@@P5^D:_ES6L#FD?S-(]*VB%;30 'YUE/_QIX MC?)=[;F^.GP3KX,YK/ZI$'=&_JSR/@WULVM2Z;"?&B\?7S$?.V!DI'=@!!AW *RF: M(V& M-9Q31MQO6;;X (U,- AN_38@&4>%1=JAZ!0<#'L<1Q%F(0Z%U!/M^EK8-1C[BM*\"*38SD@9= M>DO!.IOF.N2 2#M*-,I[%*<9TE0C35JGJT>ZAB@HDA$WJIKT49Y@;,XO=74# M/.[#( FS,$Q]&E(O2%C7#F*IEA3I?]VQ M6 =G?&M>I[]&!,36[\UR5 M%\4D1(S@V,]\2KTTYCL,B<>U7J>PV[)CO3D "^[D0^+%]\,+)R\!&TW&+#M" M3:K&\X&>C%FEWXG*:3%Y1@'=>&0:ZNC(MG*(/JVGJC?BMS_>H47Y*!._5L Y M3D+Q_SV.TR#(2!(%"6J;BJ.4:ZU.&37@6",EIOIH6XO*<#YHQIV:WCFG34_6 M]!ESHEW'6#DC4;U(G(82]3.AM-BI5&M<7M=WUIB)%9#2-.PR!'RD)CIN6'2M1 WD_LD2* M(#.&%C8XP TZX-I%(ITXY+R*C>\+/7G[:=V@6LMS;'>8U?H\XI:#7/K+-E\O M\LT"_/ZXD&?5/Y1_!R)N1.^\[&KG.JFH@)3K>I>O M^7VWM 1-95/HC!"GZY M*1^7

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�(A)#K-I\@9?]0'NQY7KI^D"=KEIEC2GF9!I[XT@-/A4@#*3G2(!IY5C#!<333=Q^' M-!FTW,9EEUI=*95=@3F45^;#LKR=K=/J.L'>AX>"A(QAQ:2TPK*XKR/#3#4+ M3^25)*=DR:_L"+Q6@3F+/-71 M*^O7T.%B[P#-H=;[/XO9EZ_KXD9%?3KY4D2:_UXLW]]N$%B]OU^OUI/%381% M3U:SZ0F5T.@] 1"J'!%,1;(: 43\1U98B CKM6B-/"*4PT$\%-VB\?;_V?O2 M[C9R+,M_U(-].6>^8*WRG$S+8SN[SGS"85(AF544Z>;BM.K7#T R*%D2R0@B M-E+5I[O3DAA@O/LN@(>'MRPVQ41&4S-_>)C/MF^O5JO%Y,_U*GE0OLXWOXM2 M[-W*:K%(C; .M19J;O (*,J^:Z%M#K^CS48EJA1?"T!8@T3LW/<>UX<[62Z MCK]]-?'J+X^'1@K.* 6B?4'B<_JP>=9X(6X7V$INJ8LFI=/> M,JM+;*#(JI(WP(RGQJR_+D'OC)#[M?N7EWY:P/7CZ^7]K]%B-^.V*'S8M:L] M1M0FOR<@B[U1$#&$#34RK1NE!<2UI5>6,] RWUZRNT=-=<5Z-5M-;M/.,?E1 M?"G&*5)P4BS=S_%T?5O<^JB!)/MZ2XZ;NU<\WU$WZR0V"%BH=SPQ2.0ZACBAO$&? :G.> MG[SI6^J7+[\YF*O9[. M,;;0"NBQPT)0+/P>/7-U!88ZY=N\=W7UO&A]>/@> ;NY4[?S[^FO\:-_6T]N M-_FH/4<#[.MEIQ#I67RCR6CZ:;Z<5';6G'X\<*@=QDX82C 'D!$L&-0:*\HP M :92(:>6I3_52.C7#P:O5+33H>%QTQ24 Q:WSU(B)6!6MZ_A+1;-*OF5YRD# MV:X.UWHT39/UR[>B6/V6M)DD/U[R\- C01I%I$O5MR)"&G(H^%Y"@]&5=8$Y M5[WS5M#LDR\G:Q\>?B@@3REA6F*-X[PR&D(I=E(2J++J-0^0,_G*KL">LY#M MBC\WJV_%8MM0_&3+H%>?#0AXR!#'$N,XI; %J9C33B;EQ#M@2UWESIN%M#.? M[^T_U\O5QL3T\\4QN_KX7E5KG!2K8;!R1E,HH;5 4+_'@@.?DPD[H*B#AC>P M-B'NBFZI)G5YB)G/3O^/CP6N.X_\!KP5"TO!4SG8G&27"7YGUTY+67[8W MRP?ZC&C-[:%V_OQ0^[GX4=B/+^?;8X'Y3'W2$7+,\8)CAHB&98: VWC M^NNLH*5P"'8;VMT^B_+T.^\.Z&98]'7TT]W=%>/51PZ/DH@GC J M).5,<,DD@FGUW@F&([37M8FUQZ!&86Z&/Q]2WT@7%]G58WR[\]AS;(R )-$* M0(\4IT9RZ(7%I5#.9K5,&F"L47O<:1#DIIB3"@!L-N3_'DW7H_-WL-,CA8B8 M(]P8(QAA1E"BXQEC)R T(*=R[ !#(=ID4<-0-V4+K2;;.&-=S(J[R6IYKBUT M?)P@F8W;,Z?>*PPD58);N!..(9M5@7B )=;:M(4:!?K,0UE'+8,!\U8HIX%C M##!D.,:RE,4BFQ.'-< M+/,,WQ2,K5*BL5[!C-.XW5)!I-6(.@&XM:5,CJ$K MZ3?>@$XK]0JNAV9W,?L[RW&W"<4\X"0\^$[A $$)"(? 6O,IZ_>$@@!&:*.*0$ 1!A TK3X+,BZR2 M9 -:5AK4[KQA2#M?6WZKT%;C]8<#BQ8 M;7HU.1?'SI:1T?);BO**_W'_LY[\&$TW[N^5&2T6C]$03T>X8X$XE9X/1++4 ML]M8+P'7"*;&3:7L+J\KRR!CB7/4_W*=:0'@SNY#M[E 3J*&R12@ZAVE^__([[< M?/$8W_0(7YY_+"@+J$[1I]A BD&4P90K-C> Y@1;#/DDG<^/#!1[",,YO8J\ M_G"0B@J#E>*,8H<@,7)_E!3@>6NLZSH8Y7,C&\O.=IR*Y/A5%NRHEBCNF%X1 M$T41D.YE(0[G7%\/V<1M8$_)@+'#FF3?B\7J\=-T-%M%2RI94=]W_[: ?:Y:) P#:+:%7_^-I_?_C693H]PI?Q( M,)@YJX3"7&+!+.? E)>D0C&?Q^$FWF[8H7V;I- M\HX'L K\J/)X8)@ZI8RW%L<36SS+(?TD.V*5V4!^&=W MYD=H],:G0]QM:32]3)PR5GHHF$!EFH_@6N64*1E@9XD&69,/9@^GGH_SV;C. MP>?I\\%QB(7T)MIGS,3=%6%1;J[29:;(#;##1#N'G[/Q[/;\<_+@$Z!#AO-X MMN>>(!U70P-T^?80V*S"NT.^_FGJR%,3P*X=KI]&C\G!5]W5^NL# ;A(:8:C M#4[B60YA"F#I_I&69MDB\'UX6;, [8HN[N'[=/Y8%)^+:>HO^-MD].=DNBEA M=)HY)Y\-BGN>6H$H@RE#7!/,2I-+CMA% .S5L:RTZ!YX(Q%&"XK$.8\,< M S#:ZGOYC,I;:J[;@]L,HIV=E^N0Y0VI!"=<%E1(72FF=1Y;I]N8T VMGM M4#%;)NW,;C?PA050]:&!OBRHZO[!MZ6TEA+- >)"6RWBM"3[E!H% MNGW=[N3&0.W!E*IF0P4"#;828DR(]JGG Z" M)';@;^+93P7]OO'IY.$BD=M.&>E1#;^(8W#[>VF9LEH^FDT MN?TP,Z/OD]7H6&#$@2>"80Q H37D BLFN&&D]#YH@&Q62:OK=ATW@VA7C/F< MJNU&^[LLD*[&X_7#>N/T3I;Y>'+,CCW]<# <1@255]2 "*&@?%_!22N%_0[O+@OI]?F M))G:QBR*;\EU44J;6K%\+%8W=U&2XS?Z=48*C&K"-!>44.,U4(K!\G2J/RQHZ0@%B&FB/89*,VLH-$Z3U#=;L4JW1BUYLSLI?4(C2Z/TW#G$ M) (4&,1+^:%UG98^Z;0U4085SBJ!4@_H[CRQ6J-00MIU=N,67?$'[7R6(T^+77SS[Y(FEZ^QQ W#Q@(HM MDGK2@$]6S\]MXT>?I]8X:VU/AK*UCM!I8-) MO1@1A#A'B%6J2M.2/;CO8-QRQ]AFOR@XR+RR3F$K.-!: PHU1(0*9H0V)"N[ M<7@+5*<CZ;+ 9W:6FL9&[7@A7.,Z: D+",9,5T%AK9J0#'$.*I=C/-8UL3E;0 /V.[3&H M49B;X4_KO?F55,2^==4IZA:22I!1. M(9-3 'R D==MVD*- GWFH:Q2([9TB[([E1[IRO?B4T%[[0%11$"!'>+*NM3R M-+U_?/N\;6N )D_FN3T?P(X(<+0#WZO/!:F()M1HXP#!W#'A!"UEL.!:3DY9 MVGN; 6?AUUW :I.]]H10#'"JXX+'#8.8$H-*&3G/RC ;H'W;D(.O*3@["\/( M[+6'/15<:"TU@I0(S+E1I51$YM42&C!)SM?NZ5Y[]2#M?&WY[>P!;0J-% M!D@\RT&O ;.E5#@*>%WGG*97DW-Q[(H=AWW:-XOM!?F;]^-;G]&3(?]_UZ/X M@;O)>*/BLX)3,KXO2!;%@U@PH:%CS$DA]Y.8(9-5:W' '#V#7//AJ>-:$ONQ MYUA[0I$2Q#,=_[_=ZT# K B?BRDFWLU2=[&89&E. O,'>(:@9$<)X M7,H%1%;F_9"-]7S.Y(/YG_(/90$"0!A$2C$LB?0:>Y "S'>X^6@?7ZF-ET_" M[L'OBK0WW^,KITW_MV*T+#Y/[K_%_?Z/Y;:?T1$Z'GTN.,*A38DP$C!@([2> ML%)6E>?#'*"SNT&B-0EK%S&J-]$"^3&)UN7L]LOZX6&T>(QGY-OB/=&U\^L) 02TZ\-=HP'TT %U4#&6:2%JI)D3;F3=ZO8P;VC(>T_YG M/=D&;"_UX[.?3L:]UQPJ:*1DBOCF0& C&50&NA(5ZZXM8[D)>AQ,BFD%\38O M2S\MYK?K\>IF\24M#>/BR)7Y6Q\--BZM5%.LL%?)BZ"0ACM)#(YB7A=WVE/T MO%&<.V#,ID[']@671Z_9#WX^"$ $4\P)38EF!'-E<2F3 #2K0^5PN).OTM?< MR :SJX.NG\PFJ^*W>(:_?=FU5S_^/OKG?+&YZCMQ&U]CE!!-.^ZP<,1IZ@A1 M!,;CVQ8'"PS+N7H=8B!/VPM2^RH8 !6?WO_CZ*$X>>%?3I6_>0^ M>^K1P"G@#FDDC1 8#_&2MJNUJPFP>R/2R07JP!-!4Y'Z M!1JFL??>&NR!*N7S0ER)8Z,A'9]BS%F8=FY\F@&)\M:5=I/'E.=DP ]1WW4U-F\& MMU9U/OIY6N?//Q,HBY8R)$0!SZ#PS@)NRW=74'>:+#%PG6?@UI4)^&DQ_UXL M5H_I,+12L]M4&/K[QMQY3 4?3IPT*CP=',$(6*R=] P#SJ*1M.G5UWF@>^MXIE][[Y%FDPM/!2TBQ=1#CB"JP"FF[>1IP*2V@N>HO6,](8KR\E>3FJOK8!FHYI_ MV8RN,90[\Y3,[U9_1=QVM[25N'3PF< -8=91#;P3F!J%H!:EC(K#G*NE 9E0 M73"I*8R[XM$;1L$)$^O $P%;KBU01F%I-!'21-%*^23R.7O<$#MA=F56-0-W MGW1*_UP4IPVID\\&)N/!E!('@8\3*"(IF"]E)IY=V4U3MN8K,"D'W].<>E4< M\;?1LEC<%X<+AK_\2/ Z3A;I@/7>Q'=*;JU=E!&'V/. MUXW?*M08.O98( YS!;W3E"FJM)6$E!LNE!+G5%4=8D?<'C>D:4Z(8U)!#C:4 Y84ZA]&*O[+DT&9T-&\*SJY6D;_-Y[=_ M3:;3:-._#(VUD^5X.E^N%T6%G,I:XP25TE>\1LQC*.-)D> TE398(.3\E153 M;91:70#>-?E2/>')8E.J8;X\MGF]_4 P&&O(M!= ,*4@IHJ5&S02Z%JN+%O6 M_ %^94'=?^K.'\OB;CW];7)W+"&ZRN/!0D,@\<:!*#4U%CGB2LF)X#F']4$6 M&.N&9BU WQ7IGF;&S=U+A#[,;HN[C6C3))K[.9ZN;R>S^Q+4(V3,&39.3V$X MMMY $3<2:BCQ^^E)-.PTP^)Z2-JA2CISAG^+^.IXSKTU\X?OQ6PYJMH<\NB# M(4Y40"QB1'M*"2$8VMT-.<> N9Q5[W[UTA36LV@"!(P\)]]IP3@PPT&*_E]X@D1,>.\"4GU;6 MLE:0[FQ->_7"Q]:O5Q\.#A)GI(00P3A_!.=P?R&*75Z7O $>2YM6]:L6L)GX M=L4:,UI^2_W-XW_2+?F/T723:7!Z53K^8& (08)M/'A[Z@E14=K2CL069W4" M&&#.3RNK4:,(G^&)_SB?_9%."K>;A)3EWXOI[=NO]*:'OO+3P1.@A$%QI@%I MC#8"@5W5#$[B%.DTNZ<+(ZDIO<[;AKJK->B_1XM)NK&*A]4BZG'E-FTB/\Y7 MGQ:35-5QVZ-M/(G_?#HF5UFC\@8.BCG% 3(Z'HFY]=![7"[^1$J3<[\XP(2C M5M:P3C70V9XY7ZY^+U;?YK?/ZLG?+";WD]EHFOYX;-L\]6Q0&MAH',13C* 2 M"*,H*NT$RH"\,CNL*X*\W%L;5D._2^7-7[.HJ&^3[Y^*Q3CI_?Z8[5]YC)!N M?!%5R2$8C5=B//.E)YM"87/BCP=X\=D3%=M21]>1/6;^\&>S]8VVPX-6"@5!H%I:78<2^TQDA!Z"0#SC &8(X-,4!'T*!LB(9UTUEXS&BR M^._1=%W4.^P?>RP0ZZRV"D"O->*IWR! Y1RE"),,%@XP);B5HWR#^';%I.T: M_NJ<=X1$!YX(GM-H=$. O"?.0>D%+*/R&:-9V_( #^7-J/IE^[-&H#W#CYVD M^9&DF=]-Y[/["-_#;?'G*DZ(G^,X2>9WX]W:N/G0F\[L>D,$KH73C&EMJ>#. M%62]7\X=B\>SU MMF\7+?_D--SZ:3Y/EO]Z\B+:8CE>3#:=N-]9]ZJ6KM=$6BRC%MC5N*I>[*52YZ=5783D\_7 %C..M$/, M:8\!QQ"#O=2>Y=AC TP4;64%;!SE,Q:]9T2^N4NE/%+?J-36>WESM[I\O26RS^6Q>V;2UW&>"':*\!I# "3P%N'X[_*2 K.".^T4D$7"UR3^I]W MKX!S2AG$P\ >5 MR]D-F#$P@(BRSPCBGO%,.X- <$Y;?)Z,_)=-/.SZP7"7W5UY(B.HN?FR^*R?UL M^\;CQTV8]K1JP933#P>'B<0\-2'AD%.%'-9E%0?IC,R*A1J0UZ#=8+JF8>Z3 M7/%MXXNG6.A4=.US,9I._GW4TJL^2!!(Q^.OM)XRH31AG)GR\"LQP5?6$[E) M6E1@7".8/S'O?_^O5W#'F?*OS9_>_,MNG%<0CNXG*5_YO\;SARWR-S^*Q8]) M\5="C&N+!08(K U$AB& 4J@V5XPI8U2EFZ1V7>9%->G1 MP.T M=5I@5X/H=L6C/Y;%S9U;KB8/J9S&$>;\^L% <30%,8V;,X#*8PR9U*4T4JHK MRTIM@2M9>)[AU_YPVCG^? MZN149U.U 8)/BS(7!!- D+,:6E4>+30F/,>(&F"F;@O,:@7GSFZ19S_25KZH M8'"=>B1PJXQEEG(MD'$*6:S+#=YPD]7SRSVLEM;*SB<7C\4 M/ /."A:ACZH,$)(%D MW N9Z@(#!XSG<(]"7K&?(:8'M$"QUL#NSJQZJZ+]3>F%_;#)ZIO\*%+L^NG5 M[(S1 M*<6(TD-TA1C)4B^W-P/!M3=V4!+:U87&VCWED.2WSY[4O?K+X5BT_1 M;ESL'2S5*%AUB&!T7/295]KQ.#.]=)24!JA10&35.7T?KO66H.[.UA_/'XJO MHY]U;/VW'PD2$((P-U[#:%5(8WDJFKVS2+G(:>0#WX?OO2%H.]LWXV9_.UK< M?EK,;]?CU3]&B\5HMGH\O4,>>RY$*Q1HXX6R3%)(-4)8[62U5.NL?CW7[8EO M ]_.(CB?FG4D3TD-6__$D\$ 39PVE$/EM$1 1$NSE-=KD16;\#X<[LTBW)V[ M?5G$[_IFBQ_%=+[)-4W=&*)UN(Y:^#*_6_T5 :WCB3]CO*"5H]',C&ASJBCD M$O'R_M0BGA<9\UZ\].WC?M:]]O_& R^M??-TN^DX [RPA9[2815"6G^)$^%9K-3OQ9(B6 -(6 M:N13Z7""#3"EK"_CX<_&UAW>6%]K;2<;T;[3>?"8([P)0UA%$>CSN$(U6NVPY"GE6OY7WX MZIO"MK-\J[(,VLV=G\Q&L_%D-'U6"NWD6E7I^2 H!0@+21QEF#IIH"U#CAS3 M*JM@]?OPQ;>!A_N^.;0[8I%3Q4B:YCLAQ\*S*7"%EA@X2W'B@"]C_YW#/$LV^E]^.(; M [>SZ^=#A?JJ$ZKJ$$$;8#6SU#INC5*0L/V=J(LS*JBG(M[&3Y M?;X<36_N7I3^^C ;3]>WFR+8;\4XUO L-/]M(=WF6PH XYX*CS%0.YPC7_* M2@5"[\-;W[]6NCMI/L5'[NHYU8RXJ#A"@((8$HU;!"B+>P;';A^UY+G).X&^ M$R]_*TCW7Z=HTV/@J;!.#>Z=/6:(!J_57,2C.HJ[C054^=(W[8'-"O3'[^,> MH"OLNZAF=/#@]*R(?#0@+2A3W#",) 8S*-]9[2"4UF#E9 M*&"80AAF$!'ONG:*.4RE=B89 ^NJZ8S7(CZH^B'S8^UX) MMMUU^JM@UNZ"X!U!BB,("(>6">XAV;3M!#CN#X962LYM1^XOXV_%[7I:I-I7 M!Z3XFBZACP695QPB $&%5I9Z[#1B2ICX/R4*&**L')CAF04-LN)EU'D[@'>8 MS+#:).V4&;-?BOO-M:'Z.3E6?^KHM+MF0@VOMUFWY,S?A.+#X5G@X6NKB>$V^ME5PH2[03I=Q4.ICCA1D@ MD]I>@IJ'O'>JI?<^N3Q5>#H@0P2&%&$L,6#"6H1*3!5&_LH*13?*A*HL.QOM M,UFV7*R>,2S^]))=\5?A\VAV?VBI^N7O@7(=T7#$*N6X) +P_5*N#38YB]$ M8Y):6XQR0&V="+\7#W\6BV-4V'XB(*Z0Q X[9 2TCD(*R\FAJ8%7TD/C3%V] MU/19F/6^M?Q6=FDX9V?9/QP,\QAAY+1PW%M@%!6DE#K%KV0P98!A:/W9,.:8"Z*4K^/(EZS8O'X'(I3?#K\4 L[O2>0T*$CTLS4,SJG90&$IT3B#A M2[=%,C6&<76.;X"0.;>6 M S2$6F15PTCW;FB?8M;Q!P-!3@&#-59$+<6?&E\7C]L-Z$E]DB*FL\V2@Q_GM:[ HHJH?Y8C7Y][:#S"$9C_"OJ:\( MEGM*A7), D$ )LJ!_9KOK>VFZKW<,G56W&_:85XH5WO22>]KY;,0KSHK96KS M3KB1S$JM.8L'(JXXL7AO<=!J+> :JXQ_E>MD?92[XM/7YR'?3_'BYMMH<7^T M1=7Q!X-QBC@K<#P-8>P]5YM4THVTE@N?DV0YP-C]%CG5*,[=I>P^K;Q'./3\ M8X$SX@"'6 IME6>0$JY*2:S**I%9.ZZ^U]C%?,YDX'J:(:^*QOGU=/IX6WYE M<3O:9(_,YM/Y[+Y83&;KY5LA;96>"P0@Q:2DU%@*C(X4Y^6!Q6*5E6TQQ$+V M+7"B#9S[CF#=7!1<:P K3?URF#?*R+B<:R"YU-M@8AIM4%3)Q]9UK$5.'/NS MU#($B("1T9H:PR6TUIE269;%.!)I*>D@0I+1(U1 M8L MGB8 = 9#SRC6F#*("!7QZ&JMK)3_U7:T>U17W+UN=3&+_]AJ]TF29?60]PKC M!!RQL%X)AYC!*-):(5OBX:W"U[6$M,*4@Q'PS>/?W7%DJ[9?\$KUX^\W:/UC MLOKV878[^3&Y78^F[N,V<'>[*#WUPMAAL=P&QVT@>OU%QZ-= M>W^W$ ^.Z<@,1[!WR%N3T[MU@'.F)3Z_.H%=EE:[GHEZ'H\= M2;CG6_@S@)[ ,?/99@$[+.[)*-_VOC1@8"2F!!@BF5"828;M#N5XVB8Y%^(# MG#L7Q.H#\[%W"G0]T7X1]& 0:X6G0FH=3)# *0A!>A%70*:2G 2 :%#P*SN= M#8$P!SB5D3CKB M "/<.K-?&D>^/]8]JZ&;?MR6-ZK%NS='"-9AQ13U<>82&:5'F/&=_-!AD-4< M;GC,:Y@3)QG7!.;]>JX6KUQ7O;FF7L#[[)7B^[[XX^MVC[7\5TU_5:!*"6(T MX0 J#)R.1M_664DX3Y>?/7K$CS7*+(W:FO5>SAPR>,V-8"2BQ*S6R$AG^ XE MH716;.X@:[_T1[,ZW5*;T]C0EK*X'J\?-JV(EWW[W2]YR%%4F19:SOA[4 M_9GO^G%O_YG1JKB?+U+AOY-N]:JC!,6L=$SJ:*U:@Q26VJD2!R#KB=QZ)E &96:*RT]$LX9+)&FI8R8\"N[9&E%^R_-KH:P M[HI/*0IC]?BE&*\7DU5\V9/.V+DN;IT]SV';%H<_%:.J6J1C92>*\_&BP5B#EL:<1)>$TBK-CCY*3+&?;&F+" M;^-LR02TN^S>MQJOGJ3+L<>"1DX8+3:>61D/,M0K]+2OVYR2%4/,ZFV<.@V" MV]U*\_Q@^^5[:K&Z^"UI]G0Y< MW1S3FD9]$$P[>4RK\'20D&.HM)5Q\C+,O,98[.7FXLIJE3;(@SH,.POK:AQ; MEB1;%N/_NI__^%^;SA&+Q\0Q7OZ0Z,6?T6OWZ_#'ES?8\_3'0)&T%!-KC'8R MSC;E."A?.!XAKNP,UJ@*YYE@=N:&C ;^-1JDS"YV/9CQ%2HC/WV P'1U/F(>Z%3%CC$GK@GMX/)NC(;('/Z,(S/ MA+H_(M4T@9\58,9,QWT80HF!,0J#]59LV]=5\DC5GH=K9%=>O297/ M)M/)_>O4HT$@!QWW'C@OD $:,K:WZA"[M@XT^8I_.ZBH*7Q[NKS_)=CA[\5H MNOIFYC^*Q>A(0>USAPK*D(BSUASH% #/%2+[I9YHEM4E^QTPKF6\SV1@XZ7Z M)?%.0*7BYJ\=T13QO3E J[4+O!RG=+NF4@ZRK;.AG_(L.1*[)TS=76@7G\]S-K4]>^3V>1A_7!4V[]\)A""(LTQP(J1N&LJ&7?/ M9ZZ#G(ZY0]1W78W-F\&M59V/?I[6^?//!"*T,8X YK7T!D0+/NZ#NWI8$DBS7Q28!@(YIE))70U= VZT4"_Z&(KQ7?-;[1*OY\NWC;J#KZ^8 )5)()2C!F M0*7B&V2/HE @)W)Q@#[N(?&Q2;V<0:(_IJO)PZ;G?$46'7L@(.\$,!82JHTS MACGFGRPRQG.N2NIW3WIG-&I0,?WM\/^O&"UV%X=1!0F1KTF&9+M\+D;C;\6R M%'/_^UK;^!GC!RT9!5IZ0BVGQ!""R-XS (7,61NK-UIZEZ3N4X\7X5W2>JD]]U9+J_BS^T%I\97UC!VP3[$I%0WQF/=*MA8\ MB4>_(W .%<,2$DN@8 ))*5V)H<;DRD+4^B9BQIFM235>Q%1HW6M8XQL#XQ%; MKQ'$7BIND.!*/GF4\)7E75[3-&E,J?U-F@.&X0:$XO9C\7/EXUHPFB8CLM;< MJ#-PX-HB[!667G&HF3'/@E\\N+8R"(.? BWJKC^FEX>< \+!6NP^-5A@C@F" M@7<8(RVPE0#N45&8Y=0\NS8G81>,;EA?3RP>1JW0M 7-9ZE^QJ0%%G%0^M!?6DIM1#BN)3;""/2#GOO&1>E=)C:*RO7V)+F MJZ74UH/Z$E-J%6/,,XNMXU@@;!%5N)0PV@\YG:T'2*9<-5=-J:V'ZC6DU"H8 MC3]"'!88V>.4%GNY%;SNDCM9/#BCU&0] MK =0:M):ISFRFCGB!>-6*+.?;D9GF6"71HZZ*GQ=:K(>F)=1-Q BAAAV'AAC M0302B85[F; R[[#09%V"-(7M=27 $^F Q$038*RGR (LT7ZN )WC2\>7;\^>"TYA8!"FTBG )10 /&WSBJ@KJ?'3/A5.NNUV2;(,W/MC69E06B:2 M[B(WZZ8J'QXF8$ZI-LIX)KC'CB$"]CL'8JP;;ZC<,G!6W(]6N\]>(0,;TT*/ MP>1,&J$EYQ*!IZ 3G^4Q MK1Y/^#[8V)02AD+&3Q&TQ3-+PD0]3^IMS54&#$@H"E+R/A;>IUXV3NRG*J!9 M6_9%)#3W1-!&M#&TXW$#Q^+ K44,(H&-(@93*Y#=W^-917(2[.OG(L]7H^FU M\K$1_/MCX.=B/+^?3?Z=,AM6:;E/J[U=%U_G7XK5:GNCFV)%S7J1(JDW/];+ M%CCK&P)72$L/<41004\)QX3M\'/>Z)PMG_]G/>U8/;T: ^OXPD]"?IC=K+X5 MBY0SL"B^I:"M'\6VX>XS\75Q-U\47T<_SW)4-O2=(1K\ $LO->40,*PUTN4F MYKC+*B9](5Z =GV:_>BIJ[EP2)0DPRY8,<[JS:=^C1U[?JL1Y?YC-MI:7,5M M"8%:3):3V;U=+^+_WZY2>U2.S)2>WBA$BE@)"&0$.J*TM 0\K562=Q-NW^OI ML7.FSR]1\V<4Q3HDV*EC2Y1%C5?KT6(2#>,HQ1NSIKG! Q1*0<:(L-Y1AKG' MNUK<$082S8?KWTCZF@"]*;'O7>9M@_;-PWK#NTE#WQR$95(;ZIC "'"CE$3E M74 TNV5FA,)_)LWYNT8_&NY[1FTVNV=+A+K]YWJY2INDC[I4-^9#Y9W4SQ<' M$09$QCL5S@:6Z/ 4[J,G5UQD8Z@P=.!$&[FUKP;T&@]86 M4>L909Q1JW5<^DI_I //VQUW<#_Q/K>SCE37]SZUBW/=UBH>/WY=Q$D<8=M. M]LU/TPV!?@4X0C$=+9>3N\DN5#]^]JP]J,FO#U@8!KR."X@2GK-4X6>/?%QA MNKE$^=5S\/4_V\P0=-VJKV"YM53+I-$ MU7,]MN?E2N.[/[UWK5)K-48)*;O4>H21 @(;PQG1'BJ%+==(65II>VWU>/I< M/9MB ">*IAU[+%C @/'.6BV]0]132&DIK0?^RAI&ML*#MX^-3< ]B*3V[/() M7J5^$,R0*"]W,IKI> ^DHS[G-FN %&M&_;6K)=0#>1#$:J1: HZS4W+LA<<0 M*T,9E'@G-T;6XNLB5X,\.*-:0CVL!U M <4C%H1&0B8,LI0A2\KIAH4"5]87 MME$5OJZ64 _,RZB6H*Q###K/*:5,<$!5/([O9.(6YJP>%UHMH2Y!FL+VTDK" M&HXY42:NL IHJ--]-"RELQ)<9QN,-HV:,Y&]Q JP3D"'-)2>>"J!-0IAL9.0 M<,2NVF:IK^:J%6#KH7H-%6"UA0#$]14S2!10$42%2HDAX:Q+'G5Q19RO^KHU M8.LA_!YJP#+CF9,.&*X<@LA#ILII2P P.9=/ ]SW&F=WD]G]EV\1=#U:%K>?1H]EFM*;3O>E M?DQ@;PHWO?ZBXP9;[^\6N'8>*"4Q,TQ:IC3&I>5+4N^A+B-1+]0VO#0E=CWQ M]'RVW@BWF$=IDMQ1_&< /8&ST7OP0.1LN2\@A( "KS0 MGN_?&9F<8,?A!M,W8V;D -FZ\@^N,B\^$:"W!$H%A.&O?)[/)P_KAJ+9_^4Q V@IEA7.2<4!2%0DJRW?G0'>Z M@[3I[SE;9_-FD&M5ZZ.?I[7^_#,!VA25['RZQR4,$I[(OWUWQIG.R88?5#)P M(UK/0*Z?FX2/HX=Z-U#E P$@SJDC0!'.HYP,2%'Z)IF@OM,$H0O;_AM%MC_> MU+R!>GHD4.V-=8 )R2 4@'A,GR1DR%^'Y="4FD^RYBQ4N^*-F4^GQ7@U^5'H MT>(^ON>O![ 3BT^%IP/14GBD(,/64,P8U:BTR9AB3F:PJ7[INLM2#T M.KE&57H^ %I,YQ;7&<2<1SLY]:$NB[-IY$@#_]0;[:HX0$ +>$.2HX0Y0 M#Z2#K!0(4)+#L0&&?+3(L7:![WE!W+E>U&Q6WN7L_IA2HY/EU_?3Y( M1HR7'"+(N 608,CW6P(W)(>0EW-3UP$ALV ?6C)VV6:FC!7 J@,=@!X[1"E;KGMH-JK5:5 M1R"KU_*2.A&/^=;CN!I;++P5AN[P\ B0S%;3K:XN/9!BWAW4EY8-I2P14BCM M))><0>(=DJ5TEKEN*G9WML&UI/EJZ5'UH+[$]"C ('4&0\>!9)YZZ 7:2PC! ME82U-*7FJNE1]5"]AO0H9 AT*D+GN?>06&7D;N)9X+IJ(]!_JDIEQ==-CJJ' M[WM(CE(&8H(%@\([B 404N$2$<%()?OR6(E\Q2(Z3UNQ>&"*F<%JJ71HZZ*GQ=7J<> MF)=17H="Y32)XGCC@"8(Q"-,*1,A((<@ ]RKVB!(4]BV&=+^)2IG(_:7<3$; M+2;S(]E+;WXV"( ,QE@X![STW%((42F+=ED5K0?9NJ==JZ8IG%OES.ZU_I@M MOQ?CR=VDN#UHKQS]? HS@"NK?!&>@3CABQL*1/&[DI"F1O0Z;QY-'LZTY\; M\G>B42DSS%FFB?,L(@@I5YZ7LAM7K?#OX5O:2UQ)VL2O/^Z4%ZM^O8KO7T9V M_1*_\+'XN?)1Q-'T_Q6C&BZB"8-,(@IQ*&-$QPB M14J\E* Y+O8!F7O=T:KFRMNL>@9*Y[1_?/UKWAR+=P.&J 8M $&, T2=9$ H M6*+C8%:\S46LN,,B[WE:&3)GX_=7: 12>\@@E,4Z(@0 M-&_/4,N0:3OYT?!ZFT8,2!F-,0742D^035W15(F/(EF.J.%6]A@V;>NK9:"T M39(\>4F67[\5BV)TMZH3!W7V5P0;-R48507C25I(P*WQ^XEOA,WQ. RW4,1@ MB=V4GH:6..-'D\5_CZ;KXN8N_;SIU?B?M)F,# DA#).*8A"/25)Z)I@FWD,J M*91:D$J!M->4-F.5P\YA3E5$ WKHN-0E'M2!S#I\G2Q&'9(B*VVF'M27EC:# M&7>&4^: L<10BH5FI72.TDX;> PMEK.RYJNES=2#^A+39HA/;7,P=1$N:0$3 MP(N=A,ICG)G,-S0RY:JY:MI,/52O(6U&6Z2IP!*B^%\HB5)Q7=])#&!62_.+ MX%%=Q=?O*50'W_>0-D,@ 2*>+81"BL1#C_<2[!%A60V"!W@MTCCC6L9[$,D, MV6DSP!B*.'.22B)@-%HMFL6#,])FZF$]@+091#'5V$LCD-4^_A2'V;VP)AV7 M\1]&5D1E%;[5E;H.F)>1-@.PX%X;P3A@P"D%#==/,J&U4;!&D*VZ[X ML@_MO_D>#;55*LF;2O1.5I-B^:6XKU"GN^((@7 K.)1,8^L 54X!6YX^=/QE MCLMI@*$V;_C&NY\TA4X]&K3DUG/L,,7(6.6EHN611L=SCKFN MK:YQ'KSD6;-P=[89EO=Q^G'_S[]/H@R+\;?'WXH?Q?3$VE9M@(",@(PZJ@$Q MJ=&+IZ(\UAJG=,[2-I#\G7,7J%8 [)P^OQ>CA,7V[OJ5&"<7JUKC!.BQH=XB M3S#AA'CLK"FQ0 Q<69QYTP0YQ+\6H.^KY084>-JX/_Q4(,9!$>>O M90@(:CQ'M-P&#'G>0_RZ*-8L!PXQ+1OO/GF%S^(5+EO&4X=AW/DA1.F.7L0- M8S]+ =-7EM?5'Z_.P[M/7J&S>+5[*ABOD2;:.:8@=X0Z2^1.3AN/Y3D-YP9X M=.R/5^?AW5^\J7[ "ZGR_BB>2$25]CE!#/- PS966*&I="&Z-*%Y^U M3N;8]?2R[?KV4.PLD.'UVYXTY \^$V0\2&/A#"2,BM1X19O236B5P9E&>R>! M>W+R./18X$YS% PNWFVLH MDTI@E))B!J\L/*H!C;_L&]<6R =G/S]&D.V],<>M5L[6;UK5@\I9$<),*!3P9@M,+20L21 MB)NWUXR4IITC$N8H?X IJ,TIOQD\^SL4M5&@3!+'#6%:IR)>BE+']^Y7!SW/ M<1BRMAC1UT$H'[\S%HLW,\^.9&R=>")P""@A3GKB#>)QHU3[X!9G/+RR#@8- M*W'>!L;]+2AO2E%K27ESA* 8]PXBC;QW4EAGXH)C\5JE+[J1_KJXN=XNKXM;I/\=_%]-K_\\W&2?(QO+D.5GPX">F0UQ\AP MYN+[^]3_>2N()TJ #+H,Z"S4-%W:0[B_!6D+B9]O;+3=[Y>D00.?/G='*_4?B'F?LY+I;+Y[B>N8TV])U!OW6P2R[NDR(U(?V[?-_WIKRC'[L?Y_O7C9S:O M__SI_SIXU&CZBP*G$EK#*#-.0.=P. ,.XS-M& M &G1:;C>]V(QF=]^68T6JX[YTKQ&YXWBWN-Y:+Q:CZ:?B]5Z,;N9/8'R93Z] MM>M%%.C31FOU#D85!PV>8."$4$9!:;50\4! 2I2LUCD;<75K4F[9.2ON4Y&S MKSTL9ZW1LW,5#9#(J\ET^O=BVA"#R]&"I,9HY[PF"AOM!?7EE0X"W#'7B0WY M'^HVH)L>'0'KQ?C;:%DLOXRF12II]J58K:;;H,UZI_LC P7#I&;4;_8<"P51A3Q4C M'"I.G .$[JT2;'(N=&K7Y-T>:^*[70M?LO$^@P9O;/.ST?1Q.5G>W+WR?BX_ MS#X7T\T_O\[KAR^T]%U!>R"\)%PAKBF!1B-1@@21R,J^K+V ==$0M"W'XC#T MTPB)#WOPO\Y7HZFZOU]L;/=7?ZY(W+/'CS8RX@I"*#G5%!.A+ (E&!K#*^F1 M/@ R':%U5]K+IO*3U_ZO5&]]CTSRX!>WR]VUU2L7?P42GSER,-%T9D#[:$ [ M;YPC!I@2 &[9E42W#Y>^W>@M)YKQ^;W2YAWW,2N[=_Q>A[7YPP;-HP$F+%36 M1;@AM,CN(4_5+*_CUG%(E.U<:3VFLU8P(&H\'83UQE!FO3+2:H><@FR_P1B= M4\WM(IJ>M'O#F(MW9RF-\X&2E3N1 C9K NG 1W86N5NG?B[X:BR&6_:D?=IQA61\0U! M. D(AH1#JAUW3%,J2T"D,CG=&P9TFNN"V_UJYAKVA?R4I9;?)5"BJ,+0."NL MQ81ZBE6I$V#]E>057,M.T(0.S]@"CKWPKRZ;[>%X^UZ[X[#2-V^N^KF#!JHA ML5$OR )@@'80@;V"E,WR.@\P%J'=A;YC9;27);"=:IM \?3:JV]/[IGG#SZ] M>5:J0/UO"U$#S&"$N/)$2P64XV4P)^9>YMPV#S RH5W6#D5+3W0>2/_7R6PT M&T]&TWT][M_*;@+_:0)[=K]/184PWNK(#1N9P#""%'K-L;(@;KB5"IFT@VH_ M36 9\ I0%^<#YE(#JSA2)1[.9;EU+Z<);&529#6!K0=U5R>GIIK FP!HA9X M3@1*/>8U**6#J63Q=7FC6M)\M2:P]:#NCTCG-X%U G#)N>8(LA2^H*"#I80> M996;&B"96(Z^T-YKL$$&K:6@@UR(,SFL#6P[HKCN6U 840.*(%9-8[X!2T/O6'W\@DH+0Y.^*E\:>N MED^V :V';36^M-LTF!EJD:, 0TP-HLH:7;XP!? =]H2M2X:SP>SO*KZ-(L(< M& 0!U\XB0) %$311RNZBU9EWY7W)EDP;^/58Q>$A\7WYN1C/[V>3?Z<*ZKM< MQ"_?BF)5_PJA^I@!7-.S*+)^&>7.Z:D,K6A@44S>U MW]/MZ:+XEEPI/XIM_?^F6'MJ_("P)4(Z::4BC%BF4MS6%CL)',SQ?PUPNQT M@QO62.]L_OIMM/K'9#K51?S%8I6$]!'W9Y$FAR3^;;Y3&*;_? MI@G-:5ER$8;394^(1I0ZN'C =0KO2\& ZV7?$8#=IX%"S*D03F.G"350.RWM M5G>.4VLJ3-_[4_Y"A4DKEU)64F&I.V178Z#AZ\+,!R&@\M@Z5,,,ZSZV=+7>7.FX7TC 0O]_!].G\LBO&S#7LT*Y-XCO6=K?1D M\))1SN+K8Z@LP5!PMU]X;3SA7M>YK$%.M /P&0QYLMWBEW__)<"O DLJ/QVP M\QI!C@A!2@&<*D3A4A L6,[J,4#';J-,:0OD0<3$94=?6D^14=P9#%@S.B M+^MAW9F+?/Y0+%>3<:7PR]CCLP)EQX9"12#NZ-/P>5N2ZJ]&$8 MGPGU)6: X DXHX;X8V 6E )][,,,9"S[@S>:JFOYJH9X/50O88,<$Z8D(QA MP8F5@EIOA=A// .NOI) 7<77S0"OA^][R !77*<6;JD3!Q#62$S\?I,'+*NB MW>#-YP88US+>UY4%E3*#H!56(ZZE\%A%N?>^72)R3*X!5D_LQN1J _G^6-=O M6WHF'):*QJ,N0LXYI+W<[PY TDZO<(?3 *TR=YIK3%]/$?W1-;_6\MO5=8&B M7AN*XM$=Q6T((<'E'G+C_M/U_DRZG&1H$^KH,0OJ0&?I6HP\-$@ C@ %K9.: M:J*!%Y;OHS$8TUC0?E]R@N7P<8 .O$'PL1E5]$?')WQ>2++Y8]SA)N/)]]&L7L9G MU4$#X(8+8ZU$& N!/+%HKP>6U[)T@,>?01"V)=T,@<&[7RX_C2;UCD-O#Q$ M($X #S&"3DAKD3=J[P&1M-/NS^^.G1F:Z(^+7XK5:KKQ="W/M#7?'"$@K 2U MVN 4J8>!P4KNPO0\ %+F.,$OHG=C#TQL0A$#.X9_VIQ;/\S&BV*T+&RQ_6_^ MX?SM<0,7*4E3<1WM;^R4!+*L;>:!,SIG<[^(QH]#.:PWHIXA[.^[:!RSCFJ? MC1^_+D:SY;;1<)DO?.:N?WK@0#3D!,4C>[O7Z.-J&,_F^77K4; MR[U9.C9@8 QYYBF61@/D*7$:[+<>S\V5)8'U=:?4H KZ(^@K(6JQ\=7300)C MN<,.:T*5L))I0DJY"?:9[9(N[1ZI&8J<9&2N&OH\T.^+,M4\QN^?"Q0)([Q$ M'$-IG10\[CP[6:%EMM-;HGY-QX[H=C[X_1'MPRQN1,5R59MISQ\,6'*+O'6. M(<-9-(<]$*6T7,@KB^#NG6@9V ]H1VWPXJ?FV($X2"" SB." 9!,"5AN RA: MSCE+8^W[GW>Q-+:KH/Y(_;%8;=U)C"!,=)6.2N$UU)$Q%%Y MZC1 Y 3>780;J]W[H<: 'Q(%,ZD7+$(.>P.BO-QJ:@&2Y7$/6:-S5L !IIFW M0XHSF%<3]].,>U6N,JOKT\=B]>J IHN[:%E\'?U\@W)M?EU J1"Z X(R !Q2 MR$$:#X:.0RTV/UQ[L'P3J^* %-2CRZB6P&\WISDV"SKZYB L)M%6LE1B[1$@ M7F"PQ5LC(5Q.@.E%N%/;-1/ZU%57<^-8\YM=Y10UV[;(^;60Q3.C M__/7]\GT_;4N4I)KK@%/5T":$4*$,E I;%,G*D,JS:QVL.BG=9$7D!DGXX). MI-:>1_:Z$@]#>:NWCRQ!P\20>O MK'!@2YJO5H6R'M276(728B4B7*F0E$$.2.J,+R74**NDZ0#)E*OFJE4HZZ%Z M#54H+3326 F$)''R::OAVQ:B\,NP:P@B1$)X0 M*D0\22@T1929.-/L?JH0;Z^L46.N MFD^RYBQ4^^%-T]VR$*#( TUP2I;5BF@13<:=S-#R*^L?T<>RE(_Z()C62+>L M.$D5IMQ1"0G4%%--]4YN(;#(20@9_+J5Q8,SNF75P[H:Q[):V?R?3V^PY^F/ M 7A(),0(6,G2@3;B44XWP8C/"0NZ-'+45>$\$\S7VK\<4[,-("_MD-)D7WEA MA-1<< T=0P(16%YH!/*H1R+8(!Q*-U8! V!W2>=3*FF3F*[MZ7_EZR';%'S4>KQ_6T]&JN#UTU7[2X59YC, 1E5Q3;UWZ M/RN-I':'@53"7]EAN DRS+N!NL<$BL=]L283Q;J?+R;%\L2&6&.40#F1'ANG M.<"("$[QWKJ2"F3581*/WZ8W:Z7J\7CB=WU^(-16L^B.0P5!4)##3D3 MI6FL*#97%MW:S8;:*.1]$:Q\Y9/GA>,/!@6%3VS9__+,:K>,HY8_5ZWIKUZ^S.6MP-C! 5-@PBYC12&F) G=A/;H>N+-6U M!6Z<7/2:0;ZS*+?2!M6/^W_^?5(LXO=_>_RM^%%,3RQ^U08(FCL&"$>"&07B MNP +RYL130E@&;P;8/V3;E:^5J#OG'B_%Z.$Q:;9RFLQ3KI(:HT3@)(."HL( M227@&<+"E4:(9MQ=67Y!TP0YQ+\6H._/.]Q&IV_!*$.*2Z*E$$);#_8WS!KZ MK$N(VB5VKF7U:P/Y_ECWE&G]L5B5U07LNO@Z?]:+"M8B8K4A@\ N)8< R6T\ MW%'L'2CQU\#A*XNZ:I@U)SG9BA)ZO#IKN/:8H(BG*L,VY6D39 UW9">W\0[F MW/T/,!BI:_+EXMUCC:>6^B1I)3$B"!$?@4V=?Z# >_DAR&D^,\" YJ[YU@3F M0RM[4.>S7T>+^V*EIM-=Y,6R[W()+U3T[%6C'"_^^$LIBQ>F6OT:?]E?%92- MIP\$$940.\!3<27J/:22Q!4L[I15IFH[J/93>$%XC7@\,T4\*-0>$>A=B8?F MYLHN7ONC4U9UAGI*&D3J1G:2$*:>:42<0H@2*1DG&I5(DM ?7X(%A$.A.,/*8Z: T4*5+VPX1^^(''55.,\$\S+*,CAL.*7"13&\ M$5HJ(/4>#FER'+$#]#>T09"FL.VOH-!YE:D(T$9YA@31#@EK!7"VE"[^\LH* M>O1AY9P)=7]$.K\R%60>*48L$\H:#?\_>V^ZY$:N9 F_R_< ,]@7L^\/UAJ- MJ4H:J:JOS2\8*S,RQ;X4F4TR55(__0 D@[EQ"09B8TAM?:NR,@,1P/$#P-WA M[K $NMU4$4#RL94YRQ5SUW-\ZXEO'ND($;,;THC[I3>_G7Z;WCY. M9N[[S>SQ=CJ___PE@JXGJ^+VX^3'YN!SYTU_4T)YI7\DL#?:Q]L/GB;JQ?QQ,[CE(HXFC3L._QE M3^!L+OV=W*R/#_>L7MO>1X-+Z0;.4B@$9QYKX2/..Y0I0SGWY U0H[DB5A^9 MC[U3H.N)]F*@5?2K8ZV"E%@1H)#@BDL] 6246DUX)QQF+'.0%EGZW@.0=Q5U^; MYU*](P?9UMEP=-EY]420SF$J 2&,(> HH.D>@EV_N5 CB>VL*:O7DJZ%69NR M_GTZGWY]_'I2VB^>"0YKI#U@!D$E!<,V51#<]=UYGN.D'J*\+Y78HAG<6I7Y MY/MYF3]_)B0?*K<<0(HALQ)!X.2N[\@8D'/F.2"/3",RS\!MO-6*"--8,0.1 M-I08882R)?>155D5_:Z^6E&&MZ(E_*^S6I&1R (N)$.*>,,=L_L]&4&45=Y^ M0/M2J]*O7*WH,JR[XI.9K+Y$JR_]*Z5,?YNDB.S56?OY5+-@%=<*8DE@RER4 M'CA=[@&( CFRJAT-2'S1&KA]%4NXN#+";G0PCLD*J' <%7,66VMVT< ":TIR M#*,!*4WM4:<16#L+&9M^3Q?8IDJ5%S#G1*M '*%,:$PI,I)IBJ4N3^4PQ#A' MYQ[@"4_S]&D.V^ZB?R8SMXK2.G^F_OK18(PBF@M&E&*,66,9W(](X:PDQP'Z MY9IG2R:@YRGRIB#C]G+??0K;B=**!Y\,SBN* 2#*$VP$U=[13,"P&H9AA*[72)(8ZS(,>G=_7%#YNSS_.1[X]U3]/E M=0+JQV)YD^1^?RH-L=X+@S4$ N>TBW@0B7G4_4K_&39Z;#&L#3/F+!];$$&- M??!MO_Y:?5PLUW>+V73QV@9XZMB'.S6+(IE/UIL2\65%M$-K8>/?")HXAY'U MFU(:S&@.3:D<$(;ER +UV^%EWU(96A& S6[S*XV_3MXU=\I@)[BW AB58OT) MA#YR3E,*K:WD:6D'U>O*:C._.E?TF'HZMW\XW*1ZHSN!_)4[&=UL!Q+Q-L_IG7K<^3- MXVK[I\WZ5H7G;7XV:!LW!0DM!MK :"U:QDR)-*59V2S#W[G[FQ(#DFE7L^=I M%5!?4\)S''R%:XY2Z;8_%[IXJNGVX5NQ_"..U4=I3&;_MY@L*\^DKKH0C(7 M:X($ 8QXZPQSN)0 %C3GE&R ONK!S*J!RK<1(W [_0\5E3U+_YS7!:$AE,QC M!(6U<4.F<2?>;\54C2S M7*O]O9N[[S?%*FIX!_7 &E,B\QL!X[BW>>9,W/>88X(KRDL, M#88Y\1L#/!09X%SH5H ]; _?'YZ;0F6B79W5O\J;@L7&660EIC(21'CB =OA MP9'P.;;O &\&&B"AVQ!3#^;L:O7X]6$S'_]:%;=UK-%3;PB*.TDYEB?K]MW\^8W5]9TGU=X8I*#$&""-=1XY M1)B7J,0'0#ZR>SB&2-\6Q34(.I]T[#1"[^I?",H:(9B'1$'..&54*%7BYZS( M2@<$O_A>C^^MR:^;0_-OQ?RQV/U+_W#SV]\GRW]'_;[O4O>[+OG(BK)P0"J? M81Y7ZPCNLL+1=\4W!$L3^_ME ML;7(/MSM1G2N#OVI9H&KN @[CI6T@"H,7+JV<#=::;,L[0&>4S?.@=>!7LU! M7<.3_S1;C^2/OGXD\+CYDFBC>Z+BBY!'W)M=ES#61HU+^LU(9]$(EEGB/9JJ M^?:A0% JUFLE,5IQIE*D-2F[!2$920W)^M(X(,Y:R-40Z, M)"WY5D\7#R]^M^W0B?R$RUX1-,+2"0TEL5HKPA2(NL=N2 :8D:SV.;)<=()L M#;*8+\7774__SC+C9,M@C8>1.T3T^1*0$ J8/<31$F:$&R@E=Z4!0Q02 M.4(?4#!!(T)O&LQ:FOVWZ7*Q^?!FETF7;\Q7<:DYRX1*+8/QRC*CA3%>8BU2 MKW$Y $= SCH_H./T1MC0!J"=I0X>MF_?5\E5/=,T&"+B\F>(-:F,&K)6H%*_ M)5$#&EOP=I.>@I8P[JXTPDF?V;YL<8H#66W.++_7]\(>>EO00 .*.+$\[L5 M>4HAV<\VS,9V-69C-'E39Z%MZ/LXHOA4W*=2P3_-\82+Q@3WW!CBJ7*2LV1_ M F<VR@"G?N,:4 M>3RVX@:-B/WU(7B# '=&IFT7SU:Z?/%<(#Y=F2B- "J5(T'("[09"^':R6HW ME5\/61J2ZVNV9"!:PZ!^/[TK/M],B_E-D=QUZN%A-BU*V_"$.5VA73#6* = MU$IHP2#GC.!-YPW BLM*&_ 5T:&>X!;M(9KG05?SV]^*^>)KLN@K^<[?- AQ MJ;3(8:>5)B(NE(@2L^EN7# !1B.[9#:7 U"6<>_NC4?S'*Q6D683OE4#ST9 M9-P#I>8211IR8(W!8KO>61D-+Y!S8#J@$Y*F9-T$AC5U@4K5]_=[VV_%XGXY M>?B2SG!.W+UR]/D@-+6(V70E,I2.*>8=W&E-7%N=LPD,< UH5(%L$MA6R;*= M#,][>%1Q//E\L(0*P4"$"#J!%&<2XMV87*JD.PZ-H2&Y+II'M$V6J&B7QXX= M5R;>/A2HI@ 9*:P20 A-%-)@LR!J0*-E/Q*#HB$)+AJ"L4T2N,?EXN'TM4W/ M'PD.<:()E<88;;'"A%N:>HY!7$(QSKD%<4"[1_,$R "QU35@-9U\G-RDG/'3 MR\#KYP*!2%!$%!26Q?]Q!MQF[\0IN(#Q'#5B0.IE"RM!)I)C.)%5U@&JE7+. M>>#2(FC-%C=/A1M=X9\V?)@-8_SSG,@21HW #)HXTX0TBGO&-K@8QP@"8[O& MMS&:-' B>QGTW9_(E@/9Y7W^1(EC3D@N610(--(0C&#+6;$O;3;\5VS))?RXG\]6TO&?\!*7JO3!0BBE'DAFM$ZP" MIAL<(6<4>P(QRJD%-T#JU:7&H@>LA\O$L^>Z=5\9O+4*. $DMYX"YA"!("+D M)2?IHI.1L;%M&F6SMI94NK/Y8F^7ZYS>)HWHW7P['%W< M+9:%FM^JNRC2/Q%_/ MQK%CS\2G(DV?:+C&>189_C5Q_JF4X'E3ZW3[8!26V%O"M?=,2Z 8);$_UF 6 M_W-T$3@9PC_L;V@4WJZH== D2Z4G_RA.&>^GF@5IM8[_8PP8Q!&/ ^71DI/: M*P(55CF)!4->C/*)U""J??+G_73R]W0V7?^XD$#[=H%@%<]UE@6 M.:R[6[YY4:"6Q:5<,JXQ<-)1*:"(: @ B!:"Y*QR TI,[WKCS,6YO^7NU>*M MYK=[[?+VV^8X<5/J\V&QFAZ\;K2A-P<$L7 :0V^\,!1"(?D&+ZF8U]$VRN#E M ,NUM[H9=,919?_Y[.S[E!6OE>\-0+ MA%/JJ,84*\6QU1ML#:$2B)RDQP$6=^]JL>U('%U1?>,#GVWE>_N?C]O[??WC M_";]9C+[<_$I3M7E>CJ_-X_+Y.+^$4W^#W=_3KY?; @U_:D *#)I0_,>2P"< M%@K)#:*>TA01ED'P 99_;Y#@/4MB$,MX;1<0! PBCCG22$DK+60RS6/DM74Z MZO!?2FB/V,'?IYP5P( Q5$.6&G#A%-"VQ1];P0E1&M4:39TFG61 M58@(<4Z9C.8HXH1A**SV;C-:#8 &YB>=^Y4Y<$DAHLN@;C.QZ^-R#3J5 ?9Q[?)Q^7)8>LS(;B00Z:SJ 0,D33-"732*:0?L M2/ZK70>/7\QP\OE@/&<^;F$ /8Y]5D'Q)-\D;[E1C:8-6J* MO)O'U>_Q:PGVB9HB!Y\,!DF#+;?$*A173@$45K&#WBDE#! CN72E(2$MFL2R MAK#_6,Q??7DRO]W<\75"[N<:!4R%C0:M(!J+5"R>@?C_FVX;G7S=XP@\:IH" M#<,ZAB1@((1QUG EN90N&D@1SBV($!G!$4KM0_$&$69$I!!$/^/F\C)>_Q^5'SVQ_H5&9?C;<%Y2#&%AO$&<,>.6>I!S!E(EINI!E)5:6NN-B^!+K8 MELJKFM]-_V,R>]R*=7[[?QXGL^G=C[2IWMQL;G!N:JNJY#@ZW943NU/UQH$R M8YVC%!'JK!;,VU3,$U))O-&1 (UM3-5J*>YOS#[=_:=+ND\M$IEO#%Q980RS MD%)!E*,6>5%BXR#HM![CMV+Y]Z)%^[MINBSZ$,&05HJ&#_@&LV ("%/"EC<0 MRY0*H25%&XE0"K@UE5+"NQKQ,T8=.=.[^!V!:@"8\5Y*P2D25C".R_$SG7O) M4&\3N[)8%]T UY4Z^C2&V6SQ3QEG_"G*9_FM6*63^C-U:ZJ]('BHHTHEH5!2 M,N24IL+N1@^=%IDEDKJF36W9+CH ;QC4.5MDIDKSP+RC1FOK$+%88VD9+JO M>.B9=B4.'J+, HQ]\.=2 9]E3U/@M1E"4'4U/G565.L]@5D&D:;>8"%@5, E M)V*' 2) 91X<7=N^U06&72U&OR^^;6*SW\U/3[A/B]G,+Y;_3):G$CIKO"U M1SSP&FLAL">2*>S*.9RRK$=R,-0R9Q9=RV$8ZM6N;&QM_6K7/@A#K16& ZTX M5![8: +MQRYQIR%5717F:)4C%VEK]:0P# ::+Y/E?50:%F:Q2LYN]_VAF)], M9*OUOB YM$RYB _4*?]/&:Q*; 2W.=EJ%Q]7M.F%'!X[FY'(,-AJBQ1>%?]: MWY?Q](H C,!&1;W8[5RQG)+2?GZ1BT:#>1;3BQ(^78)>]6/^]"^\DGP>$;E1L$N9^9[.;KZ?K' MOZ:WQ3-S>3&_?S_]5MQNW79]YU0V.>>5,)@9"[1@&&'%M8M"L=109J'@LM(& MU](H]\?YKSO_3%KZQ^Z/9V\2N?QMP40S$4,5]1\#!95<1PMQAPVF$:EQ^(V: MH\CK%:%UR-MTA3=W-R]%SD" @$.*DZ@8<6U\.2;.P,A2=5N5>J4K>R_#NU4. M-79E+T$,*.\DAM8XAN.0I"S'E#X\#@XU)-=*5_9>AF@UEJQ*FJR*F_]QO_CV M/S=^]^6/Q!1>_D=QCD^4(& MI:$V)+9%)H =2/Q_?SPA\?_],0"AF."6P*@P6^N@QD#M.DSB9!A) 'D[\KX8 MO@[D;=T)>5L7H)*0*&2K=\\%11%4E,@@ +:6XN,]:CLF-19Q:P'5#N]6;GFX]B5(_J$FON^ MRIU$%9H'HPBBG%@*@>0<2^LUWXT\76LQDOS\+DV(%N'OBGA_+.8WF_*7ZZU; MZ@3)7C\:K %>(4,\P-@X0($ENAR1%F-W;>0)>=$HML/QJ3#)5\H9>)X3I\H8I)R*TB M5D=%3V-%C2WC490D,#/78"C4:DBNE7RAER$Z %^H\D)2Z39Q(,1*JPSR98>] MXIU2H#]?:&6QO?6%7@9@!Q(W?YR0N/DC(*6)(=))3@!6-F[6NB2\YKJ:(C=\ M"[@=>5\,7X>^,0:4L,P(@12$6'@I29G[I)%T.3=_7XW/\U*YYN,X@,,-*I3& M0!J#B#!&VZCVE%%]VG!?J5+5M3M%ZT[HB^$;P.&&QY0"Y01"V@) L*"B3('3 M%F>Y, =THV,[\KX8OAH+>(.&S"FW=SL?"A&'B*DE%'B:RL9(1%D)CS(XY^+& M :D' S W!R&_KCSLKP:U\X^N4HTS]SV*>3Z9E:7(3E6]R7E=H,:8* AD&$?8 M&RN1*3=VX['*V2<'9.WV3:M%YY+JBL/]U^4%VINXOTDDL5%2<&D)*'%)_QP' M@[NA3@.U>B\31S_'4Q^7B[OI>E?4<4SG45991*DW.@524X:8T\1K*@"R5/)J MI?Y:.DU^3';DA[L/#\5RDOJ\&\/)8^5C;8(GDEBB/*#6:F\!LX:5XXQJ[$A\ MM,V)^_69Z&.1!"@:X%$W) !BGNI9E[@(K7,T%'PU MM&D?N,X(51Z;E==@\AW'/=YMO[BB^<"YX!L8DNPM2E G4I4+L&,:3N2N(B&Y7HX9K,6 MHC4\H^^G=\7GFVF1RA-,YK?JX6$V+6Y_GRS_?:J*8J5V@4$$':4*0R%IG"S6 MB'*QCNLV'&<0UJ6"6[2': TZV.GD?KY8K:(('IQH$IAUE MT>ZF3FM /.,0[N< 86!D%V;E$J!!*&M(7FT=%V:Y6*TB3"=$?O#)@*S3&'E& MH,,,$D-3#;)M![FR+%/-')NLF\"PAI!+?6:QGLQ.2/CM8X$S#3Q%A@"B+#3, M>++O&B4Z1T$D0Q52-@QCRM+17!GBJ+?I8AOEF4(&[T>>E^C?> W;7K3\YD$< M 'VVONKW<96JX1@^^9Y@,28. @L!-$H9!*R!)1:29]T@-5SML"%Z5.=>-O _ MSU$>3C?8$F"Y-U()A: 6>_0M=6.S7MOA3 -G>)?)H2M^[D\KWLUO8M<3.B?X M=^#IX#1#TC%%TT7,@#+HXQ"WXQ($T$X]_WU486N'8?E(=\4@6T09W4Q?E%0\ M0)WGCP4CHO8.#'?8NZBG>J-XJ6\*9E!.=OW%5M5X.),!<6(EY[$)=$L MOJ:*R>=H<[A!T#CA8PVP&!E$F$!(EJ.C6.>X8 84B=PM?1J!NI_8DT_%S6)^ M,YUMN9\NO4U()Y>R@B2"3G*%I!6*5-IPQWHJ MK-.-Z2(=IG*J/:'"<;S#QF$I!GDG5KZ@&S@5O@RX[JRG]72Y.8SZ.)O,*]RX M=[A!0()NE"9,==2:H$6.\G)T6LBQ'=FT*?\WEE #@/='I[,GP<>:!*F%85Y: MZ!03SF%B)2A'&%6OG"2X 5(J5\QG65,+U:YX\S$J0TG7BGV-FL3==%[ M?UB?O9#O7-,080- 4^X-M@011Y$H)YYWG(]L:$#=VW:7C_T@^';A)GBP M=0"2.4"(-HQCJ0DP\8?]/'-N)!?VM<"#2QA6"^O.'(&+KT4*\TC]/KLOOGTX ML(B* QIIX8EC EB1#DJ[%Q.MO&U,>A2.;]V!.:"VYEBM5P\%,OUC]31S2UJ M__4X?=C$'OZH8.Q5:!TT,-)0:K#PW FAE!%V.VX%I,IR" PQ?J?#K;!Y]'MG M726+L$+K((CFEEE//730(Z>#,(8R\DLB7VD"Z ML\_F5*T?X/K4D%Q/9C1Q1Z4M7+'"MTLEP7#N59KON0N2,&1D!ZHFJ M6@C[95!V&MV,==QO0=P0(99(&(8M5L >6I\2MLA@R MSJ!T ECB-5=EYZG-\@(.T?3)E'[SB X@SOE]4V'RSE&C@=?"4"$//BY4^\,"@ B))6,."=!=A2AW8G0"J=+8ZD:%8[ MA*G.QN8D4%^3F6X^/8N?3K@LMCU:S ^7'CS3)C !M1".>&L@17'-]]CL.LVQ M)2,[AV];LJ^5H89@[VHM4[?_^;A:IX[[Q5)]31C]][D(TZ-M@B!QOE%EN*&> M$BD -KHL(K7DEEKSXGZ22NB-A6%-H]\5PTH7@EE\_7LZWXKUYK\> MIZOI-@YUEJ1DHJUX2N6J_I*@B"$",,L\-59)Y[&$)0I,BFYJ;;_DX)CHUYHD M:NR.?RXG\]5^M)/9QV6J2GBD(N^QAP,#G J& 1&:4DFH)7P_;;CV.0GKU1W$ MXR-,8XAWM5"]^_HPF2X3-!_NWD59SN^GT<#97G>VST_[;;&X_6340R] Z?F-5@_*"6?COW3_EL307?"/"Y3ZMGFO/%4/%S-5P9+<,1!.B,M- 1B[74)OM".Y00$B)]^ MQ^U(*D/D[>=BO9YM3LU/;M%U7QE G,K,(6: H>D&: D1+A$R)BLP3_[:R+N2 M2QTG\$/*49_%D3[,II/Y3>S686_)L4<#L58SJZB5),XOBH&UY8F[Q"ZK)AL$ M/_OFW!#J]4\']@/\L/Y2+/>9W7%PZ4S$+Y;[T3[EON^/[DT*HYY-;Y-(3ATG M-/:18*B15#$.C4/2400P0R4L1N*L2)I?!Q"]":HS-\W\6['U?V]1BW9]$=EP MZGSU6), $+88*ZZM$E8CSXDGY0@=45D)%,.-]^G,^](,[-T1:]L]]SV5\CA5 M9^'5D\$IXURZZ YXA:C3ELK]1"$PKX)=W3.'T6ROS8#>676PM.C^L9@O7B)P MGE.G&P8=YPI&*BH3GG"#B#)0EJ/E F3%'U]7_9XVN-4H^-VM5^7XRZIZT_EC MVO?W,0>ZB*@5V^?^G'PO5K]/YXOE=/VCG$MJ?OOR+['^LKA]6KY/ MN6$Z[$7P@$%#4X2IA9!+YJSB^REO;-;E%)7G4Z2!0EJ705YS=UTMU\]H&/_K-073G=9/UF_LY<9/SA M0&VJ\(.,4E!;Z(W!!I6C\ M2HJ!='&'W([(,XQ&4MRH"9&>9$;*L8J\XZ%A M5I7N8.EI _EAYSE+2@C2%D.J+$ :&0]5.1;"\TRLX:P_#S0 @".&*XU87#4Q MY$9ONRN ]#3''AKN 4EM C0(90W)Y][<9I,[DUIO&.=60B.\@F4',1&I+.3LFN RIS#SN&>(-06;S: G>EYCW^O M*MH/+Y\,%G)F&#*<"N\8IA8Q7(['LBQ?UQ#G>Y?V0A;2/3#GO)7P^MD #142 M:^6A276 M )4[&<#86-3#>M*]#@S:N'8 ST4KMPT&:^P MCK.*&6,-\;2 MW9BA)UEW2 YQ*^IGY6D$^T'P[9+5Z:@O$ O(&#>6Q<$C%R&E&)3C-F1TIFQS M/+B$8;6P'D#=EO=-E?T12F/M' )1PR2.,6%LN2] Y7R._WZ(Z9Q=KFS-P]] MR/7+>[12)[;Q I5"J8\U#MQA*)SRQ!D7NXYY-";+85C.QE9MLE')'HV';@CM M5DAC)JLO:GZ;_I5"9KY-9D?"KNJ_+'#D+:)&>$H)$QH(0U0Y3 IAI]>.CIA4 MC:#?"LD^+HN'R?2V+JW*YB$J#4ARX[73-,*GD2=\-Q3DA>[T+M(1$ZDFWJU0 MYW0LZ(5O",D1+J*RR:GR!J=JL+:<"XACDZ.*#]'\ZXM ]2%OA4/O%_/[/XOE MU[@XEJE)15P>HTY8EU,GWABLD]I QA7G$3[(C7"E6P4AFG60/41%O"^.-2>" M5CBWZ5.61O[L#8%C9K$3# INC;?*2KD?D (B)XVV>BF5\7.J/N1=>1*.,NKE M X$P2;@G& .$%+; ,4KWO8<^)R:K>DV4ZR9,%J*=U=:9_-ALLW\N-K7PEL71 M0BTG.%/])0$0;Z,% 7RT*%1*@+-X/RLP)#G^@>LJ89+/J]90[R=IY<\7^M15 MIZDH8 "E'$K&M%4.,@JW$HVS'T;0JY"\[305-U]/US_^-;TMGLG@4_&MF#\6 MF_RG"/UR/IF9Q]5Z\37.%/TC\NOV\6:= H0^%\MOTYMB53V1I<'O!<(9Y H: MZP2F$=SDJ"_QC8OKR,N'7TZSHZDN_0FES8R&71<_+'<=/)$*<^C1X('#"D1C M$R@JA"2$,K$;"=$,927%#Y!>_;)AT:@P.J#5\[&>S)0Y^GPP'%+(#$>"&4L1 MQUKPXR4ZZ:Z_4^VHG4MMF:=N+'.KDM&SC+;E.2YG:X? MH_#L=%G;]P4U3L20+=[_ [-65U4%>*HT]G:.^GWXK;+1[ZQV]%NBCCX0RJ10$K(2JIS M.R.VT]7-;+&*"^F'N^==?WX_T]/@]F<@%5:8S#<'!RGFU%LJA;2.4N:)*S'C M (ZMP%)#!'I=J[Q3(?2W8JC9A@#%[>$_[^HS]EZ;K:7EQ7LD+-"< ^:DU(@I MN2V21ST43E0*V&W] .SKPVSQHRAV7IZ38MP8&D]%]3\6R^EBR]4+#L":^UZ@ M2FCHL(1:*VZM]="C$E^":$YT!NQI0:E,F>.'6;T!W)5BKB>S5*/_\Y>BB';N M=AAG,AJ/-0G<&ZY31CC%QD%+@&:Z'*%Q;FR)&OVRY/7-6\T(I4_:G4UL/-XH MQ$&":.]Z*I071%J)J=B-$D6+8&2%!O.%78$]M9#MBC\IFGL>13@MCA?S.?IL M ()*I0R(.T/$Q;MT,TTYIJAT9EVZ<1ULN52X!RXSR(&T.YJD^LO[PF85-[@3 MK0*3TF$!C$PE"J#CC.%R?49&@IQS]B$>$ UJCVM.+CWS[^Q.=[)=,!$D!.* MI;1:646T\.58*<\J0S; Y:L1J5=C4BU\N^)2FD ?[CY/9A6VO#?/!B %X@1) M KB1B%HA%=Z-"6-N1E;*LB'Y+II%M;MSZU41OY42;VWQK9@M-A';.__06>Y4 M:!VX-=&@%L@:KQ$W5OC]"HX]L3G''P/5W6TV_E13'G5ZF+WA.D,2EBB1/&/2/)(TQ9B87@(F<%&V"B=3N< M:Q/QSMA78K*/TE WL?/3=31&REM**I8./_V&@+ VW$. ,7!Q(D*H%2S';Y#( M"=H>(..&I>NW(Z..BRL=Z'O5"N1'FP;@J#6"4Q<57*X9,US3_:P$:B21WJWQ MX' AI:;@[BP6O)$I^KY*A'BS7PI<.T"]15P@P)DS5IKR4(9@0#++7?P,2V._ M$NF*X95/]?]^?JI?X9PY[\6!&FLLL0HQ"J EA$I%2K2%$RH%=)R@$UN.GD#=Z7%'%T&Y79'E=5&&-J31 MF<9Z9F:GN.399+6:WDVWOW@W]]/Y9'XSG+'K2TA<#5-X:[8BD!' : M?_*T=%,3S7!F;-?P-H"^Z-F*HIXKSOX"5OUDNOR/R>RQ4*O5X]>']*O^KPYN M*3R5.^H(EM1P25@D"0-PYW]P'%)6R2O3=GCJD2$LEY/Y_9;R^L>;0&GUSV1Y M>\'EPGG?"%*I=!NE58H:)IF620G;X6@HRCRG["4,M3(UCB?3=@IJORKGYK^ON# L/Z\7-__^L%E!4B6J.%SWO5C>3%?%QV5<63\E',XY_9O_ M6D 4, 6YC9N#YE@JP4OUR7%G\$CNI^V1CY74SBYE> 5SX^TXSY\Y-/^U(#@P M4CKG#64TV1B8NA)7B56G.F=?J4T=,;.Y6=*0-.M4KVVRTP">N@RPC2\%0HGF MVFJG ;'*4<6!V@$D%* C"T#OE6*+(4FR=ZJCSJB.RJ W2HDR#G@B/(988Z9% M"1!$/BZ)#L[ =S81/&39XS7%\\%:YD46$MOG"0F6D^:HW(L!)C,Z-NQ&H\Y M&/9\"E>=)O0U./Y5$=$ M.79*E2F6&NKA^_7#PPF=[NG/ 6,F%'-* 0@,<UM>4.0<@:* M=03ZY\>/GS[_=4JFSY\(#AGKXQ(+$1+$0,N)]&6'@,RZNN-J].ON"9$A@BM. MW :<8^*@XI9QBDU4(9D<=W)VH)8*Z/=RSCD,MJ\=)\B MZA3R9F0W/S0B]8N2M2_#=S"&W+%)][[*W>O9+P]:>!SG,8/Y6-SHI^NYAQP+%.JGDS'-+,FWP%%YR&5.;DR [15AWWS*HET\;.VFN.Y6-1+--K)O-MH]7F2/5? MTU5A%I$ZL\V[C^EUO?4E,.H1D)X0A3623A%&RH &C;3.-&NN\""A^:ES+<*] MRKTI9:ZF%!^_6'Y:*K#>I\3P+Q0B+M,$J10\YSKGT9 MVJ$!578:@I4(Y()D72 !+-?<['"4E69%3U^,%NIA4K>6E72:.80?E M <4$ 913@3@6%FD(6#D6&[$=&;6ZY\#)<+[+T!^,;G@%X7R>*X!@)<)HI= P,M" ',ZXTVMU$(9D.KO$:H]-H"5FH]"-BOL[!I/+GJC7(90 MNB)>:1@7MYL>_S6?KE>G(APKM0N."Z6!LYA+Z2B04!!9CC4=O?QD#OXN"=BD M8 :C1_8<302QC_@(0!4B%G!GM [U(S!:+27XO1E^W0NLAK'42\6^H^/RYLO ML3-I#I_PAE5H%9!DS&@-&'**6FXX\*CL.)%95T]!U4S#WZV*^%4>QO"E.%JQL[Z/!&(ZE5<9C*VC\#RE1 MN3>FFP4KW?<\?)VB]0DP!.$,?OW_XS$I_SM][EF1@386_F/?"MPKZSCD#&!, M&.$^HEMB"F76V=3%-F&;L2N#7/,;DDIG3$_(O5NM'HM;^[BPXH-*D'5C:*>PVO@KJ_7Q;W40N/R*RG M-].'R7R]NEG,U\OIWX^;Z*7UPGW^^/&@3M.CD]G;L+3Z 6#-?#?N%2RBK"REG%F"F4KY4SNL M-1G=K>7=.\V&*,:.<@BVBT=:-#:.[6+Y=?7A;O-S8ZD!QS\1J-)*1B2L1DX: MC85GI: L$HYVZ2<;=,1_LP3+2@9H3)R#WQ1>F97?)M-9.OCQB^5OL6TK^\&9 M3P;IL7=&*!J-!BT)O./_]CE*$SOOZQ7 M.Q?DY/[LL4S3WPL(:18-'*\H05IIE-(A=M@Z'E>GGRQJH[^)T[-D![_M/!_K MUFZ'K9@>;S\35 J^@4080A$"%&@&RY,!)P3-.;<8\F)/X\^G3@U" MJ%UR_MT\;5G3;\7S=LF4VFUF'^Y^GRS_7:PW1[?-SH*+/AVX,EAZB2TPAB;G M25P^2@BIYSEE[RYVH?Z:%P,1Y)@YA\;C>U/RO1_NW[PG.<,DD)99K M&_$FCI,R_<=)0'**#O-?'&Z P]DR:X60VSTEGY!OWA,41%Q3( @ES *J%0![ M,R7^ F<04OPB9!.$S)59&X2,"_?=8OEU$A?VC>?UK99?CZ#GWQLXIP1* S Q MG !G-3?[[<$#F7/N)'\1M@'"-B[#_JJ!_+&8IXX76\U>W40=9KK^\83C6&N# M. 45H +PE54Q$PD1K+7)<04$20J>5P&YK]R__481?=N'D?XN$FC^;#^4BS_ M_#*9;S,&5U'6WS:R_K28S?QB>>2TL9^.! :(EP3$6:,1I-(Y+54I$4FRTDO[ MNL.Z,LF:"_4[!;9]"$Q+@06DGA!A).8"Q4UB)P/A72;[ M+]OS'[:AE.O).<*Z\IS6^6FS=,9BD9)_GI3LRO MGGH2/+'2>L$]UM8918@"I@18 Y&SUPTHW>I*9MAUD.#Z-[PA^EZH 4X0;#U* MH5F*,([=7NF@(B?O\>*HBZWOQB.6T4DIA2X D%B$%O=Y(CEJ)1G3A_IGOG5+G^Z;[S=25+'N%4WQ\].ERWN\&^N%QO5I/ MYK?3^?VKT;COQ?)FNBNI_+$\&6EV&M?L1)"606&9BZLI)< AIUE)%4HARRFA M-;!#HY]K7G;#AZZ4Z'VMRF+Y+7;W: [0MZ<T)O[JU/@4FNH56$"T?C#UA@4,9W4BMA3A6O014+ M;SD]Y5H$F'/_SJFA_35?[KO\>DBK#T\CWZY^^T$\N[QM.[Q7"\MV+?EPM\,C M/7=PJQM8'X.WD'I$'?28 16M"@S+TWV*1-;=0A<;H%N@? M+[3>38V&L6:&&9E:C[F5=JDRBU^O2 MD)#N:F=_NJ_V^_24X?CBN2 9X=QHYZF1F$@HI#+0>>NP0]ADU9D:T%U_0R/& MHCF1#$9QK'&19L"@MMA"[JC"!@KF&=PAZQ0'9EQDK\FJ2W6\]@71 MN9OO]?WP5=QP;^Z41UXKC(4FFC@) 4!8LCA&1S05V/H<"V. 9.N7)L=<:YE" MZ7=MK;T9G5$ 6OA:0,)39R105@'B/3$EP!!ZW-<>0/*51@SU>M)\BK5]??E=:==:>S[#P9+.3,,:0,-BS\; MS2#?+R34Y50GQ+]LU>XEU&4=B5>C.&@0M5(KXH(/!R(GCH8RZ]^FR @F&L)#;862.0Q427 MBZE 0N3L2(.J4/0SS:8\&5_E;"HOP'Z6UG(^4:.C'@3#G30*0"&Q$#QJ+^FZ MU'(UD]4B[H9O_O],,ZPQ87*?7UVABLY-QOY[ M&+CA"&,O5%PG 3,I!Z?T\ @%L\+N!I7M<0W3]>KH,,[I_**)+NZG\P25GLQ2 MIO;9.^0'TLW@D;(46 BI UQ[CP@K0Y8EMG T=W+_FMAM<6(P ;UGC)?W_8@>":BRB.PL%X@1HTG M I7X>^!SKNN]^,+S7^;KH(1]E?KNVU$/S7RMW\-@''4$R#NHR^&N8KE='AW%.YQ=-.C-7+^Q6T% @IRD W$>3!%J%(N=VDA)&YL2^ MR%^[[""G;18#^IVK%>2U&_,S%%[J]9?/Q"8^&J(%H:2%VFF& 431A$"E?UX" MA+.NA0"_=LC,J=:#B.M4T9JOI^L?9K98Q3UW ]8&F(-Q94>>#90[EBZ-DLQ% M-1LAPVDYVQ5@61G/@SIX'UPP6#,"Z:&.Z+OY[XMY\>,9\8_>,=?>QX*0)L5B M2^JCE>@L5Q:4+E.E/NYQZ%:+0Q!K2" MTCJ,J30:EL%PRFJ:]B-2K#WU^Y4/U/J[N-!:.VB&NB< MHX9#J3TRH(21:)5S>'1%&;4#HFMCVUE+%!C,]G:T*LNQ\9]R+N3L:HUV)"#N M+8 Z:AD"ED7G^/+?5[P9&?007FI2A#:!EB1,E MUM!G%:&\(KMMN%-O2-*_^ML;3LRRUKX9A% < .0 I\Y[+H7TFYIHT NO+SXM9C._6*8_MABX>?B# 7@.E1$>"ZD 9H 284N$FMBTC0<&=D(PH.Q6ZL/]NCI16O?"M1#2P $GC@/$2/0(U=BBIC,*89YL3MH M>ZG9Y_5DN1[F1MT0/=N;+;6$VME$2;MM4N2+6_NXC+W=VL-;A?ZY;EZ:Q"<7 M\8M?%FUKIQ 0PAGJE4FGF9SO4"&$\,RZKQ6I+K=4GV_\^MS- M;G+Z:-!HZ:" PAM!!1884;!?D!S/R=8?K:7>$*/;VVP:E/A@9MQ(XS24TH9; MK3B1J4P2E\VHO N*[<4C\M//N2FG0PTQ\MJM_+$WP%M-1CG\N$.8DLQ;XYG$>X%ZD%.Q_YJLR;K\ M'J24NO+ /.DHQZ[8J6(/5UG?&_Y2"KKF@B@>]2EB"7:"I"LXMWAR0T92][OE M-;U?H73F9FSM%JF+])JV/AZBR*UV'!H5U7CBM=61##O4.Z@JSL.;#YT* MKAL/W&*Y3N4M;?'W^N7G.W6Y[7JA%\OEXI_I_+Y:9-'15D%ZAH46%DGKC%40 M,KB-_XWT(TA4JE71\E@3XI4TRH,- L" <42,!@P +:D'A)0CU#BKQN5 W5P- M2/O-D7 #T'8^34T4RW3M)S?365R,U/S63!ZFZ\GL?1&7J_ZS$)N>R@(*YQC7 MP %NA?(6&@<=-G!CIT39!.^V\8$AR8!S& M@@++]N-T64DF+68!-B"W13L(=>93BU/R22-0WZ>GZE*\?3@8S &Q2E,BH35: M,F%$.2H"7$YTT(!N8&U0NJ^=6KF0]D.4/R9?"[M(M<8KT^6I25 JW;&C@=51 MC_02."UT.4)OQ,A(DR/BDVRIC6@=R[683Q?+/Q;K8A7_PG\OC@=X''HR**^, M$9Y1Q9F(I@WE%.TZJ GFE?+PKU7D=>2T:!+.KM:(0\OCF2WE6)- C#?06LLT M9( ;J2DNIXB.TR6G7M\ RX,UO[$T!&R?U'F?U/[EV6WF7--H8"'B$>2068V1 M Y1H68X86MUI3$4_5+I,\!68E(%O5XRZ:!DZ %?4_056CFG"-"= Q 6Z7&*- MUYB-Z\RV^04H&])^B')VN3GT>+ &8@$8-0QXSBF%G);F8IQSW28IM4^6'-&> M9$DM-'O=HLJRTI?N3_MRU$923:GFSL1%E*"XE')>CA48GA/F3ZYGL6@2HUZU MW?/>PE/-@@;*^F@,$I+B"JF20MERI%B:G(S@UMQH#(P(; NW0-+RS4\[NLLIU3[E9A"V-A& MCL2.5B70T38!,(TLP1I2Y:D6J6IOJ=!;&>$<5]!G*P1J"MP^E:&GW-,^0@)"62EK"L4Z2+ RNOE%3-P]PGO7Z??)]^?7PZS3>3A_B7 M]8\+>7;L-8'%T3.@*(@+M,:82R;I#@G' >LT MY^MGBQ+G=1)!WX"4S'?@=4TRIT= MASR+Q_SP]VQZORU64L&S>:9ET(YKP*'5)B+(':$2E>>$SBJ4X]R\$C,RGU7- M8MPSI\SC,B%Y.:5V#0,2W'I"C(L8C=:3909V=EYKLA/9 )G(ELC*O3= M/ )6K-:?)NOB\S^3AP_S9[/Q2,A-A58AX@J1XIX*1A@$@$$O=QTWCN9F$PR- M$LW(<-$6O$WSXFB$3:5V 1CBI#+664WBCB:N%ZS1UK#UN-"K&:M2H MA6]N*#D"54/)RR?CL#UEU#G!A 56J6B?H[*#C.#,"\>NA "7"NMP/'E-3/LY M\8Z?/A/%>?#Y *+"J@RB%DA/&"9*"5Z.S4,SMHNFF]Q,F@2V-]*@\TB(X M08DVS")',$=QQ:XM**_)!MB? MGU35YIX.7)0@&'."'8(66A%_(F8W.L]TUN'3 $/0VK<"ZB+;SS:=[E]-]S&< MBSL[T2I$[=0"IPFG@'G)E3!*[L?)QK99YPK[Y(:= VP_!/*3FV(;&U*9/4]- M@DYN?4B\4%:X^!.SS)8C-(#!#.H,<*=JE3JU4>V'-Y^*VV);;/OCT]UQB?:5 M:73T#8$RAH@4Q$3M!U.FXQR2'L%4I0]' $975;I%5C4%QAD ++&$LO0C>QNUA)%I1\U2J3%<:YBCD:XW M"?3[J.H]+8U1[=NK^"]WW>+0+>MU7A.\YH0@0P!%PG(7C76BMD-#@!.>HU / M,/R^(YF&;CV9)X]/^J,XMO.M.9PS0TMLU-6^17%\*U9IL--YZLR1%:ABRP"8HP #*X2GEFLH M*,3[Q1;X'**(T1*E'7!KL"/NGYOK#,M=]>G[SSNXS_?X7\7M_?/N'N1-YCL# M]41Q*0E61D&/I4XE ,L%6&>52)4C9E2WL-?@VF4=4JM5L5ZI]?[O![F6^"*T=,QH0B.)*O!^T=%FQM&#$9.L6]V&XHMS\V%YY4?L@ ?:*">L(\(X;"OYLCO%F,.[,"S59SG[L"Q.4-NSSRS@.>:&.-@H4$Z$8 M--',!<"E&G RFBK6Q-4;*6FRF#1^/WECP-;8"S??7I;?7MRM-M^>IQ/FZ?QF M]I@R:1_V?W\HXKY^,"^_YIN"$]8*KZFS4E($)+'WA MW:#=+)VR6?1V.-I"+A7C"#%-D4",1-L51CLV]BK9LCGD&:_WNU60:W!&W=P4 MLV*9=+C)USC"Z7]OA+&XF^XTNO2GU3^3A_MCV2<7O2%8&/G/I1 <8VN!AO'_ MXY;,%#:4(IP5#C!F!WB;*'>E^*AG'?]PYZ/E,+])E4O25>$JJFS3U4TR6D^% M*55]1>"61WV/0P\),%AYP)6.",3]G-NH#V;5?!R_8[PEF/MRD]\L4Y)VG$++ MQR=3]0(/^<'V@2FI,*",I=KPE $.<1J[PA8!SGU.> K\^;SC36#<%;^>5Y6K M9+T=;A"HT$HKB;Q!T'OAJ("N]'\HAK.N=QFOV[Q14#LIO)"ND/ZRF$7!K+:W MB;[L0Y=7];WI2CH[KW);W\F&P1%.L?>,,6XJ%YK+QSL^%,M M@4K7<59]1T@0"*^\40)J+; $3)4X4.=SCN.'>4-G0[1X'3/=$N#]S/:XJ3U^ M?9PEW7US=W"Z@'A9?"GFJ^FW(NY\BZ_]7^&93J2W#K!MA](5HV^[66FAN.A- MJ9"O=%1R2*PR%AC+K8"6@BA3A"BI-&-:QN1LG987#P:'/"5"",>E4RSN:2;N M1+L12>M&DFG?NKS?+ D9(-=4#%?+]3.ZQ/]Z397XJZB&K,JN'4F!/?!40!HX M8W4TFP""TBNKHQ6U[3^.:N[8LJ1K"F_1%( =$>!H3NO!YX(QG#B%B4- .69 MIWLU?V\GV5O+LW#P>=UD=L4BU+*>+:B!"6Y:AT M7"\S6#'$X[R\I:$Q'#MS@IY7!M\O5BN_6!;3^_FVFN#-CS^7D_EJMA7G[7\^ MKM:;;-8B!?A,OI_RES;_M> ,Y=XXK^,<\U(@X4PY=P5S=JSZ30UBO?:J]BZ, M@9'<%G<1U%M=S.,/ZX_ISW&0\VV;CXNH,1;KZ7*#_L=91*$YPM?]<@ $:N,4 M80HI9;ABEJL=WM)(:SM9G.66_//B/HUS9/3O2#0#FPIF^U#\G?DRF=\7JW?S M.+#?HI:S61*B7,QD]<7/%O]LHNI6[NZNN&EP!\C[?E"$<("1H RG K?4"5YR M0EK@-$2MED423OFZJD[96K"4R!"!:94>D<0A.@(D7).282! M=8KS[: H0L[E1&4/,3BD6<*T 7$_9W][=>W7(>")0Z%HN#%M%-0B[A((<8:X MAL9I1JE4K-IE!KWJJ.>.""]Y3;!60"0TEQ0")RD2PN,2#1_UII$ZV)KF2CW5 MM8X(.C]9V*TM<02+>5H-SU7X/M4NH*BD]H)H1E*&--6((N88DI:E5=]+"E <^]AXE%"E587N+X"4,S/E"X()A'X5M'-80&DMX MJG@7\4.I\!W+N59O@.?VK5&T0QD,D,-_S7?I75LC.*DB31+XZ.L#QT!3H*#3 M0&/N,2!RBQQV3GB4$[D\P!.D.<(?OUE)N%/K.J+?MX8&^G[\^ZTS3X#Q6G#%&K +6$'&<>0\\)B58Z%Q MB^A2E^LB"ZW5E:HIF%NES*Y;?\U7#\7-]&X:%=%3J0A'GX_SBV# 4]$(XQQC MG#L%RC%!I[)* @UGU6E IHOFT;R6! 6GO-<28!(53:N0=-#*W:@TR8N!':#^ MW:T:5!?E\*>:8^=P!0PZC!]DH3U8[N#MSDJM@%O M=_6+;F:3U6H_ U+^0(7]81OAN][6V*U"P4:_$XBE2', .3,$( \@$WJ/I#5.U3#$-8+>NODVF\""($".),I:KD!O@XG\OQ IAU,'8=&0%MK)"7 M SL$(E6P:BKIUMHC T4ZJ)%Q/S *ETZ&30S+B=2X#J2"=J@5$UTQV\X \V\ M3%7PM0,81;7#6K[#PU"6Y0V^.!/AH:S/?RV,:Q?LKLAWHJ3 ^6#^\XT# L*E M"SL8LI9:C!W>TZ\Y-R4(C-0 MRTXO)N_*G]@DW3HH;G*9B(:@(1X:7D1U6\'BX&!S73D97PS$6<&T9" 5X-68 M,&/WLN8H*PU^@'[(%LD_# %=TP1X[9-X&OW&._'!O/NTRP7]ZV$Q_SR9%1^6 M[Z?_]3B]W3S>U:QIJIL!*4H1 ]8J@IVPP#/Q)$GN1W;K_,"G6D]2'>K\?+W^ M-#NM#KP]"E]AH3!R6 &BM")2N+WP,>^F_LK+*EI__DR3(E\F?7/Y\EVUU"H_ MIO#[^(?U>CG]^W&=PC;^7&S#G&NPOI5^!$@@!0P1KAGBF"/!77GX;KDW.;?7 M#-#GW,/$&(+8?IGJ5>U S9SQDD%*.8..,8=T&?1K#XGR?][MW\& 9',PWWVE\%UVE'/0C2$,08]PQK:[6G MD+ RSC22PXN,"3+$R]*;\[\.4T ]3I#SB\/14:N[*/K3FT,['PR.0@\-$YQI M8HWW'+GRT,52KK)N8JMI3GSLR*,[. *?GV#=2[QO8^4M",='N)RNIO-[^[A, M 8R5(ZU:_G+0.F),%69<,*<=I@SO-5N?=Z?- #W%0Y]4PY)VW[,K::O/+RQ] MZ\T[643\>:I^5'K/BZ^F;ZS++@;D!298"VO*3DLH?<]W2HI$:NC6D1&C&Q#7P[4.L@XX\K$'R A$A-? MX@V$R EXK.X]_S7)!BKO7\Z5RTQMII@S@D-O/ 2*(P+<'EVD9< M*VW[X(<^K08A[VOQY9?%UKKTWA_]9J!$:JV(%9I@892#\<>] BY-5I4-,#Q_ MRH <]DW)9.B[R+,;%%K<.@Y\)1@"0<2,62"4@4"2IPHJCDN+3+?#%3D;=L*WW*/ !>;(6 LT580SDLHX[^3CC1I;&/?PYMIU MR'T(\_)\X.V%GLXWPJPY/=OO6+!">0,]D)Q%:CG%N"N]0%XQ-;("R]-CV?C*_7:2G'E[T_N]M[Q]2[R?/CB$6=_-BG5JOCUR) MUNH7@S?8 \,LTPA&M4-10V$)F/,BQ^\P2E=Y]\Z4-&]\E[=J#/\ M\L\&!!UD$DBC*2:"6:Z?%AU$LFY-&6 <^7!FT "%^\MA<7;IBY_F+^*L7^ZER&M!I=XJO-?'KP" MAMA4^!!H*0 #0NXW92]0CKH%!U3YN067=.?@#RQQR&P?BK_;7W;[;(U(!I29 MK+[XV>*?S14CJVU41'.I1'G?#Y9YEK 7"ED J">R#"5F0&N<$RTP6']UEY2M MEW[4J5#[-C$.B>,9_@V[HS.^%JSRW#-/*/ 66DP]=JK$-6JA.;O$ %W-/4Z3 M_H77]Z2HYI=[,?KVO<"'/Q?3PZG MG:(=N9\,%F*,"(51QY30>J,D<27"7&:I00/TJPYP'G0LP5\6=Y/&&3!,(FNU MS^-S_B./9"O;S>G'S[R^+6:3%:GN%[N8WGXJ'Q^7-E\FJB/OH>C*=K5YV MK?B^+N:WQ>W_U\4U;*][^,=B753P]IYN�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htm IDEA: XBRL DOCUMENT v3.19.3.a.u2
GOODWILL AND OTHER INTANGIBLE ASSETS Amortization Expense and Future Amortization Expense (Details) - USD ($)
$ in Millions
 12 Months Ended
Oct. 31, 2019
Oct. 31, 2018
Oct. 31, 2017
Amortization Expense, Maturity Schedule [Abstract]      
Amortization of intangible assets during the period $ 128 $ 110 $ 120
Future amortization expense for 2020 186    
Future amortization expense for 2021 172    
Future amortization expense for 2022 150    
Future amortization expense for 2023 107    
Future amortization expense for 2024 86    
Future amortization thereafter $ 291    

XML 35 R71.htm IDEA: XBRL DOCUMENT v3.19.3.a.u2
INCOME TAXES INCOME TAXES - Deferred Taxes and other (Details) - USD ($)
$ in Millions
Oct. 31, 2019
Oct. 31, 2018
Components of Deferred Tax Assets    
Intangibles $ 131 $ 0
Property, plant and equipment 0 8
Pension benefits and retiree medical benefits 71 49
Employee benefits, other than retirement 34 34
Net operating loss, capital loss and credit carryforwards 195 185
Share-based compensation 32 31
Deferred revenue 38 38
Other 35 19
Subtotal 536 364
Tax valuation allowance (134) (135)
Total deferred tax assets 402 229
Components of Deferred Tax Liabilities    
Intangibles 0 (112)
Property, plant and equipment (16) 0
Unremmitted earnings of foreign subsidiaries   10
Other (7) (21)
Subtotal (23) (133)
Long Term Deferred Tax Assets And Liabilities [Abstract]    
Long-term deferred tax assets (included within other assets) 410 165
Long-term deferred tax liabilities (included within other long-term liabilities) (31) (69)
Total $ 379 $ 96
XML 36 R75.htm IDEA: XBRL DOCUMENT v3.19.3.a.u2
NET INCOME (LOSS) PER SHARE (Details) - USD ($)
shares in Millions, $ in Millions
 12 Months Ended
Oct. 31, 2019
Oct. 31, 2018
Oct. 31, 2017
Numerator:      
Net income $ 1,071 $ 316 $ 684
Denominator:      
Basic weighted average shares 314 321 322
Potential common shares - stock options and other employeee stock plans 4 4 4
Diluted weighted average shares 318 325 326
Share-based awards issued      
Total number of share-based awards issued (in shares) 2 2 3
XML 37 R85.htm IDEA: XBRL DOCUMENT v3.19.3.a.u2
DERIVATIVES (Details)
$ in Millions
 12 Months Ended
Sep. 15, 2016
USD ($)
Oct. 20, 2014
USD ($)
Oct. 31, 2019
USD ($)
contracts
Oct. 31, 2018
USD ($)
Oct. 31, 2017
USD ($)
Aug. 01, 2019
USD ($)
Feb. 01, 2016
USD ($)
Jul. 01, 2012
USD ($)
Aug. 09, 2011
USD ($)
contracts
Jul. 13, 2010
USD ($)
Oct. 24, 2007
USD ($)
Terminated Interest Rate Swaps                      
Notional Amount of Terminated Interest Rate Swaps $ 10                    
Derivative Instruments and Hedging Activities Disclosure [Abstract]                      
interest rate swap payments $ 10   $ 6 $ 0 $ 0            
Derivative, Net Liability Position, Aggregate Fair Value     $ 2                
Derivative Contracts [Abstract]                      
Number Of Foreign Exchange Forward Contracts Designated As Cash Flow Hedge | contracts     261                
Number Of Foreign Exchange Forward Contracts Not Designated As Hedges | contracts     205                
Senior Notes 2022 [Member] | Treasury Lock [Member]                      
Derivative Instruments and Hedging Activities Disclosure [Abstract]                      
Derivative, Notional Amount               $ 400      
Remaining gain loss to be amortized on derivative     $ 1                
Senior Notes 2020 [Member]                      
Terminated Interest Rate Swaps                      
Notional Amount of Terminated Interest Rate Swaps                 $ 500    
Asset value of terminated interest rate swaps                 $ 34    
Senior Notes 2026 [Member] | Treasury Lock [Member] | Cash Flow Hedges                      
Derivative Instruments and Hedging Activities Disclosure [Abstract]                      
Derivative, Notional Amount             $ 300        
Remaining gain loss to be amortized on derivative     7                
Senior Notes 2029 [Member] | Treasury Lock [Member]                      
Derivative Instruments and Hedging Activities Disclosure [Abstract]                      
Derivative, Notional Amount           $ 250          
Remaining gain loss to be amortized on derivative     $ 6                
Senior Notes 2020 [Member]                      
Terminated Interest Rate Swaps                      
Number of Interest Rate Swap Contracts Designated as Fair Value Hedges Terminated | contracts                 5    
Debt Instrument, Face Amount                 $ 500 $ 500  
Senior Notes 2017 [Member]                      
Terminated Interest Rate Swaps                      
Extinguishment of Debt, Amount   $ 500                  
Debt Instrument, Face Amount                     $ 600
XML 38 R14.htm IDEA: XBRL DOCUMENT v3.19.3.a.u2
SHARE-BASED COMPENSATION
 12 Months Ended
Oct. 31, 2019
Share-based Payment Arrangement, Noncash Expense [Abstract]  
SHARE-BASED COMPENSATION SHARE-BASED COMPENSATION

Agilent accounts for share-based awards in accordance with the provisions of the accounting guidance which requires the measurement and recognition of compensation expense for all share-based payment awards made to our employees and directors including employee stock option awards, restricted stock units, employee stock purchases made under our ESPP and performance share awards granted to selected members of our senior management under the LTPP based on estimated fair values.

Description of Share-Based Plans

Employee Stock Purchase Plan.    Effective November 1, 2000, we adopted the ESPP. The ESPP allows eligible employees to contribute up to ten percent of their base compensation to purchase shares of our common stock at 85 percent of the closing market price at purchase date. Currently, there are 75 million shares authorized for issuance in connection with the ESPP.

Under our ESPP, employees purchased 603,488 shares for $37 million in 2019, 558,116 shares for $32 million in 2018 and 618,270 shares for $26 million in 2017. As of October 31, 2019, the number of shares of common stock authorized and available for issuance under our ESPP was 26,055,571. This excludes the number of shares of common stock to be issued to participants in consideration of the aggregate participant contributions totaling $20 million as of October 31, 2019.

Incentive Compensation Plans.    On November 15, 2017 and March 21, 2018, the Board of Directors and the stockholders, respectively, approved the Agilent Technologies, Inc. 2018 Stock Plan (the "2018 Plan") which amends, including renaming and extending the term of, the Agilent Technologies, Inc. 2009 Stock Plan (the "2009 Plan"). The 2009 plan replaced the Agilent Technologies, Inc. Amended and Restated 1999 Stock Plan and 1999 Non-Employee Director Stock Plan. The 2018 Plan provides for the grant of awards in the form of stock options, stock appreciation rights ("SARs"), restricted stock, restricted stock units ("RSUs"), performance shares and performance units with performance-based conditions on vesting or exercisability, and cash awards. The 2018 Plan has a term of ten years. As of October 31, 2019, 28,676,526 shares were available for future awards under the 2018 Stock Plan.

Stock options under the 2018 Stock Plan may be either "incentive stock options", as defined in Section 422 of the Internal Revenue Code, or non-statutory. Options were granted prior to November 1, 2015 and generally vest at a rate of 25 percent per year over a period of four years from the date of grant with a maximum contractual term of ten years. The exercise price for stock options is generally not less than 100 percent of the fair market value of our common stock on the date the stock award is granted. Agilent issues new shares of common stock when employee stock options are exercised.

Effective November 1, 2003, the Compensation Committee of the Board of Directors approved the LTPP, which is a performance stock award program administered under the 2018 Stock Plan, for the company's executive officers and other key employees. Participants in this program are entitled to receive unrestricted shares of the company's stock after the end of a three-year period, if specified performance targets are met. Certain LTPP awards are generally designed to meet the criteria of a performance award with the performance metrics and peer group comparison based on the Total Stockholders’ Return (“TSR”) set at the beginning of the performance period. Effective November 1, 2015, the Compensation Committee of the Board of Directors approved another type of performance stock award, for the company's executive officers and other key employees. Participants in this program are also entitled to receive unrestricted shares of the company's stock after the end of a three-year period, if specified performance targets over the three-year period are met. The performance target for grants made in 2016 were based on Operating Margin (“OM”) and the performance grants made in 2017, 2018 and 2019 were based on Earnings Per Share ("EPS"). In the case of LTPP-OM, the performance targets for all the three years of performance period were set at the time of grant. The performance targets for LTPP-EPS grants for year 2 and year 3 of the performance period are set in the first quarter of year 2 and year 3, respectively. All LTPP awards granted after November 1, 2015, are subject to a one-year post-vest holding period.

Based on the performance metrics the final LTPP award may vary from zero to 200 percent of the target award. The maximum contractual term for awards under the LTPP program is three years and the maximum award value for awards granted in 2017 and 2016 cannot exceed 300 percent of the grant date target value. We consider the dilutive impact of these programs in our diluted net income per share calculation only to the extent that the performance conditions are expected to be met.

We also issue restricted stock units under our share-based plans. The estimated fair value of the restricted stock unit awards granted under the Stock Plans is determined based on the market price of Agilent's common stock on the date of grant adjusted for expected dividend yield. Restricted stock units generally vest, with some exceptions, at a rate of 25 percent per year over a period of four years from the date of grant. All restricted stock units granted to our executives after November 1, 2015, are subject to a one-year post-vest holding period.

Impact of Share-based Compensation Awards

We have recognized compensation expense based on the estimated grant date fair value method under the authoritative guidance. For all share-based awards we have recognized compensation expense using a straight-line amortization method. As the guidance requires that share-based compensation expense be based on awards that are ultimately expected to vest, estimated share-based compensation has been reduced for estimated forfeitures.

The impact on our results for share-based compensation was as follows:

 
Years Ended October 31,
 
2019
 
2018
 
2017
 
(in millions)
Cost of products and services
$
18

 
$
16

 
$
15

Research and development
7

 
7

 
6

Selling, general and administrative
47

 
48

 
40

Total share-based compensation expense
$
72

 
$
71

 
$
61



At October 31, 2019 and 2018 there was no share-based compensation capitalized within inventory.

Valuation Assumptions

For all periods presented, shares granted under the LTPP (TSR) were valued using a Monte Carlo simulation. The ESPP allows eligible employees to purchase shares of our common stock at 85 percent of the fair market value at the purchase date.

The estimated fair value of restricted stock unit awards, LTPP (OM) and LTPP (EPS) was determined based on the market price of Agilent's common stock on the date of grant adjusted for expected dividend yield and as appropriate, a discount related to the one-year post vesting. The compensation cost for LTPP (OM) and LTPP (EPS) awards reflect the cost of awards that are probable to vest at the end of the performance period.

The following assumptions were used to estimate the fair value of awards granted.

 
Years Ended October 31,
 
2019
 
2018
 
2017
LTPP:
 
 
 
 
 
Volatility of Agilent shares
22%
 
21%
 
23%
Volatility of selected peer-company shares
15%-66%
 
14%-66%
 
15%-63%
Pair-wise correlation with selected peers
30%
 
32%
 
36%
 
 
 
 
 
 
Post-vest restriction discount for all executive awards
5.0%
 
4.8%
 
5.3%


Shares granted under the LTPP (TSR) were valued using a Monte Carlo simulation model. The Monte Carlo simulation fair value model requires the use of highly subjective and complex assumptions, including the price volatility of the underlying stock. For LTPP (TSR) grants in 2017 and thereafter, we used our own historical stock price volatility.

All LTPP awards granted to our executives have a one-year post-vest holding restriction. The estimated discount associated with post-vest holding restrictions is calculated using the Finnerty model. The model calculates the potential lost value if the employee were able to sell the shares during the lack of marketability period, instead of being required to hold the shares.


Share-Based Payment Award Activity

Employee Stock Options

The following table summarizes employee stock option award activity of our employees and directors for 2019.

 
Options
Outstanding
 
Weighted
Average
Exercise Price
 
(in thousands)
 
 
Outstanding at October 31, 2018
1,997

 
$
35

Exercised
(552
)
 
$
33

Forfeited
—

 
$
—

Outstanding at October 31, 2019
1,445

 
$
36


The options outstanding and exercisable for equity share-based payment awards at October 31, 2019 were as follows:

 
Options Outstanding
 
Options Exercisable
Range of
Exercise Prices
Number
Outstanding
 
Weighted
Average
Remaining
Contractual
Life
 
Weighted
Average
Exercise
Price
 
Aggregate
Intrinsic
Value
 
Number
Exercisable
 
Weighted
Average
Remaining
Contractual
Life
 
Weighted
Average
Exercise
Price
 
Aggregate
Intrinsic
Value
 
(in thousands)
 
(in years)
 
 
 
(in thousands)
 
(in thousands)
 
(in years)
 
 
 
(in thousands)
$25.01 - 30
483

 
2.5
 
$
26

 
23,769

 
483

 
2.5
 
$
26

 
23,769

$30.01 - 40
296

 
4.1
 
$
39

 
10,845

 
296

 
4.1
 
$
39

 
10,845

$40.01 - over
666

 
5.0
 
$
41

 
23,211

 
666

 
5.0
 
$
41

 
23,211

 
1,445

 
4.0
 
$
36

 
$
57,825

 
1,445

 
4.0
 
$
36

 
$
57,825



The aggregate intrinsic value in the table above represents the total pre-tax intrinsic value, based on the company's closing stock price of $75.75 at October 31, 2019, which would have been received by award holders had all award holders exercised their awards that were in-the-money as of that date. The total number of in-the-money awards exercisable at October 31, 2019 was approximately 1.4 million.

The following table summarizes the aggregate intrinsic value of options exercised in 2019, 2018 and 2017:

 
Aggregate
Intrinsic Value
 
Weighted
Average
Exercise
Price
 
(in thousands)
 
 
Options exercised in fiscal 2017
$
36,175

 
$
30

Options exercised in fiscal 2018
$
28,417

 
$
32

Options exercised in fiscal 2019
$
24,409

 
$
33



As of October 31, 2019, the unrecognized share-based compensation costs for outstanding stock option awards, net of expected forfeitures, was zero. The amount of cash received from the exercise of share-based awards granted was $54 million in 2019, $56 million in 2018 and $66 million in 2017.

Non-Vested Awards

The following table summarizes non-vested award activity in 2019 primarily for our LTPP and restricted stock unit awards.
 
Shares
 
Weighted
Average
Grant Price
 
(in thousands)
 
 
Non-vested at October 31, 2018
3,181

 
$
57

Granted
1,309

 
$
68

Vested
(1,530
)
 
$
45

Forfeited
(78
)
 
$
60

Change in LTPP shares in the year due to exceeding performance targets
291

 
$
—

Non-vested at October 31, 2019
3,173

 
$
60



As of October 31, 2019, the unrecognized share-based compensation costs for non-vested restricted stock awards, net of expected forfeitures, was approximately $94 million which is expected to be amortized over a weighted average period of 2.2 years. The total fair value of restricted stock awards vested was $69 million for 2019, $58 million for 2018 and $42 million for 2017.
XML 39 R10.htm IDEA: XBRL DOCUMENT v3.19.3.a.u2
OVERVIEW AND SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES
 12 Months Ended
Oct. 31, 2019
Accounting Policies [Abstract]  
OVERVIEW AND SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES OVERVIEW AND SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES

Overview.    Agilent Technologies, Inc. ("we", "Agilent" or the "company"), incorporated in Delaware in May 1999, is a global leader in life sciences, diagnostics and applied chemical markets, providing application focused solutions that include instruments, software, services and consumables for the entire laboratory workflow.

Basis of Presentation.    The accompanying consolidated financial statements have been prepared by us pursuant to the rules and regulations of the U.S. Securities and Exchange Commission ("SEC") and is in conformity with U.S. generally accepted accounting principles ("GAAP"). Our fiscal year end is October 31. Unless otherwise stated, all years and dates refer to our fiscal year.

Principles of Consolidation.    The consolidated financial statements include the accounts of the company and our wholly- and majority-owned subsidiaries. All significant intercompany accounts and transactions have been eliminated.

Use of Estimates.    The preparation of financial statements in accordance with U.S. GAAP requires management to make estimates and assumptions that affect the amounts reported in our consolidated financial statements and accompanying notes. Management bases its estimates on historical experience and various other assumptions believed to be reasonable. Although these estimates are based on management's best knowledge of current events and actions that may impact the company in the future, actual results may be different from the estimates. Our critical accounting policies are those that affect our financial statements materially and involve difficult, subjective or complex judgments by management. Those policies are revenue recognition, valuation of goodwill and purchased intangible assets, inventory valuation, retirement and post-retirement plan assumptions and accounting for income taxes.

Retirement of Treasury Shares. Upon the formal retirement of treasury shares, we deduct the par value of the retired treasury shares from common stock and allocate the excess of cost over par as a deduction to additional paid-in capital, based on the pro-rata portion of additional paid-in-capital, and the remaining excess as a deduction to retained earnings. All retired treasury shares revert to the status of authorized but unissued shares.

Revenue Recognition.    We enter into contracts to sell products, services or combinations of products and services. Products may include hardware or software and services may include one-time service events or services performed over time.

We derive revenue primarily from the sale of analytical and diagnostics products and services. A performance obligation is a promise in a contract to transfer a distinct product or service to a customer and is the unit of account under Accounting Standard Codification Topic 606, Revenue from Contracts with Customers (“ASC 606’’). See also Note 2, "New Accounting Pronouncements" and Note 4, "Revenue" for additional information on revenue recognition.

Revenue is recognized when control of the promised products or services is transferred to our customers and the performance obligation is fulfilled in an amount that reflects the consideration that we expect to be entitled in exchange for those products or services, the transaction price. For equipment, consumables, and most software licenses, control transfers to the customer at a point in time. We use present right to payment, legal title, physical possession of the asset, and risks and rewards of ownership as indicators to determine the transfer of control to the customer. Where acceptance is not a formality, the customer must have documented their acceptance of the product or service. For products that include installation, if the installation meets the criteria to be considered a separate performance obligation, product revenue is recognized when control has passed to the customer, and recognition of installation revenue occurs once completed. Product revenue, including sales to resellers and distributors is reduced for provisions for warranties, returns, and other adjustments in the period the related sales are recorded.

Service revenue includes extended warranty, customer and software support including: Software as a Service, post contract support, consulting including companion diagnostics, and training and education. Instrument service contracts and software maintenance contracts are typically annual contracts, which are billed at the beginning of the contract or maintenance period. Revenue for these contracts is recognized on a straight-line basis to revenue over the service period, as a time-based measure of progress best reflects our performance in satisfying this obligation. There are no deferred costs associated with the service contract, as the cost of the service is recorded when the service is performed. Service calls not included in a support contract are recognized to revenue at the time a service is performed.

We have sales from standalone software. These arrangements typically include software licenses and maintenance contracts, both of which we have determined are distinct performance obligations. We determine the amount of the transaction price to allocate to the license and maintenance contract based on the relative standalone selling price of each performance obligation. Software license revenue is recognized at the point in time when control has been transferred to the customer. The revenue allocated to the software maintenance contract is recognized on a straight-line basis over the maintenance period, which is the contractual term of the contract, as a time-based measure of progress best reflects our performance in satisfying this obligation. Unspecified rights to software upgrades are typically sold as part of the maintenance contract on a when-and-if-available basis.

Our multiple-element arrangements are generally comprised of a combination of instruments, installation or other start-up services, and/or software, and/or support or services. Hardware and software elements are typically delivered at the same time and revenue is recognized when control passes to the customer. Service revenue is deferred and recognized over the contractual period or as services are rendered and accepted by the customer. Our arrangements generally do not include any provisions for cancellation, termination, or refunds that would significantly impact recognized revenue.

For contracts with multiple performance obligations, we allocate the consideration to which we expect to be entitled to each performance obligation based on relative standalone selling prices and recognize the related revenue when or as control of each individual performance obligation is transferred to customers. We estimate the standalone selling price by calculating the average historical selling price of our products and services per country for each performance obligation. Standalone selling prices are determined for each distinct good or service in the contract and then we allocate the transaction price in proportion to those standalone selling prices by performance obligations.

A portion of our revenue relates to lease arrangements. Standalone lease arrangements are outside the scope of ASC 606 and are therefore accounted for in accordance with ASC 840, Leases. Each of these contracts is evaluated as a lease arrangement, either as an operating lease or a sales-type capital lease using the current lease classification guidance.

Deferred Revenue.    Contract liabilities (deferred revenue) primarily relate to multiple element arrangements for which billing has occurred but transfer of control of all elements (performance obligations) to the customer has either partially or not occurred at the balance sheet date. This includes cash received from customers for products and related installation and services in advance of the transfer of control. Contract liabilities are classified as either in current liabilities in deferred revenue or long-term in other long-term liabilities in the consolidated balance sheet based on the timing of when we expect to complete our performance obligation.

Accounts Receivable, net.    Trade accounts receivable are recorded at the invoiced amount and do not bear interest. Such accounts receivable have been reduced by an allowance for doubtful accounts, which is our best estimate of the amount of probable credit losses in our existing accounts receivable. We determine the allowance based on customer specific experience and the aging of such receivables, among other factors. The allowance for doubtful accounts as of October 31, 2019 and 2018 was not material. We do not have any off-balance-sheet credit exposure related to our customers. Accounts receivable are also recorded net of estimated product returns which are not material.

Shipping and Handling Costs.  Our shipping and handling costs charged to customers are included in net revenue, and the associated expense is recorded in cost of products for all periods presented.

Inventory.    Inventory is valued at standard cost, which approximates actual cost computed on a first-in, first-out basis, not in excess of market value. We assess the valuation of our inventory on a periodic basis and make adjustments to the value for estimated excess and obsolete inventory based on estimates about future demand. The excess balance determined by this analysis becomes the basis for our excess inventory charge. Our excess inventory review process includes analysis of sales forecasts, managing product rollovers and working with manufacturing to maximize recovery of excess inventory.

Acquisitions. Agilent accounts for the acquisition of a business using the acquisition method of accounting and we allocate the fair value of the purchase price to the tangible assets acquired, liabilities assumed, and intangible assets acquired, including in-process research and development (“IPR&D”), based on their estimated fair values. The excess value of the cost of an acquired business over the fair value of the assets acquired and liabilities assumed is recognized as goodwill. The fair value of IPR&D is initially capitalized as an intangible asset with an indefinite life. When an IPR&D project is completed, the IPR&D is reclassified as an amortizable purchased intangible asset and amortized to costs of revenues over the asset’s estimated useful life.

Our determination of the fair value of the intangible assets acquired involves the use of significant estimates and assumptions. Specifically, our determination of the fair value of the developed product technology and IPR&D acquired involve significant estimates and assumptions related to revenue growth rates and discount rates. Our determination of the fair value of customer
relationships acquired involved significant estimates and assumptions related to revenue growth rates, discount rates, and customer attrition rates. Our determination of the fair value of the tradename acquired involved the use of significant estimates and assumptions related to revenue growth rates, royalty rates and discount rates. The company believes that the fair value assigned to the assets acquired and liabilities assumed are based on reasonable assumptions and estimates that marketplace participants would use. Actual results could differ materially from these estimates.

Goodwill and Purchased Intangible Assets. Under the authoritative guidance we have the option to perform a qualitative assessment to determine whether further impairment testing is necessary. The accounting standard gives an entity the option to first assess qualitative factors to determine whether performing the two-step test is necessary. If an entity believes, as a result of its qualitative assessment, that it is more-likely-than-not (i.e. greater than 50% chance) that the fair value of a reporting unit is less than its carrying amount, the quantitative impairment test will be required. Otherwise, no further testing will be required.

The guidance includes examples of events and circumstances that might indicate that a reporting unit's fair value is less than its carrying amount. These include macro-economic conditions such as deterioration in the entity's operating environment or industry or market considerations; entity-specific events such as increasing costs, declining financial performance, or loss of key personnel; or other events such as an expectation that a reporting unit will be sold or a sustained decrease in the stock price on either an absolute basis or relative to peers.

If it is determined, as a result of the qualitative assessment, that it is more-likely-than-not that the fair value of a reporting unit is less than its carrying amount, the provisions of authoritative guidance require that we perform a two-step impairment test on goodwill. In the first step, we compare the fair value of each reporting unit to its carrying value. The second step (if necessary) measures the amount of impairment by applying fair-value-based tests to the individual assets and liabilities within each reporting unit. As defined in the authoritative guidance, a reporting unit is an operating segment, or one level below an operating segment. We aggregate components of an operating segment that have similar economic characteristics into our reporting units.

In fiscal year 2019, we assessed goodwill impairment for our three reporting units which consisted of three segments: life sciences and applied markets, diagnostics and genomics and Agilent CrossLab. We performed a qualitative test for goodwill impairment of the three reporting units, as of September 30, 2019, our annual impairment test date. Based on the results of our qualitative testing, we believe that it is more-likely-than-not that the fair value of each reporting unit is greater than its respective carrying value. Each quarter we review the events and circumstances to determine if goodwill impairment is indicated. There was no impairment of goodwill during the years ended October 31, 2019, 2018 and 2017.

Purchased intangible assets consist primarily of acquired developed technologies, proprietary know-how, trademarks, and customer relationships and are amortized using the best estimate of the asset's useful life that reflect the pattern in which the economic benefits are consumed or used up or a straight-line method ranging from 6 months to 15 years. IPR&D is initially capitalized at fair value as an intangible asset with an indefinite life and assessed for impairment thereafter. When the IPR&D project is complete, it is reclassified as an amortizable purchased intangible asset and is amortized over its estimated useful life. If an IPR&D project is abandoned, Agilent will record a charge for the value of the related intangible asset to Agilent's consolidated statement of operations in the period it is abandoned.

Agilent's indefinite-lived intangible assets are IPR&D intangible assets. The accounting guidance allows a qualitative approach for testing indefinite-lived intangible assets for impairment, similar to the issued impairment testing guidance for goodwill and allows the option to first assess qualitative factors (events and circumstances) that could have affected the significant inputs used in determining the fair value of the indefinite-lived intangible asset to determine whether it is more-likely-than-not (i.e. greater than 50% chance) that the indefinite-lived intangible asset is impaired. An organization may choose to bypass the qualitative assessment for any indefinite-lived intangible asset in any period and proceed directly to calculating its fair value. We performed a qualitative test for impairment of indefinite-lived intangible assets as of September 30, 2019. Based on the results of our qualitative testing, we believe that it is more-likely-than-not that the fair value of these indefinite-lived intangible assets is greater than their respective carrying values. Each quarter we review the events and circumstances to determine if impairment of indefinite-lived intangible asset is indicated. During the year ended October 31, 2019, 2018 and 2017 there were no impairments of indefinite-lived intangible assets.

Share-Based Compensation.    For the years ended 2019, 2018 and 2017, we accounted for share-based awards made to our employees and directors including employee stock option awards, restricted stock units, employee stock purchases made under our Employee Stock Purchase Plan ("ESPP") and performance share awards under Agilent Technologies, Inc. Long-Term Performance Program ("LTPP") using the estimated grant date fair value method of accounting. Under the fair value method, we recorded compensation expense for all share-based awards of $72 million in 2019, $71 million in 2018 and $61 million in 2017. See Note 5, "Share-based Compensation" for additional information.

Retirement and Post-Retirement Plans. Substantially all of our employees are covered under various defined benefit and/or defined contribution retirement plans. Additionally, we sponsor post-retirement health care benefits for our eligible U.S. employees. Assumptions used to determine the benefit obligations and the expense for these plans are derived annually. See Note 14, “Retirement plans and post-retirement pension plans” for additional information.

Taxes on Income.    Income tax expense or benefit is based on income or loss before taxes. Deferred tax assets and liabilities are recognized principally for the expected tax consequences of temporary differences between the tax bases of assets and liabilities and their reported amounts. See Note 6, "Income Taxes" for more information.

Warranty.    Our standard warranty terms typically extend for one year from the date of delivery. We accrue for standard warranty costs based on historical trends in warranty charges as a percentage of net product revenue. The accrual is reviewed regularly and periodically adjusted to reflect changes in warranty cost estimates. Estimated warranty charges are recorded within cost of products at the time products are sold. See Note 15, "Guarantees".

Advertising.    Advertising costs are generally expensed as incurred and amounted to $36 million in 2019, $41 million in 2018 and $38 million in 2017.

Research and Development.    Costs related to research, design and development of our products are charged to research and development expense as they are incurred.

Sales Taxes.    Sales taxes collected from customers and remitted to governmental authorities are not included in our revenue.

Net Income Per Share.    Basic net income per share is computed by dividing net income - the numerator - by the weighted average number of common shares outstanding - the denominator - during the period excluding the dilutive effect of stock options and other employee stock plans. Diluted net income per share gives effect to all potential common shares outstanding during the period unless the effect is anti-dilutive. The dilutive effect of share-based awards is reflected in diluted net income per share by application of the treasury stock method, which includes consideration of unamortized share-based compensation expense and the dilutive effect of in-the-money options and non-vested restricted stock units. Under the treasury stock method, the amount the employee must pay for exercising stock options and unamortized share-based compensation expense are assumed proceeds to be used to repurchase hypothetical shares. See Note 7, "Net Income Per Share".

Cash, Cash Equivalents and Short-Term Investments.  We classify investments as cash equivalents if their original or remaining maturity is three months or less at the date of purchase. Cash equivalents are stated at cost, which approximates fair value.

As of October 31, 2019, approximately $1,310 million of our cash and cash equivalents is held outside of the U.S. by our foreign subsidiaries. Our cash and cash equivalents mainly consist of short-term deposits held at major global financial institutions, institutional money market funds, and similar short duration instruments with original maturities of 90 days or less. We continuously monitor the creditworthiness of the financial institutions and institutional money market funds in which we invest our funds.

We classify investments as short-term investments if their original maturities are greater than three months and their remaining maturities are one year or less. Currently, we have no short-term investments.

Variable Interest Entities. We make a determination upon entering into an arrangement whether an entity in which we have made an investment is considered a Variable Interest Entity (“VIE”).  The company evaluates its investments in privately held companies on an ongoing basis. We account for these investments under either the equity method or as equity investments without determinable fair value, depending on the circumstances. We periodically reassess whether we are the primary beneficiary of a VIE. The reassessment process considers whether we have acquired the power to direct the most significant activities of the VIE through changes in governing documents or other circumstances. We also reconsider whether entities previously determined not to be VIEs have become VIEs, based on changes in facts and circumstances including changes in contractual arrangements and capital structure.

During the year ended October 31, 2016, Agilent made a preferred stock investment in Lasergen, Inc. ("Lasergen") for $80 million. This investment in Lasergen was accounted for under the cost method. Agilent’s initial ownership stake was 48 percent and included an option to acquire the remaining shares until March 2018. During the year ended October 31, 2018, we exercised our option and acquired all of the remaining shares of Lasergen that we did not already own for an additional cash consideration of approximately $107 million. The fair value remeasurement of our previous investment immediately before the acquisition
resulted in a net gain of $20 million and was recorded in other income. Lasergen was previously considered a VIE. As of October 31, 2019 and 2018, we have no material VIE's.
Investments. Equity investments without readily determinable fair value consist of non-marketable equity securities (typically investments in privately-held companies). These investments are accounted for using the measurement alternative at cost and we adjust for impairments and observable price changes (orderly transactions for the identical or a similar security from the same issuer) included in net income as and when it occurs. Equity investments with readily determinable fair value consist of shares we own in a special fund and are reported at fair value, with gains or losses resulting from changes in fair value included in net income. Prior to fiscal year 2019, both equity investments without determinable fair value and with determinable fair value were accounted for using cost method of accounting, measured at historical cost less other-than-temporary investment. Trading securities, which is comprised of mutual funds, bonds and other similar instruments, other investments and deferred compensation liability are reported at fair value, with gains or losses resulting from changes in fair value recognized currently in net income. Equity method investments are reported at the amount of the company’s initial investment and adjusted each period for the company’s share of the investee’s income or loss and dividend paid. There are no equity method investments as of October 31, 2019 and 2018. The company assesses investments for impairment whenever events or changes in circumstances indicate that the carrying value of an investment may not be recoverable.

Fair Value of Financial Instruments. The carrying values of certain of our financial instruments including cash and cash equivalents, accounts receivable, accounts payable, accrued compensation and other accrued liabilities approximate fair value because of their short maturities. The fair value of long-term equity investments which are readily determinable, and which are not accounted under the equity method are reported at fair value using quoted market prices for those securities when available with gains and losses included in net income. The fair value of long-term equity investments which are not readily determinable, and which are not accounted under the equity method are reported at cost with adjustments for observable changes in prices or impairments included in net income. The fair value of our senior notes, calculated from quoted prices which are primarily Level 1 inputs under the accounting guidance fair value hierarchy exceeds the carrying value by approximately $62 million as of October 31, 2019 and is lower than the carrying value by approximately $15 million as of October 31, 2018. The change in the fair value over carrying value in the year ended October 31, 2019 is primarily due to fluctuations in market interest rates. The fair value of foreign currency contracts used for hedging purposes is estimated internally by using inputs tied to active markets. These inputs, for example, interest rate yield curves, foreign exchange rates, and forward and spot prices for currencies are observable in the market or can be corroborated by observable market data for substantially the full term of the assets or liabilities. See also Note 12, "Fair Value Measurements" for additional information on the fair value of financial instruments.

Concentration of Credit Risk.    Financial instruments that potentially subject Agilent to significant concentration of credit risk include money market fund investments, time deposits and demand deposit balances. These investments are categorized as cash and cash equivalents. In addition, Agilent has credit risk from derivative financial instruments used in hedging activities and accounts receivable. We invest in a variety of financial instruments and limit the amount of credit exposure with any one financial institution. We have a comprehensive credit policy in place and credit exposure is monitored on an ongoing basis.

Credit risk with respect to our accounts receivable is diversified due to the large number of entities comprising our customer base and their dispersion across many different industries and geographies. Credit evaluations are performed on customers requiring credit over a certain amount and we sell the majority of our products through our direct sales force. Credit risk is mitigated through collateral such as letter of credit, bank guarantees or payment terms like cash in advance. No single customer accounted for more than 10 percent of accounts receivable as of October 31, 2019, or 2018.

Derivative Instruments.    Agilent is exposed to global foreign currency exchange rate and interest rate risks in the normal course of business. We enter into foreign exchange hedging contracts, primarily forward contracts and purchased options, interest rate swaps and interest rate locks to manage financial exposures resulting from changes in foreign currency exchange rates and interest rates. In the vast majority of cases, these contracts are designated at inception as hedges of the related foreign currency or interest exposures. Foreign currency exposures include committed and anticipated revenue and expense transactions and assets and liabilities that are denominated in currencies other than the functional currency of the subsidiary. Interest rate exposures are associated with the company's fixed-rate debt. For option contracts, we exclude time value from the measurement of effectiveness. To qualify for hedge accounting, contracts must reduce the foreign currency exchange rate and interest rate risk otherwise inherent in the amount and duration of the hedged exposures and comply with established risk management policies. Foreign exchange hedging contracts generally mature within twelve months, interest rate swaps mature at the same time as the maturity of the debt and interest rate locks mature at the same time as the issuance of debt. In order to manage foreign currency exposures in a few limited jurisdictions we may enter into foreign exchange contracts that do not qualify for hedge accounting. In such circumstances, the local foreign currency exposure is offset by contracts owned by the parent company. We do not use derivative financial instruments for trading or speculative purposes.

All derivatives are recognized on the balance sheet at their fair values. For derivative instruments that are designated and qualify as a fair value hedge, changes in value of the derivative are recognized in the consolidated statement of operations in the current period, along with the offsetting gain or loss on the hedged item attributable to the hedged risk. For derivative instruments that are designated and qualify as a cash flow hedges, changes in the value of the effective portion of the derivative instrument is recognized in comprehensive income (loss), a component of stockholders' equity. Amounts associated with cash flow hedges are reclassified and recognized in income when either the forecasted transaction occurs or it becomes probable the forecasted transaction will not occur. Derivatives not designated as hedging instruments are recorded on the balance sheet at their fair value and changes in the fair values are recorded in the income statement in the current period. Derivative instruments are subject to master netting arrangements and are disclosed gross in the balance sheet. Changes in the fair value of the ineffective portion of derivative instruments are recognized in earnings in the current period. Ineffectiveness in 2019, 2018 and 2017 was not material. Cash flows from derivative instruments are classified in the statement of cash flows in the same category as the cash flows from the hedged or economically hedged item, primarily in operating activities.

Property, Plant and Equipment.    Property, plant and equipment are stated at cost less accumulated depreciation. Additions, improvements and major renewals are capitalized; maintenance, repairs and minor renewals are expensed as incurred. When assets are retired or disposed of, the assets and related accumulated depreciation and amortization are removed from our general ledger, and the resulting gain or loss is reflected in the consolidated statement of operations. Buildings and improvements are depreciated over the lesser of their useful lives or the remaining term of the lease and machinery and equipment over 3 years to 10 years. We use the straight-line method to depreciate assets.

Leases.    We lease buildings, machinery and equipment under operating and capital leases for original terms ranging generally from less than 1 year to 30 years. Certain leases contain renewal options for periods up to 6 years. In addition, we lease equipment to customers in connection with our diagnostics business using both capital and operating leases. As of October 31, 2019 and 2018 our diagnostics and genomics segment has approximately $37 million and $32 million, respectively, of lease receivables related to capital leases and approximately $17 million and $20 million, respectively, of net assets for operating leases.  We depreciate the assets related to the operating leases over their estimated useful lives, typically five years.

Capitalized Software.    We capitalize certain internal and external costs incurred to acquire or create internal use software. Capitalized software is included in property, plant and equipment and is depreciated over 3 years to 5 years once development is complete.

Impairment of Long-Lived Assets.    We continually monitor events and changes in circumstances that could indicate carrying amounts of long-lived assets, including intangible assets, may not be recoverable. When such events or changes in circumstances occur, we assess the recoverability of long-lived assets by determining whether the carrying value of such assets will be recovered through undiscounted expected future cash flows. If the total of the undiscounted future cash flows is less than the carrying amount of those assets, we recognize an impairment loss based on the excess of the carrying amount over the fair value of the assets. During 2019, there were no impairments of other assets or intangible assets. During 2018, we recorded an impairment charge of $21 million related to purchased intangible assets within the diagnostics and genomics segment that were deemed unrecoverable. During 2017, there were no impairments of other assets or intangible assets.

Employee Compensation and Benefits.    Amounts owed to employees, such as accrued salary, bonuses and vacation benefits are accounted for within employee compensation and benefits. The total amount of accrued vacation benefit was $115 million and $107 million as of October 31, 2019, and 2018, respectively.

Foreign Currency Translation.    We translate and remeasure balance sheet and income statement items into U.S. dollars. For those subsidiaries that operate in a local currency functional environment, all assets and liabilities are translated into U.S. dollars using current exchange rates at the balance sheet date; revenue and expenses are translated using monthly exchange rates which approximate to average exchange rates in effect during each period. Resulting translation adjustments are reported as a separate component of accumulated other comprehensive income (loss) in stockholders' equity.

For those subsidiaries that operate in a U.S. dollar functional environment, foreign currency assets and liabilities are remeasured into U.S. dollars at current exchange rates except for non-monetary assets and capital accounts which are remeasured at historical exchange rates. Revenue and expenses are generally remeasured at monthly exchange rates which approximate average exchange rates in effect during each period. Gains or losses from foreign currency remeasurement are included in consolidated net income. Net gains or losses resulting from foreign currency transactions, including hedging gains and losses, are reported in other income (expense), net and were $7 million loss for 2019, $3 million loss for 2018 and $2 million loss for 2017.
JSON 40 MetaLinks.json IDEA: XBRL DOCUMENT { "instance": { "a-10312019x10k.htm": { "axisCustom": 2, "axisStandard": 32, "contextCount": 513, "dts": { "calculationLink": { "local": [ "a-20191031_cal.xml" ] }, "definitionLink": { "local": [ "a-20191031_def.xml" ], "remote": [ "http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-eedm-def-2019-01-31.xml", "http://xbrl.fasb.org/srt/2019/elts/srt-eedm1-def-2019-01-31.xml" ] }, "inline": { "local": [ "a-10312019x10k.htm" ] }, "labelLink": { "local": [ "a-20191031_lab.xml" ], "remote": [ "http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-doc-2019-01-31.xml", "http://xbrl.fasb.org/srt/2019/elts/srt-doc-2019-01-31.xml", "http://xbrl.sec.gov/invest/2013/invest-doc-2013-01-31.xml", "https://xbrl.sec.gov/dei/2019/dei-doc-2019-01-31.xml" ] }, "presentationLink": { "local": [ "a-20191031_pre.xml" ] }, "referenceLink": { "remote": [ "http://xbrl.sec.gov/invest/2013/invest-ref-2013-01-31.xml", "http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-ref-2019-01-31.xml", "https://xbrl.sec.gov/dei/2019/dei-ref-2019-01-31.xml", "http://xbrl.fasb.org/srt/2019/elts/srt-ref-2019-01-31.xml" ] }, "schema": { "local": [ "a-20191031.xsd" ], "remote": [ "http://xbrl.fasb.org/srt/2019/elts/srt-types-2019-01-31.xsd", "http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd", "http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd", "http://www.xbrl.org/2003/xl-2003-12-31.xsd", "http://www.xbrl.org/2003/xlink-2003-12-31.xsd", "http://www.xbrl.org/dtr/type/numeric-2009-12-16.xsd", "http://www.xbrl.org/dtr/type/nonNumeric-2009-12-16.xsd", "http://www.xbrl.org/2006/ref-2006-02-27.xsd", "http://xbrl.fasb.org/srt/2019/elts/srt-2019-01-31.xsd", "http://www.xbrl.org/2005/xbrldt-2005.xsd", "http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd", "http://xbrl.fasb.org/us-gaap/2019/elts/us-roles-2019-01-31.xsd", "http://xbrl.fasb.org/srt/2019/elts/srt-roles-2019-01-31.xsd", "https://xbrl.sec.gov/country/2017/country-2017-01-31.xsd", "http://xbrl.fasb.org/us-gaap/2019/elts/us-types-2019-01-31.xsd", "http://www.xbrl.org/lrr/arcrole/factExplanatory-2009-12-16.xsd", "http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd", "http://www.xbrl.org/lrr/role/net-2009-12-16.xsd", "https://xbrl.sec.gov/currency/2019/currency-2019-01-31.xsd", "https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd", "https://xbrl.sec.gov/exch/2019/exch-2019-01-31.xsd", "http://xbrl.sec.gov/invest/2013/invest-2013-01-31.xsd", "http://xbrl.sec.gov/naics/2017/naics-2017-01-31.xsd", "http://xbrl.sec.gov/sic/2011/sic-2011-01-31.xsd", "https://xbrl.sec.gov/stpr/2018/stpr-2018-01-31.xsd", "http://www.xbrl.org/lrr/role/deprecated-2009-12-16.xsd", "http://www.xbrl.org/lrr/role/reference-2009-12-16.xsd", "http://xbrl.fasb.org/us-gaap/2019/elts/us-parts-codification-2019-01-31.xsd" ] } }, "elementCount": 1116, "entityCount": 1, "hidden": { "http://fasb.org/us-gaap/2019-01-31": 112, "http://www.agilent.com/20191031": 11, "http://xbrl.sec.gov/dei/2019-01-31": 9, "total": 132 }, "keyCustom": 94, "keyStandard": 641, "memberCustom": 44, "memberStandard": 81, "nsprefix": "a", "nsuri": "http://www.agilent.com/20191031", "report": { "R1": { "firstAnchor": { "ancestors": [ "span", "div", "div", "body", "html" ], "baseRef": "a-10312019x10k.htm", "contextRef": "FD2019Q4YTD", "decimals": null, "first": true, "lang": "en-US", "name": "dei:DocumentType", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "document", "isDefault": "true", "longName": "0001000 - Document - Document And Entity Information", "role": "http://www.agilent.com/role/DocumentAndEntityInformation", "shortName": "Document And Entity Information", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "span", "div", "div", "body", "html" ], "baseRef": "a-10312019x10k.htm", "contextRef": "FD2019Q4YTD", "decimals": null, "first": true, "lang": "en-US", "name": "dei:DocumentType", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R10": { "firstAnchor": { "ancestors": [ "span", "div", "div", "body", "html" ], "baseRef": "a-10312019x10k.htm", "contextRef": "FD2019Q4YTD", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:BasisOfPresentationAndSignificantAccountingPoliciesTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "2101100 - Disclosure - OVERVIEW AND SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES", "role": "http://www.agilent.com/role/OverviewAndSummaryOfSignificantAccountingPolicies", "shortName": "OVERVIEW AND SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "span", "div", "div", "body", "html" ], "baseRef": "a-10312019x10k.htm", "contextRef": "FD2019Q4YTD", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:BasisOfPresentationAndSignificantAccountingPoliciesTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R100": { "firstAnchor": { "ancestors": [ "span", "span", "div", "us-gaap:CommitmentsAndContingenciesDisclosureTextBlock", "div", "body", "html" ], "baseRef": "a-10312019x10k.htm", "contextRef": "FI2019Q4", "decimals": "-6", "first": true, "lang": null, "name": "us-gaap:OtherCommitment", "reportCount": 1, "unique": true, "unitRef": "usd", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "2422402 - Disclosure - COMMITMENTS AND CONTINGENCIES (Details)", "role": "http://www.agilent.com/role/CommitmentsAndContingenciesDetails", "shortName": "COMMITMENTS AND CONTINGENCIES (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "span", "span", "div", "us-gaap:CommitmentsAndContingenciesDisclosureTextBlock", "div", "body", "html" ], "baseRef": "a-10312019x10k.htm", "contextRef": "FI2019Q4", "decimals": "-6", "first": true, "lang": null, "name": "us-gaap:OtherCommitment", "reportCount": 1, "unique": true, "unitRef": "usd", "xsiNil": "false" } }, "R101": { "firstAnchor": { "ancestors": [ "span", "span", "span", "div", "ix:continuation", "div", "body", "html" ], "baseRef": "a-10312019x10k.htm", "contextRef": "D2019Q2_3.13.19", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:LineOfCreditFacilityInitiationDate1", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "2423401 - Disclosure - SHORT-TERM DEBT - Credit Facility and Capital Lease (Details)", "role": "http://www.agilent.com/role/ShortTermDebtCreditFacilityAndCapitalLeaseDetails", "shortName": "SHORT-TERM DEBT - Credit Facility and Capital Lease (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "span", "span", "span", "div", "ix:continuation", "div", "body", "html" ], "baseRef": "a-10312019x10k.htm", "contextRef": "D2019Q2_3.13.19", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:LineOfCreditFacilityInitiationDate1", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R102": { "firstAnchor": { "ancestors": [ "span", "span", "div", "ix:continuation", "div", "body", "html" ], "baseRef": "a-10312019x10k.htm", "contextRef": "I2016Q4_Sep_15_2016", "decimals": "-6", "first": true, "lang": null, "name": "a:NotionalAmountOfTerminatedInterestRateFairValueHedgeDerivatives", "reportCount": 1, "unitRef": "usd", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "2423402 - Disclosure - SHORT-TERM DEBT - Senior Notes (Details)", "role": "http://www.agilent.com/role/ShortTermDebtSeniorNotesDetails", "shortName": "SHORT-TERM DEBT - Senior Notes (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "span", "span", "span", "div", "ix:continuation", "div", "body", "html" ], "baseRef": "a-10312019x10k.htm", "contextRef": "D2007Q4_Oct_24_2007_us-gaap_DebtInstrumentAxis_a_SeniorNotes2017Member", "decimals": null, "lang": "en-US", "name": "us-gaap:DebtInstrumentIssuanceDate1", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R103": { "firstAnchor": { "ancestors": [ "span", "span", "div", "td", "tr", "table", "div", "div", "us-gaap:ScheduleOfDebtInstrumentsTextBlock", "ix:continuation", "div", "body", "html" ], "baseRef": "a-10312019x10k.htm", "contextRef": "FI2019Q4", "decimals": "-6", "first": true, "lang": null, "name": "a:DebtInstrumentNetDiscountPremiumAmount", "reportCount": 1, "unitRef": "usd", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "2424402 - Disclosure - LONG-TERM DEBT - Carrying Value (Details)", "role": "http://www.agilent.com/role/LongTermDebtCarryingValueDetails", "shortName": "LONG-TERM DEBT - Carrying Value (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "span", "span", "div", "td", "tr", "table", "div", "div", "us-gaap:ScheduleOfDebtInstrumentsTextBlock", "ix:continuation", "div", "body", "html" ], "baseRef": "a-10312019x10k.htm", "contextRef": "FI2019Q4", "decimals": "-6", "lang": null, "name": "us-gaap:DebtInstrumentCarryingAmount", "reportCount": 1, "unique": true, "unitRef": "usd", "xsiNil": "false" } }, "R104": { "firstAnchor": { "ancestors": [ "span", "span", "div", "td", "tr", "table", "div", "div", "us-gaap:ScheduleOfDebtInstrumentsTextBlock", "ix:continuation", "div", "body", "html" ], "baseRef": "a-10312019x10k.htm", "contextRef": "FI2019Q4", "decimals": "-6", "first": true, "lang": null, "name": "a:DebtInstrumentNetDiscountPremiumAmount", "reportCount": 1, "unitRef": "usd", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "2424403 - Disclosure - LONG-TERM DEBT - Senior Notes (Details)", "role": "http://www.agilent.com/role/LongTermDebtSeniorNotesDetails", "shortName": "LONG-TERM DEBT - Senior Notes (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "span", "span", "span", "div", "ix:continuation", "div", "body", "html" ], "baseRef": "a-10312019x10k.htm", "contextRef": "D2012Q4_Sept_10_2012_us-gaap_DebtInstrumentAxis_a_SeniorNotes2022Member", "decimals": null, "lang": "en-US", "name": "us-gaap:DebtInstrumentIssuanceDate1", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R105": { "firstAnchor": { "ancestors": [ "span", "span", "div", "ix:continuation", "div", "body", "html" ], "baseRef": "a-10312019x10k.htm", "contextRef": "D2016Q4SD", "decimals": "-6", "first": true, "lang": null, "name": "a:Interestrateswappayments", "reportCount": 1, "unitRef": "usd", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "2424404 - Disclosure - LONG-TERM DEBT LONG-TERM DEBT - Other (Details)", "role": "http://www.agilent.com/role/LongTermDebtLongTermDebtOtherDetails", "shortName": "LONG-TERM DEBT LONG-TERM DEBT - Other (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "span", "span", "div", "ix:continuation", "div", "body", "html" ], "baseRef": "a-10312019x10k.htm", "contextRef": "FI2019Q4", "decimals": "-6", "lang": null, "name": "us-gaap:CapitalLeaseObligationsNoncurrent", "reportCount": 1, "unique": true, "unitRef": "usd", "xsiNil": "false" } }, "R106": { "firstAnchor": { "ancestors": [ "span", "span", "div", "us-gaap:StockholdersEquityNoteDisclosureTextBlock", "div", "body", "html" ], "baseRef": "a-10312019x10k.htm", "contextRef": "I2015Q3SD_us-gaap_ShareRepurchaseProgramAxis_a_A2015RepurchaseProgramMember", "decimals": "-7", "first": true, "lang": null, "name": "us-gaap:StockRepurchaseProgramAuthorizedAmount1", "reportCount": 1, "unique": true, "unitRef": "usd", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "2427402 - Disclosure - STOCKHOLDERS' EQUITY Stock Repurchases (Details)", "role": "http://www.agilent.com/role/StockholdersEquityStockRepurchasesDetails", "shortName": "STOCKHOLDERS' EQUITY Stock Repurchases (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "span", "span", "div", "us-gaap:StockholdersEquityNoteDisclosureTextBlock", "div", "body", "html" ], "baseRef": "a-10312019x10k.htm", "contextRef": "I2015Q3SD_us-gaap_ShareRepurchaseProgramAxis_a_A2015RepurchaseProgramMember", "decimals": "-7", "first": true, "lang": null, "name": "us-gaap:StockRepurchaseProgramAuthorizedAmount1", "reportCount": 1, "unique": true, "unitRef": "usd", "xsiNil": "false" } }, "R107": { "firstAnchor": { "ancestors": [ "span", "span", "div", "us-gaap:StockholdersEquityNoteDisclosureTextBlock", "div", "body", "html" ], "baseRef": "a-10312019x10k.htm", "contextRef": "FD2019Q4YTD", "decimals": "3", "first": true, "lang": null, "name": "us-gaap:CommonStockDividendsPerShareDeclared", "reportCount": 1, "unitRef": "usdPerShare", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "2427403 - Disclosure - STOCKHOLDERS' EQUITY STOCKHOLDERS EQUITY DIvidends (Details)", "role": "http://www.agilent.com/role/StockholdersEquityStockholdersEquityDividendsDetails", "shortName": "STOCKHOLDERS' EQUITY STOCKHOLDERS EQUITY DIvidends (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "span", "span", "div", "us-gaap:StockholdersEquityNoteDisclosureTextBlock", "div", "body", "html" ], "baseRef": "a-10312019x10k.htm", "contextRef": "D2020Q1_Nov_20_2019_us-gaap_SubsequentEventTypeAxis_us-gaap_SubsequentEventMember", "decimals": "2", "lang": null, "name": "us-gaap:CommonStockDividendsPerShareDeclared", "reportCount": 1, "unique": true, "unitRef": "usdPerShare", "xsiNil": "false" } }, "R108": { "firstAnchor": { "ancestors": [ "span", "span", "div", "td", "tr", "table", "div", "div", "us-gaap:ScheduleOfAccumulatedOtherComprehensiveIncomeLossTableTextBlock", "ix:continuation", "div", "body", "html" ], "baseRef": "a-10312019x10k.htm", "contextRef": "FI2019Q4", "decimals": "-6", "first": true, "lang": null, "name": "us-gaap:AccumulatedOtherComprehensiveIncomeLossForeignCurrencyTranslationAdjustmentNetOfTax", "reportCount": 1, "unitRef": "usd", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "2427404 - Disclosure - STOCKHOLDERS' EQUITY -Accumulated other comprehensive income (Details)", "role": "http://www.agilent.com/role/StockholdersEquityAccumulatedOtherComprehensiveIncomeDetails", "shortName": "STOCKHOLDERS' EQUITY -Accumulated other comprehensive income (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "span", "span", "div", "td", "tr", "table", "div", "div", "us-gaap:ScheduleOfAccumulatedOtherComprehensiveIncomeLossTableTextBlock", "ix:continuation", "div", "body", "html" ], "baseRef": "a-10312019x10k.htm", "contextRef": "FI2019Q4", "decimals": "-6", "lang": null, "name": "us-gaap:AccumulatedOtherComprehensiveIncomeLossDefinedBenefitPensionAndOtherPostretirementPlansNetOfTax", "reportCount": 1, "unique": true, "unitRef": "usd", "xsiNil": "false" } }, "R109": { "firstAnchor": { "ancestors": [ "span", "span", "div", "td", "tr", "table", "div", "div", "us-gaap:ScheduleOfAccumulatedOtherComprehensiveIncomeLossTableTextBlock", "ix:continuation", "div", "body", "html" ], "baseRef": "a-10312019x10k.htm", "contextRef": "FI2018Q4", "decimals": "-6", "first": true, "lang": null, "name": "us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax", "reportCount": 1, "unitRef": "usd", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "2427405 - Disclosure - STOCKHOLDERS' EQUITY - Changes in accumulated other comprehensive income (Details)", "role": "http://www.agilent.com/role/StockholdersEquityChangesInAccumulatedOtherComprehensiveIncomeDetails", "shortName": "STOCKHOLDERS' EQUITY - Changes in accumulated other comprehensive income (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "span", "span", "div", "td", "tr", "table", "div", "div", "us-gaap:ScheduleOfAccumulatedOtherComprehensiveIncomeLossTableTextBlock", "ix:continuation", "div", "body", "html" ], "baseRef": "a-10312019x10k.htm", "contextRef": "FD2019Q4YTD", "decimals": "-6", "lang": null, "name": "us-gaap:OtherComprehensiveIncomeLossBeforeTax", "reportCount": 1, "unique": true, "unitRef": "usd", "xsiNil": "false" } }, "R11": { "firstAnchor": { "ancestors": [ "span", "div", "div", "body", "html" ], "baseRef": "a-10312019x10k.htm", "contextRef": "FD2019Q4YTD", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:NewAccountingPronouncementsAndChangesInAccountingPrinciplesTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "2105100 - Disclosure - NEW ACCOUNTING PRONOUNCEMENTS", "role": "http://www.agilent.com/role/NewAccountingPronouncements", "shortName": "NEW ACCOUNTING PRONOUNCEMENTS", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "span", "div", "div", "body", "html" ], "baseRef": "a-10312019x10k.htm", "contextRef": "FD2019Q4YTD", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:NewAccountingPronouncementsAndChangesInAccountingPrinciplesTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R110": { "firstAnchor": { "ancestors": [ "span", "span", "div", "td", "tr", "table", "div", "div", "us-gaap:ReclassificationOutOfAccumulatedOtherComprehensiveIncomeTableTextBlock", "ix:continuation", "div", "body", "html" ], "baseRef": "a-10312019x10k.htm", "contextRef": "FD2019Q4YTD", "decimals": "-6", "first": true, "lang": null, "name": "us-gaap:DerivativeInstrumentsGainLossReclassifiedFromAccumulatedOCIIntoIncomeEffectivePortionNet", "reportCount": 1, "unitRef": "usd", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "2427406 - Disclosure - STOCKHOLDERS' EQUITY STOCKHOLDERS' EQUITY - Reclassifications out of accumulated other comprehensive income (Details)", "role": "http://www.agilent.com/role/StockholdersEquityStockholdersEquityReclassificationsOutOfAccumulatedOtherComprehensiveIncomeDetails", "shortName": "STOCKHOLDERS' EQUITY STOCKHOLDERS' EQUITY - Reclassifications out of accumulated other comprehensive income (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "span", "span", "div", "td", "tr", "table", "div", "div", "us-gaap:ReclassificationOutOfAccumulatedOtherComprehensiveIncomeTableTextBlock", "ix:continuation", "div", "body", "html" ], "baseRef": "a-10312019x10k.htm", "contextRef": "FD2019Q4YTD", "decimals": "-6", "lang": null, "name": "us-gaap:OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIPensionAndOtherPostretirementBenefitPlansBeforeTax", "reportCount": 1, "unique": true, "unitRef": "usd", "xsiNil": "false" } }, "R111": { "firstAnchor": { "ancestors": [ "span", "span", "div", "ix:continuation", "div", "body", "html" ], "baseRef": "a-10312019x10k.htm", "contextRef": "FD2019Q4YTD", "decimals": "0", "first": true, "lang": null, "name": "us-gaap:NumberOfOperatingSegments", "reportCount": 1, "unique": true, "unitRef": "segment", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "2428402 - Disclosure - SEGMENT INFORMATION Profitability (Details)", "role": "http://www.agilent.com/role/SegmentInformationProfitabilityDetails", "shortName": "SEGMENT INFORMATION Profitability (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "span", "span", "div", "ix:continuation", "div", "body", "html" ], "baseRef": "a-10312019x10k.htm", "contextRef": "FD2019Q4YTD", "decimals": "0", "first": true, "lang": null, "name": "us-gaap:NumberOfOperatingSegments", "reportCount": 1, "unique": true, "unitRef": "segment", "xsiNil": "false" } }, "R112": { "firstAnchor": { "ancestors": [ "span", "span", "div", "td", "tr", "table", "div", "div", "us-gaap:ReconciliationOfOperatingProfitLossFromSegmentsToConsolidatedTextBlock", "ix:continuation", "div", "body", "html" ], "baseRef": "a-10312019x10k.htm", "contextRef": "FD2019Q4YTD", "decimals": "-6", "first": true, "lang": null, "name": "a:Segmentincomelossfromoperations", "reportCount": 1, "unique": true, "unitRef": "usd", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "2428403 - Disclosure - SEGMENT INFORMATION Reconciliation of Reportable Results (Details)", "role": "http://www.agilent.com/role/SegmentInformationReconciliationOfReportableResultsDetails", "shortName": "SEGMENT INFORMATION Reconciliation of Reportable Results (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "span", "span", "div", "td", "tr", "table", "div", "div", "us-gaap:ReconciliationOfOperatingProfitLossFromSegmentsToConsolidatedTextBlock", "ix:continuation", "div", "body", "html" ], "baseRef": "a-10312019x10k.htm", "contextRef": "FD2019Q4YTD", "decimals": "-6", "first": true, "lang": null, "name": "a:Segmentincomelossfromoperations", "reportCount": 1, "unique": true, "unitRef": "usd", "xsiNil": "false" } }, "R113": { "firstAnchor": { "ancestors": [ "span", "span", "div", "td", "tr", "table", "div", "div", "a:AssetsAndCapitalExpendituresDirectlyManagedByEachSegmentTableTextBlock", "ix:continuation", "div", "body", "html" ], "baseRef": "a-10312019x10k.htm", "contextRef": "FI2019Q4", "decimals": "-6", "first": true, "lang": null, "name": "a:SegmentReportingReconciliationItemAssets", "reportCount": 1, "unique": true, "unitRef": "usd", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "2428404 - Disclosure - SEGMENT INFORMATION Segment Assets (Details)", "role": "http://www.agilent.com/role/SegmentInformationSegmentAssetsDetails", "shortName": "SEGMENT INFORMATION Segment Assets (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "span", "span", "div", "td", "tr", "table", "div", "div", "a:AssetsAndCapitalExpendituresDirectlyManagedByEachSegmentTableTextBlock", "ix:continuation", "div", "body", "html" ], "baseRef": "a-10312019x10k.htm", "contextRef": "FI2019Q4", "decimals": "-6", "first": true, "lang": null, "name": "a:SegmentReportingReconciliationItemAssets", "reportCount": 1, "unique": true, "unitRef": "usd", "xsiNil": "false" } }, "R114": { "firstAnchor": { "ancestors": [ "span", "span", "div", "td", "tr", "table", "div", "div", "ix:continuation", "us-gaap:DisaggregationOfRevenueTableTextBlock", "div", "body", "html" ], "baseRef": "a-10312019x10k.htm", "contextRef": "FD2019Q4YTD", "decimals": "-6", "first": true, "lang": null, "name": "us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax", "reportCount": 1, "unitRef": "usd", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "2428405 - Disclosure - SEGMENT INFORMATION - Entity-Wide Disclosures Revenue (Details)", "role": "http://www.agilent.com/role/SegmentInformationEntityWideDisclosuresRevenueDetails", "shortName": "SEGMENT INFORMATION - Entity-Wide Disclosures Revenue (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "span", "span", "div", "td", "tr", "table", "div", "div", "us-gaap:ScheduleOfRevenuesFromExternalCustomersAndLongLivedAssetsByGeographicalAreasTableTextBlock", "ix:continuation", "div", "body", "html" ], "baseRef": "a-10312019x10k.htm", "contextRef": "FD2019Q4YTD_srt_StatementGeographicalAxis_country_US", "decimals": "-6", "lang": null, "name": "us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax", "reportCount": 1, "unique": true, "unitRef": "usd", "xsiNil": "false" } }, "R115": { "firstAnchor": { "ancestors": [ "span", "span", "div", "td", "tr", "table", "div", "div", "us-gaap:ScheduleOfRevenuesFromExternalCustomersAndLongLivedAssetsByGeographicalAreasTableTextBlock", "ix:continuation", "div", "body", "html" ], "baseRef": "a-10312019x10k.htm", "contextRef": "FI2019Q4", "decimals": "-6", "first": true, "lang": null, "name": "us-gaap:NoncurrentAssets", "reportCount": 1, "unique": true, "unitRef": "usd", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "2428406 - Disclosure - SEGMENT INFORMATION - Entity-Wide Disclosure Long-Lived Assets (Details)", "role": "http://www.agilent.com/role/SegmentInformationEntityWideDisclosureLongLivedAssetsDetails", "shortName": "SEGMENT INFORMATION - Entity-Wide Disclosure Long-Lived Assets (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "span", "span", "div", "td", "tr", "table", "div", "div", "us-gaap:ScheduleOfRevenuesFromExternalCustomersAndLongLivedAssetsByGeographicalAreasTableTextBlock", "ix:continuation", "div", "body", "html" ], "baseRef": "a-10312019x10k.htm", "contextRef": "FI2019Q4", "decimals": "-6", "first": true, "lang": null, "name": "us-gaap:NoncurrentAssets", "reportCount": 1, "unique": true, "unitRef": "usd", "xsiNil": "false" } }, "R116": { "firstAnchor": { "ancestors": [ "span", "span", "div", "td", "tr", "table", "div", "div", "srt:ScheduleOfValuationAndQualifyingAccountsDisclosureTextBlock", "div", "body", "html" ], "baseRef": "a-10312019x10k.htm", "contextRef": "FI2018Q4_us-gaap_ValuationAllowancesAndReservesTypeAxis_us-gaap_ValuationAllowanceOfDeferredTaxAssetsMember", "decimals": "-6", "first": true, "lang": null, "name": "us-gaap:ValuationAllowancesAndReservesBalance", "reportCount": 1, "unitRef": "usd", "xsiNil": "false" }, "groupType": "", "isDefault": "false", "longName": "2430401 - Schedule - Schedule II Valuation and Qualifying Accounts (Details)", "role": "http://www.agilent.com/role/ScheduleIiValuationAndQualifyingAccountsDetails", "shortName": "Schedule II Valuation and Qualifying Accounts (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "span", "span", "div", "td", "tr", "table", "div", "div", "srt:ScheduleOfValuationAndQualifyingAccountsDisclosureTextBlock", "div", "body", "html" ], "baseRef": "a-10312019x10k.htm", "contextRef": "FI2016Q4_us-gaap_ValuationAllowancesAndReservesTypeAxis_us-gaap_ValuationAllowanceOfDeferredTaxAssetsMember", "decimals": "-6", "lang": null, "name": "us-gaap:ValuationAllowancesAndReservesBalance", "reportCount": 1, "unique": true, "unitRef": "usd", "xsiNil": "false" } }, "R12": { "firstAnchor": { "ancestors": [ "span", "div", "div", "body", "html" ], "baseRef": "a-10312019x10k.htm", "contextRef": "FD2019Q4YTD", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:MergersAcquisitionsAndDispositionsDisclosuresTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "2107100 - Disclosure - ACQUISITIONS (Notes)", "role": "http://www.agilent.com/role/AcquisitionsNotes", "shortName": "ACQUISITIONS (Notes)", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "span", "div", "div", "body", "html" ], "baseRef": "a-10312019x10k.htm", "contextRef": "FD2019Q4YTD", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:MergersAcquisitionsAndDispositionsDisclosuresTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R13": { "firstAnchor": { "ancestors": [ "span", "div", "div", "body", "html" ], "baseRef": "a-10312019x10k.htm", "contextRef": "FD2019Q4YTD", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:RevenueFromContractWithCustomerTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "2108100 - Disclosure - REVENUE REVENUE (Notes)", "role": "http://www.agilent.com/role/RevenueRevenueNotes", "shortName": "REVENUE REVENUE (Notes)", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "span", "div", "div", "body", "html" ], "baseRef": "a-10312019x10k.htm", "contextRef": "FD2019Q4YTD", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:RevenueFromContractWithCustomerTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R14": { "firstAnchor": { "ancestors": [ "span", "div", "div", "body", "html" ], "baseRef": "a-10312019x10k.htm", "contextRef": "FD2019Q4YTD", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "2109100 - Disclosure - SHARE-BASED COMPENSATION", "role": "http://www.agilent.com/role/ShareBasedCompensation", "shortName": "SHARE-BASED COMPENSATION", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "span", "div", "div", "body", "html" ], "baseRef": "a-10312019x10k.htm", "contextRef": "FD2019Q4YTD", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R15": { "firstAnchor": { "ancestors": [ "span", "div", "div", "body", "html" ], "baseRef": "a-10312019x10k.htm", "contextRef": "FD2019Q4YTD", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:IncomeTaxDisclosureTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "2111100 - Disclosure - INCOME TAXES", "role": "http://www.agilent.com/role/IncomeTaxes", "shortName": "INCOME TAXES", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "span", "div", "div", "body", "html" ], "baseRef": "a-10312019x10k.htm", "contextRef": "FD2019Q4YTD", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:IncomeTaxDisclosureTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R16": { "firstAnchor": { "ancestors": [ "span", "div", "div", "body", "html" ], "baseRef": "a-10312019x10k.htm", "contextRef": "FD2019Q4YTD", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:EarningsPerShareTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "2112100 - Disclosure - NET INCOME (LOSS) PER SHARE", "role": "http://www.agilent.com/role/NetIncomeLossPerShare", "shortName": "NET INCOME (LOSS) PER SHARE", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "span", "div", "div", "body", "html" ], "baseRef": "a-10312019x10k.htm", "contextRef": "FD2019Q4YTD", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:EarningsPerShareTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R17": { "firstAnchor": { "ancestors": [ "span", "div", "div", "body", "html" ], "baseRef": "a-10312019x10k.htm", "contextRef": "FD2019Q4YTD", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:InventoryDisclosureTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "2113100 - Disclosure - INVENTORY", "role": "http://www.agilent.com/role/Inventory", "shortName": "INVENTORY", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "span", "div", "div", "body", "html" ], "baseRef": "a-10312019x10k.htm", "contextRef": "FD2019Q4YTD", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:InventoryDisclosureTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R18": { "firstAnchor": { "ancestors": [ "span", "div", "div", "body", "html" ], "baseRef": "a-10312019x10k.htm", "contextRef": "FD2019Q4YTD", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:PropertyPlantAndEquipmentDisclosureTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "2114100 - Disclosure - PROPERTY, PLANT AND EQUIPMENT, NET", "role": "http://www.agilent.com/role/PropertyPlantAndEquipmentNet", "shortName": "PROPERTY, PLANT AND EQUIPMENT, NET", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "span", "div", "div", "body", "html" ], "baseRef": "a-10312019x10k.htm", "contextRef": "FD2019Q4YTD", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:PropertyPlantAndEquipmentDisclosureTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R19": { "firstAnchor": { "ancestors": [ "span", "div", "div", "body", "html" ], "baseRef": "a-10312019x10k.htm", "contextRef": "FD2019Q4YTD", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:GoodwillAndIntangibleAssetsDisclosureTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "2115100 - Disclosure - GOODWILL AND OTHER INTANGIBLE ASSETS", "role": "http://www.agilent.com/role/GoodwillAndOtherIntangibleAssets", "shortName": "GOODWILL AND OTHER INTANGIBLE ASSETS", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "span", "div", "div", "body", "html" ], "baseRef": "a-10312019x10k.htm", "contextRef": "FD2019Q4YTD", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:GoodwillAndIntangibleAssetsDisclosureTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R2": { "firstAnchor": { "ancestors": [ "span", "span", "div", "td", "tr", "table", "div", "div", "ix:continuation", "us-gaap:DisaggregationOfRevenueTableTextBlock", "div", "body", "html" ], "baseRef": "a-10312019x10k.htm", "contextRef": "FD2019Q4YTD", "decimals": "-6", "first": true, "lang": null, "name": "us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax", "reportCount": 1, "unitRef": "usd", "xsiNil": "false" }, "groupType": "statement", "isDefault": "false", "longName": "1001000 - Statement - CONSOLIDATED STATEMENT OF OPERATIONS", "role": "http://www.agilent.com/role/ConsolidatedStatementOfOperations", "shortName": "CONSOLIDATED STATEMENT OF OPERATIONS", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "span", "span", "div", "td", "tr", "table", "div", "div", "div", "body", "html" ], "baseRef": "a-10312019x10k.htm", "contextRef": "FD2019Q4YTD", "decimals": "-6", "lang": null, "name": "us-gaap:CostOfGoodsAndServicesSold", "reportCount": 1, "unique": true, "unitRef": "usd", "xsiNil": "false" } }, "R20": { "firstAnchor": { "ancestors": [ "span", "div", "div", "body", "html" ], "baseRef": "a-10312019x10k.htm", "contextRef": "FD2019Q4YTD", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:InvestmentsInDebtAndMarketableEquitySecuritiesAndCertainTradingAssetsDisclosureTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "2116100 - Disclosure - INVESTMENTS", "role": "http://www.agilent.com/role/Investments", "shortName": "INVESTMENTS", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "span", "div", "div", "body", "html" ], "baseRef": "a-10312019x10k.htm", "contextRef": "FD2019Q4YTD", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:InvestmentsInDebtAndMarketableEquitySecuritiesAndCertainTradingAssetsDisclosureTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R21": { "firstAnchor": { "ancestors": [ "div", "body", "html" ], "baseRef": "a-10312019x10k.htm", "contextRef": "FD2019Q4YTD", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:FairValueDisclosuresTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "2118100 - Disclosure - FAIR VALUE MEASUREMENTS", "role": "http://www.agilent.com/role/FairValueMeasurements", "shortName": "FAIR VALUE MEASUREMENTS", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "div", "body", "html" ], "baseRef": "a-10312019x10k.htm", "contextRef": "FD2019Q4YTD", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:FairValueDisclosuresTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R22": { "firstAnchor": { "ancestors": [ "div", "body", "html" ], "baseRef": "a-10312019x10k.htm", "contextRef": "FD2019Q4YTD", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:DerivativeInstrumentsAndHedgingActivitiesDisclosureTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "2119100 - Disclosure - DERIVATIVES", "role": "http://www.agilent.com/role/Derivatives", "shortName": "DERIVATIVES", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "div", "body", "html" ], "baseRef": "a-10312019x10k.htm", "contextRef": "FD2019Q4YTD", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:DerivativeInstrumentsAndHedgingActivitiesDisclosureTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R23": { "firstAnchor": { "ancestors": [ "span", "div", "div", "body", "html" ], "baseRef": "a-10312019x10k.htm", "contextRef": "FD2019Q4YTD", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:PensionAndOtherPostretirementBenefitsDisclosureTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "2120100 - Disclosure - RETIREMENT PLANS AND POST RETIREMENT PENSION PLANS", "role": "http://www.agilent.com/role/RetirementPlansAndPostRetirementPensionPlans", "shortName": "RETIREMENT PLANS AND POST RETIREMENT PENSION PLANS", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "span", "div", "div", "body", "html" ], "baseRef": "a-10312019x10k.htm", "contextRef": "FD2019Q4YTD", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:PensionAndOtherPostretirementBenefitsDisclosureTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R24": { "firstAnchor": { "ancestors": [ "span", "div", "div", "body", "html" ], "baseRef": "a-10312019x10k.htm", "contextRef": "FD2019Q4YTD", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:ProductWarrantyDisclosureTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "2121100 - Disclosure - GUARANTEES", "role": "http://www.agilent.com/role/Guarantees", "shortName": "GUARANTEES", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "span", "div", "div", "body", "html" ], "baseRef": "a-10312019x10k.htm", "contextRef": "FD2019Q4YTD", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:ProductWarrantyDisclosureTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R25": { "firstAnchor": { "ancestors": [ "div", "body", "html" ], "baseRef": "a-10312019x10k.htm", "contextRef": "FD2019Q4YTD", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:CommitmentsAndContingenciesDisclosureTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "2122100 - Disclosure - COMMITMENTS AND CONTINGENCIES", "role": "http://www.agilent.com/role/CommitmentsAndContingencies", "shortName": "COMMITMENTS AND CONTINGENCIES", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "div", "body", "html" ], "baseRef": "a-10312019x10k.htm", "contextRef": "FD2019Q4YTD", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:CommitmentsAndContingenciesDisclosureTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R26": { "firstAnchor": { "ancestors": [ "span", "div", "div", "body", "html" ], "baseRef": "a-10312019x10k.htm", "contextRef": "FD2019Q4YTD", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:ShortTermDebtTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "2123100 - Disclosure - SHORT-TERM DEBT", "role": "http://www.agilent.com/role/ShortTermDebt", "shortName": "SHORT-TERM DEBT", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "span", "div", "div", "body", "html" ], "baseRef": "a-10312019x10k.htm", "contextRef": "FD2019Q4YTD", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:ShortTermDebtTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R27": { "firstAnchor": { "ancestors": [ "span", "div", "div", "body", "html" ], "baseRef": "a-10312019x10k.htm", "contextRef": "FD2019Q4YTD", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:LongTermDebtTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "2124100 - Disclosure - LONG-TERM DEBT", "role": "http://www.agilent.com/role/LongTermDebt", "shortName": "LONG-TERM DEBT", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "span", "div", "div", "body", "html" ], "baseRef": "a-10312019x10k.htm", "contextRef": "FD2019Q4YTD", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:LongTermDebtTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R28": { "firstAnchor": { "ancestors": [ "div", "body", "html" ], "baseRef": "a-10312019x10k.htm", "contextRef": "FD2019Q4YTD", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:StockholdersEquityNoteDisclosureTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "2127100 - Disclosure - STOCKHOLDERS' EQUITY", "role": "http://www.agilent.com/role/StockholdersEquity", "shortName": "STOCKHOLDERS' EQUITY", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "div", "body", "html" ], "baseRef": "a-10312019x10k.htm", "contextRef": "FD2019Q4YTD", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:StockholdersEquityNoteDisclosureTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R29": { "firstAnchor": { "ancestors": [ "span", "div", "div", "body", "html" ], "baseRef": "a-10312019x10k.htm", "contextRef": "FD2019Q4YTD", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:SegmentReportingDisclosureTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "2128100 - Disclosure - SEGMENT INFORMATION", "role": "http://www.agilent.com/role/SegmentInformation", "shortName": "SEGMENT INFORMATION", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "span", "div", "div", "body", "html" ], "baseRef": "a-10312019x10k.htm", "contextRef": "FD2019Q4YTD", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:SegmentReportingDisclosureTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R3": { "firstAnchor": { "ancestors": [ "span", "span", "div", "td", "tr", "table", "div", "div", "div", "body", "html" ], "baseRef": "a-10312019x10k.htm", "contextRef": "FD2019Q4YTD", "decimals": "-6", "first": true, "lang": null, "name": "us-gaap:ProfitLoss", "reportCount": 1, "unitRef": "usd", "xsiNil": "false" }, "groupType": "statement", "isDefault": "false", "longName": "1003000 - Statement - CONSOLIDATED STATEMENT OF COMPREHENSIVE INCOME", "role": "http://www.agilent.com/role/ConsolidatedStatementOfComprehensiveIncome", "shortName": "CONSOLIDATED STATEMENT OF COMPREHENSIVE INCOME", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "span", "span", "div", "td", "tr", "table", "div", "div", "div", "body", "html" ], "baseRef": "a-10312019x10k.htm", "contextRef": "FD2019Q4YTD", "decimals": "-6", "lang": null, "name": "us-gaap:OtherComprehensiveIncomeUnrealizedGainLossOnDerivativesArisingDuringPeriodNetOfTax", "reportCount": 1, "unique": true, "unitRef": "usd", "xsiNil": "false" } }, "R30": { "firstAnchor": { "ancestors": [ "div", "body", "html" ], "baseRef": "a-10312019x10k.htm", "contextRef": "FD2019Q4YTD", "decimals": null, "first": true, "lang": "en-US", "name": "srt:ScheduleOfValuationAndQualifyingAccountsDisclosureTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "", "isDefault": "false", "longName": "2130100 - Schedule - Schedule II Valuation and Qualifying Accounts", "role": "http://www.agilent.com/role/ScheduleIiValuationAndQualifyingAccounts", "shortName": "Schedule II Valuation and Qualifying Accounts", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "div", "body", "html" ], "baseRef": "a-10312019x10k.htm", "contextRef": "FD2019Q4YTD", "decimals": null, "first": true, "lang": "en-US", "name": "srt:ScheduleOfValuationAndQualifyingAccountsDisclosureTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R31": { "firstAnchor": { "ancestors": [ "ix:continuation", "div", "body", "html" ], "baseRef": "a-10312019x10k.htm", "contextRef": "FD2019Q4YTD", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:BusinessDescriptionAndBasisOfPresentationTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "2201201 - Disclosure - OVERVIEW AND SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Policies)", "role": "http://www.agilent.com/role/OverviewAndSummaryOfSignificantAccountingPoliciesPolicies", "shortName": "OVERVIEW AND SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Policies)", "subGroupType": "policies", "uniqueAnchor": { "ancestors": [ "ix:continuation", "div", "body", "html" ], "baseRef": "a-10312019x10k.htm", "contextRef": "FD2019Q4YTD", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:BusinessDescriptionAndBasisOfPresentationTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R32": { "firstAnchor": { "ancestors": [ "div", "body", "html" ], "baseRef": "a-10312019x10k.htm", "contextRef": "FD2019Q4YTD", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:ScheduleOfNewAccountingPronouncementsAndChangesInAccountingPrinciplesTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "2305301 - Disclosure - NEW ACCOUNTING PRONOUNCEMENTS (Tables)", "role": "http://www.agilent.com/role/NewAccountingPronouncementsTables", "shortName": "NEW ACCOUNTING PRONOUNCEMENTS (Tables)", "subGroupType": "tables", "uniqueAnchor": { "ancestors": [ "div", "body", "html" ], "baseRef": "a-10312019x10k.htm", "contextRef": "FD2019Q4YTD", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:ScheduleOfNewAccountingPronouncementsAndChangesInAccountingPrinciplesTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R33": { "firstAnchor": { "ancestors": [ "ix:continuation", "div", "body", "html" ], "baseRef": "a-10312019x10k.htm", "contextRef": "FD2019Q4YTD", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:ScheduleOfRecognizedIdentifiedAssetsAcquiredAndLiabilitiesAssumedTableTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "2307301 - Disclosure - ACQUISITIONS (Tables)", "role": "http://www.agilent.com/role/AcquisitionsTables", "shortName": "ACQUISITIONS (Tables)", "subGroupType": "tables", "uniqueAnchor": { "ancestors": [ "ix:continuation", "div", "body", "html" ], "baseRef": "a-10312019x10k.htm", "contextRef": "FD2019Q4YTD", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:ScheduleOfRecognizedIdentifiedAssetsAcquiredAndLiabilitiesAssumedTableTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R34": { "firstAnchor": { "ancestors": [ "div", "body", "html" ], "baseRef": "a-10312019x10k.htm", "contextRef": "FD2019Q4YTD", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:DisaggregationOfRevenueTableTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "2308301 - Disclosure - REVENUE REVENUE (Tables)", "role": "http://www.agilent.com/role/RevenueRevenueTables", "shortName": "REVENUE REVENUE (Tables)", "subGroupType": "tables", "uniqueAnchor": { "ancestors": [ "div", "body", "html" ], "baseRef": "a-10312019x10k.htm", "contextRef": "FD2019Q4YTD", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:DisaggregationOfRevenueTableTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R35": { "firstAnchor": { "ancestors": [ "ix:continuation", "div", "body", "html" ], "baseRef": "a-10312019x10k.htm", "contextRef": "FD2019Q4YTD", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "2309301 - Disclosure - SHARE-BASED COMPENSATION (Tables)", "role": "http://www.agilent.com/role/ShareBasedCompensationTables", "shortName": "SHARE-BASED COMPENSATION (Tables)", "subGroupType": "tables", "uniqueAnchor": { "ancestors": [ "ix:continuation", "div", "body", "html" ], "baseRef": "a-10312019x10k.htm", "contextRef": "FD2019Q4YTD", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R36": { "firstAnchor": { "ancestors": [ "ix:continuation", "div", "body", "html" ], "baseRef": "a-10312019x10k.htm", "contextRef": "FD2019Q4YTD", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:ScheduleOfIncomeBeforeIncomeTaxDomesticAndForeignTableTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "2311301 - Disclosure - INCOME TAXES (Tables)", "role": "http://www.agilent.com/role/IncomeTaxesTables", "shortName": "INCOME TAXES (Tables)", "subGroupType": "tables", "uniqueAnchor": { "ancestors": [ "ix:continuation", "div", "body", "html" ], "baseRef": "a-10312019x10k.htm", "contextRef": "FD2019Q4YTD", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:ScheduleOfIncomeBeforeIncomeTaxDomesticAndForeignTableTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R37": { "firstAnchor": { "ancestors": [ "ix:continuation", "div", "body", "html" ], "baseRef": "a-10312019x10k.htm", "contextRef": "FD2019Q4YTD", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "2312301 - Disclosure - NET INCOME (LOSS) PER SHARE (Tables)", "role": "http://www.agilent.com/role/NetIncomeLossPerShareTables", "shortName": "NET INCOME (LOSS) PER SHARE (Tables)", "subGroupType": "tables", "uniqueAnchor": { "ancestors": [ "ix:continuation", "div", "body", "html" ], "baseRef": "a-10312019x10k.htm", "contextRef": "FD2019Q4YTD", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R38": { "firstAnchor": { "ancestors": [ "ix:continuation", "div", "body", "html" ], "baseRef": "a-10312019x10k.htm", "contextRef": "FD2019Q4YTD", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:ScheduleOfInventoryCurrentTableTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "2313301 - Disclosure - INVENTORY (Tables)", "role": "http://www.agilent.com/role/InventoryTables", "shortName": "INVENTORY (Tables)", "subGroupType": "tables", "uniqueAnchor": { "ancestors": [ "ix:continuation", "div", "body", "html" ], "baseRef": "a-10312019x10k.htm", "contextRef": "FD2019Q4YTD", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:ScheduleOfInventoryCurrentTableTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R39": { "firstAnchor": { "ancestors": [ "ix:continuation", "div", "body", "html" ], "baseRef": "a-10312019x10k.htm", "contextRef": "FD2019Q4YTD", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:PropertyPlantAndEquipmentTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "2314301 - Disclosure - PROPERTY, PLANT AND EQUIPMENT, NET (Tables)", "role": "http://www.agilent.com/role/PropertyPlantAndEquipmentNetTables", "shortName": "PROPERTY, PLANT AND EQUIPMENT, NET (Tables)", "subGroupType": "tables", "uniqueAnchor": { "ancestors": [ "ix:continuation", "div", "body", "html" ], "baseRef": "a-10312019x10k.htm", "contextRef": "FD2019Q4YTD", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:PropertyPlantAndEquipmentTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R4": { "firstAnchor": { "ancestors": [ "span", "span", "div", "td", "tr", "table", "div", "div", "us-gaap:ReclassificationOutOfAccumulatedOtherComprehensiveIncomeTableTextBlock", "ix:continuation", "div", "body", "html" ], "baseRef": "a-10312019x10k.htm", "contextRef": "FD2019Q4YTD", "decimals": "-6", "first": true, "lang": null, "name": "us-gaap:OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIOnDerivativesTax", "reportCount": 1, "unitRef": "usd", "xsiNil": "false" }, "groupType": "statement", "isDefault": "false", "longName": "1003001 - Statement - CONSOLIDATED STATEMENT OF COMPREHENSIVE INCOME (Parenthetical)", "role": "http://www.agilent.com/role/ConsolidatedStatementOfComprehensiveIncomeParenthetical", "shortName": "CONSOLIDATED STATEMENT OF COMPREHENSIVE INCOME (Parenthetical)", "subGroupType": "parenthetical", "uniqueAnchor": null }, "R40": { "firstAnchor": { "ancestors": [ "ix:continuation", "div", "body", "html" ], "baseRef": "a-10312019x10k.htm", "contextRef": "FD2019Q4YTD", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:ScheduleOfGoodwillTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "2315301 - Disclosure - GOODWILL AND OTHER INTANGIBLE ASSETS (Tables)", "role": "http://www.agilent.com/role/GoodwillAndOtherIntangibleAssetsTables", "shortName": "GOODWILL AND OTHER INTANGIBLE ASSETS (Tables)", "subGroupType": "tables", "uniqueAnchor": { "ancestors": [ "ix:continuation", "div", "body", "html" ], "baseRef": "a-10312019x10k.htm", "contextRef": "FD2019Q4YTD", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:ScheduleOfGoodwillTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R41": { "firstAnchor": { "ancestors": [ "ix:continuation", "div", "body", "html" ], "baseRef": "a-10312019x10k.htm", "contextRef": "FD2019Q4YTD", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:MarketableSecuritiesTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "2316301 - Disclosure - INVESTMENTS (Tables)", "role": "http://www.agilent.com/role/InvestmentsTables", "shortName": "INVESTMENTS (Tables)", "subGroupType": "tables", "uniqueAnchor": { "ancestors": [ "ix:continuation", "div", "body", "html" ], "baseRef": "a-10312019x10k.htm", "contextRef": "FD2019Q4YTD", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:MarketableSecuritiesTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R42": { "firstAnchor": { "ancestors": [ "ix:continuation", "div", "body", "html" ], "baseRef": "a-10312019x10k.htm", "contextRef": "FD2019Q4YTD", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "2318301 - Disclosure - FAIR VALUE MEASUREMENTS (Tables)", "role": "http://www.agilent.com/role/FairValueMeasurementsTables", "shortName": "FAIR VALUE MEASUREMENTS (Tables)", "subGroupType": "tables", "uniqueAnchor": { "ancestors": [ "ix:continuation", "div", "body", "html" ], "baseRef": "a-10312019x10k.htm", "contextRef": "FD2019Q4YTD", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R43": { "firstAnchor": { "ancestors": [ "span", "div", "ix:continuation", "div", "body", "html" ], "baseRef": "a-10312019x10k.htm", "contextRef": "FD2019Q4YTD", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:ScheduleOfDerivativeInstrumentsTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "2319301 - Disclosure - DERIVATIVES (Tables)", "role": "http://www.agilent.com/role/DerivativesTables", "shortName": "DERIVATIVES (Tables)", "subGroupType": "tables", "uniqueAnchor": { "ancestors": [ "span", "div", "ix:continuation", "div", "body", "html" ], "baseRef": "a-10312019x10k.htm", "contextRef": "FD2019Q4YTD", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:ScheduleOfDerivativeInstrumentsTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R44": { "firstAnchor": { "ancestors": [ "ix:continuation", "div", "body", "html" ], "baseRef": "a-10312019x10k.htm", "contextRef": "FD2019Q4YTD", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:ScheduleOfDefinedBenefitPlansDisclosuresTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "2320301 - Disclosure - RETIREMENT PLANS AND POST RETIREMENT PENSION PLANS (Tables)", "role": "http://www.agilent.com/role/RetirementPlansAndPostRetirementPensionPlansTables", "shortName": "RETIREMENT PLANS AND POST RETIREMENT PENSION PLANS (Tables)", "subGroupType": "tables", "uniqueAnchor": { "ancestors": [ "ix:continuation", "div", "body", "html" ], "baseRef": "a-10312019x10k.htm", "contextRef": "FD2019Q4YTD", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:ScheduleOfDefinedBenefitPlansDisclosuresTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R45": { "firstAnchor": { "ancestors": [ "ix:continuation", "div", "body", "html" ], "baseRef": "a-10312019x10k.htm", "contextRef": "FD2019Q4YTD", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:ScheduleOfProductWarrantyLiabilityTableTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "2321301 - Disclosure - GUARANTEES (Tables)", "role": "http://www.agilent.com/role/GuaranteesTables", "shortName": "GUARANTEES (Tables)", "subGroupType": "tables", "uniqueAnchor": { "ancestors": [ "ix:continuation", "div", "body", "html" ], "baseRef": "a-10312019x10k.htm", "contextRef": "FD2019Q4YTD", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:ScheduleOfProductWarrantyLiabilityTableTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R46": { "firstAnchor": { "ancestors": [ "us-gaap:CommitmentsAndContingenciesDisclosureTextBlock", "div", "body", "html" ], "baseRef": "a-10312019x10k.htm", "contextRef": "FD2019Q4YTD", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:ScheduleOfFutureMinimumRentalPaymentsForOperatingLeasesTableTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "2322301 - Disclosure - COMMITMENTS AND CONTINGENCIES (Tables)", "role": "http://www.agilent.com/role/CommitmentsAndContingenciesTables", "shortName": "COMMITMENTS AND CONTINGENCIES (Tables)", "subGroupType": "tables", "uniqueAnchor": { "ancestors": [ "us-gaap:CommitmentsAndContingenciesDisclosureTextBlock", "div", "body", "html" ], "baseRef": "a-10312019x10k.htm", "contextRef": "FD2019Q4YTD", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:ScheduleOfFutureMinimumRentalPaymentsForOperatingLeasesTableTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R47": { "firstAnchor": { "ancestors": [ "ix:continuation", "div", "body", "html" ], "baseRef": "a-10312019x10k.htm", "contextRef": "FD2019Q4YTD", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:ScheduleOfDebtInstrumentsTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "2324301 - Disclosure - LONG-TERM DEBT (Tables)", "role": "http://www.agilent.com/role/LongTermDebtTables", "shortName": "LONG-TERM DEBT (Tables)", "subGroupType": "tables", "uniqueAnchor": { "ancestors": [ "ix:continuation", "div", "body", "html" ], "baseRef": "a-10312019x10k.htm", "contextRef": "FD2019Q4YTD", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:ScheduleOfDebtInstrumentsTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R48": { "firstAnchor": { "ancestors": [ "ix:continuation", "div", "body", "html" ], "baseRef": "a-10312019x10k.htm", "contextRef": "FD2019Q4YTD", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:ScheduleOfAccumulatedOtherComprehensiveIncomeLossTableTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "2327301 - Disclosure - STOCKHOLDERS' EQUITY (Tables)", "role": "http://www.agilent.com/role/StockholdersEquityTables", "shortName": "STOCKHOLDERS' EQUITY (Tables)", "subGroupType": "tables", "uniqueAnchor": { "ancestors": [ "ix:continuation", "div", "body", "html" ], "baseRef": "a-10312019x10k.htm", "contextRef": "FD2019Q4YTD", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:ScheduleOfAccumulatedOtherComprehensiveIncomeLossTableTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R49": { "firstAnchor": { "ancestors": [ "ix:continuation", "div", "body", "html" ], "baseRef": "a-10312019x10k.htm", "contextRef": "FD2019Q4YTD", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:ScheduleOfSegmentReportingInformationBySegmentTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "2328301 - Disclosure - SEGMENT INFORMATION (Tables)", "role": "http://www.agilent.com/role/SegmentInformationTables", "shortName": "SEGMENT INFORMATION (Tables)", "subGroupType": "tables", "uniqueAnchor": { "ancestors": [ "ix:continuation", "div", "body", "html" ], "baseRef": "a-10312019x10k.htm", "contextRef": "FD2019Q4YTD", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:ScheduleOfSegmentReportingInformationBySegmentTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R5": { "firstAnchor": { "ancestors": [ "span", "span", "div", "td", "tr", "table", "div", "div", "div", "body", "html" ], "baseRef": "a-10312019x10k.htm", "contextRef": "FI2019Q4", "decimals": "-6", "first": true, "lang": null, "name": "us-gaap:CashAndCashEquivalentsAtCarryingValue", "reportCount": 1, "unitRef": "usd", "xsiNil": "false" }, "groupType": "statement", "isDefault": "false", "longName": "1004000 - Statement - CONSOLIDATED BALANCE SHEET", "role": "http://www.agilent.com/role/ConsolidatedBalanceSheet", "shortName": "CONSOLIDATED BALANCE SHEET", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "span", "span", "div", "td", "tr", "table", "div", "div", "div", "body", "html" ], "baseRef": "a-10312019x10k.htm", "contextRef": "FI2019Q4", "decimals": "-6", "lang": null, "name": "us-gaap:ShortTermBorrowings", "reportCount": 1, "unique": true, "unitRef": "usd", "xsiNil": "false" } }, "R50": { "firstAnchor": { "ancestors": [ "span", "span", "div", "us-gaap:GoodwillAndIntangibleAssetsPolicyTextBlock", "ix:continuation", "div", "body", "html" ], "baseRef": "a-10312019x10k.htm", "contextRef": "FD2019Q4YTD", "decimals": "-6", "first": true, "lang": null, "name": "us-gaap:GoodwillImpairmentLoss", "reportCount": 1, "unitRef": "usd", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "2401402 - Disclosure - OVERVIEW AND SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Details)", "role": "http://www.agilent.com/role/OverviewAndSummaryOfSignificantAccountingPoliciesDetails", "shortName": "OVERVIEW AND SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "span", "span", "div", "us-gaap:AdvertisingCostsPolicyTextBlock", "ix:continuation", "div", "body", "html" ], "baseRef": "a-10312019x10k.htm", "contextRef": "FD2019Q4YTD", "decimals": "-6", "lang": null, "name": "us-gaap:AdvertisingExpense", "reportCount": 1, "unique": true, "unitRef": "usd", "xsiNil": "false" } }, "R51": { "firstAnchor": { "ancestors": [ "span", "span", "div", "td", "tr", "table", "div", "div", "div", "body", "html" ], "baseRef": "a-10312019x10k.htm", "contextRef": "FI2019Q4", "decimals": "-6", "first": true, "lang": null, "name": "us-gaap:CashAndCashEquivalentsAtCarryingValue", "reportCount": 1, "unitRef": "usd", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "2405402 - Disclosure - NEW ACCOUNTING PRONOUNCEMENTS - Impact of adopting new guidance (Details)", "role": "http://www.agilent.com/role/NewAccountingPronouncementsImpactOfAdoptingNewGuidanceDetails", "shortName": "NEW ACCOUNTING PRONOUNCEMENTS - Impact of adopting new guidance (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "span", "span", "div", "td", "tr", "table", "div", "div", "ix:continuation", "us-gaap:ScheduleOfNewAccountingPronouncementsAndChangesInAccountingPrinciplesTextBlock", "div", "body", "html" ], "baseRef": "a-10312019x10k.htm", "contextRef": "I2019Q1_11_1_18", "decimals": "-6", "lang": null, "name": "us-gaap:AccountsReceivableNetCurrent", "reportCount": 1, "unique": true, "unitRef": "usd", "xsiNil": "false" } }, "R52": { "firstAnchor": { "ancestors": [ "span", "span", "div", "td", "tr", "table", "div", "div", "us-gaap:ScheduleOfAccumulatedOtherComprehensiveIncomeLossTableTextBlock", "ix:continuation", "div", "body", "html" ], "baseRef": "a-10312019x10k.htm", "contextRef": "D2019Q1_Adoption_date", "decimals": "-6", "first": true, "lang": null, "name": "us-gaap:NewAccountingPronouncementOrChangeInAccountingPrincipleEffectOfAdoptionQuantification", "reportCount": 1, "unitRef": "usd", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "2405403 - Disclosure - NEW ACCOUNTING PRONOUNCEMENTS - Textuals (Details)", "role": "http://www.agilent.com/role/NewAccountingPronouncementsTextualsDetails", "shortName": "NEW ACCOUNTING PRONOUNCEMENTS - Textuals (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "span", "span", "div", "ix:continuation", "div", "body", "html" ], "baseRef": "a-10312019x10k.htm", "contextRef": "FI2019Q4", "decimals": "-6", "lang": null, "name": "us-gaap:OperatingLeaseRightOfUseAsset", "reportCount": 1, "unique": true, "unitRef": "usd", "xsiNil": "false" } }, "R53": { "firstAnchor": { "ancestors": [ "span", "span", "div", "td", "tr", "table", "div", "div", "div", "body", "html" ], "baseRef": "a-10312019x10k.htm", "contextRef": "FI2019Q4", "decimals": "-6", "first": true, "lang": null, "name": "us-gaap:CashAndCashEquivalentsAtCarryingValue", "reportCount": 1, "unitRef": "usd", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "2405404 - Disclosure - NEW ACCOUNTING PRONOUNCEMENTS NEW ACCOUNTING PRONOUNCEMENTS - Restricted cash (Details)", "role": "http://www.agilent.com/role/NewAccountingPronouncementsNewAccountingPronouncementsRestrictedCashDetails", "shortName": "NEW ACCOUNTING PRONOUNCEMENTS NEW ACCOUNTING PRONOUNCEMENTS - Restricted cash (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "span", "span", "div", "td", "tr", "table", "div", "div", "ix:continuation", "ix:continuation", "div", "body", "html" ], "baseRef": "a-10312019x10k.htm", "contextRef": "FI2019Q4", "decimals": "-6", "lang": null, "name": "us-gaap:RestrictedCashNoncurrent", "reportCount": 1, "unique": true, "unitRef": "usd", "xsiNil": "false" } }, "R54": { "firstAnchor": { "ancestors": [ "span", "span", "div", "td", "tr", "table", "div", "div", "ix:continuation", "us-gaap:DisaggregationOfRevenueTableTextBlock", "div", "body", "html" ], "baseRef": "a-10312019x10k.htm", "contextRef": "FD2019Q4YTD", "decimals": "-6", "first": true, "lang": null, "name": "us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax", "reportCount": 1, "unitRef": "usd", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "2407402 - Disclosure - ACQUISITIONS - Text (Details)", "role": "http://www.agilent.com/role/AcquisitionsTextDetails", "shortName": "ACQUISITIONS - Text (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "span", "span", "div", "ix:continuation", "div", "body", "html" ], "baseRef": "a-10312019x10k.htm", "contextRef": "FD2019Q4YTD_us-gaap_BusinessAcquisitionAxis_a_ACEABiosciencesInc.Member", "decimals": "-6", "lang": null, "name": "us-gaap:BusinessCombinationConsiderationTransferred1", "reportCount": 1, "unique": true, "unitRef": "usd", "xsiNil": "false" } }, "R55": { "firstAnchor": { "ancestors": [ "span", "span", "div", "td", "tr", "table", "div", "div", "us-gaap:ScheduleOfGoodwillTextBlock", "ix:continuation", "div", "body", "html" ], "baseRef": "a-10312019x10k.htm", "contextRef": "FD2019Q4YTD", "decimals": "-6", "first": true, "lang": null, "name": "us-gaap:GoodwillAcquiredDuringPeriod", "reportCount": 1, "unitRef": "usd", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "2407403 - Disclosure - ACQUISITIONS - Assets and Liabilities Assumed (Details)", "role": "http://www.agilent.com/role/AcquisitionsAssetsAndLiabilitiesAssumedDetails", "shortName": "ACQUISITIONS - Assets and Liabilities Assumed (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "span", "span", "div", "td", "tr", "table", "div", "div", "us-gaap:ScheduleOfRecognizedIdentifiedAssetsAcquiredAndLiabilitiesAssumedTableTextBlock", "ix:continuation", "div", "body", "html" ], "baseRef": "a-10312019x10k.htm", "contextRef": "FI2019Q4_us-gaap_BusinessAcquisitionAxis_a_BioTekMember", "decimals": "-6", "lang": null, "name": "us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCashAndEquivalents", "reportCount": 1, "unique": true, "unitRef": "usd", "xsiNil": "false" } }, "R56": { "firstAnchor": { "ancestors": [ "span", "span", "div", "td", "tr", "table", "div", "div", "a:ScheduleOfOtherIntangibleAssetsByMajorClassTextBlock", "ix:continuation", "div", "body", "html" ], "baseRef": "a-10312019x10k.htm", "contextRef": "FI2019Q4", "decimals": "-6", "first": true, "lang": null, "name": "us-gaap:FiniteLivedIntangibleAssetsGross", "reportCount": 1, "unitRef": "usd", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "2407404 - Disclosure - ACQUISITIONS ACQUISITIONS - Intangible Assets (Details)", "role": "http://www.agilent.com/role/AcquisitionsAcquisitionsIntangibleAssetsDetails", "shortName": "ACQUISITIONS ACQUISITIONS - Intangible Assets (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "span", "span", "div", "td", "tr", "table", "div", "div", "us-gaap:FiniteLivedAndIndefiniteLivedIntangibleAssetsAcquiredAsPartOfBusinessCombinationTableTextBlock", "ix:continuation", "div", "body", "html" ], "baseRef": "a-10312019x10k.htm", "contextRef": "FI2019Q4_us-gaap_BusinessAcquisitionAxis_a_BioTekMember", "decimals": "-6", "lang": null, "name": "us-gaap:FiniteLivedIntangibleAssetsGross", "reportCount": 1, "unique": true, "unitRef": "usd", "xsiNil": "false" } }, "R57": { "firstAnchor": { "ancestors": [ "span", "span", "div", "td", "tr", "table", "div", "div", "us-gaap:BusinessAcquisitionProFormaInformationTextBlock", "ix:continuation", "div", "body", "html" ], "baseRef": "a-10312019x10k.htm", "contextRef": "FD2019Q4YTD", "decimals": "-6", "first": true, "lang": null, "name": "us-gaap:BusinessAcquisitionsProFormaRevenue", "reportCount": 1, "unique": true, "unitRef": "usd", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "2407405 - Disclosure - ACQUISITIONS ACQUISITIONS - Proforma Operating Results (Details)", "role": "http://www.agilent.com/role/AcquisitionsAcquisitionsProformaOperatingResultsDetails", "shortName": "ACQUISITIONS ACQUISITIONS - Proforma Operating Results (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "span", "span", "div", "td", "tr", "table", "div", "div", "us-gaap:BusinessAcquisitionProFormaInformationTextBlock", "ix:continuation", "div", "body", "html" ], "baseRef": "a-10312019x10k.htm", "contextRef": "FD2019Q4YTD", "decimals": "-6", "first": true, "lang": null, "name": "us-gaap:BusinessAcquisitionsProFormaRevenue", "reportCount": 1, "unique": true, "unitRef": "usd", "xsiNil": "false" } }, "R58": { "firstAnchor": { "ancestors": [ "span", "span", "div", "td", "tr", "table", "div", "div", "ix:continuation", "us-gaap:DisaggregationOfRevenueTableTextBlock", "div", "body", "html" ], "baseRef": "a-10312019x10k.htm", "contextRef": "FD2019Q4YTD", "decimals": "-6", "first": true, "lang": null, "name": "us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax", "reportCount": 1, "unitRef": "usd", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "2408402 - Disclosure - REVENUE - Revenue by Region (Details)", "role": "http://www.agilent.com/role/RevenueRevenueByRegionDetails", "shortName": "REVENUE - Revenue by Region (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "span", "span", "div", "td", "tr", "table", "div", "div", "ix:continuation", "us-gaap:DisaggregationOfRevenueTableTextBlock", "div", "body", "html" ], "baseRef": "a-10312019x10k.htm", "contextRef": "FD2019Q4YTD_srt_StatementGeographicalAxis_srt_AmericasMember", "decimals": "-6", "lang": null, "name": "us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax", "reportCount": 1, "unique": true, "unitRef": "usd", "xsiNil": "false" } }, "R59": { "firstAnchor": { "ancestors": [ "span", "span", "div", "td", "tr", "table", "div", "div", "ix:continuation", "us-gaap:DisaggregationOfRevenueTableTextBlock", "div", "body", "html" ], "baseRef": "a-10312019x10k.htm", "contextRef": "FD2019Q4YTD", "decimals": "-6", "first": true, "lang": null, "name": "us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax", "reportCount": 1, "unitRef": "usd", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "2408403 - Disclosure - REVENUE - Revenue by End Markets (Details)", "role": "http://www.agilent.com/role/RevenueRevenueByEndMarketsDetails", "shortName": "REVENUE - Revenue by End Markets (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "span", "span", "div", "td", "tr", "table", "div", "div", "ix:continuation", "ix:continuation", "div", "body", "html" ], "baseRef": "a-10312019x10k.htm", "contextRef": "FD2019Q4YTD_a_EndMarketsAxis_a_PharmaceuticalandBiopharmaceuticalMarketMember", "decimals": "-6", "lang": null, "name": "us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax", "reportCount": 1, "unique": true, "unitRef": "usd", "xsiNil": "false" } }, "R6": { "firstAnchor": null, "groupType": "statement", "isDefault": "false", "longName": "1004501 - Statement - CONSOLIDATED BALANCE SHEET (Parenthetical)", "role": "http://www.agilent.com/role/ConsolidatedBalanceSheetParenthetical", "shortName": "CONSOLIDATED BALANCE SHEET (Parenthetical)", "subGroupType": "parenthetical", "uniqueAnchor": null }, "R60": { "firstAnchor": { "ancestors": [ "span", "span", "div", "td", "tr", "table", "div", "div", "ix:continuation", "us-gaap:DisaggregationOfRevenueTableTextBlock", "div", "body", "html" ], "baseRef": "a-10312019x10k.htm", "contextRef": "FD2019Q4YTD", "decimals": "-6", "first": true, "lang": null, "name": "us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax", "reportCount": 1, "unitRef": "usd", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "2408404 - Disclosure - REVENUE REVENUE - Revenue by Type (Details)", "role": "http://www.agilent.com/role/RevenueRevenueRevenueByTypeDetails", "shortName": "REVENUE REVENUE - Revenue by Type (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "span", "span", "div", "td", "tr", "table", "div", "div", "ix:continuation", "ix:continuation", "div", "body", "html" ], "baseRef": "a-10312019x10k.htm", "contextRef": "FD2019Q4YTD_srt_ProductOrServiceAxis_a_InstrumentationMember", "decimals": "-6", "lang": null, "name": "us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax", "reportCount": 1, "unique": true, "unitRef": "usd", "xsiNil": "false" } }, "R61": { "firstAnchor": { "ancestors": [ "span", "span", "ix:continuation", "div", "div", "body", "html" ], "baseRef": "a-10312019x10k.htm", "contextRef": "FI2019Q4", "decimals": "-6", "first": true, "lang": null, "name": "us-gaap:RevenueRemainingPerformanceObligation", "reportCount": 1, "unique": true, "unitRef": "usd", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "2408405 - Disclosure - REVENUE REVENUE - Contract Balances (Details)", "role": "http://www.agilent.com/role/RevenueRevenueContractBalancesDetails", "shortName": "REVENUE REVENUE - Contract Balances (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "span", "span", "ix:continuation", "div", "div", "body", "html" ], "baseRef": "a-10312019x10k.htm", "contextRef": "FI2019Q4", "decimals": "-6", "first": true, "lang": null, "name": "us-gaap:RevenueRemainingPerformanceObligation", "reportCount": 1, "unique": true, "unitRef": "usd", "xsiNil": "false" } }, "R62": { "firstAnchor": { "ancestors": [ "span", "span", "div", "ix:continuation", "div", "body", "html" ], "baseRef": "a-10312019x10k.htm", "contextRef": "FI2019Q4", "decimals": "INF", "first": true, "lang": null, "name": "us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardMaximumEmployeeSubscriptionRate", "reportCount": 1, "unique": true, "unitRef": "number", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "2409402 - Disclosure - SHARE-BASED COMPENSATION General Disclosures (Details)", "role": "http://www.agilent.com/role/ShareBasedCompensationGeneralDisclosuresDetails", "shortName": "SHARE-BASED COMPENSATION General Disclosures (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "span", "span", "div", "ix:continuation", "div", "body", "html" ], "baseRef": "a-10312019x10k.htm", "contextRef": "FI2019Q4", "decimals": "INF", "first": true, "lang": null, "name": "us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardMaximumEmployeeSubscriptionRate", "reportCount": 1, "unique": true, "unitRef": "number", "xsiNil": "false" } }, "R63": { "firstAnchor": { "ancestors": [ "span", "span", "div", "td", "tr", "table", "div", "div", "us-gaap:ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTextBlock", "ix:continuation", "div", "body", "html" ], "baseRef": "a-10312019x10k.htm", "contextRef": "FD2019Q4YTD", "decimals": "-6", "first": true, "lang": null, "name": "us-gaap:AllocatedShareBasedCompensationExpense", "reportCount": 1, "unitRef": "usd", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "2409403 - Disclosure - SHARE-BASED COMPENSATION Allocated Share-based compensation expense (Details)", "role": "http://www.agilent.com/role/ShareBasedCompensationAllocatedShareBasedCompensationExpenseDetails", "shortName": "SHARE-BASED COMPENSATION Allocated Share-based compensation expense (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "span", "span", "div", "td", "tr", "table", "div", "div", "us-gaap:ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTextBlock", "ix:continuation", "div", "body", "html" ], "baseRef": "a-10312019x10k.htm", "contextRef": "FD2019Q4YTD_us-gaap_IncomeStatementLocationAxis_us-gaap_CostOfSalesMember", "decimals": "-6", "lang": null, "name": "us-gaap:AllocatedShareBasedCompensationExpense", "reportCount": 1, "unique": true, "unitRef": "usd", "xsiNil": "false" } }, "R64": { "firstAnchor": { "ancestors": [ "span", "span", "div", "td", "tr", "table", "div", "div", "a:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsAndMethodologyTextBlock", "ix:continuation", "div", "body", "html" ], "baseRef": "a-10312019x10k.htm", "contextRef": "FD2019Q4YTD_us-gaap_AwardTypeAxis_a_LtppMember", "decimals": "2", "first": true, "lang": null, "name": "us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate", "reportCount": 1, "unique": true, "unitRef": "number", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "2409404 - Disclosure - SHARE-BASED COMPENSATION-Fair Value Assumptions (Details)", "role": "http://www.agilent.com/role/ShareBasedCompensationFairValueAssumptionsDetails", "shortName": "SHARE-BASED COMPENSATION-Fair Value Assumptions (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "span", "span", "div", "td", "tr", "table", "div", "div", "a:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsAndMethodologyTextBlock", "ix:continuation", "div", "body", "html" ], "baseRef": "a-10312019x10k.htm", "contextRef": "FD2019Q4YTD_us-gaap_AwardTypeAxis_a_LtppMember", "decimals": "2", "first": true, "lang": null, "name": "us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate", "reportCount": 1, "unique": true, "unitRef": "number", "xsiNil": "false" } }, "R65": { "firstAnchor": { "ancestors": [ "span", "span", "div", "td", "tr", "table", "div", "div", "us-gaap:DisclosureOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTextBlock", "ix:continuation", "div", "body", "html" ], "baseRef": "a-10312019x10k.htm", "contextRef": "FI2018Q4", "decimals": "-3", "first": true, "lang": null, "name": "us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber", "reportCount": 1, "unitRef": "shares", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "2409405 - Disclosure - SHARE-BASED COMPENSATION Stock Option Activity (Details)", "role": "http://www.agilent.com/role/ShareBasedCompensationStockOptionActivityDetails", "shortName": "SHARE-BASED COMPENSATION Stock Option Activity (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "span", "span", "div", "td", "tr", "table", "div", "div", "us-gaap:DisclosureOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTextBlock", "ix:continuation", "div", "body", "html" ], "baseRef": "a-10312019x10k.htm", "contextRef": "FD2019Q4YTD", "decimals": "-3", "lang": null, "name": "us-gaap:StockIssuedDuringPeriodSharesStockOptionsExercised", "reportCount": 1, "unique": true, "unitRef": "shares", "xsiNil": "false" } }, "R66": { "firstAnchor": { "ancestors": [ "span", "span", "div", "td", "tr", "table", "div", "div", "us-gaap:ScheduleOfShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeTextBlock", "ix:continuation", "div", "body", "html" ], "baseRef": "a-10312019x10k.htm", "contextRef": "FI2019Q4", "decimals": "-3", "first": true, "lang": null, "name": "us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfOutstandingOptions", "reportCount": 1, "unique": true, "unitRef": "shares", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "2409406 - Disclosure - SHARE-BASED COMPENSATION Shares Authorized by Exercise Price Range (Details)", "role": "http://www.agilent.com/role/ShareBasedCompensationSharesAuthorizedByExercisePriceRangeDetails", "shortName": "SHARE-BASED COMPENSATION Shares Authorized by Exercise Price Range (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "span", "span", "div", "td", "tr", "table", "div", "div", "us-gaap:ScheduleOfShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeTextBlock", "ix:continuation", "div", "body", "html" ], "baseRef": "a-10312019x10k.htm", "contextRef": "FI2019Q4", "decimals": "-3", "first": true, "lang": null, "name": "us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfOutstandingOptions", "reportCount": 1, "unique": true, "unitRef": "shares", "xsiNil": "false" } }, "R67": { "firstAnchor": { "ancestors": [ "span", "span", "div", "td", "tr", "table", "div", "div", "a:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForwardTextBlock", "ix:continuation", "div", "body", "html" ], "baseRef": "a-10312019x10k.htm", "contextRef": "FI2018Q4", "decimals": "-3", "first": true, "lang": null, "name": "us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber", "reportCount": 1, "unitRef": "shares", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "2409407 - Disclosure - SHARE-BASED COMPENSATION Non-vested award activity disclosure (Details)", "role": "http://www.agilent.com/role/ShareBasedCompensationNonVestedAwardActivityDisclosureDetails", "shortName": "SHARE-BASED COMPENSATION Non-vested award activity disclosure (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "span", "span", "div", "td", "tr", "table", "div", "div", "a:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForwardTextBlock", "ix:continuation", "div", "body", "html" ], "baseRef": "a-10312019x10k.htm", "contextRef": "FD2019Q4YTD", "decimals": "-3", "lang": null, "name": "us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod", "reportCount": 1, "unique": true, "unitRef": "shares", "xsiNil": "false" } }, "R68": { "firstAnchor": { "ancestors": [ "span", "span", "div", "ix:continuation", "div", "body", "html" ], "baseRef": "a-10312019x10k.htm", "contextRef": "FD2019Q4YTD", "decimals": "-6", "first": true, "lang": null, "name": "us-gaap:IncomeTaxReconciliationOtherReconcilingItems", "reportCount": 1, "unitRef": "usd", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "2411402 - Disclosure - INCOME TAXES INCOME TAXES- Provision (Details)", "role": "http://www.agilent.com/role/IncomeTaxesIncomeTaxesProvisionDetails", "shortName": "INCOME TAXES INCOME TAXES- Provision (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "span", "span", "div", "ix:continuation", "div", "body", "html" ], "baseRef": "a-10312019x10k.htm", "contextRef": "FI2019Q4", "decimals": "-6", "lang": null, "name": "us-gaap:TaxesPayableCurrent", "reportCount": 1, "unique": true, "unitRef": "usd", "xsiNil": "false" } }, "R69": { "firstAnchor": { "ancestors": [ "span", "span", "div", "td", "tr", "table", "div", "div", "us-gaap:ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock", "ix:continuation", "div", "body", "html" ], "baseRef": "a-10312019x10k.htm", "contextRef": "FD2019Q4YTD", "decimals": "-6", "first": true, "lang": null, "name": "us-gaap:IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate", "reportCount": 1, "unique": true, "unitRef": "usd", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "2411403 - Disclosure - INCOME TAXES INCOME TAXES Effective tax rate and tax holidays (Details)", "role": "http://www.agilent.com/role/IncomeTaxesIncomeTaxesEffectiveTaxRateAndTaxHolidaysDetails", "shortName": "INCOME TAXES INCOME TAXES Effective tax rate and tax holidays (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "span", "span", "div", "td", "tr", "table", "div", "div", "us-gaap:ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock", "ix:continuation", "div", "body", "html" ], "baseRef": "a-10312019x10k.htm", "contextRef": "FD2019Q4YTD", "decimals": "-6", "first": true, "lang": null, "name": "us-gaap:IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate", "reportCount": 1, "unique": true, "unitRef": "usd", "xsiNil": "false" } }, "R7": { "firstAnchor": { "ancestors": [ "span", "span", "div", "td", "tr", "table", "div", "div", "div", "body", "html" ], "baseRef": "a-10312019x10k.htm", "contextRef": "FD2019Q4YTD", "decimals": "-6", "first": true, "lang": null, "name": "us-gaap:ProfitLoss", "reportCount": 1, "unitRef": "usd", "xsiNil": "false" }, "groupType": "statement", "isDefault": "false", "longName": "1005000 - Statement - CONSOLIDATED STATEMENT OF CASH FLOWS", "role": "http://www.agilent.com/role/ConsolidatedStatementOfCashFlows", "shortName": "CONSOLIDATED STATEMENT OF CASH FLOWS", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "span", "span", "div", "td", "tr", "table", "div", "div", "div", "body", "html" ], "baseRef": "a-10312019x10k.htm", "contextRef": "FD2019Q4YTD", "decimals": "-6", "lang": null, "name": "us-gaap:DepreciationDepletionAndAmortization", "reportCount": 1, "unique": true, "unitRef": "usd", "xsiNil": "false" } }, "R70": { "firstAnchor": { "ancestors": [ "span", "span", "div", "ix:continuation", "div", "body", "html" ], "baseRef": "a-10312019x10k.htm", "contextRef": "FD2018Q4YTD", "decimals": "-6", "first": true, "lang": null, "name": "us-gaap:TaxCutsAndJobsActOf2017IncomeTaxExpenseBenefit", "reportCount": 1, "unitRef": "usd", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "2411404 - Disclosure - INCOME TAXES - 2017 U.S. Tax Reform - Tax Cuts and Jobs Act (Details)", "role": "http://www.agilent.com/role/IncomeTaxes2017USTaxReformTaxCutsAndJobsActDetails", "shortName": "INCOME TAXES - 2017 U.S. Tax Reform - Tax Cuts and Jobs Act (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "span", "span", "div", "ix:continuation", "div", "body", "html" ], "baseRef": "a-10312019x10k.htm", "contextRef": "FD2018Q4YTD", "decimals": "-6", "lang": null, "name": "us-gaap:TaxCutsAndJobsActOf2017DecreaseInDeferredTaxLiabilityDueToTransitionTax", "reportCount": 1, "unique": true, "unitRef": "usd", "xsiNil": "false" } }, "R71": { "firstAnchor": { "ancestors": [ "span", "span", "div", "td", "tr", "table", "div", "div", "us-gaap:ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock", "ix:continuation", "div", "body", "html" ], "baseRef": "a-10312019x10k.htm", "contextRef": "FI2019Q4", "decimals": "-6", "first": true, "lang": null, "name": "us-gaap:DeferredTaxAssetsGoodwillAndIntangibleAssets", "reportCount": 1, "unique": true, "unitRef": "usd", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "2411405 - Disclosure - INCOME TAXES INCOME TAXES - Deferred Taxes and other (Details)", "role": "http://www.agilent.com/role/IncomeTaxesIncomeTaxesDeferredTaxesAndOtherDetails", "shortName": "INCOME TAXES INCOME TAXES - Deferred Taxes and other (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "span", "span", "div", "td", "tr", "table", "div", "div", "us-gaap:ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock", "ix:continuation", "div", "body", "html" ], "baseRef": "a-10312019x10k.htm", "contextRef": "FI2019Q4", "decimals": "-6", "first": true, "lang": null, "name": "us-gaap:DeferredTaxAssetsGoodwillAndIntangibleAssets", "reportCount": 1, "unique": true, "unitRef": "usd", "xsiNil": "false" } }, "R72": { "firstAnchor": { "ancestors": [ "span", "span", "div", "ix:continuation", "div", "body", "html" ], "baseRef": "a-10312019x10k.htm", "contextRef": "FI2019Q4", "decimals": "-6", "first": true, "lang": null, "name": "us-gaap:DeferredTaxAssetsOperatingLossCarryforwardsDomestic", "reportCount": 1, "unique": true, "unitRef": "usd", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "2411406 - Disclosure - INCOME TAXES - Carryforwards (Details)", "role": "http://www.agilent.com/role/IncomeTaxesCarryforwardsDetails", "shortName": "INCOME TAXES - Carryforwards (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "span", "span", "div", "ix:continuation", "div", "body", "html" ], "baseRef": "a-10312019x10k.htm", "contextRef": "FI2019Q4", "decimals": "-6", "first": true, "lang": null, "name": "us-gaap:DeferredTaxAssetsOperatingLossCarryforwardsDomestic", "reportCount": 1, "unique": true, "unitRef": "usd", "xsiNil": "false" } }, "R73": { "firstAnchor": { "ancestors": [ "span", "span", "div", "td", "tr", "table", "div", "div", "a:CurrentAndLongTermTaxAssetsAndLiabilitiesTableTextBlock", "ix:continuation", "div", "body", "html" ], "baseRef": "a-10312019x10k.htm", "contextRef": "FI2019Q4", "decimals": "-6", "first": true, "lang": null, "name": "us-gaap:IncomeTaxesReceivable", "reportCount": 1, "unique": true, "unitRef": "usd", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "2411407 - Disclosure - INCOME TAXES - Current and long-term income tax assets and liabilities (Details)", "role": "http://www.agilent.com/role/IncomeTaxesCurrentAndLongTermIncomeTaxAssetsAndLiabilitiesDetails", "shortName": "INCOME TAXES - Current and long-term income tax assets and liabilities (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "span", "span", "div", "td", "tr", "table", "div", "div", "a:CurrentAndLongTermTaxAssetsAndLiabilitiesTableTextBlock", "ix:continuation", "div", "body", "html" ], "baseRef": "a-10312019x10k.htm", "contextRef": "FI2019Q4", "decimals": "-6", "first": true, "lang": null, "name": "us-gaap:IncomeTaxesReceivable", "reportCount": 1, "unique": true, "unitRef": "usd", "xsiNil": "false" } }, "R74": { "firstAnchor": { "ancestors": [ "span", "span", "div", "ix:continuation", "div", "body", "html" ], "baseRef": "a-10312019x10k.htm", "contextRef": "FI2019Q4", "decimals": "-6", "first": true, "lang": null, "name": "a:Unrecognizedtaxbenefitincludinginterestandpenalties", "reportCount": 1, "unique": true, "unitRef": "usd", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "2411408 - Disclosure - INCOME TAXES INCOME TAXES - Uncertain Tax Positions (Details)", "role": "http://www.agilent.com/role/IncomeTaxesIncomeTaxesUncertainTaxPositionsDetails", "shortName": "INCOME TAXES INCOME TAXES - Uncertain Tax Positions (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "span", "span", "div", "ix:continuation", "div", "body", "html" ], "baseRef": "a-10312019x10k.htm", "contextRef": "FI2019Q4", "decimals": "-6", "first": true, "lang": null, "name": "a:Unrecognizedtaxbenefitincludinginterestandpenalties", "reportCount": 1, "unique": true, "unitRef": "usd", "xsiNil": "false" } }, "R75": { "firstAnchor": { "ancestors": [ "span", "span", "div", "td", "tr", "table", "div", "div", "div", "body", "html" ], "baseRef": "a-10312019x10k.htm", "contextRef": "FD2019Q4YTD", "decimals": "-6", "first": true, "lang": null, "name": "us-gaap:ProfitLoss", "reportCount": 1, "unitRef": "usd", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "2412402 - Disclosure - NET INCOME (LOSS) PER SHARE (Details)", "role": "http://www.agilent.com/role/NetIncomeLossPerShareDetails", "shortName": "NET INCOME (LOSS) PER SHARE (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "span", "span", "div", "td", "tr", "table", "div", "div", "us-gaap:ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock", "ix:continuation", "div", "body", "html" ], "baseRef": "a-10312019x10k.htm", "contextRef": "FD2019Q4YTD", "decimals": "-6", "lang": null, "name": "us-gaap:IncrementalCommonSharesAttributableToShareBasedPaymentArrangements", "reportCount": 1, "unique": true, "unitRef": "shares", "xsiNil": "false" } }, "R76": { "firstAnchor": { "ancestors": [ "span", "span", "div", "td", "tr", "table", "div", "div", "us-gaap:ScheduleOfInventoryCurrentTableTextBlock", "ix:continuation", "div", "body", "html" ], "baseRef": "a-10312019x10k.htm", "contextRef": "FI2019Q4", "decimals": "-6", "first": true, "lang": null, "name": "us-gaap:InventoryFinishedGoods", "reportCount": 1, "unique": true, "unitRef": "usd", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "2413402 - Disclosure - INVENTORY (Details)", "role": "http://www.agilent.com/role/InventoryDetails", "shortName": "INVENTORY (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "span", "span", "div", "td", "tr", "table", "div", "div", "us-gaap:ScheduleOfInventoryCurrentTableTextBlock", "ix:continuation", "div", "body", "html" ], "baseRef": "a-10312019x10k.htm", "contextRef": "FI2019Q4", "decimals": "-6", "first": true, "lang": null, "name": "us-gaap:InventoryFinishedGoods", "reportCount": 1, "unique": true, "unitRef": "usd", "xsiNil": "false" } }, "R77": { "firstAnchor": { "ancestors": [ "span", "span", "div", "td", "tr", "table", "div", "div", "us-gaap:PropertyPlantAndEquipmentTextBlock", "ix:continuation", "div", "body", "html" ], "baseRef": "a-10312019x10k.htm", "contextRef": "FI2019Q4", "decimals": "-6", "first": true, "lang": null, "name": "us-gaap:Land", "reportCount": 1, "unique": true, "unitRef": "usd", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "2414402 - Disclosure - PROPERTY, PLANT AND EQUIPMENT, NET (Details)", "role": "http://www.agilent.com/role/PropertyPlantAndEquipmentNetDetails", "shortName": "PROPERTY, PLANT AND EQUIPMENT, NET (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "span", "span", "div", "td", "tr", "table", "div", "div", "us-gaap:PropertyPlantAndEquipmentTextBlock", "ix:continuation", "div", "body", "html" ], "baseRef": "a-10312019x10k.htm", "contextRef": "FI2019Q4", "decimals": "-6", "first": true, "lang": null, "name": "us-gaap:Land", "reportCount": 1, "unique": true, "unitRef": "usd", "xsiNil": "false" } }, "R78": { "firstAnchor": { "ancestors": [ "span", "span", "div", "td", "tr", "table", "div", "div", "us-gaap:ScheduleOfGoodwillTextBlock", "ix:continuation", "div", "body", "html" ], "baseRef": "a-10312019x10k.htm", "contextRef": "FD2019Q4YTD", "decimals": "-6", "first": true, "lang": null, "name": "us-gaap:GoodwillAcquiredDuringPeriod", "reportCount": 1, "unitRef": "usd", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "2415402 - Disclosure - GOODWILL AND OTHER INTANGIBLE ASSETS Text (Details)", "role": "http://www.agilent.com/role/GoodwillAndOtherIntangibleAssetsTextDetails", "shortName": "GOODWILL AND OTHER INTANGIBLE ASSETS Text (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "span", "span", "div", "ix:continuation", "div", "body", "html" ], "baseRef": "a-10312019x10k.htm", "contextRef": "FD2018Q4YTD", "decimals": "-6", "lang": null, "name": "us-gaap:FiniteLivedIntangibleAssetsPeriodIncreaseDecrease", "reportCount": 1, "unique": true, "unitRef": "usd", "xsiNil": "false" } }, "R79": { "firstAnchor": { "ancestors": [ "span", "span", "div", "td", "tr", "table", "div", "div", "div", "body", "html" ], "baseRef": "a-10312019x10k.htm", "contextRef": "FI2018Q4", "decimals": "-6", "first": true, "lang": null, "name": "us-gaap:Goodwill", "reportCount": 1, "unitRef": "usd", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "2415403 - Disclosure - GOODWILL AND OTHER INTANGIBLE ASSETS Roll forward (Details)", "role": "http://www.agilent.com/role/GoodwillAndOtherIntangibleAssetsRollForwardDetails", "shortName": "GOODWILL AND OTHER INTANGIBLE ASSETS Roll forward (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "span", "span", "div", "td", "tr", "table", "div", "div", "us-gaap:ScheduleOfGoodwillTextBlock", "ix:continuation", "div", "body", "html" ], "baseRef": "a-10312019x10k.htm", "contextRef": "FD2019Q4YTD", "decimals": "-6", "lang": null, "name": "us-gaap:GoodwillForeignCurrencyTranslationGainLoss", "reportCount": 1, "unique": true, "unitRef": "usd", "xsiNil": "false" } }, "R8": { "firstAnchor": { "ancestors": [ "span", "span", "div", "td", "tr", "table", "div", "div", "div", "body", "html" ], "baseRef": "a-10312019x10k.htm", "contextRef": "FI2016Q4_us-gaap_StatementEquityComponentsAxis_us-gaap_TreasuryStockMember", "decimals": "-3", "first": true, "lang": null, "name": "us-gaap:TreasuryStockShares", "reportCount": 1, "unique": true, "unitRef": "shares", "xsiNil": "false" }, "groupType": "statement", "isDefault": "false", "longName": "1006000 - Statement - CONSOLIDATED STATEMENT OF EQUITY", "role": "http://www.agilent.com/role/ConsolidatedStatementOfEquity", "shortName": "CONSOLIDATED STATEMENT OF EQUITY", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "span", "span", "div", "td", "tr", "table", "div", "div", "div", "body", "html" ], "baseRef": "a-10312019x10k.htm", "contextRef": "FI2016Q4_us-gaap_StatementEquityComponentsAxis_us-gaap_TreasuryStockMember", "decimals": "-3", "first": true, "lang": null, "name": "us-gaap:TreasuryStockShares", "reportCount": 1, "unique": true, "unitRef": "shares", "xsiNil": "false" } }, "R80": { "firstAnchor": { "ancestors": [ "span", "span", "div", "td", "tr", "table", "div", "div", "a:ScheduleOfOtherIntangibleAssetsByMajorClassTextBlock", "ix:continuation", "div", "body", "html" ], "baseRef": "a-10312019x10k.htm", "contextRef": "FI2019Q4", "decimals": "-6", "first": true, "lang": null, "name": "us-gaap:FiniteLivedIntangibleAssetsGross", "reportCount": 1, "unitRef": "usd", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "2415404 - Disclosure - GOODWILL AND OTHER INTANGIBLE ASSETS Disclosures and Components of Other Intangibles (Details)", "role": "http://www.agilent.com/role/GoodwillAndOtherIntangibleAssetsDisclosuresAndComponentsOfOtherIntangiblesDetails", "shortName": "GOODWILL AND OTHER INTANGIBLE ASSETS Disclosures and Components of Other Intangibles (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "span", "span", "div", "td", "tr", "table", "div", "div", "a:ScheduleOfOtherIntangibleAssetsByMajorClassTextBlock", "ix:continuation", "div", "body", "html" ], "baseRef": "a-10312019x10k.htm", "contextRef": "FI2019Q4", "decimals": "-6", "lang": null, "name": "us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization", "reportCount": 1, "unique": true, "unitRef": "usd", "xsiNil": "false" } }, "R81": { "firstAnchor": { "ancestors": [ "span", "span", "div", "ix:continuation", "div", "body", "html" ], "baseRef": "a-10312019x10k.htm", "contextRef": "FD2019Q4YTD", "decimals": "-6", "first": true, "lang": null, "name": "us-gaap:AmortizationOfIntangibleAssets", "reportCount": 1, "unique": true, "unitRef": "usd", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "2415405 - Disclosure - GOODWILL AND OTHER INTANGIBLE ASSETS Amortization Expense and Future Amortization Expense (Details)", "role": "http://www.agilent.com/role/GoodwillAndOtherIntangibleAssetsAmortizationExpenseAndFutureAmortizationExpenseDetails", "shortName": "GOODWILL AND OTHER INTANGIBLE ASSETS Amortization Expense and Future Amortization Expense (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "span", "span", "div", "ix:continuation", "div", "body", "html" ], "baseRef": "a-10312019x10k.htm", "contextRef": "FD2019Q4YTD", "decimals": "-6", "first": true, "lang": null, "name": "us-gaap:AmortizationOfIntangibleAssets", "reportCount": 1, "unique": true, "unitRef": "usd", "xsiNil": "false" } }, "R82": { "firstAnchor": { "ancestors": [ "span", "span", "div", "td", "tr", "table", "div", "div", "us-gaap:MarketableSecuritiesTextBlock", "ix:continuation", "div", "body", "html" ], "baseRef": "a-10312019x10k.htm", "contextRef": "FI2019Q4", "decimals": "-6", "first": true, "lang": null, "name": "us-gaap:EquitySecuritiesWithoutReadilyDeterminableFairValueAmount", "reportCount": 1, "unitRef": "usd", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "2416402 - Disclosure - INVESTMENTS (Details)", "role": "http://www.agilent.com/role/InvestmentsDetails", "shortName": "INVESTMENTS (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "span", "span", "div", "td", "tr", "table", "div", "div", "us-gaap:MarketableSecuritiesTextBlock", "ix:continuation", "div", "body", "html" ], "baseRef": "a-10312019x10k.htm", "contextRef": "FI2019Q4", "decimals": "-6", "lang": null, "name": "us-gaap:EquitySecuritiesFvNi", "reportCount": 1, "unique": true, "unitRef": "usd", "xsiNil": "false" } }, "R83": { "firstAnchor": { "ancestors": [ "span", "span", "div", "td", "tr", "table", "div", "div", "us-gaap:MarketableSecuritiesTextBlock", "ix:continuation", "div", "body", "html" ], "baseRef": "a-10312019x10k.htm", "contextRef": "FI2019Q4", "decimals": "-6", "first": true, "lang": null, "name": "us-gaap:TradingSecurities", "reportCount": 1, "unitRef": "usd", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "2418402 - Disclosure - FAIR VALUE MEASUREMENTS, Fair value of assets and liabilities measured on a recurring basis (Details)", "role": "http://www.agilent.com/role/FairValueMeasurementsFairValueOfAssetsAndLiabilitiesMeasuredOnRecurringBasisDetails", "shortName": "FAIR VALUE MEASUREMENTS, Fair value of assets and liabilities measured on a recurring basis (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "span", "span", "div", "td", "tr", "table", "div", "div", "us-gaap:ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock", "ix:continuation", "div", "body", "html" ], "baseRef": "a-10312019x10k.htm", "contextRef": "FI2019Q4_us-gaap_FairValueByMeasurementFrequencyAxis_us-gaap_FairValueMeasurementsRecurringMember", "decimals": "-6", "lang": null, "name": "us-gaap:CashAndCashEquivalentsFairValueDisclosure", "reportCount": 1, "unique": true, "unitRef": "usd", "xsiNil": "false" } }, "R84": { "firstAnchor": { "ancestors": [ "span", "span", "div", "ix:continuation", "div", "body", "html" ], "baseRef": "a-10312019x10k.htm", "contextRef": "FI2018Q4", "decimals": "-6", "first": true, "lang": null, "name": "us-gaap:ImpairedAssetsToBeDisposedOfByMethodOtherThanSaleCarryingValueOfAsset", "reportCount": 1, "unique": true, "unitRef": "usd", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "2418403 - Disclosure - FAIR VALUE MEASUREMENTS FAIR VALUE MEASURMENTS - Fair value of assets and liabilities measured on non recurring (Details)", "role": "http://www.agilent.com/role/FairValueMeasurementsFairValueMeasurmentsFairValueOfAssetsAndLiabilitiesMeasuredOnNonRecurringDetails", "shortName": "FAIR VALUE MEASUREMENTS FAIR VALUE MEASURMENTS - Fair value of assets and liabilities measured on non recurring (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "span", "span", "div", "ix:continuation", "div", "body", "html" ], "baseRef": "a-10312019x10k.htm", "contextRef": "FI2018Q4", "decimals": "-6", "first": true, "lang": null, "name": "us-gaap:ImpairedAssetsToBeDisposedOfByMethodOtherThanSaleCarryingValueOfAsset", "reportCount": 1, "unique": true, "unitRef": "usd", "xsiNil": "false" } }, "R85": { "firstAnchor": { "ancestors": [ "span", "span", "div", "ix:continuation", "div", "body", "html" ], "baseRef": "a-10312019x10k.htm", "contextRef": "I2016Q4_Sep_15_2016", "decimals": "-6", "first": true, "lang": null, "name": "a:NotionalAmountOfTerminatedInterestRateFairValueHedgeDerivatives", "reportCount": 1, "unitRef": "usd", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "2419402 - Disclosure - DERIVATIVES (Details)", "role": "http://www.agilent.com/role/DerivativesDetails", "shortName": "DERIVATIVES (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "span", "span", "div", "ix:continuation", "div", "body", "html" ], "baseRef": "a-10312019x10k.htm", "contextRef": "FI2019Q4", "decimals": "-6", "lang": null, "name": "us-gaap:DerivativeNetLiabilityPositionAggregateFairValue", "reportCount": 1, "unique": true, "unitRef": "usd", "xsiNil": "false" } }, "R86": { "firstAnchor": { "ancestors": [ "span", "span", "div", "td", "tr", "table", "div", "div", "ix:continuation", "ix:continuation", "div", "body", "html" ], "baseRef": "a-10312019x10k.htm", "contextRef": "FI2019Q4_srt_CurrencyAxis_currency_AUD_us-gaap_DerivativeInstrumentRiskAxis_us-gaap_ForwardContractsMember_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis_us-gaap_CashFlowHedgingMember_us-gaap_HedgingDesignationAxis_us-gaap_DesignatedAsHedgingInstrumentMember_us-gaap_PositionAxis_us-gaap_LongMember", "decimals": "-6", "first": true, "lang": null, "name": "invest:DerivativeNotionalAmount", "reportCount": 1, "unique": true, "unitRef": "usd", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "2419403 - Disclosure - DERIVATIVES, Disclosures and derivative instrument aggregated notional amounts by currency and designations (Details)", "role": "http://www.agilent.com/role/DerivativesDisclosuresAndDerivativeInstrumentAggregatedNotionalAmountsByCurrencyAndDesignationsDetails", "shortName": "DERIVATIVES, Disclosures and derivative instrument aggregated notional amounts by currency and designations (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "span", "span", "div", "td", "tr", "table", "div", "div", "ix:continuation", "ix:continuation", "div", "body", "html" ], "baseRef": "a-10312019x10k.htm", "contextRef": "FI2019Q4_srt_CurrencyAxis_currency_AUD_us-gaap_DerivativeInstrumentRiskAxis_us-gaap_ForwardContractsMember_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis_us-gaap_CashFlowHedgingMember_us-gaap_HedgingDesignationAxis_us-gaap_DesignatedAsHedgingInstrumentMember_us-gaap_PositionAxis_us-gaap_LongMember", "decimals": "-6", "first": true, "lang": null, "name": "invest:DerivativeNotionalAmount", "reportCount": 1, "unique": true, "unitRef": "usd", "xsiNil": "false" } }, "R87": { "firstAnchor": { "ancestors": [ "span", "span", "div", "td", "tr", "table", "div", "div", "ix:continuation", "ix:continuation", "div", "body", "html" ], "baseRef": "a-10312019x10k.htm", "contextRef": "FI2019Q4", "decimals": "-6", "first": true, "lang": null, "name": "us-gaap:DerivativeFairValueOfDerivativeAsset", "reportCount": 1, "unique": true, "unitRef": "usd", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "2419404 - Disclosure - DERIVATIVES, Fair value of derivative instruments and Consolidated Balance Sheet location (Details)", "role": "http://www.agilent.com/role/DerivativesFairValueOfDerivativeInstrumentsAndConsolidatedBalanceSheetLocationDetails", "shortName": "DERIVATIVES, Fair value of derivative instruments and Consolidated Balance Sheet location (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "span", "span", "div", "td", "tr", "table", "div", "div", "ix:continuation", "ix:continuation", "div", "body", "html" ], "baseRef": "a-10312019x10k.htm", "contextRef": "FI2019Q4", "decimals": "-6", "first": true, "lang": null, "name": "us-gaap:DerivativeFairValueOfDerivativeAsset", "reportCount": 1, "unique": true, "unitRef": "usd", "xsiNil": "false" } }, "R88": { "firstAnchor": { "ancestors": [ "span", "span", "div", "td", "tr", "table", "div", "div", "us-gaap:ScheduleOfAccumulatedOtherComprehensiveIncomeLossTableTextBlock", "ix:continuation", "div", "body", "html" ], "baseRef": "a-10312019x10k.htm", "contextRef": "FD2019Q4YTD", "decimals": "-6", "first": true, "lang": null, "name": "us-gaap:OtherComprehensiveIncomeUnrealizedGainLossOnDerivativesArisingDuringPeriodBeforeTax", "reportCount": 1, "unitRef": "usd", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "2419405 - Disclosure - DERIVATIVES, Effect of derivative instruments on Consolidated Statement of Operations (Details)", "role": "http://www.agilent.com/role/DerivativesEffectOfDerivativeInstrumentsOnConsolidatedStatementOfOperationsDetails", "shortName": "DERIVATIVES, Effect of derivative instruments on Consolidated Statement of Operations (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "span", "span", "div", "td", "tr", "table", "div", "div", "us-gaap:ScheduleOfDerivativeInstrumentsGainLossInStatementOfFinancialPerformanceTextBlock", "ix:continuation", "div", "body", "html" ], "baseRef": "a-10312019x10k.htm", "contextRef": "FD2019Q4YTD", "decimals": "-6", "lang": null, "name": "us-gaap:InterestRateCashFlowHedgeGainLossReclassifiedToEarningsNet", "reportCount": 1, "unique": true, "unitRef": "usd", "xsiNil": "false" } }, "R89": { "firstAnchor": { "ancestors": [ "span", "span", "div", "ix:continuation", "div", "body", "html" ], "baseRef": "a-10312019x10k.htm", "contextRef": "FI2019Q4_us-gaap_DeferredCompensationArrangementWithIndividualExcludingShareBasedPaymentsAndPostretirementBenefitsByTypeOfDeferredCompensationAxis_us-gaap_DeferredProfitSharingMember", "decimals": "-6", "first": true, "lang": null, "name": "us-gaap:DefinedBenefitPlanFairValueOfPlanAssets", "reportCount": 1, "unique": true, "unitRef": "usd", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "2420402 - Disclosure - RETIREMENT PLANS AND POST RETIEMENT PENSION PLANS - Deferred Profit Sharing Plan (Details)", "role": "http://www.agilent.com/role/RetirementPlansAndPostRetiementPensionPlansDeferredProfitSharingPlanDetails", "shortName": "RETIREMENT PLANS AND POST RETIEMENT PENSION PLANS - Deferred Profit Sharing Plan (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "span", "span", "div", "ix:continuation", "div", "body", "html" ], "baseRef": "a-10312019x10k.htm", "contextRef": "FI2019Q4_us-gaap_DeferredCompensationArrangementWithIndividualExcludingShareBasedPaymentsAndPostretirementBenefitsByTypeOfDeferredCompensationAxis_us-gaap_DeferredProfitSharingMember", "decimals": "-6", "first": true, "lang": null, "name": "us-gaap:DefinedBenefitPlanFairValueOfPlanAssets", "reportCount": 1, "unique": true, "unitRef": "usd", "xsiNil": "false" } }, "R9": { "firstAnchor": { "ancestors": [ "span", "span", "div", "us-gaap:StockholdersEquityNoteDisclosureTextBlock", "div", "body", "html" ], "baseRef": "a-10312019x10k.htm", "contextRef": "FD2019Q4YTD", "decimals": "3", "first": true, "lang": null, "name": "us-gaap:CommonStockDividendsPerShareDeclared", "reportCount": 1, "unitRef": "usdPerShare", "xsiNil": "false" }, "groupType": "statement", "isDefault": "false", "longName": "1006501 - Statement - CONSOLIDATED STATEMENT OF EQUITY (Parenthetical)", "role": "http://www.agilent.com/role/ConsolidatedStatementOfEquityParenthetical", "shortName": "CONSOLIDATED STATEMENT OF EQUITY (Parenthetical)", "subGroupType": "parenthetical", "uniqueAnchor": null }, "R90": { "firstAnchor": { "ancestors": [ "span", "span", "div", "ix:continuation", "div", "body", "html" ], "baseRef": "a-10312019x10k.htm", "contextRef": "FD2019Q4YTD", "decimals": "2", "first": true, "lang": null, "name": "us-gaap:DefinedContributionPlanEmployerMatchingContributionPercentOfMatch", "reportCount": 1, "unique": true, "unitRef": "number", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "2420403 - Disclosure - RETIREMENT PLANS AND POST RETIREMENT PENSION PLANS Defined Contribution (Details)", "role": "http://www.agilent.com/role/RetirementPlansAndPostRetirementPensionPlansDefinedContributionDetails", "shortName": "RETIREMENT PLANS AND POST RETIREMENT PENSION PLANS Defined Contribution (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "span", "span", "div", "ix:continuation", "div", "body", "html" ], "baseRef": "a-10312019x10k.htm", "contextRef": "FD2019Q4YTD", "decimals": "2", "first": true, "lang": null, "name": "us-gaap:DefinedContributionPlanEmployerMatchingContributionPercentOfMatch", "reportCount": 1, "unique": true, "unitRef": "number", "xsiNil": "false" } }, "R91": { "firstAnchor": { "ancestors": [ "span", "span", "div", "ix:continuation", "div", "body", "html" ], "baseRef": "a-10312019x10k.htm", "contextRef": "FD2018Q1QTD_us-gaap_RetirementPlanSponsorLocationAxis_country_JP_us-gaap_RetirementPlanTypeAxis_us-gaap_PensionPlansDefinedBenefitMember", "decimals": "-6", "first": true, "lang": null, "name": "us-gaap:DefinedBenefitPlanRecognizedNetGainLossDueToSettlements1", "reportCount": 1, "unique": true, "unitRef": "usd", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "2420404 - Disclosure - RETIREMENT PLANS AND POST RETIREMENT PENSION PLANS, JWPIL (Details)", "role": "http://www.agilent.com/role/RetirementPlansAndPostRetirementPensionPlansJwpilDetails", "shortName": "RETIREMENT PLANS AND POST RETIREMENT PENSION PLANS, JWPIL (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "span", "span", "div", "ix:continuation", "div", "body", "html" ], "baseRef": "a-10312019x10k.htm", "contextRef": "FD2018Q1QTD_us-gaap_RetirementPlanSponsorLocationAxis_country_JP_us-gaap_RetirementPlanTypeAxis_us-gaap_PensionPlansDefinedBenefitMember", "decimals": "-6", "first": true, "lang": null, "name": "us-gaap:DefinedBenefitPlanRecognizedNetGainLossDueToSettlements1", "reportCount": 1, "unique": true, "unitRef": "usd", "xsiNil": "false" } }, "R92": { "firstAnchor": { "ancestors": [ "span", "span", "div", "td", "tr", "table", "div", "div", "us-gaap:ScheduleOfAccumulatedOtherComprehensiveIncomeLossTableTextBlock", "ix:continuation", "div", "body", "html" ], "baseRef": "a-10312019x10k.htm", "contextRef": "FD2019Q4YTD", "decimals": "-6", "first": true, "lang": null, "name": "us-gaap:OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansNetUnamortizedGainLossArisingDuringPeriodBeforeTax", "reportCount": 1, "unitRef": "usd", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "2420405 - Disclosure - RETIREMENT PLANS AND POST RETIREMENT PENSION PLANS, Components of Net Periodic Costs (Details)", "role": "http://www.agilent.com/role/RetirementPlansAndPostRetirementPensionPlansComponentsOfNetPeriodicCostsDetails", "shortName": "RETIREMENT PLANS AND POST RETIREMENT PENSION PLANS, Components of Net Periodic Costs (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "span", "span", "div", "td", "tr", "table", "div", "div", "us-gaap:ScheduleOfDefinedBenefitPlansDisclosuresTextBlock", "ix:continuation", "div", "body", "html" ], "baseRef": "a-10312019x10k.htm", "contextRef": "FD2019Q4YTD_us-gaap_RetirementPlanSponsorLocationAxis_country_US_us-gaap_RetirementPlanTypeAxis_us-gaap_PensionPlansDefinedBenefitMember", "decimals": "-6", "lang": null, "name": "us-gaap:DefinedBenefitPlanExpectedReturnOnPlanAssets", "reportCount": 1, "unique": true, "unitRef": "usd", "xsiNil": "false" } }, "R93": { "firstAnchor": { "ancestors": [ "span", "span", "div", "td", "tr", "table", "div", "div", "us-gaap:ScheduleOfBenefitObligationsInExcessOfFairValueOfPlanAssetsTableTextBlock", "ix:continuation", "div", "body", "html" ], "baseRef": "a-10312019x10k.htm", "contextRef": "FI2018Q4_us-gaap_RetirementPlanSponsorLocationAxis_us-gaap_ForeignPlanMember_us-gaap_RetirementPlanTypeAxis_us-gaap_PensionPlansDefinedBenefitMember", "decimals": "-6", "first": true, "lang": null, "name": "us-gaap:DefinedBenefitPlanFairValueOfPlanAssets", "reportCount": 1, "unitRef": "usd", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "2420406 - Disclosure - RETIREMENT PLANS AND POST RETIREMENT PENSION PLANS, Funded Status (Details)", "role": "http://www.agilent.com/role/RetirementPlansAndPostRetirementPensionPlansFundedStatusDetails", "shortName": "RETIREMENT PLANS AND POST RETIREMENT PENSION PLANS, Funded Status (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "span", "span", "div", "td", "tr", "table", "div", "div", "us-gaap:ChangesInProjectedBenefitObligationsFairValueOfPlanAssetsAndFundedStatusOfPlanTableTextBlock", "ix:continuation", "div", "body", "html" ], "baseRef": "a-10312019x10k.htm", "contextRef": "FD2019Q4YTD_us-gaap_RetirementPlanSponsorLocationAxis_us-gaap_ForeignPlanMember_us-gaap_RetirementPlanTypeAxis_us-gaap_PensionPlansDefinedBenefitMember", "decimals": "-6", "lang": null, "name": "us-gaap:DefinedBenefitPlanActualReturnOnPlanAssets", "reportCount": 1, "unique": true, "unitRef": "usd", "xsiNil": "false" } }, "R94": { "firstAnchor": { "ancestors": [ "span", "span", "div", "td", "tr", "table", "div", "div", "us-gaap:ScheduleOfAmountsInAccumulatedOtherComprehensiveIncomeLossToBeRecognizedOverNextFiscalYearTableTextBlock", "ix:continuation", "div", "body", "html" ], "baseRef": "a-10312019x10k.htm", "contextRef": "FI2019Q4_us-gaap_RetirementPlanSponsorLocationAxis_us-gaap_ForeignPlanMember_us-gaap_RetirementPlanTypeAxis_us-gaap_PensionPlansDefinedBenefitMember", "decimals": "-6", "first": true, "lang": null, "name": "us-gaap:DefinedBenefitPlanExpectedAmortizationOfPriorServiceCostCreditNextFiscalYear", "reportCount": 1, "unique": true, "unitRef": "usd", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "2420407 - Disclosure - RETIREMENT PLANS AND POST RETIREMENT PENSION PLANS, Financial Statement Location (Details)", "role": "http://www.agilent.com/role/RetirementPlansAndPostRetirementPensionPlansFinancialStatementLocationDetails", "shortName": "RETIREMENT PLANS AND POST RETIREMENT PENSION PLANS, Financial Statement Location (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "span", "span", "div", "td", "tr", "table", "div", "div", "us-gaap:ScheduleOfAmountsInAccumulatedOtherComprehensiveIncomeLossToBeRecognizedOverNextFiscalYearTableTextBlock", "ix:continuation", "div", "body", "html" ], "baseRef": "a-10312019x10k.htm", "contextRef": "FI2019Q4_us-gaap_RetirementPlanSponsorLocationAxis_us-gaap_ForeignPlanMember_us-gaap_RetirementPlanTypeAxis_us-gaap_PensionPlansDefinedBenefitMember", "decimals": "-6", "first": true, "lang": null, "name": "us-gaap:DefinedBenefitPlanExpectedAmortizationOfPriorServiceCostCreditNextFiscalYear", "reportCount": 1, "unique": true, "unitRef": "usd", "xsiNil": "false" } }, "R95": { "firstAnchor": { "ancestors": [ "span", "span", "div", "ix:continuation", "div", "body", "html" ], "baseRef": "a-10312019x10k.htm", "contextRef": "FI2019Q4_us-gaap_DeferredCompensationArrangementWithIndividualExcludingShareBasedPaymentsAndPostretirementBenefitsByTypeOfDeferredCompensationAxis_us-gaap_DeferredProfitSharingMember_us-gaap_DefinedBenefitPlanByPlanAssetCategoriesAxis_us-gaap_EquitySecuritiesMember_us-gaap_RetirementPlanSponsorLocationAxis_country_US", "decimals": "2", "first": true, "lang": null, "name": "us-gaap:DefinedBenefitPlanPlanAssetsTargetAllocationPercentage", "reportCount": 1, "unique": true, "unitRef": "number", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "2420408 - Disclosure - RETIREMENT PLANS AND POST RETIREMENT PENSION PLANS RETIREMENT PLANS AND POST RETIREMENT PENSION PLANS, Target Allocations (Details)", "role": "http://www.agilent.com/role/RetirementPlansAndPostRetirementPensionPlansRetirementPlansAndPostRetirementPensionPlansTargetAllocationsDetails", "shortName": "RETIREMENT PLANS AND POST RETIREMENT PENSION PLANS RETIREMENT PLANS AND POST RETIREMENT PENSION PLANS, Target Allocations (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "span", "span", "div", "ix:continuation", "div", "body", "html" ], "baseRef": "a-10312019x10k.htm", "contextRef": "FI2019Q4_us-gaap_DeferredCompensationArrangementWithIndividualExcludingShareBasedPaymentsAndPostretirementBenefitsByTypeOfDeferredCompensationAxis_us-gaap_DeferredProfitSharingMember_us-gaap_DefinedBenefitPlanByPlanAssetCategoriesAxis_us-gaap_EquitySecuritiesMember_us-gaap_RetirementPlanSponsorLocationAxis_country_US", "decimals": "2", "first": true, "lang": null, "name": "us-gaap:DefinedBenefitPlanPlanAssetsTargetAllocationPercentage", "reportCount": 1, "unique": true, "unitRef": "number", "xsiNil": "false" } }, "R96": { "firstAnchor": { "ancestors": [ "span", "span", "div", "td", "tr", "table", "div", "div", "us-gaap:ScheduleOfBenefitObligationsInExcessOfFairValueOfPlanAssetsTableTextBlock", "ix:continuation", "div", "body", "html" ], "baseRef": "a-10312019x10k.htm", "contextRef": "FI2019Q4_us-gaap_RetirementPlanSponsorLocationAxis_country_US_us-gaap_RetirementPlanTypeAxis_us-gaap_PensionPlansDefinedBenefitMember", "decimals": "-6", "first": true, "lang": null, "name": "us-gaap:DefinedBenefitPlanFairValueOfPlanAssets", "reportCount": 1, "unitRef": "usd", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "2420409 - Disclosure - RETIREMENT PLANS AND POST RETIREMENT PENSION PLANS, Fair Value of Plan Assets (Details)", "role": "http://www.agilent.com/role/RetirementPlansAndPostRetirementPensionPlansFairValueOfPlanAssetsDetails", "shortName": "RETIREMENT PLANS AND POST RETIREMENT PENSION PLANS, Fair Value of Plan Assets (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "span", "span", "div", "td", "tr", "table", "div", "div", "ix:continuation", "ix:continuation", "div", "body", "html" ], "baseRef": "a-10312019x10k.htm", "contextRef": "FI2019Q4_us-gaap_RetirementPlanSponsorLocationAxis_country_US_us-gaap_RetirementPlanTypeAxis_us-gaap_PensionPlansDefinedBenefitMember", "decimals": "-6", "lang": null, "name": "a:Netassetvalueexcludedfromfairvaluebyinput", "reportCount": 1, "unique": true, "unitRef": "usd", "xsiNil": "false" } }, "R97": { "firstAnchor": { "ancestors": [ "span", "span", "div", "td", "tr", "table", "div", "div", "ix:continuation", "ix:continuation", "div", "body", "html" ], "baseRef": "a-10312019x10k.htm", "contextRef": "FI2019Q4_us-gaap_RetirementPlanSponsorLocationAxis_country_US_us-gaap_RetirementPlanTypeAxis_us-gaap_PensionPlansDefinedBenefitMember", "decimals": "-6", "first": true, "lang": null, "name": "us-gaap:DefinedBenefitPlanExpectedFutureBenefitPaymentsNextTwelveMonths", "reportCount": 1, "unique": true, "unitRef": "usd", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "2420410 - Disclosure - RETIREMENT PLANS AND POST RETIREMENT PENSION PLANS, Expected Benefit Payments (Details)", "role": "http://www.agilent.com/role/RetirementPlansAndPostRetirementPensionPlansExpectedBenefitPaymentsDetails", "shortName": "RETIREMENT PLANS AND POST RETIREMENT PENSION PLANS, Expected Benefit Payments (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "span", "span", "div", "td", "tr", "table", "div", "div", "ix:continuation", "ix:continuation", "div", "body", "html" ], "baseRef": "a-10312019x10k.htm", "contextRef": "FI2019Q4_us-gaap_RetirementPlanSponsorLocationAxis_country_US_us-gaap_RetirementPlanTypeAxis_us-gaap_PensionPlansDefinedBenefitMember", "decimals": "-6", "first": true, "lang": null, "name": "us-gaap:DefinedBenefitPlanExpectedFutureBenefitPaymentsNextTwelveMonths", "reportCount": 1, "unique": true, "unitRef": "usd", "xsiNil": "false" } }, "R98": { "firstAnchor": { "ancestors": [ "span", "span", "div", "td", "tr", "table", "div", "div", "us-gaap:ScheduleOfAssumptionsUsedTableTextBlock", "ix:continuation", "div", "body", "html" ], "baseRef": "a-10312019x10k.htm", "contextRef": "FD2019Q4YTD_us-gaap_RetirementPlanSponsorLocationAxis_country_US_us-gaap_RetirementPlanTypeAxis_us-gaap_PensionPlansDefinedBenefitMember", "decimals": "4", "first": true, "lang": null, "name": "us-gaap:DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostDiscountRate", "reportCount": 1, "unique": true, "unitRef": "number", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "2420411 - Disclosure - RETIREMENT PLANS AND POST RETIREMENT PENSION PLANS, Assumptions (Details)", "role": "http://www.agilent.com/role/RetirementPlansAndPostRetirementPensionPlansAssumptionsDetails", "shortName": "RETIREMENT PLANS AND POST RETIREMENT PENSION PLANS, Assumptions (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "span", "span", "div", "td", "tr", "table", "div", "div", "us-gaap:ScheduleOfAssumptionsUsedTableTextBlock", "ix:continuation", "div", "body", "html" ], "baseRef": "a-10312019x10k.htm", "contextRef": "FD2019Q4YTD_us-gaap_RetirementPlanSponsorLocationAxis_country_US_us-gaap_RetirementPlanTypeAxis_us-gaap_PensionPlansDefinedBenefitMember", "decimals": "4", "first": true, "lang": null, "name": "us-gaap:DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostDiscountRate", "reportCount": 1, "unique": true, "unitRef": "number", "xsiNil": "false" } }, "R99": { "firstAnchor": { "ancestors": [ "span", "span", "div", "td", "tr", "table", "div", "div", "us-gaap:ScheduleOfProductWarrantyLiabilityTableTextBlock", "ix:continuation", "div", "body", "html" ], "baseRef": "a-10312019x10k.htm", "contextRef": "FI2018Q4", "decimals": "-6", "first": true, "lang": null, "name": "us-gaap:StandardProductWarrantyAccrual", "reportCount": 1, "unitRef": "usd", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "2421402 - Disclosure - GUARANTEES (Details)", "role": "http://www.agilent.com/role/GuaranteesDetails", "shortName": "GUARANTEES (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "span", "span", "div", "td", "tr", "table", "div", "div", "us-gaap:ScheduleOfProductWarrantyLiabilityTableTextBlock", "ix:continuation", "div", "body", "html" ], "baseRef": "a-10312019x10k.htm", "contextRef": "FI2017Q4", "decimals": "-6", "lang": null, "name": "us-gaap:StandardProductWarrantyAccrual", "reportCount": 1, "unique": true, "unitRef": "usd", "xsiNil": "false" } } }, "segmentCount": 132, "tag": { "a_A2015RepurchaseProgramMember": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "2015 Repurchase Program - On May 28, 2015 we announced that our board of directors had approved a new share repurchase program. The new share repurchase program authorizes the purchase of up to $1.14 billion of our common stock through and including November 1, 2018. The new program will commence, at the option of the company, on either November 1, 2015, or the date on which we complete the purchase of $365 million of common stock under the existing stock repurchase program in fiscal 2015. Upon commencement, the new program replaces our existing stock repurchase program, which authorized the repurchase of shares to reduce or eliminate share dilution from equity programs.", "label": "2015 Repurchase Program [Member]", "terseLabel": "2015 Repurchase Program [Member]" } } }, "localname": "A2015RepurchaseProgramMember", "nsuri": "http://www.agilent.com/20191031", "presentation": [ "http://www.agilent.com/role/StockholdersEquityStockRepurchasesDetails" ], "xbrltype": "domainItemType" }, "a_A2019RepurchaseProgramMember": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "2019 Repurchase Program [Member]", "label": "2019 Repurchase Program [Member]", "terseLabel": "2019 Repurchase Program [Member]" } } }, "localname": "A2019RepurchaseProgramMember", "nsuri": "http://www.agilent.com/20191031", "presentation": [ "http://www.agilent.com/role/StockholdersEquityStockRepurchasesDetails" ], "xbrltype": "domainItemType" }, "a_ACEABiosciencesInc.Member": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "ACEA Biosciences, Inc. [Member]", "label": "ACEA Biosciences, Inc. [Member]", "terseLabel": "ACEA Biosciences, Inc. [Member]" } } }, "localname": "ACEABiosciencesInc.Member", "nsuri": "http://www.agilent.com/20191031", "presentation": [ "http://www.agilent.com/role/AcquisitionsTextDetails" ], "xbrltype": "domainItemType" }, "a_AcademiaandGovernmentMarketMember": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Academia and Government Market [Member]", "label": "Academia and Government Market [Member]", "terseLabel": "Academia and Government Market" } } }, "localname": "AcademiaandGovernmentMarketMember", "nsuri": "http://www.agilent.com/20191031", "presentation": [ "http://www.agilent.com/role/RevenueRevenueByEndMarketsDetails" ], "xbrltype": "domainItemType" }, "a_Acceleratedamortizationofinterestrateswapgain": { "auth_ref": [], "crdr": "credit", "lang": { "en-US": { "role": { "documentation": "accelerated amortization of interest rate swap gain", "label": "accelerated amortization of interest rate swap gain", "terseLabel": "accelerated amortization of interest rate swap gain" } } }, "localname": "Acceleratedamortizationofinterestrateswapgain", "nsuri": "http://www.agilent.com/20191031", "presentation": [ "http://www.agilent.com/role/ShortTermDebtSeniorNotesDetails" ], "xbrltype": "monetaryItemType" }, "a_AccumulatedBenefitObligationwhereFairValueofplanAssetsexceedsABO": { "auth_ref": [], "crdr": "credit", "lang": { "en-US": { "role": { "documentation": "Amount of accumulated benefit obligation for defined benefit pension plan where the fair value of plan assets exceeds accumulated benefit obligation.", "label": "Accumulated Benefit Obligation where Fair Value of plan Assets exceeds ABO", "terseLabel": "Accumulated Benefit Obligation where Fair Value of plan Assets exceeds ABO" } } }, "localname": "AccumulatedBenefitObligationwhereFairValueofplanAssetsexceedsABO", "nsuri": "http://www.agilent.com/20191031", "presentation": [ "http://www.agilent.com/role/RetirementPlansAndPostRetirementPensionPlansFairValueOfPlanAssetsDetails" ], "xbrltype": "monetaryItemType" }, "a_AdvancedAnalyticalTechnologiesIncAATIMember": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Advanced Analytical Technologies, Inc (AATI)", "label": "Advanced Analytical Technologies, Inc (AATI) [Member]", "terseLabel": "Advanced Analytical Technologies, Inc (AATI) [Member]" } } }, "localname": "AdvancedAnalyticalTechnologiesIncAATIMember", "nsuri": "http://www.agilent.com/20191031", "presentation": [ "http://www.agilent.com/role/GoodwillAndOtherIntangibleAssetsTextDetails" ], "xbrltype": "domainItemType" }, "a_AggregateparticipantscontributionstoESPP": { "auth_ref": [], "crdr": "credit", "lang": { "en-US": { "role": { "documentation": "Aggregate participant contributions to employee stock purchase plan for the purchase of shares of the company's common stock not yet issued to participants at the end of the period. Shares are excluded from the available for issuance balance at the end of the period.", "label": "Aggregate participants contributions to ESPP", "terseLabel": "Aggregate participants contributions to ESPP" } } }, "localname": "AggregateparticipantscontributionstoESPP", "nsuri": "http://www.agilent.com/20191031", "presentation": [ "http://www.agilent.com/role/ShareBasedCompensationGeneralDisclosuresDetails" ], "xbrltype": "monetaryItemType" }, "a_AgilentCrossLabMember": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Agilent CrossLab [Member]", "label": "Agilent CrossLab [Member]", "terseLabel": "Agilent CrossLab" } } }, "localname": "AgilentCrossLabMember", "nsuri": "http://www.agilent.com/20191031", "presentation": [ "http://www.agilent.com/role/GoodwillAndOtherIntangibleAssetsRollForwardDetails", "http://www.agilent.com/role/RevenueRevenueByRegionDetails", "http://www.agilent.com/role/SegmentInformationProfitabilityDetails", "http://www.agilent.com/role/SegmentInformationSegmentAssetsDetails" ], "xbrltype": "domainItemType" }, "a_AssetsAndCapitalExpendituresDirectlyManagedByEachSegmentTableTextBlock": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Tabular disclosure of the total assets and capital expenditures for each reportable segment. An entity discloses certain information on each reportable segment if the amounts (a) are included in the measure of segment profit or loss reviewed by the chief operating decision maker or (b) are otherwise regularly provided to the chief operating decision maker, even if not included in that measure of segment profit or loss.", "label": "Assets And Capital Expenditures Directly Managed By Each Segment [Table Text Block]", "verboseLabel": "Assets and capital expenditures directly managed by each segment" } } }, "localname": "AssetsAndCapitalExpendituresDirectlyManagedByEachSegmentTableTextBlock", "nsuri": "http://www.agilent.com/20191031", "presentation": [ "http://www.agilent.com/role/SegmentInformationTables" ], "xbrltype": "textBlockItemType" }, "a_BalanceBeginningOfYear": { "auth_ref": [], "crdr": "debit", "lang": { "en-US": { "role": { "documentation": "Assets, usually stocks, bonds, and other investments, that have been segregated and restricted (usually in a trust) to provide benefits, at their fair value as of the measurement date. Plan assets include amounts contributed by the employer (and by employees for a contributory plan) and amounts earned from investing the contributions, less benefits paid. If a plan has liabilities other than for benefits, those non-benefit obligations may be considered as reductions of plan assets.", "label": "Balance, beginning of year", "periodStartLabel": "Balance, beginning of year" } } }, "localname": "BalanceBeginningOfYear", "nsuri": "http://www.agilent.com/20191031", "presentation": [ "http://www.agilent.com/role/RetirementPlansAndPostRetirementPensionPlansFairValueOfPlanAssetsDetails" ], "xbrltype": "monetaryItemType" }, "a_BalanceEndOfYear": { "auth_ref": [], "crdr": "debit", "lang": { "en-US": { "role": { "documentation": "Assets, usually stocks, bonds, and other investments, that have been segregated and restricted (usually in a trust) to provide benefits, at their fair value as of the measurement date. Plan assets include amounts contributed by the employer (and by employees for a contributory plan) and amounts earned from investing the contributions, less benefits paid. If a plan has liabilities other than for benefits, those non-benefit obligations may be considered as reductions of plan assets.", "label": "Balance, end of year", "periodEndLabel": "Balance, end of year" } } }, "localname": "BalanceEndOfYear", "nsuri": "http://www.agilent.com/20191031", "presentation": [ "http://www.agilent.com/role/RetirementPlansAndPostRetirementPensionPlansFairValueOfPlanAssetsDetails" ], "xbrltype": "monetaryItemType" }, "a_BioTekMember": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "BioTek [Member]", "label": "BioTek [Member]", "terseLabel": "BioTek [Member]" } } }, "localname": "BioTekMember", "nsuri": "http://www.agilent.com/20191031", "presentation": [ "http://www.agilent.com/role/AcquisitionsAcquisitionsIntangibleAssetsDetails", "http://www.agilent.com/role/AcquisitionsAssetsAndLiabilitiesAssumedDetails", "http://www.agilent.com/role/AcquisitionsTextDetails" ], "xbrltype": "domainItemType" }, "a_BioTekandACEAMember": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "BioTek and ACEA Biosciences [Member]", "label": "BioTek and ACEA [Member]", "terseLabel": "BioTek and ACEA [Member]" } } }, "localname": "BioTekandACEAMember", "nsuri": "http://www.agilent.com/20191031", "presentation": [ "http://www.agilent.com/role/GoodwillAndOtherIntangibleAssetsTextDetails" ], "xbrltype": "domainItemType" }, "a_ChangeinassetsandliabilitiesduetoTaxAct": { "auth_ref": [], "calculation": { "http://www.agilent.com/role/ConsolidatedStatementOfCashFlows": { "order": 14.0, "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": -1.0 } }, "crdr": "credit", "lang": { "en-US": { "role": { "documentation": "Change in assets and liabilities due to Tax Act", "label": "Change in assets and liabilities due to Tax Act", "negatedTerseLabel": "Change in assets and liabilities due to Tax Act" } } }, "localname": "ChangeinassetsandliabilitiesduetoTaxAct", "nsuri": "http://www.agilent.com/20191031", "presentation": [ "http://www.agilent.com/role/ConsolidatedStatementOfCashFlows" ], "xbrltype": "monetaryItemType" }, "a_ChemicalandEnergyMarketMember": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Chemical and Energy Market [Member]", "label": "Chemical and Energy Market [Member]", "terseLabel": "Chemical and Energy Market" } } }, "localname": "ChemicalandEnergyMarketMember", "nsuri": "http://www.agilent.com/20191031", "presentation": [ "http://www.agilent.com/role/RevenueRevenueByEndMarketsDetails" ], "xbrltype": "domainItemType" }, "a_CurrentAndLongTermDeferredTaxAssetsAndLiabilitiesAbstract": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Current And Long Term Deferred Tax Assets And Liabilities [Abstract]", "label": "Current And Long Term Deferred Tax Assets And Liabilities [Abstract]", "terseLabel": "Long Term Deferred Tax Assets And Liabilities [Abstract]" } } }, "localname": "CurrentAndLongTermDeferredTaxAssetsAndLiabilitiesAbstract", "nsuri": "http://www.agilent.com/20191031", "presentation": [ "http://www.agilent.com/role/IncomeTaxesIncomeTaxesDeferredTaxesAndOtherDetails" ], "xbrltype": "stringItemType" }, "a_CurrentAndLongTermTaxAssetsAndCurrentAndLongTermTaxLiabilitiesDisclosureTextBlock": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Description containing the entire income tax comparison of temporary differences on current and long term deferred tax assets and liabilities disclosure. This element may be used as a single block of text to encapsulate the entire disclosure including data and tables.", "label": "Current And Long Term Tax Assets And Current And Long Term Tax Liabilities Disclosure [Text Block]", "verboseLabel": "Current and long-term deferred tax assets and deferred tax liabilities" } } }, "localname": "CurrentAndLongTermTaxAssetsAndCurrentAndLongTermTaxLiabilitiesDisclosureTextBlock", "nsuri": "http://www.agilent.com/20191031", "presentation": [ "http://www.agilent.com/role/IncomeTaxesTables" ], "xbrltype": "textBlockItemType" }, "a_CurrentAndLongTermTaxAssetsAndLiabilitiesTableTextBlock": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Tabular disclosure of the breakdown between current and long term income tax payable and receivable and their location in the consolidated balance sheet.", "label": "Current and Long Term Tax Assets and Liabilities [Table Text Block]", "terseLabel": "Current and Long Term Tax Assets and Liabilities [Table Text Block]" } } }, "localname": "CurrentAndLongTermTaxAssetsAndLiabilitiesTableTextBlock", "nsuri": "http://www.agilent.com/20191031", "presentation": [ "http://www.agilent.com/role/IncomeTaxesTables" ], "xbrltype": "textBlockItemType" }, "a_Currentmedicalcosttrendrate": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Weighted average rate of current medical cost trend rate used to determine net periodic benefit cost of defined benefit plan.", "label": "Current medical cost trend rate", "terseLabel": "Current medical cost trend rate" } } }, "localname": "Currentmedicalcosttrendrate", "nsuri": "http://www.agilent.com/20191031", "presentation": [ "http://www.agilent.com/role/RetirementPlansAndPostRetirementPensionPlansAssumptionsDetails" ], "xbrltype": "percentItemType" }, "a_DebtInstrumentNetDiscountPremiumAmount": { "auth_ref": [], "crdr": "credit", "lang": { "en-US": { "role": { "documentation": "The carry amount of debt instrument, stated principal amount of the debt instrument at time of issuance net of any unamortized premium or discount.", "label": "Debt Instrument Net Discount Premium Amount", "terseLabel": "Debt Instrument Net Discount Premium Amount" } } }, "localname": "DebtInstrumentNetDiscountPremiumAmount", "nsuri": "http://www.agilent.com/20191031", "presentation": [ "http://www.agilent.com/role/LongTermDebtCarryingValueDetails", "http://www.agilent.com/role/LongTermDebtSeniorNotesDetails" ], "xbrltype": "monetaryItemType" }, "a_DefinedBenefitPlanAccumulatedBenefitObligationTotalAggregateBenefitObligation": { "auth_ref": [], "crdr": "credit", "lang": { "en-US": { "role": { "documentation": "If aggregate disclosures are presented for the accumulated benefit obligation, the aggregate fair value of assets.", "label": "Defined Benefit Plan Accumulated Benefit Obligation Total Aggregate Benefit Obligation", "terseLabel": "Total accumulated benefit obligation - aggregate benefit obligation" } } }, "localname": "DefinedBenefitPlanAccumulatedBenefitObligationTotalAggregateBenefitObligation", "nsuri": "http://www.agilent.com/20191031", "presentation": [ "http://www.agilent.com/role/RetirementPlansAndPostRetirementPensionPlansFairValueOfPlanAssetsDetails" ], "xbrltype": "monetaryItemType" }, "a_DefinedBenefitPlanAmountsRecognizedInOtherComprehensiveIncomeNetActuarialGainLossBeforeTax": { "auth_ref": [], "crdr": "credit", "lang": { "en-US": { "role": { "documentation": "The net increase or decrease of changes in the value of either the benefit obligation or the plan assets resulting from experience different from that assumed or from a change in an actuarial assumption, or the consequence of a decision to temporarily deviate from the substantive plan, recognized in other comprehensive income.", "label": "Defined Benefit Plan Amounts Recognized In Other Comprehensive Income Net Actuarial Gain Loss Before Tax", "terseLabel": "Actuarial (gains) losses" } } }, "localname": "DefinedBenefitPlanAmountsRecognizedInOtherComprehensiveIncomeNetActuarialGainLossBeforeTax", "nsuri": "http://www.agilent.com/20191031", "presentation": [ "http://www.agilent.com/role/RetirementPlansAndPostRetirementPensionPlansFundedStatusDetails" ], "xbrltype": "monetaryItemType" }, "a_DefinedBenefitPlanAnalysisOfBenefitObligationsInRelationToFairValueOfPlanAssetsAbstract": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Defined Benefit Plan Analysis Of Benefit Obligations In Relation To Fair Value Of Plan Assets [Abstract]", "label": "Defined Benefit Plan Analysis Of Benefit Obligations In Relation To Fair Value Of Plan Assets [Abstract]", "verboseLabel": "Projected benefit obligation and fair value of plan assets [Abstract]" } } }, "localname": "DefinedBenefitPlanAnalysisOfBenefitObligationsInRelationToFairValueOfPlanAssetsAbstract", "nsuri": "http://www.agilent.com/20191031", "presentation": [ "http://www.agilent.com/role/RetirementPlansAndPostRetirementPensionPlansFairValueOfPlanAssetsDetails" ], "xbrltype": "stringItemType" }, "a_DefinedBenefitPlanAssetsByFairValueHierarchyTableTextBlock": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Tabular disclosure of fair value of plan assets by the level within the fair value hierarchy in which the fair value measurements in their entirety fall, segregating fair value measurements using quoted prices in active markets for identical assets or liabilities (Level 1), Significant other observable inputs (Level 2), and significant unobservable inputs (Level 3).", "label": "Defined benefit plan assets by fair value hierarchy [Table Text Block]", "terseLabel": "Defined benefit plan assets by fair value hierarchy" } } }, "localname": "DefinedBenefitPlanAssetsByFairValueHierarchyTableTextBlock", "nsuri": "http://www.agilent.com/20191031", "presentation": [ "http://www.agilent.com/role/RetirementPlansAndPostRetirementPensionPlansTables" ], "xbrltype": "textBlockItemType" }, "a_DefinedBenefitPlanProjectedBenefitObligationTotalAggregateBenefitObligation": { "auth_ref": [], "crdr": "credit", "lang": { "en-US": { "role": { "documentation": "If aggregate disclosures are presented for the projected benefit obligation, the aggregate benefit obligation value.", "label": "Defined Benefit Plan Projected Benefit Obligation Total Aggregate Benefit Obligation", "terseLabel": "Total projected benefit obligation - aggregate benefit obligation" } } }, "localname": "DefinedBenefitPlanProjectedBenefitObligationTotalAggregateBenefitObligation", "nsuri": "http://www.agilent.com/20191031", "presentation": [ "http://www.agilent.com/role/RetirementPlansAndPostRetirementPensionPlansFairValueOfPlanAssetsDetails" ], "xbrltype": "monetaryItemType" }, "a_DefinedBenefitPlanUsPortfolioEquitySecuritiesPercentageOfAlternativeInvestments": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Actual percentage of alternative investments that the US equity portfolio consist.", "label": "Defined Benefit Plan Us Portfolio Equity Securities Percentage Of Alternative Investments", "terseLabel": "Defined Benefit Plan Us Portfolio Equity Securities Percentage Of Alternative Investments" } } }, "localname": "DefinedBenefitPlanUsPortfolioEquitySecuritiesPercentageOfAlternativeInvestments", "nsuri": "http://www.agilent.com/20191031", "presentation": [ "http://www.agilent.com/role/RetirementPlansAndPostRetirementPensionPlansRetirementPlansAndPostRetirementPensionPlansTargetAllocationsDetails" ], "xbrltype": "percentItemType" }, "a_DefinedBenefitobligationwhereFairValueexceedsPensionbenefitobligation": { "auth_ref": [], "crdr": "credit", "lang": { "en-US": { "role": { "documentation": "Amount of benefit obligation for defined benefit plan where fair value of plan assets exceeds pension benefit obligation", "label": "Defined Benefit obligation where Fair Value exceeds Pension benefit obligation", "terseLabel": "Defined Benefit obligation where Fair Value exceeds Pension benefit obligation" } } }, "localname": "DefinedBenefitobligationwhereFairValueexceedsPensionbenefitobligation", "nsuri": "http://www.agilent.com/20191031", "presentation": [ "http://www.agilent.com/role/RetirementPlansAndPostRetirementPensionPlansFairValueOfPlanAssetsDetails" ], "xbrltype": "monetaryItemType" }, "a_DenominatorsAbstract": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Denominators [Abstract]", "label": "Denominators [Abstract]", "terseLabel": "Denominator:" } } }, "localname": "DenominatorsAbstract", "nsuri": "http://www.agilent.com/20191031", "presentation": [ "http://www.agilent.com/role/NetIncomeLossPerShareDetails" ], "xbrltype": "stringItemType" }, "a_DerivativeContractsAbstract": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Derivative Contracts [Abstract]", "label": "Derivative Contracts [Abstract]" } } }, "localname": "DerivativeContractsAbstract", "nsuri": "http://www.agilent.com/20191031", "presentation": [ "http://www.agilent.com/role/DerivativesDetails" ], "xbrltype": "stringItemType" }, "a_DescriptionOfTypesAndTermsOfFairValueHedgingInstrumentsUsed": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Description of the types and terms of derivatives designated as fair value hedging instruments. For example, interest rate swaps, forward contracts, and so forth.", "label": "Description Of Types And Terms Of Fair Value Hedging Instruments Used", "verboseLabel": "Hedging contracts general maturity" } } }, "localname": "DescriptionOfTypesAndTermsOfFairValueHedgingInstrumentsUsed", "nsuri": "http://www.agilent.com/20191031", "presentation": [ "http://www.agilent.com/role/OverviewAndSummaryOfSignificantAccountingPoliciesDetails" ], "xbrltype": "durationItemType" }, "a_DiagnosticsAndGenomicsMember": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Diagnostics and Genomics segment includes; DNA mutation detection; genotyping; gene copy number determination; identification of gene rearrangements; DNA methylation profiling; gene expression profiling; and automated gel electrophoresis-based sample analysis systems.", "label": "Diagnostics and Genomics [Member]", "terseLabel": "Diagnostics and Genomics" } } }, "localname": "DiagnosticsAndGenomicsMember", "nsuri": "http://www.agilent.com/20191031", "presentation": [ "http://www.agilent.com/role/GoodwillAndOtherIntangibleAssetsRollForwardDetails", "http://www.agilent.com/role/GoodwillAndOtherIntangibleAssetsTextDetails", "http://www.agilent.com/role/RevenueRevenueByRegionDetails", "http://www.agilent.com/role/SegmentInformationProfitabilityDetails", "http://www.agilent.com/role/SegmentInformationReconciliationOfReportableResultsDetails", "http://www.agilent.com/role/SegmentInformationSegmentAssetsDetails" ], "xbrltype": "domainItemType" }, "a_DiagnosticsandClinicalMarketMember": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Diagnostics and Clinical Market [Member]", "label": "Diagnostics and Clinical Market [Member]", "terseLabel": "Diagnostics and Clinical Market" } } }, "localname": "DiagnosticsandClinicalMarketMember", "nsuri": "http://www.agilent.com/20191031", "presentation": [ "http://www.agilent.com/role/RevenueRevenueByEndMarketsDetails" ], "xbrltype": "domainItemType" }, "a_DifferenceBetweenFairValuesoftheObligationSettledandAssetsTransferredMember": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Difference Between Fair Values of the Obligation Settled and Assets Transferred [Member]", "label": "Difference Between Fair Values of the Obligation Settled and Assets Transferred [Member]", "terseLabel": "Difference Between Fair Values of the Obligation Settled and Assets Transferred [Member]" } } }, "localname": "DifferenceBetweenFairValuesoftheObligationSettledandAssetsTransferredMember", "nsuri": "http://www.agilent.com/20191031", "presentation": [ "http://www.agilent.com/role/RetirementPlansAndPostRetirementPensionPlansJwpilDetails" ], "xbrltype": "domainItemType" }, "a_DocumentAndEntityInformationAbstract": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Document and Entity Information [Abstract]", "label": "Document and Entity Information [Abstract]" } } }, "localname": "DocumentAndEntityInformationAbstract", "nsuri": "http://www.agilent.com/20191031", "xbrltype": "stringItemType" }, "a_Earlyrepaymentofseniornotesincludingprepaymentpenalty": { "auth_ref": [], "crdr": "credit", "lang": { "en-US": { "role": { "documentation": "The cash outflow for the extinguishment of long-term borrowing (including prepayment penalty), with the highest claim on the assets of the entity in case of bankruptcy or liquidation, before its maturity.", "label": "Early repayment of senior notes including prepayment penalty", "terseLabel": "Early repayment of senior notes including prepayment penalty" } } }, "localname": "Earlyrepaymentofseniornotesincludingprepaymentpenalty", "nsuri": "http://www.agilent.com/20191031", "presentation": [ "http://www.agilent.com/role/ShortTermDebtSeniorNotesDetails" ], "xbrltype": "monetaryItemType" }, "a_Earlyrepaymentofseniornotesprepaymentpenalty": { "auth_ref": [], "crdr": "credit", "lang": { "en-US": { "role": { "documentation": "Early repayment of senior notes prepayment penalty", "label": "Early repayment of senior notes prepayment penalty", "terseLabel": "Early repayment of senior notes prepayment penalty" } } }, "localname": "Earlyrepaymentofseniornotesprepaymentpenalty", "nsuri": "http://www.agilent.com/20191031", "presentation": [ "http://www.agilent.com/role/ShortTermDebtSeniorNotesDetails" ], "xbrltype": "monetaryItemType" }, "a_EmployeeServiceShareBasedCompensationUnrecognizedCompensationCostsOnNonvestedEquityOtherThanStockOptionAwardsWeightedAveragePeriodOfRecognition": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "The weighted average period over which unrecognized share-based compensation costs on equity other than stock options are expected to be reported", "label": "Employee Service Share Based Compensation Unrecognized Compensation Costs On Nonvested Equity Other Than Stock Option Awards Weighted Average Period Of Recognition", "verboseLabel": "Weighted-average period non-vested restricted stock awards are expected to be amortized over (in years)" } } }, "localname": "EmployeeServiceShareBasedCompensationUnrecognizedCompensationCostsOnNonvestedEquityOtherThanStockOptionAwardsWeightedAveragePeriodOfRecognition", "nsuri": "http://www.agilent.com/20191031", "presentation": [ "http://www.agilent.com/role/ShareBasedCompensationNonVestedAwardActivityDisclosureDetails" ], "xbrltype": "decimalItemType" }, "a_EmployeeStockPurchasePlanAbstract": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Employee stock purchase plan [Abstract]", "label": "Employee stock purchase plan [Abstract]", "terseLabel": "Employee stock purchase plan [Abstract]" } } }, "localname": "EmployeeStockPurchasePlanAbstract", "nsuri": "http://www.agilent.com/20191031", "presentation": [ "http://www.agilent.com/role/ShareBasedCompensationGeneralDisclosuresDetails" ], "xbrltype": "stringItemType" }, "a_EmployeecompensationandbenefitsMember": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Employee compensation and benefits [Member]", "label": "Employee compensation and benefits [Member]", "terseLabel": "Employee compensation and benefits [Member]" } } }, "localname": "EmployeecompensationandbenefitsMember", "nsuri": "http://www.agilent.com/20191031", "presentation": [ "http://www.agilent.com/role/RetirementPlansAndPostRetirementPensionPlansFundedStatusDetails" ], "xbrltype": "domainItemType" }, "a_Employeecompensationandbenefitsassumed": { "auth_ref": [], "crdr": "credit", "lang": { "en-US": { "role": { "documentation": "Total obligations related to services received from employees, such as accrued salaries and bonuses, payroll taxes and fringe benefits. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer) assumed at the acquisition date.", "label": "Employee compensation and benefits assumed", "terseLabel": "Employee compensation and benefits" } } }, "localname": "Employeecompensationandbenefitsassumed", "nsuri": "http://www.agilent.com/20191031", "presentation": [ "http://www.agilent.com/role/AcquisitionsAssetsAndLiabilitiesAssumedDetails" ], "xbrltype": "monetaryItemType" }, "a_EndMarketsAxis": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "End Markets [Axis]", "label": "End Markets [Axis]", "terseLabel": "End Markets [Axis]" } } }, "localname": "EndMarketsAxis", "nsuri": "http://www.agilent.com/20191031", "presentation": [ "http://www.agilent.com/role/RevenueRevenueByEndMarketsDetails" ], "xbrltype": "stringItemType" }, "a_EndMarketsDomain": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "[Domain] for End Markets [Axis]", "label": "End Markets [Domain]", "terseLabel": "End Markets [Domain]" } } }, "localname": "EndMarketsDomain", "nsuri": "http://www.agilent.com/20191031", "presentation": [ "http://www.agilent.com/role/RevenueRevenueByEndMarketsDetails" ], "xbrltype": "domainItemType" }, "a_EntityClosingStockPrice": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Fair market closing stock price for entity share at end of fiscal year as reflected on national stock exchange.", "label": "Entity Closing Stock Price", "verboseLabel": "Closing stock price basis for aggregate intrinsic value (in dollars per share)" } } }, "localname": "EntityClosingStockPrice", "nsuri": "http://www.agilent.com/20191031", "presentation": [ "http://www.agilent.com/role/ShareBasedCompensationSharesAuthorizedByExercisePriceRangeDetails" ], "xbrltype": "perShareItemType" }, "a_EntityWideDisclosureOnGeographicAreasAttributedToIndividualForeignCountriesLineItems": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Entity Wide Disclosure On Geographic Areas Attributed To Individual Foreign Countries [Line Items]", "label": "Entity Wide Disclosure On Geographic Areas Attributed To Individual Foreign Countries [Line Items]", "terseLabel": "Entity Wide Disclosure" } } }, "localname": "EntityWideDisclosureOnGeographicAreasAttributedToIndividualForeignCountriesLineItems", "nsuri": "http://www.agilent.com/20191031", "presentation": [ "http://www.agilent.com/role/SegmentInformationEntityWideDisclosuresRevenueDetails" ], "xbrltype": "stringItemType" }, "a_EntityWideDisclosureOnGeographicAreasAttributedToIndividualForeignCountriesTable": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Entity Wide Disclosure On Geographic Areas Attributed To Individual Foreign Countries [Table]", "label": "Entity Wide Disclosure On Geographic Areas Attributed To Individual Foreign Countries [Table]", "terseLabel": "Entity Wide Disclosure On Geographic Areas Attributed To Individual Foreign Countries [Table]" } } }, "localname": "EntityWideDisclosureOnGeographicAreasAttributedToIndividualForeignCountriesTable", "nsuri": "http://www.agilent.com/20191031", "presentation": [ "http://www.agilent.com/role/SegmentInformationEntityWideDisclosuresRevenueDetails" ], "xbrltype": "stringItemType" }, "a_EnvironmentalandForensicsMarketMember": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Environmental and Forensics Market [Member]", "label": "Environmental and Forensics Market [Member]", "terseLabel": "Environmental and Forensics Market" } } }, "localname": "EnvironmentalandForensicsMarketMember", "nsuri": "http://www.agilent.com/20191031", "presentation": [ "http://www.agilent.com/role/RevenueRevenueByEndMarketsDetails" ], "xbrltype": "domainItemType" }, "a_Estimatedcoststocompleteinprocessresearchanddevelopmentprojects": { "auth_ref": [], "crdr": "debit", "lang": { "en-US": { "role": { "documentation": "estimated costs to complete in-process research and development projects", "label": "estimated costs to complete in-process research and development projects", "terseLabel": "Estimated costs to complete in-process research and development projects" } } }, "localname": "Estimatedcoststocompleteinprocessresearchanddevelopmentprojects", "nsuri": "http://www.agilent.com/20191031", "presentation": [ "http://www.agilent.com/role/AcquisitionsTextDetails" ], "xbrltype": "monetaryItemType" }, "a_FairValueAssetsMeasuredOnRecurringBasisDerivativeInstrumentsForeignExhangeContracts": { "auth_ref": [], "calculation": { "http://www.agilent.com/role/FairValueMeasurementsFairValueOfAssetsAndLiabilitiesMeasuredOnRecurringBasisDetails": { "order": 2.0, "parentTag": "a_FairValueAssetsMeasuredOnRecurringBasisTotalAssets", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-US": { "role": { "documentation": "This element represents a certain statement of financial position asset which includes foreign exchange contracts derivative instruments, measured at fair value on a recurring basis.", "label": "Fair Value Assets Measured On Recurring Basis Derivative Instruments Foreign Exhange Contracts", "verboseLabel": "Derivative instruments (foreign exchange contracts)" } } }, "localname": "FairValueAssetsMeasuredOnRecurringBasisDerivativeInstrumentsForeignExhangeContracts", "nsuri": "http://www.agilent.com/20191031", "presentation": [ "http://www.agilent.com/role/FairValueMeasurementsFairValueOfAssetsAndLiabilitiesMeasuredOnRecurringBasisDetails" ], "xbrltype": "monetaryItemType" }, "a_FairValueAssetsMeasuredOnRecurringBasisTotalAssets": { "auth_ref": [], "calculation": { "http://www.agilent.com/role/FairValueMeasurementsFairValueOfAssetsAndLiabilitiesMeasuredOnRecurringBasisDetails": { "order": null, "parentTag": null, "root": true, "weight": null } }, "crdr": "debit", "lang": { "en-US": { "role": { "documentation": "This element represents total assets, measured at fair value on a recurring basis.", "label": "Fair Value Assets Measured On Recurring Basis Total Assets", "totalLabel": "Total assets measured at fair value" } } }, "localname": "FairValueAssetsMeasuredOnRecurringBasisTotalAssets", "nsuri": "http://www.agilent.com/20191031", "presentation": [ "http://www.agilent.com/role/FairValueMeasurementsFairValueOfAssetsAndLiabilitiesMeasuredOnRecurringBasisDetails" ], "xbrltype": "monetaryItemType" }, "a_FairValueLiabilitiesMeasuredOnRecurringBasisDeferredCompensationLiability": { "auth_ref": [], "calculation": { "http://www.agilent.com/role/FairValueMeasurementsFairValueOfAssetsAndLiabilitiesMeasuredOnRecurringBasisDetails": { "order": 2.0, "parentTag": "a_FairValueLiabilitiesMeasuredOnRecurringBasisTotalLiabilities", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-US": { "role": { "documentation": "This element represents a certain statement of financial position liability which deferred compensation liability, measured at fair value on a recurring basis.", "label": "Fair Value Liabilities Measured On Recurring Basis Deferred Compensation Liability", "verboseLabel": "Deferred compensation liability" } } }, "localname": "FairValueLiabilitiesMeasuredOnRecurringBasisDeferredCompensationLiability", "nsuri": "http://www.agilent.com/20191031", "presentation": [ "http://www.agilent.com/role/FairValueMeasurementsFairValueOfAssetsAndLiabilitiesMeasuredOnRecurringBasisDetails" ], "xbrltype": "monetaryItemType" }, "a_FairValueLiabilitiesMeasuredOnRecurringBasisTotalLiabilities": { "auth_ref": [], "calculation": { "http://www.agilent.com/role/FairValueMeasurementsFairValueOfAssetsAndLiabilitiesMeasuredOnRecurringBasisDetails": { "order": null, "parentTag": null, "root": true, "weight": null } }, "crdr": "credit", "lang": { "en-US": { "role": { "documentation": "This element represents total liabilities, measured at fair value on a recurring basis.", "label": "Fair Value Liabilities Measured On Recurring Basis Total Liabilities", "totalLabel": "Total liabilities measured at fair value" } } }, "localname": "FairValueLiabilitiesMeasuredOnRecurringBasisTotalLiabilities", "nsuri": "http://www.agilent.com/20191031", "presentation": [ "http://www.agilent.com/role/FairValueMeasurementsFairValueOfAssetsAndLiabilitiesMeasuredOnRecurringBasisDetails" ], "xbrltype": "monetaryItemType" }, "a_FairValueOfPlanAssetsAbstract": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Fair value of plan assets [Abstract]", "label": "Fair value of plan assets [Abstract]", "terseLabel": "Fair value of plan assets [Abstract]" } } }, "localname": "FairValueOfPlanAssetsAbstract", "nsuri": "http://www.agilent.com/20191031", "presentation": [ "http://www.agilent.com/role/RetirementPlansAndPostRetirementPensionPlansFairValueOfPlanAssetsDetails" ], "xbrltype": "stringItemType" }, "a_FairValueofplanassetswherefairvalueexceedspensionbenefitobligation": { "auth_ref": [], "crdr": "credit", "lang": { "en-US": { "role": { "documentation": "Fair value of plan assets for defined benefit plan where fair value of plan assets exceeds pension benefit obligation.", "label": "Fair Value of plan assets where fair value exceeds pension benefit obligation", "terseLabel": "Fair Value of plan assets where fair value exceeds pension benefit obligation" } } }, "localname": "FairValueofplanassetswherefairvalueexceedspensionbenefitobligation", "nsuri": "http://www.agilent.com/20191031", "presentation": [ "http://www.agilent.com/role/RetirementPlansAndPostRetirementPensionPlansFairValueOfPlanAssetsDetails" ], "xbrltype": "monetaryItemType" }, "a_Fairvaluelowerthancarryingvalue": { "auth_ref": [], "crdr": "credit", "lang": { "en-US": { "role": { "documentation": "Amount of fair value of long term debt is lower than of carrying value.", "label": "Fair value lower than carrying value", "terseLabel": "Fair value lower than carrying value" } } }, "localname": "Fairvaluelowerthancarryingvalue", "nsuri": "http://www.agilent.com/20191031", "presentation": [ "http://www.agilent.com/role/OverviewAndSummaryOfSignificantAccountingPoliciesDetails" ], "xbrltype": "monetaryItemType" }, "a_Fairvalueoflongtermdebtinexcessofcarryingvalue": { "auth_ref": [], "crdr": "credit", "lang": { "en-US": { "role": { "documentation": "Amount of fair value of long term debt in excess of carrying value.", "label": "Fair value of long term debt in excess of carrying value", "terseLabel": "Fair value of long term debt in excess of carrying value" } } }, "localname": "Fairvalueoflongtermdebtinexcessofcarryingvalue", "nsuri": "http://www.agilent.com/20191031", "presentation": [ "http://www.agilent.com/role/OverviewAndSummaryOfSignificantAccountingPoliciesDetails" ], "xbrltype": "monetaryItemType" }, "a_FairvalueofplanassetsfordefinedbenefitpensionplanwherethefairvalueofplanassetsexceedsABO.": { "auth_ref": [], "crdr": "credit", "lang": { "en-US": { "role": { "documentation": "Fair value of plan assets for defined benefit pension plan where the fair value of plan assets exceeds accumulated benefit obligation.", "label": "Fair value of plan assets for defined benefit pension plan where the fair value of plan assets exceeds ABO.", "terseLabel": "Fair value of plan assets for defined benefit pension plan where the fair value of plan assets exceeds ABO." } } }, "localname": "FairvalueofplanassetsfordefinedbenefitpensionplanwherethefairvalueofplanassetsexceedsABO.", "nsuri": "http://www.agilent.com/20191031", "presentation": [ "http://www.agilent.com/role/RetirementPlansAndPostRetirementPensionPlansFairValueOfPlanAssetsDetails" ], "xbrltype": "monetaryItemType" }, "a_Fairvalueofplanassetsfordefinedbenefitplanwithbenefitobligationinexcessofplanassets.": { "auth_ref": [], "crdr": "debit", "lang": { "en-US": { "role": { "documentation": "Fair value of plan assets for defined benefit plan with benefit obligation in excess of plan assets.", "label": "Fair value of plan assets for defined benefit plan with benefit obligation in excess of plan assets.", "terseLabel": "Fair value of plan assets for defined benefit plan with benefit obligation in excess of plan assets." } } }, "localname": "Fairvalueofplanassetsfordefinedbenefitplanwithbenefitobligationinexcessofplanassets.", "nsuri": "http://www.agilent.com/20191031", "presentation": [ "http://www.agilent.com/role/RetirementPlansAndPostRetirementPensionPlansFairValueOfPlanAssetsDetails" ], "xbrltype": "monetaryItemType" }, "a_FoodMarketMember": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Food Market [Member]", "label": "Food Market [Member]", "terseLabel": "Food Market" } } }, "localname": "FoodMarketMember", "nsuri": "http://www.agilent.com/20191031", "presentation": [ "http://www.agilent.com/role/RevenueRevenueByEndMarketsDetails" ], "xbrltype": "domainItemType" }, "a_ForeignCurrencyTranslationTax": { "auth_ref": [], "crdr": "credit", "lang": { "en-US": { "role": { "documentation": "Tax effect on the change in the balance sheet adjustment that results from the adjustment that results from the process of translating subsidiary financial statements and foreign equity investments into reporting currency as of the balance sheet date.", "label": "Foreign currency translation, tax", "terseLabel": "Foreign currency translation, tax" } } }, "localname": "ForeignCurrencyTranslationTax", "nsuri": "http://www.agilent.com/20191031", "presentation": [ "http://www.agilent.com/role/StockholdersEquityAccumulatedOtherComprehensiveIncomeDetails" ], "xbrltype": "monetaryItemType" }, "a_Fullydepreciatedassetsnolongerinuse": { "auth_ref": [], "crdr": "debit", "lang": { "en-US": { "role": { "documentation": "Fully depreciated assets no longer in use retired in the period", "label": "Fully depreciated assets no longer in use", "terseLabel": "Fully depreciated assets no longer in use" } } }, "localname": "Fullydepreciatedassetsnolongerinuse", "nsuri": "http://www.agilent.com/20191031", "presentation": [ "http://www.agilent.com/role/PropertyPlantAndEquipmentNetDetails" ], "xbrltype": "monetaryItemType" }, "a_GainLossOnInvestmentsMarketableSecuritiesAbstract": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Gain (Loss) on Investments, Marketable Securities [Abstract]", "label": "Gain (Loss) on Investments, Marketable Securities [Abstract]", "terseLabel": "Amounts included in other income (expense), net [Abstract]" } } }, "localname": "GainLossOnInvestmentsMarketableSecuritiesAbstract", "nsuri": "http://www.agilent.com/20191031", "presentation": [ "http://www.agilent.com/role/InvestmentsDetails" ], "xbrltype": "stringItemType" }, "a_ImpactofAdoptingNewIntraEntityTaxGuidanceMember": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Impact of Adopting Accounting Standard 2016-16 Income Taxes (Topic 740), Intra-Entity Transfers of Assets Other Than Inventory[Member]", "label": "Impact of Adopting New Intra-Entity Tax Guidance [Member]", "terseLabel": "Impact of Adopting New Intra-Entity Tax Guidance [Member]" } } }, "localname": "ImpactofAdoptingNewIntraEntityTaxGuidanceMember", "nsuri": "http://www.agilent.com/20191031", "presentation": [ "http://www.agilent.com/role/NewAccountingPronouncementsImpactOfAdoptingNewGuidanceDetails", "http://www.agilent.com/role/NewAccountingPronouncementsTextualsDetails" ], "xbrltype": "domainItemType" }, "a_ImpactofAdoptingNewInvestmentsValuationGuidanceMember": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Impact of Adopting Accounting Standards Update No. 2016-01, Financial Instruments - Overall (Subtopic 825-10), Recognition and Measurement of Financial Assets and Financial Liabilities.", "label": "Impact of Adopting New Investments Valuation Guidance [Member]", "terseLabel": "Impact of Adopting New Investments Valuation Guidance [Member]" } } }, "localname": "ImpactofAdoptingNewInvestmentsValuationGuidanceMember", "nsuri": "http://www.agilent.com/20191031", "presentation": [ "http://www.agilent.com/role/InvestmentsDetails", "http://www.agilent.com/role/NewAccountingPronouncementsImpactOfAdoptingNewGuidanceDetails", "http://www.agilent.com/role/NewAccountingPronouncementsTextualsDetails" ], "xbrltype": "domainItemType" }, "a_ImpactofAdoptingNewRetirementBenefitsGuidanceMember": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Impact of Adopting Accounting Standard Update No. 2017-07, Compensation - Retirement Benefits (Topic 715), Improving the Presentation of Net Periodic Pension Cost and Net Periodic Postretirement Benefit Costs", "label": "Impact of Adopting New Retirement Benefits Guidance [Member]", "terseLabel": "Impact of Adopting New Retirement Benefits Guidance [Member]" } } }, "localname": "ImpactofAdoptingNewRetirementBenefitsGuidanceMember", "nsuri": "http://www.agilent.com/20191031", "presentation": [ "http://www.agilent.com/role/NewAccountingPronouncementsImpactOfAdoptingNewGuidanceDetails", "http://www.agilent.com/role/NewAccountingPronouncementsTextualsDetails" ], "xbrltype": "domainItemType" }, "a_ImpactofAdoptingNewRevenueRecognitionGuidanceMember": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Impact of Adopting Accounting Standard Update No. 2014-09, Revenue from Contracts with Customers (Topic 606) (\u201cASC 606\u2019\u2019) [Member]", "label": "Impact of Adopting New Revenue Recognition Guidance [Member]", "terseLabel": "Impact of Adopting New Revenue Recognition Guidance [Member]" } } }, "localname": "ImpactofAdoptingNewRevenueRecognitionGuidanceMember", "nsuri": "http://www.agilent.com/20191031", "presentation": [ "http://www.agilent.com/role/NewAccountingPronouncementsImpactOfAdoptingNewGuidanceDetails", "http://www.agilent.com/role/NewAccountingPronouncementsTextualsDetails" ], "xbrltype": "domainItemType" }, "a_ImpactofAdoptingNewTaxEffectsinAOCIGuidanceMember": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Impact of Adopting Accounting Standards Update No. 2018-02 Income Statement - Reporting Comprehensive Income, Reclassification of Certain Tax Effects from Accumulated Other Comprehensive Income [Member]", "label": "Impact of Adopting New Tax Effects in AOCI Guidance [Member]", "terseLabel": "Impact of Adopting New Tax Effects in AOCI Guidance [Member]" } } }, "localname": "ImpactofAdoptingNewTaxEffectsinAOCIGuidanceMember", "nsuri": "http://www.agilent.com/20191031", "presentation": [ "http://www.agilent.com/role/NewAccountingPronouncementsImpactOfAdoptingNewGuidanceDetails", "http://www.agilent.com/role/NewAccountingPronouncementsTextualsDetails" ], "xbrltype": "domainItemType" }, "a_ImpairmentOfLongLivedAssetsIncludedInNetIncomeTextBlock": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "For long-lived assets of an entity, disclosures may include a description of the impaired long-lived asset and facts and circumstances leading to the impairment, amount of the impairment loss and where the loss is located in the income statement, method(s) for determining fair value, and the segment in which the impaired long-lived asset is reported.", "label": "Impairment of Long-lived assets included in net income [Text Block]", "verboseLabel": "Impairment of Long-lived assets included in net income" } } }, "localname": "ImpairmentOfLongLivedAssetsIncludedInNetIncomeTextBlock", "nsuri": "http://www.agilent.com/20191031", "presentation": [ "http://www.agilent.com/role/FairValueMeasurementsTables" ], "xbrltype": "textBlockItemType" }, "a_IncometaxreconciliationchangeinUSdeferredtaxreserves": { "auth_ref": [], "crdr": "debit", "lang": { "en-US": { "role": { "documentation": "Income tax reconciliation change in US deferred tax reserves", "label": "Income tax reconciliation change in US deferred tax reserves", "terseLabel": "Change in unrecognized tax benefits" } } }, "localname": "IncometaxreconciliationchangeinUSdeferredtaxreserves", "nsuri": "http://www.agilent.com/20191031", "presentation": [ "http://www.agilent.com/role/IncomeTaxesIncomeTaxesEffectiveTaxRateAndTaxHolidaysDetails" ], "xbrltype": "monetaryItemType" }, "a_InstrumentationMember": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Instrumentation [Member]", "label": "Instrumentation [Member]", "terseLabel": "Instrumentation" } } }, "localname": "InstrumentationMember", "nsuri": "http://www.agilent.com/20191031", "presentation": [ "http://www.agilent.com/role/RevenueRevenueRevenueByTypeDetails" ], "xbrltype": "domainItemType" }, "a_InterestRateDerivativesTerminatedDate": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Interest Rate Swap Terminated Date", "label": "Interest Rate Derivatives Terminated Date", "terseLabel": "Interest Rate Derivatives Terminated Date" } } }, "localname": "InterestRateDerivativesTerminatedDate", "nsuri": "http://www.agilent.com/20191031", "presentation": [ "http://www.agilent.com/role/LongTermDebtLongTermDebtOtherDetails", "http://www.agilent.com/role/ShortTermDebtSeniorNotesDetails" ], "xbrltype": "normalizedStringItemType" }, "a_InterestRateSwap": { "auth_ref": [], "crdr": "credit", "lang": { "en-US": { "role": { "documentation": "Forward based contracts in which two parties agree to swap periodic payments that are fixed at the outset of the swap contract with variable payments based on a market interest rate (index rate) over a specified period recorded in debt.", "label": "Interest Rate Swap", "terseLabel": "Interest Rate Swap" } } }, "localname": "InterestRateSwap", "nsuri": "http://www.agilent.com/20191031", "presentation": [ "http://www.agilent.com/role/LongTermDebtCarryingValueDetails", "http://www.agilent.com/role/LongTermDebtLongTermDebtOtherDetails" ], "xbrltype": "monetaryItemType" }, "a_InterestRateSwapOnSeniorNotesAxis": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Pertinent information about each long-term debt arrangement including the carrying amount as of the balance sheet date, by type of long-term debt. These are debt arrangements that originally required repayment more than twelve months after issuance or greater than the normal operating cycle of the company, if longer.", "label": "Interest Rate Swap On Senior Notes [Axis]", "terseLabel": "Interest Rate Swap On Senior Notes [Axis]" } } }, "localname": "InterestRateSwapOnSeniorNotesAxis", "nsuri": "http://www.agilent.com/20191031", "presentation": [ "http://www.agilent.com/role/DerivativesDetails", "http://www.agilent.com/role/DerivativesEffectOfDerivativeInstrumentsOnConsolidatedStatementOfOperationsDetails", "http://www.agilent.com/role/DerivativesFairValueOfDerivativeInstrumentsAndConsolidatedBalanceSheetLocationDetails", "http://www.agilent.com/role/LongTermDebtLongTermDebtOtherDetails", "http://www.agilent.com/role/LongTermDebtSeniorNotesDetails", "http://www.agilent.com/role/ShortTermDebtSeniorNotesDetails" ], "xbrltype": "stringItemType" }, "a_InterestRateSwapOnSeniorNotesDomain": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Type of long-term debt arrangement, such as notes, line of credit, commercial paper, asset-based financing, project financing, letter of credit financing. These are debt arrangements that originally required repayment more than twelve months after issuance or greater than the normal operating cycle of the company, if longer.", "label": "Interest Rate Swap On Senior Notes [Domain]", "terseLabel": "Interest Rate Swap On Senior Notes [Domain]" } } }, "localname": "InterestRateSwapOnSeniorNotesDomain", "nsuri": "http://www.agilent.com/20191031", "presentation": [ "http://www.agilent.com/role/DerivativesDetails", "http://www.agilent.com/role/DerivativesEffectOfDerivativeInstrumentsOnConsolidatedStatementOfOperationsDetails", "http://www.agilent.com/role/DerivativesFairValueOfDerivativeInstrumentsAndConsolidatedBalanceSheetLocationDetails", "http://www.agilent.com/role/LongTermDebtLongTermDebtOtherDetails", "http://www.agilent.com/role/LongTermDebtSeniorNotesDetails", "http://www.agilent.com/role/ShortTermDebtSeniorNotesDetails" ], "xbrltype": "domainItemType" }, "a_Interestrateswappayments": { "auth_ref": [], "calculation": { "http://www.agilent.com/role/ConsolidatedStatementOfCashFlows": { "order": 15.0, "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": -1.0 } }, "crdr": "credit", "lang": { "en-US": { "role": { "documentation": "interest rate swap payments", "label": "interest rate swap payments", "negatedTerseLabel": "Treasury lock agreement payment", "terseLabel": "interest rate swap payments" } } }, "localname": "Interestrateswappayments", "nsuri": "http://www.agilent.com/20191031", "presentation": [ "http://www.agilent.com/role/ConsolidatedStatementOfCashFlows", "http://www.agilent.com/role/DerivativesDetails", "http://www.agilent.com/role/LongTermDebtLongTermDebtOtherDetails" ], "xbrltype": "monetaryItemType" }, "a_LTPPRSUMember": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "LTPP & RSU [Member]", "label": "LTPP & RSU [Member]", "terseLabel": "LTPP & RSU [Member]" } } }, "localname": "LTPPRSUMember", "nsuri": "http://www.agilent.com/20191031", "presentation": [ "http://www.agilent.com/role/ShareBasedCompensationFairValueAssumptionsDetails" ], "xbrltype": "domainItemType" }, "a_LasergenMember": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Lasergen [Member]", "label": "Lasergen [Member]", "terseLabel": "Lasergen [Member]" } } }, "localname": "LasergenMember", "nsuri": "http://www.agilent.com/20191031", "presentation": [ "http://www.agilent.com/role/OverviewAndSummaryOfSignificantAccountingPoliciesDetails" ], "xbrltype": "domainItemType" }, "a_LifeSciencesandAppliedMarketsMember": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Life Sciences and Applied Markets [Member]", "label": "Life Sciences and Applied Markets [Member]", "terseLabel": "Life Sciences and Applied Markets" } } }, "localname": "LifeSciencesandAppliedMarketsMember", "nsuri": "http://www.agilent.com/20191031", "presentation": [ "http://www.agilent.com/role/GoodwillAndOtherIntangibleAssetsRollForwardDetails", "http://www.agilent.com/role/GoodwillAndOtherIntangibleAssetsTextDetails", "http://www.agilent.com/role/RevenueRevenueByRegionDetails", "http://www.agilent.com/role/SegmentInformationProfitabilityDetails", "http://www.agilent.com/role/SegmentInformationReconciliationOfReportableResultsDetails", "http://www.agilent.com/role/SegmentInformationSegmentAssetsDetails" ], "xbrltype": "domainItemType" }, "a_LongLivedAssetsAbstract": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Long -Lived Assets [Abstract]", "label": "Long -Lived Assets [Abstract]", "terseLabel": "Long -Lived Assets" } } }, "localname": "LongLivedAssetsAbstract", "nsuri": "http://www.agilent.com/20191031", "presentation": [ "http://www.agilent.com/role/OverviewAndSummaryOfSignificantAccountingPoliciesDetails" ], "xbrltype": "stringItemType" }, "a_LtppMember": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Long Term Performance Plan.", "label": "LTPP [Member]" } } }, "localname": "LtppMember", "nsuri": "http://www.agilent.com/20191031", "presentation": [ "http://www.agilent.com/role/ShareBasedCompensationFairValueAssumptionsDetails" ], "xbrltype": "domainItemType" }, "a_Netassetvalueexcludedfromfairvaluebyinput": { "auth_ref": [], "crdr": "debit", "lang": { "en-US": { "role": { "documentation": "Represents investments for which fair value is measured using net asset value (NAV) per share practical expedient, and excluded from the fair value schedule by input.", "label": "Net asset value excluded from fair value by input", "terseLabel": "Net asset value excluded from fair value by input" } } }, "localname": "Netassetvalueexcludedfromfairvaluebyinput", "nsuri": "http://www.agilent.com/20191031", "presentation": [ "http://www.agilent.com/role/RetirementPlansAndPostRetirementPensionPlansFairValueOfPlanAssetsDetails" ], "xbrltype": "monetaryItemType" }, "a_Nettransitiontax": { "auth_ref": [], "crdr": "debit", "lang": { "en-US": { "role": { "documentation": "U.S. net transition tax composed of the provisional one-time transition tax on foreign earnings reduced by related deferred tax liabilities adjustment.", "label": "Net transition tax", "terseLabel": "Net transition tax" } } }, "localname": "Nettransitiontax", "nsuri": "http://www.agilent.com/20191031", "presentation": [ "http://www.agilent.com/role/IncomeTaxes2017USTaxReformTaxCutsAndJobsActDetails" ], "xbrltype": "monetaryItemType" }, "a_NonInstrumentationandOtherMember": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Non-Instrumentation and Other[Member]", "label": "Non-Instrumentation and Other [Member]", "terseLabel": "Non-Instrumentation and Other" } } }, "localname": "NonInstrumentationandOtherMember", "nsuri": "http://www.agilent.com/20191031", "presentation": [ "http://www.agilent.com/role/RevenueRevenueRevenueByTypeDetails" ], "xbrltype": "domainItemType" }, "a_NonUnitedStatesHeldCashAndCashEquivalents": { "auth_ref": [], "crdr": "debit", "lang": { "en-US": { "role": { "documentation": "Dollar amount of cash and cash equivalents held in financial institutions outside of the United States at period end.", "label": "Non-United States Held Cash And Cash Equivalents", "verboseLabel": "Cash and cash equivalents held outside the U.S." } } }, "localname": "NonUnitedStatesHeldCashAndCashEquivalents", "nsuri": "http://www.agilent.com/20191031", "presentation": [ "http://www.agilent.com/role/OverviewAndSummaryOfSignificantAccountingPoliciesDetails" ], "xbrltype": "monetaryItemType" }, "a_Noncashchangesininvestmentsinpropertyplantandequipmentincreasedecrease": { "auth_ref": [], "crdr": "credit", "lang": { "en-US": { "role": { "documentation": "Changes to the cost of fixed assets that are not the result of cash capital expenditures.", "label": "Non-cash changes in investments in property, plant and equipment increase (decrease)", "terseLabel": "Non-cash changes in investments in property, plant and equipment increase (decrease)" } } }, "localname": "Noncashchangesininvestmentsinpropertyplantandequipmentincreasedecrease", "nsuri": "http://www.agilent.com/20191031", "presentation": [ "http://www.agilent.com/role/ConsolidatedStatementOfCashFlows" ], "xbrltype": "monetaryItemType" }, "a_NotionalAmountOfTerminatedInterestRateFairValueHedgeDerivatives": { "auth_ref": [], "crdr": "debit", "lang": { "en-US": { "role": { "documentation": "Aggregate notional amount of all interest rate derivatives designated as hedging instruments in fair value hedges that were terminated. Notional amount refers to the monetary amount specified in the interest rate derivative contract.", "label": "Notional Amount Of Terminated Interest Rate Fair Value Hedge Derivatives", "terseLabel": "Notional Amount Of Terminated Interest Rate Fair Value Hedge Derivatives", "verboseLabel": "Notional Amount of Terminated Interest Rate Swaps" } } }, "localname": "NotionalAmountOfTerminatedInterestRateFairValueHedgeDerivatives", "nsuri": "http://www.agilent.com/20191031", "presentation": [ "http://www.agilent.com/role/DerivativesDetails", "http://www.agilent.com/role/LongTermDebtLongTermDebtOtherDetails", "http://www.agilent.com/role/ShortTermDebtSeniorNotesDetails" ], "xbrltype": "monetaryItemType" }, "a_NumberOfForeignExchangeForwardContractsDesignatedAsCashFlowHedge": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Number of foreign currency exchange forward contract derivatives held by the entity at the reporting date and designated as cash flow hedges.", "label": "Number Of Foreign Exchange Forward Contracts Designated As Cash Flow Hedge", "terseLabel": "Number Of Foreign Exchange Forward Contracts Designated As Cash Flow Hedge" } } }, "localname": "NumberOfForeignExchangeForwardContractsDesignatedAsCashFlowHedge", "nsuri": "http://www.agilent.com/20191031", "presentation": [ "http://www.agilent.com/role/DerivativesDetails" ], "xbrltype": "integerItemType" }, "a_NumberOfForeignExchangeForwardContractsNotDesignatedAsHedges": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Number of foreign currency exchange forward contract derivatives held by the entity at the reporting date and not designated as hedges.", "label": "Number Of Foreign Exchange Forward Contracts Not Designated As Hedges", "terseLabel": "Number Of Foreign Exchange Forward Contracts Not Designated As Hedges" } } }, "localname": "NumberOfForeignExchangeForwardContractsNotDesignatedAsHedges", "nsuri": "http://www.agilent.com/20191031", "presentation": [ "http://www.agilent.com/role/DerivativesDetails" ], "xbrltype": "integerItemType" }, "a_NumberOfInterestRateSwapContractsDesignatedAsFairValueHedgesTerminated": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Number of interest rate derivative instruments held by the entity at the reporting date.", "label": "Number of Interest Rate Swap Contracts Designated as Fair Value Hedges Terminated" } } }, "localname": "NumberOfInterestRateSwapContractsDesignatedAsFairValueHedgesTerminated", "nsuri": "http://www.agilent.com/20191031", "presentation": [ "http://www.agilent.com/role/DerivativesDetails" ], "xbrltype": "integerItemType" }, "a_NumeratorAbstract": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Numerator [Abstract]", "label": "Numerator [Abstract]", "verboseLabel": "Numerator:" } } }, "localname": "NumeratorAbstract", "nsuri": "http://www.agilent.com/20191031", "presentation": [ "http://www.agilent.com/role/NetIncomeLossPerShareDetails" ], "xbrltype": "stringItemType" }, "a_Operatingleasenetassets": { "auth_ref": [], "crdr": "debit", "lang": { "en-US": { "role": { "documentation": "operating lease net assets where Agilent is the lessor", "label": "operating lease net assets", "terseLabel": "operating lease net assets" } } }, "localname": "Operatingleasenetassets", "nsuri": "http://www.agilent.com/20191031", "presentation": [ "http://www.agilent.com/role/OverviewAndSummaryOfSignificantAccountingPoliciesDetails" ], "xbrltype": "monetaryItemType" }, "a_OtherComprehensiveIncomeDefinedBenefitPlanAmortizationOfNetActuarialLoss": { "auth_ref": [], "calculation": { "http://www.agilent.com/role/RetirementPlansAndPostRetirementPensionPlansComponentsOfNetPeriodicCostsDetails": { "order": 2.0, "parentTag": "a_OtherComprehensiveIncomeDefinedBenefitPlansPeriodIncreaseDecrease", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-US": { "role": { "documentation": "The change in other comprehensive income due to the amortization of the net actuarial gains (losses) into net periodic pension costs.", "label": "Other Comprehensive Income Defined Benefit Plan Amortization Of Net Actuarial Loss", "terseLabel": "Other Comprehensive Income Defined Benefit Plan Amortization Of Net Actuarial Loss", "verboseLabel": "Amortization of net actuarial loss" } } }, "localname": "OtherComprehensiveIncomeDefinedBenefitPlanAmortizationOfNetActuarialLoss", "nsuri": "http://www.agilent.com/20191031", "presentation": [ "http://www.agilent.com/role/RetirementPlansAndPostRetirementPensionPlansComponentsOfNetPeriodicCostsDetails", "http://www.agilent.com/role/StockholdersEquityStockholdersEquityReclassificationsOutOfAccumulatedOtherComprehensiveIncomeDetails" ], "xbrltype": "monetaryItemType" }, "a_OtherComprehensiveIncomeDefinedBenefitPlansPeriodIncreaseDecrease": { "auth_ref": [], "calculation": { "http://www.agilent.com/role/RetirementPlansAndPostRetirementPensionPlansComponentsOfNetPeriodicCostsDetails": { "order": 3.0, "parentTag": "us-gaap_OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIPensionAndOtherPostretirementBenefitPlansForNetTransitionAssetObligationBeforeTax", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-US": { "role": { "documentation": "Amounts recognized in other comprehensive income (but not yet recognized in net periodic benefit cost), including the net gain (loss) and net prior service cost (credit) arising during the period.", "label": "Other Comprehensive Income Defined Benefit Plans Period Increase Decrease", "totalLabel": "Total recognized in other comprehensive (income) loss" } } }, "localname": "OtherComprehensiveIncomeDefinedBenefitPlansPeriodIncreaseDecrease", "nsuri": "http://www.agilent.com/20191031", "presentation": [ "http://www.agilent.com/role/RetirementPlansAndPostRetirementPensionPlansComponentsOfNetPeriodicCostsDetails" ], "xbrltype": "monetaryItemType" }, "a_OtherComprehensiveIncomelosspensionandotherpostretirementbenefitplansamortizationofnetlosstax": { "auth_ref": [], "crdr": "credit", "lang": { "en-US": { "role": { "documentation": "Other Comprehensive Income (loss) pension and other post retirement benefit plans, amortization of net loss, tax", "label": "Other Comprehensive Income (loss) pension and other post retirement benefit plans, amortization of net loss, tax", "negatedLabel": "Tax (expense) benefit" } } }, "localname": "OtherComprehensiveIncomelosspensionandotherpostretirementbenefitplansamortizationofnetlosstax", "nsuri": "http://www.agilent.com/20191031", "presentation": [ "http://www.agilent.com/role/StockholdersEquityChangesInAccumulatedOtherComprehensiveIncomeDetails" ], "xbrltype": "monetaryItemType" }, "a_OtherPlanAssetsMember": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Assets held in a defined plan not otherwise previously defined.", "label": "Other Plan Assets [Member]", "terseLabel": "Other Investments" } } }, "localname": "OtherPlanAssetsMember", "nsuri": "http://www.agilent.com/20191031", "presentation": [ "http://www.agilent.com/role/RetirementPlansAndPostRetirementPensionPlansFairValueOfPlanAssetsDetails", "http://www.agilent.com/role/RetirementPlansAndPostRetirementPensionPlansRetirementPlansAndPostRetirementPensionPlansTargetAllocationsDetails" ], "xbrltype": "domainItemType" }, "a_PenaltyreduceoverperiodoftimeMember": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Penalty reduce over period of time [Member]", "label": "Penalty reduce over period of time [Member]", "terseLabel": "Penalty reduce over period of time [Member]" } } }, "localname": "PenaltyreduceoverperiodoftimeMember", "nsuri": "http://www.agilent.com/20191031", "presentation": [ "http://www.agilent.com/role/CommitmentsAndContingenciesDetails" ], "xbrltype": "domainItemType" }, "a_PercentageOfFaceAmountOfSeniorNoteInstrumentIssued": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Proceeds obtained expressed as a percentage of debt instrument face value.", "label": "Percentage Of Face Amount Of Senior Note Instrument Issued", "terseLabel": "Percentage Of Face Amount Of Senior Note Instrument Issued", "verboseLabel": "Issue rate percentage of principal amount" } } }, "localname": "PercentageOfFaceAmountOfSeniorNoteInstrumentIssued", "nsuri": "http://www.agilent.com/20191031", "presentation": [ "http://www.agilent.com/role/LongTermDebtSeniorNotesDetails", "http://www.agilent.com/role/ShortTermDebtSeniorNotesDetails" ], "xbrltype": "percentItemType" }, "a_PharmaceuticalandBiopharmaceuticalMarketMember": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Pharmaceutical and Biopharmaceutical Market [Member]", "label": "Pharmaceutical and Biopharmaceutical Market [Member]", "terseLabel": "Pharmaceutical and Biopharmaceutical Market" } } }, "localname": "PharmaceuticalandBiopharmaceuticalMarketMember", "nsuri": "http://www.agilent.com/20191031", "presentation": [ "http://www.agilent.com/role/RevenueRevenueByEndMarketsDetails" ], "xbrltype": "domainItemType" }, "a_Remaininggainlosstobeamortizedonderivative": { "auth_ref": [], "crdr": "credit", "lang": { "en-US": { "role": { "documentation": "Remaining gain loss to be amortized on derivative", "label": "Remaining gain loss to be amortized on derivative", "terseLabel": "Remaining gain loss to be amortized on derivative" } } }, "localname": "Remaininggainlosstobeamortizedonderivative", "nsuri": "http://www.agilent.com/20191031", "presentation": [ "http://www.agilent.com/role/DerivativesDetails", "http://www.agilent.com/role/LongTermDebtLongTermDebtOtherDetails", "http://www.agilent.com/role/LongTermDebtSeniorNotesDetails" ], "xbrltype": "monetaryItemType" }, "a_RestOfWorldMember": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "A specified country or group of countries about which segment information is provided by the entity. This element is used for a group of countries not specifically disclosed.", "label": "Rest Of World [Member]", "terseLabel": "Rest Of World" } } }, "localname": "RestOfWorldMember", "nsuri": "http://www.agilent.com/20191031", "presentation": [ "http://www.agilent.com/role/SegmentInformationEntityWideDisclosureLongLivedAssetsDetails", "http://www.agilent.com/role/SegmentInformationEntityWideDisclosuresRevenueDetails" ], "xbrltype": "domainItemType" }, "a_RetirementandpostretirementbenefitsMember": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Retirement and post-retirement benefits [Member]", "label": "Retirement and post-retirement benefits [Member]", "terseLabel": "Retirement and post-retirement benefits" } } }, "localname": "RetirementandpostretirementbenefitsMember", "nsuri": "http://www.agilent.com/20191031", "presentation": [ "http://www.agilent.com/role/RetirementPlansAndPostRetirementPensionPlansFundedStatusDetails" ], "xbrltype": "domainItemType" }, "a_RetirementofTreasurySharesaccountingpolicyPolicyTextBlock": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Disclosure of the accounting policy for the retirement of the company's treasury shares. [Policy Text Block]", "label": "Retirement of Treasury Shares accounting policy [Policy Text Block]", "terseLabel": "Retirement of treasury shares" } } }, "localname": "RetirementofTreasurySharesaccountingpolicyPolicyTextBlock", "nsuri": "http://www.agilent.com/20191031", "presentation": [ "http://www.agilent.com/role/OverviewAndSummaryOfSignificantAccountingPoliciesPolicies" ], "xbrltype": "textBlockItemType" }, "a_RevenueRecognitionExciseAndSalesTaxesPolicyTextBlock": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Describes whether the entity presents excise and sales taxes on either a gross basis (included in revenues and costs) or a net basis (excluded from revenue).", "label": "Revenue Recognition Excise And Sales Taxes [Policy Text Block]", "terseLabel": "Sales taxes" } } }, "localname": "RevenueRecognitionExciseAndSalesTaxesPolicyTextBlock", "nsuri": "http://www.agilent.com/20191031", "presentation": [ "http://www.agilent.com/role/OverviewAndSummaryOfSignificantAccountingPoliciesPolicies" ], "xbrltype": "textBlockItemType" }, "a_RevisionsAbstract": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Revisions [Abstract]", "label": "Revisions [Abstract]", "terseLabel": "Revisions [Abstract]" } } }, "localname": "RevisionsAbstract", "nsuri": "http://www.agilent.com/20191031", "presentation": [ "http://www.agilent.com/role/OverviewAndSummaryOfSignificantAccountingPoliciesDetails" ], "xbrltype": "stringItemType" }, "a_ScheduleOfOtherIntangibleAssetsByMajorClassTextBlock": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Disclosure of other intangibles assets, in total and by major class, including the gross carrying amount and accumulated amortization. A major class is composed of intangible assets that can be grouped together because they are similar, either by their nature or by their use in the operations of a company.", "label": "Schedule Of Other Intangible Assets By Major Class [Text Block]", "verboseLabel": "Components of other intangibles during the period" } } }, "localname": "ScheduleOfOtherIntangibleAssetsByMajorClassTextBlock", "nsuri": "http://www.agilent.com/20191031", "presentation": [ "http://www.agilent.com/role/GoodwillAndOtherIntangibleAssetsTables" ], "xbrltype": "textBlockItemType" }, "a_ScheduleofProductWarrantyLiabilityclassificationTableTextBlock": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Schedule of Product Warranty Liability classification [Table Text Block]", "label": "Schedule of Product Warranty Liability classification [Table Text Block]", "terseLabel": "Schedule of Product Warranty Liability classification" } } }, "localname": "ScheduleofProductWarrantyLiabilityclassificationTableTextBlock", "nsuri": "http://www.agilent.com/20191031", "presentation": [ "http://www.agilent.com/role/GuaranteesTables" ], "xbrltype": "textBlockItemType" }, "a_SegmentReportingOtherReconcilingItemsForOperatingProfitLossSegmentToConsolidated": { "auth_ref": [], "calculation": { "http://www.agilent.com/role/SegmentInformationReconciliationOfReportableResultsDetails": { "order": 11.0, "parentTag": "us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-US": { "role": { "documentation": "Amount of an item in the reconciliation of total profit or loss from reportable segments to the entity's consolidated income before income taxes, extraordinary items, discontinued operations.", "label": "Segment Reporting Other reconciling items for operating profit loss segment to consolidated", "terseLabel": "Other" } } }, "localname": "SegmentReportingOtherReconcilingItemsForOperatingProfitLossSegmentToConsolidated", "nsuri": "http://www.agilent.com/20191031", "presentation": [ "http://www.agilent.com/role/SegmentInformationReconciliationOfReportableResultsDetails" ], "xbrltype": "monetaryItemType" }, "a_SegmentReportingReconciliationItemAssets": { "auth_ref": [], "crdr": "debit", "lang": { "en-US": { "role": { "documentation": "Amounts of assets held by an entity, and used in a reconciliation of assets by segment to the entity consolidated balance sheet.", "label": "Segment Reporting Reconciliation Item Assets", "terseLabel": "Segment Reporting Reconciliation Item Assets" } } }, "localname": "SegmentReportingReconciliationItemAssets", "nsuri": "http://www.agilent.com/20191031", "presentation": [ "http://www.agilent.com/role/SegmentInformationSegmentAssetsDetails" ], "xbrltype": "monetaryItemType" }, "a_SegmentReportingReconciliationItemCashAndCashEquivalents": { "auth_ref": [], "crdr": "debit", "lang": { "en-US": { "role": { "documentation": "Amounts of cash, cash equivalents and short term investments held by an entity, and used in a reconciliation of assets by segment to the entity consolidated balance sheet.", "label": "Segment Reporting Reconciliation Item Cash And Cash Equivalents", "terseLabel": "Cash and cash equivalents" } } }, "localname": "SegmentReportingReconciliationItemCashAndCashEquivalents", "nsuri": "http://www.agilent.com/20191031", "presentation": [ "http://www.agilent.com/role/SegmentInformationSegmentAssetsDetails" ], "xbrltype": "monetaryItemType" }, "a_SegmentReportingReconciliationItemInvestments": { "auth_ref": [], "crdr": "debit", "lang": { "en-US": { "role": { "documentation": "Amount of investments held by an entity, and used in a reconciliation of assets by segment to the entity consolidated balance sheet.", "label": "Segment Reporting Reconciliation Item Investments", "terseLabel": "Investments" } } }, "localname": "SegmentReportingReconciliationItemInvestments", "nsuri": "http://www.agilent.com/20191031", "presentation": [ "http://www.agilent.com/role/SegmentInformationSegmentAssetsDetails" ], "xbrltype": "monetaryItemType" }, "a_SegmentReportingReconciliationItemLongTermAndOtherReceivables": { "auth_ref": [], "crdr": "debit", "lang": { "en-US": { "role": { "documentation": "Amount of long-term and other receivables held by an entity, and used in a reconciliation of assets by segment to the entity consolidated balance sheet.", "label": "Segment Reporting Reconciliation Item Long Term And Other Receivables", "terseLabel": "Long term and other receivables" } } }, "localname": "SegmentReportingReconciliationItemLongTermAndOtherReceivables", "nsuri": "http://www.agilent.com/20191031", "presentation": [ "http://www.agilent.com/role/SegmentInformationSegmentAssetsDetails" ], "xbrltype": "monetaryItemType" }, "a_SegmentReportingReconciliationItemOtherAssets": { "auth_ref": [], "crdr": "credit", "lang": { "en-US": { "role": { "documentation": "Amount of other assets and assets not otherwise identified in other reconciliation balances, and used in a reconciliation of assets by segment to the entity consolidated balance sheet.", "label": "Segment Reporting Reconciliation Item Other Assets", "terseLabel": "Other" } } }, "localname": "SegmentReportingReconciliationItemOtherAssets", "nsuri": "http://www.agilent.com/20191031", "presentation": [ "http://www.agilent.com/role/SegmentInformationSegmentAssetsDetails" ], "xbrltype": "monetaryItemType" }, "a_SegmentReportingReconciliationItemPrepaids": { "auth_ref": [], "crdr": "debit", "lang": { "en-US": { "role": { "documentation": "Amount of prepaid expense balance held by an entity, and used in a reconciliation of assets by segment to the entity consolidated balance sheet.", "label": "Segment Reporting Reconciliation Item Prepaids", "terseLabel": "Prepaid expenses" } } }, "localname": "SegmentReportingReconciliationItemPrepaids", "nsuri": "http://www.agilent.com/20191031", "presentation": [ "http://www.agilent.com/role/SegmentInformationSegmentAssetsDetails" ], "xbrltype": "monetaryItemType" }, "a_SegmentTotalMember": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Reportable amounts associated with all reporting segments included in a reconciliation from segment reporting to consolidated income from operations, before taxes.", "label": "Segment Total [Member]", "terseLabel": "Segment Total [Member]" } } }, "localname": "SegmentTotalMember", "nsuri": "http://www.agilent.com/20191031", "presentation": [ "http://www.agilent.com/role/SegmentInformationProfitabilityDetails", "http://www.agilent.com/role/SegmentInformationReconciliationOfReportableResultsDetails", "http://www.agilent.com/role/SegmentInformationSegmentAssetsDetails" ], "xbrltype": "domainItemType" }, "a_Segmentincomelossfromoperations": { "auth_ref": [], "calculation": { "http://www.agilent.com/role/SegmentInformationReconciliationOfReportableResultsDetails": { "order": 1.0, "parentTag": "us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-US": { "role": { "documentation": "The net result for the period of deducting segment operating expenses from segment operating revenues.", "label": "Segment income (loss) from operations", "terseLabel": "Total reportable segment income from operations" } } }, "localname": "Segmentincomelossfromoperations", "nsuri": "http://www.agilent.com/20191031", "presentation": [ "http://www.agilent.com/role/SegmentInformationReconciliationOfReportableResultsDetails" ], "xbrltype": "monetaryItemType" }, "a_SeniorNotes2017Member": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Notes Payable with the highest claim on the assets of the issuer in case of bankruptcy or liquidation (with maturities initially due after one year or beyond the operating cycle if longer), including current and non-current portion. Senior note holders are paid off in full before any payments are made to junior note holders.", "label": "Senior Notes 2017 [Member]", "terseLabel": "Senior Notes 2017 [Member]" } } }, "localname": "SeniorNotes2017Member", "nsuri": "http://www.agilent.com/20191031", "presentation": [ "http://www.agilent.com/role/DerivativesDetails", "http://www.agilent.com/role/ShortTermDebtCreditFacilityAndCapitalLeaseDetails", "http://www.agilent.com/role/ShortTermDebtSeniorNotesDetails" ], "xbrltype": "domainItemType" }, "a_SeniorNotes2020Member": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Notes Payable with the highest claim on the assets of the issuer in case of bankruptcy or liquidation (with maturities initially due after one year or beyond the operating cycle if longer), including current and non-current portion. Senior note holders are paid off in full before any payments are made to junior note holders.", "label": "Senior Notes 2020 [Member]", "terseLabel": "Senior Notes 2020 [Member]" } } }, "localname": "SeniorNotes2020Member", "nsuri": "http://www.agilent.com/20191031", "presentation": [ "http://www.agilent.com/role/DerivativesDetails", "http://www.agilent.com/role/DerivativesEffectOfDerivativeInstrumentsOnConsolidatedStatementOfOperationsDetails", "http://www.agilent.com/role/LongTermDebtCarryingValueDetails", "http://www.agilent.com/role/LongTermDebtLongTermDebtOtherDetails", "http://www.agilent.com/role/LongTermDebtSeniorNotesDetails", "http://www.agilent.com/role/ShortTermDebtSeniorNotesDetails" ], "xbrltype": "domainItemType" }, "a_SeniorNotes2022Member": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Bond that takes priority over other debt securities by the issuer. In the event the issuer goes bankrupt, senior debt holders receive priority for (must receive) repayment prior to (relative to) junior and unsecured ( general) creditors.", "label": "Senior Notes 2022 [Member]", "terseLabel": "Senior Notes 2022 [Member]" } } }, "localname": "SeniorNotes2022Member", "nsuri": "http://www.agilent.com/20191031", "presentation": [ "http://www.agilent.com/role/DerivativesDetails", "http://www.agilent.com/role/LongTermDebtCarryingValueDetails", "http://www.agilent.com/role/LongTermDebtSeniorNotesDetails" ], "xbrltype": "domainItemType" }, "a_SeniorNotes2023Member": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Senior Notes 2023 [Member]", "label": "Senior Notes 2023 [Member]", "terseLabel": "Senior Notes 2023 [Member]" } } }, "localname": "SeniorNotes2023Member", "nsuri": "http://www.agilent.com/20191031", "presentation": [ "http://www.agilent.com/role/LongTermDebtCarryingValueDetails", "http://www.agilent.com/role/LongTermDebtSeniorNotesDetails" ], "xbrltype": "domainItemType" }, "a_SeniorNotes2026Member": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Senior Notes 2026", "label": "Senior Notes 2026 [Member]", "terseLabel": "Senior Notes 2026 [Member]" } } }, "localname": "SeniorNotes2026Member", "nsuri": "http://www.agilent.com/20191031", "presentation": [ "http://www.agilent.com/role/DerivativesDetails", "http://www.agilent.com/role/LongTermDebtCarryingValueDetails", "http://www.agilent.com/role/LongTermDebtLongTermDebtOtherDetails", "http://www.agilent.com/role/LongTermDebtSeniorNotesDetails" ], "xbrltype": "domainItemType" }, "a_SeniorNotes2029Member": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Senior Notes 2029 [Member]", "label": "Senior Notes 2029 [Member]", "terseLabel": "Senior Notes 2029 [Member]" } } }, "localname": "SeniorNotes2029Member", "nsuri": "http://www.agilent.com/20191031", "presentation": [ "http://www.agilent.com/role/DerivativesDetails", "http://www.agilent.com/role/LongTermDebtCarryingValueDetails", "http://www.agilent.com/role/LongTermDebtSeniorNotesDetails" ], "xbrltype": "domainItemType" }, "a_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardMaximumContractualTerm": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Reflects the duration as to when the share-based award expires as specified in the award agreement, which may be presented in a variety of ways (for example, in years, months, quarter of a year).", "label": "Share Based Compensation Arrangement By Share Based Payment Award Award Maximum Contractual Term", "verboseLabel": "Maximum contractual term (in years)" } } }, "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardMaximumContractualTerm", "nsuri": "http://www.agilent.com/20191031", "presentation": [ "http://www.agilent.com/role/ShareBasedCompensationGeneralDisclosuresDetails" ], "xbrltype": "durationStringItemType" }, "a_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsFy2006LtppIncrementalIssuanceNonvestedWeightedAverageGrantDateFairValue": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "The weighted average fair value of incremental issuance associated with FY2007 LTPP nonvested awards on share-based plans excluding option plans (for example, phantom stock plan, stock appreciation rights plan, revenue or profit achievement stock award plan) for which the employer is contingently obligated to issue equity instruments or transfer assets to an employee.", "label": "Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Fy 2006 Ltpp Incremental Issuance Nonvested Weighted Average Grant Date Fair Value", "verboseLabel": "Change in LTPP shares vested in the year due to performance conditions Fair Value" } } }, "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsFy2006LtppIncrementalIssuanceNonvestedWeightedAverageGrantDateFairValue", "nsuri": "http://www.agilent.com/20191031", "presentation": [ "http://www.agilent.com/role/ShareBasedCompensationNonVestedAwardActivityDisclosureDetails" ], "xbrltype": "perShareItemType" }, "a_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsIncrementalIssuanceInPeriod": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "The issuance in the number of non-vested shares under a share-based award plan made during the period on other than stock option plans (for example, phantom stock plan, stock appreciation rights plan, performance target plan).", "label": "Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Incremental Issuance In Period", "terseLabel": "Change in LTPP shares vested in the year due to performance conditions" } } }, "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsIncrementalIssuanceInPeriod", "nsuri": "http://www.agilent.com/20191031", "presentation": [ "http://www.agilent.com/role/ShareBasedCompensationNonVestedAwardActivityDisclosureDetails" ], "xbrltype": "sharesItemType" }, "a_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForwardTextBlock": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Disclosure of components of non-vested stock option or other award plan under which share-based compensation is awarded to employees, typically comprised of the amount of unearned compensation, compensation expense, and changes in the quantity and fair value of the shares granted, exercised, forfeited, and issued and outstanding pertaining to that plan.", "label": "Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Nonvested Roll Forward [Text Block]", "verboseLabel": "Non-vested award activity disclosure" } } }, "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForwardTextBlock", "nsuri": "http://www.agilent.com/20191031", "presentation": [ "http://www.agilent.com/role/ShareBasedCompensationTables" ], "xbrltype": "textBlockItemType" }, "a_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsAndMethodologyTextBlock": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Tabular disclosure of the significant assumptions used during the year to estimate the fair value of stock options, and long-term performance plan grants.", "label": "Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions And Methodology [Text Block]", "verboseLabel": "Share-based compensation arrangement by share-based payment award fair value assumptions and methodology schedule" } } }, "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsAndMethodologyTextBlock", "nsuri": "http://www.agilent.com/20191031", "presentation": [ "http://www.agilent.com/role/ShareBasedCompensationTables" ], "xbrltype": "textBlockItemType" }, "a_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsPeerCompanySharesPriceWiseCorrelationyRate": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "The measure of the percentage amount of share price correlation during the period with a selected group of peer companies. Pair-wise correlations with selected peers is calculated as the correlation between each pair and the sum of correlations divided by the number of pairs to produce the average correlation between each pair.", "label": "Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Peer Company Shares Price Wise Correlationy Rate", "verboseLabel": "Pair-wise correlation with selected peers (in hundredths)" } } }, "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsPeerCompanySharesPriceWiseCorrelationyRate", "nsuri": "http://www.agilent.com/20191031", "presentation": [ "http://www.agilent.com/role/ShareBasedCompensationFairValueAssumptionsDetails" ], "xbrltype": "percentItemType" }, "a_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueIntrinsicValueOptionsExercisedTextBlock": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Disclosure of grant date fair value of stock options granted and the intrinsic value of a stock option exercised during the period under share-based compensation plan.", "label": "Share Based Compensation Arrangement By Share Based Payment Award Fair Value Intrinsic Value Options Exercised [Text Block]", "verboseLabel": "Schedule of intrinsic value of options exercised and the fair value of options granted" } } }, "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueIntrinsicValueOptionsExercisedTextBlock", "nsuri": "http://www.agilent.com/20191031", "presentation": [ "http://www.agilent.com/role/ShareBasedCompensationTables" ], "xbrltype": "textBlockItemType" }, "a_ShareBasedCompensationArrangementByShareBasedPaymentAwardIncentiveCompensationPlanPercentOfMarketPrice": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "An entity may opt to disclose the percent of market value on offering date that participants pay for options granted.", "label": "Share Based Compensation Arrangement By Share Based Payment Award Incentive Compensation Plan Percent Of Market Price", "verboseLabel": "Percentage market value of the common stock option exercise price is generally not less than (in hundredths)" } } }, "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardIncentiveCompensationPlanPercentOfMarketPrice", "nsuri": "http://www.agilent.com/20191031", "presentation": [ "http://www.agilent.com/role/ShareBasedCompensationGeneralDisclosuresDetails" ], "xbrltype": "percentItemType" }, "a_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsCancelledForfeituresAndExpirationsInPeriodWeightedAverageExercisePrice": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "For presentations that combine terminations, the weighted average price of expired options and the price at which grantees could have acquired the underlying shares with respect to stock options that were terminated during the reporting period due to noncompliance with plan terms during the reporting period.", "label": "Share Based Compensation Arrangement By Share Based Payment Award Options Cancelled Forfeitures And Expirations In Period Weighted Average Exercise Price", "verboseLabel": "Weighted-average exercise price per share, cancelled, expired and forfeited (in dollars per shares)" } } }, "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsCancelledForfeituresAndExpirationsInPeriodWeightedAverageExercisePrice", "nsuri": "http://www.agilent.com/20191031", "presentation": [ "http://www.agilent.com/role/ShareBasedCompensationStockOptionActivityDetails" ], "xbrltype": "perShareItemType" }, "a_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodAggregateIntrinsicValue": { "auth_ref": [], "crdr": "debit", "lang": { "en-US": { "role": { "documentation": "As of the balance sheet date, the total dollar difference between fair values of the underlying shares reserved for issuance and exercise prices of the options exercised in period.", "label": "Share Based Compensation Arrangement By Share Based Payment Award Options Exercises In Period Aggregate Intrinsic Value", "verboseLabel": "Options exercised in period aggregate intrinsic value" } } }, "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodAggregateIntrinsicValue", "nsuri": "http://www.agilent.com/20191031", "presentation": [ "http://www.agilent.com/role/ShareBasedCompensationSharesAuthorizedByExercisePriceRangeDetails" ], "xbrltype": "monetaryItemType" }, "a_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsInMoneyExercisableNumber": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "The number of Stocks options eligible for exercise and at an exercise price below the closing market price of the underlying stock on the last trading day of the fiscal year as reflected on the national stock exchange.", "label": "Share Based Compensation Arrangement By Share Based Payment Award Options In The Money Exercisable Number", "verboseLabel": "In-the-money awards exercisable (in shares)" } } }, "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsInMoneyExercisableNumber", "nsuri": "http://www.agilent.com/20191031", "presentation": [ "http://www.agilent.com/role/ShareBasedCompensationSharesAuthorizedByExercisePriceRangeDetails" ], "xbrltype": "sharesItemType" }, "a_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingPeriodEndNumber": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Period End Number", "label": "Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Period End Number", "periodEndLabel": "Weighted-average exercise price per share, end of period (in dollars per share)" } } }, "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingPeriodEndNumber", "nsuri": "http://www.agilent.com/20191031", "presentation": [ "http://www.agilent.com/role/ShareBasedCompensationStockOptionActivityDetails" ], "xbrltype": "perShareItemType" }, "a_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePricePeriodEnd": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price Period End", "label": "Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price Period End", "periodEndLabel": "Non-vested at October 31, 2019 -Weighted Average Grant Price (in dollars per share)" } } }, "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePricePeriodEnd", "nsuri": "http://www.agilent.com/20191031", "presentation": [ "http://www.agilent.com/role/ShareBasedCompensationNonVestedAwardActivityDisclosureDetails" ], "xbrltype": "perShareItemType" }, "a_ShareBasedCompensationArrangementByShareBasedPaymentStockPlanAwardTermsOfAward": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Description of pertinent provisions of share based compensation awards that have actual or potential impact upon the company's financial statements.", "label": "Share Based Compensation Arrangement By Share Based Payment Stock Plan Award Terms Of Award", "verboseLabel": "Term of the 2018 Stock Plan (in years)" } } }, "localname": "ShareBasedCompensationArrangementByShareBasedPaymentStockPlanAwardTermsOfAward", "nsuri": "http://www.agilent.com/20191031", "presentation": [ "http://www.agilent.com/role/ShareBasedCompensationGeneralDisclosuresDetails" ], "xbrltype": "stringItemType" }, "a_ShareBasedCompensationArrangementMaximumPayoutRange": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "The maximum payout range for participants of the original target grant based upon the company's attainments of pre-established operating ratio targets.", "label": "Share Based Compensation Arrangement Maximum Payout Range", "verboseLabel": "Maximum final share award percentage of the target award based on performance metrics (in hundredths)" } } }, "localname": "ShareBasedCompensationArrangementMaximumPayoutRange", "nsuri": "http://www.agilent.com/20191031", "presentation": [ "http://www.agilent.com/role/ShareBasedCompensationGeneralDisclosuresDetails" ], "xbrltype": "percentItemType" }, "a_ShareBasedCompensationArrangementMinimumPayoutRange": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "The minimum payout range for participants of the original target grant based upon the company's attainments of pre-established operating ratio targets.", "label": "Share Based Compensation Arrangement Minimum Payout Range", "verboseLabel": "Minimum final share award percentage of the target award based on performance metrics (in hundredths)" } } }, "localname": "ShareBasedCompensationArrangementMinimumPayoutRange", "nsuri": "http://www.agilent.com/20191031", "presentation": [ "http://www.agilent.com/role/ShareBasedCompensationGeneralDisclosuresDetails" ], "xbrltype": "percentItemType" }, "a_ShareBasedCompensationArrangementPerformanceStockAwardVestingPeriod": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Description of the period of time over which an employee's right to exercise an award is no longer contingent on satisfaction of either a service condition, market condition or a performance condition, which may be expressed in a variety of ways (for example, in years, month and year).", "label": "Share Based Compensation Arrangement Performance Stock Award Vesting Period", "verboseLabel": "Time period after which participants of the performance stock award plan are entitled to receive unrestricted share of the company's stock, if specified performance targets are met" } } }, "localname": "ShareBasedCompensationArrangementPerformanceStockAwardVestingPeriod", "nsuri": "http://www.agilent.com/20191031", "presentation": [ "http://www.agilent.com/role/ShareBasedCompensationGeneralDisclosuresDetails" ], "xbrltype": "durationStringItemType" }, "a_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRange01Member": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Supplementary information on outstanding and exercisable share awards as of the balance sheet date which stratifies outstanding options by ranges of exercise prices.", "label": "Share Based Compensation Shares Authorized Under Stock Option Plans Exercise Price Range 01 [Member]", "terseLabel": "Share Based Compensation Shares Authorized Under Stock Option Plans Exercise Price Range 01 [Member]", "verboseLabel": "Range of Exercise Prices - $25.01 - $30 [Member]" } } }, "localname": "ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRange01Member", "nsuri": "http://www.agilent.com/20191031", "presentation": [ "http://www.agilent.com/role/ShareBasedCompensationFairValueAssumptionsDetails", "http://www.agilent.com/role/ShareBasedCompensationSharesAuthorizedByExercisePriceRangeDetails" ], "xbrltype": "domainItemType" }, "a_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRange02Member": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Supplementary information on outstanding and exercisable share awards as of the balance sheet date which stratifies outstanding options by ranges of exercise prices.", "label": "Share Based Compensation Shares Authorized Under Stock Option Plans Exercise Price Range 02 [Member]", "terseLabel": "Share Based Compensation Shares Authorized Under Stock Option Plans Exercise Price Range 02 [Member]" } } }, "localname": "ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRange02Member", "nsuri": "http://www.agilent.com/20191031", "presentation": [ "http://www.agilent.com/role/ShareBasedCompensationFairValueAssumptionsDetails", "http://www.agilent.com/role/ShareBasedCompensationSharesAuthorizedByExercisePriceRangeDetails" ], "xbrltype": "domainItemType" }, "a_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRange03Member": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Supplementary information on outstanding and exercisable share awards as of the balance sheet date which stratifies outstanding options by ranges of exercise prices.", "label": "Share Based Compensation Shares Authorized Under Stock Option Plans Exercise Price Range 03 [Member]", "terseLabel": "Share Based Compensation Shares Authorized Under Stock Option Plans Exercise Price Range 03 [Member]" } } }, "localname": "ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRange03Member", "nsuri": "http://www.agilent.com/20191031", "presentation": [ "http://www.agilent.com/role/ShareBasedCompensationFairValueAssumptionsDetails", "http://www.agilent.com/role/ShareBasedCompensationSharesAuthorizedByExercisePriceRangeDetails" ], "xbrltype": "domainItemType" }, "a_ShareRepurchaseProgramLineItems": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Share Repurchase Program [Line Items]", "label": "Share Repurchase Program [Line Items]" } } }, "localname": "ShareRepurchaseProgramLineItems", "nsuri": "http://www.agilent.com/20191031", "presentation": [ "http://www.agilent.com/role/StockholdersEquityStockRepurchasesDetails" ], "xbrltype": "stringItemType" }, "a_ShareRepurchaseProgramTable": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Share Repurchase Program [Table]", "label": "Share Repurchase Program [Table]" } } }, "localname": "ShareRepurchaseProgramTable", "nsuri": "http://www.agilent.com/20191031", "presentation": [ "http://www.agilent.com/role/StockholdersEquityStockRepurchasesDetails" ], "xbrltype": "stringItemType" }, "a_ShareRepurchasesAuthorizationProgramDateDomain": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Date upon which the share repurchase authorization agreement was approved.", "label": "Share Repurchases Authorization Program Date [Domain]" } } }, "localname": "ShareRepurchasesAuthorizationProgramDateDomain", "nsuri": "http://www.agilent.com/20191031", "presentation": [ "http://www.agilent.com/role/StockholdersEquityStockRepurchasesDetails" ], "xbrltype": "domainItemType" }, "a_ShareRepurchasesProgramAuthorizationDateAxis": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Share repurchases programs by authorization date.", "label": "Share Repurchases Program Authorization Date [Axis]" } } }, "localname": "ShareRepurchasesProgramAuthorizationDateAxis", "nsuri": "http://www.agilent.com/20191031", "presentation": [ "http://www.agilent.com/role/StockholdersEquityStockRepurchasesDetails" ], "xbrltype": "stringItemType" }, "a_SharebasedCompensationArrangementBySharebasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedAdditionalDisclosuresAbstract": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Sharebased Compensation Arrangement By Sharebased Payment Award Equity Instruments Other Than Options Nonvested Additional Disclosures [Abstract]", "label": "Sharebased Compensation Arrangement By Sharebased Payment Award Equity Instruments Other Than Options Nonvested Additional Disclosures [Abstract]", "verboseLabel": "Share-based Compensation Arrangement by Share-based Payment Award, Options, Additional Disclosures [Abstract]" } } }, "localname": "SharebasedCompensationArrangementBySharebasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedAdditionalDisclosuresAbstract", "nsuri": "http://www.agilent.com/20191031", "presentation": [ "http://www.agilent.com/role/ShareBasedCompensationNonVestedAwardActivityDisclosureDetails" ], "xbrltype": "stringItemType" }, "a_SharebasedCompensationArrangementBySharebasedPaymentAwardStockOptionPlanByExercisePriceRangeAbstract": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Sharebased Compensation Arrangement By Sharebased Payment Award Stock Option Plan By Exercise Price Range [Abstract]", "label": "Sharebased Compensation Arrangement By Sharebased Payment Award Stock Option Plan By Exercise Price Range [Abstract]", "terseLabel": "Sharebased Compensation Arrangement By Exercise Price Range [Abstract]" } } }, "localname": "SharebasedCompensationArrangementBySharebasedPaymentAwardStockOptionPlanByExercisePriceRangeAbstract", "nsuri": "http://www.agilent.com/20191031", "presentation": [ "http://www.agilent.com/role/ShareBasedCompensationSharesAuthorizedByExercisePriceRangeDetails" ], "xbrltype": "stringItemType" }, "a_SingleCustomerAccountsRecivableConcentrationRiskPercentageDescription": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Description of amount of total accounts receivable balance that is associated with any single customer.", "label": "Single Customer Accounts Recivable Concentration Risk Percentage Description", "verboseLabel": "Maximum percentage of accounts receivable a single customer accounts for" } } }, "localname": "SingleCustomerAccountsRecivableConcentrationRiskPercentageDescription", "nsuri": "http://www.agilent.com/20191031", "presentation": [ "http://www.agilent.com/role/OverviewAndSummaryOfSignificantAccountingPoliciesDetails" ], "xbrltype": "stringItemType" }, "a_Specialcompliancecosts": { "auth_ref": [], "calculation": { "http://www.agilent.com/role/SegmentInformationReconciliationOfReportableResultsDetails": { "order": 10.0, "parentTag": "us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments", "weight": -1.0 } }, "crdr": "debit", "lang": { "en-US": { "role": { "documentation": "Special compliance costs", "label": "Special compliance costs", "negatedTerseLabel": "Special compliance costs" } } }, "localname": "Specialcompliancecosts", "nsuri": "http://www.agilent.com/20191031", "presentation": [ "http://www.agilent.com/role/SegmentInformationReconciliationOfReportableResultsDetails" ], "xbrltype": "monetaryItemType" }, "a_TaxHolidaysAbstract": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Tax Holidays [Abstract]", "label": "Tax Holidays [Abstract]", "terseLabel": "Tax Holidays [Abstract]" } } }, "localname": "TaxHolidaysAbstract", "nsuri": "http://www.agilent.com/20191031", "presentation": [ "http://www.agilent.com/role/IncomeTaxesIncomeTaxesEffectiveTaxRateAndTaxHolidaysDetails" ], "xbrltype": "stringItemType" }, "a_TaxInterestandPenaltiesMember": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Tax Interest and Penalties [Member]", "label": "Tax Interest and Penalties [Member]", "terseLabel": "Tax Interest and Penalties [Member]" } } }, "localname": "TaxInterestandPenaltiesMember", "nsuri": "http://www.agilent.com/20191031", "presentation": [ "http://www.agilent.com/role/IncomeTaxesIncomeTaxesUncertainTaxPositionsDetails" ], "xbrltype": "domainItemType" }, "a_TerminatedInterestRateFairValueHedgeAssetUnamortizedAmount": { "auth_ref": [], "crdr": "debit", "lang": { "en-US": { "role": { "documentation": "The unamortized amount of interest rate swap contracts upon termination.", "label": "Terminated Interest Rate Fair Value Hedge Asset Unamortized Amount", "terseLabel": "Terminated Interest Rate Fair Value Hedge Asset Unamortized Amount" } } }, "localname": "TerminatedInterestRateFairValueHedgeAssetUnamortizedAmount", "nsuri": "http://www.agilent.com/20191031", "presentation": [ "http://www.agilent.com/role/DerivativesDetails", "http://www.agilent.com/role/LongTermDebtLongTermDebtOtherDetails" ], "xbrltype": "monetaryItemType" }, "a_TerminatedInterestRateFairValueHedgeDerivativeAssetsAtFairValue": { "auth_ref": [], "crdr": "debit", "lang": { "en-US": { "role": { "documentation": "The asset value of interest rate swap contracts upon termination.", "label": "Terminated Interest Rate Fair Value Hedge Derivative Assets At Fair Value", "terseLabel": "Terminated Interest Rate Fair Value Hedge Derivative Assets At Fair Value", "verboseLabel": "Asset value of terminated interest rate swaps" } } }, "localname": "TerminatedInterestRateFairValueHedgeDerivativeAssetsAtFairValue", "nsuri": "http://www.agilent.com/20191031", "presentation": [ "http://www.agilent.com/role/DerivativesDetails", "http://www.agilent.com/role/LongTermDebtLongTermDebtOtherDetails", "http://www.agilent.com/role/ShortTermDebtSeniorNotesDetails" ], "xbrltype": "monetaryItemType" }, "a_ThirdPartyTechnologyandLicensesMember": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Third-Party Technology and Licenses [Member]", "label": "Third-Party Technology and Licenses [Member]", "terseLabel": "Third-Party Technology and Licenses [Member]" } } }, "localname": "ThirdPartyTechnologyandLicensesMember", "nsuri": "http://www.agilent.com/20191031", "presentation": [ "http://www.agilent.com/role/GoodwillAndOtherIntangibleAssetsDisclosuresAndComponentsOfOtherIntangiblesDetails" ], "xbrltype": "domainItemType" }, "a_TotalIncomeTaxPayableNetOfIncomeTaxReceivable": { "auth_ref": [], "crdr": "credit", "lang": { "en-US": { "role": { "documentation": "Total amounts payable to taxing authorities for taxes that are based on the reporting entity's earnings, net of amounts receivable from taxing authorities for refunds of overpayments or recoveries of income taxes.", "label": "Total income tax payable, net of income tax receivable", "terseLabel": "Total" } } }, "localname": "TotalIncomeTaxPayableNetOfIncomeTaxReceivable", "nsuri": "http://www.agilent.com/20191031", "presentation": [ "http://www.agilent.com/role/IncomeTaxesCurrentAndLongTermIncomeTaxAssetsAndLiabilitiesDetails" ], "xbrltype": "monetaryItemType" }, "a_TransformationalPrograms": { "auth_ref": [], "calculation": { "http://www.agilent.com/role/SegmentInformationReconciliationOfReportableResultsDetails": { "order": 4.0, "parentTag": "us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments", "weight": -1.0 } }, "crdr": "debit", "lang": { "en-US": { "role": { "documentation": "The charge against earnings in the period, comprised of costs associated with restructuring activities not otherwise specified in the taxonomy that are not part of a specific plan as required by GAAP.", "label": "Transformational Programs", "negatedLabel": "Transformational initiatives" } } }, "localname": "TransformationalPrograms", "nsuri": "http://www.agilent.com/20191031", "presentation": [ "http://www.agilent.com/role/SegmentInformationReconciliationOfReportableResultsDetails" ], "xbrltype": "monetaryItemType" }, "a_Transitionalcompanycontributiontoemployee401k": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Additional transitional company contribution to employee 401(k) plans for certain employees.", "label": "Transitional company contribution to employee 401(k)", "terseLabel": "Transitional company contribution to employee 401(k)" } } }, "localname": "Transitionalcompanycontributiontoemployee401k", "nsuri": "http://www.agilent.com/20191031", "presentation": [ "http://www.agilent.com/role/RetirementPlansAndPostRetirementPensionPlansDefinedContributionDetails" ], "xbrltype": "percentItemType" }, "a_U.S.TaxCutsandJobsActof2017Member": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Tax Cuts and Jobs Act enacted December 22, 2017 [Member]", "label": "U.S. Tax Cuts and Jobs Act of 2017 [Member]", "terseLabel": "U.S. Tax Cuts and Jobs Act of 2017 [Member]" } } }, "localname": "U.S.TaxCutsandJobsActof2017Member", "nsuri": "http://www.agilent.com/20191031", "presentation": [ "http://www.agilent.com/role/IncomeTaxes2017USTaxReformTaxCutsAndJobsActDetails" ], "xbrltype": "domainItemType" }, "a_Ultimatemedicalcosttrendrate": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Weighted average rate of ultimate medical cost trend rate used to determine net periodic benefit cost of defined benefit plan.", "label": "Ultimate medical cost trend rate", "terseLabel": "Ultimate medical cost trend rate" } } }, "localname": "Ultimatemedicalcosttrendrate", "nsuri": "http://www.agilent.com/20191031", "presentation": [ "http://www.agilent.com/role/RetirementPlansAndPostRetirementPensionPlansAssumptionsDetails" ], "xbrltype": "percentItemType" }, "a_UnrealizedGainsLossesOnDerivativeInstrumentsTax": { "auth_ref": [], "crdr": "debit", "lang": { "en-US": { "role": { "documentation": "Tax effect on the change in the balance sheet adjustment that results from the unrealized gains (losses) on derivative instruments as of the balance sheet date.", "label": "Unrealized gains (losses) on derivative instruments, tax", "terseLabel": "Unrealized gains (losses) on derivative instruments, tax" } } }, "localname": "UnrealizedGainsLossesOnDerivativeInstrumentsTax", "nsuri": "http://www.agilent.com/20191031", "presentation": [ "http://www.agilent.com/role/StockholdersEquityAccumulatedOtherComprehensiveIncomeDetails" ], "xbrltype": "monetaryItemType" }, "a_UnrealizedLossesOnDefinedBenefitPlansTax": { "auth_ref": [], "crdr": "debit", "lang": { "en-US": { "role": { "documentation": "The tax effect of the total net gains (losses) and changes in benefit cost which haven't yet been recognized as components of periodic benefit costs, as of the balance sheet date.", "label": "Unrealized losses on defined benefit plans, tax", "terseLabel": "Unrealized losses on defined benefit plans, tax" } } }, "localname": "UnrealizedLossesOnDefinedBenefitPlansTax", "nsuri": "http://www.agilent.com/20191031", "presentation": [ "http://www.agilent.com/role/StockholdersEquityAccumulatedOtherComprehensiveIncomeDetails" ], "xbrltype": "monetaryItemType" }, "a_Unrecognizedtaxbenefitincludinginterestandpenalties": { "auth_ref": [], "crdr": "credit", "lang": { "en-US": { "role": { "documentation": "Unrecognized tax benefit including interest and penalties.", "label": "Unrecognized tax benefit including interest and penalties", "terseLabel": "Unrecognized tax benefit including interest and penalties" } } }, "localname": "Unrecognizedtaxbenefitincludinginterestandpenalties", "nsuri": "http://www.agilent.com/20191031", "presentation": [ "http://www.agilent.com/role/IncomeTaxesIncomeTaxesUncertainTaxPositionsDetails" ], "xbrltype": "monetaryItemType" }, "a_Unrecognizedtaxbenefitsthatwouldnotimpacttheeffectivetaxrate": { "auth_ref": [], "crdr": "credit", "lang": { "en-US": { "role": { "documentation": "The total amount of unrecognized tax benefits that, if recognized, would not affect the effective tax rate.", "label": "Unrecognized tax benefits that would not impact the effective tax rate", "terseLabel": "Unrecognized tax benefits that would not impact the effective tax rate" } } }, "localname": "Unrecognizedtaxbenefitsthatwouldnotimpacttheeffectivetaxrate", "nsuri": "http://www.agilent.com/20191031", "presentation": [ "http://www.agilent.com/role/IncomeTaxesIncomeTaxesUncertainTaxPositionsDetails" ], "xbrltype": "monetaryItemType" }, "a_WeightedAvergeSharesUsedInComputingNetIncomeLossPerShareAbstract": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Weighted Averge Shares Used In Computing Net Income Loss Per Share [Abstract]", "label": "Weighted Averge Shares Used In Computing Net Income Loss Per Share [Abstract]", "terseLabel": "Weighted Averge Shares Used In Computing Net Income Per Share" } } }, "localname": "WeightedAvergeSharesUsedInComputingNetIncomeLossPerShareAbstract", "nsuri": "http://www.agilent.com/20191031", "presentation": [ "http://www.agilent.com/role/ConsolidatedStatementOfOperations" ], "xbrltype": "stringItemType" }, "country_CN": { "auth_ref": [], "lang": { "en-US": { "role": { "label": "CHINA", "terseLabel": "CHINA" } } }, "localname": "CN", "nsuri": "http://xbrl.sec.gov/country/2017-01-31", "presentation": [ "http://www.agilent.com/role/SegmentInformationEntityWideDisclosuresRevenueDetails" ], "xbrltype": "domainItemType" }, "country_DE": { "auth_ref": [], "lang": { "en-US": { "role": { "label": "GERMANY", "terseLabel": "GERMANY" } } }, "localname": "DE", "nsuri": "http://xbrl.sec.gov/country/2017-01-31", "presentation": [ "http://www.agilent.com/role/SegmentInformationEntityWideDisclosureLongLivedAssetsDetails", "http://www.agilent.com/role/SegmentInformationEntityWideDisclosuresRevenueDetails" ], "xbrltype": "domainItemType" }, "country_JP": { "auth_ref": [], "lang": { "en-US": { "role": { "label": "JAPAN", "terseLabel": "JAPAN" } } }, "localname": "JP", "nsuri": "http://xbrl.sec.gov/country/2017-01-31", "presentation": [ "http://www.agilent.com/role/RetirementPlansAndPostRetirementPensionPlansJwpilDetails", "http://www.agilent.com/role/SegmentInformationEntityWideDisclosureLongLivedAssetsDetails", "http://www.agilent.com/role/SegmentInformationEntityWideDisclosuresRevenueDetails" ], "xbrltype": "domainItemType" }, "country_US": { "auth_ref": [], "lang": { "en-US": { "role": { "label": "UNITED STATES", "terseLabel": "U.S. Plan", "verboseLabel": "UNITED STATES" } } }, "localname": "US", "nsuri": "http://xbrl.sec.gov/country/2017-01-31", "presentation": [ "http://www.agilent.com/role/RetirementPlansAndPostRetirementPensionPlansAssumptionsDetails", "http://www.agilent.com/role/RetirementPlansAndPostRetirementPensionPlansComponentsOfNetPeriodicCostsDetails", "http://www.agilent.com/role/RetirementPlansAndPostRetirementPensionPlansDefinedContributionDetails", "http://www.agilent.com/role/RetirementPlansAndPostRetirementPensionPlansExpectedBenefitPaymentsDetails", "http://www.agilent.com/role/RetirementPlansAndPostRetirementPensionPlansFairValueOfPlanAssetsDetails", "http://www.agilent.com/role/RetirementPlansAndPostRetirementPensionPlansFinancialStatementLocationDetails", "http://www.agilent.com/role/RetirementPlansAndPostRetirementPensionPlansFundedStatusDetails", "http://www.agilent.com/role/RetirementPlansAndPostRetirementPensionPlansRetirementPlansAndPostRetirementPensionPlansTargetAllocationsDetails", "http://www.agilent.com/role/SegmentInformationEntityWideDisclosureLongLivedAssetsDetails", "http://www.agilent.com/role/SegmentInformationEntityWideDisclosuresRevenueDetails" ], "xbrltype": "domainItemType" }, "currency_AUD": { "auth_ref": [], "lang": { "en-US": { "role": { "label": "Australia, Dollars", "terseLabel": "Australian Dollars" } } }, "localname": "AUD", "nsuri": "http://xbrl.sec.gov/currency/2019-01-31", "presentation": [ "http://www.agilent.com/role/DerivativesDisclosuresAndDerivativeInstrumentAggregatedNotionalAmountsByCurrencyAndDesignationsDetails" ], "xbrltype": "domainItemType" }, "currency_AllCurrenciesDomain": { "auth_ref": [], "lang": { "en-US": { "role": { "label": "All Currencies [Domain]", "terseLabel": "All Currencies [Domain]" } } }, "localname": "AllCurrenciesDomain", "nsuri": "http://xbrl.sec.gov/currency/2019-01-31", "presentation": [ "http://www.agilent.com/role/DerivativesDisclosuresAndDerivativeInstrumentAggregatedNotionalAmountsByCurrencyAndDesignationsDetails" ], "xbrltype": "domainItemType" }, "currency_CAD": { "auth_ref": [], "lang": { "en-US": { "role": { "label": "Canada, Dollars", "terseLabel": "Canadian Dollars" } } }, "localname": "CAD", "nsuri": "http://xbrl.sec.gov/currency/2019-01-31", "presentation": [ "http://www.agilent.com/role/DerivativesDisclosuresAndDerivativeInstrumentAggregatedNotionalAmountsByCurrencyAndDesignationsDetails" ], "xbrltype": "domainItemType" }, "currency_CHF": { "auth_ref": [], "lang": { "en-US": { "role": { "label": "Switzerland, Francs", "terseLabel": "Swiss Franc" } } }, "localname": "CHF", "nsuri": "http://xbrl.sec.gov/currency/2019-01-31", "presentation": [ "http://www.agilent.com/role/DerivativesDisclosuresAndDerivativeInstrumentAggregatedNotionalAmountsByCurrencyAndDesignationsDetails" ], "xbrltype": "domainItemType" }, "currency_CNY": { "auth_ref": [], "lang": { "en-US": { "role": { "label": "China, Yuan Renminbi", "terseLabel": "China, Yuan Renminbi" } } }, "localname": "CNY", "nsuri": "http://xbrl.sec.gov/currency/2019-01-31", "presentation": [ "http://www.agilent.com/role/DerivativesDisclosuresAndDerivativeInstrumentAggregatedNotionalAmountsByCurrencyAndDesignationsDetails" ], "xbrltype": "domainItemType" }, "currency_DKK": { "auth_ref": [], "lang": { "en-US": { "role": { "label": "Denmark, Kroner", "terseLabel": "Danish Krone" } } }, "localname": "DKK", "nsuri": "http://xbrl.sec.gov/currency/2019-01-31", "presentation": [ "http://www.agilent.com/role/DerivativesDisclosuresAndDerivativeInstrumentAggregatedNotionalAmountsByCurrencyAndDesignationsDetails" ], "xbrltype": "domainItemType" }, "currency_EUR": { "auth_ref": [], "lang": { "en-US": { "role": { "label": "Euro Member Countries, Euro", "terseLabel": "Euro" } } }, "localname": "EUR", "nsuri": "http://xbrl.sec.gov/currency/2019-01-31", "presentation": [ "http://www.agilent.com/role/DerivativesDisclosuresAndDerivativeInstrumentAggregatedNotionalAmountsByCurrencyAndDesignationsDetails" ], "xbrltype": "domainItemType" }, "currency_GBP": { "auth_ref": [], "lang": { "en-US": { "role": { "label": "United Kingdom, Pounds", "terseLabel": "British Pounds" } } }, "localname": "GBP", "nsuri": "http://xbrl.sec.gov/currency/2019-01-31", "presentation": [ "http://www.agilent.com/role/DerivativesDisclosuresAndDerivativeInstrumentAggregatedNotionalAmountsByCurrencyAndDesignationsDetails" ], "xbrltype": "domainItemType" }, "currency_JPY": { "auth_ref": [], "lang": { "en-US": { "role": { "label": "Japan, Yen", "terseLabel": "Japanese Yen" } } }, "localname": "JPY", "nsuri": "http://xbrl.sec.gov/currency/2019-01-31", "presentation": [ "http://www.agilent.com/role/DerivativesDisclosuresAndDerivativeInstrumentAggregatedNotionalAmountsByCurrencyAndDesignationsDetails" ], "xbrltype": "domainItemType" }, "currency_KRW": { "auth_ref": [], "lang": { "en-US": { "role": { "label": "Korea (South), Won", "terseLabel": "Korean Won" } } }, "localname": "KRW", "nsuri": "http://xbrl.sec.gov/currency/2019-01-31", "presentation": [ "http://www.agilent.com/role/DerivativesDisclosuresAndDerivativeInstrumentAggregatedNotionalAmountsByCurrencyAndDesignationsDetails" ], "xbrltype": "domainItemType" }, "currency_MYR": { "auth_ref": [], "lang": { "en-US": { "role": { "label": "Malaysia, Ringgits", "terseLabel": "Malaysian Ringgit" } } }, "localname": "MYR", "nsuri": "http://xbrl.sec.gov/currency/2019-01-31", "presentation": [ "http://www.agilent.com/role/DerivativesDisclosuresAndDerivativeInstrumentAggregatedNotionalAmountsByCurrencyAndDesignationsDetails" ], "xbrltype": "domainItemType" }, "currency_SEK": { "auth_ref": [], "lang": { "en-US": { "role": { "label": "Sweden, Kronor", "terseLabel": "Sweden, Kronor" } } }, "localname": "SEK", "nsuri": "http://xbrl.sec.gov/currency/2019-01-31", "presentation": [ "http://www.agilent.com/role/DerivativesDisclosuresAndDerivativeInstrumentAggregatedNotionalAmountsByCurrencyAndDesignationsDetails" ], "xbrltype": "domainItemType" }, "currency_SGD": { "auth_ref": [], "lang": { "en-US": { "role": { "label": "Singapore, Dollars", "terseLabel": "Singapore, Dollars" } } }, "localname": "SGD", "nsuri": "http://xbrl.sec.gov/currency/2019-01-31", "presentation": [ "http://www.agilent.com/role/DerivativesDisclosuresAndDerivativeInstrumentAggregatedNotionalAmountsByCurrencyAndDesignationsDetails" ], "xbrltype": "domainItemType" }, "currency_XXX": { "auth_ref": [], "lang": { "en-US": { "role": { "label": "No currency", "terseLabel": "Other Currency" } } }, "localname": "XXX", "nsuri": "http://xbrl.sec.gov/currency/2019-01-31", "presentation": [ "http://www.agilent.com/role/DerivativesDisclosuresAndDerivativeInstrumentAggregatedNotionalAmountsByCurrencyAndDesignationsDetails" ], "xbrltype": "domainItemType" }, "dei_AmendmentFlag": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Boolean flag that is true when the XBRL content amends previously-filed or accepted submission.", "label": "Amendment Flag" } } }, "localname": "AmendmentFlag", "nsuri": "http://xbrl.sec.gov/dei/2019-01-31", "presentation": [ "http://www.agilent.com/role/DocumentAndEntityInformation" ], "xbrltype": "booleanItemType" }, "dei_CityAreaCode": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Area code of city", "label": "City Area Code", "terseLabel": "City Area Code" } } }, "localname": "CityAreaCode", "nsuri": "http://xbrl.sec.gov/dei/2019-01-31", "presentation": [ "http://www.agilent.com/role/DocumentAndEntityInformation" ], "xbrltype": "normalizedStringItemType" }, "dei_CurrentFiscalYearEndDate": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "End date of current fiscal year in the format --MM-DD.", "label": "Current Fiscal Year End Date" } } }, "localname": "CurrentFiscalYearEndDate", "nsuri": "http://xbrl.sec.gov/dei/2019-01-31", "presentation": [ "http://www.agilent.com/role/DocumentAndEntityInformation" ], "xbrltype": "gMonthDayItemType" }, "dei_DocumentAnnualReport": { "auth_ref": [ "r661" ], "lang": { "en-US": { "role": { "documentation": "Boolean flag that is true only for a form used as an annual report.", "label": "Document Annual Report", "terseLabel": "Document Annual Report" } } }, "localname": "DocumentAnnualReport", "nsuri": "http://xbrl.sec.gov/dei/2019-01-31", "presentation": [ "http://www.agilent.com/role/DocumentAndEntityInformation" ], "xbrltype": "booleanItemType" }, "dei_DocumentFiscalPeriodFocus": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Fiscal period values are FY, Q1, Q2, and Q3. 1st, 2nd and 3rd quarter 10-Q or 10-QT statements have value Q1, Q2, and Q3 respectively, with 10-K, 10-KT or other fiscal year statements having FY.", "label": "Document Fiscal Period Focus" } } }, "localname": "DocumentFiscalPeriodFocus", "nsuri": "http://xbrl.sec.gov/dei/2019-01-31", "presentation": [ "http://www.agilent.com/role/DocumentAndEntityInformation" ], "xbrltype": "fiscalPeriodItemType" }, "dei_DocumentFiscalYearFocus": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "This is focus fiscal year of the document report in CCYY format. For a 2006 annual report, which may also provide financial information from prior periods, fiscal 2006 should be given as the fiscal year focus. Example: 2006.", "label": "Document Fiscal Year Focus" } } }, "localname": "DocumentFiscalYearFocus", "nsuri": "http://xbrl.sec.gov/dei/2019-01-31", "presentation": [ "http://www.agilent.com/role/DocumentAndEntityInformation" ], "xbrltype": "gYearItemType" }, "dei_DocumentPeriodEndDate": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "The end date of the period reflected on the cover page if a periodic report. For all other reports and registration statements containing historical data, it is the date up through which that historical data is presented. If there is no historical data in the report, use the filing date. The format of the date is CCYY-MM-DD.", "label": "Document Period End Date", "terseLabel": "Document Period End Date" } } }, "localname": "DocumentPeriodEndDate", "nsuri": "http://xbrl.sec.gov/dei/2019-01-31", "presentation": [ "http://www.agilent.com/role/DocumentAndEntityInformation" ], "xbrltype": "dateItemType" }, "dei_DocumentTransitionReport": { "auth_ref": [ "r660" ], "lang": { "en-US": { "role": { "documentation": "Boolean flag that is true only for a form used as a transition report.", "label": "Document Transition Report", "terseLabel": "Document Transition Report" } } }, "localname": "DocumentTransitionReport", "nsuri": "http://xbrl.sec.gov/dei/2019-01-31", "presentation": [ "http://www.agilent.com/role/DocumentAndEntityInformation" ], "xbrltype": "booleanItemType" }, "dei_DocumentType": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "The type of document being provided (such as 10-K, 10-Q, 485BPOS, etc). The document type is limited to the same value as the supporting SEC submission type, or the word 'Other'.", "label": "Document Type" } } }, "localname": "DocumentType", "nsuri": "http://xbrl.sec.gov/dei/2019-01-31", "presentation": [ "http://www.agilent.com/role/DocumentAndEntityInformation" ], "xbrltype": "submissionTypeItemType" }, "dei_DocumentsIncorporatedByReferenceTextBlock": { "auth_ref": [ "r658" ], "lang": { "en-US": { "role": { "documentation": "Documents incorporated by reference.", "label": "Documents Incorporated by Reference [Text Block]", "terseLabel": "Documents Incorporated by Reference [Text Block]" } } }, "localname": "DocumentsIncorporatedByReferenceTextBlock", "nsuri": "http://xbrl.sec.gov/dei/2019-01-31", "presentation": [ "http://www.agilent.com/role/DocumentAndEntityInformation" ], "xbrltype": "textBlockItemType" }, "dei_EntitiesTable": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Container to assemble all relevant information about each entity associated with the document instance", "label": "Entities [Table]", "terseLabel": "Entities [Table]" } } }, "localname": "EntitiesTable", "nsuri": "http://xbrl.sec.gov/dei/2019-01-31", "presentation": [ "http://www.agilent.com/role/DocumentAndEntityInformation" ], "xbrltype": "stringItemType" }, "dei_EntityAddressAddressLine1": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Address Line 1 such as Attn, Building Name, Street Name", "label": "Entity Address, Address Line One", "terseLabel": "Entity Address, Address Line One" } } }, "localname": "EntityAddressAddressLine1", "nsuri": "http://xbrl.sec.gov/dei/2019-01-31", "presentation": [ "http://www.agilent.com/role/DocumentAndEntityInformation" ], "xbrltype": "normalizedStringItemType" }, "dei_EntityAddressCityOrTown": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Name of the City or Town", "label": "Entity Address, City or Town", "terseLabel": "Entity Address, City or Town" } } }, "localname": "EntityAddressCityOrTown", "nsuri": "http://xbrl.sec.gov/dei/2019-01-31", "presentation": [ "http://www.agilent.com/role/DocumentAndEntityInformation" ], "xbrltype": "normalizedStringItemType" }, "dei_EntityAddressPostalZipCode": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Code for the postal or zip code", "label": "Entity Address, Postal Zip Code", "terseLabel": "Entity Address, Postal Zip Code" } } }, "localname": "EntityAddressPostalZipCode", "nsuri": "http://xbrl.sec.gov/dei/2019-01-31", "presentation": [ "http://www.agilent.com/role/DocumentAndEntityInformation" ], "xbrltype": "normalizedStringItemType" }, "dei_EntityAddressStateOrProvince": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Name of the state or province.", "label": "Entity Address, State or Province", "terseLabel": "Entity Address, State or Province" } } }, "localname": "EntityAddressStateOrProvince", "nsuri": "http://xbrl.sec.gov/dei/2019-01-31", "presentation": [ "http://www.agilent.com/role/DocumentAndEntityInformation" ], "xbrltype": "stateOrProvinceItemType" }, "dei_EntityCentralIndexKey": { "auth_ref": [ "r662" ], "lang": { "en-US": { "role": { "documentation": "A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK.", "label": "Entity Central Index Key" } } }, "localname": "EntityCentralIndexKey", "nsuri": "http://xbrl.sec.gov/dei/2019-01-31", "presentation": [ "http://www.agilent.com/role/DocumentAndEntityInformation" ], "xbrltype": "centralIndexKeyItemType" }, "dei_EntityCommonStockSharesOutstanding": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Indicate number of shares or other units outstanding of each of registrant's classes of capital or common stock or other ownership interests, if and as stated on cover of related periodic report. Where multiple classes or units exist define each class/interest by adding class of stock items such as Common Class A [Member], Common Class B [Member] or Partnership Interest [Member] onto the Instrument [Domain] of the Entity Listings, Instrument.", "label": "Entity Common Stock, Shares Outstanding" } } }, "localname": "EntityCommonStockSharesOutstanding", "nsuri": "http://xbrl.sec.gov/dei/2019-01-31", "presentation": [ "http://www.agilent.com/role/DocumentAndEntityInformation" ], "xbrltype": "sharesItemType" }, "dei_EntityCurrentReportingStatus": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Indicate 'Yes' or 'No' whether registrants (1) have filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that registrants were required to file such reports), and (2) have been subject to such filing requirements for the past 90 days. This information should be based on the registrant's current or most recent filing containing the related disclosure.", "label": "Entity Current Reporting Status" } } }, "localname": "EntityCurrentReportingStatus", "nsuri": "http://xbrl.sec.gov/dei/2019-01-31", "presentation": [ "http://www.agilent.com/role/DocumentAndEntityInformation" ], "xbrltype": "yesNoItemType" }, "dei_EntityDomain": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "All the names of the entities being reported upon in a document. Any legal structure used to conduct activities or to hold assets. Some examples of such structures are corporations, partnerships, limited liability companies, grantor trusts, and other trusts. This item does not include business and geographical segments which are included in the geographical or business segments domains.", "label": "Entity [Domain]", "terseLabel": "Entity [Domain]" } } }, "localname": "EntityDomain", "nsuri": "http://xbrl.sec.gov/dei/2019-01-31", "presentation": [ "http://www.agilent.com/role/DocumentAndEntityInformation" ], "xbrltype": "domainItemType" }, "dei_EntityEmergingGrowthCompany": { "auth_ref": [ "r662" ], "lang": { "en-US": { "role": { "documentation": "Indicate if registrant meets the emerging growth company criteria.", "label": "Entity Emerging Growth Company", "terseLabel": "Entity Emerging Growth Company" } } }, "localname": "EntityEmergingGrowthCompany", "nsuri": "http://xbrl.sec.gov/dei/2019-01-31", "presentation": [ "http://www.agilent.com/role/DocumentAndEntityInformation" ], "xbrltype": "booleanItemType" }, "dei_EntityFileNumber": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Commission file number. The field allows up to 17 characters. The prefix may contain 1-3 digits, the sequence number may contain 1-8 digits, the optional suffix may contain 1-4 characters, and the fields are separated with a hyphen.", "label": "Entity File Number", "terseLabel": "Entity File Number" } } }, "localname": "EntityFileNumber", "nsuri": "http://xbrl.sec.gov/dei/2019-01-31", "presentation": [ "http://www.agilent.com/role/DocumentAndEntityInformation" ], "xbrltype": "fileNumberItemType" }, "dei_EntityFilerCategory": { "auth_ref": [ "r662" ], "lang": { "en-US": { "role": { "documentation": "Indicate whether the registrant is one of the following: Large Accelerated Filer, Accelerated Filer, Non-accelerated Filer. Definitions of these categories are stated in Rule 12b-2 of the Exchange Act. This information should be based on the registrant's current or most recent filing containing the related disclosure.", "label": "Entity Filer Category" } } }, "localname": "EntityFilerCategory", "nsuri": "http://xbrl.sec.gov/dei/2019-01-31", "presentation": [ "http://www.agilent.com/role/DocumentAndEntityInformation" ], "xbrltype": "filerCategoryItemType" }, "dei_EntityIncorporationStateCountryCode": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Two-character EDGAR code representing the state or country of incorporation.", "label": "Entity Incorporation, State or Country Code", "terseLabel": "Entity Incorporation, State or Country Code" } } }, "localname": "EntityIncorporationStateCountryCode", "nsuri": "http://xbrl.sec.gov/dei/2019-01-31", "presentation": [ "http://www.agilent.com/role/DocumentAndEntityInformation" ], "xbrltype": "edgarStateCountryItemType" }, "dei_EntityInformationLineItems": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.", "label": "Entity Information [Line Items]", "terseLabel": "Entity Information [Line Items]" } } }, "localname": "EntityInformationLineItems", "nsuri": "http://xbrl.sec.gov/dei/2019-01-31", "presentation": [ "http://www.agilent.com/role/DocumentAndEntityInformation" ], "xbrltype": "stringItemType" }, "dei_EntityInteractiveDataCurrent": { "auth_ref": [ "r663" ], "lang": { "en-US": { "role": { "documentation": "Boolean flag that is true when the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T during the preceding 12 months (or for such shorter period that the registrant was required to submit such files).", "label": "Entity Interactive Data Current", "terseLabel": "Entity Interactive Data Current" } } }, "localname": "EntityInteractiveDataCurrent", "nsuri": "http://xbrl.sec.gov/dei/2019-01-31", "presentation": [ "http://www.agilent.com/role/DocumentAndEntityInformation" ], "xbrltype": "yesNoItemType" }, "dei_EntityPublicFloat": { "auth_ref": [], "crdr": "credit", "lang": { "en-US": { "role": { "documentation": "The aggregate market value of the voting and non-voting common equity held by non-affiliates computed by reference to the price at which the common equity was last sold, or the average bid and asked price of such common equity, as of the last business day of the registrant's most recently completed second fiscal quarter.", "label": "Entity Public Float" } } }, "localname": "EntityPublicFloat", "nsuri": "http://xbrl.sec.gov/dei/2019-01-31", "presentation": [ "http://www.agilent.com/role/DocumentAndEntityInformation" ], "xbrltype": "monetaryItemType" }, "dei_EntityRegistrantName": { "auth_ref": [ "r662" ], "lang": { "en-US": { "role": { "documentation": "The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC.", "label": "Entity Registrant Name" } } }, "localname": "EntityRegistrantName", "nsuri": "http://xbrl.sec.gov/dei/2019-01-31", "presentation": [ "http://www.agilent.com/role/DocumentAndEntityInformation" ], "xbrltype": "normalizedStringItemType" }, "dei_EntityShellCompany": { "auth_ref": [ "r662" ], "lang": { "en-US": { "role": { "documentation": "Boolean flag that is true when the registrant is a shell company as defined in Rule 12b-2 of the Exchange Act.", "label": "Entity Shell Company", "terseLabel": "Entity Shell Company" } } }, "localname": "EntityShellCompany", "nsuri": "http://xbrl.sec.gov/dei/2019-01-31", "presentation": [ "http://www.agilent.com/role/DocumentAndEntityInformation" ], "xbrltype": "booleanItemType" }, "dei_EntitySmallBusiness": { "auth_ref": [ "r662" ], "lang": { "en-US": { "role": { "documentation": "Indicates that the company is a Smaller Reporting Company (SRC).", "label": "Entity Small Business", "terseLabel": "Entity Small Business" } } }, "localname": "EntitySmallBusiness", "nsuri": "http://xbrl.sec.gov/dei/2019-01-31", "presentation": [ "http://www.agilent.com/role/DocumentAndEntityInformation" ], "xbrltype": "booleanItemType" }, "dei_EntityTaxIdentificationNumber": { "auth_ref": [ "r662" ], "lang": { "en-US": { "role": { "documentation": "The Tax Identification Number (TIN), also known as an Employer Identification Number (EIN), is a unique 9-digit value assigned by the IRS.", "label": "Entity Tax Identification Number", "terseLabel": "Entity Tax Identification Number" } } }, "localname": "EntityTaxIdentificationNumber", "nsuri": "http://xbrl.sec.gov/dei/2019-01-31", "presentation": [ "http://www.agilent.com/role/DocumentAndEntityInformation" ], "xbrltype": "employerIdItemType" }, "dei_EntityVoluntaryFilers": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Indicate 'Yes' or 'No' if the registrant is not required to file reports pursuant to Section 13 or Section 15(d) of the Act.", "label": "Entity Voluntary Filers" } } }, "localname": "EntityVoluntaryFilers", "nsuri": "http://xbrl.sec.gov/dei/2019-01-31", "presentation": [ "http://www.agilent.com/role/DocumentAndEntityInformation" ], "xbrltype": "yesNoItemType" }, "dei_EntityWellKnownSeasonedIssuer": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Indicate 'Yes' or 'No' if the registrant is a well-known seasoned issuer, as defined in Rule 405 of the Securities Act. Is used on Form Type: 10-K, 10-Q, 8-K, 20-F, 6-K, 10-K/A, 10-Q/A, 20-F/A, 6-K/A, N-CSR, N-Q, N-1A.", "label": "Entity Well-known Seasoned Issuer" } } }, "localname": "EntityWellKnownSeasonedIssuer", "nsuri": "http://xbrl.sec.gov/dei/2019-01-31", "presentation": [ "http://www.agilent.com/role/DocumentAndEntityInformation" ], "xbrltype": "yesNoItemType" }, "dei_LegalEntityAxis": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "The set of legal entities associated with a report.", "label": "Legal Entity [Axis]", "terseLabel": "Legal Entity [Axis]" } } }, "localname": "LegalEntityAxis", "nsuri": "http://xbrl.sec.gov/dei/2019-01-31", "presentation": [ "http://www.agilent.com/role/DocumentAndEntityInformation" ], "xbrltype": "stringItemType" }, "dei_LocalPhoneNumber": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Local phone number for entity.", "label": "Local Phone Number", "terseLabel": "Local Phone Number" } } }, "localname": "LocalPhoneNumber", "nsuri": "http://xbrl.sec.gov/dei/2019-01-31", "presentation": [ "http://www.agilent.com/role/DocumentAndEntityInformation" ], "xbrltype": "normalizedStringItemType" }, "dei_Security12bTitle": { "auth_ref": [ "r657" ], "lang": { "en-US": { "role": { "documentation": "Title of a 12(b) registered security.", "label": "Title of 12(b) Security", "terseLabel": "Title of 12(b) Security" } } }, "localname": "Security12bTitle", "nsuri": "http://xbrl.sec.gov/dei/2019-01-31", "presentation": [ "http://www.agilent.com/role/DocumentAndEntityInformation" ], "xbrltype": "securityTitleItemType" }, "dei_SecurityExchangeName": { "auth_ref": [ "r659" ], "lang": { "en-US": { "role": { "documentation": "Name of the Exchange on which a security is registered.", "label": "Security Exchange Name", "terseLabel": "Security Exchange Name" } } }, "localname": "SecurityExchangeName", "nsuri": "http://xbrl.sec.gov/dei/2019-01-31", "presentation": [ "http://www.agilent.com/role/DocumentAndEntityInformation" ], "xbrltype": "edgarExchangeCodeItemType" }, "dei_TradingSymbol": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Trading symbol of an instrument as listed on an exchange.", "label": "Trading Symbol", "terseLabel": "Trading Symbol" } } }, "localname": "TradingSymbol", "nsuri": "http://xbrl.sec.gov/dei/2019-01-31", "presentation": [ "http://www.agilent.com/role/DocumentAndEntityInformation" ], "xbrltype": "tradingSymbolItemType" }, "invest_DerivativeNotionalAmount": { "auth_ref": [ "r664" ], "lang": { "en-US": { "role": { "documentation": "Aggregate notional amount specified by the derivative(s). Expressed as an absolute value.", "label": "Derivative, Notional Amount", "terseLabel": "Derivative, Notional Amount" } } }, "localname": "DerivativeNotionalAmount", "nsuri": "http://xbrl.sec.gov/invest/2013-01-31", "presentation": [ "http://www.agilent.com/role/DerivativesDetails", "http://www.agilent.com/role/DerivativesDisclosuresAndDerivativeInstrumentAggregatedNotionalAmountsByCurrencyAndDesignationsDetails", "http://www.agilent.com/role/LongTermDebtSeniorNotesDetails" ], "xbrltype": "monetaryItemType" }, "srt_AmericasMember": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Continents of North and South America.", "label": "Americas [Member]", "terseLabel": "Americas" } } }, "localname": "AmericasMember", "nsuri": "http://fasb.org/srt/2019-01-31", "presentation": [ "http://www.agilent.com/role/RevenueRevenueByRegionDetails" ], "xbrltype": "domainItemType" }, "srt_AsiaPacificMember": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Region of Asia Pacific.", "label": "Asia Pacific [Member]", "terseLabel": "Asia Pacific" } } }, "localname": "AsiaPacificMember", "nsuri": "http://fasb.org/srt/2019-01-31", "presentation": [ "http://www.agilent.com/role/RevenueRevenueByRegionDetails" ], "xbrltype": "domainItemType" }, "srt_ConsolidationItemsAxis": { "auth_ref": [ "r188", "r199" ], "lang": { "en-US": { "role": { "documentation": "Information by components, eliminations, non-segment corporate-level activity and reconciling items used in consolidating a parent entity and its subsidiaries or its operating segments.", "label": "Consolidation Items [Axis]", "terseLabel": "Consolidation Items [Axis]" } } }, "localname": "ConsolidationItemsAxis", "nsuri": "http://fasb.org/srt/2019-01-31", "presentation": [ "http://www.agilent.com/role/SegmentInformationSegmentAssetsDetails" ], "xbrltype": "stringItemType" }, "srt_ConsolidationItemsDomain": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Components, elimination, non-segment corporate-level activity and reconciling items used in consolidating a parent entity and its subsidiaries or its operating segments.", "label": "Consolidation Items [Domain]", "terseLabel": "Consolidation Items [Domain]" } } }, "localname": "ConsolidationItemsDomain", "nsuri": "http://fasb.org/srt/2019-01-31", "presentation": [ "http://www.agilent.com/role/SegmentInformationSegmentAssetsDetails" ], "xbrltype": "domainItemType" }, "srt_CurrencyAxis": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Information by currency.", "label": "Currency [Axis]", "terseLabel": "Currency [Axis]" } } }, "localname": "CurrencyAxis", "nsuri": "http://fasb.org/srt/2019-01-31", "presentation": [ "http://www.agilent.com/role/DerivativesDisclosuresAndDerivativeInstrumentAggregatedNotionalAmountsByCurrencyAndDesignationsDetails" ], "xbrltype": "stringItemType" }, "srt_EuropeMember": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Continent of Europe.", "label": "Europe [Member]", "terseLabel": "Europe" } } }, "localname": "EuropeMember", "nsuri": "http://fasb.org/srt/2019-01-31", "presentation": [ "http://www.agilent.com/role/RevenueRevenueByRegionDetails" ], "xbrltype": "domainItemType" }, "srt_MaximumMember": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Upper limit of the provided range.", "label": "Maximum [Member]", "terseLabel": "Maximum", "verboseLabel": "5 Percent" } } }, "localname": "MaximumMember", "nsuri": "http://fasb.org/srt/2019-01-31", "presentation": [ "http://www.agilent.com/role/AcquisitionsAcquisitionsIntangibleAssetsDetails", "http://www.agilent.com/role/OverviewAndSummaryOfSignificantAccountingPoliciesDetails", "http://www.agilent.com/role/RetirementPlansAndPostRetirementPensionPlansAssumptionsDetails", "http://www.agilent.com/role/RetirementPlansAndPostRetirementPensionPlansDefinedContributionDetails", "http://www.agilent.com/role/RetirementPlansAndPostRetirementPensionPlansRetirementPlansAndPostRetirementPensionPlansTargetAllocationsDetails" ], "xbrltype": "domainItemType" }, "srt_MinimumMember": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Lower limit of the provided range.", "label": "Minimum [Member]", "terseLabel": "Minimum", "verboseLabel": "3 Percent" } } }, "localname": "MinimumMember", "nsuri": "http://fasb.org/srt/2019-01-31", "presentation": [ "http://www.agilent.com/role/AcquisitionsAcquisitionsIntangibleAssetsDetails", "http://www.agilent.com/role/OverviewAndSummaryOfSignificantAccountingPoliciesDetails", "http://www.agilent.com/role/RetirementPlansAndPostRetirementPensionPlansAssumptionsDetails", "http://www.agilent.com/role/RetirementPlansAndPostRetirementPensionPlansDefinedContributionDetails", "http://www.agilent.com/role/RetirementPlansAndPostRetirementPensionPlansRetirementPlansAndPostRetirementPensionPlansTargetAllocationsDetails" ], "xbrltype": "domainItemType" }, "srt_ProductOrServiceAxis": { "auth_ref": [ "r201", "r315", "r318", "r646", "r647" ], "lang": { "en-US": { "role": { "documentation": "Information by product and service, or group of similar products and similar services.", "label": "Product and Service [Axis]", "terseLabel": "Product and Service [Axis]" } } }, "localname": "ProductOrServiceAxis", "nsuri": "http://fasb.org/srt/2019-01-31", "presentation": [ "http://www.agilent.com/role/ConsolidatedStatementOfOperations", "http://www.agilent.com/role/OverviewAndSummaryOfSignificantAccountingPoliciesDetails", "http://www.agilent.com/role/RevenueRevenueRevenueByTypeDetails", "http://www.agilent.com/role/SegmentInformationTables" ], "xbrltype": "stringItemType" }, "srt_ProductsAndServicesDomain": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Product or service, or a group of similar products or similar services.", "label": "Product and Service [Domain]", "terseLabel": "Product and Service [Domain]" } } }, "localname": "ProductsAndServicesDomain", "nsuri": "http://fasb.org/srt/2019-01-31", "presentation": [ "http://www.agilent.com/role/ConsolidatedStatementOfOperations", "http://www.agilent.com/role/OverviewAndSummaryOfSignificantAccountingPoliciesDetails", "http://www.agilent.com/role/RevenueRevenueRevenueByTypeDetails", "http://www.agilent.com/role/SegmentInformationTables" ], "xbrltype": "domainItemType" }, "srt_RangeAxis": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Information by statistical measurement. Includes, but is not limited to, minimum, maximum, weighted average, arithmetic average, and median.", "label": "Statistical Measurement [Axis]", "terseLabel": "Statistical Measurement [Axis]" } } }, "localname": "RangeAxis", "nsuri": "http://fasb.org/srt/2019-01-31", "presentation": [ "http://www.agilent.com/role/AcquisitionsAcquisitionsIntangibleAssetsDetails", "http://www.agilent.com/role/LongTermDebtCarryingValueDetails", "http://www.agilent.com/role/LongTermDebtLongTermDebtOtherDetails", "http://www.agilent.com/role/OverviewAndSummaryOfSignificantAccountingPoliciesDetails", "http://www.agilent.com/role/PropertyPlantAndEquipmentNetDetails", "http://www.agilent.com/role/RetirementPlansAndPostRetirementPensionPlansAssumptionsDetails", "http://www.agilent.com/role/RetirementPlansAndPostRetirementPensionPlansDefinedContributionDetails", "http://www.agilent.com/role/RetirementPlansAndPostRetirementPensionPlansRetirementPlansAndPostRetirementPensionPlansTargetAllocationsDetails" ], "xbrltype": "stringItemType" }, "srt_RangeMember": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Statistical measurement. Includes, but is not limited to, minimum, maximum, weighted average, arithmetic average, and median.", "label": "Statistical Measurement [Domain]", "terseLabel": "Statistical Measurement [Domain]" } } }, "localname": "RangeMember", "nsuri": "http://fasb.org/srt/2019-01-31", "presentation": [ "http://www.agilent.com/role/AcquisitionsAcquisitionsIntangibleAssetsDetails", "http://www.agilent.com/role/LongTermDebtCarryingValueDetails", "http://www.agilent.com/role/LongTermDebtLongTermDebtOtherDetails", "http://www.agilent.com/role/OverviewAndSummaryOfSignificantAccountingPoliciesDetails", "http://www.agilent.com/role/PropertyPlantAndEquipmentNetDetails", "http://www.agilent.com/role/RetirementPlansAndPostRetirementPensionPlansAssumptionsDetails", "http://www.agilent.com/role/RetirementPlansAndPostRetirementPensionPlansDefinedContributionDetails", "http://www.agilent.com/role/RetirementPlansAndPostRetirementPensionPlansRetirementPlansAndPostRetirementPensionPlansTargetAllocationsDetails" ], "xbrltype": "domainItemType" }, "srt_RestatementAxis": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Information by revision of previously issued financial statements.", "label": "Restatement [Axis]", "terseLabel": "Restatement [Axis]" } } }, "localname": "RestatementAxis", "nsuri": "http://fasb.org/srt/2019-01-31", "presentation": [ "http://www.agilent.com/role/NewAccountingPronouncementsTextualsDetails", "http://www.agilent.com/role/StockholdersEquityAccumulatedOtherComprehensiveIncomeDetails" ], "xbrltype": "stringItemType" }, "srt_RestatementDomain": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Revision of previously issued financial statements.", "label": "Restatement [Domain]", "terseLabel": "Restatement [Domain]" } } }, "localname": "RestatementDomain", "nsuri": "http://fasb.org/srt/2019-01-31", "presentation": [ "http://www.agilent.com/role/NewAccountingPronouncementsTextualsDetails", "http://www.agilent.com/role/StockholdersEquityAccumulatedOtherComprehensiveIncomeDetails" ], "xbrltype": "domainItemType" }, "srt_ScenarioUnspecifiedDomain": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Scenario reported, distinguishing information from actual fact. Includes, but is not limited to, pro forma and forecast. Excludes actual facts.", "label": "Scenario [Domain]", "terseLabel": "Scenario [Domain]" } } }, "localname": "ScenarioUnspecifiedDomain", "nsuri": "http://fasb.org/srt/2019-01-31", "presentation": [ "http://www.agilent.com/role/ConsolidatedBalanceSheet", "http://www.agilent.com/role/ConsolidatedStatementOfCashFlows", "http://www.agilent.com/role/LongTermDebtSeniorNotesDetails", "http://www.agilent.com/role/NewAccountingPronouncementsImpactOfAdoptingNewGuidanceDetails", "http://www.agilent.com/role/RetirementPlansAndPostRetirementPensionPlansExpectedBenefitPaymentsDetails", "http://www.agilent.com/role/StockholdersEquityChangesInAccumulatedOtherComprehensiveIncomeDetails", "http://www.agilent.com/role/StockholdersEquityStockholdersEquityReclassificationsOutOfAccumulatedOtherComprehensiveIncomeDetails" ], "xbrltype": "domainItemType" }, "srt_ScheduleOfValuationAndQualifyingAccountsDisclosureTextBlock": { "auth_ref": [ "r153", "r667" ], "lang": { "en-US": { "role": { "documentation": "The entire disclosure for valuation and qualifying accounts and reserves.", "label": "SEC Schedule, 12-09, Schedule of Valuation and Qualifying Accounts Disclosure [Text Block]", "verboseLabel": "Schedule II - Valuation and Qualifying Accounts" } } }, "localname": "ScheduleOfValuationAndQualifyingAccountsDisclosureTextBlock", "nsuri": "http://fasb.org/srt/2019-01-31", "presentation": [ "http://www.agilent.com/role/ScheduleIiValuationAndQualifyingAccounts" ], "xbrltype": "textBlockItemType" }, "srt_SegmentGeographicalDomain": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Geographical area.", "label": "Geographical [Domain]", "terseLabel": "Geographical [Domain]" } } }, "localname": "SegmentGeographicalDomain", "nsuri": "http://fasb.org/srt/2019-01-31", "presentation": [ "http://www.agilent.com/role/RevenueRevenueByRegionDetails", "http://www.agilent.com/role/SegmentInformationEntityWideDisclosureLongLivedAssetsDetails", "http://www.agilent.com/role/SegmentInformationEntityWideDisclosuresRevenueDetails" ], "xbrltype": "domainItemType" }, "srt_StatementGeographicalAxis": { "auth_ref": [ "r203", "r315", "r319", "r648", "r651", "r655", "r665", "r666" ], "lang": { "en-US": { "role": { "documentation": "Information by geographical components.", "label": "Geographical [Axis]", "terseLabel": "Geographical [Axis]" } } }, "localname": "StatementGeographicalAxis", "nsuri": "http://fasb.org/srt/2019-01-31", "presentation": [ "http://www.agilent.com/role/RevenueRevenueByRegionDetails", "http://www.agilent.com/role/SegmentInformationEntityWideDisclosureLongLivedAssetsDetails", "http://www.agilent.com/role/SegmentInformationEntityWideDisclosuresRevenueDetails" ], "xbrltype": "stringItemType" }, "srt_StatementScenarioAxis": { "auth_ref": [ "r273", "r601" ], "lang": { "en-US": { "role": { "documentation": "Information by scenario reported, distinguishing information from actual fact. Includes, but is not limited to, pro forma and forecast. Excludes actual facts.", "label": "Scenario [Axis]", "terseLabel": "Statement, Scenario [Axis]", "verboseLabel": "Scenario [Axis]" } } }, "localname": "StatementScenarioAxis", "nsuri": "http://fasb.org/srt/2019-01-31", "presentation": [ "http://www.agilent.com/role/ConsolidatedBalanceSheet", "http://www.agilent.com/role/ConsolidatedStatementOfCashFlows", "http://www.agilent.com/role/LongTermDebtSeniorNotesDetails", "http://www.agilent.com/role/NewAccountingPronouncementsImpactOfAdoptingNewGuidanceDetails", "http://www.agilent.com/role/RetirementPlansAndPostRetirementPensionPlansExpectedBenefitPaymentsDetails", "http://www.agilent.com/role/StockholdersEquityChangesInAccumulatedOtherComprehensiveIncomeDetails", "http://www.agilent.com/role/StockholdersEquityStockholdersEquityReclassificationsOutOfAccumulatedOtherComprehensiveIncomeDetails" ], "xbrltype": "stringItemType" }, "srt_ValuationAndQualifyingAccountsAbstract": { "auth_ref": [], "lang": { "en-US": { "role": { "label": "SEC Schedule, 12-09, Valuation and Qualifying Accounts [Abstract]" } } }, "localname": "ValuationAndQualifyingAccountsAbstract", "nsuri": "http://fasb.org/srt/2019-01-31", "xbrltype": "stringItemType" }, "srt_ValuationAndQualifyingAccountsDisclosureLineItems": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.", "label": "SEC Schedule, 12-09, Valuation and Qualifying Accounts Disclosure [Line Items]" } } }, "localname": "ValuationAndQualifyingAccountsDisclosureLineItems", "nsuri": "http://fasb.org/srt/2019-01-31", "presentation": [ "http://www.agilent.com/role/ScheduleIiValuationAndQualifyingAccountsDetails" ], "xbrltype": "stringItemType" }, "srt_ValuationAndQualifyingAccountsDisclosureTable": { "auth_ref": [ "r153", "r667" ], "lang": { "en-US": { "role": { "documentation": "Disclosure of valuation and qualifying accounts and reserves.", "label": "SEC Schedule, 12-09, Valuation and Qualifying Accounts Disclosure [Table]" } } }, "localname": "ValuationAndQualifyingAccountsDisclosureTable", "nsuri": "http://fasb.org/srt/2019-01-31", "presentation": [ "http://www.agilent.com/role/ScheduleIiValuationAndQualifyingAccountsDetails" ], "xbrltype": "stringItemType" }, "us-gaap_AccountingPoliciesAbstract": { "auth_ref": [], "lang": { "en-US": { "role": { "label": "Accounting Policies [Abstract]" } } }, "localname": "AccountingPoliciesAbstract", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "xbrltype": "stringItemType" }, "us-gaap_AccountsPayableCurrent": { "auth_ref": [ "r50" ], "calculation": { "http://www.agilent.com/role/ConsolidatedBalanceSheet": { "order": 1.0, "parentTag": "us-gaap_LiabilitiesCurrent", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-US": { "role": { "documentation": "Carrying value as of the balance sheet date of liabilities incurred (and for which invoices have typically been received) and payable to vendors for goods and services received that are used in an entity's business. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).", "label": "Accounts Payable, Current", "terseLabel": "Accounts payable", "verboseLabel": "Accounts payable" } } }, "localname": "AccountsPayableCurrent", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.agilent.com/role/ConsolidatedBalanceSheet", "http://www.agilent.com/role/NewAccountingPronouncementsImpactOfAdoptingNewGuidanceDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_AccountsReceivableAdditionalDisclosuresAbstract": { "auth_ref": [], "lang": { "en-US": { "role": { "label": "Accounts Receivable Additional Disclosures [Abstract]", "terseLabel": "Accounts Receivable" } } }, "localname": "AccountsReceivableAdditionalDisclosuresAbstract", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.agilent.com/role/OverviewAndSummaryOfSignificantAccountingPoliciesDetails" ], "xbrltype": "stringItemType" }, "us-gaap_AccountsReceivableNetCurrent": { "auth_ref": [ "r6", "r32", "r205", "r206", "r316" ], "calculation": { "http://www.agilent.com/role/ConsolidatedBalanceSheet": { "order": 2.0, "parentTag": "us-gaap_AssetsCurrent", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-US": { "role": { "documentation": "Amount, after allowance for credit loss, of right to consideration from customer for product sold and service rendered in normal course of business, classified as current.", "label": "Accounts Receivable, after Allowance for Credit Loss, Current", "terseLabel": "Accounts receivable, net", "verboseLabel": "Accounts receivable, net" } } }, "localname": "AccountsReceivableNetCurrent", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.agilent.com/role/ConsolidatedBalanceSheet", "http://www.agilent.com/role/NewAccountingPronouncementsImpactOfAdoptingNewGuidanceDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_AccruedEmployeeBenefitsCurrentAndNoncurrent": { "auth_ref": [ "r619", "r642" ], "crdr": "credit", "lang": { "en-US": { "role": { "documentation": "Carrying value as of the balance sheet date of obligations, excluding pension and other postretirement benefits, incurred through that date and payable for perquisites provided to employees pertaining to services received from them.", "label": "Accrued Employee Benefits", "terseLabel": "Employee compensation and benefits accrued" } } }, "localname": "AccruedEmployeeBenefitsCurrentAndNoncurrent", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.agilent.com/role/OverviewAndSummaryOfSignificantAccountingPoliciesDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_AccruedIncomeTaxesCurrent": { "auth_ref": [ "r24", "r612", "r635" ], "crdr": "credit", "lang": { "en-US": { "role": { "documentation": "Carrying amount as of the balance sheet date of the unpaid sum of the known and estimated amounts payable to satisfy all currently due domestic and foreign income tax obligations.", "label": "Accrued Income Taxes, Current", "terseLabel": "Current income tax liabilities (included within other accrued liabilities)" } } }, "localname": "AccruedIncomeTaxesCurrent", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.agilent.com/role/IncomeTaxesCurrentAndLongTermIncomeTaxAssetsAndLiabilitiesDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_AccruedIncomeTaxesNoncurrent": { "auth_ref": [ "r26", "r612", "r635" ], "crdr": "credit", "lang": { "en-US": { "role": { "documentation": "Carrying amount as of the balance sheet date of the unpaid sum of the known and estimated amounts payable to satisfy all domestic and foreign income tax obligations due beyond one year or the operating cycle, whichever is longer. Alternate captions include income taxes payable, noncurrent.", "label": "Accrued Income Taxes, Noncurrent", "terseLabel": "Long-term income tax liabilities (included within other long-term liabilities)" } } }, "localname": "AccruedIncomeTaxesNoncurrent", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.agilent.com/role/IncomeTaxesCurrentAndLongTermIncomeTaxAssetsAndLiabilitiesDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_AccruedLiabilitiesMember": { "auth_ref": [ "r55" ], "lang": { "en-US": { "role": { "documentation": "This item represents obligations incurred and payable, pertaining to costs that are statutory in nature, are incurred on contractual obligations, or accumulate over time and for which invoices have not yet been received or will not be rendered.", "label": "Accrued Liabilities [Member]", "terseLabel": "Accrued Liabilities [Member]" } } }, "localname": "AccruedLiabilitiesMember", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.agilent.com/role/DerivativesFairValueOfDerivativeInstrumentsAndConsolidatedBalanceSheetLocationDetails" ], "xbrltype": "domainItemType" }, "us-gaap_AccumulatedDefinedBenefitPlansAdjustmentNetPriorServiceCostCreditMember": { "auth_ref": [ "r84", "r89", "r93", "r361", "r513" ], "lang": { "en-US": { "role": { "documentation": "Accumulated other comprehensive (income) loss related to prior service cost (credit) component of defined benefit plans attributable to the parent.", "label": "Accumulated Defined Benefit Plans Adjustment, Net Prior Service Attributable to Parent [Member]", "terseLabel": "Accumulated Defined Benefit Plans Adjustment, Net Prior Service Attributable to Parent [Member]" } } }, "localname": "AccumulatedDefinedBenefitPlansAdjustmentNetPriorServiceCostCreditMember", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.agilent.com/role/StockholdersEquityChangesInAccumulatedOtherComprehensiveIncomeDetails" ], "xbrltype": "domainItemType" }, "us-gaap_AccumulatedDefinedBenefitPlansAdjustmentNetUnamortizedGainLossMember": { "auth_ref": [ "r82", "r89", "r93", "r361", "r513" ], "lang": { "en-US": { "role": { "documentation": "Accumulated other comprehensive income (loss) related to gain (loss) component of defined benefit plans attributable to the parent.", "label": "Accumulated Defined Benefit Plans Adjustment, Net Gain (Loss) Attributable to Parent [Member]", "terseLabel": "Accumulated Defined Benefit Plans Adjustment, Net Gain (Loss) Attributable to Parent [Member]" } } }, "localname": "AccumulatedDefinedBenefitPlansAdjustmentNetUnamortizedGainLossMember", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.agilent.com/role/StockholdersEquityChangesInAccumulatedOtherComprehensiveIncomeDetails" ], "xbrltype": "domainItemType" }, "us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment": { "auth_ref": [ "r46", "r259" ], "calculation": { "http://www.agilent.com/role/PropertyPlantAndEquipmentNetDetails": { "order": 2.0, "parentTag": "us-gaap_PropertyPlantAndEquipmentNet", "weight": -1.0 } }, "crdr": "credit", "lang": { "en-US": { "role": { "documentation": "Amount of accumulated depreciation, depletion and amortization for physical assets used in the normal conduct of business to produce goods and services.", "label": "Accumulated Depreciation, Depletion and Amortization, Property, Plant, and Equipment", "negatedLabel": "Accumulated depreciation and amortization" } } }, "localname": "AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.agilent.com/role/PropertyPlantAndEquipmentNetDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_AccumulatedOtherComprehensiveIncomeLossCumulativeChangesInNetGainLossFromCashFlowHedgesEffectNetOfTax": { "auth_ref": [ "r81", "r86", "r88" ], "crdr": "credit", "lang": { "en-US": { "role": { "documentation": "Accumulated change, net of tax, in accumulated gains and losses from derivative instruments designated and qualifying as the effective portion of cash flow hedges. Includes an entity's share of an equity investee's Increase or Decrease in deferred hedging gains or losses.", "label": "Accumulated Other Comprehensive Income (Loss), Cumulative Changes in Net Gain (Loss) from Cash Flow Hedges, Effect Net of Tax", "periodEndLabel": "Ending Balance", "periodStartLabel": "Beginning Balance", "terseLabel": "Unrealized gains (losses) on derivative instruments, net of tax benefit of $3 and $0 for 2019 and 2018, respectively" } } }, "localname": "AccumulatedOtherComprehensiveIncomeLossCumulativeChangesInNetGainLossFromCashFlowHedgesEffectNetOfTax", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.agilent.com/role/StockholdersEquityAccumulatedOtherComprehensiveIncomeDetails", "http://www.agilent.com/role/StockholdersEquityChangesInAccumulatedOtherComprehensiveIncomeDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_AccumulatedOtherComprehensiveIncomeLossDefinedBenefitPensionAndOtherPostretirementPlansNetOfTax": { "auth_ref": [ "r83", "r89" ], "crdr": "debit", "lang": { "en-US": { "role": { "documentation": "Amount, after tax, of accumulated other comprehensive (income) loss for defined benefit plan, that has not been recognized in net periodic benefit cost (credit).", "label": "Accumulated Other Comprehensive (Income) Loss, Defined Benefit Plan, after Tax", "negatedLabel": "Unrealized losses (including prior service benefit) on defined benefit plans, net of tax benefit of $153 and $132 for 2019 and 2018, respectively" } } }, "localname": "AccumulatedOtherComprehensiveIncomeLossDefinedBenefitPensionAndOtherPostretirementPlansNetOfTax", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.agilent.com/role/StockholdersEquityAccumulatedOtherComprehensiveIncomeDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_AccumulatedOtherComprehensiveIncomeLossForeignCurrencyTranslationAdjustmentNetOfTax": { "auth_ref": [ "r78", "r86", "r88", "r89", "r570", "r578", "r585" ], "crdr": "credit", "lang": { "en-US": { "role": { "documentation": "Accumulated adjustment, net of tax, that results from the process of translating subsidiary financial statements and foreign equity investments into the reporting currency from the functional currency of the reporting entity, net of reclassification of realized foreign currency translation gains or losses.", "label": "Accumulated Other Comprehensive Income (Loss), Foreign Currency Translation Adjustment, Net of Tax", "periodEndLabel": "Ending Balance", "periodStartLabel": "Beginning Balance", "terseLabel": "Foreign currency translation, net of tax expense of $(5) and $(15) for 2019 and 2018, respectively" } } }, "localname": "AccumulatedOtherComprehensiveIncomeLossForeignCurrencyTranslationAdjustmentNetOfTax", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.agilent.com/role/StockholdersEquityAccumulatedOtherComprehensiveIncomeDetails", "http://www.agilent.com/role/StockholdersEquityChangesInAccumulatedOtherComprehensiveIncomeDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_AccumulatedOtherComprehensiveIncomeLossLineItems": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.", "label": "Accumulated Other Comprehensive Income (Loss) [Line Items]", "terseLabel": "Accumulated Other Comprehensive Income (Loss) [Line Items]" } } }, "localname": "AccumulatedOtherComprehensiveIncomeLossLineItems", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.agilent.com/role/StockholdersEquityTables" ], "xbrltype": "stringItemType" }, "us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax": { "auth_ref": [ "r86", "r88", "r89" ], "calculation": { "http://www.agilent.com/role/ConsolidatedBalanceSheet": { "order": 5.0, "parentTag": "us-gaap_StockholdersEquity", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-US": { "role": { "documentation": "Accumulated change in equity from transactions and other events and circumstances from non-owner sources, net of tax effect, at period end. Excludes Net Income (Loss), and accumulated changes in equity from transactions resulting from investments by owners and distributions to owners. Includes foreign currency translation items, certain pension adjustments, unrealized gains and losses on certain investments in debt and equity securities, other than temporary impairment (OTTI) losses related to factors other than credit losses on available-for-sale and held-to-maturity debt securities that an entity does not intend to sell and it is not more likely than not that the entity will be required to sell before recovery of the amortized cost basis, as well as changes in the fair value of derivatives related to the effective portion of a designated cash flow hedge.", "label": "Accumulated Other Comprehensive Income (Loss), Net of Tax", "periodEndLabel": "Ending Balance", "periodStartLabel": "Beginning Balance", "terseLabel": "Accumulated other comprehensive loss" } } }, "localname": "AccumulatedOtherComprehensiveIncomeLossNetOfTax", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.agilent.com/role/ConsolidatedBalanceSheet", "http://www.agilent.com/role/NewAccountingPronouncementsImpactOfAdoptingNewGuidanceDetails", "http://www.agilent.com/role/StockholdersEquityAccumulatedOtherComprehensiveIncomeDetails", "http://www.agilent.com/role/StockholdersEquityChangesInAccumulatedOtherComprehensiveIncomeDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_AccumulatedOtherComprehensiveIncomeLossTable": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Disclosure of information about components of accumulated other comprehensive income (loss).", "label": "Accumulated Other Comprehensive Income (Loss) [Table]", "terseLabel": "Accumulated Other Comprehensive Income (Loss) [Table]" } } }, "localname": "AccumulatedOtherComprehensiveIncomeLossTable", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.agilent.com/role/StockholdersEquityChangesInAccumulatedOtherComprehensiveIncomeDetails", "http://www.agilent.com/role/StockholdersEquityTables" ], "xbrltype": "stringItemType" }, "us-gaap_AccumulatedOtherComprehensiveIncomeMember": { "auth_ref": [ "r85", "r89", "r93", "r513" ], "lang": { "en-US": { "role": { "documentation": "Accumulated increase (decrease) in equity from transactions and other events and circumstances from non-owner sources, attributable to the parent. Excludes net income (loss), and accumulated changes in equity from transactions resulting from investments by owners and distributions to owners.", "label": "AOCI Attributable to Parent [Member]", "terseLabel": "Accumulated Other Comprehensive Income (Loss)" } } }, "localname": "AccumulatedOtherComprehensiveIncomeMember", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.agilent.com/role/ConsolidatedStatementOfEquity", "http://www.agilent.com/role/DerivativesDetails", "http://www.agilent.com/role/DerivativesEffectOfDerivativeInstrumentsOnConsolidatedStatementOfOperationsDetails", "http://www.agilent.com/role/RetirementPlansAndPostRetirementPensionPlansJwpilDetails" ], "xbrltype": "domainItemType" }, "us-gaap_AccumulatedTranslationAdjustmentMember": { "auth_ref": [ "r79", "r89", "r93", "r513" ], "lang": { "en-US": { "role": { "documentation": "Accumulated other comprehensive income (loss) resulting from foreign currency translation adjustments, foreign currency transactions designated and effective as economic hedges of a net investment in a foreign entity and intra-entity foreign currency transactions that are of a long-term-investment nature, attributable to the parent.", "label": "Accumulated Foreign Currency Adjustment Attributable to Parent [Member]", "terseLabel": "Accumulated Foreign Currency Adjustment Attributable to Parent [Member]" } } }, "localname": "AccumulatedTranslationAdjustmentMember", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.agilent.com/role/StockholdersEquityChangesInAccumulatedOtherComprehensiveIncomeDetails" ], "xbrltype": "domainItemType" }, "us-gaap_AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife": { "auth_ref": [ "r240" ], "lang": { "en-US": { "role": { "documentation": "Weighted average amortization period of finite-lived intangible assets acquired either individually or as part of a group of assets, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days.", "label": "Acquired Finite-lived Intangible Assets, Weighted Average Useful Life", "terseLabel": "Acquired Finite-lived Intangible Assets, Weighted Average Useful Life" } } }, "localname": "AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.agilent.com/role/AcquisitionsAcquisitionsIntangibleAssetsDetails" ], "xbrltype": "durationItemType" }, "us-gaap_AdditionalPaidInCapital": { "auth_ref": [ "r33" ], "calculation": { "http://www.agilent.com/role/ConsolidatedBalanceSheet": { "order": 3.0, "parentTag": "us-gaap_StockholdersEquity", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-US": { "role": { "documentation": "Excess of issue price over par or stated value of the entity's capital stock and amounts received from other transactions involving the entity's stock or stockholders. Includes adjustments to additional paid in capital. Some examples of such adjustments include recording the issuance of debt with a beneficial conversion feature and certain tax consequences of equity instruments awarded to employees. Use this element for the aggregate amount of additional paid-in capital associated with common and preferred stock. For additional paid-in capital associated with only common stock, use the element additional paid in capital, common stock. For additional paid-in capital associated with only preferred stock, use the element additional paid in capital, preferred stock.", "label": "Additional Paid in Capital", "terseLabel": "Additional paid-in-capital" } } }, "localname": "AdditionalPaidInCapital", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.agilent.com/role/ConsolidatedBalanceSheet", "http://www.agilent.com/role/NewAccountingPronouncementsImpactOfAdoptingNewGuidanceDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_AdditionalPaidInCapitalMember": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Excess of issue price over par or stated value of the entity's capital stock and amounts received from other transactions involving the entity's stock or stockholders.", "label": "Additional Paid-in Capital [Member]", "terseLabel": "Additional Paid-in Capital" } } }, "localname": "AdditionalPaidInCapitalMember", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.agilent.com/role/ConsolidatedStatementOfEquity", "http://www.agilent.com/role/StockholdersEquityStockRepurchasesDetails" ], "xbrltype": "domainItemType" }, "us-gaap_AdjustmentForAmortization": { "auth_ref": [ "r129", "r246" ], "calculation": { "http://www.agilent.com/role/SegmentInformationReconciliationOfReportableResultsDetails": { "order": 2.0, "parentTag": "us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments", "weight": -1.0 } }, "crdr": "debit", "lang": { "en-US": { "role": { "documentation": "The aggregate amount of recurring noncash expense charged against earnings in the period to allocate the cost of assets over their estimated remaining economic lives.", "label": "Amortization", "negatedTerseLabel": "Amortization" } } }, "localname": "AdjustmentForAmortization", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.agilent.com/role/SegmentInformationReconciliationOfReportableResultsDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_AdjustmentsForNewAccountingPronouncementsAxis": { "auth_ref": [ "r155" ], "lang": { "en-US": { "role": { "documentation": "Information by new accounting pronouncement.", "label": "Adjustments for New Accounting Pronouncements [Axis]", "terseLabel": "Adjustments for New Accounting Pronouncements [Axis]" } } }, "localname": "AdjustmentsForNewAccountingPronouncementsAxis", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.agilent.com/role/InvestmentsDetails", "http://www.agilent.com/role/LongTermDebtCarryingValueDetails", "http://www.agilent.com/role/LongTermDebtLongTermDebtOtherDetails", "http://www.agilent.com/role/NewAccountingPronouncementsImpactOfAdoptingNewGuidanceDetails", "http://www.agilent.com/role/NewAccountingPronouncementsTextualsDetails" ], "xbrltype": "stringItemType" }, "us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue": { "auth_ref": [ "r392", "r394", "r429", "r430" ], "crdr": "credit", "lang": { "en-US": { "role": { "documentation": "Amount of increase to additional paid-in capital (APIC) for recognition of cost for award under share-based payment arrangement.", "label": "APIC, Share-based Payment Arrangement, Increase for Cost Recognition", "verboseLabel": "Share-based compensation" } } }, "localname": "AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.agilent.com/role/ConsolidatedStatementOfEquity" ], "xbrltype": "monetaryItemType" }, "us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract": { "auth_ref": [], "lang": { "en-US": { "role": { "label": "Adjustments to Reconcile Net Income (Loss) to Cash Provided by (Used in) Operating Activities [Abstract]", "terseLabel": "Adjustments to reconcile net income to net cash provided by operating activities:" } } }, "localname": "AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.agilent.com/role/ConsolidatedStatementOfCashFlows" ], "xbrltype": "stringItemType" }, "us-gaap_AdvertisingCostsPolicyTextBlock": { "auth_ref": [ "r432" ], "lang": { "en-US": { "role": { "documentation": "Disclosure of accounting policy for advertising cost.", "label": "Advertising Cost [Policy Text Block]", "terseLabel": "Advertising" } } }, "localname": "AdvertisingCostsPolicyTextBlock", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.agilent.com/role/OverviewAndSummaryOfSignificantAccountingPoliciesPolicies" ], "xbrltype": "textBlockItemType" }, "us-gaap_AdvertisingExpense": { "auth_ref": [ "r433" ], "crdr": "debit", "lang": { "en-US": { "role": { "documentation": "Amount charged to advertising expense for the period, which are expenses incurred with the objective of increasing revenue for a specified brand, product or product line.", "label": "Advertising Expense", "terseLabel": "Advertising costs expensed as incurred" } } }, "localname": "AdvertisingExpense", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.agilent.com/role/OverviewAndSummaryOfSignificantAccountingPoliciesDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_AllocatedShareBasedCompensationExpense": { "auth_ref": [ "r394", "r423", "r428" ], "crdr": "debit", "lang": { "en-US": { "role": { "documentation": "Amount of expense for award under share-based payment arrangement. Excludes amount capitalized.", "label": "Share-based Payment Arrangement, Expense", "verboseLabel": "Share-based compensation expense" } } }, "localname": "AllocatedShareBasedCompensationExpense", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.agilent.com/role/OverviewAndSummaryOfSignificantAccountingPoliciesDetails", "http://www.agilent.com/role/ShareBasedCompensationAllocatedShareBasedCompensationExpenseDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_AlternativeInvestment": { "auth_ref": [ "r558", "r566" ], "calculation": { "http://www.agilent.com/role/FairValueMeasurementsFairValueOfAssetsAndLiabilitiesMeasuredOnRecurringBasisDetails": { "order": 4.0, "parentTag": "a_FairValueAssetsMeasuredOnRecurringBasisTotalAssets", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-US": { "role": { "documentation": "Fair value of investment other than investment in equity security, investment in debt security and equity method investment. Includes, but is not limited to, investment in certain entities that calculate net asset value per share. Example includes, but is not limited to, investment in hedge fund, venture capital fund, private equity fund, and real estate partnership or fund.", "label": "Alternative Investment", "terseLabel": "Other investments" } } }, "localname": "AlternativeInvestment", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.agilent.com/role/FairValueMeasurementsFairValueOfAssetsAndLiabilitiesMeasuredOnRecurringBasisDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_AmortizationOfFinancingCostsAndDiscounts": { "auth_ref": [ "r129", "r589" ], "crdr": "debit", "lang": { "en-US": { "role": { "documentation": "Amount of amortization expense attributable to debt discount (premium) and debt issuance costs.", "label": "Amortization of Debt Issuance Costs and Discounts", "terseLabel": "Amortization of Debt Issuance Costs and Discounts" } } }, "localname": "AmortizationOfFinancingCostsAndDiscounts", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.agilent.com/role/ShortTermDebtSeniorNotesDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_AmortizationOfIntangibleAssets": { "auth_ref": [ "r129", "r238", "r246" ], "crdr": "debit", "lang": { "en-US": { "role": { "documentation": "The aggregate expense charged against earnings to allocate the cost of intangible assets (nonphysical assets not used in production) in a systematic and rational manner to the periods expected to benefit from such assets. As a noncash expense, this element is added back to net income when calculating cash provided by or used in operations using the indirect method.", "label": "Amortization of Intangible Assets", "verboseLabel": "Amortization of intangible assets during the period" } } }, "localname": "AmortizationOfIntangibleAssets", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.agilent.com/role/GoodwillAndOtherIntangibleAssetsAmortizationExpenseAndFutureAmortizationExpenseDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount": { "auth_ref": [ "r166" ], "lang": { "en-US": { "role": { "documentation": "Securities (including those issuable pursuant to contingent stock agreements) that could potentially dilute basic earnings per share (EPS) or earnings per unit (EPU) in the future that were not included in the computation of diluted EPS or EPU because to do so would increase EPS or EPU amounts or decrease loss per share or unit amounts for the period presented.", "label": "Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount", "terseLabel": "Antidilutive shares excluded from EPS computation (in shares)" } } }, "localname": "AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.agilent.com/role/NetIncomeLossPerShareDetails" ], "xbrltype": "sharesItemType" }, "us-gaap_AociDerivativeQualifyingAsHedgeExcludedComponentParentMember": { "auth_ref": [ "r89", "r556" ], "lang": { "en-US": { "role": { "documentation": "Accumulated other comprehensive income (loss) from increase (decrease) in value of excluded component of derivative hedge, attributable to parent.", "label": "AOCI, Derivative Qualifying as Hedge, Excluded Component, Parent [Member]", "terseLabel": "AOCI, Derivative Qualifying as Hedge, Excluded Component, Parent [Member]" } } }, "localname": "AociDerivativeQualifyingAsHedgeExcludedComponentParentMember", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.agilent.com/role/StockholdersEquityChangesInAccumulatedOtherComprehensiveIncomeDetails" ], "xbrltype": "domainItemType" }, "us-gaap_Assets": { "auth_ref": [ "r193", "r610", "r634" ], "calculation": { "http://www.agilent.com/role/ConsolidatedBalanceSheet": { "order": null, "parentTag": null, "root": true, "weight": null } }, "crdr": "debit", "lang": { "en-US": { "role": { "documentation": "Sum of the carrying amounts as of the balance sheet date of all assets that are recognized. Assets are probable future economic benefits obtained or controlled by an entity as a result of past transactions or events.", "label": "Assets", "terseLabel": "Total assets", "totalLabel": "Total assets" } } }, "localname": "Assets", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.agilent.com/role/ConsolidatedBalanceSheet", "http://www.agilent.com/role/NewAccountingPronouncementsImpactOfAdoptingNewGuidanceDetails", "http://www.agilent.com/role/SegmentInformationSegmentAssetsDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_AssetsAbstract": { "auth_ref": [], "lang": { "en-US": { "role": { "label": "Assets [Abstract]", "terseLabel": "ASSETS" } } }, "localname": "AssetsAbstract", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.agilent.com/role/ConsolidatedBalanceSheet" ], "xbrltype": "stringItemType" }, "us-gaap_AssetsCurrent": { "auth_ref": [ "r7", "r8", "r73" ], "calculation": { "http://www.agilent.com/role/ConsolidatedBalanceSheet": { "order": 1.0, "parentTag": "us-gaap_Assets", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-US": { "role": { "documentation": "Sum of the carrying amounts as of the balance sheet date of all assets that are expected to be realized in cash, sold, or consumed within one year (or the normal operating cycle, if longer). Assets are probable future economic benefits obtained or controlled by an entity as a result of past transactions or events.", "label": "Assets, Current", "terseLabel": "Total current assets", "totalLabel": "Total current assets" } } }, "localname": "AssetsCurrent", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.agilent.com/role/ConsolidatedBalanceSheet", "http://www.agilent.com/role/NewAccountingPronouncementsImpactOfAdoptingNewGuidanceDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_AssetsCurrentAbstract": { "auth_ref": [], "lang": { "en-US": { "role": { "label": "Assets, Current [Abstract]", "terseLabel": "Current assets:", "verboseLabel": "Assets, Short-term [Abstract]" } } }, "localname": "AssetsCurrentAbstract", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.agilent.com/role/ConsolidatedBalanceSheet", "http://www.agilent.com/role/FairValueMeasurementsFairValueOfAssetsAndLiabilitiesMeasuredOnRecurringBasisDetails" ], "xbrltype": "stringItemType" }, "us-gaap_AssetsFairValueDisclosure": { "auth_ref": [ "r559" ], "crdr": "debit", "lang": { "en-US": { "role": { "documentation": "Fair value portion of probable future economic benefits obtained or controlled by an entity as a result of past transactions or events.", "label": "Assets, Fair Value Disclosure", "terseLabel": "Fair value of assets, nonrecurring" } } }, "localname": "AssetsFairValueDisclosure", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.agilent.com/role/FairValueMeasurementsFairValueMeasurmentsFairValueOfAssetsAndLiabilitiesMeasuredOnNonRecurringDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_AssetsNoncurrentAbstract": { "auth_ref": [], "lang": { "en-US": { "role": { "label": "Assets, Noncurrent [Abstract]", "verboseLabel": "Assets, Long-term [Abstract]" } } }, "localname": "AssetsNoncurrentAbstract", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.agilent.com/role/FairValueMeasurementsFairValueOfAssetsAndLiabilitiesMeasuredOnRecurringBasisDetails" ], "xbrltype": "stringItemType" }, "us-gaap_AwardTypeAxis": { "auth_ref": [ "r396", "r426" ], "lang": { "en-US": { "role": { "documentation": "Information by type of award under share-based payment arrangement.", "label": "Award Type [Axis]", "terseLabel": "Award Type [Axis]" } } }, "localname": "AwardTypeAxis", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.agilent.com/role/ShareBasedCompensationFairValueAssumptionsDetails", "http://www.agilent.com/role/ShareBasedCompensationGeneralDisclosuresDetails", "http://www.agilent.com/role/ShareBasedCompensationSharesAuthorizedByExercisePriceRangeDetails" ], "xbrltype": "stringItemType" }, "us-gaap_BalanceSheetLocationAxis": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Information by location on balance sheet (statement of financial position).", "label": "Balance Sheet Location [Axis]", "terseLabel": "Balance Sheet Location [Axis]" } } }, "localname": "BalanceSheetLocationAxis", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.agilent.com/role/DerivativesFairValueOfDerivativeInstrumentsAndConsolidatedBalanceSheetLocationDetails", "http://www.agilent.com/role/LongTermDebtCarryingValueDetails", "http://www.agilent.com/role/LongTermDebtLongTermDebtOtherDetails", "http://www.agilent.com/role/NewAccountingPronouncementsImpactOfAdoptingNewGuidanceDetails", "http://www.agilent.com/role/RetirementPlansAndPostRetirementPensionPlansFundedStatusDetails", "http://www.agilent.com/role/RetirementPlansAndPostRetirementPensionPlansJwpilDetails", "http://www.agilent.com/role/ShareBasedCompensationAllocatedShareBasedCompensationExpenseDetails" ], "xbrltype": "stringItemType" }, "us-gaap_BalanceSheetLocationDomain": { "auth_ref": [ "r532", "r537" ], "lang": { "en-US": { "role": { "documentation": "Location in the balance sheet (statement of financial position).", "label": "Balance Sheet Location [Domain]", "terseLabel": "Balance Sheet Location [Domain]" } } }, "localname": "BalanceSheetLocationDomain", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.agilent.com/role/DerivativesFairValueOfDerivativeInstrumentsAndConsolidatedBalanceSheetLocationDetails", "http://www.agilent.com/role/LongTermDebtCarryingValueDetails", "http://www.agilent.com/role/LongTermDebtLongTermDebtOtherDetails", "http://www.agilent.com/role/NewAccountingPronouncementsImpactOfAdoptingNewGuidanceDetails", "http://www.agilent.com/role/RetirementPlansAndPostRetirementPensionPlansFundedStatusDetails", "http://www.agilent.com/role/RetirementPlansAndPostRetirementPensionPlansJwpilDetails", "http://www.agilent.com/role/ShareBasedCompensationAllocatedShareBasedCompensationExpenseDetails" ], "xbrltype": "domainItemType" }, "us-gaap_BasisOfPresentationAndSignificantAccountingPoliciesTextBlock": { "auth_ref": [ "r154" ], "lang": { "en-US": { "role": { "documentation": "The entire disclosure for the basis of presentation and significant accounting policies concepts. Basis of presentation describes the underlying basis used to prepare the financial statements (for example, US Generally Accepted Accounting Principles, Other Comprehensive Basis of Accounting, IFRS). Accounting policies describe all significant accounting policies of the reporting entity.", "label": "Basis of Presentation and Significant Accounting Policies [Text Block]", "terseLabel": "OVERVIEW AND SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES" } } }, "localname": "BasisOfPresentationAndSignificantAccountingPoliciesTextBlock", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.agilent.com/role/OverviewAndSummaryOfSignificantAccountingPolicies" ], "xbrltype": "textBlockItemType" }, "us-gaap_BuildingsAndImprovementsGross": { "auth_ref": [ "r11", "r258" ], "calculation": { "http://www.agilent.com/role/PropertyPlantAndEquipmentNetDetails": { "order": 2.0, "parentTag": "us-gaap_PropertyPlantAndEquipmentGross", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-US": { "role": { "documentation": "Amount before accumulated depreciation of building structures held for productive use including addition, improvement, or renovation to the structure, including, but not limited to, interior masonry, interior flooring, electrical, and plumbing.", "label": "Buildings and Improvements, Gross", "terseLabel": "Buildings and leasehold improvements" } } }, "localname": "BuildingsAndImprovementsGross", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.agilent.com/role/PropertyPlantAndEquipmentNetDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_BusinessAcquisitionAcquireeDomain": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Identification of the acquiree in a material business combination (or series of individually immaterial business combinations), which may include the name or other type of identification of the acquiree.", "label": "Business Acquisition, Acquiree [Domain]", "terseLabel": "Business Acquisition, Acquiree [Domain]" } } }, "localname": "BusinessAcquisitionAcquireeDomain", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.agilent.com/role/AcquisitionsAcquisitionsIntangibleAssetsDetails", "http://www.agilent.com/role/AcquisitionsAcquisitionsProformaOperatingResultsDetails", "http://www.agilent.com/role/AcquisitionsAssetsAndLiabilitiesAssumedDetails", "http://www.agilent.com/role/AcquisitionsTextDetails", "http://www.agilent.com/role/DerivativesDetails", "http://www.agilent.com/role/GoodwillAndOtherIntangibleAssetsTextDetails", "http://www.agilent.com/role/OverviewAndSummaryOfSignificantAccountingPoliciesDetails" ], "xbrltype": "domainItemType" }, "us-gaap_BusinessAcquisitionAxis": { "auth_ref": [ "r489", "r490" ], "lang": { "en-US": { "role": { "documentation": "Information by business combination or series of individually immaterial business combinations.", "label": "Business Acquisition [Axis]", "terseLabel": "Business Acquisition [Axis]" } } }, "localname": "BusinessAcquisitionAxis", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.agilent.com/role/AcquisitionsAcquisitionsIntangibleAssetsDetails", "http://www.agilent.com/role/AcquisitionsAcquisitionsProformaOperatingResultsDetails", "http://www.agilent.com/role/AcquisitionsAssetsAndLiabilitiesAssumedDetails", "http://www.agilent.com/role/AcquisitionsTextDetails", "http://www.agilent.com/role/DerivativesDetails", "http://www.agilent.com/role/GoodwillAndOtherIntangibleAssetsTextDetails", "http://www.agilent.com/role/OverviewAndSummaryOfSignificantAccountingPoliciesDetails" ], "xbrltype": "stringItemType" }, "us-gaap_BusinessAcquisitionCostOfAcquiredEntityTransactionCosts": { "auth_ref": [], "crdr": "debit", "lang": { "en-US": { "role": { "documentation": "Amount of direct costs of the business combination including legal, accounting, and other costs incurred to consummate the business acquisition.", "label": "Business Acquisition, Transaction Costs", "terseLabel": "Acquisition transaction costs" } } }, "localname": "BusinessAcquisitionCostOfAcquiredEntityTransactionCosts", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.agilent.com/role/AcquisitionsTextDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_BusinessAcquisitionDateOfAcquisitionAbstract": { "auth_ref": [], "lang": { "en-US": { "role": { "label": "Business Acquisition, Date of Acquisition [Abstract]", "terseLabel": "Business Acquisition" } } }, "localname": "BusinessAcquisitionDateOfAcquisitionAbstract", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.agilent.com/role/GoodwillAndOtherIntangibleAssetsTextDetails" ], "xbrltype": "stringItemType" }, "us-gaap_BusinessAcquisitionLineItems": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.", "label": "Business Acquisition [Line Items]", "terseLabel": "Business Acquisition [Line Items]" } } }, "localname": "BusinessAcquisitionLineItems", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.agilent.com/role/AcquisitionsAcquisitionsIntangibleAssetsDetails", "http://www.agilent.com/role/AcquisitionsAcquisitionsProformaOperatingResultsDetails", "http://www.agilent.com/role/AcquisitionsAssetsAndLiabilitiesAssumedDetails", "http://www.agilent.com/role/AcquisitionsTextDetails", "http://www.agilent.com/role/OverviewAndSummaryOfSignificantAccountingPoliciesDetails" ], "xbrltype": "stringItemType" }, "us-gaap_BusinessAcquisitionProFormaEarningsPerShareBasic": { "auth_ref": [ "r487", "r488" ], "lang": { "en-US": { "role": { "documentation": "The pro forma basic net income per share for a period as if the business combination or combinations had been completed at the beginning of a period.", "label": "Business Acquisition, Pro Forma Earnings Per Share, Basic", "terseLabel": "Proforma net income per share - basic" } } }, "localname": "BusinessAcquisitionProFormaEarningsPerShareBasic", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.agilent.com/role/AcquisitionsAcquisitionsProformaOperatingResultsDetails" ], "xbrltype": "perShareItemType" }, "us-gaap_BusinessAcquisitionProFormaEarningsPerShareDiluted": { "auth_ref": [ "r487", "r488" ], "lang": { "en-US": { "role": { "documentation": "The pro forma diluted net income per share for a period as if the business combination or combinations had been completed at the beginning of a period.", "label": "Business Acquisition, Pro Forma Earnings Per Share, Diluted", "terseLabel": "Proforma net income per share - diluted" } } }, "localname": "BusinessAcquisitionProFormaEarningsPerShareDiluted", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.agilent.com/role/AcquisitionsAcquisitionsProformaOperatingResultsDetails" ], "xbrltype": "perShareItemType" }, "us-gaap_BusinessAcquisitionProFormaInformationTextBlock": { "auth_ref": [ "r487", "r488" ], "lang": { "en-US": { "role": { "documentation": "Tabular disclosure of pro forma results of operations for a material business acquisition or series of individually immaterial business acquisitions that are material in the aggregate.", "label": "Business Acquisition, Pro Forma Information [Table Text Block]", "terseLabel": "Proforma operating results" } } }, "localname": "BusinessAcquisitionProFormaInformationTextBlock", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.agilent.com/role/AcquisitionsTables" ], "xbrltype": "textBlockItemType" }, "us-gaap_BusinessAcquisitionsProFormaNetIncomeLoss": { "auth_ref": [ "r487", "r488" ], "crdr": "credit", "lang": { "en-US": { "role": { "documentation": "The pro forma net Income or Loss for the period as if the business combination or combinations had been completed at the beginning of a period.", "label": "Business Acquisition, Pro Forma Net Income (Loss)", "terseLabel": "Proforma net income" } } }, "localname": "BusinessAcquisitionsProFormaNetIncomeLoss", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.agilent.com/role/AcquisitionsAcquisitionsProformaOperatingResultsDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_BusinessAcquisitionsProFormaRevenue": { "auth_ref": [ "r487", "r488" ], "crdr": "credit", "lang": { "en-US": { "role": { "documentation": "The pro forma revenue for a period as if the business combination or combinations had been completed at the beginning of the period.", "label": "Business Acquisition, Pro Forma Revenue", "terseLabel": "Proforma net revenue" } } }, "localname": "BusinessAcquisitionsProFormaRevenue", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.agilent.com/role/AcquisitionsAcquisitionsProformaOperatingResultsDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_BusinessCombinationAcquisitionRelatedCosts": { "auth_ref": [ "r485" ], "calculation": { "http://www.agilent.com/role/SegmentInformationReconciliationOfReportableResultsDetails": { "order": 3.0, "parentTag": "us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments", "weight": -1.0 } }, "crdr": "debit", "lang": { "en-US": { "role": { "documentation": "This element represents acquisition-related costs incurred to effect a business combination which costs have been expensed during the period. Such costs include finder's fees; advisory, legal, accounting, valuation, and other professional or consulting fees; general administrative costs, including the costs of maintaining an internal acquisitions department; and may include costs of registering and issuing debt and equity securities.", "label": "Business Combination, Acquisition Related Costs", "negatedLabel": "Acquisition and integration costs" } } }, "localname": "BusinessCombinationAcquisitionRelatedCosts", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.agilent.com/role/SegmentInformationReconciliationOfReportableResultsDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_BusinessCombinationConsiderationTransferred1": { "auth_ref": [ "r499", "r500", "r501" ], "crdr": "credit", "lang": { "en-US": { "role": { "documentation": "Amount of consideration transferred, consisting of acquisition-date fair value of assets transferred by the acquirer, liabilities incurred by the acquirer, and equity interest issued by the acquirer.", "label": "Business Combination, Consideration Transferred", "terseLabel": "Purchase price for acquisition" } } }, "localname": "BusinessCombinationConsiderationTransferred1", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.agilent.com/role/AcquisitionsTextDetails", "http://www.agilent.com/role/GoodwillAndOtherIntangibleAssetsTextDetails", "http://www.agilent.com/role/OverviewAndSummaryOfSignificantAccountingPoliciesDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_BusinessCombinationConsiderationTransferredLiabilitiesIncurred": { "auth_ref": [ "r498", "r499", "r500", "r503" ], "crdr": "credit", "lang": { "en-US": { "role": { "documentation": "Amount of liabilities incurred by the acquirer as part of consideration transferred in a business combination.", "label": "Business Combination, Consideration Transferred, Liabilities Incurred", "terseLabel": "Liability incurred to pay for acquisition" } } }, "localname": "BusinessCombinationConsiderationTransferredLiabilitiesIncurred", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.agilent.com/role/AcquisitionsTextDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssets": { "auth_ref": [ "r492" ], "crdr": "debit", "lang": { "en-US": { "role": { "documentation": "Amount of assets acquired at the acquisition date.", "label": "Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Assets", "terseLabel": "Total assets acquired" } } }, "localname": "BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssets", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.agilent.com/role/AcquisitionsAssetsAndLiabilitiesAssumedDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCashAndEquivalents": { "auth_ref": [ "r492" ], "crdr": "debit", "lang": { "en-US": { "role": { "documentation": "Amount of currency on hand as well as demand deposits with banks or financial institutions, acquired at the acquisition date. Includes other kinds of accounts that have the general characteristics of demand deposits. Also includes short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates.", "label": "Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Cash and Equivalents", "terseLabel": "Cash and cash equivalents" } } }, "localname": "BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCashAndEquivalents", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.agilent.com/role/AcquisitionsAssetsAndLiabilitiesAssumedDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsOther": { "auth_ref": [ "r492" ], "crdr": "debit", "lang": { "en-US": { "role": { "documentation": "Amount of other assets expected to be realized or consumed before one year or the normal operating cycle, if longer, acquired at the acquisition date.", "label": "Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Current Assets, Other", "terseLabel": "Other current assets" } } }, "localname": "BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsOther", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.agilent.com/role/AcquisitionsAssetsAndLiabilitiesAssumedDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsReceivables": { "auth_ref": [ "r492" ], "crdr": "debit", "lang": { "en-US": { "role": { "documentation": "Amount due from customers or clients for goods or services, including trade receivables, that have been delivered or sold in the normal course of business, and amounts due from others, including related parties expected to be converted to cash, sold or exchanged within one year or the normal operating cycle, if longer, acquired at the acquisition date.", "label": "Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Current Assets, Receivables", "terseLabel": "Accounts receivables" } } }, "localname": "BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsReceivables", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.agilent.com/role/AcquisitionsAssetsAndLiabilitiesAssumedDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesAccountsPayable": { "auth_ref": [ "r492" ], "crdr": "credit", "lang": { "en-US": { "role": { "documentation": "Amount of liabilities incurred for goods and services received that are used in an entity's business and related party payables, assumed at the acquisition date.", "label": "Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Current Liabilities, Accounts Payable", "terseLabel": "Accounts payable" } } }, "localname": "BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesAccountsPayable", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.agilent.com/role/AcquisitionsAssetsAndLiabilitiesAssumedDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesDeferredRevenue": { "auth_ref": [ "r492" ], "crdr": "credit", "lang": { "en-US": { "role": { "documentation": "Amount of deferred revenue expected to be recognized as such within one year or the normal operating cycle, if longer, assumed at the acquisition date.", "label": "Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Current Liabilities, Deferred Revenue", "terseLabel": "Deferred revenue" } } }, "localname": "BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesDeferredRevenue", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.agilent.com/role/AcquisitionsAssetsAndLiabilitiesAssumedDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesOther": { "auth_ref": [ "r492" ], "crdr": "credit", "lang": { "en-US": { "role": { "documentation": "Amount of other liabilities due within one year or within the normal operating cycle, if longer, assumed at the acquisition date.", "label": "Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Current Liabilities, Other", "terseLabel": "Other accrued liabilities" } } }, "localname": "BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesOther", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.agilent.com/role/AcquisitionsAssetsAndLiabilitiesAssumedDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibleAssetsOtherThanGoodwill": { "auth_ref": [ "r492" ], "crdr": "debit", "lang": { "en-US": { "role": { "documentation": "Amount of intangible assets, excluding goodwill, acquired at the acquisition date.", "label": "Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Intangible Assets, Other than Goodwill", "terseLabel": "Intangible assets" } } }, "localname": "BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibleAssetsOtherThanGoodwill", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.agilent.com/role/AcquisitionsAssetsAndLiabilitiesAssumedDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedInventory": { "auth_ref": [ "r491", "r492" ], "crdr": "debit", "lang": { "en-US": { "role": { "documentation": "The amount of inventory recognized as of the acquisition date.", "label": "Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Inventory", "terseLabel": "Inventories" } } }, "localname": "BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedInventory", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.agilent.com/role/AcquisitionsAssetsAndLiabilitiesAssumedDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNoncurrentLiabilitiesLongTermDebt": { "auth_ref": [ "r492" ], "crdr": "credit", "lang": { "en-US": { "role": { "documentation": "Amount of long-term debt due after one year or the normal operating cycle, if longer, assumed at the acquisition date.", "label": "Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Noncurrent Liabilities, Long-term Debt", "terseLabel": "Long-term debt" } } }, "localname": "BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNoncurrentLiabilitiesLongTermDebt", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.agilent.com/role/AcquisitionsAssetsAndLiabilitiesAssumedDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedPropertyPlantAndEquipment": { "auth_ref": [ "r491", "r492" ], "crdr": "debit", "lang": { "en-US": { "role": { "documentation": "The amount of property, plant, and equipment recognized as of the acquisition date.", "label": "Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Property, Plant, and Equipment", "terseLabel": "Property, plant, and equipment" } } }, "localname": "BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedPropertyPlantAndEquipment", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.agilent.com/role/AcquisitionsAssetsAndLiabilitiesAssumedDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet": { "auth_ref": [ "r492" ], "crdr": "debit", "lang": { "en-US": { "role": { "documentation": "Amount recognized for assets, including goodwill, in excess of (less than) the aggregate liabilities assumed.", "label": "Business Combination, Recognized Identifiable Assets Acquired, Goodwill, and Liabilities Assumed, Net", "terseLabel": "Net assets acquired" } } }, "localname": "BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.agilent.com/role/AcquisitionsAssetsAndLiabilitiesAssumedDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_BusinessCombinationStepAcquisitionEquityInterestInAcquireeRemeasurementGain": { "auth_ref": [ "r486" ], "calculation": { "http://www.agilent.com/role/ConsolidatedStatementOfCashFlows": { "order": 6.0, "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": -1.0 } }, "crdr": "credit", "lang": { "en-US": { "role": { "documentation": "In a business combination achieved in stages, this element represents the amount of gain recognized by the entity as a result of remeasuring to fair value the equity interest in the acquiree it held before the business combination.", "label": "Business Combination, Step Acquisition, Equity Interest in Acquiree, Remeasurement Gain", "negatedLabel": "Gain on step acquisition", "terseLabel": "Gain on step acquisition", "verboseLabel": "Remeasurement Gain on step acquisition" } } }, "localname": "BusinessCombinationStepAcquisitionEquityInterestInAcquireeRemeasurementGain", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.agilent.com/role/ConsolidatedStatementOfCashFlows", "http://www.agilent.com/role/InvestmentsDetails", "http://www.agilent.com/role/OverviewAndSummaryOfSignificantAccountingPoliciesDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_BusinessCombinationsAbstract": { "auth_ref": [], "lang": { "en-US": { "role": { "label": "Business Combinations [Abstract]" } } }, "localname": "BusinessCombinationsAbstract", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "xbrltype": "stringItemType" }, "us-gaap_BusinessCombinationsPolicy": { "auth_ref": [ "r137", "r484" ], "lang": { "en-US": { "role": { "documentation": "Disclosure of accounting policy for completed business combinations (purchase method, acquisition method or combination of entities under common control). This accounting policy may include a general discussion of the purchase method or acquisition method of accounting (including for example, the treatment accorded contingent consideration, the identification of assets and liabilities, the purchase price allocation process, how the fair values of acquired assets and liabilities are determined) and the entity's specific application thereof. An entity that acquires another entity in a leveraged buyout transaction generally discloses the accounting policy followed by the acquiring entity in determining the basis used to value its interest in the acquired entity, and the rationale for that accounting policy.", "label": "Business Combinations Policy [Policy Text Block]", "terseLabel": "Acquisitions" } } }, "localname": "BusinessCombinationsPolicy", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.agilent.com/role/OverviewAndSummaryOfSignificantAccountingPoliciesPolicies" ], "xbrltype": "textBlockItemType" }, "us-gaap_BusinessDescriptionAndBasisOfPresentationTextBlock": { "auth_ref": [ "r3", "r154", "r186" ], "lang": { "en-US": { "role": { "documentation": "The entire disclosure for the business description and basis of presentation concepts. Business description describes the nature and type of organization including but not limited to organizational structure as may be applicable to holding companies, parent and subsidiary relationships, business divisions, business units, business segments, affiliates and information about significant ownership of the reporting entity. Basis of presentation describes the underlying basis used to prepare the financial statements (for example, US Generally Accepted Accounting Principles, Other Comprehensive Basis of Accounting, IFRS).", "label": "Business Description and Basis of Presentation [Text Block]", "terseLabel": "Business description and basis of presentation" } } }, "localname": "BusinessDescriptionAndBasisOfPresentationTextBlock", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.agilent.com/role/OverviewAndSummaryOfSignificantAccountingPoliciesPolicies" ], "xbrltype": "textBlockItemType" }, "us-gaap_BusinessExitCosts1": { "auth_ref": [ "r129", "r266", "r268", "r269" ], "calculation": { "http://www.agilent.com/role/SegmentInformationReconciliationOfReportableResultsDetails": { "order": 6.0, "parentTag": "us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments", "weight": -1.0 } }, "crdr": "debit", "lang": { "en-US": { "role": { "documentation": "Amount of expenses associated with exit or disposal activities pursuant to an authorized plan. Includes, but is not limited to, one-time termination benefits, termination of an operating lease or other contract, consolidating or closing facilities, and relocating employees, and termination benefits associated with an ongoing benefit arrangement. Excludes expenses associated with special or contractual termination benefits, a discontinued operation or an asset retirement obligation.", "label": "Business Exit Costs", "negatedLabel": "Business exit and divestiture costs (primarily our NMR business)" } } }, "localname": "BusinessExitCosts1", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.agilent.com/role/SegmentInformationReconciliationOfReportableResultsDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_CaliforniaFranchiseTaxBoardMember": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Designated tax department of the government of the state of California.", "label": "California Franchise Tax Board [Member]", "terseLabel": "State" } } }, "localname": "CaliforniaFranchiseTaxBoardMember", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.agilent.com/role/IncomeTaxesCarryforwardsDetails" ], "xbrltype": "domainItemType" }, "us-gaap_CapitalLeaseObligationsAbstract": { "auth_ref": [], "lang": { "en-US": { "role": { "label": "Capital Lease Obligations [Abstract]", "terseLabel": "Capital Lease Obligations [Abstract]" } } }, "localname": "CapitalLeaseObligationsAbstract", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.agilent.com/role/ShortTermDebtCreditFacilityAndCapitalLeaseDetails" ], "xbrltype": "stringItemType" }, "us-gaap_CapitalLeaseObligationsCurrent": { "auth_ref": [ "r22", "r595", "r596" ], "crdr": "credit", "lang": { "en-US": { "role": { "documentation": "Amount of capital lease obligation due within one year or the normal operating cycle, if longer.", "label": "Capital Lease Obligations, Current", "terseLabel": "Capital Lease Obligations, Current" } } }, "localname": "CapitalLeaseObligationsCurrent", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.agilent.com/role/ShortTermDebtCreditFacilityAndCapitalLeaseDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_CapitalLeaseObligationsNoncurrent": { "auth_ref": [ "r60", "r595", "r596" ], "crdr": "credit", "lang": { "en-US": { "role": { "documentation": "Amount equal to the present value (the principal) at the beginning of the lease term of minimum lease payments during the lease term (excluding that portion of the payments representing executory costs such as insurance, maintenance, and taxes to be paid by the lessor, together with any profit thereon) net of payments or other amounts applied to the principal, through the balance sheet date and due to be paid more than one year (or one operating cycle, if longer) after the balance sheet date.", "label": "Capital Lease Obligations, Noncurrent", "terseLabel": "Capital Lease Obligations, Noncurrent" } } }, "localname": "CapitalLeaseObligationsNoncurrent", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.agilent.com/role/LongTermDebtLongTermDebtOtherDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_CapitalizedComputerSoftwareGross": { "auth_ref": [ "r656" ], "calculation": { "http://www.agilent.com/role/PropertyPlantAndEquipmentNetDetails": { "order": 4.0, "parentTag": "us-gaap_PropertyPlantAndEquipmentGross", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-US": { "role": { "documentation": "Amount before accumulated amortization of capitalized costs for computer software, including but not limited to, acquired and internally developed computer software.", "label": "Capitalized Computer Software, Gross", "terseLabel": "Software" } } }, "localname": "CapitalizedComputerSoftwareGross", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.agilent.com/role/PropertyPlantAndEquipmentNetDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_CashAndCashEquivalentsAbstract": { "auth_ref": [], "lang": { "en-US": { "role": { "label": "Cash and Cash Equivalents [Abstract]", "terseLabel": "Cash and Cash Equivalents" } } }, "localname": "CashAndCashEquivalentsAbstract", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.agilent.com/role/OverviewAndSummaryOfSignificantAccountingPoliciesDetails" ], "xbrltype": "stringItemType" }, "us-gaap_CashAndCashEquivalentsAtCarryingValue": { "auth_ref": [ "r4", "r42", "r131" ], "calculation": { "http://www.agilent.com/role/ConsolidatedBalanceSheet": { "order": 1.0, "parentTag": "us-gaap_AssetsCurrent", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-US": { "role": { "documentation": "Amount of currency on hand as well as demand deposits with banks or financial institutions. Includes other kinds of accounts that have the general characteristics of demand deposits. Also includes short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates. Excludes cash and cash equivalents within disposal group and discontinued operation.", "label": "Cash and Cash Equivalents, at Carrying Value", "terseLabel": "Cash and cash equivalents", "verboseLabel": "Cash and cash equivalents" } } }, "localname": "CashAndCashEquivalentsAtCarryingValue", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.agilent.com/role/ConsolidatedBalanceSheet", "http://www.agilent.com/role/NewAccountingPronouncementsImpactOfAdoptingNewGuidanceDetails", "http://www.agilent.com/role/NewAccountingPronouncementsNewAccountingPronouncementsRestrictedCashDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_CashAndCashEquivalentsFairValueDisclosure": { "auth_ref": [], "calculation": { "http://www.agilent.com/role/FairValueMeasurementsFairValueOfAssetsAndLiabilitiesMeasuredOnRecurringBasisDetails": { "order": 1.0, "parentTag": "a_FairValueAssetsMeasuredOnRecurringBasisTotalAssets", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-US": { "role": { "documentation": "Fair value portion of currency on hand as well as demand deposits with banks or financial institutions. Includes other kinds of accounts that have the general characteristics of demand deposits. Also includes short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates.", "label": "Cash and Cash Equivalents, Fair Value Disclosure", "terseLabel": "Cash equivalents (money market funds)" } } }, "localname": "CashAndCashEquivalentsFairValueDisclosure", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.agilent.com/role/FairValueMeasurementsFairValueOfAssetsAndLiabilitiesMeasuredOnRecurringBasisDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_CashAndCashEquivalentsMember": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Currency on hand as well as demand deposits with banks or financial institutions. Includes other kinds of accounts that have the general characteristics of demand deposits. Also includes short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates.", "label": "Cash and Cash Equivalents [Member]", "terseLabel": "Cash and Cash Equivalents" } } }, "localname": "CashAndCashEquivalentsMember", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.agilent.com/role/RetirementPlansAndPostRetirementPensionPlansAssumptionsDetails", "http://www.agilent.com/role/RetirementPlansAndPostRetirementPensionPlansFairValueOfPlanAssetsDetails", "http://www.agilent.com/role/RetirementPlansAndPostRetirementPensionPlansRetirementPlansAndPostRetirementPensionPlansTargetAllocationsDetails" ], "xbrltype": "domainItemType" }, "us-gaap_CashAndCashEquivalentsPolicyTextBlock": { "auth_ref": [ "r15", "r132", "r137" ], "lang": { "en-US": { "role": { "documentation": "Disclosure of accounting policy for cash and cash equivalents, including the policy for determining which items are treated as cash equivalents. Other information that may be disclosed includes (1) the nature of any restrictions on the entity's use of its cash and cash equivalents, (2) whether the entity's cash and cash equivalents are insured or expose the entity to credit risk, (3) the classification of any negative balance accounts (overdrafts), and (4) the carrying basis of cash equivalents (for example, at cost) and whether the carrying amount of cash equivalents approximates fair value.", "label": "Cash and Cash Equivalents, Policy [Policy Text Block]", "terseLabel": "Cash, cash equivalents and short term investments" } } }, "localname": "CashAndCashEquivalentsPolicyTextBlock", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.agilent.com/role/OverviewAndSummaryOfSignificantAccountingPoliciesPolicies" ], "xbrltype": "textBlockItemType" }, "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents": { "auth_ref": [ "r124", "r131", "r135" ], "crdr": "debit", "lang": { "en-US": { "role": { "documentation": "Amount of cash and cash equivalents, and cash and cash equivalents restricted to withdrawal or usage. Excludes amount for disposal group and discontinued operations. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits. Cash equivalents include, but are not limited to, short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates.", "label": "Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents", "periodEndLabel": "Cash, cash equivalents and restricted cash at end of year", "periodStartLabel": "Cash, cash equivalents and restricted cash at beginning of year", "terseLabel": "Cash, cash equivalents and restricted cash" } } }, "localname": "CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.agilent.com/role/ConsolidatedStatementOfCashFlows", "http://www.agilent.com/role/NewAccountingPronouncementsNewAccountingPronouncementsRestrictedCashDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect": { "auth_ref": [ "r124", "r577" ], "calculation": { "http://www.agilent.com/role/ConsolidatedStatementOfCashFlows": { "order": null, "parentTag": null, "root": true, "weight": null } }, "crdr": "debit", "lang": { "en-US": { "role": { "documentation": "Amount of increase (decrease) in cash, cash equivalents, and cash and cash equivalents restricted to withdrawal or usage; including effect from exchange rate change. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits. Cash equivalents include, but are not limited to, short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates.", "label": "Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect", "totalLabel": "Net increase (decrease) in cash, cash equivalents and restricted cash" } } }, "localname": "CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.agilent.com/role/ConsolidatedStatementOfCashFlows" ], "xbrltype": "monetaryItemType" }, "us-gaap_CashFlowHedgeGainLossToBeReclassifiedWithinTwelveMonths": { "auth_ref": [ "r555" ], "crdr": "credit", "lang": { "en-US": { "role": { "documentation": "The estimated net amount of existing gains or losses on cash flow hedges at the reporting date expected to be reclassified to earnings within the next 12 months.", "label": "Cash Flow Hedge Gain (Loss) to be Reclassified within Twelve Months", "terseLabel": "Cash Flow Hedge Gain (Loss) to be Reclassified within Twelve Months" } } }, "localname": "CashFlowHedgeGainLossToBeReclassifiedWithinTwelveMonths", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.agilent.com/role/DerivativesEffectOfDerivativeInstrumentsOnConsolidatedStatementOfOperationsDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_CashFlowHedgingMember": { "auth_ref": [ "r528" ], "lang": { "en-US": { "role": { "documentation": "Hedge of the exposure to variability in the cash flows of a recognized asset or liability, or of a forecasted transaction, that is attributable to a particular risk.", "label": "Cash Flow Hedging [Member]", "terseLabel": "Cash Flow Hedges" } } }, "localname": "CashFlowHedgingMember", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.agilent.com/role/DerivativesDetails", "http://www.agilent.com/role/DerivativesDisclosuresAndDerivativeInstrumentAggregatedNotionalAmountsByCurrencyAndDesignationsDetails", "http://www.agilent.com/role/DerivativesEffectOfDerivativeInstrumentsOnConsolidatedStatementOfOperationsDetails", "http://www.agilent.com/role/DerivativesFairValueOfDerivativeInstrumentsAndConsolidatedBalanceSheetLocationDetails", "http://www.agilent.com/role/LongTermDebtLongTermDebtOtherDetails" ], "xbrltype": "domainItemType" }, "us-gaap_ChangesInProjectedBenefitObligationsFairValueOfPlanAssetsAndFundedStatusOfPlanTableTextBlock": { "auth_ref": [ "r335" ], "lang": { "en-US": { "role": { "documentation": "Tabular disclosure of the change in the benefit obligation, fair value of plan assets, and funded status of pension plans or other employee benefit plans.", "label": "Changes in Projected Benefit Obligations, Fair Value of Plan Assets, and Funded Status of Plan [Table Text Block]", "terseLabel": "Schedule of Funded status of Defined Benefit and Post-Retirement Benefit plans" } } }, "localname": "ChangesInProjectedBenefitObligationsFairValueOfPlanAssetsAndFundedStatusOfPlanTableTextBlock", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.agilent.com/role/RetirementPlansAndPostRetirementPensionPlansTables" ], "xbrltype": "textBlockItemType" }, "us-gaap_ClassOfStockDomain": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Share of stock differentiated by the voting rights the holder receives. Examples include, but are not limited to, common stock, redeemable preferred stock, nonredeemable preferred stock, and convertible stock.", "label": "Class of Stock [Domain]", "terseLabel": "Class of Stock [Domain]" } } }, "localname": "ClassOfStockDomain", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.agilent.com/role/NewAccountingPronouncementsImpactOfAdoptingNewGuidanceDetails", "http://www.agilent.com/role/NewAccountingPronouncementsTextualsDetails", "http://www.agilent.com/role/StockholdersEquityStockholdersEquityDividendsDetails" ], "xbrltype": "domainItemType" }, "us-gaap_ClassOfStockLineItems": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.", "label": "Class of Stock [Line Items]", "terseLabel": "Class of Stock [Line Items]" } } }, "localname": "ClassOfStockLineItems", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.agilent.com/role/StockholdersEquityStockholdersEquityDividendsDetails" ], "xbrltype": "stringItemType" }, "us-gaap_CollectiveBargainingArrangementAxis": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Information by collective bargaining arrangement. A collective bargaining arrangement is a written, legally enforceable employment contract between management of an organization and its employees represented by a union.", "label": "Collective Bargaining Arrangement [Axis]", "terseLabel": "Collective Bargaining Arrangement [Axis]" } } }, "localname": "CollectiveBargainingArrangementAxis", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.agilent.com/role/RetirementPlansAndPostRetirementPensionPlansDefinedContributionDetails" ], "xbrltype": "stringItemType" }, "us-gaap_CollectiveBargainingArrangementDomain": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Names of collective bargaining arrangements. A collective bargaining arrangement is a written, legally enforceable employment contract between management of an organization and its employees represented by a union.", "label": "Collective Bargaining Arrangement [Domain]", "terseLabel": "Collective Bargaining Arrangement [Domain]" } } }, "localname": "CollectiveBargainingArrangementDomain", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.agilent.com/role/RetirementPlansAndPostRetirementPensionPlansDefinedContributionDetails" ], "xbrltype": "domainItemType" }, "us-gaap_CommitmentsAndContingencies": { "auth_ref": [ "r62", "r272", "r620", "r641" ], "calculation": { "http://www.agilent.com/role/ConsolidatedBalanceSheet": { "order": 6.0, "parentTag": "us-gaap_StockholdersEquity", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-US": { "role": { "documentation": "Represents the caption on the face of the balance sheet to indicate that the entity has entered into (1) purchase or supply arrangements that will require expending a portion of its resources to meet the terms thereof, and (2) is exposed to potential losses or, less frequently, gains, arising from (a) possible claims against a company's resources due to future performance under contract terms, and (b) possible losses or likely gains from uncertainties that will ultimately be resolved when one or more future events that are deemed likely to occur do occur or fail to occur.", "label": "Commitments and Contingencies", "terseLabel": "Commitments and contingencies (Note 16)" } } }, "localname": "CommitmentsAndContingencies", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.agilent.com/role/ConsolidatedBalanceSheet" ], "xbrltype": "monetaryItemType" }, "us-gaap_CommitmentsAndContingenciesDisclosureAbstract": { "auth_ref": [], "lang": { "en-US": { "role": { "label": "Commitments and Contingencies Disclosure [Abstract]" } } }, "localname": "CommitmentsAndContingenciesDisclosureAbstract", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "xbrltype": "stringItemType" }, "us-gaap_CommitmentsAndContingenciesDisclosureTextBlock": { "auth_ref": [ "r271", "r279" ], "lang": { "en-US": { "role": { "documentation": "The entire disclosure for commitments and contingencies.", "label": "Commitments and Contingencies Disclosure [Text Block]", "verboseLabel": "COMMITMENTS AND CONTINGENCIES" } } }, "localname": "CommitmentsAndContingenciesDisclosureTextBlock", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.agilent.com/role/CommitmentsAndContingencies" ], "xbrltype": "textBlockItemType" }, "us-gaap_CommonStockDividendsPerShareCashPaid": { "auth_ref": [ "r303" ], "lang": { "en-US": { "role": { "documentation": "Aggregate dividends paid during the period for each share of common stock outstanding.", "label": "Common Stock, Dividends, Per Share, Cash Paid", "terseLabel": "Aggregate cash dividends paid (per common share)" } } }, "localname": "CommonStockDividendsPerShareCashPaid", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.agilent.com/role/StockholdersEquityStockholdersEquityDividendsDetails" ], "xbrltype": "perShareItemType" }, "us-gaap_CommonStockDividendsPerShareDeclared": { "auth_ref": [ "r303" ], "lang": { "en-US": { "role": { "documentation": "Aggregate dividends declared during the period for each share of common stock outstanding.", "label": "Common Stock, Dividends, Per Share, Declared", "terseLabel": "Cash Dividends Declared (per common share)" } } }, "localname": "CommonStockDividendsPerShareDeclared", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.agilent.com/role/ConsolidatedStatementOfEquityParenthetical", "http://www.agilent.com/role/StockholdersEquityStockholdersEquityDividendsDetails" ], "xbrltype": "perShareItemType" }, "us-gaap_CommonStockMember": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Stock that is subordinate to all other stock of the issuer.", "label": "Common Stock [Member]", "terseLabel": "Common Stock" } } }, "localname": "CommonStockMember", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.agilent.com/role/ConsolidatedStatementOfEquity" ], "xbrltype": "domainItemType" }, "us-gaap_CommonStockParOrStatedValuePerShare": { "auth_ref": [ "r31" ], "lang": { "en-US": { "role": { "documentation": "Face amount or stated value per share of common stock.", "label": "Common Stock, Par or Stated Value Per Share", "terseLabel": "Common stock par value (in dollars per share)" } } }, "localname": "CommonStockParOrStatedValuePerShare", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.agilent.com/role/ConsolidatedBalanceSheetParenthetical" ], "xbrltype": "perShareItemType" }, "us-gaap_CommonStockSharesAuthorized": { "auth_ref": [ "r31" ], "lang": { "en-US": { "role": { "documentation": "The maximum number of common shares permitted to be issued by an entity's charter and bylaws.", "label": "Common Stock, Shares Authorized", "terseLabel": "Common stock shares authorized (in shares)" } } }, "localname": "CommonStockSharesAuthorized", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.agilent.com/role/ConsolidatedBalanceSheetParenthetical" ], "xbrltype": "sharesItemType" }, "us-gaap_CommonStockSharesIssued": { "auth_ref": [ "r31" ], "lang": { "en-US": { "role": { "documentation": "Total number of common shares of an entity that have been sold or granted to shareholders (includes common shares that were issued, repurchased and remain in the treasury). These shares represent capital invested by the firm's shareholders and owners, and may be all or only a portion of the number of shares authorized. Shares issued include shares outstanding and shares held in the treasury.", "label": "Common Stock, Shares, Issued", "terseLabel": "Common stock issued (in shares)" } } }, "localname": "CommonStockSharesIssued", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.agilent.com/role/ConsolidatedBalanceSheetParenthetical" ], "xbrltype": "sharesItemType" }, "us-gaap_CommonStockValue": { "auth_ref": [ "r31" ], "calculation": { "http://www.agilent.com/role/ConsolidatedBalanceSheet": { "order": 2.0, "parentTag": "us-gaap_StockholdersEquity", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-US": { "role": { "documentation": "Aggregate par or stated value of issued nonredeemable common stock (or common stock redeemable solely at the option of the issuer). This item includes treasury stock repurchased by the entity. Note: elements for number of nonredeemable common shares, par value and other disclosure concepts are in another section within stockholders' equity.", "label": "Common Stock, Value, Issued", "terseLabel": "Common stock; $0.01 par value; 2 billion shares authorized; 309 million shares at October 31, 2019 and 318 million shares at October 31, 2018 issued", "verboseLabel": "Common stock; $0.01 par value; 2 billion shares authorized; 318 million shares at October 31, 2018 issued" } } }, "localname": "CommonStockValue", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.agilent.com/role/ConsolidatedBalanceSheet", "http://www.agilent.com/role/NewAccountingPronouncementsImpactOfAdoptingNewGuidanceDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_CompensationAndRetirementDisclosureAbstract": { "auth_ref": [], "lang": { "en-US": { "role": { "label": "Retirement Benefits [Abstract]", "terseLabel": "Accumulated benefit obligation and fair value of plan assets" } } }, "localname": "CompensationAndRetirementDisclosureAbstract", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.agilent.com/role/RetirementPlansAndPostRetirementPensionPlansFairValueOfPlanAssetsDetails" ], "xbrltype": "stringItemType" }, "us-gaap_CompensationRelatedCostsPolicyTextBlock": { "auth_ref": [ "r136", "r400" ], "lang": { "en-US": { "role": { "documentation": "Disclosure of accounting policy for salaries, bonuses, incentive awards, postretirement and postemployment benefits granted to employees, including equity-based arrangements; discloses methodologies for measurement, and the bases for recognizing related assets and liabilities and recognizing and reporting compensation expense.", "label": "Compensation Related Costs, Policy [Policy Text Block]", "terseLabel": "Employee compensation and benefits" } } }, "localname": "CompensationRelatedCostsPolicyTextBlock", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.agilent.com/role/OverviewAndSummaryOfSignificantAccountingPoliciesPolicies" ], "xbrltype": "textBlockItemType" }, "us-gaap_ComponentsOfDeferredTaxAssetsAbstract": { "auth_ref": [], "lang": { "en-US": { "role": { "label": "Components of Deferred Tax Assets [Abstract]", "terseLabel": "Components of Deferred Tax Assets" } } }, "localname": "ComponentsOfDeferredTaxAssetsAbstract", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.agilent.com/role/IncomeTaxesIncomeTaxesDeferredTaxesAndOtherDetails" ], "xbrltype": "stringItemType" }, "us-gaap_ComponentsOfDeferredTaxLiabilitiesAbstract": { "auth_ref": [], "lang": { "en-US": { "role": { "label": "Components of Deferred Tax Liabilities [Abstract]", "terseLabel": "Components of Deferred Tax Liabilities" } } }, "localname": "ComponentsOfDeferredTaxLiabilitiesAbstract", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.agilent.com/role/IncomeTaxesIncomeTaxesDeferredTaxesAndOtherDetails" ], "xbrltype": "stringItemType" }, "us-gaap_ComponentsOfIncomeTaxExpenseBenefitContinuingOperationsAbstract": { "auth_ref": [], "lang": { "en-US": { "role": { "label": "Components of Income Tax Expense (Benefit), Continuing Operations [Abstract]", "terseLabel": "Provision (benefit) for income taxes" } } }, "localname": "ComponentsOfIncomeTaxExpenseBenefitContinuingOperationsAbstract", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.agilent.com/role/IncomeTaxesIncomeTaxesProvisionDetails" ], "xbrltype": "stringItemType" }, "us-gaap_ComprehensiveIncomeNetOfTax": { "auth_ref": [ "r96", "r98", "r99" ], "calculation": { "http://www.agilent.com/role/ConsolidatedStatementOfEquity": { "order": null, "parentTag": null, "root": true, "weight": null } }, "crdr": "credit", "lang": { "en-US": { "role": { "documentation": "Amount after tax of increase (decrease) in equity from transactions and other events and circumstances from net income and other comprehensive income, attributable to parent entity. Excludes changes in equity resulting from investments by owners and distributions to owners.", "label": "Comprehensive Income (Loss), Net of Tax, Attributable to Parent", "totalLabel": "Total comprehensive income" } } }, "localname": "ComprehensiveIncomeNetOfTax", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.agilent.com/role/ConsolidatedStatementOfEquity" ], "xbrltype": "monetaryItemType" }, "us-gaap_ComprehensiveIncomeNetOfTaxAbstract": { "auth_ref": [], "lang": { "en-US": { "role": { "label": "Comprehensive Income (Loss), Net of Tax, Attributable to Parent [Abstract]", "terseLabel": "Components of comprehensive income, net of tax:" } } }, "localname": "ComprehensiveIncomeNetOfTaxAbstract", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.agilent.com/role/ConsolidatedStatementOfEquity" ], "xbrltype": "stringItemType" }, "us-gaap_ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest": { "auth_ref": [ "r96", "r98", "r507", "r522" ], "calculation": { "http://www.agilent.com/role/ConsolidatedStatementOfComprehensiveIncome": { "order": null, "parentTag": null, "root": true, "weight": null } }, "crdr": "credit", "lang": { "en-US": { "role": { "documentation": "Amount after tax of increase (decrease) in equity from transactions and other events and circumstances from net income and other comprehensive income. Excludes changes in equity resulting from investments by owners and distributions to owners.", "label": "Comprehensive Income (Loss), Net of Tax, Including Portion Attributable to Noncontrolling Interest", "totalLabel": "Total comprehensive income" } } }, "localname": "ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.agilent.com/role/ConsolidatedStatementOfComprehensiveIncome" ], "xbrltype": "monetaryItemType" }, "us-gaap_ConcentrationRiskCreditRisk": { "auth_ref": [ "r177", "r628" ], "lang": { "en-US": { "role": { "documentation": "Disclosure of accounting policy for credit risk.", "label": "Concentration Risk, Credit Risk, Policy [Policy Text Block]", "terseLabel": "Concentration of credit risk" } } }, "localname": "ConcentrationRiskCreditRisk", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.agilent.com/role/OverviewAndSummaryOfSignificantAccountingPoliciesPolicies" ], "xbrltype": "textBlockItemType" }, "us-gaap_ConcentrationRiskCustomer": { "auth_ref": [ "r180", "r181", "r182" ], "lang": { "en-US": { "role": { "documentation": "Description of risks that arise due to the volume of business transacted with a particular customer. At a minimum, the description informs financial statement users of the general nature of the risk, but excludes \"Information about Major Customers\" that may be disclosed elsewhere (for instance, segment disclosures).", "label": "Concentration Risk, Customer", "terseLabel": "Percentage of revenue from a single customer" } } }, "localname": "ConcentrationRiskCustomer", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.agilent.com/role/SegmentInformationProfitabilityDetails" ], "xbrltype": "stringItemType" }, "us-gaap_ConsolidationPolicyTextBlock": { "auth_ref": [ "r137", "r509", "r523", "r524" ], "lang": { "en-US": { "role": { "documentation": "Disclosure of accounting policy regarding (1) the principles it follows in consolidating or combining the separate financial statements, including the principles followed in determining the inclusion or exclusion of subsidiaries or other entities in the consolidated or combined financial statements and (2) its treatment of interests (for example, common stock, a partnership interest or other means of exerting influence) in other entities, for example consolidation or use of the equity or cost methods of accounting. The accounting policy may also address the accounting treatment for intercompany accounts and transactions, noncontrolling interest, and the income statement treatment in consolidation for issuances of stock by a subsidiary.", "label": "Consolidation, Policy [Policy Text Block]", "terseLabel": "Principles of consolidation" } } }, "localname": "ConsolidationPolicyTextBlock", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.agilent.com/role/OverviewAndSummaryOfSignificantAccountingPoliciesPolicies" ], "xbrltype": "textBlockItemType" }, "us-gaap_ConsolidationVariableInterestEntityPolicy": { "auth_ref": [ "r137", "r514", "r516", "r518" ], "lang": { "en-US": { "role": { "documentation": "Disclosure of accounting policy for consolidation to describe the significant judgments and assumptions made in determining whether a variable interest held by the entity requires the variable interest entity to be consolidated and (or) disclose information about its involvement with the variable interest entity; the methodology used by the entity for determining whether or not it is the primary beneficiary of the variable interest entity; and the significant factors considered and judgments made in determining that the power to direct the activities that significantly impact the economic performance of the variable interest entity are shared (as defined).", "label": "Consolidation, Variable Interest Entity, Policy [Policy Text Block]", "terseLabel": "Variable interest entity" } } }, "localname": "ConsolidationVariableInterestEntityPolicy", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.agilent.com/role/OverviewAndSummaryOfSignificantAccountingPoliciesPolicies" ], "xbrltype": "textBlockItemType" }, "us-gaap_ContractWithCustomerAssetAndLiabilityTableTextBlock": { "auth_ref": [ "r312" ], "lang": { "en-US": { "role": { "documentation": "Tabular disclosure of contract balances and changes in contract balances.", "label": "Contract with Customer, Asset and Liability [Table Text Block]", "terseLabel": "Contract with Customer, Asset and Liability" } } }, "localname": "ContractWithCustomerAssetAndLiabilityTableTextBlock", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.agilent.com/role/RevenueRevenueTables" ], "xbrltype": "textBlockItemType" }, "us-gaap_ContractWithCustomerAssetNet": { "auth_ref": [ "r308", "r310", "r316" ], "crdr": "debit", "lang": { "en-US": { "role": { "documentation": "Amount, after allowance for credit loss, of right to consideration in exchange for good or service transferred to customer when right is conditioned on something other than passage of time.", "label": "Contract with Customer, Asset, after Allowance for Credit Loss", "terseLabel": "Contract with Customer, Asset, after Allowance for Credit Loss" } } }, "localname": "ContractWithCustomerAssetNet", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.agilent.com/role/RevenueRevenueContractBalancesDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_ContractWithCustomerLiability": { "auth_ref": [ "r308", "r309", "r316" ], "crdr": "credit", "lang": { "en-US": { "role": { "documentation": "Amount of obligation to transfer good or service to customer for which consideration has been received or is receivable.", "label": "Contract with Customer, Liability", "periodEndLabel": "Contract Liability ending balance as of October 31, 2019", "periodStartLabel": "Contract Liability ending balance as of October 31, 2018" } } }, "localname": "ContractWithCustomerLiability", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.agilent.com/role/RevenueRevenueContractBalancesDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_ContractWithCustomerLiabilityIncreaseDecreaseForContractAcquiredInBusinessCombination": { "auth_ref": [ "r311" ], "crdr": "credit", "lang": { "en-US": { "role": { "documentation": "Amount of increase (decrease) in obligation to transfer good or service to customer for which consideration from customer has been received or is due, from business combination.", "label": "Contract with Customer, Liability, Increase (Decrease) for Contract Acquired in Business Combination", "terseLabel": "Contract with Customer, Liability, Increase (Decrease) for Contract Acquired in Business Combination" } } }, "localname": "ContractWithCustomerLiabilityIncreaseDecreaseForContractAcquiredInBusinessCombination", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.agilent.com/role/RevenueRevenueContractBalancesDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_ContractWithCustomerLiabilityRevenueRecognized": { "auth_ref": [ "r317" ], "crdr": "credit", "lang": { "en-US": { "role": { "documentation": "Amount of revenue recognized that was previously included in balance of obligation to transfer good or service to customer for which consideration from customer has been received or is due.", "label": "Contract with Customer, Liability, Revenue Recognized", "terseLabel": "Contract with Customer, Liability, Revenue Recognized" } } }, "localname": "ContractWithCustomerLiabilityRevenueRecognized", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.agilent.com/role/RevenueRevenueContractBalancesDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_CostMethodInvestmentsOriginalCost": { "auth_ref": [], "crdr": "debit", "lang": { "en-US": { "role": { "documentation": "Original amount of cost-method investments at the acquisition date.", "label": "Cost Method Investments, Original Cost", "terseLabel": "Cost method investments, original cost" } } }, "localname": "CostMethodInvestmentsOriginalCost", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.agilent.com/role/OverviewAndSummaryOfSignificantAccountingPoliciesDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_CostOfGoodsAndServicesSold": { "auth_ref": [ "r106" ], "calculation": { "http://www.agilent.com/role/ConsolidatedStatementOfOperations": { "order": 1.0, "parentTag": "us-gaap_CostsAndExpenses", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-US": { "role": { "documentation": "The aggregate costs related to goods produced and sold and services rendered by an entity during the reporting period. This excludes costs incurred during the reporting period related to financial services rendered and other revenue generating activities.", "label": "Cost of Goods and Services Sold", "terseLabel": "Cost of revenue" } } }, "localname": "CostOfGoodsAndServicesSold", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.agilent.com/role/ConsolidatedStatementOfOperations" ], "xbrltype": "monetaryItemType" }, "us-gaap_CostOfSalesMember": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Primary financial statement caption encompassing cost of sales.", "label": "Cost of Sales [Member]", "terseLabel": "Cost of Product and Services", "verboseLabel": "Cost of Sales [Member]" } } }, "localname": "CostOfSalesMember", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.agilent.com/role/DerivativesEffectOfDerivativeInstrumentsOnConsolidatedStatementOfOperationsDetails", "http://www.agilent.com/role/ShareBasedCompensationAllocatedShareBasedCompensationExpenseDetails" ], "xbrltype": "domainItemType" }, "us-gaap_CostsAndExpenses": { "auth_ref": [ "r104" ], "calculation": { "http://www.agilent.com/role/ConsolidatedStatementOfOperations": { "order": 2.0, "parentTag": "us-gaap_OperatingIncomeLoss", "weight": -1.0 } }, "crdr": "debit", "lang": { "en-US": { "role": { "documentation": "Total costs of sales and operating expenses for the period.", "label": "Costs and Expenses", "totalLabel": "Total costs and expenses" } } }, "localname": "CostsAndExpenses", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.agilent.com/role/ConsolidatedStatementOfOperations" ], "xbrltype": "monetaryItemType" }, "us-gaap_CreditFacilityAxis": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Information by type of credit facility. Credit facilities provide capital to borrowers without the need to structure a loan for each borrowing.", "label": "Credit Facility [Axis]", "terseLabel": "Credit Facility [Axis]" } } }, "localname": "CreditFacilityAxis", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.agilent.com/role/ShortTermDebtCreditFacilityAndCapitalLeaseDetails" ], "xbrltype": "stringItemType" }, "us-gaap_CreditFacilityDomain": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Type of credit facility. Credit facilities provide capital to borrowers without the need to structure a loan for each borrowing.", "label": "Credit Facility [Domain]", "terseLabel": "Credit Faciity [Domain]" } } }, "localname": "CreditFacilityDomain", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.agilent.com/role/ShortTermDebtCreditFacilityAndCapitalLeaseDetails" ], "xbrltype": "domainItemType" }, "us-gaap_CumulativeEffectOfNewAccountingPrincipleInPeriodOfAdoption": { "auth_ref": [], "crdr": "credit", "lang": { "en-US": { "role": { "documentation": "Amount after tax of increase (decrease) to equity or (increase) decrease to net assets, resulting from the cumulative effect adjustment of a new accounting principle applied in the period of adoption.", "label": "Cumulative Effect of New Accounting Principle in Period of Adoption", "terseLabel": "Adjustment due to adoption of ASU 2019-09" } } }, "localname": "CumulativeEffectOfNewAccountingPrincipleInPeriodOfAdoption", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.agilent.com/role/ConsolidatedStatementOfEquity" ], "xbrltype": "monetaryItemType" }, "us-gaap_CurrentFederalTaxExpenseBenefit": { "auth_ref": [ "r142", "r473", "r477" ], "calculation": { "http://www.agilent.com/role/IncomeTaxesIncomeTaxesProvisionDetails": { "order": 1.0, "parentTag": "us-gaap_IncomeTaxExpenseBenefit", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-US": { "role": { "documentation": "Amount of current federal tax expense (benefit) pertaining to income (loss) from continuing operations.", "label": "Current Federal Tax Expense (Benefit)", "terseLabel": "U.S. federal taxes - current" } } }, "localname": "CurrentFederalTaxExpenseBenefit", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.agilent.com/role/IncomeTaxesIncomeTaxesProvisionDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_CurrentForeignTaxExpenseBenefit": { "auth_ref": [ "r149", "r475" ], "calculation": { "http://www.agilent.com/role/IncomeTaxesIncomeTaxesProvisionDetails": { "order": 3.0, "parentTag": "us-gaap_IncomeTaxExpenseBenefit", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-US": { "role": { "documentation": "Amount of current foreign income tax expense (benefit) pertaining to income (loss) from continuing operations.", "label": "Current Foreign Tax Expense (Benefit)", "terseLabel": "Non-U.S. taxes - current" } } }, "localname": "CurrentForeignTaxExpenseBenefit", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.agilent.com/role/IncomeTaxesIncomeTaxesProvisionDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_CurrentStateAndLocalTaxExpenseBenefit": { "auth_ref": [ "r142", "r473", "r477" ], "calculation": { "http://www.agilent.com/role/IncomeTaxesIncomeTaxesProvisionDetails": { "order": 5.0, "parentTag": "us-gaap_IncomeTaxExpenseBenefit", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-US": { "role": { "documentation": "Amount of current state and local tax expense (benefit) pertaining to income (loss) from continuing operations.", "label": "Current State and Local Tax Expense (Benefit)", "terseLabel": "State taxes, net of federal benefit - current" } } }, "localname": "CurrentStateAndLocalTaxExpenseBenefit", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.agilent.com/role/IncomeTaxesIncomeTaxesProvisionDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_CustomerRelationshipsMember": { "auth_ref": [ "r496" ], "lang": { "en-US": { "role": { "documentation": "Customer relationship that exists between an entity and its customer, for example, but not limited to, tenant relationships.", "label": "Customer Relationships [Member]", "terseLabel": "Customer Relationships", "verboseLabel": "Customer relationships" } } }, "localname": "CustomerRelationshipsMember", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.agilent.com/role/AcquisitionsAcquisitionsIntangibleAssetsDetails", "http://www.agilent.com/role/GoodwillAndOtherIntangibleAssetsDisclosuresAndComponentsOfOtherIntangiblesDetails" ], "xbrltype": "domainItemType" }, "us-gaap_DebtDisclosureAbstract": { "auth_ref": [], "lang": { "en-US": { "role": { "label": "Debt Disclosure [Abstract]" } } }, "localname": "DebtDisclosureAbstract", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "xbrltype": "stringItemType" }, "us-gaap_DebtInstrumentAxis": { "auth_ref": [ "r22", "r24", "r25", "r611", "r614", "r630" ], "lang": { "en-US": { "role": { "documentation": "Information by type of debt instrument, including, but not limited to, draws against credit facilities.", "label": "Debt Instrument [Axis]", "terseLabel": "Debt Instrument [Axis]" } } }, "localname": "DebtInstrumentAxis", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.agilent.com/role/DerivativesDetails", "http://www.agilent.com/role/LongTermDebtCarryingValueDetails", "http://www.agilent.com/role/LongTermDebtSeniorNotesDetails", "http://www.agilent.com/role/ShortTermDebtCreditFacilityAndCapitalLeaseDetails", "http://www.agilent.com/role/ShortTermDebtSeniorNotesDetails" ], "xbrltype": "stringItemType" }, "us-gaap_DebtInstrumentCarryingAmount": { "auth_ref": [ "r25", "r289", "r614", "r630" ], "crdr": "credit", "lang": { "en-US": { "role": { "documentation": "Amount, before unamortized (discount) premium and debt issuance costs, of long-term debt. Includes, but is not limited to, notes payable, bonds payable, commercial loans, mortgage loans, convertible debt, subordinated debt and other types of debt.", "label": "Long-term Debt, Gross", "terseLabel": "Long-term Debt, Gross" } } }, "localname": "DebtInstrumentCarryingAmount", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.agilent.com/role/LongTermDebtCarryingValueDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_DebtInstrumentDateOfFirstRequiredPayment1": { "auth_ref": [ "r60", "r625" ], "lang": { "en-US": { "role": { "documentation": "Date the debt agreement requires the first payment to be made, in CCYY-MM-DD format.", "label": "Debt Instrument, Date of First Required Payment", "terseLabel": "Date payments commenced" } } }, "localname": "DebtInstrumentDateOfFirstRequiredPayment1", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.agilent.com/role/LongTermDebtSeniorNotesDetails" ], "xbrltype": "dateItemType" }, "us-gaap_DebtInstrumentFaceAmount": { "auth_ref": [ "r588", "r590" ], "crdr": "credit", "lang": { "en-US": { "role": { "documentation": "Face (par) amount of debt instrument at time of issuance.", "label": "Debt Instrument, Face Amount", "terseLabel": "Debt Instrument, Face Amount", "verboseLabel": "Aggregate face amount of debt" } } }, "localname": "DebtInstrumentFaceAmount", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.agilent.com/role/DerivativesDetails", "http://www.agilent.com/role/LongTermDebtLongTermDebtOtherDetails", "http://www.agilent.com/role/LongTermDebtSeniorNotesDetails", "http://www.agilent.com/role/ShortTermDebtSeniorNotesDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_DebtInstrumentFrequencyOfPeriodicPayment": { "auth_ref": [ "r60", "r625" ], "lang": { "en-US": { "role": { "documentation": "Description of the frequency of periodic payments (monthly, quarterly, annual).", "label": "Debt Instrument, Frequency of Periodic Payment", "verboseLabel": "Interest payment frequency" } } }, "localname": "DebtInstrumentFrequencyOfPeriodicPayment", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.agilent.com/role/LongTermDebtSeniorNotesDetails" ], "xbrltype": "stringItemType" }, "us-gaap_DebtInstrumentIncreaseAccruedInterest": { "auth_ref": [ "r145" ], "crdr": "credit", "lang": { "en-US": { "role": { "documentation": "Increase for accrued, but unpaid interest on the debt instrument for the period.", "label": "Debt Instrument, Increase, Accrued Interest", "terseLabel": "Debt Instrument, Increase, Accrued Interest" } } }, "localname": "DebtInstrumentIncreaseAccruedInterest", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.agilent.com/role/ShortTermDebtSeniorNotesDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_DebtInstrumentInterestRateStatedPercentage": { "auth_ref": [ "r57" ], "lang": { "en-US": { "role": { "documentation": "Contractual interest rate for funds borrowed, under the debt agreement.", "label": "Debt Instrument, Interest Rate, Stated Percentage", "terseLabel": "Fixed interest rate per annum (in hundredths)" } } }, "localname": "DebtInstrumentInterestRateStatedPercentage", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.agilent.com/role/LongTermDebtSeniorNotesDetails", "http://www.agilent.com/role/ShortTermDebtSeniorNotesDetails" ], "xbrltype": "percentItemType" }, "us-gaap_DebtInstrumentIssuanceDate1": { "auth_ref": [ "r59" ], "lang": { "en-US": { "role": { "documentation": "Date the debt instrument was issued, in CCYY-MM-DD format.", "label": "Debt Instrument, Issuance Date", "terseLabel": "Issuance date of debt" } } }, "localname": "DebtInstrumentIssuanceDate1", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.agilent.com/role/LongTermDebtSeniorNotesDetails", "http://www.agilent.com/role/ShortTermDebtSeniorNotesDetails" ], "xbrltype": "dateItemType" }, "us-gaap_DebtInstrumentLineItems": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.", "label": "Debt Instrument [Line Items]", "terseLabel": "Debt Instrument [Line Items]" } } }, "localname": "DebtInstrumentLineItems", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.agilent.com/role/LongTermDebtCarryingValueDetails", "http://www.agilent.com/role/LongTermDebtLongTermDebtOtherDetails", "http://www.agilent.com/role/LongTermDebtSeniorNotesDetails" ], "xbrltype": "stringItemType" }, "us-gaap_DebtInstrumentMaturityDate": { "auth_ref": [ "r58", "r563" ], "lang": { "en-US": { "role": { "documentation": "Date when the debt instrument is scheduled to be fully repaid, in CCYY-MM-DD format.", "label": "Debt Instrument, Maturity Date", "terseLabel": "Maturity date" } } }, "localname": "DebtInstrumentMaturityDate", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.agilent.com/role/LongTermDebtSeniorNotesDetails", "http://www.agilent.com/role/ShortTermDebtSeniorNotesDetails" ], "xbrltype": "dateItemType" }, "us-gaap_DebtInstrumentNameDomain": { "auth_ref": [ "r60" ], "lang": { "en-US": { "role": { "documentation": "The name for the particular debt instrument or borrowing that distinguishes it from other debt instruments or borrowings, including draws against credit facilities.", "label": "Debt Instrument, Name [Domain]", "terseLabel": "Debt Instrument, Name [Domain]" } } }, "localname": "DebtInstrumentNameDomain", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.agilent.com/role/DerivativesDetails", "http://www.agilent.com/role/LongTermDebtCarryingValueDetails", "http://www.agilent.com/role/LongTermDebtSeniorNotesDetails", "http://www.agilent.com/role/ShortTermDebtCreditFacilityAndCapitalLeaseDetails", "http://www.agilent.com/role/ShortTermDebtSeniorNotesDetails" ], "xbrltype": "domainItemType" }, "us-gaap_DebtInstrumentRedemptionPeriodAxis": { "auth_ref": [ "r626" ], "lang": { "en-US": { "role": { "documentation": "Information about timing of debt redemption features under terms of the debt agreement.", "label": "Debt Instrument, Redemption, Period [Axis]", "terseLabel": "Debt Instrument, Redemption, Period [Axis]" } } }, "localname": "DebtInstrumentRedemptionPeriodAxis", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.agilent.com/role/LongTermDebtCarryingValueDetails", "http://www.agilent.com/role/LongTermDebtLongTermDebtOtherDetails" ], "xbrltype": "stringItemType" }, "us-gaap_DebtInstrumentRedemptionPeriodDomain": { "auth_ref": [ "r626" ], "lang": { "en-US": { "role": { "documentation": "Period as defined under terms of the debt agreement for debt redemption features.", "label": "Debt Instrument, Redemption, Period [Domain]", "terseLabel": "Debt Instrument, Redemption, Period [Domain]" } } }, "localname": "DebtInstrumentRedemptionPeriodDomain", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.agilent.com/role/LongTermDebtCarryingValueDetails", "http://www.agilent.com/role/LongTermDebtLongTermDebtOtherDetails" ], "xbrltype": "domainItemType" }, "us-gaap_DebtInstrumentRedemptionPeriodEndDate": { "auth_ref": [ "r626" ], "lang": { "en-US": { "role": { "documentation": "End date of debt instrument redemption period, in CCYY-MM-DD format.", "label": "Debt Instrument, Redemption Period, End Date", "terseLabel": "Debt Instrument, Redemption Period, End Date" } } }, "localname": "DebtInstrumentRedemptionPeriodEndDate", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.agilent.com/role/ShortTermDebtSeniorNotesDetails" ], "xbrltype": "dateItemType" }, "us-gaap_DebtInstrumentRedemptionPeriodStartDate": { "auth_ref": [ "r626" ], "lang": { "en-US": { "role": { "documentation": "Start date of debt instrument redemption period, in CCYY-MM-DD format.", "label": "Debt Instrument, Redemption Period, Start Date", "terseLabel": "Debt Instrument, Redemption Period, Start Date" } } }, "localname": "DebtInstrumentRedemptionPeriodStartDate", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.agilent.com/role/ShortTermDebtSeniorNotesDetails" ], "xbrltype": "dateItemType" }, "us-gaap_DebtInstrumentTable": { "auth_ref": [ "r60", "r144", "r297", "r300", "r301", "r302", "r587", "r588", "r590", "r627" ], "lang": { "en-US": { "role": { "documentation": "A table or schedule providing information pertaining to long-term debt instruments or arrangements, including identification, terms, features, collateral requirements and other information necessary to a fair presentation. These are debt arrangements that originally required repayment more than twelve months after issuance or greater than the normal operating cycle of the company, if longer.", "label": "Schedule of Long-term Debt Instruments [Table]", "terseLabel": "Schedule of Long-term Debt Instruments [Table]" } } }, "localname": "DebtInstrumentTable", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.agilent.com/role/LongTermDebtCarryingValueDetails", "http://www.agilent.com/role/LongTermDebtLongTermDebtOtherDetails", "http://www.agilent.com/role/LongTermDebtSeniorNotesDetails" ], "xbrltype": "stringItemType" }, "us-gaap_DeferredBonusAndProfitSharingArrangementIndividualContractTypeOfDeferredCompensationDomain": { "auth_ref": [ "r322", "r323" ], "lang": { "en-US": { "role": { "documentation": "Deferred compensation that is not equivalent to a defined benefit pension plan or a defined benefit other postretirement benefit plan. Includes, but is not limited to, employment contracts with one or more selected officers or key employees. Excludes equity-based compensation plans, defined benefit pension plans and defined benefit other postretirement benefit plans.", "label": "Deferred Bonus and Profit Sharing Arrangement, Individual Contract, Type of Deferred Compensation [Domain]", "terseLabel": "Deferred Bonus and Profit Sharing Arrangement, Individual Contract, Type of Deferred Compensation [Domain]" } } }, "localname": "DeferredBonusAndProfitSharingArrangementIndividualContractTypeOfDeferredCompensationDomain", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.agilent.com/role/RetirementPlansAndPostRetiementPensionPlansDeferredProfitSharingPlanDetails", "http://www.agilent.com/role/RetirementPlansAndPostRetirementPensionPlansDefinedContributionDetails", "http://www.agilent.com/role/RetirementPlansAndPostRetirementPensionPlansRetirementPlansAndPostRetirementPensionPlansTargetAllocationsDetails" ], "xbrltype": "domainItemType" }, "us-gaap_DeferredCompensationArrangementWithIndividualExcludingShareBasedPaymentsAndPostretirementBenefitsByTypeOfDeferredCompensationAxis": { "auth_ref": [ "r322", "r323" ], "lang": { "en-US": { "role": { "documentation": "Information by type of deferred compensation that is not equivalent to a defined benefit pension plan or a defined benefit other postretirement benefit plan. Includes, but is not limited to, employment contracts with one or more selected officers or key employees. Excludes equity-based compensation plans, defined benefit pension plans and defined benefit other postretirement benefit plans.", "label": "Deferred Bonus and Profit Sharing Arrangements, Individual Contracts, Type of Deferred Compensation [Axis]", "terseLabel": "Deferred Bonus and Profit Sharing Arrangements, Individual Contracts, Type of Deferred Compensation [Axis]" } } }, "localname": "DeferredCompensationArrangementWithIndividualExcludingShareBasedPaymentsAndPostretirementBenefitsByTypeOfDeferredCompensationAxis", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.agilent.com/role/RetirementPlansAndPostRetiementPensionPlansDeferredProfitSharingPlanDetails", "http://www.agilent.com/role/RetirementPlansAndPostRetirementPensionPlansDefinedContributionDetails", "http://www.agilent.com/role/RetirementPlansAndPostRetirementPensionPlansRetirementPlansAndPostRetirementPensionPlansTargetAllocationsDetails" ], "xbrltype": "stringItemType" }, "us-gaap_DeferredFederalIncomeTaxExpenseBenefit": { "auth_ref": [ "r142", "r474", "r477" ], "calculation": { "http://www.agilent.com/role/IncomeTaxesIncomeTaxesProvisionDetails": { "order": 2.0, "parentTag": "us-gaap_IncomeTaxExpenseBenefit", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-US": { "role": { "documentation": "Amount of deferred federal income tax expense (benefit) pertaining to income (loss) from continuing operations.", "label": "Deferred Federal Income Tax Expense (Benefit)", "terseLabel": "U.S. federal taxes - deferred" } } }, "localname": "DeferredFederalIncomeTaxExpenseBenefit", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.agilent.com/role/IncomeTaxesIncomeTaxesProvisionDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_DeferredForeignIncomeTaxExpenseBenefit": { "auth_ref": [ "r142", "r474", "r477" ], "calculation": { "http://www.agilent.com/role/IncomeTaxesIncomeTaxesProvisionDetails": { "order": 4.0, "parentTag": "us-gaap_IncomeTaxExpenseBenefit", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-US": { "role": { "documentation": "Amount of deferred foreign income tax expense (benefit) pertaining to income (loss) from continuing operations.", "label": "Deferred Foreign Income Tax Expense (Benefit)", "terseLabel": "Non-U.S. taxes - deferred" } } }, "localname": "DeferredForeignIncomeTaxExpenseBenefit", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.agilent.com/role/IncomeTaxesIncomeTaxesProvisionDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_DeferredIncomeTaxExpenseBenefit": { "auth_ref": [ "r129", "r142", "r474", "r477" ], "calculation": { "http://www.agilent.com/role/ConsolidatedStatementOfCashFlows": { "order": 3.0, "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-US": { "role": { "documentation": "Amount of deferred income tax expense (benefit) pertaining to income (loss) from continuing operations.", "label": "Deferred Income Tax Expense (Benefit)", "terseLabel": "Deferred taxes", "verboseLabel": "Deferred Income Tax Expense (Benefit)" } } }, "localname": "DeferredIncomeTaxExpenseBenefit", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.agilent.com/role/ConsolidatedStatementOfCashFlows", "http://www.agilent.com/role/IncomeTaxesIncomeTaxesProvisionDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_DeferredIncomeTaxLiabilities": { "auth_ref": [ "r27", "r28", "r463", "r613", "r629" ], "calculation": { "http://www.agilent.com/role/IncomeTaxesIncomeTaxesDeferredTaxesAndOtherDetails": { "order": null, "parentTag": null, "root": true, "weight": null } }, "crdr": "credit", "lang": { "en-US": { "role": { "documentation": "Amount of deferred tax liability attributable to taxable temporary differences.", "label": "Deferred Tax Liabilities, Gross", "negatedTotalLabel": "Subtotal" } } }, "localname": "DeferredIncomeTaxLiabilities", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.agilent.com/role/IncomeTaxesIncomeTaxesDeferredTaxesAndOtherDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_DeferredProfitSharingMember": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "An arrangement whereby an employee is entitled to receive in the future, subject to vesting and other restrictions, a share in the profits, as defined in the agreement, of the entity or portion thereof. Employer contributions may be discretionary or may be based on a fixed formula related to profits, compensation, or other factors. It is a form of incentive compensation to employees in addition to their regular salary and bonuses.", "label": "Deferred Profit Sharing [Member]", "terseLabel": "Deferred Profit Sharing [Member]" } } }, "localname": "DeferredProfitSharingMember", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.agilent.com/role/RetirementPlansAndPostRetiementPensionPlansDeferredProfitSharingPlanDetails", "http://www.agilent.com/role/RetirementPlansAndPostRetirementPensionPlansDefinedContributionDetails", "http://www.agilent.com/role/RetirementPlansAndPostRetirementPensionPlansRetirementPlansAndPostRetirementPensionPlansTargetAllocationsDetails" ], "xbrltype": "domainItemType" }, "us-gaap_DeferredRevenueCurrent": { "auth_ref": [ "r38" ], "calculation": { "http://www.agilent.com/role/ConsolidatedBalanceSheet": { "order": 3.0, "parentTag": "us-gaap_LiabilitiesCurrent", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-US": { "role": { "documentation": "Amount of deferred income and obligation to transfer product and service to customer for which consideration has been received or is receivable, classified as current.", "label": "Deferred Revenue, Current", "terseLabel": "Deferred revenue", "verboseLabel": "Deferred revenue" } } }, "localname": "DeferredRevenueCurrent", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.agilent.com/role/ConsolidatedBalanceSheet", "http://www.agilent.com/role/NewAccountingPronouncementsImpactOfAdoptingNewGuidanceDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_DeferredRevenuePeriodIncreaseDecrease": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Amount of increase (decrease) in deferred revenue.", "label": "Deferred Revenue, Period Increase (Decrease)", "terseLabel": "Deferred Revenue, Period Increase (Decrease)" } } }, "localname": "DeferredRevenuePeriodIncreaseDecrease", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.agilent.com/role/RevenueRevenueContractBalancesDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_DeferredStateAndLocalIncomeTaxExpenseBenefit": { "auth_ref": [ "r142", "r474", "r477" ], "calculation": { "http://www.agilent.com/role/IncomeTaxesIncomeTaxesProvisionDetails": { "order": 6.0, "parentTag": "us-gaap_IncomeTaxExpenseBenefit", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-US": { "role": { "documentation": "Amount of deferred state and local tax expense (benefit) pertaining to income (loss) from continuing operations.", "label": "Deferred State and Local Income Tax Expense (Benefit)", "terseLabel": "State taxes, net of federal benefit - deferred" } } }, "localname": "DeferredStateAndLocalIncomeTaxExpenseBenefit", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.agilent.com/role/IncomeTaxesIncomeTaxesProvisionDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_DeferredTaxAssetsCapitalLossCarryforwards": { "auth_ref": [ "r436", "r471", "r472" ], "crdr": "debit", "lang": { "en-US": { "role": { "documentation": "Amount before allocation of valuation allowances of deferred tax asset attributable to deductible capital loss carryforwards.", "label": "Deferred Tax Assets, Capital Loss Carryforwards", "terseLabel": "Capital loss carryforwards" } } }, "localname": "DeferredTaxAssetsCapitalLossCarryforwards", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.agilent.com/role/IncomeTaxesCarryforwardsDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_DeferredTaxAssetsDeferredIncome": { "auth_ref": [ "r436", "r471", "r472" ], "calculation": { "http://www.agilent.com/role/IncomeTaxesIncomeTaxesDeferredTaxesAndOtherDetails": { "order": 8.0, "parentTag": "us-gaap_DeferredTaxAssetsGross", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-US": { "role": { "documentation": "Amount before allocation of valuation allowances of deferred tax asset attributable to deductible temporary differences from deferred income.", "label": "Deferred Tax Assets, Deferred Income", "verboseLabel": "Deferred revenue" } } }, "localname": "DeferredTaxAssetsDeferredIncome", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.agilent.com/role/IncomeTaxesIncomeTaxesDeferredTaxesAndOtherDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_DeferredTaxAssetsGoodwillAndIntangibleAssets": { "auth_ref": [], "calculation": { "http://www.agilent.com/role/IncomeTaxesIncomeTaxesDeferredTaxesAndOtherDetails": { "order": 1.0, "parentTag": "us-gaap_DeferredTaxAssetsGross", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-US": { "role": { "documentation": "Amount before allocation of valuation allowances of deferred tax asset attributable to deductible temporary differences from intangible assets including goodwill.", "label": "Deferred Tax Assets, Goodwill and Intangible Assets", "terseLabel": "Intangibles" } } }, "localname": "DeferredTaxAssetsGoodwillAndIntangibleAssets", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.agilent.com/role/IncomeTaxesIncomeTaxesDeferredTaxesAndOtherDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_DeferredTaxAssetsGross": { "auth_ref": [ "r464" ], "calculation": { "http://www.agilent.com/role/IncomeTaxesIncomeTaxesDeferredTaxesAndOtherDetails": { "order": 1.0, "parentTag": "us-gaap_DeferredTaxAssetsNet", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-US": { "role": { "documentation": "Amount before allocation of valuation allowances of deferred tax asset attributable to deductible temporary differences and carryforwards.", "label": "Deferred Tax Assets, Gross", "totalLabel": "Subtotal" } } }, "localname": "DeferredTaxAssetsGross", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.agilent.com/role/IncomeTaxesIncomeTaxesDeferredTaxesAndOtherDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_DeferredTaxAssetsLiabilitiesNet": { "auth_ref": [ "r467" ], "calculation": { "http://www.agilent.com/role/IncomeTaxesIncomeTaxesDeferredTaxesAndOtherDetails": { "order": null, "parentTag": null, "root": true, "weight": null } }, "crdr": "debit", "lang": { "en-US": { "role": { "documentation": "Amount, after allocation of valuation allowances and deferred tax liability, of deferred tax asset attributable to deductible differences and carryforwards, without jurisdictional netting.", "label": "Deferred Tax Assets, Net", "totalLabel": "Total" } } }, "localname": "DeferredTaxAssetsLiabilitiesNet", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.agilent.com/role/IncomeTaxesIncomeTaxesDeferredTaxesAndOtherDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_DeferredTaxAssetsNet": { "auth_ref": [ "r465" ], "calculation": { "http://www.agilent.com/role/IncomeTaxesIncomeTaxesDeferredTaxesAndOtherDetails": { "order": null, "parentTag": null, "root": true, "weight": null } }, "crdr": "debit", "lang": { "en-US": { "role": { "documentation": "Amount after allocation of valuation allowances of deferred tax asset attributable to deductible temporary differences and carryforwards.", "label": "Deferred Tax Assets, Net of Valuation Allowance", "totalLabel": "Total deferred tax assets" } } }, "localname": "DeferredTaxAssetsNet", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.agilent.com/role/IncomeTaxesIncomeTaxesDeferredTaxesAndOtherDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_DeferredTaxAssetsNetNoncurrent": { "auth_ref": [ "r443", "r444", "r445", "r446", "r464" ], "calculation": { "http://www.agilent.com/role/IncomeTaxesIncomeTaxesDeferredTaxesAndOtherDetails": { "order": 1.0, "parentTag": "us-gaap_DeferredTaxAssetsLiabilitiesNet", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-US": { "role": { "documentation": "Amount after allocation of valuation allowances of deferred tax asset attributable to deductible temporary differences and carryforwards classified as noncurrent.", "label": "Deferred Tax Assets, Net of Valuation Allowance, Noncurrent", "terseLabel": "Long-term deferred tax assets (included within other assets)" } } }, "localname": "DeferredTaxAssetsNetNoncurrent", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.agilent.com/role/IncomeTaxesIncomeTaxesDeferredTaxesAndOtherDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_DeferredTaxAssetsOperatingLossCarryforwards": { "auth_ref": [ "r435", "r471", "r472" ], "calculation": { "http://www.agilent.com/role/IncomeTaxesIncomeTaxesDeferredTaxesAndOtherDetails": { "order": 6.0, "parentTag": "us-gaap_DeferredTaxAssetsGross", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-US": { "role": { "documentation": "Amount before allocation of valuation allowances of deferred tax asset attributable to deductible operating loss carryforwards.", "label": "Deferred Tax Assets, Operating Loss Carryforwards", "verboseLabel": "Net operating loss, capital loss and credit carryforwards" } } }, "localname": "DeferredTaxAssetsOperatingLossCarryforwards", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.agilent.com/role/IncomeTaxesIncomeTaxesDeferredTaxesAndOtherDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_DeferredTaxAssetsOperatingLossCarryforwardsAlternativeAbstract": { "auth_ref": [], "lang": { "en-US": { "role": { "label": "Deferred Tax Assets, Operating Loss Carryforwards, Alternative [Abstract]", "terseLabel": "Capital Loss Carryforward" } } }, "localname": "DeferredTaxAssetsOperatingLossCarryforwardsAlternativeAbstract", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.agilent.com/role/IncomeTaxesCarryforwardsDetails" ], "xbrltype": "stringItemType" }, "us-gaap_DeferredTaxAssetsOperatingLossCarryforwardsComponentsAbstract": { "auth_ref": [], "lang": { "en-US": { "role": { "label": "Deferred Tax Assets, Operating Loss Carryforwards, Components [Abstract]", "terseLabel": "Net Operating loss carryforwards" } } }, "localname": "DeferredTaxAssetsOperatingLossCarryforwardsComponentsAbstract", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.agilent.com/role/IncomeTaxesCarryforwardsDetails" ], "xbrltype": "stringItemType" }, "us-gaap_DeferredTaxAssetsOperatingLossCarryforwardsDomestic": { "auth_ref": [ "r435", "r471", "r472" ], "crdr": "debit", "lang": { "en-US": { "role": { "documentation": "Amount before allocation of valuation allowances of deferred tax asset attributable to deductible domestic operating loss carryforwards. Excludes state and local operating loss carryforwards.", "label": "Deferred Tax Assets, Operating Loss Carryforwards, Domestic", "terseLabel": "Federal net operating loss carryforwards" } } }, "localname": "DeferredTaxAssetsOperatingLossCarryforwardsDomestic", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.agilent.com/role/IncomeTaxesCarryforwardsDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_DeferredTaxAssetsOperatingLossCarryforwardsForeign": { "auth_ref": [ "r435", "r471", "r472" ], "crdr": "debit", "lang": { "en-US": { "role": { "documentation": "Amount before allocation of valuation allowances of deferred tax asset attributable to deductible foreign operating loss carryforwards.", "label": "Deferred Tax Assets, Operating Loss Carryforwards, Foreign", "terseLabel": "Foreign net operating loss carryforwards" } } }, "localname": "DeferredTaxAssetsOperatingLossCarryforwardsForeign", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.agilent.com/role/IncomeTaxesCarryforwardsDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_DeferredTaxAssetsOperatingLossCarryforwardsNotSubjectToExpiration": { "auth_ref": [], "crdr": "debit", "lang": { "en-US": { "role": { "documentation": "Amount before allocation of valuation allowances of deferred tax asset attributable to deductible operating loss carryforwards that are not subject to expiration dates.", "label": "Deferred Tax Assets, Operating Loss Carryforwards, Not Subject to Expiration", "terseLabel": "Net operating loss carryforwards, not subject to expiration" } } }, "localname": "DeferredTaxAssetsOperatingLossCarryforwardsNotSubjectToExpiration", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.agilent.com/role/IncomeTaxesCarryforwardsDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_DeferredTaxAssetsOperatingLossCarryforwardsStateAndLocal": { "auth_ref": [ "r435", "r471", "r472" ], "crdr": "debit", "lang": { "en-US": { "role": { "documentation": "Amount before allocation of valuation allowances of deferred tax asset attributable to deductible state and local operating loss carryforwards.", "label": "Deferred Tax Assets, Operating Loss Carryforwards, State and Local", "terseLabel": "State net operating loss carryforwards" } } }, "localname": "DeferredTaxAssetsOperatingLossCarryforwardsStateAndLocal", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.agilent.com/role/IncomeTaxesCarryforwardsDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_DeferredTaxAssetsOperatingLossCarryforwardsSubjectToExpiration": { "auth_ref": [], "crdr": "debit", "lang": { "en-US": { "role": { "documentation": "Amount before allocation of valuation allowances of deferred tax asset attributable to deductible operating loss carryforwards that are subject to expiration dates.", "label": "Deferred Tax Assets, Operating Loss Carryforwards, Subject to Expiration", "terseLabel": "Net operating loss carryforwards, subject to expiration" } } }, "localname": "DeferredTaxAssetsOperatingLossCarryforwardsSubjectToExpiration", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.agilent.com/role/IncomeTaxesCarryforwardsDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_DeferredTaxAssetsOther": { "auth_ref": [ "r436", "r471", "r472" ], "calculation": { "http://www.agilent.com/role/IncomeTaxesIncomeTaxesDeferredTaxesAndOtherDetails": { "order": 9.0, "parentTag": "us-gaap_DeferredTaxAssetsGross", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-US": { "role": { "documentation": "Amount, before allocation of valuation allowance, of deferred tax asset attributable to deductible temporary differences, classified as other.", "label": "Deferred Tax Assets, Other", "verboseLabel": "Other" } } }, "localname": "DeferredTaxAssetsOther", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.agilent.com/role/IncomeTaxesIncomeTaxesDeferredTaxesAndOtherDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_DeferredTaxAssetsPropertyPlantAndEquipment": { "auth_ref": [], "calculation": { "http://www.agilent.com/role/IncomeTaxesIncomeTaxesDeferredTaxesAndOtherDetails": { "order": 2.0, "parentTag": "us-gaap_DeferredTaxAssetsGross", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-US": { "role": { "documentation": "Amount before allocation of valuation allowances of deferred tax asset attributable to deductible temporary differences from property, plant, and equipment.", "label": "Deferred Tax Assets, Property, Plant and Equipment", "verboseLabel": "Property, plant and equipment" } } }, "localname": "DeferredTaxAssetsPropertyPlantAndEquipment", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.agilent.com/role/IncomeTaxesIncomeTaxesDeferredTaxesAndOtherDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_DeferredTaxAssetsTaxCreditCarryforwardsAbstract": { "auth_ref": [], "lang": { "en-US": { "role": { "label": "Deferred Tax Assets, Tax Credit Carryforwards [Abstract]", "terseLabel": "Tax Credit Carryforwards" } } }, "localname": "DeferredTaxAssetsTaxCreditCarryforwardsAbstract", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.agilent.com/role/IncomeTaxesCarryforwardsDetails" ], "xbrltype": "stringItemType" }, "us-gaap_DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefits": { "auth_ref": [ "r435", "r471", "r472" ], "calculation": { "http://www.agilent.com/role/IncomeTaxesIncomeTaxesDeferredTaxesAndOtherDetails": { "order": 4.0, "parentTag": "us-gaap_DeferredIncomeTaxLiabilities", "weight": -1.0 } }, "crdr": "debit", "lang": { "en-US": { "role": { "documentation": "Amount before allocation of valuation allowances of deferred tax asset attributable to deductible temporary differences from compensation and benefits costs.", "label": "Deferred Tax Assets, Tax Deferred Expense, Compensation and Benefits", "terseLabel": "Employee benefits, other than retirement" } } }, "localname": "DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefits", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.agilent.com/role/IncomeTaxesIncomeTaxesDeferredTaxesAndOtherDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsEmployeeBenefits": { "auth_ref": [ "r435", "r471", "r472" ], "calculation": { "http://www.agilent.com/role/IncomeTaxesIncomeTaxesDeferredTaxesAndOtherDetails": { "order": 5.0, "parentTag": "us-gaap_DeferredTaxAssetsGross", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-US": { "role": { "documentation": "Amount, before allocation of valuation allowance, of deferred tax asset attributable to deductible temporary differences from employee benefits, classified as other.", "label": "Deferred Tax Assets, Tax Deferred Expense, Compensation and Benefits, Employee Benefits", "verboseLabel": "Employee benefits, other than retirement" } } }, "localname": "DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsEmployeeBenefits", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.agilent.com/role/IncomeTaxesIncomeTaxesDeferredTaxesAndOtherDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsPostretirementBenefits": { "auth_ref": [ "r471" ], "calculation": { "http://www.agilent.com/role/IncomeTaxesIncomeTaxesDeferredTaxesAndOtherDetails": { "order": 4.0, "parentTag": "us-gaap_DeferredTaxAssetsGross", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-US": { "role": { "documentation": "Amount before allocation of valuation allowances of deferred tax asset attributable to deductible temporary differences from postretirement benefits.", "label": "Deferred Tax Assets, Tax Deferred Expense, Compensation and Benefits, Postretirement Benefits", "verboseLabel": "Pension benefits and retiree medical benefits" } } }, "localname": "DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsPostretirementBenefits", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.agilent.com/role/IncomeTaxesIncomeTaxesDeferredTaxesAndOtherDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost": { "auth_ref": [ "r435", "r471", "r472" ], "calculation": { "http://www.agilent.com/role/IncomeTaxesIncomeTaxesDeferredTaxesAndOtherDetails": { "order": 7.0, "parentTag": "us-gaap_DeferredTaxAssetsGross", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-US": { "role": { "documentation": "Amount before allocation of valuation allowances of deferred tax asset attributable to deductible temporary differences from share-based compensation.", "label": "Deferred Tax Assets, Tax Deferred Expense, Compensation and Benefits, Share-based Compensation Cost", "verboseLabel": "Share-based compensation" } } }, "localname": "DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.agilent.com/role/IncomeTaxesIncomeTaxesDeferredTaxesAndOtherDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsWarrantyReserves": { "auth_ref": [ "r435", "r471", "r472" ], "calculation": { "http://www.agilent.com/role/IncomeTaxesIncomeTaxesDeferredTaxesAndOtherDetails": { "order": 3.0, "parentTag": "us-gaap_DeferredTaxAssetsGross", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-US": { "role": { "documentation": "Amount before allocation of valuation allowances of deferred tax asset attributable to deductible temporary differences from warranty reserves.", "label": "Deferred Tax Assets, Tax Deferred Expense, Reserves and Accruals, Warranty Reserves", "verboseLabel": "Warranty reserves" } } }, "localname": "DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsWarrantyReserves", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.agilent.com/role/IncomeTaxesIncomeTaxesDeferredTaxesAndOtherDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_DeferredTaxAssetsValuationAllowance": { "auth_ref": [ "r466" ], "calculation": { "http://www.agilent.com/role/IncomeTaxesIncomeTaxesDeferredTaxesAndOtherDetails": { "order": 2.0, "parentTag": "us-gaap_DeferredTaxAssetsNet", "weight": -1.0 } }, "crdr": "credit", "lang": { "en-US": { "role": { "documentation": "Amount of deferred tax assets for which it is more likely than not that a tax benefit will not be realized.", "label": "Deferred Tax Assets, Valuation Allowance", "negatedLabel": "Tax valuation allowance" } } }, "localname": "DeferredTaxAssetsValuationAllowance", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.agilent.com/role/IncomeTaxesIncomeTaxesDeferredTaxesAndOtherDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_DeferredTaxLiabilities": { "auth_ref": [ "r445", "r467" ], "calculation": { "http://www.agilent.com/role/IncomeTaxesIncomeTaxesDeferredTaxesAndOtherDetails": { "order": null, "parentTag": null, "root": true, "weight": null } }, "crdr": "credit", "lang": { "en-US": { "role": { "documentation": "Amount, after deferred tax asset, of deferred tax liability attributable to taxable differences without jurisdictional netting.", "label": "Deferred Tax Liabilities, Net", "totalLabel": "Total deferred tax liabilities" } } }, "localname": "DeferredTaxLiabilities", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.agilent.com/role/IncomeTaxesIncomeTaxesDeferredTaxesAndOtherDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_DeferredTaxLiabilitiesGoodwillAndIntangibleAssetsIntangibleAssets": { "auth_ref": [ "r436", "r471", "r472" ], "calculation": { "http://www.agilent.com/role/IncomeTaxesIncomeTaxesDeferredTaxesAndOtherDetails": { "order": 1.0, "parentTag": "us-gaap_DeferredIncomeTaxLiabilities", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-US": { "role": { "documentation": "Amount of deferred tax liability attributable to taxable temporary differences from intangible assets other than goodwill.", "label": "Deferred Tax Liabilities, Intangible Assets", "negatedTerseLabel": "Intangibles" } } }, "localname": "DeferredTaxLiabilitiesGoodwillAndIntangibleAssetsIntangibleAssets", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.agilent.com/role/IncomeTaxesIncomeTaxesDeferredTaxesAndOtherDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_DeferredTaxLiabilitiesNoncurrent": { "auth_ref": [ "r443", "r445", "r446" ], "calculation": { "http://www.agilent.com/role/IncomeTaxesIncomeTaxesDeferredTaxesAndOtherDetails": { "order": 2.0, "parentTag": "us-gaap_DeferredTaxAssetsLiabilitiesNet", "weight": -1.0 } }, "crdr": "credit", "lang": { "en-US": { "role": { "documentation": "Amount, after deferred tax asset, of deferred tax liability attributable to taxable differences, with jurisdictional netting and classified as noncurrent.", "label": "Deferred Tax Liabilities, Net, Noncurrent", "negatedLabel": "Long-term deferred tax liabilities (included within other long-term liabilities)" } } }, "localname": "DeferredTaxLiabilitiesNoncurrent", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.agilent.com/role/IncomeTaxesIncomeTaxesDeferredTaxesAndOtherDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_DeferredTaxLiabilitiesOther": { "auth_ref": [ "r436", "r471", "r472" ], "calculation": { "http://www.agilent.com/role/IncomeTaxesIncomeTaxesDeferredTaxesAndOtherDetails": { "order": 5.0, "parentTag": "us-gaap_DeferredTaxLiabilities", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-US": { "role": { "documentation": "Amount of deferred tax liability attributable to taxable temporary differences classified as other.", "label": "Deferred Tax Liabilities, Other", "negatedLabel": "Other" } } }, "localname": "DeferredTaxLiabilitiesOther", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.agilent.com/role/IncomeTaxesIncomeTaxesDeferredTaxesAndOtherDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_DeferredTaxLiabilitiesPropertyPlantAndEquipment": { "auth_ref": [ "r436", "r471", "r472" ], "calculation": { "http://www.agilent.com/role/IncomeTaxesIncomeTaxesDeferredTaxesAndOtherDetails": { "order": 2.0, "parentTag": "us-gaap_DeferredTaxLiabilities", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-US": { "role": { "documentation": "Amount of deferred tax liability attributable to taxable temporary differences from property, plant, and equipment.", "label": "Deferred Tax Liabilities, Property, Plant and Equipment", "negatedTerseLabel": "Property, plant and equipment" } } }, "localname": "DeferredTaxLiabilitiesPropertyPlantAndEquipment", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.agilent.com/role/IncomeTaxesIncomeTaxesDeferredTaxesAndOtherDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_DeferredTaxLiabilitiesTaxDeferredIncome": { "auth_ref": [ "r436", "r471", "r472" ], "calculation": { "http://www.agilent.com/role/IncomeTaxesIncomeTaxesDeferredTaxesAndOtherDetails": { "order": 5.0, "parentTag": "us-gaap_DeferredIncomeTaxLiabilities", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-US": { "role": { "documentation": "Amount of deferred tax liability attributable to taxable temporary differences from tax deferred revenue or income classified as other.", "label": "Deferred Tax Liabilities, Tax Deferred Income", "terseLabel": "Deferred revenue" } } }, "localname": "DeferredTaxLiabilitiesTaxDeferredIncome", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.agilent.com/role/IncomeTaxesIncomeTaxesDeferredTaxesAndOtherDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_DeferredTaxLiabilitiesUndistributedForeignEarnings": { "auth_ref": [ "r471" ], "crdr": "credit", "lang": { "en-US": { "role": { "documentation": "Amount of deferred tax liability attributable to taxable temporary differences from undistributed earnings of subsidiary and other recognized entity not within country of domicile. Includes, but is not limited to, other basis differences.", "label": "Deferred Tax Liabilities, Undistributed Foreign Earnings", "terseLabel": "Unremmitted earnings of foreign subsidiaries", "verboseLabel": "Defered Tax Liability for Unremmitted earnings of foreign subsidiaries" } } }, "localname": "DeferredTaxLiabilitiesUndistributedForeignEarnings", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.agilent.com/role/IncomeTaxes2017USTaxReformTaxCutsAndJobsActDetails", "http://www.agilent.com/role/IncomeTaxesIncomeTaxesDeferredTaxesAndOtherDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_DeferredTaxLiabilitiesUnrealizedGainsOnTradingSecurities": { "auth_ref": [ "r436", "r471", "r472" ], "crdr": "credit", "lang": { "en-US": { "role": { "documentation": "Amount of deferred tax liability attributable to taxable temporary differences from unrealized gains on trading securities.", "label": "Deferred Tax Liabilities, Unrealized Gains on Trading Securities", "terseLabel": "Deferred Tax Liabilities, Unrealized Gains on Trading Securities" } } }, "localname": "DeferredTaxLiabilitiesUnrealizedGainsOnTradingSecurities", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.agilent.com/role/IncomeTaxesIncomeTaxesDeferredTaxesAndOtherDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_DefinedBenefitPensionPlansAndDefinedBenefitPostretirementPlansDisclosureAbstract": { "auth_ref": [], "lang": { "en-US": { "role": { "label": "Defined Benefit Plan [Abstract]" } } }, "localname": "DefinedBenefitPensionPlansAndDefinedBenefitPostretirementPlansDisclosureAbstract", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "xbrltype": "stringItemType" }, "us-gaap_DefinedBenefitPlanAccumulatedOtherComprehensiveIncomeNetGainsLossesAfterTax": { "auth_ref": [ "r89", "r362" ], "crdr": "credit", "lang": { "en-US": { "role": { "documentation": "Amount, after tax, of accumulated other comprehensive income (loss) for gain (loss) of defined benefit plan, that has not been recognized in net periodic benefit (cost) credit.", "label": "Accumulated Other Comprehensive Income (Loss), Defined Benefit Plan, Gain (Loss), after Tax", "periodEndLabel": "Ending Balance", "periodStartLabel": "Beginning Balance" } } }, "localname": "DefinedBenefitPlanAccumulatedOtherComprehensiveIncomeNetGainsLossesAfterTax", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.agilent.com/role/StockholdersEquityChangesInAccumulatedOtherComprehensiveIncomeDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_DefinedBenefitPlanAccumulatedOtherComprehensiveIncomeNetPriorServiceCostCreditAfterTax": { "auth_ref": [ "r89", "r362" ], "crdr": "debit", "lang": { "en-US": { "role": { "documentation": "Amount, after tax, of accumulated other comprehensive (income) loss for cost (credit) of benefit change attributable to participants' prior service from plan amendment or plan initiation of defined benefit plan, that has not been recognized in net periodic benefit cost (credit).", "label": "Accumulated Other Comprehensive (Income) Loss, Defined Benefit Plan, Prior Service Cost (Credit), after Tax", "negatedPeriodEndLabel": "Ending Balance", "negatedPeriodStartLabel": "Beginning Balance" } } }, "localname": "DefinedBenefitPlanAccumulatedOtherComprehensiveIncomeNetPriorServiceCostCreditAfterTax", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.agilent.com/role/StockholdersEquityChangesInAccumulatedOtherComprehensiveIncomeDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_DefinedBenefitPlanActualReturnOnPlanAssets": { "auth_ref": [ "r337", "r385" ], "crdr": "debit", "lang": { "en-US": { "role": { "documentation": "Amount of increase (decrease) in plan assets of defined benefit plan from actual return (loss) determined by change in fair value of plan assets adjusted for contributions, benefit payments, and other expenses.", "label": "Defined Benefit Plan, Plan Assets, Increase (Decrease) for Actual Return (Loss)", "terseLabel": "Actual return on plan assets" } } }, "localname": "DefinedBenefitPlanActualReturnOnPlanAssets", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.agilent.com/role/RetirementPlansAndPostRetirementPensionPlansFundedStatusDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_DefinedBenefitPlanActualReturnOnPlanAssetsSoldDuringPeriod": { "auth_ref": [ "r348", "r385" ], "crdr": "debit", "lang": { "en-US": { "role": { "documentation": "Amount, measured using unobservable inputs, of increase (decrease) in plan assets of defined benefit plan from actual return (loss) on assets sold.", "label": "Defined Benefit Plan, Plan Assets Level 3 Reconciliation, Increase (Decrease) for Actual Return (Loss) on Plan Assets Sold", "negatedTerseLabel": "Realized gains/(losses)" } } }, "localname": "DefinedBenefitPlanActualReturnOnPlanAssetsSoldDuringPeriod", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.agilent.com/role/RetirementPlansAndPostRetirementPensionPlansFairValueOfPlanAssetsDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_DefinedBenefitPlanActualReturnOnPlanAssetsStillHeld": { "auth_ref": [ "r348", "r385" ], "crdr": "debit", "lang": { "en-US": { "role": { "documentation": "Amount, measured using unobservable inputs, of increase (decrease) in plan assets of defined benefit plan from actual return (loss) on assets still held.", "label": "Defined Benefit Plan, Plan Assets Level 3 Reconciliation, Increase (Decrease) for Actual Return (Loss) on Plan Assets Still Held", "negatedTerseLabel": "Unrealized gains/(losses)" } } }, "localname": "DefinedBenefitPlanActualReturnOnPlanAssetsStillHeld", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.agilent.com/role/RetirementPlansAndPostRetirementPensionPlansFairValueOfPlanAssetsDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_DefinedBenefitPlanActuarialGainLoss": { "auth_ref": [ "r332" ], "crdr": "credit", "lang": { "en-US": { "role": { "documentation": "Amount of gain (loss) from change in actuarial assumptions which (increases) decreases benefit obligation of defined benefit plan. Assumptions include, but are not limited to, interest, mortality, employee turnover, salary, and temporary deviation from substantive plan.", "label": "Defined Benefit Plan, Benefit Obligation, Actuarial Gain (Loss)", "terseLabel": "Actuarial (gain) loss" } } }, "localname": "DefinedBenefitPlanActuarialGainLoss", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.agilent.com/role/RetirementPlansAndPostRetirementPensionPlansFundedStatusDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_DefinedBenefitPlanAmortizationOfGainsLosses": { "auth_ref": [ "r357", "r381", "r385" ], "calculation": { "http://www.agilent.com/role/RetirementPlansAndPostRetirementPensionPlansComponentsOfNetPeriodicCostsDetails": { "order": 4.0, "parentTag": "us-gaap_DefinedBenefitPlanNetPeriodicBenefitCost", "weight": -1.0 } }, "crdr": "credit", "lang": { "en-US": { "role": { "documentation": "Amount of gain (loss) recognized in net periodic benefit (cost) credit of defined benefit plan.", "label": "Defined Benefit Plan, Amortization of Gain (Loss)", "negatedLabel": "Amortization of net actuarial loss" } } }, "localname": "DefinedBenefitPlanAmortizationOfGainsLosses", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.agilent.com/role/RetirementPlansAndPostRetirementPensionPlansComponentsOfNetPeriodicCostsDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_DefinedBenefitPlanAmortizationOfPriorServiceCostCredit": { "auth_ref": [ "r358", "r382", "r385" ], "calculation": { "http://www.agilent.com/role/RetirementPlansAndPostRetirementPensionPlansComponentsOfNetPeriodicCostsDetails": { "order": 5.0, "parentTag": "us-gaap_DefinedBenefitPlanNetPeriodicBenefitCost", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-US": { "role": { "documentation": "Amount of prior service cost (credit) recognized in net periodic benefit cost (credit) of defined benefit plan.", "label": "Defined Benefit Plan, Amortization of Prior Service Cost (Credit)", "terseLabel": "Amortization of prior service benefit" } } }, "localname": "DefinedBenefitPlanAmortizationOfPriorServiceCostCredit", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.agilent.com/role/RetirementPlansAndPostRetirementPensionPlansComponentsOfNetPeriodicCostsDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_DefinedBenefitPlanAmountsRecognizedInBalanceSheetAbstract": { "auth_ref": [], "lang": { "en-US": { "role": { "label": "Defined Benefit Plan, Amounts for Asset (Liability) Recognized in Statement of Financial Position [Abstract]", "terseLabel": "Amounts recognized in the consolidated balance sheet" } } }, "localname": "DefinedBenefitPlanAmountsRecognizedInBalanceSheetAbstract", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.agilent.com/role/RetirementPlansAndPostRetirementPensionPlansFinancialStatementLocationDetails" ], "xbrltype": "stringItemType" }, "us-gaap_DefinedBenefitPlanAmountsRecognizedInOtherComprehensiveIncomeAbstract": { "auth_ref": [], "lang": { "en-US": { "role": { "label": "Defined Benefit Plan, Amounts Recognized in Other Comprehensive Income (Loss) [Abstract]", "terseLabel": "Amounts Recognized in Accumulated Other Comprehensive Income (loss): [Abstract]" } } }, "localname": "DefinedBenefitPlanAmountsRecognizedInOtherComprehensiveIncomeAbstract", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.agilent.com/role/RetirementPlansAndPostRetirementPensionPlansFinancialStatementLocationDetails" ], "xbrltype": "stringItemType" }, "us-gaap_DefinedBenefitPlanAmountsRecognizedInOtherComprehensiveIncomeNetGainLossBeforeTaxAbstract": { "auth_ref": [], "lang": { "en-US": { "role": { "label": "Other Comprehensive Income (Loss), Defined Benefit Plan, Gain (Loss), after Reclassification Adjustment, before Tax [Abstract]", "terseLabel": "Other Comprehensive Income (Loss), Defined Benefit Plan, Gain (Loss), after Reclassification Adjustment, before Tax [Abstract]", "verboseLabel": "Other changes in plan assets and benefit obligations recognized in other comprehensive (income) loss [Abstract]" } } }, "localname": "DefinedBenefitPlanAmountsRecognizedInOtherComprehensiveIncomeNetGainLossBeforeTaxAbstract", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.agilent.com/role/RetirementPlansAndPostRetirementPensionPlansComponentsOfNetPeriodicCostsDetails", "http://www.agilent.com/role/StockholdersEquityChangesInAccumulatedOtherComprehensiveIncomeDetails" ], "xbrltype": "stringItemType" }, "us-gaap_DefinedBenefitPlanAmountsRecognizedInOtherComprehensiveIncomeNetPriorServiceCostCreditBeforeTax": { "auth_ref": [ "r84", "r86", "r360" ], "crdr": "debit", "lang": { "en-US": { "role": { "documentation": "Amount, before tax, after reclassification adjustment, of (increase) decrease in accumulated other comprehensive income from prior service cost (credit) of defined benefit plan.", "label": "Other Comprehensive (Income) Loss, Defined Benefit Plan, Prior Service Cost (Credit), after Reclassification Adjustment, before Tax", "terseLabel": "Prior service costs (benefits)" } } }, "localname": "DefinedBenefitPlanAmountsRecognizedInOtherComprehensiveIncomeNetPriorServiceCostCreditBeforeTax", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.agilent.com/role/RetirementPlansAndPostRetirementPensionPlansFundedStatusDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_DefinedBenefitPlanAmountsRecognizedInOtherComprehensiveIncomeNetPriorServiceCostCreditBeforeTaxAbstract": { "auth_ref": [], "lang": { "en-US": { "role": { "label": "Other Comprehensive (Income) Loss, Defined Benefit Plan, Prior Service Cost (Credit), after Reclassification Adjustment, before Tax [Abstract]", "terseLabel": "Other Comprehensive (Income) Loss, Defined Benefit Plan, Prior Service Cost (Credit), after Reclassification Adjustment, before Tax [Abstract]" } } }, "localname": "DefinedBenefitPlanAmountsRecognizedInOtherComprehensiveIncomeNetPriorServiceCostCreditBeforeTaxAbstract", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.agilent.com/role/StockholdersEquityChangesInAccumulatedOtherComprehensiveIncomeDetails" ], "xbrltype": "stringItemType" }, "us-gaap_DefinedBenefitPlanAmountsThatWillBeAmortizedFromAccumulatedOtherComprehensiveIncomeLossInNextFiscalYearAbstract": { "auth_ref": [], "lang": { "en-US": { "role": { "label": "Defined Benefit Plan, Expected Amortization, Next Fiscal Year [Abstract]", "terseLabel": "Accumulated other comprehensive income expected to be recognized as components of net expense during the next fiscal year [Abstract]" } } }, "localname": "DefinedBenefitPlanAmountsThatWillBeAmortizedFromAccumulatedOtherComprehensiveIncomeLossInNextFiscalYearAbstract", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.agilent.com/role/RetirementPlansAndPostRetirementPensionPlansFinancialStatementLocationDetails" ], "xbrltype": "stringItemType" }, "us-gaap_DefinedBenefitPlanAssetsForPlanBenefitsNoncurrent": { "auth_ref": [ "r19", "r326", "r327", "r343", "r609", "r633" ], "crdr": "debit", "lang": { "en-US": { "role": { "documentation": "Amount of asset, recognized in statement of financial position, for overfunded defined benefit pension and other postretirement plans.", "label": "Assets for Plan Benefits, Defined Benefit Plan", "terseLabel": "Other assets" } } }, "localname": "DefinedBenefitPlanAssetsForPlanBenefitsNoncurrent", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.agilent.com/role/RetirementPlansAndPostRetirementPensionPlansFairValueOfPlanAssetsDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_DefinedBenefitPlanAssumptionsUsedCalculatingBenefitObligationDiscountRate": { "auth_ref": [ "r364" ], "lang": { "en-US": { "role": { "documentation": "Weighted average rate for present value of future retirement benefits cash flows, used to determine benefit obligation of defined benefit plan.", "label": "Defined Benefit Plan, Assumptions Used Calculating Benefit Obligation, Discount Rate", "terseLabel": "Discount rate (in hundredths)" } } }, "localname": "DefinedBenefitPlanAssumptionsUsedCalculatingBenefitObligationDiscountRate", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.agilent.com/role/RetirementPlansAndPostRetirementPensionPlansAssumptionsDetails" ], "xbrltype": "percentItemType" }, "us-gaap_DefinedBenefitPlanAssumptionsUsedCalculatingBenefitObligationRateOfCompensationIncrease": { "auth_ref": [ "r365" ], "lang": { "en-US": { "role": { "documentation": "Weighted average rate increase of compensation, used to determine benefit obligation of defined benefit plan. Plan includes, but is not limited to, pay-related defined benefit plan.", "label": "Defined Benefit Plan, Assumptions Used Calculating Benefit Obligation, Rate of Compensation Increase", "terseLabel": "Defined Benefit Plan, Assumptions Used Calculating Benefit Obligation, Rate of Compensation Increase" } } }, "localname": "DefinedBenefitPlanAssumptionsUsedCalculatingBenefitObligationRateOfCompensationIncrease", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.agilent.com/role/RetirementPlansAndPostRetirementPensionPlansAssumptionsDetails" ], "xbrltype": "percentItemType" }, "us-gaap_DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostDiscountRate": { "auth_ref": [ "r364" ], "lang": { "en-US": { "role": { "documentation": "Weighted average rate for present value of future retirement benefits cash flows, used to determine net periodic benefit cost of defined benefit plan.", "label": "Defined Benefit Plan, Assumptions Used Calculating Net Periodic Benefit Cost, Discount Rate", "terseLabel": "Discount rate (in hundredths)" } } }, "localname": "DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostDiscountRate", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.agilent.com/role/RetirementPlansAndPostRetirementPensionPlansAssumptionsDetails" ], "xbrltype": "percentItemType" }, "us-gaap_DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostExpectedLongTermReturnOnAssets": { "auth_ref": [ "r366" ], "lang": { "en-US": { "role": { "documentation": "Weighted average rate of return on plan assets, reflecting average rate of earnings expected on existing plan assets and expected contributions, used to determine net periodic benefit cost of defined benefit plan.", "label": "Defined Benefit Plan, Assumptions Used Calculating Net Periodic Benefit Cost, Expected Long-term Rate of Return on Plan Assets", "terseLabel": "Expected long-term return on assets (in hundredths)" } } }, "localname": "DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostExpectedLongTermReturnOnAssets", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.agilent.com/role/RetirementPlansAndPostRetirementPensionPlansAssumptionsDetails" ], "xbrltype": "percentItemType" }, "us-gaap_DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostRateOfCompensationIncrease": { "auth_ref": [ "r365" ], "lang": { "en-US": { "role": { "documentation": "Weighted average rate of compensation increase used to determine net periodic benefit cost of defined benefit plan. Plan includes, but is not limited to, pay-related defined benefit plan.", "label": "Defined Benefit Plan, Assumptions Used Calculating Net Periodic Benefit Cost, Rate of Compensation Increase", "terseLabel": "Average increase in compensation levels (in hundredths)" } } }, "localname": "DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostRateOfCompensationIncrease", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.agilent.com/role/RetirementPlansAndPostRetirementPensionPlansAssumptionsDetails" ], "xbrltype": "percentItemType" }, "us-gaap_DefinedBenefitPlanBenefitObligation": { "auth_ref": [ "r328" ], "crdr": "credit", "lang": { "en-US": { "role": { "documentation": "Amount of actuarial present value of benefits attributed to service rendered by employee for defined benefit plan.", "label": "Defined Benefit Plan, Benefit Obligation", "periodEndLabel": "Benefit Obligation Balance, end of year", "periodStartLabel": "Benefit Obligation Balance, Beginning of year", "terseLabel": "Benefit Obligation" } } }, "localname": "DefinedBenefitPlanBenefitObligation", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.agilent.com/role/RetirementPlansAndPostRetirementPensionPlansFairValueOfPlanAssetsDetails", "http://www.agilent.com/role/RetirementPlansAndPostRetirementPensionPlansFundedStatusDetails", "http://www.agilent.com/role/RetirementPlansAndPostRetirementPensionPlansJwpilDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_DefinedBenefitPlanBenefitObligationBenefitsPaid": { "auth_ref": [ "r334", "r388" ], "crdr": "credit", "lang": { "en-US": { "role": { "documentation": "Amount of payment to participant of defined benefit plan which decreases benefit obligation. For pension plan, payment includes, but is not limited to, pension benefits and death benefits. For other postretirement plan, payment includes, but is not limited to, prescription drug benefits, health care benefits, life insurance benefits, and legal, educational and advisory services.", "label": "Defined Benefit Plan, Benefit Obligation, Benefits Paid", "terseLabel": "Benefits paid" } } }, "localname": "DefinedBenefitPlanBenefitObligationBenefitsPaid", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.agilent.com/role/RetirementPlansAndPostRetirementPensionPlansFundedStatusDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_DefinedBenefitPlanBenefitObligationContributionsByPlanParticipant": { "auth_ref": [ "r331" ], "crdr": "debit", "lang": { "en-US": { "role": { "documentation": "Amount of contributions received by defined benefit plan from participant which increase benefit obligation.", "label": "Defined Benefit Plan, Benefit Obligation, Contributions by Plan Participant", "verboseLabel": "Participant's contributions" } } }, "localname": "DefinedBenefitPlanBenefitObligationContributionsByPlanParticipant", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.agilent.com/role/RetirementPlansAndPostRetirementPensionPlansFundedStatusDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_DefinedBenefitPlanByPlanAssetCategoriesAxis": { "auth_ref": [ "r345", "r346", "r368", "r385" ], "lang": { "en-US": { "role": { "documentation": "Information by defined benefit plan asset investment.", "label": "Defined Benefit Plan, Plan Assets, Category [Axis]", "terseLabel": "Defined Benefit Plan, Plan Assets, Category [Axis]" } } }, "localname": "DefinedBenefitPlanByPlanAssetCategoriesAxis", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.agilent.com/role/RetirementPlansAndPostRetirementPensionPlansAssumptionsDetails", "http://www.agilent.com/role/RetirementPlansAndPostRetirementPensionPlansFairValueOfPlanAssetsDetails", "http://www.agilent.com/role/RetirementPlansAndPostRetirementPensionPlansJwpilDetails", "http://www.agilent.com/role/RetirementPlansAndPostRetirementPensionPlansRetirementPlansAndPostRetirementPensionPlansTargetAllocationsDetails" ], "xbrltype": "stringItemType" }, "us-gaap_DefinedBenefitPlanChangeInBenefitObligationRollForward": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "A roll forward is a reconciliation of a concept from the beginning of a period to the end of a period.", "label": "Defined Benefit Plan, Change in Benefit Obligation [Roll Forward]", "terseLabel": "Change in benefit obligation: [Roll Forward]" } } }, "localname": "DefinedBenefitPlanChangeInBenefitObligationRollForward", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.agilent.com/role/RetirementPlansAndPostRetirementPensionPlansFundedStatusDetails" ], "xbrltype": "stringItemType" }, "us-gaap_DefinedBenefitPlanChangeInFairValueOfPlanAssetsRollForward": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "A roll forward is a reconciliation of a concept from the beginning of a period to the end of a period.", "label": "Defined Benefit Plan, Change in Fair Value of Plan Assets [Roll Forward]", "terseLabel": "Defined Benefit plan, change in fair value of plan assets, significant unobservable inputs (Level 3) (Roll Forward]", "verboseLabel": "Change in fair value of plan assets: [Roll Forward]" } } }, "localname": "DefinedBenefitPlanChangeInFairValueOfPlanAssetsRollForward", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.agilent.com/role/RetirementPlansAndPostRetirementPensionPlansFairValueOfPlanAssetsDetails", "http://www.agilent.com/role/RetirementPlansAndPostRetirementPensionPlansFundedStatusDetails" ], "xbrltype": "stringItemType" }, "us-gaap_DefinedBenefitPlanContributionsByEmployer": { "auth_ref": [ "r339", "r345", "r346", "r384", "r385" ], "crdr": "debit", "lang": { "en-US": { "role": { "documentation": "Amount of contribution received by defined benefit plan from employer which increases plan assets.", "label": "Defined Benefit Plan, Plan Assets, Contributions by Employer", "terseLabel": "Employer contributions" } } }, "localname": "DefinedBenefitPlanContributionsByEmployer", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.agilent.com/role/RetirementPlansAndPostRetirementPensionPlansFundedStatusDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_DefinedBenefitPlanDisclosureLineItems": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.", "label": "Defined Benefit Plan Disclosure [Line Items]", "terseLabel": "Defined Benefit Plan Disclosure [Line Items]" } } }, "localname": "DefinedBenefitPlanDisclosureLineItems", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.agilent.com/role/RetirementPlansAndPostRetiementPensionPlansDeferredProfitSharingPlanDetails", "http://www.agilent.com/role/RetirementPlansAndPostRetirementPensionPlansAssumptionsDetails", "http://www.agilent.com/role/RetirementPlansAndPostRetirementPensionPlansComponentsOfNetPeriodicCostsDetails", "http://www.agilent.com/role/RetirementPlansAndPostRetirementPensionPlansExpectedBenefitPaymentsDetails", "http://www.agilent.com/role/RetirementPlansAndPostRetirementPensionPlansFairValueOfPlanAssetsDetails", "http://www.agilent.com/role/RetirementPlansAndPostRetirementPensionPlansFinancialStatementLocationDetails", "http://www.agilent.com/role/RetirementPlansAndPostRetirementPensionPlansFundedStatusDetails", "http://www.agilent.com/role/RetirementPlansAndPostRetirementPensionPlansJwpilDetails", "http://www.agilent.com/role/RetirementPlansAndPostRetirementPensionPlansRetirementPlansAndPostRetirementPensionPlansTargetAllocationsDetails" ], "xbrltype": "stringItemType" }, "us-gaap_DefinedBenefitPlanEstimatedFutureBenefitPaymentsAbstract": { "auth_ref": [], "lang": { "en-US": { "role": { "label": "Defined Benefit Plan, Expected Future Benefit Payment [Abstract]", "terseLabel": "Future benefit payments [Abstract]" } } }, "localname": "DefinedBenefitPlanEstimatedFutureBenefitPaymentsAbstract", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.agilent.com/role/RetirementPlansAndPostRetirementPensionPlansExpectedBenefitPaymentsDetails" ], "xbrltype": "stringItemType" }, "us-gaap_DefinedBenefitPlanExpectedAmortizationOfGainLossNextFiscalYear": { "auth_ref": [ "r370" ], "crdr": "credit", "lang": { "en-US": { "role": { "documentation": "Amount included in accumulated other comprehensive income (loss) for gain (loss) of defined benefit plan expected to be recognized in net periodic benefit (cost) credit for fiscal year following most recent annual statement of financial position.", "label": "Defined Benefit Plan, Expected Amortization of Gain (Loss), Next Fiscal Year", "terseLabel": "Defined Benefit Plan, Expected Amortization of Gain (Loss), Next Fiscal Year" } } }, "localname": "DefinedBenefitPlanExpectedAmortizationOfGainLossNextFiscalYear", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.agilent.com/role/RetirementPlansAndPostRetirementPensionPlansFinancialStatementLocationDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_DefinedBenefitPlanExpectedAmortizationOfPriorServiceCostCreditNextFiscalYear": { "auth_ref": [ "r370" ], "crdr": "debit", "lang": { "en-US": { "role": { "documentation": "Amount included in accumulated other comprehensive (income) loss for prior service cost (credit) expected to be recognized in net periodic benefit cost (credit) for fiscal year following most recent annual statement of financial position.", "label": "Defined Benefit Plan, Expected Amortization of Prior Service Cost (Credit), Next Fiscal Year", "terseLabel": "Amortization of net prior service cost (benefit)" } } }, "localname": "DefinedBenefitPlanExpectedAmortizationOfPriorServiceCostCreditNextFiscalYear", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.agilent.com/role/RetirementPlansAndPostRetirementPensionPlansFinancialStatementLocationDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsFiveFiscalYearsThereafter": { "auth_ref": [ "r351" ], "crdr": "credit", "lang": { "en-US": { "role": { "documentation": "Amount of benefits for defined benefit plan expected to be paid in five fiscal years after fifth fiscal year following latest fiscal year.", "label": "Defined Benefit Plan, Expected Future Benefit Payment, Five Fiscal Years Thereafter", "terseLabel": "2025 - 2029" } } }, "localname": "DefinedBenefitPlanExpectedFutureBenefitPaymentsFiveFiscalYearsThereafter", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.agilent.com/role/RetirementPlansAndPostRetirementPensionPlansExpectedBenefitPaymentsDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsNextTwelveMonths": { "auth_ref": [ "r351" ], "crdr": "credit", "lang": { "en-US": { "role": { "documentation": "Amount of benefits for defined benefit plan expected to be paid in next fiscal year following latest fiscal year.", "label": "Defined Benefit Plan, Expected Future Benefit Payment, Next Twelve Months", "terseLabel": "2020" } } }, "localname": "DefinedBenefitPlanExpectedFutureBenefitPaymentsNextTwelveMonths", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.agilent.com/role/RetirementPlansAndPostRetirementPensionPlansExpectedBenefitPaymentsDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsYearFive": { "auth_ref": [ "r351" ], "crdr": "credit", "lang": { "en-US": { "role": { "documentation": "Amount of benefits for defined benefit plan expected to be paid in fifth fiscal year following latest fiscal year.", "label": "Defined Benefit Plan, Expected Future Benefit Payment, Year Five", "terseLabel": "2024" } } }, "localname": "DefinedBenefitPlanExpectedFutureBenefitPaymentsYearFive", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.agilent.com/role/RetirementPlansAndPostRetirementPensionPlansExpectedBenefitPaymentsDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsYearFour": { "auth_ref": [ "r351" ], "crdr": "credit", "lang": { "en-US": { "role": { "documentation": "Amount of benefits for defined benefit plan expected to be paid in fourth fiscal year following latest fiscal year.", "label": "Defined Benefit Plan, Expected Future Benefit Payment, Year Four", "terseLabel": "2023" } } }, "localname": "DefinedBenefitPlanExpectedFutureBenefitPaymentsYearFour", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.agilent.com/role/RetirementPlansAndPostRetirementPensionPlansExpectedBenefitPaymentsDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsYearThree": { "auth_ref": [ "r351" ], "crdr": "credit", "lang": { "en-US": { "role": { "documentation": "Amount of benefits for defined benefit plan expected to be paid in third fiscal year following latest fiscal year.", "label": "Defined Benefit Plan, Expected Future Benefit Payment, Year Three", "terseLabel": "2022" } } }, "localname": "DefinedBenefitPlanExpectedFutureBenefitPaymentsYearThree", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.agilent.com/role/RetirementPlansAndPostRetirementPensionPlansExpectedBenefitPaymentsDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsYearTwo": { "auth_ref": [ "r351" ], "crdr": "credit", "lang": { "en-US": { "role": { "documentation": "Amount of benefits for defined benefit plan expected to be paid in second fiscal year following latest fiscal year.", "label": "Defined Benefit Plan, Expected Future Benefit Payment, Year Two", "terseLabel": "2021" } } }, "localname": "DefinedBenefitPlanExpectedFutureBenefitPaymentsYearTwo", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.agilent.com/role/RetirementPlansAndPostRetirementPensionPlansExpectedBenefitPaymentsDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_DefinedBenefitPlanExpectedFutureEmployerContributionsNextFiscalYear": { "auth_ref": [ "r352" ], "crdr": "debit", "lang": { "en-US": { "role": { "documentation": "Amount of contributions expected to be received by defined benefit plan from employer in next fiscal year following latest fiscal year.", "label": "Defined Benefit Plan, Expected Future Employer Contributions, Next Fiscal Year" } } }, "localname": "DefinedBenefitPlanExpectedFutureEmployerContributionsNextFiscalYear", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.agilent.com/role/RetirementPlansAndPostRetirementPensionPlansExpectedBenefitPaymentsDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_DefinedBenefitPlanExpectedReturnOnPlanAssets": { "auth_ref": [ "r356", "r380", "r385" ], "calculation": { "http://www.agilent.com/role/RetirementPlansAndPostRetirementPensionPlansComponentsOfNetPeriodicCostsDetails": { "order": 3.0, "parentTag": "us-gaap_DefinedBenefitPlanNetPeriodicBenefitCost", "weight": -1.0 } }, "crdr": "credit", "lang": { "en-US": { "role": { "documentation": "Amount of expected return (loss) recognized in net periodic benefit (cost) credit, calculated based on expected long-term rate of return and market-related value of plan assets of defined benefit plan.", "label": "Defined Benefit Plan, Expected Return (Loss) on Plan Assets", "negatedLabel": "Expected return on plan assets" } } }, "localname": "DefinedBenefitPlanExpectedReturnOnPlanAssets", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.agilent.com/role/RetirementPlansAndPostRetirementPensionPlansComponentsOfNetPeriodicCostsDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_DefinedBenefitPlanFairValueOfPlanAssets": { "auth_ref": [ "r336", "r345", "r346", "r385" ], "crdr": "debit", "lang": { "en-US": { "role": { "documentation": "Amount of asset segregated and restricted to provide benefit under defined benefit plan. Asset includes, but is not limited to, stock, bond, other investment, earning from investment, and contribution by employer and employee.", "label": "Defined Benefit Plan, Plan Assets, Amount", "periodEndLabel": "Fair Value Balance, end of year", "periodStartLabel": "Fair Value Balance, beginning of year", "terseLabel": "Fair Value of Plan Assets" } } }, "localname": "DefinedBenefitPlanFairValueOfPlanAssets", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.agilent.com/role/RetirementPlansAndPostRetiementPensionPlansDeferredProfitSharingPlanDetails", "http://www.agilent.com/role/RetirementPlansAndPostRetirementPensionPlansFairValueOfPlanAssetsDetails", "http://www.agilent.com/role/RetirementPlansAndPostRetirementPensionPlansFundedStatusDetails", "http://www.agilent.com/role/RetirementPlansAndPostRetirementPensionPlansJwpilDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_DefinedBenefitPlanFairValueOfPlanAssetsPeriodIncreaseDecrease": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Amount of increase (decrease) in plan assets of defined benefit plan.", "label": "Defined Benefit Plan, Plan Assets, Period Increase (Decrease)", "terseLabel": "Defined Benefit Plan, Benefit Obligation, (Increase) Decrease for Remeasurement due to Settlement" } } }, "localname": "DefinedBenefitPlanFairValueOfPlanAssetsPeriodIncreaseDecrease", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.agilent.com/role/RetirementPlansAndPostRetirementPensionPlansFundedStatusDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_DefinedBenefitPlanForeignCurrencyExchangeRateChangesBenefitObligation": { "auth_ref": [ "r333" ], "crdr": "credit", "lang": { "en-US": { "role": { "documentation": "Amount of foreign currency translation gain (loss) which (increases) decreases benefit obligation of defined benefit plan.", "label": "Defined Benefit Plan, Benefit Obligation, Foreign Currency Translation Gain (Loss)", "terseLabel": "Currency impact" } } }, "localname": "DefinedBenefitPlanForeignCurrencyExchangeRateChangesBenefitObligation", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.agilent.com/role/RetirementPlansAndPostRetirementPensionPlansFundedStatusDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_DefinedBenefitPlanFundedStatusOfPlan": { "auth_ref": [ "r326", "r343" ], "crdr": "debit", "lang": { "en-US": { "role": { "documentation": "Amount of funded (unfunded) status of defined benefit plan, measured as difference between fair value of plan assets and benefit obligation. Includes, but is not limited to, overfunded (underfunded) status.", "label": "Defined Benefit Plan, Funded (Unfunded) Status of Plan", "terseLabel": "Funded status of plan" } } }, "localname": "DefinedBenefitPlanFundedStatusOfPlan", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.agilent.com/role/RetirementPlansAndPostRetirementPensionPlansFundedStatusDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_DefinedBenefitPlanFundedStatusOfPlanAbstract": { "auth_ref": [], "lang": { "en-US": { "role": { "label": "Defined Benefit Plan, Funded (Unfunded) Status of Plan [Abstract]", "terseLabel": "Funded status of plan [Abstract]" } } }, "localname": "DefinedBenefitPlanFundedStatusOfPlanAbstract", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.agilent.com/role/RetirementPlansAndPostRetirementPensionPlansFundedStatusDetails" ], "xbrltype": "stringItemType" }, "us-gaap_DefinedBenefitPlanHealthCareCostTrendRateAssumedNextFiscalYear": { "auth_ref": [ "r367" ], "lang": { "en-US": { "role": { "documentation": "Assumed rate, for next fiscal year, based on annual change in cost of health care cost benefits used to measure expected cost of benefits covered by defined benefit postretirement plan. Factors include, but are not limited to, estimate of health care inflation, change in health care utilization or delivery pattern, technological advances, and change in health status of participant. Excludes factors for change in composition of plan population by age and dependency status.", "label": "Defined Benefit Plan, Health Care Cost Trend Rate Assumed, Next Fiscal Year", "terseLabel": "Defined Benefit Plan, Health Care Cost Trend Rate Assumed, Next Fiscal Year" } } }, "localname": "DefinedBenefitPlanHealthCareCostTrendRateAssumedNextFiscalYear", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.agilent.com/role/RetirementPlansAndPostRetirementPensionPlansAssumptionsDetails" ], "xbrltype": "percentItemType" }, "us-gaap_DefinedBenefitPlanInterestCost": { "auth_ref": [ "r330", "r355", "r379", "r385" ], "calculation": { "http://www.agilent.com/role/RetirementPlansAndPostRetirementPensionPlansComponentsOfNetPeriodicCostsDetails": { "order": 2.0, "parentTag": "us-gaap_DefinedBenefitPlanNetPeriodicBenefitCost", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-US": { "role": { "documentation": "Amount of cost recognized for passage of time related to defined benefit plan.", "label": "Defined Benefit Plan, Interest Cost", "terseLabel": "Interest cost", "verboseLabel": "Interest cost on benefit obligation" } } }, "localname": "DefinedBenefitPlanInterestCost", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.agilent.com/role/RetirementPlansAndPostRetirementPensionPlansComponentsOfNetPeriodicCostsDetails", "http://www.agilent.com/role/RetirementPlansAndPostRetirementPensionPlansFundedStatusDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_DefinedBenefitPlanNetPeriodicBenefitCost": { "auth_ref": [ "r353", "r377", "r385" ], "calculation": { "http://www.agilent.com/role/RetirementPlansAndPostRetirementPensionPlansComponentsOfNetPeriodicCostsDetails": { "order": 1.0, "parentTag": "us-gaap_OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIPensionAndOtherPostretirementBenefitPlansForNetTransitionAssetObligationBeforeTax", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-US": { "role": { "documentation": "Amount of net periodic benefit cost (credit) for defined benefit plan.", "label": "Defined Benefit Plan, Net Periodic Benefit Cost (Credit)", "totalLabel": "Total periodic benefit cost (benefit)" } } }, "localname": "DefinedBenefitPlanNetPeriodicBenefitCost", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.agilent.com/role/RetirementPlansAndPostRetirementPensionPlansComponentsOfNetPeriodicCostsDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_DefinedBenefitPlanNetPeriodicBenefitCostAbstract": { "auth_ref": [], "lang": { "en-US": { "role": { "label": "Defined Benefit Plan, Net Periodic Benefit Cost (Credit) [Abstract]", "terseLabel": "Net periodic benefit cost (benefit) [Abstract]" } } }, "localname": "DefinedBenefitPlanNetPeriodicBenefitCostAbstract", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.agilent.com/role/RetirementPlansAndPostRetirementPensionPlansComponentsOfNetPeriodicCostsDetails" ], "xbrltype": "stringItemType" }, "us-gaap_DefinedBenefitPlanNetPeriodicBenefitCostCreditIncreaseDecreaseForPlanAmendment": { "auth_ref": [ "r369" ], "crdr": "debit", "lang": { "en-US": { "role": { "documentation": "Amount of increase (decrease) in net periodic benefit cost from effect of change in substantive term of existing defined benefit plan or initiation of new defined benefit plan.", "label": "Defined Benefit Plan, Net Periodic Benefit Cost (Credit), Increase (Decrease) for Plan Amendment", "terseLabel": "Plan amendment" } } }, "localname": "DefinedBenefitPlanNetPeriodicBenefitCostCreditIncreaseDecreaseForPlanAmendment", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.agilent.com/role/RetirementPlansAndPostRetirementPensionPlansFundedStatusDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_DefinedBenefitPlanPensionPlanWithProjectedBenefitObligationInExcessOfPlanAssetsPlanAssets": { "auth_ref": [ "r373" ], "crdr": "debit", "lang": { "en-US": { "role": { "documentation": "Amount of plan asset for defined benefit pension plan with projected benefit obligation in excess of plan assets.", "label": "Defined Benefit Plan, Pension Plan with Projected Benefit Obligation in Excess of Plan Assets, Plan Assets", "terseLabel": "Defined Benefit Plan, Pension Plan with Projected Benefit Obligation in Excess of Plan Assets, Plan Assets" } } }, "localname": "DefinedBenefitPlanPensionPlanWithProjectedBenefitObligationInExcessOfPlanAssetsPlanAssets", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.agilent.com/role/RetirementPlansAndPostRetirementPensionPlansFairValueOfPlanAssetsDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_DefinedBenefitPlanPensionPlansWithAccumulatedBenefitObligationsInExcessOfPlanAssetsAggregateAccumulatedBenefitObligation": { "auth_ref": [ "r373", "r374", "r385" ], "crdr": "credit", "lang": { "en-US": { "role": { "documentation": "Amount of accumulated benefit obligation for defined benefit plan with accumulated benefit obligation in excess of plan assets.", "label": "Defined Benefit Plan, Plan with Accumulated Benefit Obligation in Excess of Plan Assets, Accumulated Benefit Obligation", "terseLabel": "Accumulated benefit obligation in excess of fair value of plan assets - aggregate benefit obligation" } } }, "localname": "DefinedBenefitPlanPensionPlansWithAccumulatedBenefitObligationsInExcessOfPlanAssetsAggregateAccumulatedBenefitObligation", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.agilent.com/role/RetirementPlansAndPostRetirementPensionPlansFairValueOfPlanAssetsDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_DefinedBenefitPlanPensionPlansWithAccumulatedBenefitObligationsInExcessOfPlanAssetsAggregateFairValueOfPlanAssets": { "auth_ref": [ "r373", "r374", "r385" ], "crdr": "debit", "lang": { "en-US": { "role": { "documentation": "Amount of plan asset for defined benefit plan with accumulated benefit obligation in excess of plan assets.", "label": "Defined Benefit Plan, Plan with Accumulated Benefit Obligation in Excess of Plan Assets, Plan Assets", "terseLabel": "Accumulated benefit obligation in excess of accumulated benefit obligation - aggregate fair value of plan assets" } } }, "localname": "DefinedBenefitPlanPensionPlansWithAccumulatedBenefitObligationsInExcessOfPlanAssetsAggregateFairValueOfPlanAssets", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.agilent.com/role/RetirementPlansAndPostRetirementPensionPlansFairValueOfPlanAssetsDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_DefinedBenefitPlanPlanAssetsBenefitsPaid": { "auth_ref": [ "r341", "r388" ], "crdr": "credit", "lang": { "en-US": { "role": { "documentation": "Amount of payment to participant under defined benefit plan which decreases plan assets. For pension plan, payment includes, but is not limited to, pension benefits and death benefits. For other postretirement plan, payment includes, but is not limited to, prescription drug benefits, health care benefits, life insurance benefits, and legal, educational and advisory services.", "label": "Defined Benefit Plan, Plan Assets, Benefits Paid", "terseLabel": "Benefits paid" } } }, "localname": "DefinedBenefitPlanPlanAssetsBenefitsPaid", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.agilent.com/role/RetirementPlansAndPostRetirementPensionPlansFundedStatusDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_DefinedBenefitPlanPlanAssetsContributionsByPlanParticipant": { "auth_ref": [ "r340" ], "crdr": "debit", "lang": { "en-US": { "role": { "documentation": "Amount of contributions received by defined benefit plan from participant which increases plan assets.", "label": "Defined Benefit Plan, Plan Assets, Contributions by Plan Participant", "terseLabel": "Defined Benefit Plan, Plan Assets, Contributions by Plan Participant" } } }, "localname": "DefinedBenefitPlanPlanAssetsContributionsByPlanParticipant", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.agilent.com/role/RetirementPlansAndPostRetirementPensionPlansFundedStatusDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_DefinedBenefitPlanPlanAssetsForeignCurrencyTranslationGainLoss": { "auth_ref": [ "r338" ], "crdr": "credit", "lang": { "en-US": { "role": { "documentation": "Amount of foreign currency translation gain (loss) which increases (decreases) plan assets of defined benefit plan.", "label": "Defined Benefit Plan, Plan Assets, Foreign Currency Translation Gain (Loss)", "verboseLabel": "Currency impact" } } }, "localname": "DefinedBenefitPlanPlanAssetsForeignCurrencyTranslationGainLoss", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.agilent.com/role/RetirementPlansAndPostRetirementPensionPlansFundedStatusDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_DefinedBenefitPlanPlanAssetsTargetAllocationPercentage": { "auth_ref": [ "r344", "r385" ], "lang": { "en-US": { "role": { "documentation": "Percentage of target investment allocation to total plan assets. Includes, but is not limited to, percentage on weighted-average basis if more than one plan.", "label": "Defined Benefit Plan, Plan Assets, Target Allocation, Percentage", "terseLabel": "Target Allocation Percentage of Plan Assets" } } }, "localname": "DefinedBenefitPlanPlanAssetsTargetAllocationPercentage", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.agilent.com/role/RetirementPlansAndPostRetirementPensionPlansRetirementPlansAndPostRetirementPensionPlansTargetAllocationsDetails" ], "xbrltype": "percentItemType" }, "us-gaap_DefinedBenefitPlanPurchasesSalesAndSettlements": { "auth_ref": [ "r349", "r385" ], "crdr": "debit", "lang": { "en-US": { "role": { "documentation": "Amount, measured using unobservable input, of increase (decrease) in plan asset of defined benefit plan from purchase, sale and settlement of trade associated with underlying investment.", "label": "Defined Benefit Plan, Plan Assets Level 3 Reconciliation, Increase (Decrease) for Purchase, Sale, and Settlement", "terseLabel": "Purchases, sales, issuances, and settlements" } } }, "localname": "DefinedBenefitPlanPurchasesSalesAndSettlements", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.agilent.com/role/RetirementPlansAndPostRetirementPensionPlansFairValueOfPlanAssetsDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_DefinedBenefitPlanRecognizedNetGainLossDueToCurtailments": { "auth_ref": [ "r359", "r383" ], "calculation": { "http://www.agilent.com/role/SegmentInformationReconciliationOfReportableResultsDetails": { "order": 8.0, "parentTag": "us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-US": { "role": { "documentation": "Amount of gain (loss) recognized in net periodic benefit (cost) credit from event reducing expected years of future service of present employees or eliminating accrual of defined benefits for some or all future services of present employees.", "label": "Defined Benefit Plan, Net Periodic Benefit Cost (Credit), Gain (Loss) Due to Curtailment", "terseLabel": "Pension curtailment gain" } } }, "localname": "DefinedBenefitPlanRecognizedNetGainLossDueToCurtailments", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.agilent.com/role/SegmentInformationReconciliationOfReportableResultsDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_DefinedBenefitPlanRecognizedNetGainLossDueToSettlements1": { "auth_ref": [ "r359", "r383" ], "calculation": { "http://www.agilent.com/role/RetirementPlansAndPostRetirementPensionPlansComponentsOfNetPeriodicCostsDetails": { "order": 5.0, "parentTag": "a_OtherComprehensiveIncomeDefinedBenefitPlansPeriodIncreaseDecrease", "weight": -1.0 }, "http://www.agilent.com/role/SegmentInformationReconciliationOfReportableResultsDetails": { "order": 9.0, "parentTag": "us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-US": { "role": { "documentation": "Amount of gain (loss) recognized in net periodic benefit (cost) credit from irrevocable action relieving primary responsibility for benefit obligation and eliminating risk related to obligation and assets used to effect settlement.", "label": "Defined Benefit Plan, Net Periodic Benefit Cost (Credit), Gain (Loss) Due to Settlement", "negatedLabel": "Pension settlement gain", "terseLabel": "Settlement gain (loss)", "verboseLabel": "Gain due to settlement" } } }, "localname": "DefinedBenefitPlanRecognizedNetGainLossDueToSettlements1", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.agilent.com/role/RetirementPlansAndPostRetirementPensionPlansComponentsOfNetPeriodicCostsDetails", "http://www.agilent.com/role/RetirementPlansAndPostRetirementPensionPlansJwpilDetails", "http://www.agilent.com/role/SegmentInformationReconciliationOfReportableResultsDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_DefinedBenefitPlanRecognizedNetGainLossDueToSettlementsAndCurtailments1": { "auth_ref": [ "r359", "r383" ], "calculation": { "http://www.agilent.com/role/RetirementPlansAndPostRetirementPensionPlansComponentsOfNetPeriodicCostsDetails": { "order": 2.0, "parentTag": "us-gaap_OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIPensionAndOtherPostretirementBenefitPlansForNetTransitionAssetObligationBeforeTax", "weight": -1.0 } }, "crdr": "credit", "lang": { "en-US": { "role": { "documentation": "Amount of gain (loss) recognized in net periodic benefit (cost) credit from settlement and curtailment.", "label": "Defined Benefit Plan, Net Periodic Benefit Cost (Credit), Gain (Loss) Due to Settlement and Curtailment", "terseLabel": "Curtaliment and settlement" } } }, "localname": "DefinedBenefitPlanRecognizedNetGainLossDueToSettlementsAndCurtailments1", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.agilent.com/role/RetirementPlansAndPostRetirementPensionPlansComponentsOfNetPeriodicCostsDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_DefinedBenefitPlanServiceCost": { "auth_ref": [ "r329", "r354", "r378", "r385" ], "calculation": { "http://www.agilent.com/role/RetirementPlansAndPostRetirementPensionPlansComponentsOfNetPeriodicCostsDetails": { "order": 1.0, "parentTag": "us-gaap_DefinedBenefitPlanNetPeriodicBenefitCost", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-US": { "role": { "documentation": "Amount of cost for actuarial present value of benefits attributed to service rendered by employee for defined benefit plan.", "label": "Defined Benefit Plan, Service Cost", "terseLabel": "Service cost - benefits earned during the period", "verboseLabel": "Service cost" } } }, "localname": "DefinedBenefitPlanServiceCost", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.agilent.com/role/RetirementPlansAndPostRetirementPensionPlansComponentsOfNetPeriodicCostsDetails", "http://www.agilent.com/role/RetirementPlansAndPostRetirementPensionPlansFundedStatusDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_DefinedBenefitPlanSettlementsPlanAssets": { "auth_ref": [ "r342" ], "crdr": "credit", "lang": { "en-US": { "role": { "documentation": "Amount of payment, which decreases plan assets of defined benefit plan, for irrevocable action relieving primary responsibility for benefit obligation and eliminating risk for obligation and assets used to effect settlement. Transaction constituting settlement includes, but is not limited to, making lump-sum cash payment to participant in exchange for their rights to receive specified benefits and purchasing nonparticipating annuity contract.", "label": "Defined Benefit Plan, Plan Assets, Payment for Settlement", "terseLabel": "Settlements" } } }, "localname": "DefinedBenefitPlanSettlementsPlanAssets", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.agilent.com/role/RetirementPlansAndPostRetirementPensionPlansFundedStatusDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_DefinedBenefitPlanTransfersBetweenMeasurementLevels": { "auth_ref": [ "r350", "r385" ], "crdr": "debit", "lang": { "en-US": { "role": { "documentation": "Amount, measured using unobservable inputs, of increase (decrease) in plan assets of defined benefit plan, for assets transferred into (out of) Level 3 of fair value hierarchy. Includes, but is not limited to, transfer due to change in observability of significant inputs.", "label": "Defined Benefit Plan, Plan Assets Level 3 Reconciliation, Increase (Decrease) for Assets Transferred into (out of) Level 3", "terseLabel": "Transfers in (out)" } } }, "localname": "DefinedBenefitPlanTransfersBetweenMeasurementLevels", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.agilent.com/role/RetirementPlansAndPostRetirementPensionPlansFairValueOfPlanAssetsDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_DefinedBenefitPlanUltimateHealthCareCostTrendRate1": { "auth_ref": [ "r367" ], "lang": { "en-US": { "role": { "documentation": "Ultimate trend rate for health care cost for defined benefit postretirement plan.", "label": "Defined Benefit Plan, Ultimate Health Care Cost Trend Rate", "terseLabel": "Defined Benefit Plan, Ultimate Health Care Cost Trend Rate" } } }, "localname": "DefinedBenefitPlanUltimateHealthCareCostTrendRate1", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.agilent.com/role/RetirementPlansAndPostRetirementPensionPlansAssumptionsDetails" ], "xbrltype": "percentItemType" }, "us-gaap_DefinedBenefitPlanWeightedAverageAssumptionsUsedInCalculatingBenefitObligationAbstract": { "auth_ref": [], "lang": { "en-US": { "role": { "label": "Defined Benefit Plan, Weighted Average Assumptions Used in Calculating Benefit Obligation [Abstract]", "terseLabel": "Assumptions used to calculate the benefit obligation" } } }, "localname": "DefinedBenefitPlanWeightedAverageAssumptionsUsedInCalculatingBenefitObligationAbstract", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.agilent.com/role/RetirementPlansAndPostRetirementPensionPlansAssumptionsDetails" ], "xbrltype": "stringItemType" }, "us-gaap_DefinedBenefitPlanWeightedAverageAssumptionsUsedInCalculatingNetPeriodicBenefitCostAbstract": { "auth_ref": [], "lang": { "en-US": { "role": { "label": "Defined Benefit Plan, Weighted Average Assumptions Used in Calculating Net Periodic Benefit Cost [Abstract]", "terseLabel": "Assumptions used to calculate the net periodic cost" } } }, "localname": "DefinedBenefitPlanWeightedAverageAssumptionsUsedInCalculatingNetPeriodicBenefitCostAbstract", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.agilent.com/role/RetirementPlansAndPostRetirementPensionPlansAssumptionsDetails" ], "xbrltype": "stringItemType" }, "us-gaap_DefinedBenefitPlanYearHealthCareCostTrendRateReachesUltimateTrendRate": { "auth_ref": [ "r367" ], "lang": { "en-US": { "role": { "documentation": "Year ultimate health care cost trend rate is expected to be reached, in CCYY format.", "label": "Defined Benefit Plan, Year Health Care Cost Trend Rate Reaches Ultimate Trend Rate", "terseLabel": "Medical cost trend rate decreases to ultimate rate in year" } } }, "localname": "DefinedBenefitPlanYearHealthCareCostTrendRateReachesUltimateTrendRate", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.agilent.com/role/RetirementPlansAndPostRetirementPensionPlansAssumptionsDetails" ], "xbrltype": "gYearListItemType" }, "us-gaap_DefinedBenefitPostretirementHealthCoverageMember": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Plan designed to provide postretirement health benefits to retiree or beneficiary. Includes, but is not limited to, defined benefit and defined contribution plans.", "label": "Postretirement Health Coverage [Member]", "terseLabel": "Post-Retirement Benefit Plan" } } }, "localname": "DefinedBenefitPostretirementHealthCoverageMember", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.agilent.com/role/RetirementPlansAndPostRetirementPensionPlansAssumptionsDetails", "http://www.agilent.com/role/RetirementPlansAndPostRetirementPensionPlansComponentsOfNetPeriodicCostsDetails", "http://www.agilent.com/role/RetirementPlansAndPostRetirementPensionPlansDefinedContributionDetails", "http://www.agilent.com/role/RetirementPlansAndPostRetirementPensionPlansExpectedBenefitPaymentsDetails", "http://www.agilent.com/role/RetirementPlansAndPostRetirementPensionPlansFairValueOfPlanAssetsDetails", "http://www.agilent.com/role/RetirementPlansAndPostRetirementPensionPlansFinancialStatementLocationDetails", "http://www.agilent.com/role/RetirementPlansAndPostRetirementPensionPlansFundedStatusDetails", "http://www.agilent.com/role/RetirementPlansAndPostRetirementPensionPlansRetirementPlansAndPostRetirementPensionPlansTargetAllocationsDetails" ], "xbrltype": "domainItemType" }, "us-gaap_DefinedContributionPlanCostRecognized": { "auth_ref": [ "r389" ], "crdr": "debit", "lang": { "en-US": { "role": { "documentation": "Amount of cost for defined contribution plan.", "label": "Defined Contribution Plan, Cost", "terseLabel": "401(k) Plan employer expense" } } }, "localname": "DefinedContributionPlanCostRecognized", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.agilent.com/role/RetirementPlansAndPostRetirementPensionPlansDefinedContributionDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_DefinedContributionPlanDisclosureLineItems": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.", "label": "Defined Contribution Plan Disclosure [Line Items]", "terseLabel": "Defined Contribution Plan Disclosure [Line Items]" } } }, "localname": "DefinedContributionPlanDisclosureLineItems", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.agilent.com/role/RetirementPlansAndPostRetirementPensionPlansDefinedContributionDetails" ], "xbrltype": "stringItemType" }, "us-gaap_DefinedContributionPlanEmployerMatchingContributionPercentOfMatch": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Percentage employer matches of the employee's percentage contribution matched.", "label": "Defined Contribution Plan, Employer Matching Contribution, Percent of Match", "terseLabel": "Maximum employer matching contribution in the 401(k) plan (in hundredths)" } } }, "localname": "DefinedContributionPlanEmployerMatchingContributionPercentOfMatch", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.agilent.com/role/RetirementPlansAndPostRetirementPensionPlansDefinedContributionDetails" ], "xbrltype": "percentItemType" }, "us-gaap_DefinedContributionPlanMaximumAnnualContributionsPerEmployeePercent": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Maximum percentage of employee gross pay the employee may contribute to a defined contribution plan.", "label": "Defined Contribution Plan, Maximum Annual Contributions Per Employee, Percent", "terseLabel": "Maximum employee contribution to 401(k)" } } }, "localname": "DefinedContributionPlanMaximumAnnualContributionsPerEmployeePercent", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.agilent.com/role/RetirementPlansAndPostRetirementPensionPlansDefinedContributionDetails" ], "xbrltype": "percentItemType" }, "us-gaap_DefinedContributionPlanTable": { "auth_ref": [ "r389" ], "lang": { "en-US": { "role": { "documentation": "Disclosure of information about defined contribution pension plans or defined contribution other postretirement plans, separately for pension plans and other postretirement benefit plans.", "label": "Defined Contribution Plan [Table]", "terseLabel": "Defined Contribution Plan [Table]" } } }, "localname": "DefinedContributionPlanTable", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.agilent.com/role/RetirementPlansAndPostRetirementPensionPlansDefinedContributionDetails" ], "xbrltype": "stringItemType" }, "us-gaap_Depreciation": { "auth_ref": [ "r129", "r257" ], "crdr": "debit", "lang": { "en-US": { "role": { "documentation": "The amount of expense recognized in the current period that reflects the allocation of the cost of tangible assets over the assets' useful lives. Includes production and non-production related depreciation.", "label": "Depreciation", "verboseLabel": "Depreciation expense" } } }, "localname": "Depreciation", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.agilent.com/role/PropertyPlantAndEquipmentNetDetails", "http://www.agilent.com/role/SegmentInformationProfitabilityDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_DepreciationDepletionAndAmortization": { "auth_ref": [ "r129", "r191" ], "calculation": { "http://www.agilent.com/role/ConsolidatedStatementOfCashFlows": { "order": 2.0, "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-US": { "role": { "documentation": "The aggregate expense recognized in the current period that allocates the cost of tangible assets, intangible assets, or depleting assets to periods that benefit from use of the assets.", "label": "Depreciation, Depletion and Amortization", "terseLabel": "Depreciation and amortization" } } }, "localname": "DepreciationDepletionAndAmortization", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.agilent.com/role/ConsolidatedStatementOfCashFlows" ], "xbrltype": "monetaryItemType" }, "us-gaap_DerivativeContractTypeDomain": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Financial instrument or contract with one or more underlyings, notional amount or payment provision or both, and the contract can be net settled by means outside the contract or delivery of an asset.", "label": "Derivative Contract [Domain]", "terseLabel": "Derivative Contract [Domain]", "verboseLabel": "Derivative Contract Type [Domain]" } } }, "localname": "DerivativeContractTypeDomain", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.agilent.com/role/DerivativesDetails", "http://www.agilent.com/role/DerivativesDisclosuresAndDerivativeInstrumentAggregatedNotionalAmountsByCurrencyAndDesignationsDetails", "http://www.agilent.com/role/DerivativesEffectOfDerivativeInstrumentsOnConsolidatedStatementOfOperationsDetails", "http://www.agilent.com/role/DerivativesFairValueOfDerivativeInstrumentsAndConsolidatedBalanceSheetLocationDetails", "http://www.agilent.com/role/LongTermDebtLongTermDebtOtherDetails", "http://www.agilent.com/role/LongTermDebtSeniorNotesDetails" ], "xbrltype": "domainItemType" }, "us-gaap_DerivativeFairValueOfDerivativeAsset": { "auth_ref": [ "r74", "r77", "r535", "r606" ], "crdr": "debit", "lang": { "en-US": { "role": { "documentation": "Fair value, before effects of master netting arrangements, of a financial asset or other contract with one or more underlyings, notional amount or payment provision or both, and the contract can be net settled by means outside the contract or delivery of an asset. Includes assets elected not to be offset. Excludes assets not subject to a master netting arrangement.", "label": "Derivative Asset, Fair Value, Gross Asset", "verboseLabel": "Derivative Asset, Fair Value" } } }, "localname": "DerivativeFairValueOfDerivativeAsset", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.agilent.com/role/DerivativesFairValueOfDerivativeInstrumentsAndConsolidatedBalanceSheetLocationDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_DerivativeFairValueOfDerivativeLiability": { "auth_ref": [ "r74", "r77", "r535", "r606" ], "crdr": "credit", "lang": { "en-US": { "role": { "documentation": "Fair value, before effects of master netting arrangements, of a financial liability or contract with one or more underlyings, notional amount or payment provision or both, and the contract can be net settled by means outside the contract or delivery of an asset. Includes liabilities elected not to be offset. Excludes liabilities not subject to a master netting arrangement.", "label": "Derivative Liability, Fair Value, Gross Liability", "verboseLabel": "Derivative Liability, Fair Value" } } }, "localname": "DerivativeFairValueOfDerivativeLiability", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.agilent.com/role/DerivativesFairValueOfDerivativeInstrumentsAndConsolidatedBalanceSheetLocationDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_DerivativeFairValueOfDerivativeNetAbstract": { "auth_ref": [], "lang": { "en-US": { "role": { "label": "Derivative, Fair Value, Net [Abstract]" } } }, "localname": "DerivativeFairValueOfDerivativeNetAbstract", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.agilent.com/role/DerivativesFairValueOfDerivativeInstrumentsAndConsolidatedBalanceSheetLocationDetails" ], "xbrltype": "stringItemType" }, "us-gaap_DerivativeGainLossOnDerivativeNet": { "auth_ref": [ "r534" ], "crdr": "credit", "lang": { "en-US": { "role": { "documentation": "Amount of increase (decrease) in the fair value of derivatives recognized in the income statement.", "label": "Derivative, Gain (Loss) on Derivative, Net", "terseLabel": "Gain (loss) recognized in other income (expense), net within continuing operations" } } }, "localname": "DerivativeGainLossOnDerivativeNet", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.agilent.com/role/DerivativesEffectOfDerivativeInstrumentsOnConsolidatedStatementOfOperationsDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_DerivativeInstrumentDetailAbstract": { "auth_ref": [], "lang": { "en-US": { "role": { "label": "Derivative Instrument Detail [Abstract]", "terseLabel": "Derivative Instruments", "verboseLabel": "Derivative Instruments and Hedging Activities Disclosure [Abstract]" } } }, "localname": "DerivativeInstrumentDetailAbstract", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.agilent.com/role/DerivativesDetails", "http://www.agilent.com/role/OverviewAndSummaryOfSignificantAccountingPoliciesDetails" ], "xbrltype": "stringItemType" }, "us-gaap_DerivativeInstrumentRiskAxis": { "auth_ref": [ "r533", "r536", "r540", "r545" ], "lang": { "en-US": { "role": { "documentation": "Information by type of derivative contract.", "label": "Derivative Instrument [Axis]", "terseLabel": "Derivative Instrument [Axis]", "verboseLabel": "Derivative Instrument Risk [Axis]" } } }, "localname": "DerivativeInstrumentRiskAxis", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.agilent.com/role/DerivativesDetails", "http://www.agilent.com/role/DerivativesDisclosuresAndDerivativeInstrumentAggregatedNotionalAmountsByCurrencyAndDesignationsDetails", "http://www.agilent.com/role/DerivativesEffectOfDerivativeInstrumentsOnConsolidatedStatementOfOperationsDetails", "http://www.agilent.com/role/DerivativesFairValueOfDerivativeInstrumentsAndConsolidatedBalanceSheetLocationDetails", "http://www.agilent.com/role/LongTermDebtLongTermDebtOtherDetails", "http://www.agilent.com/role/LongTermDebtSeniorNotesDetails" ], "xbrltype": "stringItemType" }, "us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract": { "auth_ref": [], "lang": { "en-US": { "role": { "label": "Derivative Instruments and Hedging Activities Disclosure [Abstract]" } } }, "localname": "DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "xbrltype": "stringItemType" }, "us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureTextBlock": { "auth_ref": [ "r557" ], "lang": { "en-US": { "role": { "documentation": "The entire disclosure for derivative instruments and hedging activities including, but not limited to, risk management strategies, non-hedging derivative instruments, assets, liabilities, revenue and expenses, and methodologies and assumptions used in determining the amounts.", "label": "Derivative Instruments and Hedging Activities Disclosure [Text Block]", "verboseLabel": "DERIVATIVES" } } }, "localname": "DerivativeInstrumentsAndHedgingActivitiesDisclosureTextBlock", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.agilent.com/role/Derivatives" ], "xbrltype": "textBlockItemType" }, "us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis": { "auth_ref": [ "r529", "r533", "r540" ], "lang": { "en-US": { "role": { "documentation": "Information by type of hedging relationship.", "label": "Hedging Relationship [Axis]", "terseLabel": "Hedging Relationship [Axis]" } } }, "localname": "DerivativeInstrumentsGainLossByHedgingRelationshipAxis", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.agilent.com/role/DerivativesDetails", "http://www.agilent.com/role/DerivativesDisclosuresAndDerivativeInstrumentAggregatedNotionalAmountsByCurrencyAndDesignationsDetails", "http://www.agilent.com/role/DerivativesEffectOfDerivativeInstrumentsOnConsolidatedStatementOfOperationsDetails", "http://www.agilent.com/role/DerivativesFairValueOfDerivativeInstrumentsAndConsolidatedBalanceSheetLocationDetails", "http://www.agilent.com/role/LongTermDebtLongTermDebtOtherDetails" ], "xbrltype": "stringItemType" }, "us-gaap_DerivativeInstrumentsGainLossReclassifiedFromAccumulatedOCIIntoIncomeEffectivePortionNet": { "auth_ref": [ "r539", "r544" ], "crdr": "credit", "lang": { "en-US": { "role": { "documentation": "The effective portion of net gain (loss) reclassified from accumulated other comprehensive income into income on derivative instruments designated and qualifying as hedging instruments.", "label": "Derivative Instruments, Gain (Loss) Reclassified from Accumulated OCI into Income, Effective Portion, Net", "terseLabel": "Gain(loss reclassified from accumulated other comprehensive income (loss) into cost of sales", "verboseLabel": "Unrealized gains (losses) on derivatives reclassification out of AOCI to cost of sales" } } }, "localname": "DerivativeInstrumentsGainLossReclassifiedFromAccumulatedOCIIntoIncomeEffectivePortionNet", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.agilent.com/role/DerivativesEffectOfDerivativeInstrumentsOnConsolidatedStatementOfOperationsDetails", "http://www.agilent.com/role/StockholdersEquityStockholdersEquityReclassificationsOutOfAccumulatedOtherComprehensiveIncomeDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_DerivativeLiabilities": { "auth_ref": [ "r75", "r76", "r572" ], "calculation": { "http://www.agilent.com/role/FairValueMeasurementsFairValueOfAssetsAndLiabilitiesMeasuredOnRecurringBasisDetails": { "order": 1.0, "parentTag": "a_FairValueLiabilitiesMeasuredOnRecurringBasisTotalLiabilities", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-US": { "role": { "documentation": "Fair value, after the effects of master netting arrangements, of a financial liability or contract with one or more underlyings, notional amount or payment provision or both, and the contract can be net settled by means outside the contract or delivery of an asset. Includes liabilities not subject to a master netting arrangement and not elected to be offset.", "label": "Derivative Liability", "terseLabel": "Derivative instruments (foreign exchange contracts)" } } }, "localname": "DerivativeLiabilities", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.agilent.com/role/FairValueMeasurementsFairValueOfAssetsAndLiabilitiesMeasuredOnRecurringBasisDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_DerivativeLineItems": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.", "label": "Derivative [Line Items]" } } }, "localname": "DerivativeLineItems", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.agilent.com/role/DerivativesDetails", "http://www.agilent.com/role/DerivativesDisclosuresAndDerivativeInstrumentAggregatedNotionalAmountsByCurrencyAndDesignationsDetails", "http://www.agilent.com/role/DerivativesEffectOfDerivativeInstrumentsOnConsolidatedStatementOfOperationsDetails", "http://www.agilent.com/role/DerivativesFairValueOfDerivativeInstrumentsAndConsolidatedBalanceSheetLocationDetails" ], "xbrltype": "stringItemType" }, "us-gaap_DerivativeNetLiabilityPositionAggregateFairValue": { "auth_ref": [ "r548" ], "crdr": "credit", "lang": { "en-US": { "role": { "documentation": "The aggregate fair value amounts of derivative instruments that contain credit-risk-related contingent features that are in a net liability position at the end of the reporting period. For nonderivative instruments that are designated and qualify as hedging instruments, the fair value amounts are the carrying value of the nonderivative hedging instrument, including the adjustment for the foreign currency transaction gain (loss) on that instrument.", "label": "Derivative, Net Liability Position, Aggregate Fair Value", "terseLabel": "Derivative, Net Liability Position, Aggregate Fair Value" } } }, "localname": "DerivativeNetLiabilityPositionAggregateFairValue", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.agilent.com/role/DerivativesDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_DerivativeTable": { "auth_ref": [ "r150", "r525", "r526", "r527", "r529", "r531", "r538", "r540", "r549", "r551", "r553" ], "lang": { "en-US": { "role": { "documentation": "Schedule that describes and identifies a derivative or group of derivatives on a disaggregated basis, such as for individual instruments, or small groups of similar instruments. May include a combination of the type of instrument, risks being hedged, notional amount, hedge designation, related hedged item, inception date, maturity date, or other relevant item.", "label": "Derivative [Table]" } } }, "localname": "DerivativeTable", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.agilent.com/role/DerivativesDetails", "http://www.agilent.com/role/DerivativesDisclosuresAndDerivativeInstrumentAggregatedNotionalAmountsByCurrencyAndDesignationsDetails", "http://www.agilent.com/role/DerivativesEffectOfDerivativeInstrumentsOnConsolidatedStatementOfOperationsDetails", "http://www.agilent.com/role/DerivativesFairValueOfDerivativeInstrumentsAndConsolidatedBalanceSheetLocationDetails" ], "xbrltype": "stringItemType" }, "us-gaap_DerivativesPolicyTextBlock": { "auth_ref": [ "r137", "r151", "r525", "r526", "r529", "r531", "r550" ], "lang": { "en-US": { "role": { "documentation": "Disclosure of accounting policy for its derivative instruments and hedging activities.", "label": "Derivatives, Policy [Policy Text Block]", "terseLabel": "Derivative instruments" } } }, "localname": "DerivativesPolicyTextBlock", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.agilent.com/role/OverviewAndSummaryOfSignificantAccountingPoliciesPolicies" ], "xbrltype": "textBlockItemType" }, "us-gaap_DesignatedAsHedgingInstrumentMember": { "auth_ref": [ "r529" ], "lang": { "en-US": { "role": { "documentation": "Derivative instrument designated as hedging instrument under Generally Accepted Accounting Principles (GAAP).", "label": "Designated as Hedging Instrument [Member]", "terseLabel": "Derivatives Designated as Hedging Instrument", "verboseLabel": "Designated as Hedging Instrument" } } }, "localname": "DesignatedAsHedgingInstrumentMember", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.agilent.com/role/DerivativesDetails", "http://www.agilent.com/role/DerivativesDisclosuresAndDerivativeInstrumentAggregatedNotionalAmountsByCurrencyAndDesignationsDetails", "http://www.agilent.com/role/DerivativesEffectOfDerivativeInstrumentsOnConsolidatedStatementOfOperationsDetails", "http://www.agilent.com/role/DerivativesFairValueOfDerivativeInstrumentsAndConsolidatedBalanceSheetLocationDetails" ], "xbrltype": "domainItemType" }, "us-gaap_DevelopedTechnologyRightsMember": { "auth_ref": [ "r497" ], "lang": { "en-US": { "role": { "documentation": "Rights to developed technology, which can include the right to develop, use, market, sell, or offer for sale products, compounds, or intellectual property.", "label": "Developed Technology Rights [Member]", "terseLabel": "Purchased technology", "verboseLabel": "Developed product technology" } } }, "localname": "DevelopedTechnologyRightsMember", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.agilent.com/role/AcquisitionsAcquisitionsIntangibleAssetsDetails", "http://www.agilent.com/role/GoodwillAndOtherIntangibleAssetsDisclosuresAndComponentsOfOtherIntangiblesDetails", "http://www.agilent.com/role/GoodwillAndOtherIntangibleAssetsTextDetails", "http://www.agilent.com/role/OverviewAndSummaryOfSignificantAccountingPoliciesDetails" ], "xbrltype": "domainItemType" }, "us-gaap_DifferenceBetweenRevenueGuidanceInEffectBeforeAndAfterTopic606Member": { "auth_ref": [ "r320" ], "lang": { "en-US": { "role": { "documentation": "Effect in current period from application of guidance for revenue from contract with customer compared with guidance for revenue recognition applicable prior to change when using transition method for cumulative effect in period including initial date of application.", "label": "Difference between Revenue Guidance in Effect before and after Topic 606 [Member]", "terseLabel": "Difference between Revenue Guidance in Effect before and after Topic 606 [Member]" } } }, "localname": "DifferenceBetweenRevenueGuidanceInEffectBeforeAndAfterTopic606Member", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.agilent.com/role/RevenueRevenueContractBalancesDetails" ], "xbrltype": "domainItemType" }, "us-gaap_DisaggregationOfRevenueLineItems": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.", "label": "Disaggregation of Revenue [Line Items]", "terseLabel": "Disaggregation of Revenue [Line Items]" } } }, "localname": "DisaggregationOfRevenueLineItems", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.agilent.com/role/RevenueRevenueByEndMarketsDetails", "http://www.agilent.com/role/RevenueRevenueByRegionDetails", "http://www.agilent.com/role/RevenueRevenueRevenueByTypeDetails" ], "xbrltype": "stringItemType" }, "us-gaap_DisaggregationOfRevenueTable": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Disclosure of information about disaggregation of revenue into categories depicting how nature, amount, timing, and uncertainty of revenue and cash flows are affected by economic factor.", "label": "Disaggregation of Revenue [Table]", "terseLabel": "Disaggregation of Revenue [Table]" } } }, "localname": "DisaggregationOfRevenueTable", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.agilent.com/role/RevenueRevenueByEndMarketsDetails", "http://www.agilent.com/role/RevenueRevenueByRegionDetails", "http://www.agilent.com/role/RevenueRevenueRevenueByTypeDetails" ], "xbrltype": "stringItemType" }, "us-gaap_DisaggregationOfRevenueTableTextBlock": { "auth_ref": [ "r315" ], "lang": { "en-US": { "role": { "documentation": "Tabular disclosure of disaggregation of revenue into categories depicting how nature, amount, timing, and uncertainty of revenue and cash flows are affected by economic factor.", "label": "Disaggregation of Revenue [Table Text Block]", "terseLabel": "Disaggregation of Revenue" } } }, "localname": "DisaggregationOfRevenueTableTextBlock", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.agilent.com/role/RevenueRevenueTables" ], "xbrltype": "textBlockItemType" }, "us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock": { "auth_ref": [ "r431" ], "lang": { "en-US": { "role": { "documentation": "The entire disclosure for share-based payment arrangement.", "label": "Share-based Payment Arrangement [Text Block]", "terseLabel": "SHARE-BASED COMPENSATION" } } }, "localname": "DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.agilent.com/role/ShareBasedCompensation" ], "xbrltype": "textBlockItemType" }, "us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract": { "auth_ref": [], "lang": { "en-US": { "role": { "label": "Share-based Payment Arrangement [Abstract]", "terseLabel": "Share-based compensation disclosures" } } }, "localname": "DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.agilent.com/role/ShareBasedCompensationAllocatedShareBasedCompensationExpenseDetails" ], "xbrltype": "stringItemType" }, "us-gaap_DisclosureOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTextBlock": { "auth_ref": [ "r396", "r426" ], "lang": { "en-US": { "role": { "documentation": "Tabular disclosure of share-based payment arrangement.", "label": "Disclosure of Share-based Compensation Arrangements by Share-based Payment Award [Table Text Block]", "terseLabel": "Summary of stock option award activity" } } }, "localname": "DisclosureOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTextBlock", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.agilent.com/role/ShareBasedCompensationTables" ], "xbrltype": "textBlockItemType" }, "us-gaap_DividendPayableDateToBePaidDayMonthAndYear": { "auth_ref": [ "r134" ], "lang": { "en-US": { "role": { "documentation": "Date the declared dividend will be paid, in CCYY-MM-DD format.", "label": "Dividends Payable, Date to be Paid", "terseLabel": "Dividends payment date" } } }, "localname": "DividendPayableDateToBePaidDayMonthAndYear", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.agilent.com/role/StockholdersEquityStockholdersEquityDividendsDetails" ], "xbrltype": "dateItemType" }, "us-gaap_DividendsAbstract": { "auth_ref": [], "lang": { "en-US": { "role": { "label": "Dividends [Abstract]", "terseLabel": "Dividends [Abstract]" } } }, "localname": "DividendsAbstract", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.agilent.com/role/StockholdersEquityStockholdersEquityDividendsDetails" ], "xbrltype": "stringItemType" }, "us-gaap_DividendsCommonStockCash": { "auth_ref": [ "r303" ], "crdr": "debit", "lang": { "en-US": { "role": { "documentation": "Amount of paid and unpaid common stock dividends declared with the form of settlement in cash.", "label": "Dividends, Common Stock, Cash", "negatedTerseLabel": "Cash dividends declared", "terseLabel": "Cash dividends declared" } } }, "localname": "DividendsCommonStockCash", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.agilent.com/role/ConsolidatedStatementOfEquity", "http://www.agilent.com/role/StockholdersEquityStockholdersEquityDividendsDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_DividendsPayableDateDeclaredDayMonthAndYear": { "auth_ref": [ "r134" ], "lang": { "en-US": { "role": { "documentation": "Date the dividend to be paid was declared, in CCYY-MM-DD format.", "label": "Dividends Payable, Date Declared", "terseLabel": "Dividends Payable, Date Declared" } } }, "localname": "DividendsPayableDateDeclaredDayMonthAndYear", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.agilent.com/role/StockholdersEquityStockholdersEquityDividendsDetails" ], "xbrltype": "dateItemType" }, "us-gaap_DividendsPayableDateOfRecordDayMonthAndYear": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Date the holder must own the stock to be entitled to the dividend, in CCYY-MM-DD format.", "label": "Dividends Payable, Date of Record", "terseLabel": "Dividends date of record" } } }, "localname": "DividendsPayableDateOfRecordDayMonthAndYear", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.agilent.com/role/StockholdersEquityStockholdersEquityDividendsDetails" ], "xbrltype": "dateItemType" }, "us-gaap_DomesticCountryMember": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Designated tax department of the government that is entitled to levy and collect income taxes from the entity in its country of domicile.", "label": "Domestic Tax Authority [Member]", "terseLabel": "Domestic" } } }, "localname": "DomesticCountryMember", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.agilent.com/role/IncomeTaxesCarryforwardsDetails" ], "xbrltype": "domainItemType" }, "us-gaap_DomesticPlanMember": { "auth_ref": [ "r372" ], "lang": { "en-US": { "role": { "documentation": "Location of employer sponsoring plan, designed to provide retirement benefits, determined as principal place of business. Includes, but is not limited to, defined benefit and defined contribution plans.", "label": "Domestic Plan [Member]", "terseLabel": "U.S. Plan" } } }, "localname": "DomesticPlanMember", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.agilent.com/role/RetirementPlansAndPostRetirementPensionPlansAssumptionsDetails", "http://www.agilent.com/role/RetirementPlansAndPostRetirementPensionPlansFundedStatusDetails", "http://www.agilent.com/role/SegmentInformationReconciliationOfReportableResultsDetails" ], "xbrltype": "domainItemType" }, "us-gaap_EarlyRepaymentOfSeniorDebt": { "auth_ref": [ "r120" ], "crdr": "credit", "lang": { "en-US": { "role": { "documentation": "The cash outflow for the extinguishment of long-term borrowing, with the highest claim on the assets of the entity in case of bankruptcy or liquidation, before its maturity.", "label": "Early Repayment of Senior Debt", "terseLabel": "Early Repayment of Senior Debt" } } }, "localname": "EarlyRepaymentOfSeniorDebt", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.agilent.com/role/ShortTermDebtSeniorNotesDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_EarningsPerShareAbstract": { "auth_ref": [], "lang": { "en-US": { "role": { "label": "Earnings Per Share [Abstract]", "verboseLabel": "Net income per share:" } } }, "localname": "EarningsPerShareAbstract", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.agilent.com/role/ConsolidatedStatementOfOperations" ], "xbrltype": "stringItemType" }, "us-gaap_EarningsPerShareBasic": { "auth_ref": [ "r103", "r156", "r161", "r163", "r164", "r165", "r169", "r622", "r645" ], "lang": { "en-US": { "role": { "documentation": "The amount of net income (loss) for the period per each share of common stock or unit outstanding during the reporting period.", "label": "Earnings Per Share, Basic", "terseLabel": "Net income per share - basic" } } }, "localname": "EarningsPerShareBasic", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.agilent.com/role/ConsolidatedStatementOfOperations" ], "xbrltype": "perShareItemType" }, "us-gaap_EarningsPerShareDiluted": { "auth_ref": [ "r103", "r156", "r161", "r163", "r164", "r165", "r169", "r622", "r645" ], "lang": { "en-US": { "role": { "documentation": "The amount of net income (loss) for the period available to each share of common stock or common unit outstanding during the reporting period and to each share or unit that would have been outstanding assuming the issuance of common shares or units for all dilutive potential common shares or units outstanding during the reporting period.", "label": "Earnings Per Share, Diluted", "terseLabel": "Net income per share - diluted" } } }, "localname": "EarningsPerShareDiluted", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.agilent.com/role/ConsolidatedStatementOfOperations" ], "xbrltype": "perShareItemType" }, "us-gaap_EarningsPerSharePolicyTextBlock": { "auth_ref": [ "r137", "r166", "r167", "r168" ], "lang": { "en-US": { "role": { "documentation": "Disclosure of accounting policy for computing basic and diluted earnings or loss per share for each class of common stock and participating security. Addresses all significant policy factors, including any antidilutive items that have been excluded from the computation and takes into account stock dividends, splits and reverse splits that occur after the balance sheet date of the latest reporting period but before the issuance of the financial statements.", "label": "Earnings Per Share, Policy [Policy Text Block]", "terseLabel": "Net income (loss) per share" } } }, "localname": "EarningsPerSharePolicyTextBlock", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.agilent.com/role/OverviewAndSummaryOfSignificantAccountingPoliciesPolicies" ], "xbrltype": "textBlockItemType" }, "us-gaap_EarningsPerShareTextBlock": { "auth_ref": [ "r170" ], "lang": { "en-US": { "role": { "documentation": "The entire disclosure for earnings per share.", "label": "Earnings Per Share [Text Block]", "verboseLabel": "NET INCOME (LOSS) PER SHARE" } } }, "localname": "EarningsPerShareTextBlock", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.agilent.com/role/NetIncomeLossPerShare" ], "xbrltype": "textBlockItemType" }, "us-gaap_EffectOfExchangeRateOnCashAndCashEquivalents": { "auth_ref": [ "r577" ], "calculation": { "http://www.agilent.com/role/ConsolidatedStatementOfCashFlows": { "order": 4.0, "parentTag": "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-US": { "role": { "documentation": "Amount of increase (decrease) from the effect of exchange rate changes on cash and cash equivalent balances held in foreign currencies.", "label": "Effect of Exchange Rate on Cash and Cash Equivalents", "terseLabel": "Effect of exchange rate movements" } } }, "localname": "EffectOfExchangeRateOnCashAndCashEquivalents", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.agilent.com/role/ConsolidatedStatementOfCashFlows" ], "xbrltype": "monetaryItemType" }, "us-gaap_EffectiveIncomeTaxRateContinuingOperations": { "auth_ref": [ "r148", "r448", "r449" ], "lang": { "en-US": { "role": { "documentation": "Percentage of current income tax expense (benefit) and deferred income tax expense (benefit) pertaining to continuing operations.", "label": "Effective Income Tax Rate Reconciliation, Percent", "terseLabel": "Effective tax rate (in hundredths)" } } }, "localname": "EffectiveIncomeTaxRateContinuingOperations", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.agilent.com/role/IncomeTaxesIncomeTaxesEffectiveTaxRateAndTaxHolidaysDetails" ], "xbrltype": "percentItemType" }, "us-gaap_EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate": { "auth_ref": [ "r448", "r449", "r476" ], "lang": { "en-US": { "role": { "documentation": "Percentage of domestic federal statutory tax rate applicable to pretax income (loss).", "label": "Effective Income Tax Rate Reconciliation, at Federal Statutory Income Tax Rate, Percent", "terseLabel": "Effective Income Tax Rate Reconciliation, at Federal Statutory Income Tax Rate, Percent" } } }, "localname": "EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.agilent.com/role/NewAccountingPronouncementsImpactOfAdoptingNewGuidanceDetails", "http://www.agilent.com/role/NewAccountingPronouncementsTextualsDetails" ], "xbrltype": "percentItemType" }, "us-gaap_EmployeeRelatedLiabilitiesCurrent": { "auth_ref": [ "r55" ], "calculation": { "http://www.agilent.com/role/ConsolidatedBalanceSheet": { "order": 2.0, "parentTag": "us-gaap_LiabilitiesCurrent", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-US": { "role": { "documentation": "Total of the carrying values as of the balance sheet date of obligations incurred through that date and payable for obligations related to services received from employees, such as accrued salaries and bonuses, payroll taxes and fringe benefits. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).", "label": "Employee-related Liabilities, Current", "terseLabel": "Employee compensation and benefits", "verboseLabel": "Employee compensation and benefits" } } }, "localname": "EmployeeRelatedLiabilitiesCurrent", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.agilent.com/role/ConsolidatedBalanceSheet", "http://www.agilent.com/role/NewAccountingPronouncementsImpactOfAdoptingNewGuidanceDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_EmployeeRelatedLiabilitiesCurrentAndNoncurrentAbstract": { "auth_ref": [], "lang": { "en-US": { "role": { "label": "Employee-related Liabilities [Abstract]", "terseLabel": "Employee Compensation and Benefits" } } }, "localname": "EmployeeRelatedLiabilitiesCurrentAndNoncurrentAbstract", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.agilent.com/role/OverviewAndSummaryOfSignificantAccountingPoliciesDetails" ], "xbrltype": "stringItemType" }, "us-gaap_EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsCapitalizedAmount": { "auth_ref": [ "r424" ], "crdr": "debit", "lang": { "en-US": { "role": { "documentation": "Amount of cost capitalized for award under share-based payment arrangement.", "label": "Share-based Payment Arrangement, Amount Capitalized", "verboseLabel": "Share-based compensation expense" } } }, "localname": "EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsCapitalizedAmount", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.agilent.com/role/ShareBasedCompensationAllocatedShareBasedCompensationExpenseDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsLineItems": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.", "label": "Share-based Payment Arrangement, Expensed and Capitalized, Amount [Line Items]" } } }, "localname": "EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsLineItems", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.agilent.com/role/ShareBasedCompensationAllocatedShareBasedCompensationExpenseDetails" ], "xbrltype": "stringItemType" }, "us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized": { "auth_ref": [ "r425" ], "crdr": "debit", "lang": { "en-US": { "role": { "documentation": "Amount of cost not yet recognized for nonvested award under share-based payment arrangement.", "label": "Share-based Payment Arrangement, Nonvested Award, Cost Not yet Recognized, Amount", "terseLabel": "Share-based Payment Arrangement, Nonvested Award, Cost Not yet Recognized, Amount" } } }, "localname": "EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.agilent.com/role/ShareBasedCompensationSharesAuthorizedByExercisePriceRangeDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedShareBasedAwardsOtherThanOptions": { "auth_ref": [ "r425" ], "crdr": "debit", "lang": { "en-US": { "role": { "documentation": "Amount of cost to be recognized for nonvested award under share-based payment arrangement. Excludes share and unit options.", "label": "Share-based Payment Arrangement, Nonvested Award, Excluding Option, Cost Not yet Recognized, Amount", "verboseLabel": "Unrecognized share-based compensation costs for non-vested restricted stock awards, net of expected forfeitures" } } }, "localname": "EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedShareBasedAwardsOtherThanOptions", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.agilent.com/role/ShareBasedCompensationNonVestedAwardActivityDisclosureDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_EmployeeStockMember": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "An Employee Stock Purchase Plan is a tax-efficient means by which employees of a corporation can purchase the corporation's stock.", "label": "Employee Stock [Member]", "terseLabel": "Employee Stock Purchase Plan" } } }, "localname": "EmployeeStockMember", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.agilent.com/role/ShareBasedCompensationGeneralDisclosuresDetails" ], "xbrltype": "domainItemType" }, "us-gaap_EmployeeStockOptionMember": { "auth_ref": [ "r421" ], "lang": { "en-US": { "role": { "documentation": "Share-based payment arrangement granting right, subject to vesting and other restrictions, to purchase or sell certain number of shares at predetermined price for specified period of time.", "label": "Share-based Payment Arrangement, Option [Member]", "terseLabel": "Share-based Payment Arrangement, Option [Member]", "verboseLabel": "Stock Options" } } }, "localname": "EmployeeStockOptionMember", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.agilent.com/role/ShareBasedCompensationFairValueAssumptionsDetails", "http://www.agilent.com/role/ShareBasedCompensationGeneralDisclosuresDetails", "http://www.agilent.com/role/ShareBasedCompensationSharesAuthorizedByExercisePriceRangeDetails" ], "xbrltype": "domainItemType" }, "us-gaap_EntityWideInformationRevenueFromExternalCustomerLineItems": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.", "label": "Revenue from External Customer [Line Items]", "terseLabel": "Revenue from External Customer [Line Items]" } } }, "localname": "EntityWideInformationRevenueFromExternalCustomerLineItems", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.agilent.com/role/SegmentInformationTables" ], "xbrltype": "stringItemType" }, "us-gaap_EquityAbstract": { "auth_ref": [], "lang": { "en-US": { "role": { "label": "Equity [Abstract]" } } }, "localname": "EquityAbstract", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "xbrltype": "stringItemType" }, "us-gaap_EquityComponentDomain": { "auth_ref": [ "r296" ], "lang": { "en-US": { "role": { "documentation": "Components of equity are the parts of the total Equity balance including that which is allocated to common, preferred, treasury stock, retained earnings, etc.", "label": "Equity Component [Domain]", "terseLabel": "Equity Component [Domain]" } } }, "localname": "EquityComponentDomain", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.agilent.com/role/ConsolidatedStatementOfEquity", "http://www.agilent.com/role/StockholdersEquityChangesInAccumulatedOtherComprehensiveIncomeDetails", "http://www.agilent.com/role/StockholdersEquityStockRepurchasesDetails", "http://www.agilent.com/role/StockholdersEquityTables" ], "xbrltype": "domainItemType" }, "us-gaap_EquityMethodInvestmentOtherThanTemporaryImpairment": { "auth_ref": [ "r216" ], "crdr": "debit", "lang": { "en-US": { "role": { "documentation": "This item represents an other than temporary decline in value that has been recognized against an investment accounted for under the equity method of accounting. The excess of the carrying amount over the fair value of the investment represents the amount of the write down which is or was reflected in earnings. The written down value is a new cost basis with the adjusted value of the investment becoming its new carrying value subject to the equity accounting method. Evidence of a loss in value might include, but would not necessarily be limited to, absence of an ability to recover the carrying amount of the investment or inability of the investee to sustain an earnings capacity which would justify the carrying amount of the investment.", "label": "Equity Method Investment, Other than Temporary Impairment", "negatedTerseLabel": "Other-than-temporary impairment of equity method investment" } } }, "localname": "EquityMethodInvestmentOtherThanTemporaryImpairment", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.agilent.com/role/InvestmentsDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_EquityMethodInvestments": { "auth_ref": [ "r43", "r194", "r217" ], "crdr": "debit", "lang": { "en-US": { "role": { "documentation": "This item represents the carrying amount on the entity's balance sheet of its investment in common stock of an equity method investee. This is not an indicator of the fair value of the investment, rather it is the initial cost adjusted for the entity's share of earnings and losses of the investee, adjusted for any distributions (dividends) and other than temporary impairment (OTTI) losses recognized.", "label": "Equity Method Investments", "terseLabel": "Equity Method Investments" } } }, "localname": "EquityMethodInvestments", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.agilent.com/role/OverviewAndSummaryOfSignificantAccountingPoliciesDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_EquitySecuritiesByIndustryAxis": { "auth_ref": [ "r221" ], "lang": { "en-US": { "role": { "documentation": "Information by industry sector, examples include but are not limited to, commercial, industrial, agricultural, financial services, technology, healthcare and real estate.", "label": "Industry Sector [Axis]", "terseLabel": "Industry Sector [Axis]" } } }, "localname": "EquitySecuritiesByIndustryAxis", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.agilent.com/role/RetirementPlansAndPostRetirementPensionPlansJwpilDetails" ], "xbrltype": "stringItemType" }, "us-gaap_EquitySecuritiesByInvestmentObjectiveAxis": { "auth_ref": [ "r344", "r385" ], "lang": { "en-US": { "role": { "documentation": "Information by investment objective.", "label": "Investment Objective [Axis]", "terseLabel": "Investment Objective [Axis]" } } }, "localname": "EquitySecuritiesByInvestmentObjectiveAxis", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.agilent.com/role/RetirementPlansAndPostRetirementPensionPlansJwpilDetails" ], "xbrltype": "stringItemType" }, "us-gaap_EquitySecuritiesFvNi": { "auth_ref": [ "r569" ], "calculation": { "http://www.agilent.com/role/InvestmentsDetails": { "order": 1.0, "parentTag": "us-gaap_LongTermInvestments", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-US": { "role": { "documentation": "Amount of investment in equity security measured at fair value with change in fair value recognized in net income (FV-NI).", "label": "Equity Securities, FV-NI", "terseLabel": "Equity investments - with readily determinable fair value" } } }, "localname": "EquitySecuritiesFvNi", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.agilent.com/role/InvestmentsDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_EquitySecuritiesFvNiUnrealizedGainLoss": { "auth_ref": [ "r215" ], "crdr": "credit", "lang": { "en-US": { "role": { "documentation": "Amount of unrealized gain (loss) on investment in equity security measured at fair value with change in fair value recognized in net income (FV-NI).", "label": "Equity Securities, FV-NI, Unrealized Gain (Loss)", "terseLabel": "Net unrealized gains on our equity securities with RDFV" } } }, "localname": "EquitySecuritiesFvNiUnrealizedGainLoss", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.agilent.com/role/InvestmentsDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_EquitySecuritiesIndustryMember": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Industry sector consisting of government, private and corporate entities engaged in business activities, including but not limited to, commercial, industrial, agricultural, financial services, technology, healthcare and real estate.", "label": "Industry Sector [Domain]", "terseLabel": "Industry Sector [Domain]" } } }, "localname": "EquitySecuritiesIndustryMember", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.agilent.com/role/RetirementPlansAndPostRetirementPensionPlansJwpilDetails" ], "xbrltype": "domainItemType" }, "us-gaap_EquitySecuritiesInvestmentObjectiveMember": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Objective of investment.", "label": "Investment Objective [Domain]", "terseLabel": "Investment Objective [Domain]" } } }, "localname": "EquitySecuritiesInvestmentObjectiveMember", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.agilent.com/role/RetirementPlansAndPostRetirementPensionPlansJwpilDetails" ], "xbrltype": "domainItemType" }, "us-gaap_EquitySecuritiesMember": { "auth_ref": [ "r16", "r23", "r212", "r617", "r632", "r649" ], "lang": { "en-US": { "role": { "documentation": "Ownership interest or right to acquire or dispose of ownership interest in corporations and other legal entities for which ownership interest is represented by shares of common or preferred stock, convertible securities, stock rights, or stock warrants.", "label": "Equity Securities [Member]", "terseLabel": "Equity Securities" } } }, "localname": "EquitySecuritiesMember", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.agilent.com/role/RetirementPlansAndPostRetirementPensionPlansAssumptionsDetails", "http://www.agilent.com/role/RetirementPlansAndPostRetirementPensionPlansFairValueOfPlanAssetsDetails", "http://www.agilent.com/role/RetirementPlansAndPostRetirementPensionPlansRetirementPlansAndPostRetirementPensionPlansTargetAllocationsDetails" ], "xbrltype": "domainItemType" }, "us-gaap_EquitySecuritiesWithoutReadilyDeterminableFairValueAmount": { "auth_ref": [ "r213" ], "calculation": { "http://www.agilent.com/role/InvestmentsDetails": { "order": 3.0, "parentTag": "us-gaap_LongTermInvestments", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-US": { "role": { "documentation": "Amount of investment in equity security without readily determinable fair value.", "label": "Equity Securities without Readily Determinable Fair Value, Amount", "terseLabel": "Equity investments - without readily determinable fair value", "verboseLabel": "carrying amount of non-marketable equity securities without readily determinable fair values" } } }, "localname": "EquitySecuritiesWithoutReadilyDeterminableFairValueAmount", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.agilent.com/role/FairValueMeasurementsFairValueMeasurmentsFairValueOfAssetsAndLiabilitiesMeasuredOnNonRecurringDetails", "http://www.agilent.com/role/InvestmentsDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_EquitySecuritiesWithoutReadilyDeterminableFairValueImpairmentLossAnnualAmount": { "auth_ref": [ "r214" ], "crdr": "debit", "lang": { "en-US": { "role": { "documentation": "Amount of impairment loss on investment in equity security without readily determinable fair value.", "label": "Equity Securities without Readily Determinable Fair Value, Impairment Loss, Annual Amount", "terseLabel": "impairments or material changes in non-marketable securities without readily determinable fair value" } } }, "localname": "EquitySecuritiesWithoutReadilyDeterminableFairValueImpairmentLossAnnualAmount", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.agilent.com/role/FairValueMeasurementsFairValueMeasurmentsFairValueOfAssetsAndLiabilitiesMeasuredOnNonRecurringDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_ExtinguishmentOfDebtAmount": { "auth_ref": [], "crdr": "debit", "lang": { "en-US": { "role": { "documentation": "Gross amount of debt extinguished.", "label": "Extinguishment of Debt, Amount", "terseLabel": "Extinguishment of Debt, Amount" } } }, "localname": "ExtinguishmentOfDebtAmount", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.agilent.com/role/DerivativesDetails", "http://www.agilent.com/role/ShortTermDebtSeniorNotesDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.", "label": "Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]", "terseLabel": "Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]" } } }, "localname": "FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.agilent.com/role/FairValueMeasurementsFairValueMeasurmentsFairValueOfAssetsAndLiabilitiesMeasuredOnNonRecurringDetails", "http://www.agilent.com/role/FairValueMeasurementsFairValueOfAssetsAndLiabilitiesMeasuredOnRecurringBasisDetails" ], "xbrltype": "stringItemType" }, "us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable": { "auth_ref": [ "r559", "r560", "r561", "r565" ], "lang": { "en-US": { "role": { "documentation": "Disclosure of information about asset and liability measured at fair value on recurring and nonrecurring basis.", "label": "Fair Value, Recurring and Nonrecurring [Table]", "terseLabel": "Fair Value, Recurring and Nonrecurring [Table]" } } }, "localname": "FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.agilent.com/role/FairValueMeasurementsFairValueMeasurmentsFairValueOfAssetsAndLiabilitiesMeasuredOnNonRecurringDetails", "http://www.agilent.com/role/FairValueMeasurementsFairValueOfAssetsAndLiabilitiesMeasuredOnRecurringBasisDetails" ], "xbrltype": "stringItemType" }, "us-gaap_FairValueByFairValueHierarchyLevelAxis": { "auth_ref": [ "r345", "r346", "r385", "r560", "r602" ], "lang": { "en-US": { "role": { "documentation": "Information by level within fair value hierarchy and fair value measured at net asset value per share as practical expedient.", "label": "Fair Value Hierarchy and NAV [Axis]", "terseLabel": "Fair Value Hierarchy and NAV [Axis]" } } }, "localname": "FairValueByFairValueHierarchyLevelAxis", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.agilent.com/role/FairValueMeasurementsFairValueMeasurmentsFairValueOfAssetsAndLiabilitiesMeasuredOnNonRecurringDetails", "http://www.agilent.com/role/FairValueMeasurementsFairValueOfAssetsAndLiabilitiesMeasuredOnRecurringBasisDetails", "http://www.agilent.com/role/RetirementPlansAndPostRetirementPensionPlansFairValueOfPlanAssetsDetails", "http://www.agilent.com/role/RetirementPlansAndPostRetirementPensionPlansJwpilDetails" ], "xbrltype": "stringItemType" }, "us-gaap_FairValueByMeasurementFrequencyAxis": { "auth_ref": [ "r559", "r560", "r562", "r563", "r567" ], "lang": { "en-US": { "role": { "documentation": "Information by measurement frequency.", "label": "Measurement Frequency [Axis]", "terseLabel": "Measurement Frequency [Axis]" } } }, "localname": "FairValueByMeasurementFrequencyAxis", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.agilent.com/role/FairValueMeasurementsFairValueMeasurmentsFairValueOfAssetsAndLiabilitiesMeasuredOnNonRecurringDetails", "http://www.agilent.com/role/FairValueMeasurementsFairValueOfAssetsAndLiabilitiesMeasuredOnRecurringBasisDetails" ], "xbrltype": "stringItemType" }, "us-gaap_FairValueDisclosuresAbstract": { "auth_ref": [], "lang": { "en-US": { "role": { "label": "Fair Value Disclosures [Abstract]", "terseLabel": "Fair Value Disclosures" } } }, "localname": "FairValueDisclosuresAbstract", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.agilent.com/role/OverviewAndSummaryOfSignificantAccountingPoliciesDetails" ], "xbrltype": "stringItemType" }, "us-gaap_FairValueDisclosuresTextBlock": { "auth_ref": [ "r564" ], "lang": { "en-US": { "role": { "documentation": "The entire disclosure for the fair value of financial instruments (as defined), including financial assets and financial liabilities (collectively, as defined), and the measurements of those instruments as well as disclosures related to the fair value of non-financial assets and liabilities. Such disclosures about the financial instruments, assets, and liabilities would include: (1) the fair value of the required items together with their carrying amounts (as appropriate); (2) for items for which it is not practicable to estimate fair value, disclosure would include: (a) information pertinent to estimating fair value (including, carrying amount, effective interest rate, and maturity, and (b) the reasons why it is not practicable to estimate fair value; (3) significant concentrations of credit risk including: (a) information about the activity, region, or economic characteristics identifying a concentration, (b) the maximum amount of loss the entity is exposed to based on the gross fair value of the related item, (c) policy for requiring collateral or other security and information as to accessing such collateral or security, and (d) the nature and brief description of such collateral or security; (4) quantitative information about market risks and how such risks are managed; (5) for items measured on both a recurring and nonrecurring basis information regarding the inputs used to develop the fair value measurement; and (6) for items presented in the financial statement for which fair value measurement is elected: (a) information necessary to understand the reasons for the election, (b) discussion of the effect of fair value changes on earnings, (c) a description of [similar groups] items for which the election is made and the relation thereof to the balance sheet, the aggregate carrying value of items included in the balance sheet that are not eligible for the election; (7) all other required (as defined) and desired information.", "label": "Fair Value Disclosures [Text Block]", "verboseLabel": "FAIR VALUE MEASUREMENTS" } } }, "localname": "FairValueDisclosuresTextBlock", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.agilent.com/role/FairValueMeasurements" ], "xbrltype": "textBlockItemType" }, "us-gaap_FairValueInputsLevel1Member": { "auth_ref": [ "r345", "r346", "r385", "r560", "r603" ], "lang": { "en-US": { "role": { "documentation": "Quoted prices in active markets for identical assets or liabilities that the reporting entity can access at the measurement date.", "label": "Fair Value, Inputs, Level 1 [Member]", "terseLabel": "Quoted Prices in Active Markets for Identical Assets (Level 1) [Member]" } } }, "localname": "FairValueInputsLevel1Member", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.agilent.com/role/FairValueMeasurementsFairValueOfAssetsAndLiabilitiesMeasuredOnRecurringBasisDetails", "http://www.agilent.com/role/RetirementPlansAndPostRetirementPensionPlansFairValueOfPlanAssetsDetails" ], "xbrltype": "domainItemType" }, "us-gaap_FairValueInputsLevel2Member": { "auth_ref": [ "r345", "r346", "r385", "r560", "r604" ], "lang": { "en-US": { "role": { "documentation": "Inputs other than quoted prices included within level 1 that are observable for an asset or liability, either directly or indirectly, including, but not limited to, quoted prices for similar assets or liabilities in active markets, or quoted prices for identical or similar assets or liabilities in inactive markets.", "label": "Fair Value, Inputs, Level 2 [Member]", "terseLabel": "Significant Other Observable Inputs (Level 2)" } } }, "localname": "FairValueInputsLevel2Member", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.agilent.com/role/FairValueMeasurementsFairValueOfAssetsAndLiabilitiesMeasuredOnRecurringBasisDetails", "http://www.agilent.com/role/RetirementPlansAndPostRetirementPensionPlansFairValueOfPlanAssetsDetails" ], "xbrltype": "domainItemType" }, "us-gaap_FairValueInputsLevel3Member": { "auth_ref": [ "r345", "r346", "r385", "r560", "r605" ], "lang": { "en-US": { "role": { "documentation": "Unobservable inputs that reflect the entity's own assumption about the assumptions market participants would use in pricing.", "label": "Fair Value, Inputs, Level 3 [Member]", "terseLabel": "Significant Unobservable Inputs (Level 3)" } } }, "localname": "FairValueInputsLevel3Member", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.agilent.com/role/FairValueMeasurementsFairValueOfAssetsAndLiabilitiesMeasuredOnRecurringBasisDetails", "http://www.agilent.com/role/RetirementPlansAndPostRetirementPensionPlansFairValueOfPlanAssetsDetails" ], "xbrltype": "domainItemType" }, "us-gaap_FairValueMeasurementFrequencyDomain": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Measurement frequency.", "label": "Measurement Frequency [Domain]", "terseLabel": "Measurement Frequency [Domain]" } } }, "localname": "FairValueMeasurementFrequencyDomain", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.agilent.com/role/FairValueMeasurementsFairValueMeasurmentsFairValueOfAssetsAndLiabilitiesMeasuredOnNonRecurringDetails", "http://www.agilent.com/role/FairValueMeasurementsFairValueOfAssetsAndLiabilitiesMeasuredOnRecurringBasisDetails" ], "xbrltype": "domainItemType" }, "us-gaap_FairValueMeasurementsFairValueHierarchyDomain": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Categories used to prioritize the inputs to valuation techniques to measure fair value.", "label": "Fair Value Hierarchy and NAV [Domain]", "terseLabel": "Fair Value Hierarchy and NAV [Domain]" } } }, "localname": "FairValueMeasurementsFairValueHierarchyDomain", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.agilent.com/role/FairValueMeasurementsFairValueMeasurmentsFairValueOfAssetsAndLiabilitiesMeasuredOnNonRecurringDetails", "http://www.agilent.com/role/FairValueMeasurementsFairValueOfAssetsAndLiabilitiesMeasuredOnRecurringBasisDetails", "http://www.agilent.com/role/RetirementPlansAndPostRetirementPensionPlansFairValueOfPlanAssetsDetails", "http://www.agilent.com/role/RetirementPlansAndPostRetirementPensionPlansJwpilDetails" ], "xbrltype": "domainItemType" }, "us-gaap_FairValueMeasurementsRecurringMember": { "auth_ref": [ "r564", "r567" ], "lang": { "en-US": { "role": { "documentation": "Frequent fair value measurement. Includes, but is not limited to, fair value adjustment for impairment of asset, liability or equity, frequently measured at fair value.", "label": "Fair Value, Recurring [Member]" } } }, "localname": "FairValueMeasurementsRecurringMember", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.agilent.com/role/FairValueMeasurementsFairValueOfAssetsAndLiabilitiesMeasuredOnRecurringBasisDetails" ], "xbrltype": "domainItemType" }, "us-gaap_FairValueOfFinancialInstrumentsPolicy": { "auth_ref": [ "r137", "r568", "r571" ], "lang": { "en-US": { "role": { "documentation": "Disclosure of accounting policy for determining the fair value of financial instruments.", "label": "Fair Value of Financial Instruments, Policy [Policy Text Block]", "terseLabel": "Fair value of financial instruments" } } }, "localname": "FairValueOfFinancialInstrumentsPolicy", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.agilent.com/role/OverviewAndSummaryOfSignificantAccountingPoliciesPolicies" ], "xbrltype": "textBlockItemType" }, "us-gaap_FiniteLivedAndIndefiniteLivedIntangibleAssetsAcquiredAsPartOfBusinessCombinationTableTextBlock": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Tabular disclosure of finite-lived and indefinite-lived intangible assets acquired as part of a business combination.", "label": "Finite-Lived and Indefinite-Lived Intangible Assets Acquired as Part of Business Combination [Table Text Block]", "terseLabel": "Components of intangible assets acquired" } } }, "localname": "FiniteLivedAndIndefiniteLivedIntangibleAssetsAcquiredAsPartOfBusinessCombinationTableTextBlock", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.agilent.com/role/AcquisitionsTables" ], "xbrltype": "textBlockItemType" }, "us-gaap_FiniteLivedIntangibleAssetUsefulLife": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Useful life of finite-lived intangible assets, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days.", "label": "Finite-Lived Intangible Asset, Useful Life", "verboseLabel": "Finite Lived Intangible Assets Useful Life" } } }, "localname": "FiniteLivedIntangibleAssetUsefulLife", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.agilent.com/role/OverviewAndSummaryOfSignificantAccountingPoliciesDetails" ], "xbrltype": "durationItemType" }, "us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization": { "auth_ref": [ "r245" ], "crdr": "credit", "lang": { "en-US": { "role": { "documentation": "Accumulated amount of amortization of assets, excluding financial assets and goodwill, lacking physical substance with a finite life.", "label": "Finite-Lived Intangible Assets, Accumulated Amortization", "terseLabel": "Accumulated Amortization" } } }, "localname": "FiniteLivedIntangibleAssetsAccumulatedAmortization", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.agilent.com/role/GoodwillAndOtherIntangibleAssetsDisclosuresAndComponentsOfOtherIntangiblesDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseAfterYearFive": { "auth_ref": [], "crdr": "debit", "lang": { "en-US": { "role": { "documentation": "Amount of amortization expense for assets, excluding financial assets and goodwill, lacking physical substance with a finite life expected to be recognized after the fifth fiscal year following the latest fiscal year. Excludes interim and annual periods when interim periods are reported on a rolling approach, from latest balance sheet date.", "label": "Finite-Lived Intangible Assets, Amortization Expense, after Year Five", "verboseLabel": "Future amortization thereafter" } } }, "localname": "FiniteLivedIntangibleAssetsAmortizationExpenseAfterYearFive", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.agilent.com/role/GoodwillAndOtherIntangibleAssetsAmortizationExpenseAndFutureAmortizationExpenseDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths": { "auth_ref": [ "r247" ], "crdr": "debit", "lang": { "en-US": { "role": { "documentation": "Amount of amortization expense for assets, excluding financial assets and goodwill, lacking physical substance with a finite life expected to be recognized during the next fiscal year following the latest fiscal year. Excludes interim and annual periods when interim periods are reported on a rolling approach, from latest balance sheet date.", "label": "Finite-Lived Intangible Assets, Amortization Expense, Next Twelve Months", "terseLabel": "Future amortization expense for 2020" } } }, "localname": "FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.agilent.com/role/GoodwillAndOtherIntangibleAssetsAmortizationExpenseAndFutureAmortizationExpenseDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFive": { "auth_ref": [ "r247" ], "crdr": "debit", "lang": { "en-US": { "role": { "documentation": "Amount of amortization expense for assets, excluding financial assets and goodwill, lacking physical substance with a finite life expected to be recognized during the fifth fiscal year following the latest fiscal year. Excludes interim and annual periods when interim periods are reported on a rolling approach, from latest balance sheet date.", "label": "Finite-Lived Intangible Assets, Amortization Expense, Year Five", "terseLabel": "Future amortization expense for 2024" } } }, "localname": "FiniteLivedIntangibleAssetsAmortizationExpenseYearFive", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.agilent.com/role/GoodwillAndOtherIntangibleAssetsAmortizationExpenseAndFutureAmortizationExpenseDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFour": { "auth_ref": [ "r247" ], "crdr": "debit", "lang": { "en-US": { "role": { "documentation": "Amount of amortization expense for assets, excluding financial assets and goodwill, lacking physical substance with a finite life expected to be recognized during the fourth fiscal year following the latest fiscal year. Excludes interim and annual periods when interim periods are reported on a rolling approach, from latest balance sheet date.", "label": "Finite-Lived Intangible Assets, Amortization Expense, Year Four", "terseLabel": "Future amortization expense for 2023" } } }, "localname": "FiniteLivedIntangibleAssetsAmortizationExpenseYearFour", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.agilent.com/role/GoodwillAndOtherIntangibleAssetsAmortizationExpenseAndFutureAmortizationExpenseDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearThree": { "auth_ref": [ "r247" ], "crdr": "debit", "lang": { "en-US": { "role": { "documentation": "Amount of amortization expense for assets, excluding financial assets and goodwill, lacking physical substance with a finite life expected to be recognized during the third fiscal year following the latest fiscal year. Excludes interim and annual periods when interim periods are reported on a rolling approach, from latest balance sheet date.", "label": "Finite-Lived Intangible Assets, Amortization Expense, Year Three", "terseLabel": "Future amortization expense for 2022" } } }, "localname": "FiniteLivedIntangibleAssetsAmortizationExpenseYearThree", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.agilent.com/role/GoodwillAndOtherIntangibleAssetsAmortizationExpenseAndFutureAmortizationExpenseDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo": { "auth_ref": [ "r247" ], "crdr": "debit", "lang": { "en-US": { "role": { "documentation": "Amount of amortization expense for assets, excluding financial assets and goodwill, lacking physical substance with a finite life expected to be recognized during the second fiscal year following the latest fiscal year. Excludes interim and annual periods when interim periods are reported on a rolling approach, from latest balance sheet date.", "label": "Finite-Lived Intangible Assets, Amortization Expense, Year Two", "terseLabel": "Future amortization expense for 2021" } } }, "localname": "FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.agilent.com/role/GoodwillAndOtherIntangibleAssetsAmortizationExpenseAndFutureAmortizationExpenseDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis": { "auth_ref": [ "r239", "r241", "r245", "r249", "r607" ], "lang": { "en-US": { "role": { "documentation": "Information by major type or class of finite-lived intangible assets.", "label": "Finite-Lived Intangible Assets by Major Class [Axis]", "terseLabel": "Finite-Lived Intangible Assets by Major Class [Axis]" } } }, "localname": "FiniteLivedIntangibleAssetsByMajorClassAxis", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.agilent.com/role/AcquisitionsAcquisitionsIntangibleAssetsDetails", "http://www.agilent.com/role/GoodwillAndOtherIntangibleAssetsDisclosuresAndComponentsOfOtherIntangiblesDetails", "http://www.agilent.com/role/GoodwillAndOtherIntangibleAssetsTextDetails", "http://www.agilent.com/role/OverviewAndSummaryOfSignificantAccountingPoliciesDetails" ], "xbrltype": "stringItemType" }, "us-gaap_FiniteLivedIntangibleAssetsForeignCurrencyTranslationGainLoss": { "auth_ref": [], "crdr": "credit", "lang": { "en-US": { "role": { "documentation": "Amount of foreign currency translation gain (loss) which increases (decreases) assets, excluding financial assets and goodwill, lacking physical substance with a finite life.", "label": "Finite Lived Intangible Assets, Foreign Currency Translation Gain (Loss)", "terseLabel": "Foreign exchange translation impact to other intangible assets" } } }, "localname": "FiniteLivedIntangibleAssetsForeignCurrencyTranslationGainLoss", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.agilent.com/role/GoodwillAndOtherIntangibleAssetsTextDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_FiniteLivedIntangibleAssetsFutureAmortizationExpenseCurrentAndFiveSucceedingFiscalYearsAbstract": { "auth_ref": [], "lang": { "en-US": { "role": { "label": "Finite-Lived Intangible Assets, Amortization Expense, Maturity Schedule [Abstract]", "terseLabel": "Amortization Expense, Maturity Schedule [Abstract]" } } }, "localname": "FiniteLivedIntangibleAssetsFutureAmortizationExpenseCurrentAndFiveSucceedingFiscalYearsAbstract", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.agilent.com/role/GoodwillAndOtherIntangibleAssetsAmortizationExpenseAndFutureAmortizationExpenseDetails" ], "xbrltype": "stringItemType" }, "us-gaap_FiniteLivedIntangibleAssetsGross": { "auth_ref": [ "r245", "r607" ], "crdr": "debit", "lang": { "en-US": { "role": { "documentation": "Amount before amortization of assets, excluding financial assets and goodwill, lacking physical substance with a finite life.", "label": "Finite-Lived Intangible Assets, Gross", "terseLabel": "Gross Carrying Amount", "verboseLabel": "Finite-lived intangible assets acquired" } } }, "localname": "FiniteLivedIntangibleAssetsGross", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.agilent.com/role/AcquisitionsAcquisitionsIntangibleAssetsDetails", "http://www.agilent.com/role/GoodwillAndOtherIntangibleAssetsDisclosuresAndComponentsOfOtherIntangiblesDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_FiniteLivedIntangibleAssetsLineItems": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.", "label": "Finite-Lived Intangible Assets [Line Items]", "terseLabel": "Finite-Lived Intangible Assets [Line Items]" } } }, "localname": "FiniteLivedIntangibleAssetsLineItems", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.agilent.com/role/GoodwillAndOtherIntangibleAssetsDisclosuresAndComponentsOfOtherIntangiblesDetails", "http://www.agilent.com/role/GoodwillAndOtherIntangibleAssetsTextDetails" ], "xbrltype": "stringItemType" }, "us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain": { "auth_ref": [ "r239", "r244" ], "lang": { "en-US": { "role": { "documentation": "The major class of finite-lived intangible asset (for example, patents, trademarks, copyrights, etc.) A major class is composed of intangible assets that can be grouped together because they are similar, either by their nature or by their use in the operations of a company.", "label": "Finite-Lived Intangible Assets, Major Class Name [Domain]", "terseLabel": "Finite-Lived Intangible Assets, Major Class Name [Domain]" } } }, "localname": "FiniteLivedIntangibleAssetsMajorClassNameDomain", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.agilent.com/role/AcquisitionsAcquisitionsIntangibleAssetsDetails", "http://www.agilent.com/role/GoodwillAndOtherIntangibleAssetsDisclosuresAndComponentsOfOtherIntangiblesDetails", "http://www.agilent.com/role/GoodwillAndOtherIntangibleAssetsTextDetails", "http://www.agilent.com/role/OverviewAndSummaryOfSignificantAccountingPoliciesDetails" ], "xbrltype": "domainItemType" }, "us-gaap_FiniteLivedIntangibleAssetsNet": { "auth_ref": [ "r245" ], "crdr": "debit", "lang": { "en-US": { "role": { "documentation": "Amount after amortization of assets, excluding financial assets and goodwill, lacking physical substance with a finite life.", "label": "Finite-Lived Intangible Assets, Net", "terseLabel": "Total amortizable intangible assets" } } }, "localname": "FiniteLivedIntangibleAssetsNet", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.agilent.com/role/GoodwillAndOtherIntangibleAssetsDisclosuresAndComponentsOfOtherIntangiblesDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_FiniteLivedIntangibleAssetsNetAbstract": { "auth_ref": [], "lang": { "en-US": { "role": { "label": "Finite-Lived Intangible Assets, Net [Abstract]", "terseLabel": "Schedule of Other Intangible Assets By Major Class [Abstract]" } } }, "localname": "FiniteLivedIntangibleAssetsNetAbstract", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.agilent.com/role/GoodwillAndOtherIntangibleAssetsDisclosuresAndComponentsOfOtherIntangiblesDetails" ], "xbrltype": "stringItemType" }, "us-gaap_FiniteLivedIntangibleAssetsPeriodIncreaseDecrease": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Amount of increase (decrease) in carrying value of assets, excluding financial assets and goodwill, lacking physical substance with a finite life.", "label": "Finite-Lived Intangible Assets, Period Increase (Decrease)", "terseLabel": "Additions and adjustments to other intangibles" } } }, "localname": "FiniteLivedIntangibleAssetsPeriodIncreaseDecrease", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.agilent.com/role/GoodwillAndOtherIntangibleAssetsTextDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_FixedIncomeSecuritiesMember": { "auth_ref": [ "r345", "r385" ], "lang": { "en-US": { "role": { "documentation": "Investment that provides a return in the form of fixed periodic payments and eventual return of principal at maturity.", "label": "Fixed Income Securities [Member]", "terseLabel": "Fixed Income Securities" } } }, "localname": "FixedIncomeSecuritiesMember", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.agilent.com/role/RetirementPlansAndPostRetirementPensionPlansAssumptionsDetails", "http://www.agilent.com/role/RetirementPlansAndPostRetirementPensionPlansFairValueOfPlanAssetsDetails", "http://www.agilent.com/role/RetirementPlansAndPostRetirementPensionPlansRetirementPlansAndPostRetirementPensionPlansTargetAllocationsDetails" ], "xbrltype": "domainItemType" }, "us-gaap_ForeignCountryMember": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Designated tax departments of governments entitled to levy and collect income taxes from the entity outside the entity's country of domicile.", "label": "Foreign Tax Authority [Member]", "terseLabel": "Foreign" } } }, "localname": "ForeignCountryMember", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.agilent.com/role/IncomeTaxesCarryforwardsDetails", "http://www.agilent.com/role/IncomeTaxesIncomeTaxesEffectiveTaxRateAndTaxHolidaysDetails" ], "xbrltype": "domainItemType" }, "us-gaap_ForeignCurrencyCashFlowHedgeGainLossToBeReclassifiedDuringNext12Months": { "auth_ref": [ "r555" ], "crdr": "credit", "lang": { "en-US": { "role": { "documentation": "The estimated net amount of unrealized gains or losses on foreign currency cash flow hedges at the reporting date expected to be reclassified to earnings within the next 12 months.", "label": "Foreign Currency Cash Flow Hedge Gain (Loss) to be Reclassified During Next 12 Months", "terseLabel": "Foreign Currency Cash Flow Hedge Gain (Loss) to be Reclassified During Next 12 Months" } } }, "localname": "ForeignCurrencyCashFlowHedgeGainLossToBeReclassifiedDuringNext12Months", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.agilent.com/role/DerivativesEffectOfDerivativeInstrumentsOnConsolidatedStatementOfOperationsDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_ForeignCurrencyTransactionGainLossRealized": { "auth_ref": [ "r574", "r575", "r576" ], "crdr": "credit", "lang": { "en-US": { "role": { "documentation": "Amount before tax of foreign currency transaction realized gain (loss) recognized in the income statement.", "label": "Foreign Currency Transaction Gain (Loss), Realized", "terseLabel": "Foreign currency translation net gain (Ioss)" } } }, "localname": "ForeignCurrencyTransactionGainLossRealized", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.agilent.com/role/OverviewAndSummaryOfSignificantAccountingPoliciesDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_ForeignCurrencyTransactionsAndTranslationsPolicyTextBlock": { "auth_ref": [ "r137", "r576", "r585" ], "lang": { "en-US": { "role": { "documentation": "Disclosure of accounting policy for (1) transactions denominated in a currency other than the reporting enterprise's functional currency, (2) translating foreign currency financial statements that are incorporated into the financial statements of the reporting enterprise by consolidation, combination, or the equity method of accounting, and (3) remeasurement of the financial statements of a foreign reporting enterprise in a hyperinflationary economy.", "label": "Foreign Currency Transactions and Translations Policy [Policy Text Block]", "terseLabel": "Foreign currency translation" } } }, "localname": "ForeignCurrencyTransactionsAndTranslationsPolicyTextBlock", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.agilent.com/role/OverviewAndSummaryOfSignificantAccountingPoliciesPolicies" ], "xbrltype": "textBlockItemType" }, "us-gaap_ForeignCurrencyTranslationAbstract": { "auth_ref": [], "lang": { "en-US": { "role": { "label": "Foreign Currency Translation [Abstract]", "terseLabel": "Foreign Currency Translation" } } }, "localname": "ForeignCurrencyTranslationAbstract", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.agilent.com/role/OverviewAndSummaryOfSignificantAccountingPoliciesDetails", "http://www.agilent.com/role/StockholdersEquityChangesInAccumulatedOtherComprehensiveIncomeDetails" ], "xbrltype": "stringItemType" }, "us-gaap_ForeignEarningsRepatriated": { "auth_ref": [], "crdr": "credit", "lang": { "en-US": { "role": { "documentation": "Amount of foreign earnings repatriated from subsidiaries outside the country of domicile.", "label": "Foreign Earnings Repatriated", "terseLabel": "Foreign Earnings Repatriated" } } }, "localname": "ForeignEarningsRepatriated", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.agilent.com/role/IncomeTaxes2017USTaxReformTaxCutsAndJobsActDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_ForeignExchangeContractMember": { "auth_ref": [ "r345", "r543" ], "lang": { "en-US": { "role": { "documentation": "Derivative instrument whose primary underlying risk is tied to foreign exchange rates.", "label": "Foreign Exchange Contract [Member]", "terseLabel": "Foreign Exchange Contracts [Member]" } } }, "localname": "ForeignExchangeContractMember", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.agilent.com/role/DerivativesDetails", "http://www.agilent.com/role/DerivativesEffectOfDerivativeInstrumentsOnConsolidatedStatementOfOperationsDetails", "http://www.agilent.com/role/DerivativesFairValueOfDerivativeInstrumentsAndConsolidatedBalanceSheetLocationDetails" ], "xbrltype": "domainItemType" }, "us-gaap_ForeignPlanMember": { "auth_ref": [ "r372" ], "lang": { "en-US": { "role": { "documentation": "Location of employer sponsoring plan, designed to provide retirement benefits, not determined as principal place of business. Includes, but is not limited to, defined benefit and defined contribution plans.", "label": "Foreign Plan [Member]", "terseLabel": "Non-U.S. Plans" } } }, "localname": "ForeignPlanMember", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.agilent.com/role/RetirementPlansAndPostRetirementPensionPlansAssumptionsDetails", "http://www.agilent.com/role/RetirementPlansAndPostRetirementPensionPlansComponentsOfNetPeriodicCostsDetails", "http://www.agilent.com/role/RetirementPlansAndPostRetirementPensionPlansDefinedContributionDetails", "http://www.agilent.com/role/RetirementPlansAndPostRetirementPensionPlansExpectedBenefitPaymentsDetails", "http://www.agilent.com/role/RetirementPlansAndPostRetirementPensionPlansFairValueOfPlanAssetsDetails", "http://www.agilent.com/role/RetirementPlansAndPostRetirementPensionPlansFinancialStatementLocationDetails", "http://www.agilent.com/role/RetirementPlansAndPostRetirementPensionPlansFundedStatusDetails", "http://www.agilent.com/role/RetirementPlansAndPostRetirementPensionPlansJwpilDetails", "http://www.agilent.com/role/RetirementPlansAndPostRetirementPensionPlansRetirementPlansAndPostRetirementPensionPlansTargetAllocationsDetails" ], "xbrltype": "domainItemType" }, "us-gaap_ForwardContractsMember": { "auth_ref": [ "r541" ], "lang": { "en-US": { "role": { "documentation": "Contracts negotiated between two parties to purchase and sell a specific quantity of a financial instrument, foreign currency, or commodity at a price specified at origination of the contract, with delivery and settlement at a specified future date.", "label": "Forward Contracts [Member]", "terseLabel": "Forward Contracts Buy/(Sell) [Member]" } } }, "localname": "ForwardContractsMember", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.agilent.com/role/DerivativesDetails", "http://www.agilent.com/role/DerivativesDisclosuresAndDerivativeInstrumentAggregatedNotionalAmountsByCurrencyAndDesignationsDetails", "http://www.agilent.com/role/DerivativesEffectOfDerivativeInstrumentsOnConsolidatedStatementOfOperationsDetails", "http://www.agilent.com/role/DerivativesFairValueOfDerivativeInstrumentsAndConsolidatedBalanceSheetLocationDetails" ], "xbrltype": "domainItemType" }, "us-gaap_GainsLossesOnExtinguishmentOfDebt": { "auth_ref": [ "r129", "r290", "r291" ], "calculation": { "http://www.agilent.com/role/ConsolidatedStatementOfCashFlows": { "order": 8.0, "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": -1.0 } }, "crdr": "credit", "lang": { "en-US": { "role": { "documentation": "Difference between the fair value of payments made and the carrying amount of debt which is extinguished prior to maturity.", "label": "Gain (Loss) on Extinguishment of Debt", "negatedTerseLabel": "Loss on extinguishment of debt" } } }, "localname": "GainsLossesOnExtinguishmentOfDebt", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.agilent.com/role/ConsolidatedStatementOfCashFlows" ], "xbrltype": "monetaryItemType" }, "us-gaap_GeographicAreasRevenuesFromExternalCustomersAbstract": { "auth_ref": [], "lang": { "en-US": { "role": { "label": "Geographic Areas, Revenues from External Customers [Abstract]", "terseLabel": "Revenue by geography" } } }, "localname": "GeographicAreasRevenuesFromExternalCustomersAbstract", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.agilent.com/role/SegmentInformationEntityWideDisclosuresRevenueDetails" ], "xbrltype": "stringItemType" }, "us-gaap_Goodwill": { "auth_ref": [ "r228", "r230" ], "calculation": { "http://www.agilent.com/role/ConsolidatedBalanceSheet": { "order": 3.0, "parentTag": "us-gaap_Assets", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-US": { "role": { "documentation": "Amount after accumulated impairment loss of an asset representing future economic benefits arising from other assets acquired in a business combination that are not individually identified and separately recognized.", "label": "Goodwill", "periodEndLabel": "Ending Balance", "periodStartLabel": "Beginning Balance", "terseLabel": "Goodwill", "verboseLabel": "Goodwill" } } }, "localname": "Goodwill", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.agilent.com/role/ConsolidatedBalanceSheet", "http://www.agilent.com/role/GoodwillAndOtherIntangibleAssetsRollForwardDetails", "http://www.agilent.com/role/NewAccountingPronouncementsImpactOfAdoptingNewGuidanceDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_GoodwillAcquiredDuringPeriod": { "auth_ref": [ "r231" ], "crdr": "debit", "lang": { "en-US": { "role": { "documentation": "Amount of increase in asset representing future economic benefits arising from other assets acquired in a business combination that are not individually identified and separately recognized resulting from a business combination.", "label": "Goodwill, Acquired During Period", "terseLabel": "Goodwill arising from acquisitions", "verboseLabel": "Goodwill Additions" } } }, "localname": "GoodwillAcquiredDuringPeriod", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.agilent.com/role/AcquisitionsAssetsAndLiabilitiesAssumedDetails", "http://www.agilent.com/role/GoodwillAndOtherIntangibleAssetsRollForwardDetails", "http://www.agilent.com/role/GoodwillAndOtherIntangibleAssetsTextDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_GoodwillAndIntangibleAssetImpairmentAbstract": { "auth_ref": [], "lang": { "en-US": { "role": { "label": "Goodwill and Intangible Asset Impairment [Abstract]", "terseLabel": "Goodwill and Intangible Asset Impairment [Abstract]" } } }, "localname": "GoodwillAndIntangibleAssetImpairmentAbstract", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.agilent.com/role/GoodwillAndOtherIntangibleAssetsTextDetails" ], "xbrltype": "stringItemType" }, "us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract": { "auth_ref": [], "lang": { "en-US": { "role": { "label": "Goodwill and Intangible Assets Disclosure [Abstract]", "terseLabel": "Goodwill and Intangible Assets" } } }, "localname": "GoodwillAndIntangibleAssetsDisclosureAbstract", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.agilent.com/role/OverviewAndSummaryOfSignificantAccountingPoliciesDetails" ], "xbrltype": "stringItemType" }, "us-gaap_GoodwillAndIntangibleAssetsDisclosureTextBlock": { "auth_ref": [ "r254" ], "lang": { "en-US": { "role": { "documentation": "The entire disclosure for goodwill and intangible assets.", "label": "Goodwill and Intangible Assets Disclosure [Text Block]", "verboseLabel": "GOODWILL AND OTHER INTANGIBLE ASSETS" } } }, "localname": "GoodwillAndIntangibleAssetsDisclosureTextBlock", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.agilent.com/role/GoodwillAndOtherIntangibleAssets" ], "xbrltype": "textBlockItemType" }, "us-gaap_GoodwillAndIntangibleAssetsPolicyTextBlock": { "auth_ref": [ "r137", "r234", "r242" ], "lang": { "en-US": { "role": { "documentation": "Disclosure of accounting policy for goodwill and intangible assets. This accounting policy also may address how an entity assesses and measures impairment of goodwill and intangible assets.", "label": "Goodwill and Intangible Assets, Policy [Policy Text Block]", "terseLabel": "Goodwill and purchased intangible assets" } } }, "localname": "GoodwillAndIntangibleAssetsPolicyTextBlock", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.agilent.com/role/OverviewAndSummaryOfSignificantAccountingPoliciesPolicies" ], "xbrltype": "textBlockItemType" }, "us-gaap_GoodwillForeignCurrencyTranslationGainLoss": { "auth_ref": [ "r233" ], "crdr": "credit", "lang": { "en-US": { "role": { "documentation": "Amount of foreign currency translation gain (loss) which increases (decreases) an asset representing future economic benefits from other assets acquired in a business combination that are not individually identified and separately recognized.", "label": "Goodwill, Foreign Currency Translation Gain (Loss)", "terseLabel": "Foreign currency translation impact" } } }, "localname": "GoodwillForeignCurrencyTranslationGainLoss", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.agilent.com/role/GoodwillAndOtherIntangibleAssetsRollForwardDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_GoodwillImpairmentLoss": { "auth_ref": [ "r129", "r229", "r232", "r235" ], "crdr": "debit", "lang": { "en-US": { "role": { "documentation": "Amount of loss from the write-down of an asset representing the future economic benefits arising from other assets acquired in a business combination that are not individually identified and separately recognized.", "label": "Goodwill, Impairment Loss", "terseLabel": "Goodwill impairment" } } }, "localname": "GoodwillImpairmentLoss", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.agilent.com/role/GoodwillAndOtherIntangibleAssetsTextDetails", "http://www.agilent.com/role/OverviewAndSummaryOfSignificantAccountingPoliciesDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_GoodwillLineItems": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.", "label": "Goodwill [Line Items]" } } }, "localname": "GoodwillLineItems", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.agilent.com/role/GoodwillAndOtherIntangibleAssetsRollForwardDetails" ], "xbrltype": "stringItemType" }, "us-gaap_GoodwillRollForward": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "A roll forward is a reconciliation of a concept from the beginning of a period to the end of a period.", "label": "Goodwill [Roll Forward]", "terseLabel": "Goodwill - Rollforward" } } }, "localname": "GoodwillRollForward", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.agilent.com/role/GoodwillAndOtherIntangibleAssetsRollForwardDetails" ], "xbrltype": "stringItemType" }, "us-gaap_GuaranteesAbstract": { "auth_ref": [], "lang": { "en-US": { "role": { "label": "Guarantees [Abstract]" } } }, "localname": "GuaranteesAbstract", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "xbrltype": "stringItemType" }, "us-gaap_HedgingDesignationAxis": { "auth_ref": [ "r529", "r546" ], "lang": { "en-US": { "role": { "documentation": "Information by designation of purpose of derivative instrument.", "label": "Hedging Designation [Axis]" } } }, "localname": "HedgingDesignationAxis", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.agilent.com/role/DerivativesDetails", "http://www.agilent.com/role/DerivativesDisclosuresAndDerivativeInstrumentAggregatedNotionalAmountsByCurrencyAndDesignationsDetails", "http://www.agilent.com/role/DerivativesEffectOfDerivativeInstrumentsOnConsolidatedStatementOfOperationsDetails", "http://www.agilent.com/role/DerivativesFairValueOfDerivativeInstrumentsAndConsolidatedBalanceSheetLocationDetails" ], "xbrltype": "stringItemType" }, "us-gaap_HedgingDesignationDomain": { "auth_ref": [ "r529" ], "lang": { "en-US": { "role": { "documentation": "Designation of purpose of derivative instrument.", "label": "Hedging Designation [Domain]" } } }, "localname": "HedgingDesignationDomain", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.agilent.com/role/DerivativesDetails", "http://www.agilent.com/role/DerivativesDisclosuresAndDerivativeInstrumentAggregatedNotionalAmountsByCurrencyAndDesignationsDetails", "http://www.agilent.com/role/DerivativesEffectOfDerivativeInstrumentsOnConsolidatedStatementOfOperationsDetails", "http://www.agilent.com/role/DerivativesFairValueOfDerivativeInstrumentsAndConsolidatedBalanceSheetLocationDetails" ], "xbrltype": "domainItemType" }, "us-gaap_HedgingRelationshipDomain": { "auth_ref": [ "r529" ], "lang": { "en-US": { "role": { "documentation": "Nature or intent of a hedge.", "label": "Hedging Relationship [Domain]", "terseLabel": "Hedging Relationship [Domain]" } } }, "localname": "HedgingRelationshipDomain", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.agilent.com/role/DerivativesDetails", "http://www.agilent.com/role/DerivativesDisclosuresAndDerivativeInstrumentAggregatedNotionalAmountsByCurrencyAndDesignationsDetails", "http://www.agilent.com/role/DerivativesEffectOfDerivativeInstrumentsOnConsolidatedStatementOfOperationsDetails", "http://www.agilent.com/role/DerivativesFairValueOfDerivativeInstrumentsAndConsolidatedBalanceSheetLocationDetails", "http://www.agilent.com/role/LongTermDebtLongTermDebtOtherDetails" ], "xbrltype": "domainItemType" }, "us-gaap_ImpairedAssetsToBeDisposedOfByMethodOtherThanSaleCarryingValueOfAsset": { "auth_ref": [ "r255", "r262" ], "crdr": "debit", "lang": { "en-US": { "role": { "documentation": "The carrying amount on the books of the entity of the impaired asset to be disposed of by a method other than sale.", "label": "Impaired Assets to be Disposed of by Method Other than Sale, Carrying Value of Asset", "terseLabel": "Carrying value of long-lived asset" } } }, "localname": "ImpairedAssetsToBeDisposedOfByMethodOtherThanSaleCarryingValueOfAsset", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.agilent.com/role/FairValueMeasurementsFairValueMeasurmentsFairValueOfAssetsAndLiabilitiesMeasuredOnNonRecurringDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_ImpairedLongLivedAssetsHeldAndUsedAssetNameDomain": { "auth_ref": [ "r262" ], "lang": { "en-US": { "role": { "documentation": "The name of the impaired assets to be held and used by the entity.", "label": "Impaired Long-Lived Assets Held and Used, Asset Name [Domain]", "terseLabel": "Impaired Long-Lived Assets Held and Used, Asset Name [Domain]" } } }, "localname": "ImpairedLongLivedAssetsHeldAndUsedAssetNameDomain", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.agilent.com/role/FairValueMeasurementsFairValueMeasurmentsFairValueOfAssetsAndLiabilitiesMeasuredOnNonRecurringDetails", "http://www.agilent.com/role/FairValueMeasurementsFairValueOfAssetsAndLiabilitiesMeasuredOnRecurringBasisDetails" ], "xbrltype": "domainItemType" }, "us-gaap_ImpairedLongLivedAssetsHeldAndUsedByTypeAxis": { "auth_ref": [ "r262" ], "lang": { "en-US": { "role": { "documentation": "This element represents the categories used to group impaired long-lived assets held and used by the type of asset.", "label": "Impaired Long-Lived Assets Held and Used by Type [Axis]", "terseLabel": "Impaired Long-Lived Assets Held and Used by Type [Axis]" } } }, "localname": "ImpairedLongLivedAssetsHeldAndUsedByTypeAxis", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.agilent.com/role/FairValueMeasurementsFairValueMeasurmentsFairValueOfAssetsAndLiabilitiesMeasuredOnNonRecurringDetails", "http://www.agilent.com/role/FairValueMeasurementsFairValueOfAssetsAndLiabilitiesMeasuredOnRecurringBasisDetails" ], "xbrltype": "stringItemType" }, "us-gaap_ImpairmentOfIntangibleAssetsExcludingGoodwill": { "auth_ref": [ "r129", "r250" ], "calculation": { "http://www.agilent.com/role/ConsolidatedStatementOfCashFlows": { "order": 7.0, "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": 1.0 }, "http://www.agilent.com/role/SegmentInformationReconciliationOfReportableResultsDetails": { "order": 5.0, "parentTag": "us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments", "weight": -1.0 } }, "crdr": "debit", "lang": { "en-US": { "role": { "documentation": "The amount of impairment loss recognized in the period resulting from the write-down of the carrying amount of an intangible asset (excluding goodwill) to fair value.", "label": "Impairment of Intangible Assets (Excluding Goodwill)", "terseLabel": "Asset impairment charges" } } }, "localname": "ImpairmentOfIntangibleAssetsExcludingGoodwill", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.agilent.com/role/ConsolidatedStatementOfCashFlows", "http://www.agilent.com/role/SegmentInformationReconciliationOfReportableResultsDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_ImpairmentOfIntangibleAssetsFinitelived": { "auth_ref": [ "r129", "r250" ], "crdr": "debit", "lang": { "en-US": { "role": { "documentation": "The amount of impairment loss recognized in the period resulting from the write-down of the carrying amount of a finite-lived intangible asset to fair value.", "label": "Impairment of Intangible Assets, Finite-lived", "terseLabel": "Impairment of finite-lived intangible assets" } } }, "localname": "ImpairmentOfIntangibleAssetsFinitelived", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.agilent.com/role/GoodwillAndOtherIntangibleAssetsTextDetails", "http://www.agilent.com/role/OverviewAndSummaryOfSignificantAccountingPoliciesDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_ImpairmentOfIntangibleAssetsIndefinitelivedExcludingGoodwill": { "auth_ref": [ "r129", "r250" ], "crdr": "debit", "lang": { "en-US": { "role": { "documentation": "Amount of impairment loss resulting from write-down of assets, excluding financial assets and goodwill, lacking physical substance and having a projected indefinite period of benefit to fair value.", "label": "Impairment of Intangible Assets, Indefinite-lived (Excluding Goodwill)", "verboseLabel": "Impairment of indefinite-lived intangible assets" } } }, "localname": "ImpairmentOfIntangibleAssetsIndefinitelivedExcludingGoodwill", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.agilent.com/role/GoodwillAndOtherIntangibleAssetsTextDetails", "http://www.agilent.com/role/OverviewAndSummaryOfSignificantAccountingPoliciesDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_ImpairmentOfLongLivedAssetsHeldForUse": { "auth_ref": [ "r129", "r256", "r261", "r654" ], "crdr": "debit", "lang": { "en-US": { "role": { "documentation": "The aggregate amount of write-downs for impairments recognized during the period for long lived assets held for use (including those held for disposal by means other than sale).", "label": "Impairment of Long-Lived Assets Held-for-use", "terseLabel": "Long lived assets held for use impairment" } } }, "localname": "ImpairmentOfLongLivedAssetsHeldForUse", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.agilent.com/role/FairValueMeasurementsFairValueMeasurmentsFairValueOfAssetsAndLiabilitiesMeasuredOnNonRecurringDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_ImpairmentOfLongLivedAssetsToBeDisposedOf": { "auth_ref": [ "r129", "r255" ], "crdr": "debit", "lang": { "en-US": { "role": { "documentation": "The aggregate amount of write-downs for impairments recognized during the period for long-lived assets held for abandonment, exchange or sale.", "label": "Impairment of Long-Lived Assets to be Disposed of", "terseLabel": "Long lived assets held for sale Impairment" } } }, "localname": "ImpairmentOfLongLivedAssetsToBeDisposedOf", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.agilent.com/role/FairValueMeasurementsFairValueMeasurmentsFairValueOfAssetsAndLiabilitiesMeasuredOnNonRecurringDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_ImpairmentOrDisposalOfLongLivedAssetsIncludingIntangibleAssetsPolicyPolicyTextBlock": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Disclosure of accounting policy for the impairment and disposal of long-lived assets including goodwill and other intangible assets.", "label": "Impairment or Disposal of Long-Lived Assets, Including Intangible Assets, Policy [Policy Text Block]", "terseLabel": "Impairment of long-lived assets" } } }, "localname": "ImpairmentOrDisposalOfLongLivedAssetsIncludingIntangibleAssetsPolicyPolicyTextBlock", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.agilent.com/role/OverviewAndSummaryOfSignificantAccountingPoliciesPolicies" ], "xbrltype": "textBlockItemType" }, "us-gaap_InProcessResearchAndDevelopmentMember": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "In process investigation of new knowledge useful in developing new product or service or new process or technique or improvement to existing product or process, and translation of knowledge into plan or design for new product or process or for improvement to existing product or process.", "label": "In Process Research and Development [Member]", "terseLabel": "In Process Research and Development [Member]" } } }, "localname": "InProcessResearchAndDevelopmentMember", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.agilent.com/role/FairValueMeasurementsFairValueMeasurmentsFairValueOfAssetsAndLiabilitiesMeasuredOnNonRecurringDetails" ], "xbrltype": "domainItemType" }, "us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic": { "auth_ref": [ "r146" ], "calculation": { "http://www.agilent.com/role/IncomeTaxesIncomeTaxesProvisionDetails": { "order": 1.0, "parentTag": "us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-US": { "role": { "documentation": "The portion of earnings or loss from continuing operations before income taxes that is attributable to domestic operations.", "label": "Income (Loss) from Continuing Operations before Income Taxes, Domestic", "terseLabel": "U.S. operations" } } }, "localname": "IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.agilent.com/role/IncomeTaxesIncomeTaxesProvisionDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterestAbstract": { "auth_ref": [], "lang": { "en-US": { "role": { "label": "Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest [Abstract]", "terseLabel": "Income before income tax" } } }, "localname": "IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterestAbstract", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.agilent.com/role/IncomeTaxesIncomeTaxesProvisionDetails" ], "xbrltype": "stringItemType" }, "us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign": { "auth_ref": [ "r146" ], "calculation": { "http://www.agilent.com/role/IncomeTaxesIncomeTaxesProvisionDetails": { "order": 2.0, "parentTag": "us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-US": { "role": { "documentation": "The portion of earnings or loss from continuing operations before income taxes that is attributable to foreign operations, which is defined as Income or Loss generated from operations located outside the entity's country of domicile.", "label": "Income (Loss) from Continuing Operations before Income Taxes, Foreign", "terseLabel": "Non-U.S. operations" } } }, "localname": "IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.agilent.com/role/IncomeTaxesIncomeTaxesProvisionDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments": { "auth_ref": [ "r146" ], "calculation": { "http://www.agilent.com/role/ConsolidatedStatementOfOperations": { "order": 1.0, "parentTag": "us-gaap_ProfitLoss", "weight": 1.0 }, "http://www.agilent.com/role/IncomeTaxesIncomeTaxesProvisionDetails": { "order": null, "parentTag": null, "root": true, "weight": null }, "http://www.agilent.com/role/SegmentInformationReconciliationOfReportableResultsDetails": { "order": null, "parentTag": null, "root": true, "weight": null } }, "crdr": "credit", "lang": { "en-US": { "role": { "documentation": "Amount of income (loss) from continuing operations before deduction of income tax expense (benefit) and income (loss) attributable to noncontrolling interest, and addition of income (loss) from equity method investments.", "label": "Income (Loss) from Continuing Operations before Equity Method Investments, Income Taxes, Noncontrolling Interest", "totalLabel": "Income before taxes" } } }, "localname": "IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.agilent.com/role/ConsolidatedStatementOfOperations", "http://www.agilent.com/role/IncomeTaxesIncomeTaxesProvisionDetails", "http://www.agilent.com/role/SegmentInformationReconciliationOfReportableResultsDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_IncomeStatementAbstract": { "auth_ref": [], "lang": { "en-US": { "role": { "label": "Income Statement [Abstract]" } } }, "localname": "IncomeStatementAbstract", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "xbrltype": "stringItemType" }, "us-gaap_IncomeStatementLocationAxis": { "auth_ref": [ "r263" ], "lang": { "en-US": { "role": { "documentation": "Information by location in the income statement.", "label": "Income Statement Location [Axis]", "terseLabel": "Income Statement Location [Axis]" } } }, "localname": "IncomeStatementLocationAxis", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.agilent.com/role/DerivativesDetails", "http://www.agilent.com/role/DerivativesEffectOfDerivativeInstrumentsOnConsolidatedStatementOfOperationsDetails", "http://www.agilent.com/role/DerivativesFairValueOfDerivativeInstrumentsAndConsolidatedBalanceSheetLocationDetails", "http://www.agilent.com/role/ShareBasedCompensationAllocatedShareBasedCompensationExpenseDetails", "http://www.agilent.com/role/ShareBasedCompensationFairValueAssumptionsDetails" ], "xbrltype": "stringItemType" }, "us-gaap_IncomeStatementLocationDomain": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Location in the income statement.", "label": "Income Statement Location [Domain]", "terseLabel": "Income Statement Location [Domain]" } } }, "localname": "IncomeStatementLocationDomain", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.agilent.com/role/DerivativesDetails", "http://www.agilent.com/role/DerivativesEffectOfDerivativeInstrumentsOnConsolidatedStatementOfOperationsDetails", "http://www.agilent.com/role/DerivativesFairValueOfDerivativeInstrumentsAndConsolidatedBalanceSheetLocationDetails", "http://www.agilent.com/role/ShareBasedCompensationAllocatedShareBasedCompensationExpenseDetails", "http://www.agilent.com/role/ShareBasedCompensationFairValueAssumptionsDetails" ], "xbrltype": "domainItemType" }, "us-gaap_IncomeTaxAuthorityAxis": { "auth_ref": [ "r453" ], "lang": { "en-US": { "role": { "documentation": "Information by tax jurisdiction.", "label": "Income Tax Authority [Axis]", "terseLabel": "Income Tax Authority [Axis]" } } }, "localname": "IncomeTaxAuthorityAxis", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.agilent.com/role/IncomeTaxes2017USTaxReformTaxCutsAndJobsActDetails", "http://www.agilent.com/role/IncomeTaxesCarryforwardsDetails", "http://www.agilent.com/role/IncomeTaxesIncomeTaxesEffectiveTaxRateAndTaxHolidaysDetails", "http://www.agilent.com/role/IncomeTaxesIncomeTaxesUncertainTaxPositionsDetails" ], "xbrltype": "stringItemType" }, "us-gaap_IncomeTaxAuthorityDomain": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Agency, division or body classification that levies income taxes, examines tax returns for compliance, or grants exemptions from or makes other decisions pertaining to income taxes.", "label": "Income Tax Authority [Domain]", "terseLabel": "Income Tax Authority [Domain]" } } }, "localname": "IncomeTaxAuthorityDomain", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.agilent.com/role/IncomeTaxes2017USTaxReformTaxCutsAndJobsActDetails", "http://www.agilent.com/role/IncomeTaxesCarryforwardsDetails", "http://www.agilent.com/role/IncomeTaxesIncomeTaxesEffectiveTaxRateAndTaxHolidaysDetails", "http://www.agilent.com/role/IncomeTaxesIncomeTaxesUncertainTaxPositionsDetails" ], "xbrltype": "domainItemType" }, "us-gaap_IncomeTaxAuthorityNameAxis": { "auth_ref": [ "r453" ], "lang": { "en-US": { "role": { "documentation": "Information by name of taxing authority.", "label": "Income Tax Authority, Name [Axis]", "terseLabel": "Income Tax Authority, Name [Axis]" } } }, "localname": "IncomeTaxAuthorityNameAxis", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.agilent.com/role/IncomeTaxes2017USTaxReformTaxCutsAndJobsActDetails", "http://www.agilent.com/role/IncomeTaxesIncomeTaxesEffectiveTaxRateAndTaxHolidaysDetails", "http://www.agilent.com/role/IncomeTaxesIncomeTaxesUncertainTaxPositionsDetails" ], "xbrltype": "stringItemType" }, "us-gaap_IncomeTaxAuthorityNameDomain": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Named agency, division or body that levies income taxes, examines tax returns for compliance, or grants exemptions from or makes other decisions pertaining to income taxes.", "label": "Income Tax Authority, Name [Domain]", "terseLabel": "Income Tax Authority, Name [Domain]" } } }, "localname": "IncomeTaxAuthorityNameDomain", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.agilent.com/role/IncomeTaxes2017USTaxReformTaxCutsAndJobsActDetails", "http://www.agilent.com/role/IncomeTaxesIncomeTaxesEffectiveTaxRateAndTaxHolidaysDetails", "http://www.agilent.com/role/IncomeTaxesIncomeTaxesUncertainTaxPositionsDetails" ], "xbrltype": "domainItemType" }, "us-gaap_IncomeTaxDisclosureAbstract": { "auth_ref": [], "lang": { "en-US": { "role": { "label": "Income Tax Disclosure [Abstract]" } } }, "localname": "IncomeTaxDisclosureAbstract", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "xbrltype": "stringItemType" }, "us-gaap_IncomeTaxDisclosureTextBlock": { "auth_ref": [ "r483" ], "lang": { "en-US": { "role": { "documentation": "The entire disclosure for income taxes. Disclosures may include net deferred tax liability or asset recognized in an enterprise's statement of financial position, net change during the year in the total valuation allowance, approximate tax effect of each type of temporary difference and carryforward that gives rise to a significant portion of deferred tax liabilities and deferred tax assets, utilization of a tax carryback, and tax uncertainties information.", "label": "Income Tax Disclosure [Text Block]", "terseLabel": "INCOME TAXES" } } }, "localname": "IncomeTaxDisclosureTextBlock", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.agilent.com/role/IncomeTaxes" ], "xbrltype": "textBlockItemType" }, "us-gaap_IncomeTaxExpenseBenefit": { "auth_ref": [ "r142", "r192", "r480" ], "calculation": { "http://www.agilent.com/role/ConsolidatedStatementOfOperations": { "order": 2.0, "parentTag": "us-gaap_ProfitLoss", "weight": -1.0 }, "http://www.agilent.com/role/IncomeTaxesIncomeTaxesProvisionDetails": { "order": null, "parentTag": null, "root": true, "weight": null } }, "crdr": "debit", "lang": { "en-US": { "role": { "documentation": "Amount of current income tax expense (benefit) and deferred income tax expense (benefit) pertaining to continuing operations.", "label": "Income Tax Expense (Benefit)", "terseLabel": "Income tax expense (benefit)", "totalLabel": "Income tax expense (benefit)", "verboseLabel": "Provision (benefit) for income taxes" } } }, "localname": "IncomeTaxExpenseBenefit", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.agilent.com/role/ConsolidatedStatementOfOperations", "http://www.agilent.com/role/IncomeTaxesIncomeTaxesEffectiveTaxRateAndTaxHolidaysDetails", "http://www.agilent.com/role/IncomeTaxesIncomeTaxesProvisionDetails", "http://www.agilent.com/role/IncomeTaxesIncomeTaxesUncertainTaxPositionsDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_IncomeTaxExpenseBenefitContinuingOperationsIncomeTaxReconciliationAbstract": { "auth_ref": [], "lang": { "en-US": { "role": { "label": "Effective Income Tax Rate Reconciliation, Amount [Abstract]", "terseLabel": "Effective Income Tax Rate Reconciliation" } } }, "localname": "IncomeTaxExpenseBenefitContinuingOperationsIncomeTaxReconciliationAbstract", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.agilent.com/role/IncomeTaxesIncomeTaxesEffectiveTaxRateAndTaxHolidaysDetails" ], "xbrltype": "stringItemType" }, "us-gaap_IncomeTaxHolidayAggregateDollarAmount": { "auth_ref": [ "r478" ], "crdr": "credit", "lang": { "en-US": { "role": { "documentation": "The amount of income taxes from which a reporting entity is exempt or for which it will receive a reduction in income taxes as a result of the income tax holiday granted by the taxing jurisdiction.", "label": "Income Tax Holiday, Aggregate Dollar Amount", "terseLabel": "Impact of the income tax holidays" } } }, "localname": "IncomeTaxHolidayAggregateDollarAmount", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.agilent.com/role/IncomeTaxesIncomeTaxesEffectiveTaxRateAndTaxHolidaysDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_IncomeTaxHolidayIncomeTaxBenefitsPerShare": { "auth_ref": [ "r478" ], "lang": { "en-US": { "role": { "documentation": "Per share amount effect of the income tax benefit resulting from the income tax holidays granted by taxing jurisdictions.", "label": "Income Tax Holiday, Income Tax Benefits Per Share", "terseLabel": "Benefit of income tax holidays on net income per share" } } }, "localname": "IncomeTaxHolidayIncomeTaxBenefitsPerShare", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.agilent.com/role/IncomeTaxesIncomeTaxesEffectiveTaxRateAndTaxHolidaysDetails" ], "xbrltype": "perShareItemType" }, "us-gaap_IncomeTaxHolidayLineItems": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.", "label": "Income Tax Holiday [Line Items]", "terseLabel": "Income Tax Holiday [Line Items]" } } }, "localname": "IncomeTaxHolidayLineItems", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.agilent.com/role/IncomeTaxesIncomeTaxesEffectiveTaxRateAndTaxHolidaysDetails" ], "xbrltype": "stringItemType" }, "us-gaap_IncomeTaxHolidayTable": { "auth_ref": [ "r437", "r478" ], "lang": { "en-US": { "role": { "documentation": "Income tax-exemptions and reductions which may be granted by a taxing authority for a specified period. Such \"tax holidays\" are typically granted to induce business investment in the tax jurisdiction.", "label": "Income Tax Holiday [Table]", "terseLabel": "Income Tax Holiday [Table]" } } }, "localname": "IncomeTaxHolidayTable", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.agilent.com/role/IncomeTaxesIncomeTaxesEffectiveTaxRateAndTaxHolidaysDetails" ], "xbrltype": "stringItemType" }, "us-gaap_IncomeTaxPolicyTextBlock": { "auth_ref": [ "r100", "r137", "r441", "r442", "r461", "r462", "r468", "r482", "r653" ], "lang": { "en-US": { "role": { "documentation": "Disclosure of accounting policy for income taxes, which may include its accounting policies for recognizing and measuring deferred tax assets and liabilities and related valuation allowances, recognizing investment tax credits, operating loss carryforwards, tax credit carryforwards, and other carryforwards, methodologies for determining its effective income tax rate and the characterization of interest and penalties in the financial statements.", "label": "Income Tax, Policy [Policy Text Block]", "terseLabel": "Taxes on income" } } }, "localname": "IncomeTaxPolicyTextBlock", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.agilent.com/role/OverviewAndSummaryOfSignificantAccountingPoliciesPolicies" ], "xbrltype": "textBlockItemType" }, "us-gaap_IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance": { "auth_ref": [ "r440", "r448", "r449" ], "crdr": "debit", "lang": { "en-US": { "role": { "documentation": "Amount of the difference between reported income tax expense (benefit) and expected income tax expense (benefit) computed by applying the domestic federal statutory income tax rates to pretax income (loss) from continuing operations attributable to increase (decrease) in the valuation allowance for deferred tax assets.", "label": "Effective Income Tax Rate Reconciliation, Change in Deferred Tax Assets Valuation Allowance, Amount", "terseLabel": "Valuation allowances" } } }, "localname": "IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.agilent.com/role/IncomeTaxesIncomeTaxesEffectiveTaxRateAndTaxHolidaysDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_IncomeTaxReconciliationChangeInEnactedTaxRate": { "auth_ref": [ "r439", "r448", "r449" ], "crdr": "debit", "lang": { "en-US": { "role": { "documentation": "Amount of the difference between reported income tax expense (benefit) and expected income tax expense (benefit) computed by applying the domestic federal statutory income tax rates to pretax income (loss) from continuing operations, attributable to increase (decrease) in the income tax rates.", "label": "Effective Income Tax Rate Reconciliation, Change in Enacted Tax Rate, Amount", "terseLabel": "U.S. Tax Reform", "verboseLabel": "U.S. Tax Reform tax expense" } } }, "localname": "IncomeTaxReconciliationChangeInEnactedTaxRate", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.agilent.com/role/IncomeTaxes2017USTaxReformTaxCutsAndJobsActDetails", "http://www.agilent.com/role/IncomeTaxesIncomeTaxesEffectiveTaxRateAndTaxHolidaysDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_IncomeTaxReconciliationForeignIncomeTaxRateDifferential": { "auth_ref": [ "r140", "r448", "r449" ], "crdr": "debit", "lang": { "en-US": { "role": { "documentation": "Amount of the difference between reported income tax expense (benefit) and expected income tax expense (benefit) computed by applying the domestic federal statutory income tax rates to pretax income (loss) from continuing operations attributable to foreign income tax expense (benefit).", "label": "Effective Income Tax Rate Reconciliation, Foreign Income Tax Rate Differential, Amount", "terseLabel": "Non-U.S. income taxed at different rates" } } }, "localname": "IncomeTaxReconciliationForeignIncomeTaxRateDifferential", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.agilent.com/role/IncomeTaxesIncomeTaxesEffectiveTaxRateAndTaxHolidaysDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate": { "auth_ref": [ "r141", "r448", "r449" ], "crdr": "debit", "lang": { "en-US": { "role": { "documentation": "The amount of income tax expense or benefit for the period computed by applying the domestic federal statutory tax rates to pretax income from continuing operations.", "label": "Effective Income Tax Rate Reconciliation at Federal Statutory Income Tax Rate, Amount", "terseLabel": "Profit before tax times statutory rate" } } }, "localname": "IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.agilent.com/role/IncomeTaxesIncomeTaxesEffectiveTaxRateAndTaxHolidaysDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_IncomeTaxReconciliationOtherAdjustments": { "auth_ref": [ "r448" ], "crdr": "debit", "lang": { "en-US": { "role": { "documentation": "Amount of the difference between reported income tax expense (benefit) and expected income tax expense (benefit) computed by applying the domestic federal statutory income tax rates to pretax income (loss) from continuing operations attributable to other adjustments.", "label": "Effective Income Tax Rate Reconciliation, Other Adjustments, Amount", "terseLabel": "Adjustments to earnings of foreign subsidiaries" } } }, "localname": "IncomeTaxReconciliationOtherAdjustments", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.agilent.com/role/IncomeTaxesIncomeTaxesEffectiveTaxRateAndTaxHolidaysDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_IncomeTaxReconciliationOtherReconcilingItems": { "auth_ref": [ "r448", "r449" ], "crdr": "debit", "lang": { "en-US": { "role": { "documentation": "Amount of the difference between reported income tax expense (benefit) and expected income tax expense (benefit) computed by applying the domestic federal statutory income tax rates to pretax income (loss) from continuing operations attributable to tax exempt income, equity in earnings (loss) of an unconsolidated subsidiary, minority noncontrolling interest income (loss), tax holiday, disposition of a business, disposition of an asset, repatriation of foreign earnings, repatriation of foreign earnings jobs creation act of 2004, increase (decrease) in enacted tax rate, prior year income taxes, increase (decrease) in deferred tax asset valuation allowance, and other adjustments.", "label": "Effective Income Tax Rate Reconciliation, Other Reconciling Items, Amount", "terseLabel": "Effective Income Tax Rate Reconciliation, Other Reconciling Items, Amount" } } }, "localname": "IncomeTaxReconciliationOtherReconcilingItems", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.agilent.com/role/IncomeTaxesIncomeTaxesEffectiveTaxRateAndTaxHolidaysDetails", "http://www.agilent.com/role/IncomeTaxesIncomeTaxesProvisionDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_IncomeTaxReconciliationStateAndLocalIncomeTaxes": { "auth_ref": [ "r141", "r448", "r449" ], "crdr": "debit", "lang": { "en-US": { "role": { "documentation": "Amount of the difference between reported income tax expense (benefit) and expected income tax expense (benefit) computed by applying the domestic federal statutory income tax rates to pretax income (loss) from continuing operations attributable to state and local income tax expense (benefit).", "label": "Effective Income Tax Rate Reconciliation, State and Local Income Taxes, Amount", "terseLabel": "State income taxes, net of federal benefit" } } }, "localname": "IncomeTaxReconciliationStateAndLocalIncomeTaxes", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.agilent.com/role/IncomeTaxesIncomeTaxesEffectiveTaxRateAndTaxHolidaysDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_IncomeTaxesPaid": { "auth_ref": [ "r126", "r133" ], "crdr": "credit", "lang": { "en-US": { "role": { "documentation": "The amount of cash paid during the current period to foreign, federal, state, and local authorities as taxes on income.", "label": "Income Taxes Paid", "terseLabel": "Income tax payments, net" } } }, "localname": "IncomeTaxesPaid", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.agilent.com/role/ConsolidatedStatementOfCashFlows" ], "xbrltype": "monetaryItemType" }, "us-gaap_IncomeTaxesReceivable": { "auth_ref": [ "r66", "r618", "r644" ], "crdr": "debit", "lang": { "en-US": { "role": { "documentation": "Carrying amount due within one year of the balance sheet date (or one operating cycle, if longer) from tax authorities as of the balance sheet date representing refunds of overpayments or recoveries based on agreed-upon resolutions of disputes.", "label": "Income Taxes Receivable, Current", "terseLabel": "Current income tax assets (included within other current assets)" } } }, "localname": "IncomeTaxesReceivable", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.agilent.com/role/IncomeTaxesCurrentAndLongTermIncomeTaxAssetsAndLiabilitiesDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_IncomeTaxesReceivableNoncurrent": { "auth_ref": [ "r19", "r631" ], "crdr": "debit", "lang": { "en-US": { "role": { "documentation": "Carrying amount due after one year of the balance sheet date (or one operating cycle, if longer) from tax authorities as of the balance sheet date representing refunds of overpayments or recoveries based on agreed-upon resolutions of disputes.", "label": "Income Taxes Receivable, Noncurrent", "terseLabel": "Long-term income tax assets (included within other assets)" } } }, "localname": "IncomeTaxesReceivableNoncurrent", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.agilent.com/role/IncomeTaxesCurrentAndLongTermIncomeTaxAssetsAndLiabilitiesDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_IncreaseDecreaseInAccountsPayable": { "auth_ref": [ "r128" ], "calculation": { "http://www.agilent.com/role/ConsolidatedStatementOfCashFlows": { "order": 12.0, "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-US": { "role": { "documentation": "The increase (decrease) during the reporting period in the aggregate amount of liabilities incurred (and for which invoices have typically been received) and payable to vendors for goods and services received that are used in an entity's business.", "label": "Increase (Decrease) in Accounts Payable", "terseLabel": "Accounts payable" } } }, "localname": "IncreaseDecreaseInAccountsPayable", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.agilent.com/role/ConsolidatedStatementOfCashFlows" ], "xbrltype": "monetaryItemType" }, "us-gaap_IncreaseDecreaseInAccountsReceivable": { "auth_ref": [ "r128" ], "calculation": { "http://www.agilent.com/role/ConsolidatedStatementOfCashFlows": { "order": 10.0, "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": -1.0 } }, "crdr": "credit", "lang": { "en-US": { "role": { "documentation": "The increase (decrease) during the reporting period in amount due within one year (or one business cycle) from customers for the credit sale of goods and services.", "label": "Increase (Decrease) in Accounts Receivable", "negatedLabel": "Accounts receivable, net" } } }, "localname": "IncreaseDecreaseInAccountsReceivable", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.agilent.com/role/ConsolidatedStatementOfCashFlows" ], "xbrltype": "monetaryItemType" }, "us-gaap_IncreaseDecreaseInContractWithCustomerLiability": { "auth_ref": [ "r128" ], "crdr": "debit", "lang": { "en-US": { "role": { "documentation": "Amount of increase (decrease) in obligation to transfer good or service to customer for which consideration has been received or is receivable.", "label": "Increase (Decrease) in Contract with Customer, Liability", "terseLabel": "Increase (Decrease) in Contract with Customer, Liability" } } }, "localname": "IncreaseDecreaseInContractWithCustomerLiability", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.agilent.com/role/RevenueRevenueContractBalancesDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_IncreaseDecreaseInDeferredRevenueAndCustomerAdvancesAndDeposits": { "auth_ref": [ "r128" ], "crdr": "debit", "lang": { "en-US": { "role": { "documentation": "The increase (decrease) during the reporting period in the amount of (a) prepayments by customers for goods or services to be provided at a later date, (b) the amount of customer money held in customer accounts, including security deposits, collateral for current or future transactions, initial payment of the cost of an acquisition or for the right to enter into a contract or agreement, (c) the increase (decrease) during the reporting period, excluding the portion taken into income, in the liability reflecting services yet to be performed by the reporting entity for which cash or other forms of consideration was received or recorded as a receivable, or (d) some combination of (a), (b), and (c).", "label": "Increase (Decrease) in Deferred Revenue and Customer Advances and Deposits", "terseLabel": "Increase (Decrease) in Deferred Revenue and Customer Advances and Deposits" } } }, "localname": "IncreaseDecreaseInDeferredRevenueAndCustomerAdvancesAndDeposits", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.agilent.com/role/RevenueRevenueContractBalancesDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_IncreaseDecreaseInEmployeeRelatedLiabilities": { "auth_ref": [ "r128" ], "calculation": { "http://www.agilent.com/role/ConsolidatedStatementOfCashFlows": { "order": 13.0, "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-US": { "role": { "documentation": "The increase (decrease) during the reporting period in the aggregate amount of obligations related to services received from employees, such as accrued salaries and bonuses, payroll taxes and fringe benefits.", "label": "Increase (Decrease) in Employee Related Liabilities", "terseLabel": "Employee compensation and benefits" } } }, "localname": "IncreaseDecreaseInEmployeeRelatedLiabilities", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.agilent.com/role/ConsolidatedStatementOfCashFlows" ], "xbrltype": "monetaryItemType" }, "us-gaap_IncreaseDecreaseInInventories": { "auth_ref": [ "r128" ], "calculation": { "http://www.agilent.com/role/ConsolidatedStatementOfCashFlows": { "order": 11.0, "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": -1.0 } }, "crdr": "credit", "lang": { "en-US": { "role": { "documentation": "The increase (decrease) during the reporting period in the aggregate value of all inventory held by the reporting entity, associated with underlying transactions that are classified as operating activities.", "label": "Increase (Decrease) in Inventories", "negatedLabel": "Inventory" } } }, "localname": "IncreaseDecreaseInInventories", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.agilent.com/role/ConsolidatedStatementOfCashFlows" ], "xbrltype": "monetaryItemType" }, "us-gaap_IncreaseDecreaseInOperatingCapitalAbstract": { "auth_ref": [], "lang": { "en-US": { "role": { "label": "Increase (Decrease) in Operating Capital [Abstract]", "terseLabel": "Changes in assets and liabilities:" } } }, "localname": "IncreaseDecreaseInOperatingCapitalAbstract", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.agilent.com/role/ConsolidatedStatementOfCashFlows" ], "xbrltype": "stringItemType" }, "us-gaap_IncreaseDecreaseInOtherOperatingCapitalNet": { "auth_ref": [ "r128" ], "calculation": { "http://www.agilent.com/role/ConsolidatedStatementOfCashFlows": { "order": 16.0, "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": -1.0 } }, "crdr": "credit", "lang": { "en-US": { "role": { "documentation": "Amount of increase (decrease) in operating assets after deduction of operating liabilities classified as other.", "label": "Increase (Decrease) in Other Operating Assets and Liabilities, Net", "negatedTerseLabel": "Other assets and liabilities" } } }, "localname": "IncreaseDecreaseInOtherOperatingCapitalNet", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.agilent.com/role/ConsolidatedStatementOfCashFlows" ], "xbrltype": "monetaryItemType" }, "us-gaap_IncrementalCommonSharesAttributableToShareBasedPaymentArrangements": { "auth_ref": [ "r162", "r167" ], "lang": { "en-US": { "role": { "documentation": "Additional shares included in the calculation of diluted EPS as a result of the potentially dilutive effect of share based payment arrangements using the treasury stock method.", "label": "Incremental Common Shares Attributable to Dilutive Effect of Share-based Payment Arrangements", "terseLabel": "Potential common shares - stock options and other employeee stock plans" } } }, "localname": "IncrementalCommonSharesAttributableToShareBasedPaymentArrangements", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.agilent.com/role/NetIncomeLossPerShareDetails" ], "xbrltype": "sharesItemType" }, "us-gaap_IndefiniteLivedIntangibleAssetsExcludingGoodwill": { "auth_ref": [ "r248" ], "crdr": "debit", "lang": { "en-US": { "role": { "documentation": "Amount of assets, excluding financial assets and goodwill, lacking physical substance and having a projected indefinite period of benefit.", "label": "Indefinite-lived Intangible Assets (Excluding Goodwill)", "terseLabel": "In-Process R&D" } } }, "localname": "IndefiniteLivedIntangibleAssetsExcludingGoodwill", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.agilent.com/role/AcquisitionsAcquisitionsIntangibleAssetsDetails", "http://www.agilent.com/role/GoodwillAndOtherIntangibleAssetsDisclosuresAndComponentsOfOtherIntangiblesDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_IndefiniteLivedIntangibleAssetsPurchaseAccountingAdjustments": { "auth_ref": [], "crdr": "debit", "lang": { "en-US": { "role": { "documentation": "Amount of increase (decrease) of assets, excluding financial assets and goodwill, lacking physical substance and having a projected indefinite period of benefit, from purchase accounting adjustments.", "label": "Indefinite-lived Intangible Assets, Purchase Accounting Adjustments", "terseLabel": "Indefinite-lived Intangible Assets, Purchase Accounting Adjustments" } } }, "localname": "IndefiniteLivedIntangibleAssetsPurchaseAccountingAdjustments", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.agilent.com/role/GoodwillAndOtherIntangibleAssetsRollForwardDetails", "http://www.agilent.com/role/GoodwillAndOtherIntangibleAssetsTextDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_InitialApplicationPeriodCumulativeEffectTransitionAxis": { "auth_ref": [ "r320" ], "lang": { "en-US": { "role": { "documentation": "Information about effect of transition method for cumulative effect in initial period of application.", "label": "Initial Application Period Cumulative Effect Transition [Axis]", "terseLabel": "Initial Application Period Cumulative Effect Transition [Axis]" } } }, "localname": "InitialApplicationPeriodCumulativeEffectTransitionAxis", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.agilent.com/role/RevenueRevenueContractBalancesDetails" ], "xbrltype": "stringItemType" }, "us-gaap_InitialApplicationPeriodCumulativeEffectTransitionDomain": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Effect of transition method for cumulative effect in initial period of application.", "label": "Initial Application Period Cumulative Effect Transition [Domain]", "terseLabel": "Initial Application Period Cumulative Effect Transition [Domain]" } } }, "localname": "InitialApplicationPeriodCumulativeEffectTransitionDomain", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.agilent.com/role/RevenueRevenueContractBalancesDetails" ], "xbrltype": "domainItemType" }, "us-gaap_IntangibleAssetsGrossExcludingGoodwill": { "auth_ref": [], "crdr": "debit", "lang": { "en-US": { "role": { "documentation": "Amount before accumulated amortization of intangible assets, excluding goodwill.", "label": "Intangible Assets, Gross (Excluding Goodwill)", "terseLabel": "Gross Book Value", "verboseLabel": "Total intangible assets acquired - excluding goodwill" } } }, "localname": "IntangibleAssetsGrossExcludingGoodwill", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.agilent.com/role/AcquisitionsAcquisitionsIntangibleAssetsDetails", "http://www.agilent.com/role/GoodwillAndOtherIntangibleAssetsDisclosuresAndComponentsOfOtherIntangiblesDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_IntangibleAssetsNetExcludingGoodwill": { "auth_ref": [ "r237", "r243" ], "calculation": { "http://www.agilent.com/role/ConsolidatedBalanceSheet": { "order": 4.0, "parentTag": "us-gaap_Assets", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-US": { "role": { "documentation": "Sum of the carrying amounts of all intangible assets, excluding goodwill, as of the balance sheet date, net of accumulated amortization and impairment charges.", "label": "Intangible Assets, Net (Excluding Goodwill)", "terseLabel": "Other intangible assets, net", "verboseLabel": "Other intangible assets, net" } } }, "localname": "IntangibleAssetsNetExcludingGoodwill", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.agilent.com/role/ConsolidatedBalanceSheet", "http://www.agilent.com/role/GoodwillAndOtherIntangibleAssetsDisclosuresAndComponentsOfOtherIntangiblesDetails", "http://www.agilent.com/role/NewAccountingPronouncementsImpactOfAdoptingNewGuidanceDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_IntangibleAssetsNetIncludingGoodwillAbstract": { "auth_ref": [], "lang": { "en-US": { "role": { "label": "Intangible Assets, Net (Including Goodwill) [Abstract]", "terseLabel": "Intangible Assets, Including Goodwill)" } } }, "localname": "IntangibleAssetsNetIncludingGoodwillAbstract", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.agilent.com/role/GoodwillAndOtherIntangibleAssetsTextDetails" ], "xbrltype": "stringItemType" }, "us-gaap_InterestExpense": { "auth_ref": [ "r102", "r190", "r586", "r589", "r623" ], "calculation": { "http://www.agilent.com/role/ConsolidatedStatementOfOperations": { "order": 3.0, "parentTag": "us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments", "weight": -1.0 }, "http://www.agilent.com/role/SegmentInformationReconciliationOfReportableResultsDetails": { "order": 13.0, "parentTag": "us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments", "weight": -1.0 } }, "crdr": "debit", "lang": { "en-US": { "role": { "documentation": "Amount of the cost of borrowed funds accounted for as interest expense.", "label": "Interest Expense", "negatedLabel": "Interest expense", "negatedTerseLabel": "Interest Expense" } } }, "localname": "InterestExpense", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.agilent.com/role/ConsolidatedStatementOfOperations", "http://www.agilent.com/role/SegmentInformationReconciliationOfReportableResultsDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_InterestPaidNet": { "auth_ref": [ "r122", "r125", "r133" ], "crdr": "credit", "lang": { "en-US": { "role": { "documentation": "Amount of cash paid for interest, excluding capitalized interest, classified as operating activity. Includes, but is not limited to, payment to settle zero-coupon bond for accreted interest of debt discount and debt instrument with insignificant coupon interest rate in relation to effective interest rate of borrowing attributable to accreted interest of debt discount.", "label": "Interest Paid, Excluding Capitalized Interest, Operating Activities", "terseLabel": "Interest payments" } } }, "localname": "InterestPaidNet", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.agilent.com/role/ConsolidatedStatementOfCashFlows" ], "xbrltype": "monetaryItemType" }, "us-gaap_InterestRateCashFlowHedgeGainLossReclassifiedToEarningsNet": { "auth_ref": [ "r539" ], "crdr": "credit", "lang": { "en-US": { "role": { "documentation": "The amount of net gains or losses on interest rate cash flow hedges reclassified during the period to earnings from accumulated other comprehensive income upon the hedged transaction affecting earnings.", "label": "Interest Rate Cash Flow Hedge Gain (Loss) Reclassified to Earnings, Net", "terseLabel": "Interest Rate Cash Flow Hedge Gain (Loss) Reclassified to Earnings, Net" } } }, "localname": "InterestRateCashFlowHedgeGainLossReclassifiedToEarningsNet", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.agilent.com/role/DerivativesEffectOfDerivativeInstrumentsOnConsolidatedStatementOfOperationsDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_InterestRateDerivativesAbstract": { "auth_ref": [], "lang": { "en-US": { "role": { "label": "Interest Rate Derivatives [Abstract]", "terseLabel": "Terminated Interest Rate Swaps" } } }, "localname": "InterestRateDerivativesAbstract", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.agilent.com/role/DerivativesDetails" ], "xbrltype": "stringItemType" }, "us-gaap_InterestRateSwapMember": { "auth_ref": [ "r542" ], "lang": { "en-US": { "role": { "documentation": "Forward based contracts in which two parties agree to swap periodic payments that are fixed at the outset of the swap contract with variable payments based on a market interest rate (index rate) over a specified period.", "label": "Interest Rate Swap [Member]", "terseLabel": "Interest Rate Swap [Member]" } } }, "localname": "InterestRateSwapMember", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.agilent.com/role/DerivativesEffectOfDerivativeInstrumentsOnConsolidatedStatementOfOperationsDetails" ], "xbrltype": "domainItemType" }, "us-gaap_InternalUseSoftwarePolicy": { "auth_ref": [ "r137", "r251", "r253" ], "lang": { "en-US": { "role": { "documentation": "Disclosure of accounting policy for costs incurred when both (1) the software is acquired, internally developed, or modified solely to meet the entity's internal needs, and (2) during the software's development or modification, no substantive plan exists or is being developed to market the software externally.", "label": "Internal Use Software, Policy [Policy Text Block]", "terseLabel": "Capitalized software" } } }, "localname": "InternalUseSoftwarePolicy", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.agilent.com/role/OverviewAndSummaryOfSignificantAccountingPoliciesPolicies" ], "xbrltype": "textBlockItemType" }, "us-gaap_InventoriesMember": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Tangible personal property held for sale in the ordinary course of business, or in process of, or to be consumed in, production for sale.", "label": "Inventories [Member]", "terseLabel": "Inventories" } } }, "localname": "InventoriesMember", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.agilent.com/role/ShareBasedCompensationAllocatedShareBasedCompensationExpenseDetails" ], "xbrltype": "domainItemType" }, "us-gaap_InventoryCurrentTable": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Disclosure of information about inventory expected to be sold or consumed within one year or operating cycle, if longer.", "label": "Inventory, Current [Table]", "terseLabel": "Inventory, Current [Table]" } } }, "localname": "InventoryCurrentTable", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.agilent.com/role/InventoryDetails" ], "xbrltype": "stringItemType" }, "us-gaap_InventoryDisclosureAbstract": { "auth_ref": [], "lang": { "en-US": { "role": { "label": "Inventory Disclosure [Abstract]" } } }, "localname": "InventoryDisclosureAbstract", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "xbrltype": "stringItemType" }, "us-gaap_InventoryDisclosureTextBlock": { "auth_ref": [ "r227" ], "lang": { "en-US": { "role": { "documentation": "The entire disclosure for inventory. Includes, but is not limited to, the basis of stating inventory, the method of determining inventory cost, the classes of inventory, and the nature of the cost elements included in inventory.", "label": "Inventory Disclosure [Text Block]", "verboseLabel": "INVENTORY" } } }, "localname": "InventoryDisclosureTextBlock", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.agilent.com/role/Inventory" ], "xbrltype": "textBlockItemType" }, "us-gaap_InventoryFinishedGoods": { "auth_ref": [ "r68" ], "crdr": "debit", "lang": { "en-US": { "role": { "documentation": "Amount before valuation and LIFO reserves of completed merchandise or goods expected to be sold within one year or operating cycle, if longer.", "label": "Inventory, Finished Goods, Gross", "terseLabel": "Finished goods" } } }, "localname": "InventoryFinishedGoods", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.agilent.com/role/InventoryDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_InventoryLineItems": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.", "label": "Inventory [Line Items]", "terseLabel": "Inventory [Line Items]" } } }, "localname": "InventoryLineItems", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.agilent.com/role/InventoryDetails" ], "xbrltype": "stringItemType" }, "us-gaap_InventoryNet": { "auth_ref": [ "r5", "r70", "r223" ], "calculation": { "http://www.agilent.com/role/ConsolidatedBalanceSheet": { "order": 3.0, "parentTag": "us-gaap_AssetsCurrent", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-US": { "role": { "documentation": "Amount after valuation and LIFO reserves of inventory expected to be sold, or consumed within one year or operating cycle, if longer.", "label": "Inventory, Net", "terseLabel": "Inventory", "verboseLabel": "Inventory" } } }, "localname": "InventoryNet", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.agilent.com/role/ConsolidatedBalanceSheet", "http://www.agilent.com/role/InventoryDetails", "http://www.agilent.com/role/NewAccountingPronouncementsImpactOfAdoptingNewGuidanceDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_InventoryPolicyTextBlock": { "auth_ref": [ "r14", "r71", "r137", "r173", "r224", "r226" ], "lang": { "en-US": { "role": { "documentation": "Disclosure of inventory accounting policy for inventory classes, including, but not limited to, basis for determining inventory amounts, methods by which amounts are added and removed from inventory classes, loss recognition on impairment of inventories, and situations in which inventories are stated above cost.", "label": "Inventory, Policy [Policy Text Block]", "terseLabel": "Inventory" } } }, "localname": "InventoryPolicyTextBlock", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.agilent.com/role/OverviewAndSummaryOfSignificantAccountingPoliciesPolicies" ], "xbrltype": "textBlockItemType" }, "us-gaap_InventoryWorkInProcessAndRawMaterials": { "auth_ref": [ "r69" ], "crdr": "debit", "lang": { "en-US": { "role": { "documentation": "The aggregate carrying amount as of the balance sheet date of items held by the entity which are partially completed at the time of measurement and unprocessed items that will go through the production process and become part of the final product. Includes supplies used directly or indirectly in the manufacturing or production process. This element may be used when the reporting entity combines work in process and raw materials into an aggregate amount.", "label": "Inventory, Work in Process and Raw Materials", "terseLabel": "Purchased parts and fabricated assemblies" } } }, "localname": "InventoryWorkInProcessAndRawMaterials", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.agilent.com/role/InventoryDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_InventoryWriteDown": { "auth_ref": [ "r225" ], "calculation": { "http://www.agilent.com/role/ConsolidatedStatementOfCashFlows": { "order": 5.0, "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-US": { "role": { "documentation": "Amount of loss from reductions in inventory due to subsequent measurement adjustments, including, but not limited to, physical deterioration, obsolescence, or changes in price levels.", "label": "Inventory Write-down", "terseLabel": "Inventory-related excess and obsolescence charges", "verboseLabel": "Excess and obsolete inventory related charges" } } }, "localname": "InventoryWriteDown", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.agilent.com/role/ConsolidatedStatementOfCashFlows", "http://www.agilent.com/role/InventoryDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_InvestmentIncomeInterest": { "auth_ref": [ "r108", "r189" ], "calculation": { "http://www.agilent.com/role/ConsolidatedStatementOfOperations": { "order": 2.0, "parentTag": "us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments", "weight": 1.0 }, "http://www.agilent.com/role/SegmentInformationReconciliationOfReportableResultsDetails": { "order": 12.0, "parentTag": "us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-US": { "role": { "documentation": "Amount before accretion (amortization) of purchase discount (premium) of interest income on nonoperating securities.", "label": "Investment Income, Interest", "terseLabel": "Interest income", "verboseLabel": "Interest income" } } }, "localname": "InvestmentIncomeInterest", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.agilent.com/role/ConsolidatedStatementOfOperations", "http://www.agilent.com/role/SegmentInformationReconciliationOfReportableResultsDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_InvestmentPolicyTextBlock": { "auth_ref": [ "r219" ], "lang": { "en-US": { "role": { "documentation": "Disclosure of accounting policy for investment in financial asset.", "label": "Investment, Policy [Policy Text Block]", "terseLabel": "Investments" } } }, "localname": "InvestmentPolicyTextBlock", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.agilent.com/role/OverviewAndSummaryOfSignificantAccountingPoliciesPolicies" ], "xbrltype": "textBlockItemType" }, "us-gaap_InvestmentsDebtAndEquitySecuritiesAbstract": { "auth_ref": [], "lang": { "en-US": { "role": { "label": "Investments, Debt and Equity Securities [Abstract]", "terseLabel": "Lasergen" } } }, "localname": "InvestmentsDebtAndEquitySecuritiesAbstract", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.agilent.com/role/InvestmentsDetails" ], "xbrltype": "stringItemType" }, "us-gaap_InvestmentsInDebtAndMarketableEquitySecuritiesAndCertainTradingAssetsDisclosureTextBlock": { "auth_ref": [ "r212", "r608", "r624", "r650" ], "lang": { "en-US": { "role": { "documentation": "The entire disclosure for investments in certain debt and equity securities.", "label": "Investments in Debt and Marketable Equity Securities (and Certain Trading Assets) Disclosure [Text Block]", "verboseLabel": "INVESTMENTS" } } }, "localname": "InvestmentsInDebtAndMarketableEquitySecuritiesAndCertainTradingAssetsDisclosureTextBlock", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.agilent.com/role/Investments" ], "xbrltype": "textBlockItemType" }, "us-gaap_Land": { "auth_ref": [ "r10", "r45" ], "calculation": { "http://www.agilent.com/role/PropertyPlantAndEquipmentNetDetails": { "order": 1.0, "parentTag": "us-gaap_PropertyPlantAndEquipmentGross", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-US": { "role": { "documentation": "Amount before accumulated depletion of real estate held for productive use, excluding land held for sale.", "label": "Land", "terseLabel": "Land" } } }, "localname": "Land", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.agilent.com/role/PropertyPlantAndEquipmentNetDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_LeaseAndRentalExpense": { "auth_ref": [], "crdr": "debit", "lang": { "en-US": { "role": { "documentation": "Amount of rent expense incurred for leased assets, including but not limited to, furniture and equipment, that is not directly or indirectly associated with the manufacture, sale or creation of a product or product line.", "label": "Operating Leases, Rent Expense", "terseLabel": "Total rent expense" } } }, "localname": "LeaseAndRentalExpense", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.agilent.com/role/CommitmentsAndContingenciesDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_LesseeLeasesPolicyTextBlock": { "auth_ref": [ "r598" ], "lang": { "en-US": { "role": { "documentation": "Disclosure of accounting policy for leasing arrangement entered into by lessee.", "label": "Lessee, Leases [Policy Text Block]", "terseLabel": "Leases" } } }, "localname": "LesseeLeasesPolicyTextBlock", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.agilent.com/role/OverviewAndSummaryOfSignificantAccountingPoliciesPolicies" ], "xbrltype": "textBlockItemType" }, "us-gaap_LesseeOperatingLeaseRenewalTerm": { "auth_ref": [ "r599" ], "lang": { "en-US": { "role": { "documentation": "Term of lessee's operating lease renewal, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days.", "label": "Lessee, Operating Lease, Renewal Term", "verboseLabel": "Lease renewal options" } } }, "localname": "LesseeOperatingLeaseRenewalTerm", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.agilent.com/role/OverviewAndSummaryOfSignificantAccountingPoliciesDetails" ], "xbrltype": "durationItemType" }, "us-gaap_LesseeOperatingLeaseTermOfContract": { "auth_ref": [ "r599" ], "lang": { "en-US": { "role": { "documentation": "Term of lessee's operating lease, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days.", "label": "Lessee, Operating Lease, Term of Contract", "terseLabel": "Operating Lease Term - Minimum" } } }, "localname": "LesseeOperatingLeaseTermOfContract", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.agilent.com/role/OverviewAndSummaryOfSignificantAccountingPoliciesDetails" ], "xbrltype": "durationItemType" }, "us-gaap_LettersOfCreditOutstandingAmount": { "auth_ref": [], "crdr": "credit", "lang": { "en-US": { "role": { "documentation": "The total amount of the contingent obligation under letters of credit outstanding as of the reporting date.", "label": "Letters of Credit Outstanding, Amount", "terseLabel": "Bank Guarantees" } } }, "localname": "LettersOfCreditOutstandingAmount", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.agilent.com/role/GuaranteesDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_Liabilities": { "auth_ref": [ "r54" ], "calculation": { "http://www.agilent.com/role/ConsolidatedBalanceSheet": { "order": 2.0, "parentTag": "us-gaap_LiabilitiesAndStockholdersEquity", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-US": { "role": { "documentation": "Sum of the carrying amounts as of the balance sheet date of all liabilities that are recognized. Liabilities are probable future sacrifices of economic benefits arising from present obligations of an entity to transfer assets or provide services to other entities in the future.", "label": "Liabilities", "terseLabel": "Total liabilities", "totalLabel": "Total liabilities" } } }, "localname": "Liabilities", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.agilent.com/role/ConsolidatedBalanceSheet", "http://www.agilent.com/role/NewAccountingPronouncementsImpactOfAdoptingNewGuidanceDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_LiabilitiesAndStockholdersEquity": { "auth_ref": [ "r37", "r616", "r639" ], "calculation": { "http://www.agilent.com/role/ConsolidatedBalanceSheet": { "order": null, "parentTag": null, "root": true, "weight": null } }, "crdr": "credit", "lang": { "en-US": { "role": { "documentation": "Amount of liabilities and equity items, including the portion of equity attributable to noncontrolling interests, if any.", "label": "Liabilities and Equity", "terseLabel": "Total liabilities and equity", "totalLabel": "Total liabilities and equity" } } }, "localname": "LiabilitiesAndStockholdersEquity", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.agilent.com/role/ConsolidatedBalanceSheet", "http://www.agilent.com/role/NewAccountingPronouncementsImpactOfAdoptingNewGuidanceDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_LiabilitiesAndStockholdersEquityAbstract": { "auth_ref": [], "lang": { "en-US": { "role": { "label": "Liabilities and Equity [Abstract]", "terseLabel": "LIABILITIES AND EQUITY" } } }, "localname": "LiabilitiesAndStockholdersEquityAbstract", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.agilent.com/role/ConsolidatedBalanceSheet", "http://www.agilent.com/role/ConsolidatedBalanceSheetParenthetical" ], "xbrltype": "stringItemType" }, "us-gaap_LiabilitiesCurrent": { "auth_ref": [ "r56" ], "calculation": { "http://www.agilent.com/role/ConsolidatedBalanceSheet": { "order": 1.0, "parentTag": "us-gaap_Liabilities", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-US": { "role": { "documentation": "Total obligations incurred as part of normal operations that are expected to be paid during the following twelve months or within one business cycle, if longer.", "label": "Liabilities, Current", "terseLabel": "Total current liabilities", "totalLabel": "Total current liabilities" } } }, "localname": "LiabilitiesCurrent", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.agilent.com/role/ConsolidatedBalanceSheet", "http://www.agilent.com/role/NewAccountingPronouncementsImpactOfAdoptingNewGuidanceDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_LiabilitiesCurrentAbstract": { "auth_ref": [], "lang": { "en-US": { "role": { "label": "Liabilities, Current [Abstract]", "terseLabel": "Liabilities, Short-term [Abstract]", "verboseLabel": "Current liabilities:" } } }, "localname": "LiabilitiesCurrentAbstract", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.agilent.com/role/ConsolidatedBalanceSheet", "http://www.agilent.com/role/FairValueMeasurementsFairValueOfAssetsAndLiabilitiesMeasuredOnRecurringBasisDetails" ], "xbrltype": "stringItemType" }, "us-gaap_LiabilitiesNoncurrentAbstract": { "auth_ref": [], "lang": { "en-US": { "role": { "label": "Liabilities, Noncurrent [Abstract]", "terseLabel": "Liabilities, Long-term [Abstract]" } } }, "localname": "LiabilitiesNoncurrentAbstract", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.agilent.com/role/FairValueMeasurementsFairValueOfAssetsAndLiabilitiesMeasuredOnRecurringBasisDetails" ], "xbrltype": "stringItemType" }, "us-gaap_LineOfCreditFacilityAbstract": { "auth_ref": [], "lang": { "en-US": { "role": { "label": "Line of Credit Facility [Abstract]" } } }, "localname": "LineOfCreditFacilityAbstract", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.agilent.com/role/ShortTermDebtCreditFacilityAndCapitalLeaseDetails" ], "xbrltype": "stringItemType" }, "us-gaap_LineOfCreditFacilityAxis": { "auth_ref": [ "r51", "r144" ], "lang": { "en-US": { "role": { "documentation": "Information by name of lender, which may be a single entity (for example, but not limited to, a bank, pension fund, venture capital firm) or a group of entities that participate in the line of credit.", "label": "Lender Name [Axis]", "terseLabel": "Lender Name [Axis]" } } }, "localname": "LineOfCreditFacilityAxis", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.agilent.com/role/ShortTermDebtCreditFacilityAndCapitalLeaseDetails" ], "xbrltype": "stringItemType" }, "us-gaap_LineOfCreditFacilityExpirationDate1": { "auth_ref": [ "r51" ], "lang": { "en-US": { "role": { "documentation": "Date the credit facility terminates, in CCYY-MM-DD format.", "label": "Line of Credit Facility, Expiration Date", "terseLabel": "Line of credit facility expiration date" } } }, "localname": "LineOfCreditFacilityExpirationDate1", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.agilent.com/role/ShortTermDebtCreditFacilityAndCapitalLeaseDetails" ], "xbrltype": "dateItemType" }, "us-gaap_LineOfCreditFacilityFairValueOfAmountOutstanding": { "auth_ref": [ "r572" ], "crdr": "credit", "lang": { "en-US": { "role": { "documentation": "Fair value of the amount outstanding under the credit facility.", "label": "Line of Credit Facility, Fair Value of Amount Outstanding", "terseLabel": "Line of credit outstanding balance" } } }, "localname": "LineOfCreditFacilityFairValueOfAmountOutstanding", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.agilent.com/role/ShortTermDebtCreditFacilityAndCapitalLeaseDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_LineOfCreditFacilityInitiationDate1": { "auth_ref": [ "r51" ], "lang": { "en-US": { "role": { "documentation": "Date the credit facility first became available, in CCYY-MM-DD format.", "label": "Line of Credit Facility, Initiation Date", "terseLabel": "Credit facility initiation date" } } }, "localname": "LineOfCreditFacilityInitiationDate1", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.agilent.com/role/ShortTermDebtCreditFacilityAndCapitalLeaseDetails" ], "xbrltype": "dateItemType" }, "us-gaap_LineOfCreditFacilityLenderDomain": { "auth_ref": [ "r51" ], "lang": { "en-US": { "role": { "documentation": "Identification of the lender, which may be a single entity (for example, a bank, pension fund, venture capital firm) or a group of entities that participate in the line of credit, including a letter of credit facility.", "label": "Line of Credit Facility, Lender [Domain]", "terseLabel": "Line of Credit Facility, Lender [Domain]" } } }, "localname": "LineOfCreditFacilityLenderDomain", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.agilent.com/role/ShortTermDebtCreditFacilityAndCapitalLeaseDetails" ], "xbrltype": "domainItemType" }, "us-gaap_LineOfCreditFacilityLineItems": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.", "label": "Line of Credit Facility [Line Items]" } } }, "localname": "LineOfCreditFacilityLineItems", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.agilent.com/role/ShortTermDebtCreditFacilityAndCapitalLeaseDetails" ], "xbrltype": "stringItemType" }, "us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity": { "auth_ref": [ "r51" ], "crdr": "credit", "lang": { "en-US": { "role": { "documentation": "Maximum borrowing capacity under the credit facility without consideration of any current restrictions on the amount that could be borrowed or the amounts currently outstanding under the facility.", "label": "Line of Credit Facility, Maximum Borrowing Capacity", "terseLabel": "Maximum borrowing capacity after increase" } } }, "localname": "LineOfCreditFacilityMaximumBorrowingCapacity", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.agilent.com/role/ShortTermDebtCreditFacilityAndCapitalLeaseDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_LineOfCreditFacilityTable": { "auth_ref": [ "r51", "r144" ], "lang": { "en-US": { "role": { "documentation": "A table or schedule providing information pertaining to short-term or long-term contractual arrangements with lenders, including letters of credit, standby letters of credit, and revolving credit arrangements, under which borrowings can be made up to maximum amount as of any point in time conditional on satisfaction of specified terms before, as of and after the date of drawdowns on the line.", "label": "Line of Credit Facility [Table]" } } }, "localname": "LineOfCreditFacilityTable", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.agilent.com/role/ShortTermDebtCreditFacilityAndCapitalLeaseDetails" ], "xbrltype": "stringItemType" }, "us-gaap_LongMember": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Indicates an ownership position in, or purchase of, a security.", "label": "Long [Member]", "terseLabel": "Buy" } } }, "localname": "LongMember", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.agilent.com/role/DerivativesDisclosuresAndDerivativeInstrumentAggregatedNotionalAmountsByCurrencyAndDesignationsDetails" ], "xbrltype": "domainItemType" }, "us-gaap_LongTermDebtAbstract": { "auth_ref": [], "lang": { "en-US": { "role": { "label": "Long-term Debt, Unclassified [Abstract]" } } }, "localname": "LongTermDebtAbstract", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "xbrltype": "stringItemType" }, "us-gaap_LongTermDebtNoncurrent": { "auth_ref": [ "r60" ], "calculation": { "http://www.agilent.com/role/ConsolidatedBalanceSheet": { "order": 2.0, "parentTag": "us-gaap_Liabilities", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-US": { "role": { "documentation": "Amount after unamortized (discount) premium and debt issuance costs of long-term debt classified as noncurrent and excluding amounts to be repaid within one year or the normal operating cycle, if longer. Includes, but not limited to, notes payable, bonds payable, debentures, mortgage loans and commercial paper. Excludes capital lease obligations.", "label": "Long-term Debt, Excluding Current Maturities", "terseLabel": "Long-term debt", "verboseLabel": "Long-term debt" } } }, "localname": "LongTermDebtNoncurrent", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.agilent.com/role/ConsolidatedBalanceSheet", "http://www.agilent.com/role/NewAccountingPronouncementsImpactOfAdoptingNewGuidanceDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_LongTermDebtTextBlock": { "auth_ref": [ "r292" ], "lang": { "en-US": { "role": { "documentation": "The entire disclosure for long-term debt.", "label": "Long-term Debt [Text Block]", "verboseLabel": "LONG-TERM DEBT" } } }, "localname": "LongTermDebtTextBlock", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.agilent.com/role/LongTermDebt" ], "xbrltype": "textBlockItemType" }, "us-gaap_LongTermInvestments": { "auth_ref": [ "r43" ], "calculation": { "http://www.agilent.com/role/ConsolidatedBalanceSheet": { "order": 5.0, "parentTag": "us-gaap_Assets", "weight": 1.0 }, "http://www.agilent.com/role/InvestmentsDetails": { "order": null, "parentTag": null, "root": true, "weight": null } }, "crdr": "debit", "lang": { "en-US": { "role": { "documentation": "The total amount of investments that are intended to be held for an extended period of time (longer than one operating cycle).", "label": "Long-term Investments", "terseLabel": "Long-term Investments", "totalLabel": "Total", "verboseLabel": "Long-term investments" } } }, "localname": "LongTermInvestments", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.agilent.com/role/ConsolidatedBalanceSheet", "http://www.agilent.com/role/InvestmentsDetails", "http://www.agilent.com/role/NewAccountingPronouncementsImpactOfAdoptingNewGuidanceDetails", "http://www.agilent.com/role/NewAccountingPronouncementsTextualsDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_LongtermDebtTypeAxis": { "auth_ref": [ "r60" ], "lang": { "en-US": { "role": { "documentation": "Information by type of long-term debt.", "label": "Long-term Debt, Type [Axis]", "terseLabel": "Long-term Debt, Type [Axis]" } } }, "localname": "LongtermDebtTypeAxis", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.agilent.com/role/LongTermDebtCarryingValueDetails", "http://www.agilent.com/role/LongTermDebtLongTermDebtOtherDetails", "http://www.agilent.com/role/LongTermDebtSeniorNotesDetails" ], "xbrltype": "stringItemType" }, "us-gaap_LongtermDebtTypeDomain": { "auth_ref": [ "r60", "r288" ], "lang": { "en-US": { "role": { "documentation": "Type of long-term debt arrangement, such as notes, line of credit, commercial paper, asset-based financing, project financing, letter of credit financing. These are debt arrangements that originally required repayment more than twelve months after issuance or greater than the normal operating cycle of the company, if longer.", "label": "Long-term Debt, Type [Domain]", "terseLabel": "Long-term Debt, Type [Domain]" } } }, "localname": "LongtermDebtTypeDomain", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.agilent.com/role/LongTermDebtCarryingValueDetails", "http://www.agilent.com/role/LongTermDebtLongTermDebtOtherDetails", "http://www.agilent.com/role/LongTermDebtSeniorNotesDetails" ], "xbrltype": "domainItemType" }, "us-gaap_LossContingenciesByNatureOfContingencyAxis": { "auth_ref": [ "r272", "r273", "r274", "r275", "r276", "r277", "r278", "r280", "r281" ], "lang": { "en-US": { "role": { "documentation": "Information by type of existing condition, situation, or set of circumstances involving uncertainty as to possible loss to an enterprise that will ultimately be resolved when one or more future events occur or fail to occur.", "label": "Loss Contingency Nature [Axis]", "terseLabel": "Loss Contingencies by Nature of Contingency [Axis]" } } }, "localname": "LossContingenciesByNatureOfContingencyAxis", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.agilent.com/role/CommitmentsAndContingenciesDetails" ], "xbrltype": "stringItemType" }, "us-gaap_LossContingenciesLineItems": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.", "label": "Loss Contingencies [Line Items]", "terseLabel": "Loss Contingencies [Line Items]" } } }, "localname": "LossContingenciesLineItems", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.agilent.com/role/CommitmentsAndContingenciesDetails" ], "xbrltype": "stringItemType" }, "us-gaap_LossContingenciesTable": { "auth_ref": [ "r272", "r273", "r274", "r275", "r276", "r277", "r278", "r280", "r281" ], "lang": { "en-US": { "role": { "documentation": "Discloses the specific components (such as the nature, name, and date) of the loss contingency and gives an estimate of the possible loss or range of loss, or states that a reasonable estimate cannot be made. Excludes environmental contingencies, warranties and unconditional purchase obligations.", "label": "Loss Contingencies [Table]", "terseLabel": "Loss Contingencies [Table]" } } }, "localname": "LossContingenciesTable", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.agilent.com/role/CommitmentsAndContingenciesDetails" ], "xbrltype": "stringItemType" }, "us-gaap_LossContingencyNatureDomain": { "auth_ref": [ "r272", "r273", "r274", "r275", "r276", "r277", "r278", "r280", "r281" ], "lang": { "en-US": { "role": { "documentation": "An existing condition, situation, or set of circumstances involving uncertainty as to possible loss to an enterprise that will ultimately be resolved when one or more future events occur or fail to occur. Resolution of the uncertainty may confirm the incurrence of a loss or impairment of an asset or the incurrence of a liability.", "label": "Loss Contingency, Nature [Domain]", "terseLabel": "Loss Contingency, Nature [Domain]" } } }, "localname": "LossContingencyNatureDomain", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.agilent.com/role/CommitmentsAndContingenciesDetails" ], "xbrltype": "domainItemType" }, "us-gaap_MachineryAndEquipmentGross": { "auth_ref": [ "r11", "r258" ], "calculation": { "http://www.agilent.com/role/PropertyPlantAndEquipmentNetDetails": { "order": 3.0, "parentTag": "us-gaap_PropertyPlantAndEquipmentGross", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-US": { "role": { "documentation": "Amount before accumulated depreciation of tangible personal property used to produce goods and services, including, but is not limited to, tools, dies and molds, computer and office equipment.", "label": "Machinery and Equipment, Gross", "terseLabel": "Machinery and equipment" } } }, "localname": "MachineryAndEquipmentGross", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.agilent.com/role/PropertyPlantAndEquipmentNetDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_MachineryAndEquipmentMember": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Tangible personal property used to produce goods and services, including, but is not limited to, tools, dies and molds, computer and office equipment.", "label": "Machinery and Equipment [Member]", "terseLabel": "Machinery and Equipment [Member]" } } }, "localname": "MachineryAndEquipmentMember", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.agilent.com/role/OverviewAndSummaryOfSignificantAccountingPoliciesDetails" ], "xbrltype": "domainItemType" }, "us-gaap_MarketableSecuritiesAbstract": { "auth_ref": [], "lang": { "en-US": { "role": { "label": "Marketable Securities [Abstract]", "terseLabel": "Long-Term [Abstract]" } } }, "localname": "MarketableSecuritiesAbstract", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.agilent.com/role/InvestmentsDetails" ], "xbrltype": "stringItemType" }, "us-gaap_MarketableSecuritiesTextBlock": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Tabular disclosure of marketable securities. This may consist of investments in certain debt and equity securities, short-term investments and other assets.", "label": "Marketable Securities [Table Text Block]", "verboseLabel": "Equity Investments" } } }, "localname": "MarketableSecuritiesTextBlock", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.agilent.com/role/InvestmentsTables" ], "xbrltype": "textBlockItemType" }, "us-gaap_MarketingAndAdvertisingExpenseAbstract": { "auth_ref": [], "lang": { "en-US": { "role": { "label": "Marketing and Advertising Expense [Abstract]", "terseLabel": "Advertising Expense" } } }, "localname": "MarketingAndAdvertisingExpenseAbstract", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.agilent.com/role/OverviewAndSummaryOfSignificantAccountingPoliciesDetails" ], "xbrltype": "stringItemType" }, "us-gaap_MergersAcquisitionsAndDispositionsDisclosuresTextBlock": { "auth_ref": [ "r2", "r504" ], "lang": { "en-US": { "role": { "documentation": "The entire disclosure for business combinations, including leverage buyout transactions (as applicable), and divestitures. This may include a description of a business combination or divestiture (or series of individually immaterial business combinations or divestitures) completed during the period, including background, timing, and assets and liabilities recognized and reclassified or sold. This element does not include fixed asset sales and plant closings.", "label": "Mergers, Acquisitions and Dispositions Disclosures [Text Block]", "terseLabel": "Acquisitions Disclosure" } } }, "localname": "MergersAcquisitionsAndDispositionsDisclosuresTextBlock", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.agilent.com/role/AcquisitionsNotes" ], "xbrltype": "textBlockItemType" }, "us-gaap_MinorityInterest": { "auth_ref": [ "r67", "r615", "r638" ], "calculation": { "http://www.agilent.com/role/ConsolidatedBalanceSheet": { "order": 1.0, "parentTag": "us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-US": { "role": { "documentation": "Total of all stockholders' equity (deficit) items, net of receivables from officers, directors, owners, and affiliates of the entity which is directly or indirectly attributable to that ownership interest in subsidiary equity which is not attributable to the parent (that is, noncontrolling interest, previously referred to as minority interest).", "label": "Stockholders' Equity Attributable to Noncontrolling Interest", "terseLabel": "Non-controlling interest" } } }, "localname": "MinorityInterest", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.agilent.com/role/ConsolidatedBalanceSheet", "http://www.agilent.com/role/NewAccountingPronouncementsImpactOfAdoptingNewGuidanceDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_MinorityInterestPeriodIncreaseDecrease": { "auth_ref": [ "r506" ], "lang": { "en-US": { "role": { "documentation": "Net Increase or Decrease in balance of noncontrolling interest in the subsidiary during the reporting period.", "label": "Noncontrolling Interest, Period Increase (Decrease)", "terseLabel": "Non-controlling interest" } } }, "localname": "MinorityInterestPeriodIncreaseDecrease", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.agilent.com/role/ConsolidatedStatementOfEquity" ], "xbrltype": "monetaryItemType" }, "us-gaap_MovementInStandardProductWarrantyAccrualRollForward": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "A roll forward is a reconciliation of a concept from the beginning of a period to the end of a period.", "label": "Movement in Standard Product Warranty Accrual [Roll Forward]", "terseLabel": "Summary of standard warranty accrual activity" } } }, "localname": "MovementInStandardProductWarrantyAccrualRollForward", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.agilent.com/role/GuaranteesDetails" ], "xbrltype": "stringItemType" }, "us-gaap_MovementInValuationAllowancesAndReservesRollForward": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "A roll forward is a reconciliation of a concept from the beginning of a period to the end of a period.", "label": "SEC Schedule, 12-09, Movement in Valuation Allowances and Reserves [Roll Forward]", "terseLabel": "Movement in valuation and qualifying accounts [Roll Forward]" } } }, "localname": "MovementInValuationAllowancesAndReservesRollForward", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.agilent.com/role/ScheduleIiValuationAndQualifyingAccountsDetails" ], "xbrltype": "stringItemType" }, "us-gaap_NetCashProvidedByUsedInFinancingActivities": { "auth_ref": [ "r124" ], "calculation": { "http://www.agilent.com/role/ConsolidatedStatementOfCashFlows": { "order": 3.0, "parentTag": "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-US": { "role": { "documentation": "Amount of cash inflow (outflow) from financing activities, including discontinued operations. Financing activity cash flows include obtaining resources from owners and providing them with a return on, and a return of, their investment; borrowing money and repaying amounts borrowed, or settling the obligation; and obtaining and paying for other resources obtained from creditors on long-term credit.", "label": "Net Cash Provided by (Used in) Financing Activities", "totalLabel": "Net cash used in financing activities" } } }, "localname": "NetCashProvidedByUsedInFinancingActivities", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.agilent.com/role/ConsolidatedStatementOfCashFlows" ], "xbrltype": "monetaryItemType" }, "us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract": { "auth_ref": [], "lang": { "en-US": { "role": { "label": "Net Cash Provided by (Used in) Financing Activities [Abstract]", "terseLabel": "Cash flows from financing activities:" } } }, "localname": "NetCashProvidedByUsedInFinancingActivitiesAbstract", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.agilent.com/role/ConsolidatedStatementOfCashFlows" ], "xbrltype": "stringItemType" }, "us-gaap_NetCashProvidedByUsedInInvestingActivities": { "auth_ref": [ "r124" ], "calculation": { "http://www.agilent.com/role/ConsolidatedStatementOfCashFlows": { "order": 2.0, "parentTag": "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-US": { "role": { "documentation": "Amount of cash inflow (outflow) from investing activities, including discontinued operations. Investing activity cash flows include making and collecting loans and acquiring and disposing of debt or equity instruments and property, plant, and equipment and other productive assets.", "label": "Net Cash Provided by (Used in) Investing Activities", "totalLabel": "Net cash used in investing activities" } } }, "localname": "NetCashProvidedByUsedInInvestingActivities", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.agilent.com/role/ConsolidatedStatementOfCashFlows" ], "xbrltype": "monetaryItemType" }, "us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract": { "auth_ref": [], "lang": { "en-US": { "role": { "label": "Net Cash Provided by (Used in) Investing Activities [Abstract]", "terseLabel": "Cash flows from investing activities:" } } }, "localname": "NetCashProvidedByUsedInInvestingActivitiesAbstract", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.agilent.com/role/ConsolidatedStatementOfCashFlows" ], "xbrltype": "stringItemType" }, "us-gaap_NetCashProvidedByUsedInOperatingActivities": { "auth_ref": [ "r124", "r127", "r130" ], "calculation": { "http://www.agilent.com/role/ConsolidatedStatementOfCashFlows": { "order": 1.0, "parentTag": "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect", "weight": 1.0 } }, "lang": { "en-US": { "role": { "documentation": "Amount of cash inflow (outflow) from operating activities, including discontinued operations. Operating activity cash flows include transactions, adjustments, and changes in value not defined as investing or financing activities.", "label": "Net Cash Provided by (Used in) Operating Activities", "totalLabel": "Net cash provided by operating activities" } } }, "localname": "NetCashProvidedByUsedInOperatingActivities", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.agilent.com/role/ConsolidatedStatementOfCashFlows" ], "xbrltype": "monetaryItemType" }, "us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract": { "auth_ref": [], "lang": { "en-US": { "role": { "label": "Net Cash Provided by (Used in) Operating Activities [Abstract]", "terseLabel": "Cash flows from operating activities:" } } }, "localname": "NetCashProvidedByUsedInOperatingActivitiesAbstract", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.agilent.com/role/ConsolidatedStatementOfCashFlows" ], "xbrltype": "stringItemType" }, "us-gaap_NewAccountingPronouncementOrChangeInAccountingPrincipleEffectOfAdoptionQuantification": { "auth_ref": [], "crdr": "credit", "lang": { "en-US": { "role": { "documentation": "Represents the quantification of the effect of adopting the new accounting standard or change in accounting principle expected by the entity to have a significant effect on the entity's financial statements.", "label": "New Accounting Pronouncement or Change in Accounting Principle, Effect of Adoption, Quantification", "terseLabel": "New Accounting Pronouncement or Change in Accounting Principle, Effect of Adoption, Quantification" } } }, "localname": "NewAccountingPronouncementOrChangeInAccountingPrincipleEffectOfAdoptionQuantification", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.agilent.com/role/NewAccountingPronouncementsTextualsDetails", "http://www.agilent.com/role/StockholdersEquityChangesInAccumulatedOtherComprehensiveIncomeDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_NewAccountingPronouncementsAndChangesInAccountingPrinciplesAbstract": { "auth_ref": [], "lang": { "en-US": { "role": { "label": "New Accounting Pronouncements and Changes in Accounting Principles [Abstract]" } } }, "localname": "NewAccountingPronouncementsAndChangesInAccountingPrinciplesAbstract", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "xbrltype": "stringItemType" }, "us-gaap_NewAccountingPronouncementsAndChangesInAccountingPrinciplesTextBlock": { "auth_ref": [ "r158" ], "lang": { "en-US": { "role": { "documentation": "The entire disclosure of changes in accounting principles, including adoption of new accounting pronouncements, that describes the new methods, amount and effects on financial statement line items.", "label": "New Accounting Pronouncements and Changes in Accounting Principles [Text Block]", "terseLabel": "NEW ACCOUNTING PRONOUNCEMENTS" } } }, "localname": "NewAccountingPronouncementsAndChangesInAccountingPrinciplesTextBlock", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.agilent.com/role/NewAccountingPronouncements" ], "xbrltype": "textBlockItemType" }, "us-gaap_NoncontrollingInterestMember": { "auth_ref": [ "r505" ], "lang": { "en-US": { "role": { "documentation": "This element represents that portion of equity (net assets) in a subsidiary not attributable, directly or indirectly, to the parent. A noncontrolling interest is sometimes called a minority interest.", "label": "Noncontrolling Interest [Member]", "terseLabel": "Non-controlling Interest" } } }, "localname": "NoncontrollingInterestMember", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.agilent.com/role/ConsolidatedStatementOfEquity" ], "xbrltype": "domainItemType" }, "us-gaap_NoncurrentAssets": { "auth_ref": [ "r202" ], "crdr": "debit", "lang": { "en-US": { "role": { "documentation": "Long-lived assets other than financial instruments, long-term customer relationships of a financial institution, mortgage and other servicing rights, deferred policy acquisition costs, and deferred tax assets.", "label": "Long-Lived Assets", "terseLabel": "Long-Lived Assets" } } }, "localname": "NoncurrentAssets", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.agilent.com/role/SegmentInformationEntityWideDisclosureLongLivedAssetsDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_NondesignatedMember": { "auth_ref": [ "r529" ], "lang": { "en-US": { "role": { "documentation": "Derivative instrument not designated as hedging instrument under Generally Accepted Accounting Principles (GAAP).", "label": "Not Designated as Hedging Instrument [Member]", "terseLabel": "Derivatives Not Designated as Hedging Instruments" } } }, "localname": "NondesignatedMember", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.agilent.com/role/DerivativesDetails", "http://www.agilent.com/role/DerivativesDisclosuresAndDerivativeInstrumentAggregatedNotionalAmountsByCurrencyAndDesignationsDetails", "http://www.agilent.com/role/DerivativesEffectOfDerivativeInstrumentsOnConsolidatedStatementOfOperationsDetails", "http://www.agilent.com/role/DerivativesFairValueOfDerivativeInstrumentsAndConsolidatedBalanceSheetLocationDetails" ], "xbrltype": "domainItemType" }, "us-gaap_NotesReceivableNet": { "auth_ref": [ "r32", "r205", "r220" ], "crdr": "debit", "lang": { "en-US": { "role": { "documentation": "Amount, after allowance for credit loss, of financing receivable. Excludes financing receivable covered under loss sharing agreement.", "label": "Financing Receivable, after Allowance for Credit Loss", "terseLabel": "Lease receivable" } } }, "localname": "NotesReceivableNet", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.agilent.com/role/OverviewAndSummaryOfSignificantAccountingPoliciesDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_NumberOfBusinessesAcquired": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "The number of businesses acquired by the entity during the period.", "label": "Number of Businesses Acquired", "terseLabel": "Number of Businesses Acquired" } } }, "localname": "NumberOfBusinessesAcquired", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.agilent.com/role/GoodwillAndOtherIntangibleAssetsTextDetails" ], "xbrltype": "integerItemType" }, "us-gaap_NumberOfOperatingSegments": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Number of operating segments. An operating segment is a component of an enterprise: (a) that engages in business activities from which it may earn revenues and incur expenses (including revenues and expenses relating to transactions with other components of the same enterprise), (b) whose operating results are regularly reviewed by the enterprise's chief operating decision maker to make decisions about resources to be allocated to the segment and assess its performance, and (c) for which discrete financial information is available. An operating segment may engage in business activities for which it has yet to earn revenues, for example, start-up operations may be operating segments before earning revenues.", "label": "Number of Operating Segments", "terseLabel": "Number of operating segments" } } }, "localname": "NumberOfOperatingSegments", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.agilent.com/role/SegmentInformationProfitabilityDetails" ], "xbrltype": "integerItemType" }, "us-gaap_OperatingExpensesAbstract": { "auth_ref": [], "lang": { "en-US": { "role": { "label": "Operating Expenses [Abstract]", "verboseLabel": "Costs and expenses:" } } }, "localname": "OperatingExpensesAbstract", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.agilent.com/role/ConsolidatedStatementOfOperations" ], "xbrltype": "stringItemType" }, "us-gaap_OperatingIncomeLoss": { "auth_ref": [], "calculation": { "http://www.agilent.com/role/ConsolidatedStatementOfOperations": { "order": 1.0, "parentTag": "us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-US": { "role": { "documentation": "The net result for the period of deducting operating expenses from operating revenues.", "label": "Operating Income (Loss)", "totalLabel": "Income from operations", "verboseLabel": "Income from operations" } } }, "localname": "OperatingIncomeLoss", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.agilent.com/role/ConsolidatedStatementOfOperations", "http://www.agilent.com/role/SegmentInformationProfitabilityDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_OperatingLeaseRightOfUseAsset": { "auth_ref": [ "r597" ], "crdr": "debit", "lang": { "en-US": { "role": { "documentation": "Amount of lessee's right to use underlying asset under operating lease.", "label": "Operating Lease, Right-of-Use Asset", "terseLabel": "Operating Lease, Right-of-Use Asset" } } }, "localname": "OperatingLeaseRightOfUseAsset", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.agilent.com/role/NewAccountingPronouncementsTextualsDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_OperatingLeasesFutureMinimumPaymentsDueAbstract": { "auth_ref": [], "lang": { "en-US": { "role": { "label": "Operating Leases, Future Minimum Payments Due, Fiscal Year Maturity [Abstract]" } } }, "localname": "OperatingLeasesFutureMinimumPaymentsDueAbstract", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.agilent.com/role/CommitmentsAndContingenciesDetails" ], "xbrltype": "stringItemType" }, "us-gaap_OperatingLeasesFutureMinimumPaymentsDueCurrent": { "auth_ref": [ "r591", "r592" ], "crdr": "credit", "lang": { "en-US": { "role": { "documentation": "Amount of required minimum rental payments for operating leases having an initial or remaining non-cancelable lease term in excess of one year due in the next fiscal year following the latest fiscal year. Excludes interim and annual periods when interim periods are reported on a rolling approach, from latest balance sheet date.", "label": "Operating Leases, Future Minimum Payments Due, Next Twelve Months", "terseLabel": "Future minimum lease payments 2020" } } }, "localname": "OperatingLeasesFutureMinimumPaymentsDueCurrent", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.agilent.com/role/CommitmentsAndContingenciesDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_OperatingLeasesFutureMinimumPaymentsDueInFiveYears": { "auth_ref": [ "r591", "r592" ], "crdr": "credit", "lang": { "en-US": { "role": { "documentation": "Amount of required minimum rental payments for operating leases having an initial or remaining non-cancelable lease term in excess of one year due in the fifth fiscal year following the latest fiscal year. Excludes interim and annual periods when interim periods are reported on a rolling approach, from latest balance sheet date.", "label": "Operating Leases, Future Minimum Payments, Due in Five Years", "terseLabel": "Future minimum lease payments 2024" } } }, "localname": "OperatingLeasesFutureMinimumPaymentsDueInFiveYears", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.agilent.com/role/CommitmentsAndContingenciesDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_OperatingLeasesFutureMinimumPaymentsDueInFourYears": { "auth_ref": [ "r591", "r592" ], "crdr": "credit", "lang": { "en-US": { "role": { "documentation": "Amount of required minimum rental payments for operating leases having an initial or remaining non-cancelable lease term in excess of one year due in the fourth fiscal year following the latest fiscal year. Excludes interim and annual periods when interim periods are reported on a rolling approach, from latest balance sheet date.", "label": "Operating Leases, Future Minimum Payments, Due in Four Years", "terseLabel": "Future minimum lease payments 2023" } } }, "localname": "OperatingLeasesFutureMinimumPaymentsDueInFourYears", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.agilent.com/role/CommitmentsAndContingenciesDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_OperatingLeasesFutureMinimumPaymentsDueInThreeYears": { "auth_ref": [ "r591", "r592" ], "crdr": "credit", "lang": { "en-US": { "role": { "documentation": "Amount of required minimum rental payments for operating leases having an initial or remaining non-cancelable lease term in excess of one year due in the third fiscal year following the latest fiscal year. Excludes interim and annual periods when interim periods are reported on a rolling approach, from latest balance sheet date.", "label": "Operating Leases, Future Minimum Payments, Due in Three Years", "terseLabel": "Future minimum lease payments 2022" } } }, "localname": "OperatingLeasesFutureMinimumPaymentsDueInThreeYears", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.agilent.com/role/CommitmentsAndContingenciesDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_OperatingLeasesFutureMinimumPaymentsDueInTwoYears": { "auth_ref": [ "r591", "r592" ], "crdr": "credit", "lang": { "en-US": { "role": { "documentation": "Amount of required minimum rental payments for operating leases having an initial or remaining non-cancelable lease term in excess of one year due in the second fiscal year following the latest fiscal year. Excludes interim and annual periods when interim periods are reported on a rolling approach, from latest balance sheet date.", "label": "Operating Leases, Future Minimum Payments, Due in Two Years", "terseLabel": "Future minimum lease payments 2021" } } }, "localname": "OperatingLeasesFutureMinimumPaymentsDueInTwoYears", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.agilent.com/role/CommitmentsAndContingenciesDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_OperatingLeasesFutureMinimumPaymentsDueThereafter": { "auth_ref": [ "r591", "r592" ], "crdr": "credit", "lang": { "en-US": { "role": { "documentation": "Amount of required minimum rental payments for operating leases having an initial or remaining non-cancelable lease term in excess of one year due after the fifth fiscal year following the latest fiscal year. Excludes interim and annual periods when interim periods are reported on a rolling approach, from latest balance sheet date.", "label": "Operating Leases, Future Minimum Payments, Due Thereafter", "terseLabel": "Future minimum lease payments thereafter" } } }, "localname": "OperatingLeasesFutureMinimumPaymentsDueThereafter", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.agilent.com/role/CommitmentsAndContingenciesDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_OperatingLeasesFutureMinimumPaymentsReceivableAbstract": { "auth_ref": [], "lang": { "en-US": { "role": { "label": "Operating Leases, Future Minimum Payments Receivable [Abstract]" } } }, "localname": "OperatingLeasesFutureMinimumPaymentsReceivableAbstract", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.agilent.com/role/CommitmentsAndContingenciesDetails" ], "xbrltype": "stringItemType" }, "us-gaap_OperatingLeasesFutureMinimumPaymentsReceivableCurrent": { "auth_ref": [ "r594" ], "crdr": "debit", "lang": { "en-US": { "role": { "documentation": "Future rental payments receivable within one year of the balance sheet date under an operating lease.", "label": "Operating Leases, Future Minimum Payments Receivable, Current", "terseLabel": "Future minimum lease income 2020" } } }, "localname": "OperatingLeasesFutureMinimumPaymentsReceivableCurrent", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.agilent.com/role/CommitmentsAndContingenciesDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_OperatingLeasesFutureMinimumPaymentsReceivableInThreeYears": { "auth_ref": [ "r594" ], "crdr": "debit", "lang": { "en-US": { "role": { "documentation": "Future rental payments receivable within the third year from the balance sheet date under an operating lease.", "label": "Operating Leases, Future Minimum Payments Receivable, in Three Years", "terseLabel": "Future minimum lease income 2022" } } }, "localname": "OperatingLeasesFutureMinimumPaymentsReceivableInThreeYears", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.agilent.com/role/CommitmentsAndContingenciesDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_OperatingLeasesFutureMinimumPaymentsReceivableInTwoYears": { "auth_ref": [ "r594" ], "crdr": "debit", "lang": { "en-US": { "role": { "documentation": "Future rental payments receivable within the second year from the balance sheet date under an operating lease.", "label": "Operating Leases, Future Minimum Payments Receivable, in Two Years", "terseLabel": "Future minimum lease income 2021" } } }, "localname": "OperatingLeasesFutureMinimumPaymentsReceivableInTwoYears", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.agilent.com/role/CommitmentsAndContingenciesDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_OperatingLossCarryforwardsLineItems": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.", "label": "Operating Loss Carryforwards [Line Items]", "terseLabel": "Operating Loss Carryforwards [Line Items]" } } }, "localname": "OperatingLossCarryforwardsLineItems", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.agilent.com/role/IncomeTaxes2017USTaxReformTaxCutsAndJobsActDetails", "http://www.agilent.com/role/IncomeTaxesCarryforwardsDetails", "http://www.agilent.com/role/IncomeTaxesIncomeTaxesUncertainTaxPositionsDetails" ], "xbrltype": "stringItemType" }, "us-gaap_OperatingLossCarryforwardsTable": { "auth_ref": [ "r470" ], "lang": { "en-US": { "role": { "documentation": "Schedule reflecting pertinent information, such as tax authority, amounts, and expiration dates, of net operating loss carryforwards, including an assessment of the likelihood of utilization.", "label": "Operating Loss Carryforwards [Table]", "terseLabel": "Operating Loss Carryforwards [Table]" } } }, "localname": "OperatingLossCarryforwardsTable", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.agilent.com/role/IncomeTaxes2017USTaxReformTaxCutsAndJobsActDetails", "http://www.agilent.com/role/IncomeTaxesCarryforwardsDetails", "http://www.agilent.com/role/IncomeTaxesIncomeTaxesUncertainTaxPositionsDetails" ], "xbrltype": "stringItemType" }, "us-gaap_OrderOrProductionBacklogMember": { "auth_ref": [ "r495" ], "lang": { "en-US": { "role": { "documentation": "Orders, production or production backlog arising from contracts such as purchase or sales orders acquired in a business combination.", "label": "Order or Production Backlog [Member]", "terseLabel": "Backlog" } } }, "localname": "OrderOrProductionBacklogMember", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.agilent.com/role/AcquisitionsAcquisitionsIntangibleAssetsDetails", "http://www.agilent.com/role/GoodwillAndOtherIntangibleAssetsDisclosuresAndComponentsOfOtherIntangiblesDetails" ], "xbrltype": "domainItemType" }, "us-gaap_OtherAssetsCurrent": { "auth_ref": [ "r72" ], "calculation": { "http://www.agilent.com/role/ConsolidatedBalanceSheet": { "order": 4.0, "parentTag": "us-gaap_AssetsCurrent", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-US": { "role": { "documentation": "Amount of current assets classified as other.", "label": "Other Assets, Current", "terseLabel": "Other current assets", "verboseLabel": "Other current assets" } } }, "localname": "OtherAssetsCurrent", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.agilent.com/role/ConsolidatedBalanceSheet", "http://www.agilent.com/role/NewAccountingPronouncementsImpactOfAdoptingNewGuidanceDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_OtherAssetsMember": { "auth_ref": [ "r532", "r552" ], "lang": { "en-US": { "role": { "documentation": "Primary financial statement caption encompassing other assets.", "label": "Other Assets [Member]", "terseLabel": "Other Assets [Member]" } } }, "localname": "OtherAssetsMember", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.agilent.com/role/NewAccountingPronouncementsImpactOfAdoptingNewGuidanceDetails", "http://www.agilent.com/role/RetirementPlansAndPostRetirementPensionPlansFundedStatusDetails" ], "xbrltype": "domainItemType" }, "us-gaap_OtherAssetsNoncurrent": { "auth_ref": [ "r48" ], "calculation": { "http://www.agilent.com/role/ConsolidatedBalanceSheet": { "order": 6.0, "parentTag": "us-gaap_Assets", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-US": { "role": { "documentation": "Amount of noncurrent assets classified as other.", "label": "Other Assets, Noncurrent", "terseLabel": "Other assets" } } }, "localname": "OtherAssetsNoncurrent", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.agilent.com/role/ConsolidatedBalanceSheet", "http://www.agilent.com/role/NewAccountingPronouncementsImpactOfAdoptingNewGuidanceDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_OtherCommitment": { "auth_ref": [], "crdr": "credit", "lang": { "en-US": { "role": { "documentation": "Minimum amount of other commitment not otherwise specified in the taxonomy. Excludes commitments explicitly modeled in the taxonomy, including but not limited to, long-term and short-term purchase commitments, recorded and unrecorded purchase obligations, supply commitments, registration payment arrangements, leases, debt, product warranties, guarantees, environmental remediation obligations, and pensions.", "label": "Other Commitment", "terseLabel": "Other Commitment" } } }, "localname": "OtherCommitment", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.agilent.com/role/CommitmentsAndContingenciesDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_OtherCommitmentsAxis": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Information by type of other commitment.", "label": "Other Commitments [Axis]", "terseLabel": "Other Commitments [Axis]" } } }, "localname": "OtherCommitmentsAxis", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.agilent.com/role/CommitmentsAndContingenciesDetails" ], "xbrltype": "stringItemType" }, "us-gaap_OtherCommitmentsDomain": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Other future obligation.", "label": "Other Commitments [Domain]", "terseLabel": "Other Commitments [Domain]" } } }, "localname": "OtherCommitmentsDomain", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.agilent.com/role/CommitmentsAndContingenciesDetails" ], "xbrltype": "domainItemType" }, "us-gaap_OtherComprehensiveIncomeDefinedBenefitPlanNetPriorServiceCostCreditArisingDuringPeriodBeforeTax": { "auth_ref": [ "r84", "r86", "r360" ], "calculation": { "http://www.agilent.com/role/RetirementPlansAndPostRetirementPensionPlansComponentsOfNetPeriodicCostsDetails": { "order": 3.0, "parentTag": "a_OtherComprehensiveIncomeDefinedBenefitPlansPeriodIncreaseDecrease", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-US": { "role": { "documentation": "Amount, before tax, of cost (credit) of benefit change attributable to participants' prior service from plan amendment or plan initiation of defined benefit plan, that has not been recognized in net periodic benefit cost (credit).", "label": "Other Comprehensive (Income) Loss, Defined Benefit Plan, Prior Service Cost (Credit), before Tax", "terseLabel": "Other Comprehensive (Income) Loss, before Reclassifications", "verboseLabel": "Prior service cost (benefit)" } } }, "localname": "OtherComprehensiveIncomeDefinedBenefitPlanNetPriorServiceCostCreditArisingDuringPeriodBeforeTax", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.agilent.com/role/RetirementPlansAndPostRetirementPensionPlansComponentsOfNetPeriodicCostsDetails", "http://www.agilent.com/role/StockholdersEquityChangesInAccumulatedOtherComprehensiveIncomeDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_OtherComprehensiveIncomeDefinedBenefitPlanNetPriorServiceCostsCreditArisingDuringPeriodNetOfTax": { "auth_ref": [ "r84", "r86", "r360" ], "calculation": { "http://www.agilent.com/role/ConsolidatedStatementOfComprehensiveIncome": { "order": 5.0, "parentTag": "us-gaap_OtherComprehensiveIncomeLossNetOfTax", "weight": -1.0 } }, "crdr": "debit", "lang": { "en-US": { "role": { "documentation": "Amount, after tax, of cost (credit) of benefit change attributable to participants' prior service from plan amendment or plan initiation of defined benefit plan, that has not been recognized in net periodic benefit cost (credit).", "label": "Other Comprehensive (Income) Loss, Defined Benefit Plan, Prior Service Cost (Credit), after Tax", "negatedLabel": "Other Comprehensive (Income) Loss", "negatedTerseLabel": "Change in net prior service benefit, net of tax benefit of $(2), $(2) and $(3)" } } }, "localname": "OtherComprehensiveIncomeDefinedBenefitPlanNetPriorServiceCostsCreditArisingDuringPeriodNetOfTax", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.agilent.com/role/ConsolidatedStatementOfComprehensiveIncome", "http://www.agilent.com/role/StockholdersEquityChangesInAccumulatedOtherComprehensiveIncomeDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_OtherComprehensiveIncomeDefinedBenefitPlansAdjustmentNetOfTaxPeriodIncreaseDecreaseAbstract": { "auth_ref": [], "lang": { "en-US": { "role": { "label": "Other Comprehensive (Income) Loss, Defined Benefit Plan, after Reclassification Adjustment, after Tax [Abstract]", "terseLabel": "Net defined benefit pension cost and post retirement plan costs:" } } }, "localname": "OtherComprehensiveIncomeDefinedBenefitPlansAdjustmentNetOfTaxPeriodIncreaseDecreaseAbstract", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.agilent.com/role/ConsolidatedStatementOfComprehensiveIncome" ], "xbrltype": "stringItemType" }, "us-gaap_OtherComprehensiveIncomeDefinedBenefitPlansNetUnamortizedGainLossArisingDuringPeriodNetOfTax": { "auth_ref": [ "r82", "r86", "r360" ], "calculation": { "http://www.agilent.com/role/ConsolidatedStatementOfComprehensiveIncome": { "order": 4.0, "parentTag": "us-gaap_OtherComprehensiveIncomeLossNetOfTax", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-US": { "role": { "documentation": "Amount, after tax, of gain (loss) for (increase) decrease in value of benefit obligation for change in actuarial assumptions and increase (decrease) in value of plan assets from experience different from that assumed of defined benefit plan, that has not been recognized in net periodic benefit (cost) credit.", "label": "Other Comprehensive Income (Loss), Defined Benefit Plan, Gain (Loss) Arising During Period, after Tax", "terseLabel": "Other comprehensive income (loss)", "verboseLabel": "Change in actuarial net loss, net of tax expense (benefit) of $(25), $(3) and $52" } } }, "localname": "OtherComprehensiveIncomeDefinedBenefitPlansNetUnamortizedGainLossArisingDuringPeriodNetOfTax", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.agilent.com/role/ConsolidatedStatementOfComprehensiveIncome", "http://www.agilent.com/role/StockholdersEquityChangesInAccumulatedOtherComprehensiveIncomeDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_OtherComprehensiveIncomeDefinedBenefitPlansNetUnamortizedGainLossArisingDuringPeriodTax": { "auth_ref": [ "r87" ], "crdr": "debit", "lang": { "en-US": { "role": { "documentation": "Amount of tax expense (benefit) for (increase) decrease in value of benefit obligation for change in actuarial assumptions and increase (decrease) in value of plan assets from experience different from that assumed of defined benefit plan, that has not been recognized in net periodic benefit (cost) credit.", "label": "Other Comprehensive Income (Loss), Defined Benefit Plan, Gain (Loss) Arising During Period, Tax", "terseLabel": "Change in actuarial net loss, tax expense (benefit)" } } }, "localname": "OtherComprehensiveIncomeDefinedBenefitPlansNetUnamortizedGainLossArisingDuringPeriodTax", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.agilent.com/role/ConsolidatedStatementOfComprehensiveIncomeParenthetical" ], "xbrltype": "monetaryItemType" }, "us-gaap_OtherComprehensiveIncomeDerivativesQualifyingAsHedgesNetOfTaxPortionAttributableToParent": { "auth_ref": [ "r507", "r508", "r512" ], "crdr": "credit", "lang": { "en-US": { "role": { "documentation": "Amount after tax and reclassification adjustments, of increase (decrease) in accumulated gain (loss) from derivative instruments designated and qualifying as the effective portion of cash flow hedges and an entity's share of an equity investee's increase (decrease) in deferred hedging gain (loss), attributable to parent entity.", "label": "Other Comprehensive Income (Loss), Derivatives Qualifying as Hedges, Net of Tax, Portion Attributable to Parent", "terseLabel": "Other Comprehensive Income (Loss)" } } }, "localname": "OtherComprehensiveIncomeDerivativesQualifyingAsHedgesNetOfTaxPortionAttributableToParent", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.agilent.com/role/StockholdersEquityChangesInAccumulatedOtherComprehensiveIncomeDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent": { "auth_ref": [ "r507", "r508", "r512" ], "crdr": "credit", "lang": { "en-US": { "role": { "documentation": "Amount after tax and reclassification adjustments of gain (loss) on foreign currency translation adjustments, foreign currency transactions designated and effective as economic hedges of a net investment in a foreign entity and intra-entity foreign currency transactions that are of a long-term-investment nature, attributable to parent entity.", "label": "Other Comprehensive Income (Loss), Foreign Currency Transaction and Translation Adjustment, Net of Tax, Portion Attributable to Parent", "terseLabel": "Other Comprehensive Income (Loss)" } } }, "localname": "OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.agilent.com/role/StockholdersEquityChangesInAccumulatedOtherComprehensiveIncomeDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationGainLossArisingDuringPeriodNetOfTax": { "auth_ref": [ "r80", "r86", "r578", "r579", "r584", "r585" ], "calculation": { "http://www.agilent.com/role/ConsolidatedStatementOfComprehensiveIncome": { "order": 3.0, "parentTag": "us-gaap_OtherComprehensiveIncomeLossNetOfTax", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-US": { "role": { "documentation": "Amount after tax, before reclassification adjustments of gain (loss) on foreign currency translation adjustments, foreign currency transactions designated and effective as economic hedges of a net investment in a foreign entity and intra-entity foreign currency transactions that are of a long-term-investment nature.", "label": "Other Comprehensive Income (Loss), Foreign Currency Transaction and Translation Gain (Loss) Arising During Period, Net of Tax", "terseLabel": "Foreign currency translation, net of tax expense (benefit) of $(10), $7 and $3" } } }, "localname": "OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationGainLossArisingDuringPeriodNetOfTax", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.agilent.com/role/ConsolidatedStatementOfComprehensiveIncome" ], "xbrltype": "monetaryItemType" }, "us-gaap_OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationGainLossBeforeReclassificationAndTax": { "auth_ref": [ "r78", "r86", "r573", "r578", "r580" ], "calculation": { "http://www.agilent.com/role/RetirementPlansAndPostRetirementPensionPlansComponentsOfNetPeriodicCostsDetails": { "order": 6.0, "parentTag": "a_OtherComprehensiveIncomeDefinedBenefitPlansPeriodIncreaseDecrease", "weight": -1.0 } }, "crdr": "credit", "lang": { "en-US": { "role": { "documentation": "Amount before tax and reclassification adjustments of gain (loss) on foreign currency translation adjustments, foreign currency transactions designated and effective as economic hedges of a net investment in a foreign entity and intra-entity foreign currency transactions that are of a long-term-investment nature.", "label": "Other Comprehensive Income (Loss), Foreign Currency Transaction and Translation Gain (Loss), before Reclassification and Tax", "negatedTerseLabel": "Foreign currency" } } }, "localname": "OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationGainLossBeforeReclassificationAndTax", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.agilent.com/role/RetirementPlansAndPostRetirementPensionPlansComponentsOfNetPeriodicCostsDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_OtherComprehensiveIncomeLossAmortizationAdjustmentFromAOCIPensionAndOtherPostretirementBenefitPlansForNetPriorServiceCostCreditBeforeTax": { "auth_ref": [ "r86", "r90", "r92", "r360" ], "calculation": { "http://www.agilent.com/role/RetirementPlansAndPostRetirementPensionPlansComponentsOfNetPeriodicCostsDetails": { "order": 4.0, "parentTag": "a_OtherComprehensiveIncomeDefinedBenefitPlansPeriodIncreaseDecrease", "weight": -1.0 } }, "crdr": "credit", "lang": { "en-US": { "role": { "documentation": "Amount, before tax, of reclassification adjustment from accumulated other comprehensive (income) loss for prior service cost (credit) of defined benefit plan.", "label": "Other Comprehensive (Income) Loss, Defined Benefit Plan, Prior Service Cost (Credit), Reclassification Adjustment from AOCI, before Tax", "negatedLabel": "Amortization of prior service benefit", "negatedTerseLabel": "Amounts Reclassified out of Accumulated Other Comprehensive Income", "terseLabel": "Amortization of prior service benefit" } } }, "localname": "OtherComprehensiveIncomeLossAmortizationAdjustmentFromAOCIPensionAndOtherPostretirementBenefitPlansForNetPriorServiceCostCreditBeforeTax", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.agilent.com/role/RetirementPlansAndPostRetirementPensionPlansComponentsOfNetPeriodicCostsDetails", "http://www.agilent.com/role/StockholdersEquityChangesInAccumulatedOtherComprehensiveIncomeDetails", "http://www.agilent.com/role/StockholdersEquityStockholdersEquityReclassificationsOutOfAccumulatedOtherComprehensiveIncomeDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_OtherComprehensiveIncomeLossBeforeTax": { "auth_ref": [ "r218" ], "crdr": "credit", "lang": { "en-US": { "role": { "documentation": "Amount before tax, after reclassification adjustments of other comprehensive income (loss).", "label": "Other Comprehensive Income (Loss), before Tax", "terseLabel": "Other Comprehensive Income (Loss), before Reclassifications" } } }, "localname": "OtherComprehensiveIncomeLossBeforeTax", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.agilent.com/role/StockholdersEquityChangesInAccumulatedOtherComprehensiveIncomeDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_OtherComprehensiveIncomeLossDerivativesQualifyingAsHedgesTax": { "auth_ref": [ "r81", "r87" ], "crdr": "debit", "lang": { "en-US": { "role": { "documentation": "Amount of tax expense (benefit), after reclassification adjustments, of increase (decrease) in accumulated gain (loss) from derivative instruments designated and qualifying as the effective portion of cash flow hedges and an entity's share of an equity investee's increase (decrease) in deferred hedging gain (loss).", "label": "Other Comprehensive Income (Loss), Derivatives Qualifying as Hedges, Tax", "terseLabel": "Tax (expense) benefit" } } }, "localname": "OtherComprehensiveIncomeLossDerivativesQualifyingAsHedgesTax", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.agilent.com/role/StockholdersEquityChangesInAccumulatedOtherComprehensiveIncomeDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentBeforeTax": { "auth_ref": [ "r78", "r86", "r573", "r581" ], "crdr": "credit", "lang": { "en-US": { "role": { "documentation": "Amount before tax, after reclassification adjustments of gain (loss) on foreign currency translation adjustments, foreign currency transactions designated and effective as economic hedges of a net investment in a foreign entity and intra-entity foreign currency transactions that are of a long-term-investment nature.", "label": "Other Comprehensive Income (Loss), Foreign Currency Transaction and Translation Adjustment, before Tax", "terseLabel": "Other Comprehensive Income (Loss), before Reclassifications" } } }, "localname": "OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentBeforeTax", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.agilent.com/role/StockholdersEquityChangesInAccumulatedOtherComprehensiveIncomeDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationReclassificationAdjustmentFromAOCIRealizedUponSaleOrLiquidationBeforeTax": { "auth_ref": [ "r86", "r90", "r91", "r92", "r583" ], "crdr": "debit", "lang": { "en-US": { "role": { "documentation": "Amount before tax of reclassification adjustment from accumulated other comprehensive income for translation gain (loss) realized upon the sale or liquidation of an investment in a foreign entity and foreign currency hedges that are designated and qualified as hedging instruments for hedges of the foreign currency exposure of a net investment in a foreign operation.", "label": "Other Comprehensive Income (Loss), Foreign Currency Transaction and Translation Reclassification Adjustment from AOCI, Realized upon Sale or Liquidation, before Tax", "terseLabel": "Amounts Reclassified Amounts Reclassified out of Accumulated Other Comprehensive Income" } } }, "localname": "OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationReclassificationAdjustmentFromAOCIRealizedUponSaleOrLiquidationBeforeTax", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.agilent.com/role/StockholdersEquityChangesInAccumulatedOtherComprehensiveIncomeDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTranslationAdjustmentTax": { "auth_ref": [ "r78", "r87" ], "crdr": "debit", "lang": { "en-US": { "role": { "documentation": "Amount of tax expense (benefit), after reclassification adjustments of gain (loss) on foreign currency translation adjustments, foreign currency transactions designated and effective as economic hedges of a net investment in a foreign entity and intra-entity foreign currency transactions that are of a long-term-investment nature.", "label": "Other Comprehensive Income (Loss), Foreign Currency Translation Adjustment, Tax", "negatedTerseLabel": "Tax (expense) benefit", "verboseLabel": "Foreign currency translation, tax expense (benefit)" } } }, "localname": "OtherComprehensiveIncomeLossForeignCurrencyTranslationAdjustmentTax", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.agilent.com/role/ConsolidatedStatementOfComprehensiveIncomeParenthetical", "http://www.agilent.com/role/StockholdersEquityChangesInAccumulatedOtherComprehensiveIncomeDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_OtherComprehensiveIncomeLossNetOfTax": { "auth_ref": [ "r95", "r98", "r101", "r296" ], "calculation": { "http://www.agilent.com/role/ConsolidatedStatementOfComprehensiveIncome": { "order": 2.0, "parentTag": "us-gaap_ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest", "weight": 1.0 }, "http://www.agilent.com/role/ConsolidatedStatementOfEquity": { "order": 2.0, "parentTag": "us-gaap_ComprehensiveIncomeNetOfTax", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-US": { "role": { "documentation": "Amount after tax and reclassification adjustments of other comprehensive income (loss).", "label": "Other Comprehensive Income (Loss), Net of Tax", "terseLabel": "Other Comprehensive Income (Loss)", "totalLabel": "Other comprehensive income (loss)", "verboseLabel": "Other comprehensive income (loss)" } } }, "localname": "OtherComprehensiveIncomeLossNetOfTax", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.agilent.com/role/ConsolidatedStatementOfComprehensiveIncome", "http://www.agilent.com/role/ConsolidatedStatementOfEquity", "http://www.agilent.com/role/StockholdersEquityChangesInAccumulatedOtherComprehensiveIncomeDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract": { "auth_ref": [], "lang": { "en-US": { "role": { "label": "Other Comprehensive Income (Loss), Net of Tax [Abstract]", "terseLabel": "Other comprehensive income (loss):" } } }, "localname": "OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.agilent.com/role/ConsolidatedStatementOfComprehensiveIncome" ], "xbrltype": "stringItemType" }, "us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParentAbstract": { "auth_ref": [], "lang": { "en-US": { "role": { "label": "Other Comprehensive Income (Loss), Net of Tax, Portion Attributable to Parent [Abstract]" } } }, "localname": "OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParentAbstract", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "xbrltype": "stringItemType" }, "us-gaap_OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentBeforeTax": { "auth_ref": [ "r83", "r86" ], "crdr": "debit", "lang": { "en-US": { "role": { "documentation": "Amount, before tax, after reclassification adjustment, of (increase) decrease in accumulated other comprehensive income for defined benefit plan.", "label": "Other Comprehensive (Income) Loss, Defined Benefit Plan, after Reclassification Adjustment, before Tax", "terseLabel": "Total" } } }, "localname": "OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentBeforeTax", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.agilent.com/role/RetirementPlansAndPostRetirementPensionPlansFundedStatusDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansBenefitPlanImprovementTaxEffect": { "auth_ref": [ "r87", "r507" ], "crdr": "credit", "lang": { "en-US": { "role": { "documentation": "Amount of tax (expense) benefit for cost (credit) of benefit change attributable to participants' prior service from plan amendment or plan initiation of defined benefit plan, that has not been recognized in net periodic benefit cost (credit).", "label": "Other Comprehensive (Income) Loss, Defined Benefit Plan, Prior Service Cost (Credit), Tax", "negatedLabel": "Tax (expense) benefit", "terseLabel": "Change in net prior service benefit, tax (benefit)" } } }, "localname": "OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansBenefitPlanImprovementTaxEffect", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.agilent.com/role/ConsolidatedStatementOfComprehensiveIncomeParenthetical", "http://www.agilent.com/role/StockholdersEquityChangesInAccumulatedOtherComprehensiveIncomeDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansNetUnamortizedGainLossArisingDuringPeriodBeforeTax": { "auth_ref": [ "r82", "r86", "r360" ], "calculation": { "http://www.agilent.com/role/RetirementPlansAndPostRetirementPensionPlansComponentsOfNetPeriodicCostsDetails": { "order": 1.0, "parentTag": "a_OtherComprehensiveIncomeDefinedBenefitPlansPeriodIncreaseDecrease", "weight": -1.0 } }, "crdr": "credit", "lang": { "en-US": { "role": { "documentation": "Amount, before tax, of gain (loss) for (increase) decrease in value of benefit obligation for change in actuarial assumptions and increase (decrease) in value of plan assets from experience different from that assumed of defined benefit plan, that has not been recognized in net periodic benefit (cost) credit.", "label": "Other Comprehensive Income (Loss), Defined Benefit Plan, Gain (Loss) Arising During Period, before Tax", "negatedLabel": "Net actuarial (gain) loss", "terseLabel": "Other Comprehensive Income (Loss), before Reclassifications" } } }, "localname": "OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansNetUnamortizedGainLossArisingDuringPeriodBeforeTax", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.agilent.com/role/RetirementPlansAndPostRetirementPensionPlansComponentsOfNetPeriodicCostsDetails", "http://www.agilent.com/role/StockholdersEquityChangesInAccumulatedOtherComprehensiveIncomeDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIOnDerivativesBeforeTax": { "auth_ref": [ "r86", "r90", "r92", "r539" ], "crdr": "debit", "lang": { "en-US": { "role": { "documentation": "Amount before tax of reclassification adjustment from accumulated other comprehensive income of accumulated gain (loss) realized from derivative instruments designated and qualifying as the effective portion of cash flow hedges and an entity's share of an equity investee's deferred hedging gain (loss).", "label": "Other Comprehensive Income (Loss), Reclassification Adjustment from AOCI on Derivatives, before Tax", "terseLabel": "Amounts Reclassified out of Accumulated Other Comprehensive Income" } } }, "localname": "OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIOnDerivativesBeforeTax", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.agilent.com/role/StockholdersEquityChangesInAccumulatedOtherComprehensiveIncomeDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIOnDerivativesNetOfTax": { "auth_ref": [ "r86", "r90", "r92", "r530" ], "calculation": { "http://www.agilent.com/role/ConsolidatedStatementOfComprehensiveIncome": { "order": 2.0, "parentTag": "us-gaap_OtherComprehensiveIncomeLossNetOfTax", "weight": -1.0 } }, "crdr": "debit", "lang": { "en-US": { "role": { "documentation": "Amount after tax of reclassification adjustment from accumulated other comprehensive income of accumulated gain (loss) realized from derivative instruments designated and qualifying as the effective portion of cash flow hedges and an entity's share of an equity investee's deferred hedging gain (loss).", "label": "Other Comprehensive Income (Loss), Reclassification Adjustment from AOCI on Derivatives, Net of Tax", "negatedLabel": "Amounts reclassified into earnings related to derivative instruments, net of tax expense (benefit) of $(2), $1 and $0", "terseLabel": "Other Comprehensive Income (Loss), Reclassification Adjustment from AOCI on Derivatives, Net of Tax" } } }, "localname": "OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIOnDerivativesNetOfTax", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.agilent.com/role/ConsolidatedStatementOfComprehensiveIncome", "http://www.agilent.com/role/StockholdersEquityStockholdersEquityReclassificationsOutOfAccumulatedOtherComprehensiveIncomeDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIOnDerivativesTax": { "auth_ref": [ "r87" ], "crdr": "credit", "lang": { "en-US": { "role": { "documentation": "Amount of tax expense (benefit) of reclassification adjustment from accumulated other comprehensive income of accumulated gain (loss) realized from derivative instruments designated and qualifying as the effective portion of cash flow hedges and an entity's share of an equity investee's deferred hedging gain (loss).", "label": "Other Comprehensive Income (Loss), Reclassification Adjustment from AOCI on Derivatives, Tax", "terseLabel": "Amounts reclassified into earnings related to derivative instruments, tax expense (benefit)", "verboseLabel": "Other Comprehensive Income (Loss), Reclassification Adjustment from AOCI on Derivatives, Tax" } } }, "localname": "OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIOnDerivativesTax", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.agilent.com/role/ConsolidatedStatementOfComprehensiveIncomeParenthetical", "http://www.agilent.com/role/StockholdersEquityStockholdersEquityReclassificationsOutOfAccumulatedOtherComprehensiveIncomeDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIPensionAndOtherPostretirementBenefitPlansBeforeTax": { "auth_ref": [ "r86", "r90", "r92" ], "crdr": "credit", "lang": { "en-US": { "role": { "documentation": "Amount, before tax, of reclassification adjustment from accumulated other comprehensive (income) loss for net period benefit cost (credit) of defined benefit plan.", "label": "Other Comprehensive (Income) Loss, Defined Benefit Plan, Reclassification Adjustment from AOCI, before Tax", "terseLabel": "Other Comprehensive (Income) Loss, Defined Benefit Plan, Reclassification Adjustment from AOCI, before Tax" } } }, "localname": "OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIPensionAndOtherPostretirementBenefitPlansBeforeTax", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.agilent.com/role/StockholdersEquityStockholdersEquityReclassificationsOutOfAccumulatedOtherComprehensiveIncomeDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIPensionAndOtherPostretirementBenefitPlansForNetGainLossBeforeTax": { "auth_ref": [ "r86", "r90", "r92", "r360" ], "crdr": "debit", "lang": { "en-US": { "role": { "documentation": "Amount, before tax, of reclassification adjustment from accumulated other comprehensive income (loss) for gain (loss) of defined benefit plan.", "label": "Other Comprehensive Income (Loss), Defined Benefit Plan, Gain (Loss), Reclassification Adjustment from AOCI, before Tax", "terseLabel": "Amounts reclassified out of accumulated other comprehensive income" } } }, "localname": "OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIPensionAndOtherPostretirementBenefitPlansForNetGainLossBeforeTax", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.agilent.com/role/StockholdersEquityChangesInAccumulatedOtherComprehensiveIncomeDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIPensionAndOtherPostretirementBenefitPlansForNetTransitionAssetObligationBeforeTax": { "auth_ref": [ "r86", "r90", "r92", "r360" ], "calculation": { "http://www.agilent.com/role/RetirementPlansAndPostRetirementPensionPlansComponentsOfNetPeriodicCostsDetails": { "order": null, "parentTag": null, "root": true, "weight": null } }, "crdr": "debit", "lang": { "en-US": { "role": { "documentation": "Amount, before tax, of reclassification adjustment from accumulated other comprehensive income (loss) for transition asset (obligation) of defined benefit plan.", "label": "Other Comprehensive Income (Loss), Defined Benefit Plan, Transition Asset (Obligation), Reclassification Adjustment from AOCI, before Tax", "totalLabel": "Total recognized in net periodic benefit cost (benefit) and other comprehensive (income) loss" } } }, "localname": "OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIPensionAndOtherPostretirementBenefitPlansForNetTransitionAssetObligationBeforeTax", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.agilent.com/role/RetirementPlansAndPostRetirementPensionPlansComponentsOfNetPeriodicCostsDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIPensionAndOtherPostretirementBenefitPlansNetOfTax": { "auth_ref": [ "r86", "r90", "r92", "r360" ], "crdr": "credit", "lang": { "en-US": { "role": { "documentation": "Amount, after tax, of reclassification adjustment from accumulated other comprehensive (income) loss for net periodic benefit cost (credit) of defined benefit plan.", "label": "Other Comprehensive (Income) Loss, Defined Benefit Plan, Reclassification Adjustment from AOCI, after Tax", "terseLabel": "Other Comprehensive (Income) Loss, Defined Benefit Plan, Reclassification Adjustment from AOCI, after Tax" } } }, "localname": "OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIPensionAndOtherPostretirementBenefitPlansNetOfTax", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.agilent.com/role/StockholdersEquityStockholdersEquityReclassificationsOutOfAccumulatedOtherComprehensiveIncomeDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIPensionAndOtherPostretirementBenefitPlansTax": { "auth_ref": [ "r87", "r507" ], "crdr": "debit", "lang": { "en-US": { "role": { "documentation": "Amount of tax (expense) benefit for reclassification adjustment from accumulated other comprehensive (income) loss of defined benefit plan.", "label": "Other Comprehensive (Income) Loss, Defined Benefit Plan, Reclassification Adjustment from AOCI, Tax", "terseLabel": "Other Comprehensive (Income) Loss, Defined Benefit Plan, Reclassification Adjustment from AOCI, Tax" } } }, "localname": "OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIPensionAndOtherPostretirementBenefitPlansTax", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.agilent.com/role/StockholdersEquityStockholdersEquityReclassificationsOutOfAccumulatedOtherComprehensiveIncomeDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_OtherComprehensiveIncomeLossTax": { "auth_ref": [ "r87", "r479", "r481" ], "crdr": "debit", "lang": { "en-US": { "role": { "documentation": "Amount of tax expense (benefit) allocated to other comprehensive income (loss).", "label": "Other Comprehensive Income (Loss), Tax", "terseLabel": "Tax (expense) benefit" } } }, "localname": "OtherComprehensiveIncomeLossTax", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.agilent.com/role/StockholdersEquityChangesInAccumulatedOtherComprehensiveIncomeDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_OtherComprehensiveIncomeMember": { "auth_ref": [ "r544" ], "lang": { "en-US": { "role": { "documentation": "Primary financial statement caption in which reported facts about other comprehensive income have been included.", "label": "Other Comprehensive Income (Loss) [Member]", "terseLabel": "Other Comprehensive Income (Loss) [Member]" } } }, "localname": "OtherComprehensiveIncomeMember", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.agilent.com/role/DerivativesEffectOfDerivativeInstrumentsOnConsolidatedStatementOfOperationsDetails" ], "xbrltype": "domainItemType" }, "us-gaap_OtherComprehensiveIncomeUnrealizedGainLossOnDerivativesArisingDuringPeriodBeforeTax": { "auth_ref": [ "r81", "r86", "r554" ], "crdr": "credit", "lang": { "en-US": { "role": { "documentation": "Amount before tax of increase (decrease) in accumulated gain (loss) from derivative instruments designated and qualifying as the effective portion of cash flow hedges and an entity's share of an equity investee's increase (decrease) in deferred hedging gain (loss).", "label": "Other Comprehensive Income (Loss), Unrealized Gain (Loss) on Derivatives Arising During Period, before Tax", "negatedTerseLabel": "Loss on interest rate swaps recognized in other comprehensive income", "terseLabel": "Other Comprehensive Income (Loss), before Reclassifications", "verboseLabel": "Gain (loss) recognized in accumulated other comprehensive income(loss)" } } }, "localname": "OtherComprehensiveIncomeUnrealizedGainLossOnDerivativesArisingDuringPeriodBeforeTax", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.agilent.com/role/DerivativesEffectOfDerivativeInstrumentsOnConsolidatedStatementOfOperationsDetails", "http://www.agilent.com/role/StockholdersEquityChangesInAccumulatedOtherComprehensiveIncomeDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_OtherComprehensiveIncomeUnrealizedGainLossOnDerivativesArisingDuringPeriodNetOfTax": { "auth_ref": [ "r81", "r86", "r554" ], "calculation": { "http://www.agilent.com/role/ConsolidatedStatementOfComprehensiveIncome": { "order": 1.0, "parentTag": "us-gaap_OtherComprehensiveIncomeLossNetOfTax", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-US": { "role": { "documentation": "Amount after tax of increase (decrease) in accumulated gain (loss) from derivative instruments designated and qualifying as the effective portion of cash flow hedges and an entity's share of an equity investee's increase (decrease) in deferred hedging gain (loss).", "label": "Other Comprehensive Income (Loss), Unrealized Gain (Loss) on Derivatives Arising During Period, Net of Tax", "terseLabel": "Gain (loss) on derivative instruments, net of tax expense (benefit) of $(2), $1 and $0" } } }, "localname": "OtherComprehensiveIncomeUnrealizedGainLossOnDerivativesArisingDuringPeriodNetOfTax", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.agilent.com/role/ConsolidatedStatementOfComprehensiveIncome" ], "xbrltype": "monetaryItemType" }, "us-gaap_OtherComprehensiveIncomeUnrealizedGainLossOnDerivativesArisingDuringPeriodTax": { "auth_ref": [ "r81", "r87" ], "crdr": "debit", "lang": { "en-US": { "role": { "documentation": "Amount of tax expense (benefit), before reclassification adjustments, related to increase (decrease) in accumulated gain (loss) from derivative instruments designated and qualifying as the effective portion of cash flow hedges and an entity's share of an equity investee's increase (decrease) in deferred hedging gain (loss).", "label": "Other Comprehensive Income (Loss), Unrealized Gain (Loss) on Derivatives Arising During Period, Tax", "terseLabel": "Gain (loss) on derivative instruments, tax expense (benefit)" } } }, "localname": "OtherComprehensiveIncomeUnrealizedGainLossOnDerivativesArisingDuringPeriodTax", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.agilent.com/role/ConsolidatedStatementOfComprehensiveIncomeParenthetical" ], "xbrltype": "monetaryItemType" }, "us-gaap_OtherCurrentAssetsMember": { "auth_ref": [ "r532", "r552" ], "lang": { "en-US": { "role": { "documentation": "Primary financial statement caption encompassing other current assets.", "label": "Other Current Assets [Member]" } } }, "localname": "OtherCurrentAssetsMember", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.agilent.com/role/DerivativesFairValueOfDerivativeInstrumentsAndConsolidatedBalanceSheetLocationDetails" ], "xbrltype": "domainItemType" }, "us-gaap_OtherIncomeMember": { "auth_ref": [ "r547" ], "lang": { "en-US": { "role": { "documentation": "Primary financial statement caption encompassing other revenue.", "label": "Other Income [Member]", "terseLabel": "Other income (expense) [Member]" } } }, "localname": "OtherIncomeMember", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.agilent.com/role/DerivativesEffectOfDerivativeInstrumentsOnConsolidatedStatementOfOperationsDetails" ], "xbrltype": "domainItemType" }, "us-gaap_OtherLiabilitiesCurrent": { "auth_ref": [ "r12", "r13", "r55" ], "calculation": { "http://www.agilent.com/role/ConsolidatedBalanceSheet": { "order": 5.0, "parentTag": "us-gaap_LiabilitiesCurrent", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-US": { "role": { "documentation": "Amount of liabilities classified as other, due within one year or the normal operating cycle, if longer.", "label": "Other Liabilities, Current", "terseLabel": "Other accrued liabilities", "verboseLabel": "Other accrued liabilities" } } }, "localname": "OtherLiabilitiesCurrent", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.agilent.com/role/ConsolidatedBalanceSheet", "http://www.agilent.com/role/NewAccountingPronouncementsImpactOfAdoptingNewGuidanceDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_OtherLiabilitiesNoncurrent": { "auth_ref": [ "r61" ], "calculation": { "http://www.agilent.com/role/ConsolidatedBalanceSheet": { "order": 4.0, "parentTag": "us-gaap_Liabilities", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-US": { "role": { "documentation": "Amount of liabilities classified as other, due after one year or the normal operating cycle, if longer.", "label": "Other Liabilities, Noncurrent", "terseLabel": "Other long-term liabilities", "verboseLabel": "Other long-term liabilities" } } }, "localname": "OtherLiabilitiesNoncurrent", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.agilent.com/role/ConsolidatedBalanceSheet", "http://www.agilent.com/role/NewAccountingPronouncementsImpactOfAdoptingNewGuidanceDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_OtherNoncashIncomeExpense": { "auth_ref": [ "r130" ], "calculation": { "http://www.agilent.com/role/ConsolidatedStatementOfCashFlows": { "order": 9.0, "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": -1.0 } }, "crdr": "credit", "lang": { "en-US": { "role": { "documentation": "Amount of income (expense) included in net income that results in no cash inflow (outflow), classified as other.", "label": "Other Noncash Income (Expense)", "negatedLabel": "Other" } } }, "localname": "OtherNoncashIncomeExpense", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.agilent.com/role/ConsolidatedStatementOfCashFlows" ], "xbrltype": "monetaryItemType" }, "us-gaap_OtherNonoperatingIncomeExpense": { "auth_ref": [ "r109" ], "calculation": { "http://www.agilent.com/role/ConsolidatedStatementOfOperations": { "order": 4.0, "parentTag": "us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments", "weight": 1.0 }, "http://www.agilent.com/role/SegmentInformationReconciliationOfReportableResultsDetails": { "order": 14.0, "parentTag": "us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-US": { "role": { "documentation": "Amount of income (expense) related to nonoperating activities, classified as other.", "label": "Other Nonoperating Income (Expense)", "terseLabel": "Other income (expense), net" } } }, "localname": "OtherNonoperatingIncomeExpense", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.agilent.com/role/ConsolidatedStatementOfOperations", "http://www.agilent.com/role/SegmentInformationReconciliationOfReportableResultsDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_OtherTaxExpenseBenefit": { "auth_ref": [ "r147", "r447", "r475" ], "crdr": "debit", "lang": { "en-US": { "role": { "documentation": "Amount of other income tax expense (benefit).", "label": "Other Tax Expense (Benefit)", "verboseLabel": "Net discrete tax expense" } } }, "localname": "OtherTaxExpenseBenefit", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.agilent.com/role/IncomeTaxesIncomeTaxesEffectiveTaxRateAndTaxHolidaysDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_ParentMember": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Portion of equity, or net assets, in the consolidated entity attributable, directly or indirectly, to the parent. Excludes noncontrolling interests.", "label": "Parent [Member]", "terseLabel": "Total Stockholders Equity" } } }, "localname": "ParentMember", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.agilent.com/role/ConsolidatedStatementOfEquity" ], "xbrltype": "domainItemType" }, "us-gaap_PaymentsForRepurchaseOfCommonStock": { "auth_ref": [ "r119" ], "calculation": { "http://www.agilent.com/role/ConsolidatedStatementOfCashFlows": { "order": 7.0, "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities", "weight": -1.0 } }, "crdr": "credit", "lang": { "en-US": { "role": { "documentation": "The cash outflow to reacquire common stock during the period.", "label": "Payments for Repurchase of Common Stock", "negatedLabel": "Treasury stock repurchases" } } }, "localname": "PaymentsForRepurchaseOfCommonStock", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.agilent.com/role/ConsolidatedStatementOfCashFlows" ], "xbrltype": "monetaryItemType" }, "us-gaap_PaymentsOfDebtIssuanceCosts": { "auth_ref": [ "r121" ], "calculation": { "http://www.agilent.com/role/ConsolidatedStatementOfCashFlows": { "order": 4.0, "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities", "weight": -1.0 } }, "crdr": "credit", "lang": { "en-US": { "role": { "documentation": "The cash outflow paid to third parties in connection with debt origination, which will be amortized over the remaining maturity period of the associated long-term debt.", "label": "Payments of Debt Issuance Costs", "negatedLabel": "Debt issuance costs" } } }, "localname": "PaymentsOfDebtIssuanceCosts", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.agilent.com/role/ConsolidatedStatementOfCashFlows" ], "xbrltype": "monetaryItemType" }, "us-gaap_PaymentsOfDividendsCommonStock": { "auth_ref": [ "r119" ], "calculation": { "http://www.agilent.com/role/ConsolidatedStatementOfCashFlows": { "order": 6.0, "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities", "weight": -1.0 } }, "crdr": "credit", "lang": { "en-US": { "role": { "documentation": "Amount of cash outflow in the form of ordinary dividends to common shareholders of the parent entity.", "label": "Payments of Ordinary Dividends, Common Stock", "negatedTerseLabel": "Payment of dividends", "terseLabel": "Aggregate cash dividends paid" } } }, "localname": "PaymentsOfDividendsCommonStock", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.agilent.com/role/ConsolidatedStatementOfCashFlows", "http://www.agilent.com/role/StockholdersEquityStockholdersEquityDividendsDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_PaymentsRelatedToTaxWithholdingForShareBasedCompensation": { "auth_ref": [ "r119" ], "calculation": { "http://www.agilent.com/role/ConsolidatedStatementOfCashFlows": { "order": 8.0, "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities", "weight": -1.0 } }, "crdr": "credit", "lang": { "en-US": { "role": { "documentation": "Amount of cash outflow to satisfy grantee's tax withholding obligation for award under share-based payment arrangement.", "label": "Payment, Tax Withholding, Share-based Payment Arrangement", "negatedTerseLabel": "Payment of taxes related to net share settlement of equity awards" } } }, "localname": "PaymentsRelatedToTaxWithholdingForShareBasedCompensation", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.agilent.com/role/ConsolidatedStatementOfCashFlows" ], "xbrltype": "monetaryItemType" }, "us-gaap_PaymentsToAcquireAdditionalInterestInSubsidiaries": { "auth_ref": [ "r114" ], "calculation": { "http://www.agilent.com/role/ConsolidatedStatementOfCashFlows": { "order": 3.0, "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities", "weight": -1.0 } }, "crdr": "credit", "lang": { "en-US": { "role": { "documentation": "The cash outflow associated with the purchase of noncontrolling interest during the period.", "label": "Payments to Acquire Additional Interest in Subsidiaries", "terseLabel": "Purchase of non-controlling interest" } } }, "localname": "PaymentsToAcquireAdditionalInterestInSubsidiaries", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.agilent.com/role/ConsolidatedStatementOfCashFlows" ], "xbrltype": "monetaryItemType" }, "us-gaap_PaymentsToAcquireBusinessesGross": { "auth_ref": [ "r114", "r502" ], "crdr": "credit", "lang": { "en-US": { "role": { "documentation": "The cash outflow associated with the acquisition of business during the period. The cash portion only of the acquisition price.", "label": "Payments to Acquire Businesses, Gross", "terseLabel": "Cash payment to acquire business", "verboseLabel": "Additional consideration paid" } } }, "localname": "PaymentsToAcquireBusinessesGross", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.agilent.com/role/AcquisitionsTextDetails", "http://www.agilent.com/role/InvestmentsDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_PaymentsToAcquireBusinessesNetOfCashAcquired": { "auth_ref": [ "r114" ], "calculation": { "http://www.agilent.com/role/ConsolidatedStatementOfCashFlows": { "order": 7.0, "parentTag": "us-gaap_NetCashProvidedByUsedInInvestingActivities", "weight": -1.0 } }, "crdr": "credit", "lang": { "en-US": { "role": { "documentation": "The cash outflow associated with the acquisition of a business, net of the cash acquired from the purchase.", "label": "Payments to Acquire Businesses, Net of Cash Acquired", "negatedLabel": "Acquisitions of businesses and intangible assets, net of cash acquired" } } }, "localname": "PaymentsToAcquireBusinessesNetOfCashAcquired", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.agilent.com/role/ConsolidatedStatementOfCashFlows" ], "xbrltype": "monetaryItemType" }, "us-gaap_PaymentsToAcquireIntangibleAssets": { "auth_ref": [ "r115" ], "calculation": { "http://www.agilent.com/role/ConsolidatedStatementOfCashFlows": { "order": 6.0, "parentTag": "us-gaap_NetCashProvidedByUsedInInvestingActivities", "weight": -1.0 } }, "crdr": "credit", "lang": { "en-US": { "role": { "documentation": "The cash outflow to acquire asset without physical form usually arising from contractual or other legal rights, excluding goodwill.", "label": "Payments to Acquire Intangible Assets", "negatedTerseLabel": "Payment to acquire intangible assets" } } }, "localname": "PaymentsToAcquireIntangibleAssets", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.agilent.com/role/ConsolidatedStatementOfCashFlows" ], "xbrltype": "monetaryItemType" }, "us-gaap_PaymentsToAcquireInvestments": { "auth_ref": [ "r116" ], "calculation": { "http://www.agilent.com/role/ConsolidatedStatementOfCashFlows": { "order": 4.0, "parentTag": "us-gaap_NetCashProvidedByUsedInInvestingActivities", "weight": -1.0 } }, "crdr": "credit", "lang": { "en-US": { "role": { "documentation": "The cash outflow associated with the purchase of all investments (debt, security, other) during the period.", "label": "Payments to Acquire Investments", "terseLabel": "Payment to acquire fair value investment" } } }, "localname": "PaymentsToAcquireInvestments", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.agilent.com/role/ConsolidatedStatementOfCashFlows" ], "xbrltype": "monetaryItemType" }, "us-gaap_PaymentsToAcquireNotesReceivable": { "auth_ref": [ "r113" ], "calculation": { "http://www.agilent.com/role/ConsolidatedStatementOfCashFlows": { "order": 5.0, "parentTag": "us-gaap_NetCashProvidedByUsedInInvestingActivities", "weight": -1.0 } }, "crdr": "credit", "lang": { "en-US": { "role": { "documentation": "The cash outflow to acquire an agreement for an unconditional promise by the maker to pay the entity (holder) a definite sum of money at a future date. Such amount may include accrued interest receivable in accordance with the terms of the note. The note also may contain provisions including a discount or premium, payable on demand, secured, or unsecured, interest bearing or noninterest bearing, among myriad other features and characteristics.", "label": "Payments to Acquire Notes Receivable", "negatedTerseLabel": "Payment in exchange for convertible note" } } }, "localname": "PaymentsToAcquireNotesReceivable", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.agilent.com/role/ConsolidatedStatementOfCashFlows" ], "xbrltype": "monetaryItemType" }, "us-gaap_PaymentsToAcquirePropertyPlantAndEquipment": { "auth_ref": [ "r115" ], "calculation": { "http://www.agilent.com/role/ConsolidatedStatementOfCashFlows": { "order": 1.0, "parentTag": "us-gaap_NetCashProvidedByUsedInInvestingActivities", "weight": -1.0 } }, "crdr": "credit", "lang": { "en-US": { "role": { "documentation": "The cash outflow associated with the acquisition of long-lived, physical assets that are used in the normal conduct of business to produce goods and services and not intended for resale; includes cash outflows to pay for construction of self-constructed assets.", "label": "Payments to Acquire Property, Plant, and Equipment", "negatedLabel": "Investments in property, plant and equipment", "terseLabel": "Capital expenditures" } } }, "localname": "PaymentsToAcquirePropertyPlantAndEquipment", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.agilent.com/role/ConsolidatedStatementOfCashFlows", "http://www.agilent.com/role/SegmentInformationSegmentAssetsDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_PensionAndOtherPostretirementBenefitsDisclosureTextBlock": { "auth_ref": [ "r391" ], "lang": { "en-US": { "role": { "documentation": "The entire disclosure for pension and other postretirement benefits.", "label": "Pension and Other Postretirement Benefits Disclosure [Text Block]", "verboseLabel": "RETIREMENT PLANS AND POST RETIREMENT PENSION PLANS" } } }, "localname": "PensionAndOtherPostretirementBenefitsDisclosureTextBlock", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.agilent.com/role/RetirementPlansAndPostRetirementPensionPlans" ], "xbrltype": "textBlockItemType" }, "us-gaap_PensionAndOtherPostretirementDefinedBenefitPlansLiabilitiesNoncurrent": { "auth_ref": [ "r26", "r326", "r327", "r343" ], "calculation": { "http://www.agilent.com/role/ConsolidatedBalanceSheet": { "order": 3.0, "parentTag": "us-gaap_Liabilities", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-US": { "role": { "documentation": "Amount of liability, recognized in statement of financial position, for defined benefit pension and other postretirement plans, classified as noncurrent.", "label": "Liability, Defined Benefit Plan, Noncurrent", "verboseLabel": "Retirement and post-retirement benefits" } } }, "localname": "PensionAndOtherPostretirementDefinedBenefitPlansLiabilitiesNoncurrent", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.agilent.com/role/ConsolidatedBalanceSheet", "http://www.agilent.com/role/NewAccountingPronouncementsImpactOfAdoptingNewGuidanceDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_PensionAndOtherPostretirementPlansPolicy": { "auth_ref": [ "r137", "r371", "r386", "r387", "r389", "r390" ], "lang": { "en-US": { "role": { "documentation": "Disclosure of accounting policy for pension and other postretirement benefit plans. This accounting policy may address (1) the types of plans sponsored by the entity, and the benefits provided by each plan (2) groups that participate in (or are covered by) each plan (3) how plan assets, liabilities and expenses are measured, including the use of any actuaries and (4) significant assumptions used by the entity to value plan assets and liabilities and how such assumptions are derived.", "label": "Pension and Other Postretirement Plans, Policy [Policy Text Block]", "terseLabel": "Retirement and post-retirement plans" } } }, "localname": "PensionAndOtherPostretirementPlansPolicy", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.agilent.com/role/OverviewAndSummaryOfSignificantAccountingPoliciesPolicies" ], "xbrltype": "textBlockItemType" }, "us-gaap_PensionPlansDefinedBenefitMember": { "auth_ref": [ "r324", "r371", "r372", "r389" ], "lang": { "en-US": { "role": { "documentation": "Plan designed to provide participant with pension benefits. Includes, but is not limited to, defined benefit and defined contribution plans. Excludes other postretirement benefits.", "label": "Pension Plan [Member]", "terseLabel": "Pension Plan", "verboseLabel": "401(k) Additional company contribution" } } }, "localname": "PensionPlansDefinedBenefitMember", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.agilent.com/role/RetirementPlansAndPostRetirementPensionPlansAssumptionsDetails", "http://www.agilent.com/role/RetirementPlansAndPostRetirementPensionPlansComponentsOfNetPeriodicCostsDetails", "http://www.agilent.com/role/RetirementPlansAndPostRetirementPensionPlansDefinedContributionDetails", "http://www.agilent.com/role/RetirementPlansAndPostRetirementPensionPlansExpectedBenefitPaymentsDetails", "http://www.agilent.com/role/RetirementPlansAndPostRetirementPensionPlansFairValueOfPlanAssetsDetails", "http://www.agilent.com/role/RetirementPlansAndPostRetirementPensionPlansFinancialStatementLocationDetails", "http://www.agilent.com/role/RetirementPlansAndPostRetirementPensionPlansFundedStatusDetails", "http://www.agilent.com/role/RetirementPlansAndPostRetirementPensionPlansJwpilDetails", "http://www.agilent.com/role/RetirementPlansAndPostRetirementPensionPlansRetirementPlansAndPostRetirementPensionPlansTargetAllocationsDetails", "http://www.agilent.com/role/SegmentInformationReconciliationOfReportableResultsDetails" ], "xbrltype": "domainItemType" }, "us-gaap_PlanAssetCategoriesDomain": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Defined benefit plan asset investment.", "label": "Defined Benefit Plan, Plan Assets, Category [Domain]", "terseLabel": "Defined Benefit Plan, Plan Assets, Category [Domain]" } } }, "localname": "PlanAssetCategoriesDomain", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.agilent.com/role/RetirementPlansAndPostRetirementPensionPlansAssumptionsDetails", "http://www.agilent.com/role/RetirementPlansAndPostRetirementPensionPlansFairValueOfPlanAssetsDetails", "http://www.agilent.com/role/RetirementPlansAndPostRetirementPensionPlansJwpilDetails", "http://www.agilent.com/role/RetirementPlansAndPostRetirementPensionPlansRetirementPlansAndPostRetirementPensionPlansTargetAllocationsDetails" ], "xbrltype": "domainItemType" }, "us-gaap_PositionAxis": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Information by position taken for a security.", "label": "Position [Axis]", "terseLabel": "Position [Axis]" } } }, "localname": "PositionAxis", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.agilent.com/role/DerivativesDisclosuresAndDerivativeInstrumentAggregatedNotionalAmountsByCurrencyAndDesignationsDetails" ], "xbrltype": "stringItemType" }, "us-gaap_PositionDomain": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Indicates position taken for a security.", "label": "Position [Domain]", "terseLabel": "Position [Domain]" } } }, "localname": "PositionDomain", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.agilent.com/role/DerivativesDisclosuresAndDerivativeInstrumentAggregatedNotionalAmountsByCurrencyAndDesignationsDetails" ], "xbrltype": "domainItemType" }, "us-gaap_PreferredStockParOrStatedValuePerShare": { "auth_ref": [ "r30" ], "lang": { "en-US": { "role": { "documentation": "Face amount or stated value per share of preferred stock nonredeemable or redeemable solely at the option of the issuer.", "label": "Preferred Stock, Par or Stated Value Per Share", "terseLabel": "Preferred stock par value (in dollars per share)" } } }, "localname": "PreferredStockParOrStatedValuePerShare", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.agilent.com/role/ConsolidatedBalanceSheetParenthetical" ], "xbrltype": "perShareItemType" }, "us-gaap_PreferredStockSharesAuthorized": { "auth_ref": [ "r30" ], "lang": { "en-US": { "role": { "documentation": "The maximum number of nonredeemable preferred shares (or preferred stock redeemable solely at the option of the issuer) permitted to be issued by an entity's charter and bylaws.", "label": "Preferred Stock, Shares Authorized", "terseLabel": "Preferred stock shares authorized (in shares)" } } }, "localname": "PreferredStockSharesAuthorized", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.agilent.com/role/ConsolidatedBalanceSheetParenthetical" ], "xbrltype": "sharesItemType" }, "us-gaap_PreferredStockSharesIssued": { "auth_ref": [ "r30" ], "lang": { "en-US": { "role": { "documentation": "Total number of nonredeemable preferred shares (or preferred stock redeemable solely at the option of the issuer) issued to shareholders (includes related preferred shares that were issued, repurchased, and remain in the treasury). May be all or portion of the number of preferred shares authorized. Excludes preferred shares that are classified as debt.", "label": "Preferred Stock, Shares Issued", "terseLabel": "Preferred Stock, Shares Issued (in shares)" } } }, "localname": "PreferredStockSharesIssued", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.agilent.com/role/ConsolidatedBalanceSheetParenthetical" ], "xbrltype": "sharesItemType" }, "us-gaap_PreferredStockSharesOutstanding": { "auth_ref": [ "r30" ], "lang": { "en-US": { "role": { "documentation": "Aggregate share number for all nonredeemable preferred stock (or preferred stock redeemable solely at the option of the issuer) held by stockholders. Does not include preferred shares that have been repurchased.", "label": "Preferred Stock, Shares Outstanding", "terseLabel": "Preferred Stock, Shares Outstanding (in shares)" } } }, "localname": "PreferredStockSharesOutstanding", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.agilent.com/role/ConsolidatedBalanceSheetParenthetical" ], "xbrltype": "sharesItemType" }, "us-gaap_PreferredStockValue": { "auth_ref": [ "r30" ], "calculation": { "http://www.agilent.com/role/ConsolidatedBalanceSheet": { "order": 1.0, "parentTag": "us-gaap_StockholdersEquity", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-US": { "role": { "documentation": "Aggregate par or stated value of issued nonredeemable preferred stock (or preferred stock redeemable solely at the option of the issuer). This item includes treasury stock repurchased by the entity. Note: elements for number of nonredeemable preferred shares, par value and other disclosure concepts are in another section within stockholders' equity.", "label": "Preferred Stock, Value, Issued", "terseLabel": "Preferred stock; $0.01 par value; 125 million shares authorized; none issued and outstanding" } } }, "localname": "PreferredStockValue", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.agilent.com/role/ConsolidatedBalanceSheet", "http://www.agilent.com/role/NewAccountingPronouncementsImpactOfAdoptingNewGuidanceDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_ProceedsFromDivestitureOfBusinessesNetOfCashDivested": { "auth_ref": [ "r111" ], "calculation": { "http://www.agilent.com/role/ConsolidatedStatementOfCashFlows": { "order": 3.0, "parentTag": "us-gaap_NetCashProvidedByUsedInInvestingActivities", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-US": { "role": { "documentation": "This element represents the cash inflow during the period from the sale of a component of the entity.", "label": "Proceeds from Divestiture of Businesses, Net of Cash Divested", "terseLabel": "Proceeds from divestitures" } } }, "localname": "ProceedsFromDivestitureOfBusinessesNetOfCashDivested", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.agilent.com/role/ConsolidatedStatementOfCashFlows" ], "xbrltype": "monetaryItemType" }, "us-gaap_ProceedsFromIssuanceOfSeniorLongTermDebt": { "auth_ref": [ "r118" ], "calculation": { "http://www.agilent.com/role/ConsolidatedStatementOfCashFlows": { "order": 5.0, "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-US": { "role": { "documentation": "The cash inflow from a borrowing with the highest claim on the assets of the entity in case of bankruptcy or liquidation (with maturities initially due after one year or beyond the operating cycle, if longer).", "label": "Proceeds from Issuance of Senior Long-term Debt", "terseLabel": "Issuance of senior notes" } } }, "localname": "ProceedsFromIssuanceOfSeniorLongTermDebt", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.agilent.com/role/ConsolidatedStatementOfCashFlows" ], "xbrltype": "monetaryItemType" }, "us-gaap_ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlansIncludingStockOptions": { "auth_ref": [ "r117", "r427" ], "calculation": { "http://www.agilent.com/role/ConsolidatedStatementOfCashFlows": { "order": 9.0, "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-US": { "role": { "documentation": "Amount of cash inflow from issuance of shares under share-based payment arrangement. Includes, but is not limited to, option exercised.", "label": "Proceeds, Issuance of Shares, Share-based Payment Arrangement, Including Option Exercised", "terseLabel": "Issuance of common stock under employee stock plans", "verboseLabel": "Amount of cash received from the exercise of share-based awards granted" } } }, "localname": "ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlansIncludingStockOptions", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.agilent.com/role/ConsolidatedStatementOfCashFlows", "http://www.agilent.com/role/ShareBasedCompensationSharesAuthorizedByExercisePriceRangeDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_ProceedsFromLinesOfCredit": { "auth_ref": [ "r118", "r145" ], "crdr": "debit", "lang": { "en-US": { "role": { "documentation": "Amount of cash inflow from contractual arrangement with the lender, including but not limited to, letter of credit, standby letter of credit and revolving credit arrangements.", "label": "Proceeds from Lines of Credit", "terseLabel": "Short-term Debt" } } }, "localname": "ProceedsFromLinesOfCredit", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.agilent.com/role/ShortTermDebtCreditFacilityAndCapitalLeaseDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_ProceedsFromSaleOfPropertyPlantAndEquipment": { "auth_ref": [ "r112" ], "calculation": { "http://www.agilent.com/role/ConsolidatedStatementOfCashFlows": { "order": 2.0, "parentTag": "us-gaap_NetCashProvidedByUsedInInvestingActivities", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-US": { "role": { "documentation": "The cash inflow from the sale of long-lived, physical assets that are used in the normal conduct of business to produce goods and services and not intended for resale.", "label": "Proceeds from Sale of Property, Plant, and Equipment", "terseLabel": "Proceeds from the sale of property, plant and equipment" } } }, "localname": "ProceedsFromSaleOfPropertyPlantAndEquipment", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.agilent.com/role/ConsolidatedStatementOfCashFlows" ], "xbrltype": "monetaryItemType" }, "us-gaap_ProceedsFromShortTermDebt": { "auth_ref": [ "r118" ], "calculation": { "http://www.agilent.com/role/ConsolidatedStatementOfCashFlows": { "order": 2.0, "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-US": { "role": { "documentation": "The cash inflow from a borrowing having initial term of repayment within one year or the normal operating cycle, if longer.", "label": "Proceeds from Short-term Debt", "terseLabel": "Proceeds from credit facility and short-term loan" } } }, "localname": "ProceedsFromShortTermDebt", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.agilent.com/role/ConsolidatedStatementOfCashFlows" ], "xbrltype": "monetaryItemType" }, "us-gaap_ProductMember": { "auth_ref": [ "r318" ], "lang": { "en-US": { "role": { "documentation": "Article or substance produced by nature, labor or machinery.", "label": "Product [Member]", "terseLabel": "Products" } } }, "localname": "ProductMember", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.agilent.com/role/ConsolidatedStatementOfOperations" ], "xbrltype": "domainItemType" }, "us-gaap_ProductWarrantiesDisclosuresAbstract": { "auth_ref": [], "lang": { "en-US": { "role": { "label": "Product Warranties Disclosures [Abstract]" } } }, "localname": "ProductWarrantiesDisclosuresAbstract", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.agilent.com/role/GuaranteesDetails" ], "xbrltype": "stringItemType" }, "us-gaap_ProductWarrantyDisclosureTextBlock": { "auth_ref": [ "r287" ], "lang": { "en-US": { "role": { "documentation": "The entire disclosure for standard and extended product warranties and other product guarantee contracts, including a tabular reconciliation of the changes in the guarantor's aggregate product warranty liability for the reporting period.", "label": "Product Warranty Disclosure [Text Block]", "verboseLabel": "GUARANTEES" } } }, "localname": "ProductWarrantyDisclosureTextBlock", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.agilent.com/role/Guarantees" ], "xbrltype": "textBlockItemType" }, "us-gaap_ProfitLoss": { "auth_ref": [ "r94", "r97", "r123", "r193", "r200", "r507", "r510", "r511", "r521", "r522" ], "calculation": { "http://www.agilent.com/role/ConsolidatedStatementOfCashFlows": { "order": 1.0, "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": 1.0 }, "http://www.agilent.com/role/ConsolidatedStatementOfComprehensiveIncome": { "order": 1.0, "parentTag": "us-gaap_ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest", "weight": 1.0 }, "http://www.agilent.com/role/ConsolidatedStatementOfEquity": { "order": 1.0, "parentTag": "us-gaap_ComprehensiveIncomeNetOfTax", "weight": 1.0 }, "http://www.agilent.com/role/ConsolidatedStatementOfOperations": { "order": null, "parentTag": null, "root": true, "weight": null } }, "crdr": "credit", "lang": { "en-US": { "role": { "documentation": "The consolidated profit or loss for the period, net of income taxes, including the portion attributable to the noncontrolling interest.", "label": "Net Income (Loss), Including Portion Attributable to Noncontrolling Interest", "terseLabel": "Net income", "totalLabel": "Net income" } } }, "localname": "ProfitLoss", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.agilent.com/role/AcquisitionsTextDetails", "http://www.agilent.com/role/ConsolidatedStatementOfCashFlows", "http://www.agilent.com/role/ConsolidatedStatementOfComprehensiveIncome", "http://www.agilent.com/role/ConsolidatedStatementOfEquity", "http://www.agilent.com/role/ConsolidatedStatementOfOperations", "http://www.agilent.com/role/NetIncomeLossPerShareDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_PropertyPlantAndEquipmentAbstract": { "auth_ref": [], "lang": { "en-US": { "role": { "label": "Property, Plant and Equipment [Abstract]" } } }, "localname": "PropertyPlantAndEquipmentAbstract", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "xbrltype": "stringItemType" }, "us-gaap_PropertyPlantAndEquipmentAdditions": { "auth_ref": [], "calculation": { "http://www.agilent.com/role/SegmentInformationReconciliationOfReportableResultsDetails": { "order": 7.0, "parentTag": "us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments", "weight": -1.0 } }, "crdr": "debit", "lang": { "en-US": { "role": { "documentation": "Amount of acquisition of long-lived, physical assets used in the normal conduct of business and not intended for resale. Examples include, but are not limited to, land, buildings, machinery and equipment, office equipment, furniture and fixtures, and computer equipment.", "label": "Property, Plant and Equipment, Additions", "negatedTerseLabel": "NASD Site costs" } } }, "localname": "PropertyPlantAndEquipmentAdditions", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.agilent.com/role/SegmentInformationReconciliationOfReportableResultsDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_PropertyPlantAndEquipmentByTypeAxis": { "auth_ref": [ "r46", "r260" ], "lang": { "en-US": { "role": { "documentation": "Information by type of long-lived, physical assets used to produce goods and services and not intended for resale.", "label": "Property, Plant and Equipment, Type [Axis]", "terseLabel": "Property, Plant and Equipment, Type [Axis]" } } }, "localname": "PropertyPlantAndEquipmentByTypeAxis", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.agilent.com/role/OverviewAndSummaryOfSignificantAccountingPoliciesDetails", "http://www.agilent.com/role/PropertyPlantAndEquipmentNetDetails", "http://www.agilent.com/role/SegmentInformationReconciliationOfReportableResultsDetails" ], "xbrltype": "stringItemType" }, "us-gaap_PropertyPlantAndEquipmentDisclosureTextBlock": { "auth_ref": [ "r265" ], "lang": { "en-US": { "role": { "documentation": "The entire disclosure for long-lived, physical assets used in the normal conduct of business and not intended for resale. Includes, but is not limited to, accounting policies and methodology, roll forwards, depreciation, depletion and amortization expense, including composite depreciation, accumulated depreciation, depletion and amortization expense, useful lives and method used, income statement disclosures, assets held for sale and public utility disclosures.", "label": "Property, Plant and Equipment Disclosure [Text Block]", "verboseLabel": "PROPERTY, PLANT AND EQUIPMENT, NET" } } }, "localname": "PropertyPlantAndEquipmentDisclosureTextBlock", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.agilent.com/role/PropertyPlantAndEquipmentNet" ], "xbrltype": "textBlockItemType" }, "us-gaap_PropertyPlantAndEquipmentGross": { "auth_ref": [ "r45", "r258" ], "calculation": { "http://www.agilent.com/role/PropertyPlantAndEquipmentNetDetails": { "order": 1.0, "parentTag": "us-gaap_PropertyPlantAndEquipmentNet", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-US": { "role": { "documentation": "Amount before accumulated depreciation, depletion and amortization of physical assets used in the normal conduct of business and not intended for resale. Examples include, but are not limited to, land, buildings, machinery and equipment, office equipment, and furniture and fixtures.", "label": "Property, Plant and Equipment, Gross", "totalLabel": "Total property, plant and equipment" } } }, "localname": "PropertyPlantAndEquipmentGross", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.agilent.com/role/PropertyPlantAndEquipmentNetDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_PropertyPlantAndEquipmentLineItems": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.", "label": "Property, Plant and Equipment [Line Items]", "terseLabel": "Property, Plant and Equipment [Line Items]" } } }, "localname": "PropertyPlantAndEquipmentLineItems", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.agilent.com/role/PropertyPlantAndEquipmentNetDetails" ], "xbrltype": "stringItemType" }, "us-gaap_PropertyPlantAndEquipmentNet": { "auth_ref": [ "r17", "r18", "r260", "r640" ], "calculation": { "http://www.agilent.com/role/ConsolidatedBalanceSheet": { "order": 2.0, "parentTag": "us-gaap_Assets", "weight": 1.0 }, "http://www.agilent.com/role/PropertyPlantAndEquipmentNetDetails": { "order": null, "parentTag": null, "root": true, "weight": null } }, "crdr": "debit", "lang": { "en-US": { "role": { "documentation": "Amount after accumulated depreciation, depletion and amortization of physical assets used in the normal conduct of business to produce goods and services and not intended for resale. Examples include, but are not limited to, land, buildings, machinery and equipment, office equipment, and furniture and fixtures.", "label": "Property, Plant and Equipment, Net", "terseLabel": "Property, plant and equipment, net", "totalLabel": "Property, plant and equipment, net" } } }, "localname": "PropertyPlantAndEquipmentNet", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.agilent.com/role/ConsolidatedBalanceSheet", "http://www.agilent.com/role/NewAccountingPronouncementsImpactOfAdoptingNewGuidanceDetails", "http://www.agilent.com/role/PropertyPlantAndEquipmentNetDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_PropertyPlantAndEquipmentPolicyTextBlock": { "auth_ref": [ "r44", "r137", "r260" ], "lang": { "en-US": { "role": { "documentation": "Disclosure of accounting policy for long-lived, physical assets used in the normal conduct of business and not intended for resale. Includes, but is not limited to, basis of assets, depreciation and depletion methods used, including composite deprecation, estimated useful lives, capitalization policy, accounting treatment for costs incurred for repairs and maintenance, capitalized interest and the method it is calculated, disposals and impairments.", "label": "Property, Plant and Equipment, Policy [Policy Text Block]", "terseLabel": "Property, plant and equipment" } } }, "localname": "PropertyPlantAndEquipmentPolicyTextBlock", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.agilent.com/role/OverviewAndSummaryOfSignificantAccountingPoliciesPolicies" ], "xbrltype": "textBlockItemType" }, "us-gaap_PropertyPlantAndEquipmentTextBlock": { "auth_ref": [ "r17", "r260" ], "lang": { "en-US": { "role": { "documentation": "Tabular disclosure of physical assets used in the normal conduct of business and not intended for resale. Includes, but is not limited to, balances by class of assets, depreciation and depletion expense and method used, including composite depreciation, and accumulated deprecation.", "label": "Property, Plant and Equipment [Table Text Block]", "terseLabel": "Property, Plant and Equipment" } } }, "localname": "PropertyPlantAndEquipmentTextBlock", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.agilent.com/role/PropertyPlantAndEquipmentNetTables" ], "xbrltype": "textBlockItemType" }, "us-gaap_PropertyPlantAndEquipmentTypeDomain": { "auth_ref": [ "r17", "r258" ], "lang": { "en-US": { "role": { "documentation": "Listing of long-lived, physical assets that are used in the normal conduct of business to produce goods and services and not intended for resale. Examples include land, buildings, machinery and equipment, and other types of furniture and equipment including, but not limited to, office equipment, furniture and fixtures, and computer equipment and software.", "label": "Property, Plant and Equipment, Type [Domain]", "terseLabel": "Property, Plant and Equipment, Type [Domain]" } } }, "localname": "PropertyPlantAndEquipmentTypeDomain", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.agilent.com/role/OverviewAndSummaryOfSignificantAccountingPoliciesDetails", "http://www.agilent.com/role/PropertyPlantAndEquipmentNetDetails", "http://www.agilent.com/role/SegmentInformationReconciliationOfReportableResultsDetails" ], "xbrltype": "domainItemType" }, "us-gaap_PropertyPlantAndEquipmentUsefulLife": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Useful life of long lived, physical assets used in the normal conduct of business and not intended for resale, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days. Examples include, but not limited to, land, buildings, machinery and equipment, office equipment, furniture and fixtures, and computer equipment.", "label": "Property, Plant and Equipment, Useful Life", "terseLabel": "Property, Plant and Equipment, Useful Life" } } }, "localname": "PropertyPlantAndEquipmentUsefulLife", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.agilent.com/role/OverviewAndSummaryOfSignificantAccountingPoliciesDetails" ], "xbrltype": "durationItemType" }, "us-gaap_PublicUtilitiesInventoryAxis": { "auth_ref": [ "r39" ], "lang": { "en-US": { "role": { "documentation": "Information by type of inventory held.", "label": "Inventory [Axis]", "terseLabel": "Inventory [Axis]" } } }, "localname": "PublicUtilitiesInventoryAxis", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.agilent.com/role/InventoryDetails" ], "xbrltype": "stringItemType" }, "us-gaap_PublicUtilitiesInventoryTypeDomain": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Tangible personal property that is held for sale in the ordinary course of business, in process of production for such sale or is to be currently consumed in the production of goods or services to be available for sale.", "label": "Inventory [Domain]", "terseLabel": "Inventory [Domain]" } } }, "localname": "PublicUtilitiesInventoryTypeDomain", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.agilent.com/role/InventoryDetails" ], "xbrltype": "domainItemType" }, "us-gaap_RealEstateMember": { "auth_ref": [ "r318" ], "lang": { "en-US": { "role": { "documentation": "Property consisting of land, land improvement and buildings.", "label": "Real Estate [Member]", "terseLabel": "Real Estate" } } }, "localname": "RealEstateMember", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.agilent.com/role/RetirementPlansAndPostRetirementPensionPlansAssumptionsDetails", "http://www.agilent.com/role/RetirementPlansAndPostRetirementPensionPlansRetirementPlansAndPostRetirementPensionPlansTargetAllocationsDetails" ], "xbrltype": "domainItemType" }, "us-gaap_ReasonablyPossibleSignificantChangeInUnrecognizedTaxBenefitsByItemAxis": { "auth_ref": [ "r452" ], "lang": { "en-US": { "role": { "documentation": "Information by nature of uncertainty related to unrecognized tax benefits.", "label": "Nature of Uncertainty [Axis]", "terseLabel": "Nature of Uncertainty [Axis]" } } }, "localname": "ReasonablyPossibleSignificantChangeInUnrecognizedTaxBenefitsByItemAxis", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.agilent.com/role/IncomeTaxesIncomeTaxesUncertainTaxPositionsDetails" ], "xbrltype": "stringItemType" }, "us-gaap_ReceivablesPolicyTextBlock": { "auth_ref": [ "r137", "r207", "r209", "r210", "r211" ], "lang": { "en-US": { "role": { "documentation": "Disclosure of accounting policy for receivable. Includes, but is not limited to, accounts receivable and financing receivable.", "label": "Receivable [Policy Text Block]", "terseLabel": "Accounts receivable, net" } } }, "localname": "ReceivablesPolicyTextBlock", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.agilent.com/role/OverviewAndSummaryOfSignificantAccountingPoliciesPolicies" ], "xbrltype": "textBlockItemType" }, "us-gaap_ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodBeforeTax": { "auth_ref": [ "r89", "r93" ], "crdr": "debit", "lang": { "en-US": { "role": { "documentation": "Amount before tax of reclassification adjustments of other comprehensive income (loss).", "label": "Reclassification from Accumulated Other Comprehensive Income, Current Period, before Tax", "terseLabel": "Amounts Reclassified out of Accumulated Other Comprehensive Income" } } }, "localname": "ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodBeforeTax", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.agilent.com/role/StockholdersEquityChangesInAccumulatedOtherComprehensiveIncomeDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax": { "auth_ref": [ "r89", "r93", "r101" ], "crdr": "debit", "lang": { "en-US": { "role": { "documentation": "Amount after tax of reclassification adjustments of other comprehensive income (loss).", "label": "Reclassification from Accumulated Other Comprehensive Income, Current Period, Net of Tax", "terseLabel": "Reclassification from Accumulated Other Comprehensive Income, Current Period, Net of Tax" } } }, "localname": "ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.agilent.com/role/StockholdersEquityStockholdersEquityReclassificationsOutOfAccumulatedOtherComprehensiveIncomeDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_ReclassificationOutOfAccumulatedOtherComprehensiveIncomeTableTextBlock": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Tabular disclosure of information about items reclassified out of accumulated other comprehensive income (loss).", "label": "Reclassification out of Accumulated Other Comprehensive Income [Table Text Block]", "terseLabel": "Reclassification out of Accumulated Other Comprehensive Income [Table Text Block]" } } }, "localname": "ReclassificationOutOfAccumulatedOtherComprehensiveIncomeTableTextBlock", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.agilent.com/role/StockholdersEquityTables" ], "xbrltype": "textBlockItemType" }, "us-gaap_ReconciliationOfOperatingProfitLossFromSegmentsToConsolidatedTextBlock": { "auth_ref": [ "r196", "r198" ], "lang": { "en-US": { "role": { "documentation": "Tabular disclosure of the reconciliation of profit (loss) from reportable segments to the consolidated income (loss) before income tax expense (benefit) and discontinued operations. Includes, but is not limited to, reconciliation after income tax if income tax is allocated to the reportable segment.", "label": "Reconciliation of Operating Profit (Loss) from Segments to Consolidated [Table Text Block]", "verboseLabel": "Reconciliation of segment results to total enterprise results" } } }, "localname": "ReconciliationOfOperatingProfitLossFromSegmentsToConsolidatedTextBlock", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.agilent.com/role/SegmentInformationTables" ], "xbrltype": "textBlockItemType" }, "us-gaap_RepaymentsOfLinesOfCredit": { "auth_ref": [ "r120", "r145" ], "crdr": "credit", "lang": { "en-US": { "role": { "documentation": "Amount of cash outflow for payment of an obligation from a lender, including but not limited to, letter of credit, standby letter of credit and revolving credit arrangements.", "label": "Repayments of Lines of Credit", "terseLabel": "Repayments of Lines of Credit" } } }, "localname": "RepaymentsOfLinesOfCredit", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.agilent.com/role/ShortTermDebtCreditFacilityAndCapitalLeaseDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_RepaymentsOfSeniorDebt": { "auth_ref": [ "r120" ], "crdr": "credit", "lang": { "en-US": { "role": { "documentation": "The cash outflow for a long-term debt where the holder has highest claim on the entity's asset in case of bankruptcy or liquidation during the period.", "label": "Repayments of Senior Debt", "terseLabel": "Repayments of senior debt" } } }, "localname": "RepaymentsOfSeniorDebt", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.agilent.com/role/LongTermDebtLongTermDebtOtherDetails", "http://www.agilent.com/role/ShortTermDebtSeniorNotesDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_RepaymentsOfShortTermDebt": { "auth_ref": [ "r120" ], "calculation": { "http://www.agilent.com/role/ConsolidatedStatementOfCashFlows": { "order": 1.0, "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities", "weight": -1.0 } }, "crdr": "credit", "lang": { "en-US": { "role": { "documentation": "The cash outflow for a borrowing having initial term of repayment within one year or the normal operating cycle, if longer.", "label": "Repayments of Short-term Debt", "terseLabel": "Repayments of debt and credit facility" } } }, "localname": "RepaymentsOfShortTermDebt", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.agilent.com/role/ConsolidatedStatementOfCashFlows" ], "xbrltype": "monetaryItemType" }, "us-gaap_ResearchAndDevelopmentExpense": { "auth_ref": [ "r434", "r656" ], "calculation": { "http://www.agilent.com/role/ConsolidatedStatementOfOperations": { "order": 2.0, "parentTag": "us-gaap_CostsAndExpenses", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-US": { "role": { "documentation": "The aggregate costs incurred (1) in a planned search or critical investigation aimed at discovery of new knowledge with the hope that such knowledge will be useful in developing a new product or service, a new process or technique, or in bringing about a significant improvement to an existing product or process; or (2) to translate research findings or other knowledge into a plan or design for a new product or process or for a significant improvement to an existing product or process whether intended for sale or the entity's use, during the reporting period charged to research and development projects, including the costs of developing computer software up to the point in time of achieving technological feasibility, and costs allocated in accounting for a business combination to in-process projects deemed to have no alternative future use.", "label": "Research and Development Expense", "verboseLabel": "Research and development" } } }, "localname": "ResearchAndDevelopmentExpense", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.agilent.com/role/ConsolidatedStatementOfOperations" ], "xbrltype": "monetaryItemType" }, "us-gaap_ResearchAndDevelopmentExpenseMember": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Primary financial statement caption in which the reported facts about research and development expense have been included.", "label": "Research and Development Expense [Member]", "terseLabel": "Research and Development" } } }, "localname": "ResearchAndDevelopmentExpenseMember", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.agilent.com/role/ShareBasedCompensationAllocatedShareBasedCompensationExpenseDetails" ], "xbrltype": "domainItemType" }, "us-gaap_ResearchDevelopmentAndComputerSoftwarePolicyTextBlock": { "auth_ref": [ "r47", "r137", "r251", "r252", "r656" ], "lang": { "en-US": { "role": { "documentation": "Disclosure of accounting policy for its research and development and computer software activities including the accounting treatment for costs incurred for (1) research and development activities, (2) development of computer software for internal use, (3) computer software to be sold, leased or otherwise marketed as a separate product or as part of a product or process and (4) in-process research and development acquired in a purchase business combination.", "label": "Research, Development, and Computer Software, Policy [Policy Text Block]", "terseLabel": "Research and development" } } }, "localname": "ResearchDevelopmentAndComputerSoftwarePolicyTextBlock", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.agilent.com/role/OverviewAndSummaryOfSignificantAccountingPoliciesPolicies" ], "xbrltype": "textBlockItemType" }, "us-gaap_RestrictedCashNoncurrent": { "auth_ref": [ "r9", "r19", "r135", "r652" ], "crdr": "debit", "lang": { "en-US": { "role": { "documentation": "Amount of cash restricted as to withdrawal or usage, classified as noncurrent. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits.", "label": "Restricted Cash, Noncurrent", "terseLabel": "Restricted cash included in other assets" } } }, "localname": "RestrictedCashNoncurrent", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.agilent.com/role/NewAccountingPronouncementsNewAccountingPronouncementsRestrictedCashDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_RestrictedStockUnitsRSUMember": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Share instrument which is convertible to stock or an equivalent amount of cash, after a specified period of time or when specified performance conditions are met.", "label": "Restricted Stock Units (RSUs) [Member]", "terseLabel": "Restricted Stock Units (RSUs) [Member]" } } }, "localname": "RestrictedStockUnitsRSUMember", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.agilent.com/role/ShareBasedCompensationGeneralDisclosuresDetails" ], "xbrltype": "domainItemType" }, "us-gaap_RestructuringPlanAxis": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Information by individual restructuring plan.", "label": "Restructuring Plan [Axis]", "terseLabel": "Restructuring Plan [Axis]" } } }, "localname": "RestructuringPlanAxis", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.agilent.com/role/OverviewAndSummaryOfSignificantAccountingPoliciesDetails" ], "xbrltype": "stringItemType" }, "us-gaap_RestructuringPlanDomain": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Identification of the individual restructuring plans.", "label": "Restructuring Plan [Domain]", "terseLabel": "Restructuring Plan [Domain]" } } }, "localname": "RestructuringPlanDomain", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.agilent.com/role/OverviewAndSummaryOfSignificantAccountingPoliciesDetails" ], "xbrltype": "domainItemType" }, "us-gaap_RetainedEarningsAccumulatedDeficit": { "auth_ref": [ "r34", "r303", "r637" ], "calculation": { "http://www.agilent.com/role/ConsolidatedBalanceSheet": { "order": 4.0, "parentTag": "us-gaap_StockholdersEquity", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-US": { "role": { "documentation": "The cumulative amount of the reporting entity's undistributed earnings or deficit.", "label": "Retained Earnings (Accumulated Deficit)", "terseLabel": "Accumulated deficit", "verboseLabel": "Retained Earnings (Accumulated Deficit)" } } }, "localname": "RetainedEarningsAccumulatedDeficit", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.agilent.com/role/ConsolidatedBalanceSheet", "http://www.agilent.com/role/InvestmentsDetails", "http://www.agilent.com/role/NewAccountingPronouncementsImpactOfAdoptingNewGuidanceDetails", "http://www.agilent.com/role/NewAccountingPronouncementsTextualsDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_RetainedEarningsMember": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "The cumulative amount of the reporting entity's undistributed earnings or deficit.", "label": "Retained Earnings [Member]", "terseLabel": "Retained Earnings", "verboseLabel": "Retained Earnings (Accumulated Deficit)" } } }, "localname": "RetainedEarningsMember", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.agilent.com/role/ConsolidatedStatementOfEquity", "http://www.agilent.com/role/StockholdersEquityStockRepurchasesDetails" ], "xbrltype": "domainItemType" }, "us-gaap_RetirementPlanNameAxis": { "auth_ref": [ "r372" ], "lang": { "en-US": { "role": { "documentation": "Information by name of plan designed to provide retirement benefits. Includes, but is not limited to, legal name of defined benefit and defined contribution plans.", "label": "Retirement Plan Name [Axis]", "terseLabel": "Retirement Plan Name [Axis]" } } }, "localname": "RetirementPlanNameAxis", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.agilent.com/role/RetirementPlansAndPostRetirementPensionPlansDefinedContributionDetails", "http://www.agilent.com/role/RetirementPlansAndPostRetirementPensionPlansJwpilDetails" ], "xbrltype": "stringItemType" }, "us-gaap_RetirementPlanNameDomain": { "auth_ref": [ "r372" ], "lang": { "en-US": { "role": { "documentation": "Name of plan designed to provide retirement benefits. Includes, but is not limited to, legal name of defined benefit and defined contribution plans.", "label": "Retirement Plan Name [Domain]", "terseLabel": "Retirement Plan Name [Domain]" } } }, "localname": "RetirementPlanNameDomain", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.agilent.com/role/RetirementPlansAndPostRetirementPensionPlansDefinedContributionDetails", "http://www.agilent.com/role/RetirementPlansAndPostRetirementPensionPlansJwpilDetails" ], "xbrltype": "domainItemType" }, "us-gaap_RetirementPlanSponsorLocationAxis": { "auth_ref": [ "r372", "r376" ], "lang": { "en-US": { "role": { "documentation": "Information by location of employer sponsoring plan designed to provide retirement benefits. Includes, but is not limited to, defined benefit and defined contribution plans.", "label": "Retirement Plan Sponsor Location [Axis]", "terseLabel": "Retirement Plan Sponsor Location [Axis]" } } }, "localname": "RetirementPlanSponsorLocationAxis", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.agilent.com/role/RetirementPlansAndPostRetirementPensionPlansAssumptionsDetails", "http://www.agilent.com/role/RetirementPlansAndPostRetirementPensionPlansComponentsOfNetPeriodicCostsDetails", "http://www.agilent.com/role/RetirementPlansAndPostRetirementPensionPlansDefinedContributionDetails", "http://www.agilent.com/role/RetirementPlansAndPostRetirementPensionPlansExpectedBenefitPaymentsDetails", "http://www.agilent.com/role/RetirementPlansAndPostRetirementPensionPlansFairValueOfPlanAssetsDetails", "http://www.agilent.com/role/RetirementPlansAndPostRetirementPensionPlansFinancialStatementLocationDetails", "http://www.agilent.com/role/RetirementPlansAndPostRetirementPensionPlansFundedStatusDetails", "http://www.agilent.com/role/RetirementPlansAndPostRetirementPensionPlansJwpilDetails", "http://www.agilent.com/role/RetirementPlansAndPostRetirementPensionPlansRetirementPlansAndPostRetirementPensionPlansTargetAllocationsDetails", "http://www.agilent.com/role/SegmentInformationReconciliationOfReportableResultsDetails" ], "xbrltype": "stringItemType" }, "us-gaap_RetirementPlanSponsorLocationDomain": { "auth_ref": [ "r372", "r376" ], "lang": { "en-US": { "role": { "documentation": "Location of employer sponsoring plan designed to provide retirement benefits. Includes, but is not limited to, defined benefit and defined contribution plans.", "label": "Retirement Plan Sponsor Location [Domain]", "terseLabel": "Retirement Plan Sponsor Location [Domain]" } } }, "localname": "RetirementPlanSponsorLocationDomain", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.agilent.com/role/RetirementPlansAndPostRetirementPensionPlansAssumptionsDetails", "http://www.agilent.com/role/RetirementPlansAndPostRetirementPensionPlansComponentsOfNetPeriodicCostsDetails", "http://www.agilent.com/role/RetirementPlansAndPostRetirementPensionPlansDefinedContributionDetails", "http://www.agilent.com/role/RetirementPlansAndPostRetirementPensionPlansExpectedBenefitPaymentsDetails", "http://www.agilent.com/role/RetirementPlansAndPostRetirementPensionPlansFairValueOfPlanAssetsDetails", "http://www.agilent.com/role/RetirementPlansAndPostRetirementPensionPlansFinancialStatementLocationDetails", "http://www.agilent.com/role/RetirementPlansAndPostRetirementPensionPlansFundedStatusDetails", "http://www.agilent.com/role/RetirementPlansAndPostRetirementPensionPlansJwpilDetails", "http://www.agilent.com/role/RetirementPlansAndPostRetirementPensionPlansRetirementPlansAndPostRetirementPensionPlansTargetAllocationsDetails", "http://www.agilent.com/role/SegmentInformationReconciliationOfReportableResultsDetails" ], "xbrltype": "domainItemType" }, "us-gaap_RetirementPlanTypeAxis": { "auth_ref": [ "r324", "r325", "r371", "r372", "r389" ], "lang": { "en-US": { "role": { "documentation": "Information by type of retirement benefit plan. Includes, but is not limited to, retirement benefit arrangement for defined benefit pension and other postretirement plans, retirement benefit arrangement for defined contribution pension and other postretirement plans, and special and contractual termination benefits payable upon retirement.", "label": "Retirement Plan Type [Axis]", "terseLabel": "Retirement Plan Type [Axis]" } } }, "localname": "RetirementPlanTypeAxis", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.agilent.com/role/RetirementPlansAndPostRetirementPensionPlansAssumptionsDetails", "http://www.agilent.com/role/RetirementPlansAndPostRetirementPensionPlansComponentsOfNetPeriodicCostsDetails", "http://www.agilent.com/role/RetirementPlansAndPostRetirementPensionPlansDefinedContributionDetails", "http://www.agilent.com/role/RetirementPlansAndPostRetirementPensionPlansExpectedBenefitPaymentsDetails", "http://www.agilent.com/role/RetirementPlansAndPostRetirementPensionPlansFairValueOfPlanAssetsDetails", "http://www.agilent.com/role/RetirementPlansAndPostRetirementPensionPlansFinancialStatementLocationDetails", "http://www.agilent.com/role/RetirementPlansAndPostRetirementPensionPlansFundedStatusDetails", "http://www.agilent.com/role/RetirementPlansAndPostRetirementPensionPlansJwpilDetails", "http://www.agilent.com/role/RetirementPlansAndPostRetirementPensionPlansRetirementPlansAndPostRetirementPensionPlansTargetAllocationsDetails", "http://www.agilent.com/role/SegmentInformationReconciliationOfReportableResultsDetails" ], "xbrltype": "stringItemType" }, "us-gaap_RetirementPlanTypeDomain": { "auth_ref": [ "r324", "r325", "r371", "r372", "r389" ], "lang": { "en-US": { "role": { "documentation": "Type of plan designed to provide participants with retirement benefits. Includes, but is not limited to, retirement benefit arrangement for defined benefit pension and other postretirement plans, retirement benefit arrangement for defined contribution pension and other postretirement plans, and special and contractual termination benefits payable upon retirement.", "label": "Retirement Plan Type [Domain]", "terseLabel": "Retirement Plan Type [Domain]" } } }, "localname": "RetirementPlanTypeDomain", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.agilent.com/role/RetirementPlansAndPostRetirementPensionPlansAssumptionsDetails", "http://www.agilent.com/role/RetirementPlansAndPostRetirementPensionPlansComponentsOfNetPeriodicCostsDetails", "http://www.agilent.com/role/RetirementPlansAndPostRetirementPensionPlansDefinedContributionDetails", "http://www.agilent.com/role/RetirementPlansAndPostRetirementPensionPlansExpectedBenefitPaymentsDetails", "http://www.agilent.com/role/RetirementPlansAndPostRetirementPensionPlansFairValueOfPlanAssetsDetails", "http://www.agilent.com/role/RetirementPlansAndPostRetirementPensionPlansFinancialStatementLocationDetails", "http://www.agilent.com/role/RetirementPlansAndPostRetirementPensionPlansFundedStatusDetails", "http://www.agilent.com/role/RetirementPlansAndPostRetirementPensionPlansJwpilDetails", "http://www.agilent.com/role/RetirementPlansAndPostRetirementPensionPlansRetirementPlansAndPostRetirementPensionPlansTargetAllocationsDetails", "http://www.agilent.com/role/SegmentInformationReconciliationOfReportableResultsDetails" ], "xbrltype": "domainItemType" }, "us-gaap_RevenueFromContractWithCustomerAbstract": { "auth_ref": [], "lang": { "en-US": { "role": { "label": "Revenue from Contract with Customer [Abstract]" } } }, "localname": "RevenueFromContractWithCustomerAbstract", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "xbrltype": "stringItemType" }, "us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax": { "auth_ref": [ "r314", "r315" ], "calculation": { "http://www.agilent.com/role/ConsolidatedStatementOfOperations": { "order": 1.0, "parentTag": "us-gaap_OperatingIncomeLoss", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-US": { "role": { "documentation": "Amount, excluding tax collected from customer, of revenue from satisfaction of performance obligation by transferring promised good or service to customer. Tax collected from customer is tax assessed by governmental authority that is both imposed on and concurrent with specific revenue-producing transaction, including, but not limited to, sales, use, value added and excise.", "label": "Revenue from Contract with Customer, Excluding Assessed Tax", "terseLabel": "Net revenue" } } }, "localname": "RevenueFromContractWithCustomerExcludingAssessedTax", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.agilent.com/role/AcquisitionsTextDetails", "http://www.agilent.com/role/ConsolidatedStatementOfOperations", "http://www.agilent.com/role/RevenueRevenueByEndMarketsDetails", "http://www.agilent.com/role/RevenueRevenueByRegionDetails", "http://www.agilent.com/role/RevenueRevenueRevenueByTypeDetails", "http://www.agilent.com/role/SegmentInformationEntityWideDisclosuresRevenueDetails", "http://www.agilent.com/role/SegmentInformationProfitabilityDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_RevenueFromContractWithCustomerTextBlock": { "auth_ref": [ "r321" ], "lang": { "en-US": { "role": { "documentation": "The entire disclosure of revenue from contract with customer to transfer good or service and to transfer nonfinancial asset. Includes, but is not limited to, disaggregation of revenue, credit loss recognized from contract with customer, judgment and change in judgment related to contract with customer, and asset recognized from cost incurred to obtain or fulfill contract with customer. Excludes insurance and lease contracts.", "label": "Revenue from Contract with Customer [Text Block]", "terseLabel": "Revenue from Contract with Customer" } } }, "localname": "RevenueFromContractWithCustomerTextBlock", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.agilent.com/role/RevenueRevenueNotes" ], "xbrltype": "textBlockItemType" }, "us-gaap_RevenueRecognitionPolicyTextBlock": { "auth_ref": [ "r138", "r139" ], "lang": { "en-US": { "role": { "documentation": "Disclosure of accounting policy for revenue. Includes revenue from contract with customer and from other sources.", "label": "Revenue [Policy Text Block]", "terseLabel": "Revenue recognition" } } }, "localname": "RevenueRecognitionPolicyTextBlock", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.agilent.com/role/OverviewAndSummaryOfSignificantAccountingPoliciesPolicies" ], "xbrltype": "textBlockItemType" }, "us-gaap_RevenueRemainingPerformanceObligation": { "auth_ref": [ "r313" ], "crdr": "credit", "lang": { "en-US": { "role": { "documentation": "Amount of transaction price allocated to performance obligation that has not been recognized as revenue.", "label": "Revenue, Remaining Performance Obligation, Amount", "terseLabel": "Revenue, Remaining Performance Obligation, Amount" } } }, "localname": "RevenueRemainingPerformanceObligation", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.agilent.com/role/RevenueRevenueContractBalancesDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_RevenuesAbstract": { "auth_ref": [], "lang": { "en-US": { "role": { "label": "Revenues [Abstract]", "terseLabel": "Net revenue:" } } }, "localname": "RevenuesAbstract", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.agilent.com/role/ConsolidatedStatementOfOperations" ], "xbrltype": "stringItemType" }, "us-gaap_ScheduleOfAccumulatedOtherComprehensiveIncomeLossTableTextBlock": { "auth_ref": [ "r89" ], "lang": { "en-US": { "role": { "documentation": "Tabular disclosure of the components of accumulated other comprehensive income (loss).", "label": "Schedule of Accumulated Other Comprehensive Income (Loss) [Table Text Block]", "terseLabel": "Accumulated other comprehensive income" } } }, "localname": "ScheduleOfAccumulatedOtherComprehensiveIncomeLossTableTextBlock", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.agilent.com/role/StockholdersEquityTables" ], "xbrltype": "textBlockItemType" }, "us-gaap_ScheduleOfAmountsInAccumulatedOtherComprehensiveIncomeLossToBeRecognizedOverNextFiscalYearTableTextBlock": { "auth_ref": [ "r370" ], "lang": { "en-US": { "role": { "documentation": "Tabular disclosure of the amounts related to pension plans and/or other employee benefit plans in accumulated other comprehensive income (loss) expected to be recognized as components of net periodic benefit cost over the next fiscal year, including the net gain (loss), net prior service cost or credit, and net transition asset or obligation.", "label": "Schedule of Amounts in Accumulated Other Comprehensive Income (Loss) to be Recognized over Next Fiscal Year [Table Text Block]", "terseLabel": "Amounts in accumulated other comprehensive income expected to be recognized as components of net expense during the next fiscal year" } } }, "localname": "ScheduleOfAmountsInAccumulatedOtherComprehensiveIncomeLossToBeRecognizedOverNextFiscalYearTableTextBlock", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.agilent.com/role/RetirementPlansAndPostRetirementPensionPlansTables" ], "xbrltype": "textBlockItemType" }, "us-gaap_ScheduleOfAmountsRecognizedInBalanceSheetTableTextBlock": { "auth_ref": [ "r343" ], "lang": { "en-US": { "role": { "documentation": "Tabular disclosure of the amounts that are recognized in the balance sheet (or statement of financial position) for pension plans and/or other employee benefit plans, showing separately the assets and current and noncurrent liabilities (if applicable) recognized.", "label": "Schedule of Amounts Recognized in Balance Sheet [Table Text Block]", "terseLabel": "Amounts recognized in the consolidated balance sheet" } } }, "localname": "ScheduleOfAmountsRecognizedInBalanceSheetTableTextBlock", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.agilent.com/role/RetirementPlansAndPostRetirementPensionPlansTables" ], "xbrltype": "textBlockItemType" }, "us-gaap_ScheduleOfAmountsRecognizedInOtherComprehensiveIncomeLossTableTextBlock": { "auth_ref": [ "r360" ], "lang": { "en-US": { "role": { "documentation": "Tabular disclosure of the net gain (loss) and net prior service cost or credit recognized in other comprehensive income (loss) for the period for pension plans and/or other employee benefit plans, and reclassification adjustments of other comprehensive income (loss) for the period, as those amounts, including amortization of the net transition asset or obligation, are recognized as components of net periodic benefit cost.", "label": "Schedule of Amounts Recognized in Other Comprehensive Income (Loss) [Table Text Block]", "terseLabel": "Amounts recognized in accumulated other comprehensive income (loss)" } } }, "localname": "ScheduleOfAmountsRecognizedInOtherComprehensiveIncomeLossTableTextBlock", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.agilent.com/role/RetirementPlansAndPostRetirementPensionPlansTables" ], "xbrltype": "textBlockItemType" }, "us-gaap_ScheduleOfAssumptionsUsedTableTextBlock": { "auth_ref": [ "r363" ], "lang": { "en-US": { "role": { "documentation": "Tabular disclosure of assumption used to determine benefit obligation and net periodic benefit cost of defined benefit plan. Includes, but is not limited to, discount rate, rate of compensation increase, expected long-term rate of return on plan assets and interest crediting rate.", "label": "Defined Benefit Plan, Assumptions [Table Text Block]", "terseLabel": "Assumptions used to calculate the net periodic cost and benefit obligation" } } }, "localname": "ScheduleOfAssumptionsUsedTableTextBlock", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.agilent.com/role/RetirementPlansAndPostRetirementPensionPlansTables" ], "xbrltype": "textBlockItemType" }, "us-gaap_ScheduleOfBenefitObligationsInExcessOfFairValueOfPlanAssetsTableTextBlock": { "auth_ref": [ "r373", "r385" ], "lang": { "en-US": { "role": { "documentation": "Tabular disclosure of benefit obligation and plan assets for defined benefit pension plan with projected benefit obligation in excess of plan assets.", "label": "Defined Benefit Plan, Plan with Projected Benefit Obligation in Excess of Plan Assets [Table Text Block]", "terseLabel": "Combined projected benefit obligation, accumulated benefit obligations and fair value of plan assets" } } }, "localname": "ScheduleOfBenefitObligationsInExcessOfFairValueOfPlanAssetsTableTextBlock", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.agilent.com/role/RetirementPlansAndPostRetirementPensionPlansTables" ], "xbrltype": "textBlockItemType" }, "us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable": { "auth_ref": [ "r489", "r490" ], "lang": { "en-US": { "role": { "documentation": "Schedule reflecting each material business combination (or series of individually immaterial business combinations) completed during the period, including background, timing, and recognized assets and liabilities.", "label": "Schedule of Business Acquisitions, by Acquisition [Table]", "terseLabel": "Schedule of Business Acquisitions, by Acquisition [Table]" } } }, "localname": "ScheduleOfBusinessAcquisitionsByAcquisitionTable", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.agilent.com/role/AcquisitionsAcquisitionsIntangibleAssetsDetails", "http://www.agilent.com/role/AcquisitionsAcquisitionsProformaOperatingResultsDetails", "http://www.agilent.com/role/AcquisitionsAssetsAndLiabilitiesAssumedDetails", "http://www.agilent.com/role/AcquisitionsTextDetails", "http://www.agilent.com/role/OverviewAndSummaryOfSignificantAccountingPoliciesDetails" ], "xbrltype": "stringItemType" }, "us-gaap_ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock": { "auth_ref": [ "r475" ], "lang": { "en-US": { "role": { "documentation": "Tabular disclosure of the components of income tax expense attributable to continuing operations for each year presented including, but not limited to: current tax expense (benefit), deferred tax expense (benefit), investment tax credits, government grants, the benefits of operating loss carryforwards, tax expense that results from allocating certain tax benefits either directly to contributed capital or to reduce goodwill or other noncurrent intangible assets of an acquired entity, adjustments of a deferred tax liability or asset for enacted changes in tax laws or rates or a change in the tax status of the entity, and adjustments of the beginning-of-the-year balances of a valuation allowance because of a change in circumstances that causes a change in judgment about the realizability of the related deferred tax asset in future years.", "label": "Schedule of Components of Income Tax Expense (Benefit) [Table Text Block]", "verboseLabel": "Provision for income taxes from operations" } } }, "localname": "ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.agilent.com/role/IncomeTaxesTables" ], "xbrltype": "textBlockItemType" }, "us-gaap_ScheduleOfDebtInstrumentsTextBlock": { "auth_ref": [ "r60", "r144", "r297", "r300", "r301", "r302", "r587", "r588", "r590", "r627" ], "lang": { "en-US": { "role": { "documentation": "Tabular disclosure of long-debt instruments or arrangements, including identification, terms, features, collateral requirements and other information necessary to a fair presentation. These are debt arrangements that originally required repayment more than twelve months after issuance or greater than the normal operating cycle of the entity, if longer.", "label": "Schedule of Long-term Debt Instruments [Table Text Block]", "verboseLabel": "Schedule of Interest Rate Swaps pertaining to Senior Notes offered" } } }, "localname": "ScheduleOfDebtInstrumentsTextBlock", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.agilent.com/role/LongTermDebtTables" ], "xbrltype": "textBlockItemType" }, "us-gaap_ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock": { "auth_ref": [ "r467" ], "lang": { "en-US": { "role": { "documentation": "Tabular disclosure of the components of net deferred tax asset or liability recognized in an entity's statement of financial position, including the following: the total of all deferred tax liabilities, the total of all deferred tax assets, the total valuation allowance recognized for deferred tax assets.", "label": "Schedule of Deferred Tax Assets and Liabilities [Table Text Block]", "verboseLabel": "Significant components of deferred tax assets and deferred tax liabilities" } } }, "localname": "ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.agilent.com/role/IncomeTaxesTables" ], "xbrltype": "textBlockItemType" }, "us-gaap_ScheduleOfDefinedBenefitPlansDisclosuresTable": { "auth_ref": [ "r371", "r372", "r375", "r376", "r385" ], "lang": { "en-US": { "role": { "documentation": "Disclosures about an individual defined benefit pension plan or an other postretirement defined benefit plan. It may be appropriate to group certain similar plans. Also includes schedule for fair value of plan assets by major categories of plan assets by the level within the fair value hierarchy in which the fair value measurements in their entirety fall, segregating fair value measurements using quoted prices in active markets for identical assets or liabilities (Level 1), Significant other observable inputs (Level 2), and significant unobservable inputs (Level 3).", "label": "Schedule of Defined Benefit Plans Disclosures [Table]", "terseLabel": "Schedule of Defined Benefit Plans Disclosures [Table]" } } }, "localname": "ScheduleOfDefinedBenefitPlansDisclosuresTable", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.agilent.com/role/RetirementPlansAndPostRetiementPensionPlansDeferredProfitSharingPlanDetails", "http://www.agilent.com/role/RetirementPlansAndPostRetirementPensionPlansAssumptionsDetails", "http://www.agilent.com/role/RetirementPlansAndPostRetirementPensionPlansComponentsOfNetPeriodicCostsDetails", "http://www.agilent.com/role/RetirementPlansAndPostRetirementPensionPlansExpectedBenefitPaymentsDetails", "http://www.agilent.com/role/RetirementPlansAndPostRetirementPensionPlansFairValueOfPlanAssetsDetails", "http://www.agilent.com/role/RetirementPlansAndPostRetirementPensionPlansFinancialStatementLocationDetails", "http://www.agilent.com/role/RetirementPlansAndPostRetirementPensionPlansFundedStatusDetails", "http://www.agilent.com/role/RetirementPlansAndPostRetirementPensionPlansJwpilDetails", "http://www.agilent.com/role/RetirementPlansAndPostRetirementPensionPlansRetirementPlansAndPostRetirementPensionPlansTargetAllocationsDetails" ], "xbrltype": "stringItemType" }, "us-gaap_ScheduleOfDefinedBenefitPlansDisclosuresTextBlock": { "auth_ref": [ "r371", "r372", "r375", "r376", "r385" ], "lang": { "en-US": { "role": { "documentation": "Tabular disclosure of one or more of the entity's defined benefit pension plans or one or more other defined benefit postretirement plans, separately for pension plans and other postretirement benefit plans including the entity's schedule of fair value of plan assets for defined benefit or other postretirement plans.", "label": "Schedule of Defined Benefit Plans Disclosures [Table Text Block]", "terseLabel": "Schedule of net pension and post-retirement benefit costs" } } }, "localname": "ScheduleOfDefinedBenefitPlansDisclosuresTextBlock", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.agilent.com/role/RetirementPlansAndPostRetirementPensionPlansTables" ], "xbrltype": "textBlockItemType" }, "us-gaap_ScheduleOfDerivativeInstrumentsGainLossInStatementOfFinancialPerformanceTextBlock": { "auth_ref": [ "r533", "r540", "r546" ], "lang": { "en-US": { "role": { "documentation": "Tabular disclosure of the location and amount of derivative instruments and nonderivative instruments designated as hedging instruments reported before netting adjustments, and the amount of gain (loss) on derivative instruments and nonderivative instruments designated and qualified as hedging instruments.", "label": "Derivative Instruments, Gain (Loss) [Table Text Block]", "terseLabel": "Effect of derivative instruments for foreign exchange contracts in the consolidated statement of operations" } } }, "localname": "ScheduleOfDerivativeInstrumentsGainLossInStatementOfFinancialPerformanceTextBlock", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.agilent.com/role/DerivativesTables" ], "xbrltype": "textBlockItemType" }, "us-gaap_ScheduleOfDerivativeInstrumentsInStatementOfFinancialPositionFairValueTextBlock": { "auth_ref": [ "r538" ], "lang": { "en-US": { "role": { "documentation": "Tabular disclosure of the location and fair value amounts of derivative instruments (and nonderivative instruments that are designated and qualify as hedging instruments) reported in the statement of financial position.", "label": "Schedule of Derivative Instruments in Statement of Financial Position, Fair Value [Table Text Block]", "terseLabel": "Gross fair values and balance sheet location of derivative instruments held in the consolidated balance sheet" } } }, "localname": "ScheduleOfDerivativeInstrumentsInStatementOfFinancialPositionFairValueTextBlock", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.agilent.com/role/DerivativesTables" ], "xbrltype": "textBlockItemType" }, "us-gaap_ScheduleOfDerivativeInstrumentsTextBlock": { "auth_ref": [ "r150", "r525", "r526", "r527", "r529", "r531", "r538", "r540", "r549", "r551" ], "lang": { "en-US": { "role": { "documentation": "Tabular disclosure of pertinent information about a derivative or group of derivatives on a disaggregated basis, such as for individual instruments, or small groups of similar instruments. May include a combination of the type of instrument, risks being hedged, notional amount, hedge designation, related hedged item, inception date, maturity date, or other relevant item.", "label": "Schedule of Derivative Instruments [Table Text Block]", "terseLabel": "Aggregated notional amounts by currency and designation" } } }, "localname": "ScheduleOfDerivativeInstrumentsTextBlock", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.agilent.com/role/DerivativesTables" ], "xbrltype": "textBlockItemType" }, "us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock": { "auth_ref": [ "r167" ], "lang": { "en-US": { "role": { "documentation": "Tabular disclosure of an entity's basic and diluted earnings per share calculations, including a reconciliation of numerators and denominators of the basic and diluted per-share computations for income from continuing operations.", "label": "Schedule of Earnings Per Share, Basic and Diluted [Table Text Block]", "verboseLabel": "Reconciliation of the numerators and denominators of the basic and diluted net income per share" } } }, "localname": "ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.agilent.com/role/NetIncomeLossPerShareTables" ], "xbrltype": "textBlockItemType" }, "us-gaap_ScheduleOfEffectOfSignificantUnobservableInputsChangesInPlanAssetsTableTextBlock": { "auth_ref": [ "r347" ], "lang": { "en-US": { "role": { "documentation": "Tabular disclosure of the effect of fair value measurements using significant unobservable inputs (Level 3) on changes in plan assets of pension plans and/or other employee benefit plans for the period.", "label": "Schedule of Effect of Significant Unobservable Inputs, Changes in Plan Assets [Table Text Block]", "terseLabel": "Defined benefit plans assets measured at fair value using significant unobservable inputs (level 3)" } } }, "localname": "ScheduleOfEffectOfSignificantUnobservableInputsChangesInPlanAssetsTableTextBlock", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.agilent.com/role/RetirementPlansAndPostRetirementPensionPlansTables" ], "xbrltype": "textBlockItemType" }, "us-gaap_ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock": { "auth_ref": [ "r448" ], "lang": { "en-US": { "role": { "documentation": "Tabular disclosure of the reconciliation using percentage or dollar amounts of the reported amount of income tax expense attributable to continuing operations for the year to the amount of income tax expense that would result from applying domestic federal statutory tax rates to pretax income from continuing operations.", "label": "Schedule of Effective Income Tax Rate Reconciliation [Table Text Block]", "verboseLabel": "Tax rate reconciliation, U.S. federal statutory rate to effective tax rate from operations" } } }, "localname": "ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.agilent.com/role/IncomeTaxesTables" ], "xbrltype": "textBlockItemType" }, "us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTable": { "auth_ref": [ "r394", "r422", "r428" ], "lang": { "en-US": { "role": { "documentation": "Disclosure of information about amount recognized for award under share-based payment arrangement. Includes, but is not limited to, amount expensed in statement of income or comprehensive income, amount capitalized in statement of financial position, and corresponding reporting line item in financial statements.", "label": "Share-based Payment Arrangement, Expensed and Capitalized, Amount [Table]" } } }, "localname": "ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTable", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.agilent.com/role/ShareBasedCompensationAllocatedShareBasedCompensationExpenseDetails" ], "xbrltype": "stringItemType" }, "us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTextBlock": { "auth_ref": [ "r394", "r422", "r428" ], "lang": { "en-US": { "role": { "documentation": "Tabular disclosure of allocation of amount expensed and capitalized for award under share-based payment arrangement to statement of income or comprehensive income and statement of financial position. Includes, but is not limited to, corresponding line item in financial statement.", "label": "Share-based Payment Arrangement, Expensed and Capitalized, Amount [Table Text Block]", "verboseLabel": "Allocated Share-based compensation expense disclosure" } } }, "localname": "ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTextBlock", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.agilent.com/role/ShareBasedCompensationTables" ], "xbrltype": "textBlockItemType" }, "us-gaap_ScheduleOfEntityWideInformationRevenueFromExternalCustomersByProductsAndServicesTable": { "auth_ref": [ "r201" ], "lang": { "en-US": { "role": { "documentation": "Tabular presentation of the description and amount of revenues from a product or service, or a group of similar products or similar services, reported from external customers during the period, if the information is not provided as part of the reportable operating segment information.", "label": "Revenue from External Customers by Products and Services [Table]", "terseLabel": "Revenue from External Customers by Products and Services [Table]" } } }, "localname": "ScheduleOfEntityWideInformationRevenueFromExternalCustomersByProductsAndServicesTable", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.agilent.com/role/SegmentInformationTables" ], "xbrltype": "stringItemType" }, "us-gaap_ScheduleOfExpectedBenefitPaymentsTableTextBlock": { "auth_ref": [ "r351" ], "lang": { "en-US": { "role": { "documentation": "Tabular disclosure of benefits expected to be paid by pension plans and/or other employee benefit plans in each of the next five fiscal years and in the aggregate for the five fiscal years thereafter.", "label": "Schedule of Expected Benefit Payments [Table Text Block]", "terseLabel": "Schedule of expected benefit payments" } } }, "localname": "ScheduleOfExpectedBenefitPaymentsTableTextBlock", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.agilent.com/role/RetirementPlansAndPostRetirementPensionPlansTables" ], "xbrltype": "textBlockItemType" }, "us-gaap_ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock": { "auth_ref": [ "r559", "r560" ], "lang": { "en-US": { "role": { "documentation": "Tabular disclosure of assets and liabilities, including [financial] instruments measured at fair value that are classified in stockholders' equity, if any, that are measured at fair value on a recurring basis. The disclosures contemplated herein include the fair value measurements at the reporting date by the level within the fair value hierarchy in which the fair value measurements in their entirety fall, segregating fair value measurements using quoted prices in active markets for identical assets (Level 1), significant other observable inputs (Level 2), and significant unobservable inputs (Level 3).", "label": "Schedule of Fair Value, Assets and Liabilities Measured on Recurring Basis [Table Text Block]", "verboseLabel": "Fair Value Assets And Liabilities Measured On Recurring Basis" } } }, "localname": "ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.agilent.com/role/FairValueMeasurementsTables" ], "xbrltype": "textBlockItemType" }, "us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTable": { "auth_ref": [ "r239", "r244" ], "lang": { "en-US": { "role": { "documentation": "Schedule of assets, excluding financial assets and goodwill, lacking physical substance with a finite life.", "label": "Schedule of Finite-Lived Intangible Assets [Table]", "terseLabel": "Schedule of Finite-Lived Intangible Assets [Table]" } } }, "localname": "ScheduleOfFiniteLivedIntangibleAssetsTable", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.agilent.com/role/GoodwillAndOtherIntangibleAssetsDisclosuresAndComponentsOfOtherIntangiblesDetails", "http://www.agilent.com/role/GoodwillAndOtherIntangibleAssetsTextDetails" ], "xbrltype": "stringItemType" }, "us-gaap_ScheduleOfFutureMinimumRentalPaymentsForOperatingLeasesTableTextBlock": { "auth_ref": [ "r593" ], "lang": { "en-US": { "role": { "documentation": "Tabular disclosure of future minimum payments required in the aggregate and for each of the five succeeding fiscal years for operating leases having initial or remaining noncancelable lease terms in excess of one year and the total minimum rentals to be received in the future under noncancelable subleases as of the balance sheet date.", "label": "Schedule of Future Minimum Rental Payments for Operating Leases [Table Text Block]", "terseLabel": "Schedule of Future Minimum Rental Payments for Operating Leases [Table Text Block]" } } }, "localname": "ScheduleOfFutureMinimumRentalPaymentsForOperatingLeasesTableTextBlock", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.agilent.com/role/CommitmentsAndContingenciesTables" ], "xbrltype": "textBlockItemType" }, "us-gaap_ScheduleOfGoodwillTable": { "auth_ref": [ "r234", "r236" ], "lang": { "en-US": { "role": { "documentation": "Schedule of goodwill and the changes during the year due to acquisition, sale, impairment or for other reasons.", "label": "Schedule of Goodwill [Table]" } } }, "localname": "ScheduleOfGoodwillTable", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.agilent.com/role/GoodwillAndOtherIntangibleAssetsRollForwardDetails" ], "xbrltype": "stringItemType" }, "us-gaap_ScheduleOfGoodwillTextBlock": { "auth_ref": [ "r234", "r236" ], "lang": { "en-US": { "role": { "documentation": "Tabular disclosure of goodwill by reportable segment and in total which includes a rollforward schedule.", "label": "Schedule of Goodwill [Table Text Block]", "terseLabel": "Goodwill balances and movements for each reportable segments during the period" } } }, "localname": "ScheduleOfGoodwillTextBlock", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.agilent.com/role/GoodwillAndOtherIntangibleAssetsTables" ], "xbrltype": "textBlockItemType" }, "us-gaap_ScheduleOfIncomeBeforeIncomeTaxDomesticAndForeignTableTextBlock": { "auth_ref": [ "r146" ], "lang": { "en-US": { "role": { "documentation": "Tabular disclosure of income before income tax between domestic and foreign jurisdictions.", "label": "Schedule of Income before Income Tax, Domestic and Foreign [Table Text Block]", "verboseLabel": "Income before income taxes domestic and foreign" } } }, "localname": "ScheduleOfIncomeBeforeIncomeTaxDomesticAndForeignTableTextBlock", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.agilent.com/role/IncomeTaxesTables" ], "xbrltype": "textBlockItemType" }, "us-gaap_ScheduleOfInventoryCurrentTableTextBlock": { "auth_ref": [ "r14", "r39", "r40", "r41" ], "lang": { "en-US": { "role": { "documentation": "Tabular disclosure of the carrying amount as of the balance sheet date of merchandise, goods, commodities, or supplies held for future sale or to be used in manufacturing, servicing or production process.", "label": "Schedule of Inventory, Current [Table Text Block]", "verboseLabel": "Inventory" } } }, "localname": "ScheduleOfInventoryCurrentTableTextBlock", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.agilent.com/role/InventoryTables" ], "xbrltype": "textBlockItemType" }, "us-gaap_ScheduleOfInvestmentsAbstract": { "auth_ref": [], "lang": { "en-US": { "role": { "label": "Schedule of Investments [Abstract]" } } }, "localname": "ScheduleOfInvestmentsAbstract", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "xbrltype": "stringItemType" }, "us-gaap_ScheduleOfNewAccountingPronouncementsAndChangesInAccountingPrinciplesTextBlock": { "auth_ref": [ "r155", "r157", "r171", "r172", "r174" ], "lang": { "en-US": { "role": { "documentation": "Tabular disclosure of changes in accounting principles, including adoption of new accounting pronouncements, that describes the new methods, amount and effects on financial statement line items.", "label": "Schedule of New Accounting Pronouncements and Changes in Accounting Principles [Table Text Block]", "terseLabel": "Schedule of New Accounting Pronouncements and Changes in Accounting Principles [Table Text Block]" } } }, "localname": "ScheduleOfNewAccountingPronouncementsAndChangesInAccountingPrinciplesTextBlock", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.agilent.com/role/NewAccountingPronouncementsTables" ], "xbrltype": "textBlockItemType" }, "us-gaap_ScheduleOfOtherNonoperatingIncomeExpenseTableTextBlock": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Tabular disclosure of the components of non-operating income or non-operating expense that may include amounts earned from dividends, interest on securities, gains (losses) on securities sold, equity earnings of unconsolidated affiliates, net gain (loss) on sales of business, interest expense and other miscellaneous income or expense items.", "label": "Schedule of Other Nonoperating Income (Expense) [Table Text Block]", "terseLabel": "Realized gains and losses on sale of available-for-sale securities and other than temporary impairments Included in Other income (expense)" } } }, "localname": "ScheduleOfOtherNonoperatingIncomeExpenseTableTextBlock", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.agilent.com/role/InvestmentsTables" ], "xbrltype": "textBlockItemType" }, "us-gaap_ScheduleOfProductWarrantyLiabilityTableTextBlock": { "auth_ref": [ "r286" ], "lang": { "en-US": { "role": { "documentation": "Tabular disclosure of the changes in the guarantor's aggregate product warranty liability, including the beginning balance of the aggregate product warranty liability, the aggregate reductions in that liability for payments made (in cash or in kind) under the warranty, the aggregate changes in the liability for accruals related to product warranties issued during the reporting period, the aggregate changes in the liability for accruals related to preexisting warranties (including adjustments related to changes in estimates), and the ending balance of the aggregate product warranty liability.", "label": "Schedule of Product Warranty Liability [Table Text Block]", "terseLabel": "Standard Warranty" } } }, "localname": "ScheduleOfProductWarrantyLiabilityTableTextBlock", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.agilent.com/role/GuaranteesTables" ], "xbrltype": "textBlockItemType" }, "us-gaap_ScheduleOfPropertyPlantAndEquipmentTable": { "auth_ref": [ "r46", "r260" ], "lang": { "en-US": { "role": { "documentation": "Disclosure of information about physical assets used in the normal conduct of business and not intended for resale. Includes, but is not limited to, balances by class of assets, depreciation and depletion expense and method used, including composite depreciation, and accumulated deprecation.", "label": "Property, Plant and Equipment [Table]", "terseLabel": "Property, Plant and Equipment [Table]" } } }, "localname": "ScheduleOfPropertyPlantAndEquipmentTable", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.agilent.com/role/PropertyPlantAndEquipmentNetDetails" ], "xbrltype": "stringItemType" }, "us-gaap_ScheduleOfRecognizedIdentifiedAssetsAcquiredAndLiabilitiesAssumedTableTextBlock": { "auth_ref": [ "r493" ], "lang": { "en-US": { "role": { "documentation": "Tabular disclosure of the amounts recognized as of the acquisition date for each major class of assets acquired and liabilities assumed. May include but not limited to the following: (a) acquired receivables; (b) contingencies recognized at the acquisition date; and (c) the fair value of noncontrolling interests in the acquiree.", "label": "Schedule of Recognized Identified Assets Acquired and Liabilities Assumed [Table Text Block]", "terseLabel": "Schedule of the fair value of assets and liabilities assumed" } } }, "localname": "ScheduleOfRecognizedIdentifiedAssetsAcquiredAndLiabilitiesAssumedTableTextBlock", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.agilent.com/role/AcquisitionsTables" ], "xbrltype": "textBlockItemType" }, "us-gaap_ScheduleOfRevenuesFromExternalCustomersAndLongLivedAssetsByGeographicalAreasTableTextBlock": { "auth_ref": [ "r105", "r203" ], "lang": { "en-US": { "role": { "documentation": "Tabular disclosure of information concerning material long-lived assets (excluding financial instruments, customer relationships with financial institutions, mortgage and other servicing rights, deferred policy acquisition costs, and deferred taxes assets) located in identified geographic areas and/or the amount of revenue from external customers attributed to that country from which revenue is material. An entity may also provide subtotals of geographic information about groups of countries.", "label": "Schedule of Revenue from External Customers and Long-Lived Assets, by Geographical Areas [Table Text Block]", "terseLabel": "Revenue and assets by geographic areas" } } }, "localname": "ScheduleOfRevenuesFromExternalCustomersAndLongLivedAssetsByGeographicalAreasTableTextBlock", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.agilent.com/role/SegmentInformationTables" ], "xbrltype": "textBlockItemType" }, "us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable": { "auth_ref": [ "r187", "r193", "r195", "r197", "r234" ], "lang": { "en-US": { "role": { "documentation": "A table disclosing the profit or loss and total assets for each reportable segment of the entity. An entity discloses certain information on each reportable segment if the amounts (a) are included in the measure of segment profit or loss reviewed by the chief operating decision maker or (b) are otherwise regularly provided to the chief operating decision maker, even if not included in that measure of segment profit or loss.", "label": "Schedule of Segment Reporting Information, by Segment [Table]", "terseLabel": "Schedule of Segment Reporting Information, by Segment [Table]" } } }, "localname": "ScheduleOfSegmentReportingInformationBySegmentTable", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.agilent.com/role/SegmentInformationEntityWideDisclosureLongLivedAssetsDetails", "http://www.agilent.com/role/SegmentInformationProfitabilityDetails", "http://www.agilent.com/role/SegmentInformationReconciliationOfReportableResultsDetails", "http://www.agilent.com/role/SegmentInformationSegmentAssetsDetails" ], "xbrltype": "stringItemType" }, "us-gaap_ScheduleOfSegmentReportingInformationBySegmentTextBlock": { "auth_ref": [ "r187", "r193", "r195", "r197", "r234" ], "lang": { "en-US": { "role": { "documentation": "Tabular disclosure of the profit or loss and total assets for each reportable segment. An entity discloses certain information on each reportable segment if the amounts (a) are included in the measure of segment profit or loss reviewed by the chief operating decision maker or (b) are otherwise regularly provided to the chief operating decision maker, even if not included in that measure of segment profit or loss.", "label": "Schedule of Segment Reporting Information, by Segment [Table Text Block]", "terseLabel": "Segment profitability" } } }, "localname": "ScheduleOfSegmentReportingInformationBySegmentTextBlock", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.agilent.com/role/SegmentInformationTables" ], "xbrltype": "textBlockItemType" }, "us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable": { "auth_ref": [ "r396", "r426" ], "lang": { "en-US": { "role": { "documentation": "Disclosure of information about share-based payment arrangement.", "label": "Schedule of Share-based Compensation Arrangements by Share-based Payment Award [Table]", "terseLabel": "Schedule of Share-based Compensation Arrangements by Share-based Payment Award [Table]" } } }, "localname": "ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.agilent.com/role/ShareBasedCompensationFairValueAssumptionsDetails", "http://www.agilent.com/role/ShareBasedCompensationGeneralDisclosuresDetails" ], "xbrltype": "stringItemType" }, "us-gaap_ScheduleOfShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeTable": { "auth_ref": [ "r426" ], "lang": { "en-US": { "role": { "documentation": "Details comprising a table providing supplementary information on outstanding and exercisable share awards as of the balance sheet date which stratifies outstanding options by ranges of exercise prices.", "label": "Share-based Payment Arrangement, Option, Exercise Price Range [Table]" } } }, "localname": "ScheduleOfShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeTable", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.agilent.com/role/ShareBasedCompensationSharesAuthorizedByExercisePriceRangeDetails" ], "xbrltype": "stringItemType" }, "us-gaap_ScheduleOfShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeTextBlock": { "auth_ref": [ "r426" ], "lang": { "en-US": { "role": { "documentation": "Tabular disclosure of option exercise prices, by grouped ranges, including the upper and lower limits of the price range, the number of shares under option, weighted average exercise price and remaining contractual option terms.", "label": "Share-based Payment Arrangement, Option, Exercise Price Range [Table Text Block]", "terseLabel": "Schedule of share-based compensation, shares authorized under stock option plans, by exercise price range" } } }, "localname": "ScheduleOfShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeTextBlock", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.agilent.com/role/ShareBasedCompensationTables" ], "xbrltype": "textBlockItemType" }, "us-gaap_ScheduleOfShortTermDebtTable": { "auth_ref": [ "r52" ], "lang": { "en-US": { "role": { "documentation": "A table or schedule providing information pertaining to borrowings under which repayment was required in less than twelve months (or normal operating cycle, if longer) after its issuance. It may include: (1) description of the short-term debt arrangement; (2) identification of the lender or type of lender; (3) repayment terms; (4) weighted average interest rate; (5) carrying amount of funds borrowed under the specified short-term debt arrangement as of the balance sheet date and measures of the maximum and average amount outstanding during the period; (6) description of the refinancing of a short-term obligation when that obligation is excluded from current liabilities in the balance sheet; and (7) amount of a short-term obligation that has been excluded from current liabilities in the balance sheet because of a refinancing of the obligation.", "label": "Schedule of Short-term Debt [Table]", "terseLabel": "Schedule of Short-term Debt [Table]" } } }, "localname": "ScheduleOfShortTermDebtTable", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.agilent.com/role/ShortTermDebtSeniorNotesDetails" ], "xbrltype": "stringItemType" }, "us-gaap_ScheduleOfStockByClassTable": { "auth_ref": [ "r63", "r143", "r293", "r294", "r295", "r297", "r298", "r299", "r300", "r301", "r302", "r303" ], "lang": { "en-US": { "role": { "documentation": "Schedule detailing information related to equity by class of stock. Class of stock includes common, convertible, and preferred stocks which are not redeemable or redeemable solely at the option of the issuer. It also includes preferred stock with redemption features that are solely within the control of the issuer and mandatorily redeemable stock if redemption is required to occur only upon liquidation or termination of the reporting entity.", "label": "Schedule of Stock by Class [Table]", "terseLabel": "Schedule of Stock by Class [Table]" } } }, "localname": "ScheduleOfStockByClassTable", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.agilent.com/role/StockholdersEquityStockholdersEquityDividendsDetails" ], "xbrltype": "stringItemType" }, "us-gaap_ScheduleofFiniteLivedIntangibleAssetsFutureAmortizationExpenseTableTextBlock": { "auth_ref": [ "r244" ], "lang": { "en-US": { "role": { "documentation": "Tabular disclosure of the amount of amortization expense expected to be recorded in succeeding fiscal years for finite-lived intangible assets.", "label": "Schedule of Finite-Lived Intangible Assets, Future Amortization Expense [Table Text Block]", "terseLabel": "Future Amortization expense for the next five years and thereafter" } } }, "localname": "ScheduleofFiniteLivedIntangibleAssetsFutureAmortizationExpenseTableTextBlock", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.agilent.com/role/GoodwillAndOtherIntangibleAssetsTables" ], "xbrltype": "textBlockItemType" }, "us-gaap_SegmentDomain": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Components of an entity that engage in business activities from which they may earn revenue and incur expenses, including transactions with other components of the same entity.", "label": "Segments [Domain]", "terseLabel": "Segments [Domain]" } } }, "localname": "SegmentDomain", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.agilent.com/role/GoodwillAndOtherIntangibleAssetsRollForwardDetails", "http://www.agilent.com/role/GoodwillAndOtherIntangibleAssetsTextDetails", "http://www.agilent.com/role/OverviewAndSummaryOfSignificantAccountingPoliciesDetails", "http://www.agilent.com/role/PropertyPlantAndEquipmentNetDetails", "http://www.agilent.com/role/RevenueRevenueByRegionDetails", "http://www.agilent.com/role/SegmentInformationProfitabilityDetails", "http://www.agilent.com/role/SegmentInformationReconciliationOfReportableResultsDetails", "http://www.agilent.com/role/SegmentInformationSegmentAssetsDetails" ], "xbrltype": "domainItemType" }, "us-gaap_SegmentOperatingActivitiesDomain": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Operations of an entity including continuing and discontinued operations.", "label": "Operating Activities [Domain]", "terseLabel": "Operating Activities [Domain]" } } }, "localname": "SegmentOperatingActivitiesDomain", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.agilent.com/role/ConsolidatedStatementOfCashFlows", "http://www.agilent.com/role/InventoryDetails", "http://www.agilent.com/role/OverviewAndSummaryOfSignificantAccountingPoliciesDetails", "http://www.agilent.com/role/RetirementPlansAndPostRetirementPensionPlansFairValueOfPlanAssetsDetails", "http://www.agilent.com/role/ShareBasedCompensationAllocatedShareBasedCompensationExpenseDetails", "http://www.agilent.com/role/StockholdersEquityChangesInAccumulatedOtherComprehensiveIncomeDetails" ], "xbrltype": "domainItemType" }, "us-gaap_SegmentReportingAbstract": { "auth_ref": [], "lang": { "en-US": { "role": { "label": "Segment Reporting [Abstract]" } } }, "localname": "SegmentReportingAbstract", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "xbrltype": "stringItemType" }, "us-gaap_SegmentReportingDisclosureTextBlock": { "auth_ref": [ "r204" ], "lang": { "en-US": { "role": { "documentation": "The entire disclosure for reporting segments including data and tables. Reportable segments include those that meet any of the following quantitative thresholds a) it's reported revenue, including sales to external customers and intersegment sales or transfers is 10 percent or more of the combined revenue, internal and external, of all operating segments b) the absolute amount of its reported profit or loss is 10 percent or more of the greater, in absolute amount of 1) the combined reported profit of all operating segments that did not report a loss or 2) the combined reported loss of all operating segments that did report a loss c) its assets are 10 percent or more of the combined assets of all operating segments.", "label": "Segment Reporting Disclosure [Text Block]", "verboseLabel": "SEGMENT INFORMATION" } } }, "localname": "SegmentReportingDisclosureTextBlock", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.agilent.com/role/SegmentInformation" ], "xbrltype": "textBlockItemType" }, "us-gaap_SegmentReportingInformationLineItems": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.", "label": "Segment Reporting Information [Line Items]", "terseLabel": "Segment Reporting Information [Line Items]" } } }, "localname": "SegmentReportingInformationLineItems", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.agilent.com/role/SegmentInformationEntityWideDisclosureLongLivedAssetsDetails", "http://www.agilent.com/role/SegmentInformationProfitabilityDetails", "http://www.agilent.com/role/SegmentInformationReconciliationOfReportableResultsDetails", "http://www.agilent.com/role/SegmentInformationSegmentAssetsDetails" ], "xbrltype": "stringItemType" }, "us-gaap_SegmentReportingInformationOperatingIncomeLossAbstract": { "auth_ref": [], "lang": { "en-US": { "role": { "label": "Segment Reporting Information, Operating Income (Loss) [Abstract]", "terseLabel": "Reconcilitation between statement results and enterprise results [Abstract]" } } }, "localname": "SegmentReportingInformationOperatingIncomeLossAbstract", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.agilent.com/role/SegmentInformationReconciliationOfReportableResultsDetails" ], "xbrltype": "stringItemType" }, "us-gaap_SegmentReportingInformationProfitLossAbstract": { "auth_ref": [], "lang": { "en-US": { "role": { "label": "Segment Reporting Information, Profit (Loss) [Abstract]", "terseLabel": "Select income statement components" } } }, "localname": "SegmentReportingInformationProfitLossAbstract", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.agilent.com/role/SegmentInformationProfitabilityDetails" ], "xbrltype": "stringItemType" }, "us-gaap_SellingGeneralAndAdministrativeExpense": { "auth_ref": [ "r107", "r222" ], "calculation": { "http://www.agilent.com/role/ConsolidatedStatementOfOperations": { "order": 3.0, "parentTag": "us-gaap_CostsAndExpenses", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-US": { "role": { "documentation": "The aggregate total costs related to selling a firm's product and services, as well as all other general and administrative expenses. Direct selling expenses (for example, credit, warranty, and advertising) are expenses that can be directly linked to the sale of specific products. Indirect selling expenses are expenses that cannot be directly linked to the sale of specific products, for example telephone expenses, Internet, and postal charges. General and administrative expenses include salaries of non-sales personnel, rent, utilities, communication, etc.", "label": "Selling, General and Administrative Expense", "terseLabel": "Selling, general and administrative" } } }, "localname": "SellingGeneralAndAdministrativeExpense", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.agilent.com/role/ConsolidatedStatementOfOperations" ], "xbrltype": "monetaryItemType" }, "us-gaap_SellingGeneralAndAdministrativeExpensesMember": { "auth_ref": [ "r110" ], "lang": { "en-US": { "role": { "documentation": "Primary financial statement caption encompassing selling, general and administrative expense.", "label": "Selling, General and Administrative Expenses [Member]", "terseLabel": "Selling, General and Administrative" } } }, "localname": "SellingGeneralAndAdministrativeExpensesMember", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.agilent.com/role/ShareBasedCompensationAllocatedShareBasedCompensationExpenseDetails" ], "xbrltype": "domainItemType" }, "us-gaap_ServiceOtherMember": { "auth_ref": [ "r318" ], "lang": { "en-US": { "role": { "documentation": "Assistance, including, but not limited to, technology, license and maintenance, license and service, maintenance, oil and gas, financial service, and other financial service, classified as other.", "label": "Service, Other [Member]", "terseLabel": "Services and Other" } } }, "localname": "ServiceOtherMember", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.agilent.com/role/ConsolidatedStatementOfOperations" ], "xbrltype": "domainItemType" }, "us-gaap_ShareBasedCompensation": { "auth_ref": [ "r128" ], "calculation": { "http://www.agilent.com/role/ConsolidatedStatementOfCashFlows": { "order": 4.0, "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-US": { "role": { "documentation": "Amount of noncash expense for share-based payment arrangement.", "label": "Share-based Payment Arrangement, Noncash Expense", "terseLabel": "Share-based compensation" } } }, "localname": "ShareBasedCompensation", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.agilent.com/role/ConsolidatedStatementOfCashFlows", "http://www.agilent.com/role/SegmentInformationProfitabilityDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_ShareBasedCompensationAbstract": { "auth_ref": [], "lang": { "en-US": { "role": { "label": "Share-based Payment Arrangement, Noncash Expense [Abstract]", "terseLabel": "Share-based Payment Arrangement, Noncash Expense [Abstract]" } } }, "localname": "ShareBasedCompensationAbstract", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.agilent.com/role/OverviewAndSummaryOfSignificantAccountingPoliciesDetails" ], "xbrltype": "stringItemType" }, "us-gaap_ShareBasedCompensationAllocationAndClassificationInFinancialStatementsAbstract": { "auth_ref": [], "lang": { "en-US": { "role": { "label": "Share-based Payment Arrangement, Expensed and Capitalized, Amount [Abstract]", "terseLabel": "Share-based Payment Arrangement, Expensed and Capitalized, Amount" } } }, "localname": "ShareBasedCompensationAllocationAndClassificationInFinancialStatementsAbstract", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.agilent.com/role/ShareBasedCompensationAllocatedShareBasedCompensationExpenseDetails" ], "xbrltype": "stringItemType" }, "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAdditionalGeneralDisclosuresAbstract": { "auth_ref": [], "lang": { "en-US": { "role": { "label": "Share-based Compensation Arrangement by Share-based Payment Award, Additional General Disclosures [Abstract]", "terseLabel": "Incentive compensation plans [Abstract]" } } }, "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardAdditionalGeneralDisclosuresAbstract", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.agilent.com/role/ShareBasedCompensationGeneralDisclosuresDetails" ], "xbrltype": "stringItemType" }, "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1": { "auth_ref": [ "r397" ], "lang": { "en-US": { "role": { "documentation": "Period over which grantee's right to exercise award under share-based payment arrangement is no longer contingent on satisfaction of service or performance condition, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days. Includes, but is not limited to, combination of market, performance or service condition.", "label": "Share-based Compensation Arrangement by Share-based Payment Award, Award Vesting Period", "terseLabel": "Number of years from the date of grant generally vest (in years)" } } }, "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.agilent.com/role/ShareBasedCompensationGeneralDisclosuresDetails" ], "xbrltype": "durationItemType" }, "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsAdditionalDisclosuresAbstract": { "auth_ref": [], "lang": { "en-US": { "role": { "label": "Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Additional Disclosures [Abstract]", "terseLabel": "Aggregate instrinsic value of options [Abstract]" } } }, "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsAdditionalDisclosuresAbstract", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.agilent.com/role/ShareBasedCompensationSharesAuthorizedByExercisePriceRangeDetails" ], "xbrltype": "stringItemType" }, "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod": { "auth_ref": [ "r406" ], "lang": { "en-US": { "role": { "documentation": "The number of equity-based payment instruments, excluding stock (or unit) options, that were forfeited during the reporting period.", "label": "Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Forfeited in Period", "negatedLabel": "Forfeited (in shares)" } } }, "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.agilent.com/role/ShareBasedCompensationNonVestedAwardActivityDisclosureDetails" ], "xbrltype": "sharesItemType" }, "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue": { "auth_ref": [ "r411" ], "lang": { "en-US": { "role": { "documentation": "Weighted average fair value as of the grant date of equity-based award plans other than stock (unit) option plans that were not exercised or put into effect as a result of the occurrence of a terminating event.", "label": "Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Forfeitures, Weighted Average Grant Date Fair Value", "terseLabel": "Foreited- Weighted Average Grant Price (in dollars per share)" } } }, "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.agilent.com/role/ShareBasedCompensationNonVestedAwardActivityDisclosureDetails" ], "xbrltype": "perShareItemType" }, "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod": { "auth_ref": [ "r409" ], "lang": { "en-US": { "role": { "documentation": "The number of grants made during the period on other than stock (or unit) option plans (for example, phantom stock or unit plan, stock or unit appreciation rights plan, performance target plan).", "label": "Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Grants in Period", "terseLabel": "Granted (in shares)" } } }, "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.agilent.com/role/ShareBasedCompensationNonVestedAwardActivityDisclosureDetails" ], "xbrltype": "sharesItemType" }, "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue": { "auth_ref": [ "r409" ], "lang": { "en-US": { "role": { "documentation": "The weighted average fair value at grant date for nonvested equity-based awards issued during the period on other than stock (or unit) option plans (for example, phantom stock or unit plan, stock or unit appreciation rights plan, performance target plan).", "label": "Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Grants in Period, Weighted Average Grant Date Fair Value", "terseLabel": "Granted - Weighted Average Grant Price (in dollars per share)" } } }, "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.agilent.com/role/ShareBasedCompensationNonVestedAwardActivityDisclosureDetails" ], "xbrltype": "perShareItemType" }, "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber": { "auth_ref": [ "r408" ], "lang": { "en-US": { "role": { "documentation": "The number of non-vested equity-based payment instruments, excluding stock (or unit) options, that validly exist and are outstanding as of the balance sheet date.", "label": "Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Nonvested, Number", "periodEndLabel": "Non-vested ending (in shares)", "periodStartLabel": "Non-vested beginning (in shares)" } } }, "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.agilent.com/role/ShareBasedCompensationNonVestedAwardActivityDisclosureDetails" ], "xbrltype": "sharesItemType" }, "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "A roll forward is a reconciliation of a concept from the beginning of a period to the end of a period.", "label": "Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Nonvested, Number of Shares [Roll Forward]" } } }, "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.agilent.com/role/ShareBasedCompensationNonVestedAwardActivityDisclosureDetails" ], "xbrltype": "stringItemType" }, "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue": { "auth_ref": [ "r408" ], "lang": { "en-US": { "role": { "documentation": "Per share or unit weighted-average fair value of nonvested award under share-based payment arrangement. Excludes share and unit options.", "label": "Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Nonvested, Weighted Average Grant Date Fair Value", "periodStartLabel": "Non-vested at October 31, 2018 -Weighted Average Grant Price (in dollars per share)" } } }, "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.agilent.com/role/ShareBasedCompensationNonVestedAwardActivityDisclosureDetails" ], "xbrltype": "perShareItemType" }, "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod": { "auth_ref": [ "r410" ], "lang": { "en-US": { "role": { "documentation": "The number of equity-based payment instruments, excluding stock (or unit) options, that vested during the reporting period.", "label": "Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Vested in Period", "negatedLabel": "Vested (in shares)" } } }, "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.agilent.com/role/ShareBasedCompensationNonVestedAwardActivityDisclosureDetails" ], "xbrltype": "sharesItemType" }, "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodTotalFairValue": { "auth_ref": [ "r414" ], "crdr": "debit", "lang": { "en-US": { "role": { "documentation": "Fair value of share-based awards for which the grantee gained the right by satisfying service and performance requirements, to receive or retain shares or units, other instruments, or cash.", "label": "Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Vested in Period, Fair Value", "terseLabel": "Total fair value of restricted stock awards vested" } } }, "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodTotalFairValue", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.agilent.com/role/ShareBasedCompensationNonVestedAwardActivityDisclosureDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue": { "auth_ref": [ "r410" ], "lang": { "en-US": { "role": { "documentation": "The weighted average fair value as of grant date pertaining to an equity-based award plan other than a stock (or unit) option plan for which the grantee gained the right during the reporting period, by satisfying service and performance requirements, to receive or retain shares or units, other instruments, or cash in accordance with the terms of the arrangement.", "label": "Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Vested in Period, Weighted Average Grant Date Fair Value", "terseLabel": "Vested- Weighted Average Grant Price (in dollars per share)" } } }, "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.agilent.com/role/ShareBasedCompensationNonVestedAwardActivityDisclosureDetails" ], "xbrltype": "perShareItemType" }, "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsDiscountForPostvestingRestrictions": { "auth_ref": [ "r420" ], "lang": { "en-US": { "role": { "documentation": "Restrictions on equity-based instruments during the vesting period, such as the inability to transfer unvested awards, are not taken into account in estimating the fair value of the award. However, restrictions that remain in effect after an award is vested, such as the inability to transfer or hedge vested options or a prohibition on the sale of outstanding vested shares (or other type of equity) for a period of time, affect the estimate of an award's fair value.", "label": "Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Discount for Postvesting Restrictions", "terseLabel": "Post-vest restriction discount for all executive awards" } } }, "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsDiscountForPostvestingRestrictions", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.agilent.com/role/ShareBasedCompensationFairValueAssumptionsDetails" ], "xbrltype": "percentItemType" }, "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate": { "auth_ref": [ "r419" ], "lang": { "en-US": { "role": { "documentation": "The estimated measure of the percentage by which a share price is expected to fluctuate during a period. Volatility also may be defined as a probability-weighted measure of the dispersion of returns about the mean. The volatility of a share price is the standard deviation of the continuously compounded rates of return on the share over a specified period. That is the same as the standard deviation of the differences in the natural logarithms of the stock prices plus dividends, if any, over the period.", "label": "Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Expected Volatility Rate", "terseLabel": "Volatility of Agilent shares (in hundreths)" } } }, "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.agilent.com/role/ShareBasedCompensationFairValueAssumptionsDetails" ], "xbrltype": "percentItemType" }, "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMaximum": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "The estimated measure of the maximum percentage by which a share price is expected to fluctuate during a period. Volatility also may be defined as a probability-weighted measure of the dispersion of returns about the mean. The volatility of a share price is the standard deviation of the continuously compounded rates of return on the share over a specified period. That is the same as the standard deviation of the differences in the natural logarithms of the stock prices plus dividends, if any, over the period.", "label": "Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Expected Volatility Rate, Maximum", "terseLabel": "Volatility of selected peer-company shares, Maximum (in hundreths)" } } }, "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMaximum", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.agilent.com/role/ShareBasedCompensationFairValueAssumptionsDetails" ], "xbrltype": "percentItemType" }, "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMinimum": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "The estimated measure of the minimum percentage by which a share price is expected to fluctuate during a period. Volatility also may be defined as a probability-weighted measure of the dispersion of returns about the mean. The volatility of a share price is the standard deviation of the continuously compounded rates of return on the share over a specified period. That is the same as the standard deviation of the differences in the natural logarithms of the stock prices plus dividends, if any, over the period.", "label": "Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Expected Volatility Rate, Minimum", "terseLabel": "Volatility of selected peer-company shares, Minimum (in hundreths)" } } }, "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMinimum", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.agilent.com/role/ShareBasedCompensationFairValueAssumptionsDetails" ], "xbrltype": "percentItemType" }, "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.", "label": "Share-based Compensation Arrangement by Share-based Payment Award [Line Items]", "terseLabel": "Share-based Compensation Arrangement by Share-based Payment Award [Line Items]" } } }, "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.agilent.com/role/ShareBasedCompensationFairValueAssumptionsDetails", "http://www.agilent.com/role/ShareBasedCompensationGeneralDisclosuresDetails" ], "xbrltype": "stringItemType" }, "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardMaximumEmployeeSubscriptionRate": { "auth_ref": [ "r426" ], "lang": { "en-US": { "role": { "documentation": "The highest percentage of annual salary that an employee is permitted to utilize with respect to the plan.", "label": "Share-based Compensation Arrangement by Share-based Payment Award, Maximum Employee Subscription Rate", "terseLabel": "Compensation percentage maximum eligible contribution to purchase shares of common stock" } } }, "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardMaximumEmployeeSubscriptionRate", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.agilent.com/role/ShareBasedCompensationGeneralDisclosuresDetails" ], "xbrltype": "percentItemType" }, "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized": { "auth_ref": [ "r398" ], "lang": { "en-US": { "role": { "documentation": "Number of shares authorized for issuance under share-based payment arrangement.", "label": "Share-based Compensation Arrangement by Share-based Payment Award, Number of Shares Authorized", "verboseLabel": "Maximum number of shares authorized for issuance under the ESPP (in shares)" } } }, "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.agilent.com/role/ShareBasedCompensationGeneralDisclosuresDetails" ], "xbrltype": "sharesItemType" }, "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant": { "auth_ref": [ "r426" ], "lang": { "en-US": { "role": { "documentation": "The difference between the maximum number of shares (or other type of equity) authorized for issuance under the plan (including the effects of amendments and adjustments), and the sum of: 1) the number of shares (or other type of equity) already issued upon exercise of options or other equity-based awards under the plan; and 2) shares (or other type of equity) reserved for issuance on granting of outstanding awards, net of cancellations and forfeitures, if applicable.", "label": "Share-based Compensation Arrangement by Share-based Payment Award, Number of Shares Available for Grant", "verboseLabel": "Common stock available for future awards under the 2018 Stock Plan (in shares)" } } }, "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.agilent.com/role/ShareBasedCompensationGeneralDisclosuresDetails" ], "xbrltype": "sharesItemType" }, "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsAdditionalDisclosuresAbstract": { "auth_ref": [], "lang": { "en-US": { "role": { "label": "Share-based Compensation Arrangement by Share-based Payment Award, Options, Additional Disclosures [Abstract]", "verboseLabel": "Share-based Compensation Arrangement by Share-based Payment Award, Options, Additional Disclosures [Abstract]" } } }, "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsAdditionalDisclosuresAbstract", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.agilent.com/role/ShareBasedCompensationStockOptionActivityDetails" ], "xbrltype": "stringItemType" }, "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriod": { "auth_ref": [ "r407" ], "lang": { "en-US": { "role": { "documentation": "For presentations that combine terminations, the number of shares under options that were cancelled during the reporting period as a result of occurrence of a terminating event specified in contractual agreements pertaining to the stock option plan or that expired.", "label": "Share-based Compensation Arrangement by Share-based Payment Award, Options, Forfeitures and Expirations in Period", "negatedLabel": "Options Forfeited (in shares)" } } }, "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriod", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.agilent.com/role/ShareBasedCompensationStockOptionActivityDetails" ], "xbrltype": "sharesItemType" }, "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber": { "auth_ref": [ "r403", "r426" ], "lang": { "en-US": { "role": { "documentation": "Number of options outstanding, including both vested and non-vested options.", "label": "Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Number", "periodEndLabel": "Outstanding, ending balance (in shares)", "periodStartLabel": "Outstanding, beginning balance (in shares)" } } }, "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.agilent.com/role/ShareBasedCompensationStockOptionActivityDetails" ], "xbrltype": "sharesItemType" }, "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "A roll forward is a reconciliation of a concept from the beginning of a period to the end of a period.", "label": "Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding [Roll Forward]" } } }, "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.agilent.com/role/ShareBasedCompensationStockOptionActivityDetails" ], "xbrltype": "stringItemType" }, "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice": { "auth_ref": [ "r402" ], "lang": { "en-US": { "role": { "documentation": "Weighted average price at which grantees can acquire the shares reserved for issuance under the stock option plan.", "label": "Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Weighted Average Exercise Price", "periodStartLabel": "Weighted-average exercise price per share, beginning of period (in dollars per share)" } } }, "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.agilent.com/role/ShareBasedCompensationStockOptionActivityDetails" ], "xbrltype": "perShareItemType" }, "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingAggregateIntrinsicValue": { "auth_ref": [ "r415" ], "crdr": "debit", "lang": { "en-US": { "role": { "documentation": "Amount by which current fair value of underlying stock exceeds exercise price of fully vested and expected to vest options outstanding. Includes, but is not limited to, unvested options for which requisite service period has not been rendered but that are expected to vest based on achievement of performance condition, if forfeitures are recognized when they occur.", "label": "Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested and Expected to Vest, Outstanding, Aggregate Intrinsic Value", "verboseLabel": "Aggregate Intrinsic Value - Options outstanding" } } }, "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingAggregateIntrinsicValue", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.agilent.com/role/ShareBasedCompensationSharesAuthorizedByExercisePriceRangeDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardSharesIssuedInPeriod": { "auth_ref": [ "r426" ], "lang": { "en-US": { "role": { "documentation": "Number of shares issued under share-based payment arrangement.", "label": "Share-based Compensation Arrangement by Share-based Payment Award, Shares Issued in Period", "terseLabel": "Total number of share-based awards issued (in shares)" } } }, "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardSharesIssuedInPeriod", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.agilent.com/role/NetIncomeLossPerShareDetails" ], "xbrltype": "sharesItemType" }, "us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain": { "auth_ref": [ "r393", "r399" ], "lang": { "en-US": { "role": { "documentation": "Award under share-based payment arrangement.", "label": "Award Type [Domain]", "terseLabel": "Award Type [Domain]" } } }, "localname": "ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.agilent.com/role/ShareBasedCompensationFairValueAssumptionsDetails", "http://www.agilent.com/role/ShareBasedCompensationGeneralDisclosuresDetails", "http://www.agilent.com/role/ShareBasedCompensationSharesAuthorizedByExercisePriceRangeDetails" ], "xbrltype": "domainItemType" }, "us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Weighted average price at which option holders acquired shares when converting their stock options into shares.", "label": "Share-based Compensation Arrangements by Share-based Payment Award, Options, Exercises in Period, Weighted Average Exercise Price", "terseLabel": "Options exercised in period aggregate weighted average exercise price (in dollars per share)", "verboseLabel": "Weighted-average exercise price per share, exercised (in dollars per share)" } } }, "localname": "ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.agilent.com/role/ShareBasedCompensationSharesAuthorizedByExercisePriceRangeDetails", "http://www.agilent.com/role/ShareBasedCompensationStockOptionActivityDetails" ], "xbrltype": "perShareItemType" }, "us-gaap_ShareBasedCompensationOptionAndIncentivePlansPolicy": { "auth_ref": [ "r137", "r396", "r401" ], "lang": { "en-US": { "role": { "documentation": "Disclosure of accounting policy for award under share-based payment arrangement. Includes, but is not limited to, methodology and assumption used in measuring cost.", "label": "Share-based Payment Arrangement [Policy Text Block]", "terseLabel": "Share-based compensation" } } }, "localname": "ShareBasedCompensationOptionAndIncentivePlansPolicy", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.agilent.com/role/OverviewAndSummaryOfSignificantAccountingPoliciesPolicies" ], "xbrltype": "textBlockItemType" }, "us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis": { "auth_ref": [ "r418" ], "lang": { "en-US": { "role": { "documentation": "Information by range of option prices pertaining to options granted.", "label": "Exercise Price Range [Axis]", "terseLabel": "Exercise Price Range [Axis]" } } }, "localname": "ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.agilent.com/role/ShareBasedCompensationFairValueAssumptionsDetails", "http://www.agilent.com/role/ShareBasedCompensationSharesAuthorizedByExercisePriceRangeDetails" ], "xbrltype": "stringItemType" }, "us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeDomain": { "auth_ref": [ "r421" ], "lang": { "en-US": { "role": { "documentation": "Supplementary information on outstanding and exercisable share awards as of the balance sheet date which stratifies outstanding options by ranges of exercise prices.", "label": "Exercise Price Range [Domain]", "terseLabel": "Exercise Price Range [Domain]" } } }, "localname": "ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeDomain", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.agilent.com/role/ShareBasedCompensationFairValueAssumptionsDetails", "http://www.agilent.com/role/ShareBasedCompensationSharesAuthorizedByExercisePriceRangeDetails" ], "xbrltype": "domainItemType" }, "us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeLineItems": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.", "label": "Share-based Payment Arrangement, Option, Exercise Price Range [Line Items]" } } }, "localname": "ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeLineItems", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.agilent.com/role/ShareBasedCompensationSharesAuthorizedByExercisePriceRangeDetails" ], "xbrltype": "stringItemType" }, "us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeLowerRangeLimit": { "auth_ref": [ "r421" ], "lang": { "en-US": { "role": { "documentation": "The floor of a customized range of exercise prices for purposes of disclosing shares potentially issuable under outstanding stock option awards on all stock option plans and other required information pertaining to awards in the customized range.", "label": "Share-based Payment Arrangement, Option, Exercise Price Range, Lower Range Limit", "terseLabel": "Minimum price of options outstanding, end of the period (in dollars per share)" } } }, "localname": "ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeLowerRangeLimit", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.agilent.com/role/ShareBasedCompensationSharesAuthorizedByExercisePriceRangeDetails" ], "xbrltype": "perShareItemType" }, "us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfExercisableOptions": { "auth_ref": [ "r412" ], "lang": { "en-US": { "role": { "documentation": "The number of shares reserved for issuance pertaining to the outstanding exercisable stock options as of the balance sheet date in the customized range of exercise prices for which the market and performance vesting condition has been satisfied.", "label": "Share-based Payment Arrangement, Option, Exercise Price Range, Shares Exercisable", "terseLabel": "Number Exercisable (in shares)" } } }, "localname": "ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfExercisableOptions", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.agilent.com/role/ShareBasedCompensationSharesAuthorizedByExercisePriceRangeDetails" ], "xbrltype": "sharesItemType" }, "us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfOutstandingOptions": { "auth_ref": [ "r403" ], "lang": { "en-US": { "role": { "documentation": "The number of shares reserved for issuance pertaining to the outstanding stock options as of the balance sheet date for all option plans in the customized range of exercise prices.", "label": "Share-based Payment Arrangement, Option, Exercise Price Range, Shares Outstanding", "terseLabel": "Number Outstanding (in shares)" } } }, "localname": "ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfOutstandingOptions", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.agilent.com/role/ShareBasedCompensationSharesAuthorizedByExercisePriceRangeDetails" ], "xbrltype": "sharesItemType" }, "us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeUpperRangeLimit": { "auth_ref": [ "r421" ], "lang": { "en-US": { "role": { "documentation": "The ceiling of a customized range of exercise prices for purposes of disclosing shares potentially issuable under outstanding stock option awards on all stock option plans and other required information pertaining to awards in the customized range.", "label": "Share-based Payment Arrangement, Option, Exercise Price Range, Upper Range Limit", "verboseLabel": "Maximum price of options outstanding, end of the period (in dollars per share)" } } }, "localname": "ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeUpperRangeLimit", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.agilent.com/role/ShareBasedCompensationSharesAuthorizedByExercisePriceRangeDetails" ], "xbrltype": "perShareItemType" }, "us-gaap_ShareRepurchaseProgramAxis": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Information by share repurchase program.", "label": "Share Repurchase Program [Axis]", "terseLabel": "Share Repurchase Program [Axis]" } } }, "localname": "ShareRepurchaseProgramAxis", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.agilent.com/role/StockholdersEquityStockRepurchasesDetails" ], "xbrltype": "stringItemType" }, "us-gaap_ShareRepurchaseProgramDomain": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Name of the share repurchase program.", "label": "Share Repurchase Program [Domain]", "terseLabel": "Share Repurchase Program [Domain]" } } }, "localname": "ShareRepurchaseProgramDomain", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.agilent.com/role/StockholdersEquityStockRepurchasesDetails" ], "xbrltype": "domainItemType" }, "us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardAwardVestingRightsPercentage": { "auth_ref": [ "r397" ], "lang": { "en-US": { "role": { "documentation": "Percentage of vesting of award under share-based payment arrangement.", "label": "Share-based Compensation Arrangement by Share-based Payment Award, Award Vesting Rights, Percentage", "terseLabel": "Percentage which rate options generally vest per year (in hundredths)" } } }, "localname": "SharebasedCompensationArrangementBySharebasedPaymentAwardAwardVestingRightsPercentage", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.agilent.com/role/ShareBasedCompensationGeneralDisclosuresDetails" ], "xbrltype": "percentItemType" }, "us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1": { "auth_ref": [ "r426" ], "crdr": "debit", "lang": { "en-US": { "role": { "documentation": "Amount of difference between fair value of the underlying shares reserved for issuance and exercise price of vested portions of options outstanding and currently exercisable.", "label": "Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercisable, Intrinsic Value", "verboseLabel": "Aggregate Intrinsic Value - Options Exercisable" } } }, "localname": "SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.agilent.com/role/ShareBasedCompensationSharesAuthorizedByExercisePriceRangeDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardPurchasePriceOfCommonStockPercent": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Purchase price of common stock expressed as a percentage of its fair value.", "label": "Share-based Compensation Arrangement by Share-based Payment Award, Purchase Price of Common Stock, Percent", "terseLabel": "ESPP eligible employee common stock purchase price ratio" } } }, "localname": "SharebasedCompensationArrangementBySharebasedPaymentAwardPurchasePriceOfCommonStockPercent", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.agilent.com/role/ShareBasedCompensationGeneralDisclosuresDetails" ], "xbrltype": "percentItemType" }, "us-gaap_SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeExercisableOptionsWeightedAverageExercisePrice1": { "auth_ref": [ "r404" ], "lang": { "en-US": { "role": { "documentation": "Weighted average exercise price as of the balance sheet date for those equity-based payment arrangements exercisable and outstanding.", "label": "Share-based Payment Arrangement, Option, Exercise Price Range, Exercisable, Weighted Average Exercise Price", "terseLabel": "Weighted Average Exercise Price (in dollars per share)" } } }, "localname": "SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeExercisableOptionsWeightedAverageExercisePrice1", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.agilent.com/role/ShareBasedCompensationSharesAuthorizedByExercisePriceRangeDetails" ], "xbrltype": "perShareItemType" }, "us-gaap_SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeExercisableOptionsWeightedAverageRemainingContractualTerm2": { "auth_ref": [ "r417" ], "lang": { "en-US": { "role": { "documentation": "Weighted average remaining contractual term of exercisable stock options, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days.", "label": "Share-based Payment Arrangement, Option, Exercise Price Range, Exercisable, Weighted Average Remaining Contractual Term", "verboseLabel": "Weighted Average Remaining Contractual Life (in years)" } } }, "localname": "SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeExercisableOptionsWeightedAverageRemainingContractualTerm2", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.agilent.com/role/ShareBasedCompensationSharesAuthorizedByExercisePriceRangeDetails" ], "xbrltype": "durationItemType" }, "us-gaap_SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageExercisePriceBeginningBalance1": { "auth_ref": [ "r403" ], "lang": { "en-US": { "role": { "documentation": "The weighted average price as of the balance sheet date at which grantees could acquire the underlying shares with respect to all outstanding stock options which are in the customized range of exercise prices.", "label": "Share-based Payment Arrangement, Option, Exercise Price Range, Outstanding, Weighted Average Exercise Price", "verboseLabel": "Weighted Average Exercise Price (in dollars per share)" } } }, "localname": "SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageExercisePriceBeginningBalance1", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.agilent.com/role/ShareBasedCompensationSharesAuthorizedByExercisePriceRangeDetails" ], "xbrltype": "perShareItemType" }, "us-gaap_SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageRemainingContractualTerm2": { "auth_ref": [ "r416" ], "lang": { "en-US": { "role": { "documentation": "Weighted average remaining contractual term of outstanding stock options, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days.", "label": "Share-based Payment Arrangement, Option, Exercise Price Range, Outstanding, Weighted Average Remaining Contractual Term", "verboseLabel": "Weighted Average Remaining Contractual Life (in years)" } } }, "localname": "SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageRemainingContractualTerm2", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.agilent.com/role/ShareBasedCompensationSharesAuthorizedByExercisePriceRangeDetails" ], "xbrltype": "durationItemType" }, "us-gaap_SharesIssued": { "auth_ref": [ "r296" ], "lang": { "en-US": { "role": { "documentation": "Number of shares of stock issued as of the balance sheet date, including shares that had been issued and were previously outstanding but which are now held in the treasury.", "label": "Shares, Issued", "periodEndLabel": "Balance (in shares)", "periodStartLabel": "Balance (in shares)" } } }, "localname": "SharesIssued", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.agilent.com/role/ConsolidatedStatementOfEquity" ], "xbrltype": "sharesItemType" }, "us-gaap_ShippingAndHandlingCostPolicyTextBlock": { "auth_ref": [ "r136", "r137" ], "lang": { "en-US": { "role": { "documentation": "Disclosure of accounting policy for the classification of shipping and handling costs, including whether the costs are included in cost of sales or included in other income statement accounts. If shipping and handling fees are significant and are not included in cost of sales, disclosure includes both the amounts of such costs and the line item on the income statement which includes such costs.", "label": "Shipping and Handling Cost, Policy [Policy Text Block]", "terseLabel": "Shipping and handling costs" } } }, "localname": "ShippingAndHandlingCostPolicyTextBlock", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.agilent.com/role/OverviewAndSummaryOfSignificantAccountingPoliciesPolicies" ], "xbrltype": "textBlockItemType" }, "us-gaap_ShortMember": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Indicates the sale of a borrowed security or written option.", "label": "Short [Member]", "terseLabel": "Sell" } } }, "localname": "ShortMember", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.agilent.com/role/DerivativesDisclosuresAndDerivativeInstrumentAggregatedNotionalAmountsByCurrencyAndDesignationsDetails" ], "xbrltype": "domainItemType" }, "us-gaap_ShortTermBankLoansAndNotesPayable": { "auth_ref": [ "r49", "r643" ], "crdr": "credit", "lang": { "en-US": { "role": { "documentation": "Amount of borrowings from a bank classified as other, maturing within one year or operating cycle, if longer.", "label": "Short-term Bank Loans and Notes Payable", "terseLabel": "Short-term Bank Loans and Notes Payable" } } }, "localname": "ShortTermBankLoansAndNotesPayable", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.agilent.com/role/ShortTermDebtCreditFacilityAndCapitalLeaseDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_ShortTermBorrowings": { "auth_ref": [ "r20", "r611", "r636" ], "calculation": { "http://www.agilent.com/role/ConsolidatedBalanceSheet": { "order": 4.0, "parentTag": "us-gaap_LiabilitiesCurrent", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-US": { "role": { "documentation": "Reflects the total carrying amount as of the balance sheet date of debt having initial terms less than one year or the normal operating cycle, if longer.", "label": "Short-term Debt", "terseLabel": "Short-term debt" } } }, "localname": "ShortTermBorrowings", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.agilent.com/role/ConsolidatedBalanceSheet" ], "xbrltype": "monetaryItemType" }, "us-gaap_ShortTermBorrowingsAbstract": { "auth_ref": [], "lang": { "en-US": { "role": { "label": "Short-term Debt [Abstract]" } } }, "localname": "ShortTermBorrowingsAbstract", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "xbrltype": "stringItemType" }, "us-gaap_ShortTermDebtLineItems": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.", "label": "Short-term Debt [Line Items]", "terseLabel": "Short-term Debt [Line Items]" } } }, "localname": "ShortTermDebtLineItems", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.agilent.com/role/ShortTermDebtSeniorNotesDetails" ], "xbrltype": "stringItemType" }, "us-gaap_ShortTermDebtTerms": { "auth_ref": [ "r21" ], "lang": { "en-US": { "role": { "documentation": "Description of the short-term debt arrangement, and disclosures pertaining to the underlying arrangements, including repayment terms, interest rates, restrictions on assets and activities, debt covenants, and other matters important to users of the financial statements.", "label": "Short-term Debt, Terms", "terseLabel": "Short-term debt terms (years)" } } }, "localname": "ShortTermDebtTerms", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.agilent.com/role/ShortTermDebtCreditFacilityAndCapitalLeaseDetails" ], "xbrltype": "stringItemType" }, "us-gaap_ShortTermDebtTextBlock": { "auth_ref": [ "r292" ], "lang": { "en-US": { "role": { "documentation": "The entire disclosure for short-term debt.", "label": "Short-term Debt [Text Block]", "verboseLabel": "SHORT-TERM DEBT" } } }, "localname": "ShortTermDebtTextBlock", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.agilent.com/role/ShortTermDebt" ], "xbrltype": "textBlockItemType" }, "us-gaap_ShortTermDebtTypeAxis": { "auth_ref": [ "r52" ], "lang": { "en-US": { "role": { "documentation": "Information by type of short-term debt arrangement.", "label": "Short-term Debt, Type [Axis]", "terseLabel": "Short-term Debt, Type [Axis]" } } }, "localname": "ShortTermDebtTypeAxis", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.agilent.com/role/ShortTermDebtSeniorNotesDetails" ], "xbrltype": "stringItemType" }, "us-gaap_ShortTermDebtTypeDomain": { "auth_ref": [ "r50" ], "lang": { "en-US": { "role": { "documentation": "Type of short-term debt arrangement, such as notes, line of credit, commercial paper, asset-based financing, project financing, letter of credit financing.", "label": "Short-term Debt, Type [Domain]", "terseLabel": "Short-term Debt, Type [Domain]" } } }, "localname": "ShortTermDebtTypeDomain", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.agilent.com/role/ShortTermDebtSeniorNotesDetails" ], "xbrltype": "domainItemType" }, "us-gaap_SignificantChangeInUnrecognizedTaxBenefitsIsReasonablyPossibleNatureOfUncertaintyDomain": { "auth_ref": [ "r452" ], "lang": { "en-US": { "role": { "documentation": "The nature of the uncertainty for which it is reasonably possible that the total amount of the unrecognized tax benefit will significantly increase or decrease within twelve months of the balance sheet date.", "label": "Significant Change in Unrecognized Tax Benefits is Reasonably Possible, Nature of Uncertainty [Domain]", "terseLabel": "Significant Change in Unrecognized Tax Benefits is Reasonably Possible, Nature of Uncertainty [Domain]" } } }, "localname": "SignificantChangeInUnrecognizedTaxBenefitsIsReasonablyPossibleNatureOfUncertaintyDomain", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.agilent.com/role/IncomeTaxesIncomeTaxesUncertainTaxPositionsDetails" ], "xbrltype": "domainItemType" }, "us-gaap_SoftwareDevelopmentMember": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Internally developed software for sale, licensing or long-term internal use.", "label": "Software Development [Member]", "terseLabel": "Software Development [Member]" } } }, "localname": "SoftwareDevelopmentMember", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.agilent.com/role/OverviewAndSummaryOfSignificantAccountingPoliciesDetails" ], "xbrltype": "domainItemType" }, "us-gaap_StandardProductWarrantyAccrual": { "auth_ref": [ "r285" ], "crdr": "credit", "lang": { "en-US": { "role": { "documentation": "Amount as of the balance sheet date of the aggregate standard product warranty liability. Does not include the balance for the extended product warranty liability.", "label": "Standard Product Warranty Accrual", "periodEndLabel": "Ending balance", "periodStartLabel": "Beginning balance" } } }, "localname": "StandardProductWarrantyAccrual", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.agilent.com/role/GuaranteesDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_StandardProductWarrantyAccrualBalanceSheetClassificationAbstract": { "auth_ref": [], "lang": { "en-US": { "role": { "label": "Standard Product Warranty Accrual, Balance Sheet Classification [Abstract]", "terseLabel": "Standard Product Warranty Accrual, Balance Sheet Classification [Abstract]" } } }, "localname": "StandardProductWarrantyAccrualBalanceSheetClassificationAbstract", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.agilent.com/role/GuaranteesDetails" ], "xbrltype": "stringItemType" }, "us-gaap_StandardProductWarrantyAccrualCurrent": { "auth_ref": [], "crdr": "credit", "lang": { "en-US": { "role": { "documentation": "Amount as of the balance sheet date of the aggregate standard product warranty liability that is expected to be paid within one year or the normal operating cycle, if longer. Does not include the balance for the extended product warranty liability.", "label": "Standard Product Warranty Accrual, Current", "terseLabel": "Accruals for warranties due within one year" } } }, "localname": "StandardProductWarrantyAccrualCurrent", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.agilent.com/role/GuaranteesDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_StandardProductWarrantyAccrualNoncurrent": { "auth_ref": [], "crdr": "credit", "lang": { "en-US": { "role": { "documentation": "Amount as of the balance sheet date of the aggregate standard product warranty liability that is expected to be paid after one year or beyond the normal operating cycle, if longer. Does not include the balance for the extended product warranty liability.", "label": "Standard Product Warranty Accrual, Noncurrent", "terseLabel": "Accruals for warranties due after one year" } } }, "localname": "StandardProductWarrantyAccrualNoncurrent", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.agilent.com/role/GuaranteesDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_StandardProductWarrantyAccrualPayments": { "auth_ref": [ "r282" ], "crdr": "debit", "lang": { "en-US": { "role": { "documentation": "Amount of decrease in the standard product warranty accrual from payments made in cash or in kind to satisfy claims under the terms of the standard product warranty. Excludes extended product warranties.", "label": "Standard Product Warranty Accrual, Decrease for Payments", "negatedLabel": "Settlements made during the period" } } }, "localname": "StandardProductWarrantyAccrualPayments", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.agilent.com/role/GuaranteesDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_StandardProductWarrantyAccrualWarrantiesIssued": { "auth_ref": [ "r283" ], "crdr": "credit", "lang": { "en-US": { "role": { "documentation": "Amount of increase in the standard product warranty accrual from warranties issued. Excludes extended product warranties.", "label": "Standard Product Warranty Accrual, Increase for Warranties Issued", "terseLabel": "Accruals for warranties including change in estimates" } } }, "localname": "StandardProductWarrantyAccrualWarrantiesIssued", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.agilent.com/role/GuaranteesDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_StandardProductWarrantyPolicy": { "auth_ref": [ "r137", "r284" ], "lang": { "en-US": { "role": { "documentation": "Disclosure of accounting policy for standard warranties including the methodology for measuring the liability.", "label": "Standard Product Warranty, Policy [Policy Text Block]", "terseLabel": "Warranty" } } }, "localname": "StandardProductWarrantyPolicy", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.agilent.com/role/OverviewAndSummaryOfSignificantAccountingPoliciesPolicies" ], "xbrltype": "textBlockItemType" }, "us-gaap_StatementBusinessSegmentsAxis": { "auth_ref": [ "r1", "r193", "r234", "r264", "r267", "r270", "r646" ], "lang": { "en-US": { "role": { "documentation": "Information by business segments.", "label": "Segments [Axis]", "terseLabel": "Segments [Axis]", "verboseLabel": "Business Segments [Axis]" } } }, "localname": "StatementBusinessSegmentsAxis", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.agilent.com/role/GoodwillAndOtherIntangibleAssetsRollForwardDetails", "http://www.agilent.com/role/GoodwillAndOtherIntangibleAssetsTextDetails", "http://www.agilent.com/role/OverviewAndSummaryOfSignificantAccountingPoliciesDetails", "http://www.agilent.com/role/PropertyPlantAndEquipmentNetDetails", "http://www.agilent.com/role/RevenueRevenueByRegionDetails", "http://www.agilent.com/role/SegmentInformationProfitabilityDetails", "http://www.agilent.com/role/SegmentInformationReconciliationOfReportableResultsDetails", "http://www.agilent.com/role/SegmentInformationSegmentAssetsDetails" ], "xbrltype": "stringItemType" }, "us-gaap_StatementClassOfStockAxis": { "auth_ref": [ "r29", "r30", "r31", "r296" ], "lang": { "en-US": { "role": { "documentation": "Information by the different classes of stock of the entity.", "label": "Class of Stock [Axis]", "terseLabel": "Class of Stock [Axis]" } } }, "localname": "StatementClassOfStockAxis", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.agilent.com/role/NewAccountingPronouncementsImpactOfAdoptingNewGuidanceDetails", "http://www.agilent.com/role/NewAccountingPronouncementsTextualsDetails", "http://www.agilent.com/role/StockholdersEquityStockholdersEquityDividendsDetails" ], "xbrltype": "stringItemType" }, "us-gaap_StatementEquityComponentsAxis": { "auth_ref": [ "r65", "r296" ], "lang": { "en-US": { "role": { "documentation": "Information by component of equity.", "label": "Equity Components [Axis]", "terseLabel": "Equity Components [Axis]" } } }, "localname": "StatementEquityComponentsAxis", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.agilent.com/role/ConsolidatedStatementOfEquity", "http://www.agilent.com/role/StockholdersEquityChangesInAccumulatedOtherComprehensiveIncomeDetails", "http://www.agilent.com/role/StockholdersEquityStockRepurchasesDetails", "http://www.agilent.com/role/StockholdersEquityTables" ], "xbrltype": "stringItemType" }, "us-gaap_StatementLineItems": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.", "label": "Statement [Line Items]", "terseLabel": "Statement [Line Items]" } } }, "localname": "StatementLineItems", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.agilent.com/role/ConsolidatedBalanceSheet", "http://www.agilent.com/role/ConsolidatedStatementOfCashFlows", "http://www.agilent.com/role/ConsolidatedStatementOfEquity", "http://www.agilent.com/role/ConsolidatedStatementOfOperations", "http://www.agilent.com/role/InvestmentsDetails", "http://www.agilent.com/role/NewAccountingPronouncementsImpactOfAdoptingNewGuidanceDetails", "http://www.agilent.com/role/NewAccountingPronouncementsTextualsDetails", "http://www.agilent.com/role/RevenueRevenueContractBalancesDetails", "http://www.agilent.com/role/StockholdersEquityAccumulatedOtherComprehensiveIncomeDetails", "http://www.agilent.com/role/StockholdersEquityChangesInAccumulatedOtherComprehensiveIncomeDetails", "http://www.agilent.com/role/StockholdersEquityStockholdersEquityReclassificationsOutOfAccumulatedOtherComprehensiveIncomeDetails" ], "xbrltype": "stringItemType" }, "us-gaap_StatementOfCashFlowsAbstract": { "auth_ref": [], "lang": { "en-US": { "role": { "label": "Statement of Cash Flows [Abstract]" } } }, "localname": "StatementOfCashFlowsAbstract", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "xbrltype": "stringItemType" }, "us-gaap_StatementOfFinancialPositionAbstract": { "auth_ref": [], "lang": { "en-US": { "role": { "label": "Statement of Financial Position [Abstract]" } } }, "localname": "StatementOfFinancialPositionAbstract", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "xbrltype": "stringItemType" }, "us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract": { "auth_ref": [], "lang": { "en-US": { "role": { "label": "Statement of Comprehensive Income [Abstract]" } } }, "localname": "StatementOfIncomeAndComprehensiveIncomeAbstract", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "xbrltype": "stringItemType" }, "us-gaap_StatementOfStockholdersEquityAbstract": { "auth_ref": [], "lang": { "en-US": { "role": { "label": "Statement of Stockholders' Equity [Abstract]" } } }, "localname": "StatementOfStockholdersEquityAbstract", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "xbrltype": "stringItemType" }, "us-gaap_StatementOperatingActivitiesSegmentAxis": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Information by continuing and discontinuing operations.", "label": "Operating Activities [Axis]", "terseLabel": "Operating Activities [Axis]" } } }, "localname": "StatementOperatingActivitiesSegmentAxis", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.agilent.com/role/ConsolidatedStatementOfCashFlows", "http://www.agilent.com/role/InventoryDetails", "http://www.agilent.com/role/OverviewAndSummaryOfSignificantAccountingPoliciesDetails", "http://www.agilent.com/role/RetirementPlansAndPostRetirementPensionPlansFairValueOfPlanAssetsDetails", "http://www.agilent.com/role/ShareBasedCompensationAllocatedShareBasedCompensationExpenseDetails", "http://www.agilent.com/role/StockholdersEquityChangesInAccumulatedOtherComprehensiveIncomeDetails" ], "xbrltype": "stringItemType" }, "us-gaap_StatementTable": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Schedule reflecting a Statement of Income, Statement of Cash Flows, Statement of Financial Position, Statement of Shareholders' Equity and Other Comprehensive Income, or other statement as needed.", "label": "Statement [Table]", "terseLabel": "Statement [Table]" } } }, "localname": "StatementTable", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.agilent.com/role/ConsolidatedBalanceSheet", "http://www.agilent.com/role/ConsolidatedStatementOfCashFlows", "http://www.agilent.com/role/ConsolidatedStatementOfEquity", "http://www.agilent.com/role/ConsolidatedStatementOfOperations", "http://www.agilent.com/role/InvestmentsDetails", "http://www.agilent.com/role/NewAccountingPronouncementsImpactOfAdoptingNewGuidanceDetails", "http://www.agilent.com/role/NewAccountingPronouncementsTextualsDetails", "http://www.agilent.com/role/RevenueRevenueContractBalancesDetails", "http://www.agilent.com/role/StockholdersEquityAccumulatedOtherComprehensiveIncomeDetails", "http://www.agilent.com/role/StockholdersEquityStockholdersEquityReclassificationsOutOfAccumulatedOtherComprehensiveIncomeDetails" ], "xbrltype": "stringItemType" }, "us-gaap_StockIssuedDuringPeriodSharebasedCompensationAbstract": { "auth_ref": [], "lang": { "en-US": { "role": { "label": "Shares Granted or Issued, Share-based Payment Arrangement [Abstract]", "terseLabel": "Share-based awards issued" } } }, "localname": "StockIssuedDuringPeriodSharebasedCompensationAbstract", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.agilent.com/role/NetIncomeLossPerShareDetails" ], "xbrltype": "stringItemType" }, "us-gaap_StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans": { "auth_ref": [ "r30", "r31", "r296", "r303" ], "lang": { "en-US": { "role": { "documentation": "Number of shares issued during the period as a result of an employee stock purchase plan.", "label": "Stock Issued During Period, Shares, Employee Stock Purchase Plans", "terseLabel": "Number of shares purchased under ESPP (in shares)" } } }, "localname": "StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.agilent.com/role/ShareBasedCompensationGeneralDisclosuresDetails" ], "xbrltype": "sharesItemType" }, "us-gaap_StockIssuedDuringPeriodSharesShareBasedCompensation": { "auth_ref": [ "r30", "r31", "r296", "r303" ], "lang": { "en-US": { "role": { "documentation": "Number, after forfeiture, of shares or units issued under share-based payment arrangement. Excludes shares or units issued under employee stock ownership plan (ESOP).", "label": "Shares Issued, Shares, Share-based Payment Arrangement, after Forfeiture", "terseLabel": "Share-based awards issued (in shares)" } } }, "localname": "StockIssuedDuringPeriodSharesShareBasedCompensation", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.agilent.com/role/ConsolidatedStatementOfEquity" ], "xbrltype": "sharesItemType" }, "us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised": { "auth_ref": [ "r30", "r31", "r296", "r303", "r405" ], "lang": { "en-US": { "role": { "documentation": "Number of share options (or share units) exercised during the current period.", "label": "Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercises in Period", "negatedLabel": "Exercised (in shares)" } } }, "localname": "StockIssuedDuringPeriodSharesStockOptionsExercised", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.agilent.com/role/ShareBasedCompensationStockOptionActivityDetails" ], "xbrltype": "sharesItemType" }, "us-gaap_StockIssuedDuringPeriodValueEmployeeStockPurchasePlan": { "auth_ref": [ "r30", "r31", "r296", "r303" ], "crdr": "credit", "lang": { "en-US": { "role": { "documentation": "Aggregate change in value for stock issued during the period as a result of employee stock purchase plan.", "label": "Stock Issued During Period, Value, Employee Stock Purchase Plan", "terseLabel": "Aggregate Value stock issued under Employee Stock Purchase Plan" } } }, "localname": "StockIssuedDuringPeriodValueEmployeeStockPurchasePlan", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.agilent.com/role/ShareBasedCompensationGeneralDisclosuresDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_StockIssuedDuringPeriodValueShareBasedCompensation": { "auth_ref": [ "r30", "r31", "r303", "r395", "r413" ], "crdr": "credit", "lang": { "en-US": { "role": { "documentation": "Value, after forfeiture, of shares issued under share-based payment arrangement. Excludes employee stock ownership plan (ESOP).", "label": "Shares Issued, Value, Share-based Payment Arrangement, after Forfeiture", "terseLabel": "Share-based awards issued" } } }, "localname": "StockIssuedDuringPeriodValueShareBasedCompensation", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.agilent.com/role/ConsolidatedStatementOfEquity" ], "xbrltype": "monetaryItemType" }, "us-gaap_StockRepurchaseProgramAuthorizedAmount1": { "auth_ref": [], "crdr": "credit", "lang": { "en-US": { "role": { "documentation": "Amount of stock repurchase plan authorized.", "label": "Stock Repurchase Program, Authorized Amount", "terseLabel": "Stock Repurchase Program, Authorized Amount" } } }, "localname": "StockRepurchaseProgramAuthorizedAmount1", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.agilent.com/role/StockholdersEquityStockRepurchasesDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_StockRepurchaseProgramRemainingAuthorizedRepurchaseAmount1": { "auth_ref": [], "crdr": "credit", "lang": { "en-US": { "role": { "documentation": "Amount remaining of a stock repurchase plan authorized.", "label": "Stock Repurchase Program, Remaining Authorized Repurchase Amount", "terseLabel": "Remaining authorized repurchase amount" } } }, "localname": "StockRepurchaseProgramRemainingAuthorizedRepurchaseAmount1", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.agilent.com/role/StockholdersEquityStockRepurchasesDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_StockRepurchasedAndRetiredDuringPeriodShares": { "auth_ref": [ "r30", "r31", "r296", "r303" ], "lang": { "en-US": { "role": { "documentation": "Number of shares that have been repurchased and retired during the period.", "label": "Stock Repurchased and Retired During Period, Shares", "terseLabel": "Stock Repurchased and Retired During Period, Shares" } } }, "localname": "StockRepurchasedAndRetiredDuringPeriodShares", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.agilent.com/role/StockholdersEquityStockRepurchasesDetails" ], "xbrltype": "sharesItemType" }, "us-gaap_StockRepurchasedAndRetiredDuringPeriodValue": { "auth_ref": [ "r30", "r31", "r296", "r303" ], "crdr": "debit", "lang": { "en-US": { "role": { "documentation": "Equity impact of the value of stock that has been repurchased and retired during the period. The excess of the purchase price over par value can be charged against retained earnings (once the excess is fully allocated to additional paid in capital).", "label": "Stock Repurchased and Retired During Period, Value", "terseLabel": "Stock Repurchased and Retired During Period, Value" } } }, "localname": "StockRepurchasedAndRetiredDuringPeriodValue", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.agilent.com/role/StockholdersEquityStockRepurchasesDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_StockRepurchasedDuringPeriodShares": { "auth_ref": [ "r30", "r31", "r296", "r303" ], "lang": { "en-US": { "role": { "documentation": "Number of shares that have been repurchased during the period and have not been retired and are not held in treasury. Some state laws may govern the circumstances under which an entity may acquire its own stock and prescribe the accounting treatment therefore. This element is used when state law does not recognize treasury stock.", "label": "Stock Repurchased During Period, Shares", "negatedLabel": "Repurchase of common stock (in shares)" } } }, "localname": "StockRepurchasedDuringPeriodShares", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.agilent.com/role/ConsolidatedStatementOfEquity" ], "xbrltype": "sharesItemType" }, "us-gaap_StockRepurchasedDuringPeriodValue": { "auth_ref": [ "r30", "r31", "r296", "r303" ], "crdr": "debit", "lang": { "en-US": { "role": { "documentation": "Equity impact of the value of stock that has been repurchased during the period and has not been retired and is not held in treasury. Some state laws may mandate the circumstances under which an entity may acquire its own stock and prescribe the accounting treatment therefore. This element is used when state law does not recognize treasury stock.", "label": "Stock Repurchased During Period, Value", "negatedLabel": "Repurchase of common stock" } } }, "localname": "StockRepurchasedDuringPeriodValue", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.agilent.com/role/ConsolidatedStatementOfEquity" ], "xbrltype": "monetaryItemType" }, "us-gaap_StockholdersEquity": { "auth_ref": [ "r31", "r35", "r36", "r208" ], "calculation": { "http://www.agilent.com/role/ConsolidatedBalanceSheet": { "order": 2.0, "parentTag": "us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-US": { "role": { "documentation": "Total of all stockholders' equity (deficit) items, net of receivables from officers, directors, owners, and affiliates of the entity which are attributable to the parent. The amount of the economic entity's stockholders' equity attributable to the parent excludes the amount of stockholders' equity which is allocable to that ownership interest in subsidiary equity which is not attributable to the parent (noncontrolling interest, minority interest). This excludes temporary equity and is sometimes called permanent equity.", "label": "Stockholders' Equity Attributable to Parent", "terseLabel": "Total stockholders' equity", "totalLabel": "Total stockholders' equity" } } }, "localname": "StockholdersEquity", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.agilent.com/role/ConsolidatedBalanceSheet", "http://www.agilent.com/role/NewAccountingPronouncementsImpactOfAdoptingNewGuidanceDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_StockholdersEquityAbstract": { "auth_ref": [], "lang": { "en-US": { "role": { "label": "Stockholders' Equity Attributable to Parent [Abstract]", "terseLabel": "Stockholders' equity:" } } }, "localname": "StockholdersEquityAbstract", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.agilent.com/role/ConsolidatedBalanceSheet", "http://www.agilent.com/role/ConsolidatedBalanceSheetParenthetical" ], "xbrltype": "stringItemType" }, "us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest": { "auth_ref": [ "r505", "r506", "r520" ], "calculation": { "http://www.agilent.com/role/ConsolidatedBalanceSheet": { "order": 1.0, "parentTag": "us-gaap_LiabilitiesAndStockholdersEquity", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-US": { "role": { "documentation": "Amount of stockholders' equity (deficit), net of receivables from officers, directors, owners, and affiliates of the entity, attributable to both the parent and noncontrolling interests. Amount excludes temporary equity. Alternate caption for the concept is permanent equity.", "label": "Stockholders' Equity, Including Portion Attributable to Noncontrolling Interest", "periodEndLabel": "Balance", "periodStartLabel": "Balance", "terseLabel": "Total equity", "totalLabel": "Total equity" } } }, "localname": "StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.agilent.com/role/ConsolidatedBalanceSheet", "http://www.agilent.com/role/ConsolidatedStatementOfEquity", "http://www.agilent.com/role/NewAccountingPronouncementsImpactOfAdoptingNewGuidanceDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterestAbstract": { "auth_ref": [], "lang": { "en-US": { "role": { "label": "Stockholders' Equity, Including Portion Attributable to Noncontrolling Interest [Abstract]", "terseLabel": "Total equity:" } } }, "localname": "StockholdersEquityIncludingPortionAttributableToNoncontrollingInterestAbstract", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.agilent.com/role/ConsolidatedBalanceSheet", "http://www.agilent.com/role/ConsolidatedBalanceSheetParenthetical" ], "xbrltype": "stringItemType" }, "us-gaap_StockholdersEquityNoteAbstract": { "auth_ref": [], "lang": { "en-US": { "role": { "label": "Stockholders' Equity Note [Abstract]" } } }, "localname": "StockholdersEquityNoteAbstract", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "xbrltype": "stringItemType" }, "us-gaap_StockholdersEquityNoteDisclosureTextBlock": { "auth_ref": [ "r307" ], "lang": { "en-US": { "role": { "documentation": "The entire disclosure for shareholders' equity comprised of portions attributable to the parent entity and noncontrolling interest, including other comprehensive income. Includes, but is not limited to, balances of common stock, preferred stock, additional paid-in capital, other capital and retained earnings, accumulated balance for each classification of other comprehensive income and amount of comprehensive income.", "label": "Stockholders' Equity Note Disclosure [Text Block]", "verboseLabel": "STOCKHOLDERS EQUITY" } } }, "localname": "StockholdersEquityNoteDisclosureTextBlock", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.agilent.com/role/StockholdersEquity" ], "xbrltype": "textBlockItemType" }, "us-gaap_SubsegmentsAxis": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Information by business subsegments.", "label": "Subsegments [Axis]", "terseLabel": "Subsegments [Axis]" } } }, "localname": "SubsegmentsAxis", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.agilent.com/role/SegmentInformationSegmentAssetsDetails" ], "xbrltype": "stringItemType" }, "us-gaap_SubsegmentsConsolidationItemsAxis": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Information by subsegments, eliminations and reconciling items used in consolidating a reportable segment and its subsegments.", "label": "Subsegments Consolidation Items [Axis]", "terseLabel": "Subsegments Consolidation Items [Axis]" } } }, "localname": "SubsegmentsConsolidationItemsAxis", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.agilent.com/role/SegmentInformationSegmentAssetsDetails" ], "xbrltype": "stringItemType" }, "us-gaap_SubsegmentsConsolidationItemsDomain": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Subsegments, eliminations and reconciling items used in consolidating a reportable segment and its subsegments.", "label": "Subsegments Consolidation Items [Domain]", "terseLabel": "Subsegments Consolidation Items [Domain]" } } }, "localname": "SubsegmentsConsolidationItemsDomain", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.agilent.com/role/SegmentInformationSegmentAssetsDetails" ], "xbrltype": "domainItemType" }, "us-gaap_SubsegmentsDomain": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Divisions of a component of an entity that engage in business activities from which they may earn revenue and incur expenses, including transactions with other components of the same entity.", "label": "Subsegments [Domain]", "terseLabel": "Subsegments [Domain]" } } }, "localname": "SubsegmentsDomain", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.agilent.com/role/SegmentInformationSegmentAssetsDetails" ], "xbrltype": "domainItemType" }, "us-gaap_SubsequentEventMember": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Identifies event that occurred after the balance sheet date but before financial statements are issued or available to be issued.", "label": "Subsequent Event [Member]", "terseLabel": "Subsequent Event [Member]" } } }, "localname": "SubsequentEventMember", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.agilent.com/role/StockholdersEquityStockRepurchasesDetails", "http://www.agilent.com/role/StockholdersEquityStockholdersEquityDividendsDetails" ], "xbrltype": "domainItemType" }, "us-gaap_SubsequentEventTypeAxis": { "auth_ref": [ "r600" ], "lang": { "en-US": { "role": { "documentation": "Information by event that occurred after the balance sheet date but before financial statements are issued or available to be issued.", "label": "Subsequent Event Type [Axis]", "terseLabel": "Subsequent Event Type [Axis]" } } }, "localname": "SubsequentEventTypeAxis", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.agilent.com/role/StockholdersEquityStockRepurchasesDetails", "http://www.agilent.com/role/StockholdersEquityStockholdersEquityDividendsDetails" ], "xbrltype": "stringItemType" }, "us-gaap_SubsequentEventTypeDomain": { "auth_ref": [ "r600" ], "lang": { "en-US": { "role": { "documentation": "Event that occurred after the balance sheet date but before financial statements are issued or available to be issued.", "label": "Subsequent Event Type [Domain]", "terseLabel": "Subsequent Event Type [Domain]" } } }, "localname": "SubsequentEventTypeDomain", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.agilent.com/role/StockholdersEquityStockRepurchasesDetails", "http://www.agilent.com/role/StockholdersEquityStockholdersEquityDividendsDetails" ], "xbrltype": "domainItemType" }, "us-gaap_SummaryOfIncomeTaxContingenciesTextBlock": { "auth_ref": [ "r451", "r460", "r462" ], "lang": { "en-US": { "role": { "documentation": "Tabular disclosure for tax positions taken in the tax returns filed or to be filed for which it is more likely than not that the tax position will not be sustained upon examination by taxing authorities and other income tax contingencies. Includes, but is not limited to, interest and penalties, reconciliation of unrecognized tax benefits, unrecognized tax benefits that would affect the effective tax rate, tax years that remain subject to examination by tax jurisdictions, and information about positions for which it is reasonably possible that amounts unrecognized will significantly change within 12 months.", "label": "Summary of Income Tax Contingencies [Table Text Block]", "terseLabel": "Income tax contingencies rollforward" } } }, "localname": "SummaryOfIncomeTaxContingenciesTextBlock", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.agilent.com/role/IncomeTaxesTables" ], "xbrltype": "textBlockItemType" }, "us-gaap_SupplementalCashFlowInformationAbstract": { "auth_ref": [], "lang": { "en-US": { "role": { "label": "Supplemental Cash Flow Information [Abstract]", "terseLabel": "Supplemental Cash Flow Information [Abstract]" } } }, "localname": "SupplementalCashFlowInformationAbstract", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.agilent.com/role/ConsolidatedStatementOfCashFlows" ], "xbrltype": "stringItemType" }, "us-gaap_SupplementalEmployeeRetirementPlanDefinedBenefitMember": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Plan designed to provide limited group of employees with supplemental retirement benefits, in addition to other pension benefits. Includes, but is not limited to, defined benefit and defined contribution plans.", "label": "Supplemental Employee Retirement Plan [Member]", "terseLabel": "Supplemental Employee Retirement Plan [Member]" } } }, "localname": "SupplementalEmployeeRetirementPlanDefinedBenefitMember", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.agilent.com/role/RetirementPlansAndPostRetirementPensionPlansComponentsOfNetPeriodicCostsDetails" ], "xbrltype": "domainItemType" }, "us-gaap_TangibleAssetImpairmentCharges": { "auth_ref": [ "r0", "r261" ], "crdr": "debit", "lang": { "en-US": { "role": { "documentation": "The charge against earnings resulting from the aggregate write down of tangible assets from their carrying value to their fair value.", "label": "Tangible Asset Impairment Charges", "terseLabel": "Tangible Asset Impairment Charges" } } }, "localname": "TangibleAssetImpairmentCharges", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.agilent.com/role/PropertyPlantAndEquipmentNetDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_TaxCreditCarryforwardAmount": { "auth_ref": [ "r469" ], "crdr": "debit", "lang": { "en-US": { "role": { "documentation": "The amount of the tax credit carryforward, before tax effects, available to reduce future taxable income under enacted tax laws.", "label": "Tax Credit Carryforward, Amount", "terseLabel": "Tax credit carryforwards" } } }, "localname": "TaxCreditCarryforwardAmount", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.agilent.com/role/IncomeTaxesCarryforwardsDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_TaxCutsAndJobsActOf2017ChangeInTaxRateIncomeTaxExpenseBenefit": { "auth_ref": [ "r475" ], "crdr": "debit", "lang": { "en-US": { "role": { "documentation": "Amount of income tax expense (benefit) for remeasurement of deferred tax from change in tax rate pursuant to Tax Cuts and Jobs Act.", "label": "Tax Cuts and Jobs Act, Change in Tax Rate, Income Tax Expense (Benefit)", "terseLabel": "Tax Cuts and Jobs Act, Change in Tax Rate, Income Tax Expense (Benefit)" } } }, "localname": "TaxCutsAndJobsActOf2017ChangeInTaxRateIncomeTaxExpenseBenefit", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.agilent.com/role/IncomeTaxes2017USTaxReformTaxCutsAndJobsActDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_TaxCutsAndJobsActOf2017DecreaseInDeferredTaxLiabilityDueToTransitionTax": { "auth_ref": [ "r471" ], "crdr": "debit", "lang": { "en-US": { "role": { "documentation": "Amount of decrease in deferred tax liability previously recognized attributable to taxable temporary differences from undistributed earnings of foreign subsidiary and other recognized entity now subject to transition tax.", "label": "Tax Cuts and Jobs Act, Decrease in Deferred Tax Liability due to Transition Tax", "terseLabel": "Tax Cuts and Jobs Act, Decrease in Deferred Tax Liability due to Transition Tax" } } }, "localname": "TaxCutsAndJobsActOf2017DecreaseInDeferredTaxLiabilityDueToTransitionTax", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.agilent.com/role/IncomeTaxes2017USTaxReformTaxCutsAndJobsActDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_TaxCutsAndJobsActOf2017IncomeTaxExpenseBenefit": { "auth_ref": [ "r475" ], "crdr": "debit", "lang": { "en-US": { "role": { "documentation": "Amount of income tax expense (benefit) from effect of Tax Cuts and Jobs Act.", "label": "Tax Cuts and Jobs Act, Income Tax Expense (Benefit)", "terseLabel": "Tax Cuts and Jobs Act, Income Tax Expense (Benefit)" } } }, "localname": "TaxCutsAndJobsActOf2017IncomeTaxExpenseBenefit", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.agilent.com/role/IncomeTaxes2017USTaxReformTaxCutsAndJobsActDetails", "http://www.agilent.com/role/IncomeTaxesIncomeTaxesEffectiveTaxRateAndTaxHolidaysDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_TaxCutsAndJobsActOf2017TransitionTaxForAccumulatedForeignEarningsIncomeTaxExpense": { "auth_ref": [ "r475" ], "crdr": "debit", "lang": { "en-US": { "role": { "documentation": "Amount of income tax expense from transition tax on accumulated earnings of controlled foreign corporation deemed repatriated pursuant to Tax Cuts and Jobs Act.", "label": "Tax Cuts and Jobs Act, Transition Tax for Accumulated Foreign Earnings, Income Tax Expense", "terseLabel": "Net transition tax" } } }, "localname": "TaxCutsAndJobsActOf2017TransitionTaxForAccumulatedForeignEarningsIncomeTaxExpense", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.agilent.com/role/IncomeTaxes2017USTaxReformTaxCutsAndJobsActDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_TaxPeriodAxis": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Information about the period subject to enacted tax laws.", "label": "Tax Period [Axis]", "terseLabel": "Tax Period [Axis]" } } }, "localname": "TaxPeriodAxis", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.agilent.com/role/IncomeTaxes2017USTaxReformTaxCutsAndJobsActDetails", "http://www.agilent.com/role/IncomeTaxesIncomeTaxesUncertainTaxPositionsDetails" ], "xbrltype": "stringItemType" }, "us-gaap_TaxPeriodDomain": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Identified tax period.", "label": "Tax Period [Domain]", "terseLabel": "Tax Period [Domain]" } } }, "localname": "TaxPeriodDomain", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.agilent.com/role/IncomeTaxes2017USTaxReformTaxCutsAndJobsActDetails", "http://www.agilent.com/role/IncomeTaxesIncomeTaxesUncertainTaxPositionsDetails" ], "xbrltype": "domainItemType" }, "us-gaap_TaxYear2014Member": { "auth_ref": [ "r453" ], "lang": { "en-US": { "role": { "documentation": "Identified as tax year 2014.", "label": "Tax Year 2014 [Member]", "terseLabel": "Tax year 2014" } } }, "localname": "TaxYear2014Member", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.agilent.com/role/IncomeTaxesIncomeTaxesUncertainTaxPositionsDetails" ], "xbrltype": "domainItemType" }, "us-gaap_TaxesPayableCurrent": { "auth_ref": [ "r53" ], "crdr": "credit", "lang": { "en-US": { "role": { "documentation": "Carrying value as of the balance sheet date of obligations incurred and payable for statutory income, sales, use, payroll, excise, real, property and other taxes. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).", "label": "Taxes Payable, Current", "terseLabel": "Taxes Payable, Current" } } }, "localname": "TaxesPayableCurrent", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.agilent.com/role/IncomeTaxesIncomeTaxesProvisionDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_TrademarksAndTradeNamesMember": { "auth_ref": [ "r494" ], "lang": { "en-US": { "role": { "documentation": "Rights acquired through registration of a trademark to gain or protect exclusive use of a business name, symbol or other device or style, or rights either acquired through registration of a business name to gain or protect exclusive use thereof.", "label": "Trademarks and Trade Names [Member]", "terseLabel": "Tradenames and trademarks" } } }, "localname": "TrademarksAndTradeNamesMember", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.agilent.com/role/AcquisitionsAcquisitionsIntangibleAssetsDetails" ], "xbrltype": "domainItemType" }, "us-gaap_TrademarksMember": { "auth_ref": [ "r494" ], "lang": { "en-US": { "role": { "documentation": "Rights acquired through registration of a trademark to gain or protect exclusive use of a business name, symbol or other device or style.", "label": "Trademarks [Member]", "terseLabel": "Trademark/Tradename" } } }, "localname": "TrademarksMember", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.agilent.com/role/GoodwillAndOtherIntangibleAssetsDisclosuresAndComponentsOfOtherIntangiblesDetails" ], "xbrltype": "domainItemType" }, "us-gaap_TradingSecurities": { "auth_ref": [ "r621" ], "calculation": { "http://www.agilent.com/role/FairValueMeasurementsFairValueOfAssetsAndLiabilitiesMeasuredOnRecurringBasisDetails": { "order": 3.0, "parentTag": "a_FairValueAssetsMeasuredOnRecurringBasisTotalAssets", "weight": 1.0 }, "http://www.agilent.com/role/InvestmentsDetails": { "order": 2.0, "parentTag": "us-gaap_LongTermInvestments", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-US": { "role": { "documentation": "Amount of investment in debt security measured at fair value with change in fair value recognized in net income (trading) and investment in equity security measured at fair value with change in fair value recognized in net income (FV-NI).", "label": "Debt Securities, Trading, and Equity Securities, FV-NI", "terseLabel": "Trading securities" } } }, "localname": "TradingSecurities", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.agilent.com/role/FairValueMeasurementsFairValueOfAssetsAndLiabilitiesMeasuredOnRecurringBasisDetails", "http://www.agilent.com/role/InvestmentsDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_TradingSecuritiesUnrealizedHoldingGainLoss": { "auth_ref": [], "crdr": "credit", "lang": { "en-US": { "role": { "documentation": "Amount of unrealized holding gain (loss) recognized in the income statement for investments in debt and equity securities and other forms of securities that provide ownership interests classified as trading.", "label": "Trading Securities, Change in Unrealized Holding Gain (Loss)", "terseLabel": "Net unrealized gains on trading securities" } } }, "localname": "TradingSecuritiesUnrealizedHoldingGainLoss", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.agilent.com/role/InvestmentsDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_TranslationAdjustmentFunctionalToReportingCurrencyNetOfTaxPeriodIncreaseDecrease": { "auth_ref": [ "r86", "r578", "r580", "r582", "r583" ], "lang": { "en-US": { "role": { "documentation": "Amount of increase (decrease) in cumulative translation adjustment, after tax, from translating foreign currency financial statements into the reporting currency.", "label": "Translation Adjustment Functional to Reporting Currency, Net of Tax, Period Increase (Decrease)", "terseLabel": "Translation Adjustment Functional to Reporting Currency, Net of Tax, Period Increase (Decrease)" } } }, "localname": "TranslationAdjustmentFunctionalToReportingCurrencyNetOfTaxPeriodIncreaseDecrease", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.agilent.com/role/RevenueRevenueContractBalancesDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_TreasuryLockMember": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Customized agreement that fixes the yield or price on a specified treasury security for a specific period.", "label": "Treasury Lock [Member]", "terseLabel": "Treasury Lock [Member]" } } }, "localname": "TreasuryLockMember", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.agilent.com/role/DerivativesDetails", "http://www.agilent.com/role/DerivativesEffectOfDerivativeInstrumentsOnConsolidatedStatementOfOperationsDetails", "http://www.agilent.com/role/DerivativesFairValueOfDerivativeInstrumentsAndConsolidatedBalanceSheetLocationDetails", "http://www.agilent.com/role/LongTermDebtLongTermDebtOtherDetails", "http://www.agilent.com/role/LongTermDebtSeniorNotesDetails" ], "xbrltype": "domainItemType" }, "us-gaap_TreasuryStockMember": { "auth_ref": [ "r64", "r305" ], "lang": { "en-US": { "role": { "documentation": "Shares of an entity that have been repurchased by the entity. This stock has no voting rights and receives no dividends. Note that treasury stock may be recorded at its total cost or separately as par (or stated) value and additional paid in capital. Classified within stockholders' equity if nonredeemable or redeemable solely at the option of the issuer. Classified within temporary equity if redemption is outside the control of the issuer.", "label": "Treasury Stock [Member]", "terseLabel": "Treasury Stock" } } }, "localname": "TreasuryStockMember", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.agilent.com/role/ConsolidatedStatementOfEquity" ], "xbrltype": "domainItemType" }, "us-gaap_TreasuryStockRetiredCostMethodAmount": { "auth_ref": [ "r31", "r296", "r304" ], "crdr": "debit", "lang": { "en-US": { "role": { "documentation": "Amount of decrease of par value, additional paid in capital (APIC) and retained earnings of common and preferred stock retired from treasury when treasury stock is accounted for under the cost method.", "label": "Treasury Stock, Retired, Cost Method, Amount", "negatedLabel": "Retirement of treasury stock, cost method" } } }, "localname": "TreasuryStockRetiredCostMethodAmount", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.agilent.com/role/ConsolidatedStatementOfEquity" ], "xbrltype": "monetaryItemType" }, "us-gaap_TreasuryStockShares": { "auth_ref": [ "r64", "r305" ], "lang": { "en-US": { "role": { "documentation": "Number of common and preferred shares that were previously issued and that were repurchased by the issuing entity and held in treasury on the financial statement date. This stock has no voting rights and receives no dividends.", "label": "Treasury Stock, Shares", "verboseLabel": "Treasury Stock, Number of shares" } } }, "localname": "TreasuryStockShares", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.agilent.com/role/ConsolidatedStatementOfEquity" ], "xbrltype": "sharesItemType" }, "us-gaap_TreasuryStockSharesRetired": { "auth_ref": [ "r31", "r296", "r303" ], "lang": { "en-US": { "role": { "documentation": "Number of shares of common and preferred stock retired from treasury during the period.", "label": "Treasury Stock, Shares, Retired", "negatedLabel": "Retirement of treasury stock (shares)" } } }, "localname": "TreasuryStockSharesRetired", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.agilent.com/role/ConsolidatedStatementOfEquity" ], "xbrltype": "sharesItemType" }, "us-gaap_TreasuryStockValue": { "auth_ref": [ "r64", "r305", "r306" ], "crdr": "debit", "lang": { "en-US": { "role": { "documentation": "The amount allocated to treasury stock. Treasury stock is common and preferred shares of an entity that were issued, repurchased by the entity, and are held in its treasury.", "label": "Treasury Stock, Value", "terseLabel": "Treasury Stock, Value" } } }, "localname": "TreasuryStockValue", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.agilent.com/role/ConsolidatedStatementOfEquity" ], "xbrltype": "monetaryItemType" }, "us-gaap_TypeOfAdoptionMember": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Adoption and early adoption of sources of change to generally accepted accounting principles (GAAP) in the United States. The FASB released the FASB Accounting Standards Codification as the authoritative source of literature effective for interim and annual periods ending after September 15, 2009. As part of the Codification process, the FASB issues Accounting Standards Updates to amend the Codification but otherwise the Accounting Standards Updates are not authoritative in their own right. All previous accounting standards (such as FASB Statements of Financial Accounting Standards, FASB Interpretations, FASB Staff Positions, Emerging Issues Task Force Consensuses, other pronouncements of the FASB or other designated bodies, or other forms of GAAP are considered accounting pronouncements) were superseded upon the adoption of the Codification. For an interim period, references to the superseded standards are included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy.", "label": "Type of Adoption [Domain]", "terseLabel": "Type of Adoption [Domain]" } } }, "localname": "TypeOfAdoptionMember", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.agilent.com/role/InvestmentsDetails", "http://www.agilent.com/role/LongTermDebtCarryingValueDetails", "http://www.agilent.com/role/LongTermDebtLongTermDebtOtherDetails", "http://www.agilent.com/role/NewAccountingPronouncementsImpactOfAdoptingNewGuidanceDetails", "http://www.agilent.com/role/NewAccountingPronouncementsTextualsDetails" ], "xbrltype": "domainItemType" }, "us-gaap_UnrealizedGainLossOnForeignCurrencyDerivativesNetBeforeTaxAbstract": { "auth_ref": [], "lang": { "en-US": { "role": { "label": "Unrealized Gain (Loss) on Foreign Currency Derivatives, Net, before Tax [Abstract]", "terseLabel": "Unrealized Gain (Loss) on Foreign Currency Derivatives, Net, before Tax [Abstract]" } } }, "localname": "UnrealizedGainLossOnForeignCurrencyDerivativesNetBeforeTaxAbstract", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.agilent.com/role/StockholdersEquityChangesInAccumulatedOtherComprehensiveIncomeDetails" ], "xbrltype": "stringItemType" }, "us-gaap_UnrecognizedTaxBenefits": { "auth_ref": [ "r438", "r454" ], "crdr": "credit", "lang": { "en-US": { "role": { "documentation": "Amount of unrecognized tax benefits.", "label": "Unrecognized Tax Benefits", "periodEndLabel": "Balance, end of year", "periodStartLabel": "Balance, beginning of year" } } }, "localname": "UnrecognizedTaxBenefits", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.agilent.com/role/IncomeTaxesIncomeTaxesUncertainTaxPositionsDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_UnrecognizedTaxBenefitsDecreasesResultingFromPriorPeriodTaxPositions": { "auth_ref": [ "r455" ], "crdr": "debit", "lang": { "en-US": { "role": { "documentation": "Amount of decrease in unrecognized tax benefits resulting from tax positions taken in prior period tax returns.", "label": "Unrecognized Tax Benefits, Decrease Resulting from Prior Period Tax Positions", "terseLabel": "Reductions for tax positions from prior years" } } }, "localname": "UnrecognizedTaxBenefitsDecreasesResultingFromPriorPeriodTaxPositions", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.agilent.com/role/IncomeTaxesIncomeTaxesUncertainTaxPositionsDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_UnrecognizedTaxBenefitsDecreasesResultingFromSettlementsWithTaxingAuthorities": { "auth_ref": [ "r457" ], "crdr": "debit", "lang": { "en-US": { "role": { "documentation": "Amount of decrease in unrecognized tax benefits resulting from settlements with taxing authorities.", "label": "Unrecognized Tax Benefits, Decrease Resulting from Settlements with Taxing Authorities", "negatedLabel": "Settlements with taxing authorities" } } }, "localname": "UnrecognizedTaxBenefitsDecreasesResultingFromSettlementsWithTaxingAuthorities", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.agilent.com/role/IncomeTaxesIncomeTaxesUncertainTaxPositionsDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestAccrued": { "auth_ref": [ "r450" ], "crdr": "credit", "lang": { "en-US": { "role": { "documentation": "Amount accrued for interest on an underpayment of income taxes and penalties related to a tax position claimed or expected to be claimed in the tax return.", "label": "Unrecognized Tax Benefits, Income Tax Penalties and Interest Accrued", "terseLabel": "Interest and penalties accrued related to unrecognized tax benefits accrued and reported" } } }, "localname": "UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestAccrued", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.agilent.com/role/IncomeTaxesIncomeTaxesUncertainTaxPositionsDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestAccruedAbstract": { "auth_ref": [], "lang": { "en-US": { "role": { "label": "Unrecognized Tax Benefits, Income Tax Penalties and Interest Accrued [Abstract]", "terseLabel": "Unrecognized Tax Benefits Rollforward" } } }, "localname": "UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestAccruedAbstract", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.agilent.com/role/IncomeTaxesIncomeTaxesUncertainTaxPositionsDetails" ], "xbrltype": "stringItemType" }, "us-gaap_UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestExpense": { "auth_ref": [ "r450" ], "crdr": "debit", "lang": { "en-US": { "role": { "documentation": "Amount of expense for interest on an underpayment of income taxes and penalties related to a tax position claimed or expected to be claimed in the tax return.", "label": "Unrecognized Tax Benefits, Income Tax Penalties and Interest Expense", "terseLabel": "Unrecognized Tax Benefits, Income Tax Penalties and Interest Expense" } } }, "localname": "UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestExpense", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.agilent.com/role/IncomeTaxesIncomeTaxesUncertainTaxPositionsDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestExpenseAbstract": { "auth_ref": [], "lang": { "en-US": { "role": { "label": "Unrecognized Tax Benefits, Income Tax Penalties and Interest Expense [Abstract]", "terseLabel": "Unrecognized Tax Benefits, Income Tax Penalties and Interest Expense [Abstract]" } } }, "localname": "UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestExpenseAbstract", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.agilent.com/role/IncomeTaxesIncomeTaxesUncertainTaxPositionsDetails" ], "xbrltype": "stringItemType" }, "us-gaap_UnrecognizedTaxBenefitsIncreasesResultingFromCurrentPeriodTaxPositions": { "auth_ref": [ "r456" ], "crdr": "credit", "lang": { "en-US": { "role": { "documentation": "Amount of increase in unrecognized tax benefits resulting from tax positions that have been or will be taken in current period tax return.", "label": "Unrecognized Tax Benefits, Increase Resulting from Current Period Tax Positions", "terseLabel": "Additions for tax positions related to the current year" } } }, "localname": "UnrecognizedTaxBenefitsIncreasesResultingFromCurrentPeriodTaxPositions", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.agilent.com/role/IncomeTaxesIncomeTaxesUncertainTaxPositionsDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_UnrecognizedTaxBenefitsIncreasesResultingFromPriorPeriodTaxPositions": { "auth_ref": [ "r455" ], "crdr": "credit", "lang": { "en-US": { "role": { "documentation": "Amount of increase in unrecognized tax benefits resulting from tax positions taken in prior period tax returns.", "label": "Unrecognized Tax Benefits, Increase Resulting from Prior Period Tax Positions", "terseLabel": "Additions for tax positions from prior years" } } }, "localname": "UnrecognizedTaxBenefitsIncreasesResultingFromPriorPeriodTaxPositions", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.agilent.com/role/IncomeTaxesIncomeTaxesUncertainTaxPositionsDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_UnrecognizedTaxBenefitsReductionsResultingFromLapseOfApplicableStatuteOfLimitations": { "auth_ref": [ "r458" ], "crdr": "debit", "lang": { "en-US": { "role": { "documentation": "Amount of decrease in unrecognized tax benefits resulting from lapses of applicable statutes of limitations.", "label": "Unrecognized Tax Benefits, Reduction Resulting from Lapse of Applicable Statute of Limitations", "negatedLabel": "Statute of limitations expirations" } } }, "localname": "UnrecognizedTaxBenefitsReductionsResultingFromLapseOfApplicableStatuteOfLimitations", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.agilent.com/role/IncomeTaxesIncomeTaxesUncertainTaxPositionsDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_UnrecognizedTaxBenefitsThatWouldImpactEffectiveTaxRate": { "auth_ref": [ "r459" ], "crdr": "credit", "lang": { "en-US": { "role": { "documentation": "The total amount of unrecognized tax benefits that, if recognized, would affect the effective tax rate.", "label": "Unrecognized Tax Benefits that Would Impact Effective Tax Rate", "terseLabel": "Unrecognized Tax Benefits that Would Impact Effective Tax Rate" } } }, "localname": "UnrecognizedTaxBenefitsThatWouldImpactEffectiveTaxRate", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.agilent.com/role/IncomeTaxesIncomeTaxesUncertainTaxPositionsDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_UseOfEstimates": { "auth_ref": [ "r175", "r176", "r178", "r179", "r183", "r184", "r185" ], "lang": { "en-US": { "role": { "documentation": "Disclosure of accounting policy for the use of estimates in the preparation of financial statements in conformity with generally accepted accounting principles.", "label": "Use of Estimates, Policy [Policy Text Block]", "terseLabel": "Use of estimates" } } }, "localname": "UseOfEstimates", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.agilent.com/role/OverviewAndSummaryOfSignificantAccountingPoliciesPolicies" ], "xbrltype": "textBlockItemType" }, "us-gaap_ValuationAllowanceOfDeferredTaxAssetsMember": { "auth_ref": [ "r152" ], "lang": { "en-US": { "role": { "documentation": "Valuation allowance of deferred tax asset attributable to deductible temporary difference and carryforward.", "label": "SEC Schedule, 12-09, Valuation Allowance, Deferred Tax Asset [Member]" } } }, "localname": "ValuationAllowanceOfDeferredTaxAssetsMember", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.agilent.com/role/ScheduleIiValuationAndQualifyingAccountsDetails" ], "xbrltype": "domainItemType" }, "us-gaap_ValuationAllowancesAndReservesBalance": { "auth_ref": [ "r153" ], "crdr": "credit", "lang": { "en-US": { "role": { "documentation": "Amount of valuation and qualifying accounts and reserves.", "label": "SEC Schedule, 12-09, Valuation Allowances and Reserves, Amount", "periodEndLabel": "Balance at End of Period", "periodStartLabel": "Balance at Beginning of Period" } } }, "localname": "ValuationAllowancesAndReservesBalance", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.agilent.com/role/ScheduleIiValuationAndQualifyingAccountsDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_ValuationAllowancesAndReservesChargedToCostAndExpense": { "auth_ref": [ "r153" ], "crdr": "credit", "lang": { "en-US": { "role": { "documentation": "Amount of increase in valuation and qualifying accounts and reserves from charge to cost and expense.", "label": "SEC Schedule, 12-09, Valuation Allowances and Reserves, Additions, Charge to Cost and Expense", "verboseLabel": "Additions Charged to Expenses or Other Accounts" } } }, "localname": "ValuationAllowancesAndReservesChargedToCostAndExpense", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.agilent.com/role/ScheduleIiValuationAndQualifyingAccountsDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_ValuationAllowancesAndReservesDeductions": { "auth_ref": [ "r153" ], "crdr": "debit", "lang": { "en-US": { "role": { "documentation": "Amount of decrease in valuation and qualifying accounts and reserves.", "label": "SEC Schedule, 12-09, Valuation Allowances and Reserves, Deduction", "negatedLabel": "Deductions Credited to Expenses or Other Accounts" } } }, "localname": "ValuationAllowancesAndReservesDeductions", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.agilent.com/role/ScheduleIiValuationAndQualifyingAccountsDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_ValuationAllowancesAndReservesDomain": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Valuation and qualifying accounts and reserves.", "label": "SEC Schedule, 12-09, Valuation Allowances and Reserves [Domain]" } } }, "localname": "ValuationAllowancesAndReservesDomain", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.agilent.com/role/ScheduleIiValuationAndQualifyingAccountsDetails" ], "xbrltype": "domainItemType" }, "us-gaap_ValuationAllowancesAndReservesTypeAxis": { "auth_ref": [ "r153" ], "lang": { "en-US": { "role": { "documentation": "Information by valuation and qualifying accounts and reserves.", "label": "SEC Schedule, 12-09, Valuation Allowances and Reserves Type [Axis]" } } }, "localname": "ValuationAllowancesAndReservesTypeAxis", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.agilent.com/role/ScheduleIiValuationAndQualifyingAccountsDetails" ], "xbrltype": "stringItemType" }, "us-gaap_VariableInterestEntityConsolidatedCarryingAmountAssets": { "auth_ref": [ "r515" ], "crdr": "debit", "lang": { "en-US": { "role": { "documentation": "The carrying amount of the consolidated Variable Interest Entity's assets included in the reporting entity's statement of financial position.", "label": "Variable Interest Entity, Consolidated, Carrying Amount, Assets", "terseLabel": "Variable interest entity" } } }, "localname": "VariableInterestEntityConsolidatedCarryingAmountAssets", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.agilent.com/role/OverviewAndSummaryOfSignificantAccountingPoliciesDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_VariableInterestEntityNonconsolidatedCarryingAmountAssets": { "auth_ref": [ "r517" ], "crdr": "debit", "lang": { "en-US": { "role": { "documentation": "Carrying amount of the assets in the reporting entity's statement of financial position that relate to the reporting entity's variable interest in the Variable Interest Entity (VIE), where the reporting entity is not the VIE's primary beneficiary.", "label": "Variable Interest Entity, Nonconsolidated, Carrying Amount, Assets", "verboseLabel": "Cost method investment, VIE" } } }, "localname": "VariableInterestEntityNonconsolidatedCarryingAmountAssets", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.agilent.com/role/InvestmentsDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_VariableInterestEntityNotPrimaryBeneficiaryDisclosuresAbstract": { "auth_ref": [], "lang": { "en-US": { "role": { "label": "Variable Interest Entity, Not Primary Beneficiary, Disclosures [Abstract]", "terseLabel": "Variable Interest Entity" } } }, "localname": "VariableInterestEntityNotPrimaryBeneficiaryDisclosuresAbstract", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.agilent.com/role/OverviewAndSummaryOfSignificantAccountingPoliciesDetails" ], "xbrltype": "stringItemType" }, "us-gaap_VariableInterestEntityOwnershipPercentage": { "auth_ref": [ "r519" ], "lang": { "en-US": { "role": { "documentation": "Percentage of the Variable Interest Entity's (VIE) voting interest owned by (or beneficial interest in) the reporting entity (directly or indirectly).", "label": "Variable Interest Entity, Qualitative or Quantitative Information, Ownership Percentage", "terseLabel": "Ownership percentage" } } }, "localname": "VariableInterestEntityOwnershipPercentage", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.agilent.com/role/OverviewAndSummaryOfSignificantAccountingPoliciesDetails" ], "xbrltype": "percentItemType" }, "us-gaap_VariableRateAxis": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Information by type of variable rate.", "label": "Variable Rate [Axis]", "terseLabel": "Variable Rate [Axis]" } } }, "localname": "VariableRateAxis", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.agilent.com/role/LongTermDebtCarryingValueDetails", "http://www.agilent.com/role/LongTermDebtLongTermDebtOtherDetails" ], "xbrltype": "stringItemType" }, "us-gaap_VariableRateDomain": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Interest rate that fluctuates over time as a result of an underlying benchmark interest rate or index.", "label": "Variable Rate [Domain]", "terseLabel": "Variable Rate [Domain]" } } }, "localname": "VariableRateDomain", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.agilent.com/role/LongTermDebtCarryingValueDetails", "http://www.agilent.com/role/LongTermDebtLongTermDebtOtherDetails" ], "xbrltype": "domainItemType" }, "us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding": { "auth_ref": [ "r160", "r165" ], "lang": { "en-US": { "role": { "documentation": "The average number of shares or units issued and outstanding that are used in calculating diluted EPS or earnings per unit (EPU), determined based on the timing of issuance of shares or units in the period.", "label": "Weighted Average Number of Shares Outstanding, Diluted", "terseLabel": "Diluted (in shares)", "verboseLabel": "Diluted weighted average shares" } } }, "localname": "WeightedAverageNumberOfDilutedSharesOutstanding", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.agilent.com/role/ConsolidatedStatementOfOperations", "http://www.agilent.com/role/NetIncomeLossPerShareDetails" ], "xbrltype": "sharesItemType" }, "us-gaap_WeightedAverageNumberOfSharesOutstandingBasic": { "auth_ref": [ "r159", "r165" ], "lang": { "en-US": { "role": { "documentation": "Number of [basic] shares or units, after adjustment for contingently issuable shares or units and other shares or units not deemed outstanding, determined by relating the portion of time within a reporting period that common shares or units have been outstanding to the total time in that period.", "label": "Weighted Average Number of Shares Outstanding, Basic", "terseLabel": "Basic weighted average shares", "verboseLabel": "Basic (in shares)" } } }, "localname": "WeightedAverageNumberOfSharesOutstandingBasic", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.agilent.com/role/ConsolidatedStatementOfOperations", "http://www.agilent.com/role/NetIncomeLossPerShareDetails" ], "xbrltype": "sharesItemType" } }, "unitCount": 7 } }, "std_ref": { "r0": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(b)", "Topic": "205", "URI": "http://asc.fasb.org/extlink&oid=109222650&loc=d3e1361-107760" }, "r1": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(d)", "Topic": "205", "URI": "http://asc.fasb.org/extlink&oid=109222650&loc=d3e1361-107760" }, "r10": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(e)", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=118951113&loc=d3e6812-107765" }, "r100": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "220", "URI": "http://asc.fasb.org/extlink&oid=116657188&loc=SL116659661-227067" }, "r101": { "Name": "Accounting Standards Codification", "Paragraph": "15", "Publisher": "FASB", "Section": "55", "SubTopic": "10", "Topic": "220", "URI": "http://asc.fasb.org/extlink&oid=118951672&loc=d3e1436-108581" }, "r102": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(210.5-03(11))", "Topic": "220", "URI": "http://asc.fasb.org/extlink&oid=116634182&loc=SL114868664-224227" }, "r103": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-03(21))", "Topic": "220", "URI": "http://asc.fasb.org/extlink&oid=116634182&loc=SL114868664-224227" }, "r104": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-03)", "Topic": "220", "URI": "http://asc.fasb.org/extlink&oid=116634182&loc=SL114868664-224227" }, "r105": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-03.1)", "Topic": "220", "URI": "http://asc.fasb.org/extlink&oid=116634182&loc=SL114868664-224227" }, "r106": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-03.2(a),(d))", "Topic": "220", "URI": "http://asc.fasb.org/extlink&oid=116634182&loc=SL114868664-224227" }, "r107": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-03.4)", "Topic": "220", "URI": "http://asc.fasb.org/extlink&oid=116634182&loc=SL114868664-224227" }, "r108": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-03.7(b))", "Topic": "220", "URI": "http://asc.fasb.org/extlink&oid=116634182&loc=SL114868664-224227" }, "r109": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-03.9)", "Topic": "220", "URI": "http://asc.fasb.org/extlink&oid=116634182&loc=SL114868664-224227" }, "r11": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(f)", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=118951113&loc=d3e6812-107765" }, "r110": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Topic": "220", "URI": "http://asc.fasb.org/extlink&oid=116634182&loc=SL114868664-224227" }, "r111": { "Name": "Accounting Standards Codification", "Paragraph": "12", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "230", "URI": "http://asc.fasb.org/extlink&oid=118932676&loc=d3e3179-108585" }, "r112": { "Name": "Accounting Standards Codification", "Paragraph": "12", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "230", "URI": "http://asc.fasb.org/extlink&oid=118932676&loc=d3e3179-108585" }, "r113": { "Name": "Accounting Standards Codification", "Paragraph": "13", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "230", "URI": "http://asc.fasb.org/extlink&oid=118932676&loc=d3e3213-108585" }, "r114": { "Name": "Accounting Standards Codification", "Paragraph": "13", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "230", "URI": "http://asc.fasb.org/extlink&oid=118932676&loc=d3e3213-108585" }, "r115": { "Name": "Accounting Standards Codification", "Paragraph": "13", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "230", "URI": "http://asc.fasb.org/extlink&oid=118932676&loc=d3e3213-108585" }, "r116": { "Name": "Accounting Standards Codification", "Paragraph": "13", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "230", "URI": "http://asc.fasb.org/extlink&oid=118932676&loc=d3e3213-108585" }, "r117": { "Name": "Accounting Standards Codification", "Paragraph": "14", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "230", "URI": "http://asc.fasb.org/extlink&oid=118932676&loc=d3e3255-108585" }, "r118": { "Name": "Accounting Standards Codification", "Paragraph": "14", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "230", "URI": "http://asc.fasb.org/extlink&oid=118932676&loc=d3e3255-108585" }, "r119": { "Name": "Accounting Standards Codification", "Paragraph": "15", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "230", "URI": "http://asc.fasb.org/extlink&oid=118932676&loc=d3e3291-108585" }, "r12": { "Name": "Accounting Standards Codification", "Paragraph": "5", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=118951113&loc=d3e6904-107765" }, "r120": { "Name": "Accounting Standards Codification", "Paragraph": "15", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "230", "URI": "http://asc.fasb.org/extlink&oid=118932676&loc=d3e3291-108585" }, "r121": { "Name": "Accounting Standards Codification", "Paragraph": "15", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(e)", "Topic": "230", "URI": "http://asc.fasb.org/extlink&oid=118932676&loc=d3e3291-108585" }, "r122": { "Name": "Accounting Standards Codification", "Paragraph": "17", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(d)", "Topic": "230", "URI": "http://asc.fasb.org/extlink&oid=118932676&loc=d3e3367-108585" }, "r123": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "230", "URI": "http://asc.fasb.org/extlink&oid=118932676&loc=d3e3000-108585" }, "r124": { "Name": "Accounting Standards Codification", "Paragraph": "24", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "230", "URI": "http://asc.fasb.org/extlink&oid=118932676&loc=d3e3521-108585" }, "r125": { "Name": "Accounting Standards Codification", "Paragraph": "25", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(e)", "Topic": "230", "URI": "http://asc.fasb.org/extlink&oid=118932676&loc=d3e3536-108585" }, "r126": { "Name": "Accounting Standards Codification", "Paragraph": "25", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(f)", "Topic": "230", "URI": "http://asc.fasb.org/extlink&oid=118932676&loc=d3e3536-108585" }, "r127": { "Name": "Accounting Standards Codification", "Paragraph": "25", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "230", "URI": "http://asc.fasb.org/extlink&oid=118932676&loc=d3e3536-108585" }, "r128": { "Name": "Accounting Standards Codification", "Paragraph": "28", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "230", "URI": "http://asc.fasb.org/extlink&oid=118932676&loc=d3e3602-108585" }, "r129": { "Name": "Accounting Standards Codification", "Paragraph": "28", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "230", "URI": "http://asc.fasb.org/extlink&oid=118932676&loc=d3e3602-108585" }, "r13": { "Name": "Accounting Standards Codification", "Paragraph": "6", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=118951113&loc=d3e6911-107765" }, "r130": { "Name": "Accounting Standards Codification", "Paragraph": "28", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "230", "URI": "http://asc.fasb.org/extlink&oid=118932676&loc=d3e3602-108585" }, "r131": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "230", "URI": "http://asc.fasb.org/extlink&oid=118932676&loc=d3e3044-108585" }, "r132": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "230", "URI": "http://asc.fasb.org/extlink&oid=98513485&loc=d3e4273-108586" }, "r133": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "230", "URI": "http://asc.fasb.org/extlink&oid=98513485&loc=d3e4297-108586" }, "r134": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "230", "URI": "http://asc.fasb.org/extlink&oid=98513485&loc=d3e4304-108586" }, "r135": { "Name": "Accounting Standards Codification", "Paragraph": "8", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "230", "URI": "http://asc.fasb.org/extlink&oid=98513485&loc=SL98516268-108586" }, "r136": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "235", "URI": "http://asc.fasb.org/extlink&oid=84158767&loc=d3e18726-107790" }, "r137": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "235", "URI": "http://asc.fasb.org/extlink&oid=84158767&loc=d3e18780-107790" }, "r138": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(e)", "Topic": "235", "URI": "http://asc.fasb.org/extlink&oid=84158767&loc=d3e18823-107790" }, "r139": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(f)", "Topic": "235", "URI": "http://asc.fasb.org/extlink&oid=84158767&loc=d3e18823-107790" }, "r14": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=6361739&loc=d3e7789-107766" }, "r140": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.4-08(h)(1))", "Topic": "235", "URI": "http://asc.fasb.org/extlink&oid=26873400&loc=d3e23780-122690" }, "r141": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.4-08(h)(2))", "Topic": "235", "URI": "http://asc.fasb.org/extlink&oid=26873400&loc=d3e23780-122690" }, "r142": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.4-08(h))", "Topic": "235", "URI": "http://asc.fasb.org/extlink&oid=26873400&loc=d3e23780-122690" }, "r143": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.4-08.(d),(e))", "Topic": "235", "URI": "http://asc.fasb.org/extlink&oid=26873400&loc=d3e23780-122690" }, "r144": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.4-08.(e),(f))", "Topic": "235", "URI": "http://asc.fasb.org/extlink&oid=26873400&loc=d3e23780-122690" }, "r145": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.4-08.(f))", "Topic": "235", "URI": "http://asc.fasb.org/extlink&oid=26873400&loc=d3e23780-122690" }, "r146": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.4-08.(h)(1)(i))", "Topic": "235", "URI": "http://asc.fasb.org/extlink&oid=26873400&loc=d3e23780-122690" }, "r147": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.4-08.(h)(1))", "Topic": "235", "URI": "http://asc.fasb.org/extlink&oid=26873400&loc=d3e23780-122690" }, "r148": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.4-08.(h)(2))", "Topic": "235", "URI": "http://asc.fasb.org/extlink&oid=26873400&loc=d3e23780-122690" }, "r149": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.4-08.(h))", "Topic": "235", "URI": "http://asc.fasb.org/extlink&oid=26873400&loc=d3e23780-122690" }, "r15": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(1))", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682" }, "r150": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.4-08.(n)(2))", "Topic": "235", "URI": "http://asc.fasb.org/extlink&oid=26873400&loc=d3e23780-122690" }, "r151": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.4-08.(n))", "Topic": "235", "URI": "http://asc.fasb.org/extlink&oid=26873400&loc=d3e23780-122690" }, "r152": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.12-09(ColumnA))", "Topic": "235", "URI": "http://asc.fasb.org/extlink&oid=26873400&loc=d3e24092-122690" }, "r153": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.12-09)", "Topic": "235", "URI": "http://asc.fasb.org/extlink&oid=26873400&loc=d3e24092-122690" }, "r154": { "Name": "Accounting Standards Codification", "Publisher": "FASB", "Topic": "235", "URI": "http://asc.fasb.org/topic&trid=2122369" }, "r155": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "250", "URI": "http://asc.fasb.org/extlink&oid=109234566&loc=d3e22499-107794" }, "r156": { "Name": "Accounting Standards Codification", "Paragraph": "11", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "250", "URI": "http://asc.fasb.org/extlink&oid=109234566&loc=d3e22694-107794" }, "r157": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "250", "URI": "http://asc.fasb.org/extlink&oid=109234566&loc=d3e22583-107794" }, "r158": { "Name": "Accounting Standards Codification", "Publisher": "FASB", "Topic": "250", "URI": "http://asc.fasb.org/topic&trid=2122394" }, "r159": { "Name": "Accounting Standards Codification", "Paragraph": "10", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "260", "URI": "http://asc.fasb.org/extlink&oid=117326831&loc=d3e1448-109256" }, "r16": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(12))", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682" }, "r160": { "Name": "Accounting Standards Codification", "Paragraph": "16", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "260", "URI": "http://asc.fasb.org/extlink&oid=117326831&loc=d3e1505-109256" }, "r161": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "260", "URI": "http://asc.fasb.org/extlink&oid=117326831&loc=d3e1252-109256" }, "r162": { "Name": "Accounting Standards Codification", "Paragraph": "28A", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "260", "URI": "http://asc.fasb.org/extlink&oid=117326831&loc=d3e1500-109256" }, "r163": { "Name": "Accounting Standards Codification", "Paragraph": "60B", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(d)", "Topic": "260", "URI": "http://asc.fasb.org/extlink&oid=117326831&loc=SL5780133-109256" }, "r164": { "Name": "Accounting Standards Codification", "Paragraph": "7", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "260", "URI": "http://asc.fasb.org/extlink&oid=117326831&loc=d3e1337-109256" }, "r165": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "260", "URI": "http://asc.fasb.org/extlink&oid=6371337&loc=d3e3550-109257" }, "r166": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "260", "URI": "http://asc.fasb.org/extlink&oid=6371337&loc=d3e3550-109257" }, "r167": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "260", "URI": "http://asc.fasb.org/extlink&oid=6371337&loc=d3e3550-109257" }, "r168": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "260", "URI": "http://asc.fasb.org/extlink&oid=6371337&loc=d3e3630-109257" }, "r169": { "Name": "Accounting Standards Codification", "Paragraph": "52", "Publisher": "FASB", "Section": "55", "SubTopic": "10", "Topic": "260", "URI": "http://asc.fasb.org/extlink&oid=117327953&loc=d3e4984-109258" }, "r17": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(13))", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682" }, "r170": { "Name": "Accounting Standards Codification", "Publisher": "FASB", "Topic": "260", "URI": "http://asc.fasb.org/topic&trid=2144383" }, "r171": { "Name": "Accounting Standards Codification", "Paragraph": "12", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "270", "URI": "http://asc.fasb.org/extlink&oid=116846552&loc=d3e725-108305" }, "r172": { "Name": "Accounting Standards Codification", "Paragraph": "13", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "270", "URI": "http://asc.fasb.org/extlink&oid=116846552&loc=d3e765-108305" }, "r173": { "Name": "Accounting Standards Codification", "Paragraph": "6", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "270", "URI": "http://asc.fasb.org/extlink&oid=116846552&loc=d3e543-108305" }, "r174": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.10-01.(b)(6))", "Topic": "270", "URI": "http://asc.fasb.org/extlink&oid=27015980&loc=d3e46468-122699" }, "r175": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "275", "URI": "http://asc.fasb.org/extlink&oid=99393423&loc=d3e5967-108592" }, "r176": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "275", "URI": "http://asc.fasb.org/extlink&oid=99393423&loc=d3e5967-108592" }, "r177": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(d)", "Topic": "275", "URI": "http://asc.fasb.org/extlink&oid=99393423&loc=d3e5967-108592" }, "r178": { "Name": "Accounting Standards Codification", "Paragraph": "11", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "275", "URI": "http://asc.fasb.org/extlink&oid=99393423&loc=d3e6161-108592" }, "r179": { "Name": "Accounting Standards Codification", "Paragraph": "12", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "275", "URI": "http://asc.fasb.org/extlink&oid=99393423&loc=d3e6191-108592" }, "r18": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(14))", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682" }, "r180": { "Name": "Accounting Standards Codification", "Paragraph": "16", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "275", "URI": "http://asc.fasb.org/extlink&oid=99393423&loc=d3e6327-108592" }, "r181": { "Name": "Accounting Standards Codification", "Paragraph": "18", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "275", "URI": "http://asc.fasb.org/extlink&oid=99393423&loc=d3e6351-108592" }, "r182": { "Name": "Accounting Standards Codification", "Paragraph": "20", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "275", "URI": "http://asc.fasb.org/extlink&oid=99393423&loc=d3e6404-108592" }, "r183": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "275", "URI": "http://asc.fasb.org/extlink&oid=99393423&loc=d3e6061-108592" }, "r184": { "Name": "Accounting Standards Codification", "Paragraph": "8", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "275", "URI": "http://asc.fasb.org/extlink&oid=99393423&loc=d3e6132-108592" }, "r185": { "Name": "Accounting Standards Codification", "Paragraph": "9", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "275", "URI": "http://asc.fasb.org/extlink&oid=99393423&loc=d3e6143-108592" }, "r186": { "Name": "Accounting Standards Codification", "Publisher": "FASB", "Topic": "275", "URI": "http://asc.fasb.org/topic&trid=2134479" }, "r187": { "Name": "Accounting Standards Codification", "Paragraph": "21", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "280", "URI": "http://asc.fasb.org/extlink&oid=115929826&loc=d3e8721-108599" }, "r188": { "Name": "Accounting Standards Codification", "Paragraph": "22", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "280", "URI": "http://asc.fasb.org/extlink&oid=115929826&loc=d3e8736-108599" }, "r189": { "Name": "Accounting Standards Codification", "Paragraph": "22", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "280", "URI": "http://asc.fasb.org/extlink&oid=115929826&loc=d3e8736-108599" }, "r19": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(17))", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682" }, "r190": { "Name": "Accounting Standards Codification", "Paragraph": "22", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(d)", "Topic": "280", "URI": "http://asc.fasb.org/extlink&oid=115929826&loc=d3e8736-108599" }, "r191": { "Name": "Accounting Standards Codification", "Paragraph": "22", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(e)", "Topic": "280", "URI": "http://asc.fasb.org/extlink&oid=115929826&loc=d3e8736-108599" }, "r192": { "Name": "Accounting Standards Codification", "Paragraph": "22", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(h)", "Topic": "280", "URI": "http://asc.fasb.org/extlink&oid=115929826&loc=d3e8736-108599" }, "r193": { "Name": "Accounting Standards Codification", "Paragraph": "22", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "280", "URI": "http://asc.fasb.org/extlink&oid=115929826&loc=d3e8736-108599" }, "r194": { "Name": "Accounting Standards Codification", "Paragraph": "25", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "280", "URI": "http://asc.fasb.org/extlink&oid=115929826&loc=d3e8813-108599" }, "r195": { "Name": "Accounting Standards Codification", "Paragraph": "25", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "280", "URI": "http://asc.fasb.org/extlink&oid=115929826&loc=d3e8813-108599" }, "r196": { "Name": "Accounting Standards Codification", "Paragraph": "30", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "280", "URI": "http://asc.fasb.org/extlink&oid=115929826&loc=d3e8906-108599" }, "r197": { "Name": "Accounting Standards Codification", "Paragraph": "30", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "280", "URI": "http://asc.fasb.org/extlink&oid=115929826&loc=d3e8906-108599" }, "r198": { "Name": "Accounting Standards Codification", "Paragraph": "31", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "280", "URI": "http://asc.fasb.org/extlink&oid=115929826&loc=d3e8924-108599" }, "r199": { "Name": "Accounting Standards Codification", "Paragraph": "32", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "280", "URI": "http://asc.fasb.org/extlink&oid=115929826&loc=d3e8933-108599" }, "r2": { "Name": "Accounting Standards Codification", "Publisher": "FASB", "SubTopic": "20", "Topic": "205", "URI": "http://asc.fasb.org/subtopic&trid=2122178" }, "r20": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(19)(a))", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682" }, "r200": { "Name": "Accounting Standards Codification", "Paragraph": "32", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "280", "URI": "http://asc.fasb.org/extlink&oid=115929826&loc=d3e8933-108599" }, "r201": { "Name": "Accounting Standards Codification", "Paragraph": "40", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "280", "URI": "http://asc.fasb.org/extlink&oid=115929826&loc=d3e9031-108599" }, "r202": { "Name": "Accounting Standards Codification", "Paragraph": "41", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "280", "URI": "http://asc.fasb.org/extlink&oid=115929826&loc=d3e9038-108599" }, "r203": { "Name": "Accounting Standards Codification", "Paragraph": "41", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "280", "URI": "http://asc.fasb.org/extlink&oid=115929826&loc=d3e9038-108599" }, "r204": { "Name": "Accounting Standards Codification", "Publisher": "FASB", "Topic": "280", "URI": "http://asc.fasb.org/topic&trid=2134510" }, "r205": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "310", "URI": "http://asc.fasb.org/extlink&oid=118952595&loc=d3e4428-111522" }, "r206": { "Name": "Accounting Standards Codification", "Paragraph": "9", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "310", "URI": "http://asc.fasb.org/extlink&oid=118952595&loc=d3e4531-111522" }, "r207": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "310", "URI": "http://asc.fasb.org/extlink&oid=118936363&loc=d3e5033-111524" }, "r208": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SAB Topic 4.E)", "Topic": "310", "URI": "http://asc.fasb.org/extlink&oid=27010918&loc=d3e74512-122707" }, "r209": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Topic": "310", "URI": "http://asc.fasb.org/extlink&oid=84159169&loc=d3e10133-111534" }, "r21": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(19)(b))", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682" }, "r210": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Topic": "310", "URI": "http://asc.fasb.org/extlink&oid=84159169&loc=d3e10149-111534" }, "r211": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Topic": "310", "URI": "http://asc.fasb.org/extlink&oid=84159169&loc=d3e10178-111534" }, "r212": { "Name": "Accounting Standards Codification", "Publisher": "FASB", "Topic": "320", "URI": "http://asc.fasb.org/topic&trid=2196928" }, "r213": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "321", "URI": "http://asc.fasb.org/extlink&oid=116654751&loc=SL75117539-209714" }, "r214": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "321", "URI": "http://asc.fasb.org/extlink&oid=116654751&loc=SL75117539-209714" }, "r215": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "321", "URI": "http://asc.fasb.org/extlink&oid=116654751&loc=SL75117546-209714" }, "r216": { "Name": "Accounting Standards Codification", "Paragraph": "32", "Publisher": "FASB", "Section": "35", "SubTopic": "10", "Topic": "323", "URI": "http://asc.fasb.org/extlink&oid=118954474&loc=d3e32787-111569" }, "r217": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "323", "URI": "http://asc.fasb.org/extlink&oid=109237563&loc=d3e33749-111570" }, "r218": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "323", "URI": "http://asc.fasb.org/extlink&oid=109237563&loc=d3e33775-111570" }, "r219": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)(2)", "Topic": "323", "URI": "http://asc.fasb.org/extlink&oid=114001798&loc=d3e33918-111571" }, "r22": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(19))", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682" }, "r220": { "Name": "Accounting Standards Codification", "Paragraph": "5", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(b)", "Topic": "326", "URI": "http://asc.fasb.org/extlink&oid=119407570&loc=SL82919230-210447" }, "r221": { "Name": "Accounting Standards Codification", "Paragraph": "12", "Publisher": "FASB", "Section": "55", "SubTopic": "20", "Subparagraph": "(c)", "Topic": "326", "URI": "http://asc.fasb.org/extlink&oid=118955255&loc=SL82921835-210448" }, "r222": { "Name": "Accounting Standards Codification", "Paragraph": "8", "Publisher": "FASB", "Section": "30", "SubTopic": "10", "Topic": "330", "URI": "http://asc.fasb.org/extlink&oid=68048583&loc=d3e3636-108311" }, "r223": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "35", "SubTopic": "10", "Topic": "330", "URI": "http://asc.fasb.org/extlink&oid=116846819&loc=d3e3927-108312" }, "r224": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "330", "URI": "http://asc.fasb.org/extlink&oid=116847112&loc=d3e4492-108314" }, "r225": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "330", "URI": "http://asc.fasb.org/extlink&oid=116847112&loc=d3e4542-108314" }, "r226": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "330", "URI": "http://asc.fasb.org/extlink&oid=116847112&loc=d3e4556-108314" }, "r227": { "Name": "Accounting Standards Codification", "Publisher": "FASB", "Topic": "330", "URI": "http://asc.fasb.org/topic&trid=2126998" }, "r228": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "45", "SubTopic": "20", "Topic": "350", "URI": "http://asc.fasb.org/extlink&oid=99380562&loc=d3e13770-109266" }, "r229": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "45", "SubTopic": "20", "Topic": "350", "URI": "http://asc.fasb.org/extlink&oid=99380562&loc=d3e13777-109266" }, "r23": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(2))", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682" }, "r230": { "Name": "Accounting Standards Codification", "Paragraph": "5", "Publisher": "FASB", "Section": "45", "SubTopic": "20", "Topic": "350", "URI": "http://asc.fasb.org/extlink&oid=77989000&loc=SL49117168-202975" }, "r231": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(b)", "Topic": "350", "URI": "http://asc.fasb.org/extlink&oid=108376223&loc=d3e13816-109267" }, "r232": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(e)", "Topic": "350", "URI": "http://asc.fasb.org/extlink&oid=108376223&loc=d3e13816-109267" }, "r233": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(f)", "Topic": "350", "URI": "http://asc.fasb.org/extlink&oid=108376223&loc=d3e13816-109267" }, "r234": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Topic": "350", "URI": "http://asc.fasb.org/extlink&oid=108376223&loc=d3e13816-109267" }, "r235": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(b)", "Topic": "350", "URI": "http://asc.fasb.org/extlink&oid=108376223&loc=d3e13854-109267" }, "r236": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Topic": "350", "URI": "http://asc.fasb.org/extlink&oid=108376223&loc=d3e13854-109267" }, "r237": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "45", "SubTopic": "30", "Topic": "350", "URI": "http://asc.fasb.org/extlink&oid=6388964&loc=d3e16212-109274" }, "r238": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "45", "SubTopic": "30", "Topic": "350", "URI": "http://asc.fasb.org/extlink&oid=6388964&loc=d3e16225-109274" }, "r239": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "30", "Subparagraph": "(a)", "Topic": "350", "URI": "http://asc.fasb.org/extlink&oid=66006027&loc=d3e16265-109275" }, "r24": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(20))", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682" }, "r240": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "30", "Subparagraph": "(a)(3)", "Topic": "350", "URI": "http://asc.fasb.org/extlink&oid=66006027&loc=d3e16265-109275" }, "r241": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "30", "Subparagraph": "(d)", "Topic": "350", "URI": "http://asc.fasb.org/extlink&oid=66006027&loc=d3e16265-109275" }, "r242": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "30", "Topic": "350", "URI": "http://asc.fasb.org/extlink&oid=66006027&loc=d3e16265-109275" }, "r243": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "30", "Subparagraph": "((a)(1),(b))", "Topic": "350", "URI": "http://asc.fasb.org/extlink&oid=66006027&loc=d3e16323-109275" }, "r244": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "30", "Subparagraph": "(a)", "Topic": "350", "URI": "http://asc.fasb.org/extlink&oid=66006027&loc=d3e16323-109275" }, "r245": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "30", "Subparagraph": "(a)(1)", "Topic": "350", "URI": "http://asc.fasb.org/extlink&oid=66006027&loc=d3e16323-109275" }, "r246": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "30", "Subparagraph": "(a)(2)", "Topic": "350", "URI": "http://asc.fasb.org/extlink&oid=66006027&loc=d3e16323-109275" }, "r247": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "30", "Subparagraph": "(a)(3)", "Topic": "350", "URI": "http://asc.fasb.org/extlink&oid=66006027&loc=d3e16323-109275" }, "r248": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "30", "Subparagraph": "(b)", "Topic": "350", "URI": "http://asc.fasb.org/extlink&oid=66006027&loc=d3e16323-109275" }, "r249": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "30", "Subparagraph": "(d)", "Topic": "350", "URI": "http://asc.fasb.org/extlink&oid=66006027&loc=d3e16323-109275" }, "r25": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(22))", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682" }, "r250": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "30", "Subparagraph": "(b)", "Topic": "350", "URI": "http://asc.fasb.org/extlink&oid=66006027&loc=d3e16373-109275" }, "r251": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "30", "SubTopic": "40", "Topic": "350", "URI": "http://asc.fasb.org/extlink&oid=118172244&loc=d3e17916-109280" }, "r252": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "25", "SubTopic": "50", "Topic": "350", "URI": "http://asc.fasb.org/extlink&oid=16397303&loc=d3e19347-109286" }, "r253": { "Name": "Accounting Standards Codification", "Paragraph": "6", "Publisher": "FASB", "Section": "25", "SubTopic": "50", "Topic": "350", "URI": "http://asc.fasb.org/extlink&oid=16397303&loc=d3e19379-109286" }, "r254": { "Name": "Accounting Standards Codification", "Publisher": "FASB", "Topic": "350", "URI": "http://asc.fasb.org/topic&trid=2144416" }, "r255": { "Name": "Accounting Standards Codification", "Paragraph": "15", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "360", "URI": "http://asc.fasb.org/extlink&oid=109226348&loc=d3e2611-110228" }, "r256": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "360", "URI": "http://asc.fasb.org/extlink&oid=109226348&loc=d3e2420-110228" }, "r257": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "360", "URI": "http://asc.fasb.org/extlink&oid=6391035&loc=d3e2868-110229" }, "r258": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "360", "URI": "http://asc.fasb.org/extlink&oid=6391035&loc=d3e2868-110229" }, "r259": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "360", "URI": "http://asc.fasb.org/extlink&oid=6391035&loc=d3e2868-110229" }, "r26": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(24))", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682" }, "r260": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "360", "URI": "http://asc.fasb.org/extlink&oid=6391035&loc=d3e2868-110229" }, "r261": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "360", "URI": "http://asc.fasb.org/extlink&oid=109226691&loc=d3e2921-110230" }, "r262": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "360", "URI": "http://asc.fasb.org/extlink&oid=109226691&loc=d3e2921-110230" }, "r263": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(d)", "Topic": "360", "URI": "http://asc.fasb.org/extlink&oid=109226691&loc=d3e2941-110230" }, "r264": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(f)", "Topic": "360", "URI": "http://asc.fasb.org/extlink&oid=109226691&loc=d3e2941-110230" }, "r265": { "Name": "Accounting Standards Codification", "Publisher": "FASB", "Topic": "360", "URI": "http://asc.fasb.org/topic&trid=2155823" }, "r266": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "420", "URI": "http://asc.fasb.org/extlink&oid=6394359&loc=d3e17939-110869" }, "r267": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(d)", "Topic": "420", "URI": "http://asc.fasb.org/extlink&oid=6394359&loc=d3e17939-110869" }, "r268": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SAB Topic 5.P.3)", "Topic": "420", "URI": "http://asc.fasb.org/extlink&oid=115931487&loc=d3e140864-122747" }, "r269": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SAB Topic 5.P.4(b))", "Topic": "420", "URI": "http://asc.fasb.org/extlink&oid=115931487&loc=d3e140904-122747" }, "r27": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(26)(a))", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682" }, "r270": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SAB Topic 5.P.4(d))", "Topic": "420", "URI": "http://asc.fasb.org/extlink&oid=115931487&loc=d3e140904-122747" }, "r271": { "Name": "Accounting Standards Codification", "Publisher": "FASB", "Topic": "440", "URI": "http://asc.fasb.org/topic&trid=2144648" }, "r272": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Topic": "450", "URI": "http://asc.fasb.org/extlink&oid=118942415&loc=d3e14326-108349" }, "r273": { "Name": "Accounting Standards Codification", "Paragraph": "10", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Topic": "450", "URI": "http://asc.fasb.org/extlink&oid=118942415&loc=d3e14615-108349" }, "r274": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Topic": "450", "URI": "http://asc.fasb.org/extlink&oid=118942415&loc=d3e14394-108349" }, "r275": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Topic": "450", "URI": "http://asc.fasb.org/extlink&oid=118942415&loc=d3e14435-108349" }, "r276": { "Name": "Accounting Standards Codification", "Paragraph": "5", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Topic": "450", "URI": "http://asc.fasb.org/extlink&oid=118942415&loc=d3e14453-108349" }, "r277": { "Name": "Accounting Standards Codification", "Paragraph": "6", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Topic": "450", "URI": "http://asc.fasb.org/extlink&oid=118942415&loc=d3e14472-108349" }, "r278": { "Name": "Accounting Standards Codification", "Paragraph": "9", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Topic": "450", "URI": "http://asc.fasb.org/extlink&oid=118942415&loc=d3e14557-108349" }, "r279": { "Name": "Accounting Standards Codification", "Publisher": "FASB", "Topic": "450", "URI": "http://asc.fasb.org/topic&trid=2127136" }, "r28": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(26)(b))", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682" }, "r280": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "460", "URI": "http://asc.fasb.org/extlink&oid=118943654&loc=d3e12021-110248" }, "r281": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "460", "URI": "http://asc.fasb.org/extlink&oid=118943654&loc=d3e12053-110248" }, "r282": { "Name": "Accounting Standards Codification", "Paragraph": "8", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "((c)(2))", "Topic": "460", "URI": "http://asc.fasb.org/extlink&oid=68068213&loc=d3e12565-110249" }, "r283": { "Name": "Accounting Standards Codification", "Paragraph": "8", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "((c)(3))", "Topic": "460", "URI": "http://asc.fasb.org/extlink&oid=68068213&loc=d3e12565-110249" }, "r284": { "Name": "Accounting Standards Codification", "Paragraph": "8", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "460", "URI": "http://asc.fasb.org/extlink&oid=68068213&loc=d3e12565-110249" }, "r285": { "Name": "Accounting Standards Codification", "Paragraph": "8", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)(1),(c)(5)", "Topic": "460", "URI": "http://asc.fasb.org/extlink&oid=68068213&loc=d3e12565-110249" }, "r286": { "Name": "Accounting Standards Codification", "Paragraph": "8", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "460", "URI": "http://asc.fasb.org/extlink&oid=68068213&loc=d3e12565-110249" }, "r287": { "Name": "Accounting Standards Codification", "Publisher": "FASB", "Topic": "460", "URI": "http://asc.fasb.org/topic&trid=2155896" }, "r288": { "Name": "Accounting Standards Codification", "Paragraph": "5", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "470", "URI": "http://asc.fasb.org/extlink&oid=6802200&loc=SL6230698-112601" }, "r289": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(b)(1)", "Topic": "470", "URI": "http://asc.fasb.org/extlink&oid=109500613&loc=SL6031897-161870" }, "r29": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(27))", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682" }, "r290": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "40", "SubTopic": "50", "Topic": "470", "URI": "http://asc.fasb.org/extlink&oid=117329964&loc=d3e12317-112629" }, "r291": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "40", "SubTopic": "50", "Topic": "470", "URI": "http://asc.fasb.org/extlink&oid=117329964&loc=d3e12355-112629" }, "r292": { "Name": "Accounting Standards Codification", "Publisher": "FASB", "Topic": "470", "URI": "http://asc.fasb.org/topic&trid=2208564" }, "r293": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(CFRR 211.02)", "Topic": "480", "URI": "http://asc.fasb.org/extlink&oid=65877616&loc=d3e177068-122764" }, "r294": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "505", "URI": "http://asc.fasb.org/extlink&oid=65888546&loc=d3e21300-112643" }, "r295": { "Name": "Accounting Standards Codification", "Paragraph": "10", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "505", "URI": "http://asc.fasb.org/extlink&oid=109259400&loc=d3e21553-112644" }, "r296": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "505", "URI": "http://asc.fasb.org/extlink&oid=109259400&loc=d3e21463-112644" }, "r297": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "505", "URI": "http://asc.fasb.org/extlink&oid=109259400&loc=d3e21475-112644" }, "r298": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "505", "URI": "http://asc.fasb.org/extlink&oid=109259400&loc=d3e21484-112644" }, "r299": { "Name": "Accounting Standards Codification", "Paragraph": "5", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "505", "URI": "http://asc.fasb.org/extlink&oid=109259400&loc=d3e21488-112644" }, "r3": { "Name": "Accounting Standards Codification", "Publisher": "FASB", "Topic": "205", "URI": "http://asc.fasb.org/topic&trid=2122149" }, "r30": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(28))", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682" }, "r300": { "Name": "Accounting Standards Codification", "Paragraph": "6", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "505", "URI": "http://asc.fasb.org/extlink&oid=109259400&loc=d3e21506-112644" }, "r301": { "Name": "Accounting Standards Codification", "Paragraph": "7", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "505", "URI": "http://asc.fasb.org/extlink&oid=109259400&loc=d3e21521-112644" }, "r302": { "Name": "Accounting Standards Codification", "Paragraph": "8", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "505", "URI": "http://asc.fasb.org/extlink&oid=109259400&loc=d3e21538-112644" }, "r303": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.3-04)", "Topic": "505", "URI": "http://asc.fasb.org/extlink&oid=27012166&loc=d3e187085-122770" }, "r304": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Topic": "505", "URI": "http://asc.fasb.org/extlink&oid=27012166&loc=d3e187085-122770" }, "r305": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "45", "SubTopic": "30", "Topic": "505", "URI": "http://asc.fasb.org/extlink&oid=6405813&loc=d3e23239-112655" }, "r306": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "30", "Topic": "505", "URI": "http://asc.fasb.org/extlink&oid=6405834&loc=d3e23315-112656" }, "r307": { "Name": "Accounting Standards Codification", "Publisher": "FASB", "Topic": "505", "URI": "http://asc.fasb.org/topic&trid=2208762" }, "r308": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "606", "URI": "http://asc.fasb.org/extlink&oid=118944033&loc=SL49130531-203044" }, "r309": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "606", "URI": "http://asc.fasb.org/extlink&oid=118944033&loc=SL49130532-203044" }, "r31": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(29))", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682" }, "r310": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "606", "URI": "http://asc.fasb.org/extlink&oid=118944033&loc=SL49130533-203044" }, "r311": { "Name": "Accounting Standards Codification", "Paragraph": "10", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "606", "URI": "http://asc.fasb.org/extlink&oid=118956577&loc=SL49130551-203045" }, "r312": { "Name": "Accounting Standards Codification", "Paragraph": "10", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "606", "URI": "http://asc.fasb.org/extlink&oid=118956577&loc=SL49130551-203045" }, "r313": { "Name": "Accounting Standards Codification", "Paragraph": "13", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "606", "URI": "http://asc.fasb.org/extlink&oid=118956577&loc=SL49130556-203045" }, "r314": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "606", "URI": "http://asc.fasb.org/extlink&oid=118956577&loc=SL49130543-203045" }, "r315": { "Name": "Accounting Standards Codification", "Paragraph": "5", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "606", "URI": "http://asc.fasb.org/extlink&oid=118956577&loc=SL49130545-203045" }, "r316": { "Name": "Accounting Standards Codification", "Paragraph": "8", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "606", "URI": "http://asc.fasb.org/extlink&oid=118956577&loc=SL49130549-203045" }, "r317": { "Name": "Accounting Standards Codification", "Paragraph": "8", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "606", "URI": "http://asc.fasb.org/extlink&oid=118956577&loc=SL49130549-203045" }, "r318": { "Name": "Accounting Standards Codification", "Paragraph": "91", "Publisher": "FASB", "Section": "55", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "606", "URI": "http://asc.fasb.org/extlink&oid=118944142&loc=SL49130690-203046-203046" }, "r319": { "Name": "Accounting Standards Codification", "Paragraph": "91", "Publisher": "FASB", "Section": "55", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "606", "URI": "http://asc.fasb.org/extlink&oid=118944142&loc=SL49130690-203046-203046" }, "r32": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(3))", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682" }, "r320": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "65", "SubTopic": "10", "Subparagraph": "(i)(1)", "Topic": "606", "URI": "http://asc.fasb.org/extlink&oid=113356391&loc=SL49131195-203048" }, "r321": { "Name": "Accounting Standards Codification", "Publisher": "FASB", "Topic": "606", "URI": "http://asc.fasb.org/topic&trid=49130388" }, "r322": { "Name": "Accounting Standards Codification", "Paragraph": "11", "Publisher": "FASB", "Section": "25", "SubTopic": "10", "Topic": "710", "URI": "http://asc.fasb.org/extlink&oid=6409733&loc=d3e19524-108361" }, "r323": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "30", "SubTopic": "10", "Topic": "710", "URI": "http://asc.fasb.org/extlink&oid=6409875&loc=d3e20015-108363" }, "r324": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "15", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "712", "URI": "http://asc.fasb.org/extlink&oid=6410066&loc=d3e79218-111664" }, "r325": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "15", "SubTopic": "10", "Subparagraph": "(d)", "Topic": "712", "URI": "http://asc.fasb.org/extlink&oid=6410066&loc=d3e79218-111664" }, "r326": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "45", "SubTopic": "20", "Topic": "715", "URI": "http://asc.fasb.org/extlink&oid=109237824&loc=d3e1703-114919" }, "r327": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "45", "SubTopic": "20", "Topic": "715", "URI": "http://asc.fasb.org/extlink&oid=109237824&loc=d3e1731-114919" }, "r328": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(a)", "Topic": "715", "URI": "http://asc.fasb.org/extlink&oid=118255775&loc=d3e1928-114920" }, "r329": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(a)(1)", "Topic": "715", "URI": "http://asc.fasb.org/extlink&oid=118255775&loc=d3e1928-114920" }, "r33": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(30)(a)(1))", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682" }, "r330": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(a)(2)", "Topic": "715", "URI": "http://asc.fasb.org/extlink&oid=118255775&loc=d3e1928-114920" }, "r331": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(a)(3)", "Topic": "715", "URI": "http://asc.fasb.org/extlink&oid=118255775&loc=d3e1928-114920" }, "r332": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(a)(4)", "Topic": "715", "URI": "http://asc.fasb.org/extlink&oid=118255775&loc=d3e1928-114920" }, "r333": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(a)(5)", "Topic": "715", "URI": "http://asc.fasb.org/extlink&oid=118255775&loc=d3e1928-114920" }, "r334": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(a)(6)", "Topic": "715", "URI": "http://asc.fasb.org/extlink&oid=118255775&loc=d3e1928-114920" }, "r335": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(a)(b)(c)", "Topic": "715", "URI": "http://asc.fasb.org/extlink&oid=118255775&loc=d3e1928-114920" }, "r336": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(b)", "Topic": "715", "URI": "http://asc.fasb.org/extlink&oid=118255775&loc=d3e1928-114920" }, "r337": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(b)(1)", "Topic": "715", "URI": "http://asc.fasb.org/extlink&oid=118255775&loc=d3e1928-114920" }, "r338": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(b)(2)", "Topic": "715", "URI": "http://asc.fasb.org/extlink&oid=118255775&loc=d3e1928-114920" }, "r339": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(b)(3)", "Topic": "715", "URI": "http://asc.fasb.org/extlink&oid=118255775&loc=d3e1928-114920" }, "r34": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(30)(a)(3))", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682" }, "r340": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(b)(4)", "Topic": "715", "URI": "http://asc.fasb.org/extlink&oid=118255775&loc=d3e1928-114920" }, "r341": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(b)(5)", "Topic": "715", "URI": "http://asc.fasb.org/extlink&oid=118255775&loc=d3e1928-114920" }, "r342": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(b)(8)", "Topic": "715", "URI": "http://asc.fasb.org/extlink&oid=118255775&loc=d3e1928-114920" }, "r343": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(c)", "Topic": "715", "URI": "http://asc.fasb.org/extlink&oid=118255775&loc=d3e1928-114920" }, "r344": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(d)(i)", "Topic": "715", "URI": "http://asc.fasb.org/extlink&oid=118255775&loc=d3e1928-114920" }, "r345": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(d)(ii)", "Topic": "715", "URI": "http://asc.fasb.org/extlink&oid=118255775&loc=d3e1928-114920" }, "r346": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(d)(iv)(01)", "Topic": "715", "URI": "http://asc.fasb.org/extlink&oid=118255775&loc=d3e1928-114920" }, "r347": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(d)(iv)(02)", "Topic": "715", "URI": "http://asc.fasb.org/extlink&oid=118255775&loc=d3e1928-114920" }, "r348": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(d)(iv)(02)(A)", "Topic": "715", "URI": "http://asc.fasb.org/extlink&oid=118255775&loc=d3e1928-114920" }, "r349": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(d)(iv)(02)(B)", "Topic": "715", "URI": "http://asc.fasb.org/extlink&oid=118255775&loc=d3e1928-114920" }, "r35": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(30))", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682" }, "r350": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(d)(iv)(02)(C)", "Topic": "715", "URI": "http://asc.fasb.org/extlink&oid=118255775&loc=d3e1928-114920" }, "r351": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(f)", "Topic": "715", "URI": "http://asc.fasb.org/extlink&oid=118255775&loc=d3e1928-114920" }, "r352": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(g)", "Topic": "715", "URI": "http://asc.fasb.org/extlink&oid=118255775&loc=d3e1928-114920" }, "r353": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(h)", "Topic": "715", "URI": "http://asc.fasb.org/extlink&oid=118255775&loc=d3e1928-114920" }, "r354": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(h)(1)", "Topic": "715", "URI": "http://asc.fasb.org/extlink&oid=118255775&loc=d3e1928-114920" }, "r355": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(h)(2)", "Topic": "715", "URI": "http://asc.fasb.org/extlink&oid=118255775&loc=d3e1928-114920" }, "r356": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(h)(3)", "Topic": "715", "URI": "http://asc.fasb.org/extlink&oid=118255775&loc=d3e1928-114920" }, "r357": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(h)(4)", "Topic": "715", "URI": "http://asc.fasb.org/extlink&oid=118255775&loc=d3e1928-114920" }, "r358": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(h)(5)", "Topic": "715", "URI": "http://asc.fasb.org/extlink&oid=118255775&loc=d3e1928-114920" }, "r359": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(h)(7)", "Topic": "715", "URI": "http://asc.fasb.org/extlink&oid=118255775&loc=d3e1928-114920" }, "r36": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(31))", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682" }, "r360": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(i)", "Topic": "715", "URI": "http://asc.fasb.org/extlink&oid=118255775&loc=d3e1928-114920" }, "r361": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(i),(j)", "Topic": "715", "URI": "http://asc.fasb.org/extlink&oid=118255775&loc=d3e1928-114920" }, "r362": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(j)", "Topic": "715", "URI": "http://asc.fasb.org/extlink&oid=118255775&loc=d3e1928-114920" }, "r363": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(k)", "Topic": "715", "URI": "http://asc.fasb.org/extlink&oid=118255775&loc=d3e1928-114920" }, "r364": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(k)(1)", "Topic": "715", "URI": "http://asc.fasb.org/extlink&oid=118255775&loc=d3e1928-114920" }, "r365": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(k)(2)", "Topic": "715", "URI": "http://asc.fasb.org/extlink&oid=118255775&loc=d3e1928-114920" }, "r366": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(k)(3)", "Topic": "715", "URI": "http://asc.fasb.org/extlink&oid=118255775&loc=d3e1928-114920" }, "r367": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(l)", "Topic": "715", "URI": "http://asc.fasb.org/extlink&oid=118255775&loc=d3e1928-114920" }, "r368": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(n)", "Topic": "715", "URI": "http://asc.fasb.org/extlink&oid=118255775&loc=d3e1928-114920" }, "r369": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(r)", "Topic": "715", "URI": "http://asc.fasb.org/extlink&oid=118255775&loc=d3e1928-114920" }, "r37": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(32))", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682" }, "r370": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(s)", "Topic": "715", "URI": "http://asc.fasb.org/extlink&oid=118255775&loc=d3e1928-114920" }, "r371": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Topic": "715", "URI": "http://asc.fasb.org/extlink&oid=118255775&loc=d3e1928-114920" }, "r372": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Topic": "715", "URI": "http://asc.fasb.org/extlink&oid=118255775&loc=d3e2410-114920" }, "r373": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(a)", "Topic": "715", "URI": "http://asc.fasb.org/extlink&oid=118255775&loc=d3e2417-114920" }, "r374": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(b)", "Topic": "715", "URI": "http://asc.fasb.org/extlink&oid=118255775&loc=d3e2417-114920" }, "r375": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Topic": "715", "URI": "http://asc.fasb.org/extlink&oid=118255775&loc=d3e2417-114920" }, "r376": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Topic": "715", "URI": "http://asc.fasb.org/extlink&oid=118255775&loc=d3e2439-114920" }, "r377": { "Name": "Accounting Standards Codification", "Paragraph": "6", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(a)", "Topic": "715", "URI": "http://asc.fasb.org/extlink&oid=118255775&loc=d3e2709-114920" }, "r378": { "Name": "Accounting Standards Codification", "Paragraph": "6", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(a)(1)", "Topic": "715", "URI": "http://asc.fasb.org/extlink&oid=118255775&loc=d3e2709-114920" }, "r379": { "Name": "Accounting Standards Codification", "Paragraph": "6", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(a)(2)", "Topic": "715", "URI": "http://asc.fasb.org/extlink&oid=118255775&loc=d3e2709-114920" }, "r38": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(5))", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682" }, "r380": { "Name": "Accounting Standards Codification", "Paragraph": "6", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(a)(3)", "Topic": "715", "URI": "http://asc.fasb.org/extlink&oid=118255775&loc=d3e2709-114920" }, "r381": { "Name": "Accounting Standards Codification", "Paragraph": "6", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(a)(4)", "Topic": "715", "URI": "http://asc.fasb.org/extlink&oid=118255775&loc=d3e2709-114920" }, "r382": { "Name": "Accounting Standards Codification", "Paragraph": "6", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(a)(5)", "Topic": "715", "URI": "http://asc.fasb.org/extlink&oid=118255775&loc=d3e2709-114920" }, "r383": { "Name": "Accounting Standards Codification", "Paragraph": "6", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(a)(7)", "Topic": "715", "URI": "http://asc.fasb.org/extlink&oid=118255775&loc=d3e2709-114920" }, "r384": { "Name": "Accounting Standards Codification", "Paragraph": "6", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(b)", "Topic": "715", "URI": "http://asc.fasb.org/extlink&oid=118255775&loc=d3e2709-114920" }, "r385": { "Name": "Accounting Standards Codification", "Paragraph": "17", "Publisher": "FASB", "Section": "55", "SubTopic": "20", "Topic": "715", "URI": "http://asc.fasb.org/extlink&oid=118257860&loc=d3e4179-114921" }, "r386": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "30", "Topic": "715", "URI": "http://asc.fasb.org/extlink&oid=6412939&loc=d3e15145-114933" }, "r387": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "60", "Topic": "715", "URI": "http://asc.fasb.org/extlink&oid=66047640&loc=d3e39622-114963" }, "r388": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "60", "Topic": "715", "URI": "http://asc.fasb.org/extlink&oid=6414203&loc=d3e39716-114964" }, "r389": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "70", "Topic": "715", "URI": "http://asc.fasb.org/extlink&oid=49170846&loc=d3e28014-114942" }, "r39": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(6)(a))", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682" }, "r390": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "80", "Topic": "715", "URI": "http://asc.fasb.org/extlink&oid=65877416&loc=d3e29149-114947" }, "r391": { "Name": "Accounting Standards Codification", "Publisher": "FASB", "Topic": "715", "URI": "http://asc.fasb.org/topic&trid=2235017" }, "r392": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "35", "SubTopic": "10", "Topic": "718", "URI": "http://asc.fasb.org/extlink&oid=116855982&loc=d3e4534-113899" }, "r393": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "718", "URI": "http://asc.fasb.org/extlink&oid=116856206&loc=d3e5047-113901" }, "r394": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "718", "URI": "http://asc.fasb.org/extlink&oid=116856206&loc=d3e5047-113901" }, "r395": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "718", "URI": "http://asc.fasb.org/extlink&oid=116856206&loc=d3e5047-113901" }, "r396": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "718", "URI": "http://asc.fasb.org/extlink&oid=116856206&loc=d3e5047-113901" }, "r397": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)(1)", "Topic": "718", "URI": "http://asc.fasb.org/extlink&oid=116856206&loc=d3e5070-113901" }, "r398": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)(3)", "Topic": "718", "URI": "http://asc.fasb.org/extlink&oid=116856206&loc=d3e5070-113901" }, "r399": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a),(g)", "Topic": "718", "URI": "http://asc.fasb.org/extlink&oid=116856206&loc=d3e5070-113901" }, "r4": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=118951113&loc=d3e6676-107765" }, "r40": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(6)(b))", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682" }, "r400": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b),(f(1))", "Topic": "718", "URI": "http://asc.fasb.org/extlink&oid=116856206&loc=d3e5070-113901" }, "r401": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b),(f)", "Topic": "718", "URI": "http://asc.fasb.org/extlink&oid=116856206&loc=d3e5070-113901" }, "r402": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)(1)(i)", "Topic": "718", "URI": "http://asc.fasb.org/extlink&oid=116856206&loc=d3e5070-113901" }, "r403": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)(1)(i)-(ii)", "Topic": "718", "URI": "http://asc.fasb.org/extlink&oid=116856206&loc=d3e5070-113901" }, "r404": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)(1)(iii)", "Topic": "718", "URI": "http://asc.fasb.org/extlink&oid=116856206&loc=d3e5070-113901" }, "r405": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)(1)(iv)(2)", "Topic": "718", "URI": "http://asc.fasb.org/extlink&oid=116856206&loc=d3e5070-113901" }, "r406": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)(1)(iv)(3)", "Topic": "718", "URI": "http://asc.fasb.org/extlink&oid=116856206&loc=d3e5070-113901" }, "r407": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)(1)(iv)(3)-(4)", "Topic": "718", "URI": "http://asc.fasb.org/extlink&oid=116856206&loc=d3e5070-113901" }, "r408": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)(2)(i)-(ii)", "Topic": "718", "URI": "http://asc.fasb.org/extlink&oid=116856206&loc=d3e5070-113901" }, "r409": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)(2)(iii)(1)", "Topic": "718", "URI": "http://asc.fasb.org/extlink&oid=116856206&loc=d3e5070-113901" }, "r41": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(6)(c))", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682" }, "r410": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)(2)(iii)(2)", "Topic": "718", "URI": "http://asc.fasb.org/extlink&oid=116856206&loc=d3e5070-113901" }, "r411": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)(2)(iii)(3)", "Topic": "718", "URI": "http://asc.fasb.org/extlink&oid=116856206&loc=d3e5070-113901" }, "r412": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)(iii)", "Topic": "718", "URI": "http://asc.fasb.org/extlink&oid=116856206&loc=d3e5070-113901" }, "r413": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(d)(1)", "Topic": "718", "URI": "http://asc.fasb.org/extlink&oid=116856206&loc=d3e5070-113901" }, "r414": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(d)(2)", "Topic": "718", "URI": "http://asc.fasb.org/extlink&oid=116856206&loc=d3e5070-113901" }, "r415": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(e)", "Topic": "718", "URI": "http://asc.fasb.org/extlink&oid=116856206&loc=d3e5070-113901" }, "r416": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(e)(1)", "Topic": "718", "URI": "http://asc.fasb.org/extlink&oid=116856206&loc=d3e5070-113901" }, "r417": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(e)(2)", "Topic": "718", "URI": "http://asc.fasb.org/extlink&oid=116856206&loc=d3e5070-113901" }, "r418": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(f)", "Topic": "718", "URI": "http://asc.fasb.org/extlink&oid=116856206&loc=d3e5070-113901" }, "r419": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(f)(2)(ii)", "Topic": "718", "URI": "http://asc.fasb.org/extlink&oid=116856206&loc=d3e5070-113901" }, "r42": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02.1)", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682" }, "r420": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(f)(2)(v)", "Topic": "718", "URI": "http://asc.fasb.org/extlink&oid=116856206&loc=d3e5070-113901" }, "r421": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(g)", "Topic": "718", "URI": "http://asc.fasb.org/extlink&oid=116856206&loc=d3e5070-113901" }, "r422": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(h)(1)", "Topic": "718", "URI": "http://asc.fasb.org/extlink&oid=116856206&loc=d3e5070-113901" }, "r423": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(h)(1)(i)", "Topic": "718", "URI": "http://asc.fasb.org/extlink&oid=116856206&loc=d3e5070-113901" }, "r424": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(h)(1)(ii)", "Topic": "718", "URI": "http://asc.fasb.org/extlink&oid=116856206&loc=d3e5070-113901" }, "r425": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(i)", "Topic": "718", "URI": "http://asc.fasb.org/extlink&oid=116856206&loc=d3e5070-113901" }, "r426": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "718", "URI": "http://asc.fasb.org/extlink&oid=116856206&loc=d3e5070-113901" }, "r427": { "Name": "Accounting Standards Codification", "Paragraph": "2A", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "718", "URI": "http://asc.fasb.org/extlink&oid=116856206&loc=SL79508275-113901" }, "r428": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SAB Topic 14.F)", "Topic": "718", "URI": "http://asc.fasb.org/extlink&oid=115993241&loc=d3e301413-122809" }, "r429": { "Name": "Accounting Standards Codification", "Paragraph": "12", "Publisher": "FASB", "Section": "55", "SubTopic": "20", "Topic": "718", "URI": "http://asc.fasb.org/extlink&oid=118258462&loc=d3e11149-113907" }, "r43": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02.12)", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682" }, "r430": { "Name": "Accounting Standards Codification", "Paragraph": "13", "Publisher": "FASB", "Section": "55", "SubTopic": "20", "Topic": "718", "URI": "http://asc.fasb.org/extlink&oid=118258462&loc=d3e11178-113907" }, "r431": { "Name": "Accounting Standards Codification", "Publisher": "FASB", "Topic": "718", "URI": "http://asc.fasb.org/topic&trid=2228938" }, "r432": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "35", "Subparagraph": "(a)", "Topic": "720", "URI": "http://asc.fasb.org/extlink&oid=6420018&loc=d3e36677-107848" }, "r433": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "35", "Subparagraph": "(b)", "Topic": "720", "URI": "http://asc.fasb.org/extlink&oid=6420018&loc=d3e36677-107848" }, "r434": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "730", "URI": "http://asc.fasb.org/extlink&oid=6420194&loc=d3e21568-108373" }, "r435": { "Name": "Accounting Standards Codification", "Paragraph": "20", "Publisher": "FASB", "Section": "25", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "740", "URI": "http://asc.fasb.org/extlink&oid=117330534&loc=d3e28680-109314" }, "r436": { "Name": "Accounting Standards Codification", "Paragraph": "20", "Publisher": "FASB", "Section": "25", "SubTopic": "10", "Topic": "740", "URI": "http://asc.fasb.org/extlink&oid=117330534&loc=d3e28680-109314" }, "r437": { "Name": "Accounting Standards Codification", "Paragraph": "35", "Publisher": "FASB", "Section": "25", "SubTopic": "10", "Topic": "740", "URI": "http://asc.fasb.org/extlink&oid=117330534&loc=d3e28937-109314" }, "r438": { "Name": "Accounting Standards Codification", "Paragraph": "10B", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "740", "URI": "http://asc.fasb.org/extlink&oid=116821951&loc=SL37586934-109318" }, "r439": { "Name": "Accounting Standards Codification", "Paragraph": "15", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "740", "URI": "http://asc.fasb.org/extlink&oid=116821951&loc=d3e32059-109318" }, "r44": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02.13(a))", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682" }, "r440": { "Name": "Accounting Standards Codification", "Paragraph": "20", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "740", "URI": "http://asc.fasb.org/extlink&oid=116821951&loc=d3e32123-109318" }, "r441": { "Name": "Accounting Standards Codification", "Paragraph": "25", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "740", "URI": "http://asc.fasb.org/extlink&oid=116821951&loc=d3e32247-109318" }, "r442": { "Name": "Accounting Standards Codification", "Paragraph": "28", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "740", "URI": "http://asc.fasb.org/extlink&oid=116821951&loc=d3e32280-109318" }, "r443": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "740", "URI": "http://asc.fasb.org/extlink&oid=116821951&loc=d3e31917-109318" }, "r444": { "Name": "Accounting Standards Codification", "Paragraph": "5", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "740", "URI": "http://asc.fasb.org/extlink&oid=116821951&loc=d3e31928-109318" }, "r445": { "Name": "Accounting Standards Codification", "Paragraph": "6", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "740", "URI": "http://asc.fasb.org/extlink&oid=116821951&loc=d3e31931-109318" }, "r446": { "Name": "Accounting Standards Codification", "Paragraph": "9", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "740", "URI": "http://asc.fasb.org/extlink&oid=116821951&loc=d3e31958-109318" }, "r447": { "Name": "Accounting Standards Codification", "Paragraph": "10", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "740", "URI": "http://asc.fasb.org/extlink&oid=84230637&loc=d3e32672-109319" }, "r448": { "Name": "Accounting Standards Codification", "Paragraph": "12", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "740", "URI": "http://asc.fasb.org/extlink&oid=84230637&loc=d3e32687-109319" }, "r449": { "Name": "Accounting Standards Codification", "Paragraph": "13", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "740", "URI": "http://asc.fasb.org/extlink&oid=84230637&loc=d3e32698-109319" }, "r45": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02.13)", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682" }, "r450": { "Name": "Accounting Standards Codification", "Paragraph": "15", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "740", "URI": "http://asc.fasb.org/extlink&oid=84230637&loc=d3e32718-109319" }, "r451": { "Name": "Accounting Standards Codification", "Paragraph": "15", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(d)", "Topic": "740", "URI": "http://asc.fasb.org/extlink&oid=84230637&loc=d3e32718-109319" }, "r452": { "Name": "Accounting Standards Codification", "Paragraph": "15", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(d)(1)", "Topic": "740", "URI": "http://asc.fasb.org/extlink&oid=84230637&loc=d3e32718-109319" }, "r453": { "Name": "Accounting Standards Codification", "Paragraph": "15", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(e)", "Topic": "740", "URI": "http://asc.fasb.org/extlink&oid=84230637&loc=d3e32718-109319" }, "r454": { "Name": "Accounting Standards Codification", "Paragraph": "15A", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "740", "URI": "http://asc.fasb.org/extlink&oid=84230637&loc=SL6600010-109319" }, "r455": { "Name": "Accounting Standards Codification", "Paragraph": "15A", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)(1)", "Topic": "740", "URI": "http://asc.fasb.org/extlink&oid=84230637&loc=SL6600010-109319" }, "r456": { "Name": "Accounting Standards Codification", "Paragraph": "15A", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)(2)", "Topic": "740", "URI": "http://asc.fasb.org/extlink&oid=84230637&loc=SL6600010-109319" }, "r457": { "Name": "Accounting Standards Codification", "Paragraph": "15A", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)(3)", "Topic": "740", "URI": "http://asc.fasb.org/extlink&oid=84230637&loc=SL6600010-109319" }, "r458": { "Name": "Accounting Standards Codification", "Paragraph": "15A", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)(4)", "Topic": "740", "URI": "http://asc.fasb.org/extlink&oid=84230637&loc=SL6600010-109319" }, "r459": { "Name": "Accounting Standards Codification", "Paragraph": "15A", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "740", "URI": "http://asc.fasb.org/extlink&oid=84230637&loc=SL6600010-109319" }, "r46": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02.14)", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682" }, "r460": { "Name": "Accounting Standards Codification", "Paragraph": "15A", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "740", "URI": "http://asc.fasb.org/extlink&oid=84230637&loc=SL6600010-109319" }, "r461": { "Name": "Accounting Standards Codification", "Paragraph": "17", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "740", "URI": "http://asc.fasb.org/extlink&oid=84230637&loc=d3e32809-109319" }, "r462": { "Name": "Accounting Standards Codification", "Paragraph": "19", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "740", "URI": "http://asc.fasb.org/extlink&oid=84230637&loc=d3e32840-109319" }, "r463": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "740", "URI": "http://asc.fasb.org/extlink&oid=84230637&loc=d3e32537-109319" }, "r464": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "740", "URI": "http://asc.fasb.org/extlink&oid=84230637&loc=d3e32537-109319" }, "r465": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b),(c)", "Topic": "740", "URI": "http://asc.fasb.org/extlink&oid=84230637&loc=d3e32537-109319" }, "r466": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "740", "URI": "http://asc.fasb.org/extlink&oid=84230637&loc=d3e32537-109319" }, "r467": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "740", "URI": "http://asc.fasb.org/extlink&oid=84230637&loc=d3e32537-109319" }, "r468": { "Name": "Accounting Standards Codification", "Paragraph": "20", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "740", "URI": "http://asc.fasb.org/extlink&oid=84230637&loc=d3e32847-109319" }, "r469": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "740", "URI": "http://asc.fasb.org/extlink&oid=84230637&loc=d3e32559-109319" }, "r47": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02.15)", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682" }, "r470": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "740", "URI": "http://asc.fasb.org/extlink&oid=84230637&loc=d3e32559-109319" }, "r471": { "Name": "Accounting Standards Codification", "Paragraph": "6", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "740", "URI": "http://asc.fasb.org/extlink&oid=84230637&loc=d3e32621-109319" }, "r472": { "Name": "Accounting Standards Codification", "Paragraph": "8", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "740", "URI": "http://asc.fasb.org/extlink&oid=84230637&loc=d3e32632-109319" }, "r473": { "Name": "Accounting Standards Codification", "Paragraph": "9", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "740", "URI": "http://asc.fasb.org/extlink&oid=84230637&loc=d3e32639-109319" }, "r474": { "Name": "Accounting Standards Codification", "Paragraph": "9", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "740", "URI": "http://asc.fasb.org/extlink&oid=84230637&loc=d3e32639-109319" }, "r475": { "Name": "Accounting Standards Codification", "Paragraph": "9", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "740", "URI": "http://asc.fasb.org/extlink&oid=84230637&loc=d3e32639-109319" }, "r476": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SAB TOPIC 6.I)", "Topic": "740", "URI": "http://asc.fasb.org/extlink&oid=116825942&loc=d3e330036-122817" }, "r477": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SAB Topic 6.I.7)", "Topic": "740", "URI": "http://asc.fasb.org/extlink&oid=116825942&loc=d3e330036-122817" }, "r478": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SAB Topic 11.C)", "Topic": "740", "URI": "http://asc.fasb.org/extlink&oid=116825942&loc=d3e330215-122817" }, "r479": { "Name": "Accounting Standards Codification", "Paragraph": "11", "Publisher": "FASB", "Section": "45", "SubTopic": "20", "Subparagraph": "(b)", "Topic": "740", "URI": "http://asc.fasb.org/extlink&oid=109238882&loc=d3e39076-109324" }, "r48": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02.17)", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682" }, "r480": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "45", "SubTopic": "20", "Subparagraph": "(a)", "Topic": "740", "URI": "http://asc.fasb.org/extlink&oid=109238882&loc=d3e38679-109324" }, "r481": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "45", "SubTopic": "20", "Subparagraph": "(d)", "Topic": "740", "URI": "http://asc.fasb.org/extlink&oid=109238882&loc=d3e38679-109324" }, "r482": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "05", "SubTopic": "30", "Topic": "740", "URI": "http://asc.fasb.org/extlink&oid=65884525&loc=d3e40913-109327" }, "r483": { "Name": "Accounting Standards Codification", "Publisher": "FASB", "Topic": "740", "URI": "http://asc.fasb.org/topic&trid=2144680" }, "r484": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "05", "SubTopic": "10", "Subparagraph": "(a)-(d)", "Topic": "805", "URI": "http://asc.fasb.org/extlink&oid=6909625&loc=d3e227-128457" }, "r485": { "Name": "Accounting Standards Codification", "Paragraph": "23", "Publisher": "FASB", "Section": "25", "SubTopic": "10", "Topic": "805", "URI": "http://asc.fasb.org/extlink&oid=116868678&loc=d3e1043-128460" }, "r486": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(g)(2)", "Topic": "805", "URI": "http://asc.fasb.org/extlink&oid=79982066&loc=d3e1392-128463" }, "r487": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(h)(2)", "Topic": "805", "URI": "http://asc.fasb.org/extlink&oid=79982066&loc=d3e1392-128463" }, "r488": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(h)(3)", "Topic": "805", "URI": "http://asc.fasb.org/extlink&oid=79982066&loc=d3e1392-128463" }, "r489": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "805", "URI": "http://asc.fasb.org/extlink&oid=79982066&loc=d3e1392-128463" }, "r49": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02.19(a)(1))", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682" }, "r490": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "805", "URI": "http://asc.fasb.org/extlink&oid=79982066&loc=d3e1486-128463" }, "r491": { "Name": "Accounting Standards Codification", "Paragraph": "37", "Publisher": "FASB", "Section": "55", "SubTopic": "10", "Topic": "805", "URI": "http://asc.fasb.org/extlink&oid=116868840&loc=d3e2207-128464" }, "r492": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(c)", "Topic": "805", "URI": "http://asc.fasb.org/extlink&oid=116869197&loc=d3e4845-128472" }, "r493": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Topic": "805", "URI": "http://asc.fasb.org/extlink&oid=116869197&loc=d3e4845-128472" }, "r494": { "Name": "Accounting Standards Codification", "Paragraph": "14", "Publisher": "FASB", "Section": "55", "SubTopic": "20", "Subparagraph": "(a)", "Topic": "805", "URI": "http://asc.fasb.org/extlink&oid=77890550&loc=d3e5263-128473" }, "r495": { "Name": "Accounting Standards Codification", "Paragraph": "20", "Publisher": "FASB", "Section": "55", "SubTopic": "20", "Subparagraph": "(b)", "Topic": "805", "URI": "http://asc.fasb.org/extlink&oid=77890550&loc=d3e5333-128473" }, "r496": { "Name": "Accounting Standards Codification", "Paragraph": "20", "Publisher": "FASB", "Section": "55", "SubTopic": "20", "Subparagraph": "(c)", "Topic": "805", "URI": "http://asc.fasb.org/extlink&oid=77890550&loc=d3e5333-128473" }, "r497": { "Name": "Accounting Standards Codification", "Paragraph": "38", "Publisher": "FASB", "Section": "55", "SubTopic": "20", "Topic": "805", "URI": "http://asc.fasb.org/extlink&oid=77890550&loc=d3e5504-128473" }, "r498": { "Name": "Accounting Standards Codification", "Paragraph": "5", "Publisher": "FASB", "Section": "25", "SubTopic": "30", "Topic": "805", "URI": "http://asc.fasb.org/extlink&oid=6911189&loc=d3e6405-128476" }, "r499": { "Name": "Accounting Standards Codification", "Paragraph": "7", "Publisher": "FASB", "Section": "30", "SubTopic": "30", "Topic": "805", "URI": "http://asc.fasb.org/extlink&oid=116859721&loc=d3e6578-128477" }, "r5": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=118951113&loc=d3e6676-107765" }, "r50": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02.19(a))", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682" }, "r500": { "Name": "Accounting Standards Codification", "Paragraph": "8", "Publisher": "FASB", "Section": "30", "SubTopic": "30", "Topic": "805", "URI": "http://asc.fasb.org/extlink&oid=116859721&loc=d3e6613-128477" }, "r501": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "30", "Subparagraph": "(b)", "Topic": "805", "URI": "http://asc.fasb.org/extlink&oid=35744584&loc=d3e6927-128479" }, "r502": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "30", "Subparagraph": "(b)(1)", "Topic": "805", "URI": "http://asc.fasb.org/extlink&oid=35744584&loc=d3e6927-128479" }, "r503": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "30", "Subparagraph": "(b)(3)", "Topic": "805", "URI": "http://asc.fasb.org/extlink&oid=35744584&loc=d3e6927-128479" }, "r504": { "Name": "Accounting Standards Codification", "Publisher": "FASB", "Topic": "805", "URI": "http://asc.fasb.org/topic&trid=2303972" }, "r505": { "Name": "Accounting Standards Codification", "Paragraph": "15", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "810", "URI": "http://asc.fasb.org/extlink&oid=108774443&loc=SL4568447-111683" }, "r506": { "Name": "Accounting Standards Codification", "Paragraph": "16", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "810", "URI": "http://asc.fasb.org/extlink&oid=108774443&loc=SL4568740-111683" }, "r507": { "Name": "Accounting Standards Codification", "Paragraph": "19", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "810", "URI": "http://asc.fasb.org/extlink&oid=108774443&loc=SL4569616-111683" }, "r508": { "Name": "Accounting Standards Codification", "Paragraph": "20", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "810", "URI": "http://asc.fasb.org/extlink&oid=108774443&loc=SL4569643-111683" }, "r509": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "810", "URI": "http://asc.fasb.org/extlink&oid=109239629&loc=d3e5614-111684" }, "r51": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02.19(b),22(b))", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682" }, "r510": { "Name": "Accounting Standards Codification", "Paragraph": "1A", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)(1)", "Topic": "810", "URI": "http://asc.fasb.org/extlink&oid=109239629&loc=SL4573702-111684" }, "r511": { "Name": "Accounting Standards Codification", "Paragraph": "1A", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)(1)", "Topic": "810", "URI": "http://asc.fasb.org/extlink&oid=109239629&loc=SL4573702-111684" }, "r512": { "Name": "Accounting Standards Codification", "Paragraph": "1A", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)(3)", "Topic": "810", "URI": "http://asc.fasb.org/extlink&oid=109239629&loc=SL4573702-111684" }, "r513": { "Name": "Accounting Standards Codification", "Paragraph": "1A", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c),(3)", "Topic": "810", "URI": "http://asc.fasb.org/extlink&oid=109239629&loc=SL4573702-111684" }, "r514": { "Name": "Accounting Standards Codification", "Paragraph": "2AA", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "a", "Topic": "810", "URI": "http://asc.fasb.org/extlink&oid=118582676&loc=SL6759068-111685" }, "r515": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(bb)", "Topic": "810", "URI": "http://asc.fasb.org/extlink&oid=118582676&loc=d3e5710-111685" }, "r516": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(e)", "Topic": "810", "URI": "http://asc.fasb.org/extlink&oid=118582676&loc=d3e5728-111685" }, "r517": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "a", "Topic": "810", "URI": "http://asc.fasb.org/extlink&oid=118582676&loc=d3e5728-111685" }, "r518": { "Name": "Accounting Standards Codification", "Paragraph": "5A", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "810", "URI": "http://asc.fasb.org/extlink&oid=118582676&loc=SL6759159-111685" }, "r519": { "Name": "Accounting Standards Codification", "Paragraph": "5A", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(d)", "Topic": "810", "URI": "http://asc.fasb.org/extlink&oid=118582676&loc=SL6759159-111685" }, "r52": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02.19)", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682" }, "r520": { "Name": "Accounting Standards Codification", "Paragraph": "4I", "Publisher": "FASB", "Section": "55", "SubTopic": "10", "Topic": "810", "URI": "http://asc.fasb.org/extlink&oid=116874947&loc=SL4590271-111686" }, "r521": { "Name": "Accounting Standards Codification", "Paragraph": "4J", "Publisher": "FASB", "Section": "55", "SubTopic": "10", "Topic": "810", "URI": "http://asc.fasb.org/extlink&oid=116874947&loc=SL4591551-111686" }, "r522": { "Name": "Accounting Standards Codification", "Paragraph": "4K", "Publisher": "FASB", "Section": "55", "SubTopic": "10", "Topic": "810", "URI": "http://asc.fasb.org/extlink&oid=116874947&loc=SL4591552-111686" }, "r523": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.3A-02)", "Topic": "810", "URI": "http://asc.fasb.org/extlink&oid=116822174&loc=d3e355033-122828" }, "r524": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.3A-03)", "Topic": "810", "URI": "http://asc.fasb.org/extlink&oid=116822174&loc=d3e355100-122828" }, "r525": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "815", "URI": "http://asc.fasb.org/extlink&oid=109980867&loc=SL5579240-113959" }, "r526": { "Name": "Accounting Standards Codification", "Paragraph": "1A", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "815", "URI": "http://asc.fasb.org/extlink&oid=109980867&loc=SL5579245-113959" }, "r527": { "Name": "Accounting Standards Codification", "Paragraph": "1B", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "815", "URI": "http://asc.fasb.org/extlink&oid=109980867&loc=SL5580258-113959" }, "r528": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)(1)(ii)", "Topic": "815", "URI": "http://asc.fasb.org/extlink&oid=109980867&loc=d3e41620-113959" }, "r529": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "815", "URI": "http://asc.fasb.org/extlink&oid=109980867&loc=d3e41620-113959" }, "r53": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02.19,20)", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682" }, "r530": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "c", "Topic": "815", "URI": "http://asc.fasb.org/extlink&oid=109980867&loc=d3e41638-113959" }, "r531": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "815", "URI": "http://asc.fasb.org/extlink&oid=109980867&loc=d3e41638-113959" }, "r532": { "Name": "Accounting Standards Codification", "Paragraph": "4A", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "815", "URI": "http://asc.fasb.org/extlink&oid=109980867&loc=SL5618551-113959" }, "r533": { "Name": "Accounting Standards Codification", "Paragraph": "4A", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "815", "URI": "http://asc.fasb.org/extlink&oid=109980867&loc=SL5618551-113959" }, "r534": { "Name": "Accounting Standards Codification", "Paragraph": "4A", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)(1)", "Topic": "815", "URI": "http://asc.fasb.org/extlink&oid=109980867&loc=SL5618551-113959" }, "r535": { "Name": "Accounting Standards Codification", "Paragraph": "4B", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a),(c)", "Topic": "815", "URI": "http://asc.fasb.org/extlink&oid=109980867&loc=SL5624163-113959" }, "r536": { "Name": "Accounting Standards Codification", "Paragraph": "4B", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)(1)", "Topic": "815", "URI": "http://asc.fasb.org/extlink&oid=109980867&loc=SL5624163-113959" }, "r537": { "Name": "Accounting Standards Codification", "Paragraph": "4B", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(d)", "Topic": "815", "URI": "http://asc.fasb.org/extlink&oid=109980867&loc=SL5624163-113959" }, "r538": { "Name": "Accounting Standards Codification", "Paragraph": "4B", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "815", "URI": "http://asc.fasb.org/extlink&oid=109980867&loc=SL5624163-113959" }, "r539": { "Name": "Accounting Standards Codification", "Paragraph": "4C", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "815", "URI": "http://asc.fasb.org/extlink&oid=109980867&loc=SL5624171-113959" }, "r54": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02.19-26)", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682" }, "r540": { "Name": "Accounting Standards Codification", "Paragraph": "4C", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "815", "URI": "http://asc.fasb.org/extlink&oid=109980867&loc=SL5624171-113959" }, "r541": { "Name": "Accounting Standards Codification", "Paragraph": "4D", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "815", "URI": "http://asc.fasb.org/extlink&oid=109980867&loc=SL5624177-113959" }, "r542": { "Name": "Accounting Standards Codification", "Paragraph": "4D", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)(1)", "Topic": "815", "URI": "http://asc.fasb.org/extlink&oid=109980867&loc=SL5624177-113959" }, "r543": { "Name": "Accounting Standards Codification", "Paragraph": "4D", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)(2)", "Topic": "815", "URI": "http://asc.fasb.org/extlink&oid=109980867&loc=SL5624177-113959" }, "r544": { "Name": "Accounting Standards Codification", "Paragraph": "4D", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "815", "URI": "http://asc.fasb.org/extlink&oid=109980867&loc=SL5624177-113959" }, "r545": { "Name": "Accounting Standards Codification", "Paragraph": "4D", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "815", "URI": "http://asc.fasb.org/extlink&oid=109980867&loc=SL5624177-113959" }, "r546": { "Name": "Accounting Standards Codification", "Paragraph": "4E", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "815", "URI": "http://asc.fasb.org/extlink&oid=109980867&loc=SL5624181-113959" }, "r547": { "Name": "Accounting Standards Codification", "Paragraph": "4F", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "815", "URI": "http://asc.fasb.org/extlink&oid=109980867&loc=SL5624186-113959" }, "r548": { "Name": "Accounting Standards Codification", "Paragraph": "4H", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "815", "URI": "http://asc.fasb.org/extlink&oid=109980867&loc=SL5624258-113959" }, "r549": { "Name": "Accounting Standards Codification", "Paragraph": "5", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "815", "URI": "http://asc.fasb.org/extlink&oid=109980867&loc=d3e41641-113959" }, "r55": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02.20)", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682" }, "r550": { "Name": "Accounting Standards Codification", "Paragraph": "7", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "815", "URI": "http://asc.fasb.org/extlink&oid=109980867&loc=d3e41675-113959" }, "r551": { "Name": "Accounting Standards Codification", "Paragraph": "8", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "815", "URI": "http://asc.fasb.org/extlink&oid=109980867&loc=d3e41678-113959" }, "r552": { "Name": "Accounting Standards Codification", "Paragraph": "182", "Publisher": "FASB", "Section": "55", "SubTopic": "10", "Topic": "815", "URI": "http://asc.fasb.org/extlink&oid=116861445&loc=SL5629052-113961" }, "r553": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "25", "Topic": "815", "URI": "http://asc.fasb.org/extlink&oid=109977999&loc=d3e76258-113986" }, "r554": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "45", "SubTopic": "30", "Topic": "815", "URI": "http://asc.fasb.org/extlink&oid=109978405&loc=d3e80720-113993" }, "r555": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "30", "Subparagraph": "(c)", "Topic": "815", "URI": "http://asc.fasb.org/extlink&oid=112277219&loc=d3e80748-113994" }, "r556": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "30", "Subparagraph": "(a)", "Topic": "815", "URI": "http://asc.fasb.org/extlink&oid=112277219&loc=d3e80784-113994" }, "r557": { "Name": "Accounting Standards Codification", "Publisher": "FASB", "Topic": "815", "URI": "http://asc.fasb.org/topic&trid=2229140" }, "r558": { "Name": "Accounting Standards Codification", "Paragraph": "54B", "Publisher": "FASB", "Section": "35", "SubTopic": "10", "Topic": "820", "URI": "http://asc.fasb.org/extlink&oid=117332851&loc=SL7495116-110257" }, "r559": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "820", "URI": "http://asc.fasb.org/extlink&oid=117815213&loc=d3e19207-110258" }, "r56": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02.21)", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682" }, "r560": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "820", "URI": "http://asc.fasb.org/extlink&oid=117815213&loc=d3e19207-110258" }, "r561": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(bb)", "Topic": "820", "URI": "http://asc.fasb.org/extlink&oid=117815213&loc=d3e19207-110258" }, "r562": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(bbb)(1)", "Topic": "820", "URI": "http://asc.fasb.org/extlink&oid=117815213&loc=d3e19207-110258" }, "r563": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(bbb)(2)", "Topic": "820", "URI": "http://asc.fasb.org/extlink&oid=117815213&loc=d3e19207-110258" }, "r564": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "820", "URI": "http://asc.fasb.org/extlink&oid=117815213&loc=d3e19207-110258" }, "r565": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "820", "URI": "http://asc.fasb.org/extlink&oid=117815213&loc=d3e19279-110258" }, "r566": { "Name": "Accounting Standards Codification", "Paragraph": "6A", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "820", "URI": "http://asc.fasb.org/extlink&oid=117815213&loc=SL6742756-110258" }, "r567": { "Name": "Accounting Standards Codification", "Paragraph": "6A", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "820", "URI": "http://asc.fasb.org/extlink&oid=117815213&loc=SL6742756-110258" }, "r568": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "60", "SubTopic": "10", "Topic": "820", "URI": "http://asc.fasb.org/extlink&oid=7493716&loc=d3e21868-110260" }, "r569": { "Name": "Accounting Standards Codification", "Paragraph": "1A", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "825", "URI": "http://asc.fasb.org/extlink&oid=99377092&loc=SL75136599-209740" }, "r57": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02.22(a)(1))", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682" }, "r570": { "Name": "Accounting Standards Codification", "Paragraph": "5A", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "825", "URI": "http://asc.fasb.org/extlink&oid=116690757&loc=SL116692626-108610" }, "r571": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "825", "URI": "http://asc.fasb.org/extlink&oid=118260190&loc=d3e13279-108611" }, "r572": { "Name": "Accounting Standards Codification", "Paragraph": "10", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "825", "URI": "http://asc.fasb.org/extlink&oid=118260190&loc=d3e13433-108611" }, "r573": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "35", "SubTopic": "20", "Topic": "830", "URI": "http://asc.fasb.org/extlink&oid=118948100&loc=d3e30304-110892" }, "r574": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "45", "SubTopic": "20", "Topic": "830", "URI": "http://asc.fasb.org/extlink&oid=109240200&loc=d3e30690-110894" }, "r575": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "45", "SubTopic": "20", "Topic": "830", "URI": "http://asc.fasb.org/extlink&oid=109240200&loc=d3e30700-110894" }, "r576": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Topic": "830", "URI": "http://asc.fasb.org/extlink&oid=6450222&loc=d3e30840-110895" }, "r577": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "45", "SubTopic": "230", "Topic": "830", "URI": "http://asc.fasb.org/extlink&oid=98513438&loc=d3e33268-110906" }, "r578": { "Name": "Accounting Standards Codification", "Paragraph": "12", "Publisher": "FASB", "Section": "45", "SubTopic": "30", "Topic": "830", "URI": "http://asc.fasb.org/extlink&oid=118261656&loc=d3e32022-110900" }, "r579": { "Name": "Accounting Standards Codification", "Paragraph": "18", "Publisher": "FASB", "Section": "45", "SubTopic": "30", "Topic": "830", "URI": "http://asc.fasb.org/extlink&oid=118261656&loc=d3e32157-110900" }, "r58": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02.22(a)(2))", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682" }, "r580": { "Name": "Accounting Standards Codification", "Paragraph": "20", "Publisher": "FASB", "Section": "45", "SubTopic": "30", "Subparagraph": "(b)", "Topic": "830", "URI": "http://asc.fasb.org/extlink&oid=118261656&loc=d3e32211-110900" }, "r581": { "Name": "Accounting Standards Codification", "Paragraph": "20", "Publisher": "FASB", "Section": "45", "SubTopic": "30", "Subparagraph": "(b,d)", "Topic": "830", "URI": "http://asc.fasb.org/extlink&oid=118261656&loc=d3e32211-110900" }, "r582": { "Name": "Accounting Standards Codification", "Paragraph": "20", "Publisher": "FASB", "Section": "45", "SubTopic": "30", "Subparagraph": "(c)", "Topic": "830", "URI": "http://asc.fasb.org/extlink&oid=118261656&loc=d3e32211-110900" }, "r583": { "Name": "Accounting Standards Codification", "Paragraph": "20", "Publisher": "FASB", "Section": "45", "SubTopic": "30", "Subparagraph": "(d)", "Topic": "830", "URI": "http://asc.fasb.org/extlink&oid=118261656&loc=d3e32211-110900" }, "r584": { "Name": "Accounting Standards Codification", "Paragraph": "20", "Publisher": "FASB", "Section": "45", "SubTopic": "30", "Topic": "830", "URI": "http://asc.fasb.org/extlink&oid=118261656&loc=d3e32211-110900" }, "r585": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "30", "Topic": "830", "URI": "http://asc.fasb.org/extlink&oid=6450520&loc=d3e32583-110901" }, "r586": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(a)", "Topic": "835", "URI": "http://asc.fasb.org/extlink&oid=6450988&loc=d3e26243-108391" }, "r587": { "Name": "Accounting Standards Codification", "Paragraph": "1A", "Publisher": "FASB", "Section": "45", "SubTopic": "30", "Topic": "835", "URI": "http://asc.fasb.org/extlink&oid=114775744&loc=d3e28541-108399" }, "r588": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "45", "SubTopic": "30", "Topic": "835", "URI": "http://asc.fasb.org/extlink&oid=114775744&loc=d3e28551-108399" }, "r589": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "45", "SubTopic": "30", "Topic": "835", "URI": "http://asc.fasb.org/extlink&oid=114775744&loc=d3e28555-108399" }, "r59": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02.22(a))", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682" }, "r590": { "Name": "Accounting Standards Codification", "Paragraph": "8", "Publisher": "FASB", "Section": "55", "SubTopic": "30", "Topic": "835", "URI": "http://asc.fasb.org/extlink&oid=114775985&loc=d3e28878-108400" }, "r591": { "Name": "Accounting Standards Codification", "Paragraph": "40", "Publisher": "FASB", "Section": "55", "SubTopic": "10", "Subparagraph": "(Note 3)", "Topic": "840", "URI": "http://asc.fasb.org/extlink&oid=82846649&loc=d3e38371-112697" }, "r592": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(a)", "Topic": "840", "URI": "http://asc.fasb.org/extlink&oid=77902758&loc=d3e41502-112717" }, "r593": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Topic": "840", "URI": "http://asc.fasb.org/extlink&oid=77902758&loc=d3e41502-112717" }, "r594": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(b)", "Topic": "840", "URI": "http://asc.fasb.org/extlink&oid=84164653&loc=d3e41551-112718" }, "r595": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "45", "SubTopic": "30", "Topic": "840", "URI": "http://asc.fasb.org/extlink&oid=84164758&loc=d3e45023-112735" }, "r596": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "30", "Subparagraph": "(b)", "Topic": "840", "URI": "http://asc.fasb.org/extlink&oid=84164817&loc=d3e45280-112737" }, "r597": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "45", "SubTopic": "20", "Subparagraph": "(a)", "Topic": "842", "URI": "http://asc.fasb.org/extlink&oid=77888419&loc=SL77918627-209977" }, "r598": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(b)", "Topic": "842", "URI": "http://asc.fasb.org/extlink&oid=77888426&loc=SL77918666-209980" }, "r599": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(a)(3)", "Topic": "842", "URI": "http://asc.fasb.org/extlink&oid=77888426&loc=SL77918673-209980" }, "r6": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=118951113&loc=d3e6676-107765" }, "r60": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02.22)", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682" }, "r600": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "855", "URI": "http://asc.fasb.org/extlink&oid=6842918&loc=SL6314017-165662" }, "r601": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "855", "URI": "http://asc.fasb.org/extlink&oid=6842918&loc=SL6314020-165662" }, "r602": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(bb)", "Topic": "860", "URI": "http://asc.fasb.org/extlink&oid=118948506&loc=d3e107207-111719" }, "r603": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(bb)(1)", "Topic": "860", "URI": "http://asc.fasb.org/extlink&oid=118948506&loc=d3e107207-111719" }, "r604": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(bb)(2)", "Topic": "860", "URI": "http://asc.fasb.org/extlink&oid=118948506&loc=d3e107207-111719" }, "r605": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(bb)(3)", "Topic": "860", "URI": "http://asc.fasb.org/extlink&oid=118948506&loc=d3e107207-111719" }, "r606": { "Name": "Accounting Standards Codification", "Paragraph": "4D", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(c)(2)", "Topic": "860", "URI": "http://asc.fasb.org/extlink&oid=118948506&loc=SL51823488-111719" }, "r607": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "340", "Topic": "928", "URI": "http://asc.fasb.org/extlink&oid=6473545&loc=d3e61844-108004" }, "r608": { "Name": "Accounting Standards Codification", "Publisher": "FASB", "SubTopic": "320", "Topic": "940", "URI": "http://asc.fasb.org/subtopic&trid=2176304" }, "r609": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.9-03(10))", "Topic": "942", "URI": "http://asc.fasb.org/extlink&oid=6876686&loc=d3e534808-122878" }, "r61": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02.24)", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682" }, "r610": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.9-03(11))", "Topic": "942", "URI": "http://asc.fasb.org/extlink&oid=6876686&loc=d3e534808-122878" }, "r611": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.9-03(13))", "Topic": "942", "URI": "http://asc.fasb.org/extlink&oid=6876686&loc=d3e534808-122878" }, "r612": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.9-03(15)(1))", "Topic": "942", "URI": "http://asc.fasb.org/extlink&oid=6876686&loc=d3e534808-122878" }, "r613": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.9-03(15)(2))", "Topic": "942", "URI": "http://asc.fasb.org/extlink&oid=6876686&loc=d3e534808-122878" }, "r614": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.9-03(16))", "Topic": "942", "URI": "http://asc.fasb.org/extlink&oid=6876686&loc=d3e534808-122878" }, "r615": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.9-03(22))", "Topic": "942", "URI": "http://asc.fasb.org/extlink&oid=6876686&loc=d3e534808-122878" }, "r616": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.9-03(23))", "Topic": "942", "URI": "http://asc.fasb.org/extlink&oid=6876686&loc=d3e534808-122878" }, "r617": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.9-03(6))", "Topic": "942", "URI": "http://asc.fasb.org/extlink&oid=6876686&loc=d3e534808-122878" }, "r618": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.9-03.10)", "Topic": "942", "URI": "http://asc.fasb.org/extlink&oid=6876686&loc=d3e534808-122878" }, "r619": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.9-03.15(5))", "Topic": "942", "URI": "http://asc.fasb.org/extlink&oid=6876686&loc=d3e534808-122878" }, "r62": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02.25)", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682" }, "r620": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.9-03.17)", "Topic": "942", "URI": "http://asc.fasb.org/extlink&oid=6876686&loc=d3e534808-122878" }, "r621": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.9-03.4)", "Topic": "942", "URI": "http://asc.fasb.org/extlink&oid=6876686&loc=d3e534808-122878" }, "r622": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "220", "Subparagraph": "(SX 210.9-04(23))", "Topic": "942", "URI": "http://asc.fasb.org/extlink&oid=116637391&loc=SL114874048-224260" }, "r623": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "220", "Subparagraph": "(SX 210.9-04.9)", "Topic": "942", "URI": "http://asc.fasb.org/extlink&oid=116637391&loc=SL114874048-224260" }, "r624": { "Name": "Accounting Standards Codification", "Publisher": "FASB", "SubTopic": "320", "Topic": "942", "URI": "http://asc.fasb.org/subtopic&trid=2209399" }, "r625": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "470", "Subparagraph": "(c)", "Topic": "942", "URI": "http://asc.fasb.org/extlink&oid=75038535&loc=d3e64711-112823" }, "r626": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "470", "Subparagraph": "e", "Topic": "942", "URI": "http://asc.fasb.org/extlink&oid=75038535&loc=d3e64711-112823" }, "r627": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "470", "Topic": "942", "URI": "http://asc.fasb.org/extlink&oid=75038535&loc=d3e64711-112823" }, "r628": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "825", "Topic": "942", "URI": "http://asc.fasb.org/extlink&oid=108315417&loc=d3e61044-112788" }, "r629": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.7-03(15)(b)(2))", "Topic": "944", "URI": "http://asc.fasb.org/extlink&oid=119400593&loc=d3e572229-122910" }, "r63": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02.28,29)", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682" }, "r630": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.7-03(16))", "Topic": "944", "URI": "http://asc.fasb.org/extlink&oid=119400593&loc=d3e572229-122910" }, "r631": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.7-03(5)(c))", "Topic": "944", "URI": "http://asc.fasb.org/extlink&oid=119400593&loc=d3e572229-122910" }, "r632": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.7-03(a)(1)(b))", "Topic": "944", "URI": "http://asc.fasb.org/extlink&oid=119400593&loc=d3e572229-122910" }, "r633": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.7-03(a)(10))", "Topic": "944", "URI": "http://asc.fasb.org/extlink&oid=119400593&loc=d3e572229-122910" }, "r634": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.7-03(a)(12))", "Topic": "944", "URI": "http://asc.fasb.org/extlink&oid=119400593&loc=d3e572229-122910" }, "r635": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.7-03(a)(15)(b)(1))", "Topic": "944", "URI": "http://asc.fasb.org/extlink&oid=119400593&loc=d3e572229-122910" }, "r636": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.7-03(a)(16)(a)(1))", "Topic": "944", "URI": "http://asc.fasb.org/extlink&oid=119400593&loc=d3e572229-122910" }, "r637": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.7-03(a)(23)(a)(4))", "Topic": "944", "URI": "http://asc.fasb.org/extlink&oid=119400593&loc=d3e572229-122910" }, "r638": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.7-03(a)(24))", "Topic": "944", "URI": "http://asc.fasb.org/extlink&oid=119400593&loc=d3e572229-122910" }, "r639": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.7-03(a)(25))", "Topic": "944", "URI": "http://asc.fasb.org/extlink&oid=119400593&loc=d3e572229-122910" }, "r64": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02.29,30)", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682" }, "r640": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.7-03(a)(8))", "Topic": "944", "URI": "http://asc.fasb.org/extlink&oid=119400593&loc=d3e572229-122910" }, "r641": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.7-03.(a),19)", "Topic": "944", "URI": "http://asc.fasb.org/extlink&oid=119400593&loc=d3e572229-122910" }, "r642": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.7-03.15(a))", "Topic": "944", "URI": "http://asc.fasb.org/extlink&oid=119400593&loc=d3e572229-122910" }, "r643": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.7-03.16)", "Topic": "944", "URI": "http://asc.fasb.org/extlink&oid=119400593&loc=d3e572229-122910" }, "r644": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.7-03.5(c))", "Topic": "944", "URI": "http://asc.fasb.org/extlink&oid=119400593&loc=d3e572229-122910" }, "r645": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "220", "Subparagraph": "(SX 210.7-04(19))", "Topic": "944", "URI": "http://asc.fasb.org/extlink&oid=116637232&loc=SL114874131-224263" }, "r646": { "Name": "Accounting Standards Codification", "Paragraph": "4H", "Publisher": "FASB", "Section": "50", "SubTopic": "40", "Topic": "944", "URI": "http://asc.fasb.org/extlink&oid=116884468&loc=SL65671331-158438" }, "r647": { "Name": "Accounting Standards Codification", "Paragraph": "13H", "Publisher": "FASB", "Section": "55", "SubTopic": "40", "Subparagraph": "(a)", "Topic": "944", "URI": "http://asc.fasb.org/extlink&oid=117419784&loc=SL117783719-158441" }, "r648": { "Name": "Accounting Standards Codification", "Paragraph": "13H", "Publisher": "FASB", "Section": "55", "SubTopic": "40", "Subparagraph": "(b)", "Topic": "944", "URI": "http://asc.fasb.org/extlink&oid=117419784&loc=SL117783719-158441" }, "r649": { "Name": "Accounting Standards Codification", "Paragraph": "7", "Publisher": "FASB", "Section": "S99", "SubTopic": "320", "Subparagraph": "(SX 210.12-15)", "Topic": "946", "URI": "http://asc.fasb.org/extlink&oid=50485924&loc=d3e611379-123010" }, "r65": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02.29-31)", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682" }, "r650": { "Name": "Accounting Standards Codification", "Publisher": "FASB", "SubTopic": "320", "Topic": "946", "URI": "http://asc.fasb.org/subtopic&trid=2324412" }, "r651": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "310", "Subparagraph": "(SX 210.12-29(Footnote 4))", "Topic": "948", "URI": "http://asc.fasb.org/extlink&oid=6589523&loc=d3e617274-123014" }, "r652": { "Name": "Accounting Standards Codification", "Paragraph": "5", "Publisher": "FASB", "Section": "45", "SubTopic": "210", "Topic": "954", "URI": "http://asc.fasb.org/extlink&oid=116631420&loc=SL116631458-115580" }, "r653": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "740", "Topic": "954", "URI": "http://asc.fasb.org/extlink&oid=6491622&loc=d3e9504-115650" }, "r654": { "Name": "Accounting Standards Codification", "Paragraph": "11", "Publisher": "FASB", "Section": "45", "SubTopic": "220", "Subparagraph": "(a)", "Topic": "958", "URI": "http://asc.fasb.org/extlink&oid=114873921&loc=SL114875236-224282" }, "r655": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "360", "Subparagraph": "(SX 210.12-28(Footnote 2))", "Topic": "970", "URI": "http://asc.fasb.org/extlink&oid=6590653&loc=d3e638233-123024" }, "r656": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Topic": "985", "URI": "http://asc.fasb.org/extlink&oid=6501960&loc=d3e128462-111756" }, "r657": { "Name": "Exchange Act", "Number": "240", "Publisher": "SEC", "Section": "12", "Subsection": "b" }, "r658": { "Name": "Exchange Act", "Number": "240", "Publisher": "SEC", "Section": "12", "Subsection": "b-23" }, "r659": { "Name": "Exchange Act", "Number": "240", "Publisher": "SEC", "Section": "12", "Subsection": "d1-1" }, "r66": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02.3(a)(4))", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682" }, "r660": { "Name": "Forms 10-K, 10-Q, 20-F", "Number": "240", "Publisher": "SEC", "Section": "13", "Subsection": "a-1-" }, "r661": { "Name": "Forms 10-K, 20-F, 40-F", "Number": "240", "Publisher": "SEC", "Section": "15", "Subsection": "d-1" }, "r662": { "Name": "Regulation 12B", "Number": "240", "Publisher": "SEC", "Section": "12", "Subsection": "b-2" }, "r663": { "Name": "Regulation S-T", "Number": "232", "Publisher": "SEC", "Section": "405" }, "r664": { "Article": "12", "Name": "Regulation S-X (SX)", "Number": "210", "Publisher": "SEC", "Section": "13", "Sentence": "Column B" }, "r665": { "Footnote": "2", "Name": "Regulation S-X (SX)", "Number": "210", "Publisher": "SEC", "Section": "12", "Subsection": "28" }, "r666": { "Footnote": "4", "Name": "Regulation S-X (SX)", "Number": "210", "Publisher": "SEC", "Section": "12", "Subsection": "29" }, "r667": { "Name": "Regulation S-X (SX)", "Number": "210", "Publisher": "SEC", "Section": "12", "Subsection": "09" }, "r67": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02.31)", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682" }, "r68": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02.6(a)(1))", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682" }, "r69": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02.6(a)(3),(4))", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682" }, "r7": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=118951113&loc=d3e6676-107765" }, "r70": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02.6(a))", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682" }, "r71": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02.6(b))", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682" }, "r72": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02.8)", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682" }, "r73": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02.9)", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682" }, "r74": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(a)", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=51824906&loc=SL20225862-175312" }, "r75": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(c)", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=51824906&loc=SL20225862-175312" }, "r76": { "Name": "Accounting Standards Codification", "Paragraph": "10", "Publisher": "FASB", "Section": "55", "SubTopic": "20", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=99393222&loc=SL20226008-175313" }, "r77": { "Name": "Accounting Standards Codification", "Paragraph": "7", "Publisher": "FASB", "Section": "55", "SubTopic": "20", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=99393222&loc=SL20226000-175313" }, "r78": { "Name": "Accounting Standards Codification", "Paragraph": "10A", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "220", "URI": "http://asc.fasb.org/extlink&oid=118930883&loc=SL7669646-108580" }, "r79": { "Name": "Accounting Standards Codification", "Paragraph": "10A", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(a),(b),(c)", "Topic": "220", "URI": "http://asc.fasb.org/extlink&oid=118930883&loc=SL7669646-108580" }, "r8": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=118951113&loc=d3e6801-107765" }, "r80": { "Name": "Accounting Standards Codification", "Paragraph": "10A", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(a-c)", "Topic": "220", "URI": "http://asc.fasb.org/extlink&oid=118930883&loc=SL7669646-108580" }, "r81": { "Name": "Accounting Standards Codification", "Paragraph": "10A", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(d)", "Topic": "220", "URI": "http://asc.fasb.org/extlink&oid=118930883&loc=SL7669646-108580" }, "r82": { "Name": "Accounting Standards Codification", "Paragraph": "10A", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(i)", "Topic": "220", "URI": "http://asc.fasb.org/extlink&oid=118930883&loc=SL7669646-108580" }, "r83": { "Name": "Accounting Standards Codification", "Paragraph": "10A", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(i-k)", "Topic": "220", "URI": "http://asc.fasb.org/extlink&oid=118930883&loc=SL7669646-108580" }, "r84": { "Name": "Accounting Standards Codification", "Paragraph": "10A", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(j)", "Topic": "220", "URI": "http://asc.fasb.org/extlink&oid=118930883&loc=SL7669646-108580" }, "r85": { "Name": "Accounting Standards Codification", "Paragraph": "10A", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "220", "URI": "http://asc.fasb.org/extlink&oid=118930883&loc=SL7669646-108580" }, "r86": { "Name": "Accounting Standards Codification", "Paragraph": "11", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "220", "URI": "http://asc.fasb.org/extlink&oid=118930883&loc=d3e637-108580" }, "r87": { "Name": "Accounting Standards Codification", "Paragraph": "12", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "220", "URI": "http://asc.fasb.org/extlink&oid=118930883&loc=d3e640-108580" }, "r88": { "Name": "Accounting Standards Codification", "Paragraph": "14", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "220", "URI": "http://asc.fasb.org/extlink&oid=118930883&loc=d3e681-108580" }, "r89": { "Name": "Accounting Standards Codification", "Paragraph": "14A", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "220", "URI": "http://asc.fasb.org/extlink&oid=118930883&loc=SL7669686-108580" }, "r9": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=118951113&loc=d3e6812-107765" }, "r90": { "Name": "Accounting Standards Codification", "Paragraph": "15", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "220", "URI": "http://asc.fasb.org/extlink&oid=118930883&loc=d3e689-108580" }, "r91": { "Name": "Accounting Standards Codification", "Paragraph": "16", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "220", "URI": "http://asc.fasb.org/extlink&oid=118930883&loc=d3e709-108580" }, "r92": { "Name": "Accounting Standards Codification", "Paragraph": "17A", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "220", "URI": "http://asc.fasb.org/extlink&oid=118930883&loc=SL34724391-108580" }, "r93": { "Name": "Accounting Standards Codification", "Paragraph": "17B", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "220", "URI": "http://asc.fasb.org/extlink&oid=118930883&loc=SL34724394-108580" }, "r94": { "Name": "Accounting Standards Codification", "Paragraph": "1A", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "220", "URI": "http://asc.fasb.org/extlink&oid=118930883&loc=SL7669619-108580" }, "r95": { "Name": "Accounting Standards Codification", "Paragraph": "1A", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "220", "URI": "http://asc.fasb.org/extlink&oid=118930883&loc=SL7669619-108580" }, "r96": { "Name": "Accounting Standards Codification", "Paragraph": "1A", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "220", "URI": "http://asc.fasb.org/extlink&oid=118930883&loc=SL7669619-108580" }, "r97": { "Name": "Accounting Standards Codification", "Paragraph": "1B", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "220", "URI": "http://asc.fasb.org/extlink&oid=118930883&loc=SL7669625-108580" }, "r98": { "Name": "Accounting Standards Codification", "Paragraph": "1B", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "220", "URI": "http://asc.fasb.org/extlink&oid=118930883&loc=SL7669625-108580" }, "r99": { "Name": "Accounting Standards Codification", "Paragraph": "5", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "220", "URI": "http://asc.fasb.org/extlink&oid=118930883&loc=d3e557-108580" } }, "version": "2.1" } XML 41 R18.htm IDEA: XBRL DOCUMENT v3.19.3.a.u2
PROPERTY, PLANT AND EQUIPMENT, NET
 12 Months Ended
Oct. 31, 2019
Property, Plant and Equipment [Abstract]  
PROPERTY, PLANT AND EQUIPMENT, NET PROPERTY, PLANT AND EQUIPMENT, NET

 
October 31,
 
2019
 
2018
 
(in millions)
Land
$
57

 
$
55

Buildings and leasehold improvements
1,012

 
952

Machinery and equipment
546

 
512

Software
160

 
141

Total property, plant and equipment
1,775

 
1,660

Accumulated depreciation and amortization
(925
)
 
(838
)
Property, plant and equipment, net
$
850

 
$
822



There were no asset impairments in 2019 and 2017 and less than $1 million asset impairments in 2018. Depreciation expenses were $111 million in 2019, $102 million in 2018 and $94 million in 2017. In 2019 we retired approximately $23 million of fully depreciated assets that were no longer in use.
XML 42 R8.htm IDEA: XBRL DOCUMENT v3.19.3.a.u2
CONSOLIDATED STATEMENT OF EQUITY - USD ($)
shares in Thousands, $ in Millions
Total
Common Stock
Additional Paid-in Capital
Treasury Stock
Retained Earnings (Accumulated Deficit)
Accumulated Other Comprehensive Income (Loss)
Total Stockholders Equity
Non-controlling Interest
Treasury Stock, Number of shares       (290,075)        
Treasury Stock, Value       $ (10,508)        
Balance (in shares) at Oct. 31, 2016   613,536            
Balance at Oct. 31, 2016 $ 4,246 $ 6 $ 9,159   $ 6,089 $ (503) $ 4,243 $ 3
Components of comprehensive income, net of tax:                
Net income 684       684   684  
Other comprehensive income (loss) 157         157 157  
Total comprehensive income 841           841  
Non-controlling interest 1             1
Cash dividends declared (170)       (170)   (170)  
Share-based awards issued (in shares)   2,621            
Share-based awards issued 51   51       51  
Repurchase of common stock (in shares)       (4,107)        
Repurchase of common stock (194)     $ (194)     (194)  
Retirement of treasury stock (shares)   (294,182)   (294,182)        
Retirement of treasury stock, cost method   $ (3) (3,970) $ (10,702) (6,729)      
Share-based compensation 60   60       60  
Balance at Oct. 31, 2017 4,835 $ 3 5,300   (126) (346) 4,831 4
Balance (in shares) at Oct. 31, 2017   321,975            
Treasury Stock, Number of shares       0        
Treasury Stock, Value       $ 0        
Components of comprehensive income, net of tax:                
Net income 316       316   316  
Other comprehensive income (loss) (62)         (62) (62)  
Total comprehensive income 254           254  
Cash dividends declared (191)       (191)   (191)  
Share-based awards issued (in shares)   2,176            
Share-based awards issued 25   25       25  
Repurchase of common stock (in shares)       (6,436)        
Repurchase of common stock (422)     $ (422)     (422)  
Retirement of treasury stock (shares)   (6,436)   (6,436)        
Retirement of treasury stock, cost method   $ 0 (87) $ (422) (335)      
Share-based compensation 70   70       70  
Balance at Oct. 31, 2018 4,571 $ 3 5,308   (336) (408) 4,567 4
Balance (in shares) at Oct. 31, 2018   317,715            
Treasury Stock, Number of shares       0        
Treasury Stock, Value       $ 0        
Components of comprehensive income, net of tax:                
Adjustment due to adoption of ASU 2019-09 26       33 (7) 26  
Net income 1,071       1,071   1,071  
Other comprehensive income (loss) (99)         (99) (99)  
Total comprehensive income 972           972  
Non-controlling interest (4)             (4)
Cash dividends declared (206)       (206)   (206)  
Share-based awards issued (in shares)   1,792            
Share-based awards issued 40   40       40  
Repurchase of common stock (in shares)       (10,436)        
Repurchase of common stock (723)     $ (723)     (723)  
Retirement of treasury stock (shares)   (10,436)   (10,436)        
Retirement of treasury stock, cost method   $ 0 (143) $ (723) (580)      
Share-based compensation 72   72       72  
Balance at Oct. 31, 2019 $ 4,748 $ 3 $ 5,277   $ (18) $ (514) $ 4,748 $ 0
Balance (in shares) at Oct. 31, 2019   309,071            
Treasury Stock, Number of shares       0        
Treasury Stock, Value       $ 0        
XML 43 R33.htm IDEA: XBRL DOCUMENT v3.19.3.a.u2
ACQUISITIONS (Tables)
 12 Months Ended
Oct. 31, 2019
Business Combinations [Abstract]  
Schedule of the fair value of assets and liabilities assumed
The following table summarizes the allocation of the purchase price to the estimated fair values of the assets acquired and liabilities assumed on the closing date of August 23, 2019 (in millions):
Cash and cash equivalents
 
 
$
10

 
Accounts receivable
 
 
28

 
Inventories
 
 
21

 
Other current assets
 
 
2

 
Property, plant and equipment
 
 
8

 
Intangible assets
 
 
641

 
Goodwill
 
 
483

 
Total assets acquired
 
1,193
 
 
Accounts payable
 
 
(4
)
 
Deferred revenue
 
 
(5
)
 
Employee compensation and benefits
 
 
(7
)
 
Other accrued liabilities
 
 
(2
)
 
Long-term debt
 
 
(4
)
 
Net assets acquired
 
 
$
1,171

 
Components of intangible assets acquired
The components of intangible assets acquired in connection with the BioTek acquisition were as follows (in millions):

 
Fair Value
 
Estimated
Useful Life
Developed product technology
 
$
387

 
 
5-13 years
Customer relationships
 
202

 
 
3-8 years
Backlog
 
5

 
 
2 months
Tradenames and trademarks
 
43

 
 
10 years
Total intangible assets subject to amortization
 
637

 
 
 
In-process research and development
 
4

 
 
 
Total intangible assets
 
$
641

 
 
 
Proforma operating results
The following represents the unaudited proforma operating results as if BioTek and ACEA had been included in the company's consolidated statements of operations as of the beginning of fiscal 2018 (in millions, except per share amounts):

 
2019
 
2018
Net revenue
$
5,308

 
$
5,112

Net income
$
1,012

 
$
210

Net income per share — basic
$
3.22

 
$
0.65

Net income per share — diluted
$
3.18

 
$
0.65
XML 44 R37.htm IDEA: XBRL DOCUMENT v3.19.3.a.u2
NET INCOME (LOSS) PER SHARE (Tables)
 12 Months Ended
Oct. 31, 2019
Earnings Per Share [Abstract]  
Reconciliation of the numerators and denominators of the basic and diluted net income per share

The following is a reconciliation of the numerators and denominators of the basic and diluted net income per share computations for the periods presented below.
 
Years Ended October 31,
 
2019
 
2018
 
2017
 
(in millions)
Numerator:
 
 
 
 
 
Net income
$
1,071

 
$
316

 
$
684

Denominators:
 
 
 
 
 
Basic weighted average shares
314

 
321

 
$
322

Potential common shares — stock options and other employee stock plans
4

 
4

 
4

Diluted weighted average shares
318

 
325

 
326
XML 45 R4.htm IDEA: XBRL DOCUMENT v3.19.3.a.u2
CONSOLIDATED STATEMENT OF COMPREHENSIVE INCOME (Parenthetical) - USD ($)
$ in Millions
 12 Months Ended
Oct. 31, 2019
Oct. 31, 2018
Oct. 31, 2017
Other Comprehensive Income (Loss), Net of Tax, Portion Attributable to Parent [Abstract]      
Gain (loss) on derivative instruments, tax expense (benefit) $ (2) $ 1 $ 0
Amounts reclassified into earnings related to derivative instruments, tax expense (benefit) (2) 1 0
Foreign currency translation, tax expense (benefit) (10) 7 3
Change in actuarial net loss, tax expense (benefit) (25) (3) 52
Change in net prior service benefit, tax (benefit) $ (2) $ (2) $ (3)
XML 46 R57.htm IDEA: XBRL DOCUMENT v3.19.3.a.u2
ACQUISITIONS ACQUISITIONS - Proforma Operating Results (Details) - USD ($)
$ / shares in Units, $ in Millions
 12 Months Ended
Oct. 31, 2019
Oct. 31, 2018
Business Acquisition [Line Items]    
Proforma net revenue $ 5,308 $ 5,112
Proforma net income $ 1,012 $ 210
Proforma net income per share - basic $ 3.22 $ 0.65
Proforma net income per share - diluted $ 3.18 $ 0.65
XML 47 R53.htm IDEA: XBRL DOCUMENT v3.19.3.a.u2
NEW ACCOUNTING PRONOUNCEMENTS NEW ACCOUNTING PRONOUNCEMENTS - Restricted cash (Details) - USD ($)
$ in Millions
Oct. 31, 2019
Nov. 01, 2018
Oct. 31, 2018
Oct. 31, 2017
Oct. 31, 2016
Statement of Cash Flows [Abstract]          
Cash and cash equivalents $ 1,382 $ 2,247 $ 2,247 $ 2,678  
Restricted cash included in other assets 6   7 8  
Cash, cash equivalents and restricted cash $ 1,388   $ 2,254 $ 2,686 $ 2,295
XML 48 R80.htm IDEA: XBRL DOCUMENT v3.19.3.a.u2
GOODWILL AND OTHER INTANGIBLE ASSETS Disclosures and Components of Other Intangibles (Details) - USD ($)
$ in Millions
Oct. 31, 2019
Nov. 01, 2018
Oct. 31, 2018
Schedule of Other Intangible Assets By Major Class [Abstract]      
Gross Carrying Amount $ 1,971   $ 1,233
Accumulated Amortization 979   853
Other intangible assets, net 1,107 $ 491 491
Total amortizable intangible assets 992   380
Gross Book Value 2,086   1,344
In-Process R&D 115   111
Purchased technology      
Schedule of Other Intangible Assets By Major Class [Abstract]      
Gross Carrying Amount 1,413   947
Accumulated Amortization 763   683
Other intangible assets, net 650   264
Backlog      
Schedule of Other Intangible Assets By Major Class [Abstract]      
Gross Carrying Amount 5    
Accumulated Amortization 5    
Other intangible assets, net 0    
Trademark/Tradename      
Schedule of Other Intangible Assets By Major Class [Abstract]      
Gross Carrying Amount 196   151
Accumulated Amortization 102   88
Other intangible assets, net 94   63
Customer Relationships      
Schedule of Other Intangible Assets By Major Class [Abstract]      
Gross Carrying Amount 329   107
Accumulated Amortization 87   63
Other intangible assets, net 242   44
Third-Party Technology and Licenses [Member]      
Schedule of Other Intangible Assets By Major Class [Abstract]      
Gross Carrying Amount 28   28
Accumulated Amortization 22   19
Other intangible assets, net $ 6   $ 9
XML 49 R70.htm IDEA: XBRL DOCUMENT v3.19.3.a.u2
INCOME TAXES - 2017 U.S. Tax Reform - Tax Cuts and Jobs Act (Details) - USD ($)
$ in Millions
 12 Months Ended
Oct. 31, 2019
Oct. 31, 2018
Oct. 31, 2017
Operating Loss Carryforwards [Line Items]      
Tax Cuts and Jobs Act, Income Tax Expense (Benefit)   $ 552  
U.S. Tax Reform tax expense $ 0   $ 0
Tax Cuts and Jobs Act, Decrease in Deferred Tax Liability due to Transition Tax   152  
Tax Cuts and Jobs Act, Change in Tax Rate, Income Tax Expense (Benefit)   53  
Net transition tax   651  
Defered Tax Liability for Unremmitted earnings of foreign subsidiaries   10  
U.S. Tax Cuts and Jobs Act of 2017 [Member]      
Operating Loss Carryforwards [Line Items]      
Net transition tax   $ 499  
XML 50 R74.htm IDEA: XBRL DOCUMENT v3.19.3.a.u2
INCOME TAXES INCOME TAXES - Uncertain Tax Positions (Details) - USD ($)
$ in Millions
 12 Months Ended
Oct. 31, 2019
Oct. 31, 2018
Oct. 31, 2017
Operating Loss Carryforwards [Line Items]      
Unrecognized tax benefit including interest and penalties $ 227    
Unrecognized Tax Benefits Rollforward      
Balance, beginning of year 214 $ 224 $ 293
Additions for tax positions related to the current year 7 27 32
Additions for tax positions from prior years 12 2 1
Reductions for tax positions from prior years 2 13 3
Settlements with taxing authorities 0 0 (52)
Statute of limitations expirations (25) (26) (47)
Balance, end of year 206 214 224
Unrecognized Tax Benefits, Income Tax Penalties and Interest Expense [Abstract]      
Interest and penalties accrued related to unrecognized tax benefits accrued and reported 36 27  
Unrecognized Tax Benefits that Would Impact Effective Tax Rate 204    
Income tax expense (benefit) (152) 630 119
Unrecognized tax benefits that would not impact the effective tax rate 23    
Tax Interest and Penalties [Member]      
Operating Loss Carryforwards [Line Items]      
Unrecognized Tax Benefits, Income Tax Penalties and Interest Expense $ 9 $ 11 $ (9)
XML 51 R84.htm IDEA: XBRL DOCUMENT v3.19.3.a.u2
FAIR VALUE MEASUREMENTS FAIR VALUE MEASURMENTS - Fair value of assets and liabilities measured on non recurring (Details) - USD ($)
$ in Millions
 12 Months Ended
Oct. 31, 2019
Oct. 31, 2018
Oct. 31, 2017
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]      
Carrying value of long-lived asset   $ 21  
Long lived assets held for use impairment $ 0 21 $ 0
impairments or material changes in non-marketable securities without readily determinable fair value 0    
Fair value of assets, nonrecurring 0    
Long lived assets held for sale Impairment 0 0 $ 0
carrying amount of non-marketable equity securities without readily determinable fair values $ 47 $ 23  
XML 52 R112.htm IDEA: XBRL DOCUMENT v3.19.3.a.u2
SEGMENT INFORMATION Reconciliation of Reportable Results (Details) - USD ($)
$ in Millions
 12 Months Ended
Oct. 31, 2019
Oct. 31, 2018
Oct. 31, 2017
Reconcilitation between statement results and enterprise results [Abstract]      
Total reportable segment income from operations $ 1,202 $ 1,104 $ 973
Amortization (125) (105) (117)
Acquisition and integration costs (48) (23) (30)
Transformational initiatives (44) (25) (12)
Asset impairment charges 0 21 0
Business exit and divestiture costs (primarily our NMR business) 0 (9) 0
NASD Site costs (12) (8) 0
Special compliance costs (2) (4) 0
Other (30) (5) (7)
Interest income 36 38 22
Interest Expense (74) (75) (79)
Other income (expense), net 16 79 53
Income before taxes $ 919 $ 946 $ 803
XML 53 R88.htm IDEA: XBRL DOCUMENT v3.19.3.a.u2
DERIVATIVES, Effect of derivative instruments on Consolidated Statement of Operations (Details) - USD ($)
$ in Millions
 3 Months Ended 12 Months Ended
Jan. 31, 2018
Oct. 31, 2019
Oct. 31, 2018
Oct. 31, 2017
Derivative [Line Items]        
Loss on interest rate swaps recognized in other comprehensive income   $ 6 $ (7)  
Interest Rate Cash Flow Hedge Gain (Loss) Reclassified to Earnings, Net   (1) (1) $ 0
Gain (loss) recognized in accumulated other comprehensive income(loss)   (6) 7  
Gain(loss reclassified from accumulated other comprehensive income (loss) into cost of sales   (8) (4)  
Foreign Currency Cash Flow Hedge Gain (Loss) to be Reclassified During Next 12 Months   4    
Cash Flow Hedge Gain (Loss) to be Reclassified within Twelve Months $ 4      
Derivatives Not Designated as Hedging Instruments | Other income (expense) [Member]        
Derivative [Line Items]        
Gain (loss) recognized in other income (expense), net within continuing operations   2 (2) 5
Cash Flow Hedges | Derivatives Designated as Hedging Instrument | Interest Rate Swap [Member] | Other Comprehensive Income (Loss) [Member]        
Derivative [Line Items]        
Loss on interest rate swaps recognized in other comprehensive income   (6) 0 0
Gain (loss) recognized in accumulated other comprehensive income(loss)   6 0 0
Cash Flow Hedges | Derivatives Designated as Hedging Instrument | Forward Contracts Buy/(Sell) [Member] | Cost of Sales [Member]        
Derivative [Line Items]        
Gain (loss) recognized in other income (expense), net within continuing operations   2 0 0
Cash Flow Hedges | Derivatives Designated as Hedging Instrument | Foreign Exchange Contracts [Member] | Accumulated Other Comprehensive Income (Loss)        
Derivative [Line Items]        
Loss on interest rate swaps recognized in other comprehensive income   0 (7) 0
Gain (loss) recognized in accumulated other comprehensive income(loss)   0 7 0
Cash Flow Hedges | Derivatives Designated as Hedging Instrument | Foreign Exchange Contracts [Member] | Cost of Sales [Member]        
Derivative [Line Items]        
Gain(loss reclassified from accumulated other comprehensive income (loss) into cost of sales   $ 9 $ (3) $ 1
XML 54 R78.htm IDEA: XBRL DOCUMENT v3.19.3.a.u2
GOODWILL AND OTHER INTANGIBLE ASSETS Text (Details) - USD ($)
 12 Months Ended
Oct. 31, 2019
Oct. 31, 2018
Oct. 31, 2017
Intangible Assets, Including Goodwill)      
Goodwill Additions $ 625,000,000 $ 381,000,000  
Additions and adjustments to other intangibles   262,000,000  
Foreign exchange translation impact to other intangible assets   1,000,000  
Goodwill and Intangible Asset Impairment [Abstract]      
Goodwill impairment 0 0 $ 0
Impairment of finite-lived intangible assets 0 21,000,000 0
Impairment of indefinite-lived intangible assets $ 0 $ 0 $ 0
Business Acquisition      
Number of Businesses Acquired 2 7  
Diagnostics and Genomics      
Intangible Assets, Including Goodwill)      
Goodwill Additions   $ 281,000,000  
Indefinite-lived Intangible Assets, Purchase Accounting Adjustments $ (11,000,000)    
Life Sciences and Applied Markets      
Intangible Assets, Including Goodwill)      
Goodwill Additions 636,000,000 $ 37,000,000  
Advanced Analytical Technologies, Inc (AATI) [Member] | Diagnostics and Genomics      
Intangible Assets, Including Goodwill)      
Indefinite-lived Intangible Assets, Purchase Accounting Adjustments (11,000,000)    
BioTek and ACEA [Member]      
Intangible Assets, Including Goodwill)      
Additions and adjustments to other intangibles 744,000,000    
Business Acquisition      
Purchase price for acquisition 1,400,000,000    
BioTek and ACEA [Member] | Life Sciences and Applied Markets      
Intangible Assets, Including Goodwill)      
Goodwill Additions $ 636,000,000    
XML 55 R116.htm IDEA: XBRL DOCUMENT v3.19.3.a.u2
Schedule II Valuation and Qualifying Accounts (Details) - SEC Schedule, 12-09, Valuation Allowance, Deferred Tax Asset [Member] - USD ($)
$ in Millions
 12 Months Ended
Oct. 31, 2019
Oct. 31, 2018
Oct. 31, 2017
Movement in valuation and qualifying accounts [Roll Forward]      
Balance at Beginning of Period $ 135 $ 138 $ 129
Additions Charged to Expenses or Other Accounts 9 4 14
Deductions Credited to Expenses or Other Accounts (10) (7) (5)
Balance at End of Period $ 134 $ 135 $ 138
XML 56 R19.htm IDEA: XBRL DOCUMENT v3.19.3.a.u2
GOODWILL AND OTHER INTANGIBLE ASSETS
 12 Months Ended
Oct. 31, 2019
Goodwill and Intangible Assets Disclosure [Abstract]  
GOODWILL AND OTHER INTANGIBLE ASSETS GOODWILL AND OTHER INTANGIBLE ASSETS

The following table presents goodwill balances and the movements for each of our reportable segments during the years ended October 31, 2018 and 2019:
 
Life Sciences and Applied Markets
 
Diagnostics and Genomics
 
Agilent CrossLab
 
Total
 
(in millions)
Goodwill as of October 31, 2017
$
773

 
$
1,330

 
$
504

 
$
2,607

Foreign currency translation impact
(7
)
 
(4
)
 
(4
)
 
(15
)
Goodwill arising from acquisitions
37

 
281

 
63

 
381

Goodwill as of October 31, 2018
$
803

 
$
1,607

 
$
563

 
$
2,973

Foreign currency translation impact
(1
)
 
(2
)
 
(2
)
 
(5
)
Goodwill arising from acquisitions and adjustments
636

 
(11
)
 
—

 
625

Goodwill as of October 31, 2019
$
1,438

 
$
1,594

 
$
561

 
$
3,593

 
 
 
 
 
 
 
 


As of September 30, 2019, our annual impairment test date, we assessed goodwill impairment for our reporting units and no impairment was indicated.

The component parts of other intangible assets at October 31, 2018 and 2019 are shown in the table below:
 
Other Intangible Assets
 
Gross
Carrying
Amount
 
Accumulated
Amortization
and Impairments
 
Net Book
Value
 
(in millions)
As of October 31, 2018:
 
 
 
 
 
Purchased technology
$
947

 
$
683

 
$
264

Trademark/Tradename
151

 
88

 
63

Customer relationships
107

 
63

 
44

Third-party technology and licenses
$
28

 
$
19

 
$
9

Total amortizable intangible assets
$
1,233

 
$
853

 
$
380

In-Process R&D
111

 
—

 
111

Total
$
1,344

 
$
853

 
$
491

As of October 31, 2019:
 
 
 
 
 
Purchased technology
$
1,413

 
$
763

 
$
650

Backlog
5

 
5

 
—

Trademark/Tradename
196

 
102

 
94

Customer relationships
329

 
87

 
242

Third-party technology and licenses
$
28

 
$
22

 
$
6

Total amortizable intangible assets
$
1,971

 
$
979

 
$
992

In-Process R&D
115

 
—

 
115

Total
$
2,086

 
$
979

 
$
1,107

 
 
 
 
 
 


In 2019, we acquired two businesses, BioTek and ACEA, for a combined purchase price of approximately $1.4 billion. See Note 3, "Acquisitions", for additional information.

During fiscal year 2019, we recorded additions to goodwill of $636 million and to other intangible assets of $744 million related to the acquisition of ACEA and BioTek. In the second quarter of fiscal year 2019, we recorded a measurement period adjustment to goodwill of $11 million for deferred tax assets related to pre-acquisition net operating losses of Advanced Analytical Technologies, Inc. The increase to other intangible assets due to foreign currency translation was not material in 2019.

During fiscal year 2018, we recorded additions to goodwill of $381 million and to intangible assets of $262 million related to the acquisition of seven businesses. During the year other intangible assets decreased $1 million, due to the impact of foreign exchange translation.

In general, for United States federal tax purposes, goodwill from asset purchases is amortizable however any goodwill created as part of a stock acquisition is not deductible.

In 2019, there were no impairments of other intangible assets recorded. During 2018, we recorded an impairment charge of $21 million related to purchased intangible assets within the diagnostics and genomics segment that were deemed unrecoverable. In 2017, there were no impairments of other intangible assets recorded.

Amortization expense of intangible assets was $128 million in 2019, $110 million in 2018, and $120 million in 2017.

Future amortization expense related to existing finite-lived purchased intangible assets associated with business combinations for the next five fiscal years and thereafter is estimated below:
Estimated future amortization expense:
 
 
(in millions)
2020
$
186

2021
$
172

2022
$
150

2023
$
107

2024
$
86

Thereafter
$
291
XML 57 R15.htm IDEA: XBRL DOCUMENT v3.19.3.a.u2
INCOME TAXES
 12 Months Ended
Oct. 31, 2019
Income Tax Disclosure [Abstract]  
INCOME TAXES INCOME TAXES

The domestic and foreign components of income before taxes are:

 
Years Ended October 31,
 
2019
 
2018
 
2017
 
(in millions)
U.S. operations
$
189

 
$
169

 
$
116

Non-U.S. operations
730

 
777

 
687

Total income before taxes
$
919

 
$
946

 
$
803



The provision for income taxes is comprised of:

 
Years Ended October 31,
 
2019
 
2018
 
2017
 
(in millions)
U.S. federal taxes:
 
 
 
 
 
Current
$
(191
)
 
$
520

 
$
15

Deferred
—

 
51

 
110

Non-U.S. taxes:
 
 
 
 
 
Current
290

 
95

 
1

Deferred
(267
)
 
(22
)
 
(7
)
State taxes, net of federal benefit:
 
 
 
 
 
Current
4

 
1

 
1

Deferred
12

 
(15
)
 
(1
)
Total provision (benefit)
$
(152
)
 
$
630

 
$
119




The differences between the U.S. federal statutory income tax rate and our effective tax rate are:

 
Years Ended October 31,
 
2019
 
2018
 
2017
 
(in millions)
Profit before tax times statutory rate
$
193

 
$
221

 
$
281

Non-U.S. income taxed at different rates
(8
)
 
(93
)
 
(43
)
Change in unrecognized tax benefits
(13
)
 
(17
)
 
(110
)
Impact of the Tax Act
—

 
552

 
—

Extension of the tax incentive in Singapore
(299
)
 
—

 
—

Other, net
(25
)
 
(33
)
 
(9
)
Provision (benefit) for income taxes
$
(152
)
 
$
630

 
$
119

Effective tax rate
(16.5
)%
 
66.6
%
 
14.8
%



For 2019, the company's income tax benefit was $152 million with an effective tax rate of (16.5) percent. For the year ended October 31, 2019, our effective tax rate and the resulting provision for income taxes were significantly impacted by the discrete benefit of $299 million related to the extension of the company’s tax incentive in Singapore.

As part of the business integration of some of our prior acquisitions, we undertook corporate restructurings in the fourth quarter of fiscal year 2019 that involved on-shoring certain intangible properties held by our foreign subsidiaries to the United States.  These restructurings resulted in a cash tax liability of $231 million.  These taxes generate tax attributes that will offset our transition tax liability which is included in other long-term liabilities in our consolidated balance sheet. 

For 2018, the company's income tax expense was $630 million with an effective tax rate of 66.6 percent. For the year ended October 31, 2018, our effective tax rate and the resulting provision for income taxes were significantly impacted by the discrete charge of $552 million related to the enactment of the U.S. Tax Cuts and Jobs Act (the “Tax Act”) as discussed below.

For 2017, the company’s income tax expense was $119 million with an effective tax rate of 14.8 percent. Our effective tax rate is impacted by earnings realized in foreign jurisdictions with statutory tax rates lower than the federal statutory tax rate. During the year, the company determined a portion of current year foreign earnings from its low tax jurisdictions would not be considered as indefinitely reinvested. As such, a deferred tax liability for that portion of unremitted foreign earnings was accrued causing an increase in the annual tax expense. Our annual effective tax rate also included tax benefits due to the settlement of an audit in Germany for the years 2005 through 2008 and the lapse of U.S. statute of limitation for the fiscal years 2012 and 2013. This benefit was offset by a deferred tax liability required for the tax expected upon repatriation of related unremitted foreign earnings that were not asserted as indefinitely invested outside the U.S.

The company has negotiated tax holidays in several different jurisdictions, most significantly in Singapore. The tax holidays provide lower rates of taxation on certain classes of income and require various thresholds of investments and employment or specific types of income in those jurisdictions. In December 2018, the tax holiday in Singapore was renegotiated and extended through 2027. Other tax holidays are due for renewal in 2020. As a result of the incentives, the impact of the tax holidays decreased income taxes by $368 million, $87 million, and $93 million in 2019, 2018, and 2017, respectively. The benefit of the tax holidays on net income per share (diluted) was approximately $1.16, $0.27, and $0.29 in 2019, 2018 and 2017, respectively. The increase in the benefit from 2018 to 2019 is primarily due to the Singapore restructuring and tax incentive modifications completed in 2019 in response to Singapore tax law changes. Of the $1.16 benefit of the tax incentives on net income per share (diluted) in 2019, $0.94 of the benefit relates to one-time items from the Singapore restructuring.

2017 U.S. Tax Reform - Tax Cuts and Jobs Act

On December 22, 2017, the Tax Act was enacted into law. The Tax Act enacted significant changes affecting our fiscal year 2018, including, but not limited to, (1) reducing the U.S. federal corporate tax rate and (2) imposing a one-time transition tax on certain unrepatriated earnings of foreign subsidiaries that had not been previously taxed in the U.S.

The Tax Act also established new tax provisions affecting our fiscal year 2019, including, but not limited to, (1) creating a new provision designed to tax global intangible low-tax income (“GILTI”); (2) generally eliminating U.S. federal taxes on
dividends from foreign subsidiaries; (3) eliminating the corporate alternative minimum tax (“AMT”); (4) creating the base erosion anti-abuse tax (“BEAT”); (5) establishing a deduction for foreign derived intangible income ("FDII"); (6) repealing domestic production activity deduction; and (7) establishing new limitations on deductible interest expense and certain executive compensation.

ASC 740, Income Taxes, requires companies to recognize the effect of the tax law changes in the period of enactment. However, the SEC staff issued Staff Accounting Bulletin 118 ("SAB 118") which allowed companies to record provisional amounts during a measurement period not extending beyond one year from the Tax Act enactment date. For the year ended October 31, 2018, the company recognized income tax expense related to the Tax Act of $552 million which includes (1) an expense of $499 million of U.S. transition tax and correlative items on deemed repatriated earnings of non-U.S. subsidiaries and (2) an expense of $53 million associated with the impact on deferred taxes resulting from the decreased U.S. corporate tax rate as described below.

Deemed Repatriation Transition Tax ("Transition Tax"): The Transition Tax is based on the company’s total unrepatriated post-1986 earnings and profits ("E&P") of its foreign subsidiaries and the amount of non-U.S. taxes paid (Tax Pools) on such earnings. Historically, the company permanently reinvested a significant portion of these post-1986 E&P outside the U.S. For the remaining portion, the company previously accrued deferred taxes. Since the Tax Act required all foreign earnings to be taxed currently, the company recorded an income tax expense of $651 million for its one-time transition U.S. federal tax and a benefit of $152 million for the reversal of related deferred tax liabilities. The resulting $499 million net transition tax, reduced by existing tax credits, will be paid over 8 years in accordance with the election available under the Tax Act. We have completed our accounting for charges related to the Transition Tax.

Reduction of U.S. Federal Corporate Tax Rate: The reduction of the corporate income tax rate requires companies to remeasure their deferred tax assets and liabilities as of the date of enactment. The amount recorded for the year ended October31, 2018 for the remeasurement due to tax rate change is $53 million. We have completed our accounting for the measurement of deferred taxes.

GILTI: The Tax Act subjects a U.S. corporation to tax on its GILTI. U.S. GAAP allows companies to make an accounting policy election to either (1) treat taxes due on future GILTI inclusions in the U.S. taxable income as a current-period expense when incurred (“period cost method”) or (2) factoring such amounts into a company’s measurement of its deferred taxes (“deferred method”). We have completed our analysis and elected to treat GILTI as a “current period cost”.

Indefinite Reinvestment Assertion: Prior to the enactment of the Tax Act, the company had indefinite investment assertion on a significant portion of its undistributed earnings from foreign subsidiaries. As a result of the enactment of the Tax Act, we have reevaluated our historic assertion and no longer consider these earnings to be indefinitely reinvested in our foreign subsidiaries. The company has recorded a deferred tax liability of $10 million for foreign withholding taxes on repatriation of remaining undistributed earnings.


The significant components of deferred tax assets and deferred tax liabilities included on the consolidated balance sheet are:

 
Years Ended October 31,
 
2019
 
2018
 
(in millions)
Deferred Tax Assets
 
 
 
Intangibles
$
131

 
$
—

Property, plant and equipment
—

 
8

Pension benefits and retiree medical benefits
71

 
49

Employee benefits, other than retirement
34

 
34

Net operating loss, capital loss, and credit carryforwards
195

 
185

Share-based compensation
32

 
31

Deferred revenue
38

 
38

Other
35

 
19

Deferred tax assets
$
536

 
$
364

Tax valuation allowance
(134
)
 
(135
)
Deferred tax assets, net of valuation allowance
$
402

 
$
229

 
 
 
 
Deferred Tax Liabilities
 
 
 
Intangibles
$
—

 
$
(112
)
Property, plant and equipment
(16
)
 
—

Other
(7
)
 
(21
)
Deferred tax liabilities
$
(23
)
 
$
(133
)
Net deferred tax assets (liabilities)
$
379

 
$
96



The increase in 2019 as compared to 2018 for the deferred tax asset and liabilities was primarily due to the benefit of $299 million related to the extension of the company’s tax incentive in Singapore.

Valuation allowances require an assessment of both positive and negative evidence when determining whether it is more likely than not that deferred tax assets are recoverable. Such assessment is required on a jurisdiction by jurisdiction basis. As of October 31, 2019, we continued to maintain a valuation allowance of $134 million until sufficient positive evidence exists to support reversal. The valuation allowance is primarily related to deferred tax assets for the states of California and Colorado, along with the net operating losses in the Netherlands and capital losses in the U.S. and Australia.

At October 31, 2019, we had federal, state and foreign net operating loss carryforwards of approximately $48 million, $571 million and $577 million, respectively. The federal and state net operating loss carryforwards are subject to various limitations under Section 382 of the Internal Revenue Code and applicable state tax laws. If not utilized, the federal and state net operating loss carryforwards will begin to expire in 2020. If not utilized, $155 million of the foreign net operating loss carryforwards will begin to expire in 2020. The remaining $422 million of the foreign net operating losses carry forward indefinitely. At October 31, 2019, we had federal and foreign capital loss carryforwards of $48 million and $116 million, respectively. If not utilized, the federal capital loss carryforwards will expire in 2022. The foreign capital losses carry forward indefinitely. At October 31, 2019, we had state tax credit carryforwards of approximately $78 million. The state tax credits carry forward indefinitely.

The breakdown between long-term deferred tax assets and deferred tax liabilities was as follows:

 
October 31,
 
2019
 
2018
 
(in millions)
Long-term deferred tax assets (included within other assets)
$
410

 
$
165

Long-term deferred tax liabilities (included within other long-term liabilities)
(31
)
 
(69
)
Total
$
379

 
$
96




The breakdown between current and long-term income tax assets and liabilities, excluding deferred tax assets and liabilities, was as follows:
 
October 31,
 
2019
 
2018
 
(in millions)
Current income tax assets (included within other current assets)
$
68

 
$
59

Long-term income tax assets (included within other assets)
4

 
19

Current income tax liabilities (included within other accrued liabilities)
(292
)
 
(71
)
Long-term income tax liabilities (included within other long-term liabilities)
(328
)
 
(607
)
Total
$
(548
)
 
$
(600
)


Uncertain Tax Positions

The aggregate changes in the balances of our gross unrecognized tax benefits including all federal, state and foreign tax jurisdictions are as follows:

 
2019
 
2018
 
2017
 
(in millions)
Balance, beginning of year
$
214

 
$
224

 
$
293

Additions for tax positions related to the current year
7

 
27

 
32

Additions for tax positions from prior years
12

 
2

 
1

Reductions for tax positions from prior years
(2
)
 
(13
)
 
(3
)
Settlements with taxing authorities
—

 
—

 
(52
)
Statute of limitations expirations
(25
)
 
(26
)
 
(47
)
Balance, end of year
$
206

 
$
214

 
$
224



As of October 31, 2019, we had $227 million of unrecognized tax benefits, including interest and penalties of which $204 million, if recognized, would affect our effective tax rate. However, approximately $23 million of the unrecognized tax benefits were related to state income tax positions that, if recognized, would be in the form of a deferred tax asset that would likely not affect our effective tax rate due to a valuation allowance.

We recognized a tax expense of $9 million, a tax expense of $11 million and a tax benefit of $9 million of interest and penalties related to unrecognized tax benefits in 2019, 2018 and 2017, respectively. Interest and penalties accrued as of October 31, 2019 and 2018 were $36 million and $27 million, respectively.

In the U.S., tax years remain open back to the year 2016 for federal income tax purposes and the year 2015 for significant states. In other major jurisdictions where the company conducts business, the tax years generally remain open back to the year 2009.

With these jurisdictions and the U.S., it is reasonably possible that there could be significant changes to our unrecognized tax benefits in the next twelve months due to either the expiration of a statute of limitation or a tax audit settlement which will be partially offset by an anticipated tax liability related to unremitted foreign earnings, where applicable. Given the number of years and numerous matters that remain subject to examination in various tax jurisdictions, management is unable to estimate the range of possible changes to the balance of our unrecognized tax benefits.
XML 58 a-10312019x10k_htm.xml IDEA: XBRL DOCUMENT 0001090872 2018-11-01 2019-10-31 0001090872 2019-04-30 0001090872 2019-12-10 0001090872 2017-11-01 2018-10-31 0001090872 2016-11-01 2017-10-31 0001090872 us-gaap:ServiceOtherMember 2017-11-01 2018-10-31 0001090872 us-gaap:ProductMember 2016-11-01 2017-10-31 0001090872 us-gaap:ServiceOtherMember 2016-11-01 2017-10-31 0001090872 us-gaap:ServiceOtherMember 2018-11-01 2019-10-31 0001090872 us-gaap:ProductMember 2017-11-01 2018-10-31 0001090872 us-gaap:ProductMember 2018-11-01 2019-10-31 0001090872 2019-10-31 0001090872 2018-10-31 0001090872 2016-10-31 0001090872 2017-10-31 0001090872 us-gaap:CommonStockMember 2016-10-31 0001090872 us-gaap:CommonStockMember 2019-10-31 0001090872 us-gaap:TreasuryStockMember 2016-11-01 2017-10-31 0001090872 us-gaap:AdditionalPaidInCapitalMember 2017-10-31 0001090872 us-gaap:CommonStockMember 2017-11-01 2018-10-31 0001090872 us-gaap:AdditionalPaidInCapitalMember 2016-11-01 2017-10-31 0001090872 us-gaap:TreasuryStockMember 2019-10-31 0001090872 us-gaap:ParentMember 2018-11-01 2019-10-31 0001090872 us-gaap:RetainedEarningsMember 2019-10-31 0001090872 us-gaap:RetainedEarningsMember 2018-11-01 2019-10-31 0001090872 us-gaap:TreasuryStockMember 2016-10-31 0001090872 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2017-10-31 0001090872 us-gaap:NoncontrollingInterestMember 2019-10-31 0001090872 us-gaap:ParentMember 2018-10-31 0001090872 us-gaap:RetainedEarningsMember 2018-10-31 0001090872 us-gaap:AdditionalPaidInCapitalMember 2017-11-01 2018-10-31 0001090872 us-gaap:TreasuryStockMember 2017-11-01 2018-10-31 0001090872 us-gaap:NoncontrollingInterestMember 2018-10-31 0001090872 us-gaap:TreasuryStockMember 2017-10-31 0001090872 us-gaap:NoncontrollingInterestMember 2016-10-31 0001090872 us-gaap:AdditionalPaidInCapitalMember 2016-10-31 0001090872 us-gaap:ParentMember 2016-11-01 2017-10-31 0001090872 us-gaap:CommonStockMember 2018-11-01 2019-10-31 0001090872 us-gaap:ParentMember 2017-11-01 2018-10-31 0001090872 us-gaap:RetainedEarningsMember 2017-11-01 2018-10-31 0001090872 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2018-11-01 2019-10-31 0001090872 us-gaap:TreasuryStockMember 2018-11-01 2019-10-31 0001090872 us-gaap:CommonStockMember 2016-11-01 2017-10-31 0001090872 us-gaap:RetainedEarningsMember 2016-11-01 2017-10-31 0001090872 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2016-10-31 0001090872 us-gaap:RetainedEarningsMember 2017-10-31 0001090872 us-gaap:AdditionalPaidInCapitalMember 2018-11-01 2019-10-31 0001090872 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2018-10-31 0001090872 us-gaap:AdditionalPaidInCapitalMember 2018-10-31 0001090872 us-gaap:CommonStockMember 2017-10-31 0001090872 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2019-10-31 0001090872 us-gaap:CommonStockMember 2018-10-31 0001090872 us-gaap:ParentMember 2019-10-31 0001090872 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2016-11-01 2017-10-31 0001090872 us-gaap:ParentMember 2016-10-31 0001090872 us-gaap:NoncontrollingInterestMember 2018-11-01 2019-10-31 0001090872 us-gaap:TreasuryStockMember 2018-10-31 0001090872 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2017-11-01 2018-10-31 0001090872 us-gaap:NoncontrollingInterestMember 2017-10-31 0001090872 us-gaap:ParentMember 2017-10-31 0001090872 us-gaap:NoncontrollingInterestMember 2016-11-01 2017-10-31 0001090872 us-gaap:AdditionalPaidInCapitalMember 2019-10-31 0001090872 us-gaap:RetainedEarningsMember 2016-10-31 0001090872 srt:MaximumMember 2018-11-01 2019-10-31 0001090872 srt:MaximumMember 2019-10-31 0001090872 srt:MinimumMember us-gaap:SoftwareDevelopmentMember 2018-11-01 2019-10-31 0001090872 a:LasergenMember 2016-03-01 2016-03-02 0001090872 srt:MaximumMember us-gaap:MachineryAndEquipmentMember 2018-11-01 2019-10-31 0001090872 srt:MinimumMember us-gaap:MachineryAndEquipmentMember 2018-11-01 2019-10-31 0001090872 a:LasergenMember 2017-11-01 2018-10-31 0001090872 srt:MinimumMember 2018-11-01 2019-10-31 0001090872 a:LasergenMember 2016-03-02 0001090872 srt:MinimumMember 2019-10-31 0001090872 srt:MaximumMember us-gaap:SoftwareDevelopmentMember 2018-11-01 2019-10-31 0001090872 a:ImpactofAdoptingNewRevenueRecognitionGuidanceMember 2018-11-01 0001090872 a:ImpactofAdoptingNewInvestmentsValuationGuidanceMember 2018-11-01 0001090872 a:ImpactofAdoptingNewIntraEntityTaxGuidanceMember 2018-11-01 0001090872 2018-11-01 0001090872 a:ImpactofAdoptingNewTaxEffectsinAOCIGuidanceMember 2018-11-01 0001090872 a:ImpactofAdoptingNewRetirementBenefitsGuidanceMember 2016-11-01 2017-10-31 0001090872 a:ImpactofAdoptingNewRetirementBenefitsGuidanceMember 2017-11-01 2018-10-31 0001090872 a:ImpactofAdoptingNewRetirementBenefitsGuidanceMember 2018-11-01 2019-10-31 0001090872 a:BioTekMember 2019-10-31 0001090872 a:BioTekMember 2018-11-01 2019-10-31 0001090872 a:BioTekMember us-gaap:DevelopedTechnologyRightsMember 2019-10-31 0001090872 a:BioTekMember us-gaap:TrademarksAndTradeNamesMember 2019-10-31 0001090872 a:BioTekMember us-gaap:CustomerRelationshipsMember 2019-10-31 0001090872 a:BioTekMember us-gaap:OrderOrProductionBacklogMember 2019-10-31 0001090872 a:BioTekMember us-gaap:OrderOrProductionBacklogMember 2018-11-01 2019-10-31 0001090872 a:BioTekMember us-gaap:TrademarksAndTradeNamesMember 2018-11-01 2019-10-31 0001090872 a:ACEABiosciencesInc.Member 2018-11-01 2019-10-31 0001090872 srt:MinimumMember a:BioTekMember us-gaap:DevelopedTechnologyRightsMember 2018-11-01 2019-10-31 0001090872 srt:MaximumMember a:BioTekMember us-gaap:DevelopedTechnologyRightsMember 2018-11-01 2019-10-31 0001090872 srt:MinimumMember a:BioTekMember us-gaap:CustomerRelationshipsMember 2018-11-01 2019-10-31 0001090872 srt:MaximumMember a:BioTekMember us-gaap:CustomerRelationshipsMember 2018-11-01 2019-10-31 0001090872 a:DiagnosticsandClinicalMarketMember 2018-11-01 2019-10-31 0001090872 a:EnvironmentalandForensicsMarketMember 2018-11-01 2019-10-31 0001090872 a:AcademiaandGovernmentMarketMember 2018-11-01 2019-10-31 0001090872 a:NonInstrumentationandOtherMember 2018-11-01 2019-10-31 0001090872 a:PharmaceuticalandBiopharmaceuticalMarketMember 2018-11-01 2019-10-31 0001090872 a:InstrumentationMember 2018-11-01 2019-10-31 0001090872 a:ChemicalandEnergyMarketMember 2018-11-01 2019-10-31 0001090872 a:FoodMarketMember 2018-11-01 2019-10-31 0001090872 srt:AmericasMember 2018-11-01 2019-10-31 0001090872 srt:AsiaPacificMember 2018-11-01 2019-10-31 0001090872 srt:EuropeMember a:LifeSciencesandAppliedMarketsMember 2018-11-01 2019-10-31 0001090872 a:LifeSciencesandAppliedMarketsMember 2018-11-01 2019-10-31 0001090872 srt:AmericasMember a:DiagnosticsAndGenomicsMember 2018-11-01 2019-10-31 0001090872 srt:AmericasMember a:AgilentCrossLabMember 2018-11-01 2019-10-31 0001090872 srt:EuropeMember a:AgilentCrossLabMember 2018-11-01 2019-10-31 0001090872 srt:AsiaPacificMember a:AgilentCrossLabMember 2018-11-01 2019-10-31 0001090872 srt:AmericasMember a:LifeSciencesandAppliedMarketsMember 2018-11-01 2019-10-31 0001090872 srt:AsiaPacificMember a:DiagnosticsAndGenomicsMember 2018-11-01 2019-10-31 0001090872 srt:AsiaPacificMember a:LifeSciencesandAppliedMarketsMember 2018-11-01 2019-10-31 0001090872 a:DiagnosticsAndGenomicsMember 2018-11-01 2019-10-31 0001090872 srt:EuropeMember 2018-11-01 2019-10-31 0001090872 a:AgilentCrossLabMember 2018-11-01 2019-10-31 0001090872 srt:EuropeMember a:DiagnosticsAndGenomicsMember 2018-11-01 2019-10-31 0001090872 us-gaap:DifferenceBetweenRevenueGuidanceInEffectBeforeAndAfterTopic606Member 2018-11-01 2018-11-01 0001090872 us-gaap:DifferenceBetweenRevenueGuidanceInEffectBeforeAndAfterTopic606Member 2019-10-31 0001090872 us-gaap:CostOfSalesMember 2018-11-01 2019-10-31 0001090872 us-gaap:SellingGeneralAndAdministrativeExpensesMember 2017-11-01 2018-10-31 0001090872 us-gaap:CostOfSalesMember 2016-11-01 2017-10-31 0001090872 us-gaap:SellingGeneralAndAdministrativeExpensesMember 2018-11-01 2019-10-31 0001090872 us-gaap:CostOfSalesMember 2017-11-01 2018-10-31 0001090872 us-gaap:ResearchAndDevelopmentExpenseMember 2016-11-01 2017-10-31 0001090872 us-gaap:ResearchAndDevelopmentExpenseMember 2017-11-01 2018-10-31 0001090872 us-gaap:SellingGeneralAndAdministrativeExpensesMember 2016-11-01 2017-10-31 0001090872 us-gaap:ResearchAndDevelopmentExpenseMember 2018-11-01 2019-10-31 0001090872 us-gaap:EmployeeStockOptionMember 2019-10-31 0001090872 us-gaap:InventoriesMember 2018-11-01 2019-10-31 0001090872 us-gaap:EmployeeStockOptionMember 2018-11-01 2019-10-31 0001090872 us-gaap:EmployeeStockMember 2019-10-31 0001090872 us-gaap:RestrictedStockUnitsRSUMember 2018-11-01 2019-10-31 0001090872 a:LTPPRSUMember 2018-11-01 2019-10-31 0001090872 a:LTPPRSUMember 2017-11-01 2018-10-31 0001090872 a:LtppMember 2016-11-01 2017-10-31 0001090872 a:LtppMember 2017-11-01 2018-10-31 0001090872 a:LtppMember 2018-11-01 2019-10-31 0001090872 a:LTPPRSUMember 2016-11-01 2017-10-31 0001090872 a:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRange03Member 2019-10-31 0001090872 a:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRange02Member 2019-10-31 0001090872 a:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRange01Member 2019-10-31 0001090872 a:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRange02Member 2018-11-01 2019-10-31 0001090872 a:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRange01Member 2018-11-01 2019-10-31 0001090872 a:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRange03Member 2018-11-01 2019-10-31 0001090872 us-gaap:InventoriesMember 2017-11-01 2018-10-31 0001090872 us-gaap:ForeignCountryMember 2019-10-31 0001090872 a:TaxInterestandPenaltiesMember 2018-11-01 2019-10-31 0001090872 a:U.S.TaxCutsandJobsActof2017Member 2017-11-01 2018-10-31 0001090872 a:TaxInterestandPenaltiesMember 2017-11-01 2018-10-31 0001090872 us-gaap:DomesticCountryMember 2019-10-31 0001090872 us-gaap:ForeignCountryMember 2018-11-01 2019-10-31 0001090872 a:TaxInterestandPenaltiesMember 2016-11-01 2017-10-31 0001090872 us-gaap:CaliforniaFranchiseTaxBoardMember 2019-10-31 0001090872 a:BioTekandACEAMember 2018-11-01 2019-10-31 0001090872 a:AdvancedAnalyticalTechnologiesIncAATIMember a:DiagnosticsAndGenomicsMember 2018-11-01 2019-10-31 0001090872 a:BioTekandACEAMember a:LifeSciencesandAppliedMarketsMember 2018-11-01 2019-10-31 0001090872 a:DiagnosticsAndGenomicsMember 2017-11-01 2018-10-31 0001090872 a:AgilentCrossLabMember 2017-11-01 2018-10-31 0001090872 a:AgilentCrossLabMember 2019-10-31 0001090872 a:LifeSciencesandAppliedMarketsMember 2017-11-01 2018-10-31 0001090872 a:LifeSciencesandAppliedMarketsMember 2017-10-31 0001090872 a:AgilentCrossLabMember 2018-10-31 0001090872 a:DiagnosticsAndGenomicsMember 2019-10-31 0001090872 a:DiagnosticsAndGenomicsMember 2018-10-31 0001090872 a:LifeSciencesandAppliedMarketsMember 2019-10-31 0001090872 a:AgilentCrossLabMember 2017-10-31 0001090872 a:LifeSciencesandAppliedMarketsMember 2018-10-31 0001090872 a:DiagnosticsAndGenomicsMember 2017-10-31 0001090872 us-gaap:OrderOrProductionBacklogMember 2019-10-31 0001090872 us-gaap:TrademarksMember 2019-10-31 0001090872 a:ThirdPartyTechnologyandLicensesMember 2018-10-31 0001090872 us-gaap:TrademarksMember 2018-10-31 0001090872 a:ThirdPartyTechnologyandLicensesMember 2019-10-31 0001090872 us-gaap:DevelopedTechnologyRightsMember 2018-10-31 0001090872 us-gaap:CustomerRelationshipsMember 2019-10-31 0001090872 us-gaap:DevelopedTechnologyRightsMember 2019-10-31 0001090872 us-gaap:CustomerRelationshipsMember 2018-10-31 0001090872 us-gaap:FairValueInputsLevel3Member us-gaap:FairValueMeasurementsRecurringMember 2019-10-31 0001090872 us-gaap:FairValueMeasurementsRecurringMember 2019-10-31 0001090872 us-gaap:FairValueInputsLevel2Member us-gaap:FairValueMeasurementsRecurringMember 2019-10-31 0001090872 us-gaap:FairValueInputsLevel1Member us-gaap:FairValueMeasurementsRecurringMember 2019-10-31 0001090872 us-gaap:FairValueInputsLevel3Member us-gaap:FairValueMeasurementsRecurringMember 2018-10-31 0001090872 us-gaap:FairValueInputsLevel1Member us-gaap:FairValueMeasurementsRecurringMember 2018-10-31 0001090872 us-gaap:FairValueMeasurementsRecurringMember 2018-10-31 0001090872 us-gaap:FairValueInputsLevel2Member us-gaap:FairValueMeasurementsRecurringMember 2018-10-31 0001090872 us-gaap:TreasuryLockMember a:SeniorNotes2022Member 2019-10-31 0001090872 us-gaap:TreasuryLockMember us-gaap:CashFlowHedgingMember a:SeniorNotes2026Member 2019-10-31 0001090872 2016-09-14 2016-09-15 0001090872 us-gaap:TreasuryLockMember a:SeniorNotes2022Member 2012-07-01 0001090872 a:SeniorNotes2020Member 2011-08-09 0001090872 2017-11-01 2018-01-31 0001090872 us-gaap:TreasuryLockMember a:SeniorNotes2029Member 2019-08-01 0001090872 us-gaap:TreasuryLockMember us-gaap:CashFlowHedgingMember a:SeniorNotes2026Member 2016-02-01 0001090872 us-gaap:TreasuryLockMember a:SeniorNotes2029Member 2019-10-31 0001090872 us-gaap:OtherCurrentAssetsMember us-gaap:ForeignExchangeContractMember us-gaap:NondesignatedMember 2019-10-31 0001090872 us-gaap:OtherCurrentAssetsMember us-gaap:ForeignExchangeContractMember us-gaap:NondesignatedMember 2018-10-31 0001090872 us-gaap:AccruedLiabilitiesMember us-gaap:ForeignExchangeContractMember us-gaap:CashFlowHedgingMember us-gaap:DesignatedAsHedgingInstrumentMember 2019-10-31 0001090872 us-gaap:OtherCurrentAssetsMember us-gaap:ForeignExchangeContractMember us-gaap:CashFlowHedgingMember us-gaap:DesignatedAsHedgingInstrumentMember 2018-10-31 0001090872 us-gaap:AccruedLiabilitiesMember us-gaap:ForeignExchangeContractMember us-gaap:NondesignatedMember 2019-10-31 0001090872 us-gaap:AccruedLiabilitiesMember us-gaap:ForeignExchangeContractMember us-gaap:CashFlowHedgingMember us-gaap:DesignatedAsHedgingInstrumentMember 2018-10-31 0001090872 us-gaap:OtherCurrentAssetsMember us-gaap:ForeignExchangeContractMember us-gaap:CashFlowHedgingMember us-gaap:DesignatedAsHedgingInstrumentMember 2019-10-31 0001090872 us-gaap:AccruedLiabilitiesMember us-gaap:ForeignExchangeContractMember us-gaap:NondesignatedMember 2018-10-31 0001090872 currency:JPY us-gaap:ForwardContractsMember us-gaap:NondesignatedMember us-gaap:ShortMember 2019-10-31 0001090872 currency:DKK us-gaap:ForwardContractsMember us-gaap:NondesignatedMember us-gaap:LongMember 2019-10-31 0001090872 currency:AUD us-gaap:ForwardContractsMember us-gaap:CashFlowHedgingMember us-gaap:DesignatedAsHedgingInstrumentMember us-gaap:LongMember 2019-10-31 0001090872 currency:KRW us-gaap:ForwardContractsMember us-gaap:CashFlowHedgingMember us-gaap:DesignatedAsHedgingInstrumentMember us-gaap:ShortMember 2019-10-31 0001090872 currency:CNY us-gaap:ForwardContractsMember us-gaap:NondesignatedMember us-gaap:ShortMember 2019-10-31 0001090872 currency:JPY us-gaap:ForwardContractsMember us-gaap:CashFlowHedgingMember us-gaap:DesignatedAsHedgingInstrumentMember us-gaap:ShortMember 2019-10-31 0001090872 us-gaap:ForwardContractsMember us-gaap:CashFlowHedgingMember us-gaap:DesignatedAsHedgingInstrumentMember us-gaap:ShortMember 2019-10-31 0001090872 currency:SEK us-gaap:ForwardContractsMember us-gaap:NondesignatedMember us-gaap:ShortMember 2019-10-31 0001090872 currency:EUR us-gaap:ForwardContractsMember us-gaap:CashFlowHedgingMember us-gaap:DesignatedAsHedgingInstrumentMember us-gaap:ShortMember 2019-10-31 0001090872 currency:KRW us-gaap:ForwardContractsMember us-gaap:NondesignatedMember us-gaap:ShortMember 2019-10-31 0001090872 currency:GBP us-gaap:ForwardContractsMember us-gaap:NondesignatedMember us-gaap:LongMember 2019-10-31 0001090872 currency:MYR us-gaap:ForwardContractsMember us-gaap:NondesignatedMember us-gaap:LongMember 2019-10-31 0001090872 us-gaap:ForwardContractsMember us-gaap:NondesignatedMember us-gaap:LongMember 2019-10-31 0001090872 currency:GBP us-gaap:ForwardContractsMember us-gaap:CashFlowHedgingMember us-gaap:DesignatedAsHedgingInstrumentMember us-gaap:ShortMember 2019-10-31 0001090872 currency:SGD us-gaap:ForwardContractsMember us-gaap:NondesignatedMember us-gaap:LongMember 2019-10-31 0001090872 currency:CHF us-gaap:ForwardContractsMember us-gaap:NondesignatedMember us-gaap:ShortMember 2019-10-31 0001090872 currency:SGD us-gaap:ForwardContractsMember us-gaap:CashFlowHedgingMember us-gaap:DesignatedAsHedgingInstrumentMember us-gaap:LongMember 2019-10-31 0001090872 currency:CAD us-gaap:ForwardContractsMember us-gaap:NondesignatedMember us-gaap:LongMember 2019-10-31 0001090872 currency:CAD us-gaap:ForwardContractsMember us-gaap:CashFlowHedgingMember us-gaap:DesignatedAsHedgingInstrumentMember us-gaap:ShortMember 2019-10-31 0001090872 currency:CNY us-gaap:ForwardContractsMember us-gaap:CashFlowHedgingMember us-gaap:DesignatedAsHedgingInstrumentMember us-gaap:ShortMember 2019-10-31 0001090872 currency:XXX us-gaap:ForwardContractsMember us-gaap:NondesignatedMember us-gaap:ShortMember 2019-10-31 0001090872 currency:EUR us-gaap:ForwardContractsMember us-gaap:NondesignatedMember us-gaap:LongMember 2019-10-31 0001090872 us-gaap:ForeignExchangeContractMember us-gaap:CashFlowHedgingMember us-gaap:DesignatedAsHedgingInstrumentMember us-gaap:CostOfSalesMember 2016-11-01 2017-10-31 0001090872 us-gaap:ForeignExchangeContractMember us-gaap:CashFlowHedgingMember us-gaap:DesignatedAsHedgingInstrumentMember us-gaap:CostOfSalesMember 2017-11-01 2018-10-31 0001090872 us-gaap:InterestRateSwapMember us-gaap:CashFlowHedgingMember us-gaap:DesignatedAsHedgingInstrumentMember us-gaap:OtherComprehensiveIncomeMember 2016-11-01 2017-10-31 0001090872 us-gaap:ForwardContractsMember us-gaap:CashFlowHedgingMember us-gaap:DesignatedAsHedgingInstrumentMember us-gaap:CostOfSalesMember 2017-11-01 2018-10-31 0001090872 us-gaap:ForeignExchangeContractMember us-gaap:CashFlowHedgingMember us-gaap:DesignatedAsHedgingInstrumentMember us-gaap:AccumulatedOtherComprehensiveIncomeMember 2017-11-01 2018-10-31 0001090872 us-gaap:NondesignatedMember us-gaap:OtherIncomeMember 2018-11-01 2019-10-31 0001090872 us-gaap:InterestRateSwapMember us-gaap:CashFlowHedgingMember us-gaap:DesignatedAsHedgingInstrumentMember us-gaap:OtherComprehensiveIncomeMember 2018-11-01 2019-10-31 0001090872 us-gaap:NondesignatedMember us-gaap:OtherIncomeMember 2016-11-01 2017-10-31 0001090872 us-gaap:InterestRateSwapMember us-gaap:CashFlowHedgingMember us-gaap:DesignatedAsHedgingInstrumentMember us-gaap:OtherComprehensiveIncomeMember 2017-11-01 2018-10-31 0001090872 us-gaap:ForeignExchangeContractMember us-gaap:CashFlowHedgingMember us-gaap:DesignatedAsHedgingInstrumentMember us-gaap:AccumulatedOtherComprehensiveIncomeMember 2018-11-01 2019-10-31 0001090872 us-gaap:ForeignExchangeContractMember us-gaap:CashFlowHedgingMember us-gaap:DesignatedAsHedgingInstrumentMember us-gaap:CostOfSalesMember 2018-11-01 2019-10-31 0001090872 us-gaap:ForwardContractsMember us-gaap:CashFlowHedgingMember us-gaap:DesignatedAsHedgingInstrumentMember us-gaap:CostOfSalesMember 2016-11-01 2017-10-31 0001090872 us-gaap:NondesignatedMember us-gaap:OtherIncomeMember 2017-11-01 2018-10-31 0001090872 us-gaap:ForwardContractsMember us-gaap:CashFlowHedgingMember us-gaap:DesignatedAsHedgingInstrumentMember us-gaap:CostOfSalesMember 2018-11-01 2019-10-31 0001090872 us-gaap:ForeignExchangeContractMember us-gaap:CashFlowHedgingMember us-gaap:DesignatedAsHedgingInstrumentMember us-gaap:AccumulatedOtherComprehensiveIncomeMember 2016-11-01 2017-10-31 0001090872 us-gaap:ForeignPlanMember us-gaap:PensionPlansDefinedBenefitMember 2018-10-31 0001090872 a:OtherPlanAssetsMember us-gaap:FairValueInputsLevel1Member us-gaap:ForeignPlanMember us-gaap:PensionPlansDefinedBenefitMember 2018-10-31 0001090872 us-gaap:CashAndCashEquivalentsMember us-gaap:FairValueInputsLevel3Member us-gaap:ForeignPlanMember us-gaap:PensionPlansDefinedBenefitMember 2018-10-31 0001090872 us-gaap:FixedIncomeSecuritiesMember us-gaap:FairValueInputsLevel2Member us-gaap:ForeignPlanMember us-gaap:PensionPlansDefinedBenefitMember 2018-10-31 0001090872 a:OtherPlanAssetsMember us-gaap:FairValueInputsLevel2Member us-gaap:ForeignPlanMember us-gaap:PensionPlansDefinedBenefitMember 2018-10-31 0001090872 us-gaap:CashAndCashEquivalentsMember us-gaap:ForeignPlanMember us-gaap:PensionPlansDefinedBenefitMember 2018-10-31 0001090872 us-gaap:EquitySecuritiesMember us-gaap:FairValueInputsLevel2Member us-gaap:ForeignPlanMember us-gaap:PensionPlansDefinedBenefitMember 2018-10-31 0001090872 us-gaap:CashAndCashEquivalentsMember us-gaap:FairValueInputsLevel1Member us-gaap:ForeignPlanMember us-gaap:PensionPlansDefinedBenefitMember 2018-10-31 0001090872 us-gaap:FixedIncomeSecuritiesMember us-gaap:FairValueInputsLevel1Member us-gaap:ForeignPlanMember us-gaap:PensionPlansDefinedBenefitMember 2018-10-31 0001090872 a:OtherPlanAssetsMember us-gaap:ForeignPlanMember us-gaap:PensionPlansDefinedBenefitMember 2018-10-31 0001090872 us-gaap:FairValueInputsLevel3Member us-gaap:ForeignPlanMember us-gaap:PensionPlansDefinedBenefitMember 2018-10-31 0001090872 us-gaap:EquitySecuritiesMember us-gaap:ForeignPlanMember us-gaap:PensionPlansDefinedBenefitMember 2018-10-31 0001090872 us-gaap:FixedIncomeSecuritiesMember us-gaap:FairValueInputsLevel3Member us-gaap:ForeignPlanMember us-gaap:PensionPlansDefinedBenefitMember 2018-10-31 0001090872 us-gaap:FixedIncomeSecuritiesMember us-gaap:ForeignPlanMember us-gaap:PensionPlansDefinedBenefitMember 2018-10-31 0001090872 us-gaap:EquitySecuritiesMember us-gaap:FairValueInputsLevel3Member us-gaap:ForeignPlanMember us-gaap:PensionPlansDefinedBenefitMember 2018-10-31 0001090872 us-gaap:FairValueInputsLevel1Member us-gaap:ForeignPlanMember us-gaap:PensionPlansDefinedBenefitMember 2018-10-31 0001090872 us-gaap:FairValueInputsLevel2Member us-gaap:ForeignPlanMember us-gaap:PensionPlansDefinedBenefitMember 2018-10-31 0001090872 us-gaap:EquitySecuritiesMember us-gaap:FairValueInputsLevel1Member us-gaap:ForeignPlanMember us-gaap:PensionPlansDefinedBenefitMember 2018-10-31 0001090872 a:OtherPlanAssetsMember us-gaap:FairValueInputsLevel3Member us-gaap:ForeignPlanMember us-gaap:PensionPlansDefinedBenefitMember 2018-10-31 0001090872 us-gaap:CashAndCashEquivalentsMember us-gaap:FairValueInputsLevel2Member us-gaap:ForeignPlanMember us-gaap:PensionPlansDefinedBenefitMember 2018-10-31 0001090872 us-gaap:CashAndCashEquivalentsMember us-gaap:FairValueInputsLevel2Member country:US us-gaap:DefinedBenefitPostretirementHealthCoverageMember 2019-10-31 0001090872 a:OtherPlanAssetsMember us-gaap:FairValueInputsLevel1Member country:US us-gaap:DefinedBenefitPostretirementHealthCoverageMember 2019-10-31 0001090872 us-gaap:FixedIncomeSecuritiesMember us-gaap:FairValueInputsLevel1Member country:US us-gaap:DefinedBenefitPostretirementHealthCoverageMember 2019-10-31 0001090872 us-gaap:CashAndCashEquivalentsMember country:US us-gaap:DefinedBenefitPostretirementHealthCoverageMember 2019-10-31 0001090872 country:US us-gaap:DefinedBenefitPostretirementHealthCoverageMember 2019-10-31 0001090872 us-gaap:EquitySecuritiesMember us-gaap:FairValueInputsLevel2Member country:US us-gaap:DefinedBenefitPostretirementHealthCoverageMember 2019-10-31 0001090872 us-gaap:FixedIncomeSecuritiesMember us-gaap:FairValueInputsLevel2Member country:US us-gaap:DefinedBenefitPostretirementHealthCoverageMember 2019-10-31 0001090872 us-gaap:CashAndCashEquivalentsMember us-gaap:FairValueInputsLevel3Member country:US us-gaap:DefinedBenefitPostretirementHealthCoverageMember 2019-10-31 0001090872 a:OtherPlanAssetsMember country:US us-gaap:DefinedBenefitPostretirementHealthCoverageMember 2019-10-31 0001090872 a:OtherPlanAssetsMember us-gaap:FairValueInputsLevel3Member country:US us-gaap:DefinedBenefitPostretirementHealthCoverageMember 2019-10-31 0001090872 us-gaap:FixedIncomeSecuritiesMember country:US us-gaap:DefinedBenefitPostretirementHealthCoverageMember 2019-10-31 0001090872 us-gaap:FairValueInputsLevel2Member country:US us-gaap:DefinedBenefitPostretirementHealthCoverageMember 2019-10-31 0001090872 us-gaap:FairValueInputsLevel3Member country:US us-gaap:DefinedBenefitPostretirementHealthCoverageMember 2019-10-31 0001090872 a:OtherPlanAssetsMember us-gaap:FairValueInputsLevel2Member country:US us-gaap:DefinedBenefitPostretirementHealthCoverageMember 2019-10-31 0001090872 us-gaap:FairValueInputsLevel1Member country:US us-gaap:DefinedBenefitPostretirementHealthCoverageMember 2019-10-31 0001090872 us-gaap:EquitySecuritiesMember us-gaap:FairValueInputsLevel3Member country:US us-gaap:DefinedBenefitPostretirementHealthCoverageMember 2019-10-31 0001090872 us-gaap:EquitySecuritiesMember us-gaap:FairValueInputsLevel1Member country:US us-gaap:DefinedBenefitPostretirementHealthCoverageMember 2019-10-31 0001090872 us-gaap:EquitySecuritiesMember country:US us-gaap:DefinedBenefitPostretirementHealthCoverageMember 2019-10-31 0001090872 us-gaap:CashAndCashEquivalentsMember us-gaap:FairValueInputsLevel1Member country:US us-gaap:DefinedBenefitPostretirementHealthCoverageMember 2019-10-31 0001090872 us-gaap:FixedIncomeSecuritiesMember us-gaap:FairValueInputsLevel3Member country:US us-gaap:DefinedBenefitPostretirementHealthCoverageMember 2019-10-31 0001090872 country:US us-gaap:DefinedBenefitPostretirementHealthCoverageMember 2016-11-01 2017-10-31 0001090872 us-gaap:ForeignPlanMember us-gaap:PensionPlansDefinedBenefitMember 2017-11-01 2018-10-31 0001090872 country:US us-gaap:PensionPlansDefinedBenefitMember 2018-11-01 2019-10-31 0001090872 country:US us-gaap:PensionPlansDefinedBenefitMember 2016-11-01 2017-10-31 0001090872 country:US us-gaap:PensionPlansDefinedBenefitMember 2017-11-01 2018-10-31 0001090872 us-gaap:ForeignPlanMember us-gaap:PensionPlansDefinedBenefitMember 2016-11-01 2017-10-31 0001090872 us-gaap:ForeignPlanMember us-gaap:PensionPlansDefinedBenefitMember 2018-11-01 2019-10-31 0001090872 country:US us-gaap:DefinedBenefitPostretirementHealthCoverageMember 2017-11-01 2018-10-31 0001090872 country:US us-gaap:DefinedBenefitPostretirementHealthCoverageMember 2018-11-01 2019-10-31 0001090872 a:OtherPlanAssetsMember country:US us-gaap:PensionPlansDefinedBenefitMember 2018-10-31 0001090872 us-gaap:EquitySecuritiesMember us-gaap:FairValueInputsLevel1Member country:US us-gaap:PensionPlansDefinedBenefitMember 2018-10-31 0001090872 us-gaap:FairValueInputsLevel3Member country:US us-gaap:PensionPlansDefinedBenefitMember 2018-10-31 0001090872 us-gaap:FixedIncomeSecuritiesMember country:US us-gaap:PensionPlansDefinedBenefitMember 2018-10-31 0001090872 us-gaap:FairValueInputsLevel2Member country:US us-gaap:PensionPlansDefinedBenefitMember 2018-10-31 0001090872 us-gaap:FixedIncomeSecuritiesMember us-gaap:FairValueInputsLevel1Member country:US us-gaap:PensionPlansDefinedBenefitMember 2018-10-31 0001090872 a:OtherPlanAssetsMember us-gaap:FairValueInputsLevel2Member country:US us-gaap:PensionPlansDefinedBenefitMember 2018-10-31 0001090872 us-gaap:FairValueInputsLevel1Member country:US us-gaap:PensionPlansDefinedBenefitMember 2018-10-31 0001090872 us-gaap:EquitySecuritiesMember us-gaap:FairValueInputsLevel3Member country:US us-gaap:PensionPlansDefinedBenefitMember 2018-10-31 0001090872 country:US us-gaap:PensionPlansDefinedBenefitMember 2018-10-31 0001090872 us-gaap:CashAndCashEquivalentsMember us-gaap:FairValueInputsLevel2Member country:US us-gaap:PensionPlansDefinedBenefitMember 2018-10-31 0001090872 us-gaap:CashAndCashEquivalentsMember us-gaap:FairValueInputsLevel3Member country:US us-gaap:PensionPlansDefinedBenefitMember 2018-10-31 0001090872 us-gaap:EquitySecuritiesMember country:US us-gaap:PensionPlansDefinedBenefitMember 2018-10-31 0001090872 us-gaap:CashAndCashEquivalentsMember us-gaap:FairValueInputsLevel1Member country:US us-gaap:PensionPlansDefinedBenefitMember 2018-10-31 0001090872 us-gaap:CashAndCashEquivalentsMember country:US us-gaap:PensionPlansDefinedBenefitMember 2018-10-31 0001090872 a:OtherPlanAssetsMember us-gaap:FairValueInputsLevel1Member country:US us-gaap:PensionPlansDefinedBenefitMember 2018-10-31 0001090872 us-gaap:EquitySecuritiesMember us-gaap:FairValueInputsLevel2Member country:US us-gaap:PensionPlansDefinedBenefitMember 2018-10-31 0001090872 a:OtherPlanAssetsMember us-gaap:FairValueInputsLevel3Member country:US us-gaap:PensionPlansDefinedBenefitMember 2018-10-31 0001090872 us-gaap:FixedIncomeSecuritiesMember us-gaap:FairValueInputsLevel2Member country:US us-gaap:PensionPlansDefinedBenefitMember 2018-10-31 0001090872 us-gaap:FixedIncomeSecuritiesMember us-gaap:FairValueInputsLevel3Member country:US us-gaap:PensionPlansDefinedBenefitMember 2018-10-31 0001090872 us-gaap:ForeignPlanMember us-gaap:PensionPlansDefinedBenefitMember 2019-10-31 0001090872 country:US us-gaap:PensionPlansDefinedBenefitMember 2019-10-31 0001090872 us-gaap:AccumulatedOtherComprehensiveIncomeMember country:JP us-gaap:PensionPlansDefinedBenefitMember 2017-10-31 0001090872 a:OtherPlanAssetsMember country:US us-gaap:PensionPlansDefinedBenefitMember 2019-10-31 0001090872 srt:MinimumMember us-gaap:EquitySecuritiesMember us-gaap:ForeignPlanMember us-gaap:PensionPlansDefinedBenefitMember 2019-10-31 0001090872 us-gaap:EquitySecuritiesMember country:US us-gaap:PensionPlansDefinedBenefitMember 2019-10-31 0001090872 us-gaap:DeferredProfitSharingMember us-gaap:FixedIncomeSecuritiesMember country:US 2019-10-31 0001090872 srt:MaximumMember us-gaap:PensionPlansDefinedBenefitMember 2018-11-01 2019-10-31 0001090872 srt:MaximumMember us-gaap:FixedIncomeSecuritiesMember us-gaap:ForeignPlanMember us-gaap:PensionPlansDefinedBenefitMember 2019-10-31 0001090872 country:JP us-gaap:PensionPlansDefinedBenefitMember 2017-11-01 2018-01-31 0001090872 us-gaap:DeferredProfitSharingMember 2018-10-31 0001090872 us-gaap:AccumulatedOtherComprehensiveIncomeMember country:JP us-gaap:PensionPlansDefinedBenefitMember 2016-11-01 2017-10-31 0001090872 srt:MaximumMember us-gaap:EquitySecuritiesMember us-gaap:ForeignPlanMember us-gaap:PensionPlansDefinedBenefitMember 2019-10-31 0001090872 us-gaap:FixedIncomeSecuritiesMember country:US us-gaap:PensionPlansDefinedBenefitMember 2019-10-31 0001090872 srt:MinimumMember us-gaap:PensionPlansDefinedBenefitMember 2018-11-01 2019-10-31 0001090872 us-gaap:DeferredProfitSharingMember 2019-10-31 0001090872 srt:MinimumMember us-gaap:FixedIncomeSecuritiesMember us-gaap:ForeignPlanMember us-gaap:PensionPlansDefinedBenefitMember 2019-10-31 0001090872 us-gaap:PensionPlansDefinedBenefitMember 2018-11-01 2019-10-31 0001090872 srt:MinimumMember us-gaap:RealEstateMember us-gaap:ForeignPlanMember us-gaap:PensionPlansDefinedBenefitMember 2019-10-31 0001090872 a:DifferenceBetweenFairValuesoftheObligationSettledandAssetsTransferredMember country:JP us-gaap:PensionPlansDefinedBenefitMember 2016-11-01 2017-10-31 0001090872 country:JP us-gaap:PensionPlansDefinedBenefitMember 2017-10-31 0001090872 us-gaap:DeferredProfitSharingMember us-gaap:EquitySecuritiesMember country:US 2019-10-31 0001090872 country:JP us-gaap:PensionPlansDefinedBenefitMember 2016-11-01 2017-10-31 0001090872 srt:MaximumMember us-gaap:RealEstateMember us-gaap:ForeignPlanMember us-gaap:PensionPlansDefinedBenefitMember 2019-10-31 0001090872 us-gaap:FairValueInputsLevel2Member country:US us-gaap:DefinedBenefitPostretirementHealthCoverageMember 2018-10-31 0001090872 us-gaap:EquitySecuritiesMember us-gaap:FairValueInputsLevel1Member country:US us-gaap:DefinedBenefitPostretirementHealthCoverageMember 2018-10-31 0001090872 a:OtherPlanAssetsMember us-gaap:FairValueInputsLevel3Member country:US us-gaap:DefinedBenefitPostretirementHealthCoverageMember 2018-10-31 0001090872 country:US us-gaap:DefinedBenefitPostretirementHealthCoverageMember 2018-10-31 0001090872 us-gaap:CashAndCashEquivalentsMember us-gaap:FairValueInputsLevel1Member country:US us-gaap:DefinedBenefitPostretirementHealthCoverageMember 2018-10-31 0001090872 us-gaap:FixedIncomeSecuritiesMember us-gaap:FairValueInputsLevel1Member country:US us-gaap:DefinedBenefitPostretirementHealthCoverageMember 2018-10-31 0001090872 us-gaap:EquitySecuritiesMember country:US us-gaap:DefinedBenefitPostretirementHealthCoverageMember 2018-10-31 0001090872 us-gaap:CashAndCashEquivalentsMember country:US us-gaap:DefinedBenefitPostretirementHealthCoverageMember 2018-10-31 0001090872 us-gaap:FairValueInputsLevel1Member country:US us-gaap:DefinedBenefitPostretirementHealthCoverageMember 2018-10-31 0001090872 us-gaap:FairValueInputsLevel3Member country:US us-gaap:DefinedBenefitPostretirementHealthCoverageMember 2018-10-31 0001090872 us-gaap:EquitySecuritiesMember us-gaap:FairValueInputsLevel3Member country:US us-gaap:DefinedBenefitPostretirementHealthCoverageMember 2018-10-31 0001090872 us-gaap:FixedIncomeSecuritiesMember country:US us-gaap:DefinedBenefitPostretirementHealthCoverageMember 2018-10-31 0001090872 a:OtherPlanAssetsMember us-gaap:FairValueInputsLevel1Member country:US us-gaap:DefinedBenefitPostretirementHealthCoverageMember 2018-10-31 0001090872 us-gaap:EquitySecuritiesMember us-gaap:FairValueInputsLevel2Member country:US us-gaap:DefinedBenefitPostretirementHealthCoverageMember 2018-10-31 0001090872 us-gaap:CashAndCashEquivalentsMember us-gaap:FairValueInputsLevel3Member country:US us-gaap:DefinedBenefitPostretirementHealthCoverageMember 2018-10-31 0001090872 a:OtherPlanAssetsMember us-gaap:FairValueInputsLevel2Member country:US us-gaap:DefinedBenefitPostretirementHealthCoverageMember 2018-10-31 0001090872 us-gaap:CashAndCashEquivalentsMember us-gaap:FairValueInputsLevel2Member country:US us-gaap:DefinedBenefitPostretirementHealthCoverageMember 2018-10-31 0001090872 us-gaap:FixedIncomeSecuritiesMember us-gaap:FairValueInputsLevel3Member country:US us-gaap:DefinedBenefitPostretirementHealthCoverageMember 2018-10-31 0001090872 a:OtherPlanAssetsMember country:US us-gaap:DefinedBenefitPostretirementHealthCoverageMember 2018-10-31 0001090872 us-gaap:FixedIncomeSecuritiesMember us-gaap:FairValueInputsLevel2Member country:US us-gaap:DefinedBenefitPostretirementHealthCoverageMember 2018-10-31 0001090872 a:OtherPlanAssetsMember us-gaap:FairValueInputsLevel1Member country:US us-gaap:PensionPlansDefinedBenefitMember 2019-10-31 0001090872 us-gaap:CashAndCashEquivalentsMember us-gaap:FairValueInputsLevel2Member country:US us-gaap:PensionPlansDefinedBenefitMember 2019-10-31 0001090872 us-gaap:FairValueInputsLevel3Member country:US us-gaap:PensionPlansDefinedBenefitMember 2019-10-31 0001090872 us-gaap:FixedIncomeSecuritiesMember us-gaap:FairValueInputsLevel2Member country:US us-gaap:PensionPlansDefinedBenefitMember 2019-10-31 0001090872 us-gaap:EquitySecuritiesMember us-gaap:FairValueInputsLevel2Member country:US us-gaap:PensionPlansDefinedBenefitMember 2019-10-31 0001090872 a:OtherPlanAssetsMember us-gaap:FairValueInputsLevel3Member country:US us-gaap:PensionPlansDefinedBenefitMember 2019-10-31 0001090872 us-gaap:FixedIncomeSecuritiesMember us-gaap:FairValueInputsLevel3Member country:US us-gaap:PensionPlansDefinedBenefitMember 2019-10-31 0001090872 us-gaap:FairValueInputsLevel2Member country:US us-gaap:PensionPlansDefinedBenefitMember 2019-10-31 0001090872 us-gaap:CashAndCashEquivalentsMember us-gaap:FairValueInputsLevel3Member country:US us-gaap:PensionPlansDefinedBenefitMember 2019-10-31 0001090872 us-gaap:EquitySecuritiesMember us-gaap:FairValueInputsLevel3Member country:US us-gaap:PensionPlansDefinedBenefitMember 2019-10-31 0001090872 us-gaap:EquitySecuritiesMember us-gaap:FairValueInputsLevel1Member country:US us-gaap:PensionPlansDefinedBenefitMember 2019-10-31 0001090872 us-gaap:FixedIncomeSecuritiesMember us-gaap:FairValueInputsLevel1Member country:US us-gaap:PensionPlansDefinedBenefitMember 2019-10-31 0001090872 us-gaap:FairValueInputsLevel1Member country:US us-gaap:PensionPlansDefinedBenefitMember 2019-10-31 0001090872 us-gaap:CashAndCashEquivalentsMember country:US us-gaap:PensionPlansDefinedBenefitMember 2019-10-31 0001090872 a:OtherPlanAssetsMember us-gaap:FairValueInputsLevel2Member country:US us-gaap:PensionPlansDefinedBenefitMember 2019-10-31 0001090872 us-gaap:CashAndCashEquivalentsMember us-gaap:FairValueInputsLevel1Member country:US us-gaap:PensionPlansDefinedBenefitMember 2019-10-31 0001090872 a:RetirementandpostretirementbenefitsMember country:US us-gaap:PensionPlansDefinedBenefitMember 2018-10-31 0001090872 a:EmployeecompensationandbenefitsMember country:US us-gaap:DefinedBenefitPostretirementHealthCoverageMember 2019-10-31 0001090872 us-gaap:OtherAssetsMember country:US us-gaap:DefinedBenefitPostretirementHealthCoverageMember 2018-10-31 0001090872 a:RetirementandpostretirementbenefitsMember country:US us-gaap:DefinedBenefitPostretirementHealthCoverageMember 2019-10-31 0001090872 a:EmployeecompensationandbenefitsMember us-gaap:ForeignPlanMember us-gaap:PensionPlansDefinedBenefitMember 2019-10-31 0001090872 us-gaap:OtherAssetsMember country:US us-gaap:DefinedBenefitPostretirementHealthCoverageMember 2019-10-31 0001090872 country:US us-gaap:PensionPlansDefinedBenefitMember 2017-10-31 0001090872 a:RetirementandpostretirementbenefitsMember country:US us-gaap:PensionPlansDefinedBenefitMember 2019-10-31 0001090872 a:EmployeecompensationandbenefitsMember country:US us-gaap:DefinedBenefitPostretirementHealthCoverageMember 2018-10-31 0001090872 country:US us-gaap:DefinedBenefitPostretirementHealthCoverageMember 2017-10-31 0001090872 us-gaap:ForeignPlanMember us-gaap:PensionPlansDefinedBenefitMember 2017-10-31 0001090872 a:EmployeecompensationandbenefitsMember us-gaap:ForeignPlanMember us-gaap:PensionPlansDefinedBenefitMember 2018-10-31 0001090872 a:RetirementandpostretirementbenefitsMember country:US us-gaap:DefinedBenefitPostretirementHealthCoverageMember 2018-10-31 0001090872 a:RetirementandpostretirementbenefitsMember us-gaap:ForeignPlanMember us-gaap:PensionPlansDefinedBenefitMember 2019-10-31 0001090872 a:RetirementandpostretirementbenefitsMember us-gaap:ForeignPlanMember us-gaap:PensionPlansDefinedBenefitMember 2018-10-31 0001090872 us-gaap:OtherAssetsMember us-gaap:ForeignPlanMember us-gaap:PensionPlansDefinedBenefitMember 2018-10-31 0001090872 a:EmployeecompensationandbenefitsMember country:US us-gaap:PensionPlansDefinedBenefitMember 2018-10-31 0001090872 a:EmployeecompensationandbenefitsMember country:US us-gaap:PensionPlansDefinedBenefitMember 2019-10-31 0001090872 us-gaap:OtherAssetsMember country:US us-gaap:PensionPlansDefinedBenefitMember 2018-10-31 0001090872 us-gaap:OtherAssetsMember country:US us-gaap:PensionPlansDefinedBenefitMember 2019-10-31 0001090872 us-gaap:OtherAssetsMember us-gaap:ForeignPlanMember us-gaap:PensionPlansDefinedBenefitMember 2019-10-31 0001090872 us-gaap:FixedIncomeSecuritiesMember us-gaap:FairValueInputsLevel3Member us-gaap:ForeignPlanMember us-gaap:PensionPlansDefinedBenefitMember 2019-10-31 0001090872 us-gaap:CashAndCashEquivalentsMember us-gaap:FairValueInputsLevel2Member us-gaap:ForeignPlanMember us-gaap:PensionPlansDefinedBenefitMember 2019-10-31 0001090872 a:OtherPlanAssetsMember us-gaap:ForeignPlanMember us-gaap:PensionPlansDefinedBenefitMember 2019-10-31 0001090872 us-gaap:FixedIncomeSecuritiesMember us-gaap:ForeignPlanMember us-gaap:PensionPlansDefinedBenefitMember 2019-10-31 0001090872 a:OtherPlanAssetsMember us-gaap:FairValueInputsLevel3Member us-gaap:ForeignPlanMember us-gaap:PensionPlansDefinedBenefitMember 2019-10-31 0001090872 us-gaap:CashAndCashEquivalentsMember us-gaap:ForeignPlanMember us-gaap:PensionPlansDefinedBenefitMember 2019-10-31 0001090872 us-gaap:CashAndCashEquivalentsMember us-gaap:FairValueInputsLevel1Member us-gaap:ForeignPlanMember us-gaap:PensionPlansDefinedBenefitMember 2019-10-31 0001090872 us-gaap:CashAndCashEquivalentsMember us-gaap:FairValueInputsLevel3Member us-gaap:ForeignPlanMember us-gaap:PensionPlansDefinedBenefitMember 2019-10-31 0001090872 us-gaap:EquitySecuritiesMember us-gaap:FairValueInputsLevel3Member us-gaap:ForeignPlanMember us-gaap:PensionPlansDefinedBenefitMember 2019-10-31 0001090872 us-gaap:FairValueInputsLevel2Member us-gaap:ForeignPlanMember us-gaap:PensionPlansDefinedBenefitMember 2019-10-31 0001090872 us-gaap:FairValueInputsLevel1Member us-gaap:ForeignPlanMember us-gaap:PensionPlansDefinedBenefitMember 2019-10-31 0001090872 us-gaap:EquitySecuritiesMember us-gaap:ForeignPlanMember us-gaap:PensionPlansDefinedBenefitMember 2019-10-31 0001090872 a:OtherPlanAssetsMember us-gaap:FairValueInputsLevel1Member us-gaap:ForeignPlanMember us-gaap:PensionPlansDefinedBenefitMember 2019-10-31 0001090872 a:OtherPlanAssetsMember us-gaap:FairValueInputsLevel2Member us-gaap:ForeignPlanMember us-gaap:PensionPlansDefinedBenefitMember 2019-10-31 0001090872 us-gaap:FixedIncomeSecuritiesMember us-gaap:FairValueInputsLevel1Member us-gaap:ForeignPlanMember us-gaap:PensionPlansDefinedBenefitMember 2019-10-31 0001090872 us-gaap:FixedIncomeSecuritiesMember us-gaap:FairValueInputsLevel2Member us-gaap:ForeignPlanMember us-gaap:PensionPlansDefinedBenefitMember 2019-10-31 0001090872 us-gaap:EquitySecuritiesMember us-gaap:FairValueInputsLevel2Member us-gaap:ForeignPlanMember us-gaap:PensionPlansDefinedBenefitMember 2019-10-31 0001090872 us-gaap:EquitySecuritiesMember us-gaap:FairValueInputsLevel1Member us-gaap:ForeignPlanMember us-gaap:PensionPlansDefinedBenefitMember 2019-10-31 0001090872 us-gaap:FairValueInputsLevel3Member us-gaap:ForeignPlanMember us-gaap:PensionPlansDefinedBenefitMember 2019-10-31 0001090872 us-gaap:FairValueInputsLevel3Member country:US us-gaap:DefinedBenefitPostretirementHealthCoverageMember 2017-11-01 2018-10-31 0001090872 us-gaap:FairValueInputsLevel3Member country:US us-gaap:DefinedBenefitPostretirementHealthCoverageMember 2018-11-01 2019-10-31 0001090872 us-gaap:FairValueInputsLevel3Member country:US us-gaap:DefinedBenefitPostretirementHealthCoverageMember 2017-10-31 0001090872 us-gaap:FairValueInputsLevel3Member country:US us-gaap:PensionPlansDefinedBenefitMember 2017-10-31 0001090872 us-gaap:FairValueInputsLevel3Member country:US us-gaap:PensionPlansDefinedBenefitMember 2017-11-01 2018-10-31 0001090872 us-gaap:FairValueInputsLevel3Member country:US us-gaap:PensionPlansDefinedBenefitMember 2018-11-01 2019-10-31 0001090872 srt:MinimumMember us-gaap:EquitySecuritiesMember us-gaap:ForeignPlanMember us-gaap:PensionPlansDefinedBenefitMember 2018-10-31 0001090872 srt:MinimumMember us-gaap:CashAndCashEquivalentsMember us-gaap:ForeignPlanMember us-gaap:PensionPlansDefinedBenefitMember 2019-10-31 0001090872 srt:MinimumMember us-gaap:FixedIncomeSecuritiesMember us-gaap:ForeignPlanMember us-gaap:PensionPlansDefinedBenefitMember 2018-10-31 0001090872 us-gaap:DeferredProfitSharingMember us-gaap:EquitySecuritiesMember country:US 2018-10-31 0001090872 srt:MaximumMember us-gaap:CashAndCashEquivalentsMember us-gaap:ForeignPlanMember us-gaap:PensionPlansDefinedBenefitMember 2019-10-31 0001090872 srt:MaximumMember us-gaap:RealEstateMember us-gaap:ForeignPlanMember us-gaap:PensionPlansDefinedBenefitMember 2018-10-31 0001090872 us-gaap:DeferredProfitSharingMember us-gaap:FixedIncomeSecuritiesMember country:US 2018-10-31 0001090872 srt:MaximumMember us-gaap:CashAndCashEquivalentsMember us-gaap:ForeignPlanMember us-gaap:PensionPlansDefinedBenefitMember 2018-10-31 0001090872 srt:MaximumMember us-gaap:EquitySecuritiesMember us-gaap:ForeignPlanMember us-gaap:PensionPlansDefinedBenefitMember 2018-10-31 0001090872 srt:MaximumMember us-gaap:FixedIncomeSecuritiesMember us-gaap:ForeignPlanMember us-gaap:PensionPlansDefinedBenefitMember 2018-10-31 0001090872 srt:MinimumMember us-gaap:CashAndCashEquivalentsMember us-gaap:ForeignPlanMember us-gaap:PensionPlansDefinedBenefitMember 2018-10-31 0001090872 srt:MinimumMember us-gaap:RealEstateMember us-gaap:ForeignPlanMember us-gaap:PensionPlansDefinedBenefitMember 2018-10-31 0001090872 srt:MinimumMember us-gaap:ForeignPlanMember us-gaap:PensionPlansDefinedBenefitMember 2017-11-01 2018-10-31 0001090872 srt:MaximumMember us-gaap:ForeignPlanMember us-gaap:PensionPlansDefinedBenefitMember 2017-11-01 2018-10-31 0001090872 srt:MinimumMember us-gaap:ForeignPlanMember us-gaap:PensionPlansDefinedBenefitMember 2016-11-01 2017-10-31 0001090872 srt:MaximumMember us-gaap:ForeignPlanMember us-gaap:PensionPlansDefinedBenefitMember 2018-11-01 2019-10-31 0001090872 srt:MaximumMember us-gaap:ForeignPlanMember us-gaap:PensionPlansDefinedBenefitMember 2016-11-01 2017-10-31 0001090872 srt:MinimumMember us-gaap:ForeignPlanMember us-gaap:PensionPlansDefinedBenefitMember 2018-11-01 2019-10-31 0001090872 srt:MinimumMember us-gaap:ForeignPlanMember us-gaap:PensionPlansDefinedBenefitMember 2019-10-31 0001090872 srt:MaximumMember us-gaap:ForeignPlanMember us-gaap:PensionPlansDefinedBenefitMember 2018-10-31 0001090872 srt:MinimumMember us-gaap:ForeignPlanMember us-gaap:PensionPlansDefinedBenefitMember 2018-10-31 0001090872 srt:MaximumMember us-gaap:ForeignPlanMember us-gaap:PensionPlansDefinedBenefitMember 2019-10-31 0001090872 a:PenaltyreduceoverperiodoftimeMember 2019-10-31 0001090872 a:SeniorNotes2020Member 2010-07-13 0001090872 a:SeniorNotes2017Member 2007-10-23 2007-10-24 0001090872 a:SeniorNotes2020Member 2019-09-17 2019-09-17 0001090872 a:SeniorNotes2020Member 2011-08-08 2011-08-09 0001090872 a:SeniorNotes2020Member 2011-08-09 0001090872 a:SeniorNotes2017Member 2017-11-01 2017-11-01 0001090872 a:SeniorNotes2017Member 2007-10-24 0001090872 a:SeniorNotes2020Member 2010-07-12 2010-07-13 0001090872 2019-08-07 0001090872 a:SeniorNotes2017Member 2014-10-20 2014-10-20 0001090872 2019-03-13 2019-03-13 0001090872 2019-10-21 0001090872 2016-09-15 0001090872 a:SeniorNotes2023Member 2013-06-17 2013-06-18 0001090872 a:SeniorNotes2022Member 2012-09-10 0001090872 a:SeniorNotes2022Member 2012-09-09 2012-09-10 0001090872 2016-02-01 0001090872 a:SeniorNotes2023Member 2013-06-18 0001090872 a:SeniorNotes2026Member 2016-09-15 0001090872 a:SeniorNotes2029Member 2019-09-04 2019-09-05 0001090872 a:SeniorNotes2029Member 2019-09-05 0001090872 a:SeniorNotes2026Member 2016-09-14 2016-09-15 0001090872 a:SeniorNotes2029Member 2018-10-31 0001090872 a:SeniorNotes2029Member 2019-10-31 0001090872 a:SeniorNotes2022Member 2019-10-31 0001090872 a:SeniorNotes2026Member 2019-10-31 0001090872 a:SeniorNotes2023Member 2019-10-31 0001090872 a:SeniorNotes2023Member 2018-10-31 0001090872 a:SeniorNotes2020Member 2018-10-31 0001090872 a:SeniorNotes2022Member 2018-10-31 0001090872 a:SeniorNotes2026Member 2018-10-31 0001090872 a:A2015RepurchaseProgramMember 2016-11-01 2017-10-31 0001090872 us-gaap:SubsequentEventMember 2019-11-20 2019-11-20 0001090872 a:A2019RepurchaseProgramMember 2018-11-01 2019-10-31 0001090872 a:A2015RepurchaseProgramMember 2018-10-31 0001090872 a:A2019RepurchaseProgramMember 2019-10-31 0001090872 a:A2015RepurchaseProgramMember 2017-11-01 2018-10-31 0001090872 a:A2015RepurchaseProgramMember 2015-05-28 0001090872 a:A2019RepurchaseProgramMember 2018-11-19 0001090872 2018-11-01 2018-11-01 0001090872 us-gaap:AccumulatedDefinedBenefitPlansAdjustmentNetPriorServiceCostCreditMember 2018-11-01 2018-11-01 0001090872 us-gaap:AociDerivativeQualifyingAsHedgeExcludedComponentParentMember 2018-11-01 2018-11-01 0001090872 us-gaap:AccumulatedDefinedBenefitPlansAdjustmentNetUnamortizedGainLossMember 2018-11-01 2018-11-01 0001090872 us-gaap:AccumulatedTranslationAdjustmentMember 2018-11-01 2018-11-01 0001090872 a:SegmentTotalMember 2018-10-31 0001090872 a:SegmentTotalMember 2018-11-01 2019-10-31 0001090872 a:SegmentTotalMember 2017-11-01 2018-10-31 0001090872 a:SegmentTotalMember 2019-10-31 0001090872 country:US 2017-11-01 2018-10-31 0001090872 a:RestOfWorldMember 2016-11-01 2017-10-31 0001090872 a:RestOfWorldMember 2017-11-01 2018-10-31 0001090872 a:RestOfWorldMember 2018-11-01 2019-10-31 0001090872 country:CN 2016-11-01 2017-10-31 0001090872 country:US 2016-11-01 2017-10-31 0001090872 country:CN 2017-11-01 2018-10-31 0001090872 country:US 2018-11-01 2019-10-31 0001090872 country:CN 2018-11-01 2019-10-31 0001090872 a:LifeSciencesandAppliedMarketsMember 2016-11-01 2017-10-31 0001090872 a:AgilentCrossLabMember 2016-11-01 2017-10-31 0001090872 a:SegmentTotalMember 2016-11-01 2017-10-31 0001090872 a:DiagnosticsAndGenomicsMember 2016-11-01 2017-10-31 0001090872 a:RestOfWorldMember 2019-10-31 0001090872 country:US 2018-10-31 0001090872 country:DE 2018-10-31 0001090872 country:US 2019-10-31 0001090872 country:DE 2019-10-31 0001090872 a:RestOfWorldMember 2018-10-31 0001090872 us-gaap:ValuationAllowanceOfDeferredTaxAssetsMember 2017-11-01 2018-10-31 0001090872 us-gaap:ValuationAllowanceOfDeferredTaxAssetsMember 2016-10-31 0001090872 us-gaap:ValuationAllowanceOfDeferredTaxAssetsMember 2019-10-31 0001090872 us-gaap:ValuationAllowanceOfDeferredTaxAssetsMember 2018-11-01 2019-10-31 0001090872 us-gaap:ValuationAllowanceOfDeferredTaxAssetsMember 2018-10-31 0001090872 us-gaap:ValuationAllowanceOfDeferredTaxAssetsMember 2017-10-31 0001090872 us-gaap:ValuationAllowanceOfDeferredTaxAssetsMember 2016-11-01 2017-10-31 pure iso4217:USD shares iso4217:USD shares utreg:Y a:contracts a:segment 0.03 0.03 0.03 15000000 5000000 less than 10 percent less than 10 percent 0 3000000 132000000 153000000 false --10-31 FY 2019 0001090872 false Large Accelerated Filer false false P8Y P13Y P3Y P5Y 0.528 0.596 0.656 0.01 0.01 2000000000 2000000000 318000000 309000000 Less than 10 percent Less than 10 percent Less than 10 percent 0.0268 0.0083 0.0181 0.0022 0.0325 0.0225 0.0300 0.0225 0.0266 0.0022 0.0252 0.0067 0.0268 0.0083 0.0625 0.0400 0.0600 0.0400 0.0575 0.0400 0.0425 0.0200 0.0325 0.0200 0.0325 0.0225 0 0 0.25 0.60 0.61 0.25 0.00 0.31 0.38 0.00 0.60 0.40 0.80 0.80 0.20 0.20 0.25 0.00 0.80 0.20 0 0 0 4000000 0 0 0 0 0 0 52000000 -3000000 -25000000 3000000 -3000000 0 0 1000000 -2000000 0.01 0.01 125000000 125000000 0 0 0 0 0.63 0.66 0.66 0.15 0.14 0.15 25.01 30.01 40.01 30 40 P4Y0M P2Y6M P4Y1M P5Y0M P4Y0M P2Y6M P4Y1M P5Y0M 0 0 0 0 10-K true 2019-10-31 false 001-15405 Agilent Technologies, Inc. DE 77-0518772 5301 Stevens Creek Blvd. Santa Clara, CA 95051 (800) 227-9770 Common Stock, $0.01 par value A NYSE Yes No Yes Yes Large Accelerated Filer false false false 18900000000 310183415 Portions of the Proxy Statement for the Annual Meeting of Stockholders (the "Proxy Statement") to be held on March 18, 2020, and to be filed pursuant to Regulation 14A within 120 days after registrant's fiscal year ended October 31, 2019 are incorporated by reference into Part III of this Report 3877000000 3746000000 3397000000 1286000000 1168000000 1075000000 5163000000 4914000000 4472000000 1680000000 1595000000 1473000000 678000000 639000000 600000000 2358000000 2234000000 2073000000 404000000 387000000 341000000 1460000000 1389000000 1251000000 4222000000 4010000000 3665000000 941000000 904000000 807000000 36000000 38000000 22000000 74000000 75000000 79000000 16000000 79000000 53000000 919000000 946000000 803000000 -152000000 630000000 119000000 1071000000 316000000 684000000 3.41 0.98 2.12 3.37 0.97 2.10 314000000 321000000 322000000 318000000 325000000 326000000 1071000000 316000000 684000000 -4000000 6000000 0 6000000 -3000000 1000000 10000000 -58000000 41000000 -93000000 -7000000 123000000 6000000 6000000 6000000 -99000000 -62000000 157000000 972000000 254000000 841000000 1382000000 2247000000 930000000 776000000 679000000 638000000 198000000 187000000 3189000000 3848000000 850000000 822000000 3593000000 2973000000 1107000000 491000000 102000000 68000000 611000000 339000000 9452000000 8541000000 354000000 340000000 334000000 304000000 336000000 324000000 616000000 0 440000000 203000000 2080000000 1171000000 1791000000 1799000000 360000000 239000000 473000000 761000000 4704000000 3970000000 0 0 3000000 3000000 5277000000 5308000000 -18000000 -336000000 -514000000 -408000000 4748000000 4567000000 0 4000000 4748000000 4571000000 9452000000 8541000000 1071000000 316000000 684000000 238000000 210000000 212000000 72000000 70000000 60000000 -255000000 -16000000 102000000 19000000 26000000 24000000 0 20000000 0 0 21000000 0 -9000000 0 0 -6000000 -9000000 -7000000 106000000 65000000 81000000 36000000 83000000 61000000 29000000 40000000 2000000 23000000 31000000 38000000 0 -552000000 0 6000000 0 0 43000000 4000000 98000000 1021000000 1087000000 889000000 155000000 177000000 176000000 0 1000000 0 0 0 2000000 23000000 11000000 1000000 3000000 2000000 1000000 1000000 0 0 1408000000 516000000 128000000 -1590000000 -705000000 -304000000 54000000 56000000 66000000 16000000 30000000 14000000 723000000 422000000 194000000 206000000 191000000 170000000 497000000 0 0 4000000 0 0 4000000 0 0 805000000 483000000 400000000 702000000 693000000 290000000 -299000000 -797000000 -202000000 2000000 -17000000 8000000 -866000000 -432000000 391000000 2254000000 2686000000 2295000000 1388000000 2254000000 2686000000 159000000 102000000 63000000 80000000 80000000 82000000 -21000000 -5000000 29000000 613536000 6000000 9159000000 -290075000 -10508000000 6089000000 -503000000 4243000000 3000000 4246000000 684000000 684000000 684000000 157000000 157000000 157000000 841000000 841000000 170000000 170000000 170000000 1000000 1000000 2621000 51000000 51000000 51000000 4107000 194000000 194000000 194000000 294182000 3000000 3970000000 294182000 10702000000 6729000000 60000000 60000000 60000000 321975000 3000000 5300000000 0 0 -126000000 -346000000 4831000000 4000000 4835000000 316000000 316000000 316000000 -62000000 -62000000 -62000000 254000000 254000000 191000000 191000000 191000000 2176000 25000000 25000000 25000000 6436000 422000000 422000000 422000000 6436000 0 87000000 6436000 422000000 335000000 70000000 70000000 70000000 317715000 3000000 5308000000 0 0 -336000000 -408000000 4567000000 4000000 4571000000 33000000 -7000000 26000000 26000000 1071000000 1071000000 1071000000 -99000000 -99000000 -99000000 972000000 972000000 -4000000 -4000000 206000000 206000000 206000000 1792000 40000000 40000000 40000000 10436000 723000000 723000000 723000000 10436000 0 143000000 10436000 723000000 580000000 72000000 72000000 72000000 309071000 3000000 5277000000 0 0 -18000000 -514000000 4748000000 0 4748000000 OVERVIEW AND SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES<div style="line-height:120%;text-align:justify;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div><div style="line-height:120%;text-align:justify;text-indent:36px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;font-style:italic;">Overview.</span><span style="font-family:inherit;font-size:10pt;">    Agilent Technologies, Inc. ("we", "Agilent" or the "company"), incorporated in Delaware in May 1999, is a global leader in life sciences, diagnostics and applied chemical markets, providing application focused solutions that include instruments, software, services and consumables for the entire laboratory workflow.</span></div><div style="line-height:120%;text-align:justify;text-indent:33px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div><div style="line-height:120%;text-align:justify;text-indent:36px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;font-style:italic;">Basis of Presentation.</span><span style="font-family:inherit;font-size:10pt;">    The accompanying consolidated financial statements have been prepared by us pursuant to the rules and regulations of the U.S. Securities and Exchange Commission ("SEC") and is in conformity with U.S. generally accepted accounting principles ("GAAP"). Our fiscal year end is October 31. Unless otherwise stated, all years and dates refer to our fiscal year.</span></div><div style="line-height:120%;text-align:justify;text-indent:36px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div><div style="line-height:120%;text-align:justify;text-indent:36px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;font-style:italic;">Principles of Consolidation.</span><span style="font-family:inherit;font-size:10pt;">    The consolidated financial statements include the accounts of the company and our wholly- and majority-owned subsidiaries. All significant intercompany accounts and transactions have been eliminated.</span></div><div style="line-height:120%;text-align:justify;text-indent:36px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div><div style="line-height:120%;text-align:justify;text-indent:36px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;font-style:italic;">Use of Estimates.</span><span style="font-family:inherit;font-size:10pt;">    The preparation of financial statements in accordance with U.S. GAAP requires management to make estimates and assumptions that affect the amounts reported in our consolidated financial statements and accompanying notes. Management bases its estimates on historical experience and various other assumptions believed to be reasonable. Although these estimates are based on management's best knowledge of current events and actions that may impact the company in the future, actual results may be different from the estimates. Our critical accounting policies are those that affect our financial statements materially and involve difficult, subjective or complex judgments by management. Those policies are revenue recognition, valuation of goodwill and purchased intangible assets, inventory valuation, retirement and post-retirement plan assumptions and accounting for income taxes.</span></div><div style="line-height:120%;text-align:justify;text-indent:36px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div><div style="line-height:120%;text-align:justify;text-indent:33px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;font-style:italic;">Retirement of Treasury Shares. </span><span style="font-family:inherit;font-size:10pt;">Upon the formal retirement of treasury shares, we deduct the par value of the retired treasury shares from common stock and allocate the excess of cost over par as a deduction to additional paid-in capital, based on the pro-rata portion of additional paid-in-capital, and the remaining excess as a deduction to retained earnings. All retired treasury shares revert to the status of authorized but unissued shares.</span></div><div style="line-height:120%;text-align:justify;text-indent:36px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div><div style="line-height:120%;text-align:justify;text-indent:36px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;font-style:italic;">Revenue Recognition.</span><span style="font-family:inherit;font-size:10pt;">    We enter into contracts to sell products, services or combinations of products and services. Products may include hardware or software and services may include one-time service events or services performed over time.</span></div><div style="line-height:120%;text-align:justify;text-indent:36px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div><div style="line-height:120%;text-align:justify;text-indent:36px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">We derive revenue primarily from the sale of analytical and diagnostics products and services. A performance obligation is a promise in a contract to transfer a distinct product or service to a customer and is the unit of account under Accounting Standard Codification Topic 606, </span><span style="font-family:inherit;font-size:10pt;font-style:italic;">Revenue from Contracts with Customers</span><span style="font-family:inherit;font-size:10pt;"> (“ASC 606’’). See also Note 2, "New Accounting Pronouncements" and Note 4, "Revenue" for additional information on revenue recognition.</span></div><div style="line-height:120%;text-align:justify;text-indent:36px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div><div style="line-height:120%;text-align:justify;text-indent:36px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Revenue is recognized when control of the promised products or services is transferred to our customers and the performance obligation is fulfilled in an amount that reflects the consideration that we expect to be entitled in exchange for those products or services, the transaction price. For equipment, consumables, and most software licenses, control transfers to the customer at a point in time. We use present right to payment, legal title, physical possession of the asset, and risks and rewards of ownership as indicators to determine the transfer of control to the customer. Where acceptance is not a formality, the customer must have documented their acceptance of the product or service. For products that include installation, if the installation meets the criteria to be considered a separate performance obligation, product revenue is recognized when control has passed to the customer, and recognition of installation revenue occurs once completed. Product revenue, including sales to resellers and distributors is reduced for provisions for warranties, returns, and other adjustments in the period the related sales are recorded.</span></div><div style="line-height:120%;text-align:justify;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div><div style="line-height:120%;text-align:justify;text-indent:36px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Service revenue includes extended warranty, customer and software support including: Software as a Service, post contract support, consulting including companion diagnostics, and training and education. Instrument service contracts and software maintenance contracts are typically annual contracts, which are billed at the beginning of the contract or maintenance period. Revenue for these contracts is recognized on a straight-line basis to revenue over the service period, as a time-based measure of progress best reflects our performance in satisfying this obligation. There are no deferred costs associated with the service contract, as the cost of the service is recorded when the service is performed. Service calls not included in a support contract are recognized to revenue at the time a service is performed. </span></div><div style="line-height:120%;text-align:justify;text-indent:36px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div><div style="line-height:120%;text-align:justify;text-indent:36px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">We have sales from standalone software. These arrangements typically include software licenses and maintenance contracts, both of which we have determined are distinct performance obligations. We determine the amount of the transaction price to allocate to the license and maintenance contract based on the relative standalone selling price of each performance obligation. Software license revenue is recognized at the point in time when control has been transferred to the customer. The revenue allocated to the software maintenance contract is recognized on a straight-line basis over the maintenance period, which is the contractual term of the contract, as a time-based measure of progress best reflects our performance in satisfying this obligation. Unspecified rights to software upgrades are typically sold as part of the maintenance contract on a when-and-if-available basis.</span></div><div style="line-height:120%;text-align:justify;text-indent:36px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div><div style="line-height:120%;text-align:justify;text-indent:36px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Our multiple-element arrangements are generally comprised of a combination of instruments, installation or other start-up services, and/or software, and/or support or services. Hardware and software elements are typically delivered at the same time and revenue is recognized when control passes to the customer. Service revenue is deferred and recognized over the contractual period or as services are rendered and accepted by the customer. Our arrangements generally do not include any provisions for cancellation, termination, or refunds that would significantly impact recognized revenue.</span></div><div style="line-height:120%;text-align:justify;text-indent:36px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div><div style="line-height:120%;text-align:justify;text-indent:36px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">For contracts with multiple performance obligations, we allocate the consideration to which we expect to be entitled to each performance obligation based on relative standalone selling prices and recognize the related revenue when or as control of each individual performance obligation is transferred to customers. We estimate the standalone selling price by calculating the average historical selling price of our products and services per country for each performance obligation. Standalone selling prices are determined for each distinct good or service in the contract and then we allocate the transaction price in proportion to those standalone selling prices by performance obligations.</span></div><div style="line-height:120%;text-align:justify;text-indent:36px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div><div style="line-height:120%;text-align:justify;text-indent:36px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">A portion of our revenue relates to lease arrangements. Standalone lease arrangements are outside the scope of ASC 606 and are therefore accounted for in accordance with ASC 840, Leases. Each of these contracts is evaluated as a lease arrangement, either as an operating lease or a sales-type capital lease using the current lease classification guidance.</span></div><div style="line-height:120%;text-align:justify;text-indent:36px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div><div style="line-height:120%;text-align:justify;text-indent:36px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;font-style:italic;">Deferred Revenue.</span><span style="font-family:inherit;font-size:10pt;">    Contract liabilities (deferred revenue) primarily relate to multiple element arrangements for which billing has occurred but transfer of control of all elements (performance obligations) to the customer has either partially or not occurred at the balance sheet date. This includes cash received from customers for products and related installation and services in advance of the transfer of control. Contract liabilities are classified as either in current liabilities in deferred revenue or long-term in other long-term liabilities in the consolidated balance sheet based on the timing of when we expect to complete our performance obligation.</span></div><div style="line-height:120%;text-align:justify;text-indent:36px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div><div style="line-height:120%;text-align:justify;text-indent:36px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;font-style:italic;">Accounts Receivable, net.</span><span style="font-family:inherit;font-size:10pt;">    Trade accounts receivable are recorded at the invoiced amount and do not bear interest. Such accounts receivable have been reduced by an allowance for doubtful accounts, which is our best estimate of the amount of probable credit losses in our existing accounts receivable. We determine the allowance based on customer specific experience and the aging of such receivables, among other factors. The allowance for doubtful accounts as of </span><span style="font-family:inherit;font-size:10pt;">October 31, 2019</span><span style="font-family:inherit;font-size:10pt;"> and </span><span style="font-family:inherit;font-size:10pt;">2018</span><span style="font-family:inherit;font-size:10pt;"> was not material. We do not have any off-balance-sheet credit exposure related to our customers. Accounts receivable are also recorded net of estimated product returns which are not material.</span></div><div style="line-height:120%;text-align:justify;text-indent:36px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div><div style="line-height:120%;text-align:justify;text-indent:36px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;font-style:italic;">Shipping and Handling Costs.</span><span style="font-family:inherit;font-size:10pt;">  Our shipping and handling costs charged to customers are included in net revenue, and the associated expense is recorded in cost of products for all periods presented.</span></div><div style="line-height:120%;text-align:justify;text-indent:36px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div><div style="line-height:120%;text-align:justify;text-indent:36px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;font-style:italic;">Inventory.</span><span style="font-family:inherit;font-size:10pt;">    Inventory is valued at standard cost, which approximates actual cost computed on a first-in, first-out basis, not in excess of market value. We assess the valuation of our inventory on a periodic basis and make adjustments to the value for estimated excess and obsolete inventory based on estimates about future demand. The excess balance determined by this analysis becomes the basis for our excess inventory charge. Our excess inventory review process includes analysis of sales forecasts, managing product rollovers and working with manufacturing to maximize recovery of excess inventory.</span></div><div style="line-height:120%;text-align:justify;text-indent:36px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div><div style="line-height:120%;text-align:justify;text-indent:36px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;font-style:italic;">Acquisitions. </span><span style="font-family:inherit;font-size:10pt;"> Agilent accounts for the acquisition of a business using the acquisition method of accounting and we allocate the fair value of the purchase price to the tangible assets acquired, liabilities assumed, and intangible assets acquired, including in-process research and development (“IPR&amp;D”), based on their estimated fair values. The excess value of the cost of an acquired business over the fair value of the assets acquired and liabilities assumed is recognized as goodwill. The fair value of IPR&amp;D is initially capitalized as an intangible asset with an indefinite life. When an IPR&amp;D project is completed, the IPR&amp;D is reclassified as an amortizable purchased intangible asset and amortized to costs of revenues over the asset’s estimated useful life.</span></div><div style="line-height:120%;text-align:justify;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div><div style="line-height:120%;text-align:justify;text-indent:36px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Our determination of the fair value of the intangible assets acquired involves the use of significant estimates and assumptions. Specifically, our determination of the fair value of the developed product technology and IPR&amp;D acquired involve significant estimates and assumptions related to revenue growth rates and discount rates. Our determination of the fair value of customer </span></div><div style="line-height:120%;text-align:justify;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">relationships acquired involved significant estimates and assumptions related to revenue growth rates, discount rates, and customer attrition rates. Our determination of the fair value of the tradename acquired involved the use of significant estimates and assumptions related to revenue growth rates, royalty rates and discount rates. The company believes that the fair value assigned to the assets acquired and liabilities assumed are based on reasonable assumptions and estimates that marketplace participants would use. Actual results could differ materially from these estimates. </span></div><div style="line-height:120%;text-align:left;text-indent:36px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div><div style="line-height:120%;text-align:justify;text-indent:36px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;font-style:italic;">Goodwill and Purchased Intangible Assets.</span><span style="font-family:inherit;font-size:10pt;"> Under the authoritative guidance we have the option to perform a qualitative assessment to determine whether further impairment testing is necessary. The accounting standard gives an entity the option to first assess qualitative factors to determine whether performing the two-step test is necessary. If an entity believes, as a result of its qualitative assessment, that it is more-likely-than-not (i.e. greater than 50% chance) that the fair value of a reporting unit is less than its carrying amount, the quantitative impairment test will be required. Otherwise, no further testing will be required.</span></div><div style="line-height:120%;text-align:justify;text-indent:36px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div><div style="line-height:120%;text-align:justify;text-indent:36px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">The guidance includes examples of events and circumstances that might indicate that a reporting unit's fair value is less than its carrying amount. These include macro-economic conditions such as deterioration in the entity's operating environment or industry or market considerations; entity-specific events such as increasing costs, declining financial performance, or loss of key personnel; or other events such as an expectation that a reporting unit will be sold or a sustained decrease in the stock price on either an absolute basis or relative to peers. </span></div><div style="line-height:120%;text-align:justify;text-indent:36px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div><div style="line-height:120%;text-align:justify;text-indent:36px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">If it is determined, as a result of the qualitative assessment, that it is more-likely-than-not that the fair value of a reporting unit is less than its carrying amount, the provisions of authoritative guidance require that we perform a two-step impairment test on goodwill. In the first step, we compare the fair value of each reporting unit to its carrying value. The second step (if necessary) measures the amount of impairment by applying fair-value-based tests to the individual assets and liabilities within each reporting unit. As defined in the authoritative guidance, a reporting unit is an operating segment, or one level below an operating segment. We aggregate components of an operating segment that have similar economic characteristics into our reporting units. </span></div><div style="line-height:120%;text-align:justify;text-indent:36px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div><div style="line-height:120%;text-align:justify;text-indent:36px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> In fiscal year </span><span style="font-family:inherit;font-size:10pt;">2019</span><span style="font-family:inherit;font-size:10pt;">, we assessed goodwill impairment for our three reporting units which consisted of three segments: life sciences and applied markets, diagnostics and genomics and Agilent CrossLab. We performed a qualitative test for goodwill impairment of the three reporting units, as of September 30, </span><span style="font-family:inherit;font-size:10pt;">2019</span><span style="font-family:inherit;font-size:10pt;">, our annual impairment test date. Based on the results of our qualitative testing, we believe that it is more-likely-than-not that the fair value of each reporting unit is greater than its respective carrying value. Each quarter we review the events and circumstances to determine if goodwill impairment is indicated. There was </span><span style="font-family:inherit;font-size:10pt;"><span>no</span></span><span style="font-family:inherit;font-size:10pt;"> impairment of goodwill during the years ended </span><span style="font-family:inherit;font-size:10pt;">October 31, 2019</span><span style="font-family:inherit;font-size:10pt;">, </span><span style="font-family:inherit;font-size:10pt;">2018</span><span style="font-family:inherit;font-size:10pt;"> and </span><span style="font-family:inherit;font-size:10pt;">2017</span><span style="font-family:inherit;font-size:10pt;">. </span></div><div style="line-height:120%;text-align:justify;text-indent:36px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div><div style="line-height:120%;text-align:justify;text-indent:36px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Purchased intangible assets consist primarily of acquired developed technologies, proprietary know-how, trademarks, and customer relationships and are amortized using the best estimate of the asset's useful life that reflect the pattern in which the economic benefits are consumed or used up or a straight-line method ranging from </span><span style="font-family:inherit;font-size:10pt;"><span>6 months</span></span><span style="font-family:inherit;font-size:10pt;"> to </span><span style="font-family:inherit;font-size:10pt;"><span>15 years</span></span><span style="font-family:inherit;font-size:10pt;">. IPR&amp;D is initially capitalized at fair value as an intangible asset with an indefinite life and assessed for impairment thereafter. When the IPR&amp;D project is complete, it is reclassified as an amortizable purchased intangible asset and is amortized over its estimated useful life. If an IPR&amp;D project is abandoned, Agilent will record a charge for the value of the related intangible asset to Agilent's consolidated statement of operations in the period it is abandoned.</span></div><div style="line-height:120%;text-align:justify;text-indent:36px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div><div style="line-height:120%;text-align:justify;text-indent:36px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Agilent's indefinite-lived intangible assets are IPR&amp;D intangible assets. The accounting guidance allows a qualitative approach for testing indefinite-lived intangible assets for impairment, similar to the issued impairment testing guidance for goodwill and allows the option to first assess qualitative factors (events and circumstances) that could have affected the significant inputs used in determining the fair value of the indefinite-lived intangible asset to determine whether it is more-likely-than-not (i.e. greater than 50% chance) that the indefinite-lived intangible asset is impaired. An organization may choose to bypass the qualitative assessment for any indefinite-lived intangible asset in any period and proceed directly to calculating its fair value. We performed a qualitative test for impairment of indefinite-lived intangible assets as of September 30, </span><span style="font-family:inherit;font-size:10pt;">2019</span><span style="font-family:inherit;font-size:10pt;">. Based on the results of our qualitative testing, we believe that it is more-likely-than-not that the fair value of these indefinite-lived intangible assets is greater than their respective carrying values. Each quarter we review the events and circumstances to determine if impairment of indefinite-lived intangible asset is indicated. During the year ended </span><span style="font-family:inherit;font-size:10pt;">October 31, 2019</span><span style="font-family:inherit;font-size:10pt;">, </span><span style="font-family:inherit;font-size:10pt;">2018</span><span style="font-family:inherit;font-size:10pt;"> and </span><span style="font-family:inherit;font-size:10pt;">2017</span><span style="font-family:inherit;font-size:10pt;"> there were </span><span style="font-family:inherit;font-size:10pt;"><span>no</span></span><span style="font-family:inherit;font-size:10pt;"> impairments of indefinite-lived intangible assets. </span></div><div style="line-height:120%;text-align:justify;text-indent:36px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div><div style="line-height:120%;text-align:justify;text-indent:36px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;font-style:italic;">Share-Based Compensation.</span><span style="font-family:inherit;font-size:10pt;">    For the years ended </span><span style="font-family:inherit;font-size:10pt;color:#000000;text-decoration:none;">2019</span><span style="font-family:inherit;font-size:10pt;">, </span><span style="font-family:inherit;font-size:10pt;color:#000000;text-decoration:none;">2018</span><span style="font-family:inherit;font-size:10pt;"> and </span><span style="font-family:inherit;font-size:10pt;color:#000000;text-decoration:none;">2017</span><span style="font-family:inherit;font-size:10pt;">, we accounted for share-based awards made to our employees and directors including employee stock option awards, restricted stock units, employee stock purchases made under our Employee Stock Purchase Plan ("ESPP") and performance share awards under Agilent Technologies, Inc. Long-Term Performance Program ("LTPP") using the estimated grant date fair value method of accounting. Under the fair value method, we recorded compensation expense for all share-based awards of </span><span style="font-family:inherit;font-size:10pt;color:#000000;text-decoration:none;"><span>$72 million</span></span><span style="font-family:inherit;font-size:10pt;"> in </span><span style="font-family:inherit;font-size:10pt;color:#000000;text-decoration:none;">2019</span><span style="font-family:inherit;font-size:10pt;">, </span><span style="font-family:inherit;font-size:10pt;"><span>$71 million</span></span><span style="font-family:inherit;font-size:10pt;"> in </span><span style="font-family:inherit;font-size:10pt;color:#000000;text-decoration:none;">2018</span><span style="font-family:inherit;font-size:10pt;"> and </span><span style="font-family:inherit;font-size:10pt;"><span>$61 million</span></span><span style="font-family:inherit;font-size:10pt;"> in </span><span style="font-family:inherit;font-size:10pt;color:#000000;text-decoration:none;">2017</span><span style="font-family:inherit;font-size:10pt;">. See Note 5, "Share-based Compensation" for additional information.</span></div><div style="line-height:120%;text-align:justify;text-indent:36px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div><div style="line-height:120%;text-align:justify;text-indent:36px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;font-style:italic;">Retirement and Post-Retirement Plans. </span><span style="font-family:inherit;font-size:10pt;"> Substantially all of our employees are covered under various defined benefit and/or defined contribution retirement plans. Additionally, we sponsor post-retirement health care benefits for our eligible U.S. employees. Assumptions used to determine the benefit obligations and the expense for these plans are derived annually. See Note 14, “Retirement plans and post-retirement pension plans” for additional information. </span></div><div style="line-height:120%;text-align:justify;text-indent:36px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div><div style="line-height:120%;text-align:justify;text-indent:36px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;font-style:italic;">Taxes on Income.</span><span style="font-family:inherit;font-size:10pt;">    Income tax expense or benefit is based on income or loss before taxes. Deferred tax assets and liabilities are recognized principally for the expected tax consequences of temporary differences between the tax bases of assets and liabilities and their reported amounts. See Note 6, "Income Taxes" for more information.</span></div><div style="line-height:120%;text-align:justify;text-indent:36px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div><div style="line-height:120%;text-align:justify;text-indent:36px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;font-style:italic;">Warranty.</span><span style="font-family:inherit;font-size:10pt;">    Our standard warranty terms typically extend for one year from the date of delivery. We accrue for standard warranty costs based on historical trends in warranty charges as a percentage of net product revenue. The accrual is reviewed regularly and periodically adjusted to reflect changes in warranty cost estimates. Estimated warranty charges are recorded within cost of products at the time products are sold. See Note 15, "Guarantees".</span></div><div style="line-height:120%;text-align:justify;text-indent:36px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div><div style="line-height:120%;text-align:justify;text-indent:36px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;font-style:italic;">Advertising.</span><span style="font-family:inherit;font-size:10pt;">    Advertising costs are generally expensed as incurred and amounted to </span><span style="font-family:inherit;font-size:10pt;color:#000000;text-decoration:none;"><span>$36 million</span></span><span style="font-family:inherit;font-size:10pt;"> in </span><span style="font-family:inherit;font-size:10pt;color:#000000;text-decoration:none;">2019</span><span style="font-family:inherit;font-size:10pt;">, </span><span style="font-family:inherit;font-size:10pt;color:#000000;text-decoration:none;"><span>$41 million</span></span><span style="font-family:inherit;font-size:10pt;"> in </span><span style="font-family:inherit;font-size:10pt;color:#000000;text-decoration:none;">2018</span><span style="font-family:inherit;font-size:10pt;"> and </span><span style="font-family:inherit;font-size:10pt;color:#000000;text-decoration:none;"><span>$38 million</span></span><span style="font-family:inherit;font-size:10pt;"> in </span><span style="font-family:inherit;font-size:10pt;color:#000000;text-decoration:none;">2017</span><span style="font-family:inherit;font-size:10pt;">.</span></div><div style="line-height:120%;text-align:justify;text-indent:36px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div><div style="line-height:120%;text-align:justify;text-indent:36px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;font-style:italic;">Research and Development.</span><span style="font-family:inherit;font-size:10pt;">    Costs related to research, design and development of our products are charged to research and development expense as they are incurred.</span></div><div style="line-height:120%;text-align:justify;text-indent:36px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div><div style="line-height:120%;text-align:justify;text-indent:36px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;font-style:italic;">Sales Taxes.</span><span style="font-family:inherit;font-size:10pt;">    Sales taxes collected from customers and remitted to governmental authorities are not included in our revenue.</span></div><div style="line-height:120%;text-align:justify;text-indent:36px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div><div style="line-height:120%;text-align:justify;text-indent:36px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;font-style:italic;">Net Income Per Share.</span><span style="font-family:inherit;font-size:10pt;">    Basic net income per share is computed by dividing net income - the numerator - by the weighted average number of common shares outstanding - the denominator - during the period excluding the dilutive effect of stock options and other employee stock plans. Diluted net income per share gives effect to all potential common shares outstanding during the period unless the effect is anti-dilutive. The dilutive effect of share-based awards is reflected in diluted net income per share by application of the treasury stock method, which includes consideration of unamortized share-based compensation expense and the dilutive effect of in-the-money options and non-vested restricted stock units. Under the treasury stock method, the amount the employee must pay for exercising stock options and unamortized share-based compensation expense are assumed proceeds to be used to repurchase hypothetical shares. See Note 7, "Net Income Per Share".</span></div><div style="line-height:120%;text-align:justify;text-indent:36px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div><div style="line-height:120%;text-align:justify;text-indent:36px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;font-style:italic;">Cash, Cash Equivalents and Short-Term Investments.</span><span style="font-family:inherit;font-size:10pt;">  We classify investments as cash equivalents if their original or remaining maturity is three months or less at the date of purchase. Cash equivalents are stated at cost, which approximates fair value.</span></div><div style="line-height:120%;text-align:justify;text-indent:36px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div><div style="line-height:120%;text-align:justify;text-indent:36px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">As of </span><span style="font-family:inherit;font-size:10pt;color:#000000;text-decoration:none;">October 31, 2019</span><span style="font-family:inherit;font-size:10pt;">, approximately </span><span style="font-family:inherit;font-size:10pt;color:#000000;text-decoration:none;"><span>$1,310 million</span></span><span style="font-family:inherit;font-size:10pt;"> of our cash and cash equivalents is held outside of the U.S. by our foreign subsidiaries. Our cash and cash equivalents mainly consist of short-term deposits held at major global financial institutions, institutional money market funds, and similar short duration instruments with original maturities of 90 days or less. We continuously monitor the creditworthiness of the financial institutions and institutional money market funds in which we invest our funds.</span></div><div style="line-height:120%;text-align:justify;text-indent:36px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div><div style="line-height:120%;text-align:justify;text-indent:36px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">We classify investments as short-term investments if their original maturities are greater than three months and their remaining maturities are one year or less. Currently, we have no short-term investments.</span></div><div style="line-height:120%;text-align:justify;text-indent:36px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div><div style="line-height:120%;text-align:justify;text-indent:36px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;font-style:italic;">Variable Interest Entities. </span><span style="font-family:inherit;font-size:10pt;">We make a determination upon entering into an arrangement whether an entity in which we have made an investment is considered a Variable Interest Entity (“VIE”).  The company evaluates its investments in privately held companies on an ongoing basis. We account for these investments under either the equity method or as equity investments without determinable fair value, depending on the circumstances. We periodically reassess whether we are the primary beneficiary of a VIE. The reassessment process considers whether we have acquired the power to direct the most significant activities of the VIE through changes in governing documents or other circumstances. We also reconsider whether entities previously determined not to be VIEs have become VIEs, based on changes in facts and circumstances including changes in contractual arrangements and capital structure. </span></div><div style="line-height:120%;text-align:justify;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div><div style="line-height:120%;padding-bottom:13px;text-align:justify;text-indent:36px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">During the year ended October 31, 2016, Agilent made a preferred stock investment in Lasergen, Inc. ("Lasergen") for </span><span style="font-family:inherit;font-size:10pt;"><span>$80 million</span></span><span style="font-family:inherit;font-size:10pt;">. This investment in Lasergen was accounted for under the cost method. Agilent’s initial ownership stake was </span><span style="font-family:inherit;font-size:10pt;"><span>48 percent</span></span><span style="font-family:inherit;font-size:10pt;"> and included an option to acquire the remaining shares until March 2018. During the year ended October 31, 2018, we exercised our option and acquired all of the remaining shares of Lasergen that we did not already own for an additional cash consideration of approximately </span><span style="font-family:inherit;font-size:10pt;"><span>$107 million</span></span><span style="font-family:inherit;font-size:10pt;">. The fair value remeasurement of our previous investment immediately before the acquisition </span></div><div style="line-height:120%;padding-bottom:13px;text-align:justify;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">resulted in a net gain of </span><span style="font-family:inherit;font-size:10pt;"><span>$20 million</span></span><span style="font-family:inherit;font-size:10pt;"> and was recorded in other income. Lasergen was previously considered a VIE. As of </span><span style="font-family:inherit;font-size:10pt;">October 31, 2019</span><span style="font-family:inherit;font-size:10pt;"> and </span><span style="font-family:inherit;font-size:10pt;">2018</span><span style="font-family:inherit;font-size:10pt;">, we have no material VIE's.</span></div><div style="line-height:120%;text-align:justify;text-indent:42px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;font-style:italic;">Investments.</span><span style="font-family:inherit;font-size:10pt;"> Equity investments without readily determinable fair value consist of non-marketable equity securities (typically investments in privately-held companies). These investments are accounted for using the measurement alternative at cost and we adjust for impairments and observable price changes (orderly transactions for the identical or a similar security from the same issuer) included in net income as and when it occurs. Equity investments with readily determinable fair value consist of shares we own in a special fund and are reported at fair value, with gains or losses resulting from changes in fair value included in net income. Prior to fiscal year 2019, both equity investments without determinable fair value and with determinable fair value were accounted for using cost method of accounting, measured at historical cost less other-than-temporary investment. Trading securities, which is comprised of mutual funds, bonds and other similar instruments, other investments and deferred compensation liability are reported at fair value, with gains or losses resulting from changes in fair value recognized currently in net income. Equity method investments are reported at the amount of the company’s initial investment and adjusted each period for the company’s share of the investee’s income or loss and dividend paid. There are no equity method investments as of </span><span style="font-family:inherit;font-size:10pt;">October 31, 2019</span><span style="font-family:inherit;font-size:10pt;"> and </span><span style="font-family:inherit;font-size:10pt;">2018</span><span style="font-family:inherit;font-size:10pt;">. The company assesses investments for impairment whenever events or changes in circumstances indicate that the carrying value of an investment may not be recoverable.</span></div><div style="line-height:120%;text-align:justify;text-indent:36px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div><div style="line-height:120%;text-align:justify;text-indent:36px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;font-style:italic;">Fair Value of Financial Instruments. </span><span style="font-family:inherit;font-size:10pt;"> The carrying values of certain of our financial instruments including cash and cash equivalents, accounts receivable, accounts payable, accrued compensation and other accrued liabilities approximate fair value because of their short maturities. The fair value of long-term equity investments which are readily determinable, and which are not accounted under the equity method are reported at fair value using quoted market prices for those securities when available with gains and losses included in net income. The fair value of long-term equity investments which are not readily determinable, and which are not accounted under the equity method are reported at cost with adjustments for observable changes in prices or impairments included in net income. The fair value of our senior notes, calculated from quoted prices which are primarily Level 1 inputs under the accounting guidance fair value hierarchy exceeds the carrying value by approximately </span><span style="font-family:inherit;font-size:10pt;"><span>$62 million</span></span><span style="font-family:inherit;font-size:10pt;"> as of </span><span style="font-family:inherit;font-size:10pt;">October 31, 2019</span><span style="font-family:inherit;font-size:10pt;"> and is lower than the carrying value by approximately </span><span style="font-family:inherit;font-size:10pt;"><span>$15 million</span></span><span style="font-family:inherit;font-size:10pt;"> as of </span><span style="font-family:inherit;font-size:10pt;">October 31, 2018</span><span style="font-family:inherit;font-size:10pt;">. The change in the fair value over carrying value in the year ended </span><span style="font-family:inherit;font-size:10pt;">October 31, 2019</span><span style="font-family:inherit;font-size:10pt;"> is primarily due to fluctuations in market interest rates. The fair value of foreign currency contracts used for hedging purposes is estimated internally by using inputs tied to active markets. These inputs, for example, interest rate yield curves, foreign exchange rates, and forward and spot prices for currencies are observable in the market or can be corroborated by observable market data for substantially the full term of the assets or liabilities. See also Note 12, "Fair Value Measurements" for additional information on the fair value of financial instruments.</span></div><div style="line-height:120%;text-align:justify;text-indent:36px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div><div style="line-height:120%;text-align:justify;text-indent:36px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;font-style:italic;">Concentration of Credit Risk.</span><span style="font-family:inherit;font-size:10pt;">    Financial instruments that potentially subject Agilent to significant concentration of credit risk include money market fund investments, time deposits and demand deposit balances. These investments are categorized as cash and cash equivalents. In addition, Agilent has credit risk from derivative financial instruments used in hedging activities and accounts receivable. We invest in a variety of financial instruments and limit the amount of credit exposure with any one financial institution. We have a comprehensive credit policy in place and credit exposure is monitored on an ongoing basis. </span></div><div style="line-height:120%;text-align:justify;text-indent:36px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div><div style="line-height:120%;text-align:justify;text-indent:36px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> Credit risk with respect to our accounts receivable is diversified due to the large number of entities comprising our customer base and their dispersion across many different industries and geographies. Credit evaluations are performed on customers requiring credit over a certain amount and we sell the majority of our products through our direct sales force. Credit risk is mitigated through collateral such as letter of credit, bank guarantees or payment terms like cash in advance. No single customer accounted for more than 10 percent of accounts receivable as of </span><span style="font-family:inherit;font-size:10pt;color:#000000;text-decoration:none;">October 31, 2019</span><span style="font-family:inherit;font-size:10pt;">, or </span><span style="font-family:inherit;font-size:10pt;color:#000000;text-decoration:none;">2018</span><span style="font-family:inherit;font-size:10pt;">.</span></div><div style="line-height:120%;text-align:justify;text-indent:36px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div><div style="line-height:120%;text-align:justify;text-indent:36px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;font-style:italic;">Derivative Instruments.</span><span style="font-family:inherit;font-size:10pt;">    Agilent is exposed to global foreign currency exchange rate and interest rate risks in the normal course of business. We enter into foreign exchange hedging contracts, primarily forward contracts and purchased options, interest rate swaps and interest rate locks to manage financial exposures resulting from changes in foreign currency exchange rates and interest rates. In the vast majority of cases, these contracts are designated at inception as hedges of the related foreign currency or interest exposures. Foreign currency exposures include committed and anticipated revenue and expense transactions and assets and liabilities that are denominated in currencies other than the functional currency of the subsidiary. Interest rate exposures are associated with the company's fixed-rate debt. For option contracts, we exclude time value from the measurement of effectiveness. To qualify for hedge accounting, contracts must reduce the foreign currency exchange rate and interest rate risk otherwise inherent in the amount and duration of the hedged exposures and comply with established risk management policies. Foreign exchange hedging contracts generally mature within </span><span style="font-family:inherit;font-size:10pt;"><span>twelve months</span></span><span style="font-family:inherit;font-size:10pt;">, interest rate swaps mature at the same time as the maturity of the debt and interest rate locks mature at the same time as the issuance of debt. In order to manage foreign currency exposures in a few limited jurisdictions we may enter into foreign exchange contracts that do not qualify for hedge accounting. In such circumstances, the local foreign currency exposure is offset by contracts owned by the parent company. We do not use derivative financial instruments for trading or speculative purposes.</span></div><div style="line-height:120%;text-align:justify;text-indent:36px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div><div style="line-height:120%;text-align:justify;text-indent:36px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">All derivatives are recognized on the balance sheet at their fair values. For derivative instruments that are designated and qualify as a fair value hedge, changes in value of the derivative are recognized in the consolidated statement of operations in the current period, along with the offsetting gain or loss on the hedged item attributable to the hedged risk. For derivative instruments that are designated and qualify as a cash flow hedges, changes in the value of the effective portion of the derivative instrument is recognized in comprehensive income (loss), a component of stockholders' equity. Amounts associated with cash flow hedges are reclassified and recognized in income when either the forecasted transaction occurs or it becomes probable the forecasted transaction will not occur. Derivatives not designated as hedging instruments are recorded on the balance sheet at their fair value and changes in the fair values are recorded in the income statement in the current period. Derivative instruments are subject to master netting arrangements and are disclosed gross in the balance sheet. Changes in the fair value of the ineffective portion of derivative instruments are recognized in earnings in the current period. Ineffectiveness in </span><span style="font-family:inherit;font-size:10pt;color:#000000;text-decoration:none;">2019</span><span style="font-family:inherit;font-size:10pt;">, </span><span style="font-family:inherit;font-size:10pt;color:#000000;text-decoration:none;">2018</span><span style="font-family:inherit;font-size:10pt;"> and </span><span style="font-family:inherit;font-size:10pt;color:#000000;text-decoration:none;">2017</span><span style="font-family:inherit;font-size:10pt;"> was not material. Cash flows from derivative instruments are classified in the statement of cash flows in the same category as the cash flows from the hedged or economically hedged item, primarily in operating activities.</span></div><div style="line-height:120%;text-align:justify;text-indent:36px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div><div style="line-height:120%;text-align:justify;text-indent:36px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;font-style:italic;">Property, Plant and Equipment.</span><span style="font-family:inherit;font-size:10pt;">    Property, plant and equipment are stated at cost less accumulated depreciation. Additions, improvements and major renewals are capitalized; maintenance, repairs and minor renewals are expensed as incurred. When assets are retired or disposed of, the assets and related accumulated depreciation and amortization are removed from our general ledger, and the resulting gain or loss is reflected in the consolidated statement of operations. Buildings and improvements are depreciated over the lesser of their useful lives or the remaining term of the lease and machinery and equipment over </span><span style="font-family:inherit;font-size:10pt;"><span>3 years</span></span><span style="font-family:inherit;font-size:10pt;"> to </span><span style="font-family:inherit;font-size:10pt;"><span>10 years</span></span><span style="font-family:inherit;font-size:10pt;">. We use the straight-line method to depreciate assets.</span></div><div style="line-height:120%;text-align:justify;text-indent:36px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div><div style="line-height:120%;text-align:justify;text-indent:36px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;font-style:italic;">Leases.</span><span style="font-family:inherit;font-size:10pt;">    We lease buildings, machinery and equipment under operating and capital leases for original terms ranging generally from less than </span><span style="font-family:inherit;font-size:10pt;color:#000000;text-decoration:none;"><span>1 year</span></span><span style="font-family:inherit;font-size:10pt;"> to </span><span style="font-family:inherit;font-size:10pt;color:#000000;text-decoration:none;"><span>30 years</span></span><span style="font-family:inherit;font-size:10pt;">. Certain leases contain renewal options for periods up to </span><span style="font-family:inherit;font-size:10pt;color:#000000;text-decoration:none;"><span>6 years</span></span><span style="font-family:inherit;font-size:10pt;">. In addition, we lease equipment to customers in connection with our diagnostics business using both capital and operating leases. As of </span><span style="font-family:inherit;font-size:10pt;">October 31, 2019</span><span style="font-family:inherit;font-size:10pt;"> and </span><span style="font-family:inherit;font-size:10pt;">2018</span><span style="font-family:inherit;font-size:10pt;"> our diagnostics and genomics segment has approximately </span><span style="font-family:inherit;font-size:10pt;"><span>$37 million</span></span><span style="font-family:inherit;font-size:10pt;"> and </span><span style="font-family:inherit;font-size:10pt;"><span>$32 million</span></span><span style="font-family:inherit;font-size:10pt;">, respectively, of lease receivables related to capital leases and approximately </span><span style="font-family:inherit;font-size:10pt;"><span>$17 million</span></span><span style="font-family:inherit;font-size:10pt;"> and </span><span style="font-family:inherit;font-size:10pt;"><span>$20 million</span></span><span style="font-family:inherit;font-size:10pt;">, respectively, of net assets for operating leases.  We depreciate the assets related to the operating leases over their estimated useful lives, typically five years.</span></div><div style="line-height:120%;text-align:justify;text-indent:36px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div><div style="line-height:120%;text-align:justify;text-indent:36px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;font-style:italic;">Capitalized Software.</span><span style="font-family:inherit;font-size:10pt;">    We capitalize certain internal and external costs incurred to acquire or create internal use software. Capitalized software is included in property, plant and equipment and is depreciated over </span><span style="font-family:inherit;font-size:10pt;"><span>3 years</span></span><span style="font-family:inherit;font-size:10pt;"> to </span><span style="font-family:inherit;font-size:10pt;"><span>5 years</span></span><span style="font-family:inherit;font-size:10pt;"> once development is complete.</span></div><div style="line-height:120%;text-align:justify;text-indent:36px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div><div style="line-height:120%;text-align:justify;text-indent:36px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;font-style:italic;">Impairment of Long-Lived Assets.</span><span style="font-family:inherit;font-size:10pt;">    We continually monitor events and changes in circumstances that could indicate carrying amounts of long-lived assets, including intangible assets, may not be recoverable. When such events or changes in circumstances occur, we assess the recoverability of long-lived assets by determining whether the carrying value of such assets will be recovered through undiscounted expected future cash flows. If the total of the undiscounted future cash flows is less than the carrying amount of those assets, we recognize an impairment loss based on the excess of the carrying amount over the fair value of the assets. During 2019, there were no impairments of other assets or intangible assets. During 2018, we recorded an impairment charge of </span><span style="font-family:inherit;font-size:10pt;"><span>$21 million</span></span><span style="font-family:inherit;font-size:10pt;"> related to purchased intangible assets within the diagnostics and genomics segment that were deemed unrecoverable. During 2017, there were no impairments of other assets or intangible assets.</span></div><div style="line-height:120%;text-align:justify;text-indent:36px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div><div style="line-height:120%;text-align:justify;text-indent:36px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;font-style:italic;">Employee Compensation and Benefits.</span><span style="font-family:inherit;font-size:10pt;">    Amounts owed to employees, such as accrued salary, bonuses and vacation benefits are accounted for within employee compensation and benefits. The total amount of accrued vacation benefit was </span><span style="font-family:inherit;font-size:10pt;"><span>$115 million</span></span><span style="font-family:inherit;font-size:10pt;"> and </span><span style="font-family:inherit;font-size:10pt;"><span>$107 million</span></span><span style="font-family:inherit;font-size:10pt;"> as of </span><span style="font-family:inherit;font-size:10pt;">October 31, 2019</span><span style="font-family:inherit;font-size:10pt;">, and </span><span style="font-family:inherit;font-size:10pt;">2018</span><span style="font-family:inherit;font-size:10pt;">, respectively.</span></div><div style="line-height:120%;text-align:justify;text-indent:36px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div><div style="line-height:120%;text-align:justify;text-indent:36px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;font-style:italic;">Foreign Currency Translation.</span><span style="font-family:inherit;font-size:10pt;">    We translate and remeasure balance sheet and income statement items into U.S. dollars. For those subsidiaries that operate in a local currency functional environment, all assets and liabilities are translated into U.S. dollars using current exchange rates at the balance sheet date; revenue and expenses are translated using monthly exchange rates which approximate to average exchange rates in effect during each period. Resulting translation adjustments are reported as a separate component of accumulated other comprehensive income (loss) in stockholders' equity.</span></div><div style="line-height:120%;text-align:justify;text-indent:36px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div><span style="font-family:inherit;font-size:10pt;">For those subsidiaries that operate in a U.S. dollar functional environment, foreign currency assets and liabilities are remeasured into U.S. dollars at current exchange rates except for non-monetary assets and capital accounts which are remeasured at historical exchange rates. Revenue and expenses are generally remeasured at monthly exchange rates which approximate average exchange rates in effect during each period. Gains or losses from foreign currency remeasurement are included in consolidated net income. Net gains or losses resulting from foreign currency transactions, including hedging gains and losses, are reported in other income (expense), net and were </span><span style="font-family:inherit;font-size:10pt;color:#000000;text-decoration:none;"><span>$7 million</span></span><span style="font-family:inherit;font-size:10pt;"> loss for </span><span style="font-family:inherit;font-size:10pt;color:#000000;text-decoration:none;">2019</span><span style="font-family:inherit;font-size:10pt;">, </span><span style="font-family:Times New Roman;font-size:10pt;color:#000000;text-decoration:none;"><span>$3 million</span></span><span style="font-family:inherit;font-size:10pt;"> loss for </span><span style="font-family:inherit;font-size:10pt;color:#000000;text-decoration:none;">2018</span><span style="font-family:inherit;font-size:10pt;"> and </span><span style="font-family:Times New Roman;font-size:10pt;color:#000000;font-style:normal;font-weight:normal;text-decoration:none;"><span>$2 million</span></span><span style="font-family:inherit;font-size:10pt;"> loss for </span><span style="font-family:inherit;font-size:10pt;color:#000000;text-decoration:none;">2017</span>. <div style="line-height:120%;text-align:justify;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div><div style="line-height:120%;text-align:justify;text-indent:36px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;font-style:italic;">Overview.</span><span style="font-family:inherit;font-size:10pt;">    Agilent Technologies, Inc. ("we", "Agilent" or the "company"), incorporated in Delaware in May 1999, is a global leader in life sciences, diagnostics and applied chemical markets, providing application focused solutions that include instruments, software, services and consumables for the entire laboratory workflow.</span></div><div style="line-height:120%;text-align:justify;text-indent:33px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div><div style="line-height:120%;text-align:justify;text-indent:36px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;font-style:italic;">Basis of Presentation.</span><span style="font-family:inherit;font-size:10pt;">    The accompanying consolidated financial statements have been prepared by us pursuant to the rules and regulations of the U.S. Securities and Exchange Commission ("SEC") and is in conformity with U.S. generally accepted accounting principles ("GAAP"). Our fiscal year end is October 31. Unless otherwise stated, all years and dates refer to our fiscal year.</span></div><div style="line-height:120%;text-align:justify;text-indent:36px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div> <div style="line-height:120%;text-align:justify;text-indent:36px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;font-style:italic;">Principles of Consolidation.</span><span style="font-family:inherit;font-size:10pt;">    The consolidated financial statements include the accounts of the company and our wholly- and majority-owned subsidiaries. All significant intercompany accounts and transactions have been eliminated.</span></div><div style="line-height:120%;text-align:justify;text-indent:36px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div> <div style="line-height:120%;text-align:justify;text-indent:36px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;font-style:italic;">Use of Estimates.</span><span style="font-family:inherit;font-size:10pt;">    The preparation of financial statements in accordance with U.S. GAAP requires management to make estimates and assumptions that affect the amounts reported in our consolidated financial statements and accompanying notes. Management bases its estimates on historical experience and various other assumptions believed to be reasonable. Although these estimates are based on management's best knowledge of current events and actions that may impact the company in the future, actual results may be different from the estimates. Our critical accounting policies are those that affect our financial statements materially and involve difficult, subjective or complex judgments by management. Those policies are revenue recognition, valuation of goodwill and purchased intangible assets, inventory valuation, retirement and post-retirement plan assumptions and accounting for income taxes.</span></div><div style="line-height:120%;text-align:justify;text-indent:36px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div> <div style="line-height:120%;text-align:justify;text-indent:33px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;font-style:italic;">Retirement of Treasury Shares. </span><span style="font-family:inherit;font-size:10pt;">Upon the formal retirement of treasury shares, we deduct the par value of the retired treasury shares from common stock and allocate the excess of cost over par as a deduction to additional paid-in capital, based on the pro-rata portion of additional paid-in-capital, and the remaining excess as a deduction to retained earnings. All retired treasury shares revert to the status of authorized but unissued shares.</span></div><div style="line-height:120%;text-align:justify;text-indent:36px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div> <div style="line-height:120%;text-align:justify;text-indent:36px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;font-style:italic;">Revenue Recognition.</span><span style="font-family:inherit;font-size:10pt;">    We enter into contracts to sell products, services or combinations of products and services. Products may include hardware or software and services may include one-time service events or services performed over time.</span></div><div style="line-height:120%;text-align:justify;text-indent:36px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div><div style="line-height:120%;text-align:justify;text-indent:36px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">We derive revenue primarily from the sale of analytical and diagnostics products and services. A performance obligation is a promise in a contract to transfer a distinct product or service to a customer and is the unit of account under Accounting Standard Codification Topic 606, </span><span style="font-family:inherit;font-size:10pt;font-style:italic;">Revenue from Contracts with Customers</span><span style="font-family:inherit;font-size:10pt;"> (“ASC 606’’). See also Note 2, "New Accounting Pronouncements" and Note 4, "Revenue" for additional information on revenue recognition.</span></div><div style="line-height:120%;text-align:justify;text-indent:36px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div><div style="line-height:120%;text-align:justify;text-indent:36px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Revenue is recognized when control of the promised products or services is transferred to our customers and the performance obligation is fulfilled in an amount that reflects the consideration that we expect to be entitled in exchange for those products or services, the transaction price. For equipment, consumables, and most software licenses, control transfers to the customer at a point in time. We use present right to payment, legal title, physical possession of the asset, and risks and rewards of ownership as indicators to determine the transfer of control to the customer. Where acceptance is not a formality, the customer must have documented their acceptance of the product or service. For products that include installation, if the installation meets the criteria to be considered a separate performance obligation, product revenue is recognized when control has passed to the customer, and recognition of installation revenue occurs once completed. Product revenue, including sales to resellers and distributors is reduced for provisions for warranties, returns, and other adjustments in the period the related sales are recorded.</span></div><div style="line-height:120%;text-align:justify;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div><div style="line-height:120%;text-align:justify;text-indent:36px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Service revenue includes extended warranty, customer and software support including: Software as a Service, post contract support, consulting including companion diagnostics, and training and education. Instrument service contracts and software maintenance contracts are typically annual contracts, which are billed at the beginning of the contract or maintenance period. Revenue for these contracts is recognized on a straight-line basis to revenue over the service period, as a time-based measure of progress best reflects our performance in satisfying this obligation. There are no deferred costs associated with the service contract, as the cost of the service is recorded when the service is performed. Service calls not included in a support contract are recognized to revenue at the time a service is performed. </span></div><div style="line-height:120%;text-align:justify;text-indent:36px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div><div style="line-height:120%;text-align:justify;text-indent:36px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">We have sales from standalone software. These arrangements typically include software licenses and maintenance contracts, both of which we have determined are distinct performance obligations. We determine the amount of the transaction price to allocate to the license and maintenance contract based on the relative standalone selling price of each performance obligation. Software license revenue is recognized at the point in time when control has been transferred to the customer. The revenue allocated to the software maintenance contract is recognized on a straight-line basis over the maintenance period, which is the contractual term of the contract, as a time-based measure of progress best reflects our performance in satisfying this obligation. Unspecified rights to software upgrades are typically sold as part of the maintenance contract on a when-and-if-available basis.</span></div><div style="line-height:120%;text-align:justify;text-indent:36px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div><div style="line-height:120%;text-align:justify;text-indent:36px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Our multiple-element arrangements are generally comprised of a combination of instruments, installation or other start-up services, and/or software, and/or support or services. Hardware and software elements are typically delivered at the same time and revenue is recognized when control passes to the customer. Service revenue is deferred and recognized over the contractual period or as services are rendered and accepted by the customer. Our arrangements generally do not include any provisions for cancellation, termination, or refunds that would significantly impact recognized revenue.</span></div><div style="line-height:120%;text-align:justify;text-indent:36px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div><div style="line-height:120%;text-align:justify;text-indent:36px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">For contracts with multiple performance obligations, we allocate the consideration to which we expect to be entitled to each performance obligation based on relative standalone selling prices and recognize the related revenue when or as control of each individual performance obligation is transferred to customers. We estimate the standalone selling price by calculating the average historical selling price of our products and services per country for each performance obligation. Standalone selling prices are determined for each distinct good or service in the contract and then we allocate the transaction price in proportion to those standalone selling prices by performance obligations.</span></div><div style="line-height:120%;text-align:justify;text-indent:36px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div><div style="line-height:120%;text-align:justify;text-indent:36px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">A portion of our revenue relates to lease arrangements. Standalone lease arrangements are outside the scope of ASC 606 and are therefore accounted for in accordance with ASC 840, Leases. Each of these contracts is evaluated as a lease arrangement, either as an operating lease or a sales-type capital lease using the current lease classification guidance.</span></div><div style="line-height:120%;text-align:justify;text-indent:36px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div><div style="line-height:120%;text-align:justify;text-indent:36px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;font-style:italic;">Deferred Revenue.</span><span style="font-family:inherit;font-size:10pt;">    Contract liabilities (deferred revenue) primarily relate to multiple element arrangements for which billing has occurred but transfer of control of all elements (performance obligations) to the customer has either partially or not occurred at the balance sheet date. This includes cash received from customers for products and related installation and services in advance of the transfer of control. Contract liabilities are classified as either in current liabilities in deferred revenue or long-term in other long-term liabilities in the consolidated balance sheet based on the timing of when we expect to complete our performance obligation.</span></div><div style="line-height:120%;text-align:justify;text-indent:36px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div> <div style="line-height:120%;text-align:justify;text-indent:36px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;font-style:italic;">Accounts Receivable, net.</span><span style="font-family:inherit;font-size:10pt;">    Trade accounts receivable are recorded at the invoiced amount and do not bear interest. Such accounts receivable have been reduced by an allowance for doubtful accounts, which is our best estimate of the amount of probable credit losses in our existing accounts receivable. We determine the allowance based on customer specific experience and the aging of such receivables, among other factors. The allowance for doubtful accounts as of </span><span style="font-family:inherit;font-size:10pt;">October 31, 2019</span><span style="font-family:inherit;font-size:10pt;"> and </span><span style="font-family:inherit;font-size:10pt;">2018</span><span style="font-family:inherit;font-size:10pt;"> was not material. We do not have any off-balance-sheet credit exposure related to our customers. Accounts receivable are also recorded net of estimated product returns which are not material.</span></div><div style="line-height:120%;text-align:justify;text-indent:36px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div> <div style="line-height:120%;text-align:justify;text-indent:36px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;font-style:italic;">Shipping and Handling Costs.</span><span style="font-family:inherit;font-size:10pt;">  Our shipping and handling costs charged to customers are included in net revenue, and the associated expense is recorded in cost of products for all periods presented.</span></div><div style="line-height:120%;text-align:justify;text-indent:36px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div> <div style="line-height:120%;text-align:justify;text-indent:36px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;font-style:italic;">Inventory.</span><span style="font-family:inherit;font-size:10pt;">    Inventory is valued at standard cost, which approximates actual cost computed on a first-in, first-out basis, not in excess of market value. We assess the valuation of our inventory on a periodic basis and make adjustments to the value for estimated excess and obsolete inventory based on estimates about future demand. The excess balance determined by this analysis becomes the basis for our excess inventory charge. Our excess inventory review process includes analysis of sales forecasts, managing product rollovers and working with manufacturing to maximize recovery of excess inventory.</span></div><div style="line-height:120%;text-align:justify;text-indent:36px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div> <div style="line-height:120%;text-align:justify;text-indent:36px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;font-style:italic;">Acquisitions. </span><span style="font-family:inherit;font-size:10pt;"> Agilent accounts for the acquisition of a business using the acquisition method of accounting and we allocate the fair value of the purchase price to the tangible assets acquired, liabilities assumed, and intangible assets acquired, including in-process research and development (“IPR&amp;D”), based on their estimated fair values. The excess value of the cost of an acquired business over the fair value of the assets acquired and liabilities assumed is recognized as goodwill. The fair value of IPR&amp;D is initially capitalized as an intangible asset with an indefinite life. When an IPR&amp;D project is completed, the IPR&amp;D is reclassified as an amortizable purchased intangible asset and amortized to costs of revenues over the asset’s estimated useful life.</span></div><div style="line-height:120%;text-align:justify;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div><div style="line-height:120%;text-align:justify;text-indent:36px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Our determination of the fair value of the intangible assets acquired involves the use of significant estimates and assumptions. Specifically, our determination of the fair value of the developed product technology and IPR&amp;D acquired involve significant estimates and assumptions related to revenue growth rates and discount rates. Our determination of the fair value of customer </span></div><div style="line-height:120%;text-align:justify;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">relationships acquired involved significant estimates and assumptions related to revenue growth rates, discount rates, and customer attrition rates. Our determination of the fair value of the tradename acquired involved the use of significant estimates and assumptions related to revenue growth rates, royalty rates and discount rates. The company believes that the fair value assigned to the assets acquired and liabilities assumed are based on reasonable assumptions and estimates that marketplace participants would use. Actual results could differ materially from these estimates. </span></div><div style="line-height:120%;text-align:left;text-indent:36px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div> <div style="line-height:120%;text-align:justify;text-indent:36px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;font-style:italic;">Goodwill and Purchased Intangible Assets.</span><span style="font-family:inherit;font-size:10pt;"> Under the authoritative guidance we have the option to perform a qualitative assessment to determine whether further impairment testing is necessary. The accounting standard gives an entity the option to first assess qualitative factors to determine whether performing the two-step test is necessary. If an entity believes, as a result of its qualitative assessment, that it is more-likely-than-not (i.e. greater than 50% chance) that the fair value of a reporting unit is less than its carrying amount, the quantitative impairment test will be required. Otherwise, no further testing will be required.</span></div><div style="line-height:120%;text-align:justify;text-indent:36px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div><div style="line-height:120%;text-align:justify;text-indent:36px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">The guidance includes examples of events and circumstances that might indicate that a reporting unit's fair value is less than its carrying amount. These include macro-economic conditions such as deterioration in the entity's operating environment or industry or market considerations; entity-specific events such as increasing costs, declining financial performance, or loss of key personnel; or other events such as an expectation that a reporting unit will be sold or a sustained decrease in the stock price on either an absolute basis or relative to peers. </span></div><div style="line-height:120%;text-align:justify;text-indent:36px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div><div style="line-height:120%;text-align:justify;text-indent:36px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">If it is determined, as a result of the qualitative assessment, that it is more-likely-than-not that the fair value of a reporting unit is less than its carrying amount, the provisions of authoritative guidance require that we perform a two-step impairment test on goodwill. In the first step, we compare the fair value of each reporting unit to its carrying value. The second step (if necessary) measures the amount of impairment by applying fair-value-based tests to the individual assets and liabilities within each reporting unit. As defined in the authoritative guidance, a reporting unit is an operating segment, or one level below an operating segment. We aggregate components of an operating segment that have similar economic characteristics into our reporting units. </span></div><div style="line-height:120%;text-align:justify;text-indent:36px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div><div style="line-height:120%;text-align:justify;text-indent:36px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> In fiscal year </span><span style="font-family:inherit;font-size:10pt;">2019</span><span style="font-family:inherit;font-size:10pt;">, we assessed goodwill impairment for our three reporting units which consisted of three segments: life sciences and applied markets, diagnostics and genomics and Agilent CrossLab. We performed a qualitative test for goodwill impairment of the three reporting units, as of September 30, </span><span style="font-family:inherit;font-size:10pt;">2019</span><span style="font-family:inherit;font-size:10pt;">, our annual impairment test date. Based on the results of our qualitative testing, we believe that it is more-likely-than-not that the fair value of each reporting unit is greater than its respective carrying value. Each quarter we review the events and circumstances to determine if goodwill impairment is indicated. There was </span><span style="font-family:inherit;font-size:10pt;"><span>no</span></span><span style="font-family:inherit;font-size:10pt;"> impairment of goodwill during the years ended </span><span style="font-family:inherit;font-size:10pt;">October 31, 2019</span><span style="font-family:inherit;font-size:10pt;">, </span><span style="font-family:inherit;font-size:10pt;">2018</span><span style="font-family:inherit;font-size:10pt;"> and </span><span style="font-family:inherit;font-size:10pt;">2017</span><span style="font-family:inherit;font-size:10pt;">. </span></div><div style="line-height:120%;text-align:justify;text-indent:36px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div><div style="line-height:120%;text-align:justify;text-indent:36px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Purchased intangible assets consist primarily of acquired developed technologies, proprietary know-how, trademarks, and customer relationships and are amortized using the best estimate of the asset's useful life that reflect the pattern in which the economic benefits are consumed or used up or a straight-line method ranging from </span><span style="font-family:inherit;font-size:10pt;"><span>6 months</span></span><span style="font-family:inherit;font-size:10pt;"> to </span><span style="font-family:inherit;font-size:10pt;"><span>15 years</span></span><span style="font-family:inherit;font-size:10pt;">. IPR&amp;D is initially capitalized at fair value as an intangible asset with an indefinite life and assessed for impairment thereafter. When the IPR&amp;D project is complete, it is reclassified as an amortizable purchased intangible asset and is amortized over its estimated useful life. If an IPR&amp;D project is abandoned, Agilent will record a charge for the value of the related intangible asset to Agilent's consolidated statement of operations in the period it is abandoned.</span></div><div style="line-height:120%;text-align:justify;text-indent:36px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div><div style="line-height:120%;text-align:justify;text-indent:36px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Agilent's indefinite-lived intangible assets are IPR&amp;D intangible assets. The accounting guidance allows a qualitative approach for testing indefinite-lived intangible assets for impairment, similar to the issued impairment testing guidance for goodwill and allows the option to first assess qualitative factors (events and circumstances) that could have affected the significant inputs used in determining the fair value of the indefinite-lived intangible asset to determine whether it is more-likely-than-not (i.e. greater than 50% chance) that the indefinite-lived intangible asset is impaired. An organization may choose to bypass the qualitative assessment for any indefinite-lived intangible asset in any period and proceed directly to calculating its fair value. We performed a qualitative test for impairment of indefinite-lived intangible assets as of September 30, </span><span style="font-family:inherit;font-size:10pt;">2019</span><span style="font-family:inherit;font-size:10pt;">. Based on the results of our qualitative testing, we believe that it is more-likely-than-not that the fair value of these indefinite-lived intangible assets is greater than their respective carrying values. Each quarter we review the events and circumstances to determine if impairment of indefinite-lived intangible asset is indicated. During the year ended </span><span style="font-family:inherit;font-size:10pt;">October 31, 2019</span><span style="font-family:inherit;font-size:10pt;">, </span><span style="font-family:inherit;font-size:10pt;">2018</span><span style="font-family:inherit;font-size:10pt;"> and </span><span style="font-family:inherit;font-size:10pt;">2017</span><span style="font-family:inherit;font-size:10pt;"> there were </span><span style="font-family:inherit;font-size:10pt;"><span>no</span></span><span style="font-family:inherit;font-size:10pt;"> impairments of indefinite-lived intangible assets. </span></div> 0 P6M P15Y 0 <div style="line-height:120%;text-align:justify;text-indent:36px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;font-style:italic;">Share-Based Compensation.</span><span style="font-family:inherit;font-size:10pt;">    For the years ended </span><span style="font-family:inherit;font-size:10pt;color:#000000;text-decoration:none;">2019</span><span style="font-family:inherit;font-size:10pt;">, </span><span style="font-family:inherit;font-size:10pt;color:#000000;text-decoration:none;">2018</span><span style="font-family:inherit;font-size:10pt;"> and </span><span style="font-family:inherit;font-size:10pt;color:#000000;text-decoration:none;">2017</span><span style="font-family:inherit;font-size:10pt;">, we accounted for share-based awards made to our employees and directors including employee stock option awards, restricted stock units, employee stock purchases made under our Employee Stock Purchase Plan ("ESPP") and performance share awards under Agilent Technologies, Inc. Long-Term Performance Program ("LTPP") using the estimated grant date fair value method of accounting. Under the fair value method, we recorded compensation expense for all share-based awards of </span><span style="font-family:inherit;font-size:10pt;color:#000000;text-decoration:none;"><span>$72 million</span></span><span style="font-family:inherit;font-size:10pt;"> in </span><span style="font-family:inherit;font-size:10pt;color:#000000;text-decoration:none;">2019</span><span style="font-family:inherit;font-size:10pt;">, </span><span style="font-family:inherit;font-size:10pt;"><span>$71 million</span></span><span style="font-family:inherit;font-size:10pt;"> in </span><span style="font-family:inherit;font-size:10pt;color:#000000;text-decoration:none;">2018</span><span style="font-family:inherit;font-size:10pt;"> and </span><span style="font-family:inherit;font-size:10pt;"><span>$61 million</span></span><span style="font-family:inherit;font-size:10pt;"> in </span><span style="font-family:inherit;font-size:10pt;color:#000000;text-decoration:none;">2017</span><span style="font-family:inherit;font-size:10pt;">. See Note 5, "Share-based Compensation" for additional information.</span></div><div style="line-height:120%;text-align:justify;text-indent:36px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div> 72000000 71000000 61000000 <div style="line-height:120%;text-align:justify;text-indent:36px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div><div style="line-height:120%;text-align:justify;text-indent:36px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;font-style:italic;">Retirement and Post-Retirement Plans. </span><span style="font-family:inherit;font-size:10pt;"> Substantially all of our employees are covered under various defined benefit and/or defined contribution retirement plans. Additionally, we sponsor post-retirement health care benefits for our eligible U.S. employees. Assumptions used to determine the benefit obligations and the expense for these plans are derived annually. See Note 14, “Retirement plans and post-retirement pension plans” for additional information. </span></div> <span style="font-family:inherit;font-size:10pt;font-style:italic;">Taxes on Income.</span>    Income tax expense or benefit is based on income or loss before taxes. Deferred tax assets and liabilities are recognized principally for the expected tax consequences of temporary differences between the tax bases of assets and liabilities and their reported amounts. See Note 6, "Income Taxes" for more information <div style="line-height:120%;text-align:justify;text-indent:36px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;font-style:italic;">Warranty.</span><span style="font-family:inherit;font-size:10pt;">    Our standard warranty terms typically extend for one year from the date of delivery. We accrue for standard warranty costs based on historical trends in warranty charges as a percentage of net product revenue. The accrual is reviewed regularly and periodically adjusted to reflect changes in warranty cost estimates. Estimated warranty charges are recorded within cost of products at the time products are sold. See Note 15, "Guarantees".</span></div><div style="line-height:120%;text-align:justify;text-indent:36px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div> <div style="line-height:120%;text-align:justify;text-indent:36px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;font-style:italic;">Advertising.</span><span style="font-family:inherit;font-size:10pt;">    Advertising costs are generally expensed as incurred and amounted to </span><span style="font-family:inherit;font-size:10pt;color:#000000;text-decoration:none;"><span>$36 million</span></span><span style="font-family:inherit;font-size:10pt;"> in </span><span style="font-family:inherit;font-size:10pt;color:#000000;text-decoration:none;">2019</span><span style="font-family:inherit;font-size:10pt;">, </span><span style="font-family:inherit;font-size:10pt;color:#000000;text-decoration:none;"><span>$41 million</span></span><span style="font-family:inherit;font-size:10pt;"> in </span><span style="font-family:inherit;font-size:10pt;color:#000000;text-decoration:none;">2018</span><span style="font-family:inherit;font-size:10pt;"> and </span><span style="font-family:inherit;font-size:10pt;color:#000000;text-decoration:none;"><span>$38 million</span></span><span style="font-family:inherit;font-size:10pt;"> in </span><span style="font-family:inherit;font-size:10pt;color:#000000;text-decoration:none;">2017</span><span style="font-family:inherit;font-size:10pt;">.</span></div> 36000000 41000000 38000000 <div style="line-height:120%;text-align:justify;text-indent:36px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;font-style:italic;">Research and Development.</span><span style="font-family:inherit;font-size:10pt;">    Costs related to research, design and development of our products are charged to research and development expense as they are incurred.</span></div><div style="line-height:120%;text-align:justify;text-indent:36px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div> <div style="line-height:120%;text-align:justify;text-indent:36px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;font-style:italic;">Sales Taxes.</span><span style="font-family:inherit;font-size:10pt;">    Sales taxes collected from customers and remitted to governmental authorities are not included in our revenue.</span></div><div style="line-height:120%;text-align:justify;text-indent:36px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div> <div style="line-height:120%;text-align:justify;text-indent:36px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;font-style:italic;">Net Income Per Share.</span><span style="font-family:inherit;font-size:10pt;">    Basic net income per share is computed by dividing net income - the numerator - by the weighted average number of common shares outstanding - the denominator - during the period excluding the dilutive effect of stock options and other employee stock plans. Diluted net income per share gives effect to all potential common shares outstanding during the period unless the effect is anti-dilutive. The dilutive effect of share-based awards is reflected in diluted net income per share by application of the treasury stock method, which includes consideration of unamortized share-based compensation expense and the dilutive effect of in-the-money options and non-vested restricted stock units. Under the treasury stock method, the amount the employee must pay for exercising stock options and unamortized share-based compensation expense are assumed proceeds to be used to repurchase hypothetical shares. See Note 7, "Net Income Per Share".</span></div> <div style="line-height:120%;text-align:justify;text-indent:36px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;font-style:italic;">Cash, Cash Equivalents and Short-Term Investments.</span><span style="font-family:inherit;font-size:10pt;">  We classify investments as cash equivalents if their original or remaining maturity is three months or less at the date of purchase. Cash equivalents are stated at cost, which approximates fair value.</span></div><div style="line-height:120%;text-align:justify;text-indent:36px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div><div style="line-height:120%;text-align:justify;text-indent:36px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">As of </span><span style="font-family:inherit;font-size:10pt;color:#000000;text-decoration:none;">October 31, 2019</span><span style="font-family:inherit;font-size:10pt;">, approximately </span><span style="font-family:inherit;font-size:10pt;color:#000000;text-decoration:none;"><span>$1,310 million</span></span><span style="font-family:inherit;font-size:10pt;"> of our cash and cash equivalents is held outside of the U.S. by our foreign subsidiaries. Our cash and cash equivalents mainly consist of short-term deposits held at major global financial institutions, institutional money market funds, and similar short duration instruments with original maturities of 90 days or less. We continuously monitor the creditworthiness of the financial institutions and institutional money market funds in which we invest our funds.</span></div><div style="line-height:120%;text-align:justify;text-indent:36px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div><div style="line-height:120%;text-align:justify;text-indent:36px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">We classify investments as short-term investments if their original maturities are greater than three months and their remaining maturities are one year or less. Currently, we have no short-term investments.</span></div> 1310000000 <div style="line-height:120%;text-align:justify;text-indent:36px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;font-style:italic;">Variable Interest Entities. </span><span style="font-family:inherit;font-size:10pt;">We make a determination upon entering into an arrangement whether an entity in which we have made an investment is considered a Variable Interest Entity (“VIE”).  The company evaluates its investments in privately held companies on an ongoing basis. We account for these investments under either the equity method or as equity investments without determinable fair value, depending on the circumstances. We periodically reassess whether we are the primary beneficiary of a VIE. The reassessment process considers whether we have acquired the power to direct the most significant activities of the VIE through changes in governing documents or other circumstances. We also reconsider whether entities previously determined not to be VIEs have become VIEs, based on changes in facts and circumstances including changes in contractual arrangements and capital structure. </span></div><div style="line-height:120%;text-align:justify;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div><div style="line-height:120%;padding-bottom:13px;text-align:justify;text-indent:36px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">During the year ended October 31, 2016, Agilent made a preferred stock investment in Lasergen, Inc. ("Lasergen") for </span><span style="font-family:inherit;font-size:10pt;"><span>$80 million</span></span><span style="font-family:inherit;font-size:10pt;">. This investment in Lasergen was accounted for under the cost method. Agilent’s initial ownership stake was </span><span style="font-family:inherit;font-size:10pt;"><span>48 percent</span></span><span style="font-family:inherit;font-size:10pt;"> and included an option to acquire the remaining shares until March 2018. During the year ended October 31, 2018, we exercised our option and acquired all of the remaining shares of Lasergen that we did not already own for an additional cash consideration of approximately </span><span style="font-family:inherit;font-size:10pt;"><span>$107 million</span></span><span style="font-family:inherit;font-size:10pt;">. The fair value remeasurement of our previous investment immediately before the acquisition </span></div><div style="line-height:120%;padding-bottom:13px;text-align:justify;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">resulted in a net gain of </span><span style="font-family:inherit;font-size:10pt;"><span>$20 million</span></span><span style="font-family:inherit;font-size:10pt;"> and was recorded in other income. Lasergen was previously considered a VIE. As of </span><span style="font-family:inherit;font-size:10pt;">October 31, 2019</span><span style="font-family:inherit;font-size:10pt;"> and </span><span style="font-family:inherit;font-size:10pt;">2018</span><span style="font-family:inherit;font-size:10pt;">, we have no material VIE's.</span></div> 80000000 0.48 107000000 20000000 <div style="line-height:120%;text-align:justify;text-indent:42px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;font-style:italic;">Investments.</span><span style="font-family:inherit;font-size:10pt;"> Equity investments without readily determinable fair value consist of non-marketable equity securities (typically investments in privately-held companies). These investments are accounted for using the measurement alternative at cost and we adjust for impairments and observable price changes (orderly transactions for the identical or a similar security from the same issuer) included in net income as and when it occurs. Equity investments with readily determinable fair value consist of shares we own in a special fund and are reported at fair value, with gains or losses resulting from changes in fair value included in net income. Prior to fiscal year 2019, both equity investments without determinable fair value and with determinable fair value were accounted for using cost method of accounting, measured at historical cost less other-than-temporary investment. Trading securities, which is comprised of mutual funds, bonds and other similar instruments, other investments and deferred compensation liability are reported at fair value, with gains or losses resulting from changes in fair value recognized currently in net income. Equity method investments are reported at the amount of the company’s initial investment and adjusted each period for the company’s share of the investee’s income or loss and dividend paid. There are no equity method investments as of </span><span style="font-family:inherit;font-size:10pt;">October 31, 2019</span><span style="font-family:inherit;font-size:10pt;"> and </span><span style="font-family:inherit;font-size:10pt;">2018</span><span style="font-family:inherit;font-size:10pt;">. The company assesses investments for impairment whenever events or changes in circumstances indicate that the carrying value of an investment may not be recoverable.</span></div> <div style="line-height:120%;text-align:justify;text-indent:36px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;font-style:italic;">Fair Value of Financial Instruments. </span><span style="font-family:inherit;font-size:10pt;"> The carrying values of certain of our financial instruments including cash and cash equivalents, accounts receivable, accounts payable, accrued compensation and other accrued liabilities approximate fair value because of their short maturities. The fair value of long-term equity investments which are readily determinable, and which are not accounted under the equity method are reported at fair value using quoted market prices for those securities when available with gains and losses included in net income. The fair value of long-term equity investments which are not readily determinable, and which are not accounted under the equity method are reported at cost with adjustments for observable changes in prices or impairments included in net income. The fair value of our senior notes, calculated from quoted prices which are primarily Level 1 inputs under the accounting guidance fair value hierarchy exceeds the carrying value by approximately </span><span style="font-family:inherit;font-size:10pt;"><span>$62 million</span></span><span style="font-family:inherit;font-size:10pt;"> as of </span><span style="font-family:inherit;font-size:10pt;">October 31, 2019</span><span style="font-family:inherit;font-size:10pt;"> and is lower than the carrying value by approximately </span><span style="font-family:inherit;font-size:10pt;"><span>$15 million</span></span><span style="font-family:inherit;font-size:10pt;"> as of </span><span style="font-family:inherit;font-size:10pt;">October 31, 2018</span><span style="font-family:inherit;font-size:10pt;">. The change in the fair value over carrying value in the year ended </span><span style="font-family:inherit;font-size:10pt;">October 31, 2019</span><span style="font-family:inherit;font-size:10pt;"> is primarily due to fluctuations in market interest rates. The fair value of foreign currency contracts used for hedging purposes is estimated internally by using inputs tied to active markets. These inputs, for example, interest rate yield curves, foreign exchange rates, and forward and spot prices for currencies are observable in the market or can be corroborated by observable market data for substantially the full term of the assets or liabilities. See also Note 12, "Fair Value Measurements" for additional information on the fair value of financial instruments.</span></div><div style="line-height:120%;text-align:justify;text-indent:36px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div> 62000000 15000000 <div style="line-height:120%;text-align:justify;text-indent:36px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;font-style:italic;">Concentration of Credit Risk.</span><span style="font-family:inherit;font-size:10pt;">    Financial instruments that potentially subject Agilent to significant concentration of credit risk include money market fund investments, time deposits and demand deposit balances. These investments are categorized as cash and cash equivalents. In addition, Agilent has credit risk from derivative financial instruments used in hedging activities and accounts receivable. We invest in a variety of financial instruments and limit the amount of credit exposure with any one financial institution. We have a comprehensive credit policy in place and credit exposure is monitored on an ongoing basis. </span></div><div style="line-height:120%;text-align:justify;text-indent:36px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div><div style="line-height:120%;text-align:justify;text-indent:36px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> Credit risk with respect to our accounts receivable is diversified due to the large number of entities comprising our customer base and their dispersion across many different industries and geographies. Credit evaluations are performed on customers requiring credit over a certain amount and we sell the majority of our products through our direct sales force. Credit risk is mitigated through collateral such as letter of credit, bank guarantees or payment terms like cash in advance. No single customer accounted for more than 10 percent of accounts receivable as of </span><span style="font-family:inherit;font-size:10pt;color:#000000;text-decoration:none;">October 31, 2019</span><span style="font-family:inherit;font-size:10pt;">, or </span><span style="font-family:inherit;font-size:10pt;color:#000000;text-decoration:none;">2018</span><span style="font-family:inherit;font-size:10pt;">.</span></div> <div style="line-height:120%;text-align:justify;text-indent:36px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;font-style:italic;">Derivative Instruments.</span><span style="font-family:inherit;font-size:10pt;">    Agilent is exposed to global foreign currency exchange rate and interest rate risks in the normal course of business. We enter into foreign exchange hedging contracts, primarily forward contracts and purchased options, interest rate swaps and interest rate locks to manage financial exposures resulting from changes in foreign currency exchange rates and interest rates. In the vast majority of cases, these contracts are designated at inception as hedges of the related foreign currency or interest exposures. Foreign currency exposures include committed and anticipated revenue and expense transactions and assets and liabilities that are denominated in currencies other than the functional currency of the subsidiary. Interest rate exposures are associated with the company's fixed-rate debt. For option contracts, we exclude time value from the measurement of effectiveness. To qualify for hedge accounting, contracts must reduce the foreign currency exchange rate and interest rate risk otherwise inherent in the amount and duration of the hedged exposures and comply with established risk management policies. Foreign exchange hedging contracts generally mature within </span><span style="font-family:inherit;font-size:10pt;"><span>twelve months</span></span><span style="font-family:inherit;font-size:10pt;">, interest rate swaps mature at the same time as the maturity of the debt and interest rate locks mature at the same time as the issuance of debt. In order to manage foreign currency exposures in a few limited jurisdictions we may enter into foreign exchange contracts that do not qualify for hedge accounting. In such circumstances, the local foreign currency exposure is offset by contracts owned by the parent company. We do not use derivative financial instruments for trading or speculative purposes.</span></div><div style="line-height:120%;text-align:justify;text-indent:36px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div><div style="line-height:120%;text-align:justify;text-indent:36px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">All derivatives are recognized on the balance sheet at their fair values. For derivative instruments that are designated and qualify as a fair value hedge, changes in value of the derivative are recognized in the consolidated statement of operations in the current period, along with the offsetting gain or loss on the hedged item attributable to the hedged risk. For derivative instruments that are designated and qualify as a cash flow hedges, changes in the value of the effective portion of the derivative instrument is recognized in comprehensive income (loss), a component of stockholders' equity. Amounts associated with cash flow hedges are reclassified and recognized in income when either the forecasted transaction occurs or it becomes probable the forecasted transaction will not occur. Derivatives not designated as hedging instruments are recorded on the balance sheet at their fair value and changes in the fair values are recorded in the income statement in the current period. Derivative instruments are subject to master netting arrangements and are disclosed gross in the balance sheet. Changes in the fair value of the ineffective portion of derivative instruments are recognized in earnings in the current period. Ineffectiveness in </span><span style="font-family:inherit;font-size:10pt;color:#000000;text-decoration:none;">2019</span><span style="font-family:inherit;font-size:10pt;">, </span><span style="font-family:inherit;font-size:10pt;color:#000000;text-decoration:none;">2018</span><span style="font-family:inherit;font-size:10pt;"> and </span><span style="font-family:inherit;font-size:10pt;color:#000000;text-decoration:none;">2017</span><span style="font-family:inherit;font-size:10pt;"> was not material. Cash flows from derivative instruments are classified in the statement of cash flows in the same category as the cash flows from the hedged or economically hedged item, primarily in operating activities.</span></div><div style="line-height:120%;text-align:justify;text-indent:36px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div> P12M <div style="line-height:120%;text-align:justify;text-indent:36px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;font-style:italic;">Property, Plant and Equipment.</span><span style="font-family:inherit;font-size:10pt;">    Property, plant and equipment are stated at cost less accumulated depreciation. Additions, improvements and major renewals are capitalized; maintenance, repairs and minor renewals are expensed as incurred. When assets are retired or disposed of, the assets and related accumulated depreciation and amortization are removed from our general ledger, and the resulting gain or loss is reflected in the consolidated statement of operations. Buildings and improvements are depreciated over the lesser of their useful lives or the remaining term of the lease and machinery and equipment over </span><span style="font-family:inherit;font-size:10pt;"><span>3 years</span></span><span style="font-family:inherit;font-size:10pt;"> to </span><span style="font-family:inherit;font-size:10pt;"><span>10 years</span></span><span style="font-family:inherit;font-size:10pt;">. We use the straight-line method to depreciate assets.</span></div><div style="line-height:120%;text-align:justify;text-indent:36px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div> P3Y P10Y <div style="line-height:120%;text-align:justify;text-indent:36px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;font-style:italic;">Leases.</span><span style="font-family:inherit;font-size:10pt;">    We lease buildings, machinery and equipment under operating and capital leases for original terms ranging generally from less than </span><span style="font-family:inherit;font-size:10pt;color:#000000;text-decoration:none;"><span>1 year</span></span><span style="font-family:inherit;font-size:10pt;"> to </span><span style="font-family:inherit;font-size:10pt;color:#000000;text-decoration:none;"><span>30 years</span></span><span style="font-family:inherit;font-size:10pt;">. Certain leases contain renewal options for periods up to </span><span style="font-family:inherit;font-size:10pt;color:#000000;text-decoration:none;"><span>6 years</span></span><span style="font-family:inherit;font-size:10pt;">. In addition, we lease equipment to customers in connection with our diagnostics business using both capital and operating leases. As of </span><span style="font-family:inherit;font-size:10pt;">October 31, 2019</span><span style="font-family:inherit;font-size:10pt;"> and </span><span style="font-family:inherit;font-size:10pt;">2018</span><span style="font-family:inherit;font-size:10pt;"> our diagnostics and genomics segment has approximately </span><span style="font-family:inherit;font-size:10pt;"><span>$37 million</span></span><span style="font-family:inherit;font-size:10pt;"> and </span><span style="font-family:inherit;font-size:10pt;"><span>$32 million</span></span><span style="font-family:inherit;font-size:10pt;">, respectively, of lease receivables related to capital leases and approximately </span><span style="font-family:inherit;font-size:10pt;"><span>$17 million</span></span><span style="font-family:inherit;font-size:10pt;"> and </span><span style="font-family:inherit;font-size:10pt;"><span>$20 million</span></span><span style="font-family:inherit;font-size:10pt;">, respectively, of net assets for operating leases.  We depreciate the assets related to the operating leases over their estimated useful lives, typically five years.</span></div><div style="line-height:120%;text-align:justify;text-indent:36px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div> P1Y P30Y P6Y 37000000 32000000 17000000 20000000 <div style="line-height:120%;text-align:justify;text-indent:36px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;font-style:italic;">Capitalized Software.</span><span style="font-family:inherit;font-size:10pt;">    We capitalize certain internal and external costs incurred to acquire or create internal use software. Capitalized software is included in property, plant and equipment and is depreciated over </span><span style="font-family:inherit;font-size:10pt;"><span>3 years</span></span><span style="font-family:inherit;font-size:10pt;"> to </span><span style="font-family:inherit;font-size:10pt;"><span>5 years</span></span><span style="font-family:inherit;font-size:10pt;"> once development is complete.</span></div> P3Y P5Y <div style="line-height:120%;text-align:justify;text-indent:36px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;font-style:italic;">Impairment of Long-Lived Assets.</span><span style="font-family:inherit;font-size:10pt;">    We continually monitor events and changes in circumstances that could indicate carrying amounts of long-lived assets, including intangible assets, may not be recoverable. When such events or changes in circumstances occur, we assess the recoverability of long-lived assets by determining whether the carrying value of such assets will be recovered through undiscounted expected future cash flows. If the total of the undiscounted future cash flows is less than the carrying amount of those assets, we recognize an impairment loss based on the excess of the carrying amount over the fair value of the assets. During 2019, there were no impairments of other assets or intangible assets. During 2018, we recorded an impairment charge of </span><span style="font-family:inherit;font-size:10pt;"><span>$21 million</span></span><span style="font-family:inherit;font-size:10pt;"> related to purchased intangible assets within the diagnostics and genomics segment that were deemed unrecoverable. During 2017, there were no impairments of other assets or intangible assets.</span></div><div style="line-height:120%;text-align:justify;text-indent:36px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div> 21000000 <div style="line-height:120%;text-align:justify;text-indent:36px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;font-style:italic;">Employee Compensation and Benefits.</span><span style="font-family:inherit;font-size:10pt;">    Amounts owed to employees, such as accrued salary, bonuses and vacation benefits are accounted for within employee compensation and benefits. The total amount of accrued vacation benefit was </span><span style="font-family:inherit;font-size:10pt;"><span>$115 million</span></span><span style="font-family:inherit;font-size:10pt;"> and </span><span style="font-family:inherit;font-size:10pt;"><span>$107 million</span></span><span style="font-family:inherit;font-size:10pt;"> as of </span><span style="font-family:inherit;font-size:10pt;">October 31, 2019</span><span style="font-family:inherit;font-size:10pt;">, and </span><span style="font-family:inherit;font-size:10pt;">2018</span><span style="font-family:inherit;font-size:10pt;">, respectively.</span></div><div style="line-height:120%;text-align:justify;text-indent:36px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div> 115000000 107000000 <div style="line-height:120%;text-align:justify;text-indent:36px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;font-style:italic;">Foreign Currency Translation.</span><span style="font-family:inherit;font-size:10pt;">    We translate and remeasure balance sheet and income statement items into U.S. dollars. For those subsidiaries that operate in a local currency functional environment, all assets and liabilities are translated into U.S. dollars using current exchange rates at the balance sheet date; revenue and expenses are translated using monthly exchange rates which approximate to average exchange rates in effect during each period. Resulting translation adjustments are reported as a separate component of accumulated other comprehensive income (loss) in stockholders' equity.</span></div><div style="line-height:120%;text-align:justify;text-indent:36px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div><div style="line-height:120%;text-align:justify;text-indent:36px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">For those subsidiaries that operate in a U.S. dollar functional environment, foreign currency assets and liabilities are remeasured into U.S. dollars at current exchange rates except for non-monetary assets and capital accounts which are remeasured at historical exchange rates. Revenue and expenses are generally remeasured at monthly exchange rates which approximate average exchange rates in effect during each period. Gains or losses from foreign currency remeasurement are included in consolidated net income. Net gains or losses resulting from foreign currency transactions, including hedging gains and losses, are reported in other income (expense), net and were </span><span style="font-family:inherit;font-size:10pt;color:#000000;text-decoration:none;"><span>$7 million</span></span><span style="font-family:inherit;font-size:10pt;"> loss for </span><span style="font-family:inherit;font-size:10pt;color:#000000;text-decoration:none;">2019</span><span style="font-family:inherit;font-size:10pt;">, </span><span style="font-family:Times New Roman;font-size:10pt;color:#000000;text-decoration:none;"><span>$3 million</span></span><span style="font-family:inherit;font-size:10pt;"> loss for </span><span style="font-family:inherit;font-size:10pt;color:#000000;text-decoration:none;">2018</span><span style="font-family:inherit;font-size:10pt;"> and </span><span style="font-family:Times New Roman;font-size:10pt;color:#000000;font-style:normal;font-weight:normal;text-decoration:none;"><span>$2 million</span></span><span style="font-family:inherit;font-size:10pt;"> loss for </span><span style="font-family:inherit;font-size:10pt;color:#000000;text-decoration:none;">2017</span><span style="font-family:inherit;font-size:10pt;">. </span></div> -7000000 -3000000 -2000000 NEW ACCOUNTING PRONOUNCEMENTS<div style="line-height:120%;text-align:justify;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div><div style="line-height:120%;padding-bottom:10px;text-align:justify;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;font-style:italic;font-weight:bold;">Recently Adopted Accounting Pronouncements </span></div><div style="line-height:120%;text-align:justify;text-indent:36px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">In May 2014, the FASB issued new revenue recognition guidance, ASC Topic 606, which provides a single comprehensive model for entities to use in accounting for revenue arising from contracts with customers and will supersede most current revenue recognition guidance. The objective of the new revenue standard is to significantly enhance comparability and clarify principles of revenue recognition practices across entities, industries, jurisdictions and capital markets. Under the new guidance, there are specific criteria to determine if a performance obligation should be recognized over time or at a point in time.</span></div><div style="line-height:120%;text-align:justify;text-indent:36px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div><div style="line-height:120%;text-align:justify;text-indent:36px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">On November 1, 2018, we adopted ASC 606 using the modified retrospective approach only to contracts not completed as of this date. Results for reporting periods after November 1, 2018 are presented under ASC 606, while prior period amounts were not adjusted and continue to be reported in accordance with ASC Topic 605, </span><span style="font-family:inherit;font-size:10pt;font-style:italic;">Revenue Recognition</span><span style="font-family:inherit;font-size:10pt;">.</span></div><div style="line-height:120%;text-align:justify;text-indent:36px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div><div style="line-height:120%;text-align:justify;text-indent:36px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">We recorded a net increase to beginning retained earnings of </span><span style="font-family:inherit;font-size:10pt;"><span>$23 million</span></span><span style="font-family:inherit;font-size:10pt;"> as of November 1, 2018 due to the cumulative impact of adopting ASC 606. The impact to beginning retained earnings is primarily due to an increase in contract assets (unbilled accounts receivable), a reduction in inventory and a reduction in contract liabilities (deferred revenue). The net increase in retained earnings and resulting changes in assets and liabilities was mainly driven by the change in timing of the recognition of revenue from the fulfillment of separate performance obligations as control transfers to the customer. </span></div><div style="line-height:120%;text-align:justify;text-indent:36px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div><div style="line-height:120%;text-align:justify;text-indent:36px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Had we continued to use the revenue recognition guidance in effect prior to fiscal year 2019, no material changes would have resulted to the consolidated statements of income, comprehensive income, or cash flows for the year ended </span><span style="font-family:inherit;font-size:10pt;">October 31, 2019</span><span style="font-family:inherit;font-size:10pt;">. As a result, comparisons of revenue and operating profit performance between periods are not materially affected by the adoption of this standard. Refer to Note 1, "Overview and Summary of Significant Accounting Policies"for a description of the company’s revenue recognition policies and Note 4, "Revenue" for the disclosures required by the standard.</span></div><div style="line-height:120%;text-align:justify;text-indent:36px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div><div style="line-height:120%;text-align:justify;text-indent:36px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">As of November 1, 2018, we elected to early adopt new accounting guidance which amends reporting comprehensive income to allow a reclassification from accumulated other comprehensive income ("AOCI") to retained earnings for the deferred taxes previously recorded in AOCI that exceed the current federal tax rate of </span><span style="font-family:inherit;font-size:10pt;"><span>21 percent</span></span><span style="font-family:inherit;font-size:10pt;"> resulting from the enacted corporate tax rate in the U.S. Tax Cuts and Jobs Act ("the Tax Act"). The adoption of this guidance resulted in a reclassification of </span><span style="font-family:inherit;font-size:10pt;"><span>$7 million</span></span><span style="font-family:inherit;font-size:10pt;"> from AOCI to beginning retained earnings on our consolidated balance sheet.</span></div><div style="line-height:120%;text-align:justify;text-indent:36px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div><div style="line-height:120%;text-align:justify;text-indent:36px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">As of November 1, 2018, we adopted new accounting guidance which eliminates the exception in ASC 740, </span><span style="font-family:inherit;font-size:10pt;font-style:italic;">Income Taxes</span><span style="font-family:inherit;font-size:10pt;"> against immediate recognition of income tax consequences of intra-entity transfers of assets other than inventory. The amendment in this update should be applied on a modified retrospective basis through a cumulative-effect adjustment directly to retained earnings as of the beginning of period of adoption. We recorded a net decrease in beginning retained earnings of </span><span style="font-family:inherit;font-size:10pt;"><span>$2 million</span></span><span style="font-family:inherit;font-size:10pt;"> as of November 1, 2018 due to removing unamortized tax expense previously deferred.</span></div><div style="line-height:120%;text-align:justify;text-indent:36px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div><div style="line-height:120%;text-align:justify;text-indent:36px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">As of November 1, 2018, we adopted new accounting guidance which addresses certain aspects of recognition, measurement, presentation and disclosure of financial instruments and also the related guidance which addresses technical corrections and improvements to this guidance. The guidance requires entities to measure equity investments that do not result in consolidation and are not accounted for under the equity method at fair value and recognize any changes in fair value in net income. The total impact of adoption to our consolidated balance sheet was an increase of </span><span style="font-family:inherit;font-size:10pt;"><span>$7 million</span></span><span style="font-family:inherit;font-size:10pt;"> to long-term investments and a net increase of </span><span style="font-family:inherit;font-size:10pt;"><span>$5 million</span></span><span style="font-family:inherit;font-size:10pt;"> to beginning retained earnings.</span></div><div style="line-height:120%;text-align:justify;text-indent:38px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div><div style="line-height:120%;text-align:justify;text-indent:36px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div><div style="line-height:120%;text-align:justify;text-indent:36px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">The following table summarizes the impacts of recently adopted accounting pronouncements on our consolidated balance sheet as of November 1, 2018:</span></div><div style="line-height:120%;text-align:justify;text-indent:36px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div><div style="line-height:120%;text-align:center;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;margin-left:auto;margin-right:auto;width:99.80506822612085%;border-collapse:collapse;text-align:left;"><tr><td colspan="24"/></tr><tr><td style="width:38%;"/><td style="width:1%;"/><td style="width:8%;"/><td style="width:1%;"/><td style="width:1%;"/><td style="width:1%;"/><td style="width:7%;"/><td style="width:1%;"/><td style="width:1%;"/><td style="width:1%;"/><td style="width:7%;"/><td style="width:1%;"/><td style="width:1%;"/><td style="width:1%;"/><td style="width:7%;"/><td style="width:1%;"/><td style="width:1%;"/><td style="width:1%;"/><td style="width:8%;"/><td style="width:1%;"/><td style="width:1%;"/><td style="width:1%;"/><td style="width:8%;"/><td style="width:1%;"/></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:1pt;"><span style="font-family:inherit;font-size:1pt;font-weight:bold;"> </span></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:8pt;"><span style="font-family:inherit;font-size:8pt;font-weight:bold;">October 31, <br/>2018</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="15" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:center;font-size:8pt;"><span style="font-family:inherit;font-size:8pt;font-weight:bold;">Impact of Adopting New</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:8pt;"><span style="font-family:inherit;font-size:8pt;font-weight:bold;">November 1, <br/>2018</span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:8pt;"><span style="font-family:inherit;font-size:8pt;font-weight:bold;">As Reported</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:8pt;"><span style="font-family:inherit;font-size:8pt;font-weight:bold;">Revenue Recognition Guidance</span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:8pt;"><span style="font-family:inherit;font-size:8pt;font-weight:bold;">Tax Effects on Items in AOCI Guidance</span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:8pt;"><span style="font-family:inherit;font-size:8pt;font-weight:bold;">Intra-Entity Tax Guidance</span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:8pt;"><span style="font-family:inherit;font-size:8pt;font-weight:bold;">Investments Valuation Guidance</span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:8pt;"><span style="font-family:inherit;font-size:8pt;font-weight:bold;">As Adopted</span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="23" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:center;font-size:8pt;"><span style="font-family:inherit;font-size:8pt;font-weight:bold;">(in millions)</span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">ASSETS</span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:1pt;"><span style="font-family:inherit;font-size:1pt;"> </span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:1pt;"><span style="font-family:inherit;font-size:1pt;"> </span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Current assets:</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:1pt;"><span style="font-family:inherit;font-size:1pt;"> </span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:1pt;"><span style="font-family:inherit;font-size:1pt;"> </span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Cash and cash equivalents</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>2,247</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>—</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>—</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>—</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>—</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>2,247</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Accounts receivable, net</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>776</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>24</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>—</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>—</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>—</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>800</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Inventory</span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>638</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>(10</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">)</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>—</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>—</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>—</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>628</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Other current assets</span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>187</span></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>3</span></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>—</span></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>—</span></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>—</span></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>190</span></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:44px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Total current assets</span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>3,848</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>17</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>—</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>—</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>—</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>3,865</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Property, plant and equipment, net</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>822</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>—</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>—</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>—</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>—</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>822</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Goodwill</span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>2,973</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>—</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>—</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>—</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>—</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>2,973</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Other intangible assets, net</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>491</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>—</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>—</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>—</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>—</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>491</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Long-term investments</span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>68</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>—</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>—</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>—</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>7</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>75</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Other assets</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>339</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>(3</span></span></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">)</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>—</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>(2</span></span></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">)</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>(2</span></span></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">)</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>332</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:44px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Total assets</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>8,541</span></span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>14</span></span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>—</span></span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>(2</span></span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">)</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>5</span></span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>8,558</span></span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">LIABILITIES AND EQUITY</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:1pt;"><span style="font-family:inherit;font-size:1pt;"> </span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:1pt;"><span style="font-family:inherit;font-size:1pt;"> </span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Current liabilities:</span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:1pt;"><span style="font-family:inherit;font-size:1pt;"> </span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:1pt;"><span style="font-family:inherit;font-size:1pt;"> </span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Accounts payable</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>340</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>—</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>—</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>—</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>—</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>340</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Employee compensation and benefits</span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>304</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>—</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>—</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>—</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>—</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>304</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Deferred revenue</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>324</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>(11</span></span></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">)</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>—</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>—</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>—</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>313</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Other accrued liabilities</span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>203</span></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>—</span></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>—</span></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>—</span></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>—</span></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>203</span></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:44px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Total current liabilities</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>1,171</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>(11</span></span></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">)</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>—</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>—</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>—</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>1,160</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Long-term debt</span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>1,799</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>—</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>—</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>—</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>—</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>1,799</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Retirement and post-retirement benefits</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>239</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>—</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>—</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>—</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>—</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>239</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Other long-term liabilities</span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>761</span></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>2</span></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>—</span></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>—</span></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>—</span></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>763</span></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:44px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Total liabilities</span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>3,970</span></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>(9</span></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">)</span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>—</span></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>—</span></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>—</span></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>3,961</span></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:16px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:16px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:16px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:16px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:16px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:16px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:16px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:16px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:16px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:16px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:16px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:16px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Total equity:</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:1pt;"><span style="font-family:inherit;font-size:1pt;"> </span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:1pt;"><span style="font-family:inherit;font-size:1pt;"> </span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Stockholders’ equity:</span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:1pt;"><span style="font-family:inherit;font-size:1pt;"> </span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:1pt;"><span style="font-family:inherit;font-size:1pt;"> </span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Preferred stock; $0.01 par value; 125 million shares authorized; none issued and outstanding</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>—</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>—</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>—</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>—</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>—</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>—</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Common stock; $0.01 par value; 2 billion shares authorized; 318 million shares at October 31, 2018 issued</span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>3</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>—</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>—</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>—</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>—</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>3</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Additional paid-in-capital</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>5,308</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>—</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>—</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>—</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>—</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>5,308</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Accumulated deficit</span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>(336</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">)</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>23</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>7</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>(2</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">)</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>5</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>(303</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">)</span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Accumulated other comprehensive loss</span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>(408</span></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">)</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>—</span></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>(7</span></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">)</span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>—</span></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>—</span></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>(415</span></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">)</span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Total stockholders' equity</span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>4,567</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>23</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>—</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>(2</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">)</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>5</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>4,593</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:28px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Non-controlling interest</span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>4</span></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>—</span></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>—</span></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>—</span></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>—</span></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>4</span></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:44px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Total equity</span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>4,571</span></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>23</span></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>—</span></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>(2</span></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">)</span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>5</span></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>4,597</span></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:52px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Total liabilities and equity</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>8,541</span></span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>14</span></span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>—</span></span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>(2</span></span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-right:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">)</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>5</span></span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>8,558</span></span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr></table></div><span style="font-family:inherit;font-size:10pt;"><br/></span></div><div style="line-height:120%;text-align:justify;text-indent:33px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div><div style="line-height:120%;text-align:justify;text-indent:33px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div><div style="line-height:120%;text-align:justify;text-indent:33px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div><div style="line-height:120%;text-align:justify;text-indent:33px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div><div style="line-height:120%;text-align:justify;text-indent:33px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div><div style="line-height:120%;text-align:justify;text-indent:36px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div><div style="line-height:120%;text-align:justify;text-indent:36px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">As of November 1, 2018, we adopted new accounting guidance which requires amounts generally described as restricted cash and restricted cash equivalents to be included with cash and cash equivalents when reconciling the beginning-of-period and end-of-period total amounts shown on the statement of cash flows. A reconciliation of cash, cash equivalents and restricted cash to the consolidated balance sheet follows:</span></div><div style="line-height:120%;text-align:center;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;margin-left:auto;margin-right:auto;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="12"/></tr><tr><td style="width:68%;"/><td style="width:1%;"/><td style="width:8%;"/><td style="width:1%;"/><td style="width:1%;"/><td style="width:1%;"/><td style="width:8%;"/><td style="width:1%;"/><td style="width:1%;"/><td style="width:1%;"/><td style="width:8%;"/><td style="width:1%;"/></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:1pt;"><span style="font-family:inherit;font-size:1pt;font-weight:bold;"> </span></div></td><td colspan="11" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:center;font-size:8pt;"><span style="font-family:inherit;font-size:8pt;font-weight:bold;">October 31</span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:1pt;"><span style="font-family:inherit;font-size:1pt;font-weight:bold;"> </span></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:8pt;"><span style="font-family:inherit;font-size:8pt;font-weight:bold;">2019</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:8pt;"><span style="font-family:inherit;font-size:8pt;font-weight:bold;">2018</span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="text-align:center;font-size:8pt;"><span style="font-family:inherit;font-size:8pt;font-weight:bold;">2017</span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="7" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:center;font-size:8pt;"><span style="font-family:inherit;font-size:8pt;font-weight:bold;">(in millions)</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Cash and cash equivalents</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>1,382</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>2,247</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>2,678</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Restricted cash included in other assets</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>6</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>7</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>8</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Total cash, cash equivalents and restricted cash</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>1,388</span></span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>2,254</span></span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>2,686</span></span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr></table></div><span style="font-family:inherit;font-size:10pt;"><br/></span></div><div style="line-height:120%;text-align:justify;text-indent:38px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div><div style="line-height:120%;text-align:justify;text-indent:36px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">As of November 1, 2018, we adopted new accounting guidance which requires employers that present a measure of operating income in their statements of operations to include only the service cost component of net periodic postretirement benefit cost in operating expenses. The service cost component of net periodic pension and postretirement benefit cost should be presented in the same operating expense line items as other employee compensation costs arising from services rendered during the period. The other components of net periodic pension and postretirement benefit costs, including interest costs, expected return on assets, amortization of prior service cost/credit and actuarial gains/losses, and settlement and curtailment effects, are to be included separately and outside of any subtotal of operating income. The adoption of this guidance resulted in a reclassification of income from our income from operations to other income (expense), net on our consolidated statement of operations of approximately </span><span style="font-family:inherit;font-size:10pt;"><span>$10 million</span></span><span style="font-family:inherit;font-size:10pt;">, </span><span style="font-family:inherit;font-size:10pt;"><span>$24 million</span></span><span style="font-family:inherit;font-size:10pt;"> and </span><span style="font-family:inherit;font-size:10pt;"><span>$34 million</span></span><span style="font-family:inherit;font-size:10pt;"> in the year ended October 31, 2019, 2018 and 2017, respectively. As adoption is required to be on a retrospective basis, we have recast our historical consolidated statements of operations and segment information to conform to current year presentation. </span></div><div style="line-height:120%;text-align:justify;text-indent:30px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div><div style="line-height:120%;text-align:justify;text-indent:30px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;font-style:italic;font-weight:bold;">New Accounting Pronouncements Not Yet Adopted</span></div><div style="line-height:120%;text-align:justify;text-indent:36px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div><div style="line-height:120%;text-align:justify;text-indent:36px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">In February 2016, the FASB issued guidance which amends the existing accounting standards for leases. Consistent with existing guidance, the recognition, measurement, and presentation of expenses and cash flows arising from a lease by a lessee primarily will depend on its classification. Under the new guidance, a lessee will be required to recognize right-of-use assets ("ROU") and lease liabilities on the balance sheet. On November 1, 2019, we adopted the lease accounting guidance using the modified retrospective method for all lease arrangements at the beginning of the period of adoption. Results for reporting periods beginning November 1, 2019 will be presented under the new accounting guidance, while prior period amounts will not be adjusted. As of November 1, 2019, the new accounting guidance had a material impact on our consolidated balance sheet but is expected to have an insignificant impact on the consolidated net income and cash flows. The most significant impact was the recognition of ROU assets and lease liabilities for operating leases, while the accounting for capital leases remained substantially unchanged. For leases that commenced before the effective date of adoption of the new accounting guidance, we elected the permitted practical expedients to not reassess the following: (i) whether any expired or existing contracts contain leases; (ii) the lease classification for any expired or existing leases; and (iii) capitalization of initial direct costs for any existing leases.</span></div><div style="line-height:120%;padding-bottom:6px;padding-top:6px;text-align:justify;text-indent:36px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">As a result of the cumulative impact of adopting the new accounting guidance we will record operating lease ROU assets around </span><span style="font-family:inherit;font-size:10pt;"><span>$195 million</span></span><span style="font-family:inherit;font-size:10pt;"> and operating lease liabilities of the same amounts, primarily related to real estate and automobile leases.</span></div><div style="line-height:120%;padding-bottom:6px;padding-top:6px;text-align:justify;text-indent:36px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">The accounting applied to lease arrangements in which we are the lessor is largely unchanged from that applied under the prior standard and will not have a significant impact to our consolidated balance sheet, net income or cash flows</span></div><div style="line-height:120%;text-align:justify;text-indent:36px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">In January 2017, the FASB issued an amendment to modify the concept of impairment from the condition that exists when the carrying amount of goodwill exceeds its implied fair value to the condition that exists when the carrying amount of a reporting unit exceeds its fair value. The amendment also simplifies the subsequent measurement of goodwill by eliminating Step 2 from the goodwill impairment test. The amendments are effective for us beginning November 1, 2020. Early adoption is permitted for interim or annual goodwill impairment tests performed on testing dates after January 1, 2017. We do not expect to early adopt nor do we expect this guidance to have a material impact on our consolidated financial statements and disclosures.</span></div><div style="line-height:120%;text-align:justify;text-indent:36px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div><div style="line-height:120%;text-align:justify;text-indent:33px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">In August 2018, the FASB issued updates to improve the disclosure requirements on fair value measurements in Topic 820, Fair Value Measurement which eliminates certain disclosure requirements and modifies others. These amendments are effective for us beginning November 1, 2020, and for interim periods within that year with early adoption permitted. We currently do not expect this guidance to have a material impact on our consolidated financial statements and disclosures.</span></div><div style="line-height:120%;text-align:justify;text-indent:33px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div><div style="line-height:120%;text-align:justify;text-indent:33px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">In August 2018, the FASB issued updates to improve the effectiveness of disclosures for defined benefit plans under Accounting Standard Codification Topic 715-20. The amendments in this guidance remove disclosures that no longer are considered cost beneficial, clarify the specific requirements of disclosures, and add disclosure requirements identified as relevant. These amendments are effective for us beginning November 1, 2021, with early adoption permitted. We currently do not expect this guidance to have a material impact on our consolidated financial statements and disclosures.</span></div><div style="line-height:120%;text-align:justify;text-indent:36px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div><div style="line-height:120%;text-align:justify;text-indent:36px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Other amendments to GAAP in the U.S. that have been issued by the FASB or other standards-setting bodies that do not require adoption until a future date are not expected to have a material impact on our consolidated financial statements upon adoption.</span></div> 23000000 0.21 7000000 -2000000 7000000 5000000 <div style="line-height:120%;text-align:justify;text-indent:36px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">The following table summarizes the impacts of recently adopted accounting pronouncements on our consolidated balance sheet as of November 1, 2018:</span></div><div style="line-height:120%;text-align:justify;text-indent:36px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div><div style="line-height:120%;text-align:center;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;margin-left:auto;margin-right:auto;width:99.80506822612085%;border-collapse:collapse;text-align:left;"><tr><td colspan="24"/></tr><tr><td style="width:38%;"/><td style="width:1%;"/><td style="width:8%;"/><td style="width:1%;"/><td style="width:1%;"/><td style="width:1%;"/><td style="width:7%;"/><td style="width:1%;"/><td style="width:1%;"/><td style="width:1%;"/><td style="width:7%;"/><td style="width:1%;"/><td style="width:1%;"/><td style="width:1%;"/><td style="width:7%;"/><td style="width:1%;"/><td style="width:1%;"/><td style="width:1%;"/><td style="width:8%;"/><td style="width:1%;"/><td style="width:1%;"/><td style="width:1%;"/><td style="width:8%;"/><td style="width:1%;"/></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:1pt;"><span style="font-family:inherit;font-size:1pt;font-weight:bold;"> </span></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:8pt;"><span style="font-family:inherit;font-size:8pt;font-weight:bold;">October 31, <br/>2018</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="15" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:center;font-size:8pt;"><span style="font-family:inherit;font-size:8pt;font-weight:bold;">Impact of Adopting New</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:8pt;"><span style="font-family:inherit;font-size:8pt;font-weight:bold;">November 1, <br/>2018</span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:8pt;"><span style="font-family:inherit;font-size:8pt;font-weight:bold;">As Reported</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:8pt;"><span style="font-family:inherit;font-size:8pt;font-weight:bold;">Revenue Recognition Guidance</span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:8pt;"><span style="font-family:inherit;font-size:8pt;font-weight:bold;">Tax Effects on Items in AOCI Guidance</span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:8pt;"><span style="font-family:inherit;font-size:8pt;font-weight:bold;">Intra-Entity Tax Guidance</span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:8pt;"><span style="font-family:inherit;font-size:8pt;font-weight:bold;">Investments Valuation Guidance</span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:8pt;"><span style="font-family:inherit;font-size:8pt;font-weight:bold;">As Adopted</span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="23" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:center;font-size:8pt;"><span style="font-family:inherit;font-size:8pt;font-weight:bold;">(in millions)</span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">ASSETS</span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:1pt;"><span style="font-family:inherit;font-size:1pt;"> </span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:1pt;"><span style="font-family:inherit;font-size:1pt;"> </span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Current assets:</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:1pt;"><span style="font-family:inherit;font-size:1pt;"> </span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:1pt;"><span style="font-family:inherit;font-size:1pt;"> </span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Cash and cash equivalents</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>2,247</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>—</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>—</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>—</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>—</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>2,247</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Accounts receivable, net</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>776</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>24</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>—</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>—</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>—</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>800</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Inventory</span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>638</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>(10</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">)</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>—</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>—</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>—</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>628</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Other current assets</span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>187</span></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>3</span></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>—</span></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>—</span></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>—</span></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>190</span></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:44px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Total current assets</span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>3,848</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>17</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>—</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>—</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>—</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>3,865</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Property, plant and equipment, net</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>822</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>—</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>—</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>—</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>—</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>822</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Goodwill</span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>2,973</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>—</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>—</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>—</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>—</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>2,973</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Other intangible assets, net</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>491</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>—</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>—</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>—</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>—</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>491</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Long-term investments</span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>68</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>—</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>—</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>—</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>7</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>75</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Other assets</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>339</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>(3</span></span></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">)</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>—</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>(2</span></span></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">)</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>(2</span></span></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">)</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>332</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:44px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Total assets</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>8,541</span></span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>14</span></span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>—</span></span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>(2</span></span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">)</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>5</span></span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>8,558</span></span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">LIABILITIES AND EQUITY</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:1pt;"><span style="font-family:inherit;font-size:1pt;"> </span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:1pt;"><span style="font-family:inherit;font-size:1pt;"> </span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Current liabilities:</span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:1pt;"><span style="font-family:inherit;font-size:1pt;"> </span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:1pt;"><span style="font-family:inherit;font-size:1pt;"> </span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Accounts payable</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>340</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>—</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>—</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>—</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>—</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>340</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Employee compensation and benefits</span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>304</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>—</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>—</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>—</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>—</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>304</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Deferred revenue</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>324</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>(11</span></span></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">)</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>—</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>—</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>—</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>313</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Other accrued liabilities</span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>203</span></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>—</span></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>—</span></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>—</span></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>—</span></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>203</span></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:44px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Total current liabilities</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>1,171</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>(11</span></span></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">)</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>—</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>—</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>—</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>1,160</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Long-term debt</span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>1,799</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>—</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>—</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>—</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>—</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>1,799</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Retirement and post-retirement benefits</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>239</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>—</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>—</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>—</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>—</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>239</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Other long-term liabilities</span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>761</span></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>2</span></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>—</span></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>—</span></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>—</span></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>763</span></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:44px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Total liabilities</span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>3,970</span></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>(9</span></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">)</span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>—</span></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>—</span></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>—</span></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>3,961</span></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:16px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:16px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:16px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:16px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:16px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:16px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:16px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:16px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:16px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:16px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:16px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:16px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Total equity:</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:1pt;"><span style="font-family:inherit;font-size:1pt;"> </span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:1pt;"><span style="font-family:inherit;font-size:1pt;"> </span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Stockholders’ equity:</span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:1pt;"><span style="font-family:inherit;font-size:1pt;"> </span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:1pt;"><span style="font-family:inherit;font-size:1pt;"> </span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Preferred stock; $0.01 par value; 125 million shares authorized; none issued and outstanding</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>—</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>—</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>—</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>—</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>—</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>—</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Common stock; $0.01 par value; 2 billion shares authorized; 318 million shares at October 31, 2018 issued</span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>3</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>—</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>—</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>—</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>—</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>3</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Additional paid-in-capital</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>5,308</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>—</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>—</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>—</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>—</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>5,308</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Accumulated deficit</span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>(336</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">)</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>23</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>7</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>(2</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">)</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>5</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>(303</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">)</span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Accumulated other comprehensive loss</span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>(408</span></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">)</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>—</span></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>(7</span></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">)</span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>—</span></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>—</span></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>(415</span></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">)</span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Total stockholders' equity</span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>4,567</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>23</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>—</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>(2</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">)</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>5</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>4,593</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:28px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Non-controlling interest</span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>4</span></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>—</span></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>—</span></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>—</span></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>—</span></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>4</span></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:44px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Total equity</span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>4,571</span></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>23</span></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>—</span></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>(2</span></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">)</span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>5</span></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>4,597</span></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:52px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Total liabilities and equity</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>8,541</span></span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>14</span></span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>—</span></span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>(2</span></span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-right:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">)</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>5</span></span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>8,558</span></span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr></table></div><span style="font-family:inherit;font-size:10pt;"><br/></span></div><div style="line-height:120%;text-align:justify;text-indent:33px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div><div style="line-height:120%;text-align:justify;text-indent:33px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div><div style="line-height:120%;text-align:justify;text-indent:33px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div><div style="line-height:120%;text-align:justify;text-indent:33px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div><div style="line-height:120%;text-align:justify;text-indent:33px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div><div style="line-height:120%;text-align:justify;text-indent:36px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div><div style="line-height:120%;text-align:justify;text-indent:36px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">As of November 1, 2018, we adopted new accounting guidance which requires amounts generally described as restricted cash and restricted cash equivalents to be included with cash and cash equivalents when reconciling the beginning-of-period and end-of-period total amounts shown on the statement of cash flows. A reconciliation of cash, cash equivalents and restricted cash to the consolidated balance sheet follows:</span></div><div style="line-height:120%;text-align:center;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;margin-left:auto;margin-right:auto;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="12"/></tr><tr><td style="width:68%;"/><td style="width:1%;"/><td style="width:8%;"/><td style="width:1%;"/><td style="width:1%;"/><td style="width:1%;"/><td style="width:8%;"/><td style="width:1%;"/><td style="width:1%;"/><td style="width:1%;"/><td style="width:8%;"/><td style="width:1%;"/></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:1pt;"><span style="font-family:inherit;font-size:1pt;font-weight:bold;"> </span></div></td><td colspan="11" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:center;font-size:8pt;"><span style="font-family:inherit;font-size:8pt;font-weight:bold;">October 31</span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:1pt;"><span style="font-family:inherit;font-size:1pt;font-weight:bold;"> </span></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:8pt;"><span style="font-family:inherit;font-size:8pt;font-weight:bold;">2019</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:8pt;"><span style="font-family:inherit;font-size:8pt;font-weight:bold;">2018</span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="text-align:center;font-size:8pt;"><span style="font-family:inherit;font-size:8pt;font-weight:bold;">2017</span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="7" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:center;font-size:8pt;"><span style="font-family:inherit;font-size:8pt;font-weight:bold;">(in millions)</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Cash and cash equivalents</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>1,382</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>2,247</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>2,678</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Restricted cash included in other assets</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>6</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>7</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>8</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Total cash, cash equivalents and restricted cash</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>1,388</span></span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>2,254</span></span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>2,686</span></span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr></table></div><span style="font-family:inherit;font-size:10pt;"><br/></span></div> 2247000000 0 0 0 0 2247000000 776000000 24000000 0 0 0 800000000 638000000 -10000000 0 0 0 628000000 187000000 3000000 0 0 0 190000000 3848000000 17000000 0 0 0 3865000000 822000000 0 0 0 0 822000000 2973000000 0 0 0 0 2973000000 491000000 0 0 0 0 491000000 68000000 0 0 0 7000000 75000000 339000000 -3000000 0 -2000000 -2000000 332000000 8541000000 14000000 0 -2000000 5000000 8558000000 340000000 0 0 0 0 340000000 304000000 0 0 0 0 304000000 324000000 -11000000 0 0 0 313000000 203000000 0 0 0 0 203000000 1171000000 -11000000 0 0 0 1160000000 1799000000 0 0 0 0 1799000000 239000000 0 0 0 0 239000000 761000000 2000000 0 0 0 763000000 3970000000 -9000000 0 0 0 3961000000 0 0 0 0 0 0 3000000 0 0 0 0 3000000 5308000000 0 0 0 0 5308000000 -336000000 23000000 7000000 -2000000 5000000 -303000000 -408000000 0 -7000000 0 0 -415000000 4567000000 23000000 0 -2000000 5000000 4593000000 4000000 0 0 0 0 4000000 4571000000 23000000 0 -2000000 5000000 4597000000 8541000000 14000000 0 -2000000 5000000 8558000000 1382000000 2247000000 2678000000 6000000 7000000 8000000 1388000000 2254000000 2686000000 10000000 24000000 34000000 195000000 ACQUISITIONS<div style="line-height:120%;text-align:justify;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div><div style="line-height:120%;text-align:left;text-indent:30px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;font-style:italic;font-weight:bold;">Acquisition of BioTek</span><span style="font-family:inherit;font-size:10pt;font-weight:bold;"> </span><span style="font-family:inherit;font-size:10pt;font-style:italic;font-weight:bold;">and ACEA</span></div><div style="line-height:120%;text-align:left;text-indent:30px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div><div style="line-height:120%;text-align:justify;text-indent:36px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">On August 23, 2019 we completed the acquisition of privately-owned Lionheart Technologies LLC ("BioTek"), a leader in the design, manufacture and distribution of innovative life science instrumentation for </span><span style="font-family:inherit;font-size:10pt;"><span>$1.17 billion</span></span><span style="font-family:inherit;font-size:10pt;">, under the merger agreement. As a result of the acquisition, BioTek has become a wholly-owned subsidiary of Agilent. Accordingly, the results of BioTek are included in Agilent's consolidated financial statements from the acquisition date. For the period from August 24, 2019 to </span><span style="font-family:inherit;font-size:10pt;">October 31, 2019</span><span style="font-family:inherit;font-size:10pt;">, BioTek’s net revenue was </span><span style="font-family:inherit;font-size:10pt;"><span>$35 million</span></span><span style="font-family:inherit;font-size:10pt;"> and net loss was </span><span style="font-family:inherit;font-size:10pt;"><span>$12 million</span></span><span style="font-family:inherit;font-size:10pt;">. The acquisition of BioTek and its portfolio is another step to expand our position in the cell analysis market.</span></div><div style="line-height:120%;text-align:justify;text-indent:36px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div><div style="line-height:120%;text-align:justify;text-indent:36px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">The consideration paid was </span><span style="font-family:inherit;font-size:10pt;"><span>$1.17 billion</span></span><span style="font-family:inherit;font-size:10pt;">. Agilent funded the acquisition using existing cash of </span><span style="font-family:inherit;font-size:10pt;"><span>$470 million</span></span><span style="font-family:inherit;font-size:10pt;"> and debt of </span><span style="font-family:inherit;font-size:10pt;"><span>$700 million</span></span><span style="font-family:inherit;font-size:10pt;">. </span></div><div style="line-height:120%;text-align:justify;text-indent:36px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div><div style="line-height:120%;text-align:justify;text-indent:36px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">The BioTek acquisition was accounted for in accordance with the authoritative accounting guidance. The acquired assets and assumed liabilities were recorded by Agilent at their estimated fair values. Agilent determined the estimated fair values with the assistance of appraisals or valuations performed by third party specialists, discounted cash flow analyses, and estimates made by management. We expect to realize revenue synergies, leverage and expand the existing sales channels and product development resources, and utilize the assembled workforce. These factors, among others, contributed to a purchase price in excess of the estimated fair value of BioTek’s net identifiable assets acquired (see summary of net assets below), and, as a result, we have recorded goodwill in connection with this transaction.</span></div><div style="line-height:120%;text-align:justify;text-indent:36px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div><div style="line-height:120%;text-align:justify;text-indent:36px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Goodwill acquired was allocated to our operating segments and reporting units as a part of the purchase price allocation. All goodwill was allocated to the life sciences and applied markets reporting unit. </span></div><div style="line-height:120%;text-align:justify;text-indent:36px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div><div style="line-height:120%;text-align:justify;text-indent:36px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Agilent’s acquisition of BioTek is treated as an asset purchase for tax purposes. The tax basis of the acquired assets equals the fair market value on acquisition date.</span></div><div style="line-height:120%;text-align:justify;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div><div style="line-height:120%;text-align:justify;text-indent:36px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">The following table summarizes the allocation of the purchase price to the estimated fair values of the assets acquired and liabilities assumed on the closing date of August 23, 2019 (in millions):</span></div><div style="line-height:120%;text-align:center;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;margin-left:auto;margin-right:auto;width:99.8046875%;border-collapse:collapse;text-align:left;"><tr><td colspan="7"/></tr><tr><td style="width:90%;"/><td style="width:1%;"/><td style="width:1%;"/><td style="width:1%;"/><td style="width:5%;"/><td style="width:1%;"/><td style="width:1%;"/></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Cash and cash equivalents</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>10</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Accounts receivable</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>28</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Inventories</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>21</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Other current assets</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>2</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Property, plant and equipment</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>8</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Intangible assets</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>641</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Goodwill</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>483</span></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Total assets acquired</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>1,193</span></span></div></td><td style="vertical-align:bottom;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Accounts payable</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>(4</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">)</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Deferred revenue</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>(5</span></span></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">)</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Employee compensation and benefits</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>(7</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">)</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Other accrued liabilities</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>(2</span></span></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">)</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Long-term debt</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>(4</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">)</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Net assets acquired</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>1,171</span></span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td></tr></table></div><span style="font-family:inherit;font-size:10pt;"><br/></span></div><div style="line-height:120%;text-align:justify;text-indent:36px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div><div style="line-height:120%;text-align:justify;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div><div style="line-height:120%;text-align:left;text-indent:36px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">The fair value of cash and cash equivalents, accounts receivable, other current assets, accounts payable and other accrued liabilities were generally determined using historical carrying values given the short-term nature of these assets and liabilities.</span></div><div style="line-height:120%;text-align:left;text-indent:36px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div><div style="line-height:120%;text-align:left;text-indent:36px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">The fair values for acquired intangible assets and deferred revenue were determined with the input from third party valuation specialists.</span></div><div style="line-height:120%;text-align:left;text-indent:36px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div><div style="line-height:120%;text-align:left;text-indent:36px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">The fair values of certain other assets, inventory, property, plant and equipment, investments, long-term debt, and certain other long-term liabilities were determined internally using historical carrying values and estimates made by management.</span></div><div style="line-height:120%;text-align:left;text-indent:36px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div><div style="line-height:120%;text-align:left;text-indent:18px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;font-style:italic;font-weight:bold;">Valuations of intangible assets acquired</span></div><div style="line-height:120%;text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div><div style="line-height:120%;text-align:left;text-indent:32px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">The components of intangible assets acquired in connection with the BioTek acquisition were as follows (in millions):</span></div><div style="line-height:120%;text-align:center;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div><div style="line-height:120%;text-align:center;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;margin-left:auto;margin-right:auto;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="8"/></tr><tr><td style="width:79%;"/><td style="width:1%;"/><td style="width:1%;"/><td style="width:5%;"/><td style="width:1%;"/><td style="width:1%;"/><td style="width:1%;"/><td style="width:11%;"/></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:1pt;"><span style="font-family:inherit;font-size:1pt;font-weight:bold;"> </span></div></td><td colspan="5" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:8pt;"><span style="font-family:inherit;font-size:8pt;font-weight:bold;">Fair Value</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:8pt;"><span style="font-family:inherit;font-size:8pt;font-weight:bold;">Estimated</span></div><div style="text-align:center;font-size:8pt;"><span style="font-family:inherit;font-size:8pt;font-weight:bold;">Useful Life</span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Developed product technology</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>387</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">5-13 years</span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Customer relationships</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>202</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">3-8 years</span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Backlog</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>5</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>2 months</span></span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Tradenames and trademarks</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>43</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>10 years</span></span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Total intangible assets subject to amortization</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>637</span></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">In-process research and development</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>4</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:right;font-size:1pt;"><span style="font-family:inherit;font-size:1pt;"> </span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Total intangible assets</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>641</span></span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:right;font-size:1pt;"><span style="font-family:inherit;font-size:1pt;"> </span></div></td></tr></table></div><span style="font-family:inherit;font-size:10pt;"><br/></span></div><div style="line-height:120%;text-align:justify;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div><div style="line-height:120%;text-align:justify;text-indent:36px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">As noted above, the intangible assets, including in-process research and development, were valued with input from valuation specialists. Agilent used variations of the income approach in determining the fair value of intangible assets acquired in the BioTek acquisition. Specifically, the developed product technology and in-process research and development were valued using the multi-period excess earnings method under the income approach by discounting forecasted cash flows directly related to the products expecting to result from the projects, net of returns on contributory assets. The Company utilized the incremental cash flow method for determining the fair value of the customer relationships acquired, and the relief from royalty method to determine the fair value of the tradename. Order backlog was valued on a direct cash flow basis. </span></div><div style="line-height:120%;text-align:justify;text-indent:36px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div><div style="line-height:120%;text-align:justify;text-indent:36px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">The primary in-process research and development project acquired relates to a next version of a product which will be released in 2020. Total costs to complete for all BioTek in-process research and development were estimated at approximately </span><span style="font-family:inherit;font-size:10pt;"><span>$2 million</span></span><span style="font-family:inherit;font-size:10pt;"> as of the close date.</span></div><div style="line-height:120%;text-align:left;text-indent:36px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div><div style="line-height:120%;text-align:justify;text-indent:36px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Acquisition and integration costs directly related to the BioTek acquisition totaled </span><span style="font-family:inherit;font-size:10pt;"><span>$4 million</span></span><span style="font-family:inherit;font-size:10pt;"> for the year ended </span><span style="font-family:inherit;font-size:10pt;">October 31, 2019</span><span style="font-family:inherit;font-size:10pt;"> and were recorded in selling, general and administrative expenses. Such costs are expensed in accordance with the authoritative accounting guidance.</span></div><div style="line-height:120%;text-align:justify;text-indent:36px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div><div style="line-height:120%;text-align:justify;text-indent:36px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div><div style="line-height:120%;text-align:left;text-indent:36px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">On November 14, 2018, we acquired 100 percent of the stock of ACEA Biosciences (“ACEA”), a developer of cell analysis tools, for </span><span style="font-family:inherit;font-size:10pt;"><span>$250 million</span></span><span style="font-family:inherit;font-size:10pt;">. The financial results of ACEA have been included in our financial results from the acquisition date.</span></div><div style="line-height:120%;text-align:left;text-indent:36px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div><div style="line-height:120%;text-align:left;text-indent:36px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">The following represents the unaudited proforma operating results as if BioTek and ACEA had been included in the company's consolidated statements of operations as of the beginning of fiscal 2018 (in millions, except per share amounts): </span></div><div style="line-height:120%;text-align:left;text-indent:36px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div><div style="line-height:120%;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="8"/></tr><tr><td style="width:73%;"/><td style="width:1%;"/><td style="width:11%;"/><td style="width:1%;"/><td style="width:1%;"/><td style="width:1%;"/><td style="width:11%;"/><td style="width:1%;"/></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:8pt;"><span style="font-family:inherit;font-size:8pt;font-weight:bold;">2019</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:8pt;"><span style="font-family:inherit;font-size:8pt;font-weight:bold;">2018</span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Net revenue</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>5,308</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>5,112</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Net income</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>1,012</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>210</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Net income per share — basic</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>3.22</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>0.65</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Net income per share — diluted</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>3.18</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>0.65</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr></table></div><span style="font-family:inherit;font-size:10pt;"><br/></span></div><div style="line-height:120%;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div><div style="line-height:120%;text-align:justify;text-indent:36px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">The unaudited proforma financial information assumes that the companies were combined as of November 1, 2017 and include business combination accounting effects from the acquisition including amortization charges from acquired intangible assets, the impact on cost of sales due to the respective estimated fair value adjustments to inventory, changes to interest income for cash used in the acquisition, interest expense and currency losses associated with debt paid in connection with the acquisition and acquisition related transaction costs and tax related effects. The proforma information as presented above is for informational purposes only and is not indicative of the results of operations that would have been achieved if the acquisition had taken place at the beginning of fiscal </span><span style="font-family:inherit;font-size:10pt;">2018</span><span style="font-family:inherit;font-size:10pt;">.</span></div><div style="line-height:120%;text-align:justify;text-indent:36px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div><div style="line-height:120%;text-align:justify;text-indent:36px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">The unaudited proforma financial information for the year ended </span><span style="font-family:inherit;font-size:10pt;">October 31, 2019</span><span style="font-family:inherit;font-size:10pt;"> combines the historical results of Agilent for the year ended </span><span style="font-family:inherit;font-size:10pt;">October 31, 2019</span><span style="font-family:inherit;font-size:10pt;"> (which includes BioTek and ACEA after the acquisition date) and for BioTek for the ten months ended August 23, 2019.</span></div><div style="line-height:120%;text-align:justify;text-indent:36px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div><div style="line-height:120%;text-align:justify;text-indent:36px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">The unaudited proforma financial information for the year ended October 31, 2018 combines the historical results of Agilent and ACEA for the year ended October 31, 2018 and BioTek for the year ended December 31, 2018 (due to differences in reporting periods).</span></div> 1170000000 35000000 -12000000 1170000000 470000000 700000000 <div style="line-height:120%;text-align:justify;text-indent:36px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">The following table summarizes the allocation of the purchase price to the estimated fair values of the assets acquired and liabilities assumed on the closing date of August 23, 2019 (in millions):</span></div><div style="line-height:120%;text-align:center;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;margin-left:auto;margin-right:auto;width:99.8046875%;border-collapse:collapse;text-align:left;"><tr><td colspan="7"/></tr><tr><td style="width:90%;"/><td style="width:1%;"/><td style="width:1%;"/><td style="width:1%;"/><td style="width:5%;"/><td style="width:1%;"/><td style="width:1%;"/></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Cash and cash equivalents</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>10</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Accounts receivable</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>28</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Inventories</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>21</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Other current assets</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>2</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Property, plant and equipment</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>8</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Intangible assets</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>641</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Goodwill</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>483</span></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Total assets acquired</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>1,193</span></span></div></td><td style="vertical-align:bottom;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Accounts payable</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>(4</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">)</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Deferred revenue</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>(5</span></span></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">)</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Employee compensation and benefits</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>(7</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">)</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Other accrued liabilities</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>(2</span></span></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">)</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Long-term debt</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>(4</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">)</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Net assets acquired</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>1,171</span></span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td></tr></table></div><span style="font-family:inherit;font-size:10pt;"><br/></span></div> 10000000 28000000 21000000 2000000 8000000 641000000 483000000 1193000000 4000000 5000000 7000000 2000000 4000000 1171000000 <div style="line-height:120%;text-align:left;text-indent:32px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">The components of intangible assets acquired in connection with the BioTek acquisition were as follows (in millions):</span></div><div style="line-height:120%;text-align:center;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div><div style="line-height:120%;text-align:center;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;margin-left:auto;margin-right:auto;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="8"/></tr><tr><td style="width:79%;"/><td style="width:1%;"/><td style="width:1%;"/><td style="width:5%;"/><td style="width:1%;"/><td style="width:1%;"/><td style="width:1%;"/><td style="width:11%;"/></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:1pt;"><span style="font-family:inherit;font-size:1pt;font-weight:bold;"> </span></div></td><td colspan="5" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:8pt;"><span style="font-family:inherit;font-size:8pt;font-weight:bold;">Fair Value</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:8pt;"><span style="font-family:inherit;font-size:8pt;font-weight:bold;">Estimated</span></div><div style="text-align:center;font-size:8pt;"><span style="font-family:inherit;font-size:8pt;font-weight:bold;">Useful Life</span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Developed product technology</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>387</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">5-13 years</span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Customer relationships</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>202</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">3-8 years</span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Backlog</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>5</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>2 months</span></span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Tradenames and trademarks</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>43</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>10 years</span></span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Total intangible assets subject to amortization</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>637</span></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">In-process research and development</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>4</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:right;font-size:1pt;"><span style="font-family:inherit;font-size:1pt;"> </span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Total intangible assets</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>641</span></span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:right;font-size:1pt;"><span style="font-family:inherit;font-size:1pt;"> </span></div></td></tr></table></div><span style="font-family:inherit;font-size:10pt;"><br/></span></div> 387000000 202000000 5000000 P2M 43000000 P10Y 637000000 4000000 641000000 2000000 4000000 250000000 <div style="line-height:120%;text-align:left;text-indent:36px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">The following represents the unaudited proforma operating results as if BioTek and ACEA had been included in the company's consolidated statements of operations as of the beginning of fiscal 2018 (in millions, except per share amounts): </span></div><div style="line-height:120%;text-align:left;text-indent:36px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div><div style="line-height:120%;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="8"/></tr><tr><td style="width:73%;"/><td style="width:1%;"/><td style="width:11%;"/><td style="width:1%;"/><td style="width:1%;"/><td style="width:1%;"/><td style="width:11%;"/><td style="width:1%;"/></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:8pt;"><span style="font-family:inherit;font-size:8pt;font-weight:bold;">2019</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:8pt;"><span style="font-family:inherit;font-size:8pt;font-weight:bold;">2018</span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Net revenue</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>5,308</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>5,112</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Net income</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>1,012</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>210</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Net income per share — basic</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>3.22</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>0.65</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Net income per share — diluted</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>3.18</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>0.65</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr></table></div><span style="font-family:inherit;font-size:10pt;"><br/></span></div> 5308000000 5112000000 1012000000 210000000 3.22 0.65 3.18 0.65 REVENUE<div style="line-height:120%;text-align:justify;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div><div style="line-height:120%;text-align:justify;text-indent:36px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">The following table presents the company’s total revenue and segment revenue disaggregated by geographical region: </span></div><div style="line-height:120%;text-align:center;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;margin-left:auto;margin-right:auto;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="16"/></tr><tr><td style="width:44%;"/><td style="width:1%;"/><td style="width:11%;"/><td style="width:1%;"/><td style="width:1%;"/><td style="width:1%;"/><td style="width:11%;"/><td style="width:1%;"/><td style="width:1%;"/><td style="width:1%;"/><td style="width:11%;"/><td style="width:1%;"/><td style="width:1%;"/><td style="width:1%;"/><td style="width:12%;"/><td style="width:1%;"/></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="15" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:center;font-size:8pt;"><span style="font-family:inherit;font-size:8pt;font-weight:bold;">Year Ended October 31, 2019</span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" style="vertical-align:middle;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:8pt;"><span style="font-family:inherit;font-size:8pt;font-weight:bold;">Life Sciences and Applied Markets</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" style="vertical-align:middle;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:8pt;"><span style="font-family:inherit;font-size:8pt;font-weight:bold;">Diagnostics and Genomics</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" style="vertical-align:middle;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:8pt;"><span style="font-family:inherit;font-size:8pt;font-weight:bold;">Agilent CrossLab</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" style="vertical-align:middle;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:8pt;"><span style="font-family:inherit;font-size:8pt;font-weight:bold;">Total</span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="15" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:center;font-size:8pt;"><span style="font-family:inherit;font-size:8pt;font-weight:bold;">(in millions)</span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="font-size:10pt;"><span style="font-family:inherit;font-size:10pt;font-weight:bold;text-decoration:underline;">Revenue by Region</span></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Americas</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>692</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>505</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>664</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>1,861</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Europe</span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>551</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>368</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>522</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>1,441</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Asia Pacific</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>1,059</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>148</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>654</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>1,861</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:20px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Total</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>2,302</span></span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>1,021</span></span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>1,840</span></span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>5,163</span></span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:13px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:13px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:13px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:13px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:13px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:13px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:13px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:13px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td></tr></table></div></div><div style="line-height:120%;text-align:justify;text-indent:36px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div><div style="line-height:120%;text-align:justify;text-indent:36px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">The following table presents the company’s total revenue disaggregated by end markets and by revenue type:</span></div><div style="line-height:120%;text-align:justify;text-indent:36px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div><div style="line-height:120%;text-align:center;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;margin-left:auto;margin-right:auto;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="5"/></tr><tr><td style="width:76%;"/><td style="width:1%;"/><td style="width:1%;"/><td style="width:21%;"/><td style="width:1%;"/></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" style="vertical-align:middle;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:8pt;"><span style="font-family:inherit;font-size:8pt;font-weight:bold;">Year Ended October 31, 2019</span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="4" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:8pt;"><span style="font-family:inherit;font-size:8pt;font-weight:bold;">(in millions)</span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;font-weight:bold;text-decoration:underline;">Revenue by End Markets</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Pharmaceutical and Biopharmaceutical</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>1,604</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Chemical and Energy</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>1,199</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Diagnostics and Clinical</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>785</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Food</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>486</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Academia and Government</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>474</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Environmental and Forensics</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>615</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:20px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Total</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>5,163</span></span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:16px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:16px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:16px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;font-weight:bold;text-decoration:underline;">Revenue by Type</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Instrumentation</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>2,150</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Non-instrumentation and other</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>3,013</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:20px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Total</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>5,163</span></span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr></table></div><span style="font-family:inherit;font-size:10pt;"><br/></span></div><div style="line-height:120%;text-align:justify;text-indent:36px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div><div style="line-height:120%;text-align:justify;text-indent:36px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Revenue by region is based on the ship to location of the customer. Revenue by end market is determined by the market indicator of the customer and by customer type. Instrumentation revenue includes sales from instruments, remarketed instruments and third-party products. Non-instrumentation and other revenue includes sales from contract and per incident services, our companion diagnostics and our nucleic acid solutions businesses as well as sales from spare parts, consumables, reagents, vacuum pumps, subscriptions, software licenses and associated services.</span></div><div style="line-height:120%;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div><div style="line-height:120%;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div><div style="line-height:120%;text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;font-style:italic;font-weight:bold;">Contract Balances</span></div><div style="line-height:120%;text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div><div style="line-height:120%;text-align:left;text-indent:12px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;font-style:italic;font-weight:bold;">Contract Assets</span><span style="font-family:inherit;font-size:10pt;font-weight:bold;"> </span></div><div style="line-height:120%;text-align:justify;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div><div style="line-height:120%;text-align:justify;text-indent:36px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Contract assets (unbilled accounts receivable) primarily relate to the company's right to consideration for work completed but not billed at the reporting date. The unbilled receivables are reclassified to trade receivables when billed to customers. Contract assets are generally classified as current assets and are included in "Accounts receivable, net" in the consolidated balance sheet. </span></div><div style="line-height:120%;text-align:justify;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div><div style="line-height:120%;text-align:justify;text-indent:36px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">The balance of contract assets as of </span><span style="font-family:inherit;font-size:10pt;">October 31, 2019</span><span style="font-family:inherit;font-size:10pt;"> and as of November 1, 2018, the date of adoption of ASC 606, were </span><span style="font-family:inherit;font-size:10pt;"><span>$110 million</span></span><span style="font-family:inherit;font-size:10pt;"> and </span><span style="font-family:inherit;font-size:10pt;"><span>$57 million</span></span><span style="font-family:inherit;font-size:10pt;">, respectively. The increase in unbilled receivables during the year ended </span><span style="font-family:inherit;font-size:10pt;">October 31, 2019</span><span style="font-family:inherit;font-size:10pt;"> is a result of recognition of revenue upon the transfer of the control to the customer. In some instances, transfer of control is prior to invoicing the customers and excluding amounts transferred to trade receivables during the period amounted to </span><span style="font-family:inherit;font-size:10pt;"><span>$53 million</span></span><span style="font-family:inherit;font-size:10pt;">.</span></div><div style="line-height:120%;text-align:justify;text-indent:48px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div><div style="line-height:120%;text-indent:12px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;font-style:italic;font-weight:bold;">Contract Liabilities</span></div><div style="line-height:120%;text-indent:36px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div><div style="line-height:120%;text-indent:36px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">The following table provides information about contract liabilities (deferred revenue) and the significant changes in the balances during the year ended </span><span style="font-family:inherit;font-size:10pt;">October 31, 2019</span><span style="font-family:inherit;font-size:10pt;">: </span></div><div style="line-height:120%;text-indent:36px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div><div style="line-height:120%;text-align:center;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;margin-left:auto;margin-right:auto;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="5"/></tr><tr><td style="width:79%;"/><td style="width:1%;"/><td style="width:1%;"/><td style="width:18%;"/><td style="width:1%;"/></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:8pt;"><span style="font-family:inherit;font-size:8pt;font-weight:bold;">Contract <br/>Liabilities</span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:8pt;"><span style="font-family:inherit;font-size:8pt;font-weight:bold;">(in millions)</span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:10px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:10px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:10px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Ending balance as of October 31, 2018</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>367</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Impact of adoption of new revenue recognition guidance</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>(11</span></span></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">)</span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Net revenue deferred in the period</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>303</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Revenue recognized that was included in the contract liability balance at the beginning of the period</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>(287</span></span></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">)</span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Change in deferrals from customer cash advances, net of revenue recognized</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>5</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Contract liabilities acquired in business combinations</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>9</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Currency translation and other adjustments</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>—</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Ending balance as of October 31, 2019</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>386</span></span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr></table></div><span style="font-family:inherit;font-size:10pt;"><br/></span></div><div style="line-height:120%;text-indent:36px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div><div style="line-height:120%;text-align:justify;text-indent:36px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Contract liabilities primarily relate to multiple element arrangements for which billing has occurred but transfer of control of all elements to the customer has either partially or not occurred at the balance sheet date. This includes cash received from customers for products and related installation and services in advance of the transfer of control. Contract liabilities are classified as either current in deferred revenue or long-term in other long-term liabilities in the consolidated balance sheet based on the timing of when we expect to complete our performance obligation.</span></div><div style="line-height:120%;text-align:justify;text-indent:36px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div><div style="line-height:120%;text-align:justify;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;font-style:italic;font-weight:bold;">Contract Costs</span></div><div style="line-height:120%;text-align:justify;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div><div style="line-height:120%;text-align:justify;text-indent:36px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Incremental costs of obtaining a contract with a customer are recognized as an asset if it expects the benefit of those costs to be longer than one year. We have determined that certain sales incentive programs meet the requirements to be capitalized. The change in total capitalized costs to obtain a contract was immaterial during the year ended </span><span style="font-family:inherit;font-size:10pt;">October 31, 2019</span><span style="font-family:inherit;font-size:10pt;"> and are included in other current and long-term assets on the consolidated balance sheet. We have applied the practical expedient to expense costs as incurred for costs to obtain a contract with a customer when the amortization period would have been one year or less. These costs include the company's internal sales force compensation program, as we have determined that annual compensation is commensurate with annual sales activities.</span></div><div style="line-height:120%;text-align:justify;text-indent:48px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div><div style="line-height:120%;text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;font-style:italic;font-weight:bold;">Transaction Price Allocated to the Remaining Performance Obligations </span></div><div style="line-height:120%;text-align:justify;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div><div style="line-height:120%;text-align:justify;text-indent:36px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">We have applied the practical expedient in ASC 606-10-50-14 and have not disclosed information about transaction price allocated to remaining performance obligations that have original expected durations of one year or less.</span></div><div style="line-height:120%;text-align:justify;text-indent:36px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div><span style="font-family:inherit;font-size:10pt;">The estimated revenue expected to be recognized for remaining performance obligations that have an original term of more than one year, as of </span><span style="font-family:inherit;font-size:10pt;">October 31, 2019</span><span style="font-family:inherit;font-size:10pt;">, was </span><span style="font-family:inherit;font-size:10pt;"><span>$207 million</span></span>, the majority of which is expected to be recognized over the next 12 months. Remaining performance obligations primarily include extended warranty, customer manufacturing contracts, and software maintenance contracts and revenue associated with lease arrangements. <div style="line-height:120%;text-align:justify;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div><div style="line-height:120%;text-align:justify;text-indent:36px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">The following table presents the company’s total revenue and segment revenue disaggregated by geographical region: </span></div><div style="line-height:120%;text-align:center;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;margin-left:auto;margin-right:auto;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="16"/></tr><tr><td style="width:44%;"/><td style="width:1%;"/><td style="width:11%;"/><td style="width:1%;"/><td style="width:1%;"/><td style="width:1%;"/><td style="width:11%;"/><td style="width:1%;"/><td style="width:1%;"/><td style="width:1%;"/><td style="width:11%;"/><td style="width:1%;"/><td style="width:1%;"/><td style="width:1%;"/><td style="width:12%;"/><td style="width:1%;"/></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="15" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:center;font-size:8pt;"><span style="font-family:inherit;font-size:8pt;font-weight:bold;">Year Ended October 31, 2019</span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" style="vertical-align:middle;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:8pt;"><span style="font-family:inherit;font-size:8pt;font-weight:bold;">Life Sciences and Applied Markets</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" style="vertical-align:middle;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:8pt;"><span style="font-family:inherit;font-size:8pt;font-weight:bold;">Diagnostics and Genomics</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" style="vertical-align:middle;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:8pt;"><span style="font-family:inherit;font-size:8pt;font-weight:bold;">Agilent CrossLab</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" style="vertical-align:middle;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:8pt;"><span style="font-family:inherit;font-size:8pt;font-weight:bold;">Total</span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="15" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:center;font-size:8pt;"><span style="font-family:inherit;font-size:8pt;font-weight:bold;">(in millions)</span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="font-size:10pt;"><span style="font-family:inherit;font-size:10pt;font-weight:bold;text-decoration:underline;">Revenue by Region</span></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Americas</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>692</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>505</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>664</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>1,861</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Europe</span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>551</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>368</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>522</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>1,441</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Asia Pacific</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>1,059</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>148</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>654</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>1,861</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:20px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Total</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>2,302</span></span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>1,021</span></span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>1,840</span></span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>5,163</span></span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:13px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:13px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:13px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:13px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:13px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:13px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:13px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:13px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td></tr></table></div></div><div style="line-height:120%;text-align:justify;text-indent:36px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div><div style="line-height:120%;text-align:justify;text-indent:36px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">The following table presents the company’s total revenue disaggregated by end markets and by revenue type:</span></div><div style="line-height:120%;text-align:justify;text-indent:36px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div><div style="line-height:120%;text-align:center;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;margin-left:auto;margin-right:auto;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="5"/></tr><tr><td style="width:76%;"/><td style="width:1%;"/><td style="width:1%;"/><td style="width:21%;"/><td style="width:1%;"/></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" style="vertical-align:middle;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:8pt;"><span style="font-family:inherit;font-size:8pt;font-weight:bold;">Year Ended October 31, 2019</span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="4" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:8pt;"><span style="font-family:inherit;font-size:8pt;font-weight:bold;">(in millions)</span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;font-weight:bold;text-decoration:underline;">Revenue by End Markets</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Pharmaceutical and Biopharmaceutical</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>1,604</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Chemical and Energy</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>1,199</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Diagnostics and Clinical</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>785</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Food</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>486</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Academia and Government</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>474</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Environmental and Forensics</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>615</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:20px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Total</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>5,163</span></span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:16px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:16px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:16px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;font-weight:bold;text-decoration:underline;">Revenue by Type</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Instrumentation</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>2,150</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Non-instrumentation and other</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>3,013</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:20px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Total</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>5,163</span></span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr></table></div><span style="font-family:inherit;font-size:10pt;"><br/></span></div> 692000000 505000000 664000000 1861000000 551000000 368000000 522000000 1441000000 1059000000 148000000 654000000 1861000000 2302000000 1021000000 1840000000 5163000000 1604000000 1199000000 785000000 486000000 474000000 615000000 5163000000 2150000000 3013000000 5163000000 110000000 57000000 53000000 <div style="line-height:120%;text-indent:36px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">The following table provides information about contract liabilities (deferred revenue) and the significant changes in the balances during the year ended </span><span style="font-family:inherit;font-size:10pt;">October 31, 2019</span><span style="font-family:inherit;font-size:10pt;">: </span></div><div style="line-height:120%;text-indent:36px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div><div style="line-height:120%;text-align:center;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;margin-left:auto;margin-right:auto;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="5"/></tr><tr><td style="width:79%;"/><td style="width:1%;"/><td style="width:1%;"/><td style="width:18%;"/><td style="width:1%;"/></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:8pt;"><span style="font-family:inherit;font-size:8pt;font-weight:bold;">Contract <br/>Liabilities</span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:8pt;"><span style="font-family:inherit;font-size:8pt;font-weight:bold;">(in millions)</span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:10px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:10px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:10px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Ending balance as of October 31, 2018</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>367</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Impact of adoption of new revenue recognition guidance</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>(11</span></span></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">)</span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Net revenue deferred in the period</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>303</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Revenue recognized that was included in the contract liability balance at the beginning of the period</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>(287</span></span></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">)</span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Change in deferrals from customer cash advances, net of revenue recognized</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>5</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Contract liabilities acquired in business combinations</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>9</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Currency translation and other adjustments</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>—</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Ending balance as of October 31, 2019</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>386</span></span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr></table></div><span style="font-family:inherit;font-size:10pt;"><br/></span></div> 367000000 -11000000 303000000 -287000000 5000000 9000000 0 386000000 207000000 SHARE-BASED COMPENSATION<div style="line-height:120%;text-align:justify;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div><div style="line-height:120%;text-align:justify;text-indent:30px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Agilent accounts for share-based awards in accordance with the provisions of the accounting guidance which requires the measurement and recognition of compensation expense for all share-based payment awards made to our employees and directors including employee stock option awards, restricted stock units, employee stock purchases made under our ESPP and performance share awards granted to selected members of our senior management under the LTPP based on estimated fair values. </span></div><div style="line-height:120%;text-align:justify;text-indent:30px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div><div style="line-height:120%;text-align:justify;text-indent:24px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;font-weight:bold;">Description of Share-Based Plans</span></div><div style="line-height:120%;text-align:justify;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div><div style="line-height:120%;text-align:justify;text-indent:36px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;font-style:italic;">Employee Stock Purchase Plan.</span><span style="font-family:inherit;font-size:10pt;">    Effective November 1, 2000, we adopted the ESPP. The ESPP allows eligible employees to contribute up to </span><span style="font-family:inherit;font-size:10pt;"><span>ten percent</span></span><span style="font-family:inherit;font-size:10pt;"> of their base compensation to purchase shares of our common stock at </span><span style="font-family:inherit;font-size:10pt;"><span>85</span></span><span style="font-family:inherit;font-size:10pt;"> percent of the closing market price at purchase date. Currently, there are </span><span style="font-family:inherit;font-size:10pt;color:#000000;text-decoration:none;"><span>75 million</span></span><span style="font-family:inherit;font-size:10pt;"> shares authorized for issuance in connection with the ESPP.</span></div><div style="line-height:120%;text-align:justify;text-indent:36px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div><div style="line-height:120%;text-align:justify;text-indent:36px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Under our ESPP, employees purchased </span><span style="font-family:inherit;font-size:10pt;color:#000000;text-decoration:none;"><span>603,488</span></span><span style="font-family:inherit;font-size:10pt;"> shares for </span><span style="font-family:inherit;font-size:10pt;color:#000000;text-decoration:none;"><span>$37 million</span></span><span style="font-family:inherit;font-size:10pt;"> in </span><span style="font-family:inherit;font-size:10pt;color:#000000;text-decoration:none;">2019</span><span style="font-family:inherit;font-size:10pt;">, </span><span style="font-family:inherit;font-size:10pt;color:#000000;text-decoration:none;"><span>558,116</span></span><span style="font-family:inherit;font-size:10pt;"> shares for </span><span style="font-family:inherit;font-size:10pt;color:#000000;text-decoration:none;"><span>$32 million</span></span><span style="font-family:inherit;font-size:10pt;"> in </span><span style="font-family:inherit;font-size:10pt;color:#000000;text-decoration:none;">2018</span><span style="font-family:inherit;font-size:10pt;"> and </span><span style="font-family:inherit;font-size:10pt;color:#000000;text-decoration:none;"><span>618,270</span></span><span style="font-family:inherit;font-size:10pt;"> shares for </span><span style="font-family:inherit;font-size:10pt;color:#000000;text-decoration:none;"><span>$26 million</span></span><span style="font-family:inherit;font-size:10pt;"> in </span><span style="font-family:inherit;font-size:10pt;color:#000000;text-decoration:none;">2017</span><span style="font-family:inherit;font-size:10pt;">. As of </span><span style="font-family:inherit;font-size:10pt;color:#000000;text-decoration:none;">October 31, 2019</span><span style="font-family:inherit;font-size:10pt;">, the number of shares of common stock authorized and available for issuance under our ESPP was </span><span style="font-family:inherit;font-size:10pt;color:#000000;text-decoration:none;"><span>26,055,571</span></span><span style="font-family:inherit;font-size:10pt;">. This excludes the number of shares of common stock to be issued to participants in consideration of the aggregate participant contributions totaling </span><span style="font-family:inherit;font-size:10pt;"><span>$20 million</span></span><span style="font-family:inherit;font-size:10pt;"> as of </span><span style="font-family:inherit;font-size:10pt;">October 31, 2019</span><span style="font-family:inherit;font-size:10pt;">.</span></div><div style="line-height:120%;text-align:justify;text-indent:36px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div><div style="line-height:120%;text-align:justify;text-indent:36px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;font-style:italic;">Incentive Compensation Plans.</span><span style="font-family:inherit;font-size:10pt;">    On November 15, 2017 and March 21, 2018, the Board of Directors and the stockholders, respectively, approved the Agilent Technologies, Inc. 2018 Stock Plan (the "2018 Plan") which amends, including renaming and extending the term of, the Agilent Technologies, Inc. 2009 Stock Plan (the "2009 Plan"). The 2009 plan replaced the Agilent Technologies, Inc. Amended and Restated 1999 Stock Plan and 1999 Non-Employee Director Stock Plan. The 2018 Plan provides for the grant of awards in the form of stock options, stock appreciation rights ("SARs"), restricted stock, restricted stock units ("RSUs"), performance shares and performance units with performance-based conditions on vesting or exercisability, and cash awards. The 2018 Plan has a term of </span><span style="font-family:inherit;font-size:10pt;"><span>ten years</span></span><span style="font-family:inherit;font-size:10pt;">. As of </span><span style="font-family:inherit;font-size:10pt;">October 31, 2019</span><span style="font-family:inherit;font-size:10pt;">, </span><span style="font-family:inherit;font-size:10pt;"><span>28,676,526</span></span><span style="font-family:inherit;font-size:10pt;"> shares were available for future awards under the 2018 Stock Plan.</span></div><div style="line-height:120%;text-align:justify;text-indent:36px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div><div style="line-height:120%;text-align:justify;text-indent:36px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Stock options under the 2018 Stock Plan may be either "incentive stock options", as defined in Section 422 of the Internal Revenue Code, or non-statutory. Options were granted prior to November 1, 2015 and generally vest at a rate of </span><span style="font-family:inherit;font-size:10pt;color:#000000;text-decoration:none;"><span>25 percent</span></span><span style="font-family:inherit;font-size:10pt;"> per year over a period of </span><span style="font-family:inherit;font-size:10pt;color:#000000;text-decoration:none;"><span>four years</span></span><span style="font-family:inherit;font-size:10pt;"> from the date of grant with a maximum contractual term of </span><span style="font-family:inherit;font-size:10pt;color:#000000;text-decoration:none;"><span>ten years</span></span><span style="font-family:inherit;font-size:10pt;">. The exercise price for stock options is generally not less than </span><span style="font-family:inherit;font-size:10pt;color:#000000;text-decoration:none;"><span>100 percent</span></span><span style="font-family:inherit;font-size:10pt;"> of the fair market value of our common stock on the date the stock award is granted. Agilent issues new shares of common stock when employee stock options are exercised. </span></div><div style="line-height:120%;text-align:justify;text-indent:36px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div><div style="line-height:120%;text-align:justify;text-indent:36px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Effective November 1, 2003, the Compensation Committee of the Board of Directors approved the LTPP, which is a performance stock award program administered under the 2018 Stock Plan, for the company's executive officers and other key employees. Participants in this program are entitled to receive unrestricted shares of the company's stock after the end of a three-year period, if specified performance targets are met. Certain LTPP awards are generally designed to meet the criteria of a performance award with the performance metrics and peer group comparison based on the Total Stockholders’ Return (“TSR”) set at the beginning of the performance period. Effective November 1, 2015, the Compensation Committee of the Board of Directors approved another type of performance stock award, for the company's executive officers and other key employees. Participants in this program are also entitled to receive unrestricted shares of the company's stock after the end of a three-year period, if specified performance targets over the three-year period are met. The performance target for grants made in 2016 were based on Operating Margin (“OM”) and the performance grants made in 2017, 2018 and 2019 were based on Earnings Per Share ("EPS"). In the case of LTPP-OM, the performance targets for all the three years of performance period were set at the time of grant. The performance targets for LTPP-EPS grants for year 2 and year 3 of the performance period are set in the first quarter of year 2 and year 3, respectively. All LTPP awards granted after November 1, 2015, are subject to a one-year post-vest holding period.</span></div><div style="line-height:120%;text-align:justify;text-indent:36px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div><div style="line-height:120%;text-align:justify;text-indent:36px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Based on the performance metrics the final LTPP award may vary from </span><span style="font-family:inherit;font-size:10pt;color:#000000;text-decoration:none;"><span>zero</span></span><span style="font-family:inherit;font-size:10pt;"> to </span><span style="font-family:inherit;font-size:10pt;color:#000000;text-decoration:none;"><span>200 percent</span></span><span style="font-family:inherit;font-size:10pt;"> of the target award. The maximum contractual term for awards under the LTPP program is </span><span style="font-family:inherit;font-size:10pt;color:#000000;text-decoration:none;"><span>three years</span></span><span style="font-family:inherit;font-size:10pt;"> and the maximum award value for awards granted in 2017 and 2016 cannot exceed 300 percent of the grant date target value. We consider the dilutive impact of these programs in our diluted net income per share calculation only to the extent that the performance conditions are expected to be met.</span></div><div style="line-height:120%;text-align:justify;text-indent:36px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div><div style="line-height:120%;text-align:justify;text-indent:36px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">We also issue restricted stock units under our share-based plans. The estimated fair value of the restricted stock unit awards granted under the Stock Plans is determined based on the market price of Agilent's common stock on the date of grant adjusted for expected dividend yield. Restricted stock units generally vest, with some exceptions, at a rate of </span><span style="font-family:inherit;font-size:10pt;color:#000000;text-decoration:none;"><span>25 percent</span></span><span style="font-family:inherit;font-size:10pt;"> per year over a period of </span><span style="font-family:inherit;font-size:10pt;"><span>four years</span></span><span style="font-family:inherit;font-size:10pt;"> from the date of grant. All restricted stock units granted to our executives after November 1, 2015, are subject to a one-year post-vest holding period.</span></div><div style="line-height:120%;text-align:justify;text-indent:24px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div><div style="line-height:120%;text-align:justify;text-indent:24px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;font-weight:bold;">Impact of Share-based Compensation Awards</span></div><div style="line-height:120%;text-align:justify;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div><div style="line-height:120%;text-align:justify;text-indent:30px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">We have recognized compensation expense based on the estimated grant date fair value method under the authoritative guidance. For all share-based awards we have recognized compensation expense using a straight-line amortization method. As the guidance requires that share-based compensation expense be based on awards that are ultimately expected to vest, estimated share-based compensation has been reduced for estimated forfeitures.</span></div><div style="line-height:120%;text-align:justify;text-indent:30px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div><div style="line-height:120%;text-align:justify;text-indent:36px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">The impact on our results for share-based compensation was as follows:</span></div><div style="line-height:120%;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div><div style="line-height:120%;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="12"/></tr><tr><td style="width:65%;"/><td style="width:1%;"/><td style="width:9%;"/><td style="width:1%;"/><td style="width:1%;"/><td style="width:1%;"/><td style="width:9%;"/><td style="width:1%;"/><td style="width:1%;"/><td style="width:1%;"/><td style="width:9%;"/><td style="width:1%;"/></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="11" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:center;font-size:8pt;"><span style="font-family:inherit;font-size:8pt;font-weight:bold;">Years Ended October 31,</span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:8pt;"><span style="font-family:inherit;font-size:8pt;font-weight:bold;">2019</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="text-align:center;font-size:8pt;"><span style="font-family:inherit;font-size:8pt;font-weight:bold;">2018</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="text-align:center;font-size:8pt;"><span style="font-family:inherit;font-size:8pt;font-weight:bold;">2017</span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="11" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:center;font-size:8pt;"><span style="font-family:inherit;font-size:8pt;font-weight:bold;">(in millions)</span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Cost of products and services</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>18</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>16</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>15</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Research and development</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>7</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>7</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>6</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Selling, general and administrative</span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>47</span></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>48</span></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>40</span></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Total share-based compensation expense</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>72</span></span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>71</span></span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>61</span></span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr></table></div><span style="font-family:inherit;font-size:10pt;"><br/></span></div><div style="line-height:120%;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div><div style="line-height:120%;text-align:justify;text-indent:36px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">At </span><span style="font-family:inherit;font-size:10pt;color:#000000;text-decoration:none;">October 31, 2019</span><span style="font-family:inherit;font-size:10pt;"> and </span><span style="font-family:inherit;font-size:10pt;">2018</span><span style="font-family:inherit;font-size:10pt;"> there was </span><span style="font-family:inherit;font-size:10pt;"><span>no</span></span><span style="font-family:inherit;font-size:10pt;"> share-based compensation capitalized within inventory. </span></div><div style="line-height:120%;text-align:justify;text-indent:36px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div><div style="line-height:120%;text-align:justify;text-indent:24px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;font-weight:bold;">Valuation Assumptions</span></div><div style="line-height:120%;text-align:justify;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div><div style="line-height:120%;text-align:justify;text-indent:36px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">For all periods presented, shares granted under the LTPP (TSR) were valued using a Monte Carlo simulation. The ESPP allows eligible employees to purchase shares of our common stock at </span><span style="font-family:inherit;font-size:10pt;color:#000000;text-decoration:none;"><span>85</span></span><span style="font-family:inherit;font-size:10pt;"> percent of the fair market value at the purchase date.</span></div><div style="line-height:120%;text-align:justify;text-indent:36px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div><div style="line-height:120%;text-align:justify;text-indent:36px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">The estimated fair value of restricted stock unit awards, LTPP (OM) and LTPP (EPS) was determined based on the market price of Agilent's common stock on the date of grant adjusted for expected dividend yield and as appropriate, a discount related to the one-year post vesting. The compensation cost for LTPP (OM) and LTPP (EPS) awards reflect the cost of awards that are probable to vest at the end of the performance period.</span></div><div style="line-height:120%;text-align:justify;text-indent:36px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div><div style="line-height:120%;text-align:justify;text-indent:36px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">The following assumptions were used to estimate the fair value of awards granted.</span></div><div style="line-height:120%;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div><div style="line-height:120%;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:99.21875%;border-collapse:collapse;text-align:left;"><tr><td colspan="6"/></tr><tr><td style="width:53%;"/><td style="width:15%;"/><td style="width:1%;"/><td style="width:15%;"/><td style="width:1%;"/><td style="width:15%;"/></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;font-weight:bold;"> </span></div></td><td colspan="5" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:8pt;"><span style="font-family:inherit;font-size:8pt;font-weight:bold;">Years Ended October 31,</span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:inherit;font-size:8pt;font-weight:bold;"> </span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:8pt;"><span style="font-family:inherit;font-size:8pt;font-weight:bold;">2019</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="text-align:center;font-size:8pt;"><span style="font-family:inherit;font-size:8pt;font-weight:bold;">2018</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="text-align:center;font-size:8pt;"><span style="font-family:inherit;font-size:8pt;font-weight:bold;">2017</span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;font-weight:bold;">LTPP:</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Volatility of Agilent shares</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>22%</span></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>21%</span></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>23%</span></span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Volatility of selected peer-company shares</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">15%-66%</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">14%-66%</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">15%-63%</span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Pair-wise correlation with selected peers</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>30%</span></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>32%</span></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>36%</span></span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:16px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:16px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:16px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:16px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:16px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:16px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Post-vest restriction discount for all executive awards</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>5.0%</span></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>4.8%</span></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>5.3%</span></span></div></td></tr></table></div><span style="font-family:inherit;font-size:10pt;"><br/></span></div><div style="line-height:120%;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div><div style="line-height:120%;text-align:justify;text-indent:36px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Shares granted under the LTPP (TSR) were valued using a Monte Carlo simulation model. The Monte Carlo simulation fair value model requires the use of highly subjective and complex assumptions, including the price volatility of the underlying stock. For LTPP (TSR) grants in 2017 and thereafter, we used our own historical stock price volatility.</span></div><div style="line-height:120%;text-align:justify;text-indent:36px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div><div style="line-height:120%;text-align:justify;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> All LTPP awards granted to our executives have a one-year post-vest holding restriction. The estimated discount associated with post-vest holding restrictions is calculated using the Finnerty model. The model calculates the potential lost value if the employee were able to sell the shares during the lack of marketability period, instead of being required to hold the shares. </span></div><div style="line-height:120%;text-align:justify;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div><div style="line-height:120%;text-align:justify;text-indent:36px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div><div style="line-height:120%;text-align:justify;text-indent:18px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;font-weight:bold;">Share-Based Payment Award Activity</span></div><div style="line-height:120%;text-align:justify;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div><div style="line-height:120%;text-align:justify;text-indent:24px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;font-style:italic;">Employee Stock Options</span></div><div style="line-height:120%;text-align:justify;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div><div style="line-height:120%;text-align:justify;text-indent:36px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">The following table summarizes employee stock option award activity of our employees and directors for </span><span style="font-family:inherit;font-size:10pt;">2019</span><span style="font-family:inherit;font-size:10pt;">. </span></div><div style="line-height:120%;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div><div style="line-height:120%;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="7"/></tr><tr><td style="width:73%;"/><td style="width:12%;"/><td style="width:1%;"/><td style="width:1%;"/><td style="width:1%;"/><td style="width:11%;"/><td style="width:1%;"/></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:8pt;"><span style="font-family:inherit;font-size:8pt;font-weight:bold;">Options</span></div><div style="text-align:center;font-size:8pt;"><span style="font-family:inherit;font-size:8pt;font-weight:bold;">Outstanding </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:8pt;"><span style="font-family:inherit;font-size:8pt;font-weight:bold;">Weighted</span></div><div style="text-align:center;font-size:8pt;"><span style="font-family:inherit;font-size:8pt;font-weight:bold;">Average</span></div><div style="text-align:center;font-size:8pt;"><span style="font-family:inherit;font-size:8pt;font-weight:bold;">Exercise Price</span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:inherit;font-size:8pt;font-weight:bold;"> </span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:8pt;"><span style="font-family:inherit;font-size:8pt;font-weight:bold;">(in thousands)</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:inherit;font-size:8pt;font-weight:bold;"> </span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Outstanding at October 31, 2018</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>1,997</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>35</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Exercised</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>(552</span></span></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">)</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>33</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Forfeited</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>—</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>—</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Outstanding at October 31, 2019</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>1,445</span></span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>36</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr></table></div></div><div style="line-height:120%;text-align:justify;text-indent:36px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div><div style="line-height:120%;text-align:justify;text-indent:36px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">The options outstanding and exercisable for equity share-based payment awards at </span><span style="font-family:inherit;font-size:10pt;">October 31, 2019</span><span style="font-family:inherit;font-size:10pt;"> were as follows:</span></div><div style="line-height:120%;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div><div style="line-height:120%;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="26"/></tr><tr><td style="width:15%;"/><td style="width:10%;"/><td style="width:1%;"/><td style="width:1%;"/><td style="width:9%;"/><td style="width:1%;"/><td style="width:1%;"/><td style="width:6%;"/><td style="width:1%;"/><td style="width:1%;"/><td style="width:1%;"/><td style="width:9%;"/><td style="width:1%;"/><td style="width:1%;"/><td style="width:10%;"/><td style="width:1%;"/><td style="width:1%;"/><td style="width:9%;"/><td style="width:1%;"/><td style="width:1%;"/><td style="width:6%;"/><td style="width:1%;"/><td style="width:1%;"/><td style="width:1%;"/><td style="width:9%;"/><td style="width:1%;"/></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:inherit;font-size:8pt;font-weight:bold;"> </span></div></td><td colspan="12" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:center;font-size:8pt;"><span style="font-family:inherit;font-size:8pt;font-weight:bold;">Options Outstanding</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="12" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:center;font-size:8pt;"><span style="font-family:inherit;font-size:8pt;font-weight:bold;">Options Exercisable</span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:8pt;"><span style="font-family:inherit;font-size:8pt;font-weight:bold;">Range of</span></div><div style="text-align:center;font-size:8pt;"><span style="font-family:inherit;font-size:8pt;font-weight:bold;">Exercise Prices</span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:8pt;"><span style="font-family:inherit;font-size:8pt;font-weight:bold;">Number</span></div><div style="text-align:center;font-size:8pt;"><span style="font-family:inherit;font-size:8pt;font-weight:bold;">Outstanding</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:8pt;"><span style="font-family:inherit;font-size:8pt;font-weight:bold;">Weighted</span></div><div style="text-align:center;font-size:8pt;"><span style="font-family:inherit;font-size:8pt;font-weight:bold;">Average</span></div><div style="text-align:center;font-size:8pt;"><span style="font-family:inherit;font-size:8pt;font-weight:bold;">Remaining</span></div><div style="text-align:center;font-size:8pt;"><span style="font-family:inherit;font-size:8pt;font-weight:bold;">Contractual</span></div><div style="text-align:center;font-size:8pt;"><span style="font-family:inherit;font-size:8pt;font-weight:bold;">Life</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:8pt;"><span style="font-family:inherit;font-size:8pt;font-weight:bold;">Weighted</span></div><div style="text-align:center;font-size:8pt;"><span style="font-family:inherit;font-size:8pt;font-weight:bold;">Average</span></div><div style="text-align:center;font-size:8pt;"><span style="font-family:inherit;font-size:8pt;font-weight:bold;">Exercise</span></div><div style="text-align:center;font-size:8pt;"><span style="font-family:inherit;font-size:8pt;font-weight:bold;">Price</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:8pt;"><span style="font-family:inherit;font-size:8pt;font-weight:bold;">Aggregate</span></div><div style="text-align:center;font-size:8pt;"><span style="font-family:inherit;font-size:8pt;font-weight:bold;">Intrinsic</span></div><div style="text-align:center;font-size:8pt;"><span style="font-family:inherit;font-size:8pt;font-weight:bold;">Value</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:8pt;"><span style="font-family:inherit;font-size:8pt;font-weight:bold;">Number</span></div><div style="text-align:center;font-size:8pt;"><span style="font-family:inherit;font-size:8pt;font-weight:bold;">Exercisable</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:8pt;"><span style="font-family:inherit;font-size:8pt;font-weight:bold;">Weighted</span></div><div style="text-align:center;font-size:8pt;"><span style="font-family:inherit;font-size:8pt;font-weight:bold;">Average</span></div><div style="text-align:center;font-size:8pt;"><span style="font-family:inherit;font-size:8pt;font-weight:bold;">Remaining</span></div><div style="text-align:center;font-size:8pt;"><span style="font-family:inherit;font-size:8pt;font-weight:bold;">Contractual</span></div><div style="text-align:center;font-size:8pt;"><span style="font-family:inherit;font-size:8pt;font-weight:bold;">Life</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:8pt;"><span style="font-family:inherit;font-size:8pt;font-weight:bold;">Weighted</span></div><div style="text-align:center;font-size:8pt;"><span style="font-family:inherit;font-size:8pt;font-weight:bold;">Average</span></div><div style="text-align:center;font-size:8pt;"><span style="font-family:inherit;font-size:8pt;font-weight:bold;">Exercise</span></div><div style="text-align:center;font-size:8pt;"><span style="font-family:inherit;font-size:8pt;font-weight:bold;">Price</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:8pt;"><span style="font-family:inherit;font-size:8pt;font-weight:bold;">Aggregate</span></div><div style="text-align:center;font-size:8pt;"><span style="font-family:inherit;font-size:8pt;font-weight:bold;">Intrinsic</span></div><div style="text-align:center;font-size:8pt;"><span style="font-family:inherit;font-size:8pt;font-weight:bold;">Value</span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:inherit;font-size:8pt;font-weight:bold;"> </span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:8pt;"><span style="font-family:inherit;font-size:8pt;font-weight:bold;">(in thousands)</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:8pt;"><span style="font-family:inherit;font-size:8pt;font-weight:bold;">(in years)</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:inherit;font-size:8pt;font-weight:bold;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:8pt;"><span style="font-family:inherit;font-size:8pt;font-weight:bold;">(in thousands)</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:8pt;"><span style="font-family:inherit;font-size:8pt;font-weight:bold;">(in thousands)</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:8pt;"><span style="font-family:inherit;font-size:8pt;font-weight:bold;">(in years)</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:inherit;font-size:8pt;font-weight:bold;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:8pt;"><span style="font-family:inherit;font-size:8pt;font-weight:bold;">(in thousands)</span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:inherit;font-size:8pt;">$25.01 - 30</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:inherit;font-size:8pt;"><span>483</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:inherit;font-size:8pt;">2.5</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;"><div style="text-align:left;font-size:8pt;"><span style="font-family:inherit;font-size:8pt;">$</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:inherit;font-size:8pt;"><span>26</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:inherit;font-size:8pt;"><span>23,769</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:inherit;font-size:8pt;"><span>483</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:inherit;font-size:8pt;">2.5</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;"><div style="text-align:left;font-size:8pt;"><span style="font-family:inherit;font-size:8pt;">$</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:inherit;font-size:8pt;"><span>26</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:inherit;font-size:8pt;"><span>23,769</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:inherit;font-size:8pt;">$30.01 - 40</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:inherit;font-size:8pt;"><span>296</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:inherit;font-size:8pt;">4.1</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:inherit;font-size:8pt;">$</span></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:inherit;font-size:8pt;"><span>39</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:inherit;font-size:8pt;"><span>10,845</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:inherit;font-size:8pt;"><span>296</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:inherit;font-size:8pt;">4.1</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:inherit;font-size:8pt;">$</span></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:inherit;font-size:8pt;"><span>39</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:inherit;font-size:8pt;"><span>10,845</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:inherit;font-size:8pt;">$40.01 - over</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:inherit;font-size:8pt;"><span>666</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:inherit;font-size:8pt;">5.0</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;"><div style="text-align:left;font-size:8pt;"><span style="font-family:inherit;font-size:8pt;">$</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:inherit;font-size:8pt;"><span>41</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:inherit;font-size:8pt;"><span>23,211</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:inherit;font-size:8pt;"><span>666</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:inherit;font-size:8pt;">5.0</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;"><div style="text-align:left;font-size:8pt;"><span style="font-family:inherit;font-size:8pt;">$</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:inherit;font-size:8pt;"><span>41</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:inherit;font-size:8pt;"><span>23,211</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:8pt;"><span style="font-family:inherit;font-size:8pt;"><span>1,445</span></span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:inherit;font-size:8pt;">4.0</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:inherit;font-size:8pt;">$</span></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:inherit;font-size:8pt;"><span>36</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:left;font-size:8pt;"><span style="font-family:inherit;font-size:8pt;">$</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:8pt;"><span style="font-family:inherit;font-size:8pt;"><span>57,825</span></span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:8pt;"><span style="font-family:inherit;font-size:8pt;"><span>1,445</span></span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:inherit;font-size:8pt;">4.0</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:inherit;font-size:8pt;">$</span></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:inherit;font-size:8pt;"><span>36</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:left;font-size:8pt;"><span style="font-family:inherit;font-size:8pt;">$</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:8pt;"><span style="font-family:inherit;font-size:8pt;"><span>57,825</span></span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr></table></div><span style="font-family:inherit;font-size:10pt;"><br/></span></div><div style="line-height:120%;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div><div style="line-height:120%;text-align:justify;text-indent:36px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">The aggregate intrinsic value in the table above represents the total pre-tax intrinsic value, based on the company's closing stock price of </span><span style="font-family:inherit;font-size:10pt;"><span>$75.75</span></span><span style="font-family:inherit;font-size:10pt;"> at </span><span style="font-family:inherit;font-size:10pt;">October 31, 2019</span><span style="font-family:inherit;font-size:10pt;">, which would have been received by award holders had all award holders exercised their awards that were in-the-money as of that date. The total number of in-the-money awards exercisable at </span><span style="font-family:inherit;font-size:10pt;color:#000000;text-decoration:none;">October 31, 2019</span><span style="font-family:inherit;font-size:10pt;"> was approximately </span><span style="font-family:inherit;font-size:10pt;color:#000000;text-decoration:none;"><span>1.4 million</span></span><span style="font-family:inherit;font-size:10pt;">.</span></div><div style="line-height:120%;text-align:justify;text-indent:36px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div><div style="line-height:120%;text-align:justify;text-indent:36px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">The following table summarizes the aggregate intrinsic value of options exercised in </span><span style="font-family:inherit;font-size:10pt;">2019</span><span style="font-family:inherit;font-size:10pt;">, </span><span style="font-family:inherit;font-size:10pt;">2018</span><span style="font-family:inherit;font-size:10pt;"> and </span><span style="font-family:inherit;font-size:10pt;">2017</span><span style="font-family:inherit;font-size:10pt;">:</span></div><div style="line-height:120%;text-indent:36px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div><div style="line-height:120%;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="8"/></tr><tr><td style="width:71%;"/><td style="width:1%;"/><td style="width:12%;"/><td style="width:1%;"/><td style="width:1%;"/><td style="width:1%;"/><td style="width:12%;"/><td style="width:1%;"/></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:8pt;"><span style="font-family:inherit;font-size:8pt;font-weight:bold;">Aggregate</span></div><div style="text-align:center;font-size:8pt;"><span style="font-family:inherit;font-size:8pt;font-weight:bold;">Intrinsic Value</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:8pt;"><span style="font-family:inherit;font-size:8pt;font-weight:bold;">Weighted</span></div><div style="text-align:center;font-size:8pt;"><span style="font-family:inherit;font-size:8pt;font-weight:bold;">Average</span></div><div style="text-align:center;font-size:8pt;"><span style="font-family:inherit;font-size:8pt;font-weight:bold;">Exercise</span></div><div style="text-align:center;font-size:8pt;"><span style="font-family:inherit;font-size:8pt;font-weight:bold;">Price</span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:inherit;font-size:8pt;font-weight:bold;"> </span></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:8pt;"><span style="font-family:inherit;font-size:8pt;font-weight:bold;">(in thousands)</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:inherit;font-size:8pt;font-weight:bold;"> </span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Options exercised in fiscal 2017</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>36,175</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>30</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Options exercised in fiscal 2018</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>28,417</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>32</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Options exercised in fiscal 2019</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>24,409</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>33</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr></table></div><span style="font-family:inherit;font-size:10pt;"><br/></span></div><div style="line-height:120%;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div><div style="line-height:120%;text-align:justify;text-indent:36px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">As of </span><span style="font-family:inherit;font-size:10pt;color:#000000;text-decoration:none;">October 31, 2019</span><span style="font-family:inherit;font-size:10pt;">, the unrecognized share-based compensation costs for outstanding stock option awards, net of expected forfeitures, was </span><span style="font-family:inherit;font-size:10pt;"><span>zero</span></span><span style="font-family:inherit;font-size:10pt;">. The amount of cash received from the exercise of share-based awards granted was </span><span style="font-family:inherit;font-size:10pt;"><span>$54 million</span></span><span style="font-family:inherit;font-size:10pt;"> in </span><span style="font-family:inherit;font-size:10pt;color:#000000;text-decoration:none;">2019</span><span style="font-family:inherit;font-size:10pt;">, </span><span style="font-family:inherit;font-size:10pt;color:#000000;text-decoration:none;"><span>$56 million</span></span><span style="font-family:inherit;font-size:10pt;"> in </span><span style="font-family:inherit;font-size:10pt;color:#000000;text-decoration:none;">2018</span><span style="font-family:inherit;font-size:10pt;"> and </span><span style="font-family:inherit;font-size:10pt;color:#000000;text-decoration:none;"><span>$66 million</span></span><span style="font-family:inherit;font-size:10pt;"> in </span><span style="font-family:inherit;font-size:10pt;color:#000000;text-decoration:none;">2017</span><span style="font-family:inherit;font-size:10pt;">. </span></div><div style="line-height:120%;text-align:justify;text-indent:32px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div><div style="line-height:120%;text-align:justify;text-indent:24px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;font-style:italic;">Non-Vested Awards</span></div><div style="line-height:120%;text-align:justify;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div><div style="line-height:120%;text-align:justify;text-indent:36px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">The following table summarizes non-vested award activity in </span><span style="font-family:inherit;font-size:10pt;color:#000000;text-decoration:none;">2019</span><span style="font-family:inherit;font-size:10pt;"> primarily for our LTPP and restricted stock unit awards. </span></div><div style="line-height:120%;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="7"/></tr><tr><td style="width:73%;"/><td style="width:12%;"/><td style="width:1%;"/><td style="width:1%;"/><td style="width:1%;"/><td style="width:11%;"/><td style="width:1%;"/></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-top:2px;padding-bottom:2px;"><div style="text-align:center;font-size:8pt;"><span style="font-family:inherit;font-size:8pt;font-weight:bold;">Shares</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:8pt;"><span style="font-family:inherit;font-size:8pt;font-weight:bold;">Weighted</span></div><div style="text-align:center;font-size:8pt;"><span style="font-family:inherit;font-size:8pt;font-weight:bold;">Average</span></div><div style="text-align:center;font-size:8pt;"><span style="font-family:inherit;font-size:8pt;font-weight:bold;">Grant Price</span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:inherit;font-size:8pt;font-weight:bold;"> </span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:8pt;"><span style="font-family:inherit;font-size:8pt;font-weight:bold;">(in thousands)</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:inherit;font-size:8pt;font-weight:bold;"> </span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Non-vested at October 31, 2018</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>3,181</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>57</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Granted</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>1,309</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>68</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Vested</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>(1,530</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">)</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>45</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Forfeited</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>(78</span></span></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">)</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>60</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Change in LTPP shares in the year due to exceeding performance targets</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>291</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>—</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Non-vested at October 31, 2019</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>3,173</span></span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>60</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr></table></div><span style="font-family:inherit;font-size:10pt;"><br/></span></div><div style="line-height:120%;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div><div style="line-height:120%;text-align:justify;text-indent:32px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">As of </span><span style="font-family:inherit;font-size:10pt;color:#000000;text-decoration:none;">October 31, 2019</span><span style="font-family:inherit;font-size:10pt;">, the unrecognized share-based compensation costs for non-vested restricted stock awards, net of expected forfeitures, was approximately </span><span style="font-family:inherit;font-size:10pt;color:#000000;text-decoration:none;"><span>$94 million</span></span><span style="font-family:inherit;font-size:10pt;"> which is expected to be amortized over a weighted average period of </span><span style="font-family:inherit;font-size:10pt;"><span>2.2</span></span><span style="font-family:inherit;font-size:10pt;"> years. The total fair value of restricted stock awards vested was </span><span style="font-family:inherit;font-size:10pt;color:#000000;text-decoration:none;"><span>$69 million</span></span><span style="font-family:inherit;font-size:10pt;"> for </span><span style="font-family:inherit;font-size:10pt;color:#000000;text-decoration:none;">2019</span><span style="font-family:inherit;font-size:10pt;">, </span><span style="font-family:inherit;font-size:10pt;color:#000000;text-decoration:none;"><span>$58 million</span></span><span style="font-family:inherit;font-size:10pt;"> for </span><span style="font-family:inherit;font-size:10pt;color:#000000;text-decoration:none;">2018</span><span style="font-family:inherit;font-size:10pt;"> and </span><span style="font-family:inherit;font-size:10pt;color:#000000;text-decoration:none;"><span>$42 million</span></span><span style="font-family:inherit;font-size:10pt;"> for </span><span style="font-family:inherit;font-size:10pt;color:#000000;text-decoration:none;">2017</span><span style="font-family:inherit;font-size:10pt;">.</span></div> 0.10 0.85 75000000 603488 37000000 558116 32000000 618270 26000000 26055571 20000000 ten years 28676526 0.25 P4Y P10Y 1 0 2 P3Y 0.25 P4Y <div style="line-height:120%;text-align:justify;text-indent:36px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">The impact on our results for share-based compensation was as follows:</span></div><div style="line-height:120%;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div><div style="line-height:120%;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="12"/></tr><tr><td style="width:65%;"/><td style="width:1%;"/><td style="width:9%;"/><td style="width:1%;"/><td style="width:1%;"/><td style="width:1%;"/><td style="width:9%;"/><td style="width:1%;"/><td style="width:1%;"/><td style="width:1%;"/><td style="width:9%;"/><td style="width:1%;"/></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="11" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:center;font-size:8pt;"><span style="font-family:inherit;font-size:8pt;font-weight:bold;">Years Ended October 31,</span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:8pt;"><span style="font-family:inherit;font-size:8pt;font-weight:bold;">2019</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="text-align:center;font-size:8pt;"><span style="font-family:inherit;font-size:8pt;font-weight:bold;">2018</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="text-align:center;font-size:8pt;"><span style="font-family:inherit;font-size:8pt;font-weight:bold;">2017</span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="11" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:center;font-size:8pt;"><span style="font-family:inherit;font-size:8pt;font-weight:bold;">(in millions)</span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Cost of products and services</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>18</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>16</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>15</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Research and development</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>7</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>7</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>6</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Selling, general and administrative</span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>47</span></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>48</span></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>40</span></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Total share-based compensation expense</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>72</span></span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>71</span></span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>61</span></span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr></table></div><span style="font-family:inherit;font-size:10pt;"><br/></span></div> 18000000 16000000 15000000 7000000 7000000 6000000 47000000 48000000 40000000 72000000 71000000 61000000 0 0.85 <div style="line-height:120%;text-align:justify;text-indent:36px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">The following assumptions were used to estimate the fair value of awards granted.</span></div><div style="line-height:120%;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div><div style="line-height:120%;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:99.21875%;border-collapse:collapse;text-align:left;"><tr><td colspan="6"/></tr><tr><td style="width:53%;"/><td style="width:15%;"/><td style="width:1%;"/><td style="width:15%;"/><td style="width:1%;"/><td style="width:15%;"/></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;font-weight:bold;"> </span></div></td><td colspan="5" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:8pt;"><span style="font-family:inherit;font-size:8pt;font-weight:bold;">Years Ended October 31,</span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:inherit;font-size:8pt;font-weight:bold;"> </span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:8pt;"><span style="font-family:inherit;font-size:8pt;font-weight:bold;">2019</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="text-align:center;font-size:8pt;"><span style="font-family:inherit;font-size:8pt;font-weight:bold;">2018</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="text-align:center;font-size:8pt;"><span style="font-family:inherit;font-size:8pt;font-weight:bold;">2017</span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;font-weight:bold;">LTPP:</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Volatility of Agilent shares</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>22%</span></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>21%</span></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>23%</span></span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Volatility of selected peer-company shares</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">15%-66%</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">14%-66%</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">15%-63%</span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Pair-wise correlation with selected peers</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>30%</span></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>32%</span></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>36%</span></span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:16px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:16px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:16px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:16px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:16px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:16px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Post-vest restriction discount for all executive awards</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>5.0%</span></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>4.8%</span></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>5.3%</span></span></div></td></tr></table></div><span style="font-family:inherit;font-size:10pt;"><br/></span></div> 0.22 0.21 0.23 0.30 0.32 0.36 0.050 0.048 0.053 <div style="line-height:120%;text-align:justify;text-indent:36px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">The following table summarizes employee stock option award activity of our employees and directors for </span><span style="font-family:inherit;font-size:10pt;">2019</span><span style="font-family:inherit;font-size:10pt;">. </span></div><div style="line-height:120%;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div><div style="line-height:120%;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="7"/></tr><tr><td style="width:73%;"/><td style="width:12%;"/><td style="width:1%;"/><td style="width:1%;"/><td style="width:1%;"/><td style="width:11%;"/><td style="width:1%;"/></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:8pt;"><span style="font-family:inherit;font-size:8pt;font-weight:bold;">Options</span></div><div style="text-align:center;font-size:8pt;"><span style="font-family:inherit;font-size:8pt;font-weight:bold;">Outstanding </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:8pt;"><span style="font-family:inherit;font-size:8pt;font-weight:bold;">Weighted</span></div><div style="text-align:center;font-size:8pt;"><span style="font-family:inherit;font-size:8pt;font-weight:bold;">Average</span></div><div style="text-align:center;font-size:8pt;"><span style="font-family:inherit;font-size:8pt;font-weight:bold;">Exercise Price</span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:inherit;font-size:8pt;font-weight:bold;"> </span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:8pt;"><span style="font-family:inherit;font-size:8pt;font-weight:bold;">(in thousands)</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:inherit;font-size:8pt;font-weight:bold;"> </span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Outstanding at October 31, 2018</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>1,997</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>35</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Exercised</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>(552</span></span></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">)</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>33</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Forfeited</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>—</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>—</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Outstanding at October 31, 2019</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>1,445</span></span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>36</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr></table></div></div><div style="line-height:120%;text-align:justify;text-indent:36px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div> 1997000 35 552000 33 0 0 1445000 36 <div style="line-height:120%;text-align:justify;text-indent:36px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">The options outstanding and exercisable for equity share-based payment awards at </span><span style="font-family:inherit;font-size:10pt;">October 31, 2019</span><span style="font-family:inherit;font-size:10pt;"> were as follows:</span></div><div style="line-height:120%;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div><div style="line-height:120%;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="26"/></tr><tr><td style="width:15%;"/><td style="width:10%;"/><td style="width:1%;"/><td style="width:1%;"/><td style="width:9%;"/><td style="width:1%;"/><td style="width:1%;"/><td style="width:6%;"/><td style="width:1%;"/><td style="width:1%;"/><td style="width:1%;"/><td style="width:9%;"/><td style="width:1%;"/><td style="width:1%;"/><td style="width:10%;"/><td style="width:1%;"/><td style="width:1%;"/><td style="width:9%;"/><td style="width:1%;"/><td style="width:1%;"/><td style="width:6%;"/><td style="width:1%;"/><td style="width:1%;"/><td style="width:1%;"/><td style="width:9%;"/><td style="width:1%;"/></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:inherit;font-size:8pt;font-weight:bold;"> </span></div></td><td colspan="12" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:center;font-size:8pt;"><span style="font-family:inherit;font-size:8pt;font-weight:bold;">Options Outstanding</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="12" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:center;font-size:8pt;"><span style="font-family:inherit;font-size:8pt;font-weight:bold;">Options Exercisable</span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:8pt;"><span style="font-family:inherit;font-size:8pt;font-weight:bold;">Range of</span></div><div style="text-align:center;font-size:8pt;"><span style="font-family:inherit;font-size:8pt;font-weight:bold;">Exercise Prices</span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:8pt;"><span style="font-family:inherit;font-size:8pt;font-weight:bold;">Number</span></div><div style="text-align:center;font-size:8pt;"><span style="font-family:inherit;font-size:8pt;font-weight:bold;">Outstanding</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:8pt;"><span style="font-family:inherit;font-size:8pt;font-weight:bold;">Weighted</span></div><div style="text-align:center;font-size:8pt;"><span style="font-family:inherit;font-size:8pt;font-weight:bold;">Average</span></div><div style="text-align:center;font-size:8pt;"><span style="font-family:inherit;font-size:8pt;font-weight:bold;">Remaining</span></div><div style="text-align:center;font-size:8pt;"><span style="font-family:inherit;font-size:8pt;font-weight:bold;">Contractual</span></div><div style="text-align:center;font-size:8pt;"><span style="font-family:inherit;font-size:8pt;font-weight:bold;">Life</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:8pt;"><span style="font-family:inherit;font-size:8pt;font-weight:bold;">Weighted</span></div><div style="text-align:center;font-size:8pt;"><span style="font-family:inherit;font-size:8pt;font-weight:bold;">Average</span></div><div style="text-align:center;font-size:8pt;"><span style="font-family:inherit;font-size:8pt;font-weight:bold;">Exercise</span></div><div style="text-align:center;font-size:8pt;"><span style="font-family:inherit;font-size:8pt;font-weight:bold;">Price</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:8pt;"><span style="font-family:inherit;font-size:8pt;font-weight:bold;">Aggregate</span></div><div style="text-align:center;font-size:8pt;"><span style="font-family:inherit;font-size:8pt;font-weight:bold;">Intrinsic</span></div><div style="text-align:center;font-size:8pt;"><span style="font-family:inherit;font-size:8pt;font-weight:bold;">Value</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:8pt;"><span style="font-family:inherit;font-size:8pt;font-weight:bold;">Number</span></div><div style="text-align:center;font-size:8pt;"><span style="font-family:inherit;font-size:8pt;font-weight:bold;">Exercisable</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:8pt;"><span style="font-family:inherit;font-size:8pt;font-weight:bold;">Weighted</span></div><div style="text-align:center;font-size:8pt;"><span style="font-family:inherit;font-size:8pt;font-weight:bold;">Average</span></div><div style="text-align:center;font-size:8pt;"><span style="font-family:inherit;font-size:8pt;font-weight:bold;">Remaining</span></div><div style="text-align:center;font-size:8pt;"><span style="font-family:inherit;font-size:8pt;font-weight:bold;">Contractual</span></div><div style="text-align:center;font-size:8pt;"><span style="font-family:inherit;font-size:8pt;font-weight:bold;">Life</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:8pt;"><span style="font-family:inherit;font-size:8pt;font-weight:bold;">Weighted</span></div><div style="text-align:center;font-size:8pt;"><span style="font-family:inherit;font-size:8pt;font-weight:bold;">Average</span></div><div style="text-align:center;font-size:8pt;"><span style="font-family:inherit;font-size:8pt;font-weight:bold;">Exercise</span></div><div style="text-align:center;font-size:8pt;"><span style="font-family:inherit;font-size:8pt;font-weight:bold;">Price</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:8pt;"><span style="font-family:inherit;font-size:8pt;font-weight:bold;">Aggregate</span></div><div style="text-align:center;font-size:8pt;"><span style="font-family:inherit;font-size:8pt;font-weight:bold;">Intrinsic</span></div><div style="text-align:center;font-size:8pt;"><span style="font-family:inherit;font-size:8pt;font-weight:bold;">Value</span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:inherit;font-size:8pt;font-weight:bold;"> </span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:8pt;"><span style="font-family:inherit;font-size:8pt;font-weight:bold;">(in thousands)</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:8pt;"><span style="font-family:inherit;font-size:8pt;font-weight:bold;">(in years)</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:inherit;font-size:8pt;font-weight:bold;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:8pt;"><span style="font-family:inherit;font-size:8pt;font-weight:bold;">(in thousands)</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:8pt;"><span style="font-family:inherit;font-size:8pt;font-weight:bold;">(in thousands)</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:8pt;"><span style="font-family:inherit;font-size:8pt;font-weight:bold;">(in years)</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:inherit;font-size:8pt;font-weight:bold;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:8pt;"><span style="font-family:inherit;font-size:8pt;font-weight:bold;">(in thousands)</span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:inherit;font-size:8pt;">$25.01 - 30</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:inherit;font-size:8pt;"><span>483</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:inherit;font-size:8pt;">2.5</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;"><div style="text-align:left;font-size:8pt;"><span style="font-family:inherit;font-size:8pt;">$</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:inherit;font-size:8pt;"><span>26</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:inherit;font-size:8pt;"><span>23,769</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:inherit;font-size:8pt;"><span>483</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:inherit;font-size:8pt;">2.5</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;"><div style="text-align:left;font-size:8pt;"><span style="font-family:inherit;font-size:8pt;">$</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:inherit;font-size:8pt;"><span>26</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:inherit;font-size:8pt;"><span>23,769</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:inherit;font-size:8pt;">$30.01 - 40</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:inherit;font-size:8pt;"><span>296</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:inherit;font-size:8pt;">4.1</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:inherit;font-size:8pt;">$</span></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:inherit;font-size:8pt;"><span>39</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:inherit;font-size:8pt;"><span>10,845</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:inherit;font-size:8pt;"><span>296</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:inherit;font-size:8pt;">4.1</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:inherit;font-size:8pt;">$</span></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:inherit;font-size:8pt;"><span>39</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:inherit;font-size:8pt;"><span>10,845</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:inherit;font-size:8pt;">$40.01 - over</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:inherit;font-size:8pt;"><span>666</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:inherit;font-size:8pt;">5.0</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;"><div style="text-align:left;font-size:8pt;"><span style="font-family:inherit;font-size:8pt;">$</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:inherit;font-size:8pt;"><span>41</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:inherit;font-size:8pt;"><span>23,211</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:inherit;font-size:8pt;"><span>666</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:inherit;font-size:8pt;">5.0</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;"><div style="text-align:left;font-size:8pt;"><span style="font-family:inherit;font-size:8pt;">$</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:inherit;font-size:8pt;"><span>41</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:inherit;font-size:8pt;"><span>23,211</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:8pt;"><span style="font-family:inherit;font-size:8pt;"><span>1,445</span></span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:inherit;font-size:8pt;">4.0</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:inherit;font-size:8pt;">$</span></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:inherit;font-size:8pt;"><span>36</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:left;font-size:8pt;"><span style="font-family:inherit;font-size:8pt;">$</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:8pt;"><span style="font-family:inherit;font-size:8pt;"><span>57,825</span></span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:8pt;"><span style="font-family:inherit;font-size:8pt;"><span>1,445</span></span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:inherit;font-size:8pt;">4.0</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:inherit;font-size:8pt;">$</span></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:inherit;font-size:8pt;"><span>36</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:left;font-size:8pt;"><span style="font-family:inherit;font-size:8pt;">$</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:8pt;"><span style="font-family:inherit;font-size:8pt;"><span>57,825</span></span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr></table></div><span style="font-family:inherit;font-size:10pt;"><br/></span></div> 483000 26 23769000 483000 26 23769000 296000 39 10845000 296000 39 10845000 666000 41 23211000 666000 41 23211000 1445000 36 57825000 1445000 36 57825000 75.75 1400000 <div style="line-height:120%;text-align:justify;text-indent:36px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">The following table summarizes the aggregate intrinsic value of options exercised in </span><span style="font-family:inherit;font-size:10pt;">2019</span><span style="font-family:inherit;font-size:10pt;">, </span><span style="font-family:inherit;font-size:10pt;">2018</span><span style="font-family:inherit;font-size:10pt;"> and </span><span style="font-family:inherit;font-size:10pt;">2017</span><span style="font-family:inherit;font-size:10pt;">:</span></div><div style="line-height:120%;text-indent:36px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div><div style="line-height:120%;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="8"/></tr><tr><td style="width:71%;"/><td style="width:1%;"/><td style="width:12%;"/><td style="width:1%;"/><td style="width:1%;"/><td style="width:1%;"/><td style="width:12%;"/><td style="width:1%;"/></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:8pt;"><span style="font-family:inherit;font-size:8pt;font-weight:bold;">Aggregate</span></div><div style="text-align:center;font-size:8pt;"><span style="font-family:inherit;font-size:8pt;font-weight:bold;">Intrinsic Value</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:8pt;"><span style="font-family:inherit;font-size:8pt;font-weight:bold;">Weighted</span></div><div style="text-align:center;font-size:8pt;"><span style="font-family:inherit;font-size:8pt;font-weight:bold;">Average</span></div><div style="text-align:center;font-size:8pt;"><span style="font-family:inherit;font-size:8pt;font-weight:bold;">Exercise</span></div><div style="text-align:center;font-size:8pt;"><span style="font-family:inherit;font-size:8pt;font-weight:bold;">Price</span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:inherit;font-size:8pt;font-weight:bold;"> </span></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:8pt;"><span style="font-family:inherit;font-size:8pt;font-weight:bold;">(in thousands)</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:inherit;font-size:8pt;font-weight:bold;"> </span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Options exercised in fiscal 2017</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>36,175</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>30</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Options exercised in fiscal 2018</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>28,417</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>32</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Options exercised in fiscal 2019</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>24,409</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>33</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr></table></div><span style="font-family:inherit;font-size:10pt;"><br/></span></div> 36175000 30 28417000 32 24409000 33 0 54000000 56000000 66000000 <div style="line-height:120%;text-align:justify;text-indent:36px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">The following table summarizes non-vested award activity in </span><span style="font-family:inherit;font-size:10pt;color:#000000;text-decoration:none;">2019</span><span style="font-family:inherit;font-size:10pt;"> primarily for our LTPP and restricted stock unit awards. </span></div><div style="line-height:120%;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="7"/></tr><tr><td style="width:73%;"/><td style="width:12%;"/><td style="width:1%;"/><td style="width:1%;"/><td style="width:1%;"/><td style="width:11%;"/><td style="width:1%;"/></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-top:2px;padding-bottom:2px;"><div style="text-align:center;font-size:8pt;"><span style="font-family:inherit;font-size:8pt;font-weight:bold;">Shares</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:8pt;"><span style="font-family:inherit;font-size:8pt;font-weight:bold;">Weighted</span></div><div style="text-align:center;font-size:8pt;"><span style="font-family:inherit;font-size:8pt;font-weight:bold;">Average</span></div><div style="text-align:center;font-size:8pt;"><span style="font-family:inherit;font-size:8pt;font-weight:bold;">Grant Price</span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:inherit;font-size:8pt;font-weight:bold;"> </span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:8pt;"><span style="font-family:inherit;font-size:8pt;font-weight:bold;">(in thousands)</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:inherit;font-size:8pt;font-weight:bold;"> </span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Non-vested at October 31, 2018</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>3,181</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>57</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Granted</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>1,309</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>68</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Vested</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>(1,530</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">)</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>45</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Forfeited</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>(78</span></span></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">)</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>60</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Change in LTPP shares in the year due to exceeding performance targets</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>291</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>—</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Non-vested at October 31, 2019</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>3,173</span></span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>60</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr></table></div><span style="font-family:inherit;font-size:10pt;"><br/></span></div> 3181000 57 1309000 68 1530000 45 78000 60 291000 0 3173000 60 94000000 2.2 69000000 58000000 42000000 INCOME TAXES <div style="line-height:120%;text-align:justify;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div><div style="line-height:120%;text-align:justify;text-indent:36px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">The domestic and foreign components of income before taxes are:</span></div><div style="line-height:120%;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div><div style="line-height:120%;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="12"/></tr><tr><td style="width:59%;"/><td style="width:1%;"/><td style="width:11%;"/><td style="width:1%;"/><td style="width:1%;"/><td style="width:1%;"/><td style="width:11%;"/><td style="width:1%;"/><td style="width:1%;"/><td style="width:1%;"/><td style="width:11%;"/><td style="width:1%;"/></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;font-weight:bold;"> </span></div></td><td colspan="11" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:center;font-size:8pt;"><span style="font-family:inherit;font-size:8pt;font-weight:bold;">Years Ended October 31,</span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:inherit;font-size:8pt;font-weight:bold;"> </span></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:8pt;"><span style="font-family:inherit;font-size:8pt;font-weight:bold;">2019</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:8pt;"><span style="font-family:inherit;font-size:8pt;font-weight:bold;">2018</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="text-align:center;font-size:8pt;"><span style="font-family:inherit;font-size:8pt;font-weight:bold;">2017</span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:inherit;font-size:8pt;font-weight:bold;"> </span></div></td><td colspan="11" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:center;font-size:8pt;"><span style="font-family:inherit;font-size:8pt;font-weight:bold;">(in millions)</span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">U.S. operations</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>189</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>169</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>116</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Non-U.S. operations</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>730</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>777</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>687</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Total income before taxes</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>919</span></span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>946</span></span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>803</span></span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr></table></div><span style="font-family:inherit;font-size:10pt;"><br/></span></div><div style="line-height:120%;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div><div style="line-height:120%;text-align:justify;text-indent:36px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">The provision for income taxes is comprised of:</span></div><div style="line-height:120%;text-align:justify;text-indent:36px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div><div style="line-height:120%;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="12"/></tr><tr><td style="width:59%;"/><td style="width:1%;"/><td style="width:11%;"/><td style="width:1%;"/><td style="width:1%;"/><td style="width:1%;"/><td style="width:11%;"/><td style="width:1%;"/><td style="width:1%;"/><td style="width:1%;"/><td style="width:11%;"/><td style="width:1%;"/></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;font-weight:bold;"> </span></div></td><td colspan="11" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:center;font-size:8pt;"><span style="font-family:inherit;font-size:8pt;font-weight:bold;">Years Ended October 31,</span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:inherit;font-size:8pt;font-weight:bold;"> </span></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:8pt;"><span style="font-family:inherit;font-size:8pt;font-weight:bold;">2019</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:8pt;"><span style="font-family:inherit;font-size:8pt;font-weight:bold;">2018</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="text-align:center;font-size:8pt;"><span style="font-family:inherit;font-size:8pt;font-weight:bold;">2017</span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:inherit;font-size:8pt;font-weight:bold;"> </span></div></td><td colspan="11" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:center;font-size:8pt;"><span style="font-family:inherit;font-size:8pt;font-weight:bold;">(in millions)</span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">U.S. federal taxes:</span></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Current</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>(191</span></span></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">)</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>520</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>15</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Deferred</span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>—</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>51</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>110</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Non-U.S. taxes:</span></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Current</span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>290</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>95</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>1</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Deferred</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>(267</span></span></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">)</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>(22</span></span></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">)</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>(7</span></span></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">)</span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">State taxes, net of federal benefit:</span></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Current</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>4</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>1</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>1</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Deferred</span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>12</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>(15</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">)</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>(1</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">)</span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Total provision (benefit)</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>(152</span></span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-right:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">)</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>630</span></span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>119</span></span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr></table></div><span style="font-family:inherit;font-size:10pt;"><br/></span></div><div style="line-height:120%;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div><div style="line-height:120%;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div><div style="line-height:120%;text-align:justify;text-indent:36px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">The differences between the U.S. federal statutory income tax rate and our effective tax rate are:</span></div><div style="line-height:120%;text-indent:36px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div><div style="line-height:120%;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:99.90069513406156%;border-collapse:collapse;text-align:left;"><tr><td colspan="12"/></tr><tr><td style="width:59%;"/><td style="width:1%;"/><td style="width:11%;"/><td style="width:1%;"/><td style="width:1%;"/><td style="width:1%;"/><td style="width:11%;"/><td style="width:1%;"/><td style="width:1%;"/><td style="width:1%;"/><td style="width:11%;"/><td style="width:1%;"/></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;font-weight:bold;"> </span></div></td><td colspan="11" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:center;font-size:8pt;"><span style="font-family:inherit;font-size:8pt;font-weight:bold;">Years Ended October 31,</span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:inherit;font-size:8pt;font-weight:bold;"> </span></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="text-align:center;font-size:8pt;"><span style="font-family:inherit;font-size:8pt;font-weight:bold;">2019</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="text-align:center;font-size:8pt;"><span style="font-family:inherit;font-size:8pt;font-weight:bold;">2018</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="text-align:center;font-size:8pt;"><span style="font-family:inherit;font-size:8pt;font-weight:bold;">2017</span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:inherit;font-size:8pt;font-weight:bold;"> </span></div></td><td colspan="11" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:center;font-size:8pt;"><span style="font-family:inherit;font-size:8pt;font-weight:bold;">(in millions)</span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Profit before tax times statutory rate</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>193</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>221</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>281</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Non-U.S. income taxed at different rates</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>(8</span></span></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">)</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>(93</span></span></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">)</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>(43</span></span></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">)</span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Change in unrecognized tax benefits</span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>(13</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">)</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>(17</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">)</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>(110</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">)</span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Impact of the Tax Act</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>—</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>552</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>—</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Extension of the tax incentive in Singapore</span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>(299</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">)</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>—</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>—</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Other, net</span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>(25</span></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">)</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>(33</span></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">)</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>(9</span></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">)</span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Provision (benefit) for income taxes</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>(152</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">)</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>630</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>119</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Effective tax rate</span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>(16.5</span></span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-right:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">)%</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>66.6</span></span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-right:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">%</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>14.8</span></span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-right:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">%</span></div></td></tr></table></div><span style="font-family:inherit;font-size:10pt;"><br/></span></div><div style="line-height:120%;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div><div style="line-height:120%;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div><div style="line-height:120%;text-align:justify;text-indent:36px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">For 2019, the company's income tax benefit was </span><span style="font-family:inherit;font-size:10pt;"><span>$152 million</span></span><span style="font-family:inherit;font-size:10pt;"> with an effective tax rate of </span><span style="font-family:inherit;font-size:10pt;"><span>(16.5) percent</span></span><span style="font-family:inherit;font-size:10pt;">. For the year ended October 31, 2019, our effective tax rate and the resulting provision for income taxes were significantly impacted by the discrete benefit of </span><span style="font-family:inherit;font-size:10pt;"><span>$299 million</span></span><span style="font-family:inherit;font-size:10pt;"> related to the extension of the company’s tax incentive in Singapore.</span></div><div style="line-height:120%;text-align:justify;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div><div style="line-height:120%;text-align:justify;text-indent:36px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">As part of the business integration of some of our prior acquisitions, we undertook corporate restructurings in the fourth quarter of fiscal year 2019 that involved on-shoring certain intangible properties held by our foreign subsidiaries to the United States.  These restructurings resulted in a cash tax liability of </span><span style="font-family:inherit;font-size:10pt;"><span>$231 million</span></span><span style="font-family:inherit;font-size:10pt;">.  These taxes generate tax attributes that will offset our transition tax liability which is included in other long-term liabilities in our consolidated balance sheet. </span><span style="font-family:inherit;font-size:10pt;color:#4472c4;"> </span></div><div style="line-height:120%;text-align:justify;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div><div style="line-height:120%;text-align:justify;text-indent:36px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">For 2018, the company's income tax expense was </span><span style="font-family:inherit;font-size:10pt;"><span>$630 million</span></span><span style="font-family:inherit;font-size:10pt;"> with an effective tax rate of </span><span style="font-family:inherit;font-size:10pt;"><span>66.6 percent</span></span><span style="font-family:inherit;font-size:10pt;">. For the year ended October 31, 2018, our effective tax rate and the resulting provision for income taxes were significantly impacted by the discrete charge of </span><span style="font-family:inherit;font-size:10pt;"><span>$552 million</span></span><span style="font-family:inherit;font-size:10pt;"> related to the enactment of the U.S. Tax Cuts and Jobs Act (the “Tax Act”) as discussed below.</span></div><div style="line-height:120%;text-align:justify;text-indent:36px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div><div style="line-height:120%;text-align:justify;text-indent:36px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">For 2017, the company’s income tax expense was </span><span style="font-family:inherit;font-size:10pt;"><span>$119 million</span></span><span style="font-family:inherit;font-size:10pt;"> with an effective tax rate of </span><span style="font-family:inherit;font-size:10pt;"><span>14.8 percent</span></span><span style="font-family:inherit;font-size:10pt;">. Our effective tax rate is impacted by earnings realized in foreign jurisdictions with statutory tax rates lower than the federal statutory tax rate. During the year, the company determined a portion of current year foreign earnings from its low tax jurisdictions would not be considered as indefinitely reinvested. As such, a deferred tax liability for that portion of unremitted foreign earnings was accrued causing an increase in the annual tax expense. Our annual effective tax rate also included tax benefits due to the settlement of an audit in Germany for the years 2005 through 2008 and the lapse of U.S. statute of limitation for the fiscal years 2012 and 2013. This benefit was offset by a deferred tax liability required for the tax expected upon repatriation of related unremitted foreign earnings that were not asserted as indefinitely invested outside the U.S.</span></div><div style="line-height:120%;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div><div style="line-height:120%;text-align:justify;text-indent:36px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">The company has negotiated tax holidays in several different jurisdictions, most significantly in Singapore. The tax holidays provide lower rates of taxation on certain classes of income and require various thresholds of investments and employment or specific types of income in those jurisdictions. In December 2018, the tax holiday in Singapore was renegotiated and extended through 2027. Other tax holidays are due for renewal in 2020. As a result of the incentives, the impact of the tax holidays decreased income taxes by </span><span style="font-family:inherit;font-size:10pt;"><span>$368 million</span></span><span style="font-family:inherit;font-size:10pt;">, </span><span style="font-family:inherit;font-size:10pt;"><span>$87 million</span></span><span style="font-family:inherit;font-size:10pt;">, and </span><span style="font-family:inherit;font-size:10pt;"><span>$93 million</span></span><span style="font-family:inherit;font-size:10pt;"> in </span><span style="font-family:inherit;font-size:10pt;">2019</span><span style="font-family:inherit;font-size:10pt;">, </span><span style="font-family:inherit;font-size:10pt;">2018</span><span style="font-family:inherit;font-size:10pt;">, and </span><span style="font-family:inherit;font-size:10pt;">2017</span><span style="font-family:inherit;font-size:10pt;">, respectively. The benefit of the tax holidays on net income per share (diluted) was approximately </span><span style="font-family:inherit;font-size:10pt;"><span>$1.16</span></span><span style="font-family:inherit;font-size:10pt;">, </span><span style="font-family:inherit;font-size:10pt;"><span>$0.27</span></span><span style="font-family:inherit;font-size:10pt;">, and </span><span style="font-family:inherit;font-size:10pt;"><span>$0.29</span></span><span style="font-family:inherit;font-size:10pt;"> in </span><span style="font-family:inherit;font-size:10pt;">2019</span><span style="font-family:inherit;font-size:10pt;">, </span><span style="font-family:inherit;font-size:10pt;">2018</span><span style="font-family:inherit;font-size:10pt;"> and </span><span style="font-family:inherit;font-size:10pt;">2017</span><span style="font-family:inherit;font-size:10pt;">, respectively. The increase in the benefit from 2018 to 2019 is primarily due to the Singapore restructuring and tax incentive modifications completed in 2019 in response to Singapore tax law changes. Of the </span><span style="font-family:inherit;font-size:10pt;"><span>$1.16</span></span><span style="font-family:inherit;font-size:10pt;"> benefit of the tax incentives on net income per share (diluted) in 2019, </span><span style="font-family:inherit;font-size:10pt;"><span>$0.94</span></span><span style="font-family:inherit;font-size:10pt;"> of the benefit relates to one-time items from the Singapore restructuring.</span></div><div style="line-height:174%;text-align:justify;text-indent:36px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div><div style="line-height:120%;text-align:justify;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;font-style:italic;font-weight:bold;">2017 U.S. Tax Reform - Tax Cuts and Jobs Act</span></div><div style="line-height:120%;text-align:justify;text-indent:36px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div><div style="line-height:120%;text-align:justify;text-indent:36px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">On December 22, 2017, the Tax Act was enacted into law. The Tax Act enacted significant changes affecting our fiscal year 2018, including, but not limited to, (1) reducing the U.S. federal corporate tax rate and (2) imposing a one-time transition tax on certain unrepatriated earnings of foreign subsidiaries that had not been previously taxed in the U.S.</span></div><div style="line-height:120%;text-align:justify;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div><div style="line-height:120%;text-align:justify;text-indent:36px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">The Tax Act also established new tax provisions affecting our fiscal year 2019, including, but not limited to, (1) creating a new provision designed to tax global intangible low-tax income (“GILTI”); (2) generally eliminating U.S. federal taxes on </span></div><div style="line-height:120%;text-align:justify;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">dividends from foreign subsidiaries; (3) eliminating the corporate alternative minimum tax (“AMT”); (4) creating the base erosion anti-abuse tax (“BEAT”); (5) establishing a deduction for foreign derived intangible income ("FDII"); (6) repealing domestic production activity deduction; and (7) establishing new limitations on deductible interest expense and certain executive compensation.</span></div><div style="line-height:120%;text-align:justify;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div><div style="line-height:120%;text-align:justify;text-indent:36px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">ASC 740, Income Taxes, requires companies to recognize the effect of the tax law changes in the period of enactment. However, the SEC staff issued Staff Accounting Bulletin 118 ("SAB 118") which allowed companies to record provisional amounts during a measurement period not extending beyond one year from the Tax Act enactment date. For the year ended October 31, 2018, the company recognized income tax expense related to the Tax Act of </span><span style="font-family:inherit;font-size:10pt;"><span>$552 million</span></span><span style="font-family:inherit;font-size:10pt;"> which includes (1) an expense of </span><span style="font-family:inherit;font-size:10pt;"><span>$499 million</span></span><span style="font-family:inherit;font-size:10pt;"> of U.S. transition tax and correlative items on deemed repatriated earnings of non-U.S. subsidiaries and (2) an expense of </span><span style="font-family:inherit;font-size:10pt;"><span>$53 million</span></span><span style="font-family:inherit;font-size:10pt;"> associated with the impact on deferred taxes resulting from the decreased U.S. corporate tax rate as described below. </span></div><div style="line-height:120%;text-align:justify;text-indent:36px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div><div style="line-height:120%;text-align:justify;text-indent:36px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;font-style:italic;">Deemed Repatriation Transition Tax ("Transition Tax")</span><span style="font-family:inherit;font-size:10pt;">: The Transition Tax is based on the company’s total unrepatriated post-1986 earnings and profits ("E&amp;P") of its foreign subsidiaries and the amount of non-U.S. taxes paid (Tax Pools) on such earnings. Historically, the company permanently reinvested a significant portion of these post-1986 E&amp;P outside the U.S. For the remaining portion, the company previously accrued deferred taxes. Since the Tax Act required all foreign earnings to be taxed currently, the company recorded an income tax expense of </span><span style="font-family:inherit;font-size:10pt;"><span>$651 million</span></span><span style="font-family:inherit;font-size:10pt;"> for its one-time transition U.S. federal tax and a benefit of </span><span style="font-family:inherit;font-size:10pt;"><span>$152 million</span></span><span style="font-family:inherit;font-size:10pt;"> for the reversal of related deferred tax liabilities. The resulting </span><span style="font-family:inherit;font-size:10pt;"><span>$499 million</span></span><span style="font-family:inherit;font-size:10pt;"> net transition tax, reduced by existing tax credits, will be paid over 8 years in accordance with the election available under the Tax Act. We have completed our accounting for charges related to the Transition Tax.</span></div><div style="line-height:120%;text-align:justify;text-indent:36px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div><div style="line-height:120%;text-align:justify;text-indent:36px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;font-style:italic;">Reduction of U.S. Federal Corporate Tax Rate</span><span style="font-family:inherit;font-size:10pt;">: The reduction of the corporate income tax rate requires companies to remeasure their deferred tax assets and liabilities as of the date of enactment. The amount recorded for the year ended October31, 2018 for the remeasurement due to tax rate change is </span><span style="font-family:inherit;font-size:10pt;"><span>$53 million</span></span><span style="font-family:inherit;font-size:10pt;">. We have completed our accounting for the measurement of deferred taxes.</span></div><div style="line-height:120%;text-align:justify;text-indent:36px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div><div style="line-height:120%;text-align:justify;text-indent:36px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;font-style:italic;">GILTI: </span><span style="font-family:inherit;font-size:10pt;"> The Tax Act subjects a U.S. corporation to tax on its GILTI. U.S. GAAP allows companies to make an accounting policy election to either (1) treat taxes due on future GILTI inclusions in the U.S. taxable income as a current-period expense when incurred (“period cost method”) or (2) factoring such amounts into a company’s measurement of its deferred taxes (“deferred method”). We have completed our analysis and elected to treat GILTI as a “current period cost”.</span></div><div style="line-height:120%;text-align:justify;text-indent:48px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div><div style="line-height:120%;text-align:justify;text-indent:36px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;font-style:italic;">Indefinite Reinvestment Assertion:</span><span style="font-family:inherit;font-size:10pt;"> Prior to the enactment of the Tax Act, the company had indefinite investment assertion on a significant portion of its undistributed earnings from foreign subsidiaries. As a result of the enactment of the Tax Act, we have reevaluated our historic assertion and no longer consider these earnings to be indefinitely reinvested in our foreign subsidiaries. The company has recorded a deferred tax liability of </span><span style="font-family:inherit;font-size:10pt;"><span>$10 million</span></span><span style="font-family:inherit;font-size:10pt;"> for foreign withholding taxes on repatriation of remaining undistributed earnings.</span></div><div style="line-height:120%;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div><div style="line-height:120%;text-align:justify;text-indent:36px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div><div style="line-height:120%;text-align:justify;text-indent:36px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">The significant components of deferred tax assets and deferred tax liabilities included on the consolidated balance sheet are:</span></div><div style="line-height:120%;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div><div style="line-height:120%;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:99.90069513406156%;border-collapse:collapse;text-align:left;"><tr><td colspan="8"/></tr><tr><td style="width:71%;"/><td style="width:1%;"/><td style="width:12%;"/><td style="width:1%;"/><td style="width:1%;"/><td style="width:1%;"/><td style="width:12%;"/><td style="width:1%;"/></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;font-weight:bold;"> </span></div></td><td colspan="7" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:center;font-size:8pt;"><span style="font-family:inherit;font-size:8pt;font-weight:bold;">Years Ended October 31,</span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:inherit;font-size:8pt;font-weight:bold;"> </span></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:8pt;"><span style="font-family:inherit;font-size:8pt;font-weight:bold;">2019</span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:8pt;"><span style="font-family:inherit;font-size:8pt;font-weight:bold;">2018</span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:inherit;font-size:8pt;font-weight:bold;"> </span></div></td><td colspan="7" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:center;font-size:8pt;"><span style="font-family:inherit;font-size:8pt;font-weight:bold;">(in millions)</span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;font-weight:bold;">Deferred Tax Assets</span></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Intangibles</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>131</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>—</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Property, plant and equipment</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>—</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>8</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Pension benefits and retiree medical benefits</span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>71</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>49</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Employee benefits, other than retirement</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>34</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>34</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Net operating loss, capital loss, and credit carryforwards</span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>195</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>185</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Share-based compensation</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>32</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>31</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Deferred revenue</span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>38</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>38</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Other</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>35</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>19</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:20px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Deferred tax assets</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>536</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>364</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Tax valuation allowance</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>(134</span></span></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">)</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>(135</span></span></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">)</span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:20px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Deferred tax assets, net of valuation allowance</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>402</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>229</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:8px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:8px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:8px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:8px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;font-weight:bold;">Deferred Tax Liabilities</span></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Intangibles</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>—</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>(112</span></span></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">)</span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Property, plant and equipment</span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>(16</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">)</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>—</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Other</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>(7</span></span></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">)</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>(21</span></span></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">)</span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:20px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Deferred tax liabilities</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>(23</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">)</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>(133</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">)</span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:28px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Net deferred tax assets (liabilities)</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>379</span></span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>96</span></span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr></table></div><span style="font-family:inherit;font-size:10pt;"><br/></span></div><div style="line-height:120%;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div><div style="line-height:120%;text-align:justify;text-indent:36px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">The increase in 2019 as compared to 2018 for the deferred tax asset and liabilities was primarily due to the benefit of </span><span style="font-family:inherit;font-size:10pt;"><span>$299 million</span></span><span style="font-family:inherit;font-size:10pt;"> related to the extension of the company’s tax incentive in Singapore.</span></div><div style="line-height:120%;text-align:justify;font-size:9pt;"><span style="font-family:inherit;font-size:9pt;"><br/></span></div><div style="line-height:120%;text-align:justify;text-indent:36px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Valuation allowances require an assessment of both positive and negative evidence when determining whether it is more likely than not that deferred tax assets are recoverable. Such assessment is required on a jurisdiction by jurisdiction basis. As of </span><span style="font-family:inherit;font-size:10pt;">October 31, 2019</span><span style="font-family:inherit;font-size:10pt;">, we continued to maintain a valuation allowance of </span><span style="font-family:inherit;font-size:10pt;"><span>$134 million</span></span><span style="font-family:inherit;font-size:10pt;"> until sufficient positive evidence exists to support reversal. The valuation allowance is primarily related to deferred tax assets for the states of California and Colorado, along with the net operating losses in the Netherlands and capital losses in the U.S. and Australia.</span></div><div style="line-height:120%;text-align:justify;font-size:9pt;"><span style="font-family:inherit;font-size:9pt;"><br/></span></div><div style="line-height:120%;text-align:justify;text-indent:36px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">At </span><span style="font-family:inherit;font-size:10pt;">October 31, 2019</span><span style="font-family:inherit;font-size:10pt;">, we had federal, state and foreign net operating loss carryforwards of approximately </span><span style="font-family:inherit;font-size:10pt;"><span>$48 million</span></span><span style="font-family:inherit;font-size:10pt;">, </span><span style="font-family:inherit;font-size:10pt;"><span>$571 million</span></span><span style="font-family:inherit;font-size:10pt;"> and </span><span style="font-family:inherit;font-size:10pt;"><span>$577 million</span></span><span style="font-family:inherit;font-size:10pt;">, respectively. The federal and state net operating loss carryforwards are subject to various limitations under Section 382 of the Internal Revenue Code and applicable state tax laws. If not utilized, the federal and state net operating loss carryforwards will begin to expire in 2020. If not utilized, </span><span style="font-family:inherit;font-size:10pt;"><span>$155 million</span></span><span style="font-family:inherit;font-size:10pt;"> of the foreign net operating loss carryforwards will begin to expire in 2020. The remaining </span><span style="font-family:inherit;font-size:10pt;"><span>$422 million</span></span><span style="font-family:inherit;font-size:10pt;"> of the foreign net operating losses carry forward indefinitely. At </span><span style="font-family:inherit;font-size:10pt;">October 31, 2019</span><span style="font-family:inherit;font-size:10pt;">, we had federal and foreign capital loss carryforwards of </span><span style="font-family:inherit;font-size:10pt;"><span>$48 million</span></span><span style="font-family:inherit;font-size:10pt;"> and </span><span style="font-family:inherit;font-size:10pt;"><span>$116 million</span></span><span style="font-family:inherit;font-size:10pt;">, respectively. If not utilized, the federal capital loss carryforwards will expire in 2022. The foreign capital losses carry forward indefinitely. At </span><span style="font-family:inherit;font-size:10pt;">October 31, 2019</span><span style="font-family:inherit;font-size:10pt;">, we had state tax credit carryforwards of approximately </span><span style="font-family:inherit;font-size:10pt;"><span>$78 million</span></span><span style="font-family:inherit;font-size:10pt;">. The state tax credits carry forward indefinitely. </span></div><div style="line-height:120%;text-align:justify;font-size:9pt;"><span style="font-family:inherit;font-size:9pt;"><br/></span></div><div style="line-height:120%;text-align:justify;text-indent:36px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">The breakdown between long-term deferred tax assets and deferred tax liabilities was as follows:</span></div><div style="line-height:120%;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div><div style="line-height:120%;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="8"/></tr><tr><td style="width:73%;"/><td style="width:1%;"/><td style="width:11%;"/><td style="width:1%;"/><td style="width:1%;"/><td style="width:1%;"/><td style="width:11%;"/><td style="width:1%;"/></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;font-weight:bold;"> </span></div></td><td colspan="7" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:center;font-size:8pt;"><span style="font-family:inherit;font-size:8pt;font-weight:bold;">October 31,</span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:inherit;font-size:8pt;font-weight:bold;"> </span></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:8pt;"><span style="font-family:inherit;font-size:8pt;font-weight:bold;">2019</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:8pt;"><span style="font-family:inherit;font-size:8pt;font-weight:bold;">2018</span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:inherit;font-size:8pt;font-weight:bold;"> </span></div></td><td colspan="7" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:center;font-size:8pt;"><span style="font-family:inherit;font-size:8pt;font-weight:bold;">(in millions)</span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Long-term deferred tax assets (included within other assets)</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>410</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>165</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Long-term deferred tax liabilities (included within other long-term liabilities)</span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>(31</span></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">)</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>(69</span></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">)</span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Total</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>379</span></span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>96</span></span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr></table></div><span style="font-family:inherit;font-size:10pt;"><br/></span></div><div style="line-height:120%;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div><div style="line-height:120%;text-align:justify;text-indent:36px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div><div style="line-height:120%;text-align:justify;text-indent:36px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">The breakdown between current and long-term income tax assets and liabilities, excluding deferred tax assets and liabilities, was as follows:</span></div><div style="line-height:120%;text-align:center;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;margin-left:auto;margin-right:auto;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="8"/></tr><tr><td style="width:77%;"/><td style="width:1%;"/><td style="width:9%;"/><td style="width:1%;"/><td style="width:1%;"/><td style="width:1%;"/><td style="width:9%;"/><td style="width:1%;"/></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="7" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:center;font-size:8pt;"><span style="font-family:inherit;font-size:8pt;font-weight:bold;">October 31,</span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:8pt;"><span style="font-family:inherit;font-size:8pt;font-weight:bold;">2019</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:8pt;"><span style="font-family:inherit;font-size:8pt;font-weight:bold;">2018</span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="7" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:center;font-size:8pt;"><span style="font-family:inherit;font-size:8pt;font-weight:bold;">(in millions)</span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Current income tax assets (included within other current assets)</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>68</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>59</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Long-term income tax assets (included within other assets)</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>4</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>19</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Current income tax liabilities (included within other accrued liabilities)</span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>(292</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">)</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>(71</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">)</span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Long-term income tax liabilities (included within other long-term liabilities)</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>(328</span></span></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">)</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>(607</span></span></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">)</span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Total</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>(548</span></span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">)</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>(600</span></span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">)</span></div></td></tr></table></div><span style="font-family:inherit;font-size:10pt;"><br/></span></div><div style="line-height:120%;text-align:justify;text-indent:36px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div><div style="line-height:120%;text-align:justify;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;font-style:italic;font-weight:bold;">Uncertain Tax Positions</span></div><div style="line-height:120%;text-align:justify;text-indent:36px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div><div style="line-height:120%;text-align:justify;text-indent:36px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">The aggregate changes in the balances of our gross unrecognized tax benefits including all federal, state and foreign tax jurisdictions are as follows:</span></div><div style="line-height:120%;text-indent:36px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div><div style="line-height:120%;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="12"/></tr><tr><td style="width:68%;"/><td style="width:1%;"/><td style="width:8%;"/><td style="width:1%;"/><td style="width:1%;"/><td style="width:1%;"/><td style="width:8%;"/><td style="width:1%;"/><td style="width:1%;"/><td style="width:1%;"/><td style="width:8%;"/><td style="width:1%;"/></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-top:2px;padding-bottom:2px;"><div style="text-align:center;font-size:8pt;"><span style="font-family:inherit;font-size:8pt;font-weight:bold;">2019</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-top:2px;padding-bottom:2px;"><div style="text-align:center;font-size:8pt;"><span style="font-family:inherit;font-size:8pt;font-weight:bold;">2018</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:8pt;"><span style="font-family:inherit;font-size:8pt;font-weight:bold;">2017</span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:inherit;font-size:8pt;font-weight:bold;"> </span></div></td><td colspan="11" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:center;font-size:8pt;"><span style="font-family:inherit;font-size:8pt;font-weight:bold;">(in millions)</span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Balance, beginning of year</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>214</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>224</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>293</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Additions for tax positions related to the current year</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>7</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>27</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>32</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Additions for tax positions from prior years</span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>12</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>2</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>1</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Reductions for tax positions from prior years</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>(2</span></span></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">)</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>(13</span></span></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">)</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>(3</span></span></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">)</span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Settlements with taxing authorities</span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>—</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>—</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>(52</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">)</span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Statute of limitations expirations</span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>(25</span></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">)</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>(26</span></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">)</span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>(47</span></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">)</span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Balance, end of year</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>206</span></span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>214</span></span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>224</span></span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr></table></div><span style="font-family:inherit;font-size:10pt;"><br/></span></div><div style="line-height:120%;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div><div style="line-height:120%;text-align:justify;text-indent:36px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">As of </span><span style="font-family:inherit;font-size:10pt;">October 31, 2019</span><span style="font-family:inherit;font-size:10pt;">, we had </span><span style="font-family:inherit;font-size:10pt;"><span>$227 million</span></span><span style="font-family:inherit;font-size:10pt;"> of unrecognized tax benefits, including interest and penalties of which </span><span style="font-family:inherit;font-size:10pt;"><span>$204 million</span></span><span style="font-family:inherit;font-size:10pt;">, if recognized, would affect our effective tax rate. However, approximately </span><span style="font-family:inherit;font-size:10pt;"><span>$23 million</span></span><span style="font-family:inherit;font-size:10pt;"> of the unrecognized tax benefits were related to state income tax positions that, if recognized, would be in the form of a deferred tax asset that would likely not affect our effective tax rate due to a valuation allowance.</span></div><div style="line-height:120%;text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div><div style="line-height:120%;text-align:justify;text-indent:36px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">We recognized a tax expense of </span><span style="font-family:inherit;font-size:10pt;"><span>$9 million</span></span><span style="font-family:inherit;font-size:10pt;">, a tax expense of </span><span style="font-family:inherit;font-size:10pt;"><span>$11 million</span></span><span style="font-family:inherit;font-size:10pt;"> and a tax benefit of </span><span style="font-family:inherit;font-size:10pt;"><span>$9 million</span></span><span style="font-family:inherit;font-size:10pt;"> of interest and penalties related to unrecognized tax benefits in </span><span style="font-family:inherit;font-size:10pt;">2019</span><span style="font-family:inherit;font-size:10pt;">, </span><span style="font-family:inherit;font-size:10pt;">2018</span><span style="font-family:inherit;font-size:10pt;"> and </span><span style="font-family:inherit;font-size:10pt;">2017</span><span style="font-family:inherit;font-size:10pt;">, respectively. Interest and penalties accrued as of </span><span style="font-family:inherit;font-size:10pt;">October 31, 2019</span><span style="font-family:inherit;font-size:10pt;"> and </span><span style="font-family:inherit;font-size:10pt;">2018</span><span style="font-family:inherit;font-size:10pt;"> were </span><span style="font-family:inherit;font-size:10pt;"><span>$36 million</span></span><span style="font-family:inherit;font-size:10pt;"> and </span><span style="font-family:inherit;font-size:10pt;"><span>$27 million</span></span><span style="font-family:inherit;font-size:10pt;">, respectively.</span></div><div style="line-height:120%;text-align:justify;text-indent:32px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div><div style="line-height:120%;text-align:justify;text-indent:36px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">In the U.S., tax years remain open back to the year 2016 for federal income tax purposes and the year 2015 for significant states. In other major jurisdictions where the company conducts business, the tax years generally remain open back to the year 2009. </span></div><div style="line-height:120%;text-align:justify;text-indent:36px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div><div style="line-height:120%;text-align:justify;text-indent:36px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">With these jurisdictions and the U.S., it is reasonably possible that there could be significant changes to our unrecognized tax benefits in the next twelve months due to either the expiration of a statute of limitation or a tax audit settlement which will be partially offset by an anticipated tax liability related to unremitted foreign earnings, where applicable. Given the number of years and numerous matters that remain subject to examination in various tax jurisdictions, management is unable to estimate the range of possible changes to the balance of our unrecognized tax benefits.</span></div> <div style="line-height:120%;text-align:justify;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div><div style="line-height:120%;text-align:justify;text-indent:36px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">The domestic and foreign components of income before taxes are:</span></div><div style="line-height:120%;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div><div style="line-height:120%;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="12"/></tr><tr><td style="width:59%;"/><td style="width:1%;"/><td style="width:11%;"/><td style="width:1%;"/><td style="width:1%;"/><td style="width:1%;"/><td style="width:11%;"/><td style="width:1%;"/><td style="width:1%;"/><td style="width:1%;"/><td style="width:11%;"/><td style="width:1%;"/></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;font-weight:bold;"> </span></div></td><td colspan="11" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:center;font-size:8pt;"><span style="font-family:inherit;font-size:8pt;font-weight:bold;">Years Ended October 31,</span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:inherit;font-size:8pt;font-weight:bold;"> </span></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:8pt;"><span style="font-family:inherit;font-size:8pt;font-weight:bold;">2019</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:8pt;"><span style="font-family:inherit;font-size:8pt;font-weight:bold;">2018</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="text-align:center;font-size:8pt;"><span style="font-family:inherit;font-size:8pt;font-weight:bold;">2017</span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:inherit;font-size:8pt;font-weight:bold;"> </span></div></td><td colspan="11" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:center;font-size:8pt;"><span style="font-family:inherit;font-size:8pt;font-weight:bold;">(in millions)</span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">U.S. operations</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>189</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>169</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>116</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Non-U.S. operations</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>730</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>777</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>687</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Total income before taxes</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>919</span></span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>946</span></span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>803</span></span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr></table></div><span style="font-family:inherit;font-size:10pt;"><br/></span></div> 189000000 169000000 116000000 730000000 777000000 687000000 919000000 946000000 803000000 <div style="line-height:120%;text-align:justify;text-indent:36px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">The provision for income taxes is comprised of:</span></div><div style="line-height:120%;text-align:justify;text-indent:36px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div><div style="line-height:120%;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="12"/></tr><tr><td style="width:59%;"/><td style="width:1%;"/><td style="width:11%;"/><td style="width:1%;"/><td style="width:1%;"/><td style="width:1%;"/><td style="width:11%;"/><td style="width:1%;"/><td style="width:1%;"/><td style="width:1%;"/><td style="width:11%;"/><td style="width:1%;"/></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;font-weight:bold;"> </span></div></td><td colspan="11" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:center;font-size:8pt;"><span style="font-family:inherit;font-size:8pt;font-weight:bold;">Years Ended October 31,</span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:inherit;font-size:8pt;font-weight:bold;"> </span></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:8pt;"><span style="font-family:inherit;font-size:8pt;font-weight:bold;">2019</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:8pt;"><span style="font-family:inherit;font-size:8pt;font-weight:bold;">2018</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="text-align:center;font-size:8pt;"><span style="font-family:inherit;font-size:8pt;font-weight:bold;">2017</span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:inherit;font-size:8pt;font-weight:bold;"> </span></div></td><td colspan="11" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:center;font-size:8pt;"><span style="font-family:inherit;font-size:8pt;font-weight:bold;">(in millions)</span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">U.S. federal taxes:</span></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Current</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>(191</span></span></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">)</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>520</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>15</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Deferred</span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>—</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>51</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>110</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Non-U.S. taxes:</span></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Current</span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>290</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>95</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>1</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Deferred</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>(267</span></span></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">)</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>(22</span></span></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">)</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>(7</span></span></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">)</span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">State taxes, net of federal benefit:</span></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Current</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>4</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>1</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>1</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Deferred</span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>12</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>(15</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">)</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>(1</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">)</span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Total provision (benefit)</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>(152</span></span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-right:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">)</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>630</span></span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>119</span></span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr></table></div><span style="font-family:inherit;font-size:10pt;"><br/></span></div> -191000000 520000000 15000000 0 51000000 110000000 290000000 95000000 1000000 -267000000 -22000000 -7000000 4000000 1000000 1000000 12000000 -15000000 -1000000 -152000000 630000000 119000000 <div style="line-height:120%;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div><div style="line-height:120%;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div><div style="line-height:120%;text-align:justify;text-indent:36px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">The differences between the U.S. federal statutory income tax rate and our effective tax rate are:</span></div><div style="line-height:120%;text-indent:36px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div><div style="line-height:120%;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:99.90069513406156%;border-collapse:collapse;text-align:left;"><tr><td colspan="12"/></tr><tr><td style="width:59%;"/><td style="width:1%;"/><td style="width:11%;"/><td style="width:1%;"/><td style="width:1%;"/><td style="width:1%;"/><td style="width:11%;"/><td style="width:1%;"/><td style="width:1%;"/><td style="width:1%;"/><td style="width:11%;"/><td style="width:1%;"/></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;font-weight:bold;"> </span></div></td><td colspan="11" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:center;font-size:8pt;"><span style="font-family:inherit;font-size:8pt;font-weight:bold;">Years Ended October 31,</span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:inherit;font-size:8pt;font-weight:bold;"> </span></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="text-align:center;font-size:8pt;"><span style="font-family:inherit;font-size:8pt;font-weight:bold;">2019</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="text-align:center;font-size:8pt;"><span style="font-family:inherit;font-size:8pt;font-weight:bold;">2018</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="text-align:center;font-size:8pt;"><span style="font-family:inherit;font-size:8pt;font-weight:bold;">2017</span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:inherit;font-size:8pt;font-weight:bold;"> </span></div></td><td colspan="11" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:center;font-size:8pt;"><span style="font-family:inherit;font-size:8pt;font-weight:bold;">(in millions)</span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Profit before tax times statutory rate</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>193</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>221</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>281</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Non-U.S. income taxed at different rates</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>(8</span></span></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">)</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>(93</span></span></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">)</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>(43</span></span></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">)</span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Change in unrecognized tax benefits</span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>(13</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">)</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>(17</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">)</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>(110</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">)</span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Impact of the Tax Act</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>—</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>552</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>—</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Extension of the tax incentive in Singapore</span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>(299</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">)</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>—</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>—</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Other, net</span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>(25</span></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">)</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>(33</span></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">)</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>(9</span></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">)</span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Provision (benefit) for income taxes</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>(152</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">)</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>630</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>119</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Effective tax rate</span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>(16.5</span></span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-right:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">)%</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>66.6</span></span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-right:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">%</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>14.8</span></span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-right:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">%</span></div></td></tr></table></div><span style="font-family:inherit;font-size:10pt;"><br/></span></div> 193000000 221000000 281000000 -8000000 -93000000 -43000000 -13000000 -17000000 -110000000 0 552000000 0 -299000000 0 0 -25000000 -33000000 -9000000 -152000000 630000000 119000000 -0.165 0.666 0.148 -152000000 -0.165 -299000000 231000000 630000000 0.666 552000000 119000000 0.148 368000000 87000000 93000000 1.16 0.27 0.29 1.16 0.94 552000000 499000000 53000000 651000000 152000000 499000000 53000000 10000000 <div style="line-height:120%;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div><div style="line-height:120%;text-align:justify;text-indent:36px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div><div style="line-height:120%;text-align:justify;text-indent:36px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">The significant components of deferred tax assets and deferred tax liabilities included on the consolidated balance sheet are:</span></div><div style="line-height:120%;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div><div style="line-height:120%;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:99.90069513406156%;border-collapse:collapse;text-align:left;"><tr><td colspan="8"/></tr><tr><td style="width:71%;"/><td style="width:1%;"/><td style="width:12%;"/><td style="width:1%;"/><td style="width:1%;"/><td style="width:1%;"/><td style="width:12%;"/><td style="width:1%;"/></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;font-weight:bold;"> </span></div></td><td colspan="7" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:center;font-size:8pt;"><span style="font-family:inherit;font-size:8pt;font-weight:bold;">Years Ended October 31,</span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:inherit;font-size:8pt;font-weight:bold;"> </span></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:8pt;"><span style="font-family:inherit;font-size:8pt;font-weight:bold;">2019</span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:8pt;"><span style="font-family:inherit;font-size:8pt;font-weight:bold;">2018</span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:inherit;font-size:8pt;font-weight:bold;"> </span></div></td><td colspan="7" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:center;font-size:8pt;"><span style="font-family:inherit;font-size:8pt;font-weight:bold;">(in millions)</span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;font-weight:bold;">Deferred Tax Assets</span></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Intangibles</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>131</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>—</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Property, plant and equipment</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>—</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>8</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Pension benefits and retiree medical benefits</span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>71</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>49</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Employee benefits, other than retirement</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>34</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>34</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Net operating loss, capital loss, and credit carryforwards</span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>195</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>185</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Share-based compensation</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>32</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>31</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Deferred revenue</span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>38</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>38</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Other</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>35</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>19</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:20px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Deferred tax assets</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>536</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>364</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Tax valuation allowance</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>(134</span></span></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">)</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>(135</span></span></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">)</span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:20px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Deferred tax assets, net of valuation allowance</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>402</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>229</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:8px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:8px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:8px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:8px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;font-weight:bold;">Deferred Tax Liabilities</span></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Intangibles</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>—</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>(112</span></span></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">)</span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Property, plant and equipment</span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>(16</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">)</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>—</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Other</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>(7</span></span></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">)</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>(21</span></span></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">)</span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:20px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Deferred tax liabilities</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>(23</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">)</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>(133</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">)</span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:28px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Net deferred tax assets (liabilities)</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>379</span></span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>96</span></span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr></table></div><span style="font-family:inherit;font-size:10pt;"><br/></span></div> 131000000 0 0 8000000 71000000 49000000 34000000 34000000 195000000 185000000 32000000 31000000 38000000 38000000 35000000 19000000 536000000 364000000 134000000 135000000 402000000 229000000 0 112000000 16000000 0 7000000 21000000 23000000 133000000 379000000 96000000 -299000000 134000000 48000000 571000000 577000000 155000000 422000000 48000000 116000000 78000000 <div style="line-height:120%;text-align:justify;text-indent:36px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">The breakdown between long-term deferred tax assets and deferred tax liabilities was as follows:</span></div><div style="line-height:120%;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div><div style="line-height:120%;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="8"/></tr><tr><td style="width:73%;"/><td style="width:1%;"/><td style="width:11%;"/><td style="width:1%;"/><td style="width:1%;"/><td style="width:1%;"/><td style="width:11%;"/><td style="width:1%;"/></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;font-weight:bold;"> </span></div></td><td colspan="7" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:center;font-size:8pt;"><span style="font-family:inherit;font-size:8pt;font-weight:bold;">October 31,</span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:inherit;font-size:8pt;font-weight:bold;"> </span></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:8pt;"><span style="font-family:inherit;font-size:8pt;font-weight:bold;">2019</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:8pt;"><span style="font-family:inherit;font-size:8pt;font-weight:bold;">2018</span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:inherit;font-size:8pt;font-weight:bold;"> </span></div></td><td colspan="7" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:center;font-size:8pt;"><span style="font-family:inherit;font-size:8pt;font-weight:bold;">(in millions)</span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Long-term deferred tax assets (included within other assets)</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>410</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>165</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Long-term deferred tax liabilities (included within other long-term liabilities)</span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>(31</span></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">)</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>(69</span></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">)</span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Total</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>379</span></span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>96</span></span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr></table></div><span style="font-family:inherit;font-size:10pt;"><br/></span></div><div style="line-height:120%;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div> 410000000 165000000 31000000 69000000 379000000 96000000 <div style="line-height:120%;text-align:justify;text-indent:36px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div><div style="line-height:120%;text-align:justify;text-indent:36px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">The breakdown between current and long-term income tax assets and liabilities, excluding deferred tax assets and liabilities, was as follows:</span></div><div style="line-height:120%;text-align:center;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;margin-left:auto;margin-right:auto;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="8"/></tr><tr><td style="width:77%;"/><td style="width:1%;"/><td style="width:9%;"/><td style="width:1%;"/><td style="width:1%;"/><td style="width:1%;"/><td style="width:9%;"/><td style="width:1%;"/></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="7" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:center;font-size:8pt;"><span style="font-family:inherit;font-size:8pt;font-weight:bold;">October 31,</span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:8pt;"><span style="font-family:inherit;font-size:8pt;font-weight:bold;">2019</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:8pt;"><span style="font-family:inherit;font-size:8pt;font-weight:bold;">2018</span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="7" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:center;font-size:8pt;"><span style="font-family:inherit;font-size:8pt;font-weight:bold;">(in millions)</span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Current income tax assets (included within other current assets)</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>68</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>59</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Long-term income tax assets (included within other assets)</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>4</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>19</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Current income tax liabilities (included within other accrued liabilities)</span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>(292</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">)</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>(71</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">)</span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Long-term income tax liabilities (included within other long-term liabilities)</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>(328</span></span></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">)</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>(607</span></span></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">)</span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Total</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>(548</span></span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">)</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>(600</span></span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">)</span></div></td></tr></table></div><span style="font-family:inherit;font-size:10pt;"><br/></span></div> 68000000 59000000 4000000 19000000 292000000 71000000 328000000 607000000 548000000 600000000 <div style="line-height:120%;text-align:justify;text-indent:36px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">The aggregate changes in the balances of our gross unrecognized tax benefits including all federal, state and foreign tax jurisdictions are as follows:</span></div><div style="line-height:120%;text-indent:36px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div><div style="line-height:120%;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="12"/></tr><tr><td style="width:68%;"/><td style="width:1%;"/><td style="width:8%;"/><td style="width:1%;"/><td style="width:1%;"/><td style="width:1%;"/><td style="width:8%;"/><td style="width:1%;"/><td style="width:1%;"/><td style="width:1%;"/><td style="width:8%;"/><td style="width:1%;"/></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-top:2px;padding-bottom:2px;"><div style="text-align:center;font-size:8pt;"><span style="font-family:inherit;font-size:8pt;font-weight:bold;">2019</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-top:2px;padding-bottom:2px;"><div style="text-align:center;font-size:8pt;"><span style="font-family:inherit;font-size:8pt;font-weight:bold;">2018</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:8pt;"><span style="font-family:inherit;font-size:8pt;font-weight:bold;">2017</span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:inherit;font-size:8pt;font-weight:bold;"> </span></div></td><td colspan="11" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:center;font-size:8pt;"><span style="font-family:inherit;font-size:8pt;font-weight:bold;">(in millions)</span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Balance, beginning of year</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>214</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>224</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>293</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Additions for tax positions related to the current year</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>7</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>27</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>32</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Additions for tax positions from prior years</span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>12</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>2</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>1</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Reductions for tax positions from prior years</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>(2</span></span></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">)</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>(13</span></span></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">)</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>(3</span></span></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">)</span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Settlements with taxing authorities</span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>—</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>—</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>(52</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">)</span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Statute of limitations expirations</span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>(25</span></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">)</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>(26</span></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">)</span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>(47</span></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">)</span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Balance, end of year</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>206</span></span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>214</span></span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>224</span></span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr></table></div><span style="font-family:inherit;font-size:10pt;"><br/></span></div> 214000000 224000000 293000000 7000000 27000000 32000000 12000000 2000000 1000000 2000000 13000000 3000000 0 0 52000000 25000000 26000000 47000000 206000000 214000000 224000000 227000000 204000000 23000000 9000000 11000000 -9000000 36000000 27000000 NET INCOME PER SHARE<div style="line-height:120%;text-align:justify;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div><div style="line-height:120%;text-align:justify;text-indent:36px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">The following is a reconciliation of the numerators and denominators of the basic and diluted net income per share computations for the periods presented below. </span></div><div style="line-height:120%;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="12"/></tr><tr><td style="width:59%;"/><td style="width:1%;"/><td style="width:11%;"/><td style="width:1%;"/><td style="width:1%;"/><td style="width:1%;"/><td style="width:11%;"/><td style="width:1%;"/><td style="width:1%;"/><td style="width:1%;"/><td style="width:11%;"/><td style="width:1%;"/></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;font-weight:bold;"> </span></div></td><td colspan="11" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:center;font-size:8pt;"><span style="font-family:inherit;font-size:8pt;font-weight:bold;">Years Ended October 31,</span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:inherit;font-size:8pt;font-weight:bold;"> </span></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:8pt;"><span style="font-family:inherit;font-size:8pt;font-weight:bold;">2019</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:8pt;"><span style="font-family:inherit;font-size:8pt;font-weight:bold;">2018</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:8pt;"><span style="font-family:inherit;font-size:8pt;font-weight:bold;">2017</span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:inherit;font-size:8pt;font-weight:bold;"> </span></div></td><td colspan="11" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:center;font-size:8pt;"><span style="font-family:inherit;font-size:8pt;font-weight:bold;">(in millions)</span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Numerator:</span></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Net income</span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>1,071</span></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>316</span></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>684</span></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Denominators:</span></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Basic weighted average shares</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>314</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>321</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>322</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Potential common shares — stock options and other employee stock plans</span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>4</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>4</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>4</span></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Diluted weighted average shares</span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>318</span></span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>325</span></span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>326</span></span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr></table></div></div><div style="line-height:120%;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div><div style="line-height:120%;text-align:justify;text-indent:36px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">The dilutive effect of share-based awards is reflected in diluted net income per share by application of the treasury stock method, which includes consideration of unamortized share-based compensation expense and the dilutive effect of in-the-money options and non-vested restricted stock units. Under the treasury stock method, the amount the employee must pay for exercising stock options and unamortized share-based compensation expense collectively are assumed proceeds to be used to repurchase hypothetical shares. An increase in the fair market value of the company's common stock can result in a greater dilutive effect from potentially dilutive awards. </span></div><div style="line-height:120%;text-align:justify;text-indent:36px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div><div style="line-height:120%;text-align:justify;text-indent:38px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">We exclude stock options with exercise prices greater than the average market price of our common stock from the calculation of diluted earnings per share because their effect would be anti-dilutive. In addition, we exclude from the calculation of diluted earnings per share, stock options, ESPP, LTPP and restricted stock awards whose combined exercise price and unamortized fair value collectively were greater than the average market price of our common stock because their effect would also be anti-dilutive.</span></div><div style="line-height:120%;text-align:justify;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div><div style="line-height:120%;text-align:justify;text-indent:36px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">In </span><span style="font-family:inherit;font-size:10pt;">2019</span><span style="font-family:inherit;font-size:10pt;">, </span><span style="font-family:inherit;font-size:10pt;">2018</span><span style="font-family:inherit;font-size:10pt;"> and </span><span style="font-family:inherit;font-size:10pt;">2017</span><span style="font-family:inherit;font-size:10pt;">, we issued approximately </span><span style="font-family:inherit;font-size:10pt;"><span>2 million</span></span><span style="font-family:inherit;font-size:10pt;">, </span><span style="font-family:inherit;font-size:10pt;"><span>2 million</span></span><span style="font-family:inherit;font-size:10pt;"> and </span><span style="font-family:inherit;font-size:10pt;"><span>3 million</span></span><span style="font-family:inherit;font-size:10pt;">, of share-based awards, respectively.  For the years ended </span><span style="font-family:inherit;font-size:10pt;">2019</span><span style="font-family:inherit;font-size:10pt;">, </span><span style="font-family:inherit;font-size:10pt;">2018</span><span style="font-family:inherit;font-size:10pt;"> and </span><span style="font-family:inherit;font-size:10pt;">2017</span><span style="font-family:inherit;font-size:10pt;">, the impact of the anti-dilutive potential common shares that were excluded from the calculation of diluted earnings per share was not material.</span></div> <div style="line-height:120%;text-align:justify;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div><div style="line-height:120%;text-align:justify;text-indent:36px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">The following is a reconciliation of the numerators and denominators of the basic and diluted net income per share computations for the periods presented below. </span></div><div style="line-height:120%;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="12"/></tr><tr><td style="width:59%;"/><td style="width:1%;"/><td style="width:11%;"/><td style="width:1%;"/><td style="width:1%;"/><td style="width:1%;"/><td style="width:11%;"/><td style="width:1%;"/><td style="width:1%;"/><td style="width:1%;"/><td style="width:11%;"/><td style="width:1%;"/></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;font-weight:bold;"> </span></div></td><td colspan="11" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:center;font-size:8pt;"><span style="font-family:inherit;font-size:8pt;font-weight:bold;">Years Ended October 31,</span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:inherit;font-size:8pt;font-weight:bold;"> </span></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:8pt;"><span style="font-family:inherit;font-size:8pt;font-weight:bold;">2019</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:8pt;"><span style="font-family:inherit;font-size:8pt;font-weight:bold;">2018</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:8pt;"><span style="font-family:inherit;font-size:8pt;font-weight:bold;">2017</span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:inherit;font-size:8pt;font-weight:bold;"> </span></div></td><td colspan="11" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:center;font-size:8pt;"><span style="font-family:inherit;font-size:8pt;font-weight:bold;">(in millions)</span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Numerator:</span></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Net income</span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>1,071</span></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>316</span></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>684</span></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Denominators:</span></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Basic weighted average shares</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>314</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>321</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>322</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Potential common shares — stock options and other employee stock plans</span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>4</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>4</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>4</span></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Diluted weighted average shares</span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>318</span></span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>325</span></span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>326</span></span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr></table></div></div><div style="line-height:120%;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div> 1071000000 316000000 684000000 314000000 321000000 322000000 4000000 4000000 4000000 318000000 325000000 326000000 2000000 2000000 3000000  INVENTORY<div style="line-height:120%;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div><div style="line-height:120%;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:99.80506822612085%;border-collapse:collapse;text-align:left;"><tr><td colspan="8"/></tr><tr><td style="width:73%;"/><td style="width:1%;"/><td style="width:11%;"/><td style="width:1%;"/><td style="width:1%;"/><td style="width:1%;"/><td style="width:11%;"/><td style="width:1%;"/></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;font-weight:bold;"> </span></div></td><td colspan="7" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:center;font-size:8pt;"><span style="font-family:inherit;font-size:8pt;font-weight:bold;">October 31,</span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:inherit;font-size:8pt;font-weight:bold;"> </span></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="text-align:center;font-size:8pt;"><span style="font-family:inherit;font-size:8pt;font-weight:bold;">2019</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="text-align:center;font-size:8pt;"><span style="font-family:inherit;font-size:8pt;font-weight:bold;">2018</span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:inherit;font-size:8pt;font-weight:bold;"> </span></div></td><td colspan="7" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:center;font-size:8pt;"><span style="font-family:inherit;font-size:8pt;font-weight:bold;">(in millions)</span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Finished goods</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>416</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>386</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Purchased parts and fabricated assemblies</span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>263</span></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>252</span></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Inventory</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>679</span></span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>638</span></span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr></table></div><span style="font-family:inherit;font-size:10pt;"><br/></span></div><div style="line-height:120%;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div><div style="line-height:120%;text-align:justify;text-indent:36px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Inventory-related excess and obsolescence charges of </span><span style="font-family:inherit;font-size:10pt;"><span>$19 million</span></span><span style="font-family:inherit;font-size:10pt;"> were recorded in cost of products in </span><span style="font-family:inherit;font-size:10pt;color:#000000;text-decoration:none;">2019</span><span style="font-family:inherit;font-size:10pt;">, </span><span style="font-family:inherit;font-size:10pt;"><span>$26 million</span></span><span style="font-family:inherit;font-size:10pt;"> in </span><span style="font-family:inherit;font-size:10pt;color:#000000;text-decoration:none;">2018</span><span style="font-family:inherit;font-size:10pt;"> and </span><span style="font-family:inherit;font-size:10pt;"><span>$24 million</span></span><span style="font-family:inherit;font-size:10pt;"> in </span><span style="font-family:inherit;font-size:10pt;color:#000000;text-decoration:none;">2017</span><span style="font-family:inherit;font-size:10pt;">. We record excess and obsolete inventory charges for both inventory on our site as well as inventory at our contract manufacturers and suppliers where we have non-cancelable purchase commitments.</span></div> <div style="line-height:120%;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div><div style="line-height:120%;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:99.80506822612085%;border-collapse:collapse;text-align:left;"><tr><td colspan="8"/></tr><tr><td style="width:73%;"/><td style="width:1%;"/><td style="width:11%;"/><td style="width:1%;"/><td style="width:1%;"/><td style="width:1%;"/><td style="width:11%;"/><td style="width:1%;"/></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;font-weight:bold;"> </span></div></td><td colspan="7" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:center;font-size:8pt;"><span style="font-family:inherit;font-size:8pt;font-weight:bold;">October 31,</span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:inherit;font-size:8pt;font-weight:bold;"> </span></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="text-align:center;font-size:8pt;"><span style="font-family:inherit;font-size:8pt;font-weight:bold;">2019</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="text-align:center;font-size:8pt;"><span style="font-family:inherit;font-size:8pt;font-weight:bold;">2018</span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:inherit;font-size:8pt;font-weight:bold;"> </span></div></td><td colspan="7" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:center;font-size:8pt;"><span style="font-family:inherit;font-size:8pt;font-weight:bold;">(in millions)</span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Finished goods</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>416</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>386</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Purchased parts and fabricated assemblies</span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>263</span></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>252</span></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Inventory</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>679</span></span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>638</span></span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr></table></div><span style="font-family:inherit;font-size:10pt;"><br/></span></div> 416000000 386000000 263000000 252000000 679000000 638000000 19000000 26000000 24000000 PROPERTY, PLANT AND EQUIPMENT, NET<div style="line-height:120%;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div><div style="line-height:120%;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="8"/></tr><tr><td style="width:73%;"/><td style="width:1%;"/><td style="width:11%;"/><td style="width:1%;"/><td style="width:1%;"/><td style="width:1%;"/><td style="width:11%;"/><td style="width:1%;"/></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;font-weight:bold;"> </span></div></td><td colspan="7" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:center;font-size:8pt;"><span style="font-family:inherit;font-size:8pt;font-weight:bold;">October 31,</span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:inherit;font-size:8pt;font-weight:bold;"> </span></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:8pt;"><span style="font-family:inherit;font-size:8pt;font-weight:bold;">2019</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:8pt;"><span style="font-family:inherit;font-size:8pt;font-weight:bold;">2018</span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:inherit;font-size:8pt;font-weight:bold;"> </span></div></td><td colspan="7" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:center;font-size:8pt;"><span style="font-family:inherit;font-size:8pt;font-weight:bold;">(in millions)</span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Land</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>57</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>55</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Buildings and leasehold improvements</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>1,012</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>952</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Machinery and equipment</span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>546</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>512</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Software</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>160</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>141</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Total property, plant and equipment</span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>1,775</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>1,660</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Accumulated depreciation and amortization</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>(925</span></span></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">)</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>(838</span></span></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">)</span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Property, plant and equipment, net</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>850</span></span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>822</span></span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr></table></div><span style="font-family:inherit;font-size:10pt;"><br/></span></div><div style="line-height:120%;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div><div style="line-height:120%;text-align:justify;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> There were no asset impairments in </span><span style="font-family:inherit;font-size:10pt;">2019</span><span style="font-family:inherit;font-size:10pt;"> and </span><span style="font-family:inherit;font-size:10pt;">2017</span><span style="font-family:inherit;font-size:10pt;"> and less than </span><span style="font-family:inherit;font-size:10pt;"><span>$1 million</span></span><span style="font-family:inherit;font-size:10pt;"> asset impairments in </span><span style="font-family:inherit;font-size:10pt;">2018</span><span style="font-family:inherit;font-size:10pt;">. Depreciation expenses were </span><span style="font-family:inherit;font-size:10pt;color:#000000;text-decoration:none;"><span>$111 million</span></span><span style="font-family:inherit;font-size:10pt;"> in </span><span style="font-family:inherit;font-size:10pt;color:#000000;text-decoration:none;">2019</span><span style="font-family:inherit;font-size:10pt;">, </span><span style="font-family:inherit;font-size:10pt;color:#000000;text-decoration:none;"><span>$102 million</span></span><span style="font-family:inherit;font-size:10pt;"> in </span><span style="font-family:inherit;font-size:10pt;color:#000000;text-decoration:none;">2018</span><span style="font-family:inherit;font-size:10pt;"> and </span><span style="font-family:inherit;font-size:10pt;color:#000000;text-decoration:none;"><span>$94 million</span></span><span style="font-family:inherit;font-size:10pt;"> in </span><span style="font-family:inherit;font-size:10pt;color:#000000;text-decoration:none;">2017</span><span style="font-family:inherit;font-size:10pt;">. In 2019 we retired approximately </span><span style="font-family:inherit;font-size:10pt;"><span>$23 million</span></span><span style="font-family:inherit;font-size:10pt;"> of fully depreciated assets that were no longer in use.</span></div> <div style="line-height:120%;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div><div style="line-height:120%;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="8"/></tr><tr><td style="width:73%;"/><td style="width:1%;"/><td style="width:11%;"/><td style="width:1%;"/><td style="width:1%;"/><td style="width:1%;"/><td style="width:11%;"/><td style="width:1%;"/></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;font-weight:bold;"> </span></div></td><td colspan="7" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:center;font-size:8pt;"><span style="font-family:inherit;font-size:8pt;font-weight:bold;">October 31,</span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:inherit;font-size:8pt;font-weight:bold;"> </span></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:8pt;"><span style="font-family:inherit;font-size:8pt;font-weight:bold;">2019</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:8pt;"><span style="font-family:inherit;font-size:8pt;font-weight:bold;">2018</span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:inherit;font-size:8pt;font-weight:bold;"> </span></div></td><td colspan="7" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:center;font-size:8pt;"><span style="font-family:inherit;font-size:8pt;font-weight:bold;">(in millions)</span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Land</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>57</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>55</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Buildings and leasehold improvements</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>1,012</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>952</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Machinery and equipment</span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>546</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>512</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Software</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>160</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>141</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Total property, plant and equipment</span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>1,775</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>1,660</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Accumulated depreciation and amortization</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>(925</span></span></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">)</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>(838</span></span></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">)</span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Property, plant and equipment, net</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>850</span></span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>822</span></span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr></table></div><span style="font-family:inherit;font-size:10pt;"><br/></span></div> 57000000 55000000 1012000000 952000000 546000000 512000000 160000000 141000000 1775000000 1660000000 925000000 838000000 850000000 822000000 1000000 111000000 102000000 94000000 23000000 GOODWILL AND OTHER INTANGIBLE ASSETS<div style="line-height:120%;text-align:justify;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div><div style="line-height:120%;text-align:justify;text-indent:36px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">The following table presents goodwill balances and the movements for each of our reportable segments during the years ended </span><span style="font-family:inherit;font-size:10pt;">October 31, 2018</span><span style="font-family:inherit;font-size:10pt;"> and </span><span style="font-family:inherit;font-size:10pt;color:#000000;text-decoration:none;">2019</span><span style="font-family:inherit;font-size:10pt;">:</span></div><div style="line-height:120%;padding-bottom:4px;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:99.8046875%;border-collapse:collapse;text-align:left;"><tr><td colspan="16"/></tr><tr><td style="width:56%;"/><td style="width:1%;"/><td style="width:8%;"/><td style="width:1%;"/><td style="width:1%;"/><td style="width:1%;"/><td style="width:8%;"/><td style="width:1%;"/><td style="width:1%;"/><td style="width:1%;"/><td style="width:9%;"/><td style="width:1%;"/><td style="width:1%;"/><td style="width:1%;"/><td style="width:8%;"/><td style="width:1%;"/></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:8pt;"><span style="font-family:inherit;font-size:8pt;font-weight:bold;">Life Sciences and Applied Markets</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:8pt;"><span style="font-family:inherit;font-size:8pt;font-weight:bold;">Diagnostics and Genomics</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:8pt;"><span style="font-family:inherit;font-size:8pt;font-weight:bold;">Agilent CrossLab</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-top:2px;padding-bottom:2px;"><div style="text-align:center;font-size:8pt;"><span style="font-family:inherit;font-size:8pt;font-weight:bold;">Total</span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:inherit;font-size:8pt;font-weight:bold;"> </span></div></td><td colspan="15" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:center;font-size:8pt;"><span style="font-family:inherit;font-size:8pt;font-weight:bold;">(in millions)</span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;font-weight:bold;">Goodwill as of October 31, 2017</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>773</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>1,330</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>504</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>2,607</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Foreign currency translation impact</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>(7</span></span></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">)</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>(4</span></span></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">)</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>(4</span></span></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">)</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>(15</span></span></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">)</span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Goodwill arising from acquisitions</span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>37</span></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>281</span></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>63</span></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>381</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;font-weight:bold;">Goodwill as of October 31, 2018</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>803</span></span></div></td><td style="vertical-align:bottom;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>1,607</span></span></div></td><td style="vertical-align:bottom;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>563</span></span></div></td><td style="vertical-align:bottom;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>2,973</span></span></div></td><td style="vertical-align:bottom;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Foreign currency translation impact</span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>(1</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">)</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>(2</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">)</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>(2</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">)</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>(5</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">)</span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Goodwill arising from acquisitions and adjustments</span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>636</span></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>(11</span></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">)</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>—</span></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>625</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;font-weight:bold;">Goodwill as of October 31, 2019</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>1,438</span></span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>1,594</span></span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>561</span></span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>3,593</span></span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:9px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:9px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:9px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:9px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:9px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:9px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:9px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:9px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td></tr></table></div><span style="font-family:inherit;font-size:10pt;"><br/></span></div><div style="line-height:120%;text-align:justify;text-indent:24px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div><div style="line-height:120%;text-align:justify;text-indent:24px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">As of September 30, </span><span style="font-family:inherit;font-size:10pt;">2019</span><span style="font-family:inherit;font-size:10pt;">, our annual impairment test date, we assessed goodwill impairment for our reporting units and </span><span style="font-family:inherit;font-size:10pt;color:#000000;text-decoration:none;"><span>no</span></span><span style="font-family:inherit;font-size:10pt;"> impairment was indicated.</span></div><div style="line-height:120%;text-align:justify;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div><div style="line-height:120%;text-align:justify;text-indent:24px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">The component parts of other intangible assets at </span><span style="font-family:inherit;font-size:10pt;">October 31, 2018</span><span style="font-family:inherit;font-size:10pt;"> and </span><span style="font-family:inherit;font-size:10pt;color:#000000;text-decoration:none;">2019</span><span style="font-family:inherit;font-size:10pt;"> are shown in the table below:</span></div><div style="line-height:120%;text-align:justify;text-indent:0px;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="12"/></tr><tr><td style="width:53%;"/><td style="width:1%;"/><td style="width:14%;"/><td style="width:1%;"/><td style="width:1%;"/><td style="width:1%;"/><td style="width:14%;"/><td style="width:1%;"/><td style="width:1%;"/><td style="width:1%;"/><td style="width:11%;"/><td style="width:1%;"/></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;font-weight:bold;"> </span></div></td><td colspan="11" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:center;font-size:8pt;"><span style="font-family:inherit;font-size:8pt;font-weight:bold;">Other Intangible Assets</span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:inherit;font-size:8pt;font-weight:bold;"> </span></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:8pt;"><span style="font-family:inherit;font-size:8pt;font-weight:bold;">Gross<br/>Carrying<br/>Amount</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:8pt;"><span style="font-family:inherit;font-size:8pt;font-weight:bold;">Accumulated<br/>Amortization<br/>and Impairments</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:8pt;"><span style="font-family:inherit;font-size:8pt;font-weight:bold;">Net Book<br/>Value</span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:inherit;font-size:8pt;font-weight:bold;"> </span></div></td><td colspan="11" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:center;font-size:8pt;"><span style="font-family:inherit;font-size:8pt;font-weight:bold;">(in millions)</span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;font-weight:bold;">As of October 31, 2018:</span></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Purchased technology</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>947</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>683</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>264</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Trademark/Tradename</span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>151</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>88</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>63</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Customer relationships</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>107</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>63</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>44</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Third-party technology and licenses</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>28</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>19</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>9</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Total amortizable intangible assets</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>1,233</span></span></div></td><td style="vertical-align:bottom;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>853</span></span></div></td><td style="vertical-align:bottom;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>380</span></span></div></td><td style="vertical-align:bottom;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">In-Process R&amp;D</span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>111</span></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">—</span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>111</span></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Total</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>1,344</span></span></div></td><td style="vertical-align:bottom;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>853</span></span></div></td><td style="vertical-align:bottom;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>491</span></span></div></td><td style="vertical-align:bottom;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;font-weight:bold;">As of October 31, 2019:</span></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:3px double #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:3px double #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:3px double #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Purchased technology</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>1,413</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>763</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>650</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Backlog</span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>5</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>5</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>—</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Trademark/Tradename</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>196</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>102</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>94</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Customer relationships</span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>329</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>87</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>242</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Third-party technology and licenses</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>28</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>22</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>6</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Total amortizable intangible assets</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>1,971</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>979</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>992</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">In-Process R&amp;D</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>115</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">—</span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>115</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Total</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>2,086</span></span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>979</span></span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>1,107</span></span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:6px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:6px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:6px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:6px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:6px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:6px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td></tr></table></div><span style="font-family:inherit;font-size:10pt;"><br/></span></div><div style="line-height:120%;text-align:justify;font-size:9pt;"><span style="font-family:inherit;font-size:9pt;"><br/></span></div><div style="line-height:120%;text-align:justify;text-indent:36px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">In 2019, we acquired </span><span style="font-family:inherit;font-size:10pt;"><span>two</span></span><span style="font-family:inherit;font-size:10pt;"> businesses, BioTek and ACEA, for a combined purchase price of approximately </span><span style="font-family:inherit;font-size:10pt;"><span>$1.4 billion</span></span><span style="font-family:inherit;font-size:10pt;">. See Note 3, "Acquisitions", for additional information.</span></div><div style="line-height:120%;text-align:justify;text-indent:36px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div><div style="line-height:120%;text-align:justify;text-indent:36px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">During fiscal year </span><span style="font-family:inherit;font-size:10pt;">2019</span><span style="font-family:inherit;font-size:10pt;">, </span><span style="font-family:inherit;font-size:10pt;color:#333333;">w</span><span style="font-family:inherit;font-size:10pt;">e recorded additions to goodwill of </span><span style="font-family:inherit;font-size:10pt;"><span>$636 million</span></span><span style="font-family:inherit;font-size:10pt;"> and to other intangible assets of </span><span style="font-family:inherit;font-size:10pt;"><span>$744 million</span></span><span style="font-family:inherit;font-size:10pt;"> related to the acquisition of ACEA and BioTek. In the second quarter of fiscal year 2019, we recorded a measurement period adjustment to goodwill of </span><span style="font-family:inherit;font-size:10pt;"><span>$11 million</span></span><span style="font-family:inherit;font-size:10pt;"> for deferred tax assets related to pre-acquisition net operating losses of Advanced Analytical Technologies, Inc. The increase to other intangible assets due to foreign currency translation was not material in 2019.</span></div><div style="line-height:120%;text-align:justify;text-indent:36px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div><div style="line-height:120%;text-align:justify;text-indent:36px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">During fiscal year </span><span style="font-family:inherit;font-size:10pt;">2018</span><span style="font-family:inherit;font-size:10pt;">, we recorded additions to goodwill of </span><span style="font-family:inherit;font-size:10pt;"><span>$381 million</span></span><span style="font-family:inherit;font-size:10pt;"> and to intangible assets of </span><span style="font-family:inherit;font-size:10pt;"><span>$262 million</span></span><span style="font-family:inherit;font-size:10pt;"> related to the acquisition of </span><span style="font-family:inherit;font-size:10pt;"><span>seven</span></span><span style="font-family:inherit;font-size:10pt;"> businesses. During the year other intangible assets decreased </span><span style="font-family:inherit;font-size:10pt;"><span>$1 million</span></span><span style="font-family:inherit;font-size:10pt;">, due to the impact of foreign exchange translation. </span></div><div style="line-height:120%;text-align:justify;text-indent:36px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div><div style="line-height:120%;text-align:left;text-indent:36px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">In general, for United States federal tax purposes, goodwill from asset purchases is amortizable however any goodwill created as part of a stock acquisition is not deductible.</span></div><div style="line-height:120%;text-align:justify;text-indent:36px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div><div style="line-height:120%;text-align:justify;text-indent:36px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">In </span><span style="font-family:inherit;font-size:10pt;">2019</span><span style="font-family:inherit;font-size:10pt;">, there were </span><span style="font-family:inherit;font-size:10pt;"><span>no</span></span><span style="font-family:inherit;font-size:10pt;"> impairments of other intangible assets recorded. During </span><span style="font-family:inherit;font-size:10pt;">2018</span><span style="font-family:inherit;font-size:10pt;">, we recorded an impairment charge of </span><span style="font-family:inherit;font-size:10pt;"><span>$21 million</span></span><span style="font-family:inherit;font-size:10pt;"> related to purchased intangible assets within the diagnostics and genomics segment that were deemed unrecoverable. In </span><span style="font-family:inherit;font-size:10pt;">2017</span><span style="font-family:inherit;font-size:10pt;">, there were </span><span style="font-family:inherit;font-size:10pt;"><span>no</span></span><span style="font-family:inherit;font-size:10pt;"> impairments of other intangible assets recorded.</span></div><div style="line-height:120%;text-align:justify;text-indent:36px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div><div style="line-height:120%;text-align:justify;text-indent:36px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Amortization expense of intangible assets was </span><span style="font-family:inherit;font-size:10pt;"><span>$128 million</span></span><span style="font-family:inherit;font-size:10pt;"> in </span><span style="font-family:inherit;font-size:10pt;">2019</span><span style="font-family:inherit;font-size:10pt;">, </span><span style="font-family:inherit;font-size:10pt;"><span>$110 million</span></span><span style="font-family:inherit;font-size:10pt;"> in </span><span style="font-family:inherit;font-size:10pt;">2018</span><span style="font-family:inherit;font-size:10pt;">, and </span><span style="font-family:inherit;font-size:10pt;"><span>$120 million</span></span><span style="font-family:inherit;font-size:10pt;"> in </span><span style="font-family:inherit;font-size:10pt;">2017</span><span style="font-family:inherit;font-size:10pt;">. </span></div><div style="line-height:120%;text-align:justify;text-indent:36px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div><div style="line-height:120%;text-align:justify;text-indent:36px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Future amortization expense related to existing finite-lived purchased intangible assets associated with business combinations for the next five fiscal years and thereafter is estimated below:</span></div><div style="line-height:120%;text-align:center;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;margin-left:auto;margin-right:auto;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="4"/></tr><tr><td style="width:88%;"/><td style="width:1%;"/><td style="width:10%;"/><td style="width:1%;"/></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;font-weight:bold;">Estimated future amortization expense:</span></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:inherit;font-size:8pt;font-weight:bold;">(in millions)</span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">2020</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>186</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">2021</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>172</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">2022</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>150</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">2023</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>107</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">2024</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>86</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Thereafter</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>291</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr></table></div><span style="font-family:inherit;font-size:10pt;"><br/></span></div> <div style="line-height:120%;text-align:justify;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div><div style="line-height:120%;text-align:justify;text-indent:36px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">The following table presents goodwill balances and the movements for each of our reportable segments during the years ended </span><span style="font-family:inherit;font-size:10pt;">October 31, 2018</span><span style="font-family:inherit;font-size:10pt;"> and </span><span style="font-family:inherit;font-size:10pt;color:#000000;text-decoration:none;">2019</span><span style="font-family:inherit;font-size:10pt;">:</span></div><div style="line-height:120%;padding-bottom:4px;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:99.8046875%;border-collapse:collapse;text-align:left;"><tr><td colspan="16"/></tr><tr><td style="width:56%;"/><td style="width:1%;"/><td style="width:8%;"/><td style="width:1%;"/><td style="width:1%;"/><td style="width:1%;"/><td style="width:8%;"/><td style="width:1%;"/><td style="width:1%;"/><td style="width:1%;"/><td style="width:9%;"/><td style="width:1%;"/><td style="width:1%;"/><td style="width:1%;"/><td style="width:8%;"/><td style="width:1%;"/></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:8pt;"><span style="font-family:inherit;font-size:8pt;font-weight:bold;">Life Sciences and Applied Markets</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:8pt;"><span style="font-family:inherit;font-size:8pt;font-weight:bold;">Diagnostics and Genomics</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:8pt;"><span style="font-family:inherit;font-size:8pt;font-weight:bold;">Agilent CrossLab</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-top:2px;padding-bottom:2px;"><div style="text-align:center;font-size:8pt;"><span style="font-family:inherit;font-size:8pt;font-weight:bold;">Total</span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:inherit;font-size:8pt;font-weight:bold;"> </span></div></td><td colspan="15" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:center;font-size:8pt;"><span style="font-family:inherit;font-size:8pt;font-weight:bold;">(in millions)</span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;font-weight:bold;">Goodwill as of October 31, 2017</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>773</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>1,330</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>504</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>2,607</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Foreign currency translation impact</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>(7</span></span></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">)</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>(4</span></span></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">)</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>(4</span></span></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">)</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>(15</span></span></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">)</span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Goodwill arising from acquisitions</span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>37</span></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>281</span></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>63</span></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>381</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;font-weight:bold;">Goodwill as of October 31, 2018</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>803</span></span></div></td><td style="vertical-align:bottom;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>1,607</span></span></div></td><td style="vertical-align:bottom;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>563</span></span></div></td><td style="vertical-align:bottom;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>2,973</span></span></div></td><td style="vertical-align:bottom;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Foreign currency translation impact</span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>(1</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">)</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>(2</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">)</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>(2</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">)</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>(5</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">)</span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Goodwill arising from acquisitions and adjustments</span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>636</span></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>(11</span></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">)</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>—</span></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>625</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;font-weight:bold;">Goodwill as of October 31, 2019</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>1,438</span></span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>1,594</span></span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>561</span></span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>3,593</span></span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:9px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:9px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:9px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:9px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:9px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:9px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:9px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:9px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td></tr></table></div><span style="font-family:inherit;font-size:10pt;"><br/></span></div> 773000000 1330000000 504000000 2607000000 -7000000 -4000000 -4000000 -15000000 37000000 281000000 63000000 381000000 803000000 1607000000 563000000 2973000000 -1000000 -2000000 -2000000 -5000000 636000000 -11000000 0 625000000 1438000000 1594000000 561000000 3593000000 0 <div style="line-height:120%;text-align:justify;text-indent:24px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">The component parts of other intangible assets at </span><span style="font-family:inherit;font-size:10pt;">October 31, 2018</span><span style="font-family:inherit;font-size:10pt;"> and </span><span style="font-family:inherit;font-size:10pt;color:#000000;text-decoration:none;">2019</span><span style="font-family:inherit;font-size:10pt;"> are shown in the table below:</span></div><div style="line-height:120%;text-align:justify;text-indent:0px;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="12"/></tr><tr><td style="width:53%;"/><td style="width:1%;"/><td style="width:14%;"/><td style="width:1%;"/><td style="width:1%;"/><td style="width:1%;"/><td style="width:14%;"/><td style="width:1%;"/><td style="width:1%;"/><td style="width:1%;"/><td style="width:11%;"/><td style="width:1%;"/></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;font-weight:bold;"> </span></div></td><td colspan="11" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:center;font-size:8pt;"><span style="font-family:inherit;font-size:8pt;font-weight:bold;">Other Intangible Assets</span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:inherit;font-size:8pt;font-weight:bold;"> </span></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:8pt;"><span style="font-family:inherit;font-size:8pt;font-weight:bold;">Gross<br/>Carrying<br/>Amount</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:8pt;"><span style="font-family:inherit;font-size:8pt;font-weight:bold;">Accumulated<br/>Amortization<br/>and Impairments</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:8pt;"><span style="font-family:inherit;font-size:8pt;font-weight:bold;">Net Book<br/>Value</span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:inherit;font-size:8pt;font-weight:bold;"> </span></div></td><td colspan="11" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:center;font-size:8pt;"><span style="font-family:inherit;font-size:8pt;font-weight:bold;">(in millions)</span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;font-weight:bold;">As of October 31, 2018:</span></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Purchased technology</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>947</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>683</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>264</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Trademark/Tradename</span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>151</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>88</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>63</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Customer relationships</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>107</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>63</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>44</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Third-party technology and licenses</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>28</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>19</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>9</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Total amortizable intangible assets</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>1,233</span></span></div></td><td style="vertical-align:bottom;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>853</span></span></div></td><td style="vertical-align:bottom;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>380</span></span></div></td><td style="vertical-align:bottom;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">In-Process R&amp;D</span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>111</span></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">—</span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>111</span></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Total</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>1,344</span></span></div></td><td style="vertical-align:bottom;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>853</span></span></div></td><td style="vertical-align:bottom;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>491</span></span></div></td><td style="vertical-align:bottom;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;font-weight:bold;">As of October 31, 2019:</span></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:3px double #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:3px double #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:3px double #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Purchased technology</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>1,413</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>763</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>650</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Backlog</span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>5</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>5</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>—</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Trademark/Tradename</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>196</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>102</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>94</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Customer relationships</span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>329</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>87</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>242</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Third-party technology and licenses</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>28</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>22</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>6</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Total amortizable intangible assets</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>1,971</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>979</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>992</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">In-Process R&amp;D</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>115</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">—</span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>115</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Total</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>2,086</span></span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>979</span></span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>1,107</span></span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:6px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:6px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:6px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:6px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:6px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:6px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td></tr></table></div><span style="font-family:inherit;font-size:10pt;"><br/></span></div> 947000000 683000000 264000000 151000000 88000000 63000000 107000000 63000000 44000000 28000000 19000000 9000000 1233000000 853000000 380000000 111000000 111000000 1344000000 853000000 491000000 1413000000 763000000 650000000 5000000 5000000 0 196000000 102000000 94000000 329000000 87000000 242000000 28000000 22000000 6000000 1971000000 979000000 992000000 115000000 115000000 2086000000 979000000 1107000000 2 1400000000 636000000 744000000 -11000000 381000000 262000000 7 1000000 0 21000000 0 128000000 110000000 120000000 <div style="line-height:120%;text-align:justify;text-indent:36px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Future amortization expense related to existing finite-lived purchased intangible assets associated with business combinations for the next five fiscal years and thereafter is estimated below:</span></div><div style="line-height:120%;text-align:center;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;margin-left:auto;margin-right:auto;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="4"/></tr><tr><td style="width:88%;"/><td style="width:1%;"/><td style="width:10%;"/><td style="width:1%;"/></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;font-weight:bold;">Estimated future amortization expense:</span></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:inherit;font-size:8pt;font-weight:bold;">(in millions)</span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">2020</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>186</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">2021</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>172</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">2022</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>150</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">2023</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>107</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">2024</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>86</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Thereafter</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>291</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr></table></div><span style="font-family:inherit;font-size:10pt;"><br/></span></div><div style="line-height:120%;text-align:center;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div><div style="line-height:120%;text-align:justify;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div> 186000000 172000000 150000000 107000000 86000000 291000000 INVESTMENTS<div style="line-height:120%;text-align:justify;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div><div style="line-height:120%;text-align:justify;text-indent:36px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">The following table summarizes the company's equity investments as of </span><span style="font-family:inherit;font-size:10pt;color:#000000;text-decoration:none;">October 31, 2019</span><span style="font-family:inherit;font-size:10pt;"> and </span><span style="font-family:inherit;font-size:10pt;color:#000000;text-decoration:none;">2018</span><span style="font-family:inherit;font-size:10pt;"> (net book value):</span></div><div style="line-height:120%;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div><div style="line-height:120%;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="8"/></tr><tr><td style="width:73%;"/><td style="width:1%;"/><td style="width:11%;"/><td style="width:1%;"/><td style="width:1%;"/><td style="width:1%;"/><td style="width:11%;"/><td style="width:1%;"/></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;font-weight:bold;"> </span></div></td><td colspan="7" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:center;font-size:8pt;"><span style="font-family:inherit;font-size:8pt;font-weight:bold;">October 31,</span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:inherit;font-size:8pt;font-weight:bold;"> </span></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:8pt;"><span style="font-family:inherit;font-size:8pt;font-weight:bold;">2019</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="text-align:center;font-size:8pt;"><span style="font-family:inherit;font-size:8pt;font-weight:bold;">2018</span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:inherit;font-size:8pt;font-weight:bold;"> </span></div></td><td colspan="7" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:center;font-size:8pt;"><span style="font-family:inherit;font-size:8pt;font-weight:bold;">(in millions)</span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;font-weight:bold;">Long-Term</span></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Equity investments - without readily determinable fair value</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>47</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>23</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Equity investments - with readily determinable fair value</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>25</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>15</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Trading securities</span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>30</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>30</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Total</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>102</span></span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>68</span></span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr></table></div><span style="font-family:inherit;font-size:10pt;"><br/></span></div><div style="line-height:120%;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div><div style="line-height:120%;text-align:justify;text-indent:36px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Equity investments without readily determinable fair value (RDFV) consist of non-marketable equity securities issued by private companies. These investments are accounted for using the measurement alternative at cost adjusting for impairments and observable price changes (orderly transactions for the identical or a similar security from the same issuer). The adjustments are included in net income in the period in which they occur. Equity investments with RDFV consist of shares we own in a special fund and are reported at fair value, with gains or losses resulting from changes in fair value included in net income. Prior to fiscal year 2019, both equity investments without RDFV and with RDFV were accounted for using cost method of accounting, measured at historical cost less other-than-temporary impairment. Trading securities are reported at fair value, with gains or losses resulting from changes in fair value recognized currently in earnings.</span></div><div style="line-height:120%;text-align:justify;text-indent:36px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div><div style="line-height:120%;text-align:justify;text-indent:36px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">During 2018, we acquired all of the remaining shares of Lasergen, Inc. (Lasergen), for an additional cash consideration of approximately </span><span style="font-family:inherit;font-size:10pt;"><span>$107 million</span></span><span style="font-family:inherit;font-size:10pt;">, an investment that was accounted for under the cost method in 2017 for approximately </span><span style="font-family:inherit;font-size:10pt;"><span>$80 million</span></span><span style="font-family:inherit;font-size:10pt;">. The fair value remeasurement of our previous investment immediately before the acquisition resulted in a net gain of </span><span style="font-family:inherit;font-size:10pt;"><span>$20 million</span></span><span style="font-family:inherit;font-size:10pt;"> and was recorded in other income. </span></div><div style="line-height:120%;text-align:justify;text-indent:36px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div><div style="line-height:120%;text-align:justify;text-indent:36px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Our investments without RDFV, are subject to periodic impairment review. The impairment analysis requires significant judgment to identify events or circumstances that would likely have significant adverse effect on the future value of the investment.</span></div><div style="line-height:120%;text-align:justify;text-indent:36px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div><div style="line-height:120%;text-align:justify;text-indent:36px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Net unrealized gains on our equity securities with RDFV were </span><span style="font-family:inherit;font-size:10pt;"><span>$3 million</span></span><span style="font-family:inherit;font-size:10pt;"> in 2019. Net unrealized gains on our equity securities without RDFV were not material in 2019. Upon adoption of new accounting guidance relating to financial instruments beginning fiscal year 2019, the gains and losses on such securities are recognized in other income (expense) and therefore not applicable in prior periods. As of November 1, 2019, total impact of adoption of said accounting guidance to our consolidated balance sheet was an increase of </span><span style="font-family:inherit;font-size:10pt;"><span>$7 million</span></span><span style="font-family:inherit;font-size:10pt;"> to equity securities with RDFV (included within long-term investments) and a net increase of</span><span style="font-family:inherit;font-size:10pt;"><span>$5 million</span></span><span style="font-family:inherit;font-size:10pt;"> to beginning retained earnings.</span></div><div style="line-height:120%;text-align:justify;text-indent:36px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div><div style="line-height:120%;text-align:justify;text-indent:36px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Net unrealized gains on our trading securities portfolio were </span><span style="font-family:inherit;font-size:10pt;"><span>$3 million</span></span><span style="font-family:inherit;font-size:10pt;"> in </span><span style="font-family:inherit;font-size:10pt;">2019</span><span style="font-family:inherit;font-size:10pt;">, </span><span style="font-family:inherit;font-size:10pt;"><span>$1 million</span></span><span style="font-family:inherit;font-size:10pt;"> in </span><span style="font-family:inherit;font-size:10pt;">2018</span><span style="font-family:inherit;font-size:10pt;"> and </span><span style="font-family:inherit;font-size:10pt;"><span>$4 million</span></span><span style="font-family:inherit;font-size:10pt;"> in </span><span style="font-family:inherit;font-size:10pt;">2017</span><span style="font-family:inherit;font-size:10pt;">.</span></div> <div style="line-height:120%;text-align:justify;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div><div style="line-height:120%;text-align:justify;text-indent:36px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">The following table summarizes the company's equity investments as of </span><span style="font-family:inherit;font-size:10pt;color:#000000;text-decoration:none;">October 31, 2019</span><span style="font-family:inherit;font-size:10pt;"> and </span><span style="font-family:inherit;font-size:10pt;color:#000000;text-decoration:none;">2018</span><span style="font-family:inherit;font-size:10pt;"> (net book value):</span></div><div style="line-height:120%;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div><div style="line-height:120%;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="8"/></tr><tr><td style="width:73%;"/><td style="width:1%;"/><td style="width:11%;"/><td style="width:1%;"/><td style="width:1%;"/><td style="width:1%;"/><td style="width:11%;"/><td style="width:1%;"/></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;font-weight:bold;"> </span></div></td><td colspan="7" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:center;font-size:8pt;"><span style="font-family:inherit;font-size:8pt;font-weight:bold;">October 31,</span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:inherit;font-size:8pt;font-weight:bold;"> </span></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:8pt;"><span style="font-family:inherit;font-size:8pt;font-weight:bold;">2019</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="text-align:center;font-size:8pt;"><span style="font-family:inherit;font-size:8pt;font-weight:bold;">2018</span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:inherit;font-size:8pt;font-weight:bold;"> </span></div></td><td colspan="7" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:center;font-size:8pt;"><span style="font-family:inherit;font-size:8pt;font-weight:bold;">(in millions)</span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;font-weight:bold;">Long-Term</span></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Equity investments - without readily determinable fair value</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>47</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>23</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Equity investments - with readily determinable fair value</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>25</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>15</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Trading securities</span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>30</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>30</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Total</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>102</span></span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>68</span></span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr></table></div><span style="font-family:inherit;font-size:10pt;"><br/></span></div> 47000000 23000000 25000000 15000000 30000000 30000000 102000000 68000000 107000000 80000000 20000000 3000000 7000000 5000000 3000000 1000000 4000000 <div style="line-height:120%;text-align:justify;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;font-weight:bold;">12.   FAIR VALUE MEASUREMENTS</span></div><div style="line-height:120%;text-align:justify;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div><div style="line-height:120%;text-align:justify;text-indent:36px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">The authoritative guidance defines fair value as the price that would be received from selling an asset or paid to transfer a liability in an orderly transaction between market participants at the measurement date. When determining the fair value measurements for assets and liabilities required or permitted to be recorded at fair value, we consider the principal or most advantageous market and assumptions that market participants would use when pricing the asset or liability.</span></div><div style="line-height:120%;text-align:justify;text-indent:32px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div><div style="line-height:120%;text-align:justify;text-indent:26px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;font-style:italic;font-weight:bold;">Fair Value Hierarchy</span></div><div style="line-height:120%;text-align:justify;text-indent:26px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div><div style="line-height:120%;text-align:justify;text-indent:36px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">The guidance establishes a fair value hierarchy that prioritizes the use of inputs used in valuation techniques into three levels. A financial instrument's categorization within the fair value hierarchy is based upon the lowest level of input that is significant to the fair value measurement. There are three levels of inputs that may be used to measure fair value:</span></div><div style="line-height:120%;text-align:justify;text-indent:36px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div><div style="line-height:120%;text-align:justify;text-indent:36px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;font-style:italic;">Level 1</span><span style="font-family:inherit;font-size:10pt;"> — applies to assets or liabilities for which there are quoted prices in active markets for identical assets or liabilities.</span></div><div style="line-height:120%;text-align:justify;text-indent:36px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div><div style="line-height:120%;text-align:justify;text-indent:36px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;font-style:italic;">Level 2</span><span style="font-family:inherit;font-size:10pt;"> — applies to assets or liabilities for which there are inputs other than quoted prices included within level 1 that are </span></div><div style="line-height:120%;text-align:justify;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">observable, either directly or indirectly, for the asset or liability such as: quoted prices for similar assets or liabilities in active markets; quoted prices for identical or similar assets or liabilities in less active markets; or other inputs that can be derived principally from, or corroborated by, observable market data.</span></div><div style="line-height:120%;text-align:justify;text-indent:36px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div><div style="line-height:120%;text-align:justify;text-indent:36px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;font-style:italic;">Level 3</span><span style="font-family:inherit;font-size:10pt;"> — applies to assets or liabilities for which there are unobservable inputs to the valuation methodology that are significant to the measurement of the fair value of the assets or liabilities.</span></div><div style="line-height:120%;text-align:justify;text-indent:36px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div><div style="line-height:120%;text-align:justify;text-indent:26px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;font-style:italic;font-weight:bold;">Financial Assets and Liabilities Measured at Fair Value on a Recurring Basis</span></div><div style="line-height:120%;text-align:justify;text-indent:26px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div><div style="line-height:120%;text-align:justify;text-indent:36px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Financial assets and liabilities measured at fair value on a recurring basis as of </span><span style="font-family:inherit;font-size:10pt;color:#000000;text-decoration:none;">October 31, 2019</span><span style="font-family:inherit;font-size:10pt;"> were as follows:</span></div><div style="line-height:120%;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div><div style="line-height:120%;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="16"/></tr><tr><td style="width:41%;"/><td style="width:1%;"/><td style="width:12%;"/><td style="width:1%;"/><td style="width:1%;"/><td style="width:1%;"/><td style="width:12%;"/><td style="width:1%;"/><td style="width:1%;"/><td style="width:1%;"/><td style="width:12%;"/><td style="width:1%;"/><td style="width:1%;"/><td style="width:1%;"/><td style="width:12%;"/><td style="width:1%;"/></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;font-weight:bold;"> </span></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;font-weight:bold;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="11" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:center;font-size:8pt;"><span style="font-family:inherit;font-size:8pt;font-weight:bold;">Fair Value Measurement at October 31, 2019 Using</span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:inherit;font-size:8pt;font-weight:bold;"> </span></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:8pt;"><span style="font-family:inherit;font-size:8pt;font-weight:bold;">October 31, <br/>2019</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:8pt;"><span style="font-family:inherit;font-size:8pt;font-weight:bold;">Quoted Prices</span></div><div style="text-align:center;font-size:8pt;"><span style="font-family:inherit;font-size:8pt;font-weight:bold;">in Active</span></div><div style="text-align:center;font-size:8pt;"><span style="font-family:inherit;font-size:8pt;font-weight:bold;">Markets for</span></div><div style="text-align:center;font-size:8pt;"><span style="font-family:inherit;font-size:8pt;font-weight:bold;">Identical Assets</span></div><div style="text-align:center;font-size:8pt;"><span style="font-family:inherit;font-size:8pt;font-weight:bold;">(Level 1)</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:8pt;"><span style="font-family:inherit;font-size:8pt;font-weight:bold;">Significant</span></div><div style="text-align:center;font-size:8pt;"><span style="font-family:inherit;font-size:8pt;font-weight:bold;">Other</span></div><div style="text-align:center;font-size:8pt;"><span style="font-family:inherit;font-size:8pt;font-weight:bold;">Observable</span></div><div style="text-align:center;font-size:8pt;"><span style="font-family:inherit;font-size:8pt;font-weight:bold;">Inputs</span></div><div style="text-align:center;font-size:8pt;"><span style="font-family:inherit;font-size:8pt;font-weight:bold;">(Level 2)</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:8pt;"><span style="font-family:inherit;font-size:8pt;font-weight:bold;">Significant</span></div><div style="text-align:center;font-size:8pt;"><span style="font-family:inherit;font-size:8pt;font-weight:bold;">Unobservable</span></div><div style="text-align:center;font-size:8pt;"><span style="font-family:inherit;font-size:8pt;font-weight:bold;">Inputs</span></div><div style="text-align:center;font-size:8pt;"><span style="font-family:inherit;font-size:8pt;font-weight:bold;">(Level 3)</span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:inherit;font-size:8pt;font-weight:bold;"> </span></div></td><td colspan="15" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:center;font-size:8pt;"><span style="font-family:inherit;font-size:8pt;font-weight:bold;">(in millions)</span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Assets:</span></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Short-term</span></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:28px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Cash equivalents (money market funds)</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>784</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>784</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>—</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>—</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:28px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Derivative instruments (foreign exchange contracts)</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>12</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>—</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>12</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>—</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Long-term</span></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:28px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Trading securities</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>30</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>30</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>—</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>—</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:28px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Other investments</span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>25</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>—</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>25</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>—</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Total assets measured at fair value</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>851</span></span></div></td><td style="vertical-align:bottom;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>814</span></span></div></td><td style="vertical-align:bottom;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>37</span></span></div></td><td style="vertical-align:bottom;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>—</span></span></div></td><td style="vertical-align:bottom;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Liabilities:</span></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:3px double #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:3px double #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:3px double #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:3px double #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Short-term</span></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:28px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Derivative instruments (foreign exchange contracts)</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>6</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>—</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>6</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>—</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Long-term</span></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:28px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Deferred compensation liability</span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>30</span></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>—</span></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>30</span></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>—</span></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Total liabilities measured at fair value</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>36</span></span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>—</span></span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>36</span></span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>—</span></span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr></table></div><span style="font-family:inherit;font-size:10pt;"><br/></span></div><div style="line-height:120%;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div><div style="line-height:120%;text-align:justify;text-indent:36px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Financial assets and liabilities measured at fair value on a recurring basis as of </span><span style="font-family:inherit;font-size:10pt;color:#000000;text-decoration:none;">October 31, 2018</span><span style="font-family:inherit;font-size:10pt;"> were as follows:</span></div><div style="line-height:120%;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div><div style="line-height:120%;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="16"/></tr><tr><td style="width:41%;"/><td style="width:1%;"/><td style="width:12%;"/><td style="width:1%;"/><td style="width:1%;"/><td style="width:1%;"/><td style="width:12%;"/><td style="width:1%;"/><td style="width:1%;"/><td style="width:1%;"/><td style="width:12%;"/><td style="width:1%;"/><td style="width:1%;"/><td style="width:1%;"/><td style="width:12%;"/><td style="width:1%;"/></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;font-weight:bold;"> </span></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;font-weight:bold;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="11" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:center;font-size:8pt;"><span style="font-family:inherit;font-size:8pt;font-weight:bold;">Fair Value Measurement at October 31, 2018 Using</span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:inherit;font-size:8pt;font-weight:bold;"> </span></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:8pt;"><span style="font-family:inherit;font-size:8pt;font-weight:bold;">October 31, <br/>2018</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:8pt;"><span style="font-family:inherit;font-size:8pt;font-weight:bold;">Quoted Prices</span></div><div style="text-align:center;font-size:8pt;"><span style="font-family:inherit;font-size:8pt;font-weight:bold;">in Active</span></div><div style="text-align:center;font-size:8pt;"><span style="font-family:inherit;font-size:8pt;font-weight:bold;">Markets for</span></div><div style="text-align:center;font-size:8pt;"><span style="font-family:inherit;font-size:8pt;font-weight:bold;">Identical Assets</span></div><div style="text-align:center;font-size:8pt;"><span style="font-family:inherit;font-size:8pt;font-weight:bold;">(Level 1)</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:8pt;"><span style="font-family:inherit;font-size:8pt;font-weight:bold;">Significant</span></div><div style="text-align:center;font-size:8pt;"><span style="font-family:inherit;font-size:8pt;font-weight:bold;">Other</span></div><div style="text-align:center;font-size:8pt;"><span style="font-family:inherit;font-size:8pt;font-weight:bold;">Observable</span></div><div style="text-align:center;font-size:8pt;"><span style="font-family:inherit;font-size:8pt;font-weight:bold;">Inputs</span></div><div style="text-align:center;font-size:8pt;"><span style="font-family:inherit;font-size:8pt;font-weight:bold;">(Level 2)</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:8pt;"><span style="font-family:inherit;font-size:8pt;font-weight:bold;">Significant</span></div><div style="text-align:center;font-size:8pt;"><span style="font-family:inherit;font-size:8pt;font-weight:bold;">Unobservable</span></div><div style="text-align:center;font-size:8pt;"><span style="font-family:inherit;font-size:8pt;font-weight:bold;">Inputs</span></div><div style="text-align:center;font-size:8pt;"><span style="font-family:inherit;font-size:8pt;font-weight:bold;">(Level 3)</span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:inherit;font-size:8pt;font-weight:bold;"> </span></div></td><td colspan="15" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:center;font-size:8pt;"><span style="font-family:inherit;font-size:8pt;font-weight:bold;">(in millions)</span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Assets:</span></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Short-term</span></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:28px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Cash equivalents (money market funds)</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>1,355</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>1,355</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>—</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>—</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:28px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Derivative instruments (foreign exchange contracts)</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>16</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>—</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>16</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>—</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Long-term</span></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:28px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Trading securities</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>30</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>30</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>—</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>—</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Total assets measured at fair value</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>1,401</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>1,385</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>16</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>—</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Liabilities:</span></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:3px double #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:3px double #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:3px double #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:3px double #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Short-term</span></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:28px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Derivative instruments (foreign exchange contracts)</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>5</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>—</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>5</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>—</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Long-term</span></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:28px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Deferred compensation liability</span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>30</span></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>—</span></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>30</span></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>—</span></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Total liabilities measured at fair value</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>35</span></span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>—</span></span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>35</span></span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>—</span></span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr></table></div></div><div style="line-height:120%;text-align:justify;text-indent:32px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div><div style="line-height:120%;text-align:justify;text-indent:36px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Our money market funds and trading securities are generally valued using quoted market prices and therefore are classified within level 1 of the fair value hierarchy. Our derivative financial instruments are classified within level 2, as there is not an active market for each hedge contract, but the inputs used to calculate the value of the instruments are tied to active markets. Our deferred compensation liability is classified as level 2 because, although the values are not directly based on quoted market prices, the inputs used in the calculations are observable. Other investments represent shares we own in a special fund that targets underlying investments of approximately 40 percent in debt securities and 60 percent in equity securities. It has been classified as level 2 because, although the shares of the fund are not traded on any active stock exchange, each of the individual underlying securities are and hence we have a readily determinable value for the underlying securities, from which we are able to determine the fair market value for the special fund itself.</span></div><div style="line-height:120%;text-align:justify;text-indent:36px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div><div style="line-height:120%;text-align:justify;text-indent:36px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Trading securities, which is comprised of mutual funds, bonds and other similar instruments, other investments and deferred compensation liability are reported at fair value, with gains or losses resulting from changes in fair value recognized currently in net income. Certain derivative instruments are reported at fair value, with unrealized gains and losses, net of tax, included in accumulated other comprehensive loss within stockholders' equity. Realized gains and losses from the sale of these instruments are recorded in net income.</span></div><div style="line-height:120%;text-align:justify;text-indent:36px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div><div style="line-height:120%;text-align:justify;text-indent:24px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;font-style:italic;font-weight:bold;">Assets and Liabilities Measured at Fair Value on a Non-Recurring Basis</span></div><div style="line-height:120%;text-align:justify;text-indent:36px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div><div style="line-height:120%;text-align:justify;text-indent:24px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;font-style:italic;font-weight:bold;">Long-Lived Assets</span></div><div style="line-height:120%;text-align:justify;text-indent:36px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div><div style="line-height:120%;text-align:justify;text-indent:36px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">For assets measured at fair value on a non-recurring basis, the following table summarizes the impairments included in net income for the years ended </span><span style="font-family:inherit;font-size:10pt;color:#000000;text-decoration:none;">October 31, 2019</span><span style="font-family:inherit;font-size:10pt;">, </span><span style="font-family:inherit;font-size:10pt;color:#000000;text-decoration:none;">2018</span><span style="font-family:inherit;font-size:10pt;"> and </span><span style="font-family:inherit;font-size:10pt;">2017</span><span style="font-family:inherit;font-size:10pt;">:</span></div><div style="line-height:120%;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div><div style="line-height:120%;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="12"/></tr><tr><td style="width:67%;"/><td style="width:1%;"/><td style="width:8%;"/><td style="width:1%;"/><td style="width:1%;"/><td style="width:1%;"/><td style="width:9%;"/><td style="width:1%;"/><td style="width:1%;"/><td style="width:1%;"/><td style="width:8%;"/><td style="width:1%;"/></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;font-weight:bold;"> </span></div></td><td colspan="11" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:center;font-size:8pt;"><span style="font-family:inherit;font-size:8pt;font-weight:bold;">Years Ended</span></div><div style="text-align:center;font-size:8pt;"><span style="font-family:inherit;font-size:8pt;font-weight:bold;">October 31,</span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:inherit;font-size:8pt;font-weight:bold;"> </span></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:8pt;"><span style="font-family:inherit;font-size:8pt;font-weight:bold;">2019</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:8pt;"><span style="font-family:inherit;font-size:8pt;font-weight:bold;">2018</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="text-align:center;font-size:8pt;"><span style="font-family:inherit;font-size:8pt;font-weight:bold;">2017</span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:inherit;font-size:8pt;font-weight:bold;"> </span></div></td><td colspan="11" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:center;font-size:8pt;"><span style="font-family:inherit;font-size:8pt;font-weight:bold;">(in millions)</span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Long-lived assets held and used</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>—</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>21</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>—</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Long-lived assets held for sale</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>—</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>—</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>—</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr></table></div><span style="font-family:inherit;font-size:10pt;"><br/></span></div><div style="line-height:120%;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div><div style="line-height:120%;text-align:justify;text-indent:36px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">There were no impairments of long-lived assets held and used in 2019 and 2017. For 2018, long lived assets held and used with a carrying amount of </span><span style="font-family:inherit;font-size:10pt;"><span>$21 million</span></span><span style="font-family:inherit;font-size:10pt;"> were written down to their fair value of </span><span style="font-family:inherit;font-size:10pt;"><span>zero</span></span><span style="font-family:inherit;font-size:10pt;">, resulting in an impairment charge of </span><span style="font-family:inherit;font-size:10pt;"><span>$21 million</span></span><span style="font-family:inherit;font-size:10pt;">, which relates to purchased intangible assets within the diagnostics and genomics segment that were deemed unrecoverable and was included in net income. </span></div><div style="line-height:120%;text-align:justify;text-indent:36px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div><div style="line-height:174%;text-align:justify;text-indent:36px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">There were no impairments of long-lived assets held for sale in 2019, 2018 and 2017.</span></div><div style="line-height:120%;text-align:justify;text-indent:36px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div><div style="line-height:120%;text-align:justify;text-indent:36px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Fair values for the impaired long-lived assets during 2018 were measured using level 3 inputs. To determine the fair value of long-lived assets in 2018, we used the income approach based on projected discounted cash flows expected to be generated by the long-lived assets over the remaining useful life.</span></div><div style="line-height:120%;text-align:justify;text-indent:36px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div><div style="line-height:120%;text-align:justify;text-indent:36px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">For 2019, there were </span><span style="font-family:inherit;font-size:10pt;"><span>no</span></span><span style="font-family:inherit;font-size:10pt;"> impairments or material changes in non-marketable securities without readily determinable fair value. As of October 31, 2019 and October 31, 2018, the carrying amount of non-marketable equity securities without readily determinable fair values was </span><span style="font-family:inherit;font-size:10pt;"><span>$47 million</span></span><span style="font-family:inherit;font-size:10pt;"> and </span><span style="font-family:inherit;font-size:10pt;"><span>$23 million</span></span><span style="font-family:inherit;font-size:10pt;">, respectively.</span></div><div style="line-height:120%;text-align:justify;text-indent:36px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div><div style="line-height:120%;text-align:justify;text-indent:36px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Fair values for the non-marketable securities included in long-term investments on the consolidated balance sheet were measured using Level 3 inputs because they are primarily equity stock issued by private companies without quoted market prices. To estimate the fair value of our non-marketable securities, we use the measurement alternative to record these investments at cost and to adjust for impairments and observable price changes (orderly transactions for the identical or a similar security from the same issuer) as and when it occurs.</span></div> <div style="line-height:120%;text-align:justify;text-indent:36px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Financial assets and liabilities measured at fair value on a recurring basis as of </span><span style="font-family:inherit;font-size:10pt;color:#000000;text-decoration:none;">October 31, 2019</span><span style="font-family:inherit;font-size:10pt;"> were as follows:</span></div><div style="line-height:120%;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div><div style="line-height:120%;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="16"/></tr><tr><td style="width:41%;"/><td style="width:1%;"/><td style="width:12%;"/><td style="width:1%;"/><td style="width:1%;"/><td style="width:1%;"/><td style="width:12%;"/><td style="width:1%;"/><td style="width:1%;"/><td style="width:1%;"/><td style="width:12%;"/><td style="width:1%;"/><td style="width:1%;"/><td style="width:1%;"/><td style="width:12%;"/><td style="width:1%;"/></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;font-weight:bold;"> </span></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;font-weight:bold;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="11" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:center;font-size:8pt;"><span style="font-family:inherit;font-size:8pt;font-weight:bold;">Fair Value Measurement at October 31, 2019 Using</span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:inherit;font-size:8pt;font-weight:bold;"> </span></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:8pt;"><span style="font-family:inherit;font-size:8pt;font-weight:bold;">October 31, <br/>2019</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:8pt;"><span style="font-family:inherit;font-size:8pt;font-weight:bold;">Quoted Prices</span></div><div style="text-align:center;font-size:8pt;"><span style="font-family:inherit;font-size:8pt;font-weight:bold;">in Active</span></div><div style="text-align:center;font-size:8pt;"><span style="font-family:inherit;font-size:8pt;font-weight:bold;">Markets for</span></div><div style="text-align:center;font-size:8pt;"><span style="font-family:inherit;font-size:8pt;font-weight:bold;">Identical Assets</span></div><div style="text-align:center;font-size:8pt;"><span style="font-family:inherit;font-size:8pt;font-weight:bold;">(Level 1)</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:8pt;"><span style="font-family:inherit;font-size:8pt;font-weight:bold;">Significant</span></div><div style="text-align:center;font-size:8pt;"><span style="font-family:inherit;font-size:8pt;font-weight:bold;">Other</span></div><div style="text-align:center;font-size:8pt;"><span style="font-family:inherit;font-size:8pt;font-weight:bold;">Observable</span></div><div style="text-align:center;font-size:8pt;"><span style="font-family:inherit;font-size:8pt;font-weight:bold;">Inputs</span></div><div style="text-align:center;font-size:8pt;"><span style="font-family:inherit;font-size:8pt;font-weight:bold;">(Level 2)</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:8pt;"><span style="font-family:inherit;font-size:8pt;font-weight:bold;">Significant</span></div><div style="text-align:center;font-size:8pt;"><span style="font-family:inherit;font-size:8pt;font-weight:bold;">Unobservable</span></div><div style="text-align:center;font-size:8pt;"><span style="font-family:inherit;font-size:8pt;font-weight:bold;">Inputs</span></div><div style="text-align:center;font-size:8pt;"><span style="font-family:inherit;font-size:8pt;font-weight:bold;">(Level 3)</span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:inherit;font-size:8pt;font-weight:bold;"> </span></div></td><td colspan="15" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:center;font-size:8pt;"><span style="font-family:inherit;font-size:8pt;font-weight:bold;">(in millions)</span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Assets:</span></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Short-term</span></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:28px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Cash equivalents (money market funds)</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>784</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>784</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>—</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>—</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:28px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Derivative instruments (foreign exchange contracts)</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>12</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>—</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>12</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>—</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Long-term</span></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:28px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Trading securities</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>30</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>30</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>—</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>—</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:28px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Other investments</span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>25</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>—</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>25</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>—</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Total assets measured at fair value</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>851</span></span></div></td><td style="vertical-align:bottom;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>814</span></span></div></td><td style="vertical-align:bottom;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>37</span></span></div></td><td style="vertical-align:bottom;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>—</span></span></div></td><td style="vertical-align:bottom;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Liabilities:</span></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:3px double #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:3px double #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:3px double #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:3px double #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Short-term</span></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:28px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Derivative instruments (foreign exchange contracts)</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>6</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>—</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>6</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>—</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Long-term</span></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:28px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Deferred compensation liability</span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>30</span></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>—</span></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>30</span></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>—</span></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Total liabilities measured at fair value</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>36</span></span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>—</span></span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>36</span></span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>—</span></span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr></table></div><span style="font-family:inherit;font-size:10pt;"><br/></span></div><div style="line-height:120%;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div><div style="line-height:120%;text-align:justify;text-indent:36px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Financial assets and liabilities measured at fair value on a recurring basis as of </span><span style="font-family:inherit;font-size:10pt;color:#000000;text-decoration:none;">October 31, 2018</span><span style="font-family:inherit;font-size:10pt;"> were as follows:</span></div><div style="line-height:120%;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div><div style="line-height:120%;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="16"/></tr><tr><td style="width:41%;"/><td style="width:1%;"/><td style="width:12%;"/><td style="width:1%;"/><td style="width:1%;"/><td style="width:1%;"/><td style="width:12%;"/><td style="width:1%;"/><td style="width:1%;"/><td style="width:1%;"/><td style="width:12%;"/><td style="width:1%;"/><td style="width:1%;"/><td style="width:1%;"/><td style="width:12%;"/><td style="width:1%;"/></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;font-weight:bold;"> </span></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;font-weight:bold;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="11" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:center;font-size:8pt;"><span style="font-family:inherit;font-size:8pt;font-weight:bold;">Fair Value Measurement at October 31, 2018 Using</span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:inherit;font-size:8pt;font-weight:bold;"> </span></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:8pt;"><span style="font-family:inherit;font-size:8pt;font-weight:bold;">October 31, <br/>2018</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:8pt;"><span style="font-family:inherit;font-size:8pt;font-weight:bold;">Quoted Prices</span></div><div style="text-align:center;font-size:8pt;"><span style="font-family:inherit;font-size:8pt;font-weight:bold;">in Active</span></div><div style="text-align:center;font-size:8pt;"><span style="font-family:inherit;font-size:8pt;font-weight:bold;">Markets for</span></div><div style="text-align:center;font-size:8pt;"><span style="font-family:inherit;font-size:8pt;font-weight:bold;">Identical Assets</span></div><div style="text-align:center;font-size:8pt;"><span style="font-family:inherit;font-size:8pt;font-weight:bold;">(Level 1)</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:8pt;"><span style="font-family:inherit;font-size:8pt;font-weight:bold;">Significant</span></div><div style="text-align:center;font-size:8pt;"><span style="font-family:inherit;font-size:8pt;font-weight:bold;">Other</span></div><div style="text-align:center;font-size:8pt;"><span style="font-family:inherit;font-size:8pt;font-weight:bold;">Observable</span></div><div style="text-align:center;font-size:8pt;"><span style="font-family:inherit;font-size:8pt;font-weight:bold;">Inputs</span></div><div style="text-align:center;font-size:8pt;"><span style="font-family:inherit;font-size:8pt;font-weight:bold;">(Level 2)</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:8pt;"><span style="font-family:inherit;font-size:8pt;font-weight:bold;">Significant</span></div><div style="text-align:center;font-size:8pt;"><span style="font-family:inherit;font-size:8pt;font-weight:bold;">Unobservable</span></div><div style="text-align:center;font-size:8pt;"><span style="font-family:inherit;font-size:8pt;font-weight:bold;">Inputs</span></div><div style="text-align:center;font-size:8pt;"><span style="font-family:inherit;font-size:8pt;font-weight:bold;">(Level 3)</span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:inherit;font-size:8pt;font-weight:bold;"> </span></div></td><td colspan="15" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:center;font-size:8pt;"><span style="font-family:inherit;font-size:8pt;font-weight:bold;">(in millions)</span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Assets:</span></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Short-term</span></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:28px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Cash equivalents (money market funds)</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>1,355</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>1,355</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>—</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>—</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:28px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Derivative instruments (foreign exchange contracts)</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>16</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>—</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>16</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>—</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Long-term</span></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:28px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Trading securities</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>30</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>30</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>—</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>—</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Total assets measured at fair value</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>1,401</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>1,385</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>16</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>—</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Liabilities:</span></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:3px double #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:3px double #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:3px double #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:3px double #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Short-term</span></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:28px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Derivative instruments (foreign exchange contracts)</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>5</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>—</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>5</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>—</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Long-term</span></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:28px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Deferred compensation liability</span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>30</span></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>—</span></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>30</span></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>—</span></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Total liabilities measured at fair value</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>35</span></span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>—</span></span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>35</span></span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>—</span></span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr></table></div></div><div style="line-height:120%;text-align:justify;text-indent:32px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div> 784000000 784000000 0 0 12000000 0 12000000 0 30000000 30000000 0 0 25000000 0 25000000 0 851000000 814000000 37000000 0 6000000 0 6000000 0 30000000 0 30000000 0 36000000 0 36000000 0 1355000000 1355000000 0 0 16000000 0 16000000 0 30000000 30000000 0 0 1401000000 1385000000 16000000 0 5000000 0 5000000 0 30000000 0 30000000 0 35000000 0 35000000 0 <div style="line-height:120%;text-align:justify;text-indent:36px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">For assets measured at fair value on a non-recurring basis, the following table summarizes the impairments included in net income for the years ended </span><span style="font-family:inherit;font-size:10pt;color:#000000;text-decoration:none;">October 31, 2019</span><span style="font-family:inherit;font-size:10pt;">, </span><span style="font-family:inherit;font-size:10pt;color:#000000;text-decoration:none;">2018</span><span style="font-family:inherit;font-size:10pt;"> and </span><span style="font-family:inherit;font-size:10pt;">2017</span><span style="font-family:inherit;font-size:10pt;">:</span></div><div style="line-height:120%;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div><div style="line-height:120%;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="12"/></tr><tr><td style="width:67%;"/><td style="width:1%;"/><td style="width:8%;"/><td style="width:1%;"/><td style="width:1%;"/><td style="width:1%;"/><td style="width:9%;"/><td style="width:1%;"/><td style="width:1%;"/><td style="width:1%;"/><td style="width:8%;"/><td style="width:1%;"/></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;font-weight:bold;"> </span></div></td><td colspan="11" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:center;font-size:8pt;"><span style="font-family:inherit;font-size:8pt;font-weight:bold;">Years Ended</span></div><div style="text-align:center;font-size:8pt;"><span style="font-family:inherit;font-size:8pt;font-weight:bold;">October 31,</span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:inherit;font-size:8pt;font-weight:bold;"> </span></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:8pt;"><span style="font-family:inherit;font-size:8pt;font-weight:bold;">2019</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:8pt;"><span style="font-family:inherit;font-size:8pt;font-weight:bold;">2018</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="text-align:center;font-size:8pt;"><span style="font-family:inherit;font-size:8pt;font-weight:bold;">2017</span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:inherit;font-size:8pt;font-weight:bold;"> </span></div></td><td colspan="11" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:center;font-size:8pt;"><span style="font-family:inherit;font-size:8pt;font-weight:bold;">(in millions)</span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Long-lived assets held and used</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>—</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>21</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>—</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Long-lived assets held for sale</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>—</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>—</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>—</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr></table></div><span style="font-family:inherit;font-size:10pt;"><br/></span></div><div style="line-height:120%;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div> 0 21000000 0 0 0 0 21000000 0 21000000 0 47000000 23000000 <div style="line-height:120%;text-align:justify;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;font-weight:bold;">13.   DERIVATIVES</span></div><div style="line-height:120%;text-align:justify;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div><div style="line-height:120%;text-align:justify;text-indent:36px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">We are exposed to foreign currency exchange rate fluctuations and interest rate changes in the normal course of our business. As part of our risk management strategy, we use derivative instruments, primarily forward contracts purchased options to hedge economic and/or accounting exposures resulting from changes in foreign currency exchange rates.</span></div><div style="line-height:120%;text-align:justify;text-indent:32px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div><div style="line-height:120%;text-align:justify;text-indent:26px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;font-style:italic;font-weight:bold;">Fair Value Hedges</span></div><div style="line-height:120%;text-align:justify;text-indent:26px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div><div style="line-height:120%;text-align:justify;text-indent:36px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">We are exposed to interest rate risk due to the mismatch between the interest expense we pay on our loans at fixed rates and the variable rates of interest we receive from cash, cash equivalents and other short-term investments. We have issued long-term debt in U.S. dollars at fixed interest rates based on the market conditions at the time of financing. The fair value of our fixed rate debt changes when the underlying market rates of interest change, and, in the past, we have used interest rate swaps to change our fixed interest rate payments to U.S. dollar LIBOR-based variable interest expense to match the floating interest income from our cash, cash equivalents and other short-term investments. As of </span><span style="font-family:inherit;font-size:10pt;color:#000000;text-decoration:none;">October 31, 2019</span><span style="font-family:inherit;font-size:10pt;">, all interest rate swap contracts had either been terminated or had expired. </span></div><div style="line-height:120%;text-align:justify;text-indent:36px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div><div style="line-height:120%;text-align:justify;text-indent:40px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">On August 9, 2011, we terminated </span><span style="font-family:inherit;font-size:10pt;"><span>five</span></span><span style="font-family:inherit;font-size:10pt;"> interest rate swap contracts related to our 2020 senior notes that represented the notional amount of </span><span style="font-family:inherit;font-size:10pt;"><span>$500 million</span></span><span style="font-family:inherit;font-size:10pt;">. On September 17, 2019, the 2020 senior notes were redeemed, and the remaining gain associated with the terminated interest rate swap contracts was realized.</span></div><div style="line-height:120%;text-align:justify;text-indent:36px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div><div style="line-height:120%;text-align:justify;text-indent:26px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;font-style:italic;font-weight:bold;">Cash Flow Hedges</span></div><div style="line-height:120%;text-align:justify;text-indent:26px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div><div style="line-height:120%;text-align:justify;text-indent:36px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">We enter into foreign exchange contracts to hedge our forecasted operational cash flow exposures resulting from changes in foreign currency exchange rates. These foreign exchange contracts, carried at fair value, have maturities between one and twelve months. These derivative instruments are designated and qualify as cash flow hedges under the criteria prescribed in the authoritative guidance and are assessed for effectiveness against the underlying exposure every reporting period. For open contracts as of </span><span style="font-family:inherit;font-size:10pt;">October 31, 2019</span><span style="font-family:inherit;font-size:10pt;"> and entered into on or after November 1, 2018, changes in the time value of the foreign exchange contract are excluded from the assessment of hedge effectiveness and are recognized in cost of sales over the life of the foreign exchange contract. The changes in fair value of the effective portion of the derivative instrument are recognized in accumulated other comprehensive income (loss).  Amounts associated with cash flow hedges are reclassified to cost of sales in the consolidated statement of operations when the forecasted transaction occurs. If it becomes probable that the forecasted transaction will not occur, the hedge relationship will be de-designated and amounts accumulated in other comprehensive income (loss) will be reclassified to other income (expense), net in the current period. Changes in the fair value of the ineffective portion of derivative instruments are recognized in other income (expense), net in the consolidated statement of operations in the current period. We record the premium paid (time value) of an option on the date of purchase as an asset. For options designated as cash flow hedges, changes in the time value are excluded from the assessment of hedge effectiveness and are recognized in cost of sales over the </span></div><div style="line-height:120%;text-align:justify;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">life of the option contract. For the years ended </span><span style="font-family:inherit;font-size:10pt;">October 31, 2019</span><span style="font-family:inherit;font-size:10pt;">, </span><span style="font-family:inherit;font-size:10pt;">2018</span><span style="font-family:inherit;font-size:10pt;"> and </span><span style="font-family:inherit;font-size:10pt;">2017</span><span style="font-family:inherit;font-size:10pt;">, ineffectiveness and gains and losses recognized in other income (expense),net due to de-designation of cash flow hedge contracts were not significant. </span></div><div style="line-height:120%;text-align:justify;text-indent:36px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div><div style="line-height:120%;text-align:justify;text-indent:36px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">In July 2012, Agilent executed treasury lock agreements for </span><span style="font-family:inherit;font-size:10pt;color:#000000;text-decoration:none;"><span>$400 million</span></span><span style="font-family:inherit;font-size:10pt;"> in connection with future interest payments to be made on our 2022 senior notes issued on September 10, 2012. We designated the treasury lock as a cash flow hedge. The treasury lock contracts were terminated on September 10, 2012 and we recognized a deferred gain in accumulated other comprehensive income which is being amortized to interest expense over the life of the 2022 senior notes. The remaining gain to be amortized related to the treasury lock agreements at </span><span style="font-family:inherit;font-size:10pt;">October 31, 2019</span><span style="font-family:inherit;font-size:10pt;"> was </span><span style="font-family:inherit;font-size:10pt;"><span>$1 million</span></span><span style="font-family:inherit;font-size:10pt;">. </span></div><div style="line-height:120%;text-align:left;font-size:11pt;"><span style="font-family:inherit;font-size:11pt;"><br/></span></div><div style="line-height:120%;text-align:justify;text-indent:36px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">In February 2016, Agilent executed three forward-starting pay fixed/receive variable interest rate swaps for the notional amount of </span><span style="font-family:inherit;font-size:10pt;"><span>$300 million</span></span><span style="font-family:inherit;font-size:10pt;"> in connection with future interest payments to be made on our 2026 senior notes issued on September 15, 2016. These derivative instruments were designated and qualified as cash flow hedges under the criteria prescribed in the authoritative guidance. The swap arrangements were terminated on September 15, 2016 with a payment of $</span><span style="font-family:inherit;font-size:10pt;"><span>10 million</span></span><span style="font-family:inherit;font-size:10pt;"> and we recognized this as a deferred loss in accumulated other comprehensive income which is being amortized to interest expense over the life of the 2026 senior notes. The remaining loss to be amortized related to the interest rate swap agreements at </span><span style="font-family:inherit;font-size:10pt;">October 31, 2019</span><span style="font-family:inherit;font-size:10pt;"> was </span><span style="font-family:inherit;font-size:10pt;"><span>$7 million</span></span><span style="font-family:inherit;font-size:10pt;">. </span></div><div style="line-height:120%;text-align:justify;text-indent:36px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div><div style="line-height:120%;text-align:justify;text-indent:32px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">In August 2019, Agilent executed treasury lock agreements for </span><span style="font-family:inherit;font-size:10pt;"><span>$250 million</span></span><span style="font-family:inherit;font-size:10pt;"> in connection with future interest payments to be made on our 2029 senior notes issued on September 5, 2019. We designated the treasury lock as a cash flow hedge. The treasury lock contracts were terminated on September 6, 2019 and we recognized a deferred loss of </span><span style="font-family:inherit;font-size:10pt;"><span>$6 million</span></span><span style="font-family:inherit;font-size:10pt;"> in accumulated other comprehensive income which is being amortized to interest expense over the life of the 2029 senior notes. The remaining loss to be amortized related to the treasury lock agreements at October 31, 2019 was </span><span style="font-family:inherit;font-size:10pt;"><span>$6 million</span></span><span style="font-family:inherit;font-size:10pt;">. </span></div><div style="line-height:120%;text-align:justify;text-indent:36px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div><div style="line-height:120%;text-align:justify;text-indent:26px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;font-style:italic;font-weight:bold;">Other Hedges</span></div><div style="line-height:120%;text-align:justify;text-indent:26px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div><div style="line-height:120%;text-align:justify;text-indent:36px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Additionally, we enter into foreign exchange contracts to hedge monetary assets and liabilities that are denominated in currencies other than the functional currency of our subsidiaries. These foreign exchange contracts are carried at fair value and do not qualify for hedge accounting treatment and are not designated as hedging instruments. Changes in value of the derivative instruments are recognized in other income (expense),net in the consolidated statement of operations, in the current period, along with the offsetting foreign currency gain or loss on the underlying assets or liabilities.</span></div><div style="line-height:120%;text-align:justify;text-indent:36px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div><div style="line-height:120%;text-align:justify;text-indent:36px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Our use of derivative instruments exposes us to credit risk to the extent that the counterparties may be unable to meet the terms of the agreement. We do, however, seek to mitigate such risks by limiting our counterparties to major financial institutions which are selected based on their credit ratings and other factors. We have established policies and procedures for mitigating credit risk that include establishing counterparty credit limits, monitoring credit exposures, and continually assessing the creditworthiness of counterparties.</span></div><div style="line-height:120%;text-align:justify;text-indent:36px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div><div style="line-height:120%;text-align:justify;text-indent:36px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">A number of our derivative agreements contain threshold limits to the net liability position with counterparties and are dependent on our corporate credit rating determined by the major credit rating agencies. The counterparties to the derivative instruments may request collateralization, in accordance with derivative agreements, on derivative instruments in net liability positions.</span></div><div style="line-height:120%;text-align:justify;text-indent:36px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div><div style="line-height:120%;text-align:justify;text-indent:36px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">The aggregate fair value of all derivative instruments with credit-risk-related contingent features that were in a net liability position as of </span><span style="font-family:inherit;font-size:10pt;color:#000000;text-decoration:none;">October 31, 2019</span><span style="font-family:inherit;font-size:10pt;">, was </span><span style="font-family:inherit;font-size:10pt;"><span>$2 million</span></span><span style="font-family:inherit;font-size:10pt;">. The credit-risk-related contingent features underlying these agreements had not been triggered as of </span><span style="font-family:inherit;font-size:10pt;color:#000000;text-decoration:none;">October 31, 2019</span><span style="font-family:inherit;font-size:10pt;">.</span></div><div style="line-height:120%;text-align:justify;text-indent:36px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div><div style="line-height:120%;text-align:justify;text-indent:36px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">There were </span><span style="font-family:inherit;font-size:10pt;color:#000000;text-decoration:none;"><span>261</span></span><span style="font-family:inherit;font-size:10pt;"> foreign exchange forward contracts open as of </span><span style="font-family:inherit;font-size:10pt;color:#000000;text-decoration:none;">October 31, 2019</span><span style="font-family:inherit;font-size:10pt;"> and designated as cash flow hedges. There were </span><span style="font-family:inherit;font-size:10pt;color:#000000;text-decoration:none;"><span>205</span></span><span style="font-family:inherit;font-size:10pt;"> foreign exchange forward contracts open as of </span><span style="font-family:inherit;font-size:10pt;color:#000000;text-decoration:none;">October 31, 2019</span><span style="font-family:inherit;font-size:10pt;"> not designated as hedging instruments. The aggregated notional amounts by currency and designation as of </span><span style="font-family:inherit;font-size:10pt;color:#000000;text-decoration:none;">October 31, 2019</span><span style="font-family:inherit;font-size:10pt;"> were as follows:</span></div><div style="line-height:120%;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="9"/></tr><tr><td style="width:68%;"/><td style="width:1%;"/><td style="width:1%;"/><td style="width:13%;"/><td style="width:1%;"/><td style="width:1%;"/><td style="width:1%;"/><td style="width:13%;"/><td style="width:1%;"/></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;font-weight:bold;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:8pt;"><span style="font-family:inherit;font-size:8pt;font-weight:bold;">Derivatives Designated as <br/>Cash Flow Hedges<br/></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:8pt;"><span style="font-family:inherit;font-size:8pt;font-weight:bold;">Derivatives</span></div><div style="text-align:center;font-size:8pt;"><span style="font-family:inherit;font-size:8pt;font-weight:bold;">Not</span></div><div style="text-align:center;font-size:8pt;"><span style="font-family:inherit;font-size:8pt;font-weight:bold;">Designated</span></div><div style="text-align:center;font-size:8pt;"><span style="font-family:inherit;font-size:8pt;font-weight:bold;">as Hedging</span></div><div style="text-align:center;font-size:8pt;"><span style="font-family:inherit;font-size:8pt;font-weight:bold;">Instruments</span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:inherit;font-size:8pt;font-weight:bold;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:8pt;"><span style="font-family:inherit;font-size:8pt;font-weight:bold;">Forward<br/>Contracts USD</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:8pt;"><span style="font-family:inherit;font-size:8pt;font-weight:bold;">Forward<br/>Contracts USD</span></div></td></tr><tr><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:8pt;"><span style="font-family:inherit;font-size:8pt;font-weight:bold;">Currency</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:8pt;"><span style="font-family:inherit;font-size:8pt;font-weight:bold;">Buy/(Sell)</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:8pt;"><span style="font-family:inherit;font-size:8pt;font-weight:bold;">Buy/(Sell)</span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:inherit;font-size:8pt;font-weight:bold;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="7" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:center;font-size:8pt;"><span style="font-family:inherit;font-size:8pt;font-weight:bold;">(in millions)</span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Euro</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>(40</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">)</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>141</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">British Pound</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>(45</span></span></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">)</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>1</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Canadian Dollar</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>(38</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">)</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>25</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Australian Dollar</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>4</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">—</span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Malaysian Ringgit</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">—</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>11</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Japanese Yen</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>(82</span></span></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">)</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>(7</span></span></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">)</span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Danish Krone</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">—</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>237</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Korean Won</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>(59</span></span></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">)</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>(32</span></span></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">)</span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Singapore Dollar</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>14</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>28</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Swiss Franc</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">—</span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>(2</span></span></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">)</span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Chinese Yuan Renminbi</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>(59</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">)</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>(70</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">)</span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Swedish Krona</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">—</span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>(8</span></span></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">)</span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Other</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">—</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>(23</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">)</span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>(305</span></span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-right:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">)</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>301</span></span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr></table></div><span style="font-family:inherit;font-size:10pt;"><br/></span></div><div style="line-height:120%;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div><div style="line-height:120%;text-align:justify;text-indent:36px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> Derivative instruments are subject to master netting arrangements and are disclosed gross in the balance sheet in accordance with the authoritative guidance. The gross fair values and balance sheet location of derivative instruments held in the consolidated balance sheet as of </span><span style="font-family:inherit;font-size:10pt;color:#000000;text-decoration:none;">October 31, 2019</span><span style="font-family:inherit;font-size:10pt;"> and </span><span style="font-family:inherit;font-size:10pt;color:#000000;text-decoration:none;">2018</span><span style="font-family:inherit;font-size:10pt;"> were as follows:</span></div><div style="line-height:120%;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div><div style="line-height:120%;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="19"/></tr><tr><td style="width:29%;"/><td style="width:1%;"/><td style="width:1%;"/><td style="width:9%;"/><td style="width:1%;"/><td style="width:1%;"/><td style="width:1%;"/><td style="width:9%;"/><td style="width:1%;"/><td style="width:1%;"/><td style="width:22%;"/><td style="width:1%;"/><td style="width:1%;"/><td style="width:9%;"/><td style="width:1%;"/><td style="width:1%;"/><td style="width:1%;"/><td style="width:9%;"/><td style="width:1%;"/></tr><tr><td colspan="19" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:8pt;"><span style="font-family:inherit;font-size:8pt;font-weight:bold;">Fair Values of Derivative Instruments</span></div></td></tr><tr><td colspan="9" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:8pt;"><span style="font-family:inherit;font-size:8pt;font-weight:bold;">Asset Derivatives</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="9" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:8pt;"><span style="font-family:inherit;font-size:8pt;font-weight:bold;">Liability Derivatives</span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:inherit;font-size:8pt;font-weight:bold;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="7" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:center;font-size:8pt;"><span style="font-family:inherit;font-size:8pt;font-weight:bold;">Fair Value</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:inherit;font-size:8pt;font-weight:bold;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="7" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:center;font-size:8pt;"><span style="font-family:inherit;font-size:8pt;font-weight:bold;">Fair Value</span></div></td></tr><tr><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:8pt;"><span style="font-family:inherit;font-size:8pt;font-weight:bold;">Balance Sheet Location</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="text-align:center;font-size:8pt;"><span style="font-family:inherit;font-size:8pt;font-weight:bold;">October 31, <br/>2019</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="text-align:center;font-size:8pt;"><span style="font-family:inherit;font-size:8pt;font-weight:bold;">October 31, <br/>2018</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:8pt;"><span style="font-family:inherit;font-size:8pt;font-weight:bold;">Balance Sheet Location</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="text-align:center;font-size:8pt;"><span style="font-family:inherit;font-size:8pt;font-weight:bold;">October 31, <br/>2019</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="text-align:center;font-size:8pt;"><span style="font-family:inherit;font-size:8pt;font-weight:bold;">October 31, <br/>2018</span></div></td></tr><tr><td colspan="19" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:8pt;"><span style="font-family:inherit;font-size:8pt;font-weight:bold;">(in millions)</span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;font-weight:bold;">Derivatives designated as hedging instruments:</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;font-style:italic;">Cash flow hedges</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Foreign exchange contracts</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Other current assets</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>3</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>11</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Other accrued liabilities</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>2</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>1</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:16px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:16px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:16px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:16px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:16px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:16px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:16px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:16px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:16px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:16px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:16px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;font-weight:bold;">Derivatives not designated as hedging instruments:</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Foreign exchange contracts</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Other current assets</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>9</span></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>5</span></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Other accrued liabilities</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>4</span></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>4</span></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Total derivatives</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>12</span></span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>16</span></span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>6</span></span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>5</span></span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr></table></div><span style="font-family:inherit;font-size:10pt;"><br/></span></div><div style="line-height:120%;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div><div style="line-height:120%;text-align:justify;text-indent:36px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">The effect of derivative instruments for foreign exchange contracts designated as hedging instruments and not designated as hedging instruments in our consolidated statement of operations were as follows:</span></div><div style="line-height:120%;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div><div style="line-height:120%;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="12"/></tr><tr><td style="width:68%;"/><td style="width:1%;"/><td style="width:8%;"/><td style="width:1%;"/><td style="width:1%;"/><td style="width:1%;"/><td style="width:8%;"/><td style="width:1%;"/><td style="width:1%;"/><td style="width:1%;"/><td style="width:8%;"/><td style="width:1%;"/></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="11" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:center;font-size:8pt;"><span style="font-family:inherit;font-size:8pt;font-weight:bold;">Years Ended October 31,</span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-top:2px;padding-bottom:2px;"><div style="text-align:center;font-size:8pt;"><span style="font-family:inherit;font-size:8pt;font-weight:bold;">2019</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-top:2px;padding-bottom:2px;"><div style="text-align:center;font-size:8pt;"><span style="font-family:inherit;font-size:8pt;font-weight:bold;">2018</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-top:2px;padding-bottom:2px;"><div style="text-align:center;font-size:8pt;"><span style="font-family:inherit;font-size:8pt;font-weight:bold;">2017</span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:inherit;font-size:8pt;font-weight:bold;"> </span></div></td><td colspan="11" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:center;font-size:8pt;"><span style="font-family:inherit;font-size:8pt;font-weight:bold;">(in millions)</span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;font-weight:bold;">Derivatives designated as hedging instruments:</span></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;font-style:italic;">Cash flow hedges</span></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Loss on interest rate swaps recognized in other comprehensive income (loss)</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>(6</span></span></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">)</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>—</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>—</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Loss reclassified from accumulated other comprehensive income into interest expense</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>(1</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">)</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>(1</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">)</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>—</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Gain (loss) recognized in accumulated other comprehensive income (loss)</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>—</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>7</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>—</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Gain (loss) reclassified from accumulated other comprehensive income (loss) into cost of sales</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>9</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>(3</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">)</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>1</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Gain (loss) on time value of forward contracts recorded in cost of sales</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>2</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>—</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>—</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;font-weight:bold;">Derivatives not designated as hedging instruments:</span></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Gain (loss) recognized in other income (expense), net </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>2</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>(2</span></span></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">)</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>5</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr></table></div><span style="font-family:inherit;font-size:10pt;"><br/></span></div><div style="line-height:120%;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div><div style="line-height:120%;text-align:justify;text-indent:36px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">At </span><span style="font-family:inherit;font-size:10pt;color:#000000;text-decoration:none;">October 31, 2019</span><span style="font-family:inherit;font-size:10pt;"> the estimated amount of existing net gain that is expected to be reclassified from accumulated other comprehensive income to cost of sales within the next twelve months is </span><span style="font-family:inherit;font-size:10pt;"><span>$4 million</span></span><span style="font-family:inherit;font-size:10pt;">.</span></div> 5 500000000 400000000 1000000 300000000 10000000 7000000 250000000 6000000 6000000 2000000 261 205 The aggregated notional amounts by currency and designation as of <span style="font-family:inherit;font-size:10pt;color:#000000;text-decoration:none;">October 31, 2019</span><span style="font-family:inherit;font-size:10pt;"> were as follows:</span><div style="line-height:120%;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="9"/></tr><tr><td style="width:68%;"/><td style="width:1%;"/><td style="width:1%;"/><td style="width:13%;"/><td style="width:1%;"/><td style="width:1%;"/><td style="width:1%;"/><td style="width:13%;"/><td style="width:1%;"/></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;font-weight:bold;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:8pt;"><span style="font-family:inherit;font-size:8pt;font-weight:bold;">Derivatives Designated as <br/>Cash Flow Hedges<br/></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:8pt;"><span style="font-family:inherit;font-size:8pt;font-weight:bold;">Derivatives</span></div><div style="text-align:center;font-size:8pt;"><span style="font-family:inherit;font-size:8pt;font-weight:bold;">Not</span></div><div style="text-align:center;font-size:8pt;"><span style="font-family:inherit;font-size:8pt;font-weight:bold;">Designated</span></div><div style="text-align:center;font-size:8pt;"><span style="font-family:inherit;font-size:8pt;font-weight:bold;">as Hedging</span></div><div style="text-align:center;font-size:8pt;"><span style="font-family:inherit;font-size:8pt;font-weight:bold;">Instruments</span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:inherit;font-size:8pt;font-weight:bold;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:8pt;"><span style="font-family:inherit;font-size:8pt;font-weight:bold;">Forward<br/>Contracts USD</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:8pt;"><span style="font-family:inherit;font-size:8pt;font-weight:bold;">Forward<br/>Contracts USD</span></div></td></tr><tr><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:8pt;"><span style="font-family:inherit;font-size:8pt;font-weight:bold;">Currency</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:8pt;"><span style="font-family:inherit;font-size:8pt;font-weight:bold;">Buy/(Sell)</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:8pt;"><span style="font-family:inherit;font-size:8pt;font-weight:bold;">Buy/(Sell)</span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:inherit;font-size:8pt;font-weight:bold;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="7" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:center;font-size:8pt;"><span style="font-family:inherit;font-size:8pt;font-weight:bold;">(in millions)</span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Euro</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>(40</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">)</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>141</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">British Pound</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>(45</span></span></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">)</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>1</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Canadian Dollar</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>(38</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">)</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>25</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Australian Dollar</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>4</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">—</span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Malaysian Ringgit</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">—</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>11</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Japanese Yen</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>(82</span></span></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">)</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>(7</span></span></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">)</span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Danish Krone</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">—</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>237</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Korean Won</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>(59</span></span></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">)</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>(32</span></span></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">)</span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Singapore Dollar</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>14</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>28</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Swiss Franc</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">—</span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>(2</span></span></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">)</span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Chinese Yuan Renminbi</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>(59</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">)</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>(70</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">)</span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Swedish Krona</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">—</span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>(8</span></span></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">)</span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Other</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">—</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>(23</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">)</span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>(305</span></span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-right:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">)</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>301</span></span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr></table></div><span style="font-family:inherit;font-size:10pt;"><br/></span></div> 40000000 141000000 45000000 1000000 38000000 25000000 4000000 11000000 82000000 7000000 237000000 59000000 32000000 14000000 28000000 2000000 59000000 70000000 8000000 23000000 305000000 301000000 The gross fair values and balance sheet location of derivative instruments held in the consolidated balance sheet as of <span style="font-family:inherit;font-size:10pt;color:#000000;text-decoration:none;">October 31, 2019</span><span style="font-family:inherit;font-size:10pt;"> and </span><span style="font-family:inherit;font-size:10pt;color:#000000;text-decoration:none;">2018</span><span style="font-family:inherit;font-size:10pt;"> were as follows:</span><div style="line-height:120%;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div><div style="line-height:120%;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="19"/></tr><tr><td style="width:29%;"/><td style="width:1%;"/><td style="width:1%;"/><td style="width:9%;"/><td style="width:1%;"/><td style="width:1%;"/><td style="width:1%;"/><td style="width:9%;"/><td style="width:1%;"/><td style="width:1%;"/><td style="width:22%;"/><td style="width:1%;"/><td style="width:1%;"/><td style="width:9%;"/><td style="width:1%;"/><td style="width:1%;"/><td style="width:1%;"/><td style="width:9%;"/><td style="width:1%;"/></tr><tr><td colspan="19" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:8pt;"><span style="font-family:inherit;font-size:8pt;font-weight:bold;">Fair Values of Derivative Instruments</span></div></td></tr><tr><td colspan="9" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:8pt;"><span style="font-family:inherit;font-size:8pt;font-weight:bold;">Asset Derivatives</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="9" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:8pt;"><span style="font-family:inherit;font-size:8pt;font-weight:bold;">Liability Derivatives</span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:inherit;font-size:8pt;font-weight:bold;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="7" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:center;font-size:8pt;"><span style="font-family:inherit;font-size:8pt;font-weight:bold;">Fair Value</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:inherit;font-size:8pt;font-weight:bold;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="7" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:center;font-size:8pt;"><span style="font-family:inherit;font-size:8pt;font-weight:bold;">Fair Value</span></div></td></tr><tr><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:8pt;"><span style="font-family:inherit;font-size:8pt;font-weight:bold;">Balance Sheet Location</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="text-align:center;font-size:8pt;"><span style="font-family:inherit;font-size:8pt;font-weight:bold;">October 31, <br/>2019</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="text-align:center;font-size:8pt;"><span style="font-family:inherit;font-size:8pt;font-weight:bold;">October 31, <br/>2018</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:8pt;"><span style="font-family:inherit;font-size:8pt;font-weight:bold;">Balance Sheet Location</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="text-align:center;font-size:8pt;"><span style="font-family:inherit;font-size:8pt;font-weight:bold;">October 31, <br/>2019</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="text-align:center;font-size:8pt;"><span style="font-family:inherit;font-size:8pt;font-weight:bold;">October 31, <br/>2018</span></div></td></tr><tr><td colspan="19" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:8pt;"><span style="font-family:inherit;font-size:8pt;font-weight:bold;">(in millions)</span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;font-weight:bold;">Derivatives designated as hedging instruments:</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;font-style:italic;">Cash flow hedges</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Foreign exchange contracts</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Other current assets</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>3</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>11</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Other accrued liabilities</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>2</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>1</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:16px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:16px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:16px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:16px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:16px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:16px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:16px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:16px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:16px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:16px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:16px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;font-weight:bold;">Derivatives not designated as hedging instruments:</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Foreign exchange contracts</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Other current assets</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>9</span></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>5</span></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Other accrued liabilities</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>4</span></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>4</span></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Total derivatives</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>12</span></span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>16</span></span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>6</span></span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>5</span></span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr></table></div><span style="font-family:inherit;font-size:10pt;"><br/></span></div><div style="line-height:120%;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div> 3000000 11000000 2000000 1000000 9000000 5000000 4000000 4000000 12000000 16000000 6000000 5000000 <div style="line-height:120%;text-align:justify;text-indent:36px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">The effect of derivative instruments for foreign exchange contracts designated as hedging instruments and not designated as hedging instruments in our consolidated statement of operations were as follows:</span></div><div style="line-height:120%;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div><div style="line-height:120%;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="12"/></tr><tr><td style="width:68%;"/><td style="width:1%;"/><td style="width:8%;"/><td style="width:1%;"/><td style="width:1%;"/><td style="width:1%;"/><td style="width:8%;"/><td style="width:1%;"/><td style="width:1%;"/><td style="width:1%;"/><td style="width:8%;"/><td style="width:1%;"/></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="11" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:center;font-size:8pt;"><span style="font-family:inherit;font-size:8pt;font-weight:bold;">Years Ended October 31,</span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-top:2px;padding-bottom:2px;"><div style="text-align:center;font-size:8pt;"><span style="font-family:inherit;font-size:8pt;font-weight:bold;">2019</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-top:2px;padding-bottom:2px;"><div style="text-align:center;font-size:8pt;"><span style="font-family:inherit;font-size:8pt;font-weight:bold;">2018</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-top:2px;padding-bottom:2px;"><div style="text-align:center;font-size:8pt;"><span style="font-family:inherit;font-size:8pt;font-weight:bold;">2017</span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:inherit;font-size:8pt;font-weight:bold;"> </span></div></td><td colspan="11" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:center;font-size:8pt;"><span style="font-family:inherit;font-size:8pt;font-weight:bold;">(in millions)</span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;font-weight:bold;">Derivatives designated as hedging instruments:</span></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;font-style:italic;">Cash flow hedges</span></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Loss on interest rate swaps recognized in other comprehensive income (loss)</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>(6</span></span></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">)</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>—</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>—</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Loss reclassified from accumulated other comprehensive income into interest expense</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>(1</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">)</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>(1</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">)</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>—</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Gain (loss) recognized in accumulated other comprehensive income (loss)</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>—</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>7</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>—</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Gain (loss) reclassified from accumulated other comprehensive income (loss) into cost of sales</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>9</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>(3</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">)</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>1</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Gain (loss) on time value of forward contracts recorded in cost of sales</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>2</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>—</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>—</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;font-weight:bold;">Derivatives not designated as hedging instruments:</span></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Gain (loss) recognized in other income (expense), net </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>2</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>(2</span></span></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">)</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>5</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr></table></div><span style="font-family:inherit;font-size:10pt;"><br/></span></div> 6000000 0 0 -1000000 -1000000 0 0 7000000 0 9000000 -3000000 1000000 2000000 0 0 2000000 -2000000 5000000 4000000 RETIREMENT PLANS AND POST RETIREMENT PENSION PLANS<div style="line-height:120%;text-align:justify;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div><div style="line-height:120%;text-align:justify;text-indent:36px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;font-style:italic;">General.</span><span style="font-family:inherit;font-size:10pt;">    Substantially all of our employees are covered under various defined benefit and/or defined contribution retirement plans. Additionally, we sponsor post-retirement health care benefits for our eligible U.S. employees.</span></div><div style="line-height:120%;text-align:justify;text-indent:36px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div><div style="line-height:120%;text-align:justify;text-indent:36px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Agilent provides defined benefits to U.S. employees, who meet eligibility criteria under the Agilent Technologies, Inc. Retirement Plan (the "RP"). </span></div><div style="line-height:120%;text-align:justify;text-indent:36px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div><div style="line-height:120%;text-align:justify;text-indent:36px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">For eligible service through October 31, 1993, the benefit payable under the Agilent Retirement Plan is reduced by any amounts due to the eligible employee under the Agilent defined contribution Deferred Profit-Sharing Plan (the "DPSP"), which was closed to new participants as of November 1993. </span></div><div style="line-height:120%;text-align:justify;text-indent:36px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div><div style="line-height:120%;text-align:justify;text-indent:36px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">As of </span><span style="font-family:inherit;font-size:10pt;">October 31, 2019</span><span style="font-family:inherit;font-size:10pt;"> and </span><span style="font-family:inherit;font-size:10pt;">2018</span><span style="font-family:inherit;font-size:10pt;">, the fair value of plan assets of the DPSP was </span><span style="font-family:inherit;font-size:10pt;"><span>$132 million</span></span><span style="font-family:inherit;font-size:10pt;"> and </span><span style="font-family:inherit;font-size:10pt;"><span>$141 million</span></span><span style="font-family:inherit;font-size:10pt;">, respectively. Note that the projected benefit obligation for the DPSP equals the fair value of plan assets.</span></div><div style="line-height:120%;text-align:justify;text-indent:36px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div><div style="line-height:120%;text-align:justify;text-indent:36px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Effective November 1, 2014, Agilent’s U.S. defined benefit retirement plan was closed to new entrants including new employees, new transfers to the U.S. payroll and rehires. As of April 30, 2016, benefits under the RP were frozen. Any pension benefit earned in the U.S. Plans through April 30, 2016 remained fully vested, and there are no additional benefit accruals after April 30, 2016.</span></div><div style="line-height:120%;text-align:justify;text-indent:36px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div><div style="line-height:120%;text-align:justify;text-indent:36px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Agilent also maintains a Supplemental Benefits Retirement Plan ("SBRP") in the U.S., which is a supplemental unfunded non-qualified defined benefit plan to provide benefits that would be provided under the RP but for limitations imposed by the Internal Revenue Code. The RP and the SBRP comprise the "U.S. Plans" in the tables below.</span></div><div style="line-height:120%;text-align:justify;text-indent:36px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div><div style="line-height:120%;text-align:justify;text-indent:36px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Eligible employees outside the U.S. generally receive retirement benefits under various retirement plans based upon factors such as years of service and/or employee compensation levels. Eligibility is generally determined in accordance with local statutory requirements.</span></div><div style="line-height:120%;text-align:justify;text-indent:36px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div><div style="line-height:120%;text-align:justify;text-indent:36px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;font-style:italic;">Post-Retirement Medical Benefit Plans.</span><span style="font-family:inherit;font-size:10pt;">    In addition to receiving retirement benefits, Agilent U.S. employees who meet eligibility requirements as of their termination date may participate in the Agilent Technologies, Inc. Health Plan for Retirees. </span></div><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman; font-size:10pt;"><tr><td style="width:60px;"/><td/></tr><tr><td style="vertical-align:top"><div style="line-height:120%;font-size:10pt;padding-left:36px;"><span style="font-family:inherit;font-size:10pt;">–</span></div></td><td style="vertical-align:top;"><div style="line-height:120%;text-align:justify;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Eligible retirees who were less than age 50 as of January 1, 2005 and who retire after age 55 with 15 or more years of service are eligible for a fixed amount which can be utilized to pay for either sponsored plans and/or individual Medicare plans. </span></div></td></tr></table><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman; font-size:10pt;"><tr><td style="width:60px;"/><td/></tr><tr><td style="vertical-align:top"><div style="line-height:120%;font-size:10pt;padding-left:36px;"><span style="font-family:inherit;font-size:10pt;">–</span></div></td><td style="vertical-align:top;"><div style="line-height:120%;text-align:justify;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Effective January 1, 2012, employees who were at least age 50 as of January 1, 2005 and who retire after age 55 with 15 or more years of service are eligible for fixed dollar subsidies and stipends. Grandfathered retirees receive a fixed monthly subsidy toward pre-65 premium costs (subsidy capped at 2011 levels) and a fixed monthly stipend post-65. The subsidy amounts will not increase. </span></div></td></tr></table><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman; font-size:10pt;"><tr><td style="width:60px;"/><td/></tr><tr><td style="vertical-align:top"><div style="line-height:120%;font-size:10pt;padding-left:36px;"><span style="font-family:inherit;font-size:10pt;">–</span></div></td><td style="vertical-align:top;"><div style="line-height:120%;text-align:justify;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Any new employee hired on or after November 1, 2014, will not be eligible to participate in the retiree medical plans upon retiring. </span></div></td></tr></table><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman; font-size:10pt;"><tr><td style="width:60px;"/><td/></tr><tr><td style="vertical-align:top"><div style="line-height:120%;font-size:10pt;padding-left:36px;"><span style="font-family:inherit;font-size:10pt;">–</span></div></td><td style="vertical-align:top;"><div style="line-height:120%;text-align:justify;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">As of April 30, 2016, benefits under this plan were changed for Active employees who have not met the eligibility requirement - 55 years old with at least 15 years of Agilent service, as of April 30, 2016 - for the Retiree Medical Account (RMA) under the U.S. Post Retirement Benefit Plan These employees will only be eligible for 50 percent of the current RMA reimbursement amount upon retirement.</span></div></td></tr></table><div style="line-height:120%;text-align:justify;text-indent:36px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div><div style="line-height:120%;text-align:justify;text-indent:36px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;font-style:italic;">401(k) Defined Contribution Plan</span><span style="font-family:inherit;font-size:10pt;">.    Eligible Agilent U.S. employees may participate in the Agilent Technologies, Inc. 401(k) Plan. Effective April 30, 2016, we began matching contributions to employees up to a maximum of </span><span style="font-family:inherit;font-size:10pt;"><span>6 percent</span></span><span style="font-family:inherit;font-size:10pt;"> of an employee's annual eligible compensation. Effective May 1, 2016 until April 30, 2022, we will provide an additional transitional company contribution for certain eligible employees equal to </span><span style="font-family:inherit;font-size:10pt;"><span>3 percent</span></span><span style="font-family:inherit;font-size:10pt;">, </span><span style="font-family:inherit;font-size:10pt;"><span>4 percent</span></span><span style="font-family:inherit;font-size:10pt;"> or </span><span style="font-family:inherit;font-size:10pt;"><span>5 percent</span></span><span style="font-family:inherit;font-size:10pt;"> of an employee's annual eligible compensation due to the RP benefits being frozen. The maximum contribution to the 401(k) Plan is </span><span style="font-family:inherit;font-size:10pt;"><span>50 percent</span></span><span style="font-family:inherit;font-size:10pt;"> of an employee's annual eligible compensation, subject to regulatory limitations. The 401(k) Plan employer expense included in income from operations was </span><span style="font-family:inherit;font-size:10pt;"><span>$39 million</span></span><span style="font-family:inherit;font-size:10pt;"> in </span><span style="font-family:inherit;font-size:10pt;">2019</span><span style="font-family:inherit;font-size:10pt;">, </span><span style="font-family:inherit;font-size:10pt;"><span>$37 million</span></span><span style="font-family:inherit;font-size:10pt;"> in </span><span style="font-family:inherit;font-size:10pt;">2018</span><span style="font-family:inherit;font-size:10pt;"> and </span><span style="font-family:inherit;font-size:10pt;"><span>$33 million</span></span><span style="font-family:inherit;font-size:10pt;"> in </span><span style="font-family:inherit;font-size:10pt;">2017</span><span style="font-family:inherit;font-size:10pt;">.</span></div><div style="line-height:120%;text-align:justify;text-indent:36px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div><div style="line-height:120%;text-align:justify;text-indent:24px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;font-style:italic;">Japanese Welfare Pension Insurance Law</span><span style="font-family:inherit;font-size:10pt;">. In Japan, Agilent has employees' pension fund plans, which are defined benefit pension plans established under the Japanese Welfare Pension Insurance Law (JWPIL). The plans are composed of (a) a substitutional portion based on the pay-related part of the old-age pension benefits prescribed by JWPIL (similar to social security benefits in the United States) and (b) a corporate portion based on a contributory defined benefit pension arrangement established at the discretion of the company. </span><span style="font-family:inherit;font-size:10pt;color:#1a1a1a;">During the year ended October</span><span style="font-family:inherit;font-size:10pt;"> 31, 2017</span><span style="font-family:inherit;font-size:10pt;color:#1a1a1a;">, </span><span style="font-family:inherit;font-size:10pt;">Agilent received government approval and returned the substitutional portion of Japan's pension plan to the Japanese government, as allowed by the JWPIL. The initial transfer resulted in a net gain of </span><span style="font-family:inherit;font-size:10pt;"><span>$32 million</span></span><span style="font-family:inherit;font-size:10pt;"> recorded in other income (expense), net in the consolidated statement of operations. The net gain consisted of two parts - a gain of </span><span style="font-family:inherit;font-size:10pt;"><span>$41 million</span></span><span style="font-family:inherit;font-size:10pt;">, representing the difference between the fair values of the Accumulated Benefit Obligation (ABO) settled of </span><span style="font-family:inherit;font-size:10pt;"><span>$65 million</span></span><span style="font-family:inherit;font-size:10pt;"> and the assets transferred from the pension trust to the government of Japan of </span><span style="font-family:inherit;font-size:10pt;"><span>$24 million</span></span><span style="font-family:inherit;font-size:10pt;">, offset by a settlement loss of </span><span style="font-family:inherit;font-size:10pt;"><span>$9 million</span></span><span style="font-family:inherit;font-size:10pt;"> related to the recognition of previously unrecognized actuarial losses included in accumulated other comprehensive income. In the first quarter of fiscal year 2018, after the Japanese government’s final review of our initial payment, we received a refund of </span><span style="font-family:inherit;font-size:10pt;"><span>$5 million</span></span><span style="font-family:inherit;font-size:10pt;"> which was recorded as a settlement gain.</span></div><div style="line-height:120%;text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div><div style="line-height:120%;text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div><div style="line-height:120%;text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div><div style="line-height:120%;text-align:justify;text-indent:33px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div><div style="line-height:120%;text-align:justify;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div><div style="line-height:120%;text-align:justify;text-indent:36px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;font-style:italic;">Components of Net periodic cost.</span><span style="font-family:inherit;font-size:10pt;">   The service cost component is recorded in cost of sales and operating expenses in the consolidated statement of operations. All other cost components are recorded in other income (expense), net in the consolidated statement of operations. The company uses alternate methods of amortization as allowed by the authoritative guidance which amortizes the actuarial gains and losses on a consistent basis for the years presented. For U.S. Plans, gains and losses are amortized over the average future lifetime of participants using the corridor method. For most Non-U.S. Plans and U.S. Post-Retirement Benefit Plans, gains and losses are amortized using a separate layer for each year's gains and losses.</span></div><div style="line-height:120%;text-align:justify;text-indent:36px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div><div style="line-height:120%;text-align:justify;text-indent:36px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">For the years ended </span><span style="font-family:inherit;font-size:10pt;">October 31, 2019</span><span style="font-family:inherit;font-size:10pt;">, </span><span style="font-family:inherit;font-size:10pt;">2018</span><span style="font-family:inherit;font-size:10pt;"> and </span><span style="font-family:inherit;font-size:10pt;">2017</span><span style="font-family:inherit;font-size:10pt;">, components of net periodic benefit cost and other amounts recognized in other comprehensive income were comprised of:</span></div><div style="line-height:120%;text-align:justify;text-indent:0px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="36"/></tr><tr><td style="width:37%;"/><td style="width:1%;"/><td style="width:4%;"/><td style="width:1%;"/><td style="width:1%;"/><td style="width:1%;"/><td style="width:4%;"/><td style="width:1%;"/><td style="width:1%;"/><td style="width:1%;"/><td style="width:4%;"/><td style="width:1%;"/><td style="width:1%;"/><td style="width:1%;"/><td style="width:4%;"/><td style="width:1%;"/><td style="width:1%;"/><td style="width:1%;"/><td style="width:4%;"/><td style="width:1%;"/><td style="width:1%;"/><td style="width:1%;"/><td style="width:4%;"/><td style="width:1%;"/><td style="width:1%;"/><td style="width:1%;"/><td style="width:4%;"/><td style="width:1%;"/><td style="width:1%;"/><td style="width:1%;"/><td style="width:4%;"/><td style="width:1%;"/><td style="width:1%;"/><td style="width:1%;"/><td style="width:5%;"/><td style="width:1%;"/></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:inherit;font-size:8pt;font-weight:bold;"> </span></div></td><td colspan="23" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:center;font-size:8pt;"><span style="font-family:inherit;font-size:8pt;font-weight:bold;">Pensions</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="11" rowspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:center;font-size:8pt;"><span style="font-family:inherit;font-size:8pt;font-weight:bold;">U.S. Post-Retirement Benefit Plans</span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:inherit;font-size:8pt;font-weight:bold;"> </span></div></td><td colspan="11" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:center;font-size:8pt;"><span style="font-family:inherit;font-size:8pt;font-weight:bold;">U.S. Plans</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="11" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:center;font-size:8pt;"><span style="font-family:inherit;font-size:8pt;font-weight:bold;">Non-U.S. Plans</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:17px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:17px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:17px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:17px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:17px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:17px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:17px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:17px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:17px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:17px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:17px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:17px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:17px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:17px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:17px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:17px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:17px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:17px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:inherit;font-size:8pt;font-weight:bold;"> </span></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:8pt;"><span style="font-family:inherit;font-size:8pt;font-weight:bold;">2019</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="text-align:center;font-size:8pt;"><span style="font-family:inherit;font-size:8pt;font-weight:bold;">2018</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:8pt;"><span style="font-family:inherit;font-size:8pt;font-weight:bold;">2017</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:8pt;"><span style="font-family:inherit;font-size:8pt;font-weight:bold;">2019</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:8pt;"><span style="font-family:inherit;font-size:8pt;font-weight:bold;">2018</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:8pt;"><span style="font-family:inherit;font-size:8pt;font-weight:bold;">2017</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:8pt;"><span style="font-family:inherit;font-size:8pt;font-weight:bold;">2019</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="text-align:center;font-size:8pt;"><span style="font-family:inherit;font-size:8pt;font-weight:bold;">2018</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:8pt;"><span style="font-family:inherit;font-size:8pt;font-weight:bold;">2017</span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:inherit;font-size:8pt;font-weight:bold;"> </span></div></td><td colspan="35" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:center;font-size:8pt;"><span style="font-family:inherit;font-size:8pt;font-weight:bold;">(in millions)</span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;font-weight:bold;">Net periodic benefit cost (benefit)</span></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Service cost — benefits earned during the period</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>—</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>—</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>—</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>20</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>20</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>19</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>—</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>1</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>1</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Interest cost on benefit obligation</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>18</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>16</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>15</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>14</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>13</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>12</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>4</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>3</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>3</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Expected return on plan assets</span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>(27</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">)</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>(28</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">)</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>(25</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">)</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>(43</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">)</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>(46</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">)</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>(41</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">)</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>(7</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">)</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>(7</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">)</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>(7</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">)</span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Amortization of net actuarial loss</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>1</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>1</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>3</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>34</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>29</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>36</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>4</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>8</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>11</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Amortization of prior service benefit</span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>—</span></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>—</span></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>—</span></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>—</span></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>—</span></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>—</span></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>(8</span></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">)</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>(8</span></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">)</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>(9</span></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">)</span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Total periodic benefit cost (benefit)</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>(8</span></span></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">)</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>(11</span></span></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">)</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>(7</span></span></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">)</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>25</span></span></div></td><td style="vertical-align:bottom;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>16</span></span></div></td><td style="vertical-align:bottom;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>26</span></span></div></td><td style="vertical-align:bottom;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>(7</span></span></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">)</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>(3</span></span></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">)</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>(1</span></span></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">)</span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Curtailments and settlements</span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>—</span></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>—</span></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>—</span></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>—</span></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>(5</span></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">)</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>(32</span></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">)</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>—</span></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>—</span></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>—</span></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;font-weight:bold;">Other changes in plan assets and benefit obligations recognized in other comprehensive (income) loss</span></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Net actuarial (gain) loss</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>51</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>2</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>(19</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">)</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>104</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>49</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>(128</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">)</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>5</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>(2</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">)</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>(9</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">)</span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Amortization of net actuarial loss</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>(1</span></span></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">)</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>(1</span></span></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">)</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>(3</span></span></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">)</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>(34</span></span></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">)</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>(29</span></span></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">)</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>(36</span></span></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">)</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>(4</span></span></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">)</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>(8</span></span></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">)</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>(11</span></span></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">)</span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Prior service cost (benefit)</span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>—</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>—</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>—</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>—</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>—</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>—</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>—</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>—</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>—</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Amortization of prior service benefit</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>—</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>—</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>—</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>—</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>—</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>—</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>8</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>8</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>9</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Gain due to settlement</span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>—</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>—</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>—</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>—</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>—</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>32</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>—</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>—</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>—</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Foreign currency</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>—</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>—</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>—</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>(3</span></span></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">)</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>1</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>2</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>—</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>—</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>—</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Total recognized in other comprehensive (income) loss</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>50</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>1</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>(22</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">)</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>67</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>21</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>(130</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">)</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>9</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>(2</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">)</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>(11</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">)</span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Total recognized in net periodic benefit cost (benefit) and other comprehensive (income) loss</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>42</span></span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>(10</span></span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-right:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">)</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>(29</span></span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-right:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">)</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>92</span></span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>32</span></span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>(136</span></span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-right:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">)</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>2</span></span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>(5</span></span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-right:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">)</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>(12</span></span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-right:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">)</span></div></td></tr></table></div><span style="font-family:inherit;font-size:10pt;"><br/></span></div><div style="line-height:120%;text-align:justify;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div><div style="line-height:120%;text-indent:36px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div><div style="line-height:120%;text-indent:36px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div><div style="line-height:120%;text-indent:36px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div><div style="line-height:120%;text-indent:36px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div><div style="line-height:120%;text-indent:36px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div><div style="line-height:120%;text-indent:36px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div><div style="line-height:120%;text-indent:36px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div><div style="line-height:120%;text-indent:36px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div><div style="line-height:120%;text-indent:36px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div><div style="line-height:120%;text-indent:36px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div><div style="line-height:120%;text-indent:36px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div><div style="line-height:120%;text-indent:36px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div><div style="line-height:120%;text-indent:36px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div><div style="line-height:120%;text-indent:36px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div><div style="line-height:120%;text-indent:36px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div><div style="line-height:120%;text-indent:36px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;font-style:italic;">Funded Status.</span><span style="font-family:inherit;font-size:10pt;">    As of </span><span style="font-family:inherit;font-size:10pt;">October 31, 2019</span><span style="font-family:inherit;font-size:10pt;"> and </span><span style="font-family:inherit;font-size:10pt;">2018</span><span style="font-family:inherit;font-size:10pt;">, the funded status of the defined benefit and post-retirement benefit plans was:</span></div><div style="line-height:120%;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div><div style="line-height:120%;text-indent:0px;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="24"/></tr><tr><td style="width:47%;"/><td style="width:1%;"/><td style="width:6%;"/><td style="width:1%;"/><td style="width:1%;"/><td style="width:1%;"/><td style="width:6%;"/><td style="width:1%;"/><td style="width:1%;"/><td style="width:1%;"/><td style="width:6%;"/><td style="width:1%;"/><td style="width:1%;"/><td style="width:1%;"/><td style="width:6%;"/><td style="width:1%;"/><td style="width:1%;"/><td style="width:1%;"/><td style="width:6%;"/><td style="width:1%;"/><td style="width:1%;"/><td style="width:1%;"/><td style="width:6%;"/><td style="width:1%;"/></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;font-weight:bold;"> </span></div></td><td colspan="7" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:center;font-size:8pt;"><span style="font-family:inherit;font-size:8pt;font-weight:bold;">U.S. Defined</span></div><div style="text-align:center;font-size:8pt;"><span style="font-family:inherit;font-size:8pt;font-weight:bold;">Benefit Plans</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="7" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:center;font-size:8pt;"><span style="font-family:inherit;font-size:8pt;font-weight:bold;">Non-U.S. Defined</span></div><div style="text-align:center;font-size:8pt;"><span style="font-family:inherit;font-size:8pt;font-weight:bold;">Benefit Plans</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="7" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:center;font-size:8pt;"><span style="font-family:inherit;font-size:8pt;font-weight:bold;">U.S.</span></div><div style="text-align:center;font-size:8pt;"><span style="font-family:inherit;font-size:8pt;font-weight:bold;">Post-Retirement</span></div><div style="text-align:center;font-size:8pt;"><span style="font-family:inherit;font-size:8pt;font-weight:bold;">Benefit Plans</span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:inherit;font-size:8pt;font-weight:bold;"> </span></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:8pt;"><span style="font-family:inherit;font-size:8pt;font-weight:bold;">2019</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="text-align:center;font-size:8pt;"><span style="font-family:inherit;font-size:8pt;font-weight:bold;">2018</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:8pt;"><span style="font-family:inherit;font-size:8pt;font-weight:bold;">2019</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="text-align:center;font-size:8pt;"><span style="font-family:inherit;font-size:8pt;font-weight:bold;">2018</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:8pt;"><span style="font-family:inherit;font-size:8pt;font-weight:bold;">2019</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:8pt;"><span style="font-family:inherit;font-size:8pt;font-weight:bold;">2018</span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:inherit;font-size:8pt;font-weight:bold;"> </span></div></td><td colspan="23" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:center;font-size:8pt;"><span style="font-family:inherit;font-size:8pt;font-weight:bold;">(in millions)</span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Change in fair value of plan assets:</span></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Fair value — beginning of year</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>401</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>414</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>825</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>855</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>90</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>95</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Actual return on plan assets</span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>50</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>8</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>85</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>(9</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">)</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>11</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>1</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Employer contributions</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>—</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>—</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>21</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>21</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>—</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>—</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Participants' contributions</span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>—</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>—</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>1</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>—</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>—</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>—</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Benefits paid</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>(19</span></span></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">)</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>(21</span></span></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">)</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>(29</span></span></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">)</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>(26</span></span></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">)</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>(6</span></span></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">)</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>(6</span></span></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">)</span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Settlements</span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>—</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>—</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>—</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>5</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>—</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>—</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Currency impact</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>—</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>—</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>8</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>(21</span></span></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">)</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>—</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>—</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Fair value — end of year</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>432</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>401</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>911</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>825</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>95</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>90</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Change in benefit obligation:</span></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:3px double #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:3px double #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:3px double #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:3px double #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:3px double #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:3px double #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Benefit obligation — beginning of year</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>420</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>445</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>913</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>935</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>87</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>97</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Service cost</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>—</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>—</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>20</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>20</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>—</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>1</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Interest cost</span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>18</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>16</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>14</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>13</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>4</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>3</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Participants' contributions</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>—</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>—</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>1</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>—</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>—</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>—</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Plan amendment</span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>—</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>—</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>—</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>1</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>—</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>—</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Actuarial (gain) loss</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>74</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>(19</span></span></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">)</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>143</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>(6</span></span></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">)</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>9</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>(7</span></span></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">)</span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Benefits paid</span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>(21</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">)</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>(22</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">)</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>(29</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">)</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>(27</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">)</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>(6</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">)</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>(7</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">)</span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Currency impact</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>—</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>—</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>5</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>(23</span></span></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">)</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>—</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>—</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:middle;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Benefit obligation — end of year</span></div></td><td style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:middle;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>491</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:middle;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>420</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:middle;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>1,067</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:middle;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>913</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:middle;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>94</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:middle;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>87</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:middle;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Overfunded (underfunded) status of PBO</span></div></td><td style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:3px double #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:middle;padding-top:2px;padding-bottom:2px;border-top:3px double #000000;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>(59</span></span></div></td><td style="vertical-align:middle;padding-right:2px;padding-top:2px;padding-bottom:2px;border-top:3px double #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">)</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:3px double #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:middle;padding-top:2px;padding-bottom:2px;border-top:3px double #000000;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>(19</span></span></div></td><td style="vertical-align:middle;padding-right:2px;padding-top:2px;padding-bottom:2px;border-top:3px double #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">)</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:3px double #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:middle;padding-top:2px;padding-bottom:2px;border-top:3px double #000000;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>(156</span></span></div></td><td style="vertical-align:middle;padding-right:2px;padding-top:2px;padding-bottom:2px;border-top:3px double #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">)</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:3px double #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:middle;padding-top:2px;padding-bottom:2px;border-top:3px double #000000;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>(88</span></span></div></td><td style="vertical-align:middle;padding-right:2px;padding-top:2px;padding-bottom:2px;border-top:3px double #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">)</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:3px double #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:middle;padding-top:2px;padding-bottom:2px;border-top:3px double #000000;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>1</span></span></div></td><td style="vertical-align:bottom;border-top:3px double #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:3px double #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:middle;padding-top:2px;padding-bottom:2px;border-top:3px double #000000;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>3</span></span></div></td><td style="vertical-align:bottom;border-top:3px double #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Amounts recognized in the consolidated balance sheet consist of:</span></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:3px double #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:3px double #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:3px double #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:3px double #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:3px double #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:3px double #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td></tr><tr><td style="vertical-align:middle;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Other assets</span></div></td><td style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:middle;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>—</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:middle;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>—</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:middle;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>106</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:middle;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>95</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:middle;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>1</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:middle;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>3</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:middle;background-color:#cceeff;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Employee compensation and benefits</span></div></td><td colspan="2" style="vertical-align:middle;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>(1</span></span></div></td><td style="vertical-align:middle;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">)</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:middle;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>(1</span></span></div></td><td style="vertical-align:middle;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">)</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:middle;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>—</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:middle;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>—</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:middle;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>—</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:middle;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>—</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:middle;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Retirement and post-retirement benefits</span></div></td><td colspan="2" style="vertical-align:middle;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>(58</span></span></div></td><td style="vertical-align:middle;border-bottom:1px solid #000000;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">)</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>(18</span></span></div></td><td style="vertical-align:middle;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">)</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>(262</span></span></div></td><td style="vertical-align:middle;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">)</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>(183</span></span></div></td><td style="vertical-align:middle;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">)</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>—</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>—</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:middle;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Total net asset (liability)</span></div></td><td style="vertical-align:middle;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:middle;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>(59</span></span></div></td><td style="vertical-align:middle;border-bottom:3px double #000000;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">)</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:middle;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:middle;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>(19</span></span></div></td><td style="vertical-align:middle;border-bottom:3px double #000000;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">)</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:middle;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:middle;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>(156</span></span></div></td><td style="vertical-align:middle;border-bottom:3px double #000000;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">)</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:middle;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:middle;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>(88</span></span></div></td><td style="vertical-align:middle;border-bottom:3px double #000000;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">)</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:middle;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:middle;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>1</span></span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:middle;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:middle;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>3</span></span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Amounts Recognized in Accumulated Other Comprehensive Income (loss):</span></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td></tr><tr><td style="vertical-align:middle;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Actuarial (gains) losses</span></div></td><td style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:middle;background-color:#cceeff;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>115</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:middle;background-color:#cceeff;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>65</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:middle;background-color:#cceeff;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>330</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:middle;background-color:#cceeff;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>263</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:middle;background-color:#cceeff;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>10</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:middle;background-color:#cceeff;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>10</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Prior service costs (benefits)</span></div></td><td colspan="2" style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>—</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>—</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>—</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>—</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>(12</span></span></div></td><td style="vertical-align:middle;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">)</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>(20</span></span></div></td><td style="vertical-align:middle;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">)</span></div></td></tr><tr><td style="vertical-align:middle;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Total</span></div></td><td style="vertical-align:middle;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:middle;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>115</span></span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:middle;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:middle;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>65</span></span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:middle;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:middle;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>330</span></span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:middle;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:middle;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>263</span></span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:middle;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:middle;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>(2</span></span></div></td><td style="vertical-align:middle;border-bottom:3px double #000000;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">)</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:middle;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:middle;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>(10</span></span></div></td><td style="vertical-align:middle;border-bottom:3px double #000000;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">)</span></div></td></tr></table></div><span style="font-family:inherit;font-size:10pt;"><br/></span></div><div style="line-height:120%;text-align:justify;text-indent:36px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div><div style="line-height:120%;text-align:justify;text-indent:36px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">The amounts in accumulated other comprehensive income expected to be recognized by Agilent as components of net expense during </span><span style="font-family:inherit;font-size:10pt;">2020</span><span style="font-family:inherit;font-size:10pt;"> are as follows:</span></div><div style="line-height:120%;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="12"/></tr><tr><td style="width:54%;"/><td style="width:1%;"/><td style="width:12%;"/><td style="width:1%;"/><td style="width:1%;"/><td style="width:1%;"/><td style="width:12%;"/><td style="width:1%;"/><td style="width:1%;"/><td style="width:1%;"/><td style="width:14%;"/><td style="width:1%;"/></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:8pt;"><span style="font-family:inherit;font-size:8pt;font-weight:bold;">U.S. Defined</span></div><div style="text-align:center;font-size:8pt;"><span style="font-family:inherit;font-size:8pt;font-weight:bold;">Benefit Plans</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:8pt;"><span style="font-family:inherit;font-size:8pt;font-weight:bold;">Non-U.S. Defined</span></div><div style="text-align:center;font-size:8pt;"><span style="font-family:inherit;font-size:8pt;font-weight:bold;">Benefit Plans</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:8pt;"><span style="font-family:inherit;font-size:8pt;font-weight:bold;">U.S. Post-Retirement</span></div><div style="text-align:center;font-size:8pt;"><span style="font-family:inherit;font-size:8pt;font-weight:bold;">Benefit Plans</span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:inherit;font-size:8pt;font-weight:bold;"> </span></div></td><td colspan="11" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:center;font-size:8pt;"><span style="font-family:inherit;font-size:8pt;font-weight:bold;">(in millions)</span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Amortization of net prior service cost (benefit)</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>—</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>—</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>(7</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">)</span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Amortization of actuarial net loss (gain)</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>3</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>48</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>4</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr></table></div><span style="font-family:inherit;font-size:10pt;"><br/></span></div><div style="line-height:120%;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div><div style="line-height:120%;text-align:justify;text-indent:36px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;font-style:italic;">Investment Policies and Strategies as of </span><span style="font-family:inherit;font-size:10pt;color:#000000;font-style:italic;text-decoration:none;">October 31, 2019</span><span style="font-family:inherit;font-size:10pt;font-style:italic;"> and </span><span style="font-family:inherit;font-size:10pt;font-style:italic;">2018</span><span style="font-family:inherit;font-size:10pt;font-style:italic;">.</span><span style="font-family:inherit;font-size:10pt;"> In the U.S., target asset allocations for our retirement and post-retirement benefit plans are approximately </span><span style="font-family:inherit;font-size:10pt;"><span>80 percent</span></span><span style="font-family:inherit;font-size:10pt;"> to equities and approximately </span><span style="font-family:inherit;font-size:10pt;"><span>20 percent</span></span><span style="font-family:inherit;font-size:10pt;"> to fixed income investments. Our DPSP target asset allocation is approximately </span><span style="font-family:inherit;font-size:10pt;"><span>60 percent</span></span><span style="font-family:inherit;font-size:10pt;"> to equities and approximately </span><span style="font-family:inherit;font-size:10pt;"><span>40 percent</span></span><span style="font-family:inherit;font-size:10pt;"> to fixed income investments. Approximately </span><span style="font-family:inherit;font-size:10pt;"><span>3 percent</span></span><span style="font-family:inherit;font-size:10pt;"> of our U.S. equity portfolio consists of limited partnerships. The general investment objective for all our plan assets is to obtain the optimum rate of investment return on the total investment portfolio consistent with the assumption of a reasonable level of risk. Specific investment objectives for the plans' portfolios are to: maintain and enhance the purchasing power of the plans' assets; achieve investment returns consistent with the level of risk being taken; and earn performance rates of return in accordance with the benchmarks adopted for each asset class. Outside the U.S., our target asset allocation ranges from </span><span style="font-family:inherit;font-size:10pt;"><span>31</span></span><span style="font-family:inherit;font-size:10pt;"> to </span><span style="font-family:inherit;font-size:10pt;"><span>60 percent</span></span><span style="font-family:inherit;font-size:10pt;"> to equities, from </span><span style="font-family:inherit;font-size:10pt;"><span>38</span></span><span style="font-family:inherit;font-size:10pt;"> to </span><span style="font-family:inherit;font-size:10pt;"><span>61 percent</span></span><span style="font-family:inherit;font-size:10pt;"> to fixed income investments, and from </span><span style="font-family:inherit;font-size:10pt;"><span>zero</span></span><span style="font-family:inherit;font-size:10pt;"> to </span><span style="font-family:inherit;font-size:10pt;"><span>25 percent</span></span><span style="font-family:inherit;font-size:10pt;"> to real estate, depending on the plan. All plans' assets are broadly diversified. Due to fluctuations in equity markets, our actual allocations of plan assets at </span><span style="font-family:inherit;font-size:10pt;color:#000000;text-decoration:none;">October 31, 2019</span><span style="font-family:inherit;font-size:10pt;"> and </span><span style="font-family:inherit;font-size:10pt;color:#000000;text-decoration:none;">2018</span><span style="font-family:inherit;font-size:10pt;"> differ from the target allocation. Our policy is to bring the actual allocation in line with the target allocation.</span></div><div style="line-height:120%;text-align:justify;text-indent:32px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div><div style="line-height:120%;text-align:justify;text-indent:36px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Equity securities include exchange-traded common stock and preferred stock of companies from broadly diversified industries. Fixed income securities include a global portfolio of corporate bonds of companies from diversified industries, government securities, mortgage-backed securities, asset-backed securities, derivative instruments and other. Other investments include a group trust consisting primarily of private equity partnerships. Portions of the cash and cash equivalent, equity, and fixed income investments are held in commingled funds that are valued using Net Asset Value (“NAV”) as the practical expedient. In addition, some of the investments valued using NAV as the practical expedient may have limits on their redemption to weekly or monthly and/or may require prior written notice specified by each fund.</span></div><div style="line-height:120%;text-align:justify;text-indent:36px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div><div style="line-height:120%;text-align:justify;text-indent:36px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;font-style:italic;">Fair Value.</span><span style="font-family:inherit;font-size:10pt;">    The measurement of the fair value of pension and post-retirement plan assets uses the valuation methodologies and the inputs as described in Note 12, "Fair Value Measurements".</span></div><div style="line-height:120%;text-align:justify;text-indent:36px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div><div style="line-height:120%;text-align:justify;text-indent:36px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Cash and Cash Equivalents - Cash and cash equivalents consist of short-term investment funds. The funds also invest in short-term domestic fixed income securities and other securities with debt-like characteristics emphasizing short-term maturities and quality. Some of our cash and cash equivalents are held in commingled funds. Other cash and cash equivalents are classified as Level 1 investments.</span></div><div style="line-height:120%;text-align:justify;text-indent:36px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div><div style="line-height:120%;text-align:justify;text-indent:36px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Equity - Some equity securities consisting of common and preferred stock that are not traded on an active market are valued at quoted prices reported by investment dealers based on the underlying terms of the security and comparison to similar securities traded on an active market; these are classified as Level 2 investments. Securities which have quoted prices in active markets are classified as Level 1 investments.</span></div><div style="line-height:120%;text-align:justify;text-indent:36px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div><div style="line-height:120%;text-align:justify;text-indent:36px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Fixed Income - Some of the fixed income securities are not actively traded and are valued at quoted prices based on the terms of the security and comparison to similar securities traded on an active market; these are classified as Level 2 investments. Securities which have quoted prices in active markets are classified as Level 1 investments.</span></div><div style="line-height:120%;text-align:justify;text-indent:36px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div><div style="line-height:120%;text-align:justify;text-indent:36px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Other Investments - Other investments also includes partnership investments where, due to their private nature, pricing inputs are not readily observable. Asset valuations are developed by the general partners that manage the partnerships. These valuations are based on proprietary appraisals, application of public market multiples to private company cash flows, utilization of market transactions that provide valuation information for comparable companies and other methods. Holdings of limited partnerships are classified as Level 3.</span></div><div style="line-height:120%;text-align:justify;text-indent:36px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div><div style="line-height:120%;text-align:justify;text-indent:36px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Agilent has adopted the accounting guidance related to the presentation of certain investments using the NAV practical expedient. The accounting guidance exempts investments using this practical expedient from categorization within the fair value hierarchy. </span></div><div style="line-height:120%;text-align:justify;text-indent:36px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div><div style="line-height:120%;text-align:justify;text-indent:36px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">The following tables present the fair value of U.S. Defined Benefit Plans assets classified under the appropriate level of the fair value hierarchy as of </span><span style="font-family:inherit;font-size:10pt;color:#000000;text-decoration:none;">October 31, 2019</span><span style="font-family:inherit;font-size:10pt;"> and </span><span style="font-family:inherit;font-size:10pt;color:#000000;text-decoration:none;">2018</span><span style="font-family:inherit;font-size:10pt;">.</span></div><div style="line-height:120%;text-align:justify;text-indent:0px;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="20"/></tr><tr><td style="width:40%;"/><td style="width:1%;"/><td style="width:9%;"/><td style="width:1%;"/><td style="width:1%;"/><td style="width:1%;"/><td style="width:10%;"/><td style="width:1%;"/><td style="width:1%;"/><td style="width:1%;"/><td style="width:9%;"/><td style="width:1%;"/><td style="width:1%;"/><td style="width:1%;"/><td style="width:9%;"/><td style="width:1%;"/><td style="width:1%;"/><td style="width:1%;"/><td style="width:9%;"/><td style="width:1%;"/></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;font-weight:bold;"> </span></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;font-weight:bold;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="11" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:center;font-size:8pt;"><span style="font-family:inherit;font-size:8pt;font-weight:bold;">Fair Value Measurement at October 31, 2019 Using</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:inherit;font-size:8pt;font-weight:bold;"> </span></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:8pt;"><span style="font-family:inherit;font-size:8pt;font-weight:bold;">October 31, <br/>2019</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:8pt;"><span style="font-family:inherit;font-size:8pt;font-weight:bold;">Quoted Prices</span></div><div style="text-align:center;font-size:8pt;"><span style="font-family:inherit;font-size:8pt;font-weight:bold;">in Active</span></div><div style="text-align:center;font-size:8pt;"><span style="font-family:inherit;font-size:8pt;font-weight:bold;">Markets for</span></div><div style="text-align:center;font-size:8pt;"><span style="font-family:inherit;font-size:8pt;font-weight:bold;">Identical Assets</span></div><div style="text-align:center;font-size:8pt;"><span style="font-family:inherit;font-size:8pt;font-weight:bold;">(Level 1)</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:8pt;"><span style="font-family:inherit;font-size:8pt;font-weight:bold;">Significant</span></div><div style="text-align:center;font-size:8pt;"><span style="font-family:inherit;font-size:8pt;font-weight:bold;">Other</span></div><div style="text-align:center;font-size:8pt;"><span style="font-family:inherit;font-size:8pt;font-weight:bold;">Observable</span></div><div style="text-align:center;font-size:8pt;"><span style="font-family:inherit;font-size:8pt;font-weight:bold;">Inputs</span></div><div style="text-align:center;font-size:8pt;"><span style="font-family:inherit;font-size:8pt;font-weight:bold;">(Level 2)</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:8pt;"><span style="font-family:inherit;font-size:8pt;font-weight:bold;">Significant</span></div><div style="text-align:center;font-size:8pt;"><span style="font-family:inherit;font-size:8pt;font-weight:bold;">Unobservable</span></div><div style="text-align:center;font-size:8pt;"><span style="font-family:inherit;font-size:8pt;font-weight:bold;">Inputs</span></div><div style="text-align:center;font-size:8pt;"><span style="font-family:inherit;font-size:8pt;font-weight:bold;">(Level 3)</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:8pt;"><span style="font-family:inherit;font-size:8pt;font-weight:bold;">Not Subject to Leveling</span><span style="font-family:inherit;font-size:8pt;font-weight:bold;"><sup style="vertical-align:top;line-height:120%;font-size:5pt"> (1)</sup></span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:inherit;font-size:8pt;font-weight:bold;"> </span></div></td><td colspan="19" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:center;font-size:8pt;"><span style="font-family:inherit;font-size:8pt;font-weight:bold;">(in millions)</span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Cash and Cash Equivalents</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>1</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>—</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>—</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>—</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>1</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Equity</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>336</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>78</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>—</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>—</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>258</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Fixed Income</span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>91</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>46</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>—</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>—</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>45</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Other Investments</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>4</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>—</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>—</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>4</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>—</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Total assets measured at fair value</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>432</span></span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>124</span></span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>—</span></span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>4</span></span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>304</span></span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr></table></div></div><div style="line-height:120%;text-align:justify;font-size:9pt;"><span style="font-family:inherit;font-size:9pt;">(1) Investments measured at the net asset value per share (or its equivalent) practical expedient have not been classified in the fair value hierarchy.</span></div><div style="line-height:120%;text-align:justify;text-indent:0px;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="20"/></tr><tr><td style="width:40%;"/><td style="width:1%;"/><td style="width:9%;"/><td style="width:1%;"/><td style="width:1%;"/><td style="width:1%;"/><td style="width:10%;"/><td style="width:1%;"/><td style="width:1%;"/><td style="width:1%;"/><td style="width:9%;"/><td style="width:1%;"/><td style="width:1%;"/><td style="width:1%;"/><td style="width:9%;"/><td style="width:1%;"/><td style="width:1%;"/><td style="width:1%;"/><td style="width:9%;"/><td style="width:1%;"/></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;font-weight:bold;"> </span></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;font-weight:bold;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="11" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:center;font-size:8pt;"><span style="font-family:inherit;font-size:8pt;font-weight:bold;">Fair Value Measurement at October 31, 2018 Using</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:inherit;font-size:8pt;font-weight:bold;"> </span></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:8pt;"><span style="font-family:inherit;font-size:8pt;font-weight:bold;">October 31, <br/>2018</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:8pt;"><span style="font-family:inherit;font-size:8pt;font-weight:bold;">Quoted Prices</span></div><div style="text-align:center;font-size:8pt;"><span style="font-family:inherit;font-size:8pt;font-weight:bold;">in Active</span></div><div style="text-align:center;font-size:8pt;"><span style="font-family:inherit;font-size:8pt;font-weight:bold;">Markets for</span></div><div style="text-align:center;font-size:8pt;"><span style="font-family:inherit;font-size:8pt;font-weight:bold;">Identical Assets</span></div><div style="text-align:center;font-size:8pt;"><span style="font-family:inherit;font-size:8pt;font-weight:bold;">(Level 1)</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:8pt;"><span style="font-family:inherit;font-size:8pt;font-weight:bold;">Significant</span></div><div style="text-align:center;font-size:8pt;"><span style="font-family:inherit;font-size:8pt;font-weight:bold;">Other</span></div><div style="text-align:center;font-size:8pt;"><span style="font-family:inherit;font-size:8pt;font-weight:bold;">Observable</span></div><div style="text-align:center;font-size:8pt;"><span style="font-family:inherit;font-size:8pt;font-weight:bold;">Inputs</span></div><div style="text-align:center;font-size:8pt;"><span style="font-family:inherit;font-size:8pt;font-weight:bold;">(Level 2)</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:8pt;"><span style="font-family:inherit;font-size:8pt;font-weight:bold;">Significant</span></div><div style="text-align:center;font-size:8pt;"><span style="font-family:inherit;font-size:8pt;font-weight:bold;">Unobservable</span></div><div style="text-align:center;font-size:8pt;"><span style="font-family:inherit;font-size:8pt;font-weight:bold;">Inputs</span></div><div style="text-align:center;font-size:8pt;"><span style="font-family:inherit;font-size:8pt;font-weight:bold;">(Level 3)</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:8pt;"><span style="font-family:inherit;font-size:8pt;font-weight:bold;">Not Subject to Leveling </span><span style="font-family:inherit;font-size:8pt;font-weight:bold;"><sup style="vertical-align:top;line-height:120%;font-size:5pt">(1)</sup></span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:inherit;font-size:8pt;font-weight:bold;"> </span></div></td><td colspan="19" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:center;font-size:8pt;"><span style="font-family:inherit;font-size:8pt;font-weight:bold;">(in millions)</span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Cash and Cash Equivalents</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>4</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>—</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>—</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>—</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>4</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Equity</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>308</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>69</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>—</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>—</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>239</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Fixed Income</span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>83</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>36</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>5</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>—</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>42</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Other Investments</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>6</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>—</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>—</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>6</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>—</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Total assets measured at fair value</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>401</span></span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>105</span></span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>5</span></span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>6</span></span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>285</span></span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr></table></div></div><div style="line-height:120%;text-align:justify;font-size:9pt;"><span style="font-family:inherit;font-size:9pt;">(1) Investments measured at the net asset value per share (or its equivalent) practical expedient have not been classified in the fair value hierarchy.</span></div><div style="line-height:120%;text-align:justify;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div><div style="line-height:120%;text-align:justify;text-indent:36px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">For U.S. Defined Benefit Plans assets measured at fair value using significant unobservable inputs (level 3), the following table summarizes the change in balances during </span><span style="font-family:inherit;font-size:10pt;color:#000000;text-decoration:none;">2019</span><span style="font-family:inherit;font-size:10pt;"> and </span><span style="font-family:inherit;font-size:10pt;color:#000000;text-decoration:none;">2018</span><span style="font-family:inherit;font-size:10pt;">:</span></div><div style="line-height:120%;text-align:justify;text-indent:0px;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="8"/></tr><tr><td style="width:73%;"/><td style="width:1%;"/><td style="width:11%;"/><td style="width:1%;"/><td style="width:1%;"/><td style="width:1%;"/><td style="width:11%;"/><td style="width:1%;"/></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;font-weight:bold;"> </span></div></td><td colspan="7" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:center;font-size:8pt;"><span style="font-family:inherit;font-size:8pt;font-weight:bold;">Years Ended</span></div><div style="text-align:center;font-size:8pt;"><span style="font-family:inherit;font-size:8pt;font-weight:bold;">October 31.</span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:inherit;font-size:8pt;font-weight:bold;"> </span></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:8pt;"><span style="font-family:inherit;font-size:8pt;font-weight:bold;">2019</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:8pt;"><span style="font-family:inherit;font-size:8pt;font-weight:bold;">2018</span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Balance, beginning of year</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>6</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>7</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Realized gains/(losses)</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>(1</span></span></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">)</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>—</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Unrealized gains/(losses)</span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>1</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>1</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Purchases, sales, issuances, and settlements</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>(2</span></span></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">)</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>(2</span></span></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">)</span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Transfers in (out)</span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>—</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>—</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Balance, end of year</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>4</span></span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>6</span></span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr></table></div><span style="font-family:inherit;font-size:10pt;"><br/></span></div><div style="line-height:120%;text-align:justify;text-indent:36px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div><div style="line-height:120%;text-align:justify;text-indent:36px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div><div style="line-height:120%;text-align:justify;text-indent:36px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div><div style="line-height:120%;text-align:justify;text-indent:36px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div><div style="line-height:120%;text-align:justify;text-indent:36px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div><div style="line-height:120%;text-align:justify;text-indent:36px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div><div style="line-height:120%;text-align:justify;text-indent:36px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div><div style="line-height:120%;text-align:justify;text-indent:36px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div><div style="line-height:120%;text-align:justify;text-indent:36px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div><div style="line-height:120%;text-align:justify;text-indent:36px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div><div style="line-height:120%;text-align:justify;text-indent:36px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div><div style="line-height:120%;text-align:justify;text-indent:36px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div><div style="line-height:120%;text-align:justify;text-indent:36px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div><div style="line-height:120%;text-align:justify;text-indent:36px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div><div style="line-height:120%;text-align:justify;text-indent:36px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div><div style="line-height:120%;text-align:justify;text-indent:36px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">The following tables present the fair value of U.S. Post-Retirement Benefit Plans assets classified under the appropriate level of the fair value hierarchy as of </span><span style="font-family:inherit;font-size:10pt;color:#000000;text-decoration:none;">October 31, 2019</span><span style="font-family:inherit;font-size:10pt;"> and </span><span style="font-family:inherit;font-size:10pt;color:#000000;text-decoration:none;">2018</span><span style="font-family:inherit;font-size:10pt;">.</span></div><div style="line-height:120%;text-align:justify;text-indent:0px;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="20"/></tr><tr><td style="width:40%;"/><td style="width:1%;"/><td style="width:9%;"/><td style="width:1%;"/><td style="width:1%;"/><td style="width:1%;"/><td style="width:10%;"/><td style="width:1%;"/><td style="width:1%;"/><td style="width:1%;"/><td style="width:9%;"/><td style="width:1%;"/><td style="width:1%;"/><td style="width:1%;"/><td style="width:9%;"/><td style="width:1%;"/><td style="width:1%;"/><td style="width:1%;"/><td style="width:9%;"/><td style="width:1%;"/></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;font-weight:bold;"> </span></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;font-weight:bold;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="11" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:center;font-size:8pt;"><span style="font-family:inherit;font-size:8pt;font-weight:bold;">Fair Value Measurement at October 31, 2019 Using</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:inherit;font-size:8pt;font-weight:bold;"> </span></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:8pt;"><span style="font-family:inherit;font-size:8pt;font-weight:bold;">October 31, <br/>2019</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:8pt;"><span style="font-family:inherit;font-size:8pt;font-weight:bold;">Quoted Prices</span></div><div style="text-align:center;font-size:8pt;"><span style="font-family:inherit;font-size:8pt;font-weight:bold;">in Active</span></div><div style="text-align:center;font-size:8pt;"><span style="font-family:inherit;font-size:8pt;font-weight:bold;">Markets for</span></div><div style="text-align:center;font-size:8pt;"><span style="font-family:inherit;font-size:8pt;font-weight:bold;">Identical Assets</span></div><div style="text-align:center;font-size:8pt;"><span style="font-family:inherit;font-size:8pt;font-weight:bold;">(Level 1)</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:8pt;"><span style="font-family:inherit;font-size:8pt;font-weight:bold;">Significant</span></div><div style="text-align:center;font-size:8pt;"><span style="font-family:inherit;font-size:8pt;font-weight:bold;">Other</span></div><div style="text-align:center;font-size:8pt;"><span style="font-family:inherit;font-size:8pt;font-weight:bold;">Observable</span></div><div style="text-align:center;font-size:8pt;"><span style="font-family:inherit;font-size:8pt;font-weight:bold;">Inputs</span></div><div style="text-align:center;font-size:8pt;"><span style="font-family:inherit;font-size:8pt;font-weight:bold;">(Level 2)</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:8pt;"><span style="font-family:inherit;font-size:8pt;font-weight:bold;">Significant</span></div><div style="text-align:center;font-size:8pt;"><span style="font-family:inherit;font-size:8pt;font-weight:bold;">Unobservable</span></div><div style="text-align:center;font-size:8pt;"><span style="font-family:inherit;font-size:8pt;font-weight:bold;">Inputs</span></div><div style="text-align:center;font-size:8pt;"><span style="font-family:inherit;font-size:8pt;font-weight:bold;">(Level 3)</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:8pt;"><span style="font-family:inherit;font-size:8pt;font-weight:bold;">Not Subject to Leveling </span><span style="font-family:inherit;font-size:8pt;font-weight:bold;"><sup style="vertical-align:top;line-height:120%;font-size:5pt">(1)</sup></span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:inherit;font-size:8pt;font-weight:bold;"> </span></div></td><td colspan="19" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:center;font-size:8pt;"><span style="font-family:inherit;font-size:8pt;font-weight:bold;">(in millions)</span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Cash and Cash Equivalents</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>3</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>—</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>—</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>—</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>3</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Equity</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>69</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>18</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>—</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>—</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>51</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Fixed Income</span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>21</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>11</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>—</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>—</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>10</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Other Investments</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>2</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>—</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>—</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>2</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>—</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Total assets measured at fair value</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>95</span></span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>29</span></span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>—</span></span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>2</span></span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>64</span></span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr></table></div></div><div style="line-height:120%;text-align:justify;font-size:9pt;"><span style="font-family:inherit;font-size:9pt;">(1) Investments measured at the net asset value per share (or its equivalent) practical expedient have not been classified in the fair value hierarchy.</span></div><div style="line-height:120%;text-align:justify;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div><div style="line-height:120%;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="20"/></tr><tr><td style="width:40%;"/><td style="width:1%;"/><td style="width:9%;"/><td style="width:1%;"/><td style="width:1%;"/><td style="width:1%;"/><td style="width:10%;"/><td style="width:1%;"/><td style="width:1%;"/><td style="width:1%;"/><td style="width:9%;"/><td style="width:1%;"/><td style="width:1%;"/><td style="width:1%;"/><td style="width:9%;"/><td style="width:1%;"/><td style="width:1%;"/><td style="width:1%;"/><td style="width:9%;"/><td style="width:1%;"/></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;font-weight:bold;"> </span></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;font-weight:bold;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="11" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:center;font-size:8pt;"><span style="font-family:inherit;font-size:8pt;font-weight:bold;">Fair Value Measurement at October 31, 2018 Using</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:inherit;font-size:8pt;font-weight:bold;"> </span></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:8pt;"><span style="font-family:inherit;font-size:8pt;font-weight:bold;">October 31, <br/>2018</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:8pt;"><span style="font-family:inherit;font-size:8pt;font-weight:bold;">Quoted Prices</span></div><div style="text-align:center;font-size:8pt;"><span style="font-family:inherit;font-size:8pt;font-weight:bold;">in Active</span></div><div style="text-align:center;font-size:8pt;"><span style="font-family:inherit;font-size:8pt;font-weight:bold;">Markets for</span></div><div style="text-align:center;font-size:8pt;"><span style="font-family:inherit;font-size:8pt;font-weight:bold;">Identical Assets</span></div><div style="text-align:center;font-size:8pt;"><span style="font-family:inherit;font-size:8pt;font-weight:bold;">(Level 1)</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:8pt;"><span style="font-family:inherit;font-size:8pt;font-weight:bold;">Significant</span></div><div style="text-align:center;font-size:8pt;"><span style="font-family:inherit;font-size:8pt;font-weight:bold;">Other</span></div><div style="text-align:center;font-size:8pt;"><span style="font-family:inherit;font-size:8pt;font-weight:bold;">Observable</span></div><div style="text-align:center;font-size:8pt;"><span style="font-family:inherit;font-size:8pt;font-weight:bold;">Inputs</span></div><div style="text-align:center;font-size:8pt;"><span style="font-family:inherit;font-size:8pt;font-weight:bold;">(Level 2)</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:8pt;"><span style="font-family:inherit;font-size:8pt;font-weight:bold;">Significant</span></div><div style="text-align:center;font-size:8pt;"><span style="font-family:inherit;font-size:8pt;font-weight:bold;">Unobservable</span></div><div style="text-align:center;font-size:8pt;"><span style="font-family:inherit;font-size:8pt;font-weight:bold;">Inputs</span></div><div style="text-align:center;font-size:8pt;"><span style="font-family:inherit;font-size:8pt;font-weight:bold;">(Level 3)</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:8pt;"><span style="font-family:inherit;font-size:8pt;font-weight:bold;">Not Subject to Leveling </span><span style="font-family:inherit;font-size:8pt;font-weight:bold;"><sup style="vertical-align:top;line-height:120%;font-size:5pt">(1)</sup></span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:inherit;font-size:8pt;font-weight:bold;"> </span></div></td><td colspan="19" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:center;font-size:8pt;"><span style="font-family:inherit;font-size:8pt;font-weight:bold;">(in millions)</span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Cash and Cash Equivalents</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>3</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>—</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>—</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>—</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>3</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Equity</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>65</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>15</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>—</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>—</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>50</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Fixed Income</span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>18</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>9</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>—</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>—</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>9</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Other Investments</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>4</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>—</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>—</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>4</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>—</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Total assets measured at fair value</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>90</span></span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>24</span></span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>—</span></span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>4</span></span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>62</span></span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr></table></div></div><div style="line-height:120%;text-align:justify;font-size:9pt;"><span style="font-family:inherit;font-size:9pt;">(1) Investments measured at the net asset value per share (or its equivalent) practical expedient have not been classified in the fair value hierarchy.</span></div><div style="line-height:120%;text-align:justify;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div><div style="line-height:120%;text-align:justify;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div><div style="line-height:120%;text-align:justify;text-indent:36px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">For U.S. Post-Retirement Benefit Plans assets measured at fair value using significant unobservable inputs (level 3), the following table summarizes the change in balances during </span><span style="font-family:inherit;font-size:10pt;color:#000000;text-decoration:none;">2019</span><span style="font-family:inherit;font-size:10pt;"> and </span><span style="font-family:inherit;font-size:10pt;color:#000000;text-decoration:none;">2018</span><span style="font-family:inherit;font-size:10pt;">:</span></div><div style="line-height:120%;text-align:justify;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="8"/></tr><tr><td style="width:73%;"/><td style="width:1%;"/><td style="width:11%;"/><td style="width:1%;"/><td style="width:1%;"/><td style="width:1%;"/><td style="width:11%;"/><td style="width:1%;"/></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;font-weight:bold;"> </span></div></td><td colspan="7" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:center;font-size:8pt;"><span style="font-family:inherit;font-size:8pt;font-weight:bold;">Years Ended</span></div><div style="text-align:center;font-size:8pt;"><span style="font-family:inherit;font-size:8pt;font-weight:bold;">October 31,</span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:inherit;font-size:8pt;font-weight:bold;"> </span></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:8pt;"><span style="font-family:inherit;font-size:8pt;font-weight:bold;">2019</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:8pt;"><span style="font-family:inherit;font-size:8pt;font-weight:bold;">2018</span></div></td></tr><tr><td style="vertical-align:middle;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Balance, beginning of year</span></div></td><td style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:middle;background-color:#cceeff;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>4</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:middle;background-color:#cceeff;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>4</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:middle;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Realized gains/(losses)</span></div></td><td colspan="2" style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>(1</span></span></div></td><td style="vertical-align:middle;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">)</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>—</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:middle;background-color:#cceeff;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Unrealized gains/(losses)</span></div></td><td colspan="2" style="vertical-align:middle;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>—</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:middle;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>1</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:middle;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Purchases, sales, issuances, and settlements</span></div></td><td colspan="2" style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>(1</span></span></div></td><td style="vertical-align:middle;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">)</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>(1</span></span></div></td><td style="vertical-align:middle;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">)</span></div></td></tr><tr><td style="vertical-align:middle;background-color:#cceeff;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Transfers in (out)</span></div></td><td colspan="2" style="vertical-align:middle;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>—</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:middle;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>—</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Balance, end of year</span></div></td><td style="vertical-align:middle;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:middle;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>2</span></span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:middle;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:middle;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>4</span></span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr></table></div><span style="font-family:inherit;font-size:10pt;"><br/></span></div><div style="line-height:120%;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div><div style="line-height:120%;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div><div style="line-height:120%;text-align:justify;text-indent:36px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">The following tables present the fair value of non-U.S. Defined Benefit Plans assets classified under the appropriate level of the fair value hierarchy as of </span><span style="font-family:inherit;font-size:10pt;color:#000000;text-decoration:none;">October 31, 2019</span><span style="font-family:inherit;font-size:10pt;"> and </span><span style="font-family:inherit;font-size:10pt;">2018</span><span style="font-family:inherit;font-size:10pt;">:</span></div><div style="line-height:120%;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div><div style="line-height:120%;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="20"/></tr><tr><td style="width:40%;"/><td style="width:1%;"/><td style="width:9%;"/><td style="width:1%;"/><td style="width:1%;"/><td style="width:1%;"/><td style="width:10%;"/><td style="width:1%;"/><td style="width:1%;"/><td style="width:1%;"/><td style="width:9%;"/><td style="width:1%;"/><td style="width:1%;"/><td style="width:1%;"/><td style="width:9%;"/><td style="width:1%;"/><td style="width:1%;"/><td style="width:1%;"/><td style="width:9%;"/><td style="width:1%;"/></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;font-weight:bold;"> </span></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;font-weight:bold;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="11" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:center;font-size:8pt;"><span style="font-family:inherit;font-size:8pt;font-weight:bold;">Fair Value Measurement at October 31, 2019 Using</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:inherit;font-size:8pt;font-weight:bold;"> </span></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:8pt;"><span style="font-family:inherit;font-size:8pt;font-weight:bold;">October 31, <br/>2019</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:8pt;"><span style="font-family:inherit;font-size:8pt;font-weight:bold;">Quoted Prices</span></div><div style="text-align:center;font-size:8pt;"><span style="font-family:inherit;font-size:8pt;font-weight:bold;">in Active</span></div><div style="text-align:center;font-size:8pt;"><span style="font-family:inherit;font-size:8pt;font-weight:bold;">Markets for</span></div><div style="text-align:center;font-size:8pt;"><span style="font-family:inherit;font-size:8pt;font-weight:bold;">Identical Assets</span></div><div style="text-align:center;font-size:8pt;"><span style="font-family:inherit;font-size:8pt;font-weight:bold;">(Level 1)</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:8pt;"><span style="font-family:inherit;font-size:8pt;font-weight:bold;">Significant</span></div><div style="text-align:center;font-size:8pt;"><span style="font-family:inherit;font-size:8pt;font-weight:bold;">Other</span></div><div style="text-align:center;font-size:8pt;"><span style="font-family:inherit;font-size:8pt;font-weight:bold;">Observable</span></div><div style="text-align:center;font-size:8pt;"><span style="font-family:inherit;font-size:8pt;font-weight:bold;">Inputs</span></div><div style="text-align:center;font-size:8pt;"><span style="font-family:inherit;font-size:8pt;font-weight:bold;">(Level 2)</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:8pt;"><span style="font-family:inherit;font-size:8pt;font-weight:bold;">Significant</span></div><div style="text-align:center;font-size:8pt;"><span style="font-family:inherit;font-size:8pt;font-weight:bold;">Unobservable</span></div><div style="text-align:center;font-size:8pt;"><span style="font-family:inherit;font-size:8pt;font-weight:bold;">Inputs</span></div><div style="text-align:center;font-size:8pt;"><span style="font-family:inherit;font-size:8pt;font-weight:bold;">(Level 3)</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:8pt;"><span style="font-family:inherit;font-size:8pt;font-weight:bold;">Not Subject to Leveling </span><span style="font-family:inherit;font-size:8pt;font-weight:bold;"><sup style="vertical-align:top;line-height:120%;font-size:5pt">(1)</sup></span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:inherit;font-size:8pt;font-weight:bold;"> </span></div></td><td colspan="19" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:center;font-size:8pt;"><span style="font-family:inherit;font-size:8pt;font-weight:bold;">(in millions)</span></div></td></tr><tr><td style="vertical-align:middle;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Cash and Cash Equivalents</span></div></td><td style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:middle;background-color:#cceeff;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>1</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:middle;background-color:#cceeff;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>—</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:middle;background-color:#cceeff;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>1</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:middle;background-color:#cceeff;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>—</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:middle;background-color:#cceeff;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>—</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Equity</span></div></td><td colspan="2" style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>512</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>318</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>61</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>—</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>133</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:middle;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Fixed Income</span></div></td><td colspan="2" style="vertical-align:middle;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>398</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:middle;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>98</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:middle;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>213</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:middle;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>—</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:middle;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>87</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Other Investments</span></div></td><td colspan="2" style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>—</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>—</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>—</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>—</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>—</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:middle;background-color:#cceeff;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Total assets measured at fair value</span></div></td><td style="vertical-align:middle;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:middle;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>911</span></span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:middle;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:middle;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>416</span></span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:middle;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:middle;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>275</span></span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:middle;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:middle;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>—</span></span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:middle;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:middle;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>220</span></span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr></table></div></div><div style="line-height:120%;text-align:justify;font-size:9pt;"><span style="font-family:inherit;font-size:9pt;">(1) Investments measured at the net asset value per share (or its equivalent) practical expedient have not been classified in the fair value hierarchy.</span></div><div style="line-height:120%;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div><div style="line-height:120%;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="20"/></tr><tr><td style="width:40%;"/><td style="width:1%;"/><td style="width:9%;"/><td style="width:1%;"/><td style="width:1%;"/><td style="width:1%;"/><td style="width:10%;"/><td style="width:1%;"/><td style="width:1%;"/><td style="width:1%;"/><td style="width:9%;"/><td style="width:1%;"/><td style="width:1%;"/><td style="width:1%;"/><td style="width:9%;"/><td style="width:1%;"/><td style="width:1%;"/><td style="width:1%;"/><td style="width:9%;"/><td style="width:1%;"/></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;font-weight:bold;"> </span></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;font-weight:bold;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="11" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:center;font-size:8pt;"><span style="font-family:inherit;font-size:8pt;font-weight:bold;">Fair Value Measurement at October 31, 2018 Using</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:inherit;font-size:8pt;font-weight:bold;"> </span></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:8pt;"><span style="font-family:inherit;font-size:8pt;font-weight:bold;">October 31, <br/>2018</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:8pt;"><span style="font-family:inherit;font-size:8pt;font-weight:bold;">Quoted Prices</span></div><div style="text-align:center;font-size:8pt;"><span style="font-family:inherit;font-size:8pt;font-weight:bold;">in Active</span></div><div style="text-align:center;font-size:8pt;"><span style="font-family:inherit;font-size:8pt;font-weight:bold;">Markets for</span></div><div style="text-align:center;font-size:8pt;"><span style="font-family:inherit;font-size:8pt;font-weight:bold;">Identical Assets</span></div><div style="text-align:center;font-size:8pt;"><span style="font-family:inherit;font-size:8pt;font-weight:bold;">(Level 1)</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:8pt;"><span style="font-family:inherit;font-size:8pt;font-weight:bold;">Significant</span></div><div style="text-align:center;font-size:8pt;"><span style="font-family:inherit;font-size:8pt;font-weight:bold;">Other</span></div><div style="text-align:center;font-size:8pt;"><span style="font-family:inherit;font-size:8pt;font-weight:bold;">Observable</span></div><div style="text-align:center;font-size:8pt;"><span style="font-family:inherit;font-size:8pt;font-weight:bold;">Inputs</span></div><div style="text-align:center;font-size:8pt;"><span style="font-family:inherit;font-size:8pt;font-weight:bold;">(Level 2)</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:8pt;"><span style="font-family:inherit;font-size:8pt;font-weight:bold;">Significant</span></div><div style="text-align:center;font-size:8pt;"><span style="font-family:inherit;font-size:8pt;font-weight:bold;">Unobservable</span></div><div style="text-align:center;font-size:8pt;"><span style="font-family:inherit;font-size:8pt;font-weight:bold;">Inputs</span></div><div style="text-align:center;font-size:8pt;"><span style="font-family:inherit;font-size:8pt;font-weight:bold;">(Level 3)</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:8pt;"><span style="font-family:inherit;font-size:8pt;font-weight:bold;">Not Subject to Leveling </span><span style="font-family:inherit;font-size:8pt;font-weight:bold;"><sup style="vertical-align:top;line-height:120%;font-size:5pt">(1)</sup></span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:inherit;font-size:8pt;font-weight:bold;"> </span></div></td><td colspan="15" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:center;font-size:8pt;"><span style="font-family:inherit;font-size:8pt;font-weight:bold;">(in millions)</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Cash and Cash Equivalents</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>2</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>—</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>2</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>—</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>—</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Equity</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>489</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>298</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>60</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>—</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>131</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Fixed Income</span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>334</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>76</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>228</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>—</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>30</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Other Investments</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>—</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>—</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>—</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>—</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>—</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Total assets measured at fair value</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>825</span></span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>374</span></span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>290</span></span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>—</span></span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>161</span></span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr></table></div></div><div style="line-height:120%;text-align:justify;font-size:9pt;"><span style="font-family:inherit;font-size:9pt;">(1) Investments measured at the net asset value per share (or its equivalent) practical expedient have not been classified in the fair value hierarchy.</span></div><div style="line-height:120%;text-align:justify;text-indent:36px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div><div style="line-height:120%;text-align:justify;text-indent:36px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div><div style="line-height:120%;text-align:justify;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div><div style="line-height:120%;text-align:justify;text-indent:36px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div><div style="line-height:120%;text-align:justify;text-indent:36px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">The table below presents the combined projected benefit obligation ("PBO"), accumulated benefit obligation ("ABO") and fair value of plan assets, grouping plans using comparisons of the PBO and ABO relative to the plan assets as of </span><span style="font-family:inherit;font-size:10pt;">October 31, 2019</span><span style="font-family:inherit;font-size:10pt;"> or </span><span style="font-family:inherit;font-size:10pt;">2018</span><span style="font-family:inherit;font-size:10pt;">.</span></div><div style="line-height:120%;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="16"/></tr><tr><td style="width:56%;"/><td style="width:1%;"/><td style="width:7%;"/><td style="width:1%;"/><td style="width:1%;"/><td style="width:1%;"/><td style="width:9%;"/><td style="width:1%;"/><td style="width:1%;"/><td style="width:1%;"/><td style="width:8%;"/><td style="width:1%;"/><td style="width:1%;"/><td style="width:1%;"/><td style="width:9%;"/><td style="width:1%;"/></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;font-weight:bold;"> </span></div></td><td colspan="7" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:center;font-size:8pt;"><span style="font-family:inherit;font-size:8pt;font-weight:bold;">2019</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="7" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:center;font-size:8pt;"><span style="font-family:inherit;font-size:8pt;font-weight:bold;">2018</span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:inherit;font-size:8pt;font-weight:bold;"> </span></div></td><td colspan="3" rowspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:8pt;"><span style="font-family:inherit;font-size:8pt;font-weight:bold;">Benefit</span></div><div style="text-align:center;font-size:8pt;"><span style="font-family:inherit;font-size:8pt;font-weight:bold;">Obligation</span></div></td><td rowspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:inherit;font-size:8pt;font-weight:bold;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" rowspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:8pt;"><span style="font-family:inherit;font-size:8pt;font-weight:bold;">Benefit</span></div><div style="text-align:center;font-size:8pt;"><span style="font-family:inherit;font-size:8pt;font-weight:bold;">Obligation</span></div></td><td rowspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:inherit;font-size:8pt;font-weight:bold;"> </span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:inherit;font-size:8pt;font-weight:bold;"> </span></div></td><td colspan="3" rowspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:8pt;"><span style="font-family:inherit;font-size:8pt;font-weight:bold;">Fair Value of</span></div><div style="text-align:center;font-size:8pt;"><span style="font-family:inherit;font-size:8pt;font-weight:bold;">Plan Assets</span></div></td><td rowspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" rowspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:8pt;"><span style="font-family:inherit;font-size:8pt;font-weight:bold;">Fair Value of</span></div><div style="text-align:center;font-size:8pt;"><span style="font-family:inherit;font-size:8pt;font-weight:bold;">Plan Assets</span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:inherit;font-size:8pt;font-weight:bold;"> </span></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:8pt;"><span style="font-family:inherit;font-size:8pt;font-weight:bold;">PBO</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:8pt;"><span style="font-family:inherit;font-size:8pt;font-weight:bold;">PBO</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:inherit;font-size:8pt;font-weight:bold;"> </span></div></td><td colspan="15" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:center;font-size:8pt;"><span style="font-family:inherit;font-size:8pt;font-weight:bold;">(in millions)</span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">U.S. defined benefit plans where PBO exceeds the fair value of plan assets </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>491</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>432</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>420</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>401</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">U.S. defined benefit plans where fair value of plan assets exceeds PBO </span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>—</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>—</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>—</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>—</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Total</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>491</span></span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>432</span></span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>420</span></span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>401</span></span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:5px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:5px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:5px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:5px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:5px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:5px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:5px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:5px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Non-U.S. defined benefit plans where PBO exceeds or is equal to the fair value of plan assets </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>752</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>490</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>563</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>380</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Non-U.S. defined benefit plans where fair value of plan assets exceeds PBO </span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>315</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>421</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>350</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>445</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Total</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>1,067</span></span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>911</span></span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>913</span></span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>825</span></span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:5px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:5px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:5px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:5px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:5px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:5px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:5px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:5px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:8pt;"><span style="font-family:inherit;font-size:8pt;font-weight:bold;"> </span></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:8pt;"><span style="font-family:inherit;font-size:8pt;font-weight:bold;">ABO</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:8pt;"><span style="font-family:inherit;font-size:8pt;font-weight:bold;"> </span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:8pt;"><span style="font-family:inherit;font-size:8pt;font-weight:bold;">ABO</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:8pt;"><span style="font-family:inherit;font-size:8pt;font-weight:bold;"> </span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">U.S. defined benefit plans where ABO exceeds the fair value of plan assets</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>491</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>432</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>420</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>401</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">U.S. defined benefit plans where the fair value of plan assets exceeds ABO</span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>—</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>—</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>—</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>—</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Total</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>491</span></span></div></td><td style="vertical-align:bottom;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>432</span></span></div></td><td style="vertical-align:bottom;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>420</span></span></div></td><td style="vertical-align:bottom;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>401</span></span></div></td><td style="vertical-align:bottom;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:8px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:3px double #000000;"><div style="overflow:hidden;height:8px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:8px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:3px double #000000;"><div style="overflow:hidden;height:8px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:8px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:3px double #000000;"><div style="overflow:hidden;height:8px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:8px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:3px double #000000;"><div style="overflow:hidden;height:8px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Non-U.S. defined benefit plans where ABO exceeds or is equal to the fair value of plan assets </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>651</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>418</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>543</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>380</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Non-U.S. defined benefit plans where fair value of plan assets exceeds ABO</span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>381</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>493</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>343</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>445</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Total</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>1,032</span></span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>911</span></span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>886</span></span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>825</span></span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr></table></div><span style="font-family:inherit;font-size:10pt;"><br/></span></div><div style="line-height:120%;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div><div style="line-height:120%;text-align:justify;text-indent:36px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;font-style:italic;">Contributions and Estimated Future Benefit Payments.</span><span style="font-family:inherit;font-size:10pt;">    During fiscal year </span><span style="font-family:inherit;font-size:10pt;">2020</span><span style="font-family:inherit;font-size:10pt;">, we do not expect to contribute to the U.S. defined benefit plans and the Post-Retirement Medical Plans. We expect to contribute </span><span style="font-family:inherit;font-size:10pt;"><span>$24 million</span></span><span style="font-family:inherit;font-size:10pt;"> to plans outside the U.S. The following table presents expected future benefit payments for the next 10 years:</span></div><div style="line-height:120%;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div><div style="line-height:120%;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="12"/></tr><tr><td style="width:53%;"/><td style="width:1%;"/><td style="width:12%;"/><td style="width:1%;"/><td style="width:1%;"/><td style="width:1%;"/><td style="width:13%;"/><td style="width:1%;"/><td style="width:1%;"/><td style="width:1%;"/><td style="width:14%;"/><td style="width:1%;"/></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:8pt;"><span style="font-family:inherit;font-size:8pt;font-weight:bold;">U.S. Defined</span></div><div style="text-align:center;font-size:8pt;"><span style="font-family:inherit;font-size:8pt;font-weight:bold;">Benefit Plans</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:8pt;"><span style="font-family:inherit;font-size:8pt;font-weight:bold;">Non-U.S. Defined</span></div><div style="text-align:center;font-size:8pt;"><span style="font-family:inherit;font-size:8pt;font-weight:bold;">Benefit Plans</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:8pt;"><span style="font-family:inherit;font-size:8pt;font-weight:bold;">U.S. Post-Retirement</span></div><div style="text-align:center;font-size:8pt;"><span style="font-family:inherit;font-size:8pt;font-weight:bold;">Benefit Plans</span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:inherit;font-size:8pt;font-weight:bold;"> </span></div></td><td colspan="11" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:center;font-size:8pt;"><span style="font-family:inherit;font-size:8pt;font-weight:bold;">(in millions)</span></div></td></tr><tr><td style="vertical-align:middle;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">2020</span></div></td><td style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:middle;background-color:#cceeff;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>35</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:middle;background-color:#cceeff;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>25</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:middle;background-color:#cceeff;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>8</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">2021</span></div></td><td style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:middle;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>36</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:middle;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>27</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:middle;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>8</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:middle;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">2022</span></div></td><td style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:middle;background-color:#cceeff;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>33</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:middle;background-color:#cceeff;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>29</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:middle;background-color:#cceeff;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>7</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">2023</span></div></td><td style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:middle;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>35</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:middle;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>32</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:middle;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>7</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:middle;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">2024</span></div></td><td style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:middle;background-color:#cceeff;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>37</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:middle;background-color:#cceeff;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>32</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:middle;background-color:#cceeff;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>7</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">2025 - 2029</span></div></td><td style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:middle;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>146</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:middle;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>170</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:middle;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>35</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr></table></div><span style="font-family:inherit;font-size:10pt;"><br/></span></div><div style="line-height:120%;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div><div style="line-height:120%;text-align:justify;text-indent:36px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;font-style:italic;">Assumptions.</span><span style="font-family:inherit;font-size:10pt;">    The assumptions used to determine the benefit obligations and expense for our defined benefit and post-retirement benefit plans are presented in the tables below. The expected long-term return on assets below represents an estimate of long-term returns on investment portfolios consisting of a mixture of equities, fixed income and alternative investments in proportion to the asset allocations of each of our plans. We consider long-term rates of return, which are weighted based on the asset classes (both historical and forecasted) in which we expect our pension and post-retirement funds to be invested. Discount rates reflect the current rate at which pension and post-retirement obligations could be settled based on the measurement dates of the plans - October 31. The U.S. discount rates at </span><span style="font-family:inherit;font-size:10pt;">October 31, 2019</span><span style="font-family:inherit;font-size:10pt;"> and </span><span style="font-family:inherit;font-size:10pt;">2018</span><span style="font-family:inherit;font-size:10pt;">, were determined based on the results of matching expected plan benefit payments with cash flows from a hypothetically constructed bond portfolio. The non-U.S. rates were generally </span></div><div style="line-height:120%;text-align:justify;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">based on published rates for high-quality corporate bonds. The range of assumptions that were used for the non-U.S. defined benefit plans reflects the different economic environments within various countries.</span></div><div style="line-height:120%;text-align:justify;text-indent:32px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div><div style="line-height:120%;text-align:justify;text-indent:36px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Assumptions used to calculate the net periodic cost in each year were as follows:</span></div><div style="line-height:120%;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div><div style="line-height:120%;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="6"/></tr><tr><td style="width:59%;"/><td style="width:13%;"/><td style="width:1%;"/><td style="width:13%;"/><td style="width:1%;"/><td style="width:13%;"/></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;font-weight:bold;"> </span></div></td><td colspan="5" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:8pt;"><span style="font-family:inherit;font-size:8pt;font-weight:bold;">For years ended October 31,</span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:inherit;font-size:8pt;font-weight:bold;"> </span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:8pt;"><span style="font-family:inherit;font-size:8pt;font-weight:bold;">2019</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:8pt;"><span style="font-family:inherit;font-size:8pt;font-weight:bold;">2018</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:8pt;"><span style="font-family:inherit;font-size:8pt;font-weight:bold;">2017</span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">U.S. defined benefit plans:</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Discount rate</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>4.50%</span></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>3.75%</span></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>3.75%</span></span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Expected long-term return on assets</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>7.00%</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>7.00%</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>7.25%</span></span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Non-U.S. defined benefit plans:</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Discount rate</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">0.83-2.68%</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">0.67-2.52%</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">0.22-2.66%</span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Average increase in compensation levels</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">2.25-3.25%</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">2.00-3.25%</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">2.00-4.25%</span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Expected long-term return on assets</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">4.00-5.75%</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">4.00-6.00%</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">4.00-6.25%</span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">U.S. post-retirement benefits plans:</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Discount rate</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>4.25%</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>3.50%</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>3.50%</span></span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Expected long-term return on assets</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>7.00%</span></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>7.00%</span></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>7.25%</span></span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Current medical cost trend rate</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>6.00%</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>6.00%</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>6.00%</span></span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Ultimate medical cost trend rate</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>3.50%</span></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>3.50%</span></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>3.50%</span></span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Medical cost trend rate decreases to ultimate rate in year</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>2029</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>2029</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>2029</span></span></div></td></tr></table></div></div><div style="line-height:120%;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div><div style="line-height:120%;text-align:justify;text-indent:36px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Assumptions used to calculate the benefit obligation were as follows:</span></div><div style="line-height:120%;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div><div style="line-height:120%;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="4"/></tr><tr><td style="width:73%;"/><td style="width:13%;"/><td style="width:1%;"/><td style="width:13%;"/></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;font-weight:bold;"> </span></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:8pt;"><span style="font-family:inherit;font-size:8pt;font-weight:bold;">As of the Years Ending October 31,</span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:inherit;font-size:8pt;font-weight:bold;"> </span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:8pt;"><span style="font-family:inherit;font-size:8pt;font-weight:bold;">2019</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:8pt;"><span style="font-family:inherit;font-size:8pt;font-weight:bold;">2018</span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">U.S. defined benefit plans:</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Discount rate</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>3.25%</span></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>4.50%</span></span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Non-U.S. defined benefit plans:</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Discount rate</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">0.22-1.81%</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">0.83-2.68%</span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Average increase in compensation levels</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">2.25-3.00%</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">2.25-3.25%</span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">U.S. post-retirement benefits plans:</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Discount rate</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>3.00%</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>4.25%</span></span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Current medical cost trend rate</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>6.25%</span></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>6.00%</span></span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Ultimate medical cost trend rate</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>4.50%</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>3.50%</span></span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Medical cost trend rate decreases to ultimate rate in year</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>2029</span></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>2029</span></span></div></td></tr></table></div><span style="font-family:inherit;font-size:10pt;"><br/></span></div><div style="line-height:120%;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div><div style="line-height:120%;text-indent:36px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Health care trend rates do not have a significant effect on the total service and interest cost components or on the post-retirement benefit obligation amounts reported for the U.S. Post-Retirement Benefit Plan for the year ended </span><span style="font-family:inherit;font-size:10pt;color:#000000;text-decoration:none;">October 31, 2019</span><span style="font-family:inherit;font-size:10pt;">.</span></div> 132000000 141000000 0.06 0.03 0.04 0.05 0.50 39000000 37000000 33000000 32000000 41000000 65000000 24000000 -9000000 5000000 <div style="line-height:120%;text-align:justify;text-indent:36px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">For the years ended </span><span style="font-family:inherit;font-size:10pt;">October 31, 2019</span><span style="font-family:inherit;font-size:10pt;">, </span><span style="font-family:inherit;font-size:10pt;">2018</span><span style="font-family:inherit;font-size:10pt;"> and </span><span style="font-family:inherit;font-size:10pt;">2017</span><span style="font-family:inherit;font-size:10pt;">, components of net periodic benefit cost and other amounts recognized in other comprehensive income were comprised of:</span></div><div style="line-height:120%;text-align:justify;text-indent:0px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="36"/></tr><tr><td style="width:37%;"/><td style="width:1%;"/><td style="width:4%;"/><td style="width:1%;"/><td style="width:1%;"/><td style="width:1%;"/><td style="width:4%;"/><td style="width:1%;"/><td style="width:1%;"/><td style="width:1%;"/><td style="width:4%;"/><td style="width:1%;"/><td style="width:1%;"/><td style="width:1%;"/><td style="width:4%;"/><td style="width:1%;"/><td style="width:1%;"/><td style="width:1%;"/><td style="width:4%;"/><td style="width:1%;"/><td style="width:1%;"/><td style="width:1%;"/><td style="width:4%;"/><td style="width:1%;"/><td style="width:1%;"/><td style="width:1%;"/><td style="width:4%;"/><td style="width:1%;"/><td style="width:1%;"/><td style="width:1%;"/><td style="width:4%;"/><td style="width:1%;"/><td style="width:1%;"/><td style="width:1%;"/><td style="width:5%;"/><td style="width:1%;"/></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:inherit;font-size:8pt;font-weight:bold;"> </span></div></td><td colspan="23" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:center;font-size:8pt;"><span style="font-family:inherit;font-size:8pt;font-weight:bold;">Pensions</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="11" rowspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:center;font-size:8pt;"><span style="font-family:inherit;font-size:8pt;font-weight:bold;">U.S. Post-Retirement Benefit Plans</span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:inherit;font-size:8pt;font-weight:bold;"> </span></div></td><td colspan="11" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:center;font-size:8pt;"><span style="font-family:inherit;font-size:8pt;font-weight:bold;">U.S. Plans</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="11" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:center;font-size:8pt;"><span style="font-family:inherit;font-size:8pt;font-weight:bold;">Non-U.S. Plans</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:17px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:17px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:17px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:17px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:17px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:17px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:17px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:17px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:17px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:17px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:17px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:17px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:17px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:17px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:17px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:17px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:17px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:17px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:inherit;font-size:8pt;font-weight:bold;"> </span></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:8pt;"><span style="font-family:inherit;font-size:8pt;font-weight:bold;">2019</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="text-align:center;font-size:8pt;"><span style="font-family:inherit;font-size:8pt;font-weight:bold;">2018</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:8pt;"><span style="font-family:inherit;font-size:8pt;font-weight:bold;">2017</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:8pt;"><span style="font-family:inherit;font-size:8pt;font-weight:bold;">2019</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:8pt;"><span style="font-family:inherit;font-size:8pt;font-weight:bold;">2018</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:8pt;"><span style="font-family:inherit;font-size:8pt;font-weight:bold;">2017</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:8pt;"><span style="font-family:inherit;font-size:8pt;font-weight:bold;">2019</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="text-align:center;font-size:8pt;"><span style="font-family:inherit;font-size:8pt;font-weight:bold;">2018</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:8pt;"><span style="font-family:inherit;font-size:8pt;font-weight:bold;">2017</span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:inherit;font-size:8pt;font-weight:bold;"> </span></div></td><td colspan="35" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:center;font-size:8pt;"><span style="font-family:inherit;font-size:8pt;font-weight:bold;">(in millions)</span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;font-weight:bold;">Net periodic benefit cost (benefit)</span></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Service cost — benefits earned during the period</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>—</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>—</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>—</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>20</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>20</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>19</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>—</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>1</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>1</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Interest cost on benefit obligation</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>18</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>16</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>15</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>14</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>13</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>12</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>4</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>3</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>3</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Expected return on plan assets</span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>(27</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">)</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>(28</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">)</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>(25</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">)</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>(43</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">)</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>(46</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">)</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>(41</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">)</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>(7</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">)</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>(7</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">)</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>(7</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">)</span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Amortization of net actuarial loss</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>1</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>1</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>3</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>34</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>29</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>36</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>4</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>8</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>11</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Amortization of prior service benefit</span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>—</span></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>—</span></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>—</span></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>—</span></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>—</span></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>—</span></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>(8</span></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">)</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>(8</span></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">)</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>(9</span></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">)</span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Total periodic benefit cost (benefit)</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>(8</span></span></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">)</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>(11</span></span></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">)</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>(7</span></span></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">)</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>25</span></span></div></td><td style="vertical-align:bottom;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>16</span></span></div></td><td style="vertical-align:bottom;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>26</span></span></div></td><td style="vertical-align:bottom;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>(7</span></span></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">)</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>(3</span></span></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">)</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>(1</span></span></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">)</span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Curtailments and settlements</span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>—</span></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>—</span></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>—</span></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>—</span></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>(5</span></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">)</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>(32</span></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">)</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>—</span></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>—</span></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>—</span></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;font-weight:bold;">Other changes in plan assets and benefit obligations recognized in other comprehensive (income) loss</span></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Net actuarial (gain) loss</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>51</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>2</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>(19</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">)</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>104</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>49</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>(128</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">)</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>5</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>(2</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">)</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>(9</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">)</span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Amortization of net actuarial loss</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>(1</span></span></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">)</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>(1</span></span></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">)</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>(3</span></span></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">)</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>(34</span></span></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">)</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>(29</span></span></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">)</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>(36</span></span></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">)</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>(4</span></span></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">)</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>(8</span></span></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">)</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>(11</span></span></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">)</span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Prior service cost (benefit)</span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>—</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>—</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>—</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>—</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>—</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>—</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>—</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>—</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>—</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Amortization of prior service benefit</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>—</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>—</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>—</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>—</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>—</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>—</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>8</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>8</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>9</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Gain due to settlement</span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>—</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>—</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>—</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>—</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>—</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>32</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>—</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>—</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>—</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Foreign currency</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>—</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>—</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>—</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>(3</span></span></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">)</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>1</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>2</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>—</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>—</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>—</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Total recognized in other comprehensive (income) loss</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>50</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>1</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>(22</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">)</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>67</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>21</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>(130</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">)</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>9</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>(2</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">)</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>(11</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">)</span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Total recognized in net periodic benefit cost (benefit) and other comprehensive (income) loss</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>42</span></span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>(10</span></span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-right:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">)</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>(29</span></span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-right:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">)</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>92</span></span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>32</span></span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>(136</span></span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-right:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">)</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>2</span></span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>(5</span></span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-right:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">)</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>(12</span></span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-right:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">)</span></div></td></tr></table></div><span style="font-family:inherit;font-size:10pt;"><br/></span></div><div style="line-height:120%;text-align:justify;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div><div style="line-height:120%;text-indent:36px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div><div style="line-height:120%;text-indent:36px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div><div style="line-height:120%;text-indent:36px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div><div style="line-height:120%;text-indent:36px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div><div style="line-height:120%;text-indent:36px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div><div style="line-height:120%;text-indent:36px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div><div style="line-height:120%;text-indent:36px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div><div style="line-height:120%;text-indent:36px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div><div style="line-height:120%;text-indent:36px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div><div style="line-height:120%;text-indent:36px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div><div style="line-height:120%;text-indent:36px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div><div style="line-height:120%;text-indent:36px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div> 0 0 0 20000000 20000000 19000000 0 1000000 1000000 18000000 16000000 15000000 14000000 13000000 12000000 4000000 3000000 3000000 27000000 28000000 25000000 43000000 46000000 41000000 7000000 7000000 7000000 -1000000 -1000000 -3000000 -34000000 -29000000 -36000000 -4000000 -8000000 -11000000 0 0 0 0 0 0 -8000000 -8000000 -9000000 -8000000 -11000000 -7000000 25000000 16000000 26000000 -7000000 -3000000 -1000000 0 0 0 0 5000000 32000000 0 0 0 -51000000 -2000000 19000000 -104000000 -49000000 128000000 -5000000 2000000 9000000 -1000000 -1000000 -3000000 -34000000 -29000000 -36000000 -4000000 -8000000 -11000000 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 -8000000 -8000000 -9000000 0 0 0 0 0 -32000000 0 0 0 0 0 0 3000000 -1000000 -2000000 0 0 0 50000000 1000000 -22000000 67000000 21000000 -130000000 9000000 -2000000 -11000000 42000000 -10000000 -29000000 92000000 32000000 -136000000 2000000 -5000000 -12000000 <div style="line-height:120%;text-indent:36px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div><div style="line-height:120%;text-indent:36px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div><div style="line-height:120%;text-indent:36px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div><div style="line-height:120%;text-indent:36px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;font-style:italic;">Funded Status.</span><span style="font-family:inherit;font-size:10pt;">    As of </span><span style="font-family:inherit;font-size:10pt;">October 31, 2019</span><span style="font-family:inherit;font-size:10pt;"> and </span><span style="font-family:inherit;font-size:10pt;">2018</span><span style="font-family:inherit;font-size:10pt;">, the funded status of the defined benefit and post-retirement benefit plans was:</span></div><div style="line-height:120%;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div><div style="line-height:120%;text-indent:0px;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="24"/></tr><tr><td style="width:47%;"/><td style="width:1%;"/><td style="width:6%;"/><td style="width:1%;"/><td style="width:1%;"/><td style="width:1%;"/><td style="width:6%;"/><td style="width:1%;"/><td style="width:1%;"/><td style="width:1%;"/><td style="width:6%;"/><td style="width:1%;"/><td style="width:1%;"/><td style="width:1%;"/><td style="width:6%;"/><td style="width:1%;"/><td style="width:1%;"/><td style="width:1%;"/><td style="width:6%;"/><td style="width:1%;"/><td style="width:1%;"/><td style="width:1%;"/><td style="width:6%;"/><td style="width:1%;"/></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;font-weight:bold;"> </span></div></td><td colspan="7" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:center;font-size:8pt;"><span style="font-family:inherit;font-size:8pt;font-weight:bold;">U.S. Defined</span></div><div style="text-align:center;font-size:8pt;"><span style="font-family:inherit;font-size:8pt;font-weight:bold;">Benefit Plans</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="7" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:center;font-size:8pt;"><span style="font-family:inherit;font-size:8pt;font-weight:bold;">Non-U.S. Defined</span></div><div style="text-align:center;font-size:8pt;"><span style="font-family:inherit;font-size:8pt;font-weight:bold;">Benefit Plans</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="7" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:center;font-size:8pt;"><span style="font-family:inherit;font-size:8pt;font-weight:bold;">U.S.</span></div><div style="text-align:center;font-size:8pt;"><span style="font-family:inherit;font-size:8pt;font-weight:bold;">Post-Retirement</span></div><div style="text-align:center;font-size:8pt;"><span style="font-family:inherit;font-size:8pt;font-weight:bold;">Benefit Plans</span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:inherit;font-size:8pt;font-weight:bold;"> </span></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:8pt;"><span style="font-family:inherit;font-size:8pt;font-weight:bold;">2019</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="text-align:center;font-size:8pt;"><span style="font-family:inherit;font-size:8pt;font-weight:bold;">2018</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:8pt;"><span style="font-family:inherit;font-size:8pt;font-weight:bold;">2019</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="text-align:center;font-size:8pt;"><span style="font-family:inherit;font-size:8pt;font-weight:bold;">2018</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:8pt;"><span style="font-family:inherit;font-size:8pt;font-weight:bold;">2019</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:8pt;"><span style="font-family:inherit;font-size:8pt;font-weight:bold;">2018</span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:inherit;font-size:8pt;font-weight:bold;"> </span></div></td><td colspan="23" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:center;font-size:8pt;"><span style="font-family:inherit;font-size:8pt;font-weight:bold;">(in millions)</span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Change in fair value of plan assets:</span></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Fair value — beginning of year</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>401</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>414</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>825</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>855</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>90</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>95</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Actual return on plan assets</span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>50</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>8</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>85</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>(9</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">)</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>11</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>1</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Employer contributions</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>—</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>—</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>21</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>21</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>—</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>—</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Participants' contributions</span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>—</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>—</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>1</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>—</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>—</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>—</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Benefits paid</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>(19</span></span></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">)</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>(21</span></span></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">)</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>(29</span></span></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">)</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>(26</span></span></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">)</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>(6</span></span></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">)</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>(6</span></span></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">)</span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Settlements</span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>—</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>—</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>—</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>5</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>—</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>—</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Currency impact</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>—</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>—</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>8</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>(21</span></span></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">)</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>—</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>—</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Fair value — end of year</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>432</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>401</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>911</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>825</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>95</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>90</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Change in benefit obligation:</span></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:3px double #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:3px double #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:3px double #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:3px double #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:3px double #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:3px double #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Benefit obligation — beginning of year</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>420</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>445</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>913</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>935</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>87</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>97</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Service cost</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>—</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>—</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>20</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>20</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>—</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>1</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Interest cost</span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>18</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>16</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>14</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>13</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>4</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>3</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Participants' contributions</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>—</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>—</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>1</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>—</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>—</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>—</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Plan amendment</span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>—</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>—</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>—</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>1</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>—</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>—</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Actuarial (gain) loss</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>74</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>(19</span></span></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">)</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>143</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>(6</span></span></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">)</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>9</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>(7</span></span></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">)</span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Benefits paid</span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>(21</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">)</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>(22</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">)</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>(29</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">)</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>(27</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">)</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>(6</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">)</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>(7</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">)</span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Currency impact</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>—</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>—</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>5</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>(23</span></span></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">)</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>—</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>—</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:middle;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Benefit obligation — end of year</span></div></td><td style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:middle;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>491</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:middle;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>420</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:middle;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>1,067</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:middle;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>913</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:middle;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>94</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:middle;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>87</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:middle;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Overfunded (underfunded) status of PBO</span></div></td><td style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:3px double #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:middle;padding-top:2px;padding-bottom:2px;border-top:3px double #000000;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>(59</span></span></div></td><td style="vertical-align:middle;padding-right:2px;padding-top:2px;padding-bottom:2px;border-top:3px double #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">)</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:3px double #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:middle;padding-top:2px;padding-bottom:2px;border-top:3px double #000000;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>(19</span></span></div></td><td style="vertical-align:middle;padding-right:2px;padding-top:2px;padding-bottom:2px;border-top:3px double #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">)</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:3px double #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:middle;padding-top:2px;padding-bottom:2px;border-top:3px double #000000;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>(156</span></span></div></td><td style="vertical-align:middle;padding-right:2px;padding-top:2px;padding-bottom:2px;border-top:3px double #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">)</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:3px double #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:middle;padding-top:2px;padding-bottom:2px;border-top:3px double #000000;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>(88</span></span></div></td><td style="vertical-align:middle;padding-right:2px;padding-top:2px;padding-bottom:2px;border-top:3px double #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">)</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:3px double #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:middle;padding-top:2px;padding-bottom:2px;border-top:3px double #000000;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>1</span></span></div></td><td style="vertical-align:bottom;border-top:3px double #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:3px double #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:middle;padding-top:2px;padding-bottom:2px;border-top:3px double #000000;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>3</span></span></div></td><td style="vertical-align:bottom;border-top:3px double #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Amounts recognized in the consolidated balance sheet consist of:</span></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:3px double #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:3px double #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:3px double #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:3px double #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:3px double #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:3px double #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td></tr><tr><td style="vertical-align:middle;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Other assets</span></div></td><td style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:middle;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>—</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:middle;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>—</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:middle;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>106</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:middle;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>95</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:middle;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>1</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:middle;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>3</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:middle;background-color:#cceeff;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Employee compensation and benefits</span></div></td><td colspan="2" style="vertical-align:middle;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>(1</span></span></div></td><td style="vertical-align:middle;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">)</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:middle;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>(1</span></span></div></td><td style="vertical-align:middle;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">)</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:middle;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>—</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:middle;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>—</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:middle;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>—</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:middle;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>—</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:middle;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Retirement and post-retirement benefits</span></div></td><td colspan="2" style="vertical-align:middle;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>(58</span></span></div></td><td style="vertical-align:middle;border-bottom:1px solid #000000;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">)</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>(18</span></span></div></td><td style="vertical-align:middle;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">)</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>(262</span></span></div></td><td style="vertical-align:middle;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">)</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>(183</span></span></div></td><td style="vertical-align:middle;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">)</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>—</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>—</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:middle;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Total net asset (liability)</span></div></td><td style="vertical-align:middle;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:middle;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>(59</span></span></div></td><td style="vertical-align:middle;border-bottom:3px double #000000;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">)</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:middle;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:middle;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>(19</span></span></div></td><td style="vertical-align:middle;border-bottom:3px double #000000;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">)</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:middle;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:middle;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>(156</span></span></div></td><td style="vertical-align:middle;border-bottom:3px double #000000;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">)</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:middle;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:middle;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>(88</span></span></div></td><td style="vertical-align:middle;border-bottom:3px double #000000;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">)</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:middle;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:middle;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>1</span></span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:middle;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:middle;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>3</span></span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Amounts Recognized in Accumulated Other Comprehensive Income (loss):</span></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td></tr><tr><td style="vertical-align:middle;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Actuarial (gains) losses</span></div></td><td style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:middle;background-color:#cceeff;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>115</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:middle;background-color:#cceeff;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>65</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:middle;background-color:#cceeff;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>330</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:middle;background-color:#cceeff;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>263</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:middle;background-color:#cceeff;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>10</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:middle;background-color:#cceeff;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>10</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Prior service costs (benefits)</span></div></td><td colspan="2" style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>—</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>—</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>—</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>—</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>(12</span></span></div></td><td style="vertical-align:middle;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">)</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>(20</span></span></div></td><td style="vertical-align:middle;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">)</span></div></td></tr><tr><td style="vertical-align:middle;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Total</span></div></td><td style="vertical-align:middle;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:middle;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>115</span></span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:middle;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:middle;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>65</span></span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:middle;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:middle;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>330</span></span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:middle;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:middle;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>263</span></span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:middle;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:middle;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>(2</span></span></div></td><td style="vertical-align:middle;border-bottom:3px double #000000;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">)</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:middle;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:middle;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>(10</span></span></div></td><td style="vertical-align:middle;border-bottom:3px double #000000;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">)</span></div></td></tr></table></div><span style="font-family:inherit;font-size:10pt;"><br/></span></div> 401000000 414000000 825000000 855000000 90000000 95000000 50000000 8000000 85000000 -9000000 11000000 1000000 0 0 21000000 21000000 0 0 0 0 1000000 0 0 0 19000000 21000000 29000000 26000000 6000000 6000000 0 0 0 5000000 0 0 0 0 8000000 -21000000 0 0 432000000 401000000 911000000 825000000 95000000 90000000 420000000 445000000 913000000 935000000 87000000 97000000 0 0 20000000 20000000 0 1000000 18000000 16000000 14000000 13000000 4000000 3000000 0 0 1000000 0 0 0 0 0 0 1000000 0 0 74000000 -19000000 143000000 -6000000 9000000 -7000000 21000000 22000000 29000000 27000000 6000000 7000000 0 0 5000000 -23000000 0 0 491000000 420000000 1067000000 913000000 94000000 87000000 -59000000 -19000000 -156000000 -88000000 1000000 3000000 0 0 106000000 95000000 1000000 3000000 1000000 1000000 0 0 0 0 58000000 18000000 262000000 183000000 0 0 -59000000 -19000000 -156000000 -88000000 1000000 3000000 -115000000 -65000000 -330000000 -263000000 -10000000 -10000000 0 0 0 0 -12000000 -20000000 115000000 65000000 330000000 263000000 -2000000 -10000000 <div style="line-height:120%;text-align:justify;text-indent:36px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">The amounts in accumulated other comprehensive income expected to be recognized by Agilent as components of net expense during </span><span style="font-family:inherit;font-size:10pt;">2020</span><span style="font-family:inherit;font-size:10pt;"> are as follows:</span></div><div style="line-height:120%;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="12"/></tr><tr><td style="width:54%;"/><td style="width:1%;"/><td style="width:12%;"/><td style="width:1%;"/><td style="width:1%;"/><td style="width:1%;"/><td style="width:12%;"/><td style="width:1%;"/><td style="width:1%;"/><td style="width:1%;"/><td style="width:14%;"/><td style="width:1%;"/></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:8pt;"><span style="font-family:inherit;font-size:8pt;font-weight:bold;">U.S. Defined</span></div><div style="text-align:center;font-size:8pt;"><span style="font-family:inherit;font-size:8pt;font-weight:bold;">Benefit Plans</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:8pt;"><span style="font-family:inherit;font-size:8pt;font-weight:bold;">Non-U.S. Defined</span></div><div style="text-align:center;font-size:8pt;"><span style="font-family:inherit;font-size:8pt;font-weight:bold;">Benefit Plans</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:8pt;"><span style="font-family:inherit;font-size:8pt;font-weight:bold;">U.S. Post-Retirement</span></div><div style="text-align:center;font-size:8pt;"><span style="font-family:inherit;font-size:8pt;font-weight:bold;">Benefit Plans</span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:inherit;font-size:8pt;font-weight:bold;"> </span></div></td><td colspan="11" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:center;font-size:8pt;"><span style="font-family:inherit;font-size:8pt;font-weight:bold;">(in millions)</span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Amortization of net prior service cost (benefit)</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>—</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>—</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>(7</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">)</span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Amortization of actuarial net loss (gain)</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>3</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>48</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>4</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr></table></div><span style="font-family:inherit;font-size:10pt;"><br/></span></div><div style="line-height:120%;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div> 0 0 -7000000 3000000 48000000 4000000 0.80 0.20 0.60 0.40 0.03 0.31 0.60 0.38 0.61 0 0.25 1000000 0 0 0 1000000 336000000 78000000 0 0 258000000 91000000 46000000 0 0 45000000 4000000 0 0 4000000 0 432000000 124000000 0 4000000 304000000 4000000 0 0 0 4000000 308000000 69000000 0 0 239000000 83000000 36000000 5000000 0 42000000 6000000 0 0 6000000 0 401000000 105000000 5000000 6000000 285000000 <div style="line-height:120%;text-align:justify;text-indent:36px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">For U.S. Defined Benefit Plans assets measured at fair value using significant unobservable inputs (level 3), the following table summarizes the change in balances during </span><span style="font-family:inherit;font-size:10pt;color:#000000;text-decoration:none;">2019</span><span style="font-family:inherit;font-size:10pt;"> and </span><span style="font-family:inherit;font-size:10pt;color:#000000;text-decoration:none;">2018</span><span style="font-family:inherit;font-size:10pt;">:</span></div><div style="line-height:120%;text-align:justify;text-indent:0px;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="8"/></tr><tr><td style="width:73%;"/><td style="width:1%;"/><td style="width:11%;"/><td style="width:1%;"/><td style="width:1%;"/><td style="width:1%;"/><td style="width:11%;"/><td style="width:1%;"/></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;font-weight:bold;"> </span></div></td><td colspan="7" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:center;font-size:8pt;"><span style="font-family:inherit;font-size:8pt;font-weight:bold;">Years Ended</span></div><div style="text-align:center;font-size:8pt;"><span style="font-family:inherit;font-size:8pt;font-weight:bold;">October 31.</span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:inherit;font-size:8pt;font-weight:bold;"> </span></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:8pt;"><span style="font-family:inherit;font-size:8pt;font-weight:bold;">2019</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:8pt;"><span style="font-family:inherit;font-size:8pt;font-weight:bold;">2018</span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Balance, beginning of year</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>6</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>7</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Realized gains/(losses)</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>(1</span></span></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">)</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>—</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Unrealized gains/(losses)</span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>1</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>1</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Purchases, sales, issuances, and settlements</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>(2</span></span></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">)</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>(2</span></span></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">)</span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Transfers in (out)</span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>—</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>—</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Balance, end of year</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>4</span></span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>6</span></span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr></table></div><span style="font-family:inherit;font-size:10pt;"><br/></span></div><div style="line-height:120%;text-align:justify;text-indent:36px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div><div style="line-height:120%;text-align:justify;text-indent:36px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div><div style="line-height:120%;text-align:justify;text-indent:36px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div><div style="line-height:120%;text-align:justify;text-indent:36px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div><div style="line-height:120%;text-align:justify;text-indent:36px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div><div style="line-height:120%;text-align:justify;text-indent:36px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div><div style="line-height:120%;text-align:justify;text-indent:36px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div><div style="line-height:120%;text-align:justify;text-indent:36px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div><div style="line-height:120%;text-align:justify;text-indent:36px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div><div style="line-height:120%;text-align:justify;text-indent:36px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div><div style="line-height:120%;text-align:justify;text-indent:36px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div><div style="line-height:120%;text-align:justify;text-indent:36px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div><div style="line-height:120%;text-align:justify;text-indent:36px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div><div style="line-height:120%;text-align:justify;text-indent:36px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div><div style="line-height:120%;text-align:justify;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div><div style="line-height:120%;text-align:justify;text-indent:36px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">For U.S. Post-Retirement Benefit Plans assets measured at fair value using significant unobservable inputs (level 3), the following table summarizes the change in balances during </span><span style="font-family:inherit;font-size:10pt;color:#000000;text-decoration:none;">2019</span><span style="font-family:inherit;font-size:10pt;"> and </span><span style="font-family:inherit;font-size:10pt;color:#000000;text-decoration:none;">2018</span><span style="font-family:inherit;font-size:10pt;">:</span></div><div style="line-height:120%;text-align:justify;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="8"/></tr><tr><td style="width:73%;"/><td style="width:1%;"/><td style="width:11%;"/><td style="width:1%;"/><td style="width:1%;"/><td style="width:1%;"/><td style="width:11%;"/><td style="width:1%;"/></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;font-weight:bold;"> </span></div></td><td colspan="7" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:center;font-size:8pt;"><span style="font-family:inherit;font-size:8pt;font-weight:bold;">Years Ended</span></div><div style="text-align:center;font-size:8pt;"><span style="font-family:inherit;font-size:8pt;font-weight:bold;">October 31,</span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:inherit;font-size:8pt;font-weight:bold;"> </span></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:8pt;"><span style="font-family:inherit;font-size:8pt;font-weight:bold;">2019</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:8pt;"><span style="font-family:inherit;font-size:8pt;font-weight:bold;">2018</span></div></td></tr><tr><td style="vertical-align:middle;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Balance, beginning of year</span></div></td><td style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:middle;background-color:#cceeff;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>4</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:middle;background-color:#cceeff;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>4</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:middle;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Realized gains/(losses)</span></div></td><td colspan="2" style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>(1</span></span></div></td><td style="vertical-align:middle;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">)</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>—</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:middle;background-color:#cceeff;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Unrealized gains/(losses)</span></div></td><td colspan="2" style="vertical-align:middle;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>—</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:middle;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>1</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:middle;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Purchases, sales, issuances, and settlements</span></div></td><td colspan="2" style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>(1</span></span></div></td><td style="vertical-align:middle;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">)</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>(1</span></span></div></td><td style="vertical-align:middle;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">)</span></div></td></tr><tr><td style="vertical-align:middle;background-color:#cceeff;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Transfers in (out)</span></div></td><td colspan="2" style="vertical-align:middle;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>—</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:middle;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>—</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Balance, end of year</span></div></td><td style="vertical-align:middle;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:middle;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>2</span></span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:middle;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:middle;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>4</span></span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr></table></div><span style="font-family:inherit;font-size:10pt;"><br/></span></div> 6000000 7000000 1000000 0 1000000 -1000000 -2000000 -2000000 0 0 4000000 6000000 3000000 0 0 0 3000000 69000000 18000000 0 0 51000000 21000000 11000000 0 0 10000000 2000000 0 0 2000000 0 95000000 29000000 0 2000000 64000000 3000000 0 0 0 3000000 65000000 15000000 0 0 50000000 18000000 9000000 0 0 9000000 4000000 0 0 4000000 0 90000000 24000000 0 4000000 62000000 4000000 4000000 1000000 0 0 -1000000 -1000000 -1000000 0 0 2000000 4000000 <div style="line-height:120%;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div><div style="line-height:120%;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div><div style="line-height:120%;text-align:justify;text-indent:36px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">The following tables present the fair value of non-U.S. Defined Benefit Plans assets classified under the appropriate level of the fair value hierarchy as of </span><span style="font-family:inherit;font-size:10pt;color:#000000;text-decoration:none;">October 31, 2019</span><span style="font-family:inherit;font-size:10pt;"> and </span><span style="font-family:inherit;font-size:10pt;">2018</span><span style="font-family:inherit;font-size:10pt;">:</span></div><div style="line-height:120%;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div><div style="line-height:120%;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="20"/></tr><tr><td style="width:40%;"/><td style="width:1%;"/><td style="width:9%;"/><td style="width:1%;"/><td style="width:1%;"/><td style="width:1%;"/><td style="width:10%;"/><td style="width:1%;"/><td style="width:1%;"/><td style="width:1%;"/><td style="width:9%;"/><td style="width:1%;"/><td style="width:1%;"/><td style="width:1%;"/><td style="width:9%;"/><td style="width:1%;"/><td style="width:1%;"/><td style="width:1%;"/><td style="width:9%;"/><td style="width:1%;"/></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;font-weight:bold;"> </span></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;font-weight:bold;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="11" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:center;font-size:8pt;"><span style="font-family:inherit;font-size:8pt;font-weight:bold;">Fair Value Measurement at October 31, 2019 Using</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:inherit;font-size:8pt;font-weight:bold;"> </span></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:8pt;"><span style="font-family:inherit;font-size:8pt;font-weight:bold;">October 31, <br/>2019</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:8pt;"><span style="font-family:inherit;font-size:8pt;font-weight:bold;">Quoted Prices</span></div><div style="text-align:center;font-size:8pt;"><span style="font-family:inherit;font-size:8pt;font-weight:bold;">in Active</span></div><div style="text-align:center;font-size:8pt;"><span style="font-family:inherit;font-size:8pt;font-weight:bold;">Markets for</span></div><div style="text-align:center;font-size:8pt;"><span style="font-family:inherit;font-size:8pt;font-weight:bold;">Identical Assets</span></div><div style="text-align:center;font-size:8pt;"><span style="font-family:inherit;font-size:8pt;font-weight:bold;">(Level 1)</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:8pt;"><span style="font-family:inherit;font-size:8pt;font-weight:bold;">Significant</span></div><div style="text-align:center;font-size:8pt;"><span style="font-family:inherit;font-size:8pt;font-weight:bold;">Other</span></div><div style="text-align:center;font-size:8pt;"><span style="font-family:inherit;font-size:8pt;font-weight:bold;">Observable</span></div><div style="text-align:center;font-size:8pt;"><span style="font-family:inherit;font-size:8pt;font-weight:bold;">Inputs</span></div><div style="text-align:center;font-size:8pt;"><span style="font-family:inherit;font-size:8pt;font-weight:bold;">(Level 2)</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:8pt;"><span style="font-family:inherit;font-size:8pt;font-weight:bold;">Significant</span></div><div style="text-align:center;font-size:8pt;"><span style="font-family:inherit;font-size:8pt;font-weight:bold;">Unobservable</span></div><div style="text-align:center;font-size:8pt;"><span style="font-family:inherit;font-size:8pt;font-weight:bold;">Inputs</span></div><div style="text-align:center;font-size:8pt;"><span style="font-family:inherit;font-size:8pt;font-weight:bold;">(Level 3)</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:8pt;"><span style="font-family:inherit;font-size:8pt;font-weight:bold;">Not Subject to Leveling </span><span style="font-family:inherit;font-size:8pt;font-weight:bold;"><sup style="vertical-align:top;line-height:120%;font-size:5pt">(1)</sup></span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:inherit;font-size:8pt;font-weight:bold;"> </span></div></td><td colspan="19" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:center;font-size:8pt;"><span style="font-family:inherit;font-size:8pt;font-weight:bold;">(in millions)</span></div></td></tr><tr><td style="vertical-align:middle;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Cash and Cash Equivalents</span></div></td><td style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:middle;background-color:#cceeff;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>1</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:middle;background-color:#cceeff;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>—</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:middle;background-color:#cceeff;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>1</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:middle;background-color:#cceeff;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>—</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:middle;background-color:#cceeff;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>—</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Equity</span></div></td><td colspan="2" style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>512</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>318</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>61</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>—</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>133</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:middle;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Fixed Income</span></div></td><td colspan="2" style="vertical-align:middle;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>398</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:middle;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>98</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:middle;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>213</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:middle;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>—</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:middle;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>87</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Other Investments</span></div></td><td colspan="2" style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>—</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>—</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>—</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>—</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>—</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:middle;background-color:#cceeff;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Total assets measured at fair value</span></div></td><td style="vertical-align:middle;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:middle;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>911</span></span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:middle;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:middle;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>416</span></span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:middle;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:middle;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>275</span></span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:middle;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:middle;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>—</span></span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:middle;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:middle;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>220</span></span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr></table></div></div><div style="line-height:120%;text-align:justify;font-size:9pt;"><span style="font-family:inherit;font-size:9pt;">(1) Investments measured at the net asset value per share (or its equivalent) practical expedient have not been classified in the fair value hierarchy.</span></div><div style="line-height:120%;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div><div style="line-height:120%;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="20"/></tr><tr><td style="width:40%;"/><td style="width:1%;"/><td style="width:9%;"/><td style="width:1%;"/><td style="width:1%;"/><td style="width:1%;"/><td style="width:10%;"/><td style="width:1%;"/><td style="width:1%;"/><td style="width:1%;"/><td style="width:9%;"/><td style="width:1%;"/><td style="width:1%;"/><td style="width:1%;"/><td style="width:9%;"/><td style="width:1%;"/><td style="width:1%;"/><td style="width:1%;"/><td style="width:9%;"/><td style="width:1%;"/></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;font-weight:bold;"> </span></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;font-weight:bold;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="11" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:center;font-size:8pt;"><span style="font-family:inherit;font-size:8pt;font-weight:bold;">Fair Value Measurement at October 31, 2018 Using</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:inherit;font-size:8pt;font-weight:bold;"> </span></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:8pt;"><span style="font-family:inherit;font-size:8pt;font-weight:bold;">October 31, <br/>2018</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:8pt;"><span style="font-family:inherit;font-size:8pt;font-weight:bold;">Quoted Prices</span></div><div style="text-align:center;font-size:8pt;"><span style="font-family:inherit;font-size:8pt;font-weight:bold;">in Active</span></div><div style="text-align:center;font-size:8pt;"><span style="font-family:inherit;font-size:8pt;font-weight:bold;">Markets for</span></div><div style="text-align:center;font-size:8pt;"><span style="font-family:inherit;font-size:8pt;font-weight:bold;">Identical Assets</span></div><div style="text-align:center;font-size:8pt;"><span style="font-family:inherit;font-size:8pt;font-weight:bold;">(Level 1)</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:8pt;"><span style="font-family:inherit;font-size:8pt;font-weight:bold;">Significant</span></div><div style="text-align:center;font-size:8pt;"><span style="font-family:inherit;font-size:8pt;font-weight:bold;">Other</span></div><div style="text-align:center;font-size:8pt;"><span style="font-family:inherit;font-size:8pt;font-weight:bold;">Observable</span></div><div style="text-align:center;font-size:8pt;"><span style="font-family:inherit;font-size:8pt;font-weight:bold;">Inputs</span></div><div style="text-align:center;font-size:8pt;"><span style="font-family:inherit;font-size:8pt;font-weight:bold;">(Level 2)</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:8pt;"><span style="font-family:inherit;font-size:8pt;font-weight:bold;">Significant</span></div><div style="text-align:center;font-size:8pt;"><span style="font-family:inherit;font-size:8pt;font-weight:bold;">Unobservable</span></div><div style="text-align:center;font-size:8pt;"><span style="font-family:inherit;font-size:8pt;font-weight:bold;">Inputs</span></div><div style="text-align:center;font-size:8pt;"><span style="font-family:inherit;font-size:8pt;font-weight:bold;">(Level 3)</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:8pt;"><span style="font-family:inherit;font-size:8pt;font-weight:bold;">Not Subject to Leveling </span><span style="font-family:inherit;font-size:8pt;font-weight:bold;"><sup style="vertical-align:top;line-height:120%;font-size:5pt">(1)</sup></span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:inherit;font-size:8pt;font-weight:bold;"> </span></div></td><td colspan="15" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:center;font-size:8pt;"><span style="font-family:inherit;font-size:8pt;font-weight:bold;">(in millions)</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Cash and Cash Equivalents</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>2</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>—</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>2</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>—</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>—</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Equity</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>489</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>298</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>60</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>—</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>131</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Fixed Income</span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>334</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>76</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>228</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>—</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>30</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Other Investments</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>—</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>—</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>—</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>—</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>—</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Total assets measured at fair value</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>825</span></span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>374</span></span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>290</span></span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>—</span></span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>161</span></span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr></table></div></div><div style="line-height:120%;text-align:justify;font-size:9pt;"><span style="font-family:inherit;font-size:9pt;">(1) Investments measured at the net asset value per share (or its equivalent) practical expedient have not been classified in the fair value hierarchy.</span></div><div style="line-height:120%;text-align:justify;text-indent:36px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div><div style="line-height:120%;text-align:justify;text-indent:36px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div><div style="line-height:120%;text-align:justify;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div><div style="line-height:120%;text-align:justify;text-indent:36px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div><div style="line-height:120%;text-align:justify;text-indent:36px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">The following tables present the fair value of U.S. Defined Benefit Plans assets classified under the appropriate level of the fair value hierarchy as of </span><span style="font-family:inherit;font-size:10pt;color:#000000;text-decoration:none;">October 31, 2019</span><span style="font-family:inherit;font-size:10pt;"> and </span><span style="font-family:inherit;font-size:10pt;color:#000000;text-decoration:none;">2018</span><span style="font-family:inherit;font-size:10pt;">.</span></div><div style="line-height:120%;text-align:justify;text-indent:0px;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="20"/></tr><tr><td style="width:40%;"/><td style="width:1%;"/><td style="width:9%;"/><td style="width:1%;"/><td style="width:1%;"/><td style="width:1%;"/><td style="width:10%;"/><td style="width:1%;"/><td style="width:1%;"/><td style="width:1%;"/><td style="width:9%;"/><td style="width:1%;"/><td style="width:1%;"/><td style="width:1%;"/><td style="width:9%;"/><td style="width:1%;"/><td style="width:1%;"/><td style="width:1%;"/><td style="width:9%;"/><td style="width:1%;"/></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;font-weight:bold;"> </span></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;font-weight:bold;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="11" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:center;font-size:8pt;"><span style="font-family:inherit;font-size:8pt;font-weight:bold;">Fair Value Measurement at October 31, 2019 Using</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:inherit;font-size:8pt;font-weight:bold;"> </span></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:8pt;"><span style="font-family:inherit;font-size:8pt;font-weight:bold;">October 31, <br/>2019</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:8pt;"><span style="font-family:inherit;font-size:8pt;font-weight:bold;">Quoted Prices</span></div><div style="text-align:center;font-size:8pt;"><span style="font-family:inherit;font-size:8pt;font-weight:bold;">in Active</span></div><div style="text-align:center;font-size:8pt;"><span style="font-family:inherit;font-size:8pt;font-weight:bold;">Markets for</span></div><div style="text-align:center;font-size:8pt;"><span style="font-family:inherit;font-size:8pt;font-weight:bold;">Identical Assets</span></div><div style="text-align:center;font-size:8pt;"><span style="font-family:inherit;font-size:8pt;font-weight:bold;">(Level 1)</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:8pt;"><span style="font-family:inherit;font-size:8pt;font-weight:bold;">Significant</span></div><div style="text-align:center;font-size:8pt;"><span style="font-family:inherit;font-size:8pt;font-weight:bold;">Other</span></div><div style="text-align:center;font-size:8pt;"><span style="font-family:inherit;font-size:8pt;font-weight:bold;">Observable</span></div><div style="text-align:center;font-size:8pt;"><span style="font-family:inherit;font-size:8pt;font-weight:bold;">Inputs</span></div><div style="text-align:center;font-size:8pt;"><span style="font-family:inherit;font-size:8pt;font-weight:bold;">(Level 2)</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:8pt;"><span style="font-family:inherit;font-size:8pt;font-weight:bold;">Significant</span></div><div style="text-align:center;font-size:8pt;"><span style="font-family:inherit;font-size:8pt;font-weight:bold;">Unobservable</span></div><div style="text-align:center;font-size:8pt;"><span style="font-family:inherit;font-size:8pt;font-weight:bold;">Inputs</span></div><div style="text-align:center;font-size:8pt;"><span style="font-family:inherit;font-size:8pt;font-weight:bold;">(Level 3)</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:8pt;"><span style="font-family:inherit;font-size:8pt;font-weight:bold;">Not Subject to Leveling</span><span style="font-family:inherit;font-size:8pt;font-weight:bold;"><sup style="vertical-align:top;line-height:120%;font-size:5pt"> (1)</sup></span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:inherit;font-size:8pt;font-weight:bold;"> </span></div></td><td colspan="19" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:center;font-size:8pt;"><span style="font-family:inherit;font-size:8pt;font-weight:bold;">(in millions)</span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Cash and Cash Equivalents</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>1</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>—</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>—</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>—</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>1</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Equity</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>336</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>78</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>—</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>—</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>258</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Fixed Income</span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>91</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>46</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>—</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>—</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>45</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Other Investments</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>4</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>—</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>—</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>4</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>—</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Total assets measured at fair value</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>432</span></span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>124</span></span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>—</span></span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>4</span></span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>304</span></span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr></table></div></div><div style="line-height:120%;text-align:justify;font-size:9pt;"><span style="font-family:inherit;font-size:9pt;">(1) Investments measured at the net asset value per share (or its equivalent) practical expedient have not been classified in the fair value hierarchy.</span></div><div style="line-height:120%;text-align:justify;text-indent:0px;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="20"/></tr><tr><td style="width:40%;"/><td style="width:1%;"/><td style="width:9%;"/><td style="width:1%;"/><td style="width:1%;"/><td style="width:1%;"/><td style="width:10%;"/><td style="width:1%;"/><td style="width:1%;"/><td style="width:1%;"/><td style="width:9%;"/><td style="width:1%;"/><td style="width:1%;"/><td style="width:1%;"/><td style="width:9%;"/><td style="width:1%;"/><td style="width:1%;"/><td style="width:1%;"/><td style="width:9%;"/><td style="width:1%;"/></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;font-weight:bold;"> </span></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;font-weight:bold;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="11" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:center;font-size:8pt;"><span style="font-family:inherit;font-size:8pt;font-weight:bold;">Fair Value Measurement at October 31, 2018 Using</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:inherit;font-size:8pt;font-weight:bold;"> </span></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:8pt;"><span style="font-family:inherit;font-size:8pt;font-weight:bold;">October 31, <br/>2018</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:8pt;"><span style="font-family:inherit;font-size:8pt;font-weight:bold;">Quoted Prices</span></div><div style="text-align:center;font-size:8pt;"><span style="font-family:inherit;font-size:8pt;font-weight:bold;">in Active</span></div><div style="text-align:center;font-size:8pt;"><span style="font-family:inherit;font-size:8pt;font-weight:bold;">Markets for</span></div><div style="text-align:center;font-size:8pt;"><span style="font-family:inherit;font-size:8pt;font-weight:bold;">Identical Assets</span></div><div style="text-align:center;font-size:8pt;"><span style="font-family:inherit;font-size:8pt;font-weight:bold;">(Level 1)</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:8pt;"><span style="font-family:inherit;font-size:8pt;font-weight:bold;">Significant</span></div><div style="text-align:center;font-size:8pt;"><span style="font-family:inherit;font-size:8pt;font-weight:bold;">Other</span></div><div style="text-align:center;font-size:8pt;"><span style="font-family:inherit;font-size:8pt;font-weight:bold;">Observable</span></div><div style="text-align:center;font-size:8pt;"><span style="font-family:inherit;font-size:8pt;font-weight:bold;">Inputs</span></div><div style="text-align:center;font-size:8pt;"><span style="font-family:inherit;font-size:8pt;font-weight:bold;">(Level 2)</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:8pt;"><span style="font-family:inherit;font-size:8pt;font-weight:bold;">Significant</span></div><div style="text-align:center;font-size:8pt;"><span style="font-family:inherit;font-size:8pt;font-weight:bold;">Unobservable</span></div><div style="text-align:center;font-size:8pt;"><span style="font-family:inherit;font-size:8pt;font-weight:bold;">Inputs</span></div><div style="text-align:center;font-size:8pt;"><span style="font-family:inherit;font-size:8pt;font-weight:bold;">(Level 3)</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:8pt;"><span style="font-family:inherit;font-size:8pt;font-weight:bold;">Not Subject to Leveling </span><span style="font-family:inherit;font-size:8pt;font-weight:bold;"><sup style="vertical-align:top;line-height:120%;font-size:5pt">(1)</sup></span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:inherit;font-size:8pt;font-weight:bold;"> </span></div></td><td colspan="19" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:center;font-size:8pt;"><span style="font-family:inherit;font-size:8pt;font-weight:bold;">(in millions)</span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Cash and Cash Equivalents</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>4</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>—</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>—</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>—</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>4</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Equity</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>308</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>69</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>—</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>—</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>239</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Fixed Income</span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>83</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>36</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>5</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>—</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>42</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Other Investments</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>6</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>—</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>—</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>6</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>—</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Total assets measured at fair value</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>401</span></span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>105</span></span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>5</span></span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>6</span></span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>285</span></span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr></table></div></div><div style="line-height:120%;text-align:justify;font-size:9pt;"><span style="font-family:inherit;font-size:9pt;">(1) Investments measured at the net asset value per share (or its equivalent) practical expedient have not been classified in the fair value hierarchy.</span></div><div style="line-height:120%;text-align:justify;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div><div style="line-height:120%;text-align:justify;text-indent:36px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div><div style="line-height:120%;text-align:justify;text-indent:36px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">The following tables present the fair value of U.S. Post-Retirement Benefit Plans assets classified under the appropriate level of the fair value hierarchy as of </span><span style="font-family:inherit;font-size:10pt;color:#000000;text-decoration:none;">October 31, 2019</span><span style="font-family:inherit;font-size:10pt;"> and </span><span style="font-family:inherit;font-size:10pt;color:#000000;text-decoration:none;">2018</span><span style="font-family:inherit;font-size:10pt;">.</span></div><div style="line-height:120%;text-align:justify;text-indent:0px;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="20"/></tr><tr><td style="width:40%;"/><td style="width:1%;"/><td style="width:9%;"/><td style="width:1%;"/><td style="width:1%;"/><td style="width:1%;"/><td style="width:10%;"/><td style="width:1%;"/><td style="width:1%;"/><td style="width:1%;"/><td style="width:9%;"/><td style="width:1%;"/><td style="width:1%;"/><td style="width:1%;"/><td style="width:9%;"/><td style="width:1%;"/><td style="width:1%;"/><td style="width:1%;"/><td style="width:9%;"/><td style="width:1%;"/></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;font-weight:bold;"> </span></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;font-weight:bold;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="11" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:center;font-size:8pt;"><span style="font-family:inherit;font-size:8pt;font-weight:bold;">Fair Value Measurement at October 31, 2019 Using</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:inherit;font-size:8pt;font-weight:bold;"> </span></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:8pt;"><span style="font-family:inherit;font-size:8pt;font-weight:bold;">October 31, <br/>2019</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:8pt;"><span style="font-family:inherit;font-size:8pt;font-weight:bold;">Quoted Prices</span></div><div style="text-align:center;font-size:8pt;"><span style="font-family:inherit;font-size:8pt;font-weight:bold;">in Active</span></div><div style="text-align:center;font-size:8pt;"><span style="font-family:inherit;font-size:8pt;font-weight:bold;">Markets for</span></div><div style="text-align:center;font-size:8pt;"><span style="font-family:inherit;font-size:8pt;font-weight:bold;">Identical Assets</span></div><div style="text-align:center;font-size:8pt;"><span style="font-family:inherit;font-size:8pt;font-weight:bold;">(Level 1)</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:8pt;"><span style="font-family:inherit;font-size:8pt;font-weight:bold;">Significant</span></div><div style="text-align:center;font-size:8pt;"><span style="font-family:inherit;font-size:8pt;font-weight:bold;">Other</span></div><div style="text-align:center;font-size:8pt;"><span style="font-family:inherit;font-size:8pt;font-weight:bold;">Observable</span></div><div style="text-align:center;font-size:8pt;"><span style="font-family:inherit;font-size:8pt;font-weight:bold;">Inputs</span></div><div style="text-align:center;font-size:8pt;"><span style="font-family:inherit;font-size:8pt;font-weight:bold;">(Level 2)</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:8pt;"><span style="font-family:inherit;font-size:8pt;font-weight:bold;">Significant</span></div><div style="text-align:center;font-size:8pt;"><span style="font-family:inherit;font-size:8pt;font-weight:bold;">Unobservable</span></div><div style="text-align:center;font-size:8pt;"><span style="font-family:inherit;font-size:8pt;font-weight:bold;">Inputs</span></div><div style="text-align:center;font-size:8pt;"><span style="font-family:inherit;font-size:8pt;font-weight:bold;">(Level 3)</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:8pt;"><span style="font-family:inherit;font-size:8pt;font-weight:bold;">Not Subject to Leveling </span><span style="font-family:inherit;font-size:8pt;font-weight:bold;"><sup style="vertical-align:top;line-height:120%;font-size:5pt">(1)</sup></span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:inherit;font-size:8pt;font-weight:bold;"> </span></div></td><td colspan="19" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:center;font-size:8pt;"><span style="font-family:inherit;font-size:8pt;font-weight:bold;">(in millions)</span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Cash and Cash Equivalents</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>3</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>—</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>—</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>—</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>3</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Equity</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>69</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>18</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>—</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>—</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>51</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Fixed Income</span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>21</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>11</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>—</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>—</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>10</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Other Investments</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>2</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>—</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>—</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>2</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>—</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Total assets measured at fair value</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>95</span></span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>29</span></span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>—</span></span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>2</span></span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>64</span></span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr></table></div></div><div style="line-height:120%;text-align:justify;font-size:9pt;"><span style="font-family:inherit;font-size:9pt;">(1) Investments measured at the net asset value per share (or its equivalent) practical expedient have not been classified in the fair value hierarchy.</span></div><div style="line-height:120%;text-align:justify;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div><div style="line-height:120%;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="20"/></tr><tr><td style="width:40%;"/><td style="width:1%;"/><td style="width:9%;"/><td style="width:1%;"/><td style="width:1%;"/><td style="width:1%;"/><td style="width:10%;"/><td style="width:1%;"/><td style="width:1%;"/><td style="width:1%;"/><td style="width:9%;"/><td style="width:1%;"/><td style="width:1%;"/><td style="width:1%;"/><td style="width:9%;"/><td style="width:1%;"/><td style="width:1%;"/><td style="width:1%;"/><td style="width:9%;"/><td style="width:1%;"/></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;font-weight:bold;"> </span></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;font-weight:bold;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="11" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:center;font-size:8pt;"><span style="font-family:inherit;font-size:8pt;font-weight:bold;">Fair Value Measurement at October 31, 2018 Using</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:inherit;font-size:8pt;font-weight:bold;"> </span></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:8pt;"><span style="font-family:inherit;font-size:8pt;font-weight:bold;">October 31, <br/>2018</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:8pt;"><span style="font-family:inherit;font-size:8pt;font-weight:bold;">Quoted Prices</span></div><div style="text-align:center;font-size:8pt;"><span style="font-family:inherit;font-size:8pt;font-weight:bold;">in Active</span></div><div style="text-align:center;font-size:8pt;"><span style="font-family:inherit;font-size:8pt;font-weight:bold;">Markets for</span></div><div style="text-align:center;font-size:8pt;"><span style="font-family:inherit;font-size:8pt;font-weight:bold;">Identical Assets</span></div><div style="text-align:center;font-size:8pt;"><span style="font-family:inherit;font-size:8pt;font-weight:bold;">(Level 1)</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:8pt;"><span style="font-family:inherit;font-size:8pt;font-weight:bold;">Significant</span></div><div style="text-align:center;font-size:8pt;"><span style="font-family:inherit;font-size:8pt;font-weight:bold;">Other</span></div><div style="text-align:center;font-size:8pt;"><span style="font-family:inherit;font-size:8pt;font-weight:bold;">Observable</span></div><div style="text-align:center;font-size:8pt;"><span style="font-family:inherit;font-size:8pt;font-weight:bold;">Inputs</span></div><div style="text-align:center;font-size:8pt;"><span style="font-family:inherit;font-size:8pt;font-weight:bold;">(Level 2)</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:8pt;"><span style="font-family:inherit;font-size:8pt;font-weight:bold;">Significant</span></div><div style="text-align:center;font-size:8pt;"><span style="font-family:inherit;font-size:8pt;font-weight:bold;">Unobservable</span></div><div style="text-align:center;font-size:8pt;"><span style="font-family:inherit;font-size:8pt;font-weight:bold;">Inputs</span></div><div style="text-align:center;font-size:8pt;"><span style="font-family:inherit;font-size:8pt;font-weight:bold;">(Level 3)</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:8pt;"><span style="font-family:inherit;font-size:8pt;font-weight:bold;">Not Subject to Leveling </span><span style="font-family:inherit;font-size:8pt;font-weight:bold;"><sup style="vertical-align:top;line-height:120%;font-size:5pt">(1)</sup></span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:inherit;font-size:8pt;font-weight:bold;"> </span></div></td><td colspan="19" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:center;font-size:8pt;"><span style="font-family:inherit;font-size:8pt;font-weight:bold;">(in millions)</span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Cash and Cash Equivalents</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>3</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>—</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>—</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>—</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>3</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Equity</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>65</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>15</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>—</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>—</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>50</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Fixed Income</span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>18</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>9</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>—</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>—</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>9</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Other Investments</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>4</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>—</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>—</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>4</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>—</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Total assets measured at fair value</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>90</span></span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>24</span></span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>—</span></span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>4</span></span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>62</span></span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr></table></div></div><div style="line-height:120%;text-align:justify;font-size:9pt;"><span style="font-family:inherit;font-size:9pt;">(1) Investments measured at the net asset value per share (or its equivalent) practical expedient have not been classified in the fair value hierarchy.</span></div> 1000000 0 1000000 0 0 512000000 318000000 61000000 0 133000000 398000000 98000000 213000000 0 87000000 0 0 0 0 0 911000000 416000000 275000000 0 220000000 2000000 0 2000000 0 0 489000000 298000000 60000000 0 131000000 334000000 76000000 228000000 0 30000000 0 0 0 0 0 825000000 374000000 290000000 0 161000000 <div style="line-height:120%;text-align:justify;text-indent:36px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">The table below presents the combined projected benefit obligation ("PBO"), accumulated benefit obligation ("ABO") and fair value of plan assets, grouping plans using comparisons of the PBO and ABO relative to the plan assets as of </span><span style="font-family:inherit;font-size:10pt;">October 31, 2019</span><span style="font-family:inherit;font-size:10pt;"> or </span><span style="font-family:inherit;font-size:10pt;">2018</span><span style="font-family:inherit;font-size:10pt;">.</span></div><div style="line-height:120%;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="16"/></tr><tr><td style="width:56%;"/><td style="width:1%;"/><td style="width:7%;"/><td style="width:1%;"/><td style="width:1%;"/><td style="width:1%;"/><td style="width:9%;"/><td style="width:1%;"/><td style="width:1%;"/><td style="width:1%;"/><td style="width:8%;"/><td style="width:1%;"/><td style="width:1%;"/><td style="width:1%;"/><td style="width:9%;"/><td style="width:1%;"/></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;font-weight:bold;"> </span></div></td><td colspan="7" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:center;font-size:8pt;"><span style="font-family:inherit;font-size:8pt;font-weight:bold;">2019</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="7" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:center;font-size:8pt;"><span style="font-family:inherit;font-size:8pt;font-weight:bold;">2018</span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:inherit;font-size:8pt;font-weight:bold;"> </span></div></td><td colspan="3" rowspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:8pt;"><span style="font-family:inherit;font-size:8pt;font-weight:bold;">Benefit</span></div><div style="text-align:center;font-size:8pt;"><span style="font-family:inherit;font-size:8pt;font-weight:bold;">Obligation</span></div></td><td rowspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:inherit;font-size:8pt;font-weight:bold;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" rowspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:8pt;"><span style="font-family:inherit;font-size:8pt;font-weight:bold;">Benefit</span></div><div style="text-align:center;font-size:8pt;"><span style="font-family:inherit;font-size:8pt;font-weight:bold;">Obligation</span></div></td><td rowspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:inherit;font-size:8pt;font-weight:bold;"> </span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:inherit;font-size:8pt;font-weight:bold;"> </span></div></td><td colspan="3" rowspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:8pt;"><span style="font-family:inherit;font-size:8pt;font-weight:bold;">Fair Value of</span></div><div style="text-align:center;font-size:8pt;"><span style="font-family:inherit;font-size:8pt;font-weight:bold;">Plan Assets</span></div></td><td rowspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" rowspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:8pt;"><span style="font-family:inherit;font-size:8pt;font-weight:bold;">Fair Value of</span></div><div style="text-align:center;font-size:8pt;"><span style="font-family:inherit;font-size:8pt;font-weight:bold;">Plan Assets</span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:inherit;font-size:8pt;font-weight:bold;"> </span></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:8pt;"><span style="font-family:inherit;font-size:8pt;font-weight:bold;">PBO</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:8pt;"><span style="font-family:inherit;font-size:8pt;font-weight:bold;">PBO</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:inherit;font-size:8pt;font-weight:bold;"> </span></div></td><td colspan="15" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:center;font-size:8pt;"><span style="font-family:inherit;font-size:8pt;font-weight:bold;">(in millions)</span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">U.S. defined benefit plans where PBO exceeds the fair value of plan assets </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>491</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>432</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>420</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>401</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">U.S. defined benefit plans where fair value of plan assets exceeds PBO </span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>—</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>—</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>—</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>—</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Total</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>491</span></span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>432</span></span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>420</span></span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>401</span></span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:5px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:5px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:5px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:5px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:5px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:5px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:5px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:5px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Non-U.S. defined benefit plans where PBO exceeds or is equal to the fair value of plan assets </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>752</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>490</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>563</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>380</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Non-U.S. defined benefit plans where fair value of plan assets exceeds PBO </span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>315</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>421</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>350</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>445</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Total</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>1,067</span></span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>911</span></span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>913</span></span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>825</span></span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:5px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:5px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:5px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:5px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:5px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:5px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:5px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:5px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:8pt;"><span style="font-family:inherit;font-size:8pt;font-weight:bold;"> </span></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:8pt;"><span style="font-family:inherit;font-size:8pt;font-weight:bold;">ABO</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:8pt;"><span style="font-family:inherit;font-size:8pt;font-weight:bold;"> </span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:8pt;"><span style="font-family:inherit;font-size:8pt;font-weight:bold;">ABO</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:8pt;"><span style="font-family:inherit;font-size:8pt;font-weight:bold;"> </span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">U.S. defined benefit plans where ABO exceeds the fair value of plan assets</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>491</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>432</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>420</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>401</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">U.S. defined benefit plans where the fair value of plan assets exceeds ABO</span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>—</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>—</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>—</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>—</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Total</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>491</span></span></div></td><td style="vertical-align:bottom;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>432</span></span></div></td><td style="vertical-align:bottom;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>420</span></span></div></td><td style="vertical-align:bottom;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>401</span></span></div></td><td style="vertical-align:bottom;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:8px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:3px double #000000;"><div style="overflow:hidden;height:8px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:8px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:3px double #000000;"><div style="overflow:hidden;height:8px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:8px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:3px double #000000;"><div style="overflow:hidden;height:8px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:8px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:3px double #000000;"><div style="overflow:hidden;height:8px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Non-U.S. defined benefit plans where ABO exceeds or is equal to the fair value of plan assets </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>651</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>418</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>543</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>380</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Non-U.S. defined benefit plans where fair value of plan assets exceeds ABO</span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>381</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>493</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>343</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>445</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Total</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>1,032</span></span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>911</span></span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>886</span></span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>825</span></span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr></table></div><span style="font-family:inherit;font-size:10pt;"><br/></span></div> 491000000 432000000 420000000 401000000 0 0 0 0 491000000 432000000 420000000 401000000 752000000 490000000 563000000 380000000 315000000 421000000 350000000 445000000 1067000000 911000000 913000000 825000000 491000000 432000000 420000000 401000000 0 0 0 0 491000000 432000000 420000000 401000000 651000000 418000000 543000000 380000000 381000000 493000000 343000000 445000000 1032000000 911000000 886000000 825000000 24000000 The following table presents expected future benefit payments for the next 10 years:<div style="line-height:120%;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div><div style="line-height:120%;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="12"/></tr><tr><td style="width:53%;"/><td style="width:1%;"/><td style="width:12%;"/><td style="width:1%;"/><td style="width:1%;"/><td style="width:1%;"/><td style="width:13%;"/><td style="width:1%;"/><td style="width:1%;"/><td style="width:1%;"/><td style="width:14%;"/><td style="width:1%;"/></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:8pt;"><span style="font-family:inherit;font-size:8pt;font-weight:bold;">U.S. Defined</span></div><div style="text-align:center;font-size:8pt;"><span style="font-family:inherit;font-size:8pt;font-weight:bold;">Benefit Plans</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:8pt;"><span style="font-family:inherit;font-size:8pt;font-weight:bold;">Non-U.S. Defined</span></div><div style="text-align:center;font-size:8pt;"><span style="font-family:inherit;font-size:8pt;font-weight:bold;">Benefit Plans</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:8pt;"><span style="font-family:inherit;font-size:8pt;font-weight:bold;">U.S. Post-Retirement</span></div><div style="text-align:center;font-size:8pt;"><span style="font-family:inherit;font-size:8pt;font-weight:bold;">Benefit Plans</span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:inherit;font-size:8pt;font-weight:bold;"> </span></div></td><td colspan="11" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:center;font-size:8pt;"><span style="font-family:inherit;font-size:8pt;font-weight:bold;">(in millions)</span></div></td></tr><tr><td style="vertical-align:middle;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">2020</span></div></td><td style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:middle;background-color:#cceeff;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>35</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:middle;background-color:#cceeff;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>25</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:middle;background-color:#cceeff;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>8</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">2021</span></div></td><td style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:middle;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>36</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:middle;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>27</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:middle;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>8</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:middle;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">2022</span></div></td><td style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:middle;background-color:#cceeff;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>33</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:middle;background-color:#cceeff;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>29</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:middle;background-color:#cceeff;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>7</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">2023</span></div></td><td style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:middle;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>35</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:middle;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>32</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:middle;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>7</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:middle;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">2024</span></div></td><td style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:middle;background-color:#cceeff;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>37</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:middle;background-color:#cceeff;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>32</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:middle;background-color:#cceeff;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>7</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">2025 - 2029</span></div></td><td style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:middle;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>146</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:middle;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>170</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:middle;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>35</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr></table></div><span style="font-family:inherit;font-size:10pt;"><br/></span></div> 35000000 25000000 8000000 36000000 27000000 8000000 33000000 29000000 7000000 35000000 32000000 7000000 37000000 32000000 7000000 146000000 170000000 35000000 <div style="line-height:120%;text-align:justify;text-indent:36px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Assumptions used to calculate the net periodic cost in each year were as follows:</span></div><div style="line-height:120%;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div><div style="line-height:120%;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="6"/></tr><tr><td style="width:59%;"/><td style="width:13%;"/><td style="width:1%;"/><td style="width:13%;"/><td style="width:1%;"/><td style="width:13%;"/></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;font-weight:bold;"> </span></div></td><td colspan="5" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:8pt;"><span style="font-family:inherit;font-size:8pt;font-weight:bold;">For years ended October 31,</span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:inherit;font-size:8pt;font-weight:bold;"> </span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:8pt;"><span style="font-family:inherit;font-size:8pt;font-weight:bold;">2019</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:8pt;"><span style="font-family:inherit;font-size:8pt;font-weight:bold;">2018</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:8pt;"><span style="font-family:inherit;font-size:8pt;font-weight:bold;">2017</span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">U.S. defined benefit plans:</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Discount rate</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>4.50%</span></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>3.75%</span></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>3.75%</span></span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Expected long-term return on assets</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>7.00%</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>7.00%</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>7.25%</span></span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Non-U.S. defined benefit plans:</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Discount rate</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">0.83-2.68%</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">0.67-2.52%</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">0.22-2.66%</span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Average increase in compensation levels</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">2.25-3.25%</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">2.00-3.25%</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">2.00-4.25%</span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Expected long-term return on assets</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">4.00-5.75%</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">4.00-6.00%</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">4.00-6.25%</span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">U.S. post-retirement benefits plans:</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Discount rate</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>4.25%</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>3.50%</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>3.50%</span></span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Expected long-term return on assets</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>7.00%</span></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>7.00%</span></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>7.25%</span></span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Current medical cost trend rate</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>6.00%</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>6.00%</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>6.00%</span></span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Ultimate medical cost trend rate</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>3.50%</span></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>3.50%</span></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>3.50%</span></span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Medical cost trend rate decreases to ultimate rate in year</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>2029</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>2029</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>2029</span></span></div></td></tr></table></div></div><div style="line-height:120%;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div><div style="line-height:120%;text-align:justify;text-indent:36px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Assumptions used to calculate the benefit obligation were as follows:</span></div><div style="line-height:120%;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div><div style="line-height:120%;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="4"/></tr><tr><td style="width:73%;"/><td style="width:13%;"/><td style="width:1%;"/><td style="width:13%;"/></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;font-weight:bold;"> </span></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:8pt;"><span style="font-family:inherit;font-size:8pt;font-weight:bold;">As of the Years Ending October 31,</span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:inherit;font-size:8pt;font-weight:bold;"> </span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:8pt;"><span style="font-family:inherit;font-size:8pt;font-weight:bold;">2019</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:8pt;"><span style="font-family:inherit;font-size:8pt;font-weight:bold;">2018</span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">U.S. defined benefit plans:</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Discount rate</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>3.25%</span></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>4.50%</span></span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Non-U.S. defined benefit plans:</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Discount rate</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">0.22-1.81%</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">0.83-2.68%</span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Average increase in compensation levels</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">2.25-3.00%</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">2.25-3.25%</span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">U.S. post-retirement benefits plans:</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Discount rate</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>3.00%</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>4.25%</span></span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Current medical cost trend rate</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>6.25%</span></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>6.00%</span></span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Ultimate medical cost trend rate</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>4.50%</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>3.50%</span></span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Medical cost trend rate decreases to ultimate rate in year</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>2029</span></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>2029</span></span></div></td></tr></table></div><span style="font-family:inherit;font-size:10pt;"><br/></span></div> 0.0450 0.0375 0.0375 0.0700 0.0700 0.0725 0.0425 0.0350 0.0350 0.0700 0.0700 0.0725 0.0600 0.0600 0.0600 0.0350 0.0350 0.0350 2029 2029 2029 0.0325 0.0450 0.0300 0.0425 0.0625 0.0600 0.0450 0.0350 2029 2029 GUARANTEES<div style="line-height:120%;text-align:justify;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div><div style="line-height:120%;text-align:justify;text-indent:24px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;font-style:italic;font-weight:bold;">Standard Warranty</span></div><div style="line-height:120%;text-align:justify;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div><div style="line-height:120%;text-align:justify;text-indent:36px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">We accrue for standard warranty costs based on historical trends in warranty charges as a percentage of net product shipments. The accrual is reviewed regularly and periodically adjusted to reflect changes in warranty cost estimates. Estimated warranty charges are recorded within cost of products at the time products are sold. The standard warranty accrual balances are held in other accrued and other long-term liabilities on our consolidated balance sheet. Our standard warranty terms typically extend to one years from the date of delivery, depending on the product.</span></div><div style="line-height:120%;text-align:justify;text-indent:36px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div><div style="line-height:120%;text-align:justify;text-indent:36px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">A summary of the standard warranty accrual activity is shown in the table below. The standard warranty accrual balances are recorded in other accrued liabilities.</span></div><div style="line-height:120%;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div><div style="line-height:120%;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="8"/></tr><tr><td style="width:73%;"/><td style="width:1%;"/><td style="width:11%;"/><td style="width:1%;"/><td style="width:1%;"/><td style="width:1%;"/><td style="width:11%;"/><td style="width:1%;"/></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;font-weight:bold;"> </span></div></td><td colspan="7" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:center;font-size:8pt;"><span style="font-family:inherit;font-size:8pt;font-weight:bold;">October 31,</span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:inherit;font-size:8pt;font-weight:bold;"> </span></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="text-align:center;font-size:8pt;"><span style="font-family:inherit;font-size:8pt;font-weight:bold;">2019</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="text-align:center;font-size:8pt;"><span style="font-family:inherit;font-size:8pt;font-weight:bold;">2018</span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:inherit;font-size:8pt;font-weight:bold;"> </span></div></td><td colspan="7" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:center;font-size:8pt;"><span style="font-family:inherit;font-size:8pt;font-weight:bold;">(in millions)</span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Balance as of October 31, 2018 and 2017</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>35</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>34</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Accruals for warranties including change in estimates</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>54</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>53</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Settlements made during the period</span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>(57</span></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">)</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>(52</span></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">)</span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Balance as of October 31, 2019 and 2018</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>32</span></span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>35</span></span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr></table></div><span style="font-family:inherit;font-size:10pt;"><br/></span></div><div style="line-height:120%;text-align:center;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;margin-left:auto;margin-right:auto;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="6"/></tr><tr><td style="width:73%;"/><td style="width:12%;"/><td style="width:1%;"/><td style="width:1%;"/><td style="width:12%;"/><td style="width:1%;"/></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Accruals for warranties due within one year</span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>32</span></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>35</span></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr></table></div><span style="font-family:inherit;font-size:10pt;"><br/></span></div><div style="line-height:120%;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div><div style="line-height:120%;text-align:left;text-indent:30px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;font-style:italic;font-weight:bold;">Bank Guarantees</span></div><div style="line-height:120%;text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div><div style="line-height:120%;text-align:justify;text-indent:36px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Guarantees consist primarily of outstanding standby letters of credit and bank guarantees and were approximately </span><span style="font-family:inherit;font-size:10pt;"><span>$40 million</span></span><span style="font-family:inherit;font-size:10pt;"> as of October 31, 2019. A standby letter of credit is a guarantee of payment issued by a bank on behalf of us that is used as payment of last resort should we fail to fulfill a contractual commitment with a third party. A bank guarantee is a promise from a bank or other lending institution that if we default on a loan, the bank will cover the loss. </span></div><div style="line-height:120%;text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div><div style="line-height:120%;text-align:left;text-indent:30px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;font-style:italic;font-weight:bold;">Indemnifications in Connection with Transactions</span></div><div style="line-height:120%;text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div><div style="line-height:120%;text-align:justify;text-indent:36px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">In connection with various divestitures, acquisitions, spin-offs and other transactions, we have agreed to indemnify certain parties, their affiliates and/or other related parties against certain damages and expenses that might occur in the future. These indemnifications may cover a variety of liabilities, including, but not limited to, employee, tax, environmental, intellectual property, litigation and other liabilities related to the business conducted prior to the date of the transaction. In our opinion, the fair value of these indemnification obligations was not material as of </span><span style="font-family:inherit;font-size:10pt;">October 31, 2019</span><span style="font-family:inherit;font-size:10pt;">. </span></div><div style="line-height:120%;text-align:justify;text-indent:32px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div><div style="line-height:120%;text-align:justify;text-indent:24px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;font-style:italic;font-weight:bold;">Indemnifications to Officers and Directors</span></div><div style="line-height:120%;text-align:justify;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div><div style="line-height:120%;text-align:justify;text-indent:36px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Our corporate bylaws require that we indemnify our officers and directors, as well as those who act as directors and officers of other entities at our request, against expenses, judgments, fines, settlements and other amounts actually and reasonably incurred in connection with any proceedings arising out of their services to Agilent and such other entities, including service with respect to employee benefit plans. In addition, we have entered into separate indemnification agreements with each director and each board-appointed officer of Agilent which provide for indemnification of these directors and officers under similar circumstances and under additional circumstances. The indemnification obligations are more fully described in the bylaws and the indemnification agreements. We purchase standard insurance to cover claims or a portion of the claims made against our directors and officers. Since a maximum obligation is not explicitly stated in our bylaws or in our indemnification agreements and will depend on the facts and circumstances that arise out of any future claims, the overall maximum amount of the obligations cannot be reasonably estimated. Historically, we have not made payments related to these obligations, and the fair value for these indemnification obligations was not material as of </span><span style="font-family:inherit;font-size:10pt;color:#000000;text-decoration:none;">October 31, 2019</span><span style="font-family:inherit;font-size:10pt;">.</span></div><div style="line-height:120%;text-align:justify;text-indent:32px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div><div style="line-height:120%;text-align:justify;text-indent:24px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;font-style:italic;font-weight:bold;">Other Indemnifications</span></div><div style="line-height:120%;text-align:justify;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div><div style="line-height:120%;text-align:justify;text-indent:36px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">As is customary in our industry and as provided for in local law in the U.S. and other jurisdictions, many of our standard contracts provide remedies to our customers and others with whom we enter into contracts, such as defense, settlement, or payment of judgment for intellectual property claims related to the use of our products. From time to time, we indemnify customers, as well as our suppliers, contractors, lessors, lessees, companies that purchase our businesses or assets and others with whom we enter into contracts, against combinations of loss, expense, or liability arising from various triggering events related to the sale and the use of our products and services, the use of their goods and services, the use of facilities and state of our owned facilities, the state of the assets and businesses that we sell and other matters covered by such contracts, usually up to a specified maximum amount. In addition, from time to time we also provide protection to these parties against claims related to undiscovered liabilities, additional product liability or environmental obligations. In our experience, claims made under such indemnifications are rare and the associated estimated fair value of the liability was not material as of </span><span style="font-family:inherit;font-size:10pt;color:#000000;text-decoration:none;">October 31, 2019</span><span style="font-family:inherit;font-size:10pt;">.</span></div><div style="line-height:120%;text-align:justify;text-indent:32px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div><div style="line-height:120%;text-align:justify;text-indent:36px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">In connection with the sale of several of our businesses, we have agreed to indemnify the buyers of such business, their respective affiliates and other related parties against certain damages that they might incur in the future. The continuing indemnifications primarily cover damages relating to liabilities of the businesses that Agilent retained and did not transfer to the buyers, as well as other specified items. In our opinion, the fair value of these indemnification obligations was not material as of </span><span style="font-family:inherit;font-size:10pt;color:#000000;text-decoration:none;">October 31, 2019</span><span style="font-family:inherit;font-size:10pt;">.</span></div> <div style="line-height:120%;text-align:justify;text-indent:36px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div><div style="line-height:120%;text-align:justify;text-indent:36px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">A summary of the standard warranty accrual activity is shown in the table below. The standard warranty accrual balances are recorded in other accrued liabilities.</span></div><div style="line-height:120%;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div><div style="line-height:120%;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="8"/></tr><tr><td style="width:73%;"/><td style="width:1%;"/><td style="width:11%;"/><td style="width:1%;"/><td style="width:1%;"/><td style="width:1%;"/><td style="width:11%;"/><td style="width:1%;"/></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;font-weight:bold;"> </span></div></td><td colspan="7" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:center;font-size:8pt;"><span style="font-family:inherit;font-size:8pt;font-weight:bold;">October 31,</span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:inherit;font-size:8pt;font-weight:bold;"> </span></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="text-align:center;font-size:8pt;"><span style="font-family:inherit;font-size:8pt;font-weight:bold;">2019</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="text-align:center;font-size:8pt;"><span style="font-family:inherit;font-size:8pt;font-weight:bold;">2018</span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:inherit;font-size:8pt;font-weight:bold;"> </span></div></td><td colspan="7" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:center;font-size:8pt;"><span style="font-family:inherit;font-size:8pt;font-weight:bold;">(in millions)</span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Balance as of October 31, 2018 and 2017</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>35</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>34</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Accruals for warranties including change in estimates</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>54</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>53</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Settlements made during the period</span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>(57</span></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">)</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>(52</span></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">)</span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Balance as of October 31, 2019 and 2018</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>32</span></span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>35</span></span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr></table></div><span style="font-family:inherit;font-size:10pt;"><br/></span></div> 35000000 34000000 54000000 53000000 57000000 52000000 32000000 35000000 <div style="line-height:120%;text-align:center;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;margin-left:auto;margin-right:auto;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="6"/></tr><tr><td style="width:73%;"/><td style="width:12%;"/><td style="width:1%;"/><td style="width:1%;"/><td style="width:12%;"/><td style="width:1%;"/></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Accruals for warranties due within one year</span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>32</span></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>35</span></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr></table></div><span style="font-family:inherit;font-size:10pt;"><br/></span></div> 32000000 35000000 40000000 <div style="line-height:120%;text-align:justify;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;font-weight:bold;">16.   COMMITMENTS AND CONTINGENCIES</span></div><div style="line-height:120%;text-align:justify;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div><div style="line-height:120%;text-align:justify;text-indent:36px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;font-style:italic;">Operating Lease Commitments:</span><span style="font-family:inherit;font-size:10pt;">    We lease certain real and personal property from unrelated third parties under non-cancelable operating leases. Certain leases require us to pay property taxes, insurance and routine maintenance, and include escalation clauses. Total rent expense was </span><span style="font-family:inherit;font-size:10pt;"><span>$75 million</span></span><span style="font-family:inherit;font-size:10pt;"> in </span><span style="font-family:inherit;font-size:10pt;">2019</span><span style="font-family:inherit;font-size:10pt;">, </span><span style="font-family:inherit;font-size:10pt;"><span>$64 million</span></span><span style="font-family:inherit;font-size:10pt;"> in </span><span style="font-family:inherit;font-size:10pt;">2018</span><span style="font-family:inherit;font-size:10pt;"> and </span><span style="font-family:inherit;font-size:10pt;"><span>$57 million</span></span><span style="font-family:inherit;font-size:10pt;"> in </span><span style="font-family:inherit;font-size:10pt;">2017</span><span style="font-family:inherit;font-size:10pt;">.</span></div><div style="line-height:120%;text-align:justify;text-indent:36px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div><div style="line-height:120%;text-align:justify;text-indent:36px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Future non-cancelable minimum lease payments and future minimum lease income under operating leases at </span><span style="font-family:inherit;font-size:10pt;">October 31, 2019</span><span style="font-family:inherit;font-size:10pt;">:</span></div><div style="line-height:120%;text-align:center;text-indent:0px;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;margin-left:auto;margin-right:auto;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="9"/></tr><tr><td style="width:50%;"/><td style="width:1%;"/><td style="width:1%;"/><td style="width:22%;"/><td style="width:1%;"/><td style="width:1%;"/><td style="width:1%;"/><td style="width:22%;"/><td style="width:1%;"/></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:8pt;"><span style="font-family:inherit;font-size:8pt;font-weight:bold;">Future Minimum <br/>Lease Payments</span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:8pt;"><span style="font-family:inherit;font-size:8pt;font-weight:bold;">Future Minimum <br/>Lease Income</span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="7" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:center;font-size:8pt;"><span style="font-family:inherit;font-size:8pt;font-weight:bold;">(in millions)</span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">2020</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>52</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>8</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">2021</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>41</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>6</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">2022</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>29</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>5</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">2023</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>21</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">—</span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">2024</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>14</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">—</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Thereafter</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>56</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">—</span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr></table></div><span style="font-family:inherit;font-size:10pt;"><br/></span></div><div style="line-height:120%;text-align:justify;text-indent:36px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div><div style="line-height:120%;text-align:justify;text-indent:36px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;font-style:italic;">Other Purchase Commitments.</span><span style="font-family:inherit;font-size:10pt;">   Typically, we can cancel contracts with professional services suppliers without penalties. For those contracts that are not cancelable without penalties, the termination fees and costs or commitments for continued spending that we are obligated to pay to a supplier under each contact's termination period before such contract can be cancelled were approximately </span><span style="font-family:inherit;font-size:10pt;"><span>$77 million</span></span><span style="font-family:inherit;font-size:10pt;">. Approximately </span><span style="font-family:inherit;font-size:10pt;"><span>$25 million</span></span><span style="font-family:inherit;font-size:10pt;"> of the penalties for the new contracts will reduce over the next 14 years.</span></div><div style="line-height:120%;text-align:justify;text-indent:36px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div><div style="line-height:120%;text-align:justify;text-indent:36px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;font-style:italic;">Contingencies: </span><span style="font-family:inherit;font-size:10pt;">We are involved in lawsuits, claims, investigations and proceedings, including, but not limited to, intellectual property, commercial, real estate, environmental and employment matters, which arise in the ordinary course of business. There are no matters pending that we currently believe are reasonably possible of having a material impact to our business, consolidated financial condition, results of operations or cash flows.</span></div> 75000000 64000000 57000000 <div style="line-height:120%;text-align:justify;text-indent:36px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Future non-cancelable minimum lease payments and future minimum lease income under operating leases at </span><span style="font-family:inherit;font-size:10pt;">October 31, 2019</span><span style="font-family:inherit;font-size:10pt;">:</span></div><div style="line-height:120%;text-align:center;text-indent:0px;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;margin-left:auto;margin-right:auto;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="9"/></tr><tr><td style="width:50%;"/><td style="width:1%;"/><td style="width:1%;"/><td style="width:22%;"/><td style="width:1%;"/><td style="width:1%;"/><td style="width:1%;"/><td style="width:22%;"/><td style="width:1%;"/></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:8pt;"><span style="font-family:inherit;font-size:8pt;font-weight:bold;">Future Minimum <br/>Lease Payments</span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:8pt;"><span style="font-family:inherit;font-size:8pt;font-weight:bold;">Future Minimum <br/>Lease Income</span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="7" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:center;font-size:8pt;"><span style="font-family:inherit;font-size:8pt;font-weight:bold;">(in millions)</span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">2020</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>52</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>8</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">2021</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>41</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>6</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">2022</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>29</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>5</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">2023</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>21</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">—</span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">2024</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>14</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">—</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Thereafter</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>56</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">—</span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr></table></div><span style="font-family:inherit;font-size:10pt;"><br/></span></div> 52000000 8000000 41000000 6000000 29000000 5000000 21000000 14000000 56000000 77000000 25000000 SHORT-TERM DEBT<div style="line-height:120%;text-align:justify;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div><div style="line-height:120%;text-align:justify;text-indent:24px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;font-style:italic;font-weight:bold;">Credit Facilities</span></div><div style="line-height:120%;text-align:justify;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div><div style="line-height:120%;text-align:justify;text-indent:36px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">On </span><span style="font-family:inherit;font-size:10pt;"><span><span style="white-space:nowrap">March 13, 2019</span></span></span><span style="font-family:inherit;font-size:10pt;">, Agilent entered into a credit agreement with a group of financial institutions which provides for a </span><span style="font-family:inherit;font-size:10pt;"><span>$1 billion</span></span><span style="font-family:inherit;font-size:10pt;"> </span><span style="font-family:inherit;font-size:10pt;"><span>five</span></span><span style="font-family:inherit;font-size:10pt;">-year unsecured credit facility that will expire on March 13, 2024. The credit facility replaces the existing credit facility which terminated on the closing date of the new facility. For the year ended </span><span style="font-family:inherit;font-size:10pt;">October 31, 2019</span><span style="font-family:inherit;font-size:10pt;">, we borrowed </span><span style="font-family:inherit;font-size:10pt;"><span>$305 million</span></span><span style="font-family:inherit;font-size:10pt;"> and repaid </span><span style="font-family:inherit;font-size:10pt;"><span>$190 million</span></span><span style="font-family:inherit;font-size:10pt;"> under the credit facility. As of </span><span style="font-family:inherit;font-size:10pt;">October 31, 2019</span><span style="font-family:inherit;font-size:10pt;">, the company had borrowings of </span><span style="font-family:inherit;font-size:10pt;"><span>$115 million</span></span><span style="font-family:inherit;font-size:10pt;"> outstanding under the credit facility. We were in compliance with the covenants for the credit facility during the year ended </span><span style="font-family:inherit;font-size:10pt;">October 31, 2019</span><span style="font-family:inherit;font-size:10pt;">. On August 7, 2019, we entered into an amendment to the credit agreement, which provides for a </span><span style="font-family:inherit;font-size:10pt;"><span>$500 million</span></span><span style="font-family:inherit;font-size:10pt;"> short-term loan facility that was used in full to complete the BioTek acquisition and which is outstanding at </span><span style="font-family:inherit;font-size:10pt;">October 31, 2019</span><span style="font-family:inherit;font-size:10pt;">. On October 21, 2019, we entered into a second amendment to the credit agreement, which refreshed the amount available for additional incremental term loan facilities under the credit agreement to permit additional incremental facilities of up to </span><span style="font-family:inherit;font-size:10pt;"><span>$500 million</span></span><span style="font-family:inherit;font-size:10pt;">. We had no borrowings under the additional incremental facilities as of October 31, 2019.</span></div><div style="line-height:120%;text-align:justify;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div><div style="line-height:120%;text-align:justify;text-indent:24px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;font-style:italic;font-weight:bold;">Capital Leases</span></div><div style="line-height:120%;text-align:justify;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div><div style="line-height:120%;text-align:justify;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">The company leases certain property and equipment under capital leases. As of October 31, 2019, the current portion of the company’s capital lease obligations had an aggregate carrying value of </span><span style="font-family:inherit;font-size:10pt;"><span>$1 million</span></span><span style="font-family:inherit;font-size:10pt;">. </span></div><div style="line-height:120%;text-align:justify;text-indent:24px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div><div style="line-height:120%;text-align:justify;text-indent:24px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;font-weight:bold;">2020 Senior Notes</span></div><div style="line-height:120%;text-align:justify;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div><div style="line-height:120%;text-align:justify;text-indent:36px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">On </span><span style="font-family:inherit;font-size:10pt;"><span><span style="white-space:nowrap">July 13, 2010</span></span></span><span style="font-family:inherit;font-size:10pt;">, the company issued an aggregate principal amount of </span><span style="font-family:inherit;font-size:10pt;"><span>$500 million</span></span><span style="font-family:inherit;font-size:10pt;"> in senior notes ("2020 senior notes"). The 2020 senior notes were issued at </span><span style="font-family:inherit;font-size:10pt;"><span>99.54%</span></span><span style="font-family:inherit;font-size:10pt;"> of their principal amount. The notes were scheduled to mature on </span><span style="font-family:inherit;font-size:10pt;"><span><span style="white-space:nowrap">July 15, 2020</span></span></span><span style="font-family:inherit;font-size:10pt;">, and bear interest at a fixed rate of </span><span style="font-family:inherit;font-size:10pt;"><span>5.00%</span></span><span style="font-family:inherit;font-size:10pt;"> per annum. </span></div><div style="line-height:120%;text-align:justify;text-indent:36px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div><div style="line-height:120%;text-align:justify;text-indent:36px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">On </span><span style="font-family:inherit;font-size:10pt;"><span><span style="white-space:nowrap">August 9, 2011</span></span></span><span style="font-family:inherit;font-size:10pt;">, we terminated our interest rate swap contracts related to our 2020 senior notes that represented the notional amount of </span><span style="font-family:inherit;font-size:10pt;"><span>$500 million</span></span><span style="font-family:inherit;font-size:10pt;">. The asset value, including interest receivable, upon termination for these contracts was approximately </span><span style="font-family:inherit;font-size:10pt;"><span>$34 million</span></span><span style="font-family:inherit;font-size:10pt;">. The gain was deferred and amortized to interest expense over the remaining life of the 2020 senior notes.</span></div><div style="line-height:120%;text-align:justify;text-indent:36px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div><div style="line-height:120%;text-align:justify;text-indent:36px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">On </span><span style="font-family:inherit;font-size:10pt;"><span><span style="white-space:nowrap">September 17, 2019</span></span></span><span style="font-family:inherit;font-size:10pt;">, we repaid the </span><span style="font-family:inherit;font-size:10pt;"><span>$500 million</span></span><span style="font-family:inherit;font-size:10pt;"> outstanding aggregate principal amount of our 2020 senior notes due July 15, 2020 that were called for redemption on August 16, 2019. The redemption price of approximately </span><span style="font-family:inherit;font-size:10pt;"><span>$512 million</span></span><span style="font-family:inherit;font-size:10pt;"> included a </span><span style="font-family:inherit;font-size:10pt;"><span>$12 million</span></span><span style="font-family:inherit;font-size:10pt;"> prepayment penalty. The redemption price was computed in accordance with the terms of the 2020 senior notes as the present value of the remaining scheduled payments of principal and unpaid interest related to the redemption.  The prepayment penalty plus amortization of the previously deferred interest swap gain of </span><span style="font-family:inherit;font-size:10pt;"><span>$4 million</span></span><span style="font-family:inherit;font-size:10pt;"> and amortization of previously deferred debt issuance costs and discount of $</span><span style="font-family:inherit;font-size:10pt;"><span>1 million</span></span><span style="font-family:inherit;font-size:10pt;"> was recorded in other income (expense), net in the consolidated statement of operations. We also paid accrued and unpaid interest of </span><span style="font-family:inherit;font-size:10pt;"><span>$4 million</span></span><span style="font-family:inherit;font-size:10pt;"> on the 2020 senior notes up to but not including the redemption date.</span></div><div style="line-height:120%;text-align:justify;text-indent:24px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div><div style="line-height:120%;text-align:justify;text-indent:24px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;font-weight:bold;">2017 Senior Notes </span></div><div style="line-height:120%;text-align:justify;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div><div style="line-height:120%;text-align:justify;text-indent:36px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">On </span><span style="font-family:inherit;font-size:10pt;"><span><span style="white-space:nowrap">October 24, 2007</span></span></span><span style="font-family:inherit;font-size:10pt;">, the company issued an aggregate principal amount of </span><span style="font-family:inherit;font-size:10pt;"><span>$600 million</span></span><span style="font-family:inherit;font-size:10pt;"> in senior notes ("2017 senior notes"). On </span><span style="font-family:inherit;font-size:10pt;"><span><span style="white-space:nowrap">October 20, 2014</span></span></span><span style="font-family:inherit;font-size:10pt;">, we settled the redemption of </span><span style="font-family:inherit;font-size:10pt;"><span>$500 million</span></span><span style="font-family:inherit;font-size:10pt;"> of the </span><span style="font-family:inherit;font-size:10pt;"><span>$600 million</span></span><span style="font-family:inherit;font-size:10pt;"> outstanding aggregate principal amount of our 2017 senior notes. The 2017 senior notes were repayable within one year as of October 31, 2017 and were reclassified to short-term debt. The remaining </span><span style="font-family:inherit;font-size:10pt;"><span>$100 million</span></span><span style="font-family:inherit;font-size:10pt;"> in 2017 senior notes matured and were paid in full on November 1, 2017.</span></div> 2019-03-13 1000000000 five 305000000 190000000 115000000 500000000 500000000 1000000 2010-07-13 500000000 0.9954 2020-07-15 0.0500 2011-08-09 500000000 34000000 2019-09-17 500000000 512000000 12000000 4000000 1000000 4000000 2007-10-24 600000000 2014-10-20 500000000 600000000 100000000 LONG-TERM DEBT<div style="line-height:120%;text-align:justify;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div><div style="line-height:120%;text-align:justify;text-indent:24px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;font-style:italic;font-weight:bold;">Senior Notes</span></div><div style="line-height:120%;text-align:justify;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div><div style="line-height:120%;text-align:justify;text-indent:36px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">The following table summarizes the company's long-term senior notes and the related interest rate swaps:</span></div><div style="line-height:120%;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div><div style="line-height:120%;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="24"/></tr><tr><td style="width:44%;"/><td style="width:1%;"/><td style="width:9%;"/><td style="width:1%;"/><td style="width:1%;"/><td style="width:1%;"/><td style="width:5%;"/><td style="width:1%;"/><td style="width:1%;"/><td style="width:1%;"/><td style="width:6%;"/><td style="width:1%;"/><td style="width:1%;"/><td style="width:1%;"/><td style="width:8%;"/><td style="width:1%;"/><td style="width:1%;"/><td style="width:1%;"/><td style="width:5%;"/><td style="width:1%;"/><td style="width:1%;"/><td style="width:1%;"/><td style="width:6%;"/><td style="width:1%;"/></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;font-weight:bold;"> </span></div></td><td colspan="11" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:center;font-size:8pt;"><span style="font-family:inherit;font-size:8pt;font-weight:bold;">October 31, 2019</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="11" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:center;font-size:8pt;"><span style="font-family:inherit;font-size:8pt;font-weight:bold;">October 31, 2018</span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:inherit;font-size:8pt;font-weight:bold;"> </span></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:8pt;"><span style="font-family:inherit;font-size:8pt;font-weight:bold;">Amortized</span></div><div style="text-align:center;font-size:8pt;"><span style="font-family:inherit;font-size:8pt;font-weight:bold;">Principal</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:8pt;"><span style="font-family:inherit;font-size:8pt;font-weight:bold;">Swap</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:8pt;"><span style="font-family:inherit;font-size:8pt;font-weight:bold;">Total</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:8pt;"><span style="font-family:inherit;font-size:8pt;font-weight:bold;">Amortized</span></div><div style="text-align:center;font-size:8pt;"><span style="font-family:inherit;font-size:8pt;font-weight:bold;">Principal</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:8pt;"><span style="font-family:inherit;font-size:8pt;font-weight:bold;">Swap</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:8pt;"><span style="font-family:inherit;font-size:8pt;font-weight:bold;">Total</span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:inherit;font-size:8pt;font-weight:bold;"> </span></div></td><td colspan="23" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:center;font-size:8pt;"><span style="font-family:inherit;font-size:8pt;font-weight:bold;">(in millions)</span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">2020 Senior Notes</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">—</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">—</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">—</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>499</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>7</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>506</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">2022 Senior Notes</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>399</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>—</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>399</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>399</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>—</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>399</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">2023 Senior Notes</span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>597</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>—</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>597</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>597</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>—</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>597</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">2026 Senior Notes</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>298</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>—</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>298</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>297</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>—</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>297</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">2029 Senior Notes</span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>492</span></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>—</span></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>492</span></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>—</span></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>—</span></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>—</span></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Total</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>1,786</span></span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>—</span></span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>1,786</span></span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>1,792</span></span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>7</span></span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>1,799</span></span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr></table></div><span style="font-family:inherit;font-size:10pt;"><br/></span></div><div style="line-height:120%;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div><div style="line-height:120%;text-align:justify;text-indent:32px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div><div style="line-height:120%;text-align:justify;text-indent:24px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;font-weight:bold;">2020 Senior Notes</span></div><div style="line-height:120%;text-indent:36px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div><div style="line-height:120%;text-align:justify;text-indent:36px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">The 2020 senior notes were repaid in 2019, see Note 17, "Short-Term Debt".</span></div><div style="line-height:120%;text-align:justify;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div><div style="line-height:120%;text-align:justify;text-indent:24px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;font-weight:bold;">2022 Senior Notes</span></div><div style="line-height:120%;text-align:justify;text-indent:32px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div><div style="line-height:120%;text-align:justify;text-indent:36px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">On </span><span style="font-family:inherit;font-size:10pt;"><span><span style="white-space:nowrap">September 10, 2012</span></span></span><span style="font-family:inherit;font-size:10pt;">, the company issued an aggregate principal amount of </span><span style="font-family:inherit;font-size:10pt;"><span>$400 million</span></span><span style="font-family:inherit;font-size:10pt;"> in senior notes ("2022 senior notes"). The 2022 senior notes were issued at </span><span style="font-family:inherit;font-size:10pt;"><span>99.80%</span></span><span style="font-family:inherit;font-size:10pt;"> of their principal amount. The notes will mature on </span><span style="font-family:inherit;font-size:10pt;"><span><span style="white-space:nowrap">October 1, 2022</span></span></span><span style="font-family:inherit;font-size:10pt;">, and bear interest at a fixed rate of </span><span style="font-family:inherit;font-size:10pt;color:#000000;text-decoration:none;"><span>3.20%</span></span><span style="font-family:inherit;font-size:10pt;"> per annum. The interest is payable </span><span style="font-family:inherit;font-size:10pt;"><span>semi-annually</span></span><span style="font-family:inherit;font-size:10pt;"> on April 1st and October 1st of each year and payments commenced on </span><span style="font-family:inherit;font-size:10pt;"><span><span style="white-space:nowrap">April 1, 2013</span></span></span><span style="font-family:inherit;font-size:10pt;">.</span></div><div style="line-height:120%;text-align:justify;text-indent:36px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div><div style="line-height:120%;text-align:justify;text-indent:36px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">In July 2012, Agilent executed treasury lock agreements for </span><span style="font-family:inherit;font-size:10pt;"><span>$400 million</span></span><span style="font-family:inherit;font-size:10pt;"> in connection with future interest payments to be made on our 2022 senior notes issued on September 10, 2012. The treasury lock contracts were terminated on September 10, 2012 and we recognized a deferred gain in accumulated other comprehensive income which is being amortized to interest expense over the life of the 2022 senior notes. The remaining gain to be amortized related to the treasury lock agreements at </span><span style="font-family:inherit;font-size:10pt;">October 31, 2019</span><span style="font-family:inherit;font-size:10pt;"> was </span><span style="font-family:inherit;font-size:10pt;"><span>$1 million</span></span><span style="font-family:inherit;font-size:10pt;">. </span></div><div style="line-height:120%;text-align:justify;text-indent:36px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div><div style="line-height:120%;text-align:justify;text-indent:24px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;font-weight:bold;">2023 Senior Notes</span></div><div style="line-height:120%;text-align:justify;text-indent:34px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div><div style="line-height:120%;text-align:justify;text-indent:34px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">On </span><span style="font-family:inherit;font-size:10pt;color:#000000;text-decoration:none;"><span><span style="white-space:nowrap">June 18, 2013</span></span></span><span style="font-family:inherit;font-size:10pt;">, the company issued aggregate principal amount of </span><span style="font-family:inherit;font-size:10pt;color:#000000;text-decoration:none;"><span>$600 million</span></span><span style="font-family:inherit;font-size:10pt;"> in senior notes ("2023 senior notes"). The 2023 senior notes were issued at </span><span style="font-family:inherit;font-size:10pt;color:#000000;text-decoration:none;"><span>99.544%</span></span><span style="font-family:inherit;font-size:10pt;"> of their principal amount. The notes will mature on </span><span style="font-family:inherit;font-size:10pt;color:#000000;text-decoration:none;"><span><span style="white-space:nowrap">July 15, 2023</span></span></span><span style="font-family:inherit;font-size:10pt;"> and bear interest at a fixed rate of </span><span style="font-family:inherit;font-size:10pt;color:#000000;text-decoration:none;"><span>3.875%</span></span><span style="font-family:inherit;font-size:10pt;"> per annum. The interest is payable </span><span style="font-family:inherit;font-size:10pt;"><span>semi-annually</span></span><span style="font-family:inherit;font-size:10pt;"> on January 15th and July 15th of each year and payments commenced </span><span style="font-family:inherit;font-size:10pt;"><span><span style="white-space:nowrap">January 15, 2014</span></span></span><span style="font-family:inherit;font-size:10pt;">. </span></div><div style="line-height:120%;text-align:justify;text-indent:34px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div><div style="line-height:120%;text-align:justify;text-indent:24px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;font-weight:bold;">2026 Senior Notes</span></div><div style="line-height:120%;text-align:justify;text-indent:34px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div><div style="line-height:120%;text-align:justify;text-indent:34px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">On </span><span style="font-family:inherit;font-size:10pt;"><span><span style="white-space:nowrap">September 15, 2016</span></span></span><span style="font-family:inherit;font-size:10pt;">, the company issued aggregate principal amount of </span><span style="font-family:inherit;font-size:10pt;"><span>$300 million</span></span><span style="font-family:inherit;font-size:10pt;"> in senior notes ("2026 senior notes"). The 2026 senior notes were issued at </span><span style="font-family:inherit;font-size:10pt;"><span>99.624%</span></span><span style="font-family:inherit;font-size:10pt;"> of their principal amount. The notes will mature on </span><span style="font-family:inherit;font-size:10pt;"><span><span style="white-space:nowrap">September 22, 2026</span></span></span><span style="font-family:inherit;font-size:10pt;"> and bear interest at a fixed rate of </span><span style="font-family:inherit;font-size:10pt;"><span>3.05%</span></span><span style="font-family:inherit;font-size:10pt;"> per annum. The interest is payable </span><span style="font-family:inherit;font-size:10pt;"><span>semi-annually</span></span><span style="font-family:inherit;font-size:10pt;"> on March 22nd and September 22nd of each year and payments commenced </span><span style="font-family:inherit;font-size:10pt;"><span><span style="white-space:nowrap">March 22, 2017</span></span></span><span style="font-family:inherit;font-size:10pt;">. </span></div><div style="line-height:120%;text-align:justify;text-indent:34px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div><div style="line-height:120%;text-align:justify;text-indent:34px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">In February 2016, Agilent executed three forward-starting pay fixed/receive variable interest rate swaps for the notional amount of </span><span style="font-family:inherit;font-size:10pt;"><span>$300 million</span></span><span style="font-family:inherit;font-size:10pt;"> in connection with future interest payments to be made on our 2026 senior notes issued on September 15, 2016. The swap arrangements were terminated on September 15, 2016 with a payment of </span><span style="font-family:inherit;font-size:10pt;"><span>$10 million</span></span><span style="font-family:inherit;font-size:10pt;"> and we recognized this as a deferred loss in accumulated other comprehensive income which is being amortized to interest expense over the life of the 2026 senior notes.The remaining loss to be amortized related to the interest rate swap agreements at </span><span style="font-family:inherit;font-size:10pt;">October 31, 2019</span><span style="font-family:inherit;font-size:10pt;"> was </span><span style="font-family:inherit;font-size:10pt;"><span>$7 million</span></span><span style="font-family:inherit;font-size:10pt;">. </span></div><div style="line-height:120%;text-align:justify;text-indent:24px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div><div style="line-height:120%;text-align:justify;text-indent:24px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;font-weight:bold;">2029 Senior Notes</span></div><div style="line-height:120%;text-align:justify;text-indent:32px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div><div style="line-height:120%;text-align:justify;text-indent:36px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">On </span><span style="font-family:inherit;font-size:10pt;"><span><span style="white-space:nowrap">September 5, 2019</span></span></span><span style="font-family:inherit;font-size:10pt;">, the company issued an aggregate principal amount of </span><span style="font-family:inherit;font-size:10pt;"><span>$500 million</span></span><span style="font-family:inherit;font-size:10pt;"> in senior notes ("2029 senior notes"). The 2029 senior notes were issued at </span><span style="font-family:inherit;font-size:10pt;"><span>99.316%</span></span><span style="font-family:inherit;font-size:10pt;"> of their principal amount. The notes will mature on </span><span style="font-family:inherit;font-size:10pt;"><span><span style="white-space:nowrap">September 15, 2029</span></span></span><span style="font-family:inherit;font-size:10pt;">, and bear interest at a fixed rate of </span><span style="font-family:inherit;font-size:10pt;"><span>2.75%</span></span><span style="font-family:inherit;font-size:10pt;"> per annum. The interest is payable </span><span style="font-family:inherit;font-size:10pt;"><span>semi-annually</span></span><span style="font-family:inherit;font-size:10pt;"> on March 15th and September 15th of each year and payments commence on </span><span style="font-family:inherit;font-size:10pt;"><span><span style="white-space:nowrap">March 15, 2020</span></span></span><span style="font-family:inherit;font-size:10pt;">.</span></div><div style="line-height:120%;text-align:justify;text-indent:36px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div><div style="line-height:120%;text-align:justify;text-indent:32px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">In August 2019, Agilent executed treasury lock agreements for </span><span style="font-family:inherit;font-size:10pt;"><span>$250 million</span></span><span style="font-family:inherit;font-size:10pt;"> in connection with future interest payments to be made on our 2029 senior notes issued on September 5, 2019. We designated the treasury lock as a cash flow hedge. The treasury lock contracts were terminated on September 6, 2019 and we recognized a deferred loss of </span><span style="font-family:inherit;font-size:10pt;"><span>$6 million</span></span><span style="font-family:inherit;font-size:10pt;"> in accumulated other comprehensive income which is being amortized to interest expense over the life of the 2029 senior notes. The remaining loss to be amortized related to the treasury lock agreements at October 31, 2019 was </span><span style="font-family:inherit;font-size:10pt;"><span>$6 million</span></span><span style="font-family:inherit;font-size:10pt;">. </span></div><div style="line-height:120%;text-align:justify;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div><div style="line-height:120%;text-align:justify;text-indent:24px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;font-weight:bold;">Capital Leases</span></div><div style="line-height:120%;text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div><div style="line-height:120%;text-align:justify;text-indent:32px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">The company leases certain property and equipment under capital leases. As of October 31, 2019, the non-current portion of the company’s capital lease obligations had an aggregate carrying value of </span><span style="font-family:inherit;font-size:10pt;"><span>$5 million</span></span><span style="font-family:inherit;font-size:10pt;"> to be paid over 12 years.</span></div> <div style="line-height:120%;text-align:justify;text-indent:36px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">The following table summarizes the company's long-term senior notes and the related interest rate swaps:</span></div><div style="line-height:120%;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div><div style="line-height:120%;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="24"/></tr><tr><td style="width:44%;"/><td style="width:1%;"/><td style="width:9%;"/><td style="width:1%;"/><td style="width:1%;"/><td style="width:1%;"/><td style="width:5%;"/><td style="width:1%;"/><td style="width:1%;"/><td style="width:1%;"/><td style="width:6%;"/><td style="width:1%;"/><td style="width:1%;"/><td style="width:1%;"/><td style="width:8%;"/><td style="width:1%;"/><td style="width:1%;"/><td style="width:1%;"/><td style="width:5%;"/><td style="width:1%;"/><td style="width:1%;"/><td style="width:1%;"/><td style="width:6%;"/><td style="width:1%;"/></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;font-weight:bold;"> </span></div></td><td colspan="11" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:center;font-size:8pt;"><span style="font-family:inherit;font-size:8pt;font-weight:bold;">October 31, 2019</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="11" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:center;font-size:8pt;"><span style="font-family:inherit;font-size:8pt;font-weight:bold;">October 31, 2018</span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:inherit;font-size:8pt;font-weight:bold;"> </span></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:8pt;"><span style="font-family:inherit;font-size:8pt;font-weight:bold;">Amortized</span></div><div style="text-align:center;font-size:8pt;"><span style="font-family:inherit;font-size:8pt;font-weight:bold;">Principal</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:8pt;"><span style="font-family:inherit;font-size:8pt;font-weight:bold;">Swap</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:8pt;"><span style="font-family:inherit;font-size:8pt;font-weight:bold;">Total</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:8pt;"><span style="font-family:inherit;font-size:8pt;font-weight:bold;">Amortized</span></div><div style="text-align:center;font-size:8pt;"><span style="font-family:inherit;font-size:8pt;font-weight:bold;">Principal</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:8pt;"><span style="font-family:inherit;font-size:8pt;font-weight:bold;">Swap</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:8pt;"><span style="font-family:inherit;font-size:8pt;font-weight:bold;">Total</span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:inherit;font-size:8pt;font-weight:bold;"> </span></div></td><td colspan="23" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:center;font-size:8pt;"><span style="font-family:inherit;font-size:8pt;font-weight:bold;">(in millions)</span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">2020 Senior Notes</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">—</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">—</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">—</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>499</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>7</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>506</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">2022 Senior Notes</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>399</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>—</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>399</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>399</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>—</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>399</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">2023 Senior Notes</span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>597</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>—</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>597</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>597</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>—</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>597</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">2026 Senior Notes</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>298</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>—</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>298</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>297</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>—</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>297</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">2029 Senior Notes</span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>492</span></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>—</span></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>492</span></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>—</span></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>—</span></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>—</span></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Total</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>1,786</span></span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>—</span></span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>1,786</span></span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>1,792</span></span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>7</span></span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>1,799</span></span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr></table></div><span style="font-family:inherit;font-size:10pt;"><br/></span></div> 499000000 7000000 506000000 399000000 0 399000000 399000000 0 399000000 597000000 0 597000000 597000000 0 597000000 298000000 0 298000000 297000000 0 297000000 492000000 0 492000000 0 0 0 1786000000 0 1786000000 1792000000 7000000 1799000000 2012-09-10 400000000 0.9980 2022-10-01 0.0320 semi-annually 2013-04-01 400000000 1000000 2013-06-18 600000000 0.99544 2023-07-15 0.03875 semi-annually 2014-01-15 2016-09-15 300000000 0.99624 2026-09-22 0.0305 semi-annually 2017-03-22 300000000 10000000 7000000 2019-09-05 500000000 0.99316 2029-09-15 0.0275 semi-annually 2020-03-15 250000000 6000000 6000000 5000000 <div style="line-height:120%;text-align:justify;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;font-weight:bold;">19.   STOCKHOLDERS' EQUITY</span></div><div style="line-height:120%;text-align:justify;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div><div style="line-height:120%;text-align:justify;text-indent:24px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;font-weight:bold;">Stock Repurchase Program</span></div><div style="line-height:120%;text-align:justify;text-indent:24px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div><div style="line-height:120%;text-align:justify;text-indent:33px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> On May 28, 2015 we announced that our board of directors had approved a share repurchase program (the "2015 repurchase program"). The 2015 share repurchase program authorizes the purchase of up to </span><span style="font-family:inherit;font-size:10pt;"><span>$1.14 billion</span></span><span style="font-family:inherit;font-size:10pt;"> of our common stock at the company's discretion through and including November 1, 2018. The 2015 repurchase program did not require the company to acquire a specific number of shares and could have been suspended or discontinued at any time. During the year ended </span><span style="font-family:inherit;font-size:10pt;">October 31, 2017</span><span style="font-family:inherit;font-size:10pt;">, we repurchased and retired approximately </span><span style="font-family:inherit;font-size:10pt;"><span>4.1 million</span></span><span style="font-family:inherit;font-size:10pt;"> shares for </span><span style="font-family:inherit;font-size:10pt;"><span>$194 million</span></span><span style="font-family:inherit;font-size:10pt;"> under this authorization. During the year ended </span><span style="font-family:inherit;font-size:10pt;">October 31, 2018</span><span style="font-family:inherit;font-size:10pt;">, we repurchased and retired approximately </span><span style="font-family:inherit;font-size:10pt;"><span>6.4 million</span></span><span style="font-family:inherit;font-size:10pt;"> shares for </span><span style="font-family:inherit;font-size:10pt;"><span>$422 million</span></span><span style="font-family:inherit;font-size:10pt;"> under this authorization. As of </span><span style="font-family:inherit;font-size:10pt;">October 31, 2018</span><span style="font-family:inherit;font-size:10pt;">, we had remaining authorization to repurchase up to </span><span style="font-family:inherit;font-size:10pt;"><span>$188 million</span></span><span style="font-family:inherit;font-size:10pt;"> of our common stock under this program which expired on November 1, 2018.</span></div><div style="line-height:120%;text-align:justify;text-indent:33px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div><div style="line-height:120%;text-align:justify;text-indent:36px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">On November 19, 2018 we announced that our board of directors had approved a new share repurchase program (the "2019 repurchase program") designed, among other things, to reduce or eliminate dilution resulting from issuance of stock under the company's employee equity incentive programs. The 2019 share repurchase program authorizes the purchase of up to </span><span style="font-family:inherit;font-size:10pt;"><span>$1.75 billion</span></span><span style="font-family:inherit;font-size:10pt;"> of our common stock at the company's discretion and has no fixed termination date. The 2019 repurchase program does not require the company to acquire a specific number of shares and may be suspended, amended or discontinued at any time. During the year ended </span><span style="font-family:inherit;font-size:10pt;">October 31, 2019</span><span style="font-family:inherit;font-size:10pt;">, we repurchased and retired approximately </span><span style="font-family:inherit;font-size:10pt;"><span>10.4 million</span></span><span style="font-family:inherit;font-size:10pt;"> shares for </span><span style="font-family:inherit;font-size:10pt;"><span>$723 million</span></span><span style="font-family:inherit;font-size:10pt;"> under this authorization. As of </span><span style="font-family:inherit;font-size:10pt;">October 31, 2019</span><span style="font-family:inherit;font-size:10pt;">, we had remaining authorization to repurchase up to </span><span style="font-family:inherit;font-size:10pt;"><span>$1.03 billion</span></span><span style="font-family:inherit;font-size:10pt;"> of our common stock under this program.</span></div><div style="line-height:120%;text-align:justify;text-indent:33px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div><div style="line-height:120%;text-align:justify;text-indent:33px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div><div style="line-height:120%;text-align:justify;text-indent:33px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;font-weight:bold;">Cash Dividends on Shares of Common Stock</span></div><div style="line-height:120%;text-align:justify;text-indent:33px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div><div style="line-height:120%;text-align:justify;text-indent:33px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> During the year ended </span><span style="font-family:inherit;font-size:10pt;">October 31, 2019</span><span style="font-family:inherit;font-size:10pt;">, cash dividends of </span><span style="font-family:inherit;font-size:10pt;"><span>0.656</span></span><span style="font-family:inherit;font-size:10pt;"> per share, or </span><span style="font-family:inherit;font-size:10pt;"><span>$206 million</span></span><span style="font-family:inherit;font-size:10pt;"> were declared and paid on the company's outstanding common stock. During the year ended </span><span style="font-family:inherit;font-size:10pt;">October 31, 2018</span><span style="font-family:inherit;font-size:10pt;">, cash dividends of </span><span style="font-family:inherit;font-size:10pt;"><span>0.596</span></span><span style="font-family:inherit;font-size:10pt;"> per share, or </span><span style="font-family:inherit;font-size:10pt;"><span>$191 million</span></span><span style="font-family:inherit;font-size:10pt;"> were declared and paid on the company's outstanding common stock. During the year ended </span><span style="font-family:inherit;font-size:10pt;">October 31, 2017</span><span style="font-family:inherit;font-size:10pt;">, cash dividends of </span><span style="font-family:inherit;font-size:10pt;"><span>0.528</span></span><span style="font-family:inherit;font-size:10pt;"> per share, or </span><span style="font-family:inherit;font-size:10pt;"><span>$170 million</span></span><span style="font-family:inherit;font-size:10pt;"> were declared and paid on the company's outstanding common stock. </span></div><div style="line-height:120%;text-align:justify;text-indent:33px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div><div style="line-height:120%;text-align:justify;text-indent:33px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">On </span><span style="font-family:inherit;font-size:10pt;"><span><span style="white-space:nowrap">November 20, 2019</span></span></span><span style="font-family:inherit;font-size:10pt;"> we declared a quarterly dividend of </span><span style="font-family:inherit;font-size:10pt;"><span>$0.18</span></span><span style="font-family:inherit;font-size:10pt;"> per share of common stock, or approximately </span><span style="font-family:inherit;font-size:10pt;"><span>$56 million</span></span><span style="font-family:inherit;font-size:10pt;"> which will be paid on </span><span style="font-family:inherit;font-size:10pt;"><span><span style="white-space:nowrap">January 22, 2020</span></span></span><span style="font-family:inherit;font-size:10pt;"> to shareholders of record as of the close of business on </span><span style="font-family:inherit;font-size:10pt;"><span><span style="white-space:nowrap">December 31, 2019</span></span></span><span style="font-family:inherit;font-size:10pt;">. The timing and amounts of any future dividends are subject to determination and approval by our board of directors.</span></div><div style="line-height:120%;text-align:justify;text-indent:33px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div><div style="line-height:120%;text-align:justify;text-indent:33px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;font-weight:bold;">Accumulated Other Comprehensive Income (Loss)</span></div><div style="line-height:120%;text-align:justify;text-indent:33px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div><div style="line-height:120%;text-align:justify;text-indent:33px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">The following table summarizes the components of our accumulated other comprehensive income (loss) as of </span><span style="font-family:inherit;font-size:10pt;">October 31, 2019</span><span style="font-family:inherit;font-size:10pt;"> and </span><span style="font-family:inherit;font-size:10pt;">2018</span><span style="font-family:inherit;font-size:10pt;">, net of tax effect:</span></div><div style="line-height:120%;text-align:justify;text-indent:33px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div><div style="line-height:120%;text-align:justify;text-indent:0px;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="8"/></tr><tr><td style="width:73%;"/><td style="width:1%;"/><td style="width:11%;"/><td style="width:1%;"/><td style="width:1%;"/><td style="width:1%;"/><td style="width:11%;"/><td style="width:1%;"/></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;font-weight:bold;"> </span></div></td><td colspan="7" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:center;font-size:8pt;"><span style="font-family:inherit;font-size:8pt;font-weight:bold;">October 31,</span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:inherit;font-size:8pt;font-weight:bold;"> </span></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="text-align:center;font-size:8pt;"><span style="font-family:inherit;font-size:8pt;font-weight:bold;">2019</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="text-align:center;font-size:8pt;"><span style="font-family:inherit;font-size:8pt;font-weight:bold;">2018</span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:inherit;font-size:8pt;font-weight:bold;"> </span></div></td><td colspan="7" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:center;font-size:8pt;"><span style="font-family:inherit;font-size:8pt;font-weight:bold;">(in millions)</span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Foreign currency translation, net of tax expense of $(5) and $(15) for 2019 and 2018, respectively</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>(204</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">)</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>(214</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">)</span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Unrealized losses (including prior service benefit) on defined benefit plans, net of tax benefit of $153 and $132 for 2019 and 2018, respectively</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>(306</span></span></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">)</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>(201</span></span></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">)</span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Unrealized gains (losses) on derivative instruments, net of tax benefit of $3 and $0 for 2019 and 2018, respectively</span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>(4</span></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">)</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>7</span></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Total accumulated other comprehensive loss</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>(514</span></span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-right:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">)</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>(408</span></span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-right:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">)</span></div></td></tr></table></div></div><div style="line-height:120%;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div><div style="line-height:120%;text-align:justify;text-indent:36px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Changes in accumulated other comprehensive income (loss) by component and related tax effects for the years ended </span><span style="font-family:inherit;font-size:10pt;">October 31, 2019</span><span style="font-family:inherit;font-size:10pt;"> and </span><span style="font-family:inherit;font-size:10pt;">2018</span><span style="font-family:inherit;font-size:10pt;"> were as follows (in millions):</span></div><div style="line-height:120%;text-align:justify;text-indent:36px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div><div style="line-height:120%;text-align:center;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;margin-left:auto;margin-right:auto;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="21"/></tr><tr><td style="width:36%;"/><td style="width:1%;"/><td style="width:1%;"/><td style="width:9%;"/><td style="width:1%;"/><td style="width:2%;"/><td style="width:1%;"/><td style="width:9%;"/><td style="width:1%;"/><td style="width:2%;"/><td style="width:1%;"/><td style="width:9%;"/><td style="width:1%;"/><td style="width:2%;"/><td style="width:1%;"/><td style="width:9%;"/><td style="width:1%;"/><td style="width:2%;"/><td style="width:1%;"/><td style="width:9%;"/><td style="width:1%;"/></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="7" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:center;font-size:8pt;"><span style="font-family:inherit;font-size:8pt;font-weight:bold;">Net defined benefit pension cost and post retirement plan costs</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:8pt;"><span style="font-family:inherit;font-size:8pt;font-weight:bold;">Foreign currency translation</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:8pt;"><span style="font-family:inherit;font-size:8pt;font-weight:bold;">Prior service credits</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:8pt;"><span style="font-family:inherit;font-size:8pt;font-weight:bold;">Actuarial Losses</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:8pt;"><span style="font-family:inherit;font-size:8pt;font-weight:bold;">Unrealized gains (losses) on derivatives</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:8pt;"><span style="font-family:inherit;font-size:8pt;font-weight:bold;">Total</span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="19" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:center;font-size:8pt;"><span style="font-family:inherit;font-size:8pt;font-weight:bold;">(in millions)</span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">As of October 31, 2017</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>(156</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">)</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>140</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>(328</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">)</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>(2</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">)</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>(346</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">)</span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:5px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:5px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:5px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:5px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:5px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:5px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:5px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:5px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:5px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:5px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:5px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Other comprehensive income (loss) before reclassifications</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>(51</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">)</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>—</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>(49</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">)</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>7</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>(93</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">)</span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:5px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:5px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:5px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:5px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:5px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:5px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:5px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:5px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:5px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:5px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:5px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Amounts reclassified out of accumulated other comprehensive income (loss)</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>—</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>(8</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">)</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>39</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>4</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>35</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:5px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:5px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:5px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:5px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:5px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:5px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:5px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:5px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:5px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:5px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:5px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Tax (expense) benefit</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>(7</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">)</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>2</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>3</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>(2</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">)</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>(4</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">)</span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:5px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:5px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:5px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:5px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:5px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:5px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:5px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:5px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:5px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:5px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:5px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Other comprehensive income (loss)</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>(58</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">)</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>(6</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">)</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>(7</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">)</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>9</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>(62</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">)</span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:5px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:5px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:5px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:5px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:5px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:5px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:5px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:5px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:5px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:5px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:5px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">As of October 31, 2018</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>(214</span></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">)</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>134</span></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>(335</span></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">)</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>7</span></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>(408</span></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">)</span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:10px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:10px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:10px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:10px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:10px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:10px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:10px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:10px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:10px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:10px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:10px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Impact of adoption of new guidance on tax effects in accumulated other comprehensive income (loss)</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>—</span></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>3</span></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>(9</span></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">)</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>(1</span></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">)</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>(7</span></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">)</span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:14px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:14px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:14px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:14px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:14px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:14px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:14px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:14px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:14px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:14px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:14px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">As of November 1, 2018</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>(214</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">)</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>137</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>(344</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">)</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>6</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>(415</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">)</span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:5px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:5px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:5px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:5px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:5px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:5px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:5px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:5px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:5px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:5px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:5px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Other comprehensive loss before reclassifications</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>—</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>—</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>(157</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">)</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>(6</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">)</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>(163</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">)</span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:10px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:10px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:10px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:10px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:10px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:10px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:10px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:10px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:10px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:10px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:10px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Amounts reclassified out of accumulated other comprehensive income</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>—</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>(8</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">)</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>39</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>(8</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">)</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>23</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:10px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:10px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:10px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:10px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:10px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:10px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:10px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:10px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:10px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:10px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:10px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Tax benefit</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>10</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>2</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>25</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>4</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>41</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:10px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:10px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:10px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:10px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:10px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:10px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:10px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:10px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:10px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:10px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:10px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Other comprehensive income (loss)</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>10</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>(6</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">)</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>(93</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">)</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>(10</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">)</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>(99</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">)</span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:10px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:10px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:10px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:10px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:10px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:10px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:10px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:10px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:10px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:10px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:10px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">As of October 31, 2019</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>(204</span></span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">)</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>131</span></span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>(437</span></span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">)</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>(4</span></span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">)</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>(514</span></span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">)</span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:8px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:8px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:8px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:8px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:8px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:8px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:8px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:8px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:8px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:8px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:8px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td></tr></table></div></div><div style="line-height:120%;text-align:justify;text-indent:36px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div><div style="line-height:120%;text-align:justify;text-indent:36px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Reclassifications out of accumulated other comprehensive income (loss) for the years ended </span><span style="font-family:inherit;font-size:10pt;">October 31, 2019</span><span style="font-family:inherit;font-size:10pt;"> and </span><span style="font-family:inherit;font-size:10pt;">2018</span><span style="font-family:inherit;font-size:10pt;"> were as follows (in millions): </span></div><div style="line-height:120%;text-align:justify;text-indent:0px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="11"/></tr><tr><td style="width:47%;"/><td style="width:1%;"/><td style="width:1%;"/><td style="width:7%;"/><td style="width:1%;"/><td style="width:1%;"/><td style="width:1%;"/><td style="width:7%;"/><td style="width:1%;"/><td style="width:2%;"/><td style="width:31%;"/></tr><tr><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:8pt;"><span style="font-family:inherit;font-size:8pt;font-weight:bold;">Details about Accumulated Other<br/>Comprehensive Income components</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:inherit;font-size:8pt;"><br/></span></div></td><td colspan="7" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:center;font-size:8pt;"><span style="font-family:inherit;font-size:8pt;font-weight:bold;">Amounts Reclassified<br/>from Other Comprehensive Income</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:8pt;"><span style="font-family:inherit;font-size:8pt;font-weight:bold;">Affected line item in<br/>statement of operations</span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:inherit;font-size:8pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:inherit;font-size:8pt;"><br/></span></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="text-align:center;font-size:8pt;"><span style="font-family:inherit;font-size:8pt;font-weight:bold;">2019</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:inherit;font-size:8pt;"><br/></span></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="text-align:center;font-size:8pt;"><span style="font-family:inherit;font-size:8pt;font-weight:bold;">2018</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:inherit;font-size:8pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:inherit;font-size:8pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Unrealized gains and (losses) on derivatives</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>8</span></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>(4</span></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">)</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Cost of products and interest expense</span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>8</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>(4</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">)</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Total before income tax</span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>(2</span></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">)</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>1</span></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">(Provision)/benefit for income tax</span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>6</span></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>(3</span></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">)</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Total net of income tax</span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Net defined benefit pension cost and post retirement plan costs:</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Actuarial net loss</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>(39</span></span></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">)</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>(39</span></span></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">)</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Other (income) expense</span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Prior service benefit</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>8</span></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>8</span></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Other (income) expense</span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>(31</span></span></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">)</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>(31</span></span></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">)</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Total before income tax</span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>12</span></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>10</span></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Benefit for income tax</span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>(19</span></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-right:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">)</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>(21</span></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-right:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">)</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Total net of income tax</span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Total reclassifications for the period</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>(13</span></span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">)</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>(24</span></span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">)</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr></table></div></div><div style="line-height:120%;text-align:justify;text-indent:36px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div><div style="line-height:120%;text-align:justify;text-indent:36px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Amounts in parentheses indicate reductions to income and increases to other comprehensive income.</span></div><div style="line-height:120%;text-align:justify;text-indent:36px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div><div style="line-height:120%;text-align:justify;text-indent:36px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Reclassifications of prior service benefit and actuarial net loss in respect of retirement plans and post retirement pension plans are included in the computation of net periodic cost (see Note 14, "Retirement Plans and Post Retirement Pension Plans").</span></div> 1140000000 4100000 194000000 6400000 422000000 188000000 1750000000 10400000 723000000 1030000000.00 0.656 206000000 0.596 191000000 0.528 170000000 2019-11-20 0.18 56000000 2020-01-22 2019-12-31 <div style="line-height:120%;text-align:justify;text-indent:33px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div><div style="line-height:120%;text-align:justify;text-indent:33px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">The following table summarizes the components of our accumulated other comprehensive income (loss) as of </span><span style="font-family:inherit;font-size:10pt;">October 31, 2019</span><span style="font-family:inherit;font-size:10pt;"> and </span><span style="font-family:inherit;font-size:10pt;">2018</span><span style="font-family:inherit;font-size:10pt;">, net of tax effect:</span></div><div style="line-height:120%;text-align:justify;text-indent:33px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div><div style="line-height:120%;text-align:justify;text-indent:0px;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="8"/></tr><tr><td style="width:73%;"/><td style="width:1%;"/><td style="width:11%;"/><td style="width:1%;"/><td style="width:1%;"/><td style="width:1%;"/><td style="width:11%;"/><td style="width:1%;"/></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;font-weight:bold;"> </span></div></td><td colspan="7" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:center;font-size:8pt;"><span style="font-family:inherit;font-size:8pt;font-weight:bold;">October 31,</span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:inherit;font-size:8pt;font-weight:bold;"> </span></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="text-align:center;font-size:8pt;"><span style="font-family:inherit;font-size:8pt;font-weight:bold;">2019</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="text-align:center;font-size:8pt;"><span style="font-family:inherit;font-size:8pt;font-weight:bold;">2018</span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:inherit;font-size:8pt;font-weight:bold;"> </span></div></td><td colspan="7" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:center;font-size:8pt;"><span style="font-family:inherit;font-size:8pt;font-weight:bold;">(in millions)</span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Foreign currency translation, net of tax expense of $(5) and $(15) for 2019 and 2018, respectively</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>(204</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">)</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>(214</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">)</span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Unrealized losses (including prior service benefit) on defined benefit plans, net of tax benefit of $153 and $132 for 2019 and 2018, respectively</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>(306</span></span></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">)</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>(201</span></span></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">)</span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Unrealized gains (losses) on derivative instruments, net of tax benefit of $3 and $0 for 2019 and 2018, respectively</span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>(4</span></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">)</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>7</span></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Total accumulated other comprehensive loss</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>(514</span></span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-right:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">)</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>(408</span></span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-right:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">)</span></div></td></tr></table></div></div><div style="line-height:120%;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div><div style="line-height:120%;text-align:justify;text-indent:36px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Changes in accumulated other comprehensive income (loss) by component and related tax effects for the years ended </span><span style="font-family:inherit;font-size:10pt;">October 31, 2019</span><span style="font-family:inherit;font-size:10pt;"> and </span><span style="font-family:inherit;font-size:10pt;">2018</span><span style="font-family:inherit;font-size:10pt;"> were as follows (in millions):</span></div><div style="line-height:120%;text-align:justify;text-indent:36px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div><div style="line-height:120%;text-align:center;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;margin-left:auto;margin-right:auto;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="21"/></tr><tr><td style="width:36%;"/><td style="width:1%;"/><td style="width:1%;"/><td style="width:9%;"/><td style="width:1%;"/><td style="width:2%;"/><td style="width:1%;"/><td style="width:9%;"/><td style="width:1%;"/><td style="width:2%;"/><td style="width:1%;"/><td style="width:9%;"/><td style="width:1%;"/><td style="width:2%;"/><td style="width:1%;"/><td style="width:9%;"/><td style="width:1%;"/><td style="width:2%;"/><td style="width:1%;"/><td style="width:9%;"/><td style="width:1%;"/></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="7" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:center;font-size:8pt;"><span style="font-family:inherit;font-size:8pt;font-weight:bold;">Net defined benefit pension cost and post retirement plan costs</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:8pt;"><span style="font-family:inherit;font-size:8pt;font-weight:bold;">Foreign currency translation</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:8pt;"><span style="font-family:inherit;font-size:8pt;font-weight:bold;">Prior service credits</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:8pt;"><span style="font-family:inherit;font-size:8pt;font-weight:bold;">Actuarial Losses</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:8pt;"><span style="font-family:inherit;font-size:8pt;font-weight:bold;">Unrealized gains (losses) on derivatives</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:8pt;"><span style="font-family:inherit;font-size:8pt;font-weight:bold;">Total</span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="19" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:center;font-size:8pt;"><span style="font-family:inherit;font-size:8pt;font-weight:bold;">(in millions)</span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">As of October 31, 2017</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>(156</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">)</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>140</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>(328</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">)</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>(2</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">)</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>(346</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">)</span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:5px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:5px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:5px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:5px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:5px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:5px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:5px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:5px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:5px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:5px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:5px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Other comprehensive income (loss) before reclassifications</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>(51</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">)</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>—</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>(49</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">)</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>7</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>(93</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">)</span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:5px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:5px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:5px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:5px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:5px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:5px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:5px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:5px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:5px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:5px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:5px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Amounts reclassified out of accumulated other comprehensive income (loss)</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>—</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>(8</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">)</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>39</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>4</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>35</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:5px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:5px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:5px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:5px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:5px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:5px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:5px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:5px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:5px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:5px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:5px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Tax (expense) benefit</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>(7</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">)</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>2</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>3</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>(2</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">)</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>(4</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">)</span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:5px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:5px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:5px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:5px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:5px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:5px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:5px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:5px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:5px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:5px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:5px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Other comprehensive income (loss)</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>(58</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">)</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>(6</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">)</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>(7</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">)</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>9</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>(62</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">)</span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:5px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:5px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:5px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:5px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:5px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:5px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:5px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:5px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:5px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:5px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:5px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">As of October 31, 2018</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>(214</span></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">)</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>134</span></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>(335</span></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">)</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>7</span></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>(408</span></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">)</span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:10px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:10px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:10px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:10px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:10px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:10px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:10px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:10px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:10px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:10px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:10px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Impact of adoption of new guidance on tax effects in accumulated other comprehensive income (loss)</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>—</span></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>3</span></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>(9</span></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">)</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>(1</span></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">)</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>(7</span></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">)</span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:14px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:14px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:14px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:14px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:14px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:14px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:14px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:14px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:14px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:14px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:14px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">As of November 1, 2018</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>(214</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">)</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>137</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>(344</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">)</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>6</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>(415</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">)</span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:5px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:5px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:5px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:5px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:5px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:5px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:5px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:5px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:5px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:5px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:5px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Other comprehensive loss before reclassifications</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>—</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>—</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>(157</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">)</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>(6</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">)</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>(163</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">)</span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:10px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:10px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:10px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:10px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:10px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:10px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:10px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:10px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:10px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:10px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:10px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Amounts reclassified out of accumulated other comprehensive income</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>—</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>(8</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">)</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>39</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>(8</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">)</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>23</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:10px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:10px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:10px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:10px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:10px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:10px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:10px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:10px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:10px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:10px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:10px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Tax benefit</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>10</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>2</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>25</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>4</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>41</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:10px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:10px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:10px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:10px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:10px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:10px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:10px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:10px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:10px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:10px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:10px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Other comprehensive income (loss)</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>10</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>(6</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">)</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>(93</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">)</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>(10</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">)</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>(99</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">)</span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:10px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:10px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:10px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:10px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:10px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:10px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:10px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:10px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:10px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:10px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:10px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">As of October 31, 2019</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>(204</span></span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">)</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>131</span></span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>(437</span></span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">)</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>(4</span></span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">)</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>(514</span></span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">)</span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:8px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:8px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:8px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:8px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:8px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:8px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:8px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:8px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:8px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:8px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:8px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td></tr></table></div></div><div style="line-height:120%;text-align:justify;text-indent:36px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div> -204000000 -214000000 306000000 201000000 -4000000 7000000 -514000000 -408000000 -156000000 -140000000 -328000000 -2000000 -346000000 -51000000 0 -49000000 7000000 -93000000 0 8000000 39000000 4000000 35000000 7000000 -2000000 -3000000 -2000000 -4000000 -58000000 6000000 -7000000 9000000 -62000000 -214000000 -134000000 -335000000 7000000 -408000000 0 3000000 -9000000 -1000000 -7000000 -214000000 -137000000 -344000000 6000000 -415000000 0 0 -157000000 -6000000 -163000000 0 8000000 39000000 -8000000 23000000 -10000000 -2000000 -25000000 4000000 41000000 10000000 6000000 -93000000 -10000000 -99000000 -204000000 -131000000 -437000000 -4000000 -514000000 <div style="line-height:120%;text-align:justify;text-indent:36px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div><div style="line-height:120%;text-align:justify;text-indent:36px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Reclassifications out of accumulated other comprehensive income (loss) for the years ended </span><span style="font-family:inherit;font-size:10pt;">October 31, 2019</span><span style="font-family:inherit;font-size:10pt;"> and </span><span style="font-family:inherit;font-size:10pt;">2018</span><span style="font-family:inherit;font-size:10pt;"> were as follows (in millions): </span></div><div style="line-height:120%;text-align:justify;text-indent:0px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="11"/></tr><tr><td style="width:47%;"/><td style="width:1%;"/><td style="width:1%;"/><td style="width:7%;"/><td style="width:1%;"/><td style="width:1%;"/><td style="width:1%;"/><td style="width:7%;"/><td style="width:1%;"/><td style="width:2%;"/><td style="width:31%;"/></tr><tr><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:8pt;"><span style="font-family:inherit;font-size:8pt;font-weight:bold;">Details about Accumulated Other<br/>Comprehensive Income components</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:inherit;font-size:8pt;"><br/></span></div></td><td colspan="7" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:center;font-size:8pt;"><span style="font-family:inherit;font-size:8pt;font-weight:bold;">Amounts Reclassified<br/>from Other Comprehensive Income</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:8pt;"><span style="font-family:inherit;font-size:8pt;font-weight:bold;">Affected line item in<br/>statement of operations</span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:inherit;font-size:8pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:inherit;font-size:8pt;"><br/></span></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="text-align:center;font-size:8pt;"><span style="font-family:inherit;font-size:8pt;font-weight:bold;">2019</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:inherit;font-size:8pt;"><br/></span></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="text-align:center;font-size:8pt;"><span style="font-family:inherit;font-size:8pt;font-weight:bold;">2018</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:inherit;font-size:8pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:inherit;font-size:8pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Unrealized gains and (losses) on derivatives</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>8</span></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>(4</span></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">)</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Cost of products and interest expense</span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>8</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>(4</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">)</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Total before income tax</span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>(2</span></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">)</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>1</span></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">(Provision)/benefit for income tax</span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>6</span></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>(3</span></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">)</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Total net of income tax</span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Net defined benefit pension cost and post retirement plan costs:</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Actuarial net loss</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>(39</span></span></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">)</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>(39</span></span></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">)</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Other (income) expense</span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Prior service benefit</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>8</span></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>8</span></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Other (income) expense</span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>(31</span></span></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">)</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>(31</span></span></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">)</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Total before income tax</span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>12</span></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>10</span></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Benefit for income tax</span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>(19</span></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-right:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">)</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>(21</span></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-right:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">)</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Total net of income tax</span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Total reclassifications for the period</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>(13</span></span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">)</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>(24</span></span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">)</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr></table></div></div><div style="line-height:120%;text-align:justify;text-indent:36px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div> -8000000 -4000000 -8000000 -4000000 -2000000 1000000 6000000 -3000000 -39000000 -39000000 8000000 8000000 -31000000 -31000000 12000000 10000000 -19000000 -21000000 -13000000 -24000000 SEGMENT INFORMATION<div style="line-height:120%;text-align:justify;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div><div style="line-height:120%;padding-bottom:16px;text-align:justify;text-indent:36px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;font-style:italic;">Description of Segments.</span><span style="font-family:inherit;font-size:10pt;"> We are a global leader in life sciences, diagnostics and applied chemical markets, providing application focused solutions that include instruments, software, services and consumables for the entire laboratory workflow. </span></div><div style="line-height:120%;padding-bottom:16px;text-align:justify;text-indent:36px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Agilent has three business segments comprised of the life sciences and applied markets business, diagnostics and genomics business and the Agilent CrossLab business each of which comprises a reportable segment. The </span><span style="font-family:inherit;font-size:10pt;"><span>three</span></span><span style="font-family:inherit;font-size:10pt;"> operating segments were determined based primarily on how the chief operating decision maker views and evaluates our operations. Operating results are regularly reviewed by the chief operating decision maker to make decisions about resources to be allocated to the segment and to assess its performance. Other factors, including market separation and customer specific applications, go-to-market channels, products and services and manufacturing are considered in determining the formation of these operating segments.</span></div><div style="line-height:120%;text-align:justify;text-indent:36px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">In 2019, we adopted new guidance related to the presentation of the net periodic pension and postretirement benefit cost. See Note 2, "New Accounting Pronouncements" for more information. As a result, we have recast our historical segment results to conform to this new presentation required under this guidance. </span></div><div style="line-height:120%;text-align:justify;text-indent:36px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div><div style="line-height:120%;text-align:justify;text-indent:36px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">A description of our </span><span style="font-family:inherit;font-size:10pt;"><span>three</span></span><span style="font-family:inherit;font-size:10pt;"> reportable segments is as follows:</span></div><div style="line-height:120%;text-align:justify;text-indent:36px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div><div style="line-height:120%;text-align:justify;text-indent:36px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Our life sciences and applied markets business provides application-focused solutions that include instruments and software that enable customers to identify, quantify and analyze the physical and biological properties of substances and products, as well as enable customers in the clinical and life sciences research areas to interrogate samples at the molecular and cellular level. Key product categories include: liquid chromatography ("LC") systems and components; liquid chromatography mass spectrometry ("LCMS") systems; gas chromatography ("GC") systems and components; gas chromatography mass spectrometry ("GCMS") systems; inductively coupled plasma mass spectrometry ("ICP-MS") instruments; atomic absorption ("AA") instruments; </span></div><div style="line-height:120%;text-align:justify;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">microwave plasma-atomic emission spectrometry ("MP-AES") instruments; inductively coupled plasma optical emission spectrometry ("ICP-OES") instruments; raman spectroscopy; cell analysis plate based assays; flow cytometer; real-time cell analyzer; cell imaging systems; microplate reader; laboratory software for sample tracking; information management and analytics; laboratory automation and robotic systems; dissolution testing; vacuum pumps and measurement technologies.</span></div><div style="line-height:120%;text-align:justify;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div><div style="line-height:120%;text-align:justify;text-indent:36px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Our diagnostics and genomics business is comprised of six areas of activity providing active pharmaceutical ingredients ("APIs") for oligo-based therapeutics as well as solutions that include reagents, instruments, software and consumables, which enable customers in the clinical and life sciences research areas to interrogate samples at the cellular and molecular level. First, our genomics business includes arrays for DNA mutation detection, genotyping, gene copy number determination, identification of gene rearrangements, DNA methylation profiling, gene expression profiling, as well as next generation sequencing ("NGS") target enrichment and genetic data management and interpretation support software. This business also includes solutions that enable clinical labs to identify DNA variants associated with genetic disease and help direct cancer therapy. Second, our nucleic acid solutions business provides equipment and expertise focused on production of synthesized oligonucleotides under pharmaceutical good manufacturing practices ("GMP") conditions for use as API in an emerging class of drugs that utilize nucleic acid molecules for disease therapy. Third, our pathology solutions business is focused on product offerings for cancer diagnostics and anatomic pathology workflows. The broad portfolio of offerings includes immunohistochemistry ("IHC"), in situ hybridization ("ISH"), hematoxylin and eosin ("H&amp;E") staining and special staining. Fourth, we also collaborate with a number of major pharmaceutical companies to develop new potential pharmacodiagnostics, also known as companion diagnostics, which may be used to identify patients most likely to benefit from a specific targeted therapy. Fifth, the reagent partnership business is a provider of reagents used for turbidimetry and flow cytometry. Finally, our biomolecular analysis business provides complete workflow solutions, including instruments, consumables and software, for quality control analysis of nucleic acid samples.  Samples are analyzed using quantitative and qualitative techniques to ensure accuracy in further genomics analysis techniques utilized in clinical and life science research applications.</span></div><div style="line-height:120%;text-align:justify;text-indent:36px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div><div style="line-height:120%;text-align:justify;text-indent:36px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> The Agilent CrossLab business spans the entire lab with its extensive consumables and services portfolio, which is designed to improve customer outcomes. Most of the portfolio is vendor neutral, meaning Agilent can serve and supply customers regardless of their instrument purchase choices. Solutions range from chemistries and supplies to services and software helping to connect the entire lab. Key product categories in consumables include GC and LC columns, sample preparation products, custom chemistries, and a large selection of laboratory instrument supplies. Services include startup, operational, training and compliance support, software as a service, as well as asset management and consultative services that help increase customer productivity. Custom service and consumable bundles are tailored to meet the specific application needs of various industries and to keep instruments fully operational and compliant with the respective industry requirements.</span></div><div style="line-height:120%;text-align:justify;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div><div style="line-height:120%;text-align:justify;text-indent:36px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">A significant portion of the segments' expenses arise from shared services and infrastructure that we have historically provided to the segments in order to realize economies of scale and to efficiently use resources. These expenses, collectively called corporate charges, include legal, accounting, tax, real estate, insurance services, information technology services, treasury, order administration, other corporate infrastructure expenses and costs of centralized research and development. Charges are allocated to the segments, and the allocations have been determined on a basis that we consider to be a reasonable reflection of the utilization of services provided to or benefits received by the segments. In addition, we do not allocate amortization and impairment of acquisition-related intangible assets, pension curtailment or settlement gains, restructuring and transformational initiatives expenses, acquisition and integration costs, business exit and divestiture costs, special compliance costs, some nucleic acid solutions division ("NASD") site costs and certain other charges to the operating margin for each segment because management does not include this information in its measurement of the performance of the operating segments.Transformational initiatives include expenses associated with targeted cost reduction activities such as manufacturing transfers, site consolidations, legal entity and other business reorganizations, in-sourcing or outsourcing of activities.</span></div><div style="line-height:120%;text-align:justify;text-indent:36px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div><div style="line-height:120%;text-align:justify;text-indent:36px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">The following tables reflect the results of our reportable segments under our management reporting system. The performance of each segment is measured based on several metrics, including segment income from operations. These results are used, in part, by the chief operating decision maker in evaluating the performance of, and in allocating resources to, each of the segments.</span></div><div style="line-height:120%;text-align:justify;text-indent:36px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div><div style="line-height:120%;text-align:justify;text-indent:36px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">The profitability of each of the segments is measured after excluding restructuring and asset impairment charges, transformational initiatives, investment gains and losses, interest income, interest expense, acquisition and integration costs, non-cash amortization and other items as noted in the reconciliations below.</span></div><div style="line-height:120%;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="16"/></tr><tr><td style="width:56%;"/><td style="width:1%;"/><td style="width:8%;"/><td style="width:1%;"/><td style="width:1%;"/><td style="width:1%;"/><td style="width:8%;"/><td style="width:1%;"/><td style="width:1%;"/><td style="width:1%;"/><td style="width:9%;"/><td style="width:1%;"/><td style="width:1%;"/><td style="width:1%;"/><td style="width:8%;"/><td style="width:1%;"/></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:8pt;"><span style="font-family:inherit;font-size:8pt;font-weight:bold;">Life Sciences and Applied Markets</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:8pt;"><span style="font-family:inherit;font-size:8pt;font-weight:bold;">Diagnostics and Genomics</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:8pt;"><span style="font-family:inherit;font-size:8pt;font-weight:bold;">Agilent CrossLab</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:8pt;"><span style="font-family:inherit;font-size:8pt;font-weight:bold;">Total<br/>Segments</span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:inherit;font-size:8pt;font-weight:bold;"> </span></div></td><td colspan="15" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:center;font-size:8pt;"><span style="font-family:inherit;font-size:8pt;font-weight:bold;">(in millions)</span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;font-weight:bold;">Year Ended October 31, 2019:</span></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Total net revenue</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>2,302</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>1,021</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>1,840</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>5,163</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Income from operations</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>542</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>185</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>475</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>1,202</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Depreciation expense</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>41</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>35</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>35</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>111</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Share-based compensation expense</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>33</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>14</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>25</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>72</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;font-weight:bold;">Year Ended October 31, 2018:</span></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Total net revenue</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>2,270</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>943</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>1,701</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>4,914</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Income from operations</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>543</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>173</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>388</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>1,104</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Depreciation expense</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>38</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>33</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>31</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>102</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Share-based compensation expense</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>33</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>14</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>24</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>71</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;font-weight:bold;">Year Ended October 31, 2017:</span></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Total net revenue</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>2,081</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>860</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>1,531</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>4,472</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Income from operations</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>470</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>167</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>336</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>973</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Depreciation expense</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>35</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>30</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>29</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>94</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Share-based compensation expense</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>30</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>10</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>21</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>61</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr></table></div><span style="font-family:inherit;font-size:10pt;"><br/></span></div><div style="line-height:120%;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div><div style="line-height:120%;text-align:justify;text-indent:36px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div><div style="line-height:120%;text-align:justify;text-indent:36px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">The following table reconciles reportable segments' income from operations to Agilent's total enterprise income before taxes:</span></div><div style="line-height:120%;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div><div style="line-height:120%;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="12"/></tr><tr><td style="width:59%;"/><td style="width:1%;"/><td style="width:11%;"/><td style="width:1%;"/><td style="width:1%;"/><td style="width:1%;"/><td style="width:11%;"/><td style="width:1%;"/><td style="width:1%;"/><td style="width:1%;"/><td style="width:11%;"/><td style="width:1%;"/></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;font-weight:bold;"> </span></div></td><td colspan="11" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:center;font-size:8pt;"><span style="font-family:inherit;font-size:8pt;font-weight:bold;">Years Ended October 31,</span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:inherit;font-size:8pt;font-weight:bold;"> </span></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:8pt;"><span style="font-family:inherit;font-size:8pt;font-weight:bold;">2019</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:8pt;"><span style="font-family:inherit;font-size:8pt;font-weight:bold;">2018</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:8pt;"><span style="font-family:inherit;font-size:8pt;font-weight:bold;">2017</span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:inherit;font-size:8pt;font-weight:bold;"> </span></div></td><td colspan="11" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:center;font-size:8pt;"><span style="font-family:inherit;font-size:8pt;font-weight:bold;">(in millions)</span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Total reportable segments' income from operations</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>1,202</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>1,104</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>973</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Amortization of intangible assets related to business combinations</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>(125</span></span></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">)</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>(105</span></span></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">)</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>(117</span></span></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">)</span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Acquisition and integration costs</span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>(48</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">)</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>(23</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">)</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>(30</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">)</span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Transformational initiatives</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>(44</span></span></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">)</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>(25</span></span></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">)</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>(12</span></span></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">)</span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Asset impairments</span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>—</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>(21</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">)</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>—</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Business exit and divestiture costs (primarily our NMR business)</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>—</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>(9</span></span></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">)</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>—</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">NASD site costs</span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>(12</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">)</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>(8</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">)</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>—</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Special compliance costs</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>(2</span></span></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">)</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>(4</span></span></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">)</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>—</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Other </span><span style="font-family:inherit;font-size:10pt;"><sup style="vertical-align:top;line-height:120%;font-size:7pt">(1)</sup></span><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>(30</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">)</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>(5</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">)</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>(7</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">)</span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Interest Income</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>36</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>38</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>22</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Interest Expense</span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>(74</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">)</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>(75</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">)</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>(79</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">)</span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Other income (expense), net</span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>16</span></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>79</span></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>53</span></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Income before taxes, as reported</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>919</span></span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>946</span></span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>803</span></span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr></table></div><span style="font-family:inherit;font-size:10pt;"><br/></span></div><div style="line-height:120%;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div><div style="line-height:120%;padding-left:12px;text-indent:6px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">(1) The other category primarily includes legal costs related to our pursuing our claim against a third party in addition to other miscellaneous adjustments and settlements.</span></div><div style="line-height:120%;padding-left:48px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div><div style="line-height:120%;text-align:justify;text-indent:36px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;font-style:italic;">Major Customers.</span><span style="font-family:inherit;font-size:10pt;">    No customer represented 10 percent or more of our total net revenue in </span><span style="font-family:inherit;font-size:10pt;">2019</span><span style="font-family:inherit;font-size:10pt;">, </span><span style="font-family:inherit;font-size:10pt;">2018</span><span style="font-family:inherit;font-size:10pt;"> or </span><span style="font-family:inherit;font-size:10pt;">2017</span><span style="font-family:inherit;font-size:10pt;">.</span></div><div style="line-height:120%;text-align:justify;text-indent:32px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div><div style="line-height:120%;padding-bottom:9px;text-align:justify;text-indent:33px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">The following table reflects segment assets and capital expenditures under our management reporting system. Segment assets include allocations of corporate assets, goodwill, net other intangibles and other assets. Unallocated assets primarily consist of cash, cash equivalents, the valuation allowance relating to deferred tax assets and other assets.</span></div><div style="line-height:120%;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="16"/></tr><tr><td style="width:56%;"/><td style="width:1%;"/><td style="width:8%;"/><td style="width:1%;"/><td style="width:1%;"/><td style="width:1%;"/><td style="width:8%;"/><td style="width:1%;"/><td style="width:1%;"/><td style="width:1%;"/><td style="width:9%;"/><td style="width:1%;"/><td style="width:1%;"/><td style="width:1%;"/><td style="width:8%;"/><td style="width:1%;"/></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:8pt;"><span style="font-family:inherit;font-size:8pt;font-weight:bold;">Life Sciences and Applied Markets</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:8pt;"><span style="font-family:inherit;font-size:8pt;font-weight:bold;">Diagnostics and Genomics</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:8pt;"><span style="font-family:inherit;font-size:8pt;font-weight:bold;">Agilent CrossLab</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:8pt;"><span style="font-family:inherit;font-size:8pt;font-weight:bold;">Total<br/>Segments</span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:inherit;font-size:8pt;font-weight:bold;"> </span></div></td><td colspan="15" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:center;font-size:8pt;"><span style="font-family:inherit;font-size:8pt;font-weight:bold;">(in millions)</span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;font-weight:bold;">As of and for the Year Ended October 31, 2019:</span></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Assets</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>3,202</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>2,620</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>1,331</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>7,153</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Capital expenditures</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>59</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>48</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>48</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>155</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;font-weight:bold;">As of and for the Year Ended October 31, 2018:</span></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Assets</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>1,744</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>2,679</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>1,267</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>5,690</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Capital expenditures</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>47</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>92</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>38</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>177</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr></table></div></div><div style="line-height:120%;text-align:justify;text-indent:32px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div><div style="line-height:120%;text-align:justify;text-indent:36px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">The following table reconciles segment assets to Agilent's total assets:</span></div><div style="line-height:120%;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div><div style="line-height:120%;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="8"/></tr><tr><td style="width:73%;"/><td style="width:1%;"/><td style="width:11%;"/><td style="width:1%;"/><td style="width:1%;"/><td style="width:1%;"/><td style="width:11%;"/><td style="width:1%;"/></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;font-weight:bold;"> </span></div></td><td colspan="7" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:center;font-size:8pt;"><span style="font-family:inherit;font-size:8pt;font-weight:bold;">October 31,</span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:inherit;font-size:8pt;font-weight:bold;"> </span></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:8pt;"><span style="font-family:inherit;font-size:8pt;font-weight:bold;">2019</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:8pt;"><span style="font-family:inherit;font-size:8pt;font-weight:bold;">2018</span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:inherit;font-size:8pt;font-weight:bold;"> </span></div></td><td colspan="7" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:center;font-size:8pt;"><span style="font-family:inherit;font-size:8pt;font-weight:bold;">(in millions)</span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Total reportable segments' assets</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>7,153</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>5,690</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Cash, cash equivalents</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>1,382</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>2,247</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Prepaid expenses</span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>94</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>80</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Investments</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>102</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>68</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Long-term and other receivables</span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>100</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>102</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Other</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>621</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>354</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Total assets</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>9,452</span></span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>8,541</span></span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr></table></div><span style="font-family:inherit;font-size:10pt;"><br/></span></div><div style="line-height:120%;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div><div style="line-height:120%;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">The other category primarily includes deferred tax assets and overfunded pension assets which are not allocated to the segments.</span></div><div style="line-height:120%;text-align:justify;text-indent:32px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div><div style="line-height:120%;text-align:justify;text-indent:32px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">The following table presents summarized information for net revenue by geographic region. Revenues from external customers are generally attributed to countries based upon the customer's location. </span></div><div style="line-height:120%;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div><div style="line-height:120%;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="16"/></tr><tr><td style="width:61%;"/><td style="width:1%;"/><td style="width:7%;"/><td style="width:1%;"/><td style="width:1%;"/><td style="width:1%;"/><td style="width:7%;"/><td style="width:1%;"/><td style="width:1%;"/><td style="width:1%;"/><td style="width:7%;"/><td style="width:1%;"/><td style="width:1%;"/><td style="width:1%;"/><td style="width:7%;"/><td style="width:1%;"/></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:8pt;"><span style="font-family:inherit;font-size:8pt;font-weight:bold;">United<br/>States</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:8pt;"><span style="font-family:inherit;font-size:8pt;font-weight:bold;">China</span><span style="font-family:inherit;font-size:8pt;font-weight:bold;"><sup style="vertical-align:top;line-height:120%;font-size:5pt">(1)</sup></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:8pt;"><span style="font-family:inherit;font-size:8pt;font-weight:bold;">Rest of the<br/>World</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-top:2px;padding-bottom:2px;"><div style="text-align:center;font-size:8pt;"><span style="font-family:inherit;font-size:8pt;font-weight:bold;">Total</span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:inherit;font-size:8pt;font-weight:bold;"> </span></div></td><td colspan="15" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:center;font-size:8pt;"><span style="font-family:inherit;font-size:8pt;font-weight:bold;">(in millions)</span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Net revenue:</span></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Year Ended October 31, 2019</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>1,619</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>1,019</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>2,525</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>5,163</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Year Ended October 31, 2018</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>1,414</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>1,015</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>2,485</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>4,914</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Year Ended October 31, 2017</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>1,314</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>900</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>2,258</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>4,472</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr></table></div></div><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman; font-size:10pt;"><tr><td style="width:48px;"/><td/></tr><tr><td style="vertical-align:top"><div style="line-height:120%;font-size:9pt;padding-left:24px;"><span style="font-family:inherit;font-size:9pt;">1.</span></div></td><td style="vertical-align:top;"><div style="line-height:120%;text-align:justify;font-size:9pt;"><span style="font-family:inherit;font-size:9pt;">China also includes Hong Kong net revenue. </span></div></td></tr></table><div style="line-height:120%;text-align:justify;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div><div style="line-height:120%;text-align:justify;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div><div style="line-height:120%;text-align:justify;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div><div style="line-height:120%;text-align:justify;text-indent:32px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">The following table presents summarized information for long-lived assets by geographic region. Long lived assets consist of property, plant, and equipment, long-term receivables and other long-term assets excluding intangible assets. The rest of the world primarily consists of Asia and the rest of Europe.</span></div><div style="line-height:120%;text-align:justify;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div><div style="line-height:120%;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="16"/></tr><tr><td style="width:61%;"/><td style="width:1%;"/><td style="width:7%;"/><td style="width:1%;"/><td style="width:1%;"/><td style="width:1%;"/><td style="width:7%;"/><td style="width:1%;"/><td style="width:1%;"/><td style="width:1%;"/><td style="width:7%;"/><td style="width:1%;"/><td style="width:1%;"/><td style="width:1%;"/><td style="width:7%;"/><td style="width:1%;"/></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:8pt;"><span style="font-family:inherit;font-size:8pt;font-weight:bold;">United<br/>States</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:8pt;"><span style="font-family:inherit;font-size:8pt;font-weight:bold;">Germany</span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:8pt;"><span style="font-family:inherit;font-size:8pt;font-weight:bold;">Rest of the<br/>World</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-top:2px;padding-bottom:2px;"><div style="text-align:center;font-size:8pt;"><span style="font-family:inherit;font-size:8pt;font-weight:bold;">Total</span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:inherit;font-size:8pt;font-weight:bold;"> </span></div></td><td colspan="15" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:center;font-size:8pt;"><span style="font-family:inherit;font-size:8pt;font-weight:bold;">(in millions)</span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Long-lived assets:</span></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">October 31, 2019</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>621</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>122</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>404</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>1,147</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">October 31, 2018</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>565</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>117</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>362</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>1,044</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr></table></div><span style="font-family:inherit;font-size:10pt;"><br/></span></div> 3 3 <div style="line-height:120%;text-align:justify;text-indent:36px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">The profitability of each of the segments is measured after excluding restructuring and asset impairment charges, transformational initiatives, investment gains and losses, interest income, interest expense, acquisition and integration costs, non-cash amortization and other items as noted in the reconciliations below.</span></div><div style="line-height:120%;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="16"/></tr><tr><td style="width:56%;"/><td style="width:1%;"/><td style="width:8%;"/><td style="width:1%;"/><td style="width:1%;"/><td style="width:1%;"/><td style="width:8%;"/><td style="width:1%;"/><td style="width:1%;"/><td style="width:1%;"/><td style="width:9%;"/><td style="width:1%;"/><td style="width:1%;"/><td style="width:1%;"/><td style="width:8%;"/><td style="width:1%;"/></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:8pt;"><span style="font-family:inherit;font-size:8pt;font-weight:bold;">Life Sciences and Applied Markets</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:8pt;"><span style="font-family:inherit;font-size:8pt;font-weight:bold;">Diagnostics and Genomics</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:8pt;"><span style="font-family:inherit;font-size:8pt;font-weight:bold;">Agilent CrossLab</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:8pt;"><span style="font-family:inherit;font-size:8pt;font-weight:bold;">Total<br/>Segments</span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:inherit;font-size:8pt;font-weight:bold;"> </span></div></td><td colspan="15" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:center;font-size:8pt;"><span style="font-family:inherit;font-size:8pt;font-weight:bold;">(in millions)</span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;font-weight:bold;">Year Ended October 31, 2019:</span></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Total net revenue</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>2,302</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>1,021</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>1,840</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>5,163</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Income from operations</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>542</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>185</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>475</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>1,202</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Depreciation expense</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>41</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>35</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>35</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>111</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Share-based compensation expense</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>33</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>14</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>25</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>72</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;font-weight:bold;">Year Ended October 31, 2018:</span></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Total net revenue</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>2,270</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>943</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>1,701</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>4,914</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Income from operations</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>543</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>173</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>388</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>1,104</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Depreciation expense</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>38</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>33</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>31</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>102</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Share-based compensation expense</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>33</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>14</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>24</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>71</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;font-weight:bold;">Year Ended October 31, 2017:</span></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Total net revenue</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>2,081</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>860</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>1,531</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>4,472</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Income from operations</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>470</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>167</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>336</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>973</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Depreciation expense</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>35</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>30</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>29</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>94</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Share-based compensation expense</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>30</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>10</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>21</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>61</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr></table></div><span style="font-family:inherit;font-size:10pt;"><br/></span></div> 2302000000 1021000000 1840000000 5163000000 542000000 185000000 475000000 1202000000 41000000 35000000 35000000 111000000 33000000 14000000 25000000 72000000 2270000000 943000000 1701000000 4914000000 543000000 173000000 388000000 1104000000 38000000 33000000 31000000 102000000 33000000 14000000 24000000 71000000 2081000000 860000000 1531000000 4472000000 470000000 167000000 336000000 973000000 35000000 30000000 29000000 94000000 30000000 10000000 21000000 61000000 <div style="line-height:120%;text-align:justify;text-indent:36px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">The following table reconciles reportable segments' income from operations to Agilent's total enterprise income before taxes:</span></div><div style="line-height:120%;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div><div style="line-height:120%;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="12"/></tr><tr><td style="width:59%;"/><td style="width:1%;"/><td style="width:11%;"/><td style="width:1%;"/><td style="width:1%;"/><td style="width:1%;"/><td style="width:11%;"/><td style="width:1%;"/><td style="width:1%;"/><td style="width:1%;"/><td style="width:11%;"/><td style="width:1%;"/></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;font-weight:bold;"> </span></div></td><td colspan="11" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:center;font-size:8pt;"><span style="font-family:inherit;font-size:8pt;font-weight:bold;">Years Ended October 31,</span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:inherit;font-size:8pt;font-weight:bold;"> </span></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:8pt;"><span style="font-family:inherit;font-size:8pt;font-weight:bold;">2019</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:8pt;"><span style="font-family:inherit;font-size:8pt;font-weight:bold;">2018</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:8pt;"><span style="font-family:inherit;font-size:8pt;font-weight:bold;">2017</span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:inherit;font-size:8pt;font-weight:bold;"> </span></div></td><td colspan="11" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:center;font-size:8pt;"><span style="font-family:inherit;font-size:8pt;font-weight:bold;">(in millions)</span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Total reportable segments' income from operations</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>1,202</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>1,104</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>973</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Amortization of intangible assets related to business combinations</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>(125</span></span></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">)</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>(105</span></span></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">)</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>(117</span></span></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">)</span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Acquisition and integration costs</span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>(48</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">)</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>(23</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">)</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>(30</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">)</span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Transformational initiatives</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>(44</span></span></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">)</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>(25</span></span></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">)</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>(12</span></span></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">)</span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Asset impairments</span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>—</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>(21</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">)</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>—</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Business exit and divestiture costs (primarily our NMR business)</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>—</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>(9</span></span></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">)</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>—</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">NASD site costs</span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>(12</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">)</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>(8</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">)</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>—</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Special compliance costs</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>(2</span></span></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">)</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>(4</span></span></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">)</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>—</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Other </span><span style="font-family:inherit;font-size:10pt;"><sup style="vertical-align:top;line-height:120%;font-size:7pt">(1)</sup></span><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>(30</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">)</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>(5</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">)</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>(7</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">)</span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Interest Income</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>36</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>38</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>22</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Interest Expense</span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>(74</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">)</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>(75</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">)</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>(79</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">)</span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Other income (expense), net</span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>16</span></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>79</span></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>53</span></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Income before taxes, as reported</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>919</span></span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>946</span></span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>803</span></span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr></table></div><span style="font-family:inherit;font-size:10pt;"><br/></span></div><div style="line-height:120%;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div><div style="line-height:120%;padding-left:12px;text-indent:6px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">(1) The other category primarily includes legal costs related to our pursuing our claim against a third party in addition to other miscellaneous adjustments and settlements.</span></div> 1202000000 1104000000 973000000 125000000 105000000 117000000 48000000 23000000 30000000 44000000 25000000 12000000 0 21000000 0 0 9000000 0 12000000 8000000 0 2000000 4000000 0 -30000000 -5000000 -7000000 36000000 38000000 22000000 74000000 75000000 79000000 16000000 79000000 53000000 919000000 946000000 803000000 <div style="line-height:120%;padding-bottom:9px;text-align:justify;text-indent:33px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">The following table reflects segment assets and capital expenditures under our management reporting system. Segment assets include allocations of corporate assets, goodwill, net other intangibles and other assets. Unallocated assets primarily consist of cash, cash equivalents, the valuation allowance relating to deferred tax assets and other assets.</span></div><div style="line-height:120%;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="16"/></tr><tr><td style="width:56%;"/><td style="width:1%;"/><td style="width:8%;"/><td style="width:1%;"/><td style="width:1%;"/><td style="width:1%;"/><td style="width:8%;"/><td style="width:1%;"/><td style="width:1%;"/><td style="width:1%;"/><td style="width:9%;"/><td style="width:1%;"/><td style="width:1%;"/><td style="width:1%;"/><td style="width:8%;"/><td style="width:1%;"/></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:8pt;"><span style="font-family:inherit;font-size:8pt;font-weight:bold;">Life Sciences and Applied Markets</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:8pt;"><span style="font-family:inherit;font-size:8pt;font-weight:bold;">Diagnostics and Genomics</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:8pt;"><span style="font-family:inherit;font-size:8pt;font-weight:bold;">Agilent CrossLab</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:8pt;"><span style="font-family:inherit;font-size:8pt;font-weight:bold;">Total<br/>Segments</span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:inherit;font-size:8pt;font-weight:bold;"> </span></div></td><td colspan="15" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:center;font-size:8pt;"><span style="font-family:inherit;font-size:8pt;font-weight:bold;">(in millions)</span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;font-weight:bold;">As of and for the Year Ended October 31, 2019:</span></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Assets</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>3,202</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>2,620</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>1,331</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>7,153</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Capital expenditures</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>59</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>48</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>48</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>155</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;font-weight:bold;">As of and for the Year Ended October 31, 2018:</span></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Assets</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>1,744</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>2,679</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>1,267</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>5,690</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Capital expenditures</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>47</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>92</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>38</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>177</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr></table></div></div><div style="line-height:120%;text-align:justify;text-indent:32px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div><div style="line-height:120%;text-align:justify;text-indent:36px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">The following table reconciles segment assets to Agilent's total assets:</span></div><div style="line-height:120%;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div><div style="line-height:120%;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="8"/></tr><tr><td style="width:73%;"/><td style="width:1%;"/><td style="width:11%;"/><td style="width:1%;"/><td style="width:1%;"/><td style="width:1%;"/><td style="width:11%;"/><td style="width:1%;"/></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;font-weight:bold;"> </span></div></td><td colspan="7" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:center;font-size:8pt;"><span style="font-family:inherit;font-size:8pt;font-weight:bold;">October 31,</span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:inherit;font-size:8pt;font-weight:bold;"> </span></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:8pt;"><span style="font-family:inherit;font-size:8pt;font-weight:bold;">2019</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:8pt;"><span style="font-family:inherit;font-size:8pt;font-weight:bold;">2018</span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:inherit;font-size:8pt;font-weight:bold;"> </span></div></td><td colspan="7" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:center;font-size:8pt;"><span style="font-family:inherit;font-size:8pt;font-weight:bold;">(in millions)</span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Total reportable segments' assets</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>7,153</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>5,690</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Cash, cash equivalents</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>1,382</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>2,247</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Prepaid expenses</span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>94</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>80</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Investments</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>102</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>68</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Long-term and other receivables</span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>100</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>102</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Other</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>621</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>354</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Total assets</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>9,452</span></span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>8,541</span></span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr></table></div><span style="font-family:inherit;font-size:10pt;"><br/></span></div><div style="line-height:120%;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div><div style="line-height:120%;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">The other category primarily includes deferred tax assets and overfunded pension assets which are not allocated to the segments.</span></div> 3202000000 2620000000 1331000000 7153000000 59000000 48000000 48000000 155000000 1744000000 2679000000 1267000000 5690000000 47000000 92000000 38000000 177000000 7153000000 5690000000 1382000000 2247000000 94000000 80000000 102000000 68000000 100000000 102000000 621000000 354000000 9452000000 8541000000 <div style="line-height:120%;text-align:justify;text-indent:32px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">The following table presents summarized information for net revenue by geographic region. Revenues from external customers are generally attributed to countries based upon the customer's location. </span></div><div style="line-height:120%;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div><div style="line-height:120%;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="16"/></tr><tr><td style="width:61%;"/><td style="width:1%;"/><td style="width:7%;"/><td style="width:1%;"/><td style="width:1%;"/><td style="width:1%;"/><td style="width:7%;"/><td style="width:1%;"/><td style="width:1%;"/><td style="width:1%;"/><td style="width:7%;"/><td style="width:1%;"/><td style="width:1%;"/><td style="width:1%;"/><td style="width:7%;"/><td style="width:1%;"/></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:8pt;"><span style="font-family:inherit;font-size:8pt;font-weight:bold;">United<br/>States</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:8pt;"><span style="font-family:inherit;font-size:8pt;font-weight:bold;">China</span><span style="font-family:inherit;font-size:8pt;font-weight:bold;"><sup style="vertical-align:top;line-height:120%;font-size:5pt">(1)</sup></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:8pt;"><span style="font-family:inherit;font-size:8pt;font-weight:bold;">Rest of the<br/>World</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-top:2px;padding-bottom:2px;"><div style="text-align:center;font-size:8pt;"><span style="font-family:inherit;font-size:8pt;font-weight:bold;">Total</span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:inherit;font-size:8pt;font-weight:bold;"> </span></div></td><td colspan="15" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:center;font-size:8pt;"><span style="font-family:inherit;font-size:8pt;font-weight:bold;">(in millions)</span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Net revenue:</span></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Year Ended October 31, 2019</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>1,619</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>1,019</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>2,525</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>5,163</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Year Ended October 31, 2018</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>1,414</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>1,015</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>2,485</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>4,914</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Year Ended October 31, 2017</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>1,314</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>900</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>2,258</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>4,472</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr></table></div></div><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman; font-size:10pt;"><tr><td style="width:48px;"/><td/></tr><tr><td style="vertical-align:top"><div style="line-height:120%;font-size:9pt;padding-left:24px;"><span style="font-family:inherit;font-size:9pt;">1.</span></div></td><td style="vertical-align:top;"><div style="line-height:120%;text-align:justify;font-size:9pt;"><span style="font-family:inherit;font-size:9pt;">China also includes Hong Kong net revenue. </span></div></td></tr></table><div style="line-height:120%;text-align:justify;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div><div style="line-height:120%;text-align:justify;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div><div style="line-height:120%;text-align:justify;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div><div style="line-height:120%;text-align:justify;text-indent:32px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">The following table presents summarized information for long-lived assets by geographic region. Long lived assets consist of property, plant, and equipment, long-term receivables and other long-term assets excluding intangible assets. The rest of the world primarily consists of Asia and the rest of Europe.</span></div><div style="line-height:120%;text-align:justify;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div><div style="line-height:120%;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="16"/></tr><tr><td style="width:61%;"/><td style="width:1%;"/><td style="width:7%;"/><td style="width:1%;"/><td style="width:1%;"/><td style="width:1%;"/><td style="width:7%;"/><td style="width:1%;"/><td style="width:1%;"/><td style="width:1%;"/><td style="width:7%;"/><td style="width:1%;"/><td style="width:1%;"/><td style="width:1%;"/><td style="width:7%;"/><td style="width:1%;"/></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:8pt;"><span style="font-family:inherit;font-size:8pt;font-weight:bold;">United<br/>States</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:8pt;"><span style="font-family:inherit;font-size:8pt;font-weight:bold;">Germany</span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:8pt;"><span style="font-family:inherit;font-size:8pt;font-weight:bold;">Rest of the<br/>World</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-top:2px;padding-bottom:2px;"><div style="text-align:center;font-size:8pt;"><span style="font-family:inherit;font-size:8pt;font-weight:bold;">Total</span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:inherit;font-size:8pt;font-weight:bold;"> </span></div></td><td colspan="15" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:center;font-size:8pt;"><span style="font-family:inherit;font-size:8pt;font-weight:bold;">(in millions)</span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Long-lived assets:</span></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">October 31, 2019</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>621</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>122</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>404</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>1,147</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">October 31, 2018</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>565</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>117</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>362</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>1,044</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr></table></div><span style="font-family:inherit;font-size:10pt;"><br/></span></div> 1619000000 1019000000 2525000000 5163000000 1414000000 1015000000 2485000000 4914000000 1314000000 900000000 2258000000 4472000000 621000000 122000000 404000000 1147000000 565000000 117000000 362000000 1044000000 <div style="line-height:120%;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div><div style="line-height:120%;text-align:center;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;font-weight:bold;">SCHEDULE II</span></div><div style="line-height:120%;text-align:center;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;font-weight:bold;">VALUATION AND QUALIFYING ACCOUNTS</span></div><div style="line-height:120%;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div><div style="line-height:120%;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:99.80506822612085%;border-collapse:collapse;text-align:left;"><tr><td colspan="17"/></tr><tr><td style="width:32%;"/><td style="width:1%;"/><td style="width:1%;"/><td style="width:11%;"/><td style="width:1%;"/><td style="width:1%;"/><td style="width:1%;"/><td style="width:21%;"/><td style="width:1%;"/><td style="width:1%;"/><td style="width:1%;"/><td style="width:13%;"/><td style="width:1%;"/><td style="width:1%;"/><td style="width:1%;"/><td style="width:11%;"/><td style="width:1%;"/></tr><tr><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:8pt;"><span style="font-family:inherit;font-size:8pt;font-weight:bold;">Column A</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:8pt;"><span style="font-family:inherit;font-size:8pt;font-weight:bold;">Column B</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:8pt;"><span style="font-family:inherit;font-size:8pt;font-weight:bold;">Column C</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:8pt;"><span style="font-family:inherit;font-size:8pt;font-weight:bold;">Column D</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:8pt;"><span style="font-family:inherit;font-size:8pt;font-weight:bold;">Column E</span></div></td></tr><tr><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:8pt;"><span style="font-family:inherit;font-size:8pt;font-weight:bold;">Description</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:8pt;"><span style="font-family:inherit;font-size:8pt;font-weight:bold;">Balance at<br/>Beginning<br/>of Period</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:8pt;"><span style="font-family:inherit;font-size:8pt;font-weight:bold;">Additions Charged to<br/>Expenses or<br/>Other Accounts*</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:8pt;"><span style="font-family:inherit;font-size:8pt;font-weight:bold;">Deductions Credited to Expenses or Other Accounts**</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:8pt;"><span style="font-family:inherit;font-size:8pt;font-weight:bold;">Balance at<br/>End of<br/>Period</span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:inherit;font-size:8pt;font-weight:bold;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="15" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:center;font-size:8pt;"><span style="font-family:inherit;font-size:8pt;font-weight:bold;">(in millions)</span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;font-weight:bold;">2019</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Tax valuation allowance</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>135</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>9</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>(10</span></span></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">)</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>134</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;font-weight:bold;">2018</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Tax valuation allowance</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>138</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>4</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>(7</span></span></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">)</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>135</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;font-weight:bold;">2017</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Tax valuation allowance</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>129</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>14</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>(5</span></span></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">)</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>138</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr></table></div></div><div style="line-height:120%;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div><div style="line-height:120%;text-align:justify;text-indent:36px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">* Additions include current year additions charged to expenses and current year build due to increases in net deferred tax assets, return to provision true-ups, other adjustments and other comprehensive income impact to deferred taxes. </span></div><div style="line-height:120%;text-align:justify;text-indent:36px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div><div style="line-height:120%;text-align:justify;text-indent:36px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">** Deductions include current year releases credited to expenses and current year reductions due to decreases in net deferred tax assets, return to provision true-ups, other adjustments and other comprehensive income impact to deferred taxes. </span></div><div style="line-height:120%;text-align:justify;text-indent:36px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div> 135000000 9000000 10000000 134000000 138000000 4000000 7000000 135000000 129000000 14000000 5000000 138000000 XML 59 R11.htm IDEA: XBRL DOCUMENT v3.19.3.a.u2
NEW ACCOUNTING PRONOUNCEMENTS
 12 Months Ended
Oct. 31, 2019
New Accounting Pronouncements and Changes in Accounting Principles [Abstract]  
NEW ACCOUNTING PRONOUNCEMENTS NEW ACCOUNTING PRONOUNCEMENTS

Recently Adopted Accounting Pronouncements
In May 2014, the FASB issued new revenue recognition guidance, ASC Topic 606, which provides a single comprehensive model for entities to use in accounting for revenue arising from contracts with customers and will supersede most current revenue recognition guidance. The objective of the new revenue standard is to significantly enhance comparability and clarify principles of revenue recognition practices across entities, industries, jurisdictions and capital markets. Under the new guidance, there are specific criteria to determine if a performance obligation should be recognized over time or at a point in time.

On November 1, 2018, we adopted ASC 606 using the modified retrospective approach only to contracts not completed as of this date. Results for reporting periods after November 1, 2018 are presented under ASC 606, while prior period amounts were not adjusted and continue to be reported in accordance with ASC Topic 605, Revenue Recognition.

We recorded a net increase to beginning retained earnings of $23 million as of November 1, 2018 due to the cumulative impact of adopting ASC 606. The impact to beginning retained earnings is primarily due to an increase in contract assets (unbilled accounts receivable), a reduction in inventory and a reduction in contract liabilities (deferred revenue). The net increase in retained earnings and resulting changes in assets and liabilities was mainly driven by the change in timing of the recognition of revenue from the fulfillment of separate performance obligations as control transfers to the customer.

Had we continued to use the revenue recognition guidance in effect prior to fiscal year 2019, no material changes would have resulted to the consolidated statements of income, comprehensive income, or cash flows for the year ended October 31, 2019. As a result, comparisons of revenue and operating profit performance between periods are not materially affected by the adoption of this standard. Refer to Note 1, "Overview and Summary of Significant Accounting Policies"for a description of the company’s revenue recognition policies and Note 4, "Revenue" for the disclosures required by the standard.

As of November 1, 2018, we elected to early adopt new accounting guidance which amends reporting comprehensive income to allow a reclassification from accumulated other comprehensive income ("AOCI") to retained earnings for the deferred taxes previously recorded in AOCI that exceed the current federal tax rate of 21 percent resulting from the enacted corporate tax rate in the U.S. Tax Cuts and Jobs Act ("the Tax Act"). The adoption of this guidance resulted in a reclassification of $7 million from AOCI to beginning retained earnings on our consolidated balance sheet.

As of November 1, 2018, we adopted new accounting guidance which eliminates the exception in ASC 740, Income Taxes against immediate recognition of income tax consequences of intra-entity transfers of assets other than inventory. The amendment in this update should be applied on a modified retrospective basis through a cumulative-effect adjustment directly to retained earnings as of the beginning of period of adoption. We recorded a net decrease in beginning retained earnings of $2 million as of November 1, 2018 due to removing unamortized tax expense previously deferred.

As of November 1, 2018, we adopted new accounting guidance which addresses certain aspects of recognition, measurement, presentation and disclosure of financial instruments and also the related guidance which addresses technical corrections and improvements to this guidance. The guidance requires entities to measure equity investments that do not result in consolidation and are not accounted for under the equity method at fair value and recognize any changes in fair value in net income. The total impact of adoption to our consolidated balance sheet was an increase of $7 million to long-term investments and a net increase of $5 million to beginning retained earnings.


The following table summarizes the impacts of recently adopted accounting pronouncements on our consolidated balance sheet as of November 1, 2018:

 
October 31,
2018
 
Impact of Adopting New
 
November 1,
2018
 
As Reported
 
Revenue Recognition Guidance
 
Tax Effects on Items in AOCI Guidance
 
Intra-Entity Tax Guidance
 
Investments Valuation Guidance
 
As Adopted
 
(in millions)
ASSETS
 

 
 
 
 
 
 
 
 
 
 

Current assets:
 

 
 
 
 
 
 
 
 
 
 

Cash and cash equivalents
$
2,247

 
$
—

 
$
—

 
$
—

 
$
—

 
$
2,247

Accounts receivable, net
776

 
24

 
—

 
—

 
—

 
800

Inventory
638

 
(10
)
 
—

 
—

 
—

 
628

Other current assets
187

 
3

 
—

 
—

 
—

 
190

Total current assets
3,848

 
17

 
—

 
—

 
—

 
3,865

Property, plant and equipment, net
822

 
—

 
—

 
—

 
—

 
822

Goodwill
2,973

 
—

 
—

 
—

 
—

 
2,973

Other intangible assets, net
491

 
—

 
—

 
—

 
—

 
491

Long-term investments
68

 
—

 
—

 
—

 
7

 
75

Other assets
339

 
(3
)
 
—

 
(2
)
 
(2
)
 
332

Total assets
$
8,541

 
$
14

 
$
—

 
$
(2
)
 
$
5

 
$
8,558

LIABILITIES AND EQUITY
 

 
 
 
 
 
 
 
 
 
 

Current liabilities:
 

 
 
 
 
 
 
 
 
 
 

Accounts payable
$
340

 
$
—

 
$
—

 
$
—

 
$
—

 
$
340

Employee compensation and benefits
304

 
—

 
—

 
—

 
—

 
304

Deferred revenue
324

 
(11
)
 
—

 
—

 
—

 
313

Other accrued liabilities
203

 
—

 
—

 
—

 
—

 
203

Total current liabilities
1,171

 
(11
)
 
—

 
—

 
—

 
1,160

Long-term debt
1,799

 
—

 
—

 
—

 
—

 
1,799

Retirement and post-retirement benefits
239

 
—

 
—

 
—

 
—

 
239

Other long-term liabilities
761

 
2

 
—

 
—

 
—

 
763

Total liabilities
3,970

 
(9
)
 
—

 
—

 
—

 
3,961

 
 
 
 
 
 
 
 
 
 
 
 
Total equity:
 

 
 
 
 
 
 
 
 
 
 

Stockholders’ equity:
 

 
 
 
 
 
 
 
 
 
 

Preferred stock; $0.01 par value; 125 million shares authorized; none issued and outstanding
—

 
—

 
—

 
—

 
—

 
—

Common stock; $0.01 par value; 2 billion shares authorized; 318 million shares at October 31, 2018 issued
3

 
—

 
—

 
—

 
—

 
3

Additional paid-in-capital
5,308

 
—

 
—

 
—

 
—

 
5,308

Accumulated deficit
(336
)
 
23

 
7

 
(2
)
 
5

 
(303
)
Accumulated other comprehensive loss
(408
)
 
—

 
(7
)
 
—

 
—

 
(415
)
Total stockholders' equity
4,567

 
23

 
—

 
(2
)
 
5

 
4,593

Non-controlling interest
4

 
—

 
—

 
—

 
—

 
4

Total equity
4,571

 
23

 
—

 
(2
)
 
5

 
4,597

Total liabilities and equity
$
8,541

 
$
14

 
$
—

 
$
(2
)
 
$
5

 
$
8,558








As of November 1, 2018, we adopted new accounting guidance which requires amounts generally described as restricted cash and restricted cash equivalents to be included with cash and cash equivalents when reconciling the beginning-of-period and end-of-period total amounts shown on the statement of cash flows. A reconciliation of cash, cash equivalents and restricted cash to the consolidated balance sheet follows:
 
October 31
 
2019
 
2018
 
2017
 
(in millions)
 
 
Cash and cash equivalents
$
1,382

 
$
2,247

 
$
2,678

Restricted cash included in other assets
6

 
7

 
8

Total cash, cash equivalents and restricted cash
$
1,388

 
$
2,254

 
$
2,686



As of November 1, 2018, we adopted new accounting guidance which requires employers that present a measure of operating income in their statements of operations to include only the service cost component of net periodic postretirement benefit cost in operating expenses. The service cost component of net periodic pension and postretirement benefit cost should be presented in the same operating expense line items as other employee compensation costs arising from services rendered during the period. The other components of net periodic pension and postretirement benefit costs, including interest costs, expected return on assets, amortization of prior service cost/credit and actuarial gains/losses, and settlement and curtailment effects, are to be included separately and outside of any subtotal of operating income. The adoption of this guidance resulted in a reclassification of income from our income from operations to other income (expense), net on our consolidated statement of operations of approximately $10 million, $24 million and $34 million in the year ended October 31, 2019, 2018 and 2017, respectively. As adoption is required to be on a retrospective basis, we have recast our historical consolidated statements of operations and segment information to conform to current year presentation.

New Accounting Pronouncements Not Yet Adopted

In February 2016, the FASB issued guidance which amends the existing accounting standards for leases. Consistent with existing guidance, the recognition, measurement, and presentation of expenses and cash flows arising from a lease by a lessee primarily will depend on its classification. Under the new guidance, a lessee will be required to recognize right-of-use assets ("ROU") and lease liabilities on the balance sheet. On November 1, 2019, we adopted the lease accounting guidance using the modified retrospective method for all lease arrangements at the beginning of the period of adoption. Results for reporting periods beginning November 1, 2019 will be presented under the new accounting guidance, while prior period amounts will not be adjusted. As of November 1, 2019, the new accounting guidance had a material impact on our consolidated balance sheet but is expected to have an insignificant impact on the consolidated net income and cash flows. The most significant impact was the recognition of ROU assets and lease liabilities for operating leases, while the accounting for capital leases remained substantially unchanged. For leases that commenced before the effective date of adoption of the new accounting guidance, we elected the permitted practical expedients to not reassess the following: (i) whether any expired or existing contracts contain leases; (ii) the lease classification for any expired or existing leases; and (iii) capitalization of initial direct costs for any existing leases.
As a result of the cumulative impact of adopting the new accounting guidance we will record operating lease ROU assets around $195 million and operating lease liabilities of the same amounts, primarily related to real estate and automobile leases.
The accounting applied to lease arrangements in which we are the lessor is largely unchanged from that applied under the prior standard and will not have a significant impact to our consolidated balance sheet, net income or cash flows
In January 2017, the FASB issued an amendment to modify the concept of impairment from the condition that exists when the carrying amount of goodwill exceeds its implied fair value to the condition that exists when the carrying amount of a reporting unit exceeds its fair value. The amendment also simplifies the subsequent measurement of goodwill by eliminating Step 2 from the goodwill impairment test. The amendments are effective for us beginning November 1, 2020. Early adoption is permitted for interim or annual goodwill impairment tests performed on testing dates after January 1, 2017. We do not expect to early adopt nor do we expect this guidance to have a material impact on our consolidated financial statements and disclosures.

In August 2018, the FASB issued updates to improve the disclosure requirements on fair value measurements in Topic 820, Fair Value Measurement which eliminates certain disclosure requirements and modifies others. These amendments are effective for us beginning November 1, 2020, and for interim periods within that year with early adoption permitted. We currently do not expect this guidance to have a material impact on our consolidated financial statements and disclosures.

In August 2018, the FASB issued updates to improve the effectiveness of disclosures for defined benefit plans under Accounting Standard Codification Topic 715-20. The amendments in this guidance remove disclosures that no longer are considered cost beneficial, clarify the specific requirements of disclosures, and add disclosure requirements identified as relevant. These amendments are effective for us beginning November 1, 2021, with early adoption permitted. We currently do not expect this guidance to have a material impact on our consolidated financial statements and disclosures.

Other amendments to GAAP in the U.S. that have been issued by the FASB or other standards-setting bodies that do not require adoption until a future date are not expected to have a material impact on our consolidated financial statements upon adoption.
XML 60 R5.htm IDEA: XBRL DOCUMENT v3.19.3.a.u2
CONSOLIDATED BALANCE SHEET - USD ($)
$ in Millions
Oct. 31, 2019
Oct. 31, 2018
Current assets:    
Cash and cash equivalents $ 1,382 $ 2,247
Accounts receivable, net 930 776
Inventory 679 638
Other current assets 198 187
Total current assets 3,189 3,848
Property, plant and equipment, net 850 822
Goodwill 3,593 2,973
Other intangible assets, net 1,107 491
Long-term investments 102 68
Other assets 611 339
Total assets 9,452 8,541
Current liabilities:    
Accounts payable 354 340
Employee compensation and benefits 334 304
Deferred revenue 336 324
Short-term debt 616 0
Other accrued liabilities 440 203
Total current liabilities 2,080 1,171
Long-term debt 1,791 1,799
Retirement and post-retirement benefits 360 239
Other long-term liabilities 473 761
Total liabilities 4,704 3,970
Commitments and contingencies (Note 16)
Stockholders' equity:    
Preferred stock; $0.01 par value; 125 million shares authorized; none issued and outstanding 0 0
Common stock; $0.01 par value; 2 billion shares authorized; 309 million shares at October 31, 2019 and 318 million shares at October 31, 2018 issued 3 3
Additional paid-in-capital 5,277 5,308
Accumulated deficit (18) (336)
Accumulated other comprehensive loss (514) (408)
Total stockholders' equity 4,748 4,567
Non-controlling interest 0 4
Total equity 4,748 4,571
Total liabilities and equity $ 9,452 $ 8,541
XML 61 R1.htm IDEA: XBRL DOCUMENT v3.19.3.a.u2
Document And Entity Information - USD ($)
$ in Billions
 12 Months Ended
Oct. 31, 2019
Dec. 10, 2019
Apr. 30, 2019
Entity Information [Line Items]      
Document Type 10-K    
Document Annual Report true    
Document Period End Date Oct. 31, 2019    
Document Transition Report false    
Entity File Number 001-15405    
Entity Registrant Name Agilent Technologies, Inc.    
Entity Incorporation, State or Country Code DE    
Entity Tax Identification Number 77-0518772    
Entity Address, Address Line One 5301 Stevens Creek Blvd.    
Entity Address, City or Town Santa Clara,    
Entity Address, State or Province CA    
Entity Address, Postal Zip Code 95051    
City Area Code (800)    
Local Phone Number 227-9770    
Title of 12(b) Security Common Stock, $0.01 par value    
Trading Symbol A    
Security Exchange Name NYSE    
Entity Well-known Seasoned Issuer Yes    
Entity Voluntary Filers No    
Entity Current Reporting Status Yes    
Entity Interactive Data Current Yes    
Entity Filer Category Large Accelerated Filer    
Entity Small Business false    
Entity Emerging Growth Company false    
Entity Shell Company false    
Entity Public Float     $ 18.9
Entity Common Stock, Shares Outstanding   310,183,415  
Documents Incorporated by Reference [Text Block] Portions of the Proxy Statement for the Annual Meeting of Stockholders (the "Proxy Statement") to be held on March 18, 2020, and to be filed pursuant to Regulation 14A within 120 days after registrant's fiscal year ended October 31, 2019 are incorporated by reference into Part III of this Report    
Amendment Flag false    
Document Fiscal Year Focus 2019    
Document Fiscal Period Focus FY    
Current Fiscal Year End Date --10-31    
Entity Central Index Key 0001090872    
XML 62 R32.htm IDEA: XBRL DOCUMENT v3.19.3.a.u2
NEW ACCOUNTING PRONOUNCEMENTS (Tables)
 12 Months Ended
Oct. 31, 2019
New Accounting Pronouncements and Changes in Accounting Principles [Abstract]  
Schedule of New Accounting Pronouncements and Changes in Accounting Principles [Table Text Block]
The following table summarizes the impacts of recently adopted accounting pronouncements on our consolidated balance sheet as of November 1, 2018:

 
October 31,
2018
 
Impact of Adopting New
 
November 1,
2018
 
As Reported
 
Revenue Recognition Guidance
 
Tax Effects on Items in AOCI Guidance
 
Intra-Entity Tax Guidance
 
Investments Valuation Guidance
 
As Adopted
 
(in millions)
ASSETS
 

 
 
 
 
 
 
 
 
 
 

Current assets:
 

 
 
 
 
 
 
 
 
 
 

Cash and cash equivalents
$
2,247

 
$
—

 
$
—

 
$
—

 
$
—

 
$
2,247

Accounts receivable, net
776

 
24

 
—

 
—

 
—

 
800

Inventory
638

 
(10
)
 
—

 
—

 
—

 
628

Other current assets
187

 
3

 
—

 
—

 
—

 
190

Total current assets
3,848

 
17

 
—

 
—

 
—

 
3,865

Property, plant and equipment, net
822

 
—

 
—

 
—

 
—

 
822

Goodwill
2,973

 
—

 
—

 
—

 
—

 
2,973

Other intangible assets, net
491

 
—

 
—

 
—

 
—

 
491

Long-term investments
68

 
—

 
—

 
—

 
7

 
75

Other assets
339

 
(3
)
 
—

 
(2
)
 
(2
)
 
332

Total assets
$
8,541

 
$
14

 
$
—

 
$
(2
)
 
$
5

 
$
8,558

LIABILITIES AND EQUITY
 

 
 
 
 
 
 
 
 
 
 

Current liabilities:
 

 
 
 
 
 
 
 
 
 
 

Accounts payable
$
340

 
$
—

 
$
—

 
$
—

 
$
—

 
$
340

Employee compensation and benefits
304

 
—

 
—

 
—

 
—

 
304

Deferred revenue
324

 
(11
)
 
—

 
—

 
—

 
313

Other accrued liabilities
203

 
—

 
—

 
—

 
—

 
203

Total current liabilities
1,171

 
(11
)
 
—

 
—

 
—

 
1,160

Long-term debt
1,799

 
—

 
—

 
—

 
—

 
1,799

Retirement and post-retirement benefits
239

 
—

 
—

 
—

 
—

 
239

Other long-term liabilities
761

 
2

 
—

 
—

 
—

 
763

Total liabilities
3,970

 
(9
)
 
—

 
—

 
—

 
3,961

 
 
 
 
 
 
 
 
 
 
 
 
Total equity:
 

 
 
 
 
 
 
 
 
 
 

Stockholders’ equity:
 

 
 
 
 
 
 
 
 
 
 

Preferred stock; $0.01 par value; 125 million shares authorized; none issued and outstanding
—

 
—

 
—

 
—

 
—

 
—

Common stock; $0.01 par value; 2 billion shares authorized; 318 million shares at October 31, 2018 issued
3

 
—

 
—

 
—

 
—

 
3

Additional paid-in-capital
5,308

 
—

 
—

 
—

 
—

 
5,308

Accumulated deficit
(336
)
 
23

 
7

 
(2
)
 
5

 
(303
)
Accumulated other comprehensive loss
(408
)
 
—

 
(7
)
 
—

 
—

 
(415
)
Total stockholders' equity
4,567

 
23

 
—

 
(2
)
 
5

 
4,593

Non-controlling interest
4

 
—

 
—

 
—

 
—

 
4

Total equity
4,571

 
23

 
—

 
(2
)
 
5

 
4,597

Total liabilities and equity
$
8,541

 
$
14

 
$
—

 
$
(2
)
 
$
5

 
$
8,558








As of November 1, 2018, we adopted new accounting guidance which requires amounts generally described as restricted cash and restricted cash equivalents to be included with cash and cash equivalents when reconciling the beginning-of-period and end-of-period total amounts shown on the statement of cash flows. A reconciliation of cash, cash equivalents and restricted cash to the consolidated balance sheet follows:
 
October 31
 
2019
 
2018
 
2017
 
(in millions)
 
 
Cash and cash equivalents
$
1,382

 
$
2,247

 
$
2,678

Restricted cash included in other assets
6

 
7

 
8

Total cash, cash equivalents and restricted cash
$
1,388

 
$
2,254

 
$
2,686
XML 63 R9.htm IDEA: XBRL DOCUMENT v3.19.3.a.u2
CONSOLIDATED STATEMENT OF EQUITY (Parenthetical) - $ / shares
 12 Months Ended
Oct. 31, 2019
Oct. 31, 2018
Oct. 31, 2017
Statement of Stockholders' Equity [Abstract]      
Cash Dividends Declared (per common share) $ 0.656 $ 0.596 $ 0.528
XML 64 R36.htm IDEA: XBRL DOCUMENT v3.19.3.a.u2
INCOME TAXES (Tables)
 12 Months Ended
Oct. 31, 2019
Income Tax Disclosure [Abstract]  
Income before income taxes domestic and foreign

The domestic and foreign components of income before taxes are:

 
Years Ended October 31,
 
2019
 
2018
 
2017
 
(in millions)
U.S. operations
$
189

 
$
169

 
$
116

Non-U.S. operations
730

 
777

 
687

Total income before taxes
$
919

 
$
946

 
$
803
Provision for income taxes from operations
The provision for income taxes is comprised of:

 
Years Ended October 31,
 
2019
 
2018
 
2017
 
(in millions)
U.S. federal taxes:
 
 
 
 
 
Current
$
(191
)
 
$
520

 
$
15

Deferred
—

 
51

 
110

Non-U.S. taxes:
 
 
 
 
 
Current
290

 
95

 
1

Deferred
(267
)
 
(22
)
 
(7
)
State taxes, net of federal benefit:
 
 
 
 
 
Current
4

 
1

 
1

Deferred
12

 
(15
)
 
(1
)
Total provision (benefit)
$
(152
)
 
$
630

 
$
119
Tax rate reconciliation, U.S. federal statutory rate to effective tax rate from operations


The differences between the U.S. federal statutory income tax rate and our effective tax rate are:

 
Years Ended October 31,
 
2019
 
2018
 
2017
 
(in millions)
Profit before tax times statutory rate
$
193

 
$
221

 
$
281

Non-U.S. income taxed at different rates
(8
)
 
(93
)
 
(43
)
Change in unrecognized tax benefits
(13
)
 
(17
)
 
(110
)
Impact of the Tax Act
—

 
552

 
—

Extension of the tax incentive in Singapore
(299
)
 
—

 
—

Other, net
(25
)
 
(33
)
 
(9
)
Provision (benefit) for income taxes
$
(152
)
 
$
630

 
$
119

Effective tax rate
(16.5
)%
 
66.6
%
 
14.8
%
Significant components of deferred tax assets and deferred tax liabilities


The significant components of deferred tax assets and deferred tax liabilities included on the consolidated balance sheet are:

 
Years Ended October 31,
 
2019
 
2018
 
(in millions)
Deferred Tax Assets
 
 
 
Intangibles
$
131

 
$
—

Property, plant and equipment
—

 
8

Pension benefits and retiree medical benefits
71

 
49

Employee benefits, other than retirement
34

 
34

Net operating loss, capital loss, and credit carryforwards
195

 
185

Share-based compensation
32

 
31

Deferred revenue
38

 
38

Other
35

 
19

Deferred tax assets
$
536

 
$
364

Tax valuation allowance
(134
)
 
(135
)
Deferred tax assets, net of valuation allowance
$
402

 
$
229

 
 
 
 
Deferred Tax Liabilities
 
 
 
Intangibles
$
—

 
$
(112
)
Property, plant and equipment
(16
)
 
—

Other
(7
)
 
(21
)
Deferred tax liabilities
$
(23
)
 
$
(133
)
Net deferred tax assets (liabilities)
$
379

 
$
96
Current and long-term deferred tax assets and deferred tax liabilities
The breakdown between long-term deferred tax assets and deferred tax liabilities was as follows:

 
October 31,
 
2019
 
2018
 
(in millions)
Long-term deferred tax assets (included within other assets)
$
410

 
$
165

Long-term deferred tax liabilities (included within other long-term liabilities)
(31
)
 
(69
)
Total
$
379

 
$
96
Current and Long Term Tax Assets and Liabilities [Table Text Block]

The breakdown between current and long-term income tax assets and liabilities, excluding deferred tax assets and liabilities, was as follows:
 
October 31,
 
2019
 
2018
 
(in millions)
Current income tax assets (included within other current assets)
$
68

 
$
59

Long-term income tax assets (included within other assets)
4

 
19

Current income tax liabilities (included within other accrued liabilities)
(292
)
 
(71
)
Long-term income tax liabilities (included within other long-term liabilities)
(328
)
 
(607
)
Total
$
(548
)
 
$
(600
)
Income tax contingencies rollforward
The aggregate changes in the balances of our gross unrecognized tax benefits including all federal, state and foreign tax jurisdictions are as follows:

 
2019
 
2018
 
2017
 
(in millions)
Balance, beginning of year
$
214

 
$
224

 
$
293

Additions for tax positions related to the current year
7

 
27

 
32

Additions for tax positions from prior years
12

 
2

 
1

Reductions for tax positions from prior years
(2
)
 
(13
)
 
(3
)
Settlements with taxing authorities
—

 
—

 
(52
)
Statute of limitations expirations
(25
)
 
(26
)
 
(47
)
Balance, end of year
$
206

 
$
214

 
$
224
XML 65 FilingSummary.xml IDEA: XBRL DOCUMENT 3.19.3.a.u2 html 513 735 1 false 132 0 false 7 false false R1.htm 0001000 - Document - Document And Entity Information Sheet http://www.agilent.com/role/DocumentAndEntityInformation Document And Entity Information Cover 1 false false R2.htm 1001000 - Statement - CONSOLIDATED STATEMENT OF OPERATIONS Sheet http://www.agilent.com/role/ConsolidatedStatementOfOperations CONSOLIDATED STATEMENT OF OPERATIONS Statements 2 false false R3.htm 1003000 - Statement - CONSOLIDATED STATEMENT OF COMPREHENSIVE INCOME Sheet http://www.agilent.com/role/ConsolidatedStatementOfComprehensiveIncome CONSOLIDATED STATEMENT OF COMPREHENSIVE INCOME Statements 3 false false R4.htm 1003001 - Statement - CONSOLIDATED STATEMENT OF COMPREHENSIVE INCOME (Parenthetical) Sheet http://www.agilent.com/role/ConsolidatedStatementOfComprehensiveIncomeParenthetical CONSOLIDATED STATEMENT OF COMPREHENSIVE INCOME (Parenthetical) Statements 4 false false R5.htm 1004000 - Statement - CONSOLIDATED BALANCE SHEET Sheet http://www.agilent.com/role/ConsolidatedBalanceSheet CONSOLIDATED BALANCE SHEET Statements 5 false false R6.htm 1004501 - Statement - CONSOLIDATED BALANCE SHEET (Parenthetical) Sheet http://www.agilent.com/role/ConsolidatedBalanceSheetParenthetical CONSOLIDATED BALANCE SHEET (Parenthetical) Statements 6 false false R7.htm 1005000 - Statement - CONSOLIDATED STATEMENT OF CASH FLOWS Sheet http://www.agilent.com/role/ConsolidatedStatementOfCashFlows CONSOLIDATED STATEMENT OF CASH FLOWS Statements 7 false false R8.htm 1006000 - Statement - CONSOLIDATED STATEMENT OF EQUITY Sheet http://www.agilent.com/role/ConsolidatedStatementOfEquity CONSOLIDATED STATEMENT OF EQUITY Statements 8 false false R9.htm 1006501 - Statement - CONSOLIDATED STATEMENT OF EQUITY (Parenthetical) Sheet http://www.agilent.com/role/ConsolidatedStatementOfEquityParenthetical CONSOLIDATED STATEMENT OF EQUITY (Parenthetical) Statements 9 false false R10.htm 2101100 - Disclosure - OVERVIEW AND SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES Sheet http://www.agilent.com/role/OverviewAndSummaryOfSignificantAccountingPolicies OVERVIEW AND SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES Notes 10 false false R11.htm 2105100 - Disclosure - NEW ACCOUNTING PRONOUNCEMENTS Sheet http://www.agilent.com/role/NewAccountingPronouncements NEW ACCOUNTING PRONOUNCEMENTS Notes 11 false false R12.htm 2107100 - Disclosure - ACQUISITIONS (Notes) Notes http://www.agilent.com/role/AcquisitionsNotes ACQUISITIONS (Notes) Notes 12 false false R13.htm 2108100 - Disclosure - REVENUE REVENUE (Notes) Notes http://www.agilent.com/role/RevenueRevenueNotes REVENUE REVENUE (Notes) Notes 13 false false R14.htm 2109100 - Disclosure - SHARE-BASED COMPENSATION Sheet http://www.agilent.com/role/ShareBasedCompensation SHARE-BASED COMPENSATION Notes 14 false false R15.htm 2111100 - Disclosure - INCOME TAXES Sheet http://www.agilent.com/role/IncomeTaxes INCOME TAXES Notes 15 false false R16.htm 2112100 - Disclosure - NET INCOME (LOSS) PER SHARE Sheet http://www.agilent.com/role/NetIncomeLossPerShare NET INCOME (LOSS) PER SHARE Notes 16 false false R17.htm 2113100 - Disclosure - INVENTORY Sheet http://www.agilent.com/role/Inventory INVENTORY Notes 17 false false R18.htm 2114100 - Disclosure - PROPERTY, PLANT AND EQUIPMENT, NET Sheet http://www.agilent.com/role/PropertyPlantAndEquipmentNet PROPERTY, PLANT AND EQUIPMENT, NET Notes 18 false false R19.htm 2115100 - Disclosure - GOODWILL AND OTHER INTANGIBLE ASSETS Sheet http://www.agilent.com/role/GoodwillAndOtherIntangibleAssets GOODWILL AND OTHER INTANGIBLE ASSETS Notes 19 false false R20.htm 2116100 - Disclosure - INVESTMENTS Sheet http://www.agilent.com/role/Investments INVESTMENTS Notes 20 false false R21.htm 2118100 - Disclosure - FAIR VALUE MEASUREMENTS Sheet http://www.agilent.com/role/FairValueMeasurements FAIR VALUE MEASUREMENTS Notes 21 false false R22.htm 2119100 - Disclosure - DERIVATIVES Sheet http://www.agilent.com/role/Derivatives DERIVATIVES Notes 22 false false R23.htm 2120100 - Disclosure - RETIREMENT PLANS AND POST RETIREMENT PENSION PLANS Sheet http://www.agilent.com/role/RetirementPlansAndPostRetirementPensionPlans RETIREMENT PLANS AND POST RETIREMENT PENSION PLANS Notes 23 false false R24.htm 2121100 - Disclosure - GUARANTEES Sheet http://www.agilent.com/role/Guarantees GUARANTEES Notes 24 false false R25.htm 2122100 - Disclosure - COMMITMENTS AND CONTINGENCIES Sheet http://www.agilent.com/role/CommitmentsAndContingencies COMMITMENTS AND CONTINGENCIES Notes 25 false false R26.htm 2123100 - Disclosure - SHORT-TERM DEBT Sheet http://www.agilent.com/role/ShortTermDebt SHORT-TERM DEBT Notes 26 false false R27.htm 2124100 - Disclosure - LONG-TERM DEBT Sheet http://www.agilent.com/role/LongTermDebt LONG-TERM DEBT Notes 27 false false R28.htm 2127100 - Disclosure - STOCKHOLDERS' EQUITY Sheet http://www.agilent.com/role/StockholdersEquity STOCKHOLDERS' EQUITY Notes 28 false false R29.htm 2128100 - Disclosure - SEGMENT INFORMATION Sheet http://www.agilent.com/role/SegmentInformation SEGMENT INFORMATION Notes 29 false false R30.htm 2130100 - Schedule - Schedule II Valuation and Qualifying Accounts Sheet http://www.agilent.com/role/ScheduleIiValuationAndQualifyingAccounts Schedule II Valuation and Qualifying Accounts Uncategorized 30 false false R31.htm 2201201 - Disclosure - OVERVIEW AND SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Policies) Sheet http://www.agilent.com/role/OverviewAndSummaryOfSignificantAccountingPoliciesPolicies OVERVIEW AND SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Policies) Notes 31 false false R32.htm 2305301 - Disclosure - NEW ACCOUNTING PRONOUNCEMENTS (Tables) Sheet http://www.agilent.com/role/NewAccountingPronouncementsTables NEW ACCOUNTING PRONOUNCEMENTS (Tables) Tables http://www.agilent.com/role/NewAccountingPronouncements 32 false false R33.htm 2307301 - Disclosure - ACQUISITIONS (Tables) Sheet http://www.agilent.com/role/AcquisitionsTables ACQUISITIONS (Tables) Tables http://www.agilent.com/role/AcquisitionsNotes 33 false false R34.htm 2308301 - Disclosure - REVENUE REVENUE (Tables) Sheet http://www.agilent.com/role/RevenueRevenueTables REVENUE REVENUE (Tables) Tables http://www.agilent.com/role/RevenueRevenueNotes 34 false false R35.htm 2309301 - Disclosure - SHARE-BASED COMPENSATION (Tables) Sheet http://www.agilent.com/role/ShareBasedCompensationTables SHARE-BASED COMPENSATION (Tables) Tables http://www.agilent.com/role/ShareBasedCompensation 35 false false R36.htm 2311301 - Disclosure - INCOME TAXES (Tables) Sheet http://www.agilent.com/role/IncomeTaxesTables INCOME TAXES (Tables) Tables http://www.agilent.com/role/IncomeTaxes 36 false false R37.htm 2312301 - Disclosure - NET INCOME (LOSS) PER SHARE (Tables) Sheet http://www.agilent.com/role/NetIncomeLossPerShareTables NET INCOME (LOSS) PER SHARE (Tables) Tables http://www.agilent.com/role/NetIncomeLossPerShare 37 false false R38.htm 2313301 - Disclosure - INVENTORY (Tables) Sheet http://www.agilent.com/role/InventoryTables INVENTORY (Tables) Tables http://www.agilent.com/role/Inventory 38 false false R39.htm 2314301 - Disclosure - PROPERTY, PLANT AND EQUIPMENT, NET (Tables) Sheet http://www.agilent.com/role/PropertyPlantAndEquipmentNetTables PROPERTY, PLANT AND EQUIPMENT, NET (Tables) Tables http://www.agilent.com/role/PropertyPlantAndEquipmentNet 39 false false R40.htm 2315301 - Disclosure - GOODWILL AND OTHER INTANGIBLE ASSETS (Tables) Sheet http://www.agilent.com/role/GoodwillAndOtherIntangibleAssetsTables GOODWILL AND OTHER INTANGIBLE ASSETS (Tables) Tables http://www.agilent.com/role/GoodwillAndOtherIntangibleAssets 40 false false R41.htm 2316301 - Disclosure - INVESTMENTS (Tables) Sheet http://www.agilent.com/role/InvestmentsTables INVESTMENTS (Tables) Tables http://www.agilent.com/role/Investments 41 false false R42.htm 2318301 - Disclosure - FAIR VALUE MEASUREMENTS (Tables) Sheet http://www.agilent.com/role/FairValueMeasurementsTables FAIR VALUE MEASUREMENTS (Tables) Tables http://www.agilent.com/role/FairValueMeasurements 42 false false R43.htm 2319301 - Disclosure - DERIVATIVES (Tables) Sheet http://www.agilent.com/role/DerivativesTables DERIVATIVES (Tables) Tables http://www.agilent.com/role/Derivatives 43 false false R44.htm 2320301 - Disclosure - RETIREMENT PLANS AND POST RETIREMENT PENSION PLANS (Tables) Sheet http://www.agilent.com/role/RetirementPlansAndPostRetirementPensionPlansTables RETIREMENT PLANS AND POST RETIREMENT PENSION PLANS (Tables) Tables http://www.agilent.com/role/RetirementPlansAndPostRetirementPensionPlans 44 false false R45.htm 2321301 - Disclosure - GUARANTEES (Tables) Sheet http://www.agilent.com/role/GuaranteesTables GUARANTEES (Tables) Tables http://www.agilent.com/role/Guarantees 45 false false R46.htm 2322301 - Disclosure - COMMITMENTS AND CONTINGENCIES (Tables) Sheet http://www.agilent.com/role/CommitmentsAndContingenciesTables COMMITMENTS AND CONTINGENCIES (Tables) Tables http://www.agilent.com/role/CommitmentsAndContingencies 46 false false R47.htm 2324301 - Disclosure - LONG-TERM DEBT (Tables) Sheet http://www.agilent.com/role/LongTermDebtTables LONG-TERM DEBT (Tables) Tables http://www.agilent.com/role/LongTermDebt 47 false false R48.htm 2327301 - Disclosure - STOCKHOLDERS' EQUITY (Tables) Sheet http://www.agilent.com/role/StockholdersEquityTables STOCKHOLDERS' EQUITY (Tables) Tables http://www.agilent.com/role/StockholdersEquity 48 false false R49.htm 2328301 - Disclosure - SEGMENT INFORMATION (Tables) Sheet http://www.agilent.com/role/SegmentInformationTables SEGMENT INFORMATION (Tables) Tables http://www.agilent.com/role/SegmentInformation 49 false false R50.htm 2401402 - Disclosure - OVERVIEW AND SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Details) Sheet http://www.agilent.com/role/OverviewAndSummaryOfSignificantAccountingPoliciesDetails OVERVIEW AND SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Details) Details http://www.agilent.com/role/OverviewAndSummaryOfSignificantAccountingPolicies 50 false false R51.htm 2405402 - Disclosure - NEW ACCOUNTING PRONOUNCEMENTS - Impact of adopting new guidance (Details) Sheet http://www.agilent.com/role/NewAccountingPronouncementsImpactOfAdoptingNewGuidanceDetails NEW ACCOUNTING PRONOUNCEMENTS - Impact of adopting new guidance (Details) Details 51 false false R52.htm 2405403 - Disclosure - NEW ACCOUNTING PRONOUNCEMENTS - Textuals (Details) Sheet http://www.agilent.com/role/NewAccountingPronouncementsTextualsDetails NEW ACCOUNTING PRONOUNCEMENTS - Textuals (Details) Details 52 false false R53.htm 2405404 - Disclosure - NEW ACCOUNTING PRONOUNCEMENTS NEW ACCOUNTING PRONOUNCEMENTS - Restricted cash (Details) Sheet http://www.agilent.com/role/NewAccountingPronouncementsNewAccountingPronouncementsRestrictedCashDetails NEW ACCOUNTING PRONOUNCEMENTS NEW ACCOUNTING PRONOUNCEMENTS - Restricted cash (Details) Details 53 false false R54.htm 2407402 - Disclosure - ACQUISITIONS - Text (Details) Sheet http://www.agilent.com/role/AcquisitionsTextDetails ACQUISITIONS - Text (Details) Details 54 false false R55.htm 2407403 - Disclosure - ACQUISITIONS - Assets and Liabilities Assumed (Details) Sheet http://www.agilent.com/role/AcquisitionsAssetsAndLiabilitiesAssumedDetails ACQUISITIONS - Assets and Liabilities Assumed (Details) Details 55 false false R56.htm 2407404 - Disclosure - ACQUISITIONS ACQUISITIONS - Intangible Assets (Details) Sheet http://www.agilent.com/role/AcquisitionsAcquisitionsIntangibleAssetsDetails ACQUISITIONS ACQUISITIONS - Intangible Assets (Details) Details 56 false false R57.htm 2407405 - Disclosure - ACQUISITIONS ACQUISITIONS - Proforma Operating Results (Details) Sheet http://www.agilent.com/role/AcquisitionsAcquisitionsProformaOperatingResultsDetails ACQUISITIONS ACQUISITIONS - Proforma Operating Results (Details) Details 57 false false R58.htm 2408402 - Disclosure - REVENUE - Revenue by Region (Details) Sheet http://www.agilent.com/role/RevenueRevenueByRegionDetails REVENUE - Revenue by Region (Details) Details 58 false false R59.htm 2408403 - Disclosure - REVENUE - Revenue by End Markets (Details) Sheet http://www.agilent.com/role/RevenueRevenueByEndMarketsDetails REVENUE - Revenue by End Markets (Details) Details 59 false false R60.htm 2408404 - Disclosure - REVENUE REVENUE - Revenue by Type (Details) Sheet http://www.agilent.com/role/RevenueRevenueRevenueByTypeDetails REVENUE REVENUE - Revenue by Type (Details) Details 60 false false R61.htm 2408405 - Disclosure - REVENUE REVENUE - Contract Balances (Details) Sheet http://www.agilent.com/role/RevenueRevenueContractBalancesDetails REVENUE REVENUE - Contract Balances (Details) Details 61 false false R62.htm 2409402 - Disclosure - SHARE-BASED COMPENSATION General Disclosures (Details) Sheet http://www.agilent.com/role/ShareBasedCompensationGeneralDisclosuresDetails SHARE-BASED COMPENSATION General Disclosures (Details) Details 62 false false R63.htm 2409403 - Disclosure - SHARE-BASED COMPENSATION Allocated Share-based compensation expense (Details) Sheet http://www.agilent.com/role/ShareBasedCompensationAllocatedShareBasedCompensationExpenseDetails SHARE-BASED COMPENSATION Allocated Share-based compensation expense (Details) Details 63 false false R64.htm 2409404 - Disclosure - SHARE-BASED COMPENSATION-Fair Value Assumptions (Details) Sheet http://www.agilent.com/role/ShareBasedCompensationFairValueAssumptionsDetails SHARE-BASED COMPENSATION-Fair Value Assumptions (Details) Details 64 false false R65.htm 2409405 - Disclosure - SHARE-BASED COMPENSATION Stock Option Activity (Details) Sheet http://www.agilent.com/role/ShareBasedCompensationStockOptionActivityDetails SHARE-BASED COMPENSATION Stock Option Activity (Details) Details 65 false false R66.htm 2409406 - Disclosure - SHARE-BASED COMPENSATION Shares Authorized by Exercise Price Range (Details) Sheet http://www.agilent.com/role/ShareBasedCompensationSharesAuthorizedByExercisePriceRangeDetails SHARE-BASED COMPENSATION Shares Authorized by Exercise Price Range (Details) Details 66 false false R67.htm 2409407 - Disclosure - SHARE-BASED COMPENSATION Non-vested award activity disclosure (Details) Sheet http://www.agilent.com/role/ShareBasedCompensationNonVestedAwardActivityDisclosureDetails SHARE-BASED COMPENSATION Non-vested award activity disclosure (Details) Details 67 false false R68.htm 2411402 - Disclosure - INCOME TAXES INCOME TAXES- Provision (Details) Sheet http://www.agilent.com/role/IncomeTaxesIncomeTaxesProvisionDetails INCOME TAXES INCOME TAXES- Provision (Details) Details 68 false false R69.htm 2411403 - Disclosure - INCOME TAXES INCOME TAXES Effective tax rate and tax holidays (Details) Sheet http://www.agilent.com/role/IncomeTaxesIncomeTaxesEffectiveTaxRateAndTaxHolidaysDetails INCOME TAXES INCOME TAXES Effective tax rate and tax holidays (Details) Details 69 false false R70.htm 2411404 - Disclosure - INCOME TAXES - 2017 U.S. Tax Reform - Tax Cuts and Jobs Act (Details) Sheet http://www.agilent.com/role/IncomeTaxes2017USTaxReformTaxCutsAndJobsActDetails INCOME TAXES - 2017 U.S. Tax Reform - Tax Cuts and Jobs Act (Details) Details 70 false false R71.htm 2411405 - Disclosure - INCOME TAXES INCOME TAXES - Deferred Taxes and other (Details) Sheet http://www.agilent.com/role/IncomeTaxesIncomeTaxesDeferredTaxesAndOtherDetails INCOME TAXES INCOME TAXES - Deferred Taxes and other (Details) Details 71 false false R72.htm 2411406 - Disclosure - INCOME TAXES - Carryforwards (Details) Sheet http://www.agilent.com/role/IncomeTaxesCarryforwardsDetails INCOME TAXES - Carryforwards (Details) Details 72 false false R73.htm 2411407 - Disclosure - INCOME TAXES - Current and long-term income tax assets and liabilities (Details) Sheet http://www.agilent.com/role/IncomeTaxesCurrentAndLongTermIncomeTaxAssetsAndLiabilitiesDetails INCOME TAXES - Current and long-term income tax assets and liabilities (Details) Details 73 false false R74.htm 2411408 - Disclosure - INCOME TAXES INCOME TAXES - Uncertain Tax Positions (Details) Sheet http://www.agilent.com/role/IncomeTaxesIncomeTaxesUncertainTaxPositionsDetails INCOME TAXES INCOME TAXES - Uncertain Tax Positions (Details) Details 74 false false R75.htm 2412402 - Disclosure - NET INCOME (LOSS) PER SHARE (Details) Sheet http://www.agilent.com/role/NetIncomeLossPerShareDetails NET INCOME (LOSS) PER SHARE (Details) Details http://www.agilent.com/role/NetIncomeLossPerShareTables 75 false false R76.htm 2413402 - Disclosure - INVENTORY (Details) Sheet http://www.agilent.com/role/InventoryDetails INVENTORY (Details) Details http://www.agilent.com/role/InventoryTables 76 false false R77.htm 2414402 - Disclosure - PROPERTY, PLANT AND EQUIPMENT, NET (Details) Sheet http://www.agilent.com/role/PropertyPlantAndEquipmentNetDetails PROPERTY, PLANT AND EQUIPMENT, NET (Details) Details http://www.agilent.com/role/PropertyPlantAndEquipmentNetTables 77 false false R78.htm 2415402 - Disclosure - GOODWILL AND OTHER INTANGIBLE ASSETS Text (Details) Sheet http://www.agilent.com/role/GoodwillAndOtherIntangibleAssetsTextDetails GOODWILL AND OTHER INTANGIBLE ASSETS Text (Details) Details http://www.agilent.com/role/GoodwillAndOtherIntangibleAssetsTables 78 false false R79.htm 2415403 - Disclosure - GOODWILL AND OTHER INTANGIBLE ASSETS Roll forward (Details) Sheet http://www.agilent.com/role/GoodwillAndOtherIntangibleAssetsRollForwardDetails GOODWILL AND OTHER INTANGIBLE ASSETS Roll forward (Details) Details 79 false false R80.htm 2415404 - Disclosure - GOODWILL AND OTHER INTANGIBLE ASSETS Disclosures and Components of Other Intangibles (Details) Sheet http://www.agilent.com/role/GoodwillAndOtherIntangibleAssetsDisclosuresAndComponentsOfOtherIntangiblesDetails GOODWILL AND OTHER INTANGIBLE ASSETS Disclosures and Components of Other Intangibles (Details) Details 80 false false R81.htm 2415405 - Disclosure - GOODWILL AND OTHER INTANGIBLE ASSETS Amortization Expense and Future Amortization Expense (Details) Sheet http://www.agilent.com/role/GoodwillAndOtherIntangibleAssetsAmortizationExpenseAndFutureAmortizationExpenseDetails GOODWILL AND OTHER INTANGIBLE ASSETS Amortization Expense and Future Amortization Expense (Details) Details 81 false false R82.htm 2416402 - Disclosure - INVESTMENTS (Details) Sheet http://www.agilent.com/role/InvestmentsDetails INVESTMENTS (Details) Details http://www.agilent.com/role/InvestmentsTables 82 false false R83.htm 2418402 - Disclosure - FAIR VALUE MEASUREMENTS, Fair value of assets and liabilities measured on a recurring basis (Details) Sheet http://www.agilent.com/role/FairValueMeasurementsFairValueOfAssetsAndLiabilitiesMeasuredOnRecurringBasisDetails FAIR VALUE MEASUREMENTS, Fair value of assets and liabilities measured on a recurring basis (Details) Details 83 false false R84.htm 2418403 - Disclosure - FAIR VALUE MEASUREMENTS FAIR VALUE MEASURMENTS - Fair value of assets and liabilities measured on non recurring (Details) Sheet http://www.agilent.com/role/FairValueMeasurementsFairValueMeasurmentsFairValueOfAssetsAndLiabilitiesMeasuredOnNonRecurringDetails FAIR VALUE MEASUREMENTS FAIR VALUE MEASURMENTS - Fair value of assets and liabilities measured on non recurring (Details) Details 84 false false R85.htm 2419402 - Disclosure - DERIVATIVES (Details) Sheet http://www.agilent.com/role/DerivativesDetails DERIVATIVES (Details) Details http://www.agilent.com/role/DerivativesTables 85 false false R86.htm 2419403 - Disclosure - DERIVATIVES, Disclosures and derivative instrument aggregated notional amounts by currency and designations (Details) Sheet http://www.agilent.com/role/DerivativesDisclosuresAndDerivativeInstrumentAggregatedNotionalAmountsByCurrencyAndDesignationsDetails DERIVATIVES, Disclosures and derivative instrument aggregated notional amounts by currency and designations (Details) Details 86 false false R87.htm 2419404 - Disclosure - DERIVATIVES, Fair value of derivative instruments and Consolidated Balance Sheet location (Details) Sheet http://www.agilent.com/role/DerivativesFairValueOfDerivativeInstrumentsAndConsolidatedBalanceSheetLocationDetails DERIVATIVES, Fair value of derivative instruments and Consolidated Balance Sheet location (Details) Details 87 false false R88.htm 2419405 - Disclosure - DERIVATIVES, Effect of derivative instruments on Consolidated Statement of Operations (Details) Sheet http://www.agilent.com/role/DerivativesEffectOfDerivativeInstrumentsOnConsolidatedStatementOfOperationsDetails DERIVATIVES, Effect of derivative instruments on Consolidated Statement of Operations (Details) Details 88 false false R89.htm 2420402 - Disclosure - RETIREMENT PLANS AND POST RETIEMENT PENSION PLANS - Deferred Profit Sharing Plan (Details) Sheet http://www.agilent.com/role/RetirementPlansAndPostRetiementPensionPlansDeferredProfitSharingPlanDetails RETIREMENT PLANS AND POST RETIEMENT PENSION PLANS - Deferred Profit Sharing Plan (Details) Details 89 false false R90.htm 2420403 - Disclosure - RETIREMENT PLANS AND POST RETIREMENT PENSION PLANS Defined Contribution (Details) Sheet http://www.agilent.com/role/RetirementPlansAndPostRetirementPensionPlansDefinedContributionDetails RETIREMENT PLANS AND POST RETIREMENT PENSION PLANS Defined Contribution (Details) Details 90 false false R91.htm 2420404 - Disclosure - RETIREMENT PLANS AND POST RETIREMENT PENSION PLANS, JWPIL (Details) Sheet http://www.agilent.com/role/RetirementPlansAndPostRetirementPensionPlansJwpilDetails RETIREMENT PLANS AND POST RETIREMENT PENSION PLANS, JWPIL (Details) Details http://www.agilent.com/role/RetirementPlansAndPostRetirementPensionPlansTables 91 false false R92.htm 2420405 - Disclosure - RETIREMENT PLANS AND POST RETIREMENT PENSION PLANS, Components of Net Periodic Costs (Details) Sheet http://www.agilent.com/role/RetirementPlansAndPostRetirementPensionPlansComponentsOfNetPeriodicCostsDetails RETIREMENT PLANS AND POST RETIREMENT PENSION PLANS, Components of Net Periodic Costs (Details) Details 92 false false R93.htm 2420406 - Disclosure - RETIREMENT PLANS AND POST RETIREMENT PENSION PLANS, Funded Status (Details) Sheet http://www.agilent.com/role/RetirementPlansAndPostRetirementPensionPlansFundedStatusDetails RETIREMENT PLANS AND POST RETIREMENT PENSION PLANS, Funded Status (Details) Details 93 false false R94.htm 2420407 - Disclosure - RETIREMENT PLANS AND POST RETIREMENT PENSION PLANS, Financial Statement Location (Details) Sheet http://www.agilent.com/role/RetirementPlansAndPostRetirementPensionPlansFinancialStatementLocationDetails RETIREMENT PLANS AND POST RETIREMENT PENSION PLANS, Financial Statement Location (Details) Details 94 false false R95.htm 2420408 - Disclosure - RETIREMENT PLANS AND POST RETIREMENT PENSION PLANS RETIREMENT PLANS AND POST RETIREMENT PENSION PLANS, Target Allocations (Details) Sheet http://www.agilent.com/role/RetirementPlansAndPostRetirementPensionPlansRetirementPlansAndPostRetirementPensionPlansTargetAllocationsDetails RETIREMENT PLANS AND POST RETIREMENT PENSION PLANS RETIREMENT PLANS AND POST RETIREMENT PENSION PLANS, Target Allocations (Details) Details 95 false false R96.htm 2420409 - Disclosure - RETIREMENT PLANS AND POST RETIREMENT PENSION PLANS, Fair Value of Plan Assets (Details) Sheet http://www.agilent.com/role/RetirementPlansAndPostRetirementPensionPlansFairValueOfPlanAssetsDetails RETIREMENT PLANS AND POST RETIREMENT PENSION PLANS, Fair Value of Plan Assets (Details) Details 96 false false R97.htm 2420410 - Disclosure - RETIREMENT PLANS AND POST RETIREMENT PENSION PLANS, Expected Benefit Payments (Details) Sheet http://www.agilent.com/role/RetirementPlansAndPostRetirementPensionPlansExpectedBenefitPaymentsDetails RETIREMENT PLANS AND POST RETIREMENT PENSION PLANS, Expected Benefit Payments (Details) Details 97 false false R98.htm 2420411 - Disclosure - RETIREMENT PLANS AND POST RETIREMENT PENSION PLANS, Assumptions (Details) Sheet http://www.agilent.com/role/RetirementPlansAndPostRetirementPensionPlansAssumptionsDetails RETIREMENT PLANS AND POST RETIREMENT PENSION PLANS, Assumptions (Details) Details 98 false false R99.htm 2421402 - Disclosure - GUARANTEES (Details) Sheet http://www.agilent.com/role/GuaranteesDetails GUARANTEES (Details) Details http://www.agilent.com/role/GuaranteesTables 99 false false R100.htm 2422402 - Disclosure - COMMITMENTS AND CONTINGENCIES (Details) Sheet http://www.agilent.com/role/CommitmentsAndContingenciesDetails COMMITMENTS AND CONTINGENCIES (Details) Details http://www.agilent.com/role/CommitmentsAndContingenciesTables 100 false false R101.htm 2423401 - Disclosure - SHORT-TERM DEBT - Credit Facility and Capital Lease (Details) Sheet http://www.agilent.com/role/ShortTermDebtCreditFacilityAndCapitalLeaseDetails SHORT-TERM DEBT - Credit Facility and Capital Lease (Details) Details 101 false false R102.htm 2423402 - Disclosure - SHORT-TERM DEBT - Senior Notes (Details) Notes http://www.agilent.com/role/ShortTermDebtSeniorNotesDetails SHORT-TERM DEBT - Senior Notes (Details) Details 102 false false R103.htm 2424402 - Disclosure - LONG-TERM DEBT - Carrying Value (Details) Sheet http://www.agilent.com/role/LongTermDebtCarryingValueDetails LONG-TERM DEBT - Carrying Value (Details) Details 103 false false R104.htm 2424403 - Disclosure - LONG-TERM DEBT - Senior Notes (Details) Notes http://www.agilent.com/role/LongTermDebtSeniorNotesDetails LONG-TERM DEBT - Senior Notes (Details) Details 104 false false R105.htm 2424404 - Disclosure - LONG-TERM DEBT LONG-TERM DEBT - Other (Details) Sheet http://www.agilent.com/role/LongTermDebtLongTermDebtOtherDetails LONG-TERM DEBT LONG-TERM DEBT - Other (Details) Details 105 false false R106.htm 2427402 - Disclosure - STOCKHOLDERS' EQUITY Stock Repurchases (Details) Sheet http://www.agilent.com/role/StockholdersEquityStockRepurchasesDetails STOCKHOLDERS' EQUITY Stock Repurchases (Details) Details 106 false false R107.htm 2427403 - Disclosure - STOCKHOLDERS' EQUITY STOCKHOLDERS EQUITY DIvidends (Details) Sheet http://www.agilent.com/role/StockholdersEquityStockholdersEquityDividendsDetails STOCKHOLDERS' EQUITY STOCKHOLDERS EQUITY DIvidends (Details) Details 107 false false R108.htm 2427404 - Disclosure - STOCKHOLDERS' EQUITY -Accumulated other comprehensive income (Details) Sheet http://www.agilent.com/role/StockholdersEquityAccumulatedOtherComprehensiveIncomeDetails STOCKHOLDERS' EQUITY -Accumulated other comprehensive income (Details) Details 108 false false R109.htm 2427405 - Disclosure - STOCKHOLDERS' EQUITY - Changes in accumulated other comprehensive income (Details) Sheet http://www.agilent.com/role/StockholdersEquityChangesInAccumulatedOtherComprehensiveIncomeDetails STOCKHOLDERS' EQUITY - Changes in accumulated other comprehensive income (Details) Details 109 false false R110.htm 2427406 - Disclosure - STOCKHOLDERS' EQUITY STOCKHOLDERS' EQUITY - Reclassifications out of accumulated other comprehensive income (Details) Sheet http://www.agilent.com/role/StockholdersEquityStockholdersEquityReclassificationsOutOfAccumulatedOtherComprehensiveIncomeDetails STOCKHOLDERS' EQUITY STOCKHOLDERS' EQUITY - Reclassifications out of accumulated other comprehensive income (Details) Details 110 false false R111.htm 2428402 - Disclosure - SEGMENT INFORMATION Profitability (Details) Sheet http://www.agilent.com/role/SegmentInformationProfitabilityDetails SEGMENT INFORMATION Profitability (Details) Details 111 false false R112.htm 2428403 - Disclosure - SEGMENT INFORMATION Reconciliation of Reportable Results (Details) Sheet http://www.agilent.com/role/SegmentInformationReconciliationOfReportableResultsDetails SEGMENT INFORMATION Reconciliation of Reportable Results (Details) Details 112 false false R113.htm 2428404 - Disclosure - SEGMENT INFORMATION Segment Assets (Details) Sheet http://www.agilent.com/role/SegmentInformationSegmentAssetsDetails SEGMENT INFORMATION Segment Assets (Details) Details 113 false false R114.htm 2428405 - Disclosure - SEGMENT INFORMATION - Entity-Wide Disclosures Revenue (Details) Sheet http://www.agilent.com/role/SegmentInformationEntityWideDisclosuresRevenueDetails SEGMENT INFORMATION - Entity-Wide Disclosures Revenue (Details) Details 114 false false R115.htm 2428406 - Disclosure - SEGMENT INFORMATION - Entity-Wide Disclosure Long-Lived Assets (Details) Sheet http://www.agilent.com/role/SegmentInformationEntityWideDisclosureLongLivedAssetsDetails SEGMENT INFORMATION - Entity-Wide Disclosure Long-Lived Assets (Details) Details 115 false false R116.htm 2430401 - Schedule - Schedule II Valuation and Qualifying Accounts (Details) Sheet http://www.agilent.com/role/ScheduleIiValuationAndQualifyingAccountsDetails Schedule II Valuation and Qualifying Accounts (Details) Details 116 false false All Reports Book All Reports a-10312019x10k.htm a-10312019xexx211.htm a-10312019xexx231.htm a-10312019xexx311.htm a-10312019xexx312.htm a-10312019xexx32.htm a-10312019xexx321.htm a-10312019xexx322.htm a-10312019xexx48.htm a-20191031.xsd a-20191031_cal.xml a-20191031_def.xml a-20191031_lab.xml a-20191031_pre.xml chart-4a62e386e6ad510aa63.jpg http://xbrl.sec.gov/country/2017-01-31 http://xbrl.sec.gov/currency/2019-01-31 http://fasb.org/us-gaap/2019-01-31 http://xbrl.sec.gov/dei/2019-01-31 http://xbrl.sec.gov/invest/2013-01-31 http://fasb.org/srt/2019-01-31 true true XML 66 R27.htm IDEA: XBRL DOCUMENT v3.19.3.a.u2
LONG-TERM DEBT
 12 Months Ended
Oct. 31, 2019
Debt Disclosure [Abstract]  
LONG-TERM DEBT LONG-TERM DEBT

Senior Notes

The following table summarizes the company's long-term senior notes and the related interest rate swaps:

 
October 31, 2019
 
October 31, 2018
 
Amortized
Principal
 
Swap
 
Total
 
Amortized
Principal
 
Swap
 
Total
 
(in millions)
2020 Senior Notes
$
—

 
$
—

 
$
—

 
$
499

 
$
7

 
$
506

2022 Senior Notes
399

 
—

 
399

 
399

 
—

 
399

2023 Senior Notes
597

 
—

 
597

 
597

 
—

 
597

2026 Senior Notes
298

 
—

 
298

 
297

 
—

 
297

2029 Senior Notes
492

 
—

 
492

 
—

 
—

 
—

Total
$
1,786

 
$
—

 
$
1,786

 
$
1,792

 
$
7

 
$
1,799




2020 Senior Notes

The 2020 senior notes were repaid in 2019, see Note 17, "Short-Term Debt".

2022 Senior Notes

On September 10, 2012, the company issued an aggregate principal amount of $400 million in senior notes ("2022 senior notes"). The 2022 senior notes were issued at 99.80% of their principal amount. The notes will mature on October 1, 2022, and bear interest at a fixed rate of 3.20% per annum. The interest is payable semi-annually on April 1st and October 1st of each year and payments commenced on April 1, 2013.

In July 2012, Agilent executed treasury lock agreements for $400 million in connection with future interest payments to be made on our 2022 senior notes issued on September 10, 2012. The treasury lock contracts were terminated on September 10, 2012 and we recognized a deferred gain in accumulated other comprehensive income which is being amortized to interest expense over the life of the 2022 senior notes. The remaining gain to be amortized related to the treasury lock agreements at October 31, 2019 was $1 million.

2023 Senior Notes

On June 18, 2013, the company issued aggregate principal amount of $600 million in senior notes ("2023 senior notes"). The 2023 senior notes were issued at 99.544% of their principal amount. The notes will mature on July 15, 2023 and bear interest at a fixed rate of 3.875% per annum. The interest is payable semi-annually on January 15th and July 15th of each year and payments commenced January 15, 2014.

2026 Senior Notes

On September 15, 2016, the company issued aggregate principal amount of $300 million in senior notes ("2026 senior notes"). The 2026 senior notes were issued at 99.624% of their principal amount. The notes will mature on September 22, 2026 and bear interest at a fixed rate of 3.05% per annum. The interest is payable semi-annually on March 22nd and September 22nd of each year and payments commenced March 22, 2017.

In February 2016, Agilent executed three forward-starting pay fixed/receive variable interest rate swaps for the notional amount of $300 million in connection with future interest payments to be made on our 2026 senior notes issued on September 15, 2016. The swap arrangements were terminated on September 15, 2016 with a payment of $10 million and we recognized this as a deferred loss in accumulated other comprehensive income which is being amortized to interest expense over the life of the 2026 senior notes.The remaining loss to be amortized related to the interest rate swap agreements at October 31, 2019 was $7 million.

2029 Senior Notes

On September 5, 2019, the company issued an aggregate principal amount of $500 million in senior notes ("2029 senior notes"). The 2029 senior notes were issued at 99.316% of their principal amount. The notes will mature on September 15, 2029, and bear interest at a fixed rate of 2.75% per annum. The interest is payable semi-annually on March 15th and September 15th of each year and payments commence on March 15, 2020.

In August 2019, Agilent executed treasury lock agreements for $250 million in connection with future interest payments to be made on our 2029 senior notes issued on September 5, 2019. We designated the treasury lock as a cash flow hedge. The treasury lock contracts were terminated on September 6, 2019 and we recognized a deferred loss of $6 million in accumulated other comprehensive income which is being amortized to interest expense over the life of the 2029 senior notes. The remaining loss to be amortized related to the treasury lock agreements at October 31, 2019 was $6 million.

Capital Leases

The company leases certain property and equipment under capital leases. As of October 31, 2019, the non-current portion of the company’s capital lease obligations had an aggregate carrying value of $5 million to be paid over 12 years.
XML 67 R23.htm IDEA: XBRL DOCUMENT v3.19.3.a.u2
RETIREMENT PLANS AND POST RETIREMENT PENSION PLANS
 12 Months Ended
Oct. 31, 2019
Defined Benefit Plan [Abstract]  
RETIREMENT PLANS AND POST RETIREMENT PENSION PLANS RETIREMENT PLANS AND POST RETIREMENT PENSION PLANS

General.    Substantially all of our employees are covered under various defined benefit and/or defined contribution retirement plans. Additionally, we sponsor post-retirement health care benefits for our eligible U.S. employees.

Agilent provides defined benefits to U.S. employees, who meet eligibility criteria under the Agilent Technologies, Inc. Retirement Plan (the "RP").

For eligible service through October 31, 1993, the benefit payable under the Agilent Retirement Plan is reduced by any amounts due to the eligible employee under the Agilent defined contribution Deferred Profit-Sharing Plan (the "DPSP"), which was closed to new participants as of November 1993.

As of October 31, 2019 and 2018, the fair value of plan assets of the DPSP was $132 million and $141 million, respectively. Note that the projected benefit obligation for the DPSP equals the fair value of plan assets.

Effective November 1, 2014, Agilent’s U.S. defined benefit retirement plan was closed to new entrants including new employees, new transfers to the U.S. payroll and rehires. As of April 30, 2016, benefits under the RP were frozen. Any pension benefit earned in the U.S. Plans through April 30, 2016 remained fully vested, and there are no additional benefit accruals after April 30, 2016.

Agilent also maintains a Supplemental Benefits Retirement Plan ("SBRP") in the U.S., which is a supplemental unfunded non-qualified defined benefit plan to provide benefits that would be provided under the RP but for limitations imposed by the Internal Revenue Code. The RP and the SBRP comprise the "U.S. Plans" in the tables below.

Eligible employees outside the U.S. generally receive retirement benefits under various retirement plans based upon factors such as years of service and/or employee compensation levels. Eligibility is generally determined in accordance with local statutory requirements.

Post-Retirement Medical Benefit Plans.    In addition to receiving retirement benefits, Agilent U.S. employees who meet eligibility requirements as of their termination date may participate in the Agilent Technologies, Inc. Health Plan for Retirees.
–
Eligible retirees who were less than age 50 as of January 1, 2005 and who retire after age 55 with 15 or more years of service are eligible for a fixed amount which can be utilized to pay for either sponsored plans and/or individual Medicare plans.
–
Effective January 1, 2012, employees who were at least age 50 as of January 1, 2005 and who retire after age 55 with 15 or more years of service are eligible for fixed dollar subsidies and stipends. Grandfathered retirees receive a fixed monthly subsidy toward pre-65 premium costs (subsidy capped at 2011 levels) and a fixed monthly stipend post-65. The subsidy amounts will not increase.
–
Any new employee hired on or after November 1, 2014, will not be eligible to participate in the retiree medical plans upon retiring.
–
As of April 30, 2016, benefits under this plan were changed for Active employees who have not met the eligibility requirement - 55 years old with at least 15 years of Agilent service, as of April 30, 2016 - for the Retiree Medical Account (RMA) under the U.S. Post Retirement Benefit Plan These employees will only be eligible for 50 percent of the current RMA reimbursement amount upon retirement.

401(k) Defined Contribution Plan.    Eligible Agilent U.S. employees may participate in the Agilent Technologies, Inc. 401(k) Plan. Effective April 30, 2016, we began matching contributions to employees up to a maximum of 6 percent of an employee's annual eligible compensation. Effective May 1, 2016 until April 30, 2022, we will provide an additional transitional company contribution for certain eligible employees equal to 3 percent, 4 percent or 5 percent of an employee's annual eligible compensation due to the RP benefits being frozen. The maximum contribution to the 401(k) Plan is 50 percent of an employee's annual eligible compensation, subject to regulatory limitations. The 401(k) Plan employer expense included in income from operations was $39 million in 2019, $37 million in 2018 and $33 million in 2017.

Japanese Welfare Pension Insurance Law. In Japan, Agilent has employees' pension fund plans, which are defined benefit pension plans established under the Japanese Welfare Pension Insurance Law (JWPIL). The plans are composed of (a) a substitutional portion based on the pay-related part of the old-age pension benefits prescribed by JWPIL (similar to social security benefits in the United States) and (b) a corporate portion based on a contributory defined benefit pension arrangement established at the discretion of the company. During the year ended October 31, 2017, Agilent received government approval and returned the substitutional portion of Japan's pension plan to the Japanese government, as allowed by the JWPIL. The initial transfer resulted in a net gain of $32 million recorded in other income (expense), net in the consolidated statement of operations. The net gain consisted of two parts - a gain of $41 million, representing the difference between the fair values of the Accumulated Benefit Obligation (ABO) settled of $65 million and the assets transferred from the pension trust to the government of Japan of $24 million, offset by a settlement loss of $9 million related to the recognition of previously unrecognized actuarial losses included in accumulated other comprehensive income. In the first quarter of fiscal year 2018, after the Japanese government’s final review of our initial payment, we received a refund of $5 million which was recorded as a settlement gain.





Components of Net periodic cost.   The service cost component is recorded in cost of sales and operating expenses in the consolidated statement of operations. All other cost components are recorded in other income (expense), net in the consolidated statement of operations. The company uses alternate methods of amortization as allowed by the authoritative guidance which amortizes the actuarial gains and losses on a consistent basis for the years presented. For U.S. Plans, gains and losses are amortized over the average future lifetime of participants using the corridor method. For most Non-U.S. Plans and U.S. Post-Retirement Benefit Plans, gains and losses are amortized using a separate layer for each year's gains and losses.

For the years ended October 31, 2019, 2018 and 2017, components of net periodic benefit cost and other amounts recognized in other comprehensive income were comprised of:
 
Pensions
 
U.S. Post-Retirement Benefit Plans
 
U.S. Plans
 
Non-U.S. Plans
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
2019
 
2018
 
2017
 
2019
 
2018
 
2017
 
2019
 
2018
 
2017
 
(in millions)
Net periodic benefit cost (benefit)
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Service cost — benefits earned during the period
$
—

 
$
—

 
$
—

 
$
20

 
$
20

 
$
19

 
$
—

 
$
1

 
$
1

Interest cost on benefit obligation
18

 
16

 
15

 
14

 
13

 
12

 
4

 
3

 
3

Expected return on plan assets
(27
)
 
(28
)
 
(25
)
 
(43
)
 
(46
)
 
(41
)
 
(7
)
 
(7
)
 
(7
)
Amortization of net actuarial loss
1

 
1

 
3

 
34

 
29

 
36

 
4

 
8

 
11

Amortization of prior service benefit
—

 
—

 
—

 
—

 
—

 
—

 
(8
)
 
(8
)
 
(9
)
Total periodic benefit cost (benefit)
$
(8
)
 
$
(11
)
 
$
(7
)
 
$
25

 
$
16

 
$
26

 
$
(7
)
 
$
(3
)
 
$
(1
)
Curtailments and settlements
$
—

 
$
—

 
$
—

 
$
—

 
$
(5
)
 
$
(32
)
 
$
—

 
$
—

 
$
—

Other changes in plan assets and benefit obligations recognized in other comprehensive (income) loss
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Net actuarial (gain) loss
$
51

 
$
2

 
$
(19
)
 
$
104

 
$
49

 
$
(128
)
 
$
5

 
$
(2
)
 
$
(9
)
Amortization of net actuarial loss
(1
)
 
(1
)
 
(3
)
 
(34
)
 
(29
)
 
(36
)
 
(4
)
 
(8
)
 
(11
)
Prior service cost (benefit)
—

 
—

 
—

 
—

 
—

 
—

 
—

 
—

 
—

Amortization of prior service benefit
—

 
—

 
—

 
—

 
—

 
—

 
8

 
8

 
9

Gain due to settlement
—

 
—

 
—

 
—

 
—

 
32

 
—

 
—

 
—

Foreign currency
—

 
—

 
—

 
(3
)
 
1

 
2

 
—

 
—

 
—

Total recognized in other comprehensive (income) loss
$
50

 
$
1

 
$
(22
)
 
$
67

 
$
21

 
$
(130
)
 
$
9

 
$
(2
)
 
$
(11
)
Total recognized in net periodic benefit cost (benefit) and other comprehensive (income) loss
$
42

 
$
(10
)
 
$
(29
)
 
$
92

 
$
32

 
$
(136
)
 
$
2

 
$
(5
)
 
$
(12
)

















Funded Status.    As of October 31, 2019 and 2018, the funded status of the defined benefit and post-retirement benefit plans was:

 
U.S. Defined
Benefit Plans
 
Non-U.S. Defined
Benefit Plans
 
U.S.
Post-Retirement
Benefit Plans
 
2019
 
2018
 
2019
 
2018
 
2019
 
2018
 
(in millions)
Change in fair value of plan assets:
 
 
 
 
 
 
 
 
 
 
 
Fair value — beginning of year
$
401

 
$
414

 
$
825

 
$
855

 
$
90

 
$
95

Actual return on plan assets
50

 
8

 
85

 
(9
)
 
11

 
1

Employer contributions
—

 
—

 
21

 
21

 
—

 
—

Participants' contributions
—

 
—

 
1

 
—

 
—

 
—

Benefits paid
(19
)
 
(21
)
 
(29
)
 
(26
)
 
(6
)
 
(6
)
Settlements
—

 
—

 
—

 
5

 
—

 
—

Currency impact
—

 
—

 
8

 
(21
)
 
—

 
—

Fair value — end of year
$
432

 
$
401

 
$
911

 
$
825

 
$
95

 
$
90

Change in benefit obligation:
 
 
 
 
 
 
 
 
 
 
 
Benefit obligation — beginning of year
$
420

 
$
445

 
$
913

 
$
935

 
$
87

 
$
97

Service cost
—

 
—

 
20

 
20

 
—

 
1

Interest cost
18

 
16

 
14

 
13

 
4

 
3

Participants' contributions
—

 
—

 
1

 
—

 
—

 
—

Plan amendment
—

 
—

 
—

 
1

 
—

 
—

Actuarial (gain) loss
74

 
(19
)
 
143

 
(6
)
 
9

 
(7
)
Benefits paid
(21
)
 
(22
)
 
(29
)
 
(27
)
 
(6
)
 
(7
)
Currency impact
—

 
—

 
5

 
(23
)
 
—

 
—

Benefit obligation — end of year
$
491

 
$
420

 
$
1,067

 
$
913

 
$
94

 
$
87

Overfunded (underfunded) status of PBO
$
(59
)
 
$
(19
)
 
$
(156
)
 
$
(88
)
 
$
1

 
$
3

Amounts recognized in the consolidated balance sheet consist of:
 
 
 
 
 
 
 
 
 
 
 
Other assets
$
—

 
$
—

 
$
106

 
$
95

 
$
1

 
$
3

Employee compensation and benefits
(1
)
 
(1
)
 
—

 
—

 
—

 
—

Retirement and post-retirement benefits
(58
)
 
(18
)
 
(262
)
 
(183
)
 
—

 
—

Total net asset (liability)
$
(59
)
 
$
(19
)
 
$
(156
)
 
$
(88
)
 
$
1

 
$
3

Amounts Recognized in Accumulated Other Comprehensive Income (loss):
 
 
 
 
 
 
 
 
 
 
 
Actuarial (gains) losses
$
115

 
$
65

 
$
330

 
$
263

 
$
10

 
$
10

Prior service costs (benefits)
—

 
—

 
—

 
—

 
(12
)
 
(20
)
Total
$
115

 
$
65

 
$
330

 
$
263

 
$
(2
)
 
$
(10
)


The amounts in accumulated other comprehensive income expected to be recognized by Agilent as components of net expense during 2020 are as follows:
 
U.S. Defined
Benefit Plans
 
Non-U.S. Defined
Benefit Plans
 
U.S. Post-Retirement
Benefit Plans
 
(in millions)
Amortization of net prior service cost (benefit)
$
—

 
$
—

 
$
(7
)
Amortization of actuarial net loss (gain)
$
3

 
$
48

 
$
4



Investment Policies and Strategies as of October 31, 2019 and 2018. In the U.S., target asset allocations for our retirement and post-retirement benefit plans are approximately 80 percent to equities and approximately 20 percent to fixed income investments. Our DPSP target asset allocation is approximately 60 percent to equities and approximately 40 percent to fixed income investments. Approximately 3 percent of our U.S. equity portfolio consists of limited partnerships. The general investment objective for all our plan assets is to obtain the optimum rate of investment return on the total investment portfolio consistent with the assumption of a reasonable level of risk. Specific investment objectives for the plans' portfolios are to: maintain and enhance the purchasing power of the plans' assets; achieve investment returns consistent with the level of risk being taken; and earn performance rates of return in accordance with the benchmarks adopted for each asset class. Outside the U.S., our target asset allocation ranges from 31 to 60 percent to equities, from 38 to 61 percent to fixed income investments, and from zero to 25 percent to real estate, depending on the plan. All plans' assets are broadly diversified. Due to fluctuations in equity markets, our actual allocations of plan assets at October 31, 2019 and 2018 differ from the target allocation. Our policy is to bring the actual allocation in line with the target allocation.

Equity securities include exchange-traded common stock and preferred stock of companies from broadly diversified industries. Fixed income securities include a global portfolio of corporate bonds of companies from diversified industries, government securities, mortgage-backed securities, asset-backed securities, derivative instruments and other. Other investments include a group trust consisting primarily of private equity partnerships. Portions of the cash and cash equivalent, equity, and fixed income investments are held in commingled funds that are valued using Net Asset Value (“NAV”) as the practical expedient. In addition, some of the investments valued using NAV as the practical expedient may have limits on their redemption to weekly or monthly and/or may require prior written notice specified by each fund.

Fair Value.    The measurement of the fair value of pension and post-retirement plan assets uses the valuation methodologies and the inputs as described in Note 12, "Fair Value Measurements".

Cash and Cash Equivalents - Cash and cash equivalents consist of short-term investment funds. The funds also invest in short-term domestic fixed income securities and other securities with debt-like characteristics emphasizing short-term maturities and quality. Some of our cash and cash equivalents are held in commingled funds. Other cash and cash equivalents are classified as Level 1 investments.

Equity - Some equity securities consisting of common and preferred stock that are not traded on an active market are valued at quoted prices reported by investment dealers based on the underlying terms of the security and comparison to similar securities traded on an active market; these are classified as Level 2 investments. Securities which have quoted prices in active markets are classified as Level 1 investments.

Fixed Income - Some of the fixed income securities are not actively traded and are valued at quoted prices based on the terms of the security and comparison to similar securities traded on an active market; these are classified as Level 2 investments. Securities which have quoted prices in active markets are classified as Level 1 investments.

Other Investments - Other investments also includes partnership investments where, due to their private nature, pricing inputs are not readily observable. Asset valuations are developed by the general partners that manage the partnerships. These valuations are based on proprietary appraisals, application of public market multiples to private company cash flows, utilization of market transactions that provide valuation information for comparable companies and other methods. Holdings of limited partnerships are classified as Level 3.

Agilent has adopted the accounting guidance related to the presentation of certain investments using the NAV practical expedient. The accounting guidance exempts investments using this practical expedient from categorization within the fair value hierarchy.

The following tables present the fair value of U.S. Defined Benefit Plans assets classified under the appropriate level of the fair value hierarchy as of October 31, 2019 and 2018.
 
 
 
Fair Value Measurement at October 31, 2019 Using
 
 
 
October 31,
2019
 
Quoted Prices
in Active
Markets for
Identical Assets
(Level 1)
 
Significant
Other
Observable
Inputs
(Level 2)
 
Significant
Unobservable
Inputs
(Level 3)
 
Not Subject to Leveling (1)
 
(in millions)
Cash and Cash Equivalents
$
1

 
$
—

 
$
—

 
$
—

 
$
1

Equity
336

 
78

 
—

 
—

 
258

Fixed Income
91

 
46

 
—

 
—

 
45

Other Investments
4

 
—

 
—

 
4

 
—

Total assets measured at fair value
$
432

 
$
124

 
$
—

 
$
4

 
$
304

(1) Investments measured at the net asset value per share (or its equivalent) practical expedient have not been classified in the fair value hierarchy.
 
 
 
Fair Value Measurement at October 31, 2018 Using
 
 
 
October 31,
2018
 
Quoted Prices
in Active
Markets for
Identical Assets
(Level 1)
 
Significant
Other
Observable
Inputs
(Level 2)
 
Significant
Unobservable
Inputs
(Level 3)
 
Not Subject to Leveling (1)
 
(in millions)
Cash and Cash Equivalents
$
4

 
$
—

 
$
—

 
$
—

 
$
4

Equity
308

 
69

 
—

 
—

 
239

Fixed Income
83

 
36

 
5

 
—

 
42

Other Investments
6

 
—

 
—

 
6

 
—

Total assets measured at fair value
$
401

 
$
105

 
$
5

 
$
6

 
$
285

(1) Investments measured at the net asset value per share (or its equivalent) practical expedient have not been classified in the fair value hierarchy.

For U.S. Defined Benefit Plans assets measured at fair value using significant unobservable inputs (level 3), the following table summarizes the change in balances during 2019 and 2018:
 
Years Ended
October 31.
 
2019
 
2018
Balance, beginning of year
$
6

 
$
7

Realized gains/(losses)
(1
)
 
—

Unrealized gains/(losses)
1

 
1

Purchases, sales, issuances, and settlements
(2
)
 
(2
)
Transfers in (out)
—

 
—

Balance, end of year
$
4

 
$
6

















The following tables present the fair value of U.S. Post-Retirement Benefit Plans assets classified under the appropriate level of the fair value hierarchy as of October 31, 2019 and 2018.
 
 
 
Fair Value Measurement at October 31, 2019 Using
 
 
 
October 31,
2019
 
Quoted Prices
in Active
Markets for
Identical Assets
(Level 1)
 
Significant
Other
Observable
Inputs
(Level 2)
 
Significant
Unobservable
Inputs
(Level 3)
 
Not Subject to Leveling (1)
 
(in millions)
Cash and Cash Equivalents
$
3

 
$
—

 
$
—

 
$
—

 
$
3

Equity
69

 
18

 
—

 
—

 
51

Fixed Income
21

 
11

 
—

 
—

 
10

Other Investments
2

 
—

 
—

 
2

 
—

Total assets measured at fair value
$
95

 
$
29

 
$
—

 
$
2

 
$
64

(1) Investments measured at the net asset value per share (or its equivalent) practical expedient have not been classified in the fair value hierarchy.

 
 
 
Fair Value Measurement at October 31, 2018 Using
 
 
 
October 31,
2018
 
Quoted Prices
in Active
Markets for
Identical Assets
(Level 1)
 
Significant
Other
Observable
Inputs
(Level 2)
 
Significant
Unobservable
Inputs
(Level 3)
 
Not Subject to Leveling (1)
 
(in millions)
Cash and Cash Equivalents
$
3

 
$
—

 
$
—

 
$
—

 
$
3

Equity
65

 
15

 
—

 
—

 
50

Fixed Income
18

 
9

 
—

 
—

 
9

Other Investments
4

 
—

 
—

 
4

 
—

Total assets measured at fair value
$
90

 
$
24

 
$
—

 
$
4

 
$
62

(1) Investments measured at the net asset value per share (or its equivalent) practical expedient have not been classified in the fair value hierarchy.


For U.S. Post-Retirement Benefit Plans assets measured at fair value using significant unobservable inputs (level 3), the following table summarizes the change in balances during 2019 and 2018:
 
Years Ended
October 31,
 
2019
 
2018
Balance, beginning of year
$
4

 
$
4

Realized gains/(losses)
(1
)
 
—

Unrealized gains/(losses)
—

 
1

Purchases, sales, issuances, and settlements
(1
)
 
(1
)
Transfers in (out)
—

 
—

Balance, end of year
$
2

 
$
4




The following tables present the fair value of non-U.S. Defined Benefit Plans assets classified under the appropriate level of the fair value hierarchy as of October 31, 2019 and 2018:

 
 
 
Fair Value Measurement at October 31, 2019 Using
 
 
 
October 31,
2019
 
Quoted Prices
in Active
Markets for
Identical Assets
(Level 1)
 
Significant
Other
Observable
Inputs
(Level 2)
 
Significant
Unobservable
Inputs
(Level 3)
 
Not Subject to Leveling (1)
 
(in millions)
Cash and Cash Equivalents
$
1

 
$
—

 
$
1

 
$
—

 
$
—

Equity
512

 
318

 
61

 
—

 
133

Fixed Income
398

 
98

 
213

 
—

 
87

Other Investments
—

 
—

 
—

 
—

 
—

Total assets measured at fair value
$
911

 
$
416

 
$
275

 
$
—

 
$
220

(1) Investments measured at the net asset value per share (or its equivalent) practical expedient have not been classified in the fair value hierarchy.

 
 
 
Fair Value Measurement at October 31, 2018 Using
 
 
 
October 31,
2018
 
Quoted Prices
in Active
Markets for
Identical Assets
(Level 1)
 
Significant
Other
Observable
Inputs
(Level 2)
 
Significant
Unobservable
Inputs
(Level 3)
 
Not Subject to Leveling (1)
 
(in millions)
 
 
Cash and Cash Equivalents
$
2

 
$
—

 
$
2

 
$
—

 
$
—

Equity
489

 
298

 
60

 
—

 
131

Fixed Income
334

 
76

 
228

 
—

 
30

Other Investments
—

 
—

 
—

 
—

 
—

Total assets measured at fair value
$
825

 
$
374

 
$
290

 
$
—

 
$
161

(1) Investments measured at the net asset value per share (or its equivalent) practical expedient have not been classified in the fair value hierarchy.




The table below presents the combined projected benefit obligation ("PBO"), accumulated benefit obligation ("ABO") and fair value of plan assets, grouping plans using comparisons of the PBO and ABO relative to the plan assets as of October 31, 2019 or 2018.
 
2019
 
2018
 
Benefit
Obligation
 
 
 
Benefit
Obligation
 
 
 
Fair Value of
Plan Assets
 
Fair Value of
Plan Assets
 
PBO
 
PBO
 
 
(in millions)
U.S. defined benefit plans where PBO exceeds the fair value of plan assets
$
491

 
$
432

 
$
420

 
$
401

U.S. defined benefit plans where fair value of plan assets exceeds PBO
—

 
—

 
—

 
—

Total
$
491

 
$
432

 
$
420

 
$
401

 
 
 
 
 
 
 
 
Non-U.S. defined benefit plans where PBO exceeds or is equal to the fair value of plan assets
$
752

 
$
490

 
$
563

 
$
380

Non-U.S. defined benefit plans where fair value of plan assets exceeds PBO
315

 
421

 
350

 
445

Total
$
1,067

 
$
911

 
$
913

 
$
825

 
 
 
 
 
 
 
 
 
ABO
 
 
 
ABO
 
 
U.S. defined benefit plans where ABO exceeds the fair value of plan assets
$
491

 
$
432

 
$
420

 
$
401

U.S. defined benefit plans where the fair value of plan assets exceeds ABO
—

 
—

 
—

 
—

Total
$
491

 
$
432

 
$
420

 
$
401

 
 
 
 
 
 
 
 
Non-U.S. defined benefit plans where ABO exceeds or is equal to the fair value of plan assets
$
651

 
$
418

 
$
543

 
$
380

Non-U.S. defined benefit plans where fair value of plan assets exceeds ABO
381

 
493

 
343

 
445

Total
$
1,032

 
$
911

 
$
886

 
$
825



Contributions and Estimated Future Benefit Payments.    During fiscal year 2020, we do not expect to contribute to the U.S. defined benefit plans and the Post-Retirement Medical Plans. We expect to contribute $24 million to plans outside the U.S. The following table presents expected future benefit payments for the next 10 years:

 
U.S. Defined
Benefit Plans
 
Non-U.S. Defined
Benefit Plans
 
U.S. Post-Retirement
Benefit Plans
 
(in millions)
2020
$
35

 
$
25

 
$
8

2021
$
36

 
$
27

 
$
8

2022
$
33

 
$
29

 
$
7

2023
$
35

 
$
32

 
$
7

2024
$
37

 
$
32

 
$
7

2025 - 2029
$
146

 
$
170

 
$
35



Assumptions.    The assumptions used to determine the benefit obligations and expense for our defined benefit and post-retirement benefit plans are presented in the tables below. The expected long-term return on assets below represents an estimate of long-term returns on investment portfolios consisting of a mixture of equities, fixed income and alternative investments in proportion to the asset allocations of each of our plans. We consider long-term rates of return, which are weighted based on the asset classes (both historical and forecasted) in which we expect our pension and post-retirement funds to be invested. Discount rates reflect the current rate at which pension and post-retirement obligations could be settled based on the measurement dates of the plans - October 31. The U.S. discount rates at October 31, 2019 and 2018, were determined based on the results of matching expected plan benefit payments with cash flows from a hypothetically constructed bond portfolio. The non-U.S. rates were generally
based on published rates for high-quality corporate bonds. The range of assumptions that were used for the non-U.S. defined benefit plans reflects the different economic environments within various countries.

Assumptions used to calculate the net periodic cost in each year were as follows:

 
For years ended October 31,
 
2019
 
2018
 
2017
U.S. defined benefit plans:
 
 
 
 
 
Discount rate
4.50%
 
3.75%
 
3.75%
Expected long-term return on assets
7.00%
 
7.00%
 
7.25%
Non-U.S. defined benefit plans:
 
 
 
 
 
Discount rate
0.83-2.68%
 
0.67-2.52%
 
0.22-2.66%
Average increase in compensation levels
2.25-3.25%
 
2.00-3.25%
 
2.00-4.25%
Expected long-term return on assets
4.00-5.75%
 
4.00-6.00%
 
4.00-6.25%
U.S. post-retirement benefits plans:
 
 
 
 
 
Discount rate
4.25%
 
3.50%
 
3.50%
Expected long-term return on assets
7.00%
 
7.00%
 
7.25%
Current medical cost trend rate
6.00%
 
6.00%
 
6.00%
Ultimate medical cost trend rate
3.50%
 
3.50%
 
3.50%
Medical cost trend rate decreases to ultimate rate in year
2029
 
2029
 
2029

Assumptions used to calculate the benefit obligation were as follows:

 
As of the Years Ending October 31,
 
2019
 
2018
U.S. defined benefit plans:
 
 
 
Discount rate
3.25%
 
4.50%
Non-U.S. defined benefit plans:
 
 
 
Discount rate
0.22-1.81%
 
0.83-2.68%
Average increase in compensation levels
2.25-3.00%
 
2.25-3.25%
U.S. post-retirement benefits plans:
 
 
 
Discount rate
3.00%
 
4.25%
Current medical cost trend rate
6.25%
 
6.00%
Ultimate medical cost trend rate
4.50%
 
3.50%
Medical cost trend rate decreases to ultimate rate in year
2029
 
2029


Health care trend rates do not have a significant effect on the total service and interest cost components or on the post-retirement benefit obligation amounts reported for the U.S. Post-Retirement Benefit Plan for the year ended October 31, 2019.
XML 68 Show.js IDEA: XBRL DOCUMENT // Edgar(tm) Renderer was created by staff of the U.S. Securities and Exchange Commission. Data and content created by government employees within the scope of their employment are not subject to domestic copyright protection. 17 U.S.C. 105. var Show={};Show.LastAR=null,Show.showAR=function(a,r,w){if(Show.LastAR)Show.hideAR();var e=a;while(e&&e.nodeName!='TABLE')e=e.nextSibling;if(!e||e.nodeName!='TABLE'){var ref=((window)?w.document:document).getElementById(r);if(ref){e=ref.cloneNode(!0); e.removeAttribute('id');a.parentNode.appendChild(e)}} if(e)e.style.display='block';Show.LastAR=e};Show.hideAR=function(){Show.LastAR.style.display='none'};Show.toggleNext=function(a){var e=a;while(e.nodeName!='DIV')e=e.nextSibling;if(!e.style){}else if(!e.style.display){}else{var d,p_;if(e.style.display=='none'){d='block';p='-'}else{d='none';p='+'} e.style.display=d;if(a.textContent){a.textContent=p+a.textContent.substring(1)}else{a.innerText=p+a.innerText.substring(1)}}} XML 69 R42.htm IDEA: XBRL DOCUMENT v3.19.3.a.u2
FAIR VALUE MEASUREMENTS (Tables)
 12 Months Ended
Oct. 31, 2019
Fair Value Disclosures [Abstract]  
Fair Value Assets And Liabilities Measured On Recurring Basis
Financial assets and liabilities measured at fair value on a recurring basis as of October 31, 2019 were as follows:

 
 
 
Fair Value Measurement at October 31, 2019 Using
 
October 31,
2019
 
Quoted Prices
in Active
Markets for
Identical Assets
(Level 1)
 
Significant
Other
Observable
Inputs
(Level 2)
 
Significant
Unobservable
Inputs
(Level 3)
 
(in millions)
Assets:
 
 
 
 
 
 
 
Short-term
 
 
 
 
 
 
 
Cash equivalents (money market funds)
$
784

 
$
784

 
$
—

 
$
—

Derivative instruments (foreign exchange contracts)
12

 
—

 
12

 
—

Long-term
 
 
 
 
 
 
 
Trading securities
30

 
30

 
—

 
—

Other investments
25

 
—

 
25

 
—

Total assets measured at fair value
$
851

 
$
814

 
$
37

 
$
—

Liabilities:
 
 
 
 
 
 
 
Short-term
 
 
 
 
 
 
 
Derivative instruments (foreign exchange contracts)
$
6

 
$
—

 
$
6

 
$
—

Long-term
 
 
 
 
 
 
 
Deferred compensation liability
30

 
—

 
30

 
—

Total liabilities measured at fair value
$
36

 
$
—

 
$
36

 
$
—



Financial assets and liabilities measured at fair value on a recurring basis as of October 31, 2018 were as follows:

 
 
 
Fair Value Measurement at October 31, 2018 Using
 
October 31,
2018
 
Quoted Prices
in Active
Markets for
Identical Assets
(Level 1)
 
Significant
Other
Observable
Inputs
(Level 2)
 
Significant
Unobservable
Inputs
(Level 3)
 
(in millions)
Assets:
 
 
 
 
 
 
 
Short-term
 
 
 
 
 
 
 
Cash equivalents (money market funds)
$
1,355

 
$
1,355

 
$
—

 
$
—

Derivative instruments (foreign exchange contracts)
16

 
—

 
16

 
—

Long-term
 
 
 
 
 
 
 
Trading securities
30

 
30

 
—

 
—

Total assets measured at fair value
$
1,401

 
$
1,385

 
$
16

 
$
—

Liabilities:
 
 
 
 
 
 

Short-term
 
 
 
 
 
 
 
Derivative instruments (foreign exchange contracts)
$
5

 
$
—

 
$
5

 
$
—

Long-term
 
 
 
 
 
 
 
Deferred compensation liability
30

 
—

 
30

 
—

Total liabilities measured at fair value
$
35

 
$
—

 
$
35

 
$
—
Impairment of Long-lived assets included in net income
For assets measured at fair value on a non-recurring basis, the following table summarizes the impairments included in net income for the years ended October 31, 2019, 2018 and 2017:

 
Years Ended
October 31,
 
2019
 
2018
 
2017
 
(in millions)
Long-lived assets held and used
$
—

 
$
21

 
$
—

Long-lived assets held for sale
$
—

 
$
—

 
$
—
XML 70 R46.htm IDEA: XBRL DOCUMENT v3.19.3.a.u2
COMMITMENTS AND CONTINGENCIES (Tables)
 12 Months Ended
Oct. 31, 2019
Commitments and Contingencies Disclosure [Abstract]  
Schedule of Future Minimum Rental Payments for Operating Leases [Table Text Block]
Future non-cancelable minimum lease payments and future minimum lease income under operating leases at October 31, 2019:
 
 
Future Minimum
Lease Payments
 
Future Minimum
Lease Income
 
 
(in millions)
2020
 
$
52

 
$
8

2021
 
$
41

 
$
6

2022
 
$
29

 
$
5

2023
 
$
21

 
$
—

2024
 
$
14

 
$
—

Thereafter
 
$
56

 
$
—
XML 71 R69.htm IDEA: XBRL DOCUMENT v3.19.3.a.u2
INCOME TAXES INCOME TAXES Effective tax rate and tax holidays (Details) - USD ($)
$ / shares in Units, $ in Millions
 12 Months Ended
Oct. 31, 2019
Oct. 31, 2018
Oct. 31, 2017
Effective Income Tax Rate Reconciliation      
Profit before tax times statutory rate $ 193 $ 221 $ 281
Non-U.S. income taxed at different rates (8) (93) (43)
Change in unrecognized tax benefits (13) (17) (110)
U.S. Tax Reform 0   0
Tax Cuts and Jobs Act, Income Tax Expense (Benefit)   552  
Effective Income Tax Rate Reconciliation, Other Reconciling Items, Amount (299) 0 0
Adjustments to earnings of foreign subsidiaries (25) (33) (9)
Income tax expense (benefit) $ (152) $ 630 $ 119
Effective tax rate (in hundredths) (16.50%) 66.60% 14.80%
Tax Holidays [Abstract]      
Impact of the income tax holidays $ 368 $ 87 $ 93
Benefit of income tax holidays on net income per share $ 1.16 $ 0.27 $ 0.29
Foreign      
Tax Holidays [Abstract]      
Benefit of income tax holidays on net income per share $ 0.94    
XML 72 R107.htm IDEA: XBRL DOCUMENT v3.19.3.a.u2
STOCKHOLDERS' EQUITY STOCKHOLDERS EQUITY DIvidends (Details) - USD ($)
$ / shares in Units, $ in Millions
 12 Months Ended
Nov. 20, 2019
Oct. 31, 2019
Oct. 31, 2018
Oct. 31, 2017
Dividends [Abstract]        
Cash Dividends Declared (per common share)   $ 0.656 $ 0.596 $ 0.528
Cash dividends declared   $ 206 $ 191 $ 170
Aggregate cash dividends paid (per common share)   $ 0.656 $ 0.596 $ 0.528
Aggregate cash dividends paid   $ 206 $ 191 $ 170
Subsequent Event [Member]        
Dividends [Abstract]        
Cash Dividends Declared (per common share) $ 0.18      
Cash dividends declared $ 56      
Dividends Payable, Date Declared Nov. 20, 2019      
Dividends payment date Jan. 22, 2020      
Dividends date of record Dec. 31, 2019      
XML 73 R99.htm IDEA: XBRL DOCUMENT v3.19.3.a.u2
GUARANTEES (Details) - USD ($)
$ in Millions
 12 Months Ended
Oct. 31, 2019
Oct. 31, 2018
Summary of standard warranty accrual activity    
Beginning balance $ 35 $ 34
Accruals for warranties including change in estimates 54 53
Settlements made during the period (57) (52)
Ending balance 32 35
Standard Product Warranty Accrual, Balance Sheet Classification [Abstract]    
Accruals for warranties due within one year 32 $ 35
Bank Guarantees $ 40  
XML 74 R103.htm IDEA: XBRL DOCUMENT v3.19.3.a.u2
LONG-TERM DEBT - Carrying Value (Details) - USD ($)
$ in Millions
Oct. 31, 2019
Oct. 31, 2018
Feb. 01, 2016
Debt Instrument [Line Items]      
Debt Instrument Net Discount Premium Amount $ 1,786 $ 1,792  
Interest Rate Swap 0 7 $ 300
Long-term Debt, Gross 1,786 1,799  
Senior Notes 2020 [Member]      
Debt Instrument [Line Items]      
Debt Instrument Net Discount Premium Amount   499  
Interest Rate Swap   7  
Long-term Debt, Gross   506  
Senior Notes 2022 [Member]      
Debt Instrument [Line Items]      
Debt Instrument Net Discount Premium Amount 399 399  
Interest Rate Swap 0 0  
Long-term Debt, Gross 399 399  
Senior Notes 2023 [Member]      
Debt Instrument [Line Items]      
Debt Instrument Net Discount Premium Amount 597 597  
Interest Rate Swap 0 0  
Long-term Debt, Gross 597 597  
Senior Notes 2026 [Member]      
Debt Instrument [Line Items]      
Debt Instrument Net Discount Premium Amount 298 297  
Interest Rate Swap 0 0  
Long-term Debt, Gross 298 297  
Senior Notes 2029 [Member]      
Debt Instrument [Line Items]      
Debt Instrument Net Discount Premium Amount 492 0  
Interest Rate Swap 0 0  
Long-term Debt, Gross $ 492 $ 0  
XML 75 R95.htm IDEA: XBRL DOCUMENT v3.19.3.a.u2
RETIREMENT PLANS AND POST RETIREMENT PENSION PLANS RETIREMENT PLANS AND POST RETIREMENT PENSION PLANS, Target Allocations (Details)
Oct. 31, 2019
Oct. 31, 2018
U.S. Plan | Deferred Profit Sharing [Member] | Equity Securities    
Defined Benefit Plan Disclosure [Line Items]    
Target Allocation Percentage of Plan Assets 60.00% 60.00%
U.S. Plan | Deferred Profit Sharing [Member] | Fixed Income Securities    
Defined Benefit Plan Disclosure [Line Items]    
Target Allocation Percentage of Plan Assets 40.00% 40.00%
U.S. Plan | Pension Plan | Equity Securities    
Defined Benefit Plan Disclosure [Line Items]    
Target Allocation Percentage of Plan Assets 80.00% 80.00%
U.S. Plan | Pension Plan | Fixed Income Securities    
Defined Benefit Plan Disclosure [Line Items]    
Target Allocation Percentage of Plan Assets 20.00% 20.00%
U.S. Plan | Pension Plan | Other Investments    
Defined Benefit Plan Disclosure [Line Items]    
Defined Benefit Plan Us Portfolio Equity Securities Percentage Of Alternative Investments 3.00% 3.00%
U.S. Plan | Post-Retirement Benefit Plan | Equity Securities    
Defined Benefit Plan Disclosure [Line Items]    
Target Allocation Percentage of Plan Assets 80.00% 80.00%
U.S. Plan | Post-Retirement Benefit Plan | Fixed Income Securities    
Defined Benefit Plan Disclosure [Line Items]    
Target Allocation Percentage of Plan Assets 20.00% 20.00%
U.S. Plan | Post-Retirement Benefit Plan | Other Investments    
Defined Benefit Plan Disclosure [Line Items]    
Defined Benefit Plan Us Portfolio Equity Securities Percentage Of Alternative Investments 3.00% 3.00%
Non-U.S. Plans | Pension Plan | Minimum | Cash and Cash Equivalents    
Defined Benefit Plan Disclosure [Line Items]    
Target Allocation Percentage of Plan Assets 0.00% 0.00%
Non-U.S. Plans | Pension Plan | Minimum | Equity Securities    
Defined Benefit Plan Disclosure [Line Items]    
Target Allocation Percentage of Plan Assets 31.00% 31.00%
Non-U.S. Plans | Pension Plan | Minimum | Fixed Income Securities    
Defined Benefit Plan Disclosure [Line Items]    
Target Allocation Percentage of Plan Assets 38.00% 38.00%
Non-U.S. Plans | Pension Plan | Minimum | Real Estate    
Defined Benefit Plan Disclosure [Line Items]    
Target Allocation Percentage of Plan Assets 0.00% 0.00%
Non-U.S. Plans | Pension Plan | Maximum | Cash and Cash Equivalents    
Defined Benefit Plan Disclosure [Line Items]    
Target Allocation Percentage of Plan Assets 25.00% 25.00%
Non-U.S. Plans | Pension Plan | Maximum | Equity Securities    
Defined Benefit Plan Disclosure [Line Items]    
Target Allocation Percentage of Plan Assets 60.00% 60.00%
Non-U.S. Plans | Pension Plan | Maximum | Fixed Income Securities    
Defined Benefit Plan Disclosure [Line Items]    
Target Allocation Percentage of Plan Assets 61.00% 61.00%
Non-U.S. Plans | Pension Plan | Maximum | Real Estate    
Defined Benefit Plan Disclosure [Line Items]    
Target Allocation Percentage of Plan Assets 25.00% 25.00%
XML 76 R65.htm IDEA: XBRL DOCUMENT v3.19.3.a.u2
SHARE-BASED COMPENSATION Stock Option Activity (Details) - $ / shares
shares in Thousands
 12 Months Ended
Oct. 31, 2019
Oct. 31, 2018
Oct. 31, 2017
Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding [Roll Forward]      
Outstanding, beginning balance (in shares) 1,997    
Exercised (in shares) (552)    
Options Forfeited (in shares) 0    
Outstanding, ending balance (in shares) 1,445 1,997  
Share-based Compensation Arrangement by Share-based Payment Award, Options, Additional Disclosures [Abstract]      
Weighted-average exercise price per share, beginning of period (in dollars per share) $ 35    
Weighted-average exercise price per share, exercised (in dollars per share) 33 $ 32 $ 30
Weighted-average exercise price per share, cancelled, expired and forfeited (in dollars per shares) 0    
Weighted-average exercise price per share, end of period (in dollars per share) $ 36    
XML 77 R61.htm IDEA: XBRL DOCUMENT v3.19.3.a.u2
REVENUE REVENUE - Contract Balances (Details) - USD ($)
$ in Millions
 12 Months Ended
Nov. 01, 2018
Oct. 31, 2019
Revenue, Remaining Performance Obligation, Amount   $ 207
Contract with Customer, Asset, after Allowance for Credit Loss $ 57 110
Contract Liability ending balance as of October 31, 2018 367 367
Increase (Decrease) in Contract with Customer, Liability   303
Contract with Customer, Liability, Revenue Recognized   (287)
Increase (Decrease) in Deferred Revenue and Customer Advances and Deposits   5
Contract with Customer, Liability, Increase (Decrease) for Contract Acquired in Business Combination   9
Translation Adjustment Functional to Reporting Currency, Net of Tax, Period Increase (Decrease)   0
Contract Liability ending balance as of October 31, 2019   386
Difference between Revenue Guidance in Effect before and after Topic 606 [Member]    
Contract with Customer, Asset, after Allowance for Credit Loss   $ 53
Deferred Revenue, Period Increase (Decrease) $ (11)  
XML 78 R91.htm IDEA: XBRL DOCUMENT v3.19.3.a.u2
RETIREMENT PLANS AND POST RETIREMENT PENSION PLANS, JWPIL (Details) - Pension Plan - USD ($)
$ in Millions
 3 Months Ended 12 Months Ended
Jan. 31, 2018
Oct. 31, 2019
Oct. 31, 2018
Oct. 31, 2017
JAPAN        
Defined Benefit Plan Disclosure [Line Items]        
Settlement gain (loss) $ 5     $ 32
Benefit Obligation       65
JAPAN | Difference Between Fair Values of the Obligation Settled and Assets Transferred [Member]        
Defined Benefit Plan Disclosure [Line Items]        
Settlement gain (loss)       41
JAPAN | Accumulated Other Comprehensive Income (Loss)        
Defined Benefit Plan Disclosure [Line Items]        
Settlement gain (loss)       (9)
Fair Value of Plan Assets       24
Non-U.S. Plans        
Defined Benefit Plan Disclosure [Line Items]        
Settlement gain (loss)   $ 0 $ 0 (32)
Benefit Obligation   1,067 913 935
Fair Value of Plan Assets   $ 911 $ 825 $ 855
XML 79 R82.htm IDEA: XBRL DOCUMENT v3.19.3.a.u2
INVESTMENTS (Details) - USD ($)
$ in Millions
 12 Months Ended
Oct. 31, 2019
Oct. 31, 2018
Oct. 31, 2017
Nov. 01, 2018
Long-Term [Abstract]        
Equity investments - without readily determinable fair value $ 47 $ 23    
Equity investments - with readily determinable fair value 25 15    
Trading securities 30 30    
Total 102 68   $ 75
Lasergen        
Additional consideration paid 107      
Gain on step acquisition 0 20 $ 0  
Cost method investment, VIE   80    
Amounts included in other income (expense), net [Abstract]        
Net unrealized gains on our equity securities with RDFV 3      
Net unrealized gains on trading securities 3 1 $ 4  
Accumulated deficit $ (18) $ (336)   (303)
Impact of Adopting New Investments Valuation Guidance [Member]        
Long-Term [Abstract]        
Total       7
Amounts included in other income (expense), net [Abstract]        
Accumulated deficit       $ 5
XML 80 R72.htm IDEA: XBRL DOCUMENT v3.19.3.a.u2
INCOME TAXES - Carryforwards (Details)
$ in Millions
Oct. 31, 2019
USD ($)
Net Operating loss carryforwards  
Federal net operating loss carryforwards $ 48
State net operating loss carryforwards 571
Foreign net operating loss carryforwards 577
Foreign  
Net Operating loss carryforwards  
Net operating loss carryforwards, subject to expiration 155
Net operating loss carryforwards, not subject to expiration 422
Capital Loss Carryforward  
Capital loss carryforwards 116
Domestic  
Capital Loss Carryforward  
Capital loss carryforwards 48
State  
Tax Credit Carryforwards  
Tax credit carryforwards $ 78
EXCEL 81 Financial_Report.xlsx IDEA: XBRL DOCUMENT begin 644 Financial_Report.xlsx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

DRA,HS!A8I3#AN )&1$H(P)D M&/7,>TP\SF% 5C8$1;",&)01 S*,,\MC*T?@&S)N0JYD)*",Q)*!,E-&8F_5 M-R^IC8E3XP8FUL$E$Q5+0:DI< $3F" #"3*@Y(;(/ /V.I$$^;!G^'9)(S.- M!HWSF"<+0+"!66M, M)@@$O,8]X@VT3,'W5&S4\-6$'U7UVSI:>&BZ;@M'JT.$^8-DP M&>LYFJW[/O6#IF^;?Q3L4#:=\T*Y:,=4T[2GE!.AT+\7-^N.HT80A5\%\0 +?3,PLBUE M)XH2*9%&&R7YS=CM,5HN#C#CS=N'VUCNKM-M_HR!.5U]JF@^5 M1%5>U.%^.UU[:??;YKTOBUJ_M$'W7E5Y^]]773;77NN:.J@U:==^!-[>E9J'# I_B[TM;L[#L947IOF M^WCRVW$7QJ,C7>I#/X;(AY\/_:S+YAP'WA]_1O]E2GY(YC7O M]'-3_E,<^_,N3,/@J$_Y>]E_:ZZ_ZB4A%09+]K_K#UT.\M'),,>A*;OI;W!X M[_JF6J(,5JK\Q_Q;U-/O=8G_.0P/X,L ?AO I'> 6 8(:T T.YM2_3GO\_VV M;:Y!.]^M2SXN"O8DAF(>QHM3[:;_#=EVP]6/?9J*;?0Q!EHT7V<-O]-P4_%, M%1MUDT2#@9L+#EWP:;PP7$@<0, 8@H@[P,D&RN-69-,FGK2B-C*PRLQ;$AH M0U(;J:,0"@90H! ;'& # VR @\0JQ*S9W&69W%5[K@35,*$-W8Z5.*J M+(8#DR 7[@B!\< 4N#D$U^KQ:O1K3"L8- R0)I.V%8H10>H*-*["8M(P@)K, M%0)3@B%,.#C#,"<8 5!+Z,8H.P%(C=\.:8%1[2P5SVGM+ 7BE=B&L$\X6P] M@+FC.^ K$+R(O*O>KS&M8)AP!!,;PIR2PC4+)@4'?01A\"(R&,SLI01$3+A: M$HZAPT%3XF(PQ[#@J"TAJY&"@-Q G\0T@E'!D_4,YA@5/%W!X$7DS<4G,8U@ MX' '$)@3EE"C/@D9N^-62, :S('/ 6FA$"4<(7 E!" $H2_@A* [ %\$M.( M8R^RIN$0E!&D]44:5TTP2 1H.9P;*_ST"]!RT*T5;2=(67T2TPAFB$ ,L=$K M*"!<_:_ A!"HF;#9*^BN1"1VPNMW+@*31H"FQ 5>@1DA4%-"UB(%@-VD 8FC MK!(S0L;KP2LQ(R3:F=C@E7330=H O\:T@EDC 6L(>B7H-NRZ(HVKL)@V$M F M2QPA'&\M$"4<2U5B2DA "0)?^9@27HEI!%-"KNDTY.-.PRLQC6".2-!IN- K M\?,O0:=!T"L?=QI>B6D$4T0BBMCHE:O;"(41H5 ;89-7/=ZR>"6F$0P:!9H1 M%W<5!H1"S8B]#-7C9L0K,8U@/"BQGKL*XT&AW8C-744W&B07G\0TXG@YBMY^ MV-1=1(G/B$\R&XGNWI^/'S3^R-NWHNZ"UZ;OFVIZ87YJFEX/X>(O0[BSSH^W MDU*?^O$P&8[;^4/"?-(WE^4C273[4K/_'U!+ P04 " !;B9-/,N$M*$(" M M!P &0 'AL+W=O!-]P7LX<=X\(L:*$!K,'TD$KGAP);3 76WI"K*. #RJIJ9'G."%J M<-7:6:IB.YJEY,SKJH4=M=BY:3#]FT--^K7MVM? 50-="RBK06A>/:?G(?MXG$*\!+!3V;K"U9R9Z05[GY=EC;CC0$-11< M,F!QN\ &ZEH2"1M_!DY[E)2)T_65_8NJ7=2RQPPVI/Y='7BYMF/;.L 1GVO^ M3/JO,-2SLJVA^.]P@5K I1.A49":J:M5G!DGS< BK#3X3=^K5MW[@?^:9D[P MA@1O3'##NPG^D."_)P1W$X(A(9@E(%V*ZLT6JI:9NT)%R--#9XC(1R$0^=! M?)6E.+O&30U'+I>16%,]P?6&DVXXG-!X0F;_ %!+ P04 " !;B9-/5-(U M=(X# !L$0 &0 'AL+W=OY46>JWFNO,S?7:?N9TZC, ;& >OWW#1"M278M_2($GWUVD]TG M&Q@?1?5>;SEOG(\B+^N)NVV:W8WGU\5P<)RYQ3P]>L\VV M:1]XT_$NW?!OO/F^>ZGDR#NSK+*"EW4F2J?BZXG[F=P\,]8:=(@?&3_6%_=. M.Y4W(=[;P>-JXOIM1#SGRZ:E2.7EP.<\SULF&<J>?;:&E_HF,>( S5,8\0ANF8)P@3Z)@O M$";4,<\0YF\N/)G(PDL,*D40@SA#!#"(1IE, LO!9F7Y$VQ*C]6QMA5N,UA#:5")Y*9$^%FG%& ME@\*^XAA'[%=%Y3 #".8801$:6AET6.BRR@CQ$L">TD +X;:%HGMQ4>*I]V# MP4W/!_P$" >V<9+A14P0N1(*Q!&:.Q"UDA_X2(D11-4$D#6-S.T9T#7B!M$U M"0 WR/Y#$&631A!)$4!3YB[V1&Q1A>BZ(KHB,3!ARU%L.6)8L2'J(Y#\ M$H0#T19)AA$8!?N@0-I\L86EB+HH&5"P"G2Y%2"%0K%^"0B08:$B MVJ+L/]85$0Z%A&.LZ[T":5T@Q()%U$6!QFFOZ[6VJ+M!!$BAIH;E!M$6!9H6 MMA%01#<4T TSCH%/U.Y;6/H0:5&@;S%JNDFN[C?],?$?(/T$AXB4 2)E#.% M],?L[H:?)!%Q,4AUWR&^IM4F M*VOG333R):Q[3UH+T7!)Z'^2*MGR='4>Y'S=M+>QO*_Z]_]^T(B=^K;AG3^P M3/\ 4$L#!!0 ( %N)DT]G!([;X@, 7 9 >&PO=V]R:W-H965T M#.MN[_33;<,%;\5]A+>W,<#5:>G?LVG/QYV,;I,");VGTW M2.3]QYO]9,MR4.K'\7T6C:\]AQMOC]_5OXSF>S//>6L_N?+_XM"=MO$JC@[V MF+^6W5=W^>U>VX]]H_]IVKII5^J%4^8_ILZC' MS\NL_WX;OD'.-\CK#7+R,C4:1_XY[_+=IG&7J)F^_',^/&/Q(/OO9C]<'+^* M\7_]X-O^ZMMNK6B3O U"<\WC5"-O:K)L?:U)>OUK$PF;R%% WS4Q6$!! 34* MJ#N!# MH**#]$ZR 2^9=6$.!=;A+D>)7-@WP.1?=&E4I,7T8-(3?1Z>,!'[QA5S@%K_Z M0H6X59Y;=J08$ $(T8*1P (6F 6(R!,B%GCF^6>+ 9% %*T9"0P!V*UP"PF M0:Q#S*[]]YB9523&10)%F%29!@37!,SL7W:\]S%RJ,"X*X**YH3*9:4%H4A@%%1*;YJ+[ M2,&YQ;PHP(MF9CF%65 +TI/"+*B0_*1 @&*Z8%P4P$4S*"B,@EJ0H31&08=D M*.UG*,E,+QKCH@$NQ 03C4G0"R*4QB3HD BE_0@EF">KF=\8@!;B)# (>D&$ MTA@$'1*AM!^A)-L'TZ(!+<0LUAJCH!=D*(U1T"$92OL92C*S"V%<".!"3(8B MC (MR%"$4:"0#$5^AN*Z8%H(T$+<+V%, BV(4,3\F@Z)4.1'*,6\@H1I(4 + M,7,<81!H080B# *%1"CR(Q3G%;-"@!5B$I3!')@%"Y*+M; M>'YKD]SL70Y[PW_GS4M1M]&SZSI7C9N51^E/7;#8=8? M-].>['32N?.\WYQ<-[UWOP!02P,$% @ 6XF33YCLI%I, @ A0@ !D M !X;"]W;W)K&ULE5;;CILP%/P5Q >L,;=<1)": M5*M6:J5HJ[;/3N($M :SMA.V?U_;$$3@L&)?\(4YXYEC'TQ2<_$J,TJ5\UZP M4F[<3*EJC9 \9K0@\HE7M-1OSEP41.FAN"!9"4I.-JA@R/>\&!4D+]TTL7-[ MD2;\JEA>TKUPY+4HB/BWI8S7&Q>[]XF7_)(I,X'2I"(7^HNJW]5>Z!'J6$YY M04N9\](1]+QQO^#U#L-ZQE%E-&C,A1$-S>Z MHXP9)JWCK25UNS5-8+]_9W^VYK69 Y%TQ]G?_*2RC;MTG1,]DRM3+[S^1EM# MD>NT[G_0&V4:;I3H-8Z<2?MTCE>I>-&R:"D%>6_:O+1MW?+?P^ OPWPNP < M?A@0M '!( URJS5KT21-!&\=D2S6Q4QAP*O YW,HYFTN;/OM%NI9V_I*EHE MZ&:(6LRVP?@]C/^(V(T1<=1!D!;0J?!!%;Z-#_HJ8@\F"$""P!*$#P1X8*/! M+"RFM!@\] % 8EA&",H( 1F#-;8-)NZM$0]4C!$3R8Q $1$@(H )8I @GK\; M"Y!@,6,W%B.3@V.W&R,FTK $12P!$2%,L ()5O/3@#VXN+P9YZ$%]7V&P_+Z M"/(H9*+*,2!D(IL8+E'\B1K%<)'B.57:@OI>@V$ZQA",)Y3 =8JA0IVH= Q7 M&8X^D0^XSG \YWC$HV_2Z.L[A@S3@7KW@;F@?Q)QR4OI'+C25XN] ,Z<*ZKI MO"?M+-/_!-V T;,RW87NB^9B; :*5^VEC[H_C_0_4$L#!!0 ( %N)DT\8 M1J"W0P, /\. 9 >&PO=V]R:W-H965TNWON MG'OBFU]9]<)/E KK-<\*OK!/0I3WCL-W)YH3?L=*6LAO#JS*B9#+ZNCPLJ)D M7QOEF8-=-W1RDA;V4F.]"<5O\K'2JZWI@9PS\<2N7VF;4&!;;?;?Z85F$JZ8R!@[EO'ZT]J=N6!Y MZT52R"U!MZ[03AIX+<&_KN!/VD0M :! M9N TN=?%W!!!EO.*7:VJ^3V41/WLT'T@CVNG-NO3J;^3]>1R][),PFCN7)2C M%K-J,'B B8>8M8E!'<*1##H:&**QPD"(1 MA8O 0L3$183"$; %("!/UP'IY MM;W7)^I%L ,?=.#7#OR^@\C5,FTP48TI&I):IB9B-L(B %D$ NDL6@P83^& M!ME\#-D&!E,7)AJ"1$. J';LZ]!DH=?+A(R4*P)91 +3V,1F2RT)MD $!^F M$8,T8H"&K]&(C1@C(1(P1 *$T'IHE1A'.A("N;#FN$"0D2Y$([*%/M^'")2< M!X0!%I$N:]@HIRXZ &2F8;8 )A@A"\L.\@"R\8@+6'B0?T/)8-5 D&SHXH4 M4=#;$<"X>LFF($.RL'*@ST@',H7!X&I"#*Y3D"%76%\0)##)B M8&U!\P_'" MO8^@YC@_M]AHE?,A,P\O60F1L_7Z5WJW32CX0]2'=."6\],R)&C'@P.C DJ&;IWLJ G.8UVBXP> MA'J-Y'O5C&3-0K"R'3>=;N9=_@=02P,$% @ 6XF33[:[2;BY 0 $00 M !D !X;"]W;W)K&UL?53;CML@$/T5BP]8XDMV MMY%MJ9NJ:J56BK;J]IG8XQ@M%Q=(O/W[#IA86=?JBV&&P"7 MO$FA;$5ZYX8=I;;I03)[IP=0N-)I(YG#T)RH'0RP-I"DH-EF0.BQ(BFY)I[YJ7<^0>MR8"?X >[G<# 8T5FEY1*4 MY5HE!KJ*?$QW^\+C ^"%PVAOYHFOY*CUJP^^MA79>$,@H'%>@>%P@3T(X870 MQN^H2>8M/?%V?E7_'&K'6H[,PEZ+7[QU?44>2=)"Q\["/>OQ"\1ZMB2)Q7^# M"PB$>R>X1Z.%#=^D.5NG951!*Y*]32-781RC_I6V3L@B(9L):?%?0AX)^8) M)V>AU$_,L;HT>DS,=%@#\W78S,8G0^_"&E9K,7NI/SQF);UXH8AYFC#9 M#6:!V/^+N-_.$(H&9A?9JHLL\(MW+O)U@7Q5( \"^3N!8EV@6!4H5AQL%WV8 M, \!HP(FS9>=6,$4Z<((O3D<_UB^,W/BRB9'[?"W^<< M".B&PO=V]R:W-H965T9:RDZS*AFZY)4YU3?C?%:U8M["Q?3&\E,=":@/*TI82]J)J[6E4]DQ]J8WW_8+V]$1T8KF4DL0 M]3C3-:TJK:3B^#.(VJ-/3;Q>7]2_F.15,CLBZ)I5O\N]+!9V;%M[>B"G2KZP M[BL=$@IL:\C^.SW32L%U),I'SBIA?JW\)"2K!Q452DW>^V?9F&!\$_U."/Q#\"0'UJ9C:;(@D6%NBOR+\[*OJY]IH MBFW>J?((93UG21RFZ*R%!LRJQ[A7&#PBD%(?7;B0BY5[1W=O':SO$6%P"]D MD! .P@/S] S?N\DS@@5\4, W OZ-0#PI%(1)8"(>@D M! 0F)[+J,9'!- ;C)9-# R#1Y- B ='&H&11D"D,P(Q*! _?NH)*) $?B3 M6D&8 ':"';@)'4!BYO/&,WV,'T\5@WVZQ.X#R8*@.3]P*V(/D(AG).!FQ/Y_ M9 NW&H;ZZ"[;>U 8.1,_Z.JNK2D_FCDFK)R=&JFOK"OK."N7KKZK)_:5GJ'F M#O^0Z0?P#\*/92.L'9-J$IC[^L"8I"I&YTG%6*B9/VXJ>I!Z&:DU[P=?OY&L M'88Z&O]99/\ 4$L#!!0 ( %N)DT^4T'?GQP( *\* 9 >&PO=V]R M:W-H965T>>"UQS9R?&7\2>4NF]UE4CYOY>RO8F M",1Z3VLBKEE+&_7/EO&:2#7DNT"TG)*-(=55@,,P#6I2-OYB9N8>^&+&#K(J M&_K /7&H:\+_WM&*G>8^\M\F'LO=7NJ)8#%KR8X^4?FS?>!J%/0JF[*FC2A9 MXW&ZG?NWZ&:%6;L10^^;>9^J!W1BJZEEB#J<:1+6E5: M2?GX8T7]/J8F#M_?U+^8Y%4RST30):M^EQNYG_NY[VWHEAPJ^J25@FLG*L::5<+\>NN#D*RV*LI*35Z[9]F8Y\GJO]%@ K8$W!-4[(\( MD25$[X3T0T)L"?$[(?Z0D%A"XA""+G>SF/=$DL6,LY/'N_/0$GWLT$VBMFNM M)\WNF/_4>@HU>UP413$+CEK(8NXZ#!YBTOP!H9LW&$@A&-C M.<;@<\3]&)$FYY 5 $EAHQ&X7I'AQ\,\PS"$%6)0(38*T3#5/(8%$E @@2P@ M9\\Z4&9 C0&Y*S%&1!BVD8(V4LB&LR.K#I0.@@QVY"Q(!@;)H" 1K)"#"OGE MRUV L4%R[TJ1GG&$^"H=N-90#*4S<0(17&XH^8]5A4L%@;6"W$]H.JK(T/G M?0Y9H7')74T5-H*+#H%5AUV[V2@0"M/,=3Q&%2AR/0.@:&J7X#)'^><':FE! MV9D9Y#H>@W(\.IH *'$=!X-+N*9\9SHBX:W9H9'Z#AK,]EW7+=:7N#._U-V8 MN=S?9;I6[@?AN[(1WC.3JD4P%_F6,4F5Q_!:'=R]ZA[[046W4K]FZIUW+50W MD*RU[6'0]ZB+?U!+ P04 " !;B9-/+A9NF!P& !X)P &0 'AL+W=O M0G@_&9\;-^YY\YX%J>B_%YMG:M'/_;Y MH7H8;^OZ>)\DU7KK]EGUI3BZ0_.?EZ+<9W7SLWQ-JF/ILDW7:)\G MW9^N_NOXM6Q^)9=>-KN].U2[XC JW>K[_VB&&\B^@;PT$.E@ ]4W4#\;Z,$&NF^@ M28/D?"G=O;%9G2T797$:E>?'>\S:*!+WNKG[Z_9@=[.[_S6WIVJ.OB]%$S.+ MY+WMJ8>>SI"\ABY$TG1_.8=$YWB2K+GT3[#B1&I\Q (DQ2(4O%#5M5?^AM-_#';E59VC608G62B2+,:ICQ ME*1020J4B"E1DK*S$&(U1'@J9E#%#*D01,6,G8,\NM40X:FX@RKND J)>YC# M'N8@1(7"/8@I'LY3I$+3\3R-/I(X8GMD%G]L(I![!!)KJ%C!E CZZ!"34KF M,0&],(\]"HGTLF0I^:B2- 5 Z(XJ1E!(,LYZ0MV2*WK*NS54,I%?,D8D(>*G Z5_,;QJK MIQ6PA)D=O:DXXP%3"C[2YS])X7+*ZBB!U$?+'8=!0T M'99AN%DPL5'$#B+^\BMV' T=AP:#CL\WXH@%R"0T9#5V&XW>9F-YP%C$A%[380_8 V'#E?$L/@??BWA"\9&8Z#1T!+(Q(TFCMA!Q!>+C<;< M]!K9@!D"RRYQQB(F% W8:PST&A8-\8E&'+&#B"\6&XU!1L.*81.?:,01.XCX MFQJPSZ3(9U@MG')_H/LK ,+2 F)"PRS%/I/"F0:MA'OJ^G4]+80!,J%K&8AA M2X?)U?:CO2M?NZU=U6A=O!WJ=A//U='+]K%'V6Y?(L>?Q+T];P+[VFE*&K7:)Q^:5+7UF6;RX_&PO=V]R M:W-H965TF>?ZX7![OGJI=>?Q0/U?[]C\/]6%7-NW'P^/R^'RHROO^H-UVJ;/, M+W?E9C^_N>J_^WRXN:I?FNUF7WT^S(XONUUY^.^VVM:OUW,U?_OBR^;QJ>F^ M6-Y/U9]5\]?SYT/[:7ENY7ZSJ_;'3;V?':J'Z_DG]7&M,M<=T4O^WE2O MQW=_S[J^?*WK;]V'W^ZOYUEGJ=I6=TW71MG^^EZMJNVV:ZHU\N_0ZOQ\TN[ M]W^_M?Y+W_NV-U_+8[6JM_]L[INGZWD^G]U7#^7+MOE2O_Y:#3UR\]G0_=^K M[]6VE7=.VG/NM+'9ETVY1?B\Z*Y9M\^=S:'2.6\T.U_$)5ESA MB8 /@+P83+B(["3:$5\)"61CQSZR)$/ M6XE2-\Q1(),)@ MHBJ$5$N1JC@PV87F$BD'PDC5"*F6(E5SI"HJ6@'10N"[QN#5$+PT+)J#ESUJ MD$9 @\9TUI/HK#EZ:2X") MM!"^8SAK1V5KJA8-793Y0.XCA=*PAD00SC?&L M$9ZMU ;<9XMO2II#EY%\IYVF^@RG/!#N:S1GRV@=H!R:>AR>,*J;27;@O, M7PWY2Y]>FG.3F4E)8B>8K!J0M6#7B5,3Q(6+Y+!@N&H(5^'19C 6379!564P MS0RB&:NK#">5S>@#!XG>/41C-YAG!O&,U58&\(Q>(J 1QI$1:EZ8;-*\P7 & M,2P$0\K8*076H$HZ24EB)QAU!F:B]-%G.,04??0!C50,&,PY _-0FA,8 M3C 6E90D=H()9V A3A_"9IQP24GL!!/.P%*<(LYP>EEZ$5=(1$?\&HG$$8\Y M:(H+"B2+.6AAQ4T99GGF9UE-@D12/F Q42W,#RG#+(Q$F-%$5&;5D1VG>1 2>YHPH!$TJWI M,)@= C.KC!Q'ZD(IMH@ 5%X*#D:O@^AE*QH9WLYG8@%FD+R@D'J)ZT7^?$Z'4AH M/9J4Q&8Q:?VDQ2+/*4HS:2"AT]=)26P6L]A/6BGRXRQ.2F(GF,5^TDJ1'V=Q M4A)OB< L#I-6B@('+AD)1)IR0V&:9BR.!0X*!?,"]"( MD<$X#0BG3MJ3A4&8H[4AZ<[-,<%R6##3H.0<3RJC# ,B*2_*,<1R!#$G3 CE M&#^YN20H& DYG/=C01F?]TM*8B<8+#D"BQ.0D&,DY/Z2B."!G,.!S"*2*CV' MB$S.B')A)R+*B)RP()'CP9=?,N]5X,%73)KW*E); $\124IB)W@(%V@(2WO8 M"CSR"GU)1/#(*^"#GT4$S#'1B*0DL1,\?@LXP234V04>>06:8!(C@D=> 1_& M+"+C=5%2$CO!X[= X]<)B5*!1UZ17Q(180OR.!6)B78;[*0&$IIS7.S[I[NT2\OUM]]I/_];)SV9.[PS]41X>-_OC[&O=-/6N?\/DH:Z;JK68 M?6@=/E7E_?G#MGIHNC^[ZN!P>E7G]*&IGZ]/[R$MSR]#W?P/4$L#!!0 ( M %N)DT\ZF%/B% ( *8& 9 >&PO=V]R:W-H965T>XX=2 "%2,>=JE9J)735M<\&%A*=$Z>V(==_7]L)40X6 MB7O!'YF=V1WL==9*]:8+ !.\5Z+6R[ PIED0HK<%5%P_R 9J^V4O5<6-7:H# MT8T"OO-!E2 LBA)2\;(.\\SOK56>R:,190UK%>AC57'U;P5"MLN0AN>-E_)0 M&+=!\JSA!_@%YK59*[LB \NNK*#6I:P#!?ME^$@7*QJ[ (_X74*K1_/ E;*1 M\LTMON^68>0R @%;XRBX'4[P!$(X)IO'WYXT'#1=X'A^9O_JB[?%;+B&)RG^ ME#M3+,-9&.Q@SX_"O,CV&_0%3<.@K_X'G$!8N,O$:FRET/XWV!ZUD57/8E.I M^'LWEK4?VY[_'(8'L#Z #0&LJZ43\ID_<\/S3,DV4)WY#7?_,5TPZ\W6;7HK M_#>;O+:[IYQ&2921DV/J0:L.Q$:@-)T/&&(%!A6&JC!/,/F@PF*<(4898L\0 M?\R3X@P3E&&"Y)"PBTH[4.I!M0=%N,84U9AB&O&%1@=*1AJ3&2Z2H"()(D(9 MSI"B#.DGS)RA#+-[S)Q=%7K#S#FJ,;_'S/F5QHUC12/\_$?8T9S-R_V2WM#![Q&-[W&U1XWOP:4E9-1A7 ?_R=6AK'6PD<8V M*]]2]E(:L'31@SWRA7TTAH6 O7'3U,Y5USF[A9%-_RJ0X6G*_P-02P,$% M @ 6XF33WIW>':! P 6!0 !D !X;"]W;W)K&ULE9AKCYI &(7_"N$'+,Q%+ALUZ=HT;=(FFVW:?F9U5++ 6!AU^^\[(!H' MSBSP12Z>.9YYY6%>F)]E^5;MA5#.>YX5U<+=*W5X]+QJO1=Y4CW(@RCT-UM9 MYHG2A^7.JPZE2#;-H#SSJ.\'7IZDA;N<-^>>R^5<'E66%N*Y=*ICGB?EOR>1 MR?/")>[UQ$NZVZOZA+><'Y*=^"G4K\-SJ8^\F\LFS451I;)P2K%=N)_(XXK' M]8!&\3L5Y^INWZFG\BKE6WWP;;-P_3J1R,1:U1:)WIS$2F19[:1S_&U-W=MO MU@/O]Z_N7YK)Z\F\)I58R>Q/NE'[A1NYSD9LDV.F7N3YJV@G-'.==O;?Q4ED M6EXGT;^QEEG5?#KK8Z5DWKKH*'GR?MFF1;,]M_[787@ ;0?0VP#"/QS V@&L M,\"[)&NF^CE1R7)>RK-37OZM0U)?%.21Z6*NZY--[9KO]&PK??:T)'[ Y]ZI M=FI%3Q<1O1-14['J*X+93>+I!+<8%,:@S7ANQK X,.C &@=VYQ!''!MP:,!1 MA*!3"2@*.\48$!E99C#+##E$V"& #L'XS<9$)EI,,L$(1@&%@_, M((DF% 5#2.)1UPI2]1$:4)EK#D::0@PMI:480TK&EX5:UCZX^'7+ E4]A(94 M9AZ,-(486E8?BC&D?$)9,(44+8(]A("JC]" R$R#@:80:,LJ1C&&-)Q0%$PA M14MA_UKIJP(VZQ;E8Y&9!@--$82196%F&$+FCR\*PPPRM!3VB@)54?>^,J0R M\V"@&8(PLBS-S-+.3NAG&6:0C>IHH2KJWE>&5&8>##1#0%OGA#%D$_I:ABED MHSI;H.HC-" RTV"@&0(ZLGE@#-F$[I9C"OFH[A:H MY]%!P0F6DPT!Q":.E7 M.(:03^AM.6:0C^IML:KW3#B@,O-8GE AA#8/#"&?T-MRS"!'2V&_+$@51=VR M#*C,/!AHCH".+$LSQQCR"=TMQQ3R4=TM4 &$/A9=TGAWKWCJ=VX_DG*7%I7S M*I62>?-.9RNE$MK0?]#_^EXDF]M!)K:JW@WU?GEYUW4Y4/+0OL?S;B\3E_\! M4$L#!!0 ( %N)DT_)RS\,P0T #UI 9 >&PO=V]R:W-H965T)BO?UT^+1ZW__-EN7J8;[8_KKY>K9]6B_GG_4$/]U=>5=W5 MP_SN\?+M]?YW'U9OKY??-_=WCXL/JXOU]X>'^>I_MXO[Y<^;2[M\_L5O=U^_ M;7:_N'I[_33_NOCG8O.OIP^K[4]7+V?Y?/>P>%S?+1\O5HLO-Y?O[,U[;\?= M$?N0?]\M?JY?_?MB=R\?E\O?=S_\[?/-9;5+:7&_^+39G6.^_>O'8K:XO]^= M:IO(?X]GO7RYZ.[ U_]^/OM?]G>_O9N/\_5BMKS_S]WGS;>;R^'RXO/BR_S[ M_>:WY<^_+HYWU%Y>'&__[XL?B_MM^"Z3[34^+>_7^S\O/GU?;Y8/Q[-L4WF8 M_W'X^^YQ__?/X_F?#^,#_'B OQQ@W>0!]?& ^L\#FLD#FN,!37+ U>%6]K5Y M/]_,WUZOEC\O5H?V?9KO'B-[TVRK_VGWRWVQ]_^W+<]Z^]L?;ZT:J^NK'[LS M'8-N#T'^.N@EXFI[^I=K.%WCUL/A?GJ!68SHVM.0]Q#2<1(UWFB]/[XYN5%S M/D.#9VCV9ZA/2R4*T>(9VI##."3W>7N(Z?W65NFJ2;&.,O[KKDTQZS*2/F=B0)-*'B\2R04PEVF_ 1 8J M29UD,L2KC$GCS"#&*\YDQ$Q&RB0I_.V841.(436QBAVD(EV(!C;A0D;WTZ4V M9"'9Q*EFDR&GF:!7O3.G3/HT$S^?R53(:29L6$:.5:4"/$9-/VX4Y$G"[RFH M4#BG0DXS82,NSR:15UW:4D@J!+^YNPHGC6N6HQ>8I*CLU3PP BK4@,43?#=E W68W3G.UW)D-.,V%3J6&<8E4O MSL%>4'Z5,R&7*:" NX00$+CVY8P$V)@!L6<),CX":JLT_['(CIU.V(9120\+8F MXAPLOJ8M*0F+KXD=,90$!NWIH !B:N%J#6NX(0V;NAV67E/2"SR]%HK*$C+TFMA+!W,M9T:)Q\7[&*(>$):UF]; MQYLQ$P.;EH771N$-82K;QGXQ?=XA1'1[K5@&I:[3TM6K-HZU?TE'>Q"C'C0V M@9;F]Q;69*/"8RHQ1CUK; (MFD"Z!M;&3OJ7L#P\&7.:"YM)2_VXI:M@[?GI M_63(:29L26VTI*$*18%5S#21&"(4V+$E=6A)8FC3L25U)9;4L25UT9*B1W?G MUR8E:;^S8 M!+J^I" LWBZ*%PIR7KN3(:>)L'8[6IIS<3,]RZXO69KK679]SM),,:^%YZ0\^OJDR&GB;!V>^IX72R9]BR[OF0"/;#LAIP)]'!^ CT9 M@";2+IVQ@V0TE$^B!93?D3*"'.#D.!8DAZF98NP-IUX4/#2R[H63Z M/+#LAISI\Q 'Q:$@4R&GB;!V!Q@W5\I#!O%BOV3R/+#LAIS)\T!+V($.@#5L M3WD8"FK%HS2RR,>LE>XQ2MC3E\.1#V%5_UCG"Q04\6HUTUU<#8*JE7. H_"(9 "42H% M-J$_!A2EBM[7M8%%@:BV$4^I50*3JG TE)KD<]AI8T0@!<*&08PDMEVJ2(GF M-)&0J6"1-'7W&45)=]K>D<@(L8- R53DA+'9($HWF\"B*AJS15JFBM.I)NUS M9A@E.:U*0%85^J]8O-D*69RE9.IEE8":*K2[6)T,K&DR)LE&@$T5S<"BPL#N M0C(Q1DSUM[(@Q2F8DK(=8S=A4 M &*V%KP0HII!Z4$1FX1L3MR6< NF*.59A,*9HXS-%0=/0]IK4Y!^"(57($D9 M&PM&3V/H)BBJ%HLDIEA*A"EKI5#%05K)S-$4PT@0(S76^5>OTS$) 2W\PNE5 M1V@J/[_Z,QV3)"-L![A*>VTHR5D4U5VR!&2"9S0$&F-A8!Z6OL>;453=JV=8 MP)'F-+"02A!XI'G)&Y&$L M3,;4>S(F24;HNB%=*V+>!,-H3T! HE"N%@@2TMF@,+"@^ XR/"@.07JP,!,D/=0IU(\S7 MJ,&BH/FL".G4/43]* 1/@@[ O0P M60[U@Z!TW??]<]#K341&Y0,"5[0>W41YD@ 6K2]R$T$;&N"&()H>5KO5A813 M],@3Q):"=>S04%,Q239JUX",0?[,@%V4%Q*FA/1BH^;" E^T(G[1!,!H602C M 9^H/LYF@E T0A2AL8RC2MD :;RBNI!0-V&)T-K '(;&GHQ)LA':)BXQ-C8@ MAVJ4*HA#(^306ED\(6U&!65;"VD#+$AM#=)66A(8H!$'".6%N;FLKU M,7[6 MJ@Y7H'DV%DW.!2QG8PZY_!R5\?2Z .J<@+I07@=23EY([,6#G%RK=IX1:)M7 M)0MF+G T!QP-MC8!SDSYLPO,S!$SB^6-*]@F.GX7^)@C/J;H1'VY0+[=>I"0HX&RUMRIP(76)7#_G)QKP*'S>/2A8[IF"09(4?<8B[L5^! 7H5= M BA(/;]JLSK$L\*>!9[!9U&,>H+5MG?(9X5M"QRVM8O%F0Y*\E&[WY&-A*T+ M'#:WB]7)]QJU QX08W'[ @<6+.R03%292D98%M)BK1IEJ,WTBF@Q5[O@ 2T& MQI=/@KG:X Y)L&!\GOWVVM4N>(ZS8]7UJWWPO&1V[(+P8Y!-C,\^DN M%W27(]VE/K_I@N[R(KK+!=WE0'=1=;,_7.&"W'(DMV)UI_:6.;V0@+L<=J/; M5E>E*^ N;TK>-KN@LARH+*AND]_S"7#+8<SV2Y8+("M'WBI4M\WOU022Y;B_G'H-XP+)PY:NI"5Z^^ M0N9AL?JZ_WJ>]<6GY??'S>Z+6%[]]N4[@-[Y[BMHDM_?VIO9X8M\_CS-X8N% M_C%??;U[7%]\7&XVRX>;W=?0?%DN-XMMBM6OV_;_MIA_?OGA?O%EL_OG[O7\ MZO!]/H&PO=V]R:W-H965TZXJ)O\]\5)<-R&$MX[7XGA274>T73?LR']R M]:MYD;H5C5GV1<7KMA!U(/EA$WZ"QZ?$## 1OPM^;2?W03>5-R'>N\:W_2:, MNXIXR7>J2\'TY<*?>5EVF70=?X>DX[D@IAV) M*10"L)7DX.4=/Y MHHM#:PGW> FTF.!E)MAJHNM9H]T$+SG!MA-=SQJM)WCY";:@Z%HWVE#P4A0( M1QVO!Z0=12]'D7#4Q:$=12]'D7 T<[Q*T/'*)!UU//A(.XIW.(JTH^CE*-J. MNF9+*XKW*(JTHNBE*-J*Y@X,;2AZ&8JVH2X,+2AZ"8JVH([_ :3]1"\_T?;3 M@4EH/1,O/1-;3Q>&MC/QLG.(FF[SK!U!--E =P>4'TP>B[H-WH32>W&S8SX( MH;C.%S_HA_>DST1CH^0'U=UF^E[V!X.^H40S''JB\>2U_0]02P,$% @ M6XF33P%%S!;/ P O!0 !D !X;"]W;W)K&UL ME9CO;ILP%,5?!?$ !=LDX"J)U 1-F[1)5:=MGVGB)*B ,W":[NUG_C0-]J$A M7P(XOWLYMB\'X]E)EB_57@CEO.594\^KUGN1)]6=/(A"_[.599XH M?5GNO.I0BF33!.691WU_ZN5)6KB+6=/V6"YF\JBRM!"/I5,=\SPI_RU%)D]S ME[CO#4_I;J_J!F\Q.R0[\5.H7X?'4E]YYRR;-!=%E9;RI;[XMIF[?JU(9&*MZA2)/KR*E MGK]G_])T7G?F.:G$2F9_THW:S]W(=39BFQPS]21/7T77H8GK=+W_+EY%IO%: MB;['6F95\^NLCY62>9=%2\F3M_:8%LWQU.5_#\,!M N@YP R_32 =0'L(R#X M-"#H @(CP&N[THQ-G*AD,2OER2G;Z3TD=161^T"/_KIN; :[^4\/3Z5;7Q>$ MA-.9]UIGZJ!E"]%+Z$QX.OWY'A3=8TFM<-J_P7 M?? #CC,$,$/09&#]H0IQA@G,,+$UD# R!AM"W!@P!$6^,617H)[@*10\11F( M(1A"Y@R/@6((,2PXA()#,$=1@#-$,$,T9HX0%!D5NX*9!BJ.0RT0<:,":0BPTI6F J-0KA&]55#UWD@=$SQ8LJLWE%4C*F!^B78 MI@CP*1)98VU3/#(]8@P47X'ZDK$OD@!)YJ9D2(6FYC%4?(WJJ\9>3) [HOFILR&1Z@\$1[)$D'/4XVQ3GUG2A5-' >YE@PR7()SDUY4"* MF7IL:KB:L><28+J$!Z8<1%EO:4@-U2G%!DY]I&K!34N"!U!]87U!L;Y3?8 4,6Q)#EF3-$Z*H;QCI"E-F@6)JZ/L/FR!# M:TK+"B!E+>U'43&FAE1CVV6C5K&(HK[YM@:4O2"$-^0#1<8&OK79#6; L C/8EN8_;C;2/-.V^WH^DW*5%Y3Q+I63>; -MI51"B_3O MM,B]2#;GBTQL57T:ZO.RW4]K+Y0\='N%WGG#&PO=V]R:W-H965TFA4XTK',X'+?N?;#9!;Y.,(A?#0QB\>UH*WO&GO7DVV'K M^EH14*BDIB!JN, .*-5,2L>?B=2=:^K$Y? M(4)=1"8_NG(1^#A#C#+$AB&^9@BL?1A!F0%U!A0EEA,$$N,Z$E1'@NFPMJL< M0>FB2!);.A!(A.M(41TIIB.R=*0W13XEF24$PX2XD@Q5DF%*++ME=E,ELL\8 M GGGC*U0'2OLC+W#L$89UIB3U'*R_K^3]4?'\$J':K#HI?-$LGYZG[SYD2S^ 5!+ P04 M " !;B9-/[/GN*;P" !4"@ &@ 'AL+W=O&ULE5;;CML@$/T5RQ^P-O@>)9%R4=5*K11MU>TS24ABK6U<(,GV[PO8 MZW7PL%)?;, SY\R,.3#S.^.OXD*I]-[JJA$+_R)E.PL"<;C0FH@GUM)&?3DQ M7A.IIOP4O.]">5O]H=5[-@0#F6-6U$R1J/T]/"7Z'9%A7:P5B\ ME/0N1F-/I[)G[%5/OAT7?J@CHA4]2 U!U.M&-[2J-)**XT\/Z@^R)H!M6_2Z/\K+P<]\[TA.Y5O*9W;_2/J'$]_KLO],;K92YCD1Q'%@E MS-,[7(5D=8^B0JG)6_#'7#O@ <'E'[J$/4.T8=#_*E#W#O$ MED/0I6)JLR62+.>_=Z6Z%V$9K&J_D$OFF*;;ZH\0JW>E@BC?![<-%)O MM.Z,\-AHL @4_,"!(8XUGKCC1X+-U")-'DVV@$D*!Q&!B4;&/WI,M( 18A A M-@CQ P(.K5)U1IDQ:HQ1EL$D"4B2 &%B1[53$"&%PK0*ONZ,TE&8"89),I D M@T@BBR2;D,2.3'*0)(=(8HLDGY!@QU\M0)("(K$VW[J8DC@R02$LLQ"B26V= MA1,>%#MX'')&$$]F\Z#I[W>("8&27B$,[=/<@0$K$D50K(4=:S2)U44#RQ9! MNHULW?968QI716#AH@2B039-,JV\@P96-X+D'=GR1E-]9]:>WO0VXZ,JM<2U M!6P2QW&&X(,"02=%%#DPX', Y?]Q=B-8Y@C4^607%)-\L?U_@M'56E-^-FV+ M\ [LVDA]08U6A]9HA?75;*VO=CXQ)JD* M,7Q2.^BB6KQA4M&3U,-,C7G7YW03R=J^APN&1G+Y#U!+ P04 " !;B9-/ MZRQ&#T$" "4!P &@ 'AL+W=O&ULC57K M;ML@%'X5RP]0C*]QY5A:TTZ;M$E1IVZ_24)BJ]AX0.+N[0>8>+%S$NV/N?B[ M< X'*'HNWF5%J?(^&M;*I5\IU3TB)+<5;8A\X!UM]9\]%PU1>B@.2':"DITE M-0R%09"BAM2M7Q9V;BW*@A\5JUNZ%IX\-@T1?YXHX_W2Q_YYXK4^5,I,H++H MR('^H.JM6PL]0J/*KFYH*VO>>H+NE_XG_/B"+<$B?M:TEQ=]SX2RX?S=#+[N MEGY@5D09W2HC071SHBO*F%'2Z_CM1/W1TQ O^V?USS9X']4]72 M7_C>CN[)D:E7WG^A+J#$]USTW^B),@TW*]$>6\ZD_7K;HU2\<2IZ*0WY&-JZ MM6WO],\TF! Z0C@2<'J7$#E"](\0WR7$CA#_+R%QA&1&0$/L-IG/1)&R$+SW MQ% /'3%EAQ\3O5U;,VEWQ_[3^91Z]E3B,(H+=#)*#O0T@,(I*)F"5M>@<(IX M!F72*>@%!&4C".EHQI!",*30*D13A06L$($*D56(IPKY+"D0* Y@FQBTB2$% M/$LK" IAFP2T22"%:&8S@#(+:BTH"A+8)05=4LAE5DBK 91>N.#\1LHRT"6# M7.:5F%V[!,$-FP5HLX!L9I6Z6ES;X!LIRT&7''+)9HM+?5 MGG-%M5SPH NWTD_D.&!TKTPWTWTQO!/#0/'.O8%H?(C+OU!+ P04 " !; MB9-/C.#IECL# \#P &@ 'AL+W=O&UL ME5?;CILP$/T5Q ZW42JM6;9_9Q$G0 D[!2;9_7P->-MC'4?(2 ML#DS9\:>,[&G1UZ_-5O&A/->%E4S<[="[&X]KUEN69DU-WS'*OEES>LR$W)8 M;[QF5[-LU1F5A4=]/_;*+*_<^;2;>ZGG4[X715ZQE]II]F69U?\6K.#'F4O< MCXD?^68KV@EO/MUE&_:3B5^[EUJ.O,'+*B]9U>2\)W MSH[-R;O3IO+*^5L[^+J:N7X;$2O84K0N,ODXL#M6%*TG&<=?Y=0=.%O#T_=%TO\YRWPA>*B\RE#)[[Y]YU3V/_9_UV=/M[GXEL/JWYT:G[$MUE MK1+(;2HK:-E.=@73?9-;W,C9PYS0R)]ZA]:3 BUZ$!V#R!AT!T%T#+J'H& , M>H"@< QZA*!H#'J"H'@,>H:@9 !YB8H3V^)AP1,DYD3[ M'UQ@%+4P8P33?8+A8I/B8@E(XIE3TW92Z)()R(& MD97'\E=,$4^L\U"#)[30X/9!46-($ITF,-.QT.#>0(6E2G<;L"[9L<%>@ MIMZM/9EBN=/XBIY,L9 I%+)V"GJ J-16]EC)%&E4/V\]*-1E^L)"IDC(*=&) M3"$'^@YZ)R?Z]E[Y/:LW>=4XKUS(RT%WA%]S+ICTY]_(_=S*J^PP*-A:M*^) M?*_[^UP_$'RG[JK><&&>_P=02P,$% @ 6XF33RN"XN$I P S \ !H M !X;"]W;W)K$[PZLKJ]^9$*;<^ MBKQLUO:)\^K1<9K=B1:D>6 5+<63 ZL+PL5E?72:JJ9DWP85N8-=-W0*DI7V M9M7>>ZXW*W;F>5;2Y]IJSD5!ZG\IS=EU;2/[\\9+=CQQ>,7IO!N25+>6/L75Y\WZ]M5RJB M.=UQ24'$X4*W-,\ED]#Q5Y':?4X9.#S_9/_:%B^*>2,-W;+\3[;GI[4=V]:> M'L@YYR_L^HVJ@@+;4M7_H!>:"[A4(G+L6-ZTO];NW'!6*!8AI2 ?W3$KV^.U M>Q*&*@P.P"H ]P'(7PSP5(!G&N"K '\2X'2EM+UY(IQL5C6[6G7W>BLB5Q%Z M]$7W=_)FV^SVF6A/(^Y>-@C'>.5<)),"I1T(#T 3Q%9'A,$8\J1#1":O!SE" M9J\5@UIQR^"-&7R8P0,9O);!'S-,A*8=*&I!90>*XG!2, 1*,*S%![7XD)9) MFK0#A8,T[D2(CH@FC?. YQS=,^@(GG1D,NHITF<]2+09 M6@:-U<".@$PL(46Z)VBK90DR_A^&;0.;V$:* =O0^G(#-%8#>PN&O"69JVCF MT^(>;\&PMV C;\&Z;> DGG8% LUU!?86;.0M^+:W+$+&2F!OP4;>@G7; /H" M@>;Z GL+AKPE03,[P%P]Z"C;P%0]\1TX]O #3WAF!GP4;.@F\[RR)D M_'T..XMGY"P*%2UV!0!-M3B#79+N#R-!+G=;>_["XXJ]3>V>DW\)O_4$L#!!0 ( %N)DT_)H6(! MQ00 &\< : >&PO=V]R:W-H965T M2U_>!P+31J7U6'^ MXA6GW,3;)BA-/.G[@9?&A^-X/FW./>;S:?9:)H>C>?GN(7\Z7 MFG7@]??W[)^;P5>#>8H+L\R2?P[;CSJ1O^[ M>3-)):\[J6H\9TG1_!T]OQ9EEG99JE;2^$?[>3@VG^?VET!U87R [ +D)4 $ M'P90%T"N :H+4*X!N@O0K@%!%Q"X!H1=0/@SX.-9FG0!$]> J N(7 .$_[YR MOG/(9;&%%>*UNZ39=JNXC.?3/#N/\M8YI[@VJ+BKHJKD]=EF(S<_5ENOJ,Z^ MS86,Y-1[JU-UHD4KDGT1]45+3J3#OFC%9E)]T9H5Z;[H,UO.$GT9BJRAW;.U M@KYH,Q0%5J6O;!YK] ]LSS]'[U5+=5DOR:^7;%)0+\4$I" ^!34I5#^%/7.M M*&Q$QU843NQYX417FZ?7C.*;48-F(AGR&32?0=\P(P&?(G"8D4TK"JX&JZ*( M+Q/R94*F3.!;^YH5:;[.A*\S85)$$ZO.9+!VVK=Z>?A8TVLEXEN)N%8BJQ5. M%(!-4#.2Y9C/);$'S:O *@J$3,$D">UU9%1!""9/ +,+R6W,"4@"["[H!H,( M8%,Q]"D#C4YU[1&R5WOS"U&_'>!YH1VLM.94A#:P &P0'!QL-ZT[U;55%*P$ M\" XZ]O3M^94Y M0"A!"<(BPW;+F5.0#O@M ,&YVW;+FE.13WPI"1@@&7>3 M;]]=\"I 6 D8(!D&D!_8I5@5()M$5WP6 L P$D! W@(!"2 @G2 @A_[6]IW0 MYA>B?CL M(% BM.13Y@J 00D"X06,DA! ($ 0D@(%T@L.)4Y*,] 2 @72"P MXE0DT*@ !*0+!%:RGRUM.M&U7X!;%$" X#%$" !'/73:8&:_ZN&S.?C 00,WZJ'/F)F-!H5L)WI7;QOJ5W%_Q/G+X5B,GK*R MS-+F[<(NRTI3I?,_50NU-_'V?L*K#THLU/W>L^[O&.<_P]0 M2P,$% @ 6XF33Y,.0X\9*B%]PC6J^)V6DBU_8D3?"5%7F%]L2BU[*$Y.\S*G"S MM(']L?"27S(F%IPTJ>$%O2+VL]X3/G,ZE5->HHKFN+((.B_M+V"Q X$@2,2O M'#6T-[9$* >,W\3DVVEIN\(C5* C$Q*0OVYHA8I"*'$__BA1N[,IB/WQA_I6 M!L^#.4"*5KCXG9]8MK1GMG5"9W@MV MNOB(54&A;*OKOZ(8*#A>>6:PT93!."&XNT'5=#T=A@$?.&.(I%67_YC5>, M\M5;"GPO3)R;4%*@YQ;D]4%>& ]!*R,H&(+6.L@;(C8Z(AJYLS5 HB%D9W)F MYG<@A^>D2XQG3(PG%?RA0F!6\(T*OE0(>@IS,!]EML7$$E.U5MQ1RG3(*-B- MCAAI;.\A!I$$QD@"+1*>BY$7ZQ8437NQ"30O1CVTTQ&^.^%I:/0T-'@:CI,> MWDOZP$AD-!+I1GQOG(Y(2T=HMA$;;<1Z\WBQ66!F%)A]HG_G1H6Y(9?Q*)J4$FJ@?, MAP?P/U$_8-ZV0-^WC\3<4/Y *;*^.7HFY2H#,3PYB/27LS:"<,U^K6XW17K_0?4$L#!!0 ( %N)DT]' M]!A,GP( "\) : >&PO=V]R:W-H965T<%!$@%6FW2)E6=MGUVP4#4),YL ]V_G^V8E"27BGTA]O$\ MS]W99Y_G%R[>Y)$QY;V71247_E&I>A8$ M_,YWZKCP,]_;L3T]%>J%7[XPEU#L>R[[;^S,"@TWD6@?6UY(^^MM3U+QTJGH M4$KZWGSSRGXO3O]*@PG8$7!+0,FGA,@1H@\"^91 '('<2X@=(;Z7D#A"\D&( M['XTBV57?T,57, MZVSH)-1VH-@=?$ \)W M5-O*H3J5A,+)R 8B^ @C\ S'?5?1(*D41R..X)..R!VULG*HSNJ%@TLIN+G3 M2R8.MB-+;\M/E3(WVHVU[?H/V/2$GGV%9INF=W_(-$^)[U0<\DIZKUSICF/[ MPIYSQ720X41?)T?]>FDG!=LK,TSU6#0MO)DH7KOG2="^D9;_ %!+ P04 M" !;B9-/>!$H,7P" !%"0 &@ 'AL+W=O&ULE5;M;ILP%'T5Q ,4S#<505IHIDW:I*A3M]].X@14P,QVDN[M9QO"^+BT MV1^PS3GGGGMM;"=7REYY3H@PWJJRYBLS%Z)YM"R^STF%^0-M2"V_'"FKL)!= M=K)XPP@^:%)56HYM!U:%B]I,$SVV96E"SZ(L:K)E!C]7%69_UJ2DUY6)S-O M5J:M')&2[(62P/)U(1DI2Z4D??SN1,T^IB(.VS?USSIYFOU"NH1\T^BR_T8NI)1PY43&V-.2ZZ>Q/W-! MJTY%6JGP6_LN:OV^=OHW&DQP.H+3$U#P+L'M".X_@OL(WKT$OR/X$X+5 MYJZ+^80%3A-&KP9KUT.#U;)#C[Z]D?+_UU!QI6 MU%_85-#")HF@DGK3."#*7X@$[U_(@32":200%2Y$@O&PO=V]R M:W-H965T]?<#"@BD4J2JI5:*=IJ MVV8DOG#-SCF=D)^L8?Q<%I=+YJ*M&+-U"RG:! MD#@4M";BA;6T45].C-=$JB4_(]%R2HZ&5%1,?U+YUNZX6J$QRK&L:2-*UCB< MGI;N9W^Q337> 'Z5M!.3N:.=[!E[UXMOQZ7K:4&TH@>I(Q U7.F:5I4.I&3\ M&6*Z8TI-G,YOT;\8[\K+G@BZ9M7O\BB+I9NZSI&>R*62KZS[2@<_V'4&\]_I ME58*KI6H' =6"?/K'"Y"LGJ(HJ34Y*,?R\:,W1#_1H,)P4 (1H(?_9<0#H3P M64(T$*)G"7@@8(N >N_F,#=$DE7&6>?POAU:HKO.7V!5KH/>--4QW]1Y"K5[ M7?DA]C)TU9$&4-Z#@@DHN$>LYP@<6%$VU \31-ZL248 M 6>#VN)0"T1I"6TM$3S-/;YSB&VUCDBL4X62!/ 7C#H!0->4LL*GN? =HG7 M>%[BR+=Z>P-$BCPKW1:(%$8/FB4&3<50@2S!>3S38JN=(R:&[F0DH(P$DF$E MR1,@B=5+&P 3/JAR"BI)(256L^7I[-QM'7.$9ZE DSM7O[(_"#^7C7#V3*KK MVURR)\8D5=&\%U7H0CWLXZ*B)ZFGB9KS_GGK%Y*UP\N-QK\/JW]02P,$% M @ 6XF33S%;8?+!! "AL !H !X;"]W;W)KP;Z MB1;6EC/-J5=J5H1KO[3.QVC :,!T@\^^^W MP<2"JM,.+[%Q3E>?ZLO7!2PO9?6C/AK3S'X5^:E>><>F.3_Z?KT[FB*MOY1G M<[+_.915D3;VLGKUZW-ETGW7J,A]&0217Z39R5LON]^>J_6R?&OR[&2>JUG] M5A1I]=^3RQP_?LM=CT_[@KY?G]-5\-\W?Y^?*7OFW*/NL,*2G+'^W%'_N5%[2.3&YV31LBM1_O9F/R MO(UD??SL@WJW/MN&P^\?T;]VR=MD7M+:;,K\WVS?'%?>W)OMS2%]RYMOY>5W MTR<4>K,^^S_-N\FMO'5B^]B5>=W]G>W>ZJ8L^BC62I'^NGYFI^[STL?_:(8; MR+Z!O#40^FX#U3=04QOHOH&>VB#L&X2D@7_-O1O,)&W2];(J+[/JNA[.:;OL MQ&-HIVO7_MC-3O<_.YZU_?5]+508+_WW-E(O>KJ*Y$ 4RF"LV7"-'"L2KHC" ML60+)-%-XMM$;ME(F(WLVNM!^[E>D&2NFKC3G#K-@P[F))LIH@2(E';X5="O M8GY#)8C?JR8:]A+C/C3L0[,^[ S3?#7O1$2*Y M$"X6MA-!*B*R0^=F$K!=) MC7")"K&/"/J(@(^(+NB(=:+)U"1<\J"QCQCZB)$/TLDF!J-.QBP!FHALOVW, M5JL('0MI#MW.^>8*22=/ FJ&2^QD.KQ@: M. M;;L-)/4B/_=R3S)V@G$L.(\!& 0GLF!6[E*[/^R QH%3@=$N$-L90 3G-O<+ MV#Y8#F,S&.Z"TYWS07!THWV 5 ';!U-B;9'*O5OP>2$B1@D[SJZYPJP7'/8 M$QSD0K'1F2!*D$B[=@/FO># MUDS-YS!;''=DXR=8$B+Q93"H5>-9IJ6;/\'G@83% M/^,(Q[AD$\4U+DI@T$L.^@6;(U!J+^A]&1+1J@=HA'3YQ<>!Y,?2Q(@>9 .LYCX M"A7_C!"*,YB=4$#CN+U5CHA$CQVQ- 8;IJ7SMRIGESS:HP_C6K> MV/%(0F,J:4XEX!1 R3%U&A-'(^+$CB6D'8]W.2J 5O92-DU9=.\(#F79&!LO^&)W\M&D^]M%;@Y-^S6VWZOKVYGK15.>^S=/ M_NWUU_I_4$L#!!0 ( %N)DT^JQVG$B0( @) : >&PO=V]R:W-H M965T.PP\% MJ3%_IBUIY)L39346.Y[J14^.RL;-4K[VR+*47494->646 MO]0U9O]R4M%N8R/[MO!6G@NA%IPL;?&9_"3B5_O*Y,P9O1S+FC2\I(W%R&EC MOZ#U#FD#K?A=DHY/QI8*94_INYI\.VYL5Q&1BAR$<;&GUISR*8F,GMG4D)WRIQ!OMOI(AH-"VANB_DRNI MI%R1R#T.M.+ZUSI+E>O&?)C M/W6NRM,@RGN1-Q6-"D>Z'_?PH#UR;V'NS3?8+A51.)?L $D$0_A@H+ZV#^:! M!D:@O2C6HD:+GA(#%9 $,$< <@00AQ%LWHNBZ29FRI829&0L6)"Z,&@(@H80 M:&2 A@L*0[%=*IZ,\MJ%"] [Y16!H!$$&AN@$8"Q,E ?:V8D,4@2+TE<9'R6 M/%[N8M;80\F,(P$Y$B@CQB9Y D1KL&X?:V8D*Y!D!9$8><]7RU(VJQV0W"EF MY,+GG N0)*YYT+G+@)%9)I#(NY,5=.?411"-62F#:G;6(-^D 42>>2(YDW90 M$W;6K99;!WIIA#I4)ZMC.W_Q5#LQUG/5YG6;^733WQ%^8'8N&V[MJ9#-2K>4 M$Z6"2$;W6?[#"WDM&2<5.0DUC.68];VYGPC:#O<.9[S\9/\!4$L#!!0 ( M %N)DT\*)HO&,@0 &P5 : >&PO=V]R:W-H965TG!$@S8"J7:F51EWM[N<,&(B:Q#0Q0_OOF[?2 MX'O<8;X "8^OCV]\3VPO+KKYVAZ5,M[WJJS;I7\TYO00!.WVJ*J\_:!/JN[^ MV>NFRDUWV1R"]M2H?#%*EOBQ]YO^Z\:4X'$U_(U@M3OE!_:/,OZ?GIKL*KE%V1:7JMM"UUZC]TG]D M#QL1]0T&XK]"7=K9;Z\?RHO67_N+OW=+/^P5J5)M31\B[[Y>U5J591^IT_%M M"NI?^^P;SG__BOYQ&'PWF)>\56M=_E_LS''I2]_;J7U^+LT7??E+30.*?6\: M_2?UJLH.[Y5T?6QUV0Z?WO;<&EU-43HI5?Y]_"[JX?LR_A/+J1ENP*<&_-J M_[F!F!J(WPW8'QM$4X/(:A",0QERL\E-OEHT^N(UX^,]Y?TL8@]1E_UM?W-( M]O!?EYZVN_NZ8D+R1?#:1YJ@IQ'B<^A*!%WX:Q\<]?'$:7,AQ6T?:PIE++QE M-I1)PPPK$7"T8@@@9@&X3'& " :(A@#1[5 B*UTCE Q0/4 "]Q'#/F+41VSU M :'$RND]T.8-Z$9P @4G)*M=!$=:4Q@A)1H2:0UX1-)94F.6V).(0E'&K,>S M 5"4"4P;*2,.BFI(4:--(Z(9 0) M6S&%HM3UK+$K,^J3M) FZ*8?NY (Z2M%S"Q0R[V9);<4TD)[<:VU#N8#6)< MV<4O $;? +&S"K I,_F>2L)FR:A;TDJ"3DB>,O)"DC<*29<%<>R8G#HFJ2-. MC8[9"XHU@E);,((21XHY]DQ./9/6T00YYO\D&#!$+V!<^<7^S/D==31!-VF) M;+EO,QO$N.3B5P&GKX(X4ML,C2#A6W1Q[)J>>"2HIO:.2 $,R3!GN MV'IQ[,^]B,1UF_PXSGD)_SYE#4K?>BC='5 M<&RUU]JH3F+XH7L%'%6^NUZ4:F_ZGVGWNQG/_\8+HT_3V69P/6!=_0102P,$ M% @ 6XF33X@?-V(< P #0T !H !X;"]W;W)K,ZLJCOA]Y=5$V[GIIYI[$>LE/LBH;]B2<[E37A?B; ML8I?5BYQ/R:>R\-1Z@EOO6R+ _O)Y$O[)-3(&[WLRIHU7/]B@E?!O!8=V_#J=[F3QY6;N,Z.[8M3)9_YY2L; EJXSA#]=W9FE9)K M$K7&EE>=^76VIT[R>O"B4.KBO;^6C;E>!O\?9K@!'0SH:- G9]8@& R"3X/P MID$X&(3 P.M#,;G)"UFLEX)?'-$_WK;0NX@\A"K[6SUIDFW^4^GIU.QY38(D M77IG[6D09;V(3D6CPE/NQS4HMD9&+7-ZO<#&5D2+:TF.2"(<(D ##8Q]0M1#:#R$UQX(2%4OBHVHZ474A^$B(N*'(&!;E,8!SKM >1<8+T#)>E$T M6>6.4)#[#2;RX0/"1"3&@2,4.,* P !%-!3XR1%-,+,=8I0VQFC! M0\QBA!9H-H@&/H$@Q,=/3A]#C>#1Z=]\&/( M2Y#="'$1#3R]$,T<+EHT'@FU<2-XV@ZBN;=XP$5$\/W"-#-G%\'K"PDLWACN MVT$S726(("VBL?:"K:$SIP'!:QE!BUD">4,D*_#X0D56?C%1.H.,ES-BU[/8 MVKUV$2)6@FU-#,\&1+.8J;T$KV7$+F:QE=[(+O$DA;B(*(P@KRU*? CL37K" MFHF#Z;<[9\M/C=2=U61V[.D?J>XIP7RF>WW3:WZZZ3\4?A3B4#:=\\JEZEA- M7[GG7#+%Z-^KG![5M\DXJ-A>ZMM8W8N^0>\'DK?#QX?^2A- M?*^KY@]@<^[UL8\Y^$[/JGYI]E)J[[4LJF;F[[4^3(*@6>]EF35WZB K\V:K MZC+3IEGO@N90RVS3!95%0,,P#LHLK_SYM.M[JN=3==1%7LFGVFN.99G5_Q:R M4.>93_RWCN=\M]=M1S"?'K*=_"GUK\-3;5K!F&63E[)J:2B M#>@0OW-Y;BZ>O78J*Z5>VL:WS

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end XML 82 R76.htm IDEA: XBRL DOCUMENT v3.19.3.a.u2
INVENTORY (Details) - USD ($)
$ in Millions
 12 Months Ended
Oct. 31, 2019
Oct. 31, 2018
Oct. 31, 2017
Nov. 01, 2018
Inventory [Line Items]        
Finished goods $ 416 $ 386    
Purchased parts and fabricated assemblies 263 252    
Inventory 679 638   $ 628
Inventory-related excess and obsolescence charges $ 19 $ 26 $ 24  

XML 84 R86.htm IDEA: XBRL DOCUMENT v3.19.3.a.u2
DERIVATIVES, Disclosures and derivative instrument aggregated notional amounts by currency and designations (Details) - Forward Contracts Buy/(Sell) [Member]
$ in Millions
Oct. 31, 2019
USD ($)
Designated as Hedging Instrument | Cash Flow Hedges | Buy | Australian Dollars  
Derivative [Line Items]  
Derivative, Notional Amount $ 4
Designated as Hedging Instrument | Cash Flow Hedges | Buy | Singapore, Dollars  
Derivative [Line Items]  
Derivative, Notional Amount 14
Designated as Hedging Instrument | Cash Flow Hedges | Sell  
Derivative [Line Items]  
Derivative, Notional Amount 305
Designated as Hedging Instrument | Cash Flow Hedges | Sell | Euro  
Derivative [Line Items]  
Derivative, Notional Amount 40
Designated as Hedging Instrument | Cash Flow Hedges | Sell | British Pounds  
Derivative [Line Items]  
Derivative, Notional Amount 45
Designated as Hedging Instrument | Cash Flow Hedges | Sell | Canadian Dollars  
Derivative [Line Items]  
Derivative, Notional Amount 38
Designated as Hedging Instrument | Cash Flow Hedges | Sell | Japanese Yen  
Derivative [Line Items]  
Derivative, Notional Amount 82
Designated as Hedging Instrument | Cash Flow Hedges | Sell | Korean Won  
Derivative [Line Items]  
Derivative, Notional Amount 59
Designated as Hedging Instrument | Cash Flow Hedges | Sell | China, Yuan Renminbi  
Derivative [Line Items]  
Derivative, Notional Amount 59
Derivatives Not Designated as Hedging Instruments | Buy  
Derivative [Line Items]  
Derivative, Notional Amount 301
Derivatives Not Designated as Hedging Instruments | Buy | Euro  
Derivative [Line Items]  
Derivative, Notional Amount 141
Derivatives Not Designated as Hedging Instruments | Buy | British Pounds  
Derivative [Line Items]  
Derivative, Notional Amount 1
Derivatives Not Designated as Hedging Instruments | Buy | Canadian Dollars  
Derivative [Line Items]  
Derivative, Notional Amount 25
Derivatives Not Designated as Hedging Instruments | Buy | Malaysian Ringgit  
Derivative [Line Items]  
Derivative, Notional Amount 11
Derivatives Not Designated as Hedging Instruments | Buy | Danish Krone  
Derivative [Line Items]  
Derivative, Notional Amount 237
Derivatives Not Designated as Hedging Instruments | Buy | Singapore, Dollars  
Derivative [Line Items]  
Derivative, Notional Amount 28
Derivatives Not Designated as Hedging Instruments | Sell | Japanese Yen  
Derivative [Line Items]  
Derivative, Notional Amount 7
Derivatives Not Designated as Hedging Instruments | Sell | Korean Won  
Derivative [Line Items]  
Derivative, Notional Amount 32
Derivatives Not Designated as Hedging Instruments | Sell | Swiss Franc  
Derivative [Line Items]  
Derivative, Notional Amount 2
Derivatives Not Designated as Hedging Instruments | Sell | China, Yuan Renminbi  
Derivative [Line Items]  
Derivative, Notional Amount 70
Derivatives Not Designated as Hedging Instruments | Sell | Sweden, Kronor  
Derivative [Line Items]  
Derivative, Notional Amount 8
Derivatives Not Designated as Hedging Instruments | Sell | Other Currency  
Derivative [Line Items]  
Derivative, Notional Amount $ 23
XML 85 R110.htm IDEA: XBRL DOCUMENT v3.19.3.a.u2
STOCKHOLDERS' EQUITY STOCKHOLDERS' EQUITY - Reclassifications out of accumulated other comprehensive income (Details) - USD ($)
$ in Millions
 12 Months Ended
Oct. 31, 2019
Oct. 31, 2018
Oct. 31, 2017
Unrealized gains (losses) on derivatives reclassification out of AOCI to cost of sales $ (8) $ (4)  
Other Comprehensive Income (Loss), Reclassification Adjustment from AOCI on Derivatives, Tax (2) 1 $ 0
Other Comprehensive Income (Loss), Reclassification Adjustment from AOCI on Derivatives, Net of Tax 6 (3) $ 1
Other Comprehensive Income Defined Benefit Plan Amortization Of Net Actuarial Loss (39) (39)  
Amortization of prior service benefit (8) (8)  
Other Comprehensive (Income) Loss, Defined Benefit Plan, Reclassification Adjustment from AOCI, before Tax (31) (31)  
Other Comprehensive (Income) Loss, Defined Benefit Plan, Reclassification Adjustment from AOCI, Tax 12 10  
Other Comprehensive (Income) Loss, Defined Benefit Plan, Reclassification Adjustment from AOCI, after Tax (19) (21)  
Reclassification from Accumulated Other Comprehensive Income, Current Period, Net of Tax $ (13) $ (24)  
XML 86 R114.htm IDEA: XBRL DOCUMENT v3.19.3.a.u2
SEGMENT INFORMATION - Entity-Wide Disclosures Revenue (Details) - USD ($)
$ in Millions
 12 Months Ended
Oct. 31, 2019
Oct. 31, 2018
Oct. 31, 2017
Revenue by geography      
Net revenue $ 5,163 $ 4,914 $ 4,472
UNITED STATES      
Revenue by geography      
Net revenue 1,619 1,414 1,314
CHINA      
Revenue by geography      
Net revenue 1,019 1,015 900
Rest Of World      
Revenue by geography      
Net revenue $ 2,525 $ 2,485 $ 2,258
XML 87 R55.htm IDEA: XBRL DOCUMENT v3.19.3.a.u2
ACQUISITIONS - Assets and Liabilities Assumed (Details) - USD ($)
$ in Millions
 12 Months Ended
Oct. 31, 2019
Oct. 31, 2018
Business Acquisition [Line Items]    
Goodwill Additions $ 625 $ 381
BioTek [Member]    
Business Acquisition [Line Items]    
Cash and cash equivalents 10  
Accounts receivables 28  
Inventories 21  
Other current assets 2  
Property, plant, and equipment 8  
Intangible assets 641  
Goodwill Additions 483  
Total assets acquired 1,193  
Accounts payable 4  
Deferred revenue 5  
Employee compensation and benefits 7  
Other accrued liabilities 2  
Long-term debt 4  
Net assets acquired $ 1,171  
XML 88 R51.htm IDEA: XBRL DOCUMENT v3.19.3.a.u2
NEW ACCOUNTING PRONOUNCEMENTS - Impact of adopting new guidance (Details) - USD ($)
$ in Millions
 12 Months Ended
Oct. 31, 2019
Nov. 01, 2018
Oct. 31, 2018
Oct. 31, 2017
Oct. 31, 2016
Cash and cash equivalents $ 1,382 $ 2,247 $ 2,247 $ 2,678  
Accounts receivable, net 930 800 776    
Inventory 679 628 638    
Other current assets 198 190 187    
Total current assets 3,189 3,865 3,848    
Property, plant and equipment, net 850 822 822    
Goodwill 3,593 2,973 2,973 2,607  
Other intangible assets, net 1,107 491 491    
Long-term Investments 102 75 68    
Other assets 611 332 339    
Total assets 9,452 8,558 8,541    
Accounts payable 354 340 340    
Employee compensation and benefits 334 304 304    
Deferred revenue 336 313 324    
Other accrued liabilities 440 203 203    
Total current liabilities 2,080 1,160 1,171    
Long-term debt 1,791 1,799 1,799    
Retirement and post-retirement benefits 360 239 239    
Other long-term liabilities 473 763 761    
Total liabilities 4,704 3,961 3,970    
Preferred stock; $0.01 par value; 125 million shares authorized; none issued and outstanding 0 0 0    
Common stock; $0.01 par value; 2 billion shares authorized; 318 million shares at October 31, 2018 issued 3 3 3    
Additional paid-in-capital 5,277 5,308 5,308    
Accumulated deficit $ (18) (303) (336)    
Effective Income Tax Rate Reconciliation, at Federal Statutory Income Tax Rate, Percent 21.00%        
Accumulated other comprehensive loss $ (514) (415) (408) (346)  
Total stockholders' equity 4,748 4,593 4,567    
Non-controlling interest 0 4 4    
Total equity 4,748 4,597 4,571 $ 4,835 $ 4,246
Total liabilities and equity $ 9,452 8,558 $ 8,541    
Impact of Adopting New Revenue Recognition Guidance [Member]          
Cash and cash equivalents   0      
Accounts receivable, net   24      
Inventory   (10)      
Other current assets   3      
Total current assets   17      
Property, plant and equipment, net   0      
Goodwill   0      
Other intangible assets, net   0      
Long-term Investments   0      
Other assets   (3)      
Total assets   14      
Accounts payable   0      
Employee compensation and benefits   0      
Deferred revenue   (11)      
Other accrued liabilities   0      
Total current liabilities   (11)      
Long-term debt   0      
Retirement and post-retirement benefits   0      
Other long-term liabilities   2      
Total liabilities   (9)      
Preferred stock; $0.01 par value; 125 million shares authorized; none issued and outstanding   0      
Common stock; $0.01 par value; 2 billion shares authorized; 318 million shares at October 31, 2018 issued   0      
Additional paid-in-capital   0      
Accumulated deficit   23      
Accumulated other comprehensive loss   0      
Total stockholders' equity   23      
Non-controlling interest   0      
Total equity   23      
Total liabilities and equity   14      
Impact of Adopting New Tax Effects in AOCI Guidance [Member]          
Cash and cash equivalents   0      
Accounts receivable, net   0      
Inventory   0      
Other current assets   0      
Total current assets   0      
Property, plant and equipment, net   0      
Goodwill   0      
Other intangible assets, net   0      
Long-term Investments   0      
Other assets   0      
Total assets   0      
Accounts payable   0      
Employee compensation and benefits   0      
Deferred revenue   0      
Other accrued liabilities   0      
Total current liabilities   0      
Long-term debt   0      
Retirement and post-retirement benefits   0      
Other long-term liabilities   0      
Total liabilities   0      
Preferred stock; $0.01 par value; 125 million shares authorized; none issued and outstanding   0      
Common stock; $0.01 par value; 2 billion shares authorized; 318 million shares at October 31, 2018 issued   0      
Additional paid-in-capital   0      
Accumulated deficit   7      
Accumulated other comprehensive loss   (7)      
Total stockholders' equity   0      
Non-controlling interest   0      
Total equity   0      
Total liabilities and equity   0      
Impact of Adopting New Intra-Entity Tax Guidance [Member]          
Cash and cash equivalents   0      
Accounts receivable, net   0      
Inventory   0      
Other current assets   0      
Total current assets   0      
Property, plant and equipment, net   0      
Goodwill   0      
Other intangible assets, net   0      
Long-term Investments   0      
Other assets   (2)      
Total assets   (2)      
Accounts payable   0      
Employee compensation and benefits   0      
Deferred revenue   0      
Other accrued liabilities   0      
Total current liabilities   0      
Long-term debt   0      
Retirement and post-retirement benefits   0      
Other long-term liabilities   0      
Total liabilities   0      
Preferred stock; $0.01 par value; 125 million shares authorized; none issued and outstanding   0      
Common stock; $0.01 par value; 2 billion shares authorized; 318 million shares at October 31, 2018 issued   0      
Additional paid-in-capital   0      
Accumulated deficit   (2)      
Accumulated other comprehensive loss   0      
Total stockholders' equity   (2)      
Non-controlling interest   0      
Total equity   (2)      
Total liabilities and equity   (2)      
Impact of Adopting New Investments Valuation Guidance [Member]          
Cash and cash equivalents   0      
Accounts receivable, net   0      
Inventory   0      
Other current assets   0      
Total current assets   0      
Property, plant and equipment, net   0      
Goodwill   0      
Other intangible assets, net   0      
Long-term Investments   7      
Other assets   (2)      
Total assets   5      
Accounts payable   0      
Employee compensation and benefits   0      
Deferred revenue   0      
Other accrued liabilities   0      
Total current liabilities   0      
Long-term debt   0      
Retirement and post-retirement benefits   0      
Other long-term liabilities   0      
Total liabilities   0      
Preferred stock; $0.01 par value; 125 million shares authorized; none issued and outstanding   0      
Common stock; $0.01 par value; 2 billion shares authorized; 318 million shares at October 31, 2018 issued   0      
Additional paid-in-capital   0      
Accumulated deficit   5      
Accumulated other comprehensive loss   0      
Total stockholders' equity   5      
Non-controlling interest   0      
Total equity   5      
Total liabilities and equity   $ 5      
XML 89 R59.htm IDEA: XBRL DOCUMENT v3.19.3.a.u2
REVENUE - Revenue by End Markets (Details) - USD ($)
$ in Millions
 12 Months Ended
Oct. 31, 2019
Oct. 31, 2018
Oct. 31, 2017
Disaggregation of Revenue [Line Items]      
Net revenue $ 5,163 $ 4,914 $ 4,472
Pharmaceutical and Biopharmaceutical Market      
Disaggregation of Revenue [Line Items]      
Net revenue 1,604    
Chemical and Energy Market      
Disaggregation of Revenue [Line Items]      
Net revenue 1,199    
Diagnostics and Clinical Market      
Disaggregation of Revenue [Line Items]      
Net revenue 785    
Food Market      
Disaggregation of Revenue [Line Items]      
Net revenue 486    
Academia and Government Market      
Disaggregation of Revenue [Line Items]      
Net revenue 474    
Environmental and Forensics Market      
Disaggregation of Revenue [Line Items]      
Net revenue $ 615    
XML 90 R7.htm IDEA: XBRL DOCUMENT v3.19.3.a.u2
CONSOLIDATED STATEMENT OF CASH FLOWS - USD ($)
$ in Millions
 12 Months Ended
Oct. 31, 2019
Oct. 31, 2018
Oct. 31, 2017
Cash flows from operating activities:      
Net income $ 1,071 $ 316 $ 684
Adjustments to reconcile net income to net cash provided by operating activities:      
Depreciation and amortization 238 210 212
Share-based compensation 72 70 60
Deferred taxes (255) (16) 102
Excess and obsolete inventory related charges 19 26 24
Gain on step acquisition 0 (20) 0
Asset impairment charges 0 21 0
Loss on extinguishment of debt 9 0 0
Other 6 9 7
Changes in assets and liabilities:      
Accounts receivable, net (106) (65) (81)
Inventory (36) (83) (61)
Accounts payable 29 40 2
Employee compensation and benefits 23 31 38
Change in assets and liabilities due to Tax Act 0 552 0
Treasury lock agreement payment (6) 0 0
Other assets and liabilities (43) (4) (98)
Net cash provided by operating activities 1,021 1,087 889
Cash flows from investing activities:      
Investments in property, plant and equipment (155) (177) (176)
Proceeds from the sale of property, plant and equipment 0 1 0
Proceeds from divestitures 0 0 2
Payment to acquire fair value investment 23 11 1
Payment in exchange for convertible note (3) (2) (1)
Payment to acquire intangible assets (1) 0 0
Acquisitions of businesses and intangible assets, net of cash acquired (1,408) (516) (128)
Net cash used in investing activities (1,590) (705) (304)
Cash flows from financing activities:      
Issuance of common stock under employee stock plans 54 56 66
Payment of taxes related to net share settlement of equity awards (16) (30) (14)
Treasury stock repurchases (723) (422) (194)
Payment of dividends (206) (191) (170)
Issuance of senior notes 497 0 0
Debt issuance costs (4) 0 0
Purchase of non-controlling interest 4 0 0
Proceeds from credit facility and short-term loan 805 483 400
Repayments of debt and credit facility 702 693 290
Net cash used in financing activities (299) (797) (202)
Effect of exchange rate movements 2 (17) 8
Net increase (decrease) in cash, cash equivalents and restricted cash (866) (432) 391
Cash, cash equivalents and restricted cash at beginning of year 2,254 2,686 2,295
Cash, cash equivalents and restricted cash at end of year 1,388 2,254 2,686
Supplemental Cash Flow Information [Abstract]      
Income tax payments, net 159 102 63
Interest payments 80 80 82
Non-cash changes in investments in property, plant and equipment increase (decrease) $ (21) $ (5) $ 29
XML 91 R38.htm IDEA: XBRL DOCUMENT v3.19.3.a.u2
INVENTORY (Tables)
 12 Months Ended
Oct. 31, 2019
Inventory Disclosure [Abstract]  
Inventory

 
October 31,
 
2019
 
2018
 
(in millions)
Finished goods
$
416

 
$
386

Purchased parts and fabricated assemblies
263

 
252

Inventory
$
679

 
$
638
XML 92 R3.htm IDEA: XBRL DOCUMENT v3.19.3.a.u2
CONSOLIDATED STATEMENT OF COMPREHENSIVE INCOME - USD ($)
$ in Millions
 12 Months Ended
Oct. 31, 2019
Oct. 31, 2018
Oct. 31, 2017
Statement of Comprehensive Income [Abstract]      
Net income $ 1,071 $ 316 $ 684
Other comprehensive income (loss):      
Gain (loss) on derivative instruments, net of tax expense (benefit) of $(2), $1 and $0 (4) 6 0
Amounts reclassified into earnings related to derivative instruments, net of tax expense (benefit) of $(2), $1 and $0 (6) 3 (1)
Foreign currency translation, net of tax expense (benefit) of $(10), $7 and $3 10 (58) 41
Net defined benefit pension cost and post retirement plan costs:      
Change in actuarial net loss, net of tax expense (benefit) of $(25), $(3) and $52 (93) (7) 123
Change in net prior service benefit, net of tax benefit of $(2), $(2) and $(3) (6) (6) (6)
Other comprehensive income (loss) (99) (62) 157
Total comprehensive income $ 972 $ 254 $ 841
XML 93 R30.htm IDEA: XBRL DOCUMENT v3.19.3.a.u2
Schedule II Valuation and Qualifying Accounts
 12 Months Ended
Oct. 31, 2019
SEC Schedule, 12-09, Valuation and Qualifying Accounts [Abstract]  
Schedule II - Valuation and Qualifying Accounts

SCHEDULE II
VALUATION AND QUALIFYING ACCOUNTS

Column A
 
Column B
 
Column C
 
Column D
 
Column E
Description
 
Balance at
Beginning
of Period
 
Additions Charged to
Expenses or
Other Accounts*
 
Deductions Credited to Expenses or Other Accounts**
 
Balance at
End of
Period
 
 
(in millions)
2019
 
 
 
 
 
 
 
 
Tax valuation allowance
 
$
135

 
$
9

 
$
(10
)
 
$
134

2018
 
 
 
 
 
 
 
 
Tax valuation allowance
 
$
138

 
$
4

 
$
(7
)
 
$
135

2017
 
 
 
 
 
 
 
 
Tax valuation allowance
 
$
129

 
$
14

 
$
(5
)
 
$
138


* Additions include current year additions charged to expenses and current year build due to increases in net deferred tax assets, return to provision true-ups, other adjustments and other comprehensive income impact to deferred taxes.

** Deductions include current year releases credited to expenses and current year reductions due to decreases in net deferred tax assets, return to provision true-ups, other adjustments and other comprehensive income impact to deferred taxes.

XML 94 R34.htm IDEA: XBRL DOCUMENT v3.19.3.a.u2
REVENUE REVENUE (Tables)
 12 Months Ended
Oct. 31, 2019
Revenue from Contract with Customer [Abstract]  
Disaggregation of Revenue

The following table presents the company’s total revenue and segment revenue disaggregated by geographical region:
 
Year Ended October 31, 2019
 
Life Sciences and Applied Markets
 
Diagnostics and Genomics
 
Agilent CrossLab
 
Total
 
(in millions)
Revenue by Region
 
 
 
 
 
 
 
Americas
$
692

 
$
505

 
$
664

 
$
1,861

Europe
551

 
368

 
522

 
1,441

Asia Pacific
1,059

 
148

 
654

 
1,861

Total
$
2,302

 
$
1,021

 
$
1,840

 
$
5,163

 
 
 
 
 
 
 
 

The following table presents the company’s total revenue disaggregated by end markets and by revenue type:
 
 
 
Year Ended October 31, 2019
 
(in millions)
Revenue by End Markets
 
 
Pharmaceutical and Biopharmaceutical
 
$
1,604

Chemical and Energy
 
1,199

Diagnostics and Clinical
 
785

Food
 
486

Academia and Government
 
474

Environmental and Forensics
 
615

Total
 
$
5,163

 
 
 
Revenue by Type
 
 
Instrumentation
 
$
2,150

Non-instrumentation and other
 
3,013

Total
 
$
5,163
Contract with Customer, Asset and Liability
The following table provides information about contract liabilities (deferred revenue) and the significant changes in the balances during the year ended October 31, 2019:

 
 
Contract
Liabilities
 
 
(in millions)
 
 
 
Ending balance as of October 31, 2018
 
$
367

Impact of adoption of new revenue recognition guidance
 
(11
)
Net revenue deferred in the period
 
303

Revenue recognized that was included in the contract liability balance at the beginning of the period
 
(287
)
Change in deferrals from customer cash advances, net of revenue recognized
 
5

Contract liabilities acquired in business combinations
 
9

Currency translation and other adjustments
 
—

Ending balance as of October 31, 2019
 
$
386
XML 95 R17.htm IDEA: XBRL DOCUMENT v3.19.3.a.u2
INVENTORY
 12 Months Ended
Oct. 31, 2019
Inventory Disclosure [Abstract]  
INVENTORY  INVENTORY

 
October 31,
 
2019
 
2018
 
(in millions)
Finished goods
$
416

 
$
386

Purchased parts and fabricated assemblies
263

 
252

Inventory
$
679

 
$
638



Inventory-related excess and obsolescence charges of $19 million were recorded in cost of products in 2019, $26 million in 2018 and $24 million in 2017. We record excess and obsolete inventory charges for both inventory on our site as well as inventory at our contract manufacturers and suppliers where we have non-cancelable purchase commitments.
XML 96 R13.htm IDEA: XBRL DOCUMENT v3.19.3.a.u2
REVENUE REVENUE (Notes)
 12 Months Ended
Oct. 31, 2019
Revenue from Contract with Customer [Abstract]  
Revenue from Contract with Customer REVENUE

The following table presents the company’s total revenue and segment revenue disaggregated by geographical region:
 
Year Ended October 31, 2019
 
Life Sciences and Applied Markets
 
Diagnostics and Genomics
 
Agilent CrossLab
 
Total
 
(in millions)
Revenue by Region
 
 
 
 
 
 
 
Americas
$
692

 
$
505

 
$
664

 
$
1,861

Europe
551

 
368

 
522

 
1,441

Asia Pacific
1,059

 
148

 
654

 
1,861

Total
$
2,302

 
$
1,021

 
$
1,840

 
$
5,163

 
 
 
 
 
 
 
 

The following table presents the company’s total revenue disaggregated by end markets and by revenue type:
 
 
 
Year Ended October 31, 2019
 
(in millions)
Revenue by End Markets
 
 
Pharmaceutical and Biopharmaceutical
 
$
1,604

Chemical and Energy
 
1,199

Diagnostics and Clinical
 
785

Food
 
486

Academia and Government
 
474

Environmental and Forensics
 
615

Total
 
$
5,163

 
 
 
Revenue by Type
 
 
Instrumentation
 
$
2,150

Non-instrumentation and other
 
3,013

Total
 
$
5,163



Revenue by region is based on the ship to location of the customer. Revenue by end market is determined by the market indicator of the customer and by customer type. Instrumentation revenue includes sales from instruments, remarketed instruments and third-party products. Non-instrumentation and other revenue includes sales from contract and per incident services, our companion diagnostics and our nucleic acid solutions businesses as well as sales from spare parts, consumables, reagents, vacuum pumps, subscriptions, software licenses and associated services.


Contract Balances

Contract Assets

Contract assets (unbilled accounts receivable) primarily relate to the company's right to consideration for work completed but not billed at the reporting date. The unbilled receivables are reclassified to trade receivables when billed to customers. Contract assets are generally classified as current assets and are included in "Accounts receivable, net" in the consolidated balance sheet.

The balance of contract assets as of October 31, 2019 and as of November 1, 2018, the date of adoption of ASC 606, were $110 million and $57 million, respectively. The increase in unbilled receivables during the year ended October 31, 2019 is a result of recognition of revenue upon the transfer of the control to the customer. In some instances, transfer of control is prior to invoicing the customers and excluding amounts transferred to trade receivables during the period amounted to $53 million.

Contract Liabilities

The following table provides information about contract liabilities (deferred revenue) and the significant changes in the balances during the year ended October 31, 2019:

 
 
Contract
Liabilities
 
 
(in millions)
 
 
 
Ending balance as of October 31, 2018
 
$
367

Impact of adoption of new revenue recognition guidance
 
(11
)
Net revenue deferred in the period
 
303

Revenue recognized that was included in the contract liability balance at the beginning of the period
 
(287
)
Change in deferrals from customer cash advances, net of revenue recognized
 
5

Contract liabilities acquired in business combinations
 
9

Currency translation and other adjustments
 
—

Ending balance as of October 31, 2019
 
$
386



Contract liabilities primarily relate to multiple element arrangements for which billing has occurred but transfer of control of all elements to the customer has either partially or not occurred at the balance sheet date. This includes cash received from customers for products and related installation and services in advance of the transfer of control. Contract liabilities are classified as either current in deferred revenue or long-term in other long-term liabilities in the consolidated balance sheet based on the timing of when we expect to complete our performance obligation.

Contract Costs

Incremental costs of obtaining a contract with a customer are recognized as an asset if it expects the benefit of those costs to be longer than one year. We have determined that certain sales incentive programs meet the requirements to be capitalized. The change in total capitalized costs to obtain a contract was immaterial during the year ended October 31, 2019 and are included in other current and long-term assets on the consolidated balance sheet. We have applied the practical expedient to expense costs as incurred for costs to obtain a contract with a customer when the amortization period would have been one year or less. These costs include the company's internal sales force compensation program, as we have determined that annual compensation is commensurate with annual sales activities.

Transaction Price Allocated to the Remaining Performance Obligations

We have applied the practical expedient in ASC 606-10-50-14 and have not disclosed information about transaction price allocated to remaining performance obligations that have original expected durations of one year or less.
 
The estimated revenue expected to be recognized for remaining performance obligations that have an original term of more than one year, as of October 31, 2019, was $207 million, the majority of which is expected to be recognized over the next 12 months. Remaining performance obligations primarily include extended warranty, customer manufacturing contracts, and software maintenance contracts and revenue associated with lease arrangements.
XML 97 R25.htm IDEA: XBRL DOCUMENT v3.19.3.a.u2
COMMITMENTS AND CONTINGENCIES
 12 Months Ended
Oct. 31, 2019
Commitments and Contingencies Disclosure [Abstract]  
COMMITMENTS AND CONTINGENCIES
16.   COMMITMENTS AND CONTINGENCIES

Operating Lease Commitments:    We lease certain real and personal property from unrelated third parties under non-cancelable operating leases. Certain leases require us to pay property taxes, insurance and routine maintenance, and include escalation clauses. Total rent expense was $75 million in 2019, $64 million in 2018 and $57 million in 2017.

Future non-cancelable minimum lease payments and future minimum lease income under operating leases at October 31, 2019:
 
 
Future Minimum
Lease Payments
 
Future Minimum
Lease Income
 
 
(in millions)
2020
 
$
52

 
$
8

2021
 
$
41

 
$
6

2022
 
$
29

 
$
5

2023
 
$
21

 
$
—

2024
 
$
14

 
$
—

Thereafter
 
$
56

 
$
—



Other Purchase Commitments.   Typically, we can cancel contracts with professional services suppliers without penalties. For those contracts that are not cancelable without penalties, the termination fees and costs or commitments for continued spending that we are obligated to pay to a supplier under each contact's termination period before such contract can be cancelled were approximately $77 million. Approximately $25 million of the penalties for the new contracts will reduce over the next 14 years.

Contingencies: We are involved in lawsuits, claims, investigations and proceedings, including, but not limited to, intellectual property, commercial, real estate, environmental and employment matters, which arise in the ordinary course of business. There are no matters pending that we currently believe are reasonably possible of having a material impact to our business, consolidated financial condition, results of operations or cash flows.
XML 98 R21.htm IDEA: XBRL DOCUMENT v3.19.3.a.u2
FAIR VALUE MEASUREMENTS
 12 Months Ended
Oct. 31, 2019
Fair Value Disclosures [Abstract]  
FAIR VALUE MEASUREMENTS
12.   FAIR VALUE MEASUREMENTS

The authoritative guidance defines fair value as the price that would be received from selling an asset or paid to transfer a liability in an orderly transaction between market participants at the measurement date. When determining the fair value measurements for assets and liabilities required or permitted to be recorded at fair value, we consider the principal or most advantageous market and assumptions that market participants would use when pricing the asset or liability.

Fair Value Hierarchy

The guidance establishes a fair value hierarchy that prioritizes the use of inputs used in valuation techniques into three levels. A financial instrument's categorization within the fair value hierarchy is based upon the lowest level of input that is significant to the fair value measurement. There are three levels of inputs that may be used to measure fair value:

Level 1 — applies to assets or liabilities for which there are quoted prices in active markets for identical assets or liabilities.

Level 2 — applies to assets or liabilities for which there are inputs other than quoted prices included within level 1 that are
observable, either directly or indirectly, for the asset or liability such as: quoted prices for similar assets or liabilities in active markets; quoted prices for identical or similar assets or liabilities in less active markets; or other inputs that can be derived principally from, or corroborated by, observable market data.

Level 3 — applies to assets or liabilities for which there are unobservable inputs to the valuation methodology that are significant to the measurement of the fair value of the assets or liabilities.

Financial Assets and Liabilities Measured at Fair Value on a Recurring Basis

Financial assets and liabilities measured at fair value on a recurring basis as of October 31, 2019 were as follows:

 
 
 
Fair Value Measurement at October 31, 2019 Using
 
October 31,
2019
 
Quoted Prices
in Active
Markets for
Identical Assets
(Level 1)
 
Significant
Other
Observable
Inputs
(Level 2)
 
Significant
Unobservable
Inputs
(Level 3)
 
(in millions)
Assets:
 
 
 
 
 
 
 
Short-term
 
 
 
 
 
 
 
Cash equivalents (money market funds)
$
784

 
$
784

 
$
—

 
$
—

Derivative instruments (foreign exchange contracts)
12

 
—

 
12

 
—

Long-term
 
 
 
 
 
 
 
Trading securities
30

 
30

 
—

 
—

Other investments
25

 
—

 
25

 
—

Total assets measured at fair value
$
851

 
$
814

 
$
37

 
$
—

Liabilities:
 
 
 
 
 
 
 
Short-term
 
 
 
 
 
 
 
Derivative instruments (foreign exchange contracts)
$
6

 
$
—

 
$
6

 
$
—

Long-term
 
 
 
 
 
 
 
Deferred compensation liability
30

 
—

 
30

 
—

Total liabilities measured at fair value
$
36

 
$
—

 
$
36

 
$
—



Financial assets and liabilities measured at fair value on a recurring basis as of October 31, 2018 were as follows:

 
 
 
Fair Value Measurement at October 31, 2018 Using
 
October 31,
2018
 
Quoted Prices
in Active
Markets for
Identical Assets
(Level 1)
 
Significant
Other
Observable
Inputs
(Level 2)
 
Significant
Unobservable
Inputs
(Level 3)
 
(in millions)
Assets:
 
 
 
 
 
 
 
Short-term
 
 
 
 
 
 
 
Cash equivalents (money market funds)
$
1,355

 
$
1,355

 
$
—

 
$
—

Derivative instruments (foreign exchange contracts)
16

 
—

 
16

 
—

Long-term
 
 
 
 
 
 
 
Trading securities
30

 
30

 
—

 
—

Total assets measured at fair value
$
1,401

 
$
1,385

 
$
16

 
$
—

Liabilities:
 
 
 
 
 
 

Short-term
 
 
 
 
 
 
 
Derivative instruments (foreign exchange contracts)
$
5

 
$
—

 
$
5

 
$
—

Long-term
 
 
 
 
 
 
 
Deferred compensation liability
30

 
—

 
30

 
—

Total liabilities measured at fair value
$
35

 
$
—

 
$
35

 
$
—


Our money market funds and trading securities are generally valued using quoted market prices and therefore are classified within level 1 of the fair value hierarchy. Our derivative financial instruments are classified within level 2, as there is not an active market for each hedge contract, but the inputs used to calculate the value of the instruments are tied to active markets. Our deferred compensation liability is classified as level 2 because, although the values are not directly based on quoted market prices, the inputs used in the calculations are observable. Other investments represent shares we own in a special fund that targets underlying investments of approximately 40 percent in debt securities and 60 percent in equity securities. It has been classified as level 2 because, although the shares of the fund are not traded on any active stock exchange, each of the individual underlying securities are and hence we have a readily determinable value for the underlying securities, from which we are able to determine the fair market value for the special fund itself.

Trading securities, which is comprised of mutual funds, bonds and other similar instruments, other investments and deferred compensation liability are reported at fair value, with gains or losses resulting from changes in fair value recognized currently in net income. Certain derivative instruments are reported at fair value, with unrealized gains and losses, net of tax, included in accumulated other comprehensive loss within stockholders' equity. Realized gains and losses from the sale of these instruments are recorded in net income.

Assets and Liabilities Measured at Fair Value on a Non-Recurring Basis

Long-Lived Assets

For assets measured at fair value on a non-recurring basis, the following table summarizes the impairments included in net income for the years ended October 31, 2019, 2018 and 2017:

 
Years Ended
October 31,
 
2019
 
2018
 
2017
 
(in millions)
Long-lived assets held and used
$
—

 
$
21

 
$
—

Long-lived assets held for sale
$
—

 
$
—

 
$
—



There were no impairments of long-lived assets held and used in 2019 and 2017. For 2018, long lived assets held and used with a carrying amount of $21 million were written down to their fair value of zero, resulting in an impairment charge of $21 million, which relates to purchased intangible assets within the diagnostics and genomics segment that were deemed unrecoverable and was included in net income.

There were no impairments of long-lived assets held for sale in 2019, 2018 and 2017.

Fair values for the impaired long-lived assets during 2018 were measured using level 3 inputs. To determine the fair value of long-lived assets in 2018, we used the income approach based on projected discounted cash flows expected to be generated by the long-lived assets over the remaining useful life.

For 2019, there were no impairments or material changes in non-marketable securities without readily determinable fair value. As of October 31, 2019 and October 31, 2018, the carrying amount of non-marketable equity securities without readily determinable fair values was $47 million and $23 million, respectively.

Fair values for the non-marketable securities included in long-term investments on the consolidated balance sheet were measured using Level 3 inputs because they are primarily equity stock issued by private companies without quoted market prices. To estimate the fair value of our non-marketable securities, we use the measurement alternative to record these investments at cost and to adjust for impairments and observable price changes (orderly transactions for the identical or a similar security from the same issuer) as and when it occurs.
XML 99 R29.htm IDEA: XBRL DOCUMENT v3.19.3.a.u2
SEGMENT INFORMATION
 12 Months Ended
Oct. 31, 2019
Segment Reporting [Abstract]  
SEGMENT INFORMATION SEGMENT INFORMATION

Description of Segments. We are a global leader in life sciences, diagnostics and applied chemical markets, providing application focused solutions that include instruments, software, services and consumables for the entire laboratory workflow.
Agilent has three business segments comprised of the life sciences and applied markets business, diagnostics and genomics business and the Agilent CrossLab business each of which comprises a reportable segment. The three operating segments were determined based primarily on how the chief operating decision maker views and evaluates our operations. Operating results are regularly reviewed by the chief operating decision maker to make decisions about resources to be allocated to the segment and to assess its performance. Other factors, including market separation and customer specific applications, go-to-market channels, products and services and manufacturing are considered in determining the formation of these operating segments.
In 2019, we adopted new guidance related to the presentation of the net periodic pension and postretirement benefit cost. See Note 2, "New Accounting Pronouncements" for more information. As a result, we have recast our historical segment results to conform to this new presentation required under this guidance.

A description of our three reportable segments is as follows:

Our life sciences and applied markets business provides application-focused solutions that include instruments and software that enable customers to identify, quantify and analyze the physical and biological properties of substances and products, as well as enable customers in the clinical and life sciences research areas to interrogate samples at the molecular and cellular level. Key product categories include: liquid chromatography ("LC") systems and components; liquid chromatography mass spectrometry ("LCMS") systems; gas chromatography ("GC") systems and components; gas chromatography mass spectrometry ("GCMS") systems; inductively coupled plasma mass spectrometry ("ICP-MS") instruments; atomic absorption ("AA") instruments;
microwave plasma-atomic emission spectrometry ("MP-AES") instruments; inductively coupled plasma optical emission spectrometry ("ICP-OES") instruments; raman spectroscopy; cell analysis plate based assays; flow cytometer; real-time cell analyzer; cell imaging systems; microplate reader; laboratory software for sample tracking; information management and analytics; laboratory automation and robotic systems; dissolution testing; vacuum pumps and measurement technologies.

Our diagnostics and genomics business is comprised of six areas of activity providing active pharmaceutical ingredients ("APIs") for oligo-based therapeutics as well as solutions that include reagents, instruments, software and consumables, which enable customers in the clinical and life sciences research areas to interrogate samples at the cellular and molecular level. First, our genomics business includes arrays for DNA mutation detection, genotyping, gene copy number determination, identification of gene rearrangements, DNA methylation profiling, gene expression profiling, as well as next generation sequencing ("NGS") target enrichment and genetic data management and interpretation support software. This business also includes solutions that enable clinical labs to identify DNA variants associated with genetic disease and help direct cancer therapy. Second, our nucleic acid solutions business provides equipment and expertise focused on production of synthesized oligonucleotides under pharmaceutical good manufacturing practices ("GMP") conditions for use as API in an emerging class of drugs that utilize nucleic acid molecules for disease therapy. Third, our pathology solutions business is focused on product offerings for cancer diagnostics and anatomic pathology workflows. The broad portfolio of offerings includes immunohistochemistry ("IHC"), in situ hybridization ("ISH"), hematoxylin and eosin ("H&E") staining and special staining. Fourth, we also collaborate with a number of major pharmaceutical companies to develop new potential pharmacodiagnostics, also known as companion diagnostics, which may be used to identify patients most likely to benefit from a specific targeted therapy. Fifth, the reagent partnership business is a provider of reagents used for turbidimetry and flow cytometry. Finally, our biomolecular analysis business provides complete workflow solutions, including instruments, consumables and software, for quality control analysis of nucleic acid samples.  Samples are analyzed using quantitative and qualitative techniques to ensure accuracy in further genomics analysis techniques utilized in clinical and life science research applications.

The Agilent CrossLab business spans the entire lab with its extensive consumables and services portfolio, which is designed to improve customer outcomes. Most of the portfolio is vendor neutral, meaning Agilent can serve and supply customers regardless of their instrument purchase choices. Solutions range from chemistries and supplies to services and software helping to connect the entire lab. Key product categories in consumables include GC and LC columns, sample preparation products, custom chemistries, and a large selection of laboratory instrument supplies. Services include startup, operational, training and compliance support, software as a service, as well as asset management and consultative services that help increase customer productivity. Custom service and consumable bundles are tailored to meet the specific application needs of various industries and to keep instruments fully operational and compliant with the respective industry requirements.

A significant portion of the segments' expenses arise from shared services and infrastructure that we have historically provided to the segments in order to realize economies of scale and to efficiently use resources. These expenses, collectively called corporate charges, include legal, accounting, tax, real estate, insurance services, information technology services, treasury, order administration, other corporate infrastructure expenses and costs of centralized research and development. Charges are allocated to the segments, and the allocations have been determined on a basis that we consider to be a reasonable reflection of the utilization of services provided to or benefits received by the segments. In addition, we do not allocate amortization and impairment of acquisition-related intangible assets, pension curtailment or settlement gains, restructuring and transformational initiatives expenses, acquisition and integration costs, business exit and divestiture costs, special compliance costs, some nucleic acid solutions division ("NASD") site costs and certain other charges to the operating margin for each segment because management does not include this information in its measurement of the performance of the operating segments.Transformational initiatives include expenses associated with targeted cost reduction activities such as manufacturing transfers, site consolidations, legal entity and other business reorganizations, in-sourcing or outsourcing of activities.

The following tables reflect the results of our reportable segments under our management reporting system. The performance of each segment is measured based on several metrics, including segment income from operations. These results are used, in part, by the chief operating decision maker in evaluating the performance of, and in allocating resources to, each of the segments.

The profitability of each of the segments is measured after excluding restructuring and asset impairment charges, transformational initiatives, investment gains and losses, interest income, interest expense, acquisition and integration costs, non-cash amortization and other items as noted in the reconciliations below.
 
Life Sciences and Applied Markets
 
Diagnostics and Genomics
 
Agilent CrossLab
 
Total
Segments
 
(in millions)
Year Ended October 31, 2019:
 
 
 
 
 
 
 
Total net revenue
$
2,302

 
$
1,021

 
$
1,840

 
$
5,163

Income from operations
$
542

 
$
185

 
$
475

 
$
1,202

Depreciation expense
$
41

 
$
35

 
$
35

 
$
111

Share-based compensation expense
$
33

 
$
14

 
$
25

 
$
72

Year Ended October 31, 2018:
 
 
 
 
 
 
 
Total net revenue
$
2,270

 
$
943

 
$
1,701

 
$
4,914

Income from operations
$
543

 
$
173

 
$
388

 
$
1,104

Depreciation expense
$
38

 
$
33

 
$
31

 
$
102

Share-based compensation expense
$
33

 
$
14

 
$
24

 
$
71

Year Ended October 31, 2017:
 
 
 
 
 
 
 
Total net revenue
$
2,081

 
$
860

 
$
1,531

 
$
4,472

Income from operations
$
470

 
$
167

 
$
336

 
$
973

Depreciation expense
$
35

 
$
30

 
$
29

 
$
94

Share-based compensation expense
$
30

 
$
10

 
$
21

 
$
61




The following table reconciles reportable segments' income from operations to Agilent's total enterprise income before taxes:

 
Years Ended October 31,
 
2019
 
2018
 
2017
 
(in millions)
Total reportable segments' income from operations
$
1,202

 
$
1,104

 
$
973

Amortization of intangible assets related to business combinations
(125
)
 
(105
)
 
(117
)
Acquisition and integration costs
(48
)
 
(23
)
 
(30
)
Transformational initiatives
(44
)
 
(25
)
 
(12
)
Asset impairments
—

 
(21
)
 
—

Business exit and divestiture costs (primarily our NMR business)
—

 
(9
)
 
—

NASD site costs
(12
)
 
(8
)
 
—

Special compliance costs
(2
)
 
(4
)
 
—

Other (1) 
(30
)
 
(5
)
 
(7
)
Interest Income
36

 
38

 
22

Interest Expense
(74
)
 
(75
)
 
(79
)
Other income (expense), net
16

 
79

 
53

Income before taxes, as reported
$
919

 
$
946

 
$
803



(1) The other category primarily includes legal costs related to our pursuing our claim against a third party in addition to other miscellaneous adjustments and settlements.
 
Major Customers.    No customer represented 10 percent or more of our total net revenue in 2019, 2018 or 2017.

The following table reflects segment assets and capital expenditures under our management reporting system. Segment assets include allocations of corporate assets, goodwill, net other intangibles and other assets. Unallocated assets primarily consist of cash, cash equivalents, the valuation allowance relating to deferred tax assets and other assets.
 
Life Sciences and Applied Markets
 
Diagnostics and Genomics
 
Agilent CrossLab
 
Total
Segments
 
(in millions)
As of and for the Year Ended October 31, 2019:
 
 
 
 
 
 
 
Assets
$
3,202

 
$
2,620

 
$
1,331

 
$
7,153

Capital expenditures
$
59

 
$
48

 
$
48

 
$
155

As of and for the Year Ended October 31, 2018:
 
 
 
 
 
 
 
Assets
$
1,744

 
$
2,679

 
$
1,267

 
$
5,690

Capital expenditures
$
47

 
$
92

 
$
38

 
$
177


The following table reconciles segment assets to Agilent's total assets:

 
October 31,
 
2019
 
2018
 
(in millions)
Total reportable segments' assets
$
7,153

 
$
5,690

Cash, cash equivalents
1,382

 
2,247

Prepaid expenses
94

 
80

Investments
102

 
68

Long-term and other receivables
100

 
102

Other
621

 
354

Total assets
$
9,452

 
$
8,541



The other category primarily includes deferred tax assets and overfunded pension assets which are not allocated to the segments.

The following table presents summarized information for net revenue by geographic region. Revenues from external customers are generally attributed to countries based upon the customer's location.

 
United
States
 
China(1)
 
Rest of the
World
 
Total
 
(in millions)
Net revenue:
 
 
 
 
 
 
 
Year Ended October 31, 2019
$
1,619

 
$
1,019

 
$
2,525

 
$
5,163

Year Ended October 31, 2018
$
1,414

 
$
1,015

 
$
2,485

 
$
4,914

Year Ended October 31, 2017
$
1,314

 
$
900

 
$
2,258

 
$
4,472

1.
China also includes Hong Kong net revenue.



The following table presents summarized information for long-lived assets by geographic region. Long lived assets consist of property, plant, and equipment, long-term receivables and other long-term assets excluding intangible assets. The rest of the world primarily consists of Asia and the rest of Europe.

 
United
States
 
Germany
 
Rest of the
World
 
Total
 
(in millions)
Long-lived assets:
 
 
 
 
 
 
 
October 31, 2019
$
621

 
$
122

 
$
404

 
$
1,147

October 31, 2018
$
565

 
$
117

 
$
362

 
$
1,044
XML 100 R105.htm IDEA: XBRL DOCUMENT v3.19.3.a.u2
LONG-TERM DEBT LONG-TERM DEBT - Other (Details) - USD ($)
$ in Millions
 12 Months Ended
Sep. 15, 2016
Aug. 09, 2011
Oct. 31, 2019
Oct. 31, 2018
Oct. 31, 2017
Feb. 01, 2016
Debt Instrument [Line Items]            
interest rate swap payments $ 10   $ 6 $ 0 $ 0  
Interest Rate Swap     0 $ 7   $ 300
Notional Amount Of Terminated Interest Rate Fair Value Hedge Derivatives $ 10          
Capital Lease Obligations, Noncurrent     5      
Senior Notes 2020 [Member]            
Debt Instrument [Line Items]            
Interest Rate Derivatives Terminated Date   Aug. 09, 2011        
Notional Amount Of Terminated Interest Rate Fair Value Hedge Derivatives   $ 500        
Terminated Interest Rate Fair Value Hedge Derivative Assets At Fair Value   $ 34        
Cash Flow Hedges | Treasury Lock [Member] | Senior Notes 2026 [Member]            
Debt Instrument [Line Items]            
Remaining gain loss to be amortized on derivative     $ 7      
XML 101 R101.htm IDEA: XBRL DOCUMENT v3.19.3.a.u2
SHORT-TERM DEBT - Credit Facility and Capital Lease (Details) - USD ($)
$ in Millions
 12 Months Ended
Mar. 13, 2019
Oct. 31, 2019
Oct. 21, 2019
Aug. 07, 2019
Line of Credit Facility [Abstract]        
Credit facility initiation date Mar. 13, 2019      
Short-term debt terms (years)   five    
Short-term Debt   $ 305    
Repayments of Lines of Credit   190    
Maximum borrowing capacity after increase   1,000    
Line of credit outstanding balance   115    
Short-term Bank Loans and Notes Payable     $ 500 $ 500
Capital Lease Obligations [Abstract]        
Capital Lease Obligations, Current   $ 1    
XML 102 R97.htm IDEA: XBRL DOCUMENT v3.19.3.a.u2
RETIREMENT PLANS AND POST RETIREMENT PENSION PLANS, Expected Benefit Payments (Details)
$ in Millions
Oct. 31, 2019
USD ($)
Pension Plan | U.S. Plan  
Defined Benefit Plan Disclosure [Line Items]  
Defined Benefit Plan, Expected Future Employer Contributions, Next Fiscal Year $ 0
Future benefit payments [Abstract]  
2020 35
2021 36
2022 33
2023 35
2024 37
2025 - 2029 146
Pension Plan | Non-U.S. Plans  
Defined Benefit Plan Disclosure [Line Items]  
Defined Benefit Plan, Expected Future Employer Contributions, Next Fiscal Year 24
Future benefit payments [Abstract]  
2020 25
2021 27
2022 29
2023 32
2024 32
2025 - 2029 170
Post-Retirement Benefit Plan | U.S. Plan  
Defined Benefit Plan Disclosure [Line Items]  
Defined Benefit Plan, Expected Future Employer Contributions, Next Fiscal Year 0
Future benefit payments [Abstract]  
2020 8
2021 8
2022 7
2023 7
2024 7
2025 - 2029 $ 35
XML 103 R109.htm IDEA: XBRL DOCUMENT v3.19.3.a.u2
STOCKHOLDERS' EQUITY - Changes in accumulated other comprehensive income (Details) - USD ($)
$ in Millions
 12 Months Ended
Nov. 01, 2018
Oct. 31, 2019
Oct. 31, 2018
Oct. 31, 2017
Beginning Balance $ (408) $ (408) $ (346)  
New Accounting Pronouncement or Change in Accounting Principle, Effect of Adoption, Quantification (7)      
Other Comprehensive Income (Loss), before Reclassifications   (163) (93)  
Amounts Reclassified out of Accumulated Other Comprehensive Income   23 35  
Tax (expense) benefit   41 (4)  
Other Comprehensive Income (Loss)   (99) (62) $ 157
Ending Balance (415) (514) (408) (346)
Foreign Currency Translation        
Beginning Balance (214) (214) (156)  
Other Comprehensive Income (Loss), before Reclassifications   0 (51)  
Amounts Reclassified Amounts Reclassified out of Accumulated Other Comprehensive Income   0 0  
Tax (expense) benefit   10 (7) (3)
Other Comprehensive Income (Loss)   10 (58)  
Ending Balance (214) (204) (214) (156)
Other Comprehensive (Income) Loss, Defined Benefit Plan, Prior Service Cost (Credit), after Reclassification Adjustment, before Tax [Abstract]        
Beginning Balance 134 134 140  
Other Comprehensive (Income) Loss, before Reclassifications   0 0  
Amounts Reclassified out of Accumulated Other Comprehensive Income   (8) (8)  
Tax (expense) benefit   2 2 3
Other Comprehensive (Income) Loss   (6) (6) (6)
Ending Balance 137 131 134 140
Other Comprehensive Income (Loss), Defined Benefit Plan, Gain (Loss), after Reclassification Adjustment, before Tax [Abstract]        
Beginning Balance (335) (335) (328)  
Other Comprehensive Income (Loss), before Reclassifications   (157) (49)  
Amounts reclassified out of accumulated other comprehensive income   39 39  
Tax (expense) benefit   25 3  
Other comprehensive income (loss)   (93) (7) 123
Ending Balance (344) (437) (335) (328)
Unrealized Gain (Loss) on Foreign Currency Derivatives, Net, before Tax [Abstract]        
Beginning Balance 7 7 (2)  
Other Comprehensive Income (Loss), before Reclassifications   (6) 7  
Amounts Reclassified out of Accumulated Other Comprehensive Income   (8) 4  
Tax (expense) benefit   4 (2)  
Other Comprehensive Income (Loss)   (10) 9  
Ending Balance 6 $ (4) $ 7 $ (2)
Accumulated Foreign Currency Adjustment Attributable to Parent [Member]        
New Accounting Pronouncement or Change in Accounting Principle, Effect of Adoption, Quantification 0      
Accumulated Defined Benefit Plans Adjustment, Net Prior Service Attributable to Parent [Member]        
New Accounting Pronouncement or Change in Accounting Principle, Effect of Adoption, Quantification 3      
Accumulated Defined Benefit Plans Adjustment, Net Gain (Loss) Attributable to Parent [Member]        
New Accounting Pronouncement or Change in Accounting Principle, Effect of Adoption, Quantification (9)      
AOCI, Derivative Qualifying as Hedge, Excluded Component, Parent [Member]        
New Accounting Pronouncement or Change in Accounting Principle, Effect of Adoption, Quantification $ (1)      
XML 104 R67.htm IDEA: XBRL DOCUMENT v3.19.3.a.u2
SHARE-BASED COMPENSATION Non-vested award activity disclosure (Details)
$ / shares in Units, shares in Thousands, $ in Millions
 12 Months Ended
Oct. 31, 2019
USD ($)
yr
$ / shares
shares
Oct. 31, 2018
USD ($)
shares
Oct. 31, 2017
USD ($)
Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Nonvested, Number of Shares [Roll Forward]      
Non-vested beginning (in shares) | shares 3,181    
Granted (in shares) | shares 1,309    
Vested (in shares) | shares (1,530)    
Forfeited (in shares) | shares (78)    
Change in LTPP shares vested in the year due to performance conditions | shares 291    
Non-vested ending (in shares) | shares 3,173 3,181  
Share-based Compensation Arrangement by Share-based Payment Award, Options, Additional Disclosures [Abstract]      
Non-vested at October 31, 2018 -Weighted Average Grant Price (in dollars per share) | $ / shares $ 57    
Granted - Weighted Average Grant Price (in dollars per share) | $ / shares 68    
Vested- Weighted Average Grant Price (in dollars per share) | $ / shares 45    
Foreited- Weighted Average Grant Price (in dollars per share) | $ / shares 60    
Change in LTPP shares vested in the year due to performance conditions Fair Value | $ / shares 0    
Non-vested at October 31, 2019 -Weighted Average Grant Price (in dollars per share) | $ / shares $ 60    
Unrecognized share-based compensation costs for non-vested restricted stock awards, net of expected forfeitures | $ $ 94    
Weighted-average period non-vested restricted stock awards are expected to be amortized over (in years) | yr 2.2    
Total fair value of restricted stock awards vested | $ $ 69 $ 58 $ 42
XML 105 R63.htm IDEA: XBRL DOCUMENT v3.19.3.a.u2
SHARE-BASED COMPENSATION Allocated Share-based compensation expense (Details) - USD ($)
$ in Millions
 12 Months Ended
Oct. 31, 2019
Oct. 31, 2018
Oct. 31, 2017
Share-based compensation disclosures      
Share-based compensation expense $ 72 $ 71 $ 61
Cost of Product and Services      
Share-based compensation disclosures      
Share-based compensation expense 18 16 15
Research and Development      
Share-based compensation disclosures      
Share-based compensation expense 7 7 6
Selling, General and Administrative      
Share-based compensation disclosures      
Share-based compensation expense 47 48 $ 40
Inventories      
Share-based Payment Arrangement, Expensed and Capitalized, Amount      
Share-based compensation expense $ 0 $ 0  
XML 106 R93.htm IDEA: XBRL DOCUMENT v3.19.3.a.u2
RETIREMENT PLANS AND POST RETIREMENT PENSION PLANS, Funded Status (Details) - USD ($)
$ in Millions
 12 Months Ended
Oct. 31, 2019
Oct. 31, 2018
Oct. 31, 2017
Non-U.S. Plans | Pension Plan      
Change in fair value of plan assets: [Roll Forward]      
Fair Value Balance, beginning of year $ 825 $ 855  
Actual return on plan assets 85 (9)  
Employer contributions 21 21  
Defined Benefit Plan, Plan Assets, Contributions by Plan Participant 1 0  
Benefits paid 29 26  
Settlements 0    
Defined Benefit Plan, Benefit Obligation, (Increase) Decrease for Remeasurement due to Settlement   5  
Currency impact 8 (21)  
Fair Value Balance, end of year 911 825 $ 855
Change in benefit obligation: [Roll Forward]      
Benefit Obligation Balance, Beginning of year 913 935  
Service cost 20 20 19
Interest cost 14 13 12
Participant's contributions 1 0  
Plan amendment 0 1  
Actuarial (gain) loss 143 (6)  
Benefits paid 29 27  
Currency impact 5 (23)  
Benefit Obligation Balance, end of year 1,067 913 935
Funded status of plan [Abstract]      
Funded status of plan (156) (88)  
Actuarial (gains) losses (330) (263)  
Prior service costs (benefits) 0 0  
Total 330 263  
U.S. Plan | Pension Plan      
Change in fair value of plan assets: [Roll Forward]      
Fair Value Balance, beginning of year 401 414  
Actual return on plan assets 50 8  
Employer contributions 0 0  
Defined Benefit Plan, Plan Assets, Contributions by Plan Participant 0 0  
Benefits paid 19 21  
Settlements 0 0  
Currency impact 0 0  
Fair Value Balance, end of year 432 401 414
Change in benefit obligation: [Roll Forward]      
Benefit Obligation Balance, Beginning of year 420 445  
Service cost 0 0 0
Interest cost 18 16 15
Participant's contributions 0 0  
Plan amendment 0 0  
Actuarial (gain) loss 74 (19)  
Benefits paid 21 22  
Currency impact 0 0  
Benefit Obligation Balance, end of year 491 420 445
Funded status of plan [Abstract]      
Funded status of plan (59) (19)  
Actuarial (gains) losses (115) (65)  
Prior service costs (benefits) 0 0  
Total 115 65  
U.S. Plan | Post-Retirement Benefit Plan      
Change in fair value of plan assets: [Roll Forward]      
Fair Value Balance, beginning of year 90 95  
Actual return on plan assets 11 1  
Employer contributions 0 0  
Defined Benefit Plan, Plan Assets, Contributions by Plan Participant 0 0  
Benefits paid 6 6  
Settlements 0 0  
Currency impact 0 0  
Fair Value Balance, end of year 95 90 95
Change in benefit obligation: [Roll Forward]      
Benefit Obligation Balance, Beginning of year 87 97  
Service cost 0 1 1
Interest cost 4 3 3
Participant's contributions 0 0  
Plan amendment 0 0  
Actuarial (gain) loss 9 (7)  
Benefits paid 6 7  
Currency impact 0 0  
Benefit Obligation Balance, end of year 94 87 $ 97
Funded status of plan [Abstract]      
Funded status of plan 1 3  
Actuarial (gains) losses (10) (10)  
Prior service costs (benefits) (12) (20)  
Total (2) (10)  
Other Assets [Member] | Non-U.S. Plans | Pension Plan      
Funded status of plan [Abstract]      
Funded status of plan 106 95  
Other Assets [Member] | U.S. Plan | Pension Plan      
Funded status of plan [Abstract]      
Funded status of plan 0 0  
Other Assets [Member] | U.S. Plan | Post-Retirement Benefit Plan      
Funded status of plan [Abstract]      
Funded status of plan 1 3  
Employee compensation and benefits [Member] | Non-U.S. Plans | Pension Plan      
Funded status of plan [Abstract]      
Funded status of plan 0 0  
Employee compensation and benefits [Member] | U.S. Plan | Pension Plan      
Funded status of plan [Abstract]      
Funded status of plan 1 1  
Employee compensation and benefits [Member] | U.S. Plan | Post-Retirement Benefit Plan      
Funded status of plan [Abstract]      
Funded status of plan 0 0  
Retirement and post-retirement benefits | Non-U.S. Plans | Pension Plan      
Funded status of plan [Abstract]      
Funded status of plan 262 183  
Retirement and post-retirement benefits | U.S. Plan | Pension Plan      
Funded status of plan [Abstract]      
Funded status of plan 58 18  
Retirement and post-retirement benefits | U.S. Plan | Post-Retirement Benefit Plan      
Funded status of plan [Abstract]      
Funded status of plan $ 0 $ 0  
XML 108 R48.htm IDEA: XBRL DOCUMENT v3.19.3.a.u2
STOCKHOLDERS' EQUITY (Tables)
 12 Months Ended
Oct. 31, 2019
Accumulated Other Comprehensive Income (Loss) [Line Items]  
Accumulated other comprehensive income

The following table summarizes the components of our accumulated other comprehensive income (loss) as of October 31, 2019 and 2018, net of tax effect:

 
October 31,
 
2019
 
2018
 
(in millions)
Foreign currency translation, net of tax expense of $(5) and $(15) for 2019 and 2018, respectively
$
(204
)
 
(214
)
Unrealized losses (including prior service benefit) on defined benefit plans, net of tax benefit of $153 and $132 for 2019 and 2018, respectively
(306
)
 
(201
)
Unrealized gains (losses) on derivative instruments, net of tax benefit of $3 and $0 for 2019 and 2018, respectively
(4
)
 
7

Total accumulated other comprehensive loss
$
(514
)
 
$
(408
)

Changes in accumulated other comprehensive income (loss) by component and related tax effects for the years ended October 31, 2019 and 2018 were as follows (in millions):

 
 
 
 
Net defined benefit pension cost and post retirement plan costs
 
 
 
 
 
 
Foreign currency translation
 
Prior service credits
 
Actuarial Losses
 
Unrealized gains (losses) on derivatives
 
Total
 
 
(in millions)
As of October 31, 2017
 
$
(156
)
 
$
140

 
$
(328
)
 
$
(2
)
 
$
(346
)
 
 
 
 
 
 
 
 
 
 
 
Other comprehensive income (loss) before reclassifications
 
(51
)
 
—

 
(49
)
 
7

 
(93
)
 
 
 
 
 
 
 
 
 
 
 
Amounts reclassified out of accumulated other comprehensive income (loss)
 
—

 
(8
)
 
39

 
4

 
35

 
 
 
 
 
 
 
 
 
 
 
Tax (expense) benefit
 
(7
)
 
2

 
3

 
(2
)
 
(4
)
 
 
 
 
 
 
 
 
 
 
 
Other comprehensive income (loss)
 
(58
)
 
(6
)
 
(7
)
 
9

 
(62
)
 
 
 
 
 
 
 
 
 
 
 
As of October 31, 2018
 
$
(214
)
 
$
134

 
$
(335
)
 
$
7

 
$
(408
)
 
 
 
 
 
 
 
 
 
 
 
Impact of adoption of new guidance on tax effects in accumulated other comprehensive income (loss)
 
—

 
3

 
(9
)
 
(1
)
 
(7
)
 
 
 
 
 
 
 
 
 
 
 
As of November 1, 2018
 
(214
)
 
137

 
(344
)
 
6

 
(415
)
 
 
 
 
 
 
 
 
 
 
 
Other comprehensive loss before reclassifications
 
—

 
—

 
(157
)
 
(6
)
 
(163
)
 
 
 
 
 
 
 
 
 
 
 
Amounts reclassified out of accumulated other comprehensive income
 
—

 
(8
)
 
39

 
(8
)
 
23

 
 
 
 
 
 
 
 
 
 
 
Tax benefit
 
10

 
2

 
25

 
4

 
41

 
 
 
 
 
 
 
 
 
 
 
Other comprehensive income (loss)
 
10

 
(6
)
 
(93
)
 
(10
)
 
(99
)
 
 
 
 
 
 
 
 
 
 
 
As of October 31, 2019
 
$
(204
)
 
$
131

 
$
(437
)
 
$
(4
)
 
$
(514
)
 
 
 
 
 
 
 
 
 
 
 
Reclassification out of Accumulated Other Comprehensive Income [Table Text Block]

Reclassifications out of accumulated other comprehensive income (loss) for the years ended October 31, 2019 and 2018 were as follows (in millions):
Details about Accumulated Other
Comprehensive Income components

Amounts Reclassified
from Other Comprehensive Income

Affected line item in
statement of operations


2019

2018









Unrealized gains and (losses) on derivatives

$
8


$
(4
)

Cost of products and interest expense


8


(4
)

Total before income tax


(2
)

1


(Provision)/benefit for income tax


6


(3
)

Total net of income tax
Net defined benefit pension cost and post retirement plan costs:













Actuarial net loss

(39
)

(39
)

Other (income) expense
Prior service benefit

8


8


Other (income) expense


(31
)

(31
)

Total before income tax


12


10


Benefit for income tax


(19
)

(21
)

Total net of income tax







Total reclassifications for the period

$
(13
)

$
(24
)
XML 109 R40.htm IDEA: XBRL DOCUMENT v3.19.3.a.u2
GOODWILL AND OTHER INTANGIBLE ASSETS (Tables)
 12 Months Ended
Oct. 31, 2019
Goodwill and Intangible Assets Disclosure [Abstract]  
Goodwill balances and movements for each reportable segments during the period

The following table presents goodwill balances and the movements for each of our reportable segments during the years ended October 31, 2018 and 2019:
 
Life Sciences and Applied Markets
 
Diagnostics and Genomics
 
Agilent CrossLab
 
Total
 
(in millions)
Goodwill as of October 31, 2017
$
773

 
$
1,330

 
$
504

 
$
2,607

Foreign currency translation impact
(7
)
 
(4
)
 
(4
)
 
(15
)
Goodwill arising from acquisitions
37

 
281

 
63

 
381

Goodwill as of October 31, 2018
$
803

 
$
1,607

 
$
563

 
$
2,973

Foreign currency translation impact
(1
)
 
(2
)
 
(2
)
 
(5
)
Goodwill arising from acquisitions and adjustments
636

 
(11
)
 
—

 
625

Goodwill as of October 31, 2019
$
1,438

 
$
1,594

 
$
561

 
$
3,593

 
 
 
 
 
 
 
 
Components of other intangibles during the period
The component parts of other intangible assets at October 31, 2018 and 2019 are shown in the table below:
 
Other Intangible Assets
 
Gross
Carrying
Amount
 
Accumulated
Amortization
and Impairments
 
Net Book
Value
 
(in millions)
As of October 31, 2018:
 
 
 
 
 
Purchased technology
$
947

 
$
683

 
$
264

Trademark/Tradename
151

 
88

 
63

Customer relationships
107

 
63

 
44

Third-party technology and licenses
$
28

 
$
19

 
$
9

Total amortizable intangible assets
$
1,233

 
$
853

 
$
380

In-Process R&D
111

 
—

 
111

Total
$
1,344

 
$
853

 
$
491

As of October 31, 2019:
 
 
 
 
 
Purchased technology
$
1,413

 
$
763

 
$
650

Backlog
5

 
5

 
—

Trademark/Tradename
196

 
102

 
94

Customer relationships
329

 
87

 
242

Third-party technology and licenses
$
28

 
$
22

 
$
6

Total amortizable intangible assets
$
1,971

 
$
979

 
$
992

In-Process R&D
115

 
—

 
115

Total
$
2,086

 
$
979

 
$
1,107

 
 
 
 
 
 
Future Amortization expense for the next five years and thereafter
Future amortization expense related to existing finite-lived purchased intangible assets associated with business combinations for the next five fiscal years and thereafter is estimated below:
Estimated future amortization expense:
 
 
(in millions)
2020
$
186

2021
$
172

2022
$
150

2023
$
107

2024
$
86

Thereafter
$
291
XML 110 R44.htm IDEA: XBRL DOCUMENT v3.19.3.a.u2
RETIREMENT PLANS AND POST RETIREMENT PENSION PLANS (Tables)
 12 Months Ended
Oct. 31, 2019
Defined Benefit Plan [Abstract]  
Schedule of net pension and post-retirement benefit costs
For the years ended October 31, 2019, 2018 and 2017, components of net periodic benefit cost and other amounts recognized in other comprehensive income were comprised of:
 
Pensions
 
U.S. Post-Retirement Benefit Plans
 
U.S. Plans
 
Non-U.S. Plans
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
2019
 
2018
 
2017
 
2019
 
2018
 
2017
 
2019
 
2018
 
2017
 
(in millions)
Net periodic benefit cost (benefit)
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Service cost — benefits earned during the period
$
—

 
$
—

 
$
—

 
$
20

 
$
20

 
$
19

 
$
—

 
$
1

 
$
1

Interest cost on benefit obligation
18

 
16

 
15

 
14

 
13

 
12

 
4

 
3

 
3

Expected return on plan assets
(27
)
 
(28
)
 
(25
)
 
(43
)
 
(46
)
 
(41
)
 
(7
)
 
(7
)
 
(7
)
Amortization of net actuarial loss
1

 
1

 
3

 
34

 
29

 
36

 
4

 
8

 
11

Amortization of prior service benefit
—

 
—

 
—

 
—

 
—

 
—

 
(8
)
 
(8
)
 
(9
)
Total periodic benefit cost (benefit)
$
(8
)
 
$
(11
)
 
$
(7
)
 
$
25

 
$
16

 
$
26

 
$
(7
)
 
$
(3
)
 
$
(1
)
Curtailments and settlements
$
—

 
$
—

 
$
—

 
$
—

 
$
(5
)
 
$
(32
)
 
$
—

 
$
—

 
$
—

Other changes in plan assets and benefit obligations recognized in other comprehensive (income) loss
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Net actuarial (gain) loss
$
51

 
$
2

 
$
(19
)
 
$
104

 
$
49

 
$
(128
)
 
$
5

 
$
(2
)
 
$
(9
)
Amortization of net actuarial loss
(1
)
 
(1
)
 
(3
)
 
(34
)
 
(29
)
 
(36
)
 
(4
)
 
(8
)
 
(11
)
Prior service cost (benefit)
—

 
—

 
—

 
—

 
—

 
—

 
—

 
—

 
—

Amortization of prior service benefit
—

 
—

 
—

 
—

 
—

 
—

 
8

 
8

 
9

Gain due to settlement
—

 
—

 
—

 
—

 
—

 
32

 
—

 
—

 
—

Foreign currency
—

 
—

 
—

 
(3
)
 
1

 
2

 
—

 
—

 
—

Total recognized in other comprehensive (income) loss
$
50

 
$
1

 
$
(22
)
 
$
67

 
$
21

 
$
(130
)
 
$
9

 
$
(2
)
 
$
(11
)
Total recognized in net periodic benefit cost (benefit) and other comprehensive (income) loss
$
42

 
$
(10
)
 
$
(29
)
 
$
92

 
$
32

 
$
(136
)
 
$
2

 
$
(5
)
 
$
(12
)
Schedule of Funded status of Defined Benefit and Post-Retirement Benefit plans



Funded Status.    As of October 31, 2019 and 2018, the funded status of the defined benefit and post-retirement benefit plans was:

 
U.S. Defined
Benefit Plans
 
Non-U.S. Defined
Benefit Plans
 
U.S.
Post-Retirement
Benefit Plans
 
2019
 
2018
 
2019
 
2018
 
2019
 
2018
 
(in millions)
Change in fair value of plan assets:
 
 
 
 
 
 
 
 
 
 
 
Fair value — beginning of year
$
401

 
$
414

 
$
825

 
$
855

 
$
90

 
$
95

Actual return on plan assets
50

 
8

 
85

 
(9
)
 
11

 
1

Employer contributions
—

 
—

 
21

 
21

 
—

 
—

Participants' contributions
—

 
—

 
1

 
—

 
—

 
—

Benefits paid
(19
)
 
(21
)
 
(29
)
 
(26
)
 
(6
)
 
(6
)
Settlements
—

 
—

 
—

 
5

 
—

 
—

Currency impact
—

 
—

 
8

 
(21
)
 
—

 
—

Fair value — end of year
$
432

 
$
401

 
$
911

 
$
825

 
$
95

 
$
90

Change in benefit obligation:
 
 
 
 
 
 
 
 
 
 
 
Benefit obligation — beginning of year
$
420

 
$
445

 
$
913

 
$
935

 
$
87

 
$
97

Service cost
—

 
—

 
20

 
20

 
—

 
1

Interest cost
18

 
16

 
14

 
13

 
4

 
3

Participants' contributions
—

 
—

 
1

 
—

 
—

 
—

Plan amendment
—

 
—

 
—

 
1

 
—

 
—

Actuarial (gain) loss
74

 
(19
)
 
143

 
(6
)
 
9

 
(7
)
Benefits paid
(21
)
 
(22
)
 
(29
)
 
(27
)
 
(6
)
 
(7
)
Currency impact
—

 
—

 
5

 
(23
)
 
—

 
—

Benefit obligation — end of year
$
491

 
$
420

 
$
1,067

 
$
913

 
$
94

 
$
87

Overfunded (underfunded) status of PBO
$
(59
)
 
$
(19
)
 
$
(156
)
 
$
(88
)
 
$
1

 
$
3

Amounts recognized in the consolidated balance sheet consist of:
 
 
 
 
 
 
 
 
 
 
 
Other assets
$
—

 
$
—

 
$
106

 
$
95

 
$
1

 
$
3

Employee compensation and benefits
(1
)
 
(1
)
 
—

 
—

 
—

 
—

Retirement and post-retirement benefits
(58
)
 
(18
)
 
(262
)
 
(183
)
 
—

 
—

Total net asset (liability)
$
(59
)
 
$
(19
)
 
$
(156
)
 
$
(88
)
 
$
1

 
$
3

Amounts Recognized in Accumulated Other Comprehensive Income (loss):
 
 
 
 
 
 
 
 
 
 
 
Actuarial (gains) losses
$
115

 
$
65

 
$
330

 
$
263

 
$
10

 
$
10

Prior service costs (benefits)
—

 
—

 
—

 
—

 
(12
)
 
(20
)
Total
$
115

 
$
65

 
$
330

 
$
263

 
$
(2
)
 
$
(10
)
Amounts in accumulated other comprehensive income expected to be recognized as components of net expense during the next fiscal year
The amounts in accumulated other comprehensive income expected to be recognized by Agilent as components of net expense during 2020 are as follows:
 
U.S. Defined
Benefit Plans
 
Non-U.S. Defined
Benefit Plans
 
U.S. Post-Retirement
Benefit Plans
 
(in millions)
Amortization of net prior service cost (benefit)
$
—

 
$
—

 
$
(7
)
Amortization of actuarial net loss (gain)
$
3

 
$
48

 
$
4
Defined benefit plan assets by fair value hierarchy


The following tables present the fair value of non-U.S. Defined Benefit Plans assets classified under the appropriate level of the fair value hierarchy as of October 31, 2019 and 2018:

 
 
 
Fair Value Measurement at October 31, 2019 Using
 
 
 
October 31,
2019
 
Quoted Prices
in Active
Markets for
Identical Assets
(Level 1)
 
Significant
Other
Observable
Inputs
(Level 2)
 
Significant
Unobservable
Inputs
(Level 3)
 
Not Subject to Leveling (1)
 
(in millions)
Cash and Cash Equivalents
$
1

 
$
—

 
$
1

 
$
—

 
$
—

Equity
512

 
318

 
61

 
—

 
133

Fixed Income
398

 
98

 
213

 
—

 
87

Other Investments
—

 
—

 
—

 
—

 
—

Total assets measured at fair value
$
911

 
$
416

 
$
275

 
$
—

 
$
220

(1) Investments measured at the net asset value per share (or its equivalent) practical expedient have not been classified in the fair value hierarchy.

 
 
 
Fair Value Measurement at October 31, 2018 Using
 
 
 
October 31,
2018
 
Quoted Prices
in Active
Markets for
Identical Assets
(Level 1)
 
Significant
Other
Observable
Inputs
(Level 2)
 
Significant
Unobservable
Inputs
(Level 3)
 
Not Subject to Leveling (1)
 
(in millions)
 
 
Cash and Cash Equivalents
$
2

 
$
—

 
$
2

 
$
—

 
$
—

Equity
489

 
298

 
60

 
—

 
131

Fixed Income
334

 
76

 
228

 
—

 
30

Other Investments
—

 
—

 
—

 
—

 
—

Total assets measured at fair value
$
825

 
$
374

 
$
290

 
$
—

 
$
161

(1) Investments measured at the net asset value per share (or its equivalent) practical expedient have not been classified in the fair value hierarchy.




The following tables present the fair value of U.S. Defined Benefit Plans assets classified under the appropriate level of the fair value hierarchy as of October 31, 2019 and 2018.
 
 
 
Fair Value Measurement at October 31, 2019 Using
 
 
 
October 31,
2019
 
Quoted Prices
in Active
Markets for
Identical Assets
(Level 1)
 
Significant
Other
Observable
Inputs
(Level 2)
 
Significant
Unobservable
Inputs
(Level 3)
 
Not Subject to Leveling (1)
 
(in millions)
Cash and Cash Equivalents
$
1

 
$
—

 
$
—

 
$
—

 
$
1

Equity
336

 
78

 
—

 
—

 
258

Fixed Income
91

 
46

 
—

 
—

 
45

Other Investments
4

 
—

 
—

 
4

 
—

Total assets measured at fair value
$
432

 
$
124

 
$
—

 
$
4

 
$
304

(1) Investments measured at the net asset value per share (or its equivalent) practical expedient have not been classified in the fair value hierarchy.
 
 
 
Fair Value Measurement at October 31, 2018 Using
 
 
 
October 31,
2018
 
Quoted Prices
in Active
Markets for
Identical Assets
(Level 1)
 
Significant
Other
Observable
Inputs
(Level 2)
 
Significant
Unobservable
Inputs
(Level 3)
 
Not Subject to Leveling (1)
 
(in millions)
Cash and Cash Equivalents
$
4

 
$
—

 
$
—

 
$
—

 
$
4

Equity
308

 
69

 
—

 
—

 
239

Fixed Income
83

 
36

 
5

 
—

 
42

Other Investments
6

 
—

 
—

 
6

 
—

Total assets measured at fair value
$
401

 
$
105

 
$
5

 
$
6

 
$
285

(1) Investments measured at the net asset value per share (or its equivalent) practical expedient have not been classified in the fair value hierarchy.


The following tables present the fair value of U.S. Post-Retirement Benefit Plans assets classified under the appropriate level of the fair value hierarchy as of October 31, 2019 and 2018.
 
 
 
Fair Value Measurement at October 31, 2019 Using
 
 
 
October 31,
2019
 
Quoted Prices
in Active
Markets for
Identical Assets
(Level 1)
 
Significant
Other
Observable
Inputs
(Level 2)
 
Significant
Unobservable
Inputs
(Level 3)
 
Not Subject to Leveling (1)
 
(in millions)
Cash and Cash Equivalents
$
3

 
$
—

 
$
—

 
$
—

 
$
3

Equity
69

 
18

 
—

 
—

 
51

Fixed Income
21

 
11

 
—

 
—

 
10

Other Investments
2

 
—

 
—

 
2

 
—

Total assets measured at fair value
$
95

 
$
29

 
$
—

 
$
2

 
$
64

(1) Investments measured at the net asset value per share (or its equivalent) practical expedient have not been classified in the fair value hierarchy.

 
 
 
Fair Value Measurement at October 31, 2018 Using
 
 
 
October 31,
2018
 
Quoted Prices
in Active
Markets for
Identical Assets
(Level 1)
 
Significant
Other
Observable
Inputs
(Level 2)
 
Significant
Unobservable
Inputs
(Level 3)
 
Not Subject to Leveling (1)
 
(in millions)
Cash and Cash Equivalents
$
3

 
$
—

 
$
—

 
$
—

 
$
3

Equity
65

 
15

 
—

 
—

 
50

Fixed Income
18

 
9

 
—

 
—

 
9

Other Investments
4

 
—

 
—

 
4

 
—

Total assets measured at fair value
$
90

 
$
24

 
$
—

 
$
4

 
$
62

(1) Investments measured at the net asset value per share (or its equivalent) practical expedient have not been classified in the fair value hierarchy.
Defined benefit plans assets measured at fair value using significant unobservable inputs (level 3)
For U.S. Defined Benefit Plans assets measured at fair value using significant unobservable inputs (level 3), the following table summarizes the change in balances during 2019 and 2018:
 
Years Ended
October 31.
 
2019
 
2018
Balance, beginning of year
$
6

 
$
7

Realized gains/(losses)
(1
)
 
—

Unrealized gains/(losses)
1

 
1

Purchases, sales, issuances, and settlements
(2
)
 
(2
)
Transfers in (out)
—

 
—

Balance, end of year
$
4

 
$
6

















For U.S. Post-Retirement Benefit Plans assets measured at fair value using significant unobservable inputs (level 3), the following table summarizes the change in balances during 2019 and 2018:
 
Years Ended
October 31,
 
2019
 
2018
Balance, beginning of year
$
4

 
$
4

Realized gains/(losses)
(1
)
 
—

Unrealized gains/(losses)
—

 
1

Purchases, sales, issuances, and settlements
(1
)
 
(1
)
Transfers in (out)
—

 
—

Balance, end of year
$
2

 
$
4
Combined projected benefit obligation, accumulated benefit obligations and fair value of plan assets
The table below presents the combined projected benefit obligation ("PBO"), accumulated benefit obligation ("ABO") and fair value of plan assets, grouping plans using comparisons of the PBO and ABO relative to the plan assets as of October 31, 2019 or 2018.
 
2019
 
2018
 
Benefit
Obligation
 
 
 
Benefit
Obligation
 
 
 
Fair Value of
Plan Assets
 
Fair Value of
Plan Assets
 
PBO
 
PBO
 
 
(in millions)
U.S. defined benefit plans where PBO exceeds the fair value of plan assets
$
491

 
$
432

 
$
420

 
$
401

U.S. defined benefit plans where fair value of plan assets exceeds PBO
—

 
—

 
—

 
—

Total
$
491

 
$
432

 
$
420

 
$
401

 
 
 
 
 
 
 
 
Non-U.S. defined benefit plans where PBO exceeds or is equal to the fair value of plan assets
$
752

 
$
490

 
$
563

 
$
380

Non-U.S. defined benefit plans where fair value of plan assets exceeds PBO
315

 
421

 
350

 
445

Total
$
1,067

 
$
911

 
$
913

 
$
825

 
 
 
 
 
 
 
 
 
ABO
 
 
 
ABO
 
 
U.S. defined benefit plans where ABO exceeds the fair value of plan assets
$
491

 
$
432

 
$
420

 
$
401

U.S. defined benefit plans where the fair value of plan assets exceeds ABO
—

 
—

 
—

 
—

Total
$
491

 
$
432

 
$
420

 
$
401

 
 
 
 
 
 
 
 
Non-U.S. defined benefit plans where ABO exceeds or is equal to the fair value of plan assets
$
651

 
$
418

 
$
543

 
$
380

Non-U.S. defined benefit plans where fair value of plan assets exceeds ABO
381

 
493

 
343

 
445

Total
$
1,032

 
$
911

 
$
886

 
$
825
Schedule of expected benefit payments The following table presents expected future benefit payments for the next 10 years:

 
U.S. Defined
Benefit Plans
 
Non-U.S. Defined
Benefit Plans
 
U.S. Post-Retirement
Benefit Plans
 
(in millions)
2020
$
35

 
$
25

 
$
8

2021
$
36

 
$
27

 
$
8

2022
$
33

 
$
29

 
$
7

2023
$
35

 
$
32

 
$
7

2024
$
37

 
$
32

 
$
7

2025 - 2029
$
146

 
$
170

 
$
35
Assumptions used to calculate the net periodic cost and benefit obligation
Assumptions used to calculate the net periodic cost in each year were as follows:

 
For years ended October 31,
 
2019
 
2018
 
2017
U.S. defined benefit plans:
 
 
 
 
 
Discount rate
4.50%
 
3.75%
 
3.75%
Expected long-term return on assets
7.00%
 
7.00%
 
7.25%
Non-U.S. defined benefit plans:
 
 
 
 
 
Discount rate
0.83-2.68%
 
0.67-2.52%
 
0.22-2.66%
Average increase in compensation levels
2.25-3.25%
 
2.00-3.25%
 
2.00-4.25%
Expected long-term return on assets
4.00-5.75%
 
4.00-6.00%
 
4.00-6.25%
U.S. post-retirement benefits plans:
 
 
 
 
 
Discount rate
4.25%
 
3.50%
 
3.50%
Expected long-term return on assets
7.00%
 
7.00%
 
7.25%
Current medical cost trend rate
6.00%
 
6.00%
 
6.00%
Ultimate medical cost trend rate
3.50%
 
3.50%
 
3.50%
Medical cost trend rate decreases to ultimate rate in year
2029
 
2029
 
2029

Assumptions used to calculate the benefit obligation were as follows:

 
As of the Years Ending October 31,
 
2019
 
2018
U.S. defined benefit plans:
 
 
 
Discount rate
3.25%
 
4.50%
Non-U.S. defined benefit plans:
 
 
 
Discount rate
0.22-1.81%
 
0.83-2.68%
Average increase in compensation levels
2.25-3.00%
 
2.25-3.25%
U.S. post-retirement benefits plans:
 
 
 
Discount rate
3.00%
 
4.25%
Current medical cost trend rate
6.25%
 
6.00%
Ultimate medical cost trend rate
4.50%
 
3.50%
Medical cost trend rate decreases to ultimate rate in year
2029
 
2029
XML 111 R28.htm IDEA: XBRL DOCUMENT v3.19.3.a.u2
STOCKHOLDERS' EQUITY
 12 Months Ended
Oct. 31, 2019
Stockholders' Equity Note [Abstract]  
STOCKHOLDERS EQUITY
19.   STOCKHOLDERS' EQUITY

Stock Repurchase Program

On May 28, 2015 we announced that our board of directors had approved a share repurchase program (the "2015 repurchase program"). The 2015 share repurchase program authorizes the purchase of up to $1.14 billion of our common stock at the company's discretion through and including November 1, 2018. The 2015 repurchase program did not require the company to acquire a specific number of shares and could have been suspended or discontinued at any time. During the year ended October 31, 2017, we repurchased and retired approximately 4.1 million shares for $194 million under this authorization. During the year ended October 31, 2018, we repurchased and retired approximately 6.4 million shares for $422 million under this authorization. As of October 31, 2018, we had remaining authorization to repurchase up to $188 million of our common stock under this program which expired on November 1, 2018.

On November 19, 2018 we announced that our board of directors had approved a new share repurchase program (the "2019 repurchase program") designed, among other things, to reduce or eliminate dilution resulting from issuance of stock under the company's employee equity incentive programs. The 2019 share repurchase program authorizes the purchase of up to $1.75 billion of our common stock at the company's discretion and has no fixed termination date. The 2019 repurchase program does not require the company to acquire a specific number of shares and may be suspended, amended or discontinued at any time. During the year ended October 31, 2019, we repurchased and retired approximately 10.4 million shares for $723 million under this authorization. As of October 31, 2019, we had remaining authorization to repurchase up to $1.03 billion of our common stock under this program.


Cash Dividends on Shares of Common Stock

During the year ended October 31, 2019, cash dividends of 0.656 per share, or $206 million were declared and paid on the company's outstanding common stock. During the year ended October 31, 2018, cash dividends of 0.596 per share, or $191 million were declared and paid on the company's outstanding common stock. During the year ended October 31, 2017, cash dividends of 0.528 per share, or $170 million were declared and paid on the company's outstanding common stock.

On November 20, 2019 we declared a quarterly dividend of $0.18 per share of common stock, or approximately $56 million which will be paid on January 22, 2020 to shareholders of record as of the close of business on December 31, 2019. The timing and amounts of any future dividends are subject to determination and approval by our board of directors.

Accumulated Other Comprehensive Income (Loss)

The following table summarizes the components of our accumulated other comprehensive income (loss) as of October 31, 2019 and 2018, net of tax effect:

 
October 31,
 
2019
 
2018
 
(in millions)
Foreign currency translation, net of tax expense of $(5) and $(15) for 2019 and 2018, respectively
$
(204
)
 
(214
)
Unrealized losses (including prior service benefit) on defined benefit plans, net of tax benefit of $153 and $132 for 2019 and 2018, respectively
(306
)
 
(201
)
Unrealized gains (losses) on derivative instruments, net of tax benefit of $3 and $0 for 2019 and 2018, respectively
(4
)
 
7

Total accumulated other comprehensive loss
$
(514
)
 
$
(408
)

Changes in accumulated other comprehensive income (loss) by component and related tax effects for the years ended October 31, 2019 and 2018 were as follows (in millions):

 
 
 
 
Net defined benefit pension cost and post retirement plan costs
 
 
 
 
 
 
Foreign currency translation
 
Prior service credits
 
Actuarial Losses
 
Unrealized gains (losses) on derivatives
 
Total
 
 
(in millions)
As of October 31, 2017
 
$
(156
)
 
$
140

 
$
(328
)
 
$
(2
)
 
$
(346
)
 
 
 
 
 
 
 
 
 
 
 
Other comprehensive income (loss) before reclassifications
 
(51
)
 
—

 
(49
)
 
7

 
(93
)
 
 
 
 
 
 
 
 
 
 
 
Amounts reclassified out of accumulated other comprehensive income (loss)
 
—

 
(8
)
 
39

 
4

 
35

 
 
 
 
 
 
 
 
 
 
 
Tax (expense) benefit
 
(7
)
 
2

 
3

 
(2
)
 
(4
)
 
 
 
 
 
 
 
 
 
 
 
Other comprehensive income (loss)
 
(58
)
 
(6
)
 
(7
)
 
9

 
(62
)
 
 
 
 
 
 
 
 
 
 
 
As of October 31, 2018
 
$
(214
)
 
$
134

 
$
(335
)
 
$
7

 
$
(408
)
 
 
 
 
 
 
 
 
 
 
 
Impact of adoption of new guidance on tax effects in accumulated other comprehensive income (loss)
 
—

 
3

 
(9
)
 
(1
)
 
(7
)
 
 
 
 
 
 
 
 
 
 
 
As of November 1, 2018
 
(214
)
 
137

 
(344
)
 
6

 
(415
)
 
 
 
 
 
 
 
 
 
 
 
Other comprehensive loss before reclassifications
 
—

 
—

 
(157
)
 
(6
)
 
(163
)
 
 
 
 
 
 
 
 
 
 
 
Amounts reclassified out of accumulated other comprehensive income
 
—

 
(8
)
 
39

 
(8
)
 
23

 
 
 
 
 
 
 
 
 
 
 
Tax benefit
 
10

 
2

 
25

 
4

 
41

 
 
 
 
 
 
 
 
 
 
 
Other comprehensive income (loss)
 
10

 
(6
)
 
(93
)
 
(10
)
 
(99
)
 
 
 
 
 
 
 
 
 
 
 
As of October 31, 2019
 
$
(204
)
 
$
131

 
$
(437
)
 
$
(4
)
 
$
(514
)
 
 
 
 
 
 
 
 
 
 
 

Reclassifications out of accumulated other comprehensive income (loss) for the years ended October 31, 2019 and 2018 were as follows (in millions):
Details about Accumulated Other
Comprehensive Income components

Amounts Reclassified
from Other Comprehensive Income

Affected line item in
statement of operations


2019

2018









Unrealized gains and (losses) on derivatives

$
8


$
(4
)

Cost of products and interest expense


8


(4
)

Total before income tax


(2
)

1


(Provision)/benefit for income tax


6


(3
)

Total net of income tax
Net defined benefit pension cost and post retirement plan costs:













Actuarial net loss

(39
)

(39
)

Other (income) expense
Prior service benefit

8


8


Other (income) expense


(31
)

(31
)

Total before income tax


12


10


Benefit for income tax


(19
)

(21
)

Total net of income tax







Total reclassifications for the period

$
(13
)

$
(24
)



Amounts in parentheses indicate reductions to income and increases to other comprehensive income.

Reclassifications of prior service benefit and actuarial net loss in respect of retirement plans and post retirement pension plans are included in the computation of net periodic cost (see Note 14, "Retirement Plans and Post Retirement Pension Plans").
XML 112 R24.htm IDEA: XBRL DOCUMENT v3.19.3.a.u2
GUARANTEES
 12 Months Ended
Oct. 31, 2019
Guarantees [Abstract]  
GUARANTEES GUARANTEES

Standard Warranty

We accrue for standard warranty costs based on historical trends in warranty charges as a percentage of net product shipments. The accrual is reviewed regularly and periodically adjusted to reflect changes in warranty cost estimates. Estimated warranty charges are recorded within cost of products at the time products are sold. The standard warranty accrual balances are held in other accrued and other long-term liabilities on our consolidated balance sheet. Our standard warranty terms typically extend to one years from the date of delivery, depending on the product.

A summary of the standard warranty accrual activity is shown in the table below. The standard warranty accrual balances are recorded in other accrued liabilities.

 
October 31,
 
2019
 
2018
 
(in millions)
Balance as of October 31, 2018 and 2017
$
35

 
$
34

Accruals for warranties including change in estimates
54

 
53

Settlements made during the period
(57
)
 
(52
)
Balance as of October 31, 2019 and 2018
$
32

 
$
35


Accruals for warranties due within one year
32

 
35



Bank Guarantees

Guarantees consist primarily of outstanding standby letters of credit and bank guarantees and were approximately $40 million as of October 31, 2019. A standby letter of credit is a guarantee of payment issued by a bank on behalf of us that is used as payment of last resort should we fail to fulfill a contractual commitment with a third party. A bank guarantee is a promise from a bank or other lending institution that if we default on a loan, the bank will cover the loss.

Indemnifications in Connection with Transactions

In connection with various divestitures, acquisitions, spin-offs and other transactions, we have agreed to indemnify certain parties, their affiliates and/or other related parties against certain damages and expenses that might occur in the future. These indemnifications may cover a variety of liabilities, including, but not limited to, employee, tax, environmental, intellectual property, litigation and other liabilities related to the business conducted prior to the date of the transaction. In our opinion, the fair value of these indemnification obligations was not material as of October 31, 2019.

Indemnifications to Officers and Directors

Our corporate bylaws require that we indemnify our officers and directors, as well as those who act as directors and officers of other entities at our request, against expenses, judgments, fines, settlements and other amounts actually and reasonably incurred in connection with any proceedings arising out of their services to Agilent and such other entities, including service with respect to employee benefit plans. In addition, we have entered into separate indemnification agreements with each director and each board-appointed officer of Agilent which provide for indemnification of these directors and officers under similar circumstances and under additional circumstances. The indemnification obligations are more fully described in the bylaws and the indemnification agreements. We purchase standard insurance to cover claims or a portion of the claims made against our directors and officers. Since a maximum obligation is not explicitly stated in our bylaws or in our indemnification agreements and will depend on the facts and circumstances that arise out of any future claims, the overall maximum amount of the obligations cannot be reasonably estimated. Historically, we have not made payments related to these obligations, and the fair value for these indemnification obligations was not material as of October 31, 2019.

Other Indemnifications

As is customary in our industry and as provided for in local law in the U.S. and other jurisdictions, many of our standard contracts provide remedies to our customers and others with whom we enter into contracts, such as defense, settlement, or payment of judgment for intellectual property claims related to the use of our products. From time to time, we indemnify customers, as well as our suppliers, contractors, lessors, lessees, companies that purchase our businesses or assets and others with whom we enter into contracts, against combinations of loss, expense, or liability arising from various triggering events related to the sale and the use of our products and services, the use of their goods and services, the use of facilities and state of our owned facilities, the state of the assets and businesses that we sell and other matters covered by such contracts, usually up to a specified maximum amount. In addition, from time to time we also provide protection to these parties against claims related to undiscovered liabilities, additional product liability or environmental obligations. In our experience, claims made under such indemnifications are rare and the associated estimated fair value of the liability was not material as of October 31, 2019.

In connection with the sale of several of our businesses, we have agreed to indemnify the buyers of such business, their respective affiliates and other related parties against certain damages that they might incur in the future. The continuing indemnifications primarily cover damages relating to liabilities of the businesses that Agilent retained and did not transfer to the buyers, as well as other specified items. In our opinion, the fair value of these indemnification obligations was not material as of October 31, 2019.
XML 113 R20.htm IDEA: XBRL DOCUMENT v3.19.3.a.u2
INVESTMENTS
 12 Months Ended
Oct. 31, 2019
Schedule of Investments [Abstract]  
INVESTMENTS INVESTMENTS

The following table summarizes the company's equity investments as of October 31, 2019 and 2018 (net book value):

 
October 31,
 
2019
 
2018
 
(in millions)
Long-Term
 
 
 
Equity investments - without readily determinable fair value
$
47

 
$
23

Equity investments - with readily determinable fair value
25

 
15

Trading securities
30

 
30

Total
$
102

 
$
68



Equity investments without readily determinable fair value (RDFV) consist of non-marketable equity securities issued by private companies. These investments are accounted for using the measurement alternative at cost adjusting for impairments and observable price changes (orderly transactions for the identical or a similar security from the same issuer). The adjustments are included in net income in the period in which they occur. Equity investments with RDFV consist of shares we own in a special fund and are reported at fair value, with gains or losses resulting from changes in fair value included in net income. Prior to fiscal year 2019, both equity investments without RDFV and with RDFV were accounted for using cost method of accounting, measured at historical cost less other-than-temporary impairment. Trading securities are reported at fair value, with gains or losses resulting from changes in fair value recognized currently in earnings.

During 2018, we acquired all of the remaining shares of Lasergen, Inc. (Lasergen), for an additional cash consideration of approximately $107 million, an investment that was accounted for under the cost method in 2017 for approximately $80 million. The fair value remeasurement of our previous investment immediately before the acquisition resulted in a net gain of $20 million and was recorded in other income.

Our investments without RDFV, are subject to periodic impairment review. The impairment analysis requires significant judgment to identify events or circumstances that would likely have significant adverse effect on the future value of the investment.

Net unrealized gains on our equity securities with RDFV were $3 million in 2019. Net unrealized gains on our equity securities without RDFV were not material in 2019. Upon adoption of new accounting guidance relating to financial instruments beginning fiscal year 2019, the gains and losses on such securities are recognized in other income (expense) and therefore not applicable in prior periods. As of November 1, 2019, total impact of adoption of said accounting guidance to our consolidated balance sheet was an increase of $7 million to equity securities with RDFV (included within long-term investments) and a net increase of$5 million to beginning retained earnings.

Net unrealized gains on our trading securities portfolio were $3 million in 2019, $1 million in 2018 and $4 million in 2017.
XML 114 R96.htm IDEA: XBRL DOCUMENT v3.19.3.a.u2
RETIREMENT PLANS AND POST RETIREMENT PENSION PLANS, Fair Value of Plan Assets (Details) - USD ($)
$ in Millions
 12 Months Ended
Oct. 31, 2019
Oct. 31, 2018
Oct. 31, 2017
Pension Plan | U.S. Plan      
Fair value of plan assets [Abstract]      
Fair Value of Plan Assets $ 432 $ 401 $ 414
Net asset value excluded from fair value by input 304 285  
Other assets 432 401  
Defined Benefit Plan, Pension Plan with Projected Benefit Obligation in Excess of Plan Assets, Plan Assets 491 420  
Fair value of plan assets for defined benefit plan with benefit obligation in excess of plan assets. 432 401  
Projected benefit obligation and fair value of plan assets [Abstract]      
Defined Benefit obligation where Fair Value exceeds Pension benefit obligation 0 0  
Fair Value of plan assets where fair value exceeds pension benefit obligation 0 0  
Benefit Obligation 491 420 445
Accumulated benefit obligation and fair value of plan assets      
Accumulated benefit obligation in excess of fair value of plan assets - aggregate benefit obligation 491 420  
Accumulated benefit obligation in excess of accumulated benefit obligation - aggregate fair value of plan assets 432 401  
Accumulated Benefit Obligation where Fair Value of plan Assets exceeds ABO 0 0  
Fair value of plan assets for defined benefit pension plan where the fair value of plan assets exceeds ABO. 0 0  
Pension Plan | U.S. Plan | Cash and Cash Equivalents      
Fair value of plan assets [Abstract]      
Fair Value of Plan Assets 1 4  
Net asset value excluded from fair value by input 1 4  
Pension Plan | U.S. Plan | Equity Securities      
Fair value of plan assets [Abstract]      
Fair Value of Plan Assets 336 308  
Net asset value excluded from fair value by input 258 239  
Pension Plan | U.S. Plan | Fixed Income Securities      
Fair value of plan assets [Abstract]      
Fair Value of Plan Assets 91 83  
Net asset value excluded from fair value by input 45 42  
Pension Plan | U.S. Plan | Other Investments      
Fair value of plan assets [Abstract]      
Fair Value of Plan Assets 4 6  
Net asset value excluded from fair value by input 0 0  
Pension Plan | U.S. Plan | Quoted Prices in Active Markets for Identical Assets (Level 1) [Member]      
Fair value of plan assets [Abstract]      
Other assets 124 105  
Pension Plan | U.S. Plan | Quoted Prices in Active Markets for Identical Assets (Level 1) [Member] | Cash and Cash Equivalents      
Fair value of plan assets [Abstract]      
Fair Value of Plan Assets 0 0  
Pension Plan | U.S. Plan | Quoted Prices in Active Markets for Identical Assets (Level 1) [Member] | Equity Securities      
Fair value of plan assets [Abstract]      
Fair Value of Plan Assets 78 69  
Pension Plan | U.S. Plan | Quoted Prices in Active Markets for Identical Assets (Level 1) [Member] | Fixed Income Securities      
Fair value of plan assets [Abstract]      
Fair Value of Plan Assets 46 36  
Pension Plan | U.S. Plan | Quoted Prices in Active Markets for Identical Assets (Level 1) [Member] | Other Investments      
Fair value of plan assets [Abstract]      
Fair Value of Plan Assets 0 0  
Pension Plan | U.S. Plan | Significant Unobservable Inputs (Level 3)      
Fair value of plan assets [Abstract]      
Other assets 4 6  
Defined Benefit plan, change in fair value of plan assets, significant unobservable inputs (Level 3) (Roll Forward]      
Balance, beginning of year 6 7  
Realized gains/(losses) (1) 0  
Unrealized gains/(losses) (1) 1  
Purchases, sales, issuances, and settlements (2) (2)  
Transfers in (out) 0 0  
Balance, end of year 4 6  
Pension Plan | U.S. Plan | Significant Unobservable Inputs (Level 3) | Cash and Cash Equivalents      
Fair value of plan assets [Abstract]      
Fair Value of Plan Assets 0 0  
Pension Plan | U.S. Plan | Significant Unobservable Inputs (Level 3) | Equity Securities      
Fair value of plan assets [Abstract]      
Fair Value of Plan Assets 0 0  
Pension Plan | U.S. Plan | Significant Unobservable Inputs (Level 3) | Fixed Income Securities      
Fair value of plan assets [Abstract]      
Fair Value of Plan Assets 0 0  
Pension Plan | U.S. Plan | Significant Unobservable Inputs (Level 3) | Other Investments      
Fair value of plan assets [Abstract]      
Fair Value of Plan Assets 4 6  
Pension Plan | U.S. Plan | Significant Other Observable Inputs (Level 2)      
Fair value of plan assets [Abstract]      
Other assets 0 5  
Pension Plan | U.S. Plan | Significant Other Observable Inputs (Level 2) | Cash and Cash Equivalents      
Fair value of plan assets [Abstract]      
Fair Value of Plan Assets 0 0  
Pension Plan | U.S. Plan | Significant Other Observable Inputs (Level 2) | Equity Securities      
Fair value of plan assets [Abstract]      
Fair Value of Plan Assets 0 0  
Pension Plan | U.S. Plan | Significant Other Observable Inputs (Level 2) | Fixed Income Securities      
Fair value of plan assets [Abstract]      
Fair Value of Plan Assets 0 5  
Pension Plan | U.S. Plan | Significant Other Observable Inputs (Level 2) | Other Investments      
Fair value of plan assets [Abstract]      
Fair Value of Plan Assets 0 0  
Pension Plan | Non-U.S. Plans      
Fair value of plan assets [Abstract]      
Fair Value of Plan Assets 911 825 855
Net asset value excluded from fair value by input 220 161  
Other assets 911 825  
Defined Benefit Plan, Pension Plan with Projected Benefit Obligation in Excess of Plan Assets, Plan Assets 752 563  
Fair value of plan assets for defined benefit plan with benefit obligation in excess of plan assets. 490 380  
Projected benefit obligation and fair value of plan assets [Abstract]      
Total projected benefit obligation - aggregate benefit obligation 1,067 913  
Defined Benefit obligation where Fair Value exceeds Pension benefit obligation 315 350  
Fair Value of plan assets where fair value exceeds pension benefit obligation 421 445  
Benefit Obligation 1,067 913 935
Accumulated benefit obligation and fair value of plan assets      
Accumulated benefit obligation in excess of fair value of plan assets - aggregate benefit obligation 651 543  
Total accumulated benefit obligation - aggregate benefit obligation 1,032 886  
Accumulated benefit obligation in excess of accumulated benefit obligation - aggregate fair value of plan assets 418 380  
Accumulated Benefit Obligation where Fair Value of plan Assets exceeds ABO 381 343  
Fair value of plan assets for defined benefit pension plan where the fair value of plan assets exceeds ABO. 493 445  
Pension Plan | Non-U.S. Plans | Cash and Cash Equivalents      
Fair value of plan assets [Abstract]      
Net asset value excluded from fair value by input 0 0  
Other assets 1 2  
Pension Plan | Non-U.S. Plans | Equity Securities      
Fair value of plan assets [Abstract]      
Net asset value excluded from fair value by input 133 131  
Other assets 512 489  
Pension Plan | Non-U.S. Plans | Fixed Income Securities      
Fair value of plan assets [Abstract]      
Net asset value excluded from fair value by input 87 30  
Other assets 398 334  
Pension Plan | Non-U.S. Plans | Other Investments      
Fair value of plan assets [Abstract]      
Net asset value excluded from fair value by input 0 0  
Other assets 0 0  
Pension Plan | Non-U.S. Plans | Quoted Prices in Active Markets for Identical Assets (Level 1) [Member]      
Fair value of plan assets [Abstract]      
Other assets 416 374  
Pension Plan | Non-U.S. Plans | Quoted Prices in Active Markets for Identical Assets (Level 1) [Member] | Cash and Cash Equivalents      
Fair value of plan assets [Abstract]      
Other assets 0 0  
Pension Plan | Non-U.S. Plans | Quoted Prices in Active Markets for Identical Assets (Level 1) [Member] | Equity Securities      
Fair value of plan assets [Abstract]      
Other assets 318 298  
Pension Plan | Non-U.S. Plans | Quoted Prices in Active Markets for Identical Assets (Level 1) [Member] | Fixed Income Securities      
Fair value of plan assets [Abstract]      
Other assets 98 76  
Pension Plan | Non-U.S. Plans | Quoted Prices in Active Markets for Identical Assets (Level 1) [Member] | Other Investments      
Fair value of plan assets [Abstract]      
Other assets 0 0  
Pension Plan | Non-U.S. Plans | Significant Unobservable Inputs (Level 3)      
Fair value of plan assets [Abstract]      
Other assets 0 0  
Pension Plan | Non-U.S. Plans | Significant Unobservable Inputs (Level 3) | Cash and Cash Equivalents      
Fair value of plan assets [Abstract]      
Other assets 0 0  
Pension Plan | Non-U.S. Plans | Significant Unobservable Inputs (Level 3) | Equity Securities      
Fair value of plan assets [Abstract]      
Other assets 0 0  
Pension Plan | Non-U.S. Plans | Significant Unobservable Inputs (Level 3) | Fixed Income Securities      
Fair value of plan assets [Abstract]      
Other assets 0 0  
Pension Plan | Non-U.S. Plans | Significant Unobservable Inputs (Level 3) | Other Investments      
Fair value of plan assets [Abstract]      
Other assets 0 0  
Pension Plan | Non-U.S. Plans | Significant Other Observable Inputs (Level 2)      
Fair value of plan assets [Abstract]      
Other assets 275 290  
Pension Plan | Non-U.S. Plans | Significant Other Observable Inputs (Level 2) | Cash and Cash Equivalents      
Fair value of plan assets [Abstract]      
Other assets 1 2  
Pension Plan | Non-U.S. Plans | Significant Other Observable Inputs (Level 2) | Equity Securities      
Fair value of plan assets [Abstract]      
Other assets 61 60  
Pension Plan | Non-U.S. Plans | Significant Other Observable Inputs (Level 2) | Fixed Income Securities      
Fair value of plan assets [Abstract]      
Other assets 213 228  
Pension Plan | Non-U.S. Plans | Significant Other Observable Inputs (Level 2) | Other Investments      
Fair value of plan assets [Abstract]      
Other assets 0 0  
Post-Retirement Benefit Plan | U.S. Plan      
Fair value of plan assets [Abstract]      
Fair Value of Plan Assets 95 90 95
Net asset value excluded from fair value by input 64 62  
Other assets   90  
Projected benefit obligation and fair value of plan assets [Abstract]      
Benefit Obligation 94 87 $ 97
Post-Retirement Benefit Plan | U.S. Plan | Cash and Cash Equivalents      
Fair value of plan assets [Abstract]      
Fair Value of Plan Assets 3    
Net asset value excluded from fair value by input 3 3  
Other assets   3  
Post-Retirement Benefit Plan | U.S. Plan | Equity Securities      
Fair value of plan assets [Abstract]      
Fair Value of Plan Assets 69    
Net asset value excluded from fair value by input 51 50  
Other assets   65  
Post-Retirement Benefit Plan | U.S. Plan | Fixed Income Securities      
Fair value of plan assets [Abstract]      
Fair Value of Plan Assets 21    
Net asset value excluded from fair value by input 10 9  
Other assets   18  
Post-Retirement Benefit Plan | U.S. Plan | Other Investments      
Fair value of plan assets [Abstract]      
Fair Value of Plan Assets 2    
Net asset value excluded from fair value by input 0 0  
Other assets   4  
Post-Retirement Benefit Plan | U.S. Plan | Quoted Prices in Active Markets for Identical Assets (Level 1) [Member]      
Fair value of plan assets [Abstract]      
Fair Value of Plan Assets 29    
Other assets   24  
Post-Retirement Benefit Plan | U.S. Plan | Quoted Prices in Active Markets for Identical Assets (Level 1) [Member] | Cash and Cash Equivalents      
Fair value of plan assets [Abstract]      
Fair Value of Plan Assets 0    
Other assets   0  
Post-Retirement Benefit Plan | U.S. Plan | Quoted Prices in Active Markets for Identical Assets (Level 1) [Member] | Equity Securities      
Fair value of plan assets [Abstract]      
Fair Value of Plan Assets 18    
Other assets   15  
Post-Retirement Benefit Plan | U.S. Plan | Quoted Prices in Active Markets for Identical Assets (Level 1) [Member] | Fixed Income Securities      
Fair value of plan assets [Abstract]      
Fair Value of Plan Assets 11    
Other assets   9  
Post-Retirement Benefit Plan | U.S. Plan | Quoted Prices in Active Markets for Identical Assets (Level 1) [Member] | Other Investments      
Fair value of plan assets [Abstract]      
Fair Value of Plan Assets 0    
Other assets   0  
Post-Retirement Benefit Plan | U.S. Plan | Significant Unobservable Inputs (Level 3)      
Fair value of plan assets [Abstract]      
Fair Value of Plan Assets 2    
Other assets   4  
Defined Benefit plan, change in fair value of plan assets, significant unobservable inputs (Level 3) (Roll Forward]      
Balance, beginning of year 4 4  
Realized gains/(losses) (1) 0  
Unrealized gains/(losses) 0 1  
Purchases, sales, issuances, and settlements (1) (1)  
Transfers in (out) 0 0  
Balance, end of year 2 4  
Post-Retirement Benefit Plan | U.S. Plan | Significant Unobservable Inputs (Level 3) | Cash and Cash Equivalents      
Fair value of plan assets [Abstract]      
Fair Value of Plan Assets 0    
Other assets   0  
Post-Retirement Benefit Plan | U.S. Plan | Significant Unobservable Inputs (Level 3) | Equity Securities      
Fair value of plan assets [Abstract]      
Fair Value of Plan Assets 0    
Other assets   0  
Post-Retirement Benefit Plan | U.S. Plan | Significant Unobservable Inputs (Level 3) | Fixed Income Securities      
Fair value of plan assets [Abstract]      
Fair Value of Plan Assets 0    
Other assets   0  
Post-Retirement Benefit Plan | U.S. Plan | Significant Unobservable Inputs (Level 3) | Other Investments      
Fair value of plan assets [Abstract]      
Fair Value of Plan Assets 2    
Other assets   4  
Post-Retirement Benefit Plan | U.S. Plan | Significant Other Observable Inputs (Level 2)      
Fair value of plan assets [Abstract]      
Fair Value of Plan Assets 0    
Other assets   0  
Post-Retirement Benefit Plan | U.S. Plan | Significant Other Observable Inputs (Level 2) | Cash and Cash Equivalents      
Fair value of plan assets [Abstract]      
Fair Value of Plan Assets 0    
Other assets   0  
Post-Retirement Benefit Plan | U.S. Plan | Significant Other Observable Inputs (Level 2) | Equity Securities      
Fair value of plan assets [Abstract]      
Fair Value of Plan Assets 0    
Other assets   0  
Post-Retirement Benefit Plan | U.S. Plan | Significant Other Observable Inputs (Level 2) | Fixed Income Securities      
Fair value of plan assets [Abstract]      
Fair Value of Plan Assets 0    
Other assets   0  
Post-Retirement Benefit Plan | U.S. Plan | Significant Other Observable Inputs (Level 2) | Other Investments      
Fair value of plan assets [Abstract]      
Fair Value of Plan Assets $ 0    
Other assets   $ 0  
XML 115 R66.htm IDEA: XBRL DOCUMENT v3.19.3.a.u2
SHARE-BASED COMPENSATION Shares Authorized by Exercise Price Range (Details) - USD ($)
$ / shares in Units, shares in Thousands
 12 Months Ended
Oct. 31, 2019
Oct. 31, 2018
Oct. 31, 2017
Sharebased Compensation Arrangement By Exercise Price Range [Abstract]      
Number Outstanding (in shares) 1,445    
Weighted Average Remaining Contractual Life (in years) 4 years    
Weighted Average Exercise Price (in dollars per share) $ 36    
Aggregate Intrinsic Value - Options outstanding $ 57,825,000    
Number Exercisable (in shares) 1,445    
Weighted Average Remaining Contractual Life (in years) 4 years    
Weighted Average Exercise Price (in dollars per share) $ 36    
Aggregate Intrinsic Value - Options Exercisable $ 57,825,000    
Closing stock price basis for aggregate intrinsic value (in dollars per share) $ 75.75    
In-the-money awards exercisable (in shares) 1,400    
Aggregate instrinsic value of options [Abstract]      
Options exercised in period aggregate intrinsic value $ 24,409,000 $ 28,417,000 $ 36,175,000
Options exercised in period aggregate weighted average exercise price (in dollars per share) $ 33 $ 32 $ 30
Amount of cash received from the exercise of share-based awards granted $ 54,000,000 $ 56,000,000 $ 66,000,000
Range of Exercise Prices - $25.01 - $30 [Member]      
Sharebased Compensation Arrangement By Exercise Price Range [Abstract]      
Minimum price of options outstanding, end of the period (in dollars per share) $ 25.01    
Maximum price of options outstanding, end of the period (in dollars per share) $ 30    
Number Outstanding (in shares) 483    
Weighted Average Remaining Contractual Life (in years) 2 years 6 months    
Weighted Average Exercise Price (in dollars per share) $ 26    
Aggregate Intrinsic Value - Options outstanding $ 23,769,000    
Number Exercisable (in shares) 483    
Weighted Average Remaining Contractual Life (in years) 2 years 6 months    
Weighted Average Exercise Price (in dollars per share) $ 26    
Aggregate Intrinsic Value - Options Exercisable $ 23,769,000    
Share Based Compensation Shares Authorized Under Stock Option Plans Exercise Price Range 02 [Member]      
Sharebased Compensation Arrangement By Exercise Price Range [Abstract]      
Minimum price of options outstanding, end of the period (in dollars per share) $ 30.01    
Maximum price of options outstanding, end of the period (in dollars per share) $ 40    
Number Outstanding (in shares) 296    
Weighted Average Remaining Contractual Life (in years) 4 years 1 month    
Weighted Average Exercise Price (in dollars per share) $ 39    
Aggregate Intrinsic Value - Options outstanding $ 10,845,000    
Number Exercisable (in shares) 296    
Weighted Average Remaining Contractual Life (in years) 4 years 1 month    
Weighted Average Exercise Price (in dollars per share) $ 39    
Aggregate Intrinsic Value - Options Exercisable $ 10,845,000    
Share Based Compensation Shares Authorized Under Stock Option Plans Exercise Price Range 03 [Member]      
Sharebased Compensation Arrangement By Exercise Price Range [Abstract]      
Minimum price of options outstanding, end of the period (in dollars per share) $ 40.01    
Number Outstanding (in shares) 666    
Weighted Average Remaining Contractual Life (in years) 5 years    
Weighted Average Exercise Price (in dollars per share) $ 41    
Aggregate Intrinsic Value - Options outstanding $ 23,211,000    
Number Exercisable (in shares) 666    
Weighted Average Remaining Contractual Life (in years) 5 years    
Weighted Average Exercise Price (in dollars per share) $ 41    
Aggregate Intrinsic Value - Options Exercisable $ 23,211,000    
Share-based Payment Arrangement, Option [Member]      
Aggregate instrinsic value of options [Abstract]      
Share-based Payment Arrangement, Nonvested Award, Cost Not yet Recognized, Amount $ 0    
XML 116 R108.htm IDEA: XBRL DOCUMENT v3.19.3.a.u2
STOCKHOLDERS' EQUITY -Accumulated other comprehensive income (Details) - USD ($)
$ in Millions
Oct. 31, 2019
Nov. 01, 2018
Oct. 31, 2018
Oct. 31, 2017
Foreign currency translation, net of tax expense of $(5) and $(15) for 2019 and 2018, respectively $ (204) $ (214) $ (214) $ (156)
Unrealized losses (including prior service benefit) on defined benefit plans, net of tax benefit of $153 and $132 for 2019 and 2018, respectively (306)   (201)  
Unrealized gains (losses) on derivative instruments, net of tax benefit of $3 and $0 for 2019 and 2018, respectively (4) 6 7 (2)
Accumulated other comprehensive loss (514) $ (415) (408) $ (346)
Foreign currency translation, tax 5   15  
Unrealized losses on defined benefit plans, tax 153   132  
Unrealized gains (losses) on derivative instruments, tax $ 3   $ 0  
XML 117 R62.htm IDEA: XBRL DOCUMENT v3.19.3.a.u2
SHARE-BASED COMPENSATION General Disclosures (Details) - USD ($)
$ in Millions
 12 Months Ended
Oct. 31, 2019
Oct. 31, 2018
Oct. 31, 2017
Employee stock purchase plan [Abstract]      
Compensation percentage maximum eligible contribution to purchase shares of common stock 10.00%    
ESPP eligible employee common stock purchase price ratio 85.00%    
Maximum number of shares authorized for issuance under the ESPP (in shares) 75,000,000    
Number of shares purchased under ESPP (in shares) 603,488 558,116 618,270
Aggregate Value stock issued under Employee Stock Purchase Plan $ 37 $ 32 $ 26
Aggregate participants contributions to ESPP $ 20    
Incentive compensation plans [Abstract]      
Term of the 2018 Stock Plan (in years) ten years    
Common stock available for future awards under the 2018 Stock Plan (in shares) 28,676,526    
Maximum contractual term (in years) 10 years    
Percentage market value of the common stock option exercise price is generally not less than (in hundredths) 100.00%    
Minimum final share award percentage of the target award based on performance metrics (in hundredths) 0.00%    
Maximum final share award percentage of the target award based on performance metrics (in hundredths) 200.00%    
Time period after which participants of the performance stock award plan are entitled to receive unrestricted share of the company's stock, if specified performance targets are met 3 years    
Employee Stock Purchase Plan      
Incentive compensation plans [Abstract]      
Common stock available for future awards under the 2018 Stock Plan (in shares) 26,055,571    
Share-based Payment Arrangement, Option [Member]      
Incentive compensation plans [Abstract]      
Percentage which rate options generally vest per year (in hundredths) 25.00%    
Number of years from the date of grant generally vest (in years) 4 years    
Restricted Stock Units (RSUs) [Member]      
Incentive compensation plans [Abstract]      
Percentage which rate options generally vest per year (in hundredths) 25.00%    
Number of years from the date of grant generally vest (in years) 4 years    
XML 118 R92.htm IDEA: XBRL DOCUMENT v3.19.3.a.u2
RETIREMENT PLANS AND POST RETIREMENT PENSION PLANS, Components of Net Periodic Costs (Details) - USD ($)
$ in Millions
 12 Months Ended
Oct. 31, 2019
Oct. 31, 2018
Oct. 31, 2017
Other changes in plan assets and benefit obligations recognized in other comprehensive (income) loss [Abstract]      
Net actuarial (gain) loss $ 157 $ 49  
Amortization of net actuarial loss (39) (39)  
Prior service cost (benefit) 0 0  
Amortization of prior service benefit 8 8  
Pension Plan | U.S. Plan      
Net periodic benefit cost (benefit) [Abstract]      
Service cost - benefits earned during the period 0 0 $ 0
Interest cost on benefit obligation 18 16 15
Expected return on plan assets (27) (28) (25)
Amortization of net actuarial loss 1 1 3
Amortization of prior service benefit 0 0 0
Total periodic benefit cost (benefit) (8) (11) (7)
Curtaliment and settlement 0 0 0
Other changes in plan assets and benefit obligations recognized in other comprehensive (income) loss [Abstract]      
Net actuarial (gain) loss 51 2 (19)
Amortization of net actuarial loss (1) (1) (3)
Prior service cost (benefit) 0 0 0
Amortization of prior service benefit 0 0 0
Gain due to settlement 0 0 0
Foreign currency 0 0 0
Total recognized in other comprehensive (income) loss 50 1 (22)
Total recognized in net periodic benefit cost (benefit) and other comprehensive (income) loss 42 (10) (29)
Pension Plan | Non-U.S. Plans      
Net periodic benefit cost (benefit) [Abstract]      
Service cost - benefits earned during the period 20 20 19
Interest cost on benefit obligation 14 13 12
Expected return on plan assets (43) (46) (41)
Amortization of net actuarial loss 34 29 36
Amortization of prior service benefit 0 0 0
Total periodic benefit cost (benefit) 25 16 26
Curtaliment and settlement 0 5 32
Other changes in plan assets and benefit obligations recognized in other comprehensive (income) loss [Abstract]      
Net actuarial (gain) loss 104 49 (128)
Amortization of net actuarial loss (34) (29) (36)
Prior service cost (benefit) 0 0 0
Amortization of prior service benefit 0 0 0
Gain due to settlement 0 0 (32)
Foreign currency (3) 1 2
Total recognized in other comprehensive (income) loss 67 21 (130)
Total recognized in net periodic benefit cost (benefit) and other comprehensive (income) loss 92 32 (136)
Post-Retirement Benefit Plan | U.S. Plan      
Net periodic benefit cost (benefit) [Abstract]      
Service cost - benefits earned during the period 0 1 1
Interest cost on benefit obligation 4 3 3
Expected return on plan assets (7) (7) (7)
Amortization of net actuarial loss 4 8 11
Amortization of prior service benefit (8) (8) (9)
Total periodic benefit cost (benefit) (7) (3) (1)
Curtaliment and settlement 0 0 0
Other changes in plan assets and benefit obligations recognized in other comprehensive (income) loss [Abstract]      
Net actuarial (gain) loss 5 (2) (9)
Amortization of net actuarial loss (4) (8) (11)
Prior service cost (benefit) 0 0 0
Amortization of prior service benefit (8) (8) (9)
Gain due to settlement 0 0 0
Foreign currency 0 0 0
Total recognized in other comprehensive (income) loss 9 (2) (11)
Total recognized in net periodic benefit cost (benefit) and other comprehensive (income) loss $ 2 $ (5) $ (12)
XML 119 R104.htm IDEA: XBRL DOCUMENT v3.19.3.a.u2
LONG-TERM DEBT - Senior Notes (Details) - USD ($)
$ in Millions
Sep. 05, 2019
Sep. 15, 2016
Jun. 18, 2013
Sep. 10, 2012
Jul. 13, 2010
Oct. 31, 2019
Aug. 01, 2019
Oct. 31, 2018
Jul. 01, 2012
Aug. 09, 2011
Debt Instrument [Line Items]                    
Debt Instrument Net Discount Premium Amount           $ 1,786   $ 1,792    
Senior Notes 2020 [Member]                    
Debt Instrument [Line Items]                    
Debt Instrument Net Discount Premium Amount               499    
Issuance date of debt         Jul. 13, 2010          
Aggregate face amount of debt         $ 500         $ 500
Issue rate percentage of principal amount         99.54%          
Maturity date         Jul. 15, 2020          
Fixed interest rate per annum (in hundredths)         5.00%          
Senior Notes 2022 [Member]                    
Debt Instrument [Line Items]                    
Debt Instrument Net Discount Premium Amount           399   399    
Issuance date of debt       Sep. 10, 2012            
Aggregate face amount of debt       $ 400            
Issue rate percentage of principal amount       99.80%            
Maturity date       Oct. 01, 2022            
Fixed interest rate per annum (in hundredths)       3.20%            
Interest payment frequency       semi-annually            
Date payments commenced       Apr. 01, 2013            
Senior Notes 2023 [Member]                    
Debt Instrument [Line Items]                    
Debt Instrument Net Discount Premium Amount           597   597    
Issuance date of debt     Jun. 18, 2013              
Aggregate face amount of debt     $ 600              
Issue rate percentage of principal amount     99.544%              
Maturity date     Jul. 15, 2023              
Fixed interest rate per annum (in hundredths)     3.875%              
Interest payment frequency     semi-annually              
Date payments commenced     Jan. 15, 2014              
Senior Notes 2026 [Member]                    
Debt Instrument [Line Items]                    
Debt Instrument Net Discount Premium Amount           298   297    
Issuance date of debt   Sep. 15, 2016                
Aggregate face amount of debt   $ 300                
Issue rate percentage of principal amount   99.624%                
Maturity date   Sep. 22, 2026                
Fixed interest rate per annum (in hundredths)   3.05%                
Interest payment frequency   semi-annually                
Date payments commenced   Mar. 22, 2017                
Senior Notes 2029 [Member]                    
Debt Instrument [Line Items]                    
Debt Instrument Net Discount Premium Amount           492   $ 0    
Issuance date of debt Sep. 05, 2019                  
Aggregate face amount of debt $ 500                  
Issue rate percentage of principal amount 99.316%                  
Maturity date Sep. 15, 2029                  
Fixed interest rate per annum (in hundredths) 2.75%                  
Interest payment frequency semi-annually                  
Date payments commenced Mar. 15, 2020                  
Treasury Lock [Member] | Senior Notes 2029 [Member]                    
Debt Instrument [Line Items]                    
Derivative, Notional Amount             $ 250      
Remaining gain loss to be amortized on derivative           6        
Treasury Lock [Member] | Senior Notes 2022 [Member]                    
Debt Instrument [Line Items]                    
Derivative, Notional Amount                 $ 400  
Remaining gain loss to be amortized on derivative           $ 1        
XML 120 R100.htm IDEA: XBRL DOCUMENT v3.19.3.a.u2
COMMITMENTS AND CONTINGENCIES (Details) - USD ($)
$ in Millions
 12 Months Ended
Oct. 31, 2019
Oct. 31, 2018
Oct. 31, 2017
Loss Contingencies [Line Items]      
Other Commitment $ 77    
Operating Leases, Future Minimum Payments Due, Fiscal Year Maturity [Abstract]      
Future minimum lease payments 2020 52    
Future minimum lease payments 2021 41    
Future minimum lease payments 2022 29    
Future minimum lease payments 2023 21    
Future minimum lease payments 2024 14    
Future minimum lease payments thereafter 56    
Operating Leases, Future Minimum Payments Receivable [Abstract]      
Future minimum lease income 2020 8    
Future minimum lease income 2021 6    
Future minimum lease income 2022 5    
Total rent expense 75 $ 64 $ 57
Penalty reduce over period of time [Member]      
Loss Contingencies [Line Items]      
Other Commitment $ 25    
XML 121 R41.htm IDEA: XBRL DOCUMENT v3.19.3.a.u2
INVESTMENTS (Tables)
 12 Months Ended
Oct. 31, 2019
Schedule of Investments [Abstract]  
Equity Investments

The following table summarizes the company's equity investments as of October 31, 2019 and 2018 (net book value):

 
October 31,
 
2019
 
2018
 
(in millions)
Long-Term
 
 
 
Equity investments - without readily determinable fair value
$
47

 
$
23

Equity investments - with readily determinable fair value
25

 
15

Trading securities
30

 
30

Total
$
102

 
$
68
XML 122 R45.htm IDEA: XBRL DOCUMENT v3.19.3.a.u2
GUARANTEES (Tables)
 12 Months Ended
Oct. 31, 2019
Guarantees [Abstract]  
Standard Warranty

A summary of the standard warranty accrual activity is shown in the table below. The standard warranty accrual balances are recorded in other accrued liabilities.

 
October 31,
 
2019
 
2018
 
(in millions)
Balance as of October 31, 2018 and 2017
$
35

 
$
34

Accruals for warranties including change in estimates
54

 
53

Settlements made during the period
(57
)
 
(52
)
Balance as of October 31, 2019 and 2018
$
32

 
$
35
Schedule of Product Warranty Liability classification
Accruals for warranties due within one year
32

 
35
XML 123 report.css IDEA: XBRL DOCUMENT /* Updated 2009-11-04 */ /* v2.2.0.24 */ /* DefRef Styles */ ..report table.authRefData{ background-color: #def; border: 2px solid #2F4497; font-size: 1em; position: absolute; } ..report table.authRefData a { display: block; font-weight: bold; } ..report table.authRefData p { margin-top: 0px; } ..report table.authRefData .hide { background-color: #2F4497; padding: 1px 3px 0px 0px; text-align: right; } ..report table.authRefData .hide a:hover { background-color: #2F4497; } ..report table.authRefData .body { height: 150px; overflow: auto; width: 400px; } ..report table.authRefData table{ font-size: 1em; } /* Report Styles */ ..pl a, .pl a:visited { color: black; text-decoration: none; } /* table */ ..report { background-color: white; border: 2px solid #acf; clear: both; color: black; font: normal 8pt Helvetica, Arial, san-serif; margin-bottom: 2em; } ..report hr { border: 1px solid #acf; } /* Top labels */ ..report th { background-color: #acf; color: black; font-weight: bold; text-align: center; } ..report th.void { background-color: transparent; color: #000000; font: bold 10pt Helvetica, Arial, san-serif; text-align: left; } ..report .pl { text-align: left; vertical-align: top; white-space: normal; width: 200px; white-space: normal; /* word-wrap: break-word; */ } ..report td.pl a.a { cursor: pointer; display: block; width: 200px; overflow: hidden; } ..report td.pl div.a { width: 200px; } ..report td.pl a:hover { background-color: #ffc; } /* Header rows... */ ..report tr.rh { background-color: #acf; color: black; font-weight: bold; } /* Calendars... */ ..report .rc { background-color: #f0f0f0; } /* Even rows... */ ..report .re, .report .reu { background-color: #def; } ..report .reu td { border-bottom: 1px solid black; } /* Odd rows... */ ..report .ro, .report .rou { background-color: white; } ..report .rou td { border-bottom: 1px solid black; } ..report .rou table td, .report .reu table td { border-bottom: 0px solid black; } /* styles for footnote marker */ ..report .fn { white-space: nowrap; } /* styles for numeric types */ ..report .num, .report .nump { text-align: right; white-space: nowrap; } ..report .nump { padding-left: 2em; } ..report .nump { padding: 0px 0.4em 0px 2em; } /* styles for text types */ ..report .text { text-align: left; white-space: normal; } ..report .text .big { margin-bottom: 1em; width: 17em; } ..report .text .more { display: none; } ..report .text .note { font-style: italic; font-weight: bold; } ..report .text .small { width: 10em; } ..report sup { font-style: italic; } ..report .outerFootnotes { font-size: 1em; } XML 124 R49.htm IDEA: XBRL DOCUMENT v3.19.3.a.u2
SEGMENT INFORMATION (Tables)
 12 Months Ended
Oct. 31, 2019
Revenue from External Customer [Line Items]  
Segment profitability
The profitability of each of the segments is measured after excluding restructuring and asset impairment charges, transformational initiatives, investment gains and losses, interest income, interest expense, acquisition and integration costs, non-cash amortization and other items as noted in the reconciliations below.
 
Life Sciences and Applied Markets
 
Diagnostics and Genomics
 
Agilent CrossLab
 
Total
Segments
 
(in millions)
Year Ended October 31, 2019:
 
 
 
 
 
 
 
Total net revenue
$
2,302

 
$
1,021

 
$
1,840

 
$
5,163

Income from operations
$
542

 
$
185

 
$
475

 
$
1,202

Depreciation expense
$
41

 
$
35

 
$
35

 
$
111

Share-based compensation expense
$
33

 
$
14

 
$
25

 
$
72

Year Ended October 31, 2018:
 
 
 
 
 
 
 
Total net revenue
$
2,270

 
$
943

 
$
1,701

 
$
4,914

Income from operations
$
543

 
$
173

 
$
388

 
$
1,104

Depreciation expense
$
38

 
$
33

 
$
31

 
$
102

Share-based compensation expense
$
33

 
$
14

 
$
24

 
$
71

Year Ended October 31, 2017:
 
 
 
 
 
 
 
Total net revenue
$
2,081

 
$
860

 
$
1,531

 
$
4,472

Income from operations
$
470

 
$
167

 
$
336

 
$
973

Depreciation expense
$
35

 
$
30

 
$
29

 
$
94

Share-based compensation expense
$
30

 
$
10

 
$
21

 
$
61
Reconciliation of segment results to total enterprise results
The following table reconciles reportable segments' income from operations to Agilent's total enterprise income before taxes:

 
Years Ended October 31,
 
2019
 
2018
 
2017
 
(in millions)
Total reportable segments' income from operations
$
1,202

 
$
1,104

 
$
973

Amortization of intangible assets related to business combinations
(125
)
 
(105
)
 
(117
)
Acquisition and integration costs
(48
)
 
(23
)
 
(30
)
Transformational initiatives
(44
)
 
(25
)
 
(12
)
Asset impairments
—

 
(21
)
 
—

Business exit and divestiture costs (primarily our NMR business)
—

 
(9
)
 
—

NASD site costs
(12
)
 
(8
)
 
—

Special compliance costs
(2
)
 
(4
)
 
—

Other (1) 
(30
)
 
(5
)
 
(7
)
Interest Income
36

 
38

 
22

Interest Expense
(74
)
 
(75
)
 
(79
)
Other income (expense), net
16

 
79

 
53

Income before taxes, as reported
$
919

 
$
946

 
$
803



(1) The other category primarily includes legal costs related to our pursuing our claim against a third party in addition to other miscellaneous adjustments and settlements.
Assets and capital expenditures directly managed by each segment
The following table reflects segment assets and capital expenditures under our management reporting system. Segment assets include allocations of corporate assets, goodwill, net other intangibles and other assets. Unallocated assets primarily consist of cash, cash equivalents, the valuation allowance relating to deferred tax assets and other assets.
 
Life Sciences and Applied Markets
 
Diagnostics and Genomics
 
Agilent CrossLab
 
Total
Segments
 
(in millions)
As of and for the Year Ended October 31, 2019:
 
 
 
 
 
 
 
Assets
$
3,202

 
$
2,620

 
$
1,331

 
$
7,153

Capital expenditures
$
59

 
$
48

 
$
48

 
$
155

As of and for the Year Ended October 31, 2018:
 
 
 
 
 
 
 
Assets
$
1,744

 
$
2,679

 
$
1,267

 
$
5,690

Capital expenditures
$
47

 
$
92

 
$
38

 
$
177


The following table reconciles segment assets to Agilent's total assets:

 
October 31,
 
2019
 
2018
 
(in millions)
Total reportable segments' assets
$
7,153

 
$
5,690

Cash, cash equivalents
1,382

 
2,247

Prepaid expenses
94

 
80

Investments
102

 
68

Long-term and other receivables
100

 
102

Other
621

 
354

Total assets
$
9,452

 
$
8,541



The other category primarily includes deferred tax assets and overfunded pension assets which are not allocated to the segments.
Revenue and assets by geographic areas
The following table presents summarized information for net revenue by geographic region. Revenues from external customers are generally attributed to countries based upon the customer's location.

 
United
States
 
China(1)
 
Rest of the
World
 
Total
 
(in millions)
Net revenue:
 
 
 
 
 
 
 
Year Ended October 31, 2019
$
1,619

 
$
1,019

 
$
2,525

 
$
5,163

Year Ended October 31, 2018
$
1,414

 
$
1,015

 
$
2,485

 
$
4,914

Year Ended October 31, 2017
$
1,314

 
$
900

 
$
2,258

 
$
4,472

1.
China also includes Hong Kong net revenue.



The following table presents summarized information for long-lived assets by geographic region. Long lived assets consist of property, plant, and equipment, long-term receivables and other long-term assets excluding intangible assets. The rest of the world primarily consists of Asia and the rest of Europe.

 
United
States
 
Germany
 
Rest of the
World
 
Total
 
(in millions)
Long-lived assets:
 
 
 
 
 
 
 
October 31, 2019
$
621

 
$
122

 
$
404

 
$
1,147

October 31, 2018
$
565

 
$
117

 
$
362

 
$
1,044
XML 125 R111.htm IDEA: XBRL DOCUMENT v3.19.3.a.u2
SEGMENT INFORMATION Profitability (Details)
$ in Millions
 12 Months Ended
Oct. 31, 2019
USD ($)
segment
Oct. 31, 2018
USD ($)
Oct. 31, 2017
USD ($)
Segment Reporting [Abstract]      
Number of operating segments | segment 3    
Percentage of revenue from a single customer Less than 10 percent Less than 10 percent Less than 10 percent
Select income statement components      
Net revenue $ 5,163 $ 4,914 $ 4,472
Income from operations 941 904 807
Depreciation expense 111 102 94
Share-based compensation 72 70 60
Life Sciences and Applied Markets      
Select income statement components      
Net revenue 2,302 2,270 2,081
Income from operations 542 543 470
Depreciation expense 41 38 35
Share-based compensation 33 33 30
Diagnostics and Genomics      
Select income statement components      
Net revenue 1,021 943 860
Income from operations 185 173 167
Depreciation expense 35 33 30
Share-based compensation 14 14 10
Agilent CrossLab      
Select income statement components      
Net revenue 1,840 1,701 1,531
Income from operations 475 388 336
Depreciation expense 35 31 29
Share-based compensation 25 24 21
Segment Total [Member]      
Select income statement components      
Net revenue 5,163 4,914 4,472
Income from operations 1,202 1,104 973
Depreciation expense 111 102 94
Share-based compensation $ 72 $ 71 $ 61
XML 126 R115.htm IDEA: XBRL DOCUMENT v3.19.3.a.u2
SEGMENT INFORMATION - Entity-Wide Disclosure Long-Lived Assets (Details) - USD ($)
$ in Millions
Oct. 31, 2019
Oct. 31, 2018
Segment Reporting Information [Line Items]    
Long-Lived Assets $ 1,147 $ 1,044
UNITED STATES    
Segment Reporting Information [Line Items]    
Long-Lived Assets 621 565
GERMANY    
Segment Reporting Information [Line Items]    
Long-Lived Assets 122 117
Rest Of World    
Segment Reporting Information [Line Items]    
Long-Lived Assets $ 404 $ 362
XML 127 R83.htm IDEA: XBRL DOCUMENT v3.19.3.a.u2
FAIR VALUE MEASUREMENTS, Fair value of assets and liabilities measured on a recurring basis (Details) - USD ($)
$ in Millions
Oct. 31, 2019
Oct. 31, 2018
Assets, Long-term [Abstract]    
Trading securities $ 30 $ 30
Fair Value, Recurring [Member]    
Assets, Short-term [Abstract]    
Cash equivalents (money market funds) 784 1,355
Derivative instruments (foreign exchange contracts) 12 16
Assets, Long-term [Abstract]    
Trading securities 30 30
Other investments 25  
Total assets measured at fair value 851 1,401
Liabilities, Short-term [Abstract]    
Derivative instruments (foreign exchange contracts) 6 5
Liabilities, Long-term [Abstract]    
Deferred compensation liability 30 30
Total liabilities measured at fair value 36 35
Fair Value, Recurring [Member] | Quoted Prices in Active Markets for Identical Assets (Level 1) [Member]    
Assets, Short-term [Abstract]    
Cash equivalents (money market funds) 784 1,355
Derivative instruments (foreign exchange contracts) 0 0
Assets, Long-term [Abstract]    
Trading securities 30 30
Other investments 0  
Total assets measured at fair value 814 1,385
Liabilities, Short-term [Abstract]    
Derivative instruments (foreign exchange contracts) 0 0
Liabilities, Long-term [Abstract]    
Deferred compensation liability 0 0
Total liabilities measured at fair value 0 0
Fair Value, Recurring [Member] | Significant Other Observable Inputs (Level 2)    
Assets, Short-term [Abstract]    
Cash equivalents (money market funds) 0 0
Derivative instruments (foreign exchange contracts) 12 16
Assets, Long-term [Abstract]    
Trading securities 0 0
Other investments 25  
Total assets measured at fair value 37 16
Liabilities, Short-term [Abstract]    
Derivative instruments (foreign exchange contracts) 6 5
Liabilities, Long-term [Abstract]    
Deferred compensation liability 30 30
Total liabilities measured at fair value 36 35
Fair Value, Recurring [Member] | Significant Unobservable Inputs (Level 3)    
Assets, Short-term [Abstract]    
Cash equivalents (money market funds) 0 0
Derivative instruments (foreign exchange contracts) 0 0
Assets, Long-term [Abstract]    
Trading securities 0 0
Other investments 0  
Total assets measured at fair value 0 0
Liabilities, Short-term [Abstract]    
Derivative instruments (foreign exchange contracts) 0 0
Liabilities, Long-term [Abstract]    
Deferred compensation liability 0 0
Total liabilities measured at fair value $ 0 $ 0
XML 128 R73.htm IDEA: XBRL DOCUMENT v3.19.3.a.u2
INCOME TAXES - Current and long-term income tax assets and liabilities (Details) - USD ($)
$ in Millions
Oct. 31, 2019
Oct. 31, 2018
Income Tax Disclosure [Abstract]    
Current income tax assets (included within other current assets) $ 68 $ 59
Long-term income tax assets (included within other assets) 4 19
Current income tax liabilities (included within other accrued liabilities) 292 71
Long-term income tax liabilities (included within other long-term liabilities) 328 607
Total $ 548 $ 600
XML 129 R77.htm IDEA: XBRL DOCUMENT v3.19.3.a.u2
PROPERTY, PLANT AND EQUIPMENT, NET (Details) - USD ($)
$ in Millions
 12 Months Ended
Oct. 31, 2019
Oct. 31, 2018
Oct. 31, 2017
Nov. 01, 2018
Property, Plant and Equipment [Line Items]        
Land $ 57 $ 55    
Buildings and leasehold improvements 1,012 952    
Machinery and equipment 546 512    
Software 160 141    
Total property, plant and equipment 1,775 1,660    
Accumulated depreciation and amortization (925) (838)    
Property, plant and equipment, net 850 822   $ 822
Tangible Asset Impairment Charges 0 1 $ 0  
Depreciation expense 111 $ 102 $ 94  
Fully depreciated assets no longer in use $ 23      
XML 130 R87.htm IDEA: XBRL DOCUMENT v3.19.3.a.u2
DERIVATIVES, Fair value of derivative instruments and Consolidated Balance Sheet location (Details) - USD ($)
$ in Millions
Oct. 31, 2019
Oct. 31, 2018
Derivative, Fair Value, Net [Abstract]    
Derivative Asset, Fair Value $ 12 $ 16
Derivative Liability, Fair Value 6 5
Derivatives Not Designated as Hedging Instruments | Foreign Exchange Contracts [Member] | Other Current Assets [Member]    
Derivative, Fair Value, Net [Abstract]    
Derivative Asset, Fair Value 9 5
Derivatives Not Designated as Hedging Instruments | Foreign Exchange Contracts [Member] | Accrued Liabilities [Member]    
Derivative, Fair Value, Net [Abstract]    
Derivative Liability, Fair Value 4 4
Cash Flow Hedges | Derivatives Designated as Hedging Instrument | Foreign Exchange Contracts [Member] | Other Current Assets [Member]    
Derivative, Fair Value, Net [Abstract]    
Derivative Asset, Fair Value 3 11
Cash Flow Hedges | Derivatives Designated as Hedging Instrument | Foreign Exchange Contracts [Member] | Accrued Liabilities [Member]    
Derivative, Fair Value, Net [Abstract]    
Derivative Liability, Fair Value $ 2 $ 1
XML 131 R58.htm IDEA: XBRL DOCUMENT v3.19.3.a.u2
REVENUE - Revenue by Region (Details) - USD ($)
$ in Millions
 12 Months Ended
Oct. 31, 2019
Oct. 31, 2018
Oct. 31, 2017
Disaggregation of Revenue [Line Items]      
Net revenue $ 5,163 $ 4,914 $ 4,472
Americas      
Disaggregation of Revenue [Line Items]      
Net revenue 1,861    
Europe      
Disaggregation of Revenue [Line Items]      
Net revenue 1,441    
Asia Pacific      
Disaggregation of Revenue [Line Items]      
Net revenue 1,861    
Life Sciences and Applied Markets      
Disaggregation of Revenue [Line Items]      
Net revenue 2,302 2,270 2,081
Life Sciences and Applied Markets | Americas      
Disaggregation of Revenue [Line Items]      
Net revenue 692    
Life Sciences and Applied Markets | Europe      
Disaggregation of Revenue [Line Items]      
Net revenue 551    
Life Sciences and Applied Markets | Asia Pacific      
Disaggregation of Revenue [Line Items]      
Net revenue 1,059    
Diagnostics and Genomics      
Disaggregation of Revenue [Line Items]      
Net revenue 1,021 943 860
Diagnostics and Genomics | Americas      
Disaggregation of Revenue [Line Items]      
Net revenue 505    
Diagnostics and Genomics | Europe      
Disaggregation of Revenue [Line Items]      
Net revenue 368    
Diagnostics and Genomics | Asia Pacific      
Disaggregation of Revenue [Line Items]      
Net revenue 148    
Agilent CrossLab      
Disaggregation of Revenue [Line Items]      
Net revenue 1,840 $ 1,701 $ 1,531
Agilent CrossLab | Americas      
Disaggregation of Revenue [Line Items]      
Net revenue 664    
Agilent CrossLab | Europe      
Disaggregation of Revenue [Line Items]      
Net revenue 522    
Agilent CrossLab | Asia Pacific      
Disaggregation of Revenue [Line Items]      
Net revenue $ 654    
XML 132 R54.htm IDEA: XBRL DOCUMENT v3.19.3.a.u2
ACQUISITIONS - Text (Details) - USD ($)
$ in Millions
 12 Months Ended
Oct. 31, 2019
Oct. 31, 2018
Oct. 31, 2017
Business Acquisition [Line Items]      
Net revenue $ 5,163 $ 4,914 $ 4,472
Net income 1,071 $ 316 $ 684
Cash payment to acquire business 107    
ACEA Biosciences, Inc. [Member]      
Business Acquisition [Line Items]      
Purchase price for acquisition 250    
BioTek [Member]      
Business Acquisition [Line Items]      
Purchase price for acquisition 1,170    
Net revenue 35    
Net income (12)    
Cash payment to acquire business 470    
Liability incurred to pay for acquisition 700    
Acquisition transaction costs 4    
Estimated costs to complete in-process research and development projects $ 2    
XML 133 R50.htm IDEA: XBRL DOCUMENT v3.19.3.a.u2
OVERVIEW AND SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Details) - USD ($)
$ in Millions
 12 Months Ended
Mar. 02, 2016
Oct. 31, 2019
Oct. 31, 2018
Oct. 31, 2017
Goodwill and Intangible Assets        
Goodwill impairment   $ 0 $ 0 $ 0
Impairment of indefinite-lived intangible assets   0 0 0
Share-based Payment Arrangement, Noncash Expense [Abstract]        
Share-based compensation expense   72 71 61
Advertising Expense        
Advertising costs expensed as incurred   36 41 38
Cash and Cash Equivalents        
Cash and cash equivalents held outside the U.S.   1,310    
Variable Interest Entity        
Remeasurement Gain on step acquisition   0 20 0
Variable interest entity   0 0  
Fair Value Disclosures        
Equity Method Investments   0 0  
Fair value of long term debt in excess of carrying value     $ 15  
Fair value lower than carrying value   $ 62    
Accounts Receivable        
Maximum percentage of accounts receivable a single customer accounts for   less than 10 percent less than 10 percent  
Derivative Instruments        
Hedging contracts general maturity   12 months    
Long -Lived Assets        
Lease renewal options   6 years    
Lease receivable   $ 37 $ 32  
operating lease net assets   17 20  
Impairment of finite-lived intangible assets   0 21 0
Employee Compensation and Benefits        
Employee compensation and benefits accrued   115 107  
Foreign Currency Translation        
Foreign currency translation net gain (Ioss)   $ (7) (3) $ (2)
Lasergen [Member]        
Variable Interest Entity        
Cost method investments, original cost $ 80      
Ownership percentage 48.00%      
Purchase price for acquisition     107  
Remeasurement Gain on step acquisition     $ 20  
Minimum        
Goodwill and Intangible Assets        
Finite Lived Intangible Assets Useful Life   6 months    
Long -Lived Assets        
Operating Lease Term - Minimum   1 year    
Minimum | Machinery and Equipment [Member]        
Long -Lived Assets        
Property, Plant and Equipment, Useful Life   3 years    
Minimum | Software Development [Member]        
Long -Lived Assets        
Property, Plant and Equipment, Useful Life   3 years    
Maximum        
Goodwill and Intangible Assets        
Finite Lived Intangible Assets Useful Life   15 years    
Long -Lived Assets        
Operating Lease Term - Minimum   30 years    
Maximum | Machinery and Equipment [Member]        
Long -Lived Assets        
Property, Plant and Equipment, Useful Life   10 years    
Maximum | Software Development [Member]        
Long -Lived Assets        
Property, Plant and Equipment, Useful Life   5 years    
XML 134 R31.htm IDEA: XBRL DOCUMENT v3.19.3.a.u2
OVERVIEW AND SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Policies)
 12 Months Ended
Oct. 31, 2019
Accounting Policies [Abstract]  
Business description and basis of presentation

Overview.    Agilent Technologies, Inc. ("we", "Agilent" or the "company"), incorporated in Delaware in May 1999, is a global leader in life sciences, diagnostics and applied chemical markets, providing application focused solutions that include instruments, software, services and consumables for the entire laboratory workflow.

Basis of Presentation.    The accompanying consolidated financial statements have been prepared by us pursuant to the rules and regulations of the U.S. Securities and Exchange Commission ("SEC") and is in conformity with U.S. generally accepted accounting principles ("GAAP"). Our fiscal year end is October 31. Unless otherwise stated, all years and dates refer to our fiscal year.
Principles of consolidation
Principles of Consolidation.    The consolidated financial statements include the accounts of the company and our wholly- and majority-owned subsidiaries. All significant intercompany accounts and transactions have been eliminated.
Use of estimates
Use of Estimates.    The preparation of financial statements in accordance with U.S. GAAP requires management to make estimates and assumptions that affect the amounts reported in our consolidated financial statements and accompanying notes. Management bases its estimates on historical experience and various other assumptions believed to be reasonable. Although these estimates are based on management's best knowledge of current events and actions that may impact the company in the future, actual results may be different from the estimates. Our critical accounting policies are those that affect our financial statements materially and involve difficult, subjective or complex judgments by management. Those policies are revenue recognition, valuation of goodwill and purchased intangible assets, inventory valuation, retirement and post-retirement plan assumptions and accounting for income taxes.
Retirement of treasury shares
Retirement of Treasury Shares. Upon the formal retirement of treasury shares, we deduct the par value of the retired treasury shares from common stock and allocate the excess of cost over par as a deduction to additional paid-in capital, based on the pro-rata portion of additional paid-in-capital, and the remaining excess as a deduction to retained earnings. All retired treasury shares revert to the status of authorized but unissued shares.
Revenue recognition
Revenue Recognition.    We enter into contracts to sell products, services or combinations of products and services. Products may include hardware or software and services may include one-time service events or services performed over time.

We derive revenue primarily from the sale of analytical and diagnostics products and services. A performance obligation is a promise in a contract to transfer a distinct product or service to a customer and is the unit of account under Accounting Standard Codification Topic 606, Revenue from Contracts with Customers (“ASC 606’’). See also Note 2, "New Accounting Pronouncements" and Note 4, "Revenue" for additional information on revenue recognition.

Revenue is recognized when control of the promised products or services is transferred to our customers and the performance obligation is fulfilled in an amount that reflects the consideration that we expect to be entitled in exchange for those products or services, the transaction price. For equipment, consumables, and most software licenses, control transfers to the customer at a point in time. We use present right to payment, legal title, physical possession of the asset, and risks and rewards of ownership as indicators to determine the transfer of control to the customer. Where acceptance is not a formality, the customer must have documented their acceptance of the product or service. For products that include installation, if the installation meets the criteria to be considered a separate performance obligation, product revenue is recognized when control has passed to the customer, and recognition of installation revenue occurs once completed. Product revenue, including sales to resellers and distributors is reduced for provisions for warranties, returns, and other adjustments in the period the related sales are recorded.

Service revenue includes extended warranty, customer and software support including: Software as a Service, post contract support, consulting including companion diagnostics, and training and education. Instrument service contracts and software maintenance contracts are typically annual contracts, which are billed at the beginning of the contract or maintenance period. Revenue for these contracts is recognized on a straight-line basis to revenue over the service period, as a time-based measure of progress best reflects our performance in satisfying this obligation. There are no deferred costs associated with the service contract, as the cost of the service is recorded when the service is performed. Service calls not included in a support contract are recognized to revenue at the time a service is performed.

We have sales from standalone software. These arrangements typically include software licenses and maintenance contracts, both of which we have determined are distinct performance obligations. We determine the amount of the transaction price to allocate to the license and maintenance contract based on the relative standalone selling price of each performance obligation. Software license revenue is recognized at the point in time when control has been transferred to the customer. The revenue allocated to the software maintenance contract is recognized on a straight-line basis over the maintenance period, which is the contractual term of the contract, as a time-based measure of progress best reflects our performance in satisfying this obligation. Unspecified rights to software upgrades are typically sold as part of the maintenance contract on a when-and-if-available basis.

Our multiple-element arrangements are generally comprised of a combination of instruments, installation or other start-up services, and/or software, and/or support or services. Hardware and software elements are typically delivered at the same time and revenue is recognized when control passes to the customer. Service revenue is deferred and recognized over the contractual period or as services are rendered and accepted by the customer. Our arrangements generally do not include any provisions for cancellation, termination, or refunds that would significantly impact recognized revenue.

For contracts with multiple performance obligations, we allocate the consideration to which we expect to be entitled to each performance obligation based on relative standalone selling prices and recognize the related revenue when or as control of each individual performance obligation is transferred to customers. We estimate the standalone selling price by calculating the average historical selling price of our products and services per country for each performance obligation. Standalone selling prices are determined for each distinct good or service in the contract and then we allocate the transaction price in proportion to those standalone selling prices by performance obligations.

A portion of our revenue relates to lease arrangements. Standalone lease arrangements are outside the scope of ASC 606 and are therefore accounted for in accordance with ASC 840, Leases. Each of these contracts is evaluated as a lease arrangement, either as an operating lease or a sales-type capital lease using the current lease classification guidance.

Deferred Revenue.    Contract liabilities (deferred revenue) primarily relate to multiple element arrangements for which billing has occurred but transfer of control of all elements (performance obligations) to the customer has either partially or not occurred at the balance sheet date. This includes cash received from customers for products and related installation and services in advance of the transfer of control. Contract liabilities are classified as either in current liabilities in deferred revenue or long-term in other long-term liabilities in the consolidated balance sheet based on the timing of when we expect to complete our performance obligation.
Accounts receivable, net
Accounts Receivable, net.    Trade accounts receivable are recorded at the invoiced amount and do not bear interest. Such accounts receivable have been reduced by an allowance for doubtful accounts, which is our best estimate of the amount of probable credit losses in our existing accounts receivable. We determine the allowance based on customer specific experience and the aging of such receivables, among other factors. The allowance for doubtful accounts as of October 31, 2019 and 2018 was not material. We do not have any off-balance-sheet credit exposure related to our customers. Accounts receivable are also recorded net of estimated product returns which are not material.
Shipping and handling costs
Shipping and Handling Costs.  Our shipping and handling costs charged to customers are included in net revenue, and the associated expense is recorded in cost of products for all periods presented.
Inventory
Inventory.    Inventory is valued at standard cost, which approximates actual cost computed on a first-in, first-out basis, not in excess of market value. We assess the valuation of our inventory on a periodic basis and make adjustments to the value for estimated excess and obsolete inventory based on estimates about future demand. The excess balance determined by this analysis becomes the basis for our excess inventory charge. Our excess inventory review process includes analysis of sales forecasts, managing product rollovers and working with manufacturing to maximize recovery of excess inventory.
Acquisitions
Acquisitions. Agilent accounts for the acquisition of a business using the acquisition method of accounting and we allocate the fair value of the purchase price to the tangible assets acquired, liabilities assumed, and intangible assets acquired, including in-process research and development (“IPR&D”), based on their estimated fair values. The excess value of the cost of an acquired business over the fair value of the assets acquired and liabilities assumed is recognized as goodwill. The fair value of IPR&D is initially capitalized as an intangible asset with an indefinite life. When an IPR&D project is completed, the IPR&D is reclassified as an amortizable purchased intangible asset and amortized to costs of revenues over the asset’s estimated useful life.

Our determination of the fair value of the intangible assets acquired involves the use of significant estimates and assumptions. Specifically, our determination of the fair value of the developed product technology and IPR&D acquired involve significant estimates and assumptions related to revenue growth rates and discount rates. Our determination of the fair value of customer
relationships acquired involved significant estimates and assumptions related to revenue growth rates, discount rates, and customer attrition rates. Our determination of the fair value of the tradename acquired involved the use of significant estimates and assumptions related to revenue growth rates, royalty rates and discount rates. The company believes that the fair value assigned to the assets acquired and liabilities assumed are based on reasonable assumptions and estimates that marketplace participants would use. Actual results could differ materially from these estimates.

Goodwill and purchased intangible assets
Goodwill and Purchased Intangible Assets. Under the authoritative guidance we have the option to perform a qualitative assessment to determine whether further impairment testing is necessary. The accounting standard gives an entity the option to first assess qualitative factors to determine whether performing the two-step test is necessary. If an entity believes, as a result of its qualitative assessment, that it is more-likely-than-not (i.e. greater than 50% chance) that the fair value of a reporting unit is less than its carrying amount, the quantitative impairment test will be required. Otherwise, no further testing will be required.

The guidance includes examples of events and circumstances that might indicate that a reporting unit's fair value is less than its carrying amount. These include macro-economic conditions such as deterioration in the entity's operating environment or industry or market considerations; entity-specific events such as increasing costs, declining financial performance, or loss of key personnel; or other events such as an expectation that a reporting unit will be sold or a sustained decrease in the stock price on either an absolute basis or relative to peers.

If it is determined, as a result of the qualitative assessment, that it is more-likely-than-not that the fair value of a reporting unit is less than its carrying amount, the provisions of authoritative guidance require that we perform a two-step impairment test on goodwill. In the first step, we compare the fair value of each reporting unit to its carrying value. The second step (if necessary) measures the amount of impairment by applying fair-value-based tests to the individual assets and liabilities within each reporting unit. As defined in the authoritative guidance, a reporting unit is an operating segment, or one level below an operating segment. We aggregate components of an operating segment that have similar economic characteristics into our reporting units.

In fiscal year 2019, we assessed goodwill impairment for our three reporting units which consisted of three segments: life sciences and applied markets, diagnostics and genomics and Agilent CrossLab. We performed a qualitative test for goodwill impairment of the three reporting units, as of September 30, 2019, our annual impairment test date. Based on the results of our qualitative testing, we believe that it is more-likely-than-not that the fair value of each reporting unit is greater than its respective carrying value. Each quarter we review the events and circumstances to determine if goodwill impairment is indicated. There was no impairment of goodwill during the years ended October 31, 2019, 2018 and 2017.

Purchased intangible assets consist primarily of acquired developed technologies, proprietary know-how, trademarks, and customer relationships and are amortized using the best estimate of the asset's useful life that reflect the pattern in which the economic benefits are consumed or used up or a straight-line method ranging from 6 months to 15 years. IPR&D is initially capitalized at fair value as an intangible asset with an indefinite life and assessed for impairment thereafter. When the IPR&D project is complete, it is reclassified as an amortizable purchased intangible asset and is amortized over its estimated useful life. If an IPR&D project is abandoned, Agilent will record a charge for the value of the related intangible asset to Agilent's consolidated statement of operations in the period it is abandoned.

Agilent's indefinite-lived intangible assets are IPR&D intangible assets. The accounting guidance allows a qualitative approach for testing indefinite-lived intangible assets for impairment, similar to the issued impairment testing guidance for goodwill and allows the option to first assess qualitative factors (events and circumstances) that could have affected the significant inputs used in determining the fair value of the indefinite-lived intangible asset to determine whether it is more-likely-than-not (i.e. greater than 50% chance) that the indefinite-lived intangible asset is impaired. An organization may choose to bypass the qualitative assessment for any indefinite-lived intangible asset in any period and proceed directly to calculating its fair value. We performed a qualitative test for impairment of indefinite-lived intangible assets as of September 30, 2019. Based on the results of our qualitative testing, we believe that it is more-likely-than-not that the fair value of these indefinite-lived intangible assets is greater than their respective carrying values. Each quarter we review the events and circumstances to determine if impairment of indefinite-lived intangible asset is indicated. During the year ended October 31, 2019, 2018 and 2017 there were no impairments of indefinite-lived intangible assets.
Share-based compensation
Share-Based Compensation.    For the years ended 2019, 2018 and 2017, we accounted for share-based awards made to our employees and directors including employee stock option awards, restricted stock units, employee stock purchases made under our Employee Stock Purchase Plan ("ESPP") and performance share awards under Agilent Technologies, Inc. Long-Term Performance Program ("LTPP") using the estimated grant date fair value method of accounting. Under the fair value method, we recorded compensation expense for all share-based awards of $72 million in 2019, $71 million in 2018 and $61 million in 2017. See Note 5, "Share-based Compensation" for additional information.
Retirement and post-retirement plans

Retirement and Post-Retirement Plans. Substantially all of our employees are covered under various defined benefit and/or defined contribution retirement plans. Additionally, we sponsor post-retirement health care benefits for our eligible U.S. employees. Assumptions used to determine the benefit obligations and the expense for these plans are derived annually. See Note 14, “Retirement plans and post-retirement pension plans” for additional information.
Taxes on income Taxes on Income.    Income tax expense or benefit is based on income or loss before taxes. Deferred tax assets and liabilities are recognized principally for the expected tax consequences of temporary differences between the tax bases of assets and liabilities and their reported amounts. See Note 6, "Income Taxes" for more information
Warranty
Warranty.    Our standard warranty terms typically extend for one year from the date of delivery. We accrue for standard warranty costs based on historical trends in warranty charges as a percentage of net product revenue. The accrual is reviewed regularly and periodically adjusted to reflect changes in warranty cost estimates. Estimated warranty charges are recorded within cost of products at the time products are sold. See Note 15, "Guarantees".
Advertising
Advertising.    Advertising costs are generally expensed as incurred and amounted to $36 million in 2019, $41 million in 2018 and $38 million in 2017.
Research and development
Research and Development.    Costs related to research, design and development of our products are charged to research and development expense as they are incurred.
Sales taxes
Sales Taxes.    Sales taxes collected from customers and remitted to governmental authorities are not included in our revenue.
Net income (loss) per share
Net Income Per Share.    Basic net income per share is computed by dividing net income - the numerator - by the weighted average number of common shares outstanding - the denominator - during the period excluding the dilutive effect of stock options and other employee stock plans. Diluted net income per share gives effect to all potential common shares outstanding during the period unless the effect is anti-dilutive. The dilutive effect of share-based awards is reflected in diluted net income per share by application of the treasury stock method, which includes consideration of unamortized share-based compensation expense and the dilutive effect of in-the-money options and non-vested restricted stock units. Under the treasury stock method, the amount the employee must pay for exercising stock options and unamortized share-based compensation expense are assumed proceeds to be used to repurchase hypothetical shares. See Note 7, "Net Income Per Share".
Cash, cash equivalents and short term investments
Cash, Cash Equivalents and Short-Term Investments.  We classify investments as cash equivalents if their original or remaining maturity is three months or less at the date of purchase. Cash equivalents are stated at cost, which approximates fair value.

As of October 31, 2019, approximately $1,310 million of our cash and cash equivalents is held outside of the U.S. by our foreign subsidiaries. Our cash and cash equivalents mainly consist of short-term deposits held at major global financial institutions, institutional money market funds, and similar short duration instruments with original maturities of 90 days or less. We continuously monitor the creditworthiness of the financial institutions and institutional money market funds in which we invest our funds.

We classify investments as short-term investments if their original maturities are greater than three months and their remaining maturities are one year or less. Currently, we have no short-term investments.
Variable interest entity
Variable Interest Entities. We make a determination upon entering into an arrangement whether an entity in which we have made an investment is considered a Variable Interest Entity (“VIE”).  The company evaluates its investments in privately held companies on an ongoing basis. We account for these investments under either the equity method or as equity investments without determinable fair value, depending on the circumstances. We periodically reassess whether we are the primary beneficiary of a VIE. The reassessment process considers whether we have acquired the power to direct the most significant activities of the VIE through changes in governing documents or other circumstances. We also reconsider whether entities previously determined not to be VIEs have become VIEs, based on changes in facts and circumstances including changes in contractual arrangements and capital structure.

During the year ended October 31, 2016, Agilent made a preferred stock investment in Lasergen, Inc. ("Lasergen") for $80 million. This investment in Lasergen was accounted for under the cost method. Agilent’s initial ownership stake was 48 percent and included an option to acquire the remaining shares until March 2018. During the year ended October 31, 2018, we exercised our option and acquired all of the remaining shares of Lasergen that we did not already own for an additional cash consideration of approximately $107 million. The fair value remeasurement of our previous investment immediately before the acquisition
resulted in a net gain of $20 million and was recorded in other income. Lasergen was previously considered a VIE. As of October 31, 2019 and 2018, we have no material VIE's.
Investments
Investments. Equity investments without readily determinable fair value consist of non-marketable equity securities (typically investments in privately-held companies). These investments are accounted for using the measurement alternative at cost and we adjust for impairments and observable price changes (orderly transactions for the identical or a similar security from the same issuer) included in net income as and when it occurs. Equity investments with readily determinable fair value consist of shares we own in a special fund and are reported at fair value, with gains or losses resulting from changes in fair value included in net income. Prior to fiscal year 2019, both equity investments without determinable fair value and with determinable fair value were accounted for using cost method of accounting, measured at historical cost less other-than-temporary investment. Trading securities, which is comprised of mutual funds, bonds and other similar instruments, other investments and deferred compensation liability are reported at fair value, with gains or losses resulting from changes in fair value recognized currently in net income. Equity method investments are reported at the amount of the company’s initial investment and adjusted each period for the company’s share of the investee’s income or loss and dividend paid. There are no equity method investments as of October 31, 2019 and 2018. The company assesses investments for impairment whenever events or changes in circumstances indicate that the carrying value of an investment may not be recoverable.
Fair value of financial instruments
Fair Value of Financial Instruments. The carrying values of certain of our financial instruments including cash and cash equivalents, accounts receivable, accounts payable, accrued compensation and other accrued liabilities approximate fair value because of their short maturities. The fair value of long-term equity investments which are readily determinable, and which are not accounted under the equity method are reported at fair value using quoted market prices for those securities when available with gains and losses included in net income. The fair value of long-term equity investments which are not readily determinable, and which are not accounted under the equity method are reported at cost with adjustments for observable changes in prices or impairments included in net income. The fair value of our senior notes, calculated from quoted prices which are primarily Level 1 inputs under the accounting guidance fair value hierarchy exceeds the carrying value by approximately $62 million as of October 31, 2019 and is lower than the carrying value by approximately $15 million as of October 31, 2018. The change in the fair value over carrying value in the year ended October 31, 2019 is primarily due to fluctuations in market interest rates. The fair value of foreign currency contracts used for hedging purposes is estimated internally by using inputs tied to active markets. These inputs, for example, interest rate yield curves, foreign exchange rates, and forward and spot prices for currencies are observable in the market or can be corroborated by observable market data for substantially the full term of the assets or liabilities. See also Note 12, "Fair Value Measurements" for additional information on the fair value of financial instruments.
Concentration of credit risk
Concentration of Credit Risk.    Financial instruments that potentially subject Agilent to significant concentration of credit risk include money market fund investments, time deposits and demand deposit balances. These investments are categorized as cash and cash equivalents. In addition, Agilent has credit risk from derivative financial instruments used in hedging activities and accounts receivable. We invest in a variety of financial instruments and limit the amount of credit exposure with any one financial institution. We have a comprehensive credit policy in place and credit exposure is monitored on an ongoing basis.

Credit risk with respect to our accounts receivable is diversified due to the large number of entities comprising our customer base and their dispersion across many different industries and geographies. Credit evaluations are performed on customers requiring credit over a certain amount and we sell the majority of our products through our direct sales force. Credit risk is mitigated through collateral such as letter of credit, bank guarantees or payment terms like cash in advance. No single customer accounted for more than 10 percent of accounts receivable as of October 31, 2019, or 2018.
Derivative instruments
Derivative Instruments.    Agilent is exposed to global foreign currency exchange rate and interest rate risks in the normal course of business. We enter into foreign exchange hedging contracts, primarily forward contracts and purchased options, interest rate swaps and interest rate locks to manage financial exposures resulting from changes in foreign currency exchange rates and interest rates. In the vast majority of cases, these contracts are designated at inception as hedges of the related foreign currency or interest exposures. Foreign currency exposures include committed and anticipated revenue and expense transactions and assets and liabilities that are denominated in currencies other than the functional currency of the subsidiary. Interest rate exposures are associated with the company's fixed-rate debt. For option contracts, we exclude time value from the measurement of effectiveness. To qualify for hedge accounting, contracts must reduce the foreign currency exchange rate and interest rate risk otherwise inherent in the amount and duration of the hedged exposures and comply with established risk management policies. Foreign exchange hedging contracts generally mature within twelve months, interest rate swaps mature at the same time as the maturity of the debt and interest rate locks mature at the same time as the issuance of debt. In order to manage foreign currency exposures in a few limited jurisdictions we may enter into foreign exchange contracts that do not qualify for hedge accounting. In such circumstances, the local foreign currency exposure is offset by contracts owned by the parent company. We do not use derivative financial instruments for trading or speculative purposes.

All derivatives are recognized on the balance sheet at their fair values. For derivative instruments that are designated and qualify as a fair value hedge, changes in value of the derivative are recognized in the consolidated statement of operations in the current period, along with the offsetting gain or loss on the hedged item attributable to the hedged risk. For derivative instruments that are designated and qualify as a cash flow hedges, changes in the value of the effective portion of the derivative instrument is recognized in comprehensive income (loss), a component of stockholders' equity. Amounts associated with cash flow hedges are reclassified and recognized in income when either the forecasted transaction occurs or it becomes probable the forecasted transaction will not occur. Derivatives not designated as hedging instruments are recorded on the balance sheet at their fair value and changes in the fair values are recorded in the income statement in the current period. Derivative instruments are subject to master netting arrangements and are disclosed gross in the balance sheet. Changes in the fair value of the ineffective portion of derivative instruments are recognized in earnings in the current period. Ineffectiveness in 2019, 2018 and 2017 was not material. Cash flows from derivative instruments are classified in the statement of cash flows in the same category as the cash flows from the hedged or economically hedged item, primarily in operating activities.
Property, plant and equipment
Property, Plant and Equipment.    Property, plant and equipment are stated at cost less accumulated depreciation. Additions, improvements and major renewals are capitalized; maintenance, repairs and minor renewals are expensed as incurred. When assets are retired or disposed of, the assets and related accumulated depreciation and amortization are removed from our general ledger, and the resulting gain or loss is reflected in the consolidated statement of operations. Buildings and improvements are depreciated over the lesser of their useful lives or the remaining term of the lease and machinery and equipment over 3 years to 10 years. We use the straight-line method to depreciate assets.
Leases
Leases.    We lease buildings, machinery and equipment under operating and capital leases for original terms ranging generally from less than 1 year to 30 years. Certain leases contain renewal options for periods up to 6 years. In addition, we lease equipment to customers in connection with our diagnostics business using both capital and operating leases. As of October 31, 2019 and 2018 our diagnostics and genomics segment has approximately $37 million and $32 million, respectively, of lease receivables related to capital leases and approximately $17 million and $20 million, respectively, of net assets for operating leases.  We depreciate the assets related to the operating leases over their estimated useful lives, typically five years.
Capitalized software
Capitalized Software.    We capitalize certain internal and external costs incurred to acquire or create internal use software. Capitalized software is included in property, plant and equipment and is depreciated over 3 years to 5 years once development is complete.
Impairment of long-lived assets
Impairment of Long-Lived Assets.    We continually monitor events and changes in circumstances that could indicate carrying amounts of long-lived assets, including intangible assets, may not be recoverable. When such events or changes in circumstances occur, we assess the recoverability of long-lived assets by determining whether the carrying value of such assets will be recovered through undiscounted expected future cash flows. If the total of the undiscounted future cash flows is less than the carrying amount of those assets, we recognize an impairment loss based on the excess of the carrying amount over the fair value of the assets. During 2019, there were no impairments of other assets or intangible assets. During 2018, we recorded an impairment charge of $21 million related to purchased intangible assets within the diagnostics and genomics segment that were deemed unrecoverable. During 2017, there were no impairments of other assets or intangible assets.
Employee compensation and benefits
Employee Compensation and Benefits.    Amounts owed to employees, such as accrued salary, bonuses and vacation benefits are accounted for within employee compensation and benefits. The total amount of accrued vacation benefit was $115 million and $107 million as of October 31, 2019, and 2018, respectively.
Foreign currency translation
Foreign Currency Translation.    We translate and remeasure balance sheet and income statement items into U.S. dollars. For those subsidiaries that operate in a local currency functional environment, all assets and liabilities are translated into U.S. dollars using current exchange rates at the balance sheet date; revenue and expenses are translated using monthly exchange rates which approximate to average exchange rates in effect during each period. Resulting translation adjustments are reported as a separate component of accumulated other comprehensive income (loss) in stockholders' equity.

For those subsidiaries that operate in a U.S. dollar functional environment, foreign currency assets and liabilities are remeasured into U.S. dollars at current exchange rates except for non-monetary assets and capital accounts which are remeasured at historical exchange rates. Revenue and expenses are generally remeasured at monthly exchange rates which approximate average exchange rates in effect during each period. Gains or losses from foreign currency remeasurement are included in consolidated net income. Net gains or losses resulting from foreign currency transactions, including hedging gains and losses, are reported in other income (expense), net and were $7 million loss for 2019, $3 million loss for 2018 and $2 million loss for 2017.
XML 135 R35.htm IDEA: XBRL DOCUMENT v3.19.3.a.u2
SHARE-BASED COMPENSATION (Tables)
 12 Months Ended
Oct. 31, 2019
Share-based Payment Arrangement, Noncash Expense [Abstract]  
Allocated Share-based compensation expense disclosure
The impact on our results for share-based compensation was as follows:

 
Years Ended October 31,
 
2019
 
2018
 
2017
 
(in millions)
Cost of products and services
$
18

 
$
16

 
$
15

Research and development
7

 
7

 
6

Selling, general and administrative
47

 
48

 
40

Total share-based compensation expense
$
72

 
$
71

 
$
61
Share-based compensation arrangement by share-based payment award fair value assumptions and methodology schedule
The following assumptions were used to estimate the fair value of awards granted.

 
Years Ended October 31,
 
2019
 
2018
 
2017
LTPP:
 
 
 
 
 
Volatility of Agilent shares
22%
 
21%
 
23%
Volatility of selected peer-company shares
15%-66%
 
14%-66%
 
15%-63%
Pair-wise correlation with selected peers
30%
 
32%
 
36%
 
 
 
 
 
 
Post-vest restriction discount for all executive awards
5.0%
 
4.8%
 
5.3%
Summary of stock option award activity
The following table summarizes employee stock option award activity of our employees and directors for 2019.

 
Options
Outstanding
 
Weighted
Average
Exercise Price
 
(in thousands)
 
 
Outstanding at October 31, 2018
1,997

 
$
35

Exercised
(552
)
 
$
33

Forfeited
—

 
$
—

Outstanding at October 31, 2019
1,445

 
$
36
Schedule of share-based compensation, shares authorized under stock option plans, by exercise price range
The options outstanding and exercisable for equity share-based payment awards at October 31, 2019 were as follows:

 
Options Outstanding
 
Options Exercisable
Range of
Exercise Prices
Number
Outstanding
 
Weighted
Average
Remaining
Contractual
Life
 
Weighted
Average
Exercise
Price
 
Aggregate
Intrinsic
Value
 
Number
Exercisable
 
Weighted
Average
Remaining
Contractual
Life
 
Weighted
Average
Exercise
Price
 
Aggregate
Intrinsic
Value
 
(in thousands)
 
(in years)
 
 
 
(in thousands)
 
(in thousands)
 
(in years)
 
 
 
(in thousands)
$25.01 - 30
483

 
2.5
 
$
26

 
23,769

 
483

 
2.5
 
$
26

 
23,769

$30.01 - 40
296

 
4.1
 
$
39

 
10,845

 
296

 
4.1
 
$
39

 
10,845

$40.01 - over
666

 
5.0
 
$
41

 
23,211

 
666

 
5.0
 
$
41

 
23,211

 
1,445

 
4.0
 
$
36

 
$
57,825

 
1,445

 
4.0
 
$
36

 
$
57,825
Schedule of intrinsic value of options exercised and the fair value of options granted
The following table summarizes the aggregate intrinsic value of options exercised in 2019, 2018 and 2017:

 
Aggregate
Intrinsic Value
 
Weighted
Average
Exercise
Price
 
(in thousands)
 
 
Options exercised in fiscal 2017
$
36,175

 
$
30

Options exercised in fiscal 2018
$
28,417

 
$
32

Options exercised in fiscal 2019
$
24,409

 
$
33
Non-vested award activity disclosure
The following table summarizes non-vested award activity in 2019 primarily for our LTPP and restricted stock unit awards.
 
Shares
 
Weighted
Average
Grant Price
 
(in thousands)
 
 
Non-vested at October 31, 2018
3,181

 
$
57

Granted
1,309

 
$
68

Vested
(1,530
)
 
$
45

Forfeited
(78
)
 
$
60

Change in LTPP shares in the year due to exceeding performance targets
291

 
$
—

Non-vested at October 31, 2019
3,173

 
$
60
XML 136 R6.htm IDEA: XBRL DOCUMENT v3.19.3.a.u2
CONSOLIDATED BALANCE SHEET (Parenthetical) - $ / shares
shares in Millions
Oct. 31, 2019
Oct. 31, 2018
Stockholders' equity:    
Preferred stock par value (in dollars per share) $ 0.01 $ 0.01
Preferred stock shares authorized (in shares) 125 125
Preferred Stock, Shares Issued (in shares) 0 0
Preferred Stock, Shares Outstanding (in shares) 0 0
Common stock par value (in dollars per share) $ 0.01 $ 0.01
Common stock shares authorized (in shares) 2,000 2,000
Common stock issued (in shares) 309 318
XML 137 R2.htm IDEA: XBRL DOCUMENT v3.19.3.a.u2
CONSOLIDATED STATEMENT OF OPERATIONS - USD ($)
shares in Millions, $ in Millions
 12 Months Ended
Oct. 31, 2019
Oct. 31, 2018
Oct. 31, 2017
Net revenue:      
Net revenue $ 5,163 $ 4,914 $ 4,472
Costs and expenses:      
Cost of revenue 2,358 2,234 2,073
Research and development 404 387 341
Selling, general and administrative 1,460 1,389 1,251
Total costs and expenses 4,222 4,010 3,665
Income from operations 941 904 807
Interest income 36 38 22
Interest expense (74) (75) (79)
Other income (expense), net 16 79 53
Income before taxes 919 946 803
Provision (benefit) for income taxes (152) 630 119
Net income $ 1,071 $ 316 $ 684
Net income per share:      
Net income per share - basic $ 3.41 $ 0.98 $ 2.12
Net income per share - diluted $ 3.37 $ 0.97 $ 2.10
Weighted Averge Shares Used In Computing Net Income Per Share      
Basic (in shares) 314 321 322
Diluted (in shares) 318 325 326
Products      
Net revenue:      
Net revenue $ 3,877 $ 3,746 $ 3,397
Costs and expenses:      
Cost of revenue 1,680 1,595 1,473
Services and Other      
Net revenue:      
Net revenue 1,286 1,168 1,075
Costs and expenses:      
Cost of revenue $ 678 $ 639 $ 600
XML 138 R39.htm IDEA: XBRL DOCUMENT v3.19.3.a.u2
PROPERTY, PLANT AND EQUIPMENT, NET (Tables)
 12 Months Ended
Oct. 31, 2019
Property, Plant and Equipment [Abstract]  
Property, Plant and Equipment

 
October 31,
 
2019
 
2018
 
(in millions)
Land
$
57

 
$
55

Buildings and leasehold improvements
1,012

 
952

Machinery and equipment
546

 
512

Software
160

 
141

Total property, plant and equipment
1,775

 
1,660

Accumulated depreciation and amortization
(925
)
 
(838
)
Property, plant and equipment, net
$
850

 
$
822
XML 139 R16.htm IDEA: XBRL DOCUMENT v3.19.3.a.u2
NET INCOME (LOSS) PER SHARE
 12 Months Ended
Oct. 31, 2019
Earnings Per Share [Abstract]  
NET INCOME (LOSS) PER SHARE NET INCOME PER SHARE

The following is a reconciliation of the numerators and denominators of the basic and diluted net income per share computations for the periods presented below.
 
Years Ended October 31,
 
2019
 
2018
 
2017
 
(in millions)
Numerator:
 
 
 
 
 
Net income
$
1,071

 
$
316

 
$
684

Denominators:
 
 
 
 
 
Basic weighted average shares
314

 
321

 
$
322

Potential common shares — stock options and other employee stock plans
4

 
4

 
4

Diluted weighted average shares
318

 
325

 
326


The dilutive effect of share-based awards is reflected in diluted net income per share by application of the treasury stock method, which includes consideration of unamortized share-based compensation expense and the dilutive effect of in-the-money options and non-vested restricted stock units. Under the treasury stock method, the amount the employee must pay for exercising stock options and unamortized share-based compensation expense collectively are assumed proceeds to be used to repurchase hypothetical shares. An increase in the fair market value of the company's common stock can result in a greater dilutive effect from potentially dilutive awards.

We exclude stock options with exercise prices greater than the average market price of our common stock from the calculation of diluted earnings per share because their effect would be anti-dilutive. In addition, we exclude from the calculation of diluted earnings per share, stock options, ESPP, LTPP and restricted stock awards whose combined exercise price and unamortized fair value collectively were greater than the average market price of our common stock because their effect would also be anti-dilutive.

In 2019, 2018 and 2017, we issued approximately 2 million, 2 million and 3 million, of share-based awards, respectively.  For the years ended 2019, 2018 and 2017, the impact of the anti-dilutive potential common shares that were excluded from the calculation of diluted earnings per share was not material.
XML 140 R12.htm IDEA: XBRL DOCUMENT v3.19.3.a.u2
ACQUISITIONS (Notes)
 12 Months Ended
Oct. 31, 2019
Business Combinations [Abstract]  
Acquisitions Disclosure ACQUISITIONS

Acquisition of BioTek and ACEA

On August 23, 2019 we completed the acquisition of privately-owned Lionheart Technologies LLC ("BioTek"), a leader in the design, manufacture and distribution of innovative life science instrumentation for $1.17 billion, under the merger agreement. As a result of the acquisition, BioTek has become a wholly-owned subsidiary of Agilent. Accordingly, the results of BioTek are included in Agilent's consolidated financial statements from the acquisition date. For the period from August 24, 2019 to October 31, 2019, BioTek’s net revenue was $35 million and net loss was $12 million. The acquisition of BioTek and its portfolio is another step to expand our position in the cell analysis market.

The consideration paid was $1.17 billion. Agilent funded the acquisition using existing cash of $470 million and debt of $700 million.

The BioTek acquisition was accounted for in accordance with the authoritative accounting guidance. The acquired assets and assumed liabilities were recorded by Agilent at their estimated fair values. Agilent determined the estimated fair values with the assistance of appraisals or valuations performed by third party specialists, discounted cash flow analyses, and estimates made by management. We expect to realize revenue synergies, leverage and expand the existing sales channels and product development resources, and utilize the assembled workforce. These factors, among others, contributed to a purchase price in excess of the estimated fair value of BioTek’s net identifiable assets acquired (see summary of net assets below), and, as a result, we have recorded goodwill in connection with this transaction.
 
Goodwill acquired was allocated to our operating segments and reporting units as a part of the purchase price allocation. All goodwill was allocated to the life sciences and applied markets reporting unit.

Agilent’s acquisition of BioTek is treated as an asset purchase for tax purposes. The tax basis of the acquired assets equals the fair market value on acquisition date.

The following table summarizes the allocation of the purchase price to the estimated fair values of the assets acquired and liabilities assumed on the closing date of August 23, 2019 (in millions):
Cash and cash equivalents
 
 
$
10

 
Accounts receivable
 
 
28

 
Inventories
 
 
21

 
Other current assets
 
 
2

 
Property, plant and equipment
 
 
8

 
Intangible assets
 
 
641

 
Goodwill
 
 
483

 
Total assets acquired
 
1,193
 
 
Accounts payable
 
 
(4
)
 
Deferred revenue
 
 
(5
)
 
Employee compensation and benefits
 
 
(7
)
 
Other accrued liabilities
 
 
(2
)
 
Long-term debt
 
 
(4
)
 
Net assets acquired
 
 
$
1,171

 



The fair value of cash and cash equivalents, accounts receivable, other current assets, accounts payable and other accrued liabilities were generally determined using historical carrying values given the short-term nature of these assets and liabilities.
 
The fair values for acquired intangible assets and deferred revenue were determined with the input from third party valuation specialists.
 
The fair values of certain other assets, inventory, property, plant and equipment, investments, long-term debt, and certain other long-term liabilities were determined internally using historical carrying values and estimates made by management.
 
Valuations of intangible assets acquired
 
The components of intangible assets acquired in connection with the BioTek acquisition were as follows (in millions):

 
Fair Value
 
Estimated
Useful Life
Developed product technology
 
$
387

 
 
5-13 years
Customer relationships
 
202

 
 
3-8 years
Backlog
 
5

 
 
2 months
Tradenames and trademarks
 
43

 
 
10 years
Total intangible assets subject to amortization
 
637

 
 
 
In-process research and development
 
4

 
 
 
Total intangible assets
 
$
641

 
 
 


As noted above, the intangible assets, including in-process research and development, were valued with input from valuation specialists. Agilent used variations of the income approach in determining the fair value of intangible assets acquired in the BioTek acquisition. Specifically, the developed product technology and in-process research and development were valued using the multi-period excess earnings method under the income approach by discounting forecasted cash flows directly related to the products expecting to result from the projects, net of returns on contributory assets. The Company utilized the incremental cash flow method for determining the fair value of the customer relationships acquired, and the relief from royalty method to determine the fair value of the tradename. Order backlog was valued on a direct cash flow basis.

The primary in-process research and development project acquired relates to a next version of a product which will be released in 2020. Total costs to complete for all BioTek in-process research and development were estimated at approximately $2 million as of the close date.

Acquisition and integration costs directly related to the BioTek acquisition totaled $4 million for the year ended October 31, 2019 and were recorded in selling, general and administrative expenses. Such costs are expensed in accordance with the authoritative accounting guidance.


On November 14, 2018, we acquired 100 percent of the stock of ACEA Biosciences (“ACEA”), a developer of cell analysis tools, for $250 million. The financial results of ACEA have been included in our financial results from the acquisition date.
 
The following represents the unaudited proforma operating results as if BioTek and ACEA had been included in the company's consolidated statements of operations as of the beginning of fiscal 2018 (in millions, except per share amounts):

 
2019
 
2018
Net revenue
$
5,308

 
$
5,112

Net income
$
1,012

 
$
210

Net income per share — basic
$
3.22

 
$
0.65

Net income per share — diluted
$
3.18

 
$
0.65



The unaudited proforma financial information assumes that the companies were combined as of November 1, 2017 and include business combination accounting effects from the acquisition including amortization charges from acquired intangible assets, the impact on cost of sales due to the respective estimated fair value adjustments to inventory, changes to interest income for cash used in the acquisition, interest expense and currency losses associated with debt paid in connection with the acquisition and acquisition related transaction costs and tax related effects. The proforma information as presented above is for informational purposes only and is not indicative of the results of operations that would have been achieved if the acquisition had taken place at the beginning of fiscal 2018.
 
The unaudited proforma financial information for the year ended October 31, 2019 combines the historical results of Agilent for the year ended October 31, 2019 (which includes BioTek and ACEA after the acquisition date) and for BioTek for the ten months ended August 23, 2019.
 
The unaudited proforma financial information for the year ended October 31, 2018 combines the historical results of Agilent and ACEA for the year ended October 31, 2018 and BioTek for the year ended December 31, 2018 (due to differences in reporting periods).

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